Psyllid ID: psy3151

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370--
Protein Sequence
MTPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRKNQSPS
Secondary Structure (PSIPRED)
ccccccccccccccccEEEccccccccccEEEEEEEEcccccEEEEEEEcccccHHHHHHHHHHHcccccEEEEEEEEccccccccEEEEEEEccccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccEEEEEccccEEEccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHccEEEccccccccccHHHHHHHHHHccccccccccHHHHHHccccccccccccccccHHHHHHccccccHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccHcHEEEccEEEccccccEEEEEEEcccccEEEEHEccccHHHHHHHHHHHHHcccccEEEEEccEEcccccccEEEEEEEcccccHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccccccccHEEEEcccccccEEEEccccccccccccccccccccEEEEccccEEEEEcccccEccccccHHHccHHHHHcccEccHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccHHHHHHHHHHHcccccHcEcHHHHHccccHEcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHEEEccccccccHHHHHHHHccccc
Coil and Loop (DISEMBL)
mtptfkpfkttpiqddydiSTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFlhdqniahrdvkpenllytkpgdggilkltdfgdvkpenllytkpgdggilklTDFGFAKKIVSnkaslqtpcytpyyvapevlgpdkydkscdiwSLGVIMYILLcgfppffsnhgqaispgmknrirlgqfdfpnpewehVSQEAKTLIKNmlcvdpserltiDQVMENKWIsqfnqvpqtplctgkmlkegeetwpEVQDEMTRSLATMRVDYDQIHIKSLInsknpllnkrrknqsps
Flexible Loop (DISEMBL)
mtptfkpfkttpiqddydISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQlavgshkhivniKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENllytkpgdggiLKLTDFGFAKKIVsnkaslqtpcYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKslinsknpllnkrrknqsps
Low Complexity Region (SEG)
MtptfkpfkttpIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRKNQSPS
Disordered region (IsUnstruct)
***********PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLK***************SLATMRVDYDQIHIKSLI*****************
Disordered Region (DISOPRED)
********KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ*******************QDEMTRSLATMRV*********************R******
Disordered Region (DISEMBL)
MTPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLN*********
Disordered Region (DISPRO)
****FKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRKNQSPS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	372	2.2.26 [Sep-21-2011]
P49071	359	MAP kinase-activated prot	yes	N/A	0.897	0.930	0.654	1e-138
P49139	366	MAP kinase-activated prot	no	N/A	0.900	0.915	0.6	1e-124
Q16644	382	MAP kinase-activated prot	yes	N/A	0.908	0.884	0.598	1e-124
P49137	400	MAP kinase-activated prot	no	N/A	0.900	0.837	0.597	1e-123
P49138	386	MAP kinase-activated prot	yes	N/A	0.900	0.867	0.588	1e-123
Q66H84	384	MAP kinase-activated prot	no	N/A	0.908	0.880	0.590	1e-122
Q3SYZ2	384	MAP kinase-activated prot	no	N/A	0.908	0.880	0.593	1e-122
Q3UMW7	384	MAP kinase-activated prot	no	N/A	0.908	0.880	0.590	1e-122
P49136	329	MAP kinase-activated prot	N/A	N/A	0.852	0.963	0.602	1e-118
Q8IW41	473	MAP kinase-activated prot	no	N/A	0.876	0.689	0.375	7e-63

>sp|P49071|MAPK2_DROME MAP kinase-activated protein kinase 2 OS=Drosophila melanogaster GN=MAPk-Ak2 PE=2 SV=1

 Score =  493 bits (1268), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 235/359 (65%), Positives = 276/359 (76%), Gaps = 25/359 (6%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           KTTP+ DDY  S  +LG GINGKV+Q   ++T + YALKVL D+ +ARREV+L   V   
Sbjct: 11  KTTPLTDDYVTSNTVLGYGINGKVVQCTHRRTQQNYALKVLLDSERARREVDLHWRVSGC 70

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           ++IVNI DVYEN +   +CLLV+MECM GGELFQRIQ K DGAFTEREAA IM+EIC+A+
Sbjct: 71  RYIVNIIDVYENTFKDRKCLLVVMECMEGGELFQRIQDKADGAFTEREAAQIMHEICAAV 130

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            +LH ++IAHRD+KPEN                        LLYT       LKLTDFGF
Sbjct: 131 DYLHSRDIAHRDLKPEN------------------------LLYTTTQPNATLKLTDFGF 166

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+  ++  +LQTPCYTPYYVAPEVLGP+KYDKSCDIWSLGV+MYI++CGFPPF+SNHG 
Sbjct: 167 AKETFTS-YTLQTPCYTPYYVAPEVLGPEKYDKSCDIWSLGVVMYIIMCGFPPFYSNHGL 225

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMKNRIR GQ+DFP+PEW +VSQ AK LIK ML VDPS+RL I  V+ NKWI+Q+N
Sbjct: 226 AISPGMKNRIRTGQYDFPDPEWTNVSQAAKDLIKGMLNVDPSKRLRIQDVISNKWIAQYN 285

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
            VPQTPLCTG+MLKE EETWPEVQ+EMTRSLATMRVDYDQ+ IK+L  S NPLL KRRK
Sbjct: 286 AVPQTPLCTGRMLKEAEETWPEVQEEMTRSLATMRVDYDQMQIKALDKSNNPLLTKRRK 344

Its physiological substrate seems to be the small heat shock protein (HSP27/HSP25).
Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P49139|MAPK2_RABIT MAP kinase-activated protein kinase 2 (Fragment) OS=Oryctolagus cuniculus GN=MAPKAPK2 PE=1 SV=2

 Score =  444 bits (1141), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 216/360 (60%), Positives = 262/360 (72%), Gaps = 25/360 (6%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS 67
            K   I DDY +++++LGLGINGKVLQI  KKT E +ALK+L D  KARREVEL      
Sbjct: 20  IKKNAIIDDYKVTSQVLGLGINGKVLQIFSKKTQEKFALKMLQDCPKARREVELHWRASQ 79

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
             HIV I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  A
Sbjct: 80  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 139

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I++LH  NIAHRDVKPE                        NLLYT      ILKLTDFG
Sbjct: 140 IQYLHSINIAHRDVKPE------------------------NLLYTSKRPKAILKLTDFG 175

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           FAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG
Sbjct: 176 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 234

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q 
Sbjct: 235 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 294

Query: 308 NQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
            +VPQTPL T ++LKE +E W +V++EMT +LATMRVDY+QI IK + ++ NPLL KRRK
Sbjct: 295 TKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRK 354

Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, ELAVL1, HNRNPA0, HSF1, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilize GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q16644|MAPK3_HUMAN MAP kinase-activated protein kinase 3 OS=Homo sapiens GN=MAPKAPK3 PE=1 SV=1

 Score =  443 bits (1140), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 218/364 (59%), Positives = 265/364 (72%), Gaps = 26/364 (7%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K   + DDY +S ++LGLG+NGKVL+   ++T +  ALK+L+D+ KAR+EV+        
Sbjct: 35  KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG 94

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            HIV I DVYEN+++G RCLL+IMECM GGELF RIQ++ D AFTEREAA IM +I +AI
Sbjct: 95  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 154

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           +FLH  NIAHRDVKPE                        NLLYT      +LKLTDFGF
Sbjct: 155 QFLHSHNIAHRDVKPE------------------------NLLYTSKEKDAVLKLTDFGF 190

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+   N  +LQTPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCGFPPF+SN GQ
Sbjct: 191 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 248

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIRLGQ+ FPNPEW  VS++AK LI+ +L  DP+ERLTI Q M + WI+Q  
Sbjct: 249 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 308

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRKN 368
            VPQTPL T ++L+E ++ W EV++EMT +LATMRVDYDQ+ IK L  S N LLNKRRK 
Sbjct: 309 VVPQTPLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQVKIKDLKTSNNRLLNKRRKK 368

Query: 369 QSPS 372
           Q+ S
Sbjct: 369 QAGS 372

Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, cell migration, chromatin remodeling and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. MAPKAPK2 and MAPKAPK3, share the same function and substrate specificity, but MAPKAPK3 kinase activity and level in protein expression are lower compared to MAPKAPK2. Phosphorylates HSP27/HSPB1, KRT18, KRT20, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins, such as TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. Also acts as a modulator of Polycomb-mediated repression.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P49137|MAPK2_HUMAN MAP kinase-activated protein kinase 2 OS=Homo sapiens GN=MAPKAPK2 PE=1 SV=1

 Score =  443 bits (1139), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 215/360 (59%), Positives = 262/360 (72%), Gaps = 25/360 (6%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS 67
            K   I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL      
Sbjct: 54  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ 113

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
             HIV I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  A
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I++LH  NIAHRDVKPE                        NLLYT      ILKLTDFG
Sbjct: 174 IQYLHSINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFG 209

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           FAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG
Sbjct: 210 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q 
Sbjct: 269 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

Query: 308 NQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
            +VPQTPL T ++LKE +E W +V++EMT +LATMRVDY+QI IK + ++ NPLL KRRK
Sbjct: 329 TKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRK 388

Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, ELAVL1, HNRNPA0, HSF1, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilize GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P49138|MAPK2_MOUSE MAP kinase-activated protein kinase 2 OS=Mus musculus GN=Mapkapk2 PE=1 SV=2

 Score =  442 bits (1136), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 212/360 (58%), Positives = 264/360 (73%), Gaps = 25/360 (6%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS 67
            +   I DDY +++++LGLGINGKVL+I +K+T + +ALK+L D  KARREVEL      
Sbjct: 40  IRKNAITDDYKVTSQVLGLGINGKVLRIFDKRTQQKFALKMLQDCPKARREVELHWRASQ 99

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
             HIV+I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  A
Sbjct: 100 CPHIVHIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 159

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I++LH  NIAHRDVKPE                        NLLYT      ILKLTDFG
Sbjct: 160 IQYLHSINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFG 195

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           FAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG
Sbjct: 196 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 254

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q 
Sbjct: 255 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 314

Query: 308 NQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
            +VPQTPL T ++LKE +E W +V++EMT +LATMRVDY+QI IK + ++ NPLL KRRK
Sbjct: 315 TKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRK 374

Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, ELAVL1, HNRNPA0, HSF1, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilize GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q66H84|MAPK3_RAT MAP kinase-activated protein kinase 3 OS=Rattus norvegicus GN=Mapkapk3 PE=2 SV=1

 Score =  439 bits (1129), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 215/364 (59%), Positives = 265/364 (72%), Gaps = 26/364 (7%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K   + DDY +S ++LGLG+NGKVL+   +++ +  ALK+L+D+ KAR+EV+        
Sbjct: 37  KKYAVTDDYQLSKQVLGLGVNGKVLECYHRRSGQKCALKLLYDSPKARQEVDHHWQASGG 96

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            HIV I DVYEN+++G RCLL++MECM GGELF RIQ++ D AFTEREAA IM +I +AI
Sbjct: 97  PHIVRILDVYENMHHGKRCLLIVMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 156

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           +FLH QNIAHRDVKPE                        NLLYT      +LKLTDFGF
Sbjct: 157 QFLHSQNIAHRDVKPE------------------------NLLYTSKEKDAVLKLTDFGF 192

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+   N  +LQTPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCGFPPF+SN GQ
Sbjct: 193 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 250

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIRLGQ+ FP PEW  VS++AK LI+ +L  DP+ERLTI Q M + WI+Q  
Sbjct: 251 AISPGMKRRIRLGQYGFPKPEWADVSEDAKQLIRLLLKTDPTERLTIMQFMNHPWINQSM 310

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRKN 368
           +VPQTPL T ++L+E ++ W +V++EMT +LATMRVDYDQ+ IK L  S N LLNKRRK 
Sbjct: 311 EVPQTPLHTARVLEEDKDHWDDVKEEMTSALATMRVDYDQVKIKDLKTSNNRLLNKRRKK 370

Query: 369 QSPS 372
           Q  S
Sbjct: 371 QGGS 374

Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, cell migration, chromatin remodeling and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. MAPKAPK2 and MAPKAPK3, share the same function and substrate specificity, but MAPKAPK3 kinase activity and level in protein expression are lower compared to MAPKAPK2. Phosphorylates HSP27/HSPB1, KRT18, KRT20, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins, such as TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. Also acts as a modulator of Polycomb-mediated repression.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3SYZ2|MAPK3_BOVIN MAP kinase-activated protein kinase 3 OS=Bos taurus GN=MAPKAPK3 PE=2 SV=1

 Score =  439 bits (1129), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 216/364 (59%), Positives = 264/364 (72%), Gaps = 26/364 (7%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K   + DDY +S ++LGLG+NGKVL+   ++T +  ALK+L+D+ KAR+EV+        
Sbjct: 37  KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG 96

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            HIV I DVYEN+++  RCLL+IMECM GGELF RIQ++ D AFTEREAA IM +I +AI
Sbjct: 97  PHIVRILDVYENMHHSKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 156

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           +FLH +NIAHRDVKPE                        NLLYT      +LKLTDFGF
Sbjct: 157 QFLHSRNIAHRDVKPE------------------------NLLYTSKDKDAVLKLTDFGF 192

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+   N  +LQTPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCGFPPF+SN GQ
Sbjct: 193 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 250

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIRLGQ+ FP+PEW  VS++AK LI+ +L  DP+ERLTI Q M + WI+Q  
Sbjct: 251 AISPGMKRRIRLGQYGFPSPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 310

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRKN 368
            VPQTPL T ++L+E  + W EV++EMT +LATMRVDYDQ+ IK L  S N LLNKRRK 
Sbjct: 311 VVPQTPLHTARVLQEDRDHWDEVKEEMTSALATMRVDYDQVKIKDLKTSNNRLLNKRRKK 370

Query: 369 QSPS 372
           Q+ S
Sbjct: 371 QAGS 374

Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, cell migration, chromatin remodeling and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. MAPKAPK2 and MAPKAPK3, share the same function and substrate specificity, but MAPKAPK3 kinase activity and level in protein expression are lower compared to MAPKAPK2. Phosphorylates HSP27/HSPB1, KRT18, KRT20, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins, such as TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. Also acts as a modulator of Polycomb-mediated repression.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3UMW7|MAPK3_MOUSE MAP kinase-activated protein kinase 3 OS=Mus musculus GN=Mapkapk3 PE=1 SV=2

 Score =  439 bits (1128), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 215/364 (59%), Positives = 266/364 (73%), Gaps = 26/364 (7%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K   + DDY +S ++LGLG+NGKVL+   +++ +  ALK+L+D+ KAR+EV+        
Sbjct: 37  KKYAVTDDYQLSKQVLGLGVNGKVLECYHRRSGQKCALKLLYDSPKARQEVDHHWQASGG 96

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            HIV I DVYEN+++G RCLL++MECM GGELF RIQ++ D AFTEREAA IM +I +AI
Sbjct: 97  PHIVRILDVYENMHHGKRCLLIVMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 156

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           +FLH +NIAHRDVKPE                        NLLYT      +LKLTDFGF
Sbjct: 157 QFLHSRNIAHRDVKPE------------------------NLLYTSKEKDAVLKLTDFGF 192

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+   N  +LQTPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCGFPPF+SN GQ
Sbjct: 193 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 250

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIRLGQ+ FPNPEW  VS++AK LI+ +L  DP+ERLTI Q M + WI+Q  
Sbjct: 251 AISPGMKRRIRLGQYSFPNPEWLDVSEDAKQLIRLLLKTDPTERLTIMQFMNHPWINQSM 310

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRKN 368
            VPQTPL T ++L+E ++ W +V++EMT +LATMRVDYDQ+ IK L  S N LLNKRRK 
Sbjct: 311 VVPQTPLYTARVLQEDKDHWDDVKEEMTSALATMRVDYDQVKIKDLKTSNNRLLNKRRKK 370

Query: 369 QSPS 372
           Q+ S
Sbjct: 371 QAGS 374

Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, cell migration, chromatin remodeling and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. MAPKAPK2 and MAPKAPK3, share the same function and substrate specificity, but MAPKAPK3 kinase activity and level in protein expression are lower compared to MAPKAPK2. Phosphorylates HSP27/HSPB1, KRT18, KRT20, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins, such as TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. Also acts as a modulator of Polycomb-mediated repression.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P49136|MAPK2_CRILO MAP kinase-activated protein kinase 2 (Fragment) OS=Cricetulus longicaudatus GN=MAPKAPK2 PE=2 SV=1

 Score =  424 bits (1090), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 206/342 (60%), Positives = 252/342 (73%), Gaps = 25/342 (7%)

Query: 26  LGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGS 85
           LGINGKVL+I +K+T + +ALK+L D  KARREVEL        HIV+I DVYEN+Y G 
Sbjct: 1   LGINGKVLRIFDKRTQQKFALKMLQDCPKARREVELHWRASQCPHIVDIVDVYENLYAGR 60

Query: 86  RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
           +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH  NIAHRDVKPE 
Sbjct: 61  KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE- 119

Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT 205
                                  NLLYT      ILKLTDFGFAK+  S+  SL TPCYT
Sbjct: 120 -----------------------NLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYT 155

Query: 206 PYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDF 265
           PYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISPGMK RIR+GQ++F
Sbjct: 156 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 215

Query: 266 PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGE 325
           PNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQTPL T ++LKE +
Sbjct: 216 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 275

Query: 326 ETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           E W +V++EMT +LATMRVDY+QI IK + ++ NPLL KRRK
Sbjct: 276 ERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRK 317

Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, ELAVL1, HNRNPA0, HSF1, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilize GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3.

Cricetulus longicaudatus (taxid: 10030)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8IW41|MAPK5_HUMAN MAP kinase-activated protein kinase 5 OS=Homo sapiens GN=MAPKAPK5 PE=1 SV=2

 Score =  241 bits (615), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 147/391 (37%), Positives = 211/391 (53%), Gaps = 65/391 (16%)

Query: 6   KPFKTTPIQDDYDIS-TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLA 64
           K  K T I ++Y I+ T+ LG GI+G V   V+K T E +ALK+L D  KAR EV L + 
Sbjct: 9   KAIKETSILEEYSINWTQKLGAGISGPVRVCVKKSTQERFALKILLDRPKARNEVRLHMM 68

Query: 65  VGSHKHIVNIKDVYENIY-----NGSRC-LLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
             +H +IV I +V+ N       +  R  LL++ME M GGELF RI Q     FTE++A+
Sbjct: 69  CATHPNIVQIIEVFANSVQFPHESSPRARLLIVMEMMEGGELFHRISQHRH--FTEKQAS 126

Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
            +  +I  A++  H  NIAHRD+KPEN                        LL+      
Sbjct: 127 QVTKQIALALRHCHLLNIAHRDLKPEN------------------------LLFKDNSLD 162

Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL------------------GPDKYD 220
             +KL DFGFAK    ++  L TP +TPYYVAP+VL                   P  Y+
Sbjct: 163 APVKLCDFGFAK---IDQGDLMTPQFTPYYVAPQVLEAQRRHQKEKSGIIPTSPTPYTYN 219

Query: 221 KSCDIWSLGVIMYILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKT 279
           KSCD+WSLGVI+Y++LCG+PPF+S +H + I   M+ +I  G F+FP  EW  +S+ AK 
Sbjct: 220 KSCDLWSLGVIIYVMLCGYPPFYSKHHSRTIPKDMRRKIMTGSFEFPEEEWSQISEMAKD 279

Query: 280 LIKNMLCVDPSERLTIDQVMENKWISQF----NQVPQTPLCTGKMLKEGEETWPEVQDEM 335
           +++ +L V P ERLTI+ V+++ W++      N +P   L   K +  G      +Q   
Sbjct: 280 VVRKLLKVKPEERLTIEGVLDHPWLNSTEALDNVLPSAQLMMDKAVVAG------IQQAH 333

Query: 336 TRSLATMRVDYDQIHIKSLINSKNPLLNKRR 366
              LA MR+   ++ +K L +  NP+L KR+
Sbjct: 334 AEQLANMRIQDLKVSLKPLHSVNNPILRKRK 364

Tumor suppressor serine/threonine-protein kinase involved in mTORC1 signaling and post-transcriptional regulation. Phosphorylates FOXO3, ERK3/MAPK6, ERK4/MAPK4, HSP27/HSPB1, p53/TP53 and RHEB. Acts as a tumor suppressor by mediating Ras-induced senescence and phosphorylating p53/TP53. Involved in post-transcriptional regulation of MYC by mediating phosphorylation of FOXO3: phosphorylation of FOXO3 leads to promote nuclear localization of FOXO3, enabling expression of miR-34b and miR-34c, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent MYC translation. Acts as a negative regulator of mTORC1 signaling by mediating phosphorylation and inhibition of RHEB. Part of the atypical MAPK signaling via its interaction with ERK3/MAPK6 or ERK4/MAPK4: the precise role of the complex formed with ERK3/MAPK6 or ERK4/MAPK4 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPK (ERK3/MAPK6 or ERK4/MAPK4), ERK3/MAPK6 (or ERK4/MAPK4) is phosphorylated and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK3/MAPK6 (or ERK4/MAPK4). Mediates phosphorylation of HSP27/HSPB1 in response to PKA/PRKACA stimulation, inducing F-actin rearrangement.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	372
91082767	358	PREDICTED: similar to map kinase-activat	0.927	0.963	0.675	1e-143
383862587	991	PREDICTED: uncharacterized protein LOC10	0.897	0.337	0.682	1e-143
157123126	372	map kinase-activated protein kinase (map	0.897	0.897	0.693	1e-143
380014638	992	PREDICTED: uncharacterized protein LOC10	0.897	0.336	0.682	1e-142
242004036	353	cAMP-dependent protein kinase catalytic	0.897	0.946	0.685	1e-142
83595261	353	MAP kinase activated protein-kinase-2 [G	0.897	0.946	0.685	1e-142
350400753	992	PREDICTED: hypothetical protein LOC10074	0.897	0.336	0.679	1e-142
340710944	992	PREDICTED: hypothetical protein LOC10064	0.897	0.336	0.679	1e-142
328786232	992	PREDICTED: hypothetical protein LOC40924	0.897	0.336	0.679	1e-142
194764304	360	GF21465 [Drosophila ananassae] gi|190619	0.900	0.930	0.674	1e-141

>gi|91082767|ref|XP_973630.1| PREDICTED: similar to map kinase-activated protein kinase (mapkapk) [Tribolium castaneum] gi|270014946|gb|EFA11394.1| hypothetical protein TcasGA2_TC013565 [Tribolium castaneum]

 Score =  514 bits (1325), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 250/370 (67%), Positives = 289/370 (78%), Gaps = 25/370 (6%)

Query: 1   MTPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVE 60
           M  + +  K TPI DDYDI+  +LGLGINGKV++   K T E +ALK+L ++ KARREV+
Sbjct: 5   MRQSHRTPKKTPITDDYDITKTVLGLGINGKVVECFSKATKEKFALKILVESQKARREVD 64

Query: 61  LQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
           L       +HIVNI DVYEN YN + CLLV+MECM GGELFQRIQ K DGAFTEREAA I
Sbjct: 65  LHWQASGCRHIVNIIDVYENKYNNNPCLLVVMECMEGGELFQRIQDKPDGAFTEREAAQI 124

Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
           M+EIC A+K+LHD NIAHRD+KPEN                        LLY+K G  GI
Sbjct: 125 MHEICIAVKYLHDNNIAHRDLKPEN------------------------LLYSKKGTYGI 160

Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
           LKLTDFGFAK+ +  K +LQTPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCGFP
Sbjct: 161 LKLTDFGFAKETLV-KDTLQTPCYTPYYVAPEVLGPEKYDKSCDVWSLGVIMYILLCGFP 219

Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF+SNHG AISPGMKNRIR+GQ+ FPNPEW++VSQ+AK LI  ML VDP++RLTIDQVM 
Sbjct: 220 PFYSNHGLAISPGMKNRIRMGQYTFPNPEWQNVSQDAKDLINGMLNVDPAKRLTIDQVMS 279

Query: 301 NKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNP 360
           N+WI+Q+  VPQTPL T KMLKEGEE WPEVQ+EMTRSLATMRVDYDQ+HIK+L NS NP
Sbjct: 280 NRWIAQYTAVPQTPLHTHKMLKEGEEMWPEVQEEMTRSLATMRVDYDQVHIKTLENSNNP 339

Query: 361 LLNKRRKNQS 370
           LLNKRRK  +
Sbjct: 340 LLNKRRKRSA 349

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383862587|ref|XP_003706765.1| PREDICTED: uncharacterized protein LOC100878424 [Megachile rotundata]

 Score =  514 bits (1325), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 245/359 (68%), Positives = 285/359 (79%), Gaps = 25/359 (6%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K TPI DDY+IS  +LGLGINGKV+Q  +K T E YALKVL+D VKARREVEL     + 
Sbjct: 641 KATPITDDYEISNHVLGLGINGKVVQCYDKNTREKYALKVLYDCVKARREVELHWRASNC 700

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +HIV +KDVYEN Y+G++CLLV+MECM GGELF+RIQ ++DGAFTEREAA IM EIC A+
Sbjct: 701 RHIVQVKDVYENTYSGNKCLLVVMECMEGGELFERIQDRQDGAFTEREAAQIMYEICVAV 760

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           K LHD NIAHRD+KPEN                        LLY+KP + GILKLTDFGF
Sbjct: 761 KHLHDMNIAHRDLKPEN------------------------LLYSKPDNTGILKLTDFGF 796

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+  S K +LQTPCYTPYYVAPEVLGP+KYDKSCDIWSLGVIMYILLCGFPPF+SNHG 
Sbjct: 797 AKETHS-KDTLQTPCYTPYYVAPEVLGPEKYDKSCDIWSLGVIMYILLCGFPPFYSNHGL 855

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIRLGQ+DFP PEW +VS EAKTLIK MLC DP++RL ID+VM NKWI+Q+ 
Sbjct: 856 AISPGMKKRIRLGQYDFPAPEWSNVSSEAKTLIKGMLCTDPAQRLQIDEVMRNKWIAQYT 915

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           +VP TPL TG++L+EGEE WPEVQ+EMTRSLATMRVDYD  ++K L ++ N LLNKRR+
Sbjct: 916 EVPPTPLHTGRVLREGEELWPEVQEEMTRSLATMRVDYDTANLKQLDHTNNALLNKRRR 974

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157123126|ref|XP_001660020.1| map kinase-activated protein kinase (mapkapk) [Aedes aegypti] gi|108874513|gb|EAT38738.1| AAEL009402-PA [Aedes aegypti]

 Score =  513 bits (1320), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 249/359 (69%), Positives = 282/359 (78%), Gaps = 25/359 (6%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K TPI DDY+IS  +LGLGINGKV+Q   KKTS  YALKVLHD  KARREVEL       
Sbjct: 31  KATPITDDYEISNTVLGLGINGKVVQCTAKKTSNKYALKVLHDNAKARREVELHWRASGC 90

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           ++IVNI DVYEN Y+G+RCLLV+MECM GGELFQRIQ+++DG FTEREAA IM+EIC A+
Sbjct: 91  RNIVNIIDVYENSYSGNRCLLVVMECMEGGELFQRIQERQDGPFTEREAAQIMHEICVAV 150

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           K+LHD NIAHRDVKPE                        NLLYT P    ILKLTDFGF
Sbjct: 151 KYLHDSNIAHRDVKPE------------------------NLLYTSPHPNAILKLTDFGF 186

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           +K+    K +LQTPCYTPYYVAPEVLGP+KYDKSCDIWSLGVIMYILLCGFPPF+SNHG 
Sbjct: 187 SKETFV-KDTLQTPCYTPYYVAPEVLGPEKYDKSCDIWSLGVIMYILLCGFPPFYSNHGL 245

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIR GQ+DFPNPEW++VSQ AK LIK ML V+P +RLTIDQVM N W+  + 
Sbjct: 246 AISPGMKTRIRTGQYDFPNPEWQNVSQAAKDLIKGMLSVEPEKRLTIDQVMRNPWVRLYT 305

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           +VPQTPL TG++LKEGEETWPEVQ+EMTRSLA MRVDYDQ+HIK+L +S N LLNKRRK
Sbjct: 306 EVPQTPLHTGRVLKEGEETWPEVQEEMTRSLANMRVDYDQMHIKNLDSSNNALLNKRRK 364

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380014638|ref|XP_003691332.1| PREDICTED: uncharacterized protein LOC100870376 [Apis florea]

 Score =  512 bits (1318), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 245/359 (68%), Positives = 283/359 (78%), Gaps = 25/359 (6%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K TPI DDY+IS  +LGLGINGKV+Q  +K T E YALKVL+D VKARREVEL     + 
Sbjct: 642 KITPIIDDYEISNHVLGLGINGKVVQCYDKNTREKYALKVLYDCVKARREVELHWRASNC 701

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           KHIV +KDVYEN Y+G++CLLV+MECM GGELF+RIQ ++DGAFTEREAA IM EIC A+
Sbjct: 702 KHIVQVKDVYENTYSGNKCLLVVMECMEGGELFERIQDRQDGAFTEREAAQIMYEICVAV 761

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           K LHD NIAHRD+KPEN                        LLY+KPG  GILKLTDFGF
Sbjct: 762 KHLHDMNIAHRDLKPEN------------------------LLYSKPGSTGILKLTDFGF 797

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+    K +LQTPCYTPYYVAPEVLGP+KYDKSCDIWSLGVIMYILLCGFPPF+SNHG 
Sbjct: 798 AKE-THLKDTLQTPCYTPYYVAPEVLGPEKYDKSCDIWSLGVIMYILLCGFPPFYSNHGL 856

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIRLGQ+DFP PEW +VS EAK LIK MLC DP++RL ID+VM NKWI+Q+ 
Sbjct: 857 AISPGMKKRIRLGQYDFPAPEWSNVSTEAKNLIKGMLCTDPAQRLQIDEVMRNKWIAQYT 916

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           +VP TPL TG++L+EGEE WPEVQ+EMTRSLATMRVDYD  ++K L ++ N LLNKRR+
Sbjct: 917 EVPPTPLHTGRVLREGEELWPEVQEEMTRSLATMRVDYDTANLKQLDHTNNALLNKRRR 975

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242004036|ref|XP_002422947.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212505863|gb|EEB10209.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis]

 Score =  512 bits (1318), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 246/359 (68%), Positives = 286/359 (79%), Gaps = 25/359 (6%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K+TPI +DY+IS  +LGLGI+GKV++   K + E +ALKVLHD VKARREVEL      H
Sbjct: 12  KSTPIINDYEISNNVLGLGISGKVVECCSKISKEKFALKVLHDNVKARREVELHWKASGH 71

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +HIVNI DVYEN Y+G++CLLV+MECM GGELFQRIQ K+DGAFTEREAA IM EICSA+
Sbjct: 72  RHIVNIIDVYENTYSGNKCLLVVMECMEGGELFQRIQDKQDGAFTEREAAQIMREICSAV 131

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           K+LHD NIAHRD+KPEN                        LLY+     GILKLTDFGF
Sbjct: 132 KYLHDMNIAHRDLKPEN------------------------LLYSHKSSSGILKLTDFGF 167

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+  + K +LQTPCYTPYYVAPEVLGP+KYDKSCDIWSLGVIMYILLCGFPPF+SNHG 
Sbjct: 168 AKETFT-KDTLQTPCYTPYYVAPEVLGPEKYDKSCDIWSLGVIMYILLCGFPPFYSNHGL 226

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIR GQFDFP+PEW+ VSQ+AK LIK ML +DP +R TI+++M+NKWI+Q+ 
Sbjct: 227 AISPGMKKRIRTGQFDFPSPEWKSVSQDAKDLIKKMLTIDPVKRPTIEEIMKNKWIAQYT 286

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           +VPQTPL T +MLKEGE+ WPEVQ+EMTRSLATMRVDYDQIHIK+L NS N LL KRRK
Sbjct: 287 EVPQTPLHTNRMLKEGEDHWPEVQEEMTRSLATMRVDYDQIHIKNLDNSNNQLLIKRRK 345

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|83595261|gb|ABC25082.1| MAP kinase activated protein-kinase-2 [Glossina morsitans morsitans] gi|289740361|gb|ADD18928.1| MAP kinase-activated protein kinase 2 [Glossina morsitans morsitans]

 Score =  511 bits (1317), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 246/359 (68%), Positives = 286/359 (79%), Gaps = 25/359 (6%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K T + DDY+IS  +LGLGINGKV+Q   ++T++ YALKVL D+ KARREV+L   V   
Sbjct: 10  KATHLVDDYEISNTVLGLGINGKVVQCTHRQTNQKYALKVLLDSPKARREVDLHWRVSDC 69

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +HIVNI DVYEN Y G++CLLV+MECM GGELFQRIQ   DGAFTEREAA IM+EIC A+
Sbjct: 70  RHIVNIVDVYENTYAGNKCLLVVMECMEGGELFQRIQDNADGAFTEREAAQIMHEICVAV 129

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            +LH ++IAHRD+KPEN                        LLYT P    ILKLTDFGF
Sbjct: 130 HYLHSRDIAHRDLKPEN------------------------LLYTSPQPNAILKLTDFGF 165

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+  S K +LQTPCYTPYYVAPEVLGP+KYDKSCDIWSLGVIMYILLCGFPPF+SN+G 
Sbjct: 166 AKE-TSVKDTLQTPCYTPYYVAPEVLGPEKYDKSCDIWSLGVIMYILLCGFPPFYSNNGL 224

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIR GQ+DFPNPEW++VSQ AK+LIK ML VDPS+RLTI+ VM NKWI+Q+ 
Sbjct: 225 AISPGMKKRIRTGQYDFPNPEWQNVSQAAKSLIKGMLNVDPSKRLTIEDVMRNKWIAQYT 284

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           +VPQTPLCTG+MLKEGEETWPEVQ+EMTRSLATMRVDYDQ+HIK+L  S NPLL+KRR+
Sbjct: 285 EVPQTPLCTGRMLKEGEETWPEVQEEMTRSLATMRVDYDQMHIKALDKSNNPLLSKRRR 343

Source: Glossina morsitans morsitans

Species: Glossina morsitans

Genus: Glossina

Family: Glossinidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350400753|ref|XP_003485947.1| PREDICTED: hypothetical protein LOC100747039 [Bombus impatiens]

 Score =  511 bits (1315), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 244/359 (67%), Positives = 282/359 (78%), Gaps = 25/359 (6%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K TPI DDY+IS  +LGLGINGKV+Q  +K T E YALKVL+D VKARREVEL     + 
Sbjct: 642 KVTPITDDYEISNHVLGLGINGKVVQCYDKNTREKYALKVLYDCVKARREVELHWRASNC 701

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +HIV +KDVYEN Y+G++CLLVIMECM GGELF+RIQ ++DGAFTEREAA IM EIC A+
Sbjct: 702 RHIVQVKDVYENTYSGNKCLLVIMECMEGGELFERIQDRQDGAFTEREAAQIMYEICVAV 761

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           K LHD NIAHRD+KPEN                        LLY+KP   GILKLTDFGF
Sbjct: 762 KHLHDMNIAHRDLKPEN------------------------LLYSKPDSTGILKLTDFGF 797

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+    K +LQTPCYTPYYVAPEVLGP+KYDKSCDIWSLGVIMYILLCGFPPF+SNHG 
Sbjct: 798 AKE-THMKDTLQTPCYTPYYVAPEVLGPEKYDKSCDIWSLGVIMYILLCGFPPFYSNHGL 856

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIRLGQ+DFP PEW +VS EAK LIK MLC DP++RL ID+VM NKWI+Q+ 
Sbjct: 857 AISPGMKKRIRLGQYDFPAPEWSNVSTEAKNLIKGMLCTDPAQRLQIDEVMRNKWIAQYT 916

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           +VP TPL TG++L+EGEE WPEVQ+EMTRSLATMRVDYD  ++K L ++ N LLNKRR+
Sbjct: 917 EVPPTPLHTGRVLREGEELWPEVQEEMTRSLATMRVDYDTANLKQLDHTNNALLNKRRR 975

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340710944|ref|XP_003394042.1| PREDICTED: hypothetical protein LOC100642195 [Bombus terrestris]

 Score =  510 bits (1314), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 244/359 (67%), Positives = 282/359 (78%), Gaps = 25/359 (6%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K TPI DDY+IS  +LGLGINGKV+Q  +K T E YALKVL+D VKARREVEL     + 
Sbjct: 642 KVTPITDDYEISNHVLGLGINGKVVQCYDKNTREKYALKVLYDCVKARREVELHWRASNC 701

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +HIV +KDVYEN Y+G++CLLVIMECM GGELF+RIQ ++DGAFTEREAA IM EIC A+
Sbjct: 702 RHIVQVKDVYENTYSGNKCLLVIMECMEGGELFERIQDRQDGAFTEREAAQIMYEICVAV 761

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           K LHD NIAHRD+KPEN                        LLY+KP   GILKLTDFGF
Sbjct: 762 KHLHDMNIAHRDLKPEN------------------------LLYSKPDSTGILKLTDFGF 797

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+    K +LQTPCYTPYYVAPEVLGP+KYDKSCDIWSLGVIMYILLCGFPPF+SNHG 
Sbjct: 798 AKE-THMKDTLQTPCYTPYYVAPEVLGPEKYDKSCDIWSLGVIMYILLCGFPPFYSNHGL 856

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIRLGQ+DFP PEW +VS EAK LIK MLC DP++RL ID+VM NKWI+Q+ 
Sbjct: 857 AISPGMKKRIRLGQYDFPAPEWSNVSTEAKNLIKGMLCTDPAQRLQIDEVMRNKWIAQYT 916

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           +VP TPL TG++L+EGEE WPEVQ+EMTRSLATMRVDYD  ++K L ++ N LLNKRR+
Sbjct: 917 EVPPTPLHTGRVLREGEELWPEVQEEMTRSLATMRVDYDTANLKQLDHTNNALLNKRRR 975

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328786232|ref|XP_392769.4| PREDICTED: hypothetical protein LOC409246 [Apis mellifera]

 Score =  510 bits (1313), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 244/359 (67%), Positives = 282/359 (78%), Gaps = 25/359 (6%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K TPI DDY+IS  +LGLGINGKV+Q  +K T E YALKVL+D VKARREVEL     + 
Sbjct: 642 KITPIIDDYEISNHVLGLGINGKVVQCYDKNTREKYALKVLYDCVKARREVELHWRASNC 701

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           KHIV +KDVYEN Y+G++CLLV+MECM GGELF+RIQ ++DGAFTEREAA IM EIC A+
Sbjct: 702 KHIVQVKDVYENTYSGNKCLLVVMECMEGGELFERIQDRQDGAFTEREAAQIMYEICVAV 761

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           K LHD NIAHRD+KPEN                        LLY+KP   GILKLTDFGF
Sbjct: 762 KHLHDMNIAHRDLKPEN------------------------LLYSKPDSTGILKLTDFGF 797

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+    K +LQTPCYTPYYVAPEVLGP+KYDKSCDIWSLGVIMYILLCGFPPF+SNHG 
Sbjct: 798 AKE-THLKDTLQTPCYTPYYVAPEVLGPEKYDKSCDIWSLGVIMYILLCGFPPFYSNHGL 856

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIRLGQ+DFP PEW +VS EAK LIK MLC DP++RL ID+VM NKWI+Q+ 
Sbjct: 857 AISPGMKKRIRLGQYDFPAPEWSNVSTEAKNLIKGMLCTDPAQRLQIDEVMRNKWIAQYT 916

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           +VP TPL TG++L+EGEE WPEVQ+EMTRSLATMRVDYD  ++K L ++ N LLNKRR+
Sbjct: 917 EVPPTPLHTGRVLREGEELWPEVQEEMTRSLATMRVDYDTANLKQLDHTNNALLNKRRR 975

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|194764304|ref|XP_001964270.1| GF21465 [Drosophila ananassae] gi|190619195|gb|EDV34719.1| GF21465 [Drosophila ananassae]

 Score =  507 bits (1305), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 242/359 (67%), Positives = 278/359 (77%), Gaps = 24/359 (6%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           KTTP+ DDY+IS  +LGLGINGKV+Q   ++T + YALKVL D  KARREV+L   V   
Sbjct: 11  KTTPLVDDYEISDTVLGLGINGKVVQCTNRRTKQNYALKVLLDNEKARREVDLHWRVSGC 70

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +HIVNI DV+EN Y+G +CLLV+MECM GGELFQRIQ K DGAFTEREAA IM+EIC AI
Sbjct: 71  RHIVNIIDVFENTYSGRKCLLVVMECMEGGELFQRIQDKADGAFTEREAAQIMHEICEAI 130

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            +LH ++IAHRD+KPEN                        LLYT      ILKLTDFGF
Sbjct: 131 DYLHSRDIAHRDLKPEN------------------------LLYTTSQPNAILKLTDFGF 166

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+ ++N  +LQTPCYTPYYVAPEVLGP+KYDKSCDIWSLGV+MYI++CGFPPF+SNHG 
Sbjct: 167 AKETLTNDTTLQTPCYTPYYVAPEVLGPEKYDKSCDIWSLGVVMYIIMCGFPPFYSNHGL 226

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIR GQ+DFP+PEW +VSQ AK LIK ML VDPS+RL I  VM N WI+QFN
Sbjct: 227 AISPGMKKRIRTGQYDFPDPEWTNVSQSAKDLIKGMLNVDPSKRLRIQDVMRNSWIAQFN 286

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
            VPQTPLCTG+MLKE  ETWPEVQ+EMTRSLATMRVDYDQ+ IK+L  S NPLL KRRK
Sbjct: 287 AVPQTPLCTGRMLKESGETWPEVQEEMTRSLATMRVDYDQMQIKALDKSNNPLLTKRRK 345

Source: Drosophila ananassae

Species: Drosophila ananassae

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	372
FB|FBgn0013987	359	MAPk-Ak2 "MAP kinase activated	0.545	0.565	0.754	3.7e-133
ZFIN|ZDB-GENE-061215-124	408	mapkapk3 "mitogen-activated pr	0.545	0.497	0.700	2.7e-126
UNIPROTKB|F1SEZ4	413	LOC100521986 "Uncharacterized	0.545	0.491	0.671	3.5e-124
UNIPROTKB|P49137	400	MAPKAPK2 "MAP kinase-activated	0.545	0.507	0.671	1.2e-123
UNIPROTKB|F1MCX5	388	MAPKAPK2 "Uncharacterized prot	0.545	0.523	0.673	1.2e-123
UNIPROTKB|P49139	366	MAPKAPK2 "MAP kinase-activated	0.545	0.554	0.671	1.5e-123
MGI|MGI:109298	386	Mapkapk2 "MAP kinase-activated	0.545	0.525	0.671	1.9e-123
RGD|631362	386	Mapkapk2 "mitogen-activated pr	0.545	0.525	0.666	2.4e-123
ZFIN|ZDB-GENE-030131-5532	382	mapkapk2a "mitogen-activated p	0.545	0.531	0.666	1.3e-122
UNIPROTKB|P49136	329	MAPKAPK2 "MAP kinase-activated	0.545	0.617	0.671	4.1e-119

FB|FBgn0013987 MAPk-Ak2 "MAP kinase activated protein-kinase-2" [Drosophila melanogaster (taxid:7227)]

 Score = 839 (300.4 bits), Expect = 3.7e-133, Sum P(2) = 3.7e-133
 Identities = 154/204 (75%), Positives = 175/204 (85%)

Query:   164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             D+KPENLLYT       LKLTDFGFAK+  ++  +LQTPCYTPYYVAPEVLGP+KYDKSC
Sbjct:   142 DLKPENLLYTTTQPNATLKLTDFGFAKETFTSY-TLQTPCYTPYYVAPEVLGPEKYDKSC 200

Query:   224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
             DIWSLGV+MYI++CGFPPF+SNHG AISPGMKNRIR GQ+DFP+PEW +VSQ AK LIK 
Sbjct:   201 DIWSLGVVMYIIMCGFPPFYSNHGLAISPGMKNRIRTGQYDFPDPEWTNVSQAAKDLIKG 260

Query:   284 MLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
             ML VDPS+RL I  V+ NKWI+Q+N VPQTPLCTG+MLKE EETWPEVQ+EMTRSLATMR
Sbjct:   261 MLNVDPSKRLRIQDVISNKWIAQYNAVPQTPLCTGRMLKEAEETWPEVQEEMTRSLATMR 320

Query:   344 VDYDQIHIKSLINSKNPLLNKRRK 367
             VDYDQ+ IK+L  S NPLL KRRK
Sbjct:   321 VDYDQMQIKALDKSNNPLLTKRRK 344

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;NAS

GO:0004672 "protein kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;NAS

GO:0007155 "cell adhesion" evidence=IMP

GO:0008360 "regulation of cell shape" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0045793 "positive regulation of cell size" evidence=IGI

GO:0009651 "response to salt stress" evidence=IMP

GO:0046328 "regulation of JNK cascade" evidence=IGI

ZFIN|ZDB-GENE-061215-124 mapkapk3 "mitogen-activated protein kinase-activated protein kinase 3" [Danio rerio (taxid:7955)]

 Score = 768 (275.4 bits), Expect = 2.7e-126, Sum P(2) = 2.7e-126
 Identities = 143/204 (70%), Positives = 166/204 (81%)

Query:   164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             D+KPENLLYT   D G+LKLTDFGFAK+  S    LQTPCYTPYYVAPEVLGP+KYDKSC
Sbjct:   190 DIKPENLLYTSKNDTGVLKLTDFGFAKE-TSLHNPLQTPCYTPYYVAPEVLGPEKYDKSC 248

Query:   224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
             D+WSLGVIMYILLCGFPPF+SN GQAISPGMK RIR+GQ++FPNPEW  VS+EAK LI  
Sbjct:   249 DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRMGQYEFPNPEWAEVSEEAKQLIHQ 308

Query:   284 MLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
             +L  DPSER+TI+Q M + WI+Q   VPQTPL T ++L E  E W EV++E+T +LATMR
Sbjct:   309 LLKTDPSERMTIEQFMNHPWINQSMVVPQTPLHTSRVLTEDSEMWDEVKEELTSALATMR 368

Query:   344 VDYDQIHIKSLINSKNPLLNKRRK 367
             VDY+Q+ IK L  S NPLLNKRRK
Sbjct:   369 VDYEQVKIKDLDASSNPLLNKRRK 392

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

UNIPROTKB|F1SEZ4 LOC100521986 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 753 (270.1 bits), Expect = 3.5e-124, Sum P(2) = 3.5e-124
 Identities = 137/204 (67%), Positives = 168/204 (82%)

Query:   164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             DVKPENLLYT      ILKLTDFGFAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSC
Sbjct:   199 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSC 257

Query:   224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
             D+WSLGVIMYILLCG+PPF+SNHG AISPGMK+RIR+GQ++FPNPEW  VS+E K LI+N
Sbjct:   258 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKSRIRMGQYEFPNPEWSEVSEEVKMLIRN 317

Query:   284 MLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
             +L  +P++R+TI + M + WI Q  +VPQTPL T ++LKE +E W +V++EMT +LATMR
Sbjct:   318 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 377

Query:   344 VDYDQIHIKSLINSKNPLLNKRRK 367
             VDY+QI IK + ++ NPLL KRRK
Sbjct:   378 VDYEQIKIKKIEDASNPLLLKRRK 401

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|P49137 MAPKAPK2 "MAP kinase-activated protein kinase 2" [Homo sapiens (taxid:9606)]

 Score = 752 (269.8 bits), Expect = 1.2e-123, Sum P(2) = 1.2e-123
 Identities = 137/204 (67%), Positives = 167/204 (81%)

Query:   164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             DVKPENLLYT      ILKLTDFGFAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSC
Sbjct:   186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSC 244

Query:   224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
             D+WSLGVIMYILLCG+PPF+SNHG AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N
Sbjct:   245 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 304

Query:   284 MLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
             +L  +P++R+TI + M + WI Q  +VPQTPL T ++LKE +E W +V++EMT +LATMR
Sbjct:   305 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 364

Query:   344 VDYDQIHIKSLINSKNPLLNKRRK 367
             VDY+QI IK + ++ NPLL KRRK
Sbjct:   365 VDYEQIKIKKIEDASNPLLLKRRK 388

GO:0005524 "ATP binding" evidence=IEA

GO:0048839 "inner ear development" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0032680 "regulation of tumor necrosis factor production" evidence=IDA

GO:0070935 "3'-UTR-mediated mRNA stabilization" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0006950 "response to stress" evidence=IDA

GO:0006974 "response to DNA damage stimulus" evidence=IMP

GO:0031572 "G2 DNA damage checkpoint" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0002224 "toll-like receptor signaling pathway" evidence=ISS;TAS

GO:0006954 "inflammatory response" evidence=ISS

GO:0032496 "response to lipopolysaccharide" evidence=ISS

GO:0032675 "regulation of interleukin-6 production" evidence=ISS

GO:0044351 "macropinocytosis" evidence=ISS

GO:0000165 "MAPK cascade" evidence=TAS

GO:0004672 "protein kinase activity" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=TAS

GO:0004871 "signal transducer activity" evidence=TAS

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0010467 "gene expression" evidence=TAS

GO:0016070 "RNA metabolic process" evidence=TAS

GO:0016071 "mRNA metabolic process" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0035924 "cellular response to vascular endothelial growth factor stimulus" evidence=IMP

GO:0048010 "vascular endothelial growth factor receptor signaling pathway" evidence=IMP

GO:0018105 "peptidyl-serine phosphorylation" evidence=IDA

UNIPROTKB|F1MCX5 MAPKAPK2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 748 (268.4 bits), Expect = 1.2e-123, Sum P(2) = 1.2e-123
 Identities = 138/205 (67%), Positives = 169/205 (82%)

Query:   164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             DVKPENLLYT      ILKLTDFGFAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSC
Sbjct:   173 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSC 231

Query:   224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEA-KTLIK 282
             D+WSLGVIMYILLCG+PPF+SNHG AISPGMK+RIR+GQ++FPNPEW  VS+EA K LI+
Sbjct:   232 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKSRIRMGQYEFPNPEWSEVSEEAVKMLIR 291

Query:   283 NMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATM 342
             N+L  +P++R+TI + M + WI Q  +VPQTPL T ++LKE +E W +V++EMT +LATM
Sbjct:   292 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATM 351

Query:   343 RVDYDQIHIKSLINSKNPLLNKRRK 367
             RVDY+QI IK + ++ NPLL KRRK
Sbjct:   352 RVDYEQIKIKKIEDASNPLLLKRRK 376

GO:0070935 "3'-UTR-mediated mRNA stabilization" evidence=IEA

GO:0048839 "inner ear development" evidence=IEA

GO:0048010 "vascular endothelial growth factor receptor signaling pathway" evidence=IEA

GO:0044351 "macropinocytosis" evidence=IEA

GO:0035924 "cellular response to vascular endothelial growth factor stimulus" evidence=IEA

GO:0032680 "regulation of tumor necrosis factor production" evidence=IEA

GO:0032675 "regulation of interleukin-6 production" evidence=IEA

GO:0032496 "response to lipopolysaccharide" evidence=IEA

GO:0031572 "G2 DNA damage checkpoint" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0006954 "inflammatory response" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0002224 "toll-like receptor signaling pathway" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P49139 MAPKAPK2 "MAP kinase-activated protein kinase 2" [Oryctolagus cuniculus (taxid:9986)]

 Score = 750 (269.1 bits), Expect = 1.5e-123, Sum P(2) = 1.5e-123
 Identities = 137/204 (67%), Positives = 167/204 (81%)

Query:   164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             DVKPENLLYT      ILKLTDFGFAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSC
Sbjct:   152 DVKPENLLYTSKRPKAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSC 210

Query:   224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
             D+WSLGVIMYILLCG+PPF+SNHG AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N
Sbjct:   211 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 270

Query:   284 MLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
             +L  +P++R+TI + M + WI Q  +VPQTPL T ++LKE +E W +V++EMT +LATMR
Sbjct:   271 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 330

Query:   344 VDYDQIHIKSLINSKNPLLNKRRK 367
             VDY+QI IK + ++ NPLL KRRK
Sbjct:   331 VDYEQIKIKKIEDASNPLLLKRRK 354

GO:0002224 "toll-like receptor signaling pathway" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0006950 "response to stress" evidence=ISS

GO:0006954 "inflammatory response" evidence=ISS

GO:0006974 "response to DNA damage stimulus" evidence=ISS

GO:0031572 "G2 DNA damage checkpoint" evidence=ISS

GO:0032496 "response to lipopolysaccharide" evidence=ISS

GO:0032675 "regulation of interleukin-6 production" evidence=ISS

GO:0032680 "regulation of tumor necrosis factor production" evidence=ISS

GO:0044351 "macropinocytosis" evidence=ISS

GO:0070935 "3'-UTR-mediated mRNA stabilization" evidence=ISS

MGI|MGI:109298 Mapkapk2 "MAP kinase-activated protein kinase 2" [Mus musculus (taxid:10090)]

 Score = 752 (269.8 bits), Expect = 1.9e-123, Sum P(2) = 1.9e-123
 Identities = 137/204 (67%), Positives = 167/204 (81%)

Query:   164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             DVKPENLLYT      ILKLTDFGFAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSC
Sbjct:   172 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSC 230

Query:   224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
             D+WSLGVIMYILLCG+PPF+SNHG AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N
Sbjct:   231 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 290

Query:   284 MLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
             +L  +P++R+TI + M + WI Q  +VPQTPL T ++LKE +E W +V++EMT +LATMR
Sbjct:   291 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 350

Query:   344 VDYDQIHIKSLINSKNPLLNKRRK 367
             VDY+QI IK + ++ NPLL KRRK
Sbjct:   351 VDYEQIKIKKIEDASNPLLLKRRK 374

GO:0000166 "nucleotide binding" evidence=IEA

GO:0002224 "toll-like receptor signaling pathway" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005737 "cytoplasm" evidence=ISO;IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0006950 "response to stress" evidence=ISO

GO:0006954 "inflammatory response" evidence=IMP

GO:0006974 "response to DNA damage stimulus" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO

GO:0031572 "G2 DNA damage checkpoint" evidence=ISO

GO:0032496 "response to lipopolysaccharide" evidence=IMP

GO:0032675 "regulation of interleukin-6 production" evidence=IMP

GO:0032680 "regulation of tumor necrosis factor production" evidence=ISO;IMP

GO:0035924 "cellular response to vascular endothelial growth factor stimulus" evidence=ISO

GO:0044351 "macropinocytosis" evidence=IMP

GO:0048010 "vascular endothelial growth factor receptor signaling pathway" evidence=ISO

GO:0048255 "mRNA stabilization" evidence=IMP

GO:0048839 "inner ear development" evidence=IDA

GO:0070935 "3'-UTR-mediated mRNA stabilization" evidence=ISO

RGD|631362 Mapkapk2 "mitogen-activated protein kinase-activated protein kinase 2" [Rattus norvegicus (taxid:10116)]

 Score = 751 (269.4 bits), Expect = 2.4e-123, Sum P(2) = 2.4e-123
 Identities = 136/204 (66%), Positives = 167/204 (81%)

Query:   164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             DVKPENLLYT      ILKLTDFGFAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSC
Sbjct:   172 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSC 230

Query:   224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
             D+WSLGVIMYILLCG+PPF+SNHG AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N
Sbjct:   231 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 290

Query:   284 MLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
             +L  +P++R+TI + M + WI Q  +VPQTPL T ++LKE +E W +V++EMT +LATMR
Sbjct:   291 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 350

Query:   344 VDYDQIHIKSLINSKNPLLNKRRK 367
             VDY+Q+ IK + ++ NPLL KRRK
Sbjct:   351 VDYEQVKIKKIEDASNPLLLKRRK 374

GO:0002224 "toll-like receptor signaling pathway" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0006950 "response to stress" evidence=ISO

GO:0006954 "inflammatory response" evidence=ISO

GO:0006974 "response to DNA damage stimulus" evidence=ISO

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO

GO:0031572 "G2 DNA damage checkpoint" evidence=ISO

GO:0032496 "response to lipopolysaccharide" evidence=ISO

GO:0032675 "regulation of interleukin-6 production" evidence=ISO

GO:0032680 "regulation of tumor necrosis factor production" evidence=ISO

GO:0035924 "cellular response to vascular endothelial growth factor stimulus" evidence=ISO

GO:0044351 "macropinocytosis" evidence=ISO

GO:0048010 "vascular endothelial growth factor receptor signaling pathway" evidence=ISO

GO:0048255 "mRNA stabilization" evidence=ISO

GO:0048839 "inner ear development" evidence=ISO

GO:0070935 "3'-UTR-mediated mRNA stabilization" evidence=ISO

ZFIN|ZDB-GENE-030131-5532 mapkapk2a "mitogen-activated protein kinase-activated protein kinase 2a" [Danio rerio (taxid:7955)]

 Score = 749 (268.7 bits), Expect = 1.3e-122, Sum P(2) = 1.3e-122
 Identities = 136/204 (66%), Positives = 169/204 (82%)

Query:   164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             DVKPENLLYT      +LKLTDFGFAK+  ++  SL TPCYTPYYVAPEVLGP+KYDKSC
Sbjct:   167 DVKPENLLYTSKRPNALLKLTDFGFAKETTTHN-SLATPCYTPYYVAPEVLGPEKYDKSC 225

Query:   224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
             D+WSLGVIMYILLCG+PPF+SNHG AISPGMK RIR+GQ++FPNPEW  VS+EAK LI+ 
Sbjct:   226 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKKRIRMGQYEFPNPEWSEVSEEAKQLIRT 285

Query:   284 MLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
             +L  +P++R+TI + M + WI+Q  +VPQTPL T ++LKE ++TW +V++EMT +LATMR
Sbjct:   286 LLKTEPTQRMTITEFMNHPWINQSMEVPQTPLHTSRVLKEEKDTWEDVKEEMTSALATMR 345

Query:   344 VDYDQIHIKSLINSKNPLLNKRRK 367
             VDY+QI IK + +S NPLL KRRK
Sbjct:   346 VDYEQIKIKRIEDSTNPLLIKRRK 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA;IMP

GO:0055113 "epiboly involved in gastrulation with mouth forming second" evidence=IMP

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|P49136 MAPKAPK2 "MAP kinase-activated protein kinase 2" [Cricetulus longicaudatus (taxid:10030)]

 Score = 752 (269.8 bits), Expect = 4.1e-119, Sum P(2) = 4.1e-119
 Identities = 137/204 (67%), Positives = 167/204 (81%)

Query:   164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             DVKPENLLYT      ILKLTDFGFAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSC
Sbjct:   115 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSC 173

Query:   224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
             D+WSLGVIMYILLCG+PPF+SNHG AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N
Sbjct:   174 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 233

Query:   284 MLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
             +L  +P++R+TI + M + WI Q  +VPQTPL T ++LKE +E W +V++EMT +LATMR
Sbjct:   234 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 293

Query:   344 VDYDQIHIKSLINSKNPLLNKRRK 367
             VDY+QI IK + ++ NPLL KRRK
Sbjct:   294 VDYEQIKIKKIEDASNPLLLKRRK 317

GO:0002224 "toll-like receptor signaling pathway" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0006950 "response to stress" evidence=ISS

GO:0006954 "inflammatory response" evidence=ISS

GO:0006974 "response to DNA damage stimulus" evidence=ISS

GO:0031572 "G2 DNA damage checkpoint" evidence=ISS

GO:0032496 "response to lipopolysaccharide" evidence=ISS

GO:0032675 "regulation of interleukin-6 production" evidence=ISS

GO:0032680 "regulation of tumor necrosis factor production" evidence=ISS

GO:0044351 "macropinocytosis" evidence=ISS

GO:0070935 "3'-UTR-mediated mRNA stabilization" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q66H84	MAPK3_RAT	2, ., 7, ., 1, 1, ., 1	0.5906	0.9086	0.8802	no	N/A
Q869W6	MYLKG_DICDI	2, ., 7, ., 1, 1, ., 1, 8	0.3552	0.6989	0.7449	yes	N/A
Q3SYZ2	MAPK3_BOVIN	2, ., 7, ., 1, 1, ., 1	0.5934	0.9086	0.8802	no	N/A
P49138	MAPK2_MOUSE	2, ., 7, ., 1, 1, ., 1	0.5888	0.9005	0.8678	yes	N/A
P49071	MAPK2_DROME	2, ., 7, ., 1, 1, ., 1	0.6545	0.8978	0.9303	yes	N/A
P49137	MAPK2_HUMAN	2, ., 7, ., 1, 1, ., 1	0.5972	0.9005	0.8375	no	N/A
P49136	MAPK2_CRILO	2, ., 7, ., 1, 1, ., 1	0.6023	0.8521	0.9635	N/A	N/A
Q16644	MAPK3_HUMAN	2, ., 7, ., 1, 1, ., 1	0.5989	0.9086	0.8848	yes	N/A
Q3UMW7	MAPK3_MOUSE	2, ., 7, ., 1, 1, ., 1	0.5906	0.9086	0.8802	no	N/A
P49139	MAPK2_RABIT	2, ., 7, ., 1, 1, ., 1	0.6	0.9005	0.9153	no	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	372
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-83
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-74
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-61
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-51
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-50
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-45
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-45
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-44
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-42
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-41
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-41
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-37
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-37
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-36
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-36
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-36
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-35
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-35
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-35
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-33
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-33
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-33
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-33
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-32
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-32
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-32
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-32
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-31
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-31
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-31
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-31
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-31
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-30
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-30
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-30
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-30
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-29
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-29
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-29
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-28
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-28
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-28
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-27
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-27
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-27
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-27
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-27
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-27
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-27
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-26
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-26
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-26
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-26
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-26
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-25
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-25
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-25
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-25
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-25
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-25
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-25
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-25
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-24
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-24
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-24
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-24
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-23
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-23
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-23
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-23
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-23
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-23
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-22
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-22
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-22
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-22
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-22
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-21
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-21
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-21
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-21
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-21
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-21
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-21
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-20
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-20
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-20
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-20
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-20
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-19
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-19
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-19
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-19
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-19
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-19
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-19
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-18
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-18
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-17
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-16
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-16
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-16
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-15
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-14
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-13
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-13
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-10
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-07
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-07
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-06
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-05
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-04
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-04
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-04
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	0.001
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.001
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  254 bits (651), Expect = 2e-83
 Identities = 99/289 (34%), Positives = 152/289 (52%), Gaps = 45/289 (15%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNIK 75
           E LG G  GKV    +KKT ++ A+KV+       D  +  RE+++   +  H +IV + 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK-HPNIVRLY 63

Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
           DV+E+       L ++ME   GG+LF  ++++  G  +E EA   + +I SA+++LH + 
Sbjct: 64  DVFED----EDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSKG 117

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I HRD+KPEN+L  + G                            +KL DFG A+++   
Sbjct: 118 IVHRDLKPENILLDEDGH---------------------------VKLADFGLARQL-DP 149

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
              L T   TP Y+APEVL    Y K+ DIWSLGVI+Y LL G PPF  +        + 
Sbjct: 150 GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLE---LF 206

Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            +I   +  FP PEW+ +S EAK LI+ +L  DP +RLT ++ +++ + 
Sbjct: 207 KKIGKPKPPFPPPEWD-ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  230 bits (589), Expect = 3e-74
 Identities = 100/291 (34%), Positives = 144/291 (49%), Gaps = 43/291 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNI 74
             LG G  G V +   K T ++ A+K+L            ARRE+ + L   SH +IV +
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRI-LRRLSHPNIVRL 63

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            D +E+       L  +ME   GG+LF  +     G  +E EA  I  +I   +++LH  
Sbjct: 64  IDAFED--KDHLYL--VMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KPEN+L  + G                            +K+ DFG AKK++ 
Sbjct: 118 GIIHRDLKPENILLDENGV---------------------------VKIADFGLAKKLLK 150

Query: 195 NKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
           + +SL T   TP+Y+APEVL G + Y    D+WSLGVI+Y LL G PP FS         
Sbjct: 151 SSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP-FSGENILDQLQ 209

Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  RI     +F  P+W   S+EAK LIK  L  DPS+R T ++++++ W 
Sbjct: 210 LIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  196 bits (502), Expect = 2e-61
 Identities = 99/295 (33%), Positives = 144/295 (48%), Gaps = 61/295 (20%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVE--------LQLAVGSHKHIVNI 74
           LG G  GKVL + +K T ++YA+KVL    +  R+EVE        L     +H  IV +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI--NHPFIVKL 58

Query: 75  K---DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
                  E +Y       +++E   GGELF  + ++  G F+E  A     EI  A+++L
Sbjct: 59  HYAFQTEEKLY-------LVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYL 109

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I +RD+KPEN+L           L                 DG I KLTDFG AK+
Sbjct: 110 HSLGIIYRDLKPENIL-----------LDA---------------DGHI-KLTDFGLAKE 142

Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           + S  +   T C TP Y+APEVL    Y K+ D WSLGV++Y +L G PPF++   + I 
Sbjct: 143 LSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202

Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT---IDQVMENKW 303
                +I      FP    E +S EA+ LI  +L  DP++RL     +++  + +
Sbjct: 203 ----EKILKDPLRFP----EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  174 bits (444), Expect = 1e-52
 Identities = 86/295 (29%), Positives = 140/295 (47%), Gaps = 49/295 (16%)

Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSH 68
            Y+I  + +G G  GKV  +  K   ++Y LK +        +   A  EV++ L   +H
Sbjct: 1   KYEI-IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKI-LKKLNH 58

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRI--QQKEDGAFTEREAAIIMNEICS 126
            +I+   + +E    G   L ++ME   GG+L Q+I  Q+KE   F E +      ++C 
Sbjct: 59  PNIIKYYESFE--EKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+K+LH + I HRD+KP+N+  T                             G++KL DF
Sbjct: 115 ALKYLHSRKILHRDIKPQNIFLTS---------------------------NGLVKLGDF 147

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G +K + S     +T   TPYY++PE+     Y+   DIWSLG ++Y L     PF   +
Sbjct: 148 GISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
              ++     +I  GQ+  P P     S E + L+ ++L  DP ER +I Q++++
Sbjct: 208 LLELA----LKILKGQYP-PIP--SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  170 bits (434), Expect = 1e-51
 Identities = 82/285 (28%), Positives = 125/285 (43%), Gaps = 78/285 (27%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL------HDTVKARREVELQLAVGSHKHIVNIKDV 77
           LG G  G V    +KKT +  A+K++          +  RE+E+   + +H +IV +  V
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59

Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           +E+       L ++ME   GG L   +++ E    +E E   I+ +I   +++LH   I 
Sbjct: 60  FED----ENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGII 114

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+KPEN+L                             D G +KL DFG +K + S+K+
Sbjct: 115 HRDLKPENILLDS--------------------------DNGKVKLADFGLSKLLTSDKS 148

Query: 198 SLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            L+T   TP Y+APEVL G   Y +  DIWSLGVI+Y L                     
Sbjct: 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------- 187

Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
                              E K LI+ ML  DP +R +  +++E+
Sbjct: 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  169 bits (431), Expect = 3e-50
 Identities = 92/307 (29%), Positives = 153/307 (49%), Gaps = 69/307 (22%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVGSHKHIVN 73
           DD++   + LG G  G+V+ +  K + + YALK+L    +   ++VE         H++N
Sbjct: 1   DDFEF-IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE---------HVLN 50

Query: 74  IKDVYENIYN-------GS----RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
            K + ++I +       GS      L ++ME + GGELF  +++   G F E  A     
Sbjct: 51  EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAA 108

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++  A+++LH  +I +RD+KPENLL                               G +K
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDS---------------------------DGYIK 141

Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           +TDFGFAK++     +L   C TP Y+APE++    Y K+ D W+LG+++Y +L G+PPF
Sbjct: 142 ITDFGFAKRVKGRTYTL---CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198

Query: 243 FSNHGQAISP-GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQ---- 297
           F +     +P  +  +I  G+  FP+      S +AK LI+N+L VD ++RL   +    
Sbjct: 199 FDD-----NPIQIYEKILEGKVRFPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVN 249

Query: 298 -VMENKW 303
            +  + W
Sbjct: 250 DIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  156 bits (397), Expect = 1e-45
 Identities = 77/294 (26%), Positives = 131/294 (44%), Gaps = 50/294 (17%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVL------HDTVKA-RREVEL--QLAVGSHKHIV 72
           E+LG G  G V   ++K T E+ A+K +       + ++A  RE+ +   L    H +IV
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL---QHPNIV 62

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                  +       L + +E + GG L   +++   G   E        +I   + +LH
Sbjct: 63  RYYGSERD--EEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLH 118

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+K  N+L                               G++KL DFG AK++
Sbjct: 119 SNGIVHRDIKGANILVDS---------------------------DGVVKLADFGCAKRL 151

Query: 193 VSN--KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
                     +   TPY++APEV+  ++Y ++ DIWSLG  +  +  G PP +S  G  +
Sbjct: 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP-WSELGNPM 210

Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +   K    +G    P    EH+S+EAK  ++  L  DP +R T D+++++ ++
Sbjct: 211 AALYK----IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  155 bits (394), Expect = 4e-45
 Identities = 84/292 (28%), Positives = 131/292 (44%), Gaps = 53/292 (18%)

Query: 30  GKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQLAVGSHKHIVNIKDVYE 79
           G+V    +K T ++YA+KV+           D V   R++  Q       ++V +   Y 
Sbjct: 7   GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA---QSPYVVKL---YY 60

Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
           +   G + L ++ME + GG+L   ++    G+  E  A I + EI  A+++LH   I HR
Sbjct: 61  SF-QGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHR 117

Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF---AKKIVSNK 196
           D+KP+N+L       G LKLTDFG                   L+  G       +  ++
Sbjct: 118 DLKPDNILIDS---NGHLKLTDFG-------------------LSKVGLVRRQINLNDDE 155

Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
              +    TP Y+APEV+    + K+ D WSLG I+Y  L G PPF     + I   + N
Sbjct: 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215

Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL---TIDQVMENKWIS 305
                      PE   VS EA  LI  +L  DP +RL   +I+++  + +  
Sbjct: 216 G------KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  153 bits (390), Expect = 3e-44
 Identities = 86/298 (28%), Positives = 139/298 (46%), Gaps = 36/298 (12%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL----------HDTVKARREVELQLA 64
           DD+    +I+G G    V+   EK+T++ YA+K+L             VK  +EV  +L 
Sbjct: 1   DDFKFG-KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN 59

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H  I+ +   +++       L  ++E    GEL Q I++   G+  E+       EI
Sbjct: 60  --GHPGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEI 111

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
             A+++LH + I HRD+KPEN+L  K      +K+TDFG  K    +          K  
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMH---IKITDFGTAK----VLDPNSSPESNKGD 164

Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF- 243
                 +I  N+    +   T  YV+PE+L      KS D+W+LG I+Y +L G PPF  
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           SN           +I   ++ FP     +   +AK LI+ +L +DP +RL +++  + 
Sbjct: 225 SNEYL-----TFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  150 bits (380), Expect = 1e-42
 Identities = 95/315 (30%), Positives = 153/315 (48%), Gaps = 59/315 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--DTVKARREVELQ-----LAVGS 67
           DD +    + G G  G+V  + ++ +   YALKV+   + ++ ++E  +      L   S
Sbjct: 1   DDLERIKTV-GTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H  I+ +     +       L ++ME + GGELF  ++    G F+        +EI  A
Sbjct: 60  HPFIIRLFWTEHDQRF----LYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCA 113

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +++LH + I +RD+KPEN+L  K G                            +KLTDFG
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGH---------------------------IKLTDFG 146

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           FAKK+     +L   C TP Y+APEV+    ++K+ D W+LG+++Y +L G+PPFF ++ 
Sbjct: 147 FAKKLRDRTWTL---CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN- 202

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENK 302
                G+  +I  G+ +FP     H+   AK LIK +L VD + RL       D V  ++
Sbjct: 203 ---PFGIYEKILAGKLEFP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255

Query: 303 WISQ--FNQVPQTPL 315
           W     ++ VPQ  L
Sbjct: 256 WFKSVDWDDVPQRKL 270

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  146 bits (371), Expect = 1e-41
 Identities = 96/305 (31%), Positives = 144/305 (47%), Gaps = 66/305 (21%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENI-- 81
           LG+G  G+V  +  K  +  +ALK     VK R  VE        +HI + K++ E    
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKC----VKKRHIVETGQ----QEHIFSEKEILEECNH 52

Query: 82  ---------YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                    +   + + ++ME   GGEL+  ++ +  G F E  A   +  +  A ++LH
Sbjct: 53  PFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLH 110

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           ++ I +RD+KPENLL                               G +KL DFGFAKK+
Sbjct: 111 NRGIIYRDLKPENLLL---------------------------DSNGYVKLVDFGFAKKL 143

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
             +     T C TP YVAPE++    YD S D WSLG+++Y LL G PPF    G+    
Sbjct: 144 -KSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF----GEDDED 198

Query: 253 GMK--NRI--RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKW 303
            M+  N I    G+ +FPN    ++ + AK LIK +L  +P ERL      I  + ++KW
Sbjct: 199 PMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254

Query: 304 ISQFN 308
            + F+
Sbjct: 255 FNGFD 259

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  147 bits (372), Expect = 7e-41
 Identities = 88/370 (23%), Positives = 144/370 (38%), Gaps = 47/370 (12%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVK--------ARREVELQLAVGSHKHIVN 73
             LG G  G+V    ++K     ALKVL   ++          RE+++  ++    +IV 
Sbjct: 6   RKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLH 132
           + D +++       L ++ME + GG L   +++    G  +E EA  I+ +I SA+++LH
Sbjct: 63  LYDFFQD----EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
            + I HRD+KPEN+L  +  DG ++KL DFG  K                          
Sbjct: 119 SKGIIHRDIKPENILLDR--DGRVVKLIDFGLAKL------------------LPDPGST 158

Query: 193 VSNKASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
            S  A   T   TP Y+APEVL          S DIWSLG+ +Y LL G PPF      +
Sbjct: 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218

Query: 250 ISPGMKNRIRLGQFDFPNPEW-----EHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            +      I                 E +S+ A  L+K +L  DP  RL+    + +  +
Sbjct: 219 ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Query: 305 SQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQI--HIKSLINSKNPLL 362
           +             K   +       +   +   ++++               N    L 
Sbjct: 279 AHLKLKESDLSDLLK-PDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELA 337

Query: 363 NKRRKNQSPS 372
                +   +
Sbjct: 338 PNGVSSSPHN 347

Length = 384

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  136 bits (344), Expect = 3e-37
 Identities = 89/279 (31%), Positives = 141/279 (50%), Gaps = 48/279 (17%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVG------SHKHIVNI 74
           ++LG G  GKV+ + EK T + YA+K+L  + + A+ EV   L          H  +  +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           K  ++        L  +ME  +GGELF  + +  +  F+E  A     EI SA+ +LH  
Sbjct: 61  KYSFQT----HDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSC 114

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
           ++ +RD+K ENL+  K                          DG I K+TDFG  K+ +S
Sbjct: 115 DVVYRDLKLENLMLDK--------------------------DGHI-KITDFGLCKEGIS 147

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           + A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++   + +    
Sbjct: 148 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF--- 204

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
              I + +  FP      +S EAK+L+  +L  DP +RL
Sbjct: 205 -ELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  136 bits (344), Expect = 3e-37
 Identities = 93/300 (31%), Positives = 150/300 (50%), Gaps = 55/300 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVG------SHKHIVNI 74
           ++LG G  GKV+ + EK T   YA+K+L  + + A+ EV   +          H  +  +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           K  ++        L  +ME  +GGELF  + ++    FTE  A     EI SA+++LH +
Sbjct: 61  KYAFQT----HDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR 114

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
           ++ +RD+K ENL+  K G                            +K+TDFG  K+ +S
Sbjct: 115 DVVYRDIKLENLMLDKDGH---------------------------IKITDFGLCKEGIS 147

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISPG 253
           + A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H +     
Sbjct: 148 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFN 308
           +   IR     FP      +S EAK+L+  +L  DP +RL        +VME+++    N
Sbjct: 208 LMEEIR-----FP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 9e-37
 Identities = 96/312 (30%), Positives = 147/312 (47%), Gaps = 42/312 (13%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLA 64
           DD++ S +++G G  G+V  + +K T  +YA+K L  +          V+A R++   LA
Sbjct: 1   DDFE-SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI---LA 56

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              +  +V +   +++       L +IME + GG++   + +K+   FTE E    + E 
Sbjct: 57  EADNPWVVKLYYSFQDENY----LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAET 110

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP----------ENLLYTK 174
             AI  +H     HRD+KP+NLL    G    +KL+DFG                L +  
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHAL 167

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCY----TPYYVAPEVLGPDKYDKSCDIWSLGV 230
           P +            +K  + K + +   Y    TP Y+APEV     Y+K CD WSLGV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227

Query: 231 IMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPS 290
           IMY +L G+PPF S++ Q     + N     QF    P+   +S EAK LIK + C +  
Sbjct: 228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQF----PDEVPLSPEAKDLIKRLCC-EAE 282

Query: 291 ERLTIDQVMENK 302
            RL  + V E K
Sbjct: 283 RRLGNNGVNEIK 294

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (335), Expect = 1e-36
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 50/290 (17%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREV---ELQ-LAVGSHKHIVNIKDV 77
           E +G G  G+V +   K+T +  A+KV+    K ++E    E+Q L    H +IV     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY--- 62

Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y +       L ++ME   GG L   ++   +   TE + A +  E+   +++LH   I 
Sbjct: 63  YGSYLKKDE-LWIVMEFCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNGII 120

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+K  N+L           LT  G+V                KL DFG + ++   KA
Sbjct: 121 HRDIKAANIL-----------LTSDGEV----------------KLIDFGLSAQLSDTKA 153

Query: 198 SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI-LLCGFPPFFSNHGQAISPGMKN 256
              T   TPY++APEV+    YD   DIWSLG I  I L  G PP+         P MK 
Sbjct: 154 R-NTMVGTPYWMAPEVINGKPYDYKADIWSLG-ITAIELAEGKPPYSE------LPPMKA 205

Query: 257 RIRLGQFDFP---NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
             ++     P   NPE    S E K  +K  L  +P +R T +Q++++ +
Sbjct: 206 LFKIATNGPPGLRNPEK--WSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 2e-36
 Identities = 83/290 (28%), Positives = 130/290 (44%), Gaps = 48/290 (16%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALK--VLHDTVKA-----RREVELQLAVGSHKHIVNI 74
           +++G G  G V + +  +T +  A+K   L    +       +E++L L    H +IV  
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDL-LKNLKHPNIVKY 64

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
               E     S  L +I+E    G L Q I  K+ G F E   A+ + ++   + +LH+Q
Sbjct: 65  IGSIET----SDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+K  N+L TK                            G++KL DFG A K+  
Sbjct: 119 GVIHRDIKAANILTTK---------------------------DGVVKLADFGVATKLND 151

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
                 +   TPY++APEV+       + DIWSLG  +  LL G PP++      ++P M
Sbjct: 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD-----LNP-M 205

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
               R+ Q D P P  E +S E K  +      DP+ R T  Q++++ WI
Sbjct: 206 AALFRIVQDDHP-PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 5e-36
 Identities = 83/302 (27%), Positives = 136/302 (45%), Gaps = 45/302 (14%)

Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNI 74
            E++G G  G V +     T  V ALK+++      D    +REV L L+        NI
Sbjct: 6   LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVAL-LSQLRQSQPPNI 64

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              Y +   G R L +IME   GG +   +   + G   E+  ++I+ E+  A+K++H  
Sbjct: 65  TKYYGSYLKGPR-LWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+K  N+L T  G+                           +KL DFG A  +  
Sbjct: 121 GVIHRDIKAANILVTNTGN---------------------------VKLCDFGVAALLNQ 153

Query: 195 NKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
           N +   T   TPY++APEV      YD   DIWSLG+ +Y +  G PP +S+        
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP-YSDV-----DA 207

Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT 313
            +  + + +   P  E    S+  +  +   L  +P ERL+ ++++++KWI   ++ P +
Sbjct: 208 FRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVS 267

Query: 314 PL 315
            L
Sbjct: 268 IL 269

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 6e-36
 Identities = 95/333 (28%), Positives = 145/333 (43%), Gaps = 66/333 (19%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNI 74
           DD+++   ++G G  G+V  + +K T +VYA+KVL  +   +R    Q+A     H+   
Sbjct: 1   DDFEVIK-VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN---QIA-----HVRAE 51

Query: 75  KDVY------------------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTERE 116
           +D+                   E++Y       ++ME M GG+L   + +K+   F E  
Sbjct: 52  RDILADADSPWIVKLYYSFQDEEHLY-------LVMEYMPGGDLMNLLIRKDV--FPEET 102

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
           A   + E+  A+  +H     HRD+KP+N+L     DG I KL DFG       L  K  
Sbjct: 103 ARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA--DGHI-KLADFG-------LCKKMN 152

Query: 177 DGG------ILKLTDFGFAKKIVSNKASLQTPCY------TPYYVAPEVLGPDKYDKSCD 224
                                +V  +   Q          TP Y+APEVL    Y   CD
Sbjct: 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECD 212

Query: 225 IWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNM 284
            WSLGVI+Y +L GFPPF+S+  Q       N+I   +     P    VS EA  LI  +
Sbjct: 213 WWSLGVILYEMLYGFPPFYSDTLQ----ETYNKIINWKESLRFPPDPPVSPEAIDLICRL 268

Query: 285 LCVDPSERLT-IDQVMENKWIS--QFNQVPQTP 314
           LC DP +RL   +++  + +     +  + +T 
Sbjct: 269 LC-DPEDRLGSFEEIKSHPFFKGIDWENLRETK 300

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  129 bits (327), Expect = 2e-35
 Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 48/291 (16%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALK----VLHDTVKARREV--ELQLAVG-SHKHIVNIK 75
           ++G G  GKV  + ++ T +++A+K           + R V  E ++    +H  +VN+ 
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
             +++  N    + ++++ + GG+L   + QK    F+E +    + EI  A+++LH + 
Sbjct: 67  YSFQDEEN----MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I HRD+KP+N+L  + G                            + +TDF  A K V+ 
Sbjct: 121 IIHRDIKPDNILLDEQGH---------------------------VHITDFNIATK-VTP 152

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
                +   TP Y+APEVL    Y  + D WSLGV  Y  L G  P+     +  S  ++
Sbjct: 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY-----RGHSRTIR 207

Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL--TIDQVMENKWI 304
           ++IR  Q           S EA   I  +L  DP +RL   +  +  + + 
Sbjct: 208 DQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  129 bits (327), Expect = 4e-35
 Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 48/292 (16%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREV--ELQLAVGS-HKHIVNIKDVY 78
           E +G G +G+V +  ++ T +  A+K +    + +  +  E+ +     H +IV+  D Y
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
             +      L V+ME M GG L   I Q       E + A +  E+   +++LH QN+ H
Sbjct: 85  --LVGD--ELWVVMEYMDGGSLTDIITQN-FVRMNEPQIAYVCREVLQGLEYLHSQNVIH 139

Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K +N+L +K G                            +KL DFGFA ++   K+ 
Sbjct: 140 RDIKSDNILLSKDGS---------------------------VKLADFGFAAQLTKEKSK 172

Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNR 257
             +   TPY++APEV+    Y    DIWSLG IM I +  G PP+         P ++  
Sbjct: 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLG-IMCIEMAEGEPPYLRE------PPLRAL 225

Query: 258 IRL---GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             +   G     NP  E  S E K  +   L  DP +R + ++++++ ++ +
Sbjct: 226 FLITTKGIPPLKNP--EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  128 bits (325), Expect = 6e-35
 Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 42/287 (14%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH--DTVKARREV--EL-QLAVGSHKHIVNIKDVY 78
           LG G +G V ++  K T ++YALK +H     + R+++  EL  L      ++V     +
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-DQNIA 137
                G   +  ++E M GG L   +  K+ G   E   A I  +I   + +LH  ++I 
Sbjct: 69  YK--EGEISI--VLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHTKRHII 122

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+KP NLL    G+                           +K+ DFG +K + +   
Sbjct: 123 HRDIKPSNLLINSKGE---------------------------VKIADFGISKVLENTLD 155

Query: 198 SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNR 257
              T   T  Y++PE +  + Y  + DIWSLG+ +     G  PF    GQ     +   
Sbjct: 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP-GQPSFFELMQA 214

Query: 258 IRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           I       P+   E  S E +  I   L  DP +R +  +++++ +I
Sbjct: 215 IC--DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  127 bits (320), Expect = 1e-33
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 49/279 (17%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VGSHKHIVNI 74
           +LG G  GKVL    K T E+YA+KVL  D +    +VE  +         G H  +  +
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              ++        L  +ME ++GG+L   IQ+   G F E  A     EI   ++FLH++
Sbjct: 62  HSCFQTKDR----LFFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K +N+L    G                            +K+ DFG  K+ + 
Sbjct: 116 GIIYRDLKLDNVLLDSEGH---------------------------IKIADFGMCKEGIL 148

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
              +  T C TP Y+APE+L    Y  + D W+LGV++Y +L G  PF    G      +
Sbjct: 149 GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF---EGDD-EDEL 204

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
              I   +  +P      +S+EAK+++K+ L  +P +RL
Sbjct: 205 FQSILEDEVRYP----RWLSKEAKSILKSFLTKNPEKRL 239

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  125 bits (316), Expect = 1e-33
 Identities = 88/307 (28%), Positives = 133/307 (43%), Gaps = 60/307 (19%)

Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVG-------- 66
           DY++  E +G G  G V ++  K   ++   K +    +    E E Q  V         
Sbjct: 1   DYEV-LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---EKEKQQLVSEVNILREL 56

Query: 67  SHKHIVNIKDVYENIYNGSRCLL-VIMECMHGGELFQRIQ--QKEDGAFTEREAAIIMNE 123
            H +IV     Y+ I + S   L ++ME   GG+L Q IQ  +KE     E     I+ +
Sbjct: 57  KHPNIVRY---YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 124 ICSAIKFLH-----DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           +  A+   H        + HRD+KP N+               F D              
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANI---------------FLD------------AN 146

Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG 238
             +KL DFG AK +  + +  +T   TPYY++PE L    YD+  DIWSLG ++Y L   
Sbjct: 147 NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL 206

Query: 239 FPPFF-SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQ 297
            PPF   N  Q  S     +I+ G+F    P     S E   +IK+ML VDP +R + ++
Sbjct: 207 SPPFTARNQLQLAS-----KIKEGKFR-RIP--YRYSSELNEVIKSMLNVDPDKRPSTEE 258

Query: 298 VMENKWI 304
           +++   I
Sbjct: 259 LLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  127 bits (320), Expect = 1e-33
 Identities = 86/283 (30%), Positives = 134/283 (47%), Gaps = 59/283 (20%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQLAVGSHKHI 71
           E LG G  G+V     K T E YA+K L             V   + + ++L   SH  I
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL---SHPFI 80

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           VN+   +++       +  ++E + GGELF  +++   G F    A     E+  A ++L
Sbjct: 81  VNMMCSFQD----ENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYL 134

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H ++I +RD+KPENLL    G                            +K+TDFGFAKK
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGH---------------------------VKVTDFGFAKK 167

Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +     +L   C TP Y+APEV+    + K+ D W++GV++Y  + G+PPFF +     +
Sbjct: 168 VPDRTFTL---CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD-----T 219

Query: 252 P-GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           P  +  +I  G+  FPN  W      A+ L+K +L  D ++RL
Sbjct: 220 PFRIYEKILAGRLKFPN--W--FDGRARDLVKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 1e-33
 Identities = 82/286 (28%), Positives = 136/286 (47%), Gaps = 41/286 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL---QLAVGSHKHIVNIKDVY 78
           E +G G  G+V + ++K+T++V A+KV+ D  +A  E+E    ++   S      I   Y
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65

Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
            +   GS+ L +IME   GG     +   + G   E   A I+ E+   +++LH++   H
Sbjct: 66  GSFLKGSK-LWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEEGKIH 121

Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  N+L           L++ GDVK                L DFG + ++ S  + 
Sbjct: 122 RDIKAANIL-----------LSEEGDVK----------------LADFGVSGQLTSTMSK 154

Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
             T   TP+++APEV+    YD+  DIWSLG+    L  G PP    H     P M+   
Sbjct: 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-----P-MRVLF 208

Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            + + + P+ E    S+  K  +   L  DP ER +  +++++K+I
Sbjct: 209 LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 4e-33
 Identities = 77/318 (24%), Positives = 126/318 (39%), Gaps = 75/318 (23%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-D------TVKARREVEL--QLAVGSHKHIV 72
           E LG G  G V +  +KKT E+ ALK +  D         A RE+ L  +L    H +IV
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL---KHPNIV 61

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGEL-FQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
            + DV     +  R L ++ E     ++  ++   K  G  +      IM ++   + + 
Sbjct: 62  KLLDVI----HTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I HRD+KP+N+L  +                            G+LKL DFG A+ 
Sbjct: 115 HSHRILHRDLKPQNILINR---------------------------DGVLKLADFGLARA 147

Query: 192 IVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFF--SNHGQ 248
                 +      T +Y APE+L G   Y  + DIWS+G I   ++ G P F   S   Q
Sbjct: 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207

Query: 249 AIS-------------PGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNMLC 286
                           PG+     L  +    P++           +  E   L+  ML 
Sbjct: 208 LFKIFQILGTPTEESWPGVTK---LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQ 264

Query: 287 VDPSERLTIDQVMENKWI 304
            +P++R++  + +++ + 
Sbjct: 265 YNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  123 bits (309), Expect = 3e-32
 Identities = 89/281 (31%), Positives = 141/281 (50%), Gaps = 51/281 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAV------GSHKHIVNI 74
           ++LG G  GKV+ + EK T   YA+K+L  + + A+ EV   L          H  +  +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-D 133
           K  ++        L  +ME  +GGELF  + +  +  F+E  A     EI SA+ +LH +
Sbjct: 61  KYSFQT----HDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSE 114

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           +N+ +RD+K ENL+  K G                            +K+TDFG  K+ +
Sbjct: 115 KNVVYRDLKLENLMLDKDGH---------------------------IKITDFGLCKEGI 147

Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISP 252
            + A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H +    
Sbjct: 148 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207

Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            +   IR     FP      +S EAK+L+  +L  DP +RL
Sbjct: 208 ILMEEIR-----FPRT----LSPEAKSLLSGLLKKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  122 bits (308), Expect = 4e-32
 Identities = 90/284 (31%), Positives = 136/284 (47%), Gaps = 56/284 (19%)

Query: 23  ILGLGINGKVLQI---VEKKTSEVYALKVLH---------DTVKARREVELQLAVGSHKH 70
           +LG G  GKV Q+       T +++A+KVL          DT   + E  +  AV  H  
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPF 61

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IV++  +Y     G   L +I+E + GGELF  +++  +G F E  A   ++EI  A++ 
Sbjct: 62  IVDL--IYAFQTGGK--LYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEH 115

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH Q I +RD+KPEN+L    G                            +KLTDFG  K
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGH---------------------------VKLTDFGLCK 148

Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQA 249
           + +       T C T  Y+APE+L    + K+ D WSLG +MY +L G PPF + N  + 
Sbjct: 149 ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT 208

Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           I   +K ++ L  +         ++ EA+ L+K +L  +PS RL
Sbjct: 209 IDKILKGKLNLPPY---------LTPEARDLLKKLLKRNPSSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  122 bits (307), Expect = 5e-32
 Identities = 84/279 (30%), Positives = 140/279 (50%), Gaps = 48/279 (17%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVGS------HKHIVNI 74
           ++LG G  GKV+ + EK + + YA+K+L  + + A+ EV   L          H  + ++
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           K  ++        L  +ME ++GGELF  + ++    F+E        EI SA+ +LH  
Sbjct: 61  KYSFQT----KDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG 114

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K ENL+  K G                            +K+TDFG  K+ ++
Sbjct: 115 KIVYRDLKLENLMLDKDGH---------------------------IKITDFGLCKEGIT 147

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           + A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++   + +    
Sbjct: 148 DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF--- 204

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
              I +    FP      +S +AK+L+  +L  DP++RL
Sbjct: 205 -ELILMEDIKFPRT----LSADAKSLLSGLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 9e-32
 Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 53/282 (18%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHK-----------HIV 72
           +G G  G+V Q+ +K T  +YA+KVL       ++ E+   +G               IV
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK-EVAHTIGERNILVRTLLDESPFIV 59

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +K  ++   +    L ++ + M GGELF  +Q+  +G F+E  A   + E+  A++ LH
Sbjct: 60  GLKFSFQTDSD----LYLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLH 113

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I +RD+KPEN+L    G                            + L DFG +K  
Sbjct: 114 KYDIVYRDLKPENILLDATGH---------------------------IALCDFGLSKAN 146

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +++  +  T C T  Y+APEVL  +K Y K  D WSLGV+++ + CG+ PF++   Q   
Sbjct: 147 LTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-- 204

Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             M   I  G+  FP      +S E +  +K +L  +P  RL
Sbjct: 205 --MYRNIAFGKVRFPK---NVLSDEGRQFVKGLLNRNPQHRL 241

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  119 bits (301), Expect = 1e-31
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 56/288 (19%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----------HDTVKARREVELQLAVGSHKHIVN 73
           LG G  G V ++     ++ YALK +           D V    E+ + LA  +H +I++
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN---EIRI-LASVNHPNIIS 63

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQ--QKEDGAFTEREAAIIMNEICSAIKFL 131
            K+ + +       L ++ME    G+L + I   +K+     E+E   I  ++   ++ L
Sbjct: 64  YKEAFLD----GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H+Q I HRD+K  N+L                                ++K+ D G +K 
Sbjct: 120 HEQKILHRDLKSANILLV---------------------------ANDLVKIGDLGISKV 152

Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +  N A  Q    TP+Y+APEV     Y    DIWSLG ++Y +    PPF +   Q + 
Sbjct: 153 LKKNMAKTQIG--TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210

Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
                +++ G++    P     SQ+ +  I++ML V P  R   D+++
Sbjct: 211 ----YKVQRGKYP---PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  121 bits (304), Expect = 1e-31
 Identities = 88/304 (28%), Positives = 140/304 (46%), Gaps = 48/304 (15%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARREVELQLAVGS------HKHIVNIKD 76
           +G G  GKV+Q+ ++ T  +YALK +    + +R EV   LA  +         IV +K 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            +++       L +++  ++GGELF  +Q+  +G F    A     E+  A++ LH  N+
Sbjct: 61  SFQS----PEKLYLVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNV 114

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            +RD+KPEN+L                      L Y      G + L DFG  K  + + 
Sbjct: 115 IYRDLKPENIL----------------------LDYQ-----GHIALCDFGLCKLNMKDD 147

Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
               T C TP Y+APE+L    Y K+ D W+LGV++Y +L G PPF+  +       M  
Sbjct: 148 DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN----VNEMYR 203

Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
           +I      FP    +   ++AK L+  +L  DP+ RL  +   E K    F+Q+    L 
Sbjct: 204 KILQEPLRFP----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLL 259

Query: 317 TGKM 320
              +
Sbjct: 260 MKGI 263

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  120 bits (303), Expect = 2e-31
 Identities = 82/280 (29%), Positives = 134/280 (47%), Gaps = 51/280 (18%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVGS-------HKHIVNI 74
           ++G G  GKVL    K   + YA+KVL    +  ++E +  +A  +       H  +V +
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              ++     +  L  +++ ++GGELF  +Q++   +F E  A     EI SA+ +LH  
Sbjct: 62  HYSFQT----ADKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL 115

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
           NI +RD+KPEN+L                               G + LTDFG  K+ + 
Sbjct: 116 NIIYRDLKPENILLD---------------------------SQGHVVLTDFGLCKEGIE 148

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISPG 253
           +  +  T C TP Y+APEVL    YD++ D W LG ++Y +L G PPF+S +  +     
Sbjct: 149 HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208

Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           +   +RL     PN     +S  A+ L++ +L  D ++RL
Sbjct: 209 LNKPLRLK----PN-----ISVSARHLLEGLLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  120 bits (303), Expect = 2e-31
 Identities = 89/316 (28%), Positives = 142/316 (44%), Gaps = 54/316 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ-------LAVGS 67
            D+D+ + ++G G  G+V  + EK T ++YA+KV+  +V   +E           L++ +
Sbjct: 1   KDFDVKS-LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              I  ++  +++  N    L ++ME   GG+L   + + ED  F E  A   + E+  A
Sbjct: 60  SPWIPQLQYAFQDKDN----LYLVMEYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLA 114

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I  +H     HRD+KPEN+L  + G                            +KL DFG
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGH---------------------------IKLADFG 147

Query: 188 FAKKIVSNKASLQT-PCYTPYYVAPEVL------GPDKYDKSCDIWSLGVIMYILLCGFP 240
            A ++ +NK      P  TP Y+APEVL      G   Y   CD WSLGVI Y ++ G  
Sbjct: 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207

Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF           + N  R  +F    PE   VS +   LI+++LC    ERL  + +  
Sbjct: 208 PFHEGTSAKTYNNIMNFQRFLKF----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262

Query: 301 NKWISQ--FNQVPQTP 314
           + + S+  +N +  + 
Sbjct: 263 HPFFSKIDWNNIRNSL 278

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  118 bits (298), Expect = 7e-31
 Identities = 84/308 (27%), Positives = 128/308 (41%), Gaps = 77/308 (25%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAVGSHKHIVNIKD 76
           +G G +G V +  +++T E  ALK +            A RE++   A   H ++V + D
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLD 66

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V+ +   GS  +LV ME M   +L + ++  E+    E +    M  +   + ++H   I
Sbjct: 67  VFPH---GSGFVLV-MEYM-PSDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHANGI 120

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KP NLL                               G+LK+ DFG A+     +
Sbjct: 121 MHRDLKPANLLI---------------------------SADGVLKIADFGLARLFSEEE 153

Query: 197 ASLQTP-CYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF------------ 242
             L +    T +Y APE+L G  KYD   D+W++G I   LL G P F            
Sbjct: 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213

Query: 243 FSNHG---QAISPGM-------------KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
           F   G   +   PG+                I L +  FP+      S EA  L+K +L 
Sbjct: 214 FRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEI-FPD-----ASPEALDLLKGLLV 267

Query: 287 VDPSERLT 294
            DPS+RL+
Sbjct: 268 YDPSKRLS 275

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  116 bits (292), Expect = 5e-30
 Identities = 86/304 (28%), Positives = 137/304 (45%), Gaps = 55/304 (18%)

Query: 23  ILGLGINGKVL---QIVEKKTSEVYALKVLHDTV---KA------RREVELQLAVGSHKH 70
           +LG G  GKV    ++      ++YA+KVL       KA      R E ++  AV     
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +V +   ++        L +I++ ++GGELF  + Q+E   FTE E  + + EI  A+  
Sbjct: 67  LVTLHYAFQT----DTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIAEIVLALDH 120

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH   I +RD+K EN+L    G                            + LTDFG +K
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGH---------------------------VVLTDFGLSK 153

Query: 191 KIVS-NKASLQTPCYTPYYVAPEVL--GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           + ++  +    + C T  Y+APEV+  G   +DK+ D WSLGV+ + LL G  PF  +  
Sbjct: 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL---TIDQVMENKWI 304
           Q     +  RI   +  FP      +S EA+  I+ +L  DP +RL     D++  + + 
Sbjct: 214 QNSQSEISRRILKSKPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Query: 305 SQFN 308
              +
Sbjct: 270 QGID 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  114 bits (288), Expect = 8e-30
 Identities = 73/290 (25%), Positives = 140/290 (48%), Gaps = 50/290 (17%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNIKD 76
           +G G  GK + +  K+  + Y +K ++       +  ++R+EV + L+   H +IV  ++
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAV-LSNMKHPNIVQYQE 66

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            +E     +  L ++M+   GG+L+++I  +    F E +      +IC A+K +HD+ I
Sbjct: 67  SFEE----NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+K +N+  TK                            G +KL DFG A +++++ 
Sbjct: 123 LHRDIKSQNIFLTK---------------------------DGTIKLGDFGIA-RVLNST 154

Query: 197 ASLQTPCY-TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
             L   C  TPYY++PE+     Y+   DIW+LG ++Y  +C     F       +  MK
Sbjct: 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLY-EMCTLKHAFE------AGNMK 207

Query: 256 NRI-RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           N + ++ +  +P P   H S + + L+  +   +P +R +++ ++E  +I
Sbjct: 208 NLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 8e-30
 Identities = 89/322 (27%), Positives = 128/322 (39%), Gaps = 88/322 (27%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR----------REVELQLAVGSHKHIVN 73
           LG G  G V     K+T E+ A+K     +K +          REV+    +  H +IV 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 74  IKDVY-ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +K+V+ EN       L  + E M G  L+Q ++ ++   F+E     I+ +I   +  +H
Sbjct: 63  LKEVFREN-----DELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
                HRD+KPENLL + P                            ++K+ DFG A++I
Sbjct: 117 KHGFFHRDLKPENLLVSGP---------------------------EVVKIADFGLAREI 149

Query: 193 VSNKASLQTPCYTPY-----YVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPF---- 242
            S       P YT Y     Y APE+L     Y    DIW+LG IM  L    P F    
Sbjct: 150 RSR------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203

Query: 243 --------FSNHGQAISPGMKNRIRLGQ---FDFPN----------PEWEHVSQEAKTLI 281
                    S  G           +L     F FP           P   + S EA  LI
Sbjct: 204 EIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIP---NASPEAIDLI 260

Query: 282 KNMLCVDPSERLTIDQVMENKW 303
           K+ML  DP +R T  Q +++ +
Sbjct: 261 KDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 9e-30
 Identities = 80/316 (25%), Positives = 120/316 (37%), Gaps = 74/316 (23%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNIKD 76
           +G G  G V +  +K T E+ A+K +            A RE++L   + +H +I+ + D
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLD 65

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V     +     LV  E M   +L++ I+ ++ G   E      + ++   + F H   I
Sbjct: 66  V---FRHKGDLYLV-FEFMDT-DLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KPENLL    G                            LKL DFG A+      
Sbjct: 120 LHRDLKPENLLINTEGV---------------------------LKLADFGLAR-----S 147

Query: 197 ASLQTPCYTPY-----YVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH---- 246
                  YT Y     Y APE+L G   Y    DIWS+G I   LL   P F        
Sbjct: 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ 207

Query: 247 -----------GQAISPGMKNRIRLGQFDFPNP---EWEHV----SQEAKTLIKNMLCVD 288
                         + P   +  R  +F FP         +    S +A  L+  ML  D
Sbjct: 208 LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYD 267

Query: 289 PSERLTIDQVMENKWI 304
           P +R+T +Q + + + 
Sbjct: 268 PHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  113 bits (285), Expect = 3e-29
 Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 39/247 (15%)

Query: 55  ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTE 114
           A  E+ + L++  H +I+     Y N +     LL+ ME  +GG L+ +I +++   F E
Sbjct: 46  ALNEIVI-LSLLQHPNIIA----YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE 100

Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
                 + +I SA+ ++H   I HRD+K  N+  TK                        
Sbjct: 101 EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK------------------------ 136

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI 234
               G++KL DFG +K + S  +  +T   TPYY++PE+    KY+   DIW+LG ++Y 
Sbjct: 137 ---AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYE 193

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
           LL     F + +       +  +I  G +    P     S E  +L+ ++L  DP +R T
Sbjct: 194 LLTLKRTFDATN----PLNLVVKIVQGNY---TPVVSVYSSELISLVHSLLQQDPEKRPT 246

Query: 295 IDQVMEN 301
            D+V++ 
Sbjct: 247 ADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  114 bits (287), Expect = 4e-29
 Identities = 74/229 (32%), Positives = 112/229 (48%), Gaps = 37/229 (16%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHD-TVKARRE-----VELQLAVGSHKHIVNIK 75
           +++G G  GKVL    K     YA+KVL   T+  ++E      E  + + + KH   + 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
             Y   +  +  L  +++ ++GGELF  +Q++    F E  A     E+ SAI +LH  N
Sbjct: 61  LHYS--FQTAEKLYFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN 116

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I +RD+KPEN+L    G                            + LTDFG  K+ V  
Sbjct: 117 IIYRDLKPENILLDSQGH---------------------------VVLTDFGLCKEGVEP 149

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           + +  T C TP Y+APEVL  + YD++ D W LG ++Y +L G PPF+S
Sbjct: 150 EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  114 bits (286), Expect = 5e-29
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 42/286 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVY--- 78
           +++G G  GKVL    K   + YA+KVL      +++ E  +    +  + N+K  +   
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 79  -ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
               +  +  L  +++ ++GGELF  +Q++    F E  A     EI SA+ +LH  NI 
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIV 118

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           +RD+KPEN+L    G                            + LTDFG  K+ + +  
Sbjct: 119 YRDLKPENILLDSQGH---------------------------IVLTDFGLCKENIEHNG 151

Query: 198 SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNR 257
           +  T C TP Y+APEVL    YD++ D W LG ++Y +L G PPF+S +   +   + N+
Sbjct: 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211

Query: 258 IRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-TIDQVMENK 302
                   P     +++  A+ L++ +L  D ++RL   D  ME K
Sbjct: 212 --------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 6e-29
 Identities = 82/286 (28%), Positives = 123/286 (43%), Gaps = 53/286 (18%)

Query: 27  GINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKD 76
           G  G V    ++ T + +A+KVL  +          VKA R + +            +  
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP-----YVAK 61

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           +Y +  +     LV ME ++GG+    I+    G   E  A   + E+   ++ LH + I
Sbjct: 62  LYYSFQSKDYLYLV-MEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KPENLL  + G    LKLTDFG                   L+  G   K     
Sbjct: 119 IHRDIKPENLLIDQTGH---LKLTDFG-------------------LSRNGLENKKFVG- 155

Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
                   TP Y+APE +     DK  D WSLG +++  L G+PPF +    A+     +
Sbjct: 156 --------TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF----D 203

Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
            I   + ++P    E  S EA  LI  +LC+DP++RL  +   E K
Sbjct: 204 NILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 2e-28
 Identities = 87/294 (29%), Positives = 128/294 (43%), Gaps = 63/294 (21%)

Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAV 65
           D+ I T++ G G  G+V    +K T E+ ALK +  +          V   R++   L  
Sbjct: 2   DFQILTQV-GQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDI---LTT 57

Query: 66  GSHKHIVNIKDVY-----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
              + +V  K +Y     E +Y       + ME + GG+   R      G  +E  A   
Sbjct: 58  TKSEWLV--KLLYAFQDDEYLY-------LAMEYVPGGDF--RTLLNNLGVLSEDHARFY 106

Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
           M E+  A+  LH+    HRD+KPEN L    G                            
Sbjct: 107 MAEMFEAVDALHELGYIHRDLKPENFLIDASGH--------------------------- 139

Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
           +KLTDFG +K IV+   S+     +P Y+APEVL    YD + D WSLG ++Y  LCGFP
Sbjct: 140 IKLTDFGLSKGIVTYANSVVG---SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196

Query: 241 PFFSNHGQAISPGMKN-RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           PF  +        +K  +  L +  + +P +  +S EA  LI  ++  DPS R 
Sbjct: 197 PFSGSTPNETWENLKYWKETLQRPVYDDPRFN-LSDEAWDLITKLI-NDPSRRF 248

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  111 bits (279), Expect = 5e-28
 Identities = 89/283 (31%), Positives = 136/283 (48%), Gaps = 51/283 (18%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQ------LAVGS-HKHIVNI 74
           +LG G  GKV+    K T+E +A+K L  D V    +VE        LA+   H  + ++
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              ++   +    L  +ME ++GG+L   IQ    G F E  A     EI   ++FLH +
Sbjct: 62  FCTFQTKEH----LFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK 115

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K +N+L  K                          DG I K+ DFG  K+ ++
Sbjct: 116 GIIYRDLKLDNVLLDK--------------------------DGHI-KIADFGMCKENMN 148

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            +    T C TP Y+APE+L   KY++S D WS GV++Y +L G  PF   HG+     +
Sbjct: 149 GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF---HGED-EDEL 204

Query: 255 KNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTID 296
            + I     D P+ P W  +S+EAK  +  +   DP++RL +D
Sbjct: 205 FDSILN---DRPHFPRW--ISKEAKDCLSKLFERDPTKRLGVD 242

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  110 bits (277), Expect = 9e-28
 Identities = 81/281 (28%), Positives = 131/281 (46%), Gaps = 51/281 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVE--------LQLAVGSHKHIV 72
           ++LG G  GKV+    K T EVYA+KVL  D +    +V+        L LA   H  + 
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK-HPFLT 59

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +   ++        L  +ME ++GG+L  +IQ+     F E  +     E+  A+ FLH
Sbjct: 60  ALHCCFQT----KDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLH 113

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              + +RD+K +N+L    G                             KL DFG  K+ 
Sbjct: 114 RHGVIYRDLKLDNILLDAEGH---------------------------CKLADFGMCKEG 146

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           + N  +  T C TP Y+APE+L   +Y  S D W+LGV+MY ++ G PPF +++   +  
Sbjct: 147 ILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206

Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            + +       D   P W  +S+EA +++K  +  +P++RL
Sbjct: 207 SILHD------DVLYPVW--LSKEAVSILKAFMTKNPNKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  110 bits (276), Expect = 1e-27
 Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 33/227 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVY--- 78
           +++G G  GKVL    K   + YA+KVL   +   R+ +  +    +  + N+K  +   
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 79  -ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
               +  +  L  +++ ++GGELF  +Q++   +F E  A     EI SA+ +LH  NI 
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIV 118

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           +RD+KPEN+L    G                            + LTDFG  K+ ++   
Sbjct: 119 YRDLKPENILLDSQGH---------------------------VVLTDFGLCKEGIAQSD 151

Query: 198 SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           +  T C TP Y+APEV+    YD + D W LG ++Y +L G PPF+ 
Sbjct: 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  111 bits (278), Expect = 2e-27
 Identities = 87/312 (27%), Positives = 143/312 (45%), Gaps = 51/312 (16%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLA 64
           +D+  + +++G G  G+V  + +K T ++YA+K L  +          VKA R+V   LA
Sbjct: 1   EDFH-TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV---LA 56

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
                 +V++   +++    ++ L +IME + GG+L   + + +   F+E      M E 
Sbjct: 57  ESDSPWVVSLYYSFQD----AQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAEC 110

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTKPGDGG 179
             AI+ +H     HRD+KP+N+L  +   GG +KL+DFG       + ++  Y K   G 
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDR---GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167

Query: 180 ILKLTDFGFAKKIV-------SNKASLQT-----------PCYTPYYVAPEVLGPDKYDK 221
             K          V       S+K  + T              TP Y+APE+     Y +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227

Query: 222 SCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLI 281
            CD WSLG IM+  L G+PPF S +       + N      F    P+  H+S EA+ LI
Sbjct: 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF----PDDIHLSVEAEDLI 283

Query: 282 KNMLCVDPSERL 293
           + ++  +   RL
Sbjct: 284 RRLIT-NAENRL 294

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  108 bits (271), Expect = 2e-27
 Identities = 80/284 (28%), Positives = 126/284 (44%), Gaps = 48/284 (16%)

Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVL------HDTVKARREVELQLAVGSHK 69
            Y++   ++G G  G+ L +    + + YA+K +           +R+E  L LA   H 
Sbjct: 1   QYNV-LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL-LAKMKHP 58

Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           +IV  K+ +E        L ++ME   GG+L Q+I+ +    F E        ++C  ++
Sbjct: 59  NIVAFKESFE----ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
            +H++ + HRD+K +N+  T+ G                            +KL DFG A
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGK---------------------------VKLGDFGSA 147

Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
           + + S  A   T   TPYYV PE+     Y+   DIWSLG I+Y L     PF +N    
Sbjct: 148 RLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN---- 203

Query: 250 ISPGMKNRI-RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
                KN I ++ Q  +  P   H S E ++LIK M   +P  R
Sbjct: 204 ---SWKNLILKVCQGSY-KPLPSHYSYELRSLIKQMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 2e-27
 Identities = 85/293 (29%), Positives = 138/293 (47%), Gaps = 43/293 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVL--------HDTVKARREVELQLAVGSHKHIVN 73
           ++LG G  G+V  +  K T +++ALKVL        +   +   E E+ LA   H  +  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI-LATLDHPFLPT 65

Query: 74  IKDVYENIYNGSRCLLVIME-CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +   ++        L ++M+ C  GGELF+ +Q++     +E  A     E+  A+++LH
Sbjct: 66  LYASFQT----ETYLCLVMDYCP-GGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDF-----GDVKPENLLYTKPGDGGILKLTDFG 187
              I +RD+KPEN+L      G I+ L+DF      DV+P  +           K +   
Sbjct: 121 LLGIVYRDLKPENILLH--ESGHIM-LSDFDLSKQSDVEPPPVSKALR------KGSRRS 171

Query: 188 FAKKI----VSNKASLQTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
               I     S + S ++  +  T  Y+APEV+  D +  + D W+LG+++Y +L G  P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Query: 242 FF-SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           F  SN  +  S      I   +  FP      VS  A+ LI+ +L  DPS+RL
Sbjct: 232 FKGSNRDETFS-----NILKKEVTFP-GSPP-VSSSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  110 bits (276), Expect = 3e-27
 Identities = 96/309 (31%), Positives = 146/309 (47%), Gaps = 39/309 (12%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLA 64
           DD++ S +++G G  G+V  + +K T  +YA+K+L             ++A R++ ++ A
Sbjct: 1   DDFE-SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-A 58

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
            G+      +K  Y   +   R L +IME + GG++   + +K+    +E      + E 
Sbjct: 59  DGAWV----VKMFYS--FQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAET 110

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKP-------ENLLYTK 174
             AI  +H     HRD+KP+NLL    G    +KL+DFG    +K         NL +  
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNP 167

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQ-TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
           P D     +     A+    N+  L  +   TP Y+APEV     Y+K CD WSLGVIMY
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            +L G+PPF S   Q     + N        FP PE   +S++AK LI    C D   R+
Sbjct: 228 EMLIGYPPFCSETPQETYRKVMNWKE--TLVFP-PEVP-ISEKAKDLILR-FCTDSENRI 282

Query: 294 TIDQVMENK 302
             + V E K
Sbjct: 283 GSNGVEEIK 291

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 3e-27
 Identities = 79/334 (23%), Positives = 128/334 (38%), Gaps = 102/334 (30%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALK-VLHDTVK------ARREVEL--QLAVGSHKHIV 72
             +G G  G+V +   KKT E+ ALK +  +  K      A RE++L  +L    H +IV
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL---RHPNIV 61

Query: 73  NIKDVYENIYNGSRCLLVIMECM-HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
            +K++  +   GS  + ++ E M H       +    +  FTE +    M ++   +++L
Sbjct: 62  RLKEIVTSKGKGS--IYMVFEYMDHD---LTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I HRD+K  N+L                             + G+LKL DFG A+ 
Sbjct: 117 HSNGILHRDIKGSNILIN---------------------------NDGVLKLADFGLARP 149

Query: 192 IVSNKASLQTPCYTP-----YYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
                +      YT      +Y  PE+L G  +Y    D+WS+G I+  L  G P F   
Sbjct: 150 YTKRNS----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF--- 202

Query: 246 HGQAISPGMKNRIRLGQFD-------FPNPE-WEHV------------------------ 273
                  G      L Q +        P  E W  V                        
Sbjct: 203 ------QG---STELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFK 253

Query: 274 ---SQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                 A  L+  +L +DP +R++ DQ +++++ 
Sbjct: 254 HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  108 bits (271), Expect = 8e-27
 Identities = 79/281 (28%), Positives = 125/281 (44%), Gaps = 52/281 (18%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVE-------LQLAVGSHKH--IV 72
           +LG G  GKVL    KKT E+YA+K L    + AR EVE       +     S +H  +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   ++       C   +ME   GG+L   I       F+E  A      +   +++LH
Sbjct: 66  NLFACFQT--EDHVCF--VMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLH 118

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           +  I +RD+K +NLL            T+                 G +K+ DFG  K+ 
Sbjct: 119 ENKIVYRDLKLDNLLLD----------TE-----------------GFVKIADFGLCKEG 151

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           +       T C TP ++APEVL    Y ++ D W LGV++Y +L G  PF  +  + +  
Sbjct: 152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211

Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            + N       +   P    +S+EA ++++ +L  +P  RL
Sbjct: 212 SIVND------EVRYP--RFLSREAISIMRRLLRRNPERRL 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  108 bits (270), Expect = 9e-27
 Identities = 82/279 (29%), Positives = 130/279 (46%), Gaps = 47/279 (16%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVGSHKHIVNIKDVYEN 80
            +LG G  GKV+    K++  +YA+KVL  D +    +VE  +   + K I+++   +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTM---TEKRILSLARNHPF 57

Query: 81  IYNGSRC------LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           +     C      L  +ME ++GG+L   IQ+     F E  A     EI SA+ FLHD+
Sbjct: 58  LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK 115

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K +N+L    G                             KL DFG  K+ + 
Sbjct: 116 GIIYRDLKLDNVLLDHEGH---------------------------CKLADFGMCKEGIF 148

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           N  +  T C TP Y+APE+L    Y  S D W++GV++Y +LCG  PF + +   +   +
Sbjct: 149 NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            N       +   P W  +SQ+A  ++K  +  +P+ RL
Sbjct: 209 LND------EVVYPTW--LSQDAVDILKAFMTKNPTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  107 bits (269), Expect = 1e-26
 Identities = 78/279 (27%), Positives = 125/279 (44%), Gaps = 49/279 (17%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQ------LAVGSHKH-IVNI 74
           +LG G  GKV+    K T E+YA+K+L  D +    +VE        LA+      +  +
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              ++ +      L  +ME ++GG+L   IQQ   G F E  A     EI   + FLH +
Sbjct: 67  HSCFQTMDR----LYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K +N++    G                            +K+ DFG  K+ + 
Sbjct: 121 GIIYRDLKLDNVMLDAEGH---------------------------IKIADFGMCKENIF 153

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
              + +T C TP Y+APE++    Y KS D W+ GV++Y +L G PPF       +    
Sbjct: 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF--- 210

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
              I      +P    + +S+EA ++ K +L   P++RL
Sbjct: 211 -QSIMEHNVSYP----KSLSKEAVSICKGLLTKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 74/314 (23%), Positives = 131/314 (41%), Gaps = 68/314 (21%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAV----GSHKH 70
             +++  E++G G  GKV +   KKT ++ A+K++        E++ +  +     +H +
Sbjct: 6   GIFEL-VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPN 64

Query: 71  IVNIKDVYENIYNGSRC----LLVIME-CMHGG--ELFQRIQQKEDGAFTEREAAIIMNE 123
           I      +  I          L ++ME C  G   +L + ++ K+     E   A I+ E
Sbjct: 65  IATFYGAF--IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRE 121

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
               + +LH+  + HRD+K +N+L           LT   +VK                L
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNIL-----------LTKNAEVK----------------L 154

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-----YDKSCDIWSLGVIMYILLCG 238
            DFG + ++ S      T   TPY++APEV+  D+     YD   D+WSLG+    L  G
Sbjct: 155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Query: 239 FPPFFSNHG-QAI-------SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPS 290
            PP    H  +A+        P +K              W   S++    I   L  +  
Sbjct: 215 KPPLCDMHPMRALFKIPRNPPPTLK----------SPENW---SKKFNDFISECLIKNYE 261

Query: 291 ERLTIDQVMENKWI 304
           +R  +++++E+ +I
Sbjct: 262 QRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  105 bits (265), Expect = 2e-26
 Identities = 76/289 (26%), Positives = 132/289 (45%), Gaps = 47/289 (16%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYENIY 82
           +G G  G V    +K T    A+K +    + RRE+   ++ +       NI ++Y +  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 83  NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK 142
            G   L V+ME + GG L   +         E + A +   +  A+ FLH Q + HRD+K
Sbjct: 87  VGDE-LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142

Query: 143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP 202
            +++L T                             G +KL+DFGF  ++       ++ 
Sbjct: 143 SDSILLTS---------------------------DGRVKLSDFGFCAQVSKEVPRRKSL 175

Query: 203 CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP--GMKNRIRL 260
             TPY++APEV+    Y    DIWSLG+++  ++ G PP+F+       P   MK RIR 
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-----PPLQAMK-RIR- 228

Query: 261 GQFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
              D   P+ ++   VS   ++ +  ML  DP++R T  +++ + ++++
Sbjct: 229 ---DNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 5e-26
 Identities = 94/320 (29%), Positives = 135/320 (42%), Gaps = 82/320 (25%)

Query: 22  EILGL---GINGKVLQIVEKKTSEVYALKVLHDT-----VK--ARREVE-LQLAVGSHKH 70
           E+LG+   G  G VL+   K T E+ A+K   ++     VK  A REV+ L+     H++
Sbjct: 4   EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL--RHEN 61

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IVN+K+ +       R  LV         L + ++    G          + ++  AI +
Sbjct: 62  IVNLKEAFRR---KGRLYLVFEYVER--TLLELLEASPGG-LPPDAVRSYIWQLLQAIAY 115

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H  NI HRD+KPEN+L ++                            G+LKL DFGFA+
Sbjct: 116 CHSHNIIHRDIKPENILVSE---------------------------SGVLKLCDFGFAR 148

Query: 191 KIVSNKASLQTPCY--TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCG---FP---- 240
            + +  AS  T  Y  T +Y APE+L G   Y K  D+W++G IM  LL G   FP    
Sbjct: 149 ALRARPASPLTD-YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207

Query: 241 ------------PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKT 279
                       P   +H +  S    N  R     FP P             VS  A  
Sbjct: 208 IDQLYLIQKCLGPLPPSHQELFS---SNP-RFAGVAFPEPSQPESLERRYPGKVSSPALD 263

Query: 280 LIKNMLCVDPSERLTIDQVM 299
            +K  L +DP ERLT D+++
Sbjct: 264 FLKACLRMDPKERLTCDELL 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 8e-26
 Identities = 92/296 (31%), Positives = 142/296 (47%), Gaps = 58/296 (19%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--DTVKAR-----REVELQLAVGS 67
           DD++I  +++G G  G+V  +  K T +VYA+K+L+  + +K       RE    L  G 
Sbjct: 1   DDFEI-LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD 59

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
            + I N+   +++  N    L ++M+   GG+L   + + ED    E  A   + E+  A
Sbjct: 60  RRWITNLHYAFQDENN----LYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVLA 114

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I  +H     HRD+KP+N+L  K G    ++L DFG                 L+L   G
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGH---IRLADFGSC---------------LRLLADG 156

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
               + SN A       TP Y++PE+L     G  +Y   CD WSLGV MY +L G  PF
Sbjct: 157 ---TVQSNVA-----VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Query: 243 FSN-----HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           ++      +G+ ++   K       F FP P+   VS+EAK LI+ ++C  P  RL
Sbjct: 209 YAESLVETYGKIMN--HKEH-----FQFP-PDVTDVSEEAKDLIRRLICS-PETRL 255

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  105 bits (264), Expect = 1e-25
 Identities = 79/343 (23%), Positives = 137/343 (39%), Gaps = 84/343 (24%)

Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK----VLHDTVKAR---REVELQLAVGSHKHIVN 73
            + +G G  G V   V+K+T    A+K    V  D + A+   RE++L   +  H++I+ 
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIG 63

Query: 74  IKDV--------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
           + D+        + ++Y       ++ E M   +L + I+  +    T+      + +I 
Sbjct: 64  LLDILRPPSPEDFNDVY-------IVTELMET-DLHKVIKSPQP--LTDDHIQYFLYQIL 113

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +K+LH  N+ HRD+KP N+L     D                           LK+ D
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCD---------------------------LKICD 146

Query: 186 FGFAKKIVSNKASLQ--TPCY--TPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFP 240
           FG A+ +  ++      T  Y  T +Y APE+ L   +Y K+ DIWS+G I   LL   P
Sbjct: 147 FGLARGVDPDEDEKGFLTE-YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Query: 241 PFFSNH--------------------GQAISPGMKNRIRLGQFDFPNPEWEHV----SQE 276
            F                            S   +N ++        P    +    S E
Sbjct: 206 LFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKP-LSKLFPGASPE 264

Query: 277 AKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGK 319
           A  L++ ML  DP +R+T D+ + + +++Q +     P+    
Sbjct: 265 AIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPP 307

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  103 bits (260), Expect = 2e-25
 Identities = 78/317 (24%), Positives = 126/317 (39%), Gaps = 78/317 (24%)

Query: 27  GINGKVLQIVEKKTSEVYALKVLH-DTVK------ARREVELQLAVGSHKHIVNIKDV-- 77
           G  G V +  +KKT E+ ALK L  +  K      + RE+ + L +  H +IV +K+V  
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVV 74

Query: 78  ---YENIYNGSRCLLVIMECM-HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
               + IY       ++ME + H  +L   ++      F + E   +M ++ S +  LHD
Sbjct: 75  GSNLDKIY-------MVMEYVEH--DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHD 124

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             I HRD+K  NLL                               GILK+ DFG A++  
Sbjct: 125 NWILHRDLKTSNLLLNNR---------------------------GILKICDFGLAREYG 157

Query: 194 SNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA--- 249
           S          T +Y APE+L G  +Y  + D+WS+G I   LL    P F    +    
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK-KPLFPGKSEIDQL 216

Query: 250 -------------ISPGMKNRIRLGQFDFPN-PEWE--------HVSQEAKTLIKNMLCV 287
                        I PG        +  F   P  +         +S     L+  +L  
Sbjct: 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTY 276

Query: 288 DPSERLTIDQVMENKWI 304
           DP++R++ +  +++ + 
Sbjct: 277 DPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  105 bits (262), Expect = 2e-25
 Identities = 91/293 (31%), Positives = 139/293 (47%), Gaps = 38/293 (12%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLA 64
           +D++ S +++G G  G+V  + +K T  VYA+K+L             ++A R++   L 
Sbjct: 1   EDFE-SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI---LV 56

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
                 +V +   +++  N    L +IME + GG++   + +K+    TE E    + E 
Sbjct: 57  EADSLWVVKMFYSFQDKLN----LYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAET 110

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKP-------ENLLYTK 174
             AI  +H     HRD+KP+NLL    G    +KL+DFG    +K         NL ++ 
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSL 167

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQ-TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
           P D     +     A+    N+  L  +   TP Y+APEV     Y+K CD WSLGVIMY
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
            +L G+PPF S   Q     + N        FP PE   +S++AK LI    C
Sbjct: 228 EMLIGYPPFCSETPQETYKKVMNWKE--TLIFP-PEVP-ISEKAKDLILRFCC 276

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  104 bits (262), Expect = 3e-25
 Identities = 87/314 (27%), Positives = 138/314 (43%), Gaps = 58/314 (18%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVN 73
           +G+G  G+V  + +  T+ +YA+K L             VKA R++   LA   ++ +V 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI---LAEADNEWVVK 65

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +   +++       L  +M+ + GG++   + +   G F E  A   + E+  AI+ +H 
Sbjct: 66  LYYSFQD----KDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK 119

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFG---------DVKPENLLYTKPGD------- 177
               HRD+KP+N+L  +  DG I KLTDFG         D K     Y + GD       
Sbjct: 120 MGFIHRDIKPDNILIDR--DGHI-KLTDFGLCTGFRWTHDSK-----YYQKGDHHRQDSM 171

Query: 178 --GGILKLTDFGFAKKIVSNKASLQTPCY------TPYYVAPEVLGPDKYDKSCDIWSLG 229
                    D    K +   +      C       TP Y+APEVL    Y + CD WS+G
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231

Query: 230 VIMYILLCGFPPFFSNHGQAISPG-MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVD 288
           VI+Y +L G PPF ++     +P   + ++   +     P    +S+EA  LI   LC  
Sbjct: 232 VILYEMLVGQPPFLAD-----TPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCG 285

Query: 289 PSERLTIDQVMENK 302
             +RL  +   E K
Sbjct: 286 AEDRLGKNGADEIK 299

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  103 bits (259), Expect = 3e-25
 Identities = 81/281 (28%), Positives = 134/281 (47%), Gaps = 50/281 (17%)

Query: 22  EILGLGINGKVL---QIVEKKTSEVYALKVLHD-TVKARREVELQ-----LAVGSHKHIV 72
           ++LG G  GKV    +I      ++YA+KVL   T+K R  V  +     LA  +H  IV
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +   ++    G   L +I++ + GG+LF R+ +  +  FTE +    + E+  A+  LH
Sbjct: 62  KLHYAFQT--EGK--LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLH 115

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I +RD+KPEN+L  + G                            +KLTDFG +K+ 
Sbjct: 116 SLGIIYRDLKPENILLDEEGH---------------------------IKLTDFGLSKES 148

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           + ++    + C T  Y+APEV+    + +S D WS GV+M+ +L G  PF    G+    
Sbjct: 149 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF---QGKDRKE 205

Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            M   I   +   P    + +S EA++L++ +   +P+ RL
Sbjct: 206 TM-TMILKAKLGMP----QFLSPEAQSLLRALFKRNPANRL 241

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 5e-25
 Identities = 80/298 (26%), Positives = 132/298 (44%), Gaps = 56/298 (18%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE-----VELQ-LAVGSHKHIVNIKDV 77
           LG G  GKV +   K+T    A K++   +++  E     VE+  L+   H +IV + + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y   Y     L +++E   GG L   + + E G  TE +   +  ++  A+ FLH   + 
Sbjct: 71  Y--FYENK--LWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVI 125

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+K  N+L T  GD                           +KL DFG + K  S   
Sbjct: 126 HRDLKAGNILLTLDGD---------------------------VKLADFGVSAKNKSTLQ 158

Query: 198 SLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
              T   TPY++APEV+       + YD   DIWSLG+ +  L    PP   +H   ++P
Sbjct: 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP---HH--ELNP 213

Query: 253 GMKNRIRLGQFDFP---NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            M+  +++ + + P    P     S      +K+ L  DP +R T  +++++ ++S  
Sbjct: 214 -MRVLLKILKSEPPTLDQP--SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  103 bits (258), Expect = 5e-25
 Identities = 84/283 (29%), Positives = 130/283 (45%), Gaps = 48/283 (16%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQLAVGSHKHIV 72
           ++G G   KVL +  KKT  +YA+KV+           D V+  + V    +  +H  +V
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS--NHPFLV 59

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +   ++     SR   VI E + GG+L   +Q++      E  A     EI  A+ FLH
Sbjct: 60  GLHSCFQTE---SRLFFVI-EFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLH 113

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           ++ I +RD+K +N+L    G    +KLTD+G  K E +   +PGD               
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGH---IKLTDYGMCK-EGI---RPGD--------------- 151

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
                +  T C TP Y+APE+L  + Y  S D W+LGV+M+ ++ G  P F   G + +P
Sbjct: 152 -----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP-FDIVGMSDNP 205

Query: 253 GMKNRIRLGQFDFPNPEW--EHVSQEAKTLIKNMLCVDPSERL 293
                  L Q            +S +A +++K  L  DP ERL
Sbjct: 206 DQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  102 bits (256), Expect = 5e-25
 Identities = 80/290 (27%), Positives = 139/290 (47%), Gaps = 49/290 (16%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAV--GSHKHIVNIKDVYENI 81
           +G G  G V    EK +    A+K++    + RRE+     V    ++H  N+ ++Y++ 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-QNVVEMYKSY 87

Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
             G   L V+ME + GG L   + Q       E + A +   +  A+ +LH Q + HRD+
Sbjct: 88  LVGEE-LWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQGVIHRDI 143

Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT 201
           K +++L T  G                            +KL+DFGF  +I  +    ++
Sbjct: 144 KSDSILLTLDGR---------------------------VKLSDFGFCAQISKDVPKRKS 176

Query: 202 PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP--GMKNRIR 259
              TPY++APEV+    Y    DIWSLG+++  ++ G PP+FS+     SP   MK R+R
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-----SPVQAMK-RLR 230

Query: 260 LGQFDFPNPEWEHVSQEAKTL---IKNMLCVDPSERLTIDQVMENKWISQ 306
               D P P+ ++  + +  L   ++ ML  +P ER T  +++++ ++ Q
Sbjct: 231 ----DSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  101 bits (254), Expect = 1e-24
 Identities = 83/325 (25%), Positives = 127/325 (39%), Gaps = 73/325 (22%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALK--------VLHDTVK--ARREVELQLAVGSHKHIVN 73
           LG G    V +  +K+T  + A+K           D +   A RE++L L    H +I+ 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKL-LQELKHPNIIG 66

Query: 74  IKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           + DV+    NI       LV  E M   +L + I+ K     T  +    M      +++
Sbjct: 67  LLDVFGHKSNIN------LV-FEFMET-DLEKVIKDKSI-VLTPADIKSYMLMTLRGLEY 117

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH   I HRD+KP NLL                               G+LKL DFG A+
Sbjct: 118 LHSNWILHRDLKPNNLLIAS---------------------------DGVLKLADFGLAR 150

Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF------- 242
              S    +     T +Y APE+L G   Y    D+WS+G I   LL   P         
Sbjct: 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID 210

Query: 243 --------FSNHGQAISPGMKNRIRLGQFD-FPNPEWEH----VSQEAKTLIKNMLCVDP 289
                        +   PG+ +     +F  FP    +      S +A  L++ +L ++P
Sbjct: 211 QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270

Query: 290 SERLTIDQVMENKWISQFNQVPQTP 314
           ++R+T  Q +E+ + S  N    TP
Sbjct: 271 NKRITARQALEHPYFS--NDPAPTP 293

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  101 bits (254), Expect = 2e-24
 Identities = 80/279 (28%), Positives = 132/279 (47%), Gaps = 49/279 (17%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVGSHKHIVNIKDVYENI 81
           +LG G  GKV+    K T E+YA+K+L  D V    +VE  +     K ++ ++D    +
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV---EKRVLALQDKPPFL 63

Query: 82  YNGSRC------LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
                C      L  +ME ++GG+L   IQQ   G F E +A     EI   + FLH + 
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I +RD+K +N++    G                            +K+ DFG  K+ + +
Sbjct: 122 IIYRDLKLDNVMLDSEGH---------------------------IKIADFGMCKEHMVD 154

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAISPGM 254
             + +T C TP Y+APE++    Y KS D W+ GV++Y +L G PPF   +  +     M
Sbjct: 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           ++ +      +P    + +S+EA ++ K ++   PS+RL
Sbjct: 215 EHNV-----SYP----KSLSKEAVSICKGLMTKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  100 bits (251), Expect = 2e-24
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 58/302 (19%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL---HDTVKARREVELQLAVGSHKH 70
           ++ +DI  E LG G  G V + + K+T +V A+KV+    D  +  +E+ + L      +
Sbjct: 2   EEVFDI-LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISI-LKQCDSPY 59

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IV     Y + +  +   +V ME    G +   ++       TE E A I+ +    +++
Sbjct: 60  IVK---YYGSYFKNTDLWIV-MEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEY 114

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH     HRD+K  N+L  +                            G  KL DFG + 
Sbjct: 115 LHSNKKIHRDIKAGNILLNE---------------------------EGQAKLADFGVSG 147

Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG-QA 249
           ++    A   T   TP+++APEV+    Y+   DIWSLG+    +  G PP+   H  +A
Sbjct: 148 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA 207

Query: 250 I-------SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
           I        P + +         P    E  S E    +K  L  DP ER +  Q++++ 
Sbjct: 208 IFMIPNKPPPTLSD---------P----EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254

Query: 303 WI 304
           +I
Sbjct: 255 FI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  100 bits (250), Expect = 2e-24
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 35/227 (15%)

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           NI + YEN     + L+++ME   GG L + IQ++ +    E        +I  A+  +H
Sbjct: 60  NIIEYYENFLE-DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
            + I HRD+K +N+L  K                             ++K+ DFG + KI
Sbjct: 119 TKLILHRDLKTQNILLDK--------------------------HKMVVKIGDFGIS-KI 151

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           +S+K+   T   TP Y++PE+     Y++  DIW+LG ++Y L      F +    A  P
Sbjct: 152 LSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA----ANLP 207

Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
            +  +I  G F    P  +  S + + LI +ML +DPS+R  + Q+M
Sbjct: 208 ALVLKIMSGTF---APISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  103 bits (259), Expect = 2e-24
 Identities = 89/295 (30%), Positives = 138/295 (46%), Gaps = 53/295 (17%)

Query: 55  ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAF 112
           AR E+   LA   H  IV   D +++       LL+IME   GG+L ++I+Q  KE   F
Sbjct: 112 ARSELHC-LAACDHFGIVKHFDDFKS----DDKLLLIMEYGSGGDLNKQIKQRLKEHLPF 166

Query: 113 TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY 172
            E E  ++  +I  A+  +H + + HRD+K  N+                       L+ 
Sbjct: 167 QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF----------------------LMP 204

Query: 173 TKPGDGGILKLTDFGFAKKIVSNKASLQTP---CYTPYYVAPEVLGPDKYDKSCDIWSLG 229
           T     GI+KL DFGF+K+  S+  SL      C TPYY+APE+    +Y K  D+WSLG
Sbjct: 205 T-----GIIKLGDFGFSKQ-YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258

Query: 230 VIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFD-FPNPEWEHVSQEAKTLIKNMLCVD 288
           VI+Y LL    PF     + I      ++  G++D FP P    VS   K L+  +L  +
Sbjct: 259 VILYELLTLHRPFKGPSQREI----MQQVLYGKYDPFPCP----VSSGMKALLDPLLSKN 310

Query: 289 PSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
           P+ R T  Q++  +++     + Q       +++  E   P  ++E+ R L    
Sbjct: 311 PALRPTTQQLLHTEFLKYVANLFQ------DIVRHSETISPHDREEILRQLQESG 359

Length = 478

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 99.7 bits (249), Expect = 4e-24
 Identities = 73/241 (30%), Positives = 108/241 (44%), Gaps = 42/241 (17%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----DTVKA-RREVELQLAVGSH 68
           Q+DY++   I G G  G V +  +  T E+ A+KV+     D  +  ++E+ + L    H
Sbjct: 2   QEDYELIQRI-GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISM-LKECRH 59

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            +IV     Y   Y     L ++ME   GG L Q I Q   G  +E + A +  E    +
Sbjct: 60  PNIVA----YFGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETLKGL 114

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            +LH+    HRD+K  N+L           LT+ GDV                KL DFG 
Sbjct: 115 AYLHETGKIHRDIKGANIL-----------LTEDGDV----------------KLADFGV 147

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
           + ++ +  A  ++   TPY++APEV        YD  CDIW+LG+    L    PP F  
Sbjct: 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207

Query: 246 H 246
           H
Sbjct: 208 H 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.9 bits (247), Expect = 6e-24
 Identities = 70/304 (23%), Positives = 117/304 (38%), Gaps = 70/304 (23%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENI-- 81
           +G G  GKV   V   T E+ A+K +       R  +      + K I +   V E +  
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEI-------RIQDNDPK--TIKEIADEMKVLELLKH 58

Query: 82  -----YNGSRC----LLVIMECMHGGELFQ--RIQQKEDGAFTEREAAIIMNEICSAIKF 130
                Y G       + + ME   GG L +     +  D             ++   + +
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYT----LQLLEGLAY 114

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH   I HRD+KP N+                                G++KL DFG A 
Sbjct: 115 LHSHGIVHRDIKPANIFLDH---------------------------NGVIKLGDFGCAV 147

Query: 191 KIVSNKAS----LQTPCYTPYYVAPEVLGPDKYD---KSCDIWSLGVIMYILLCGFPPF- 242
           K+ +N  +    +Q+   TP Y+APEV+   K     ++ DIWSLG ++  +  G  P+ 
Sbjct: 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207

Query: 243 -FSNHGQ-AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
              N  Q     G  ++  +       P+   +S E K  +   L  DP +R T  ++++
Sbjct: 208 ELDNEFQIMFHVGAGHKPPI-------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260

Query: 301 NKWI 304
           + ++
Sbjct: 261 HPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  100 bits (249), Expect = 8e-24
 Identities = 90/284 (31%), Positives = 136/284 (47%), Gaps = 53/284 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVGSHKHIVNIKDVYEN 80
           ++LG G  GKVL    K   E +A+K L  D V    +VE  +     K ++ +   +EN
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMV---EKRVLAL--AWEN 55

Query: 81  --------IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                    +     L  +ME ++GG+L   IQ K  G F    A     EI   ++FLH
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH 113

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
            + I +RD+K +N++  + G    +K+ DFG  K EN+     GD               
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGH---IKIADFGMCK-ENVF----GD--------------- 150

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
             N+AS  T C TP Y+APE+L   KY  S D WS GV++Y +L G  PF   HG     
Sbjct: 151 --NRAS--TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF---HGDD-ED 202

Query: 253 GMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTI 295
            +   IR+   D P+ P W  +++E+K +++ +   DP+ RL +
Sbjct: 203 ELFESIRV---DTPHYPRW--ITKESKDILEKLFERDPTRRLGV 241

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 98.3 bits (245), Expect = 1e-23
 Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 54/295 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALK---VLHDTVKAR-------REVELQLAVGSHKHI 71
           E+LG G  G V + +     + +A+K   +  D    +       +E+ L L+   H +I
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIAL-LSKLQHPNI 64

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           V     Y         L + +E + GG L +    K+ G+F E    +   +I   +++L
Sbjct: 65  VQ----YLGTEREEDNLYIFLELVPGGSLAK--LLKKYGSFPEPVIRLYTRQILLGLEYL 118

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           HD+N  HRD+K  N+L       G++KL DFG  K               ++ +F FAK 
Sbjct: 119 HDRNTVHRDIKGANILVDT---NGVVKLADFGMAK---------------QVVEFSFAKS 160

Query: 192 IVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHG-QA 249
                        +PY++APEV+     Y  + DIWSLG  +  +  G PP+    G  A
Sbjct: 161 FKG----------SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA 210

Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +        ++G+     P  +H+S EAK  I   L  DPS R T  +++E+ ++
Sbjct: 211 V-------FKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 76/302 (25%), Positives = 122/302 (40%), Gaps = 71/302 (23%)

Query: 32  VLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS 85
           VL+   +KT + YA+K +         V   RE++    +  H +I+ + +V  +   G 
Sbjct: 15  VLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG- 73

Query: 86  RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
             L ++ E M    L++ I+ ++     E+     M ++  ++  +H   I HRD+KPEN
Sbjct: 74  -RLALVFELMDM-NLYELIKGRKR-PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPEN 130

Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT 205
           +L                                ILKL DFG  + I S       P YT
Sbjct: 131 ILI----------------------------KDDILKLADFGSCRGIYS------KPPYT 156

Query: 206 PY-----YVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAIS------- 251
            Y     Y APE L  D  Y    DIW++G + + +L  FP F  +N    I+       
Sbjct: 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG 216

Query: 252 -PG-----MKNRIRLGQFDFPNPE-------WEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
            P         + R   ++FP+ +         + S E   L+K +L  DP ER+T  Q 
Sbjct: 217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA 276

Query: 299 ME 300
           + 
Sbjct: 277 LR 278

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 97.4 bits (242), Expect = 4e-23
 Identities = 79/290 (27%), Positives = 132/290 (45%), Gaps = 58/290 (20%)

Query: 22  EILGLGINGKVL---QIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVY 78
           ++LG G  GKV    ++    + ++YA+KVL      ++         + +H    + V 
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK-------AKTTEHTRTERQVL 58

Query: 79  ENI------------YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           E+I            +     L +I++ ++GGELF  + Q+E   F E+E  I   EI  
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVL 116

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A++ LH   I +RD+K EN+L    G                            + LTDF
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGH---------------------------VVLTDF 149

Query: 187 GFAKKIVSNKAS-LQTPCYTPYYVAPEVL--GPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
           G +K+   ++     + C T  Y+AP+++  G   +DK+ D WS+GV+MY LL G  PF 
Sbjct: 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            +  +     +  RI   +  +P    + +S  AK +I+ +L  DP +RL
Sbjct: 210 VDGEKNSQAEISRRILKSEPPYP----QEMSALAKDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 96.6 bits (240), Expect = 4e-23
 Identities = 78/294 (26%), Positives = 134/294 (45%), Gaps = 44/294 (14%)

Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVE------LQLAVGSHKH 70
           Y+I  + +G G  GK+     K  SE   +K +  T    +E E      + LA   H +
Sbjct: 2   YEI-IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IV     ++   NG   L ++ME   GG+L +RI ++    F+E +      +I   +K 
Sbjct: 61  IVTFFASFQE--NGR--LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKH 116

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           +HD+ I HRD+K +N+  +K                          +G + KL DFG A+
Sbjct: 117 IHDRKILHRDIKSQNIFLSK--------------------------NGMVAKLGDFGIAR 150

Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
           ++  +     T   TPYY++PE+     Y+   DIWSLG ++Y L     PF  N+   +
Sbjct: 151 QLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL 210

Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                 +I  G F   +P   + S++ ++LI  +  V P +R +I  +++  ++
Sbjct: 211 VL----KICQGYFAPISP---NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 97.4 bits (243), Expect = 5e-23
 Identities = 78/318 (24%), Positives = 131/318 (41%), Gaps = 76/318 (23%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALK-VLHDTVK------ARREVELQLAVGSHKHIVNIK 75
            +G G  G V +  +  + E+ ALK V  D  +      + RE+ L L +  H +IV +K
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELK 72

Query: 76  DV-----YENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           +V      ++I+      LV+  C      L   +       F+E +   +M ++   ++
Sbjct: 73  EVVVGKHLDSIF------LVMEYCEQDLASLLDNMPT----PFSESQVKCLMLQLLRGLQ 122

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           +LH+  I HRD+K  NLL T                           D G LK+ DFG A
Sbjct: 123 YLHENFIIHRDLKVSNLLLT---------------------------DKGCLKIADFGLA 155

Query: 190 KKIVSNKASLQTPC-YTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH- 246
           +      A   TP   T +Y APE+L G   Y  + D+W++G I+  LL   P       
Sbjct: 156 RTY-GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214

Query: 247 --------------GQAISPGMKNRIRLGQFDFPN-------PEWEHVSQEAKTLIKNML 285
                          ++I PG  +   +G+F  P         ++  +S+    L+  +L
Sbjct: 215 IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLL 274

Query: 286 CVDPSERLTIDQVMENKW 303
             DP +R T ++ +E+ +
Sbjct: 275 MYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 97.4 bits (242), Expect = 6e-23
 Identities = 84/285 (29%), Positives = 131/285 (45%), Gaps = 54/285 (18%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQLAVGSHKHIV 72
           ++G G   KVL +  KK  ++YA+KV+           D V+  + V  Q +  S+  +V
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS--SNPFLV 59

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +   ++     SR  LVI E ++GG+L   +Q++      E  A     EIC A+ FLH
Sbjct: 60  GLHSCFQTT---SRLFLVI-EYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLH 113

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           ++ I +RD+K +N+L    G                            +KLTD+G  K+ 
Sbjct: 114 ERGIIYRDLKLDNVLLDADGH---------------------------IKLTDYGMCKEG 146

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS- 251
           +    +  T C TP Y+APE+L  ++Y  S D W+LGV+M+ ++ G  PF       I+ 
Sbjct: 147 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF-----DIITD 201

Query: 252 -PGMKNRIRLGQFDFPNPEW--EHVSQEAKTLIKNMLCVDPSERL 293
            P M     L Q     P      +S +A  ++K  L  DP ERL
Sbjct: 202 NPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 97.2 bits (242), Expect = 7e-23
 Identities = 70/215 (32%), Positives = 102/215 (47%), Gaps = 33/215 (15%)

Query: 86  RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
           R L ++ME + GG+    +  K  GA     A +   E   A+++LH+  I HRD+KP+N
Sbjct: 74  RHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDN 131

Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP--C 203
           LL T  G    +KLTDFG  K            G++ LT   +   I  +         C
Sbjct: 132 LLITSMGH---IKLTDFGLSKI-----------GLMSLTTNLYEGHIEKDTREFLDKQVC 177

Query: 204 YTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN-----HGQAISPGMKNRI 258
            TP Y+APEV+    Y K  D W++G+I+Y  L G  PFF +      GQ IS       
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS------- 230

Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
                ++P  + E +  +A+ LI  +L  +P ERL
Sbjct: 231 --DDIEWPEGD-EALPADAQDLISRLLRQNPLERL 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.9 bits (239), Expect = 1e-22
 Identities = 76/307 (24%), Positives = 128/307 (41%), Gaps = 57/307 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSH 68
           DDY++   I G+G    V   +    +E  A+K +          + R+EV+  ++  +H
Sbjct: 1   DDYELIEVI-GVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQA-MSQCNH 58

Query: 69  KHIVNIKDVYENIYNGS----RCLLVIMECMHGGELFQRIQQK-EDGAFTEREAAIIMNE 123
            ++V         Y  S      L ++M  + GG L   ++     G   E   A ++ E
Sbjct: 59  PNVVK--------YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKE 110

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +   +++LH     HRD+K  N+L    G+ G +K+ DFG       L    GD      
Sbjct: 111 VLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFG---VSASLAD-GGDRTRKVR 163

Query: 184 TDF-GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPP 241
             F G                 TP ++APEV+     YD   DIWS G+    L  G  P
Sbjct: 164 KTFVG-----------------TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Query: 242 FFSNHGQAISPGMKNRIRLGQFDFP----NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQ 297
           +      +  P MK  +   Q D P      +++  S+  + +I   L  DPS+R T ++
Sbjct: 207 Y------SKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260

Query: 298 VMENKWI 304
           ++++K+ 
Sbjct: 261 LLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 96.6 bits (240), Expect = 1e-22
 Identities = 84/284 (29%), Positives = 127/284 (44%), Gaps = 53/284 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVE--------LQLAVGSHKHIV 72
           ++LG G  GKV     K T++ +A+K L  D V    +VE        L LA   H  + 
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLT 59

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           ++   ++   N    L  +ME ++GG+L   IQ      F    A     EI   ++FLH
Sbjct: 60  HLYCTFQTKEN----LFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLH 113

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
            + I +RD+K +N+L    G                            +K+ DFG  K+ 
Sbjct: 114 SKGIVYRDLKLDNILLDTDGH---------------------------IKIADFGMCKEN 146

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           +   A   T C TP Y+APE+L   KY+ S D WS GV++Y +L G  PF   HG     
Sbjct: 147 MLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF---HGHD-EE 202

Query: 253 GMKNRIRLGQFDFP-NPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
            +   IR+   D P  P W  +++EAK ++  +   +P  RL +
Sbjct: 203 ELFQSIRM---DNPCYPRW--LTREAKDILVKLFVREPERRLGV 241

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 42/286 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVE---LQLAVGSHKHIVNIKDVY 78
           E +G G  G+V + ++ +T +V A+K++ D  +A  E+E    ++ V S      +   Y
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
            +   G++ L +IME + GG     ++    G F E + A ++ EI   + +LH +   H
Sbjct: 69  GSYLKGTK-LWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIH 124

Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  N+L ++ GD                           +KL DFG A ++   +  
Sbjct: 125 RDIKAANVLLSEQGD---------------------------VKLADFGVAGQLTDTQIK 157

Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
             T   TP+++APEV+    YD   DIWSLG+    L  G PP    H       M+   
Sbjct: 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH------PMRVLF 211

Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            + + + P    E  S+  K  I   L  DPS R T  +++++K+I
Sbjct: 212 LIPKNNPPTLTGE-FSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 61/301 (20%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIVNIKDVYENI 81
           LG G +G V +++ + T ++ A+K +   +    ++++  +L +    +   I   Y   
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRD 140
           YN     +  ME M GG L  +I ++  G   ER    I   +   + +LH++  I HRD
Sbjct: 69  YNNGDISI-CMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126

Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           VKP N+L    G                            +KL DFG + ++V++ A   
Sbjct: 127 VKPSNILVNSRGQ---------------------------IKLCDFGVSGQLVNSLAKTF 159

Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG-FPPFFSNHG--------QAI- 250
               +  Y+APE +  + Y    DIWSLG+ +  L  G FP    N          Q I 
Sbjct: 160 VGTSS--YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV 217

Query: 251 ---SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
               P      RL     P+ ++   S + +  +   L  DP ER +  +++E+ +I ++
Sbjct: 218 NEPPP------RL-----PSGKF---SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263

Query: 308 N 308
            
Sbjct: 264 E 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 76/302 (25%), Positives = 137/302 (45%), Gaps = 43/302 (14%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYENIY 82
           +G G  G V    EK T +  A+K +    + RRE+   ++ +    H  N+ D+Y +  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 83  NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK 142
            G   L V+ME + GG L   +         E + A +   +  A+ +LH+Q + HRD+K
Sbjct: 90  VGDE-LWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP 202
            +++L T  G                            +KL+DFGF  ++       ++ 
Sbjct: 146 SDSILLTSDGR---------------------------IKLSDFGFCAQVSKEVPKRKSL 178

Query: 203 CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ 262
             TPY++APEV+    Y    DIWSLG+++  ++ G PP+F+       P ++   R+  
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN------EPPLQAMRRIRD 232

Query: 263 FDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKML 321
              P  +  H VS   +  +  ML  +PS+R T  +++++     F ++   P C   ++
Sbjct: 233 NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP----FLKLAGPPSCIVPLM 288

Query: 322 KE 323
           ++
Sbjct: 289 RQ 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 94.1 bits (234), Expect = 4e-22
 Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 45/278 (16%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE------VELQ-LAVGSHKHIVNIKD 76
           LG G  G+V     K T ++YA K L      +R+       E + L   S + IV++  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            +E        L ++M  M+GG+L   I    +  F E  A     +I   ++ LH + I
Sbjct: 61  AFET----KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            +RD+KPEN+L           L D G+V                +++D G A + +   
Sbjct: 117 VYRDLKPENVL-----------LDDHGNV----------------RISDLGLAVE-LKGG 148

Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS-PGMK 255
             ++    TP Y+APEVL  + YD S D ++LG  +Y ++ G  P F    + +    +K
Sbjct: 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP-FRQRKEKVEKEELK 207

Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            R      ++P    +  S EAK L + +L  DP +RL
Sbjct: 208 RRTLEMAVEYP----DKFSPEAKDLCEALLQKDPEKRL 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 96.9 bits (241), Expect = 5e-22
 Identities = 83/296 (28%), Positives = 133/296 (44%), Gaps = 61/296 (20%)

Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------HDTVKARREVELQLA----- 64
           Y IS  +LG G  G VL        E +A+KV+        D  +A+ EV   L      
Sbjct: 34  YWISR-VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92

Query: 65  -VGSHKHIVNIKDVYENIYNGSRCLLV--IMECMHGGELFQRIQQ--KEDGAFTEREAAI 119
            V  H+         ++  N    L++  +++  + G+L Q I+   K +  F E EA +
Sbjct: 93  IVKCHEDFA-----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           +  ++  A+  +H +++ HRD+K  N+L                               G
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCS---------------------------NG 180

Query: 180 ILKLTDFGFAK---KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
           ++KL DFGF+K     VS+    +T C TPYYVAPE+     Y K  D++SLGV++Y LL
Sbjct: 181 LVKLGDFGFSKMYAATVSDDVG-RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239

Query: 237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
               PF    G+ +   M ++   G++D P P    +S E + ++  +L  DP  R
Sbjct: 240 TLKRPF---DGENMEEVM-HKTLAGRYD-PLP--PSISPEMQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 94.3 bits (234), Expect = 5e-22
 Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 42/291 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVE---LQLAVGSHKHIVNIKDVY 78
           E +G G  G+V + ++ +T EV A+K++ D  +A  E+E    ++ V S      I   Y
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
            +   G++ L +IME + GG     ++    G   E   A I+ EI   + +LH +   H
Sbjct: 69  GSYLKGTK-LWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIH 124

Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  N+L ++ GD                           +KL DFG A ++   +  
Sbjct: 125 RDIKAANVLLSEQGD---------------------------VKLADFGVAGQLTDTQIK 157

Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
             T   TP+++APEV+    YD   DIWSLG+    L  G PP    H       M+   
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH------PMRVLF 211

Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
            + +   P  E ++ S+  K  ++  L  DP  R T  +++++K+I+++ +
Sbjct: 212 LIPKNSPPTLEGQY-SKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK 261

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 94.3 bits (234), Expect = 9e-22
 Identities = 76/280 (27%), Positives = 127/280 (45%), Gaps = 51/280 (18%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VGSHKHIVNI 74
           +LG G  GKV+    K T E+YA+K+L  D V    +VE  +         G    +  +
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              ++ +      L  +ME ++GG+L  +IQQ   G F E  A     EI   + FLH +
Sbjct: 67  HSCFQTMDR----LYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K +N++    G                            +K+ DFG  K+ + 
Sbjct: 121 GIIYRDLKLDNVMLDSEGH---------------------------IKIADFGMCKENMW 153

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAISPG 253
           +  + +T C TP Y+APE++    Y KS D W+ GV++Y +L G  PF   +  +     
Sbjct: 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213

Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           M++ +      +P    + +S+EA  + K ++   P +RL
Sbjct: 214 MEHNVA-----YP----KSMSKEAVAICKGLMTKHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.9 bits (231), Expect = 1e-21
 Identities = 68/277 (24%), Positives = 126/277 (45%), Gaps = 45/277 (16%)

Query: 28  INGKVLQIVEKKTSEVYALKVLHDTVKARREVEL--QLAVGSHKHIVNIKDVYENIYNGS 85
           ++G+V+ + + +  E+   K   D +K   E++L  QL    H +++     +  I N  
Sbjct: 25  LDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLKQL---DHPNVIKYLASF--IENNE 76

Query: 86  RCLLVIMECMHGGELFQRIQ--QKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKP 143
             L +++E    G+L + I+  +K+     ER       ++CSA++ +H + I HRD+KP
Sbjct: 77  --LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKP 134

Query: 144 ENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPC 203
            N+  T                             G++KL D G  +   S   +  +  
Sbjct: 135 ANVFITA---------------------------TGVVKLGDLGLGRFFSSKTTAAHSLV 167

Query: 204 YTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQF 263
            TPYY++PE +  + Y+   DIWSLG ++Y +     PF+ +     S  +  +I   + 
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--LCKKIE--KC 223

Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           D+P    +H S+E + L+   +  DP +R  I  V++
Sbjct: 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 82/285 (28%), Positives = 131/285 (45%), Gaps = 49/285 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVG 66
           DD++I  +++G G  G+V  +  K T  +YA+K+L+        +T   R E  + L  G
Sbjct: 1   DDFEI-IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV-LVNG 58

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
             + I  +   +++       L ++M+   GG+L   + + ED    E  A   + E+  
Sbjct: 59  DCQWITTLHYAFQD----ENYLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVL 113

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           AI  +H  +  HRD+KP+N+L    G    ++L DFG                 LK+   
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGH---IRLADFGSC---------------LKMNQD 155

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFPP 241
           G  +  V+          TP Y++PE+L     G  KY   CD WSLGV MY +L G  P
Sbjct: 156 GTVQSSVA--------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
           F++         + N     +F FP+     VS+EAK LI+ ++C
Sbjct: 208 FYAESLVETYGKIMNHEE--RFQFPS-HITDVSEEAKDLIQRLIC 249

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 45/279 (16%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARR-------EVELQLAVGSHKHIVNI 74
           +LG G  G+V     + T ++YA K L    +K R+       E ++   V S + +V++
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-RFVVSL 65

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              YE        L +++  M+GG+L   I    +  F E  A     EIC  ++ LH +
Sbjct: 66  AYAYET----KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+KPEN+L                             D G ++++D G A  +  
Sbjct: 122 RIVYRDLKPENILLD---------------------------DHGHIRISDLGLAVHVPE 154

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            + +++    T  Y+APEV+  ++Y  S D W+LG ++Y ++ G  PF     +     +
Sbjct: 155 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           +  ++  Q ++     E  S +A++L K +LC DP ERL
Sbjct: 214 ERLVKEVQEEYS----EKFSPDARSLCKMLLCKDPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 93.2 bits (231), Expect = 2e-21
 Identities = 87/286 (30%), Positives = 133/286 (46%), Gaps = 54/286 (18%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQLAVGSHKHIV 72
           ++G G   KVL +  KKT  +YA+KV+           D V+  + V  Q +  +H  +V
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS--NHPFLV 59

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +   ++     SR   VI E ++GG+L   +Q++      E  A     EI  A+ +LH
Sbjct: 60  GLHSCFQT---ESRLFFVI-EYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLH 113

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           ++ I +RD+K +N+L    G    +KLTD+G  K E L   +PGD      T   F    
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCK-EGL---RPGD------TTSTF---- 156

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-----FSNHG 247
                     C TP Y+APE+L  + Y  S D W+LGV+M+ ++ G  PF       N  
Sbjct: 157 ----------CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           Q     +   I   Q   P      +S +A +++K+ L  DP ERL
Sbjct: 207 QNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 45/279 (16%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARR-------EVELQLAVGSHKHIVNI 74
           +LG G  G+V     + T ++YA K L    +K R+       E ++   V S + +V++
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSL 65

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              YE        L +++  M+GG+L   I    +  F E  A     EI   ++ LH +
Sbjct: 66  AYAYET----KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+KPEN+L           L D+G +                +++D G A +I  
Sbjct: 122 RIVYRDLKPENIL-----------LDDYGHI----------------RISDLGLAVEIPE 154

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            + +++    T  Y+APEV+  ++Y  S D W LG ++Y ++ G  PF     +     +
Sbjct: 155 GE-TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           + R++  Q ++     E  S+ A+++ + +L  DP  RL
Sbjct: 214 ERRVKEDQEEYS----EKFSEAARSICRQLLTKDPGFRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 90.7 bits (226), Expect = 7e-21
 Identities = 65/272 (23%), Positives = 115/272 (42%), Gaps = 54/272 (19%)

Query: 30  GKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAV----GSHKHIVNIKDVYENIYNGS 85
           GKV  +  K T +++  K     +KA+    ++  V      + + + +      +    
Sbjct: 30  GKVSVLKHKPTQKLFVQK----IIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTL---- 81

Query: 86  RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
           +  ++IM+ +  G+LF  ++++  G  +E E   I+ ++  A+  LH  NI H D+K EN
Sbjct: 82  KGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLEN 139

Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY- 204
           +LY +  D   + L D+G  K                                    CY 
Sbjct: 140 VLYDRAKDR--IYLCDYGLCKIIG------------------------------TPSCYD 167

Query: 205 -TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG-MKNRIRLGQ 262
            T  Y +PE +    YD S D W++GV+ Y LL G  PF  +  + +    +  R    Q
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---Q 224

Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
              P    ++VS+ A   +++ML  + + RLT
Sbjct: 225 KKLPFI--KNVSKNANDFVQSMLKYNINYRLT 254

Length = 267

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 91.9 bits (228), Expect = 8e-21
 Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 57/289 (19%)

Query: 22  EILGLGINGKVL---QIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVY 78
           ++LG G  GKV    ++    T ++YA+KVL      ++         + +H    ++V 
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKA-------KTVEHTRTERNVL 58

Query: 79  ENI------------YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           E++            +     L +I++ + GGE+F  + Q+++  F+E E      EI  
Sbjct: 59  EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIIL 116

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A++ LH   I +RD+K EN+L    G                            + LTDF
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGH---------------------------VVLTDF 149

Query: 187 GFAKKIVSN-KASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           G +K+ +S  K    + C T  Y+APE++ G   + K+ D WSLG++++ LL G  PF  
Sbjct: 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209

Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
              +     +  RI      FP+     +  EA+ L+  +L  DP +RL
Sbjct: 210 EGERNTQSEVSRRILKCDPPFPS----FIGPEAQDLLHKLLRKDPKKRL 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 91.3 bits (226), Expect = 1e-20
 Identities = 81/285 (28%), Positives = 135/285 (47%), Gaps = 49/285 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVG 66
           +D++I  +++G G  G+V  +  K   +V+A+K+L+        +T   R E ++ L  G
Sbjct: 1   EDFEI-LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV-LVNG 58

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
            ++ I  +   +++  N    L ++M+   GG+L   + + ED    E  A   + E+  
Sbjct: 59  DNQWITTLHYAFQDENN----LYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVI 113

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           AI  +H  +  HRD+KP+N+L    G    ++L DFG                 LKL + 
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMDMNGH---IRLADFGSC---------------LKLMED 155

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFPP 241
           G  +  V+          TP Y++PE+L     G  KY   CD WSLGV MY +L G  P
Sbjct: 156 GTVQSSVA--------VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
           F++         + N     +F FP  +   VS++AK LI+ ++C
Sbjct: 208 FYAESLVETYGKIMNHKE--RFQFP-AQVTDVSEDAKDLIRRLIC 249

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 89.5 bits (222), Expect = 1e-20
 Identities = 76/293 (25%), Positives = 122/293 (41%), Gaps = 47/293 (16%)

Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ------LAVGSHK 69
           D++I  +I G G  G V ++V K    VYA+K +  +   RRE E        LA     
Sbjct: 1   DFEILNKI-GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59

Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           +I+     YE+  +  + L ++ME    G+L + ++ +      E +      +I   + 
Sbjct: 60  YIIR---YYESFLDKGK-LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
            LH + I HRD+K  NL      +                           +K+ D G A
Sbjct: 116 HLHSKKILHRDIKSLNLFLDAYDN---------------------------VKIGDLGVA 148

Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQ 248
           K +  N     T   TPYY++PE+     Y++  D+W+LGV++Y    G  PF  +N G 
Sbjct: 149 KLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
            I   ++         FP P  +  SQ+   LI   L  D  +R    Q++ N
Sbjct: 209 LILKIIRGV-------FP-PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 49/278 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARR-------EVELQLAVGS 67
           +DY++  +++G G  G+V  +  K T +VYA+K+L      +R       E    +A  +
Sbjct: 43  EDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              +V +   +++     R L ++ME M GG+L   +   +     E+ A     E+  A
Sbjct: 102 SPWVVQLFYAFQD----DRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLA 154

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H     HRDVKP+N+L  K G    LKL DFG                 +K+   G
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTC---------------MKMNKEG 196

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL----GPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
             +          T   TP Y++PEVL    G   Y + CD WS+GV +Y +L G  PF+
Sbjct: 197 MVR--------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLI 281
           ++       G  ++I   +     P+   +S+EAK LI
Sbjct: 249 ADS----LVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 282

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 80/303 (26%), Positives = 125/303 (41%), Gaps = 60/303 (19%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ----LAVGSHKHIVNIKDV 77
             LG G  G V +   K T  ++ALK +  T     +++ Q    L +        I   
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTI--TTDPNPDLQKQILRELEINKSCKSPYIVKY 64

Query: 78  YENIYNGSRCLLVI-MECMHGGEL---FQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           Y    + S   + I ME   GG L   +++++ K  G   E+    I   +   + +LH 
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHS 123

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           + I HRD+KP N+L T+ G                            +KL DFG + ++V
Sbjct: 124 RKIIHRDIKPSNILLTRKGQ---------------------------VKLCDFGVSGELV 156

Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
           ++ A   T   T +Y+APE +    Y  + D+WSLG+ +  +     PF       + P 
Sbjct: 157 NSLAGTFTG--TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP- 213

Query: 254 MKNRIRLGQF--DFPNPE----------WEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
               I L  +  + PNPE          W   S+E K  IK  L  DP+ R T   ++E+
Sbjct: 214 ----IELLSYIVNMPNPELKDEPGNGIKW---SEEFKDFIKQCLEKDPTRRPTPWDMLEH 266

Query: 302 KWI 304
            WI
Sbjct: 267 PWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.5 bits (219), Expect = 4e-20
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 33/215 (15%)

Query: 88  LLVIMECMHGGELFQRIQ--QKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
           L +++E    G+L Q I+  +K+     ER       ++CSA++ +H + + HRD+KP N
Sbjct: 77  LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPAN 136

Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT 205
           +  T  G                           ++KL D G  +   S   +  +   T
Sbjct: 137 VFITATG---------------------------VVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 206 PYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDF 265
           PYY++PE +  + Y+   DIWSLG ++Y +     PF+ +     S   K    + Q D+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK----IEQCDY 225

Query: 266 PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           P    EH S++ + L+   +  DP +R  I  V +
Sbjct: 226 PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 79/337 (23%), Positives = 137/337 (40%), Gaps = 76/337 (22%)

Query: 38  KKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKD---VYENIYNGSRCLLVIMEC 94
           KK + V++ K+L    +A RE++L      HK+I  + D   V+   +N       +ME 
Sbjct: 33  KKITNVFSKKIL--AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA 90

Query: 95  MHGGELFQRI---QQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
               +L Q I   Q   D  F        + +I   +K++H  N+ HRD+KP NLL    
Sbjct: 91  ----DLHQIIRSGQPLTDAHFQS-----FIYQILCGLKYIHSANVLHRDLKPGNLLVNA- 140

Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY---- 207
                                        LK+ DFG A+    N         T Y    
Sbjct: 141 --------------------------DCELKICDFGLARGFSENPGE-NAGFMTEYVATR 173

Query: 208 -YVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF----FSNHGQAI-----SPGMKN 256
            Y APE+ L    Y K+ D+WS+G I+  LL   P F    + +    I     +P  + 
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233

Query: 257 RIRLGQ-------FDFPNPE-------WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
             R+G           PN         + + +  A  L++ +L  DP++R+++++ +E+ 
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293

Query: 303 WISQFNQVPQTPLCTGKMLK--EGEETWPEVQDEMTR 337
           +++ ++     P+C        E E++  E++D +  
Sbjct: 294 YLAIWHDPDDEPVCQKPFDFSFESEDSMEELRDMIIE 330

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 87/356 (24%), Positives = 147/356 (41%), Gaps = 106/356 (29%)

Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-----TVKAR--REVELQLAVGSHK 69
           Y+I  ++ G G  G V + ++++T EV ALK + D     T   R  RE+     +G H 
Sbjct: 9   YEILQKL-GKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHP 67

Query: 70  HIVNIKDVY--EN---IYNGSRCLLVIMECM----HG---GELFQRIQQKEDGAFTEREA 117
           +IV + +V   EN   IY       ++ E M    H      + + + ++          
Sbjct: 68  NIVKLLNVIKAENDKDIY-------LVFEYMETDLHAVIRANILEDVHKR---------- 110

Query: 118 AIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
             IM ++  A+K++H  N+ HRD+KP N+L                D +           
Sbjct: 111 -YIMYQLLKALKYIHSGNVIHRDLKPSNILLN-------------SDCR----------- 145

Query: 178 GGILKLTDFGFAKKIVSNKASLQTPCYTPY-----YVAPEVL-GPDKYDKSCDIWSLGVI 231
              +KL DFG A+ +   + + + P  T Y     Y APE+L G  +Y K  D+WS+G I
Sbjct: 146 ---VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI 202

Query: 232 MYILLCGFPPF---------------------------FSNHGQAI--SPGMKNRIRLGQ 262
           +  +L G P F                            S     +  S   + R  L +
Sbjct: 203 LGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE 262

Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
              P       S +A  L+K +L  +P++RLT ++ +E+ +++QF+     P+   
Sbjct: 263 L-LPK-----ASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPY 312

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 85/334 (25%), Positives = 136/334 (40%), Gaps = 74/334 (22%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALK--VLHDT-----VKARREVELQLAVG 66
             DY+I  + LG G  G+V +  + KT  V ALK  ++H+      + A RE+++ L   
Sbjct: 7   LRDYEILGK-LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKI-LKKL 64

Query: 67  SHKHIVNIKD-VYENIYNGSR---CLLVIMECM-H--GGELF-QRIQQKEDGAFTEREAA 118
            H ++V + D   E      R    + ++   M H   G L    ++       TE +  
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------LTESQIK 118

Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             M ++   I +LH+ +I HRD+K  N+L     + GILK+ DFG  +P +     P  G
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGPPPNPKGG 175

Query: 179 GILKLTDFGFAKKIVSNKASLQTPC-YTPYYVAPE-VLGPDKYDKSCDIWSLGVI---MY 233
           G      +              T    T +Y  PE +LG  +Y  + DIW +G +   M+
Sbjct: 176 GGGGTRKY--------------TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221

Query: 234 ----IL--------------LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPE------ 269
               IL              LCG P   +  G    PG +         F N        
Sbjct: 222 TRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEG-----VHSFTNYPRTLEER 276

Query: 270 WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           +  +  E   L+  +L +DP +RLT    +E+ +
Sbjct: 277 FGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.4 bits (219), Expect = 6e-20
 Identities = 76/290 (26%), Positives = 133/290 (45%), Gaps = 45/290 (15%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ--LAVGSHKH--IVNIKDV 77
           E +G G +G V   ++  T +  A+K ++   + ++E+ +   L +  +KH  IVN    
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN---- 80

Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y + Y     L V+ME + GG L   + +       E + A +  E   A++FLH   + 
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVI 137

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+K +N+L                            G  G +KLTDFGF  +I   ++
Sbjct: 138 HRDIKSDNILL---------------------------GMDGSVKLTDFGFCAQITPEQS 170

Query: 198 SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISPGMKN 256
              T   TPY++APEV+    Y    DIWSLG++   ++ G PP+ + N  +A+     N
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230

Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               G  +  NP  E +S   +  +   L +D  +R +  +++++ ++  
Sbjct: 231 ----GTPELQNP--EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 88.1 bits (218), Expect = 7e-20
 Identities = 71/274 (25%), Positives = 123/274 (44%), Gaps = 35/274 (12%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARREVELQLAVGSHKHIVNIKDVYE-- 79
           +LG G  G+V     + T ++YA K L    +K R+   + L        VN + V    
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
             Y     L +++  M+GG+L   I    +  F E+ A     E+C  ++ L  + I +R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126

Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+KPEN+L                             D G ++++D G A +I   + ++
Sbjct: 127 DLKPENILLD---------------------------DRGHIRISDLGLAVQIPEGE-TV 158

Query: 200 QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIR 259
           +    T  Y+APEV+  +KY  S D W LG ++Y ++ G  PF     +     +  R++
Sbjct: 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK 218

Query: 260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             Q ++     E  S++AK++ + +L  +P ERL
Sbjct: 219 EDQEEYS----EKFSEDAKSICRMLLTKNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 88.1 bits (218), Expect = 8e-20
 Identities = 82/284 (28%), Positives = 129/284 (45%), Gaps = 55/284 (19%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARR-------EVELQLAVGSHKHIVNI 74
           +LG G  G+V     + T ++YA K L    +K R+       E ++   V S + +VN+
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-QFVVNL 65

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              YE        L +++  M+GG+L   I    +  F E  A     EI   ++ LH +
Sbjct: 66  AYAYET----KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
           N  +RD+KPEN+L           L D+G +                +++D G A KI  
Sbjct: 122 NTVYRDLKPENIL-----------LDDYGHI----------------RISDLGLAVKIPE 154

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            + S++    T  Y+APEVL   +Y  S D W LG ++Y ++ G  PF          G 
Sbjct: 155 GE-SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---------RGR 204

Query: 255 KNRIRLGQFDFPNPEWEHV-----SQEAKTLIKNMLCVDPSERL 293
           K +++  + D    E E V     S+EAK++ K +L  DP +RL
Sbjct: 205 KEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 9e-20
 Identities = 78/325 (24%), Positives = 116/325 (35%), Gaps = 95/325 (29%)

Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVEL--QLA 64
           Y+   EI G G  G V +  +  T    ALK +            T+   RE+ L  QL 
Sbjct: 1   YEELAEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL---REIALLKQLE 56

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLV--IMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
              H +IV + DV        R L +  + E +   +L   + +             +M 
Sbjct: 57  SFEHPNIVRLLDVCHGPRT-DRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR 114

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++   + FLH   I HRD+KP+N+L T                             G +K
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTS---------------------------DGQVK 147

Query: 183 LTDFGFAKKIVSNKASLQTPCY-TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           + DFG A +I S + +L T    T +Y APEVL    Y    D+WS+G I   L    P 
Sbjct: 148 IADFGLA-RIYSFEMAL-TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPL 205

Query: 242 FFSNHGQAISPG-----MKNRIRLGQFDF----PNPEW---------------------- 270
           F          G       ++I    FD        EW                      
Sbjct: 206 F---------RGTSEADQLDKI----FDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSF 252

Query: 271 -EHVSQEAKTLIKNMLCVDPSERLT 294
              + +E   L+K ML  +P +R++
Sbjct: 253 VPEICEEGLDLLKKMLTFNPHKRIS 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 87.8 bits (217), Expect = 9e-20
 Identities = 77/286 (26%), Positives = 131/286 (45%), Gaps = 42/286 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVE---LQLAVGSHKHIVNIKDVY 78
           E +G G  G+V + ++ +T +V A+K++ D  +A  E+E    ++ V S      +   Y
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
            +    ++ L +IME + GG     +   E G   E + A I+ EI   + +LH +   H
Sbjct: 69  GSYLKDTK-LWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIH 124

Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  N+L ++ G+                           +KL DFG A ++   +  
Sbjct: 125 RDIKAANVLLSEHGE---------------------------VKLADFGVAGQLTDTQIK 157

Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
             T   TP+++APEV+    YD   DIWSLG+    L  G PP    H       MK   
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH------PMKVLF 211

Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            + + + P  E  + S+  K  ++  L  +PS R T  +++++K+I
Sbjct: 212 LIPKNNPPTLEGNY-SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 74/333 (22%), Positives = 140/333 (42%), Gaps = 68/333 (20%)

Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-------VLHDTVKARREVELQLAVGSHKHIVN 73
            E +G G  G V   ++ ++ +  A+K       V     +  RE+++ L    H +I+ 
Sbjct: 10  IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKI-LRHFKHDNIIA 68

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           I+D+        + + V+M+ M   +L   I   +    TE      + ++   +K++H 
Sbjct: 69  IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHS 125

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
            N+ HRD+KP NLL  +  +   L++ DFG  +    L + P +          F  + V
Sbjct: 126 ANVIHRDLKPSNLLVNEDCE---LRIGDFGMAR---GLSSSPTEHK-------YFMTEYV 172

Query: 194 SNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI--------------------- 231
           +          T +Y APE+L    +Y  + D+WS+G I                     
Sbjct: 173 A----------TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222

Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNP---EWEHV----SQEAKTLIKNM 284
           + + + G P       + ++    +R+R    + P      W  +    S EA  L+  M
Sbjct: 223 LILSVLGSPS-----EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQM 277

Query: 285 LCVDPSERLTIDQVMENKWISQFNQVPQTPLCT 317
           L  DP ER+T++Q +++ +++Q++     P C 
Sbjct: 278 LQFDPEERITVEQALQHPFLAQYHDPDDEPTCP 310

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 90.6 bits (224), Expect = 1e-19
 Identities = 90/298 (30%), Positives = 141/298 (47%), Gaps = 44/298 (14%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVG-----SH 68
           ++Y++  +I G G  G+V  +  K+T E +  K + +  +K R + +L + V       H
Sbjct: 13  NEYEVIKKI-GNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICS 126
           K+IV   D + N  N    L ++ME    G+L + IQ+  K  G   E     I  ++  
Sbjct: 72  KNIVRYIDRFLNKANQK--LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129

Query: 127 AIKFLHD-------QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           A+ + H+       + + HRD+KP+N+ +   G   I K+T        N L  +P    
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNI-FLSTGIRHIGKIT-----AQANNLNGRP---- 179

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCY-TPYYVAPEVL--GPDKYDKSCDIWSLGVIMYILL 236
           I K+ DFG +K I     S+   C  TPYY +PE+L      YD   D+W+LG I+Y L 
Sbjct: 180 IAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 237 CGFPPFF--SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
            G  PF   +N  Q IS      ++ G    P+   +  S+E   LIKN+L +   ER
Sbjct: 238 SGKTPFHKANNFSQLIS-----ELKRG----PDLPIKGKSKELNILIKNLLNLSAKER 286

Length = 1021

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 81/307 (26%), Positives = 134/307 (43%), Gaps = 55/307 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQL----AVGSHKH 70
           D ++I  E +G G  GKV +++ KK     A+K+L        E+E +     A+  H +
Sbjct: 18  DTWEI-IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76

Query: 71  IVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICS 126
           +V    +Y  +++ NG +  LV+  C +GG +   ++   K      E   A I++E   
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELC-NGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            ++ LH     HRDVK  N+L T                             G +KL DF
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTT---------------------------EGGVKLVDF 168

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-----YDKSCDIWSLGVIMYILLCGFPP 241
           G + ++ S +    T   TP+++APEV+  ++     YD  CD+WSLG+    L  G PP
Sbjct: 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228

Query: 242 FFSNHGQAISPGMKNRIRLGQFDFP---NPE-WEHVSQEAKTLIKNMLCVDPSERLTIDQ 297
               H       M+   ++ +   P    PE W   S E    I+  L  D  +R T+  
Sbjct: 229 LADLH------PMRALFKIPRNPPPTLHQPELW---SNEFNDFIRKCLTKDYEKRPTVSD 279

Query: 298 VMENKWI 304
           ++++ +I
Sbjct: 280 LLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 93/322 (28%), Positives = 141/322 (43%), Gaps = 60/322 (18%)

Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSH 68
           +  + LG+G  G+V    +  T  +YA+K L             VKA R++   LA   +
Sbjct: 4   VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDI---LAEADN 60

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           + +V +   +++  N    L  +M+ + GG++   + +   G F E  A   + E+  A+
Sbjct: 61  EWVVRLYYSFQDKDN----LYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAV 114

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---------DVKPENLLYTKPGDGG 179
           + +H     HRD+KP+N+L  + G    +KLTDFG         D K     Y + GD  
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDSK-----YYQSGDHV 166

Query: 180 ILKLTDF------------GFAKKIVSNKASLQ-TPCY------TPYYVAPEVLGPDKYD 220
                DF            G   K +  +A+ Q   C       TP Y+APEVL    Y 
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226

Query: 221 KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTL 280
           + CD WS+GVI+Y +L G PPF +     +   MK  +   Q     P    +S EA  L
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQ--TPLETQMK--VINWQTSLHIPPQAKLSPEASDL 282

Query: 281 IKNMLCVDPSERLTIDQVMENK 302
           I   LC  P +RL  +   E K
Sbjct: 283 IIK-LCRGPEDRLGKNGADEIK 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 49/278 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARR-------EVELQLAVGS 67
           +DYD+  +++G G  G+V  +  K + +VYA+K+L      +R       E    +A  +
Sbjct: 43  EDYDV-VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              +V +   +++     + L ++ME M GG+L   +   +     E+ A     E+  A
Sbjct: 102 SPWVVQLFCAFQD----DKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLA 154

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H   + HRDVKP+N+L  K G    LKL DFG                 +K+ + G
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGH---LKLADFGTC---------------MKMDETG 196

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL----GPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
             +          T   TP Y++PEVL    G   Y + CD WS+GV ++ +L G  PF+
Sbjct: 197 MVR--------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLI 281
           ++       G  ++I   +     PE   +S+ AK LI
Sbjct: 249 ADS----LVGTYSKIMDHKNSLNFPEDVEISKHAKNLI 282

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 85.7 bits (212), Expect = 4e-19
 Identities = 82/308 (26%), Positives = 131/308 (42%), Gaps = 64/308 (20%)

Query: 16  DYDISTE--ILGLGINGKV---------LQIVEKKTSEVYALKV--LHDTVKARREVELQ 62
           +YD + E  +LG G  G V         ++I  K+  E  +  V  LH+ +     +   
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL--- 62

Query: 63  LAVGSHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM 121
                H++IV  +    EN +       + ME + GG L   ++ K  G   + E  II 
Sbjct: 63  ----KHRNIVQYLGSDSENGF-----FKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIF 112

Query: 122 --NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
              +I   +K+LHD  I HRD+K +N+L                        Y+     G
Sbjct: 113 YTKQILEGLKYLHDNQIVHRDIKGDNVLVNT---------------------YS-----G 146

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL--GPDKYDKSCDIWSLGVIMYILLC 237
           ++K++DFG +K++       +T   T  Y+APEV+  GP  Y    DIWSLG  +  +  
Sbjct: 147 VVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT 206

Query: 238 GFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID 296
           G PPF      QA    M    ++G F       E +S EAK  I      DP +R +  
Sbjct: 207 GKPPFIELGEPQA---AM---FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAH 260

Query: 297 QVMENKWI 304
            ++++ ++
Sbjct: 261 DLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 77/283 (27%), Positives = 128/283 (45%), Gaps = 51/283 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARR-------EVELQLAVGS 67
           +D+D+  +++G G  G+V  +  K + +VYA+K+L      +R       E    +A  +
Sbjct: 43  EDFDV-IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
            + IV +   +++     + L ++ME M GG+L   +   +     E+ A     E+  A
Sbjct: 102 SEWIVQLHYAFQD----DKYLYMVMEYMPGGDLVNLMSNYD---IPEKWARFYTAEVVLA 154

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H     HRDVKP+N+L  K G                            LKL DFG
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGH---------------------------LKLADFG 187

Query: 188 FAKKIVSN-KASLQTPCYTPYYVAPEVL----GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
              K+ +N      T   TP Y++PEVL    G   Y + CD WS+GV +Y +L G  PF
Sbjct: 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
           ++    ++  G  ++I   +     P+   +S++AK LI   L
Sbjct: 248 YA---DSLV-GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL 286

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 85.8 bits (212), Expect = 5e-19
 Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 46/247 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQL----AVGSHKH 70
           D ++I  E +G G  GKV ++  KK   + A+K+L        E+E +     ++ +H +
Sbjct: 22  DTWEI-IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80

Query: 71  IVNIKDVYENIYNGSRC----LLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEI 124
           +V     Y   Y   +     L +++E  +GG + + ++          E   + I+   
Sbjct: 81  VVKF---YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              ++ LH+  I HRDVK  N+L T                           +GG+ KL 
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTT--------------------------EGGV-KLV 170

Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-----YDKSCDIWSLGVIMYILLCGF 239
           DFG + ++ S +    T   TP+++APEV+  ++     YD  CD+WSLG+    L  G 
Sbjct: 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230

Query: 240 PPFFSNH 246
           PP F  H
Sbjct: 231 PPLFDMH 237

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 85.7 bits (212), Expect = 6e-19
 Identities = 72/279 (25%), Positives = 131/279 (46%), Gaps = 44/279 (15%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE------VELQLAVGSH-KHIVNIKD 76
           LG G  G+V     + T ++YA K L+     +R+      VE ++    H + IV++  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            ++   +    L ++M  M+GG+L   I    +E+  F E  A     +I S ++ LH +
Sbjct: 61  AFQTKTD----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+KPEN+L           L + G+V+                ++D G A ++  
Sbjct: 117 RIIYRDLKPENVL-----------LDNDGNVR----------------ISDLGLAVELKD 149

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            ++  +    TP ++APE+L  ++YD S D ++LGV +Y ++    PF +   +  +  +
Sbjct: 150 GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           K RI      +P    +  S  +K+  + +L  DP +RL
Sbjct: 210 KQRILNDSVTYP----DKFSPASKSFCEALLAKDPEKRL 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 86/340 (25%), Positives = 130/340 (38%), Gaps = 79/340 (23%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVK------ARREVE 60
           F        Y+   +I G G  G+V +   KKT ++ ALK VL +  K      A RE++
Sbjct: 5   FPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK 63

Query: 61  -LQLAVGSHKHIVNIKDV---YENIYNGSRC--LLVIMECMHG-GELFQRIQQKEDGAFT 113
            LQL    H+++VN+ ++       YN  +    LV   C H    L      K    FT
Sbjct: 64  ILQLL--KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK----FT 117

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
             E   +M  + + + ++H   I HRD+K  N+L TK                       
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITK----------------------- 154

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP-----YYVAPEV-LGPDKYDKSCDIWS 227
                GILKL DFG A+    +K S +   YT      +Y  PE+ LG   Y    D+W 
Sbjct: 155 ----DGILKLADFGLARAFSLSKNS-KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWG 209

Query: 228 LGVIMYILLCGFPPFFSNHGQ---------------AISPGMKNRIRLGQFDFPNPEWEH 272
            G IM  +    P    N  Q                + PG+       + + P  +   
Sbjct: 210 AGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRK 269

Query: 273 V---------SQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           V            A  LI  +L +DP++R+  D  + + +
Sbjct: 270 VKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 79/323 (24%), Positives = 132/323 (40%), Gaps = 86/323 (26%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALK--VLHDTVK-----ARREVELQLAVGSHKHIVNI 74
           E +G G  G V +   ++T E+ ALK   L D  +     A RE+ L L    HK+IV +
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL-LKELKHKNIVRL 64

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNEICSAIKFL 131
            DV   +++  +  LV   C       Q +++  D    + +  I+   M ++   + F 
Sbjct: 65  YDV---LHSDKKLTLVFEYCD------QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  N+ HRD+KP+NLL  K G+   LKL DFG  +                   FG   +
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGE---LKLADFGLARA------------------FGIPVR 154

Query: 192 IVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
             S +        T +Y  P+VL G   Y  S D+WS G I   L        +N G+ +
Sbjct: 155 CYSAEV------VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL--------ANAGRPL 200

Query: 251 SPGMK-----NRI----------------RLGQFDF-----PNPEWEHV----SQEAKTL 280
            PG        RI                +L  +             +V    +   + L
Sbjct: 201 FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDL 260

Query: 281 IKNMLCVDPSERLTIDQVMENKW 303
           ++N+L  +P +R++ ++ +++ +
Sbjct: 261 LQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 84.6 bits (209), Expect = 7e-19
 Identities = 66/289 (22%), Positives = 129/289 (44%), Gaps = 45/289 (15%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVL---HDTVKARREVELQLAVGS---HKHIVNIKD 76
           ++G G  G+V  +  +   + Y +K L   + + + R+  E +  + S   H +IV  ++
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 77  VYENIYNGSRCLL-VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
            +E    G   LL ++M    GG+L+ ++++++     E +      +I  A+++LH+++
Sbjct: 67  SWE----GEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I HRD+K +N+  T+                             I+K+ D G A+ + + 
Sbjct: 123 ILHRDLKTQNVFLTRT---------------------------NIIKVGDLGIARVLENQ 155

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
                T   TPYY++PE+     Y+   D+W+LG  +Y +      F +    ++     
Sbjct: 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV---- 211

Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            RI  G+   P P  +  S E   LI  ML   P +R ++  ++   +I
Sbjct: 212 YRIIEGKLP-PMP--KDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 68/287 (23%), Positives = 134/287 (46%), Gaps = 43/287 (14%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYENIY 82
           +G G  G V     K + ++ A+K +    + RRE+   ++ +       N+ ++Y +  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 83  NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK 142
            G   L V+ME + GG L   +         E + A +   +  A+  LH Q + HRD+K
Sbjct: 88  VGDE-LWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP 202
            +++L T  G                            +KL+DFGF  ++       ++ 
Sbjct: 144 SDSILLTHDGR---------------------------VKLSDFGFCAQVSKEVPRRKSL 176

Query: 203 CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ 262
             TPY++APE++    Y    DIWSLG+++  ++ G PP+F+       P +K  +++ +
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN------EPPLK-AMKMIR 229

Query: 263 FDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            + P P+ ++   VS   K  +  +L  DP++R T  +++++ ++++
Sbjct: 230 DNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 45/228 (19%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           L +++E + GGE F  +++ +   F          +I    ++L   NI +RD+KPENLL
Sbjct: 106 LYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLL 163

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
             K                            G +K+TDFGFAK + +   +L   C TP 
Sbjct: 164 LDK---------------------------DGFIKMTDFGFAKVVDTRTYTL---CGTPE 193

Query: 208 YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           Y+APE+L    + K+ D W+LG+ +Y +L G PPF++N    I      +I  G   FP 
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY----QKILEGIIYFP- 248

Query: 268 PEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFNQV 310
              + +    K L+K +L  D ++R          V E+ W    + V
Sbjct: 249 ---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293

Length = 340

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 84.4 bits (208), Expect = 2e-18
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 32/226 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYEN 80
           E +G G +G V   ++  T +  A+K ++   + ++E+ + ++ V       NI +  ++
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
              G   L V+ME + GG L   + +       E + A +  E   A+ FLH   + HRD
Sbjct: 85  YLVGDE-LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRD 140

Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +K +N+L                            G  G +KLTDFGF  +I   ++   
Sbjct: 141 IKSDNILL---------------------------GMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           T   TPY++APEV+    Y    DIWSLG++   ++ G PP+ + +
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 33/213 (15%)

Query: 88  LLVIMECMHGGELFQRIQ--QKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
           L +++E    G+L + I+  +K+     E+       ++CSA++ +H + + HRD+KP N
Sbjct: 77  LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 136

Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT 205
           +  T  G                           ++KL D G  +   S   +  +   T
Sbjct: 137 VFITATG---------------------------VVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 206 PYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDF 265
           PYY++PE +  + Y+   DIWSLG ++Y +     PF+ +     S   K    + Q D+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEQCDY 225

Query: 266 PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
           P    +H S+E + L+   +  DP +R  I  V
Sbjct: 226 PPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 89/312 (28%), Positives = 138/312 (44%), Gaps = 58/312 (18%)

Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSH 68
           +  + LG+G  G+V    +  T  +YA+K L             VKA R++   LA   +
Sbjct: 4   VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDI---LAEADN 60

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           + +V +   +++  N    L  +M+ + GG++   + + E   F E  A   + E+  AI
Sbjct: 61  EWVVKLYYSFQDKDN----LYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAI 114

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK----PENLLYTKPGD---GGIL 181
           + +H     HRD+KP+N+L    G    +KLTDFG         N  Y + G       +
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGH---IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171

Query: 182 KLTDF---------GFAKKIVSNKASLQ-TPCY------TPYYVAPEVLGPDKYDKSCDI 225
           + +D          G   K +  +A+ Q   C       TP Y+APEVL    Y + CD 
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231

Query: 226 WSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPN----PEWEHVSQEAKTLI 281
           WS+GVI++ +L G PPF      A +P      +L   ++ N    P    +S EA  LI
Sbjct: 232 WSVGVILFEMLVGQPPFL-----APTP---TETQLKVINWENTLHIPPQVKLSPEAVDLI 283

Query: 282 KNMLCVDPSERL 293
              LC    ERL
Sbjct: 284 TK-LCCSAEERL 294

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 82.1 bits (202), Expect = 1e-17
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYEN 80
           E +G G +G V   ++  T +  A++ ++   + ++E+ + ++ V       NI +  ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
              G   L V+ME + GG L   + +       E + A +  E   A++FLH   + HRD
Sbjct: 86  YLVGDE-LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141

Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +K +N+L                            G  G +KLTDFGF  +I   ++   
Sbjct: 142 IKSDNILL---------------------------GMDGSVKLTDFGFCAQITPEQSKRS 174

Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           T   TPY++APEV+    Y    DIWSLG++   ++ G PP+ + +
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 81.7 bits (201), Expect = 2e-17
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYEN 80
           E +G G +G V   ++  T +  A+K ++   + ++E+ + ++ V       NI +  ++
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
              G   L V+ME + GG L   + +       E + A +  E   A++FLH   + HRD
Sbjct: 85  FLVGDE-LFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRD 140

Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +K +N+L                            G  G +KLTDFGF  +I   ++   
Sbjct: 141 IKSDNVLL---------------------------GMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           T   TPY++APEV+    Y    DIWSLG++   ++ G PP+ + +
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 54/300 (18%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE---VELQ-LAVGSHKHIVNIKDVYE 79
           LG G  GKV +   K+T  + A KV+    +   E   VE++ LA  +H +IV +   + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF- 78

Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
             ++G   L +++E   GG +   I  + D   TE +  +I  ++  A+++LH   I HR
Sbjct: 79  -YWDGK--LWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR 134

Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+K  N+L T  GD                           +KL DFG + K V      
Sbjct: 135 DLKAGNVLLTLDGD---------------------------IKLADFGVSAKNVKTLQRR 167

Query: 200 QTPCYTPYYVAPEV-----LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            +   TPY++APEV     +    YD   DIWSLG+ +  +    PP        ++P M
Sbjct: 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-----HELNP-M 221

Query: 255 KNRIRLGQFDFPN----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV 310
           +  +++ + + P      +W   S E +  +K  L   P  R +  Q++E+ ++S     
Sbjct: 222 RVLLKIAKSEPPTLSQPSKW---SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 82/301 (27%), Positives = 135/301 (44%), Gaps = 65/301 (21%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH----DTVKAR--REVELQLAVGSHKHIVNIKD 76
            +G G  G V +++ + T  +YALKV++    DTV+ +  RE+E+ L   +H ++V   D
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEI-LRDVNHPNVVKCHD 139

Query: 77  VYENIYNGSRCLLVIMECMHGGEL-FQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
           +++  +NG   + V++E M GG L    I         E+  A +  +I S I +LH ++
Sbjct: 140 MFD--HNGE--IQVLLEFMDGGSLEGTHIAD-------EQFLADVARQILSGIAYLHRRH 188

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I HRD+KP NLL                                 +K+ DFG ++ +   
Sbjct: 189 IVHRDIKPSNLLINS---------------------------AKNVKIADFGVSRIL--- 218

Query: 196 KASLQTPCY----TPYYVAPEVLGPD----KYDK-SCDIWSLGV-IMYILLCGFPPFFSN 245
            A    PC     T  Y++PE +  D     YD  + DIWSLGV I+   L  FP     
Sbjct: 219 -AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
            G   S  +   I + Q           S+E +  I   L  +P++R +  Q++++ +I 
Sbjct: 278 QGDWAS--LMCAICMSQPPEAPAT---ASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332

Query: 306 Q 306
           +
Sbjct: 333 R 333

Length = 353

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.3 bits (198), Expect = 3e-17
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 55/288 (19%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVL----------HDTVKA-RREVELQLAVGSHKH 70
           + LG G      Q  + KT  + A+K +           + V+A R+E+ L +A  +H H
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRL-MARLNHPH 64

Query: 71  IVNI--KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           I+ +      ++ +N      + +E M GG +   +   + GAF E        ++   +
Sbjct: 65  IIRMLGATCEDSHFN------LFVEWMAGGSVSHLL--SKYGAFKEAVIINYTEQLLRGL 116

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            +LH+  I HRDVK  NLL    G    L++ DFG         T  G+          F
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQ--RLRIADFGAAARLAAKGTGAGE----------F 164

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF----FS 244
             +++   A          ++APEVL  ++Y +SCD+WS+G ++  +    PP+     S
Sbjct: 165 QGQLLGTIA----------FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214

Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
           NH   I        ++          EH+S   + +    L + P +R
Sbjct: 215 NHLALI-------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDR 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 79/314 (25%), Positives = 132/314 (42%), Gaps = 73/314 (23%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VK--ARREVEL--QLAVGSHKHIV 72
            ++G G  G V++   K+T ++ A+K   ++     VK  A RE+ +  QL    H+++V
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL---RHENLV 63

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+ +V+       R  LV     H   +   +++  +G    R    +  +I   I+F H
Sbjct: 64  NLIEVFRR---KKRLYLVFEFVDH--TVLDDLEKYPNGLDESRVRKYLF-QILRGIEFCH 117

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NI HRD+KPEN+L ++                            G++KL DFGFA+ +
Sbjct: 118 SHNIIHRDIKPENILVSQ---------------------------SGVVKLCDFGFARTL 150

Query: 193 VSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF--------- 242
            +          T +Y APE+L G  KY ++ DIW++G ++  +L G P F         
Sbjct: 151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210

Query: 243 ---------FSNHGQAISPGMKNRI----RLGQFDFPNP---EWEHVSQEAKTLIKNMLC 286
                         Q I    KN +    RL +     P    +  +S     L K  L 
Sbjct: 211 YHIIKCLGNLIPRHQEIF--QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLR 268

Query: 287 VDPSERLTIDQVME 300
           +DP +R +  Q++ 
Sbjct: 269 IDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.1 bits (197), Expect = 4e-17
 Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 44/294 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQL-AVGSHKHIVNIKDVY-- 78
           E++G G  G+V +    KT ++ A+KV+  T     E++ ++  +  + H  NI   Y  
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 79  ---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
              +N       L ++ME    G +   I+  +     E   A I  EI   +  LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           + HRD+K +N+L T+  +                           +KL DFG + ++   
Sbjct: 132 VIHRDIKGQNVLLTENAE---------------------------VKLVDFGVSAQLDRT 164

Query: 196 KASLQTPCYTPYYVAPEVLGPDK-----YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
                T   TPY++APEV+  D+     YD   D+WSLG+    +  G PP    H    
Sbjct: 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---- 220

Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
              M+    + +   P  + +  S++ ++ I++ L  + S+R T +Q+M++ +I
Sbjct: 221 --PMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.0 bits (197), Expect = 4e-17
 Identities = 72/293 (24%), Positives = 128/293 (43%), Gaps = 52/293 (17%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----------HDTVKARREVELQLAVGSHKHIVN 73
           LG G  G V  + +KK      LKVL          ++TV+A +E +L L+   H  IV 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQL-LSKLDHPAIVK 66

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ-KEDG-AFTEREAAIIMNEICSAIKFL 131
               +  +   + C  +I E   G +L  ++++ K  G   +E +      ++   + ++
Sbjct: 67  FHASF--LERDAFC--IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H + I HRD+K +N+                                 +LK+ DFG ++ 
Sbjct: 123 HQRRILHRDLKAKNIFLKN----------------------------NLLKIGDFGVSRL 154

Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           ++ +     T   TPYY++PE L    YD   DIWSLG I+Y + C        H     
Sbjct: 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC------LAHAFEGQ 208

Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
             +   +R+ +   P+   E  S++  +++++ML  DPS R +  +++ N +I
Sbjct: 209 NFLSVVLRIVEGPTPSLP-ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 78/340 (22%), Positives = 136/340 (40%), Gaps = 88/340 (25%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVG----------------- 66
           LG G  GKV +  +  T ++ A+K +     +    + +  VG                 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 67  -SHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
             H++I+ + DVY   +  N      ++M+ M   +L + + +K     TE +   I+ +
Sbjct: 77  IKHENIMGLVDVYVEGDFIN------LVMDIMAS-DLKKVVDRKI--RLTESQVKCILLQ 127

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           I + +  LH     HRD+ P N+        GI K+ DFG       L  + G       
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFIN---SKGICKIADFG-------LARRYGYPPYSDT 177

Query: 184 TDFGFAKKIVSNKASLQTP-CYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPP 241
                +K     +    T    T +Y APE+L G +KY  + D+WS+G I   LL G P 
Sbjct: 178 L----SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233

Query: 242 FFSNHGQAISPGMKNRIR-LG------------------------QFDFPNPE-----WE 271
           F         PG +N I  LG                        +F    P+     + 
Sbjct: 234 F---------PG-ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFP 283

Query: 272 HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVP 311
           + S +A  L++++L ++P ER++  + +++++   F   P
Sbjct: 284 NASDDAIDLLQSLLKLNPLERISAKEALKHEY---FKSDP 320

Length = 335

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 79.1 bits (196), Expect = 7e-17
 Identities = 61/286 (21%), Positives = 109/286 (38%), Gaps = 62/286 (21%)

Query: 30  GKVLQIVEKKTSEVYALKVLHDTVKA------RREVEL--QLAVGSHKHIVNIKDVYENI 81
           G +    + K  EV A+K L +           RE  +  +L    H +IV +  V    
Sbjct: 18  GTLKGKGDGKEVEV-AVKTLKEDASEQQIEEFLREARIMRKL---DHPNIVKLLGV---- 69

Query: 82  YNGSRC-----LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
                C     L+++ME M GG+L   +++      +  +      +I   +++L  +N 
Sbjct: 70  -----CTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+   N L                            G+  ++K++DFG ++ +  + 
Sbjct: 125 IHRDLAARNCLV---------------------------GENLVVKISDFGLSRDLYDDD 157

Query: 197 ASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGM 254
                    P  ++APE L   K+    D+WS GV+++ I   G  P+       +   +
Sbjct: 158 YYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           K   RL     P P   +   E   L+      DP +R T  +++E
Sbjct: 218 KKGYRL-----PKP--PNCPPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 80.1 bits (198), Expect = 9e-17
 Identities = 76/291 (26%), Positives = 126/291 (43%), Gaps = 73/291 (25%)

Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ   D  
Sbjct: 61  RAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLD-- 116

Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK     
Sbjct: 117 -HERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VK----- 152

Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 153 -----SDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205

Query: 231 IMYILLCG---FP--------------------PFFSNHGQAISPGMKNRIRLG--QFD- 264
           IM  ++ G   FP                     F S     +   ++NR +     F+ 
Sbjct: 206 IMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEE 265

Query: 265 ------FPNPEWEHV---SQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
                 FP     H    + +A+ L+  ML +DP +R+++D  +++ +I+ 
Sbjct: 266 LFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 69/303 (22%), Positives = 121/303 (39%), Gaps = 63/303 (20%)

Query: 22  EILGLGINGKV-LQIVEKKTSEVYALK--VLH--DTVKARREVE-LQLAVG-----SHKH 70
           E+LG G  G V   +      ++ A+K   L   + + A +E E LQ  V       H +
Sbjct: 6   EVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 71  IVNIKD--VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           IV      + +N  +      + ME + GG +   +     G   E        +I   +
Sbjct: 64  IVQYLGTCLDDNTIS------IFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGV 115

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            +LH+  + HRD+K  N++                 + P           GI+KL DFG 
Sbjct: 116 AYLHNNCVVHRDIKGNNVM-----------------LMPN----------GIIKLIDFGC 148

Query: 189 AKKI------VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           A+++       ++   L++   TPY++APEV+    Y +  DIWS+G  ++ +  G PP 
Sbjct: 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEW-EHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
            S         +     +G      P   +  S  A   + + L  D  ER +  Q++ +
Sbjct: 209 AS------MDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262

Query: 302 KWI 304
            ++
Sbjct: 263 DFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 50/300 (16%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----DTVKARREVELQLAVGSHK 69
           Q DY++   + G G  G V +     T E+ A+K++     D     ++    +    H 
Sbjct: 8   QHDYELIQRV-GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC 66

Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           +IV     Y   Y     L + ME   GG L Q I     G  +E + A +  E    + 
Sbjct: 67  NIV----AYFGSYLSREKLWICMEYCGGGSL-QDIYHVT-GPLSELQIAYVCRETLQGLA 120

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           +LH +   HRD+K  N+L           LTD GDVK                L DFG A
Sbjct: 121 YLHSKGKMHRDIKGANIL-----------LTDNGDVK----------------LADFGVA 153

Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYILLCGFPPFFSNH 246
            KI +  A  ++   TPY++APEV   +K   Y++ CDIW++G+    L    PP F  H
Sbjct: 154 AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKT---LIKNMLCVDPSERLTIDQVMENKW 303
                  M+    + + +F  P+ +  ++ + T    +K  L  +P +R T ++++ + +
Sbjct: 214 ------PMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 80/320 (25%), Positives = 126/320 (39%), Gaps = 80/320 (25%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVK-----ARREVELQLAVGSHKHIVNIK 75
           E LG G    V +   + T E+ ALK +H D  +     A RE+ L   +  H++IV + 
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLH 64

Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQ-QKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           DV   I+  ++ L+++ E M   +L + +      GA           ++   I F H+ 
Sbjct: 65  DV---IHTENK-LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+KP+NLL  K G+                           LKL DFG A+    
Sbjct: 120 RVLHRDLKPQNLLINKRGE---------------------------LKLADFGLARAFGI 152

Query: 195 NKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
              +      T +Y AP+VL G   Y  S DIWS+G IM  ++ G P F         PG
Sbjct: 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF---------PG 203

Query: 254 MKNRIRLGQ-FDF---PN----------PEWEHVSQEAKT----------------LIKN 283
             N  +L + F     P           PE++                        L+  
Sbjct: 204 TNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHR 263

Query: 284 MLCVDPSERLTIDQVMENKW 303
           +L ++P  R++    +++ W
Sbjct: 264 LLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 72/343 (20%), Positives = 134/343 (39%), Gaps = 85/343 (24%)

Query: 17  YDISTEILGLGINGKVLQIVEK--KTSEVYALKVLHDTVK--------ARREVELQLAVG 66
           Y+I   I G G  G+V +   K  K  + YA+K      +        A RE+ L   + 
Sbjct: 2   YEIEGCI-GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL- 59

Query: 67  SHKHIVNIKDVYENIYNGSRCL-LVIMECMHGGELFQRIQ---QKEDGAFTEREAAIIMN 122
            H+++V++ +V+  + +  + + L+     H  +L+Q I+   Q +  +        ++ 
Sbjct: 60  KHENVVSLVEVF--LEHADKSVYLLFDYAEH--DLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I + + +LH   + HRD+KP N+L    G                        + G++K
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGP-----------------------ERGVVK 152

Query: 183 LTDFGFAKKIVS---NKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG 238
           + D G A+   +     A L     T +Y APE+ LG   Y K+ DIW++G I   LL  
Sbjct: 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL 212

Query: 239 FPPFFS-----------NHGQAIS-------------PGMKN---------RIRLGQFDF 265
            P F                Q                P +K            +   +  
Sbjct: 213 EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS 272

Query: 266 PN-PEWEH----VSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
            +  +W         +   L++ +L  DP++R+T ++ +E+ +
Sbjct: 273 NSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 67/256 (26%), Positives = 115/256 (44%), Gaps = 49/256 (19%)

Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
            RE+ L L    H++IV     Y      +  L + +E + GG +   +     GAF E 
Sbjct: 54  AREIAL-LKELQHENIVQ----YLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEET 106

Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
                + +I   + +LH++ I HRD+K  N+L                D K         
Sbjct: 107 LVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---------------DNK--------- 142

Query: 176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTP------YYVAPEVLGPDKYDKSCDIWSLG 229
             GGI K++DFG +KK+ +N  S +T    P      +++APEV+    Y +  DIWSLG
Sbjct: 143 --GGI-KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLG 199

Query: 230 VIMYILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVD 288
            ++  +L G  PF      QAI        ++G+   P     ++S EA   ++    +D
Sbjct: 200 CLVVEMLTGKHPFPDCTQLQAI-------FKIGENASPEIP-SNISSEAIDFLEKTFEID 251

Query: 289 PSERLTIDQVMENKWI 304
            ++R T  +++++ ++
Sbjct: 252 HNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 62/298 (20%), Positives = 113/298 (37%), Gaps = 66/298 (22%)

Query: 22  EILGLGINGKVLQ----IVEKKTSEVYALKVLHDTVKA------RREVEL--QLAVGSHK 69
           + LG G  G+V +        K     A+K L +           RE  +  +L    H 
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL---DHP 61

Query: 70  HIVNIKDVYENIYNGSRC-----LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
           ++V +  V         C     L ++ME M GG+L   +++      +  +      +I
Sbjct: 62  NVVKLLGV---------CTEEEPLYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQI 111

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              +++L  +N  HRD+   N L  +                             ++K++
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVGE---------------------------NLVVKIS 144

Query: 185 DFGFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
           DFG ++ +  +    +     P  ++APE L   K+    D+WS GV+++ I   G  P+
Sbjct: 145 DFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY 204

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
                + +   +KN  RL     P P   +   E   L+      DP +R T  +++E
Sbjct: 205 PGMSNEEVLEYLKNGYRL-----PQP--PNCPPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 40/230 (17%)

Query: 73  NIKDVYENIYNGSRCLLVIMECMHG---GELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           NI   Y+      R L ++M+ + G   GE F  +++K+   FTE     I  ++  A++
Sbjct: 70  NIVRYYKTFLENDR-LYIVMDLIEGAPLGEHFNSLKEKK-QRFTEERIWNIFVQMVLALR 127

Query: 130 FLH-DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           +LH ++ I HRD+ P N++                            G+   + +TDFG 
Sbjct: 128 YLHKEKRIVHRDLTPNNIML---------------------------GEDDKVTITDFGL 160

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+    ++ L +   T  Y  PE++  + Y +  D+W+ G I+Y +    PPF+S +  
Sbjct: 161 AKQ-KQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-- 217

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
            +S   K  I    ++ P PE  + S++   +I + L  D   R  I QV
Sbjct: 218 MLSLATK--IVEAVYE-PLPEGMY-SEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 78/323 (24%), Positives = 121/323 (37%), Gaps = 81/323 (25%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR-------------REVELQLAVGSH 68
           E +G G  GKV +  +K T ++ ALK      K R             RE+ L   +   
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALK------KTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 69  KHIVNIKDVYENIY--NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNE 123
            +IV + DV E++   NG   L ++ E +   +L + +     G      A  I   M +
Sbjct: 61  IYIVRLLDV-EHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +   +   H   + HRD+KP+NLL  K                            G+LK+
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDK--------------------------QKGLLKI 152

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
            D G  +       S      T +Y APEVL G   Y    DIWS+G I   +    P F
Sbjct: 153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212

Query: 243 ------------FSNHG---QAISPGMKNRIRLGQFDFPNPEW---------EHVSQEAK 278
                       F   G   + + PG+       +F    P+W           +S E  
Sbjct: 213 PGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF----PQWKPQDLSRAVPDLSPEGL 268

Query: 279 TLIKNMLCVDPSERLTIDQVMEN 301
            L++ ML  DP++R++    + +
Sbjct: 269 DLLQKMLRYDPAKRISAKAALTH 291

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 38/236 (16%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQL-AVGSHKHIVNIKDVYEN 80
           E++G G  G+V +    KT ++ A+KV+  T     E++L++  +  + H  NI   Y  
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 81  IYNGSRC-----LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
               S       L ++ME    G +   ++  +  A  E   A I  EI   +  LH   
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK 141

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           + HRD+K +N+L T+  +                           +KL DFG + ++   
Sbjct: 142 VIHRDIKGQNVLLTENAE---------------------------VKLVDFGVSAQLDRT 174

Query: 196 KASLQTPCYTPYYVAPEVLGPDK-----YDKSCDIWSLGVIMYILLCGFPPFFSNH 246
                T   TPY++APEV+  D+     YD   DIWSLG+    +  G PP    H
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 76.0 bits (188), Expect = 8e-16
 Identities = 62/298 (20%), Positives = 121/298 (40%), Gaps = 62/298 (20%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHI 71
           + LG G  G+V    L+  + KT+EV A+K L +           +E  +   +G H ++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEV-AVKTLKEDASEEERKDFLKEARVMKKLG-HPNV 58

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-------IMNEI 124
           V +  V          L +++E M GG+L   +++      +  ++ +          +I
Sbjct: 59  VRLLGVC--TEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              +++L  +   HRD+   N L  +                             ++K++
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGE---------------------------DLVVKIS 147

Query: 185 DFGFAKKI-VSNKASLQTPCYTP-YYVAPEVLGPDKYD-KSCDIWSLGVIMY-ILLCGFP 240
           DFG ++ +   +    +T    P  ++APE L    +  KS D+WS GV+++ I   G  
Sbjct: 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS-DVWSFGVLLWEIFTLGAT 206

Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
           P+     + +   ++   RL     P P  E+   E   L+ +   +DP +R T  ++
Sbjct: 207 PYPGLSNEEVLEYLRKGYRL-----PKP--EYCPDELYELMLSCWQLDPEDRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 76.6 bits (188), Expect = 9e-16
 Identities = 78/303 (25%), Positives = 132/303 (43%), Gaps = 58/303 (19%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE---VELQ-LAVGSHKHIVNIKDV-- 77
           LG G  GKV +   K+T  + A KV+    +   E   VE+  LA   H +IV + D   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           YEN       L +++E   GG +   +  + +   TE +  ++  +   A+ +LH+  I 
Sbjct: 73  YEN------NLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+K  N+L+T  GD                           +KL DFG + K      
Sbjct: 126 HRDLKAGNILFTLDGD---------------------------IKLADFGVSAKNTRTIQ 158

Query: 198 SLQTPCYTPYYVAPEVL----GPDK-YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
              +   TPY++APEV+      D+ YD   D+WSLG+ +  +    PP        ++P
Sbjct: 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH-----HELNP 213

Query: 253 GMKNRIRLGQFDFPN----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
            M+  +++ + + P       W   S E K  +K  L  +   R T  Q++++ +++  +
Sbjct: 214 -MRVLLKIAKSEPPTLAQPSRW---SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269

Query: 309 QVP 311
             P
Sbjct: 270 NKP 272

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.9 bits (186), Expect = 1e-15
 Identities = 76/299 (25%), Positives = 129/299 (43%), Gaps = 52/299 (17%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-----HDTVKARREVELQLAVGSH 68
           Q+D+++   I G G  G V +     T E+ A+KV+      D    ++E+ + +    H
Sbjct: 8   QEDFELIQRI-GSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI-IMMKDCKH 65

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            +IV     Y   Y     L + ME   GG L Q I     G  +E + A +  E    +
Sbjct: 66  SNIV----AYFGSYLRRDKLWICMEFCGGGSL-QDIYHVT-GPLSESQIAYVSRETLQGL 119

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            +LH +   HRD+K  N+L T                           D G +KL DFG 
Sbjct: 120 YYLHSKGKMHRDIKGANILLT---------------------------DNGHVKLADFGV 152

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYILLCGFPPFFSN 245
           + +I +  A  ++   TPY++APEV   ++   Y++ CDIW++G+    L    PP F  
Sbjct: 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212

Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHV---SQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           H       M+    + + +F  P+ +     S      +K  L  +P +R T ++++++
Sbjct: 213 H------PMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 80/339 (23%), Positives = 138/339 (40%), Gaps = 80/339 (23%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALK--VLHDTVK---ARREVELQLAVGSHKHIVNIKDVY 78
           LG G NG V   V+    +  A+K  VL D      A RE+++ +    H +IV    VY
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKI-IRRLDHDNIVK---VY 68

Query: 79  ENIYNGS-------------RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
           E +                   + ++ E M   +L   ++Q   G  +E  A + M ++ 
Sbjct: 69  EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ---GPLSEEHARLFMYQLL 124

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +K++H  N+ HRD+KP N+                  +  E+L+         LK+ D
Sbjct: 125 RGLKYIHSANVLHRDLKPANVF-----------------INTEDLV---------LKIGD 158

Query: 186 FGFAKKIV----SNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFP 240
           FG A +IV    S+K  L     T +Y +P  +L P+ Y K+ D+W+ G I   +L G P
Sbjct: 159 FGLA-RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217

Query: 241 PFFSNHG-----------QAISPGMKNRI-RLGQFDFPNPEWE----------HVSQEAK 278
            F   H              +    +N +  +      N   E           V+ EA 
Sbjct: 218 LFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL 277

Query: 279 TLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCT 317
             ++ +L  +P +RLT ++ + + ++S ++     P+  
Sbjct: 278 DFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSL 316

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 82/323 (25%), Positives = 133/323 (41%), Gaps = 89/323 (27%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDT-----VK--ARREVEL--QLAVGSHKHIVNI 74
           +G G  G V +   ++T ++ A+K   ++     +K  A RE+ +  QL    H ++VN+
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL---KHPNLVNL 65

Query: 75  KDVYENIYNGSRCL-LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
            +V+       R L LV   C H   +   +++   G   E     I+ +   A+ F H 
Sbjct: 66  IEVFRR----KRKLHLVFEYCDH--TVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHK 118

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
            N  HRDVKPEN+L TK                            G +KL DFGFA+ + 
Sbjct: 119 HNCIHRDVKPENILITK---------------------------QGQIKLCDFGFARILT 151

Query: 194 SNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
                      T +Y APE+L G  +Y    D+W++G +   LL          GQ + P
Sbjct: 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT---------GQPLWP 202

Query: 253 GMKN-------RIRLGQF-----------------DFPNPE--------WEHVSQEAKTL 280
           G  +       R  LG                     P PE        + ++S  A + 
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSF 262

Query: 281 IKNMLCVDPSERLTIDQVMENKW 303
           +K  L +DP+ERL+ ++++E+ +
Sbjct: 263 LKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 54/303 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA----RREVELQLAVGSH-- 68
           +D +   EI G G  G+V ++  KKT  V A+K +  T       R  ++L + + SH  
Sbjct: 15  NDLENLGEI-GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDC 73

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            +IV     +  I +    + + ME M       ++ ++  G   E     +   I  A+
Sbjct: 74  PYIVKCYGYF--ITDSD--VFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127

Query: 129 KFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
            +L +   + HRDVKP N+L    G+                           +KL DFG
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASGN---------------------------VKLCDFG 160

Query: 188 FAKKIVSNKA-SLQTPCYTPYYVAPEVLGP----DKYDKSCDIWSLGVIMYILLCGFPPF 242
            + ++V +KA +    C    Y+APE + P     KYD   D+WSLG+ +  L  G  P+
Sbjct: 161 ISGRLVDSKAKTRSAGC--AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
            +   +      +   ++ Q + P+ P  E  S +  + +   L  D  +R    +++++
Sbjct: 219 KNCKTE-----FEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273

Query: 302 KWI 304
            +I
Sbjct: 274 PFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 77/364 (21%), Positives = 140/364 (38%), Gaps = 97/364 (26%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNIKD 76
           +G G  G V      +T+E  A+K +        D  +  RE++L L    H++++ IKD
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKL-LRHLDHENVIAIKD 71

Query: 77  V--------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +        + ++Y       ++ E M   +L Q I  +     ++      + ++   +
Sbjct: 72  IMPPPHREAFNDVY-------IVYELMDT-DLHQII--RSSQTLSDDHCQYFLYQLLRGL 121

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           K++H  N+ HRD+KP NLL     D                           LK+ DFG 
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCD---------------------------LKICDFGL 154

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           A+        +     T +Y APE+ L   +Y  + D+WS+G I   LL   P F     
Sbjct: 155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF----- 209

Query: 248 QAISPGMK--NRIRL-------------GQFDFPNPE-----------------WEHVSQ 275
               PG    ++++L             G                         + H + 
Sbjct: 210 ----PGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANP 265

Query: 276 EAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEM 335
            A  L++ ML  DPS+R+T+++ + + +++  +     P+C      + EE    + +E 
Sbjct: 266 LAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEE--DALTEED 323

Query: 336 TRSL 339
            + L
Sbjct: 324 IKEL 327

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 77/310 (24%), Positives = 131/310 (42%), Gaps = 64/310 (20%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQ-LAVGSHKHIVNIKD 76
           ++G G  G VL+   K+T E+ A+K   D+     VK     EL+ L     ++IV +K+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            +     G   L ++ E +    + + +++  +G   E+  + I  ++  AI + H  +I
Sbjct: 68  AFRR--RGK--LYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIY-QLIKAIHWCHKNDI 121

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS-N 195
            HRD+KPENLL +                              +LKL DFGFA+ +   +
Sbjct: 122 VHRDIKPENLLISH---------------------------NDVLKLCDFGFARNLSEGS 154

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH--------- 246
            A+      T +Y +PE+L    Y K+ D+WS+G I+  L  G P F             
Sbjct: 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214

Query: 247 ---GQAISPGMK---NRIRLGQFDFPNPEWEH---------VSQEAKTLIKNMLCVDPSE 291
              G   +  MK   +  R     FP               +S     L+KN+L ++P++
Sbjct: 215 KVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTD 274

Query: 292 RLTIDQVMEN 301
           R   +Q + +
Sbjct: 275 RYLTEQCLNH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 73.2 bits (179), Expect = 9e-15
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 43/233 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH---DTVKARREV-----ELQLAVG-SHKHIV 72
           ++LG G  G+V    +  T    A K +    ++ +  +EV     E+QL     H+ IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                  +     + L + ME M GG +  + Q K  GA TE        +I   + +LH
Sbjct: 68  QYYGCLRD--RAEKTLTIFMEYMPGGSV--KDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK- 191
              I HRD+K  N+L    G+                           +KL DFG +K+ 
Sbjct: 124 SNMIVHRDIKGANILRDSAGN---------------------------VKLGDFGASKRL 156

Query: 192 --IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
             I  +   +++   TPY+++PEV+  + Y +  D+WSLG  +  +L   PP+
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 9e-15
 Identities = 69/293 (23%), Positives = 126/293 (43%), Gaps = 53/293 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH---DTVKARREV-----ELQLAVG-SHKHIV 72
           ++LG G  G+V    +  T    A+K +    D+ + ++EV     E+QL     H+ IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                Y         L + ME M GG +  +++    GA TE        +I   +++LH
Sbjct: 68  Q----YYGCLRDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLH 121

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK- 191
              I HRD+K  N+L    G+                           +KL DFG +K+ 
Sbjct: 122 SNMIVHRDIKGANILRDSAGN---------------------------VKLGDFGASKRL 154

Query: 192 --IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
             I S+   +++   TPY+++PEV+  + Y +  D+WS+G  +  +L   PP+      A
Sbjct: 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214

Query: 250 ISPGMKNRIRLGQFDFPNPEW-EHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
               +  +         NP+   HVS +A+  ++     +  +R + ++++ +
Sbjct: 215 AIFKIATQP-------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 85/334 (25%), Positives = 138/334 (41%), Gaps = 82/334 (24%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVK------ARREVEL--QLAV 65
           D +DI    +G G  G+V +  +K T E+ ALK V  D  K      A RE+++  QL  
Sbjct: 7   DKFDI-IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-- 63

Query: 66  GSHKHIVNIKDVYENIYNG------SRCLLVIMECM-HG--GELFQRIQQKEDG--AFTE 114
            +H++IVN+K++  +  +            ++ E M H   G L       E G   F+E
Sbjct: 64  -NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-------ESGLVHFSE 115

Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
                 M ++   + + H +N  HRD+K  N+L    G                      
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--------------------- 154

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQT-PCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIM 232
                 +KL DFG A+   S ++   T    T +Y  PE +LG ++Y  + D+WS G I+
Sbjct: 155 ------IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208

Query: 233 YILLCGFPPFFSNH------------GQAISPGMKNRIRLGQFDFPNP----------EW 270
             L    P F +N             G        + I+L  F+   P          E+
Sbjct: 209 GELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF 268

Query: 271 EHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
             +   A  L+ +ML +DPS+R T ++ + + W+
Sbjct: 269 SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 84/322 (26%), Positives = 140/322 (43%), Gaps = 79/322 (24%)

Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 62  RAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMELD-- 117

Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 118 -HERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 155

Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 156 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206

Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 266

Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D+ +++ +I+ +    +    
Sbjct: 267 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAP 326

Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 327 PPQIYDKQLDEREHTIEEWKEL 348

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 83/322 (25%), Positives = 135/322 (41%), Gaps = 79/322 (24%)

Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELD-- 124

Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 125 -HERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162

Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 163 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213

Query: 231 IMYILLCG---FP--------------------PFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G   FP                     F       +   ++NR +   + F  
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 273

Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333

Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPKIPDKQLDEREHTIEEWKEL 355

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 62/243 (25%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNI 74
           E++G G  G V   ++  T E  A+K ++       D  +  RE++L L +  H  IV I
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL-LRLLRHPDIVEI 64

Query: 75  KDV--------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           K +        +++IY       V+ E M   +L Q I+  +D   T       + ++  
Sbjct: 65  KHIMLPPSRREFKDIY-------VVFELM-ESDLHQVIKANDD--LTPEHHQFFLYQLLR 114

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+K++H  N+ HRD+KP+N+L                D K              LK+ DF
Sbjct: 115 ALKYIHTANVFHRDLKPKNILAN-------------ADCK--------------LKICDF 147

Query: 187 GFAKKIVSNKASLQTPCYTPY-----YVAPEVLGP--DKYDKSCDIWSLGVIMYILLCGF 239
           G A+   ++  +     +T Y     Y APE+ G    KY  + DIWS+G I   +L G 
Sbjct: 148 GLARVAFNDTPT--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Query: 240 PPF 242
           P F
Sbjct: 206 PLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.4 bits (172), Expect = 7e-14
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 51/237 (21%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH---DTVKARREV-----ELQLAVG-SHKHIV 72
           ++LG G  G+V    +  T    A+K +    ++ +  +EV     E+QL     H+ IV
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 73  N----IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
                ++D  E      R L + ME M GG +  + Q K  GA TE        +I   +
Sbjct: 68  QYYGCLRDPME------RTLSIFMEHMPGGSI--KDQLKSYGALTENVTRKYTRQILEGV 119

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            +LH   I HRD+K  N+L    G+                           +KL DFG 
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGN---------------------------VKLGDFGA 152

Query: 189 AKK---IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           +K+   I  +   +++   TPY+++PEV+  + Y +  DIWS+G  +  +L   PP+
Sbjct: 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 78/339 (23%), Positives = 134/339 (39%), Gaps = 87/339 (25%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL----HDTVKAR--REVELQLAVG 66
           +   Y      +G G  G V     K T    A+K +    H T   R  RE+++ L   
Sbjct: 3   VGPRYQNL-SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKI-LRRF 60

Query: 67  SHKHIVNIKDV-----YEN---IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
            H++I+ I D+     +E+   +Y        I++ +   +L++ I+ +     +     
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVY--------IVQELMETDLYKLIKTQH---LSNDHIQ 109

Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             + +I   +K++H  N+ HRD+KP NLL     D                         
Sbjct: 110 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD------------------------- 144

Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPY-----YVAPEV-LGPDKYDKSCDIWSLGVIM 232
             LK+ DFG A+  +++     T   T Y     Y APE+ L    Y K+ DIWS+G I+
Sbjct: 145 --LKICDFGLAR--IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL 200

Query: 233 YILLCGFPPFFSNH------------GQA--------ISPGMKNRIRLGQFDFPNPEWE- 271
             +L   P F                G          IS   +N I+   F  P   W  
Sbjct: 201 AEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPF-KPKVPWNK 259

Query: 272 ---HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
              +   +A  L+  ML  +P +R+T+++ + + ++ Q+
Sbjct: 260 LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 72/297 (24%), Positives = 117/297 (39%), Gaps = 56/297 (18%)

Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR--------REVELQLAVGSHKHIV 72
            EI G G  G V    + +T+EV A+K +  + K          +EV   L    H + +
Sbjct: 21  REI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRF-LQQLRHPNTI 78

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
             K  Y          LV+  C+        + +K      E E A I +     + +LH
Sbjct: 79  EYKGCY---LREHTAWLVMEYCLGSASDILEVHKK---PLQEVEIAAICHGALQGLAYLH 132

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
                HRD+K  N+L T+PG                            +KL DFG A   
Sbjct: 133 SHERIHRDIKAGNILLTEPG---------------------------TVKLADFGSA--- 162

Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPD--KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
            S  +   +   TPY++APEV L  D  +YD   D+WSLG+    L    PP F+ +   
Sbjct: 163 -SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--- 218

Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               M     + Q D P       S   +  + + L   P +R + +++++++++ +
Sbjct: 219 ---AMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 75/302 (24%), Positives = 123/302 (40%), Gaps = 63/302 (20%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIVNIKDVYE 79
           EILG G  G V +     T  + A+KV  L  TV+ ++++  +L +        I   Y 
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 80  NIYNGSRCLLVIMECMHGGEL--FQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
             +  +R + +  E M GG L  +++I +   G         I   +   + +L    I 
Sbjct: 67  AFFVENR-ISICTEFMDGGSLDVYRKIPEHVLGR--------IAVAVVKGLTYLWSLKIL 117

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRDVKP N+L    G                            +KL DFG + ++V++ A
Sbjct: 118 HRDVKPSNMLVNTRGQ---------------------------VKLCDFGVSTQLVNSIA 150

Query: 198 SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHG------- 247
             +T   T  Y+APE +  ++Y    D+WSLG+    L  G   +P    N G       
Sbjct: 151 --KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL 208

Query: 248 -QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q I       + +GQF   + ++ H        I   +   P ER   + +M++ +I Q
Sbjct: 209 LQCIVDEDPPVLPVGQF---SEKFVH-------FITQCMRKQPKERPAPENLMDHPFIVQ 258

Query: 307 FN 308
           +N
Sbjct: 259 YN 260

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 45/232 (19%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY--- 78
           I+G G  G V + +   TSE  A+K VL D     RE+ +   + +H +I+ +KD Y   
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNL-NHINIIFLKDYYYTE 131

Query: 79  ------ENIYNGSRCLLVIMECM-HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
                 +NI+     L V+ME +      + +   + + A       +   ++C A+ ++
Sbjct: 132 CFKKNEKNIF-----LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H + I HRD+KP+NLL                 + P             LKL DFG AK 
Sbjct: 187 HSKFICHRDLKPQNLL-----------------IDPNT---------HTLKLCDFGSAKN 220

Query: 192 IVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           +++ + S+   C + +Y APE+ LG   Y    D+WSLG I+  ++ G+P F
Sbjct: 221 LLAGQRSVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271

Length = 440

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 69.1 bits (170), Expect = 2e-13
 Identities = 69/300 (23%), Positives = 119/300 (39%), Gaps = 69/300 (23%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKHI 71
           + LG G  G+V    L+   + T    A+K L +            E  + +   SH +I
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASI-MKKLSHPNI 63

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           V +  V          L ++ E M GG+L   +++      T ++   +  +I   +++L
Sbjct: 64  VRLLGVCT----QGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYL 118

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGGILKLTDFGF 188
             +N  HRD+   N L T   +  ++K++DFG   D+  ++  Y +   GG L       
Sbjct: 119 ESKNFVHRDLAARNCLVT---ENLVVKISDFGLSRDIYEDD--YYRKRGGGKL------- 166

Query: 189 AKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                            P  ++APE L   K+    D+WS GV+++ I   G  P+    
Sbjct: 167 -----------------PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY---- 205

Query: 247 GQAISPGMKN-----RIRLG-QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
                PGM N      +  G +   P    E+   E   L+      DP +R T  +++E
Sbjct: 206 -----PGMSNEEVLELLEDGYRLPRP----ENCPDELYELMLQCWAYDPEDRPTFSELVE 256

Length = 258

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 88/350 (25%), Positives = 148/350 (42%), Gaps = 86/350 (24%)

Query: 26  LGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVY--ENIYN 83
           LGIN  V ++     ++ +A        +A RE+ L L   +HK+I+++ +V+  +    
Sbjct: 45  LGINVAVKKLSRPFQNQTHA-------KRAYRELVL-LKCVNHKNIISLLNVFTPQKSLE 96

Query: 84  GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKP 143
             + + ++ME M    L Q I  + D    ER + ++   +C  IK LH   I HRD+KP
Sbjct: 97  EFQDVYLVMELMDA-NLCQVIHMELD---HERMSYLLYQMLC-GIKHLHSAGIIHRDLKP 151

Query: 144 ENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP- 202
            N++                 VK +            LK+ DFG A+   +N   + TP 
Sbjct: 152 SNIV-----------------VKSD----------CTLKILDFGLARTACTN--FMMTPY 182

Query: 203 CYTPYYVAPEVLGPDKYDKSCDIWSLGVIM---------------------YILLCGFPP 241
             T YY APEV+    Y ++ DIWS+G IM                      I   G P 
Sbjct: 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242

Query: 242 --FFSNHGQAISPGMKNRIRLGQFDFPN--PEW------EH---VSQEAKTLIKNMLCVD 288
             F +     +   ++NR +     F    P+W      E     + +A+ L+  ML +D
Sbjct: 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID 302

Query: 289 PSERLTIDQVMENKWISQFNQVPQT----PLCTGKMLKEGE---ETWPEV 331
           P +R+++D+ + + +I+ +    +     P      L+E E   E W E+
Sbjct: 303 PDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKEL 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 74/319 (23%), Positives = 129/319 (40%), Gaps = 78/319 (24%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVL---HDT----VKARREVELQLAVGSHKHIVNI 74
           E +G G  G V +  +K T E+ ALK +    +       A RE+ L L   +H +IV +
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISL-LKELNHPNIVRL 63

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            DV   +++ ++ L ++ E +   +L + +                + ++   I + H  
Sbjct: 64  LDV---VHSENK-LYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG-----FA 189
            + HRD+KP+NLL  + G    LKL DFG  +                   FG     + 
Sbjct: 119 RVLHRDLKPQNLLIDREGA---LKLADFGLARA------------------FGVPVRTYT 157

Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF------ 242
            ++V           T +Y APE+L G  +Y    DIWS+G I   ++   P F      
Sbjct: 158 HEVV-----------TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI 206

Query: 243 ------FSNHG---QAISPGMKNRIRLGQFD--FPN---PEWEHV----SQEAKTLIKNM 284
                 F   G   + + PG+     L  +   FP     +   V     ++   L+  M
Sbjct: 207 DQLFRIFRTLGTPDEDVWPGVT---SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKM 263

Query: 285 LCVDPSERLTIDQVMENKW 303
           L  DP++R++    +++ +
Sbjct: 264 LVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 82/304 (26%), Positives = 122/304 (40%), Gaps = 66/304 (21%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREV------ELQLAVGSH-KHIVNIKD 76
           LG G  G V ++    T  V A KV+H  + A+  V      ELQ+       +IV+   
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QN 135
            + N  N   C    ME M  G L  RI  K+ G         I   +   + +L++   
Sbjct: 71  AFLNENNICMC----MEFMDCGSL-DRIY-KKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I HRD+KP N+L    G                            +KL DFG + +++++
Sbjct: 125 IMHRDIKPSNILVNSRGQ---------------------------IKLCDFGVSGELINS 157

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGV-IMYILLCGFPPFFSN---HGQAIS 251
            A   T   T  Y++PE +   KY    D+WSLG+ I+ + L  FP  FSN    GQ   
Sbjct: 158 IA--DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215

Query: 252 PGMKNRI---------RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
            G+ + +         RL   DFP        ++ +  +   L  DP+ER T  Q+    
Sbjct: 216 MGILDLLQQIVQEPPPRLPSSDFP--------EDLRDFVDACLLKDPTERPTPQQLCAMP 267

Query: 303 WISQ 306
              Q
Sbjct: 268 PFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 80/329 (24%), Positives = 129/329 (39%), Gaps = 68/329 (20%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----DTV--KARREVELQLAVGS 67
           D Y+   E +G G  G V +  ++ T+E  ALK +      + V   A RE+ L L    
Sbjct: 2   DQYE-KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISL-LKEMQ 59

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +IV ++DV  +     + L ++ E +   +L + +    D A   R     + +I   
Sbjct: 60  HGNIVRLQDVVHS----EKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRG 114

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I + H   + HRD+KP+NLL  +  +                           LKL DFG
Sbjct: 115 IAYCHSHRVLHRDLKPQNLLIDRRTN--------------------------ALKLADFG 148

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF---- 242
            A+       +      T +Y APE+L G   Y    DIWS+G I   ++   P F    
Sbjct: 149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208

Query: 243 --------FSNHG---QAISPGMKNRIRLGQFDFPNPEWE---------HVSQEAKTLIK 282
                   F   G   +   PG+ +   L  +    P+W           +      L+ 
Sbjct: 209 EIDELFKIFRILGTPNEETWPGVTS---LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLS 265

Query: 283 NMLCVDPSERLTIDQVMENKWISQFNQVP 311
            ML +DPS+R+T    +E+++       P
Sbjct: 266 KMLRLDPSKRITARAALEHEYFKDLGDAP 294

Length = 294

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 67.6 bits (165), Expect = 5e-13
 Identities = 72/281 (25%), Positives = 120/281 (42%), Gaps = 75/281 (26%)

Query: 26  LGINGKVLQIVEKKTSEVYALKVL---HDTVKARREV---ELQLAVGSHKHIVNIKDVYE 79
           LG+  KVL +++ +T + + LK L    +  + R  +    +   V  HK+IV+   V+ 
Sbjct: 3   LGVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVF- 61

Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQ----KEDGAFTEREAAIIMNEICSAIKFLHDQN 135
                     ++++   GG+L+  I +     E+    +R AA    E+  A+  LH + 
Sbjct: 62  ----------LVLQHAEGGKLWSHISKFLNIPEE--CVKRWAA----EMVVALDALHREG 105

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           I  RD+ P N+L     D G ++LT F    +V+                        + 
Sbjct: 106 IVCRDLNPNNILLD---DRGHIQLTYFSRWSEVEDS-------------------CDGEA 143

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           V N            Y APEV G  +  ++CD WSLG I++ LL G       H   I+ 
Sbjct: 144 VEN-----------MYCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGIN- 190

Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
                      + P    E VS+EA++L++ +L  +P+ERL
Sbjct: 191 ------THTTLNIP----EWVSEEARSLLQQLLQFNPTERL 221

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 68.6 bits (167), Expect = 6e-13
 Identities = 75/300 (25%), Positives = 124/300 (41%), Gaps = 51/300 (17%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDV----YE 79
           +G G  G V    + +T+EV A+K +  + K   E + Q  +   K +  IK      Y+
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 80  NIYNGSRCLLVIME-CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
             Y       ++ME C+        + +K      E E A I +     + +LH  N+ H
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHNMIH 148

Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  N+L T+PG                            +KL DFG A  I S   S
Sbjct: 149 RDIKAGNILLTEPGQ---------------------------VKLADFGSAS-IASPANS 180

Query: 199 LQTPCYTPYYVAPEV---LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
                 TPY++APEV   +   +YD   D+WSLG+    L    PP F+ +       M 
Sbjct: 181 FVG---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMS 231

Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPL 315
               + Q + P  +    S   +  + + L   P +R T ++++++ ++    + P+T L
Sbjct: 232 ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV--LRERPETVL 289

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 68.2 bits (166), Expect = 8e-13
 Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 45/228 (19%)

Query: 89  LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY 148
           LV+  C+        + +K      E E A + +     + +LH  N+ HRDVK  N+L 
Sbjct: 92  LVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148

Query: 149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYY 208
           ++P                           G++KL DFG A  I++          TPY+
Sbjct: 149 SEP---------------------------GLVKLGDFGSA-SIMAPANXFVG---TPYW 177

Query: 209 VAPEV---LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDF 265
           +APEV   +   +YD   D+WSLG+    L    PP F+ +       M     + Q + 
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNES 231

Query: 266 PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT 313
           P  +  H S+  +  + + L   P +R T + +++++++ +  + P T
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR--ERPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 74/285 (25%), Positives = 120/285 (42%), Gaps = 57/285 (20%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH---------DTVKARREVELQL-AVGSHKHIV 72
           I+G G  G+V    +  T ++YA+K L          +T+     + L L + G    IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +   +         L  I++ M+GG+L   + Q   G F+E E      EI   ++ +H
Sbjct: 61  CMSYAFHT----PDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH 114

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           ++ + +RD+KP N+L           L + G V                +++D G A   
Sbjct: 115 NRFVVYRDLKPANIL-----------LDEHGHV----------------RISDLGLACDF 147

Query: 193 VSNK--ASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
              K  AS+ T      Y+APEVL     YD S D +SLG +++ LL G  PF     + 
Sbjct: 148 SKKKPHASVGTHG----YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-----RQ 198

Query: 250 ISPGMKNRIRLGQFDFPNPEW-EHVSQEAKTLIKNMLCVDPSERL 293
                K+ I          E  +  S E ++L++ +L  D + RL
Sbjct: 199 HKTKDKHEIDRMTLTM-AVELPDSFSPELRSLLEGLLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 77/334 (23%), Positives = 133/334 (39%), Gaps = 79/334 (23%)

Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHI 71
            S + +G G  G V   ++K+T E  A+K L           +A RE+ L L    H+++
Sbjct: 18  TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL-LKHMQHENV 76

Query: 72  VNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           + + DV+      +  +   ++M  M        +Q+      +E +   ++ ++   +K
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           ++H   I HRD+KP NL   +  +                           LK+ DFG A
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCE---------------------------LKILDFGLA 164

Query: 190 KKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF-----F 243
           +      A +     T +Y APEV L    Y+++ DIWS+G IM  +L G   F      
Sbjct: 165 R---HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221

Query: 244 SNHGQAIS----PG-----------MKNRIR-LGQFD-------FPNPEWEHVSQEAKTL 280
               Q +     PG            K+ I+ L ++        FP       S +A  L
Sbjct: 222 DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPK-----ASPQAVDL 276

Query: 281 IKNMLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
           ++ ML +D  +RLT  + +E+ +   F    +  
Sbjct: 277 LEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 44/278 (15%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHK--------HIVNIK 75
           LG G  G+V  +  K T ++YA K L D  + +++   ++A+   +         IVN+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKL-DKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
             +E+  +    L ++M  M+GG+L   I    +             +I   I  LH  +
Sbjct: 60  YAFESKTH----LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I +RD+KPEN+L                             D G  +L+D G A ++   
Sbjct: 116 IVYRDMKPENVLLD---------------------------DQGNCRLSDLGLAVELKDG 148

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
           K   Q    T  Y+APE+L  + Y    D +++G  +Y ++ G  PF  +  +     +K
Sbjct: 149 KTITQRAG-TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK 207

Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            R    +  F   E ++ ++E+K + +  L   P +RL
Sbjct: 208 RRTLEDEVKF---EHQNFTEESKDICRLFLAKKPEDRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 82/309 (26%), Positives = 126/309 (40%), Gaps = 76/309 (24%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVNI 74
           E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV +
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVKL 64

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA-FTEREAAIIMN---EICSAIKF 130
            DV   I+  ++  LV  E +H     Q +++  D +  +     +I +   ++   + F
Sbjct: 65  LDV---IHTENKLYLV-FEFLH-----QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+KP+NLL                             +G I KL DFG A+
Sbjct: 116 CHSHRVLHRDLKPQNLLINT--------------------------EGAI-KLADFGLAR 148

Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP------ 240
                  +      T +Y APE+L G   Y  + DIWSLG I   M      FP      
Sbjct: 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208

Query: 241 ---PFFSNHG---QAISPGMKNRIRLGQFDFPNPEW-----EHV----SQEAKTLIKNML 285
                F   G   + + PG+ +   L  +    P+W       V     ++ + L+  ML
Sbjct: 209 QLFRIFRTLGTPDEVVWPGVTS---LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQML 265

Query: 286 CVDPSERLT 294
             DP++R++
Sbjct: 266 HYDPNKRIS 274

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.8 bits (163), Expect = 8e-12
 Identities = 57/210 (27%), Positives = 85/210 (40%), Gaps = 33/210 (15%)

Query: 40  TSEVYALKVL--------HDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI 91
           T    A+K+L        H   + RRE  L  A   H +IV + D  E        L  +
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETAL-CARLYHPNIVALLDSGEA---PPGLLFAV 57

Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
            E + G  L + +    DGA    E   +M ++  A+   H+Q I HRD+KP+N++ ++ 
Sbjct: 58  FEYVPGRTLREVLAA--DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115

Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY-TPYYVA 210
           G     K+ DFG      LL   PG       T             +  T    TP Y A
Sbjct: 116 GVRPHAKVLDFG---IGTLL---PGVRDADVAT------------LTRTTEVLGTPTYCA 157

Query: 211 PEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
           PE L  +    + D+++ G+I    L G  
Sbjct: 158 PEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 41/231 (17%)

Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK------ARREVELQLAVGSHKHIV 72
           ++ E LG G    V + + +   ++ ALKV+    +      A RE  L L    H +IV
Sbjct: 8   LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASL-LKGLKHANIV 66

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            + D    I +    L  + E MH  +L Q + Q   G        + M ++   + ++H
Sbjct: 67  LLHD----IIHTKETLTFVFEYMHT-DLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIH 120

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
            Q+I HRD+KP+NLL +  G+                           LKL DFG A+  
Sbjct: 121 GQHILHRDLKPQNLLISYLGE---------------------------LKLADFGLARAK 153

Query: 193 VSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
                +  +   T +Y  P+VL G   Y  + DIW  G I   +L G P F
Sbjct: 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.7 bits (158), Expect = 9e-12
 Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 58/304 (19%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQL---AVGSHKHIVNIKDVYEN 80
           +G G  G V +++ K +  + A+K +  TV  + +  L +    V        I   Y  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 81  IYNGSRCLLVIMECMHGG--ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL-HDQNIA 137
           ++    C  + ME M     + ++ + +       E     I      A+ +L  +  I 
Sbjct: 72  LFREGDCW-ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKII 130

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRDVKP N+L                               G +KL DFG + ++V + A
Sbjct: 131 HRDVKPSNILLD---------------------------RNGNIKLCDFGISGQLVDSIA 163

Query: 198 SLQTPCYTPYYVAPEVLGP---DKYDKSCDIWSLGVIMYILLCG-FP-----PFFSNHGQ 248
             +     PY +APE + P   D YD   D+WSLG+ +Y +  G FP       F    Q
Sbjct: 164 KTRDAGCRPY-MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ 222

Query: 249 AIS---PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
            +    P + N                 S      I   L  D S+R    +++E+ +I 
Sbjct: 223 VVKGDPPILSNSEER-----------EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Query: 306 QFNQ 309
            + +
Sbjct: 272 DYEE 275

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 74/308 (24%), Positives = 122/308 (39%), Gaps = 67/308 (21%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH--------------DTVKA-RREVELQLAVG 66
           E++G G  G+V   +   T E+ A+K +               D VKA R E+E  L   
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET-LKDL 65

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
            H +IV     Y         L + +E + GG +   ++    G F E+       ++  
Sbjct: 66  DHLNIVQ----YLGFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLE 119

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            + +LH + I HRD+K +NL            L D                 GI K++DF
Sbjct: 120 GLAYLHSKGILHRDLKADNL------------LVDA---------------DGICKISDF 152

Query: 187 GFAKK---IVSNKA--SLQTPCYTPYYVAPEVLGPDK--YDKSCDIWSLGVIMYILLCGF 239
           G +KK   I  N    S+Q    + +++APEV+      Y    DIWSLG ++  +  G 
Sbjct: 153 GISKKSDDIYDNDQNMSMQG---SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Query: 240 PPFFSNHG-QAISPGMKNRIRLGQFDFPNPE--WEHVSQEAKTLIKNMLCVDPSERLTID 296
            P+       A+      R        P P     ++S  A   +     ++P  R T  
Sbjct: 210 RPWSDEEAIAAMFKLGNKRSAP-----PIPPDVSMNLSPVALDFLNACFTINPDNRPTAR 264

Query: 297 QVMENKWI 304
           +++++ +I
Sbjct: 265 ELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 32/160 (20%)

Query: 86  RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
           + L + +E M GG +  + Q K  GA TE        +I   + +LH   I HRD+K  N
Sbjct: 79  KKLSIFVEYMPGGSI--KDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGAN 136

Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS---NKASLQTP 202
           +L    G+                           +KL DFG +K+I +   +   +++ 
Sbjct: 137 ILRDSAGN---------------------------VKLGDFGASKRIQTICMSGTGIKSV 169

Query: 203 CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
             TPY+++PEV+  + Y +  D+WS+   +  +L   PP+
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 76/328 (23%), Positives = 127/328 (38%), Gaps = 76/328 (23%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHK--- 69
           DD++   E LG G  G V +++ + +  + A K++H  +K   R ++  +L V  H+   
Sbjct: 1   DDFEKLGE-LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKV-LHECNS 58

Query: 70  -HIVNIKDVYENIY-NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
            +IV     Y   Y +G   +   ME M GG L Q +  K+ G   E     I   +   
Sbjct: 59  PYIVGF---YGAFYSDGEISIC--MEHMDGGSLDQVL--KKAGRIPENILGKISIAVLRG 111

Query: 128 IKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           + +L ++  I HRDVKP N+L    G+                           +KL DF
Sbjct: 112 LTYLREKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDF 144

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG-FP----- 240
           G + +++ + A+  +   T  Y++PE L    Y    DIWSLG+ +  +  G +P     
Sbjct: 145 GVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202

Query: 241 -----PFFSNHGQAISPGMKNRIRLGQF-DFPNP------------------EWEHVSQE 276
                  F            +R   G   D P P                       S E
Sbjct: 203 AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDE 262

Query: 277 AKTLIKNMLCVDPSERLTIDQVMENKWI 304
            +  +   L  +P ER  + ++ ++ +I
Sbjct: 263 FQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 62/226 (27%), Positives = 94/226 (41%), Gaps = 41/226 (18%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL---HDT---VKARREVELQLAVGSHKHIVNIKDV 77
           LG G    V +   K T  + ALK +   H+      A REV L L    H +IV + D 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSL-LKNLKHANIVTLHD- 70

Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
              I +  RCL ++ E +   +L Q +    +   +     I M ++   + + H + I 
Sbjct: 71  ---IIHTERCLTLVFEYLDS-DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKIL 125

Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+KP+NLL  + G+                           LKL DFG A+       
Sbjct: 126 HRDLKPQNLLINEKGE---------------------------LKLADFGLARAKSVPTK 158

Query: 198 SLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           +      T +Y  P+V LG  +Y    D+W +G I+Y +  G P F
Sbjct: 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 66/245 (26%), Positives = 100/245 (40%), Gaps = 58/245 (23%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALK----VLHDTVKARREV-ELQ-LAVGSHKHIVNIKDV 77
           +G G  G V  + + +  +  ALK    V  + V  +R   EL+ L    H ++++  D+
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 78  --------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
                   +E IY       V+ E M   +L + I   +    +     + + +I   +K
Sbjct: 68  LQPPHIDPFEEIY-------VVTELMQS-DLHKIIVSPQ--PLSSDHVKVFLYQILRGLK 117

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           +LH   I HRD+KP NLL                     N          +LK+ DFG A
Sbjct: 118 YLHSAGILHRDIKPGNLLVN------------------SNC---------VLKICDFGLA 150

Query: 190 KKIVSNKASLQT-PCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           +    +++   T    T YY APE+L G   Y  + DIWS+G I   LL     F     
Sbjct: 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF----- 205

Query: 248 QAISP 252
           QA SP
Sbjct: 206 QAQSP 210

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 71/282 (25%), Positives = 117/282 (41%), Gaps = 51/282 (18%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH---------DTVKARREVELQL-AVGSHKHIV 72
           I+G G  G+V    +  T ++YA+K L          +T+     + L L + G    IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +   +         L  I++ M+GG+L   + Q   G F+E+E      EI   ++ +H
Sbjct: 61  CMTYAFHT----PDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMH 114

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           ++ + +RD+KP N+L  + G                            ++++D G A   
Sbjct: 115 NRFVVYRDLKPANILLDEHGH---------------------------VRISDLGLACDF 147

Query: 193 VSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
              K        T  Y+APEVL     YD S D +SLG +++ LL G  P F  H     
Sbjct: 148 SKKKP--HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDK 204

Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             +         + P+      S E K+L++ +L  D S+RL
Sbjct: 205 HEIDRMTLTVNVELPDS----FSPELKSLLEGLLQRDVSKRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 63/244 (25%), Positives = 100/244 (40%), Gaps = 54/244 (22%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVL---HDT---VKARREVELQLAVGSHKHIVNIK 75
           + LG G    V +   K T ++ ALK +   H+      A RE  L L    H +IV + 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASL-LKDLKHANIVTLH 69

Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
           D    I +  + L ++ E +   +L Q +     G  +     + + ++   + + H + 
Sbjct: 70  D----IIHTKKTLTLVFEYLDT-DLKQYMD-DCGGGLSMHNVRLFLFQLLRGLAYCHQRR 123

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF--AKKIV 193
           + HRD+KP+NLL +                           + G LKL DFG   AK + 
Sbjct: 124 VLHRDLKPQNLLIS---------------------------ERGELKLADFGLARAKSVP 156

Query: 194 SNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           S   S +    T +Y  P+VL G  +Y  S D+W +G I Y +  G P F         P
Sbjct: 157 SKTYSNEV--VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF---------P 205

Query: 253 GMKN 256
           G  +
Sbjct: 206 GSTD 209

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 38/112 (33%), Positives = 50/112 (44%), Gaps = 28/112 (25%)

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           +M +    + FLH   I HRD+KPEN+L T                            GG
Sbjct: 113 LMRQFLRGLDFLHANCIVHRDLKPENILVTS---------------------------GG 145

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI 231
            +KL DFG A+ I S + +L     T +Y APEVL    Y    D+WS+G I
Sbjct: 146 QVKLADFGLAR-IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 73/336 (21%), Positives = 136/336 (40%), Gaps = 72/336 (21%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------HDTVKARREVE 60
            KT     D   +   +G G  G+V    + KT    A+K L           +  RE+ 
Sbjct: 7   NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR 66

Query: 61  LQLAVGSHKHIVNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREA 117
           L L    H++++ + DV+    ++ +     LV    M G +L   ++ +     ++   
Sbjct: 67  L-LKHMDHENVIGLLDVFTPASSLEDFQDVYLV-THLM-GADLNNIVKCQ---KLSDDHI 120

Query: 118 AIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
             ++ +I   +K++H   I HRD+KP N+   +  +                        
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE------------------------ 156

Query: 178 GGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILL 236
              LK+ DFG A+        +     T +Y APE+ L    Y+++ DIWS+G IM  LL
Sbjct: 157 ---LKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210

Query: 237 CGFPPF-FSNH-------------------GQAISPGMKNRIRLGQFDFPNPEWEHV--- 273
            G   F  S+H                    +  S   +N I+      P  +++ V   
Sbjct: 211 TGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQ-SLPQMPKKDFKEVFSG 269

Query: 274 -SQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
            +  A  L++ ML +DP +R+T  + + + ++++++
Sbjct: 270 ANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 82/350 (23%), Positives = 145/350 (41%), Gaps = 85/350 (24%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHD----TVKAR---REVELQLAVGSHKHIVNIKD 76
           +G+G  G V    ++ T +  A+K +       V A+   RE++L L    H++I+++ D
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKL-LKHLRHENIISLSD 76

Query: 77  VY----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           ++    E+IY        + E + G +L + +  +      ++     + +I   +K++H
Sbjct: 77  IFISPLEDIY-------FVTELL-GTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVH 125

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              + HRD+KP N+L  +  D   LK+ DFG  + ++   T             G+    
Sbjct: 126 SAGVVHRDLKPSNILINENCD---LKICDFGLARIQDPQMT-------------GY---- 165

Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAI 250
           VS          T YY APE+ L   KYD   DIWS G I   +L G P F   +H    
Sbjct: 166 VS----------TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF 215

Query: 251 S--------PGMK--------NRIRLGQFDFPNPEWEHVSQ-------EAKTLIKNMLCV 287
           S        P           N +R  Q   P  E    S+        A  L++ ML  
Sbjct: 216 SIITDLLGTPPDDVINTICSENTLRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVF 274

Query: 288 DPSERLTIDQVMENKWISQFNQVPQTPLCTGK---MLKEGE---ETWPEV 331
           DP +R++  + + + +++ ++     P+   K      + +   +TW  +
Sbjct: 275 DPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVDTWKVM 324

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 42/218 (19%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ME + GG L   +++K++   T ++   +  +  + +++L  +N  HRD+   N L
Sbjct: 67  IYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCL 125

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
               G+  +LK++DFG  + E        +GGI  ++D              Q P     
Sbjct: 126 V---GENNVLKISDFGMSREE--------EGGIYTVSD-----------GLKQIPIK--- 160

Query: 208 YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFD-- 264
           + APE L   +Y    D+WS G++++     G  P+         PGM N+    + +  
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY---------PGMSNQQTRERIESG 211

Query: 265 --FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
              P P  +   +E   L+      DP  R +  ++  
Sbjct: 212 YRMPAP--QLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 68/324 (20%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNIKD 76
           +G G  G V   ++++T    A+K L+          +A RE+ L L    H++++ + D
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL-LKHMKHENVIGLLD 81

Query: 77  VYENIYNGSRC--LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           V+    +  R     ++M  M G +L + ++ ++    +E     ++ ++   +K++H  
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSEDRIQFLVYQMLKGLKYIHAA 137

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KP NL   +  +                           LK+ DFG A++  S
Sbjct: 138 GIIHRDLKPGNLAVNEDCE---------------------------LKILDFGLARQTDS 170

Query: 195 NKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFF-SNHGQAISP 252
               +     T +Y APEV L    Y ++ DIWS+G IM  +L G P F   +H   +  
Sbjct: 171 ---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227

Query: 253 GMKNR--------IRLGQFDFPN-----PEWE---------HVSQEAKTLIKNMLCVDPS 290
            MK           +L   D  N     P +          + +  A  +++ ML +D  
Sbjct: 228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAE 287

Query: 291 ERLTIDQVMENKWISQFNQVPQTP 314
            R+T  + + + +  +F+      
Sbjct: 288 SRITAAEALAHPYFEEFHDPEDET 311

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 73/309 (23%), Positives = 114/309 (36%), Gaps = 80/309 (25%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV----------- 72
           LG G  G V +++ + T    A+K          E+ L+L       I+           
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMK----------EIRLELDESKFNQIIMELDILHKAVS 58

Query: 73  -NIKDVYENIYNGSRCLLVIMECMHGGELFQRI-QQKEDGAFTEREAAIIMNEICSAIKF 130
             I D Y   +     + + ME M  G L +            E     I   +   +KF
Sbjct: 59  PYIVDFYGAFFIEG-AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 131 LHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           L ++ NI HRDVKP N+L    G                            +KL DFG +
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQ---------------------------VKLCDFGVS 150

Query: 190 KKIVSNKASLQTPCYTPYYVAPE---VLGPDK---YDKSCDIWSLGVIMYILLCG---FP 240
             +V++ A     C +  Y+APE     GP++   Y    D+WSLG+ +  +  G   +P
Sbjct: 151 GNLVASLAKTNIGCQS--YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208

Query: 241 P-----FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           P      F+    AI  G    +  G            S +A+  +   L   P+ R T 
Sbjct: 209 PETYANIFAQL-SAIVDGDPPTLPSG-----------YSDDAQDFVAKCLNKIPNRRPTY 256

Query: 296 DQVMENKWI 304
            Q++E+ W+
Sbjct: 257 AQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 69/289 (23%), Positives = 113/289 (39%), Gaps = 49/289 (16%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDV----YE 79
           +G G  G V       T+EV A+K +  + K   E + Q  +   K +  +K      Y+
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 80  NIYNGSRCLLVIME-CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
             Y       ++ME C+        + +K      E E A I +     + +LH  N+ H
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHNMIH 144

Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  N+L T+PG                            +KL DFG A K     + 
Sbjct: 145 RDIKAGNILLTEPGQ---------------------------VKLADFGSASKSSPANSF 177

Query: 199 LQTPCYTPYYVAPEV---LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
           + TP    Y++APEV   +   +YD   D+WSLG+    L    PP F+ +       M 
Sbjct: 178 VGTP----YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMS 227

Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
               + Q D P  +    +   +  +   L   P ER    +++ + ++
Sbjct: 228 ALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 63.3 bits (154), Expect = 9e-11
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 36/186 (19%)

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTK 174
           I ++IC+ I+++H + + HRD+KP+N+L    G+  IL   D+G      ++ E+LL   
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL---DWGAAIFKKLEEEDLLDID 174

Query: 175 PGDGGIL--KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM 232
             +  I    +T  G   KIV           TP Y+APE L      +S DI++LGVI+
Sbjct: 175 VDERNICYSSMTIPG---KIVG----------TPDYMAPERLLGVPASESTDIYALGVIL 221

Query: 233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPE----WEHVSQEAKTLIKNMLCVD 288
           Y +L    P+    G+ IS   ++ I        +P     +  +      +    L VD
Sbjct: 222 YQMLTLSFPYRRKKGRKIS--YRDVI-------LSPIEVAPYREIPPFLSQIAMKALAVD 272

Query: 289 PSERLT 294
           P+ER +
Sbjct: 273 PAERYS 278

Length = 932

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 41/205 (20%)

Query: 40  TSEVYALKVL-HDTVKA----RREVELQLAVGSHKHIVNIKDVYENIYN-GSRCLLVIME 93
           T EV A+K L H T +      RE+E+ L    H +IV  K V    Y+ G R L ++ME
Sbjct: 32  TGEVVAVKKLQHSTAEHLRDFEREIEI-LKSLQHDNIVKYKGV---CYSAGRRNLRLVME 87

Query: 94  CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD 153
            +  G L   +Q+  +     R+  +  ++IC  +++L  +   HRD+   N+L      
Sbjct: 88  YLPYGSLRDYLQKHRERLDH-RKLLLYASQICKGMEYLGSKRYVHRDLATRNIL------ 140

Query: 154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTP-YYVA 210
                      V+ EN +          K+ DFG  K +  +K    ++ P  +P ++ A
Sbjct: 141 -----------VESENRV----------KIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 211 PEVLGPDKYDKSCDIWSLGVIMYIL 235
           PE L   K+  + D+WS GV++Y L
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 58/233 (24%)

Query: 24  LGLGINGKV----LQIVEKKTSEVYALKVL-HDTVKA-----RREVELQLAVGSHKHIVN 73
           LG G  GKV       +   T E  A+K L H   +       RE+E+   +  H++IV 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVK 70

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGEL---FQRIQQKEDGA----FTEREAAIIMNEICS 126
            K V E    G R L +IME +  G L    QR + + +      F+         +IC 
Sbjct: 71  YKGVCEK--PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS--------QICK 120

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            + +L  Q   HRD+   N+L                 V+ E+L          +K++DF
Sbjct: 121 GMDYLGSQRYIHRDLAARNIL-----------------VESEDL----------VKISDF 153

Query: 187 GFAKKIVSNKA--SLQTPCYTP-YYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
           G AK +  +K    ++ P  +P ++ APE L   K+  + D+WS GV +Y L 
Sbjct: 154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 63/283 (22%), Positives = 107/283 (37%), Gaps = 62/283 (21%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARREVELQLAVGS-----HKHIVNIKD 76
           LG G  G+V + + K    V A+K+L   D +K +   + Q  V +     HKH++++  
Sbjct: 14  LGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQ---DFQKEVQALKRLRHKHLISLFA 69

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V     +    + +I E M  G L   ++  E           +  ++   + +L +QN 
Sbjct: 70  VC----SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+   N+L                            G+  + K+ DFG A+ I   K
Sbjct: 126 IHRDLAARNILV---------------------------GEDLVCKVADFGLARLI---K 155

Query: 197 ASLQTPCYT--PY-YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
             +        PY + APE      +    D+WS G+++Y +          +GQ   PG
Sbjct: 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF--------TYGQVPYPG 207

Query: 254 MKNRIRLGQ----FDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
           M N     Q    +  P P      QE   ++      +P +R
Sbjct: 208 MNNHEVYDQITAGYRMPCP--AKCPQEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 28/126 (22%)

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           +M ++   + FLH   + HRD+KP+N+L T                             G
Sbjct: 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---------------------------SG 147

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
            +KL DFG A+ I S + +L +   T +Y APEVL    Y    D+WS+G I   +    
Sbjct: 148 QIKLADFGLAR-IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Query: 240 PPFFSN 245
           P F  +
Sbjct: 207 PLFRGS 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 39/233 (16%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  + A K++H  +K   R ++  +L V    +  
Sbjct: 5   DDFEKISE-LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 63

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + +L 
Sbjct: 64  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 120

Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 153

Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG---FPP 241
           ++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  +  G    PP
Sbjct: 154 LIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 75/318 (23%), Positives = 128/318 (40%), Gaps = 93/318 (29%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAVGSHKHIVNI 74
           E +G G  G V +   KKT ++ A+K +    +       A RE+ L L    H +IV +
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISL-LKELQHPNIVCL 64

Query: 75  KDVYENIYNGSRCLLVI----------MECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
           +DV   +   SR  L+           ++ +  G+       K             + +I
Sbjct: 65  QDV---LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS-----------YLYQI 110

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              I F H + + HRD+KP+NLL     + G++KL DFG  +                  
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARA----------------- 150

Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
            FG   ++ +++        T +Y APEVL G  +Y    DIWS+G I   +    P F 
Sbjct: 151 -FGIPVRVYTHEV------VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF- 202

Query: 244 SNHGQA------------------ISPGMKNRIRLGQFDFPNPEW---------EHVSQE 276
             HG +                  + PG+ +   L  +    P+W         +++ ++
Sbjct: 203 --HGDSEIDQLFRIFRILGTPTEDVWPGVTS---LPDYKNTFPKWKKGSLRSAVKNLDED 257

Query: 277 AKTLIKNMLCVDPSERLT 294
              L++ ML  DP++R++
Sbjct: 258 GLDLLEKMLIYDPAKRIS 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 52/199 (26%)

Query: 109 DGAFTEREAAI------IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF 162
           D AF  ++  +      IM ++  A++++HD+ + HRD+K EN+      DG I+ L DF
Sbjct: 255 DEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN--CDGKIV-LGDF 311

Query: 163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKS 222
           G   P    + K  +       D+G+   + +N              +PE+L  D Y + 
Sbjct: 312 GTAMP----FEKEREA-----FDYGWVGTVATN--------------SPEILAGDGYCEI 348

Query: 223 CDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNR-----IRLGQFDFPNP-------- 268
            DIWS G+I+  +L   F P     G+   PG +       + +   +FP+P        
Sbjct: 349 TDIWSCGLILLDMLSHDFCPIGDGGGK---PGKQLLKIIDSLSVCDEEFPDPPCKLFDYI 405

Query: 269 ---EWEHVSQEAKTLIKNM 284
              E +H       LI+N+
Sbjct: 406 DSAEIDHAGHSVPPLIRNL 424

Length = 501

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 62/257 (24%), Positives = 115/257 (44%), Gaps = 54/257 (21%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHD--TVKARREVELQLAVG---SHKHIV 72
           E++G G  G+V    L++  K+   V A+K L    T K RR+   + ++     H +I+
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFV-AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           ++    E +   SR +++I E M  G L   ++Q  DG FT  +   ++  I + +K+L 
Sbjct: 69  HL----EGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS 123

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           + N  HRD+   N+L                     NL         + K++DFG ++ +
Sbjct: 124 EMNYVHRDLAARNILVN------------------SNL---------VCKVSDFGLSRFL 156

Query: 193 VSNKASLQTPCYTP--------YYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFF 243
             + +    P YT          + APE +   K+  + D+WS G++M+ ++  G  P++
Sbjct: 157 EDDTSD---PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 213

Query: 244 SNHGQAISPGMKNRIRL 260
               Q +   ++   RL
Sbjct: 214 DMSNQDVINAIEQDYRL 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 46/218 (21%)

Query: 57  REVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTERE 116
           RE+++ L   SH+ I+N+   Y      S   +V+ +     +LF  + +   G     +
Sbjct: 135 REIDI-LKTISHRAIINLIHAYRW---KSTVCMVMPKYKC--DLFTYVDRS--GPLPLEQ 186

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
           A  I   +  A+ +LH + I HRDVK EN+   +P +                       
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENA---------------------- 224

Query: 177 DGGILKLTDFGFAKKIVSNKASLQTP-CY----TPYYVAPEVLGPDKYDKSCDIWSLGVI 231
                 L DFG A K+    A   TP CY    T    +PE+L  D Y    DIWS G++
Sbjct: 225 -----VLGDFGAACKL---DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLV 276

Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---FDFP 266
           ++ +       F    ++ S  +++ IR  Q    +FP
Sbjct: 277 LFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314

Length = 392

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 36/130 (27%), Positives = 55/130 (42%), Gaps = 28/130 (21%)

Query: 107 KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK 166
           K        +A II  +I   +++LH Q I HRDVK EN+      D   + + D G  +
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---DVDQVCIGDLGAAQ 205

Query: 167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIW 226
                        ++     G A  + +N              APEVL  DKY+   DIW
Sbjct: 206 FP-----------VVAPAFLGLAGTVETN--------------APEVLARDKYNSKADIW 240

Query: 227 SLGVIMYILL 236
           S G++++ +L
Sbjct: 241 SAGIVLFEML 250

Length = 357

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 56/245 (22%), Positives = 94/245 (38%), Gaps = 45/245 (18%)

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H++IV  K        G + L +IME +  G L   + + +       +  +   +IC  
Sbjct: 65  HENIVKYKGCCSE--QGGKGLQLIMEYVPLGSLRDYLPKHKLNL---AQLLLFAQQICEG 119

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK--PENLLYTKPGDGGILKLTD 185
           + +LH Q+  HRD+   N+L        ++K+ DFG  K  PE   Y +  + G      
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVREDG------ 170

Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
                          +P +   + A E L  +K+  + D+WS GV +Y LL       S 
Sbjct: 171 --------------DSPVF---WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213

Query: 246 HGQ-----AISPGMKNRIRLGQF-----DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             +         G    +RL +        P P  ++  QE   L+KN    +   R T 
Sbjct: 214 PKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP--KNCPQEVYILMKNCWETEAKFRPTF 271

Query: 296 DQVME 300
             ++ 
Sbjct: 272 RSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.6 bits (141), Expect = 1e-09
 Identities = 64/249 (25%), Positives = 99/249 (39%), Gaps = 51/249 (20%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSH 68
           D Y+   E LG G    V +   K   ++ ALKV+           A RE  L   +  H
Sbjct: 5   DSYE-KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KH 62

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            +IV + D    I +    L ++ E +H  +L Q +  K  G        + + ++   +
Sbjct: 63  ANIVLLHD----IIHTKETLTLVFEYVHT-DLCQYMD-KHPGGLHPENVKLFLFQLLRGL 116

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            ++H + I HRD+KP+NLL +                           D G LKL DFG 
Sbjct: 117 SYIHQRYILHRDLKPQNLLIS---------------------------DTGELKLADFGL 149

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           A+       +      T +Y  P+V LG  +Y    D+W +G I   ++ G   F     
Sbjct: 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF----- 204

Query: 248 QAISPGMKN 256
               PGMK+
Sbjct: 205 ----PGMKD 209

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 72/317 (22%), Positives = 121/317 (38%), Gaps = 69/317 (21%)

Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVL---HDT---VKARREVELQLAVGSHKHIV 72
           I  E LG G    V +   K T  + ALK +   H+      A REV L L    H +IV
Sbjct: 9   IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSL-LKDLKHANIV 67

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED---GAFTEREAAIIMNEICSAIK 129
            + D    I +  + L ++ E      L + ++Q  D      +     I + +I   + 
Sbjct: 68  TLHD----IVHTDKSLTLVFE-----YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           + H + + HRD+KP+NLL  + G+                           LKL DFG A
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGE---------------------------LKLADFGLA 151

Query: 190 KKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF------ 242
           +       +      T +Y  P+V LG  +Y    D+W +G I + +  G P F      
Sbjct: 152 RAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211

Query: 243 ---------FSNHGQAISPGMKNRIRLGQFDF----PNPEWEH---VSQEAKTLIKNMLC 286
                         +   PG+ +      ++F    P P   H   +  E   L+   L 
Sbjct: 212 DELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQ 271

Query: 287 VDPSERLTIDQVMENKW 303
            +  +R++ ++ M++ +
Sbjct: 272 YESKKRISAEEAMKHAY 288

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 39/128 (30%), Positives = 56/128 (43%), Gaps = 26/128 (20%)

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           I   +  AI++LH+  I HRD+K EN+    PGD   + L DFG           P D  
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAA-------CFPVD-- 234

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
           I     +G+A  I +N              APE+L  D Y  + DIWS G++++ +    
Sbjct: 235 INANKYYGWAGTIATN--------------APELLARDPYGPAVDIWSAGIVLFEMATCH 280

Query: 240 PPFFSNHG 247
              F   G
Sbjct: 281 DSLFEKDG 288

Length = 391

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 48/215 (22%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L + +Q     A    +   +  ++ S + +L  QN  HRD+   N+L
Sbjct: 76  IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVL 135

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  I K+ DFG A+ I  +    +     P 
Sbjct: 136 V---------------------------GENNICKVADFGLARVIKEDIYEAREGAKFPI 168

Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFD-- 264
            + APE    +++    D+WS G+++  ++         +G+   PGM N   L Q D  
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIV--------TYGRMPYPGMTNAEVLQQVDQG 220

Query: 265 --FPNPEWEHVSQEAKTLIKNML-C--VDPSERLT 294
              P P         K L   ML C   DP +R T
Sbjct: 221 YRMPCPP-----GCPKELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 45/215 (20%), Positives = 88/215 (40%), Gaps = 39/215 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVG---SHKHIVNIKDVY 78
             +G G  G V+    +   +  A+K L D   A +    + +V     H ++V +  V 
Sbjct: 12  ATIGKGEFGDVMLGDYRG--QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV- 68

Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
             +  G+  L ++ E M  G L   ++ +     T  +      ++C  +++L ++N  H
Sbjct: 69  --VLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVH 125

Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+   N+L +                           +  + K++DFG AK+    + S
Sbjct: 126 RDLAARNVLVS---------------------------EDLVAKVSDFGLAKEASQGQDS 158

Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            + P     + APE L   K+    D+WS G++++
Sbjct: 159 GKLPVK---WTAPEALREKKFSTKSDVWSFGILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 36/230 (15%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  + A K++H  +K   R ++  +L V    +  
Sbjct: 5   DDFERISE-LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 63

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  KE     E     +   +   + +L 
Sbjct: 64  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLR 120

Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 153

Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           ++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  L  G  P
Sbjct: 154 LIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 35/164 (21%), Positives = 70/164 (42%), Gaps = 32/164 (19%)

Query: 86  RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
           R + ++ E M  G L   +++++ G         + +++C A+++L      HRD+   N
Sbjct: 72  RPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN 130

Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT 205
            L                            G+  ++K++DFG A+ ++ ++ +       
Sbjct: 131 CLV---------------------------GEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163

Query: 206 PY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF--FSN 245
           P  +  PEV    ++    D+WS GV+M+ +   G  P+  FSN
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 57/254 (22%), Positives = 107/254 (42%), Gaps = 50/254 (19%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHD--TVKARREVELQLAVG---SHKHIV 72
           +++G G  G+V    L++  +K   V A+K L    T K R++   + ++    SH +I+
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAV-AIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +    +  ++I E M  G L + ++   DG F+  +   ++  I + +K+L 
Sbjct: 70  RL----EGVVTKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTKPGDGGILKLTDFG 187
           D N  HRD+   N+L          K++DFG     +  PE    T  G   I       
Sbjct: 125 DMNYVHRDLAARNILVN---SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI------- 174

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + APE +   K+  + D+WS G++M+ ++  G  P++   
Sbjct: 175 -------------------RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215

Query: 247 GQAISPGMKNRIRL 260
              +   + +  RL
Sbjct: 216 NHEVMKAINDGFRL 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 50/227 (22%)

Query: 21  TEILGLGINGKV----LQIVEKKTSEVYALKVLHD--TVKARRE-VELQLAVG--SHKHI 71
            +++G G  G+V    L++  KK  +V A+K L    + K R + +     +G   H +I
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDV-AIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           + +    E +   SR +++I E M  G L + +++  DG FT  +   ++  I S +K+L
Sbjct: 68  IRL----EGVVTKSRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYL 122

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
            + N  HRD+   N+L                     NL         + K++DFG +++
Sbjct: 123 SEMNYVHRDLAARNILVNS------------------NL---------VCKVSDFGLSRR 155

Query: 192 IVSNKASLQT-----PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
           +  ++A+  T     P     + APE +   K+  + D+WS G++M+
Sbjct: 156 LEDSEATYTTKGGKIPI---RWTAPEAIAYRKFTSASDVWSFGIVMW 199

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 25/111 (22%)

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++ SAI ++H + I HRD+K EN+L   P D   + L DFG        ++ P       
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARGSWSTP------- 317

Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
              +G A  + +N              APEVL  D Y  S DIWS G++++
Sbjct: 318 -FHYGIAGTVDTN--------------APEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 60/230 (26%), Positives = 90/230 (39%), Gaps = 72/230 (31%)

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           ++ +I   I +LH   + HRD+KP N+L    G              PE          G
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEG--------------PER---------G 149

Query: 180 ILKLTDFGFAKKIVS---NKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYIL 235
            +K+ D GFA+   S     A L     T +Y APE +LG   Y K+ DIW++G I   L
Sbjct: 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFD-------FP-NPEWEHVSQ--EAKTLIKN-- 283
           L   P F   H +       N     Q D       FP + +WE + +  E  TL+K+  
Sbjct: 210 LTSEPIF---HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR 266

Query: 284 ------------------------------MLCVDPSERLTIDQVMENKW 303
                                         +L +DP +R+T +Q M++ +
Sbjct: 267 RNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 39/129 (30%), Positives = 56/129 (43%), Gaps = 34/129 (26%)

Query: 118 AIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
             I   I  A+++LH + ++ HRDVKP N+L  + G                        
Sbjct: 106 GKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ----------------------- 142

Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK----YDKSCDIWSLGVIM 232
               +KL DFG +  +V + A        PY +APE + P+     YD   D+WSLG+ M
Sbjct: 143 ----VKLCDFGISGYLVDSVAKTIDAGCKPY-MAPERINPELNQKGYDVKSDVWSLGITM 197

Query: 233 YILLCG-FP 240
             L  G FP
Sbjct: 198 IELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 47/147 (31%), Positives = 75/147 (51%), Gaps = 22/147 (14%)

Query: 27  GINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKD 76
           G  GKV    +K  S++YA+KV+             V+A R+    LA+     IV++  
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDA---LALSKSPFIVHL-- 69

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            Y ++ + +   LV ME + GG++   +     G F E  A   ++E+  A+ +LH   I
Sbjct: 70  -YYSLQSANNVYLV-MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGI 125

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFG 163
            HRD+KP+N+L +  G    +KLTDFG
Sbjct: 126 IHRDLKPDNMLISNEGH---IKLTDFG 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 74/320 (23%), Positives = 126/320 (39%), Gaps = 79/320 (24%)

Query: 12  PIQDDYDISTE----------ILGLGINGKVLQ-----IVEKKTSEVYALKVLHDTVKAR 56
           P Q  YD+  E           LG G  GKV++     + +       A+K+L  T  + 
Sbjct: 21  PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80

Query: 57  R------EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG 110
                  E+++   +G+H++IVN+             +LVI E    G+L   +++K + 
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTI----GGPILVITEYCCYGDLLNFLRRKRES 136

Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T  +      ++   + FL  +N  HRD+   N+L T                     
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT--------------------- 175

Query: 171 LYTKPGDGGILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDI 225
                  G I+K+ DFG A+ I+++     K + + P     ++APE +    Y    D+
Sbjct: 176 ------HGKIVKICDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDV 226

Query: 226 WSLGVIMY-ILLCGFPPFFSNHGQAISPGMK------NRIRLGQFDFPNPEWEHVSQEAK 278
           WS G++++ I   G  P+         PGM         I+ G +    P  EH   E  
Sbjct: 227 WSYGILLWEIFSLGSNPY---------PGMPVDSKFYKLIKEG-YRMAQP--EHAPAEIY 274

Query: 279 TLIKNMLCVDPSERLTIDQV 298
            ++K     DP +R T  Q+
Sbjct: 275 DIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 37/169 (21%)

Query: 90  VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYT 149
           ++ME + GG+    +++K+D   T++     ++   + + +L  +N  HRD+   N L  
Sbjct: 69  IVMELVPGGDFLSFLRKKKDELKTKQLVKFALDA-AAGMAYLESKNCIHRDLAARNCLV- 126

Query: 150 KPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV 209
             G+  +LK++DFG  + E        D GI             S+    Q P     + 
Sbjct: 127 --GENNVLKISDFGMSRQE--------DDGIY------------SSSGLKQIPIK---WT 161

Query: 210 APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
           APE L   +Y    D+WS G++++     G  P+         PGM N+
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPY---------PGMTNQ 201

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 57/230 (24%), Positives = 91/230 (39%), Gaps = 72/230 (31%)

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           ++ +I   I +LH   + HRD+KP N+L    G              PE          G
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEG--------------PER---------G 149

Query: 180 ILKLTDFGFAKKIVS---NKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYIL 235
            +K+ D GFA+   S     A L     T +Y APE +LG   Y K+ DIW++G I   L
Sbjct: 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFD-------FP-NPEWEHVSQ------------ 275
           L   P F   H +       N     Q D       FP + +WE + +            
Sbjct: 210 LTSEPIF---HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFR 266

Query: 276 --------------------EAKT--LIKNMLCVDPSERLTIDQVMENKW 303
                               ++K   L++ +L +DP++R+T +Q +++ +
Sbjct: 267 RTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 63/256 (24%), Positives = 99/256 (38%), Gaps = 71/256 (27%)

Query: 68  HKHIVNIKDVYENIYNGSRCLL-----VIMECMHGGELFQ-----RIQQKEDGAFTEREA 117
           H +IV +  V         CLL     +IME M GG+L       R+++      T +E 
Sbjct: 58  HPNIVKLLGV---------CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108

Query: 118 AIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
             I  ++     +L   +  HRD+   N L ++ G                   Y     
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKG-------------------YDADR- 148

Query: 178 GGILKLTDFGFAKKIVSNKASLQTPCYTPYY------------VAPEVLGPDKYDKSCDI 225
             ++K+ DFG A+ I  +           YY            +APE L   K+    D+
Sbjct: 149 --VVKIGDFGLARDIYKSD----------YYRKEGEGLLPVRWMAPESLLDGKFTTQSDV 196

Query: 226 WSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNM 284
           WS GV+M+ IL  G  P+ + + Q +   +    RL +   P     +   +   L+ N 
Sbjct: 197 WSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK---PE----NCPDKIYQLMTNC 249

Query: 285 LCVDPSERLTIDQVME 300
              DPSER T D++ E
Sbjct: 250 WAQDPSERPTFDRIQE 265

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 47/234 (20%)

Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVL---HDT---VKARREVELQLAVGSHKHIV 72
           I  + LG G    V +   K T  + ALK +   H+      A REV L L    H +IV
Sbjct: 9   IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSL-LKDLKHANIV 67

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED---GAFTEREAAIIMNEICSAIK 129
            + D    I +  + L ++ E      L + ++Q  D    +       + + ++   + 
Sbjct: 68  TLHD----IIHTEKSLTLVFE-----YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLN 118

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           + H + + HRD+KP+NLL  + G+                           LKL DFG A
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGE---------------------------LKLADFGLA 151

Query: 190 KKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           +       +      T +Y  P++ LG   Y    D+W +G I Y +  G P F
Sbjct: 152 RAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 52.2 bits (125), Expect = 9e-08
 Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 29/149 (19%)

Query: 86  RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
           + L ++ E M  G L   ++Q++ G  ++     +  ++C  +++L   +  HRD+   N
Sbjct: 72  KPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN 130

Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT 205
            L +                             G++K++DFG  + ++ ++ +  +    
Sbjct: 131 CLVS---------------------------STGVVKVSDFGMTRYVLDDEYTSSSGAKF 163

Query: 206 PY-YVAPEVLGPDKYDKSCDIWSLGVIMY 233
           P  +  PEV    KY    D+WS GV+M+
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 205 TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFD 264
           TP Y+APE+L    +  + D W+LGV ++  L G PPF     Q +   + NR      D
Sbjct: 543 TPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR------D 596

Query: 265 FPNPEWEHV-SQEAKTLIKNMLCVDPSER 292
            P PE E   S  A+  I+ +L +DP++R
Sbjct: 597 IPWPEGEEKLSVNAQNAIEILLTMDPTKR 625

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 59/251 (23%), Positives = 111/251 (44%), Gaps = 46/251 (18%)

Query: 23  ILGLGINGKV----LQIVEKKTSEVYALKVLHD--TVKARREVELQLAVGS---HKHIVN 73
           ++G G  G+V    L++  K+   V A+K L    T K RR+   + ++     H +I++
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPV-AIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +    E +   S+ ++++ E M  G L     +K DG FT  +   ++  I S +K+L D
Sbjct: 70  L----EGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
               HRD+   N+L                     NL         + K++DFG ++ + 
Sbjct: 125 MGYVHRDLAARNILVN------------------SNL---------VCKVSDFGLSRVLE 157

Query: 194 SNKASLQTPC--YTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQA 249
            +  +  T      P  + APE +   K+  + D+WS G++M+ ++  G  P++    Q 
Sbjct: 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217

Query: 250 ISPGMKNRIRL 260
           +   ++   RL
Sbjct: 218 VIKAIEEGYRL 228

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 66/299 (22%), Positives = 114/299 (38%), Gaps = 68/299 (22%)

Query: 22  EILGLGINGKVLQ-IVEKKTSEVYALKVL---HDTVKARREVELQLAVG----SHKHIVN 73
             +G G  G V Q +     +E  A+ V    + T  + RE  LQ A       H HIV 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 74  IKDVYEN--IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           +  V     ++       ++ME    GEL   +Q  +  +       +   ++ +A+ +L
Sbjct: 72  LIGVITENPVW-------IVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYL 123

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
             +   HRD+   N+L                   P+ +           KL DFG ++ 
Sbjct: 124 ESKRFVHRDIAARNVLV----------------SSPDCV-----------KLGDFGLSRY 156

Query: 192 IVSN---KASL-QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
           +      KAS  + P     ++APE +   ++  + D+W  GV M+ IL+ G  PF    
Sbjct: 157 LEDESYYKASKGKLPIK---WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ--- 210

Query: 247 GQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
                 G+KN   +G+ +     P P   +      +L+      DPS+R    ++   
Sbjct: 211 ------GVKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 61/240 (25%), Positives = 109/240 (45%), Gaps = 36/240 (15%)

Query: 15  DDYDISTE------ILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE--VELQLA-- 64
           +D D+ST+      +LG G  GKV++  ++K  E  A+K++ +  K  R+  +E+Q    
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181

Query: 65  -----VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
                      ++ I+  ++N   G  C   I+   +G  L   I +   G F+ R  A 
Sbjct: 182 VRQADPADRFPLMKIQRYFQN-ETGHMC---IVMPKYGPCLLDWIMKH--GPFSHRHLAQ 235

Query: 120 IMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           I+ +   A+ + H + ++ H D+KPEN+L  +  D  +  +T+             P D 
Sbjct: 236 IIFQTGVALDYFHTELHLMHTDLKPENIL-METSDTVVDPVTN----------RALPPDP 284

Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG 238
             +++ D G        + S      T +Y +PEV+    +  S D+WS+G I+Y L  G
Sbjct: 285 CRVRICDLG---GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 55/230 (23%), Positives = 92/230 (40%), Gaps = 58/230 (25%)

Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
            T+     ++ +I   +K++H  +I HRD+KP NL   +  +                  
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE------------------ 158

Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+              T +Y APE+ L    Y+++ DIWS+G 
Sbjct: 159 ---------LKILDFGLARHTDDEMTGYVA---TRWYRAPEIMLNWMHYNQTVDIWSVGC 206

Query: 231 IMYILLCG---FP-----------------PFFSNHGQAISPGMKNRIR-LGQFDFPNPE 269
           IM  LL G   FP                 P      +  S   +N I+ L Q   P   
Sbjct: 207 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ--MPKMN 264

Query: 270 WEHV----SQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPL 315
           + +V    +  A  L++ ML +D  +R+T  Q + + + +Q++     P+
Sbjct: 265 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 314

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 45/221 (20%)

Query: 24  LGLGINGKVLQIV---EKKTSEVYALKVL-HDTVKARREVELQLAVGSHK----HIVNIK 75
           LG G  G V + V    KK  +V A+KVL ++  K+ R+  ++ A   H+    +IV + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
            V E     +  L+++ME   GG L + +  K+D   T      +M+++   +K+L  +N
Sbjct: 62  GVCE-----AEALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKN 115

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
             HRD+   N+L                     N  Y         K++DFG +K + ++
Sbjct: 116 FVHRDLAARNVLLV-------------------NQHYA--------KISDFGLSKALGAD 148

Query: 196 KASLQTPCYTPY---YVAPEVLGPDKYDKSCDIWSLGVIMY 233
            +  +      +   + APE +   K+    D+WS G+ M+
Sbjct: 149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMW 189

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 52/244 (21%), Positives = 88/244 (36%), Gaps = 66/244 (27%)

Query: 68  HKHIVNIKDV---YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
           H  +V +  V    E IY       ++ E M  G L   ++  E       +   +  +I
Sbjct: 60  HDKLVQLYAVCSEEEPIY-------IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI 112

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              + +L  +N  HRD+   N+L                            G+  + K+ 
Sbjct: 113 AEGMAYLESRNYIHRDLAARNILV---------------------------GENLVCKIA 145

Query: 185 DFGFAKKIVSNKASLQTPCYTPY--------YVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
           DFG A+ I  ++       YT          + APE     ++    D+WS G+++  ++
Sbjct: 146 DFGLARLIEDDE-------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV 198

Query: 237 CGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSER 292
                    +G+   PGM NR  L Q +     P P   +  +E   L+      DP ER
Sbjct: 199 --------TYGRVPYPGMTNREVLEQVERGYRMPRP--PNCPEELYDLMLQCWDKDPEER 248

Query: 293 LTID 296
            T +
Sbjct: 249 PTFE 252

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.3 bits (120), Expect = 6e-07
 Identities = 45/187 (24%), Positives = 82/187 (43%), Gaps = 40/187 (21%)

Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
           ++E+E+ L    H++IV  K +     +G   + +IME +  G L + + + ++     +
Sbjct: 54  KKEIEI-LRNLYHENIVKYKGICTE--DGGNGIKLIMEFLPSGSLKEYLPRNKN-KINLK 109

Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
           +      +IC  + +L  +   HRD+   N+L                 V+ E+      
Sbjct: 110 QQLKYAVQICKGMDYLGSRQYVHRDLAARNVL-----------------VESEH------ 146

Query: 176 GDGGILKLTDFGFAKKIVSNKA------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG 229
                +K+ DFG  K I ++K        L +P +   + APE L   K+  + D+WS G
Sbjct: 147 ----QVKIGDFGLTKAIETDKEYYTVKDDLDSPVF---WYAPECLIQSKFYIASDVWSFG 199

Query: 230 VIMYILL 236
           V +Y LL
Sbjct: 200 VTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 59/285 (20%)

Query: 39  KTSEVYALKVLHDTVKAR------REVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM 92
           K +   A+K+L D    +       E+E+   +G HK+I+N+        +G   L VI+
Sbjct: 45  KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGP--LYVIV 100

Query: 93  ECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
           E    G L + ++ +               D   T ++      ++   +++L  Q   H
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIH 160

Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKP-ENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           RD+   N+L T   +  ++K+ DFG  +   N+ Y K    G L +              
Sbjct: 161 RDLAARNVLVT---ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK------------- 204

Query: 198 SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKN 256
                     ++APE L    Y    D+WS GV+M+ I   G  P+     + +   +K 
Sbjct: 205 ----------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254

Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
             R+   D P     + + E   ++++     PS R T  Q++E+
Sbjct: 255 GHRM---DKP----ANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 71/333 (21%), Positives = 134/333 (40%), Gaps = 86/333 (25%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + +  +  A+K L       + ARR   EL+L     H++++ + DV
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 78  YE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           +    +I N +   LV    + G +L   ++ +     ++     ++ ++   +K++H  
Sbjct: 83  FTPATSIENFNEVYLVTN--LMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KP N+   +  +                           L++ DFG A++   
Sbjct: 138 GIIHRDLKPSNVAVNEDCE---------------------------LRILDFGLARQ--- 167

Query: 195 NKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
               +     T +Y APE+ L    Y+++ DIWS+G IM  LL          G+A+ PG
Sbjct: 168 ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL---------KGKALFPG 218

Query: 254 MKNRIRLGQF----DFPNPEW----------------EHVSQE------------AKTLI 281
                +L +       P+PE                  H+ Q+            A  L+
Sbjct: 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLL 278

Query: 282 KNMLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
           + ML +D  +R++  + + + + SQ++     P
Sbjct: 279 EKMLVLDSDKRISASEALAHPYFSQYHDPEDEP 311

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 59/256 (23%), Positives = 94/256 (36%), Gaps = 66/256 (25%)

Query: 22  EILGLGINGKVL-----QIVEKKTSEVYALKVLHDTV--KAR----REVELQLAVGSHKH 70
             LG G  GKV       +  +   E+ A+K L +T    AR    RE EL L    H++
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL-LTNFQHEN 69

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGEL------------FQRIQQKEDGAFTEREAA 118
           IV    V      G    +++ E M  G+L            F +      G  T  +  
Sbjct: 70  IVKFYGV---CTEGDP-PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
            I  +I S + +L  Q+  HRD+   N L                            G  
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLV---------------------------GYD 158

Query: 179 GILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            ++K+ DFG ++ + +            P     ++ PE +   K+    D+WS GV+++
Sbjct: 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVVLW 215

Query: 234 -ILLCGFPPFF--SNH 246
            I   G  P++  SN 
Sbjct: 216 EIFTYGKQPWYGLSNE 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 42/214 (19%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++  E  A        +  ++ + + ++   N  HRD++  N+L
Sbjct: 75  IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANIL 134

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       GDG + K+ DFG A+ I  N+ + +     P 
Sbjct: 135 V---------------------------GDGLVCKIADFGLARLIEDNEYTARQGAKFPI 167

Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L+          G+   PGM NR  L Q    
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELV--------TKGRVPYPGMNNREVLEQVERG 219

Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID 296
           +  P P+   +S     L+      DP ER T +
Sbjct: 220 YRMPCPQDCPIS--LHELMLQCWKKDPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 46/229 (20%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV--- 70

Query: 81  IYNGSRCLL-----VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
                 C       +I E M  G L   +++             +  +I SA+++L  +N
Sbjct: 71  ------CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 124

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
             HRD+   N L                            G+  ++K+ DFG ++ +  +
Sbjct: 125 FIHRDLAARNCLV---------------------------GENHLVKVADFGLSRLMTGD 157

Query: 196 KASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
             +       P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 26/67 (38%), Positives = 36/67 (53%), Gaps = 7/67 (10%)

Query: 100 LFQRIQQKEDGAFTEREAAII---MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGI 156
           L  ++Q    G   ERE  II   M +I  A+  LH   I HRDVKP+N++++  G G  
Sbjct: 239 LLGKVQDLPKGL--ERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS-EGSGS- 294

Query: 157 LKLTDFG 163
            K+ D G
Sbjct: 295 FKIIDLG 301

Length = 566

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 39/214 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS--HKHIVNIKDVYE 79
           EI+G G  G VLQ   + T +  A+K +   V A+  +E    +    HK++V +  V  
Sbjct: 12  EIIGEGEFGAVLQ--GEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI- 68

Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
            ++NG   L ++ME M  G L   ++ +     +  +      ++   +++L  + + HR
Sbjct: 69  -LHNG---LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHR 124

Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+   N+L +                           + G+ K++DFG A+        +
Sbjct: 125 DLAARNILVS---------------------------EDGVAKVSDFGLAR---VGSMGV 154

Query: 200 QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
                   + APE L   K+    D+WS GV+++
Sbjct: 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLW 188

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 33/168 (19%)

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH  +V +  V         CL  + E M  G L   ++ +  G F++     +  ++C 
Sbjct: 57  SHPKLVQLYGVC--TERSPICL--VFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCE 111

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            + +L   N+ HRD+   N L                            G+  ++K++DF
Sbjct: 112 GMAYLESSNVIHRDLAARNCLV---------------------------GENQVVKVSDF 144

Query: 187 GFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY 233
           G  + ++ ++ +  T    P  + +PEV    KY    D+WS GV+M+
Sbjct: 145 GMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 46/212 (21%), Positives = 83/212 (39%), Gaps = 38/212 (17%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++  E G     +      +I   + ++  +N  HRD++  N+L
Sbjct: 76  IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVL 135

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                  E+L+          K+ DFG A+ I  N+ + +     P 
Sbjct: 136 VS------------------ESLM---------CKIADFGLARVIEDNEYTAREGAKFPI 168

Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG--QFD 264
            + APE +    +    D+WS G+++Y ++         +G+   PGM N   +   Q  
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIV--------TYGKIPYPGMSNSDVMSALQRG 220

Query: 265 FPNPEWEHVSQEAKTLIKNMLCVDPSERLTID 296
           +  P  E+   E   ++K        ER T D
Sbjct: 221 YRMPRMENCPDELYDIMKTCWKEKAEERPTFD 252

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 47.4 bits (112), Expect = 4e-06
 Identities = 45/214 (21%), Positives = 83/214 (38%), Gaps = 38/214 (17%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   +++ +       +   +  +I   + ++   N  HRD++  N+L
Sbjct: 75  IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANIL 134

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       GD  + K+ DFG A+ I  N+ + +     P 
Sbjct: 135 V---------------------------GDNLVCKIADFGLARLIEDNEYTARQGAKFPI 167

Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFD-- 264
            + APE     ++    D+WS G+++  L+          G+   PGM NR  L Q +  
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELV--------TKGRVPYPGMVNREVLEQVERG 219

Query: 265 FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
           +  P  +   +    L+K     DP ER T + +
Sbjct: 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 33/147 (22%), Positives = 65/147 (44%), Gaps = 28/147 (19%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ME + GG+ F    + E      +E   ++    + +++L  ++  HRD+   N L
Sbjct: 68  IYIVMELVQGGD-FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCL 126

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL-QTPCYTP 206
            T   +  +LK++DFG  + E        DG             + ++   + Q P    
Sbjct: 127 VT---EKNVLKISDFGMSREEE-------DG-------------VYASTGGMKQIPVK-- 161

Query: 207 YYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            + APE L   +Y    D+WS G++++
Sbjct: 162 -WTAPEALNYGRYSSESDVWSFGILLW 187

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 53/225 (23%)

Query: 24  LGLGINGKVLQIV--EKKTSEV-YALKVLHDTVKARREVEL--------QLAVGSHKHIV 72
           LG G  G V++ V   K   EV  A+K L     A  + E         QL    H  IV
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL---DHPCIV 59

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +  V +        L+++ME    G L + ++++ +      +   + +++   + +L 
Sbjct: 60  RLIGVCK-----GEPLMLVMELAPLGPLLKYLKKRRE--IPVSDLKELAHQVAMGMAYLE 112

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
            ++  HRD+   N+L           L +                    K++DFG ++ +
Sbjct: 113 SKHFVHRDLAARNVL-----------LVNRHQA----------------KISDFGMSRAL 145

Query: 193 V--SNKASLQTPCYTP--YYVAPEVLGPDKYDKSCDIWSLGVIMY 233
              S+     T    P  +Y APE +   K+    D+WS GV ++
Sbjct: 146 GAGSDYYRATTAGRWPLKWY-APECINYGKFSSKSDVWSYGVTLW 189

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 64/256 (25%), Positives = 101/256 (39%), Gaps = 78/256 (30%)

Query: 24  LGLGINGKVL-----QIVEKKTSEVYALKVLHDTVKA-----RREVELQLAVGSHKHIVN 73
           LG G  GKV       ++ ++   + A+K L +  ++     +RE EL L V  H+HIV 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL-LTVLQHQHIVR 71

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGEL--FQR--------IQQKED---GAFTEREAAII 120
               +  +    R LL++ E M  G+L  F R        +   ED   G  T  +   I
Sbjct: 72  ----FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
            ++I S + +L   +  HRD+   N L                            G G +
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLV---------------------------GQGLV 160

Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYY------------VAPEVLGPDKYDKSCDIWSL 228
           +K+ DFG ++ I S          T YY            + PE +   K+    DIWS 
Sbjct: 161 VKIGDFGMSRDIYS----------TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210

Query: 229 GVIMY-ILLCGFPPFF 243
           GV+++ I   G  P++
Sbjct: 211 GVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 27/111 (24%), Positives = 49/111 (44%), Gaps = 30/111 (27%)

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++C A+++L   N  HRD+   N+L                 V  +N          + K
Sbjct: 110 DVCEAMEYLEANNFVHRDLAARNVL-----------------VSEDN----------VAK 142

Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
           ++DFG  K+  S + + + P     + APE L   K+    D+WS G++++
Sbjct: 143 VSDFGLTKEASSTQDTGKLPVK---WTAPEALREKKFSTKSDVWSFGILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 37/178 (20%), Positives = 69/178 (38%), Gaps = 36/178 (20%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 75  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 134

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 135 V---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFPI 167

Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFD 264
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q +
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVE 217

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 30/149 (20%), Positives = 60/149 (40%), Gaps = 29/149 (19%)

Query: 86  RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
           R + ++ E M  G L   +++     F   +   +  ++C  + +L  +   HRD+   N
Sbjct: 72  RPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN 130

Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT 205
            L                             D G +K++DFG ++ ++ ++ +       
Sbjct: 131 CLVD---------------------------DQGCVKVSDFGLSRYVLDDEYTSSVGSKF 163

Query: 206 PY-YVAPEVLGPDKYDKSCDIWSLGVIMY 233
           P  +  PEVL   K+    D+W+ GV+M+
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 53/253 (20%), Positives = 107/253 (42%), Gaps = 52/253 (20%)

Query: 24  LGLGINGKVLQIV--EKKTSEVYALKVLH---------DTVKARREVELQLAVGSHKHIV 72
           LG G  G V + +   KK+ +  A+K+L          D +     V  QL    + +IV
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL---DNPYIV 59

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +  + E     +   +++ME    G L + +Q+ +    TE+    +++++   +K+L 
Sbjct: 60  RMIGICE-----AESWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLE 112

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           + N  HRD+   N+L                       L T+       K++DFG +K +
Sbjct: 113 ETNFVHRDLAARNVL-----------------------LVTQ----HYAKISDFGLSKAL 145

Query: 193 VSNKASLQTPCYTPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ 248
            +++   +   +  +   + APE +   K+    D+WS GV+M+     G  P+    G 
Sbjct: 146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205

Query: 249 AISPGMKNRIRLG 261
            ++  +++  R+ 
Sbjct: 206 EVTQMIESGERME 218

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 40/173 (23%), Positives = 73/173 (42%), Gaps = 36/173 (20%)

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++   ++FL  +N  HRD+   N+L  +                           G I+K
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQ---------------------------GKIVK 277

Query: 183 LTDFGFAKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGF 239
           + DFG A+ I+  SN  S  +      ++APE +  + Y    D+WS G++++ I   G 
Sbjct: 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337

Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
            P+    G  +     N+I+ G +    P  +H +QE   ++      +P +R
Sbjct: 338 TPY---PGMIVDSTFYNKIKSG-YRMAKP--DHATQEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 64/248 (25%), Positives = 99/248 (39%), Gaps = 61/248 (24%)

Query: 24  LGLGINGKVL-----QIVEKKTSEVYALKVLHD-TVKAR----REVELQLAVGSHKHIVN 73
           LG G  GKV       +   K   + A+K L D T+ AR    RE EL L    H+HIV 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL-LTNLQHEHIVK 71

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGEL--FQRIQ------------QKEDGAFTEREAAI 119
               +  +      L+++ E M  G+L  F R              ++  G     +   
Sbjct: 72  ----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPG 176
           I ++I S + +L  Q+  HRD+   N L    G   ++K+ DFG   DV   +  Y + G
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTD--YYRVG 182

Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
              +L +                        ++ PE +   K+    D+WS GVI++ I 
Sbjct: 183 GHTMLPIR-----------------------WMPPESIMYRKFTTESDVWSFGVILWEIF 219

Query: 236 LCGFPPFF 243
             G  P+F
Sbjct: 220 TYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 36/156 (23%), Positives = 62/156 (39%), Gaps = 39/156 (25%)

Query: 89  LVIMECMHGGEL--FQRIQQKED-----GAFTEREAAIIM-NEICSAIKFLHDQNIAHRD 140
           LV+ME M  G+L  + R ++ E            +  I M  EI   + +L  +   HRD
Sbjct: 85  LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRD 144

Query: 141 VKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           +   N +     +   +K+ DFG   D+   +  Y + G  G+L +              
Sbjct: 145 LAARNCMVA---EDLTVKIGDFGMTRDIYETD--YYRKGGKGLLPVR------------- 186

Query: 198 SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
                     ++APE L    +    D+WS GV+++
Sbjct: 187 ----------WMAPESLKDGVFTTKSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 61/300 (20%), Positives = 116/300 (38%), Gaps = 60/300 (20%)

Query: 15  DDYDISTE-ILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKARREV-----ELQLA 64
           D+  I  E ILG G  G++    L++  K+   V A+  L      ++        L L 
Sbjct: 3   DNKSIKIERILGTGRFGELCRGCLKLPSKRELPV-AIHTLRAGCSDKQRRGFLAEALTLG 61

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGEL--FQRIQQKEDGAFTEREAAIIMN 122
              H +IV ++ V   I  G+  ++++ E M  G L  F R   K +G     +   ++ 
Sbjct: 62  QFDHSNIVRLEGV---ITRGN-TMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLP 114

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV---KPENLLYTKPGDGG 179
            + S +K+L +    H+ +    +L        + K++ F  +   K E +  T  G   
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDKSEAIYTTMSGKSP 171

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCG 238
           +L                          + APE +    +  + D+WS G++M+ ++  G
Sbjct: 172 VL--------------------------WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYG 205

Query: 239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
             P++   GQ +   +++  RL     P P   +       L+ +    +  ER    Q+
Sbjct: 206 ERPYWDMSGQDVIKAVEDGFRL-----PAP--RNCPNLLHQLMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 50/219 (22%), Positives = 90/219 (41%), Gaps = 50/219 (22%)

Query: 45  ALKVLHDTVKAR------REVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGG 98
           A+K+L D    +       E+EL   +G HK+I+N+  V      G   L VI+E    G
Sbjct: 48  AVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--EGP--LYVIVEYAAKG 103

Query: 99  EL--FQR------------IQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
            L  F R            I +  +   + ++      ++   +++L  +   HRD+   
Sbjct: 104 NLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163

Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L T   +  ++K+ DFG  +                + D  + KK  + +  ++    
Sbjct: 164 NVLVT---EDNVMKIADFGLAR---------------GVHDIDYYKKTSNGRLPVK---- 201

Query: 205 TPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
              ++APE L    Y    D+WS G++M+ I   G  P+
Sbjct: 202 ---WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 60/254 (23%), Positives = 108/254 (42%), Gaps = 47/254 (18%)

Query: 22  EILGLGINGKV---LQIVEKKTSEV-YALKVLHDTVKARREVEL---QLAVGS--HKHIV 72
           ++LG G+ G V   + I E  + ++  A+K + D    +   E+    LA+GS  H +IV
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN---EICSAIK 129
            +      I  G+   LV      G  L   ++Q  D    +R    ++N   +I   + 
Sbjct: 73  RLL----GICPGASLQLVTQLSPLG-SLLDHVRQHRDSLDPQR----LLNWCVQIAKGMY 123

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           +L +  + HR++   N+L        I+++ DFG     +LLY  P D            
Sbjct: 124 YLEEHRMVHRNLAARNILLKSD---SIVQIADFGVA---DLLY--PDD------------ 163

Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ 248
           KK   ++   +TP     ++A E +   +Y    D+WS GV ++ ++  G  P+      
Sbjct: 164 KKYFYSEH--KTPI---KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218

Query: 249 AISPGMKNRIRLGQ 262
            +   ++   RL Q
Sbjct: 219 EVPDLLEKGERLAQ 232

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 53/234 (22%), Positives = 100/234 (42%), Gaps = 60/234 (25%)

Query: 22  EILGLGINGKVLQ---IVEKKTSEV-YALKVLHDTVKARREVE-----LQLAVGSHKHIV 72
           ++LG G  G V +   + E +T ++  A+K+L++T   +  VE     L +A   H H+V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN---EICSAIK 129
            +  V       S  + ++ + M  G L   + + +D   ++    +++N   +I   + 
Sbjct: 73  RLLGVCL-----SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQ----LLLNWCVQIAKGMM 123

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF-------GDVKPENLLYTKPGDGGILK 182
           +L ++ + HRD+   N+L   P     +K+TDF       GD K  N       DGG + 
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYN------ADGGKMP 174

Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
           +                        ++A E +   K+    D+WS GV ++ L+
Sbjct: 175 IK-----------------------WMALECIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 2e-04
 Identities = 19/44 (43%), Positives = 28/44 (63%), Gaps = 3/44 (6%)

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
           +M ++ + ++ LH   I HRD+KPENLL T  G    +K+ DFG
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFG 354

Length = 507

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 43/212 (20%), Positives = 80/212 (37%), Gaps = 38/212 (17%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++  E       +      +I   + F+  +N  HRD++  N+L
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                              + K+ DFG A+ I  N+ + +     P 
Sbjct: 135 VSA---------------------------SLVCKIADFGLARVIEDNEYTAREGAKFPI 167

Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNR--IRLGQFD 264
            + APE +    +    D+WS G+++  ++         +G+   PGM N   IR  +  
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIV--------TYGRIPYPGMSNPEVIRALERG 219

Query: 265 FPNPEWEHVSQEAKTLIKNMLCVDPSERLTID 296
           +  P  E+  +E   ++       P ER T +
Sbjct: 220 YRMPRPENCPEELYNIMMRCWKNRPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 46/201 (22%)

Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE----DGAF- 112
           E+E+   +G HK+I+N+        +G   L V++E    G L + ++ +     D +F 
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQ--DGP--LYVLVEYASKGNLREYLRARRPPGMDYSFD 122

Query: 113 ---------TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                    T ++      ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFG 179

Query: 164 DVKP-ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKS 222
             +   N+ Y K    G L +                        ++APE L    Y   
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVK-----------------------WMAPEALFDRVYTHQ 216

Query: 223 CDIWSLGVIMY-ILLCGFPPF 242
            D+WS GV+++ I   G  P+
Sbjct: 217 SDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 54/251 (21%), Positives = 98/251 (39%), Gaps = 63/251 (25%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVL------HDTVKARREVELQLAVGSHKH 70
           + LG G  G+V++     +     +   A+K+L       D      E+E+   +G HK+
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+  V      G   L V++E    G L   ++ +               +   T+++
Sbjct: 78  IINLLGVCTQ--EGP--LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYT 173
                 ++   ++FL  +   HRD+   N+L T   +  ++K+ DFG   D+      Y 
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIH-HIDYYR 189

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIM 232
           K  +G +                         P  ++APE L    Y    D+WS GV++
Sbjct: 190 KTTNGRL-------------------------PVKWMAPEALFDRVYTHQSDVWSFGVLL 224

Query: 233 Y-ILLCGFPPF 242
           + I   G  P+
Sbjct: 225 WEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 51/259 (19%), Positives = 108/259 (41%), Gaps = 51/259 (19%)

Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------- 108
           E+E+   +G HK+I+N+        +G   L VI+E    G L + ++ +          
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYCYN 128

Query: 109 -----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                +   + ++      ++   +++L  +   HRD+   N+L T   +  ++K+ DFG
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFG 185

Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             +                +    + KK  + +  ++       ++APE L    Y    
Sbjct: 186 LAR---------------DIHHIDYYKKTTNGRLPVK-------WMAPEALFDRIYTHQS 223

Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           D+WS GV+++ I   G  P+     + +   +K   R+   D P+    + + E   +++
Sbjct: 224 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS----NCTNELYMMMR 276

Query: 283 NMLCVDPSERLTIDQVMEN 301
           +     PS+R T  Q++E+
Sbjct: 277 DCWHAVPSQRPTFKQLVED 295

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 25/123 (20%), Positives = 52/123 (42%), Gaps = 30/123 (24%)

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I   +++L +  + HRD+   N+L                             +G  +K
Sbjct: 135 QISRGMQYLAEMKLVHRDLAARNVLV---------------------------AEGRKMK 167

Query: 183 LTDFGFAKKIVSNKASLQ-TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGF 239
           ++DFG ++ +    + ++ +    P  ++A E L    Y    D+WS GV+++ I+  G 
Sbjct: 168 ISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227

Query: 240 PPF 242
            P+
Sbjct: 228 NPY 230

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 44/183 (24%)

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++   + FL  +N  HRDV   N+L T                           DG + K
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLT---------------------------DGRVAK 252

Query: 183 LTDFGFAKKIV--SN---KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILL 236
           + DFG A+ I+  SN   K + + P     ++APE +    Y    D+WS G++++ I  
Sbjct: 253 ICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Query: 237 CGFPPFFSNHGQAISPGMKNRIRLG-QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
            G  P+    G  ++      ++ G Q   P    +    E  +++K    ++P+ER T 
Sbjct: 310 LGKSPY---PGILVNSKFYKMVKRGYQMSRP----DFAPPEIYSIMKMCWNLEPTERPTF 362

Query: 296 DQV 298
            Q+
Sbjct: 363 SQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 55/250 (22%), Positives = 99/250 (39%), Gaps = 54/250 (21%)

Query: 22  EILGLGINGKV-----LQIVEKKTSEVYALKVLHDTVKA------RREVELQLAVGSHKH 70
           E LG G  GKV         E+ ++   A+K L +  +       R+E EL ++   H +
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL-MSDLQHPN 69

Query: 71  IVNIKDV----------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
           IV +  V          +E + +G     ++    H     +   +    +    +   I
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
             +I + +++L   +  HRD+   N L                            G+G  
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCLV---------------------------GEGLT 162

Query: 181 LKLTDFGFAKKIVS-NKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLC 237
           +K++DFG ++ I S +   +Q+    P  ++ PE +   K+    DIWS GV+++ I   
Sbjct: 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222

Query: 238 GFPPF--FSN 245
           G  P+  FSN
Sbjct: 223 GLQPYYGFSN 232

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 52/281 (18%), Positives = 104/281 (37%), Gaps = 56/281 (19%)

Query: 29  NGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL 88
            GKV+ +  K         ++ D     +E  +  ++  H++++ +  V       +  L
Sbjct: 20  GGKVIPVAVKCLKSDKLSDIMDDF---LKEAAIMHSL-DHENLIRLYGVVL-----THPL 70

Query: 89  LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY 148
           +++ E    G L  R+++   G F          +I + +++L  +   HRD+   N+L 
Sbjct: 71  MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL 130

Query: 149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT--- 205
                          D K              +K+ DFG  + +  N+       Y    
Sbjct: 131 -------------ASDDK--------------VKIGDFGLMRALPQNE-----DHYVMEE 158

Query: 206 ----PY-YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIR 259
               P+ + APE L    +  + D+W  GV ++ +   G  P+    G  I   +K   +
Sbjct: 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK 215

Query: 260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
            G+     P  E   Q+   ++      +P++R T   + E
Sbjct: 216 EGE-RLERP--EACPQDIYNVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 40.4 bits (94), Expect = 8e-04
 Identities = 63/254 (24%), Positives = 98/254 (38%), Gaps = 76/254 (29%)

Query: 24  LGLGINGKVL-----QIVEKKTSEVYALKVLHDTV-KAR----REVELQLAVGSHKHIVN 73
           LG G  GKV       +  ++   + A+K L D    AR    RE EL L    H+HIV 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL-LTNLQHEHIVK 71

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA-----------FTEREAAIIMN 122
               Y     G   L+++ E M  G+L + ++     A            T+ +   I  
Sbjct: 72  F---YGVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I + + +L  Q+  HRD+   N L                    ENLL         +K
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVG------------------ENLL---------VK 160

Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYY------------VAPEVLGPDKYDKSCDIWSLGV 230
           + DFG ++ + S          T YY            + PE +   K+    D+WSLGV
Sbjct: 161 IGDFGMSRDVYS----------TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210

Query: 231 IMY-ILLCGFPPFF 243
           +++ I   G  P++
Sbjct: 211 VLWEIFTYGKQPWY 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 38/212 (17%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++  E    T  +   +  +I   + F+  +N  HRD++  N+L
Sbjct: 75  IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                  E L           K+ DFG A+ I  N+ + +     P 
Sbjct: 135 VS------------------ETL---------CCKIADFGLARLIEDNEYTAREGAKFPI 167

Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNR--IRLGQFD 264
            + APE +    +    D+WS G+++  ++         +G+   PGM N   I+  +  
Sbjct: 168 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------TYGRIPYPGMTNPEVIQNLERG 219

Query: 265 FPNPEWEHVSQEAKTLIKNMLCVDPSERLTID 296
           +  P  ++  +E   L++      P ER T +
Sbjct: 220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 43/175 (24%)

Query: 89  LVIMECMHGGEL--FQRIQQKEDGAFTEREAAII--MNEICSAIKFLHDQNIAHRDVKPE 144
           +VI+  M  G+L  F  + +  +  FT     ++  M +I S +++L  +N  HRD+   
Sbjct: 83  MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAAR 142

Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N +                    EN+          + + DFG +KKI S     Q  C 
Sbjct: 143 NCMLN------------------ENM---------TVCVADFGLSKKIYSGDYYRQG-CA 174

Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
           +     ++A E L  + Y    D+W+ GV M+ ++          GQ    G++N
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM--------TRGQTPYAGVEN 221

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 40/189 (21%), Positives = 75/189 (39%), Gaps = 50/189 (26%)

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++   ++FL  +   HRD+   N+L +                           +  ++K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLS---------------------------ENNVVK 219

Query: 183 LTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILL 236
           + DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++ I  
Sbjct: 220 ICDFGLARDIYKDPDYVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Query: 237 CGFPPFFSNH-GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--DPSER 292
            G  P+      +     +K   R+   D+  PE          + + ML C   +PS+R
Sbjct: 277 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEPSQR 326

Query: 293 LTIDQVMEN 301
            T  +++E+
Sbjct: 327 PTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 29/123 (23%), Positives = 54/123 (43%), Gaps = 30/123 (24%)

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++ + ++FL  +N  HRD+   N+L                             +G ++K
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLIC---------------------------EGKLVK 279

Query: 183 LTDFGFAKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGF 239
           + DFG A+ I+  SN  S  +      ++APE +  + Y    D+WS G++++ I   G 
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339

Query: 240 PPF 242
            P+
Sbjct: 340 TPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 56/249 (22%), Positives = 105/249 (42%), Gaps = 56/249 (22%)

Query: 18  DISTE-ILGLGINGKVLQIVEKKTSEVY--ALKVL------HDTVKARREVELQLAVGSH 68
           DI  E ++G G  G+V++ + KK       A+K+L      +D      E+E+   +G H
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ----KEDGAF----------TE 114
            +I+N+    EN       L + +E    G L   +++    + D AF          T 
Sbjct: 63  PNIINLLGACEN----RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118

Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
           ++     +++ + +++L ++   HRD+   N+L    G+    K+ DFG  + E +    
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEV---- 171

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY- 233
                        + KK +      + P     ++A E L    Y    D+WS GV+++ 
Sbjct: 172 -------------YVKKTMG-----RLPVR---WMAIESLNYSVYTTKSDVWSFGVLLWE 210

Query: 234 ILLCGFPPF 242
           I+  G  P+
Sbjct: 211 IVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 44/216 (20%), Positives = 80/216 (37%), Gaps = 47/216 (21%)

Query: 95  MHGGELFQRIQQKED---GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
                     Q+ +D      T  +      ++   ++FL  +   HRD+   N+L +  
Sbjct: 151 PSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS-- 208

Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN-----KASLQTPCYTP 206
                                    +  ++K+ DFG A+ I  +     K S + P    
Sbjct: 209 -------------------------ENNVVKICDFGLARDIYKDPDYVRKGSARLPLK-- 241

Query: 207 YYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLG-QFD 264
            ++APE +    Y    D+WS GV+++ I   G  P+    G  I+     R++ G +  
Sbjct: 242 -WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY---PGVQINEEFCQRLKDGTRMR 297

Query: 265 FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
            P    E+ + E   ++      DP ER T   ++E
Sbjct: 298 AP----ENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	372
KOG0604|consensus	400		100.0
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0033|consensus	355		100.0
KOG0598|consensus	357		100.0
KOG0581|consensus	364		100.0
KOG0588|consensus	786		100.0
KOG0592|consensus	604		100.0
KOG0593|consensus	396		100.0
KOG0583|consensus	370		100.0
KOG0616|consensus	355		100.0
KOG0595|consensus	429		100.0
KOG0605|consensus	550		100.0
KOG0661|consensus	538		100.0
KOG0660|consensus	359		100.0
KOG0599|consensus	411		100.0
KOG0659|consensus	318		100.0
KOG0032|consensus	382		100.0
KOG0600|consensus	560		100.0
KOG0591|consensus	375		100.0
KOG0663|consensus	419		100.0
KOG0585|consensus	576		100.0
KOG0694|consensus	694		100.0
KOG0607|consensus	463		100.0
KOG0198|consensus	313		100.0
KOG0578|consensus	550		100.0
KOG0597|consensus	808		100.0
KOG0582|consensus	516		100.0
KOG0611|consensus	668		100.0
KOG4717|consensus	864		100.0
KOG0610|consensus	459		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0594|consensus	323		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0658|consensus	364		100.0
KOG0580|consensus	281		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589|consensus	426		100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0667|consensus	586		100.0
KOG0201|consensus	467		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0986|consensus	591		100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0192|consensus	362		100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0612|consensus	1317		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG4236|consensus	888		100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0690|consensus	516		100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0603|consensus	612		100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0586|consensus	596		100.0
KOG0666|consensus	438		100.0
KOG0579|consensus	1187		100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG4279|consensus	1226		100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0574|consensus	502		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0671|consensus	415		100.0
KOG0662|consensus	292		100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0197|consensus	468		100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG1989|consensus	738		100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0696|consensus	683		100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0584|consensus	632		100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0596|consensus	677		100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG2345|consensus	302		100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG1290|consensus	590		100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0577|consensus	948		100.0
KOG4721|consensus	904		100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0695|consensus	593		100.0
KOG0983|consensus	391		100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0669|consensus	376		100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0608|consensus	1034		100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG4645|consensus	1509		100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG1035|consensus	1351		100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG4250|consensus	732		100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0665|consensus	369		100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1026|consensus	774		100.0
KOG0587|consensus	953		100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0668|consensus	338		100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1151|consensus	775		100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0614|consensus	732		100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0193|consensus	678		100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG1187|consensus	361		100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0194|consensus	474		100.0
KOG1027|consensus	903		100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1095|consensus	1025		100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0670|consensus	752		100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1006|consensus	361		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664|consensus	449		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0199|consensus	1039		100.0
KOG4257|consensus	974		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0196|consensus	996		100.0
KOG2052|consensus	513		100.0
KOG1094|consensus	807		100.0
KOG1167|consensus	418		100.0
KOG4278|consensus	1157		100.0
KOG0576|consensus	829		100.0
KOG0984|consensus	282		100.0
KOG1345|consensus	378		100.0
KOG0200|consensus	609		100.0
KOG3653|consensus	534		100.0
KOG1152|consensus	772		100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
KOG1025|consensus	1177		100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0590|consensus	601		99.96
KOG1024|consensus	563		99.96
KOG1164|consensus	322		99.94
KOG0603|consensus	612		99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG1165|consensus	449		99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1163|consensus	341		99.93
KOG0606|consensus	1205		99.92
KOG1240|consensus	1431		99.92
KOG4158|consensus	598		99.91
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK10345	210	hypothetical protein; Provisional	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG0195|consensus	448		99.85
KOG1033|consensus	516		99.84
KOG1166|consensus	974		99.84
smart00090	237	RIO RIO-like kinase.	99.81
KOG0590|consensus	601		99.8
KOG1023|consensus	484		99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
KOG0601|consensus	524		99.68
KOG0606|consensus	1205		99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
KOG0601|consensus	524		99.51
KOG1266|consensus	458		99.5
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
KOG1243|consensus	690		99.43
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
KOG3741|consensus	655		99.41
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
KOG3087|consensus	229		99.17
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
KOG2137|consensus	700		99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.12
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
COG4248	637	Uncharacterized protein with protein kinase and he	99.1
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.07
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.93
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.87
KOG0576|consensus	829		98.84
PRK09902	216	hypothetical protein; Provisional	98.71
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.57
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.48
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.44
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.33
PF01636	239	APH: Phosphotransferase enzyme family This family	98.33
KOG1035|consensus	1351		98.29
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.14
KOG1235|consensus	538		98.11
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.91
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.87
PLN02876	822	acyl-CoA dehydrogenase	97.83
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.75
KOG1826|consensus	2724		97.69
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.56
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.52
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.43
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.41
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.33
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.26
KOG2268|consensus	465		97.18
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.08
KOG2270|consensus	520		97.03
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.96
PRK05231	319	homoserine kinase; Provisional	96.89
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.86
KOG1093|consensus	725		96.61
PLN02756	418	S-methyl-5-thioribose kinase	96.35
PLN02236	344	choline kinase	96.25
PRK10593	297	hypothetical protein; Provisional	96.23
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.18
PRK12396	409	5-methylribose kinase; Reviewed	96.18
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.13
KOG1236|consensus	565		95.93
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.71
COG2334	331	Putative homoserine kinase type II (protein kinase	95.35
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.34
PHA03111	444	Ser/Thr kinase; Provisional	95.22
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.97
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.8
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.71
PRK06148	1013	hypothetical protein; Provisional	94.36
PTZ00384	383	choline kinase; Provisional	93.6
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	92.93
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	92.22
PTZ00296	442	choline kinase; Provisional	90.73

>KOG0604|consensus

Probab=100.00  E-value=5.5e-73  Score=489.01  Aligned_cols=337  Identities=64%  Similarity=1.072  Sum_probs=321.9

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +..++.++|.|..++||-|-.|+|..+.++.||+.+|+|++.+..++++|++...+...|||||.++++|++.+.+-..+
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            45568999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      .+|||.|+||+|+..++.++.+.++|.++..|++||..|+.|||+.+|.||||||+|+|...++                
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~----------------  198 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS----------------  198 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC----------------
Confidence            9999999999999999999888999999999999999999999999999999999999998655                


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .+..+|++|||+|+.... .....+.|.||.|.|||++....|+..+|+||+||++|-|++|.+||++..+.
T Consensus       199 --------~na~lKLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~  269 (400)
T KOG0604|consen  199 --------PNAPLKLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  269 (400)
T ss_pred             --------CCcceEecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence                    567789999999886543 45678889999999999999999999999999999999999999999999999


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCCCCccccccccCCCCc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETW  328 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (372)
                      .+.++++.++..+++.+|.++|..+|++++|+|++||..+|++|.|+.+++.|||+.+....|++|.++..++.+..+.|
T Consensus       270 aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~~a~e~w  349 (400)
T KOG0604|consen  270 AISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLKEAVEAW  349 (400)
T ss_pred             cCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcchhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhHHHHHHHHHHhhccCCcceeecccCCCChHHHhhhccCC
Q psy3151         329 PEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRKNQS  370 (372)
Q Consensus       329 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (372)
                      +++++|++..|+.||++..+..++.+..++||++.|+|+...
T Consensus       350 ~dvqeem~~~lA~mrv~~~~v~ik~l~~~nn~Ll~krrk~g~  391 (400)
T KOG0604|consen  350 DDVQEEMTETLATMRVDPLQVQIKPLGSSNNPLLRKRRKKGA  391 (400)
T ss_pred             HHHHHHHHHHHHhcccCcceeEEeeccccCcHHHHHHHHhcc
Confidence            999999999999999999999999999999999999998764

>KOG0615|consensus

Probab=100.00  E-value=1.2e-63  Score=447.93  Aligned_cols=259  Identities=37%  Similarity=0.680  Sum_probs=229.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh------------hhHHHHHHHHHhcCCCCEeEEeEeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------------KARREVELQLAVGSHKHIVNIKDVYEN   80 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~e~~~~~~~~~h~ni~~~~~~~~~   80 (372)
                      +.+.|.+ .+.||+|+||.|.+|..+.||+.||||++++..            ...+|+++ ++.++|||||+++++|+.
T Consensus       170 ~~d~yii-~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieI-LkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  170 FNDYYII-SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEI-LKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             hcceeEe-eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHH-HHhcCCCCEEEEeeeeec
Confidence            6667766 688999999999999999999999999996321            23589998 677799999999999986


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                          ....|+||||+.||+|.+++..+  +.+.+..-+.+++|++.|+.|||++||+||||||+|||++.+.        
T Consensus       248 ----~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~--------  313 (475)
T KOG0615|consen  248 ----PDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA--------  313 (475)
T ss_pred             ----CCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC--------
Confidence                66789999999999999999876  4599999999999999999999999999999999999998543        


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC---CCCccchhhHHHHHHHHHh
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~  237 (372)
                                      .+..+||+|||+|+... ....+.+.||||.|.|||++.+..   +..++|||||||+||-+++
T Consensus       314 ----------------e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs  376 (475)
T KOG0615|consen  314 ----------------EDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS  376 (475)
T ss_pred             ----------------cceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec
Confidence                            35679999999999875 456788999999999999996654   3358899999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |.+||.+..+.   ..+.+.+..|.+.+-++.|..+|+++++||.+||.+||+.|||++|+|+||||+..
T Consensus       377 G~pPFS~~~~~---~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  377 GYPPFSEEYTD---PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             cCCCcccccCC---ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            99999765543   34688999999999999999999999999999999999999999999999999865

>KOG0575|consensus

Probab=100.00  E-value=4e-59  Score=438.04  Aligned_cols=249  Identities=34%  Similarity=0.585  Sum_probs=229.0

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc--------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD--------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      .+|.. +++||+|||+.||.+++..+|+.||+|++.+        ..+..+|+++ .+.++|||||+++++|++    .+
T Consensus        18 ~~Y~~-g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeI-Hr~L~HpnIV~f~~~FED----s~   91 (592)
T KOG0575|consen   18 KRYKR-GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEI-HRSLKHPNIVQFYHFFED----SN   91 (592)
T ss_pred             ceeee-eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHH-HHhcCCCcEEeeeeEeec----CC
Confidence            46887 7999999999999999999999999999964        3467789998 788899999999999998    88


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      +.|+|.|+|..++|.+++++.  +.++|.+++.+++||+.||.|||+.+|+|||||..|+|++                 
T Consensus        92 nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~-----------------  152 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN-----------------  152 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec-----------------
Confidence            999999999999999999854  5699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .+.+|||+|||+|..+..+.+...+.||||.|+|||++.....+..+||||+||++|.||+|++||...+
T Consensus       153 ----------~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~  222 (592)
T KOG0575|consen  153 ----------ENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT  222 (592)
T ss_pred             ----------CcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence                      6788999999999999887788899999999999999999999999999999999999999999996544


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                          ......++....+.+|.    .+|.++++||.+||+.||.+|||++++|.|+||..
T Consensus       223 ----vkety~~Ik~~~Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  223 ----VKETYNKIKLNEYSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             ----HHHHHHHHHhcCccccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence                34567888888888875    78999999999999999999999999999999943

>KOG0033|consensus

Probab=100.00  E-value=9.9e-59  Score=390.43  Aligned_cols=261  Identities=37%  Similarity=0.693  Sum_probs=234.0

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ..-|.+.|++ .+.||+|.|+.|+++.+..||+.+|+|+++.       ..+..+|+.+ .+.++||||+++.+.+..  
T Consensus         6 ~~~f~d~y~l-~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarI-C~~LqHP~IvrL~~ti~~--   81 (355)
T KOG0033|consen    6 STKFSDNYDV-KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQE--   81 (355)
T ss_pred             ccccchhhhH-HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHH-HHhcCCCcEeehhhhhcc--
Confidence            3458899999 5779999999999999999999999999862       3456678887 888999999999998765  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        ..+.|+|+|++.|++|..-|..+.  .++|..+..+++||+.||+|+|.+||||||+||.|+++.++.          
T Consensus        82 --~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~----------  147 (355)
T KOG0033|consen   82 --ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA----------  147 (355)
T ss_pred             --cceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc----------
Confidence              788999999999999988777653  489999999999999999999999999999999999998655          


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    ....+|++|||+|..+. .....-..+|||.|||||++...+|+.++|||+.||+||-|+.|++||
T Consensus       148 --------------~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF  212 (355)
T KOG0033|consen  148 --------------KGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF  212 (355)
T ss_pred             --------------CCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCC
Confidence                          45678999999999887 455566788999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ++.+.    ..+.+++..+.++++.++|..+++++++||++||..||.+|+|+.|+|+|||+.+-
T Consensus       213 ~~~~~----~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  213 WDEDQ----HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             CCccH----HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            87553    45689999999999999999999999999999999999999999999999999763

>KOG0598|consensus

Probab=100.00  E-value=1.7e-56  Score=398.55  Aligned_cols=263  Identities=35%  Similarity=0.661  Sum_probs=227.3

Q ss_pred             ccCCCccC--CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeE
Q psy3151           4 TFKPFKTT--PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVN   73 (372)
Q Consensus         4 ~~~~~~~~--~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~   73 (372)
                      .|.|....  .=.++|+++ ++||+|+||+||+++.+.|++.||+|++++.        .....|..+ +...+||.||+
T Consensus        12 ~~~p~~~~~~~~~~dF~~l-kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~I-L~~v~hPFiv~   89 (357)
T KOG0598|consen   12 SYKPSNNAEMVGPDDFEIL-KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNI-LSKIKHPFIVK   89 (357)
T ss_pred             ccCCCcccccCChhheeee-eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHH-HHhCCCCcEee
Confidence            34444442  225789996 8899999999999999999999999999643        234567777 45589999999


Q ss_pred             EeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          74 IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        74 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                      ++..|++    ..++|+|+||+.||+|...+++.  +.++|..++.++..|+.||.|||+.|||||||||+|||++    
T Consensus        90 l~ysFQt----~~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd----  159 (357)
T KOG0598|consen   90 LIYSFQT----EEKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD----  159 (357)
T ss_pred             eEEeccc----CCeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec----
Confidence            9999987    78999999999999999999876  4599999999999999999999999999999999999998    


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHH
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  233 (372)
                                             ..|.++|+|||+|+..........+.|||+.|||||++.+.+|+..+|.||||+++|
T Consensus       160 -----------------------~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillY  216 (357)
T KOG0598|consen  160 -----------------------EQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLY  216 (357)
T ss_pred             -----------------------CCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHH
Confidence                                   788899999999997766666677889999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC----ChhHHhcCCccccCC
Q psy3151         234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL----TIDQVMENKWISQFN  308 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~----s~~eil~hp~~~~~~  308 (372)
                      +|++|.+||.+.+.    ..+.+.+..+....++   ..++.++++|++++|..||++|.    ++.++..||||..++
T Consensus       217 eML~G~pPF~~~~~----~~~~~~I~~~k~~~~p---~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  217 EMLTGKPPFYAEDV----KKMYDKILKGKLPLPP---GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             HHhhCCCCCcCccH----HHHHHHHhcCcCCCCC---ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence            99999999976653    3456666666644443   24899999999999999999996    689999999998764

>KOG0581|consensus

Probab=100.00  E-value=2.3e-56  Score=397.93  Aligned_cols=252  Identities=29%  Similarity=0.419  Sum_probs=214.4

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEec------chhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce-EE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSR-CL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~------~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~-~~   88 (372)
                      +.+.+ ..||+|..|+||+|+|+.|++.+|+|++.      ...+..+|++++.+. +||+||.+++.|..    +. .+
T Consensus        80 dle~~-~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~----~~~~i  153 (364)
T KOG0581|consen   80 DLERL-GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYS----NGEEI  153 (364)
T ss_pred             Hhhhh-hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEe----CCceE
Confidence            34443 56999999999999999999999999994      234667899995555 99999999999986    33 59


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +++||||++|+|.+++...  ++++|..+..++.+|++||.|||. .+||||||||+|||++                  
T Consensus       154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN------------------  213 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN------------------  213 (364)
T ss_pred             EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec------------------
Confidence            9999999999999999876  569999999999999999999995 8999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               ..|.|||||||.+..+...  ...+.+||..|||||.+.+..|+.++||||||+++.|+++|+.||.....
T Consensus       214 ---------skGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~  282 (364)
T KOG0581|consen  214 ---------SKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP  282 (364)
T ss_pred             ---------cCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC
Confidence                     6778999999999988654  56788999999999999999999999999999999999999999966422


Q ss_pred             -CCCCHhHHHHHhhCCccCCCCccc-ccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 -QAISPGMKNRIRLGQFDFPNPEWE-HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 -~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                       ......+...+..+..+   .... .+|+++++||..||++||.+|||+.|+++|||++++
T Consensus       283 ~~~~~~~Ll~~Iv~~ppP---~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  283 PYLDIFELLCAIVDEPPP---RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             CCCCHHHHHHHHhcCCCC---CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence             11223344555443322   2223 489999999999999999999999999999999875

>KOG0588|consensus

Probab=100.00  E-value=7.2e-56  Score=417.98  Aligned_cols=257  Identities=33%  Similarity=0.630  Sum_probs=231.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      --+-|++ ++.||.|+.|.|.+|+|..||+..|||++...        ....+|+.+ ++++.||||+.+++++++    
T Consensus        10 tiGpwkL-gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIvi-MkLi~HpnVl~LydVwe~----   83 (786)
T KOG0588|consen   10 TIGPWKL-GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVI-MKLIEHPNVLRLYDVWEN----   83 (786)
T ss_pred             cccceec-cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHH-HHHhcCCCeeeeeeeecc----
Confidence            3467887 89999999999999999999999999999643        356788887 899999999999999987    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ..++|+|.||++||.|++++.++  |++++.++.++++||+.|+.|||..+|+||||||+|+|++               
T Consensus        84 ~~~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd---------------  146 (786)
T KOG0588|consen   84 KQHLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD---------------  146 (786)
T ss_pred             CceEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh---------------
Confidence            88999999999999999999887  5699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCC-CccchhhHHHHHHHHHhCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                  ..+.+||+|||+|.... +..-..+.||+|.|+|||++.+.+|+ .++||||+|||||.|++|+.||+
T Consensus       147 ------------~~~nIKIADFGMAsLe~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd  213 (786)
T KOG0588|consen  147 ------------VKNNIKIADFGMASLEV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD  213 (786)
T ss_pred             ------------cccCEeeeccceeeccc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence                        45569999999997543 35567889999999999999999996 89999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT  313 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~  313 (372)
                      +.+    ...+..++..|.|++|.    .+|+++++||.+||.+||++|+|.+||++|||+.++...+..
T Consensus       214 DdN----ir~LLlKV~~G~f~MPs----~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  214 DDN----IRVLLLKVQRGVFEMPS----NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             Ccc----HHHHHHHHHcCcccCCC----cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            433    45678889999999995    899999999999999999999999999999999988654443

>KOG0592|consensus

Probab=100.00  E-value=9.1e-56  Score=409.30  Aligned_cols=252  Identities=33%  Similarity=0.567  Sum_probs=221.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      .+|.+ +++||.|+|++|++|+++.+++.||||++.+.        ....+|...+..+.+||.|++++-.|++    +.
T Consensus        73 ~DF~F-g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD----~~  147 (604)
T KOG0592|consen   73 NDFKF-GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD----EE  147 (604)
T ss_pred             hhcch-hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec----cc
Confidence            57887 78999999999999999999999999998632        2345777776677799999999999987    78


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+|+||+++|+|.++|.+.  |.|++..++.++.||+.||+|||++|||||||||+|||++                 
T Consensus       148 sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd-----------------  208 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD-----------------  208 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc-----------------
Confidence            899999999999999999987  4599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCC-------------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHH
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKA-------------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  233 (372)
                                .++++||+|||.|..+.+...             .....+||..|.+||++.....++.+|||+||||||
T Consensus       209 ----------~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCily  278 (604)
T KOG0592|consen  209 ----------KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILY  278 (604)
T ss_pred             ----------CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHH
Confidence                      677788888888876643211             124579999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      .|+.|.+||.+.+.    ..+.+++..-.+.+|.    +.++.++|||+++|..||.+|+|+++|.+||||.++.
T Consensus       279 QmlaG~PPFra~Ne----yliFqkI~~l~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  279 QMLAGQPPFRAANE----YLIFQKIQALDYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             HHhcCCCCCccccH----HHHHHHHHHhcccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence            99999999976543    3457778888888885    8899999999999999999999999999999998753

>KOG0593|consensus

Probab=100.00  E-value=1.7e-56  Score=387.32  Aligned_cols=259  Identities=27%  Similarity=0.499  Sum_probs=216.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|+.+++ +|+|+||+|++|+++.||+.||||.+-..       .-+.||++. ++.+.|+|+|+++++|..    ...
T Consensus         2 ekYE~Lgk-vGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrm-LKqLkH~NLVnLiEVFrr----krk   75 (396)
T KOG0593|consen    2 EKYEKLGK-VGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRM-LKQLKHENLVNLIEVFRR----KRK   75 (396)
T ss_pred             cHHhhhhc-cccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHH-HHhcccchHHHHHHHHHh----cce
Confidence            57888755 99999999999999999999999999532       346789987 788899999999999975    788


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +++|+|||+. ++.+-+....+ .++.+.++.+++|++.|+.|+|+++++||||||+||||+                  
T Consensus        76 lhLVFE~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit------------------  135 (396)
T KOG0593|consen   76 LHLVFEYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT------------------  135 (396)
T ss_pred             eEEEeeecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe------------------
Confidence            9999999965 67777777664 499999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               ..|.+|+||||+|+.+..+....+.++.|.||+|||.+.+ ..|+.++||||+||++.||++|.+.|.+.+
T Consensus       136 ---------~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S  206 (396)
T KOG0593|consen  136 ---------QNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS  206 (396)
T ss_pred             ---------cCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence                     7889999999999998766666777889999999999866 789999999999999999999999998776


Q ss_pred             CCCCCHhHHHHHh----------h-----CCccCCCCc--------ccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         247 GQAISPGMKNRIR----------L-----GQFDFPNPE--------WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       247 ~~~~~~~~~~~~~----------~-----~~~~~~~~~--------~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      +.+....+...+.          .     ..+.+|.+.        ...++.-+.||+++||+.||.+|+|.+|+|.|||
T Consensus       207 DiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y  286 (396)
T KOG0593|consen  207 DIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY  286 (396)
T ss_pred             hHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence            6543322221110          0     011122221        2456778999999999999999999999999999


Q ss_pred             cccCC
Q psy3151         304 ISQFN  308 (372)
Q Consensus       304 ~~~~~  308 (372)
                      |.++.
T Consensus       287 Fd~~~  291 (396)
T KOG0593|consen  287 FDGFI  291 (396)
T ss_pred             HHHHH
Confidence            98764

>KOG0583|consensus

Probab=100.00  E-value=4e-54  Score=403.75  Aligned_cols=254  Identities=37%  Similarity=0.669  Sum_probs=223.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ...++|.+ ++.||+|+||+|++|.+..+|..||+|++.+.          ....+|+.++..+..||||+++++++.. 
T Consensus        14 ~~~g~y~~-~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-   91 (370)
T KOG0583|consen   14 LSIGKYEL-GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-   91 (370)
T ss_pred             cccCceee-eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-
Confidence            46789998 68899999999999999999999999977542          1234788885555559999999999986 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         ...+|+||||+.||+|.+++.+.  ++++|.+++.+++||+.|++|||++||+||||||+|||++            
T Consensus        92 ---~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld------------  154 (370)
T KOG0583|consen   92 ---PTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD------------  154 (370)
T ss_pred             ---CCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec------------
Confidence               56799999999999999999883  6799999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCC-CCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC-CC-CccchhhHHHHHHHHHhC
Q psy3151         162 FGDVKPENLLYTKPGDG-GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YD-KSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~-~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~~ll~g  238 (372)
                                     .+ +.+||+|||++...........+.||||.|+|||++.+.. |+ .++|+||+|++||.|++|
T Consensus       155 ---------------~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G  219 (370)
T KOG0583|consen  155 ---------------GNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCG  219 (370)
T ss_pred             ---------------CCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhC
Confidence                           44 7899999999997754456788899999999999998877 86 899999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCccccc-CHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHV-SQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ..||.+.+    ...+...+..+.+.+|.    .+ |+++++|+++||..||.+|+|+.+++.||||+..
T Consensus       220 ~~PF~d~~----~~~l~~ki~~~~~~~p~----~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  220 RLPFDDSN----VPNLYRKIRKGEFKIPS----YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             CCCCCCcc----HHHHHHHHhcCCccCCC----CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            99997632    34566778888888775    55 9999999999999999999999999999999973

>KOG0616|consensus

Probab=100.00  E-value=1.4e-54  Score=374.53  Aligned_cols=248  Identities=35%  Similarity=0.682  Sum_probs=222.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|+++ ..||.|+||+|-+++++.+|..||+|++.+..        -...|..+ ++...||.+++++..|.+    .
T Consensus        43 l~dfe~~-~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~v-L~~v~~PFlv~l~~t~~d----~  116 (355)
T KOG0616|consen   43 LQDFERL-KTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRV-LKAVSHPFLVKLYGTFKD----N  116 (355)
T ss_pred             hhhhhhe-eeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHH-HhhccCceeEEEEEeecc----C
Confidence            3568885 78999999999999999999999999997432        12356666 666689999999998876    7


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +++|+||||++||.|..++++.  ++|++..++.++.||+.||+|||+.+|++|||||+|||++                
T Consensus       117 ~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD----------------  178 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD----------------  178 (355)
T ss_pred             CeEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec----------------
Confidence            8999999999999999999886  4599999999999999999999999999999999999999                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .+|.+||+|||+|+....   ...+.||||.|+|||++...+|+.++|.||||+++|||+.|.+||.+.
T Consensus       179 -----------~~G~iKitDFGFAK~v~~---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  179 -----------QNGHIKITDFGFAKRVSG---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             -----------cCCcEEEEeccceEEecC---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence                       688899999999998743   367899999999999999999999999999999999999999999876


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      ..    ..+.+++..+.+.+|.    .++++++|||+++|+.|-.+|.     ..++|..||||+.+
T Consensus       245 ~~----~~iY~KI~~~~v~fP~----~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  245 NP----IQIYEKILEGKVKFPS----YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             Ch----HHHHHHHHhCcccCCc----ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence            54    5678999999999986    7899999999999999999994     57899999999875

>KOG0595|consensus

Probab=100.00  E-value=3e-54  Score=387.67  Aligned_cols=262  Identities=29%  Similarity=0.538  Sum_probs=221.7

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .-+..++|.+.. .||.|+||+||+|+++.++..||||.+.+.       .....|+.+ ++.++|||||.++++.+.  
T Consensus         5 ~~~~~~~y~~~~-~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~i-Lkel~H~nIV~l~d~~~~--   80 (429)
T KOG0595|consen    5 SMRVVGDYELSR-EIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKI-LKELKHPNIVRLLDCIED--   80 (429)
T ss_pred             cccccccceehh-hccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHH-HHhcCCcceeeEEEEEec--
Confidence            345678999964 499999999999999999999999999754       234678888 677789999999999987  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        ++++|+|||||+||||.++|++++  .++|..++.++.||+.||++||+++||||||||+|||++.+...+       
T Consensus        81 --~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~-------  149 (429)
T KOG0595|consen   81 --DDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARND-------  149 (429)
T ss_pred             --CCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCC-------
Confidence              779999999999999999999874  599999999999999999999999999999999999998542100       


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    ..-.+||+|||+|+.+.. .....+.||+|-|||||++..+.|+.|+|+||+|+++|+|++|..||
T Consensus       150 --------------~~~~LKIADFGfAR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf  214 (429)
T KOG0595|consen  150 --------------TSPVLKIADFGFARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPF  214 (429)
T ss_pred             --------------CCceEEecccchhhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCc
Confidence                          115799999999998864 45567899999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      ...+.    .++...+..+.-..|... ...+....+|+..+|+.+|.+|.+..+-+.|+++..
T Consensus       215 ~a~t~----~eL~~~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  215 DAETP----KELLLYIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             cccCH----HHHHHHHhccccccCchh-hhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence            65544    334455555544433322 456777889999999999999999999999999865

>KOG0605|consensus

Probab=100.00  E-value=2.1e-54  Score=400.31  Aligned_cols=279  Identities=32%  Similarity=0.516  Sum_probs=218.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhh--------hHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK--------ARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|+++ +.||+|+||.||+|+-+.||+.+|+|++.+..-        .+.|..+ +...+.|+||+++..|++    .
T Consensus       140 ~~DFe~L-k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdi-L~~~ds~~vVKLyYsFQD----~  213 (550)
T KOG0605|consen  140 LDDFELL-KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDI-LAEVDSPWVVKLYYSFQD----K  213 (550)
T ss_pred             cccchhh-eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHH-hhhcCCCcEEEEEEEecC----C
Confidence            4788887 779999999999999999999999999975432        2345555 455799999999999987    8


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      .++||||||++|||+..+|.+.+  .|+++.++.++.+++.|++.||+.|+|||||||+|+||+.   .+.++++|||++
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~---~GHiKLSDFGLs  288 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDA---KGHIKLSDFGLS  288 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecC---CCCEeecccccc
Confidence            89999999999999999998874  5999999999999999999999999999999999999995   445888888887


Q ss_pred             CccccccCCC---------CCCCCeeeeccccc--cccc------------cCCCcccccccCCCcCCCcccCCCCCCCc
Q psy3151         166 KPENLLYTKP---------GDGGILKLTDFGFA--KKIV------------SNKASLQTPCYTPYYVAPEVLGPDKYDKS  222 (372)
Q Consensus       166 ~~~~~~~~~~---------~~~~~~ki~Dfg~a--~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  222 (372)
                      .+-.......         ......+..||...  ....            .........+|||.|+|||++.+..|+..
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~  368 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE  368 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence            5332211100         01112234444421  0000            00111234789999999999999999999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC---hhHHh
Q psy3151         223 CDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT---IDQVM  299 (372)
Q Consensus       223 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s---~~eil  299 (372)
                      +|.||||||+||||.|.+||.+.+..++    ..++......+.-|....++++++|||.+||+ ||++|..   ++||.
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T----~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQET----YRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            9999999999999999999988776655    34444444333333345788999999999999 9999985   99999


Q ss_pred             cCCccccCC
Q psy3151         300 ENKWISQFN  308 (372)
Q Consensus       300 ~hp~~~~~~  308 (372)
                      +||||+++.
T Consensus       444 ~HPfF~~v~  452 (550)
T KOG0605|consen  444 KHPFFKGVD  452 (550)
T ss_pred             cCCccccCC
Confidence            999999753

>KOG0661|consensus

Probab=100.00  E-value=1.1e-55  Score=402.83  Aligned_cols=264  Identities=29%  Similarity=0.460  Sum_probs=217.0

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..+.+||.++ +.||.|+||.||+|+.+.+|+.||||.+.+.      ....||+..+.++-.||||+++.+++.+   .
T Consensus         6 ~~~m~RY~~i-~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d---~   81 (538)
T KOG0661|consen    6 VIFMDRYTVI-RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD---N   81 (538)
T ss_pred             hhHHHHHHHH-HHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc---c
Confidence            4578999997 5599999999999999999999999988642      2346899886666559999999999876   2


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ++.+|+||||| ..+|+++++.+ +..|++..++.|+.||+.||+|+|.+|+.|||+||+|||+.               
T Consensus        82 ~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---------------  144 (538)
T KOG0661|consen   82 DRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---------------  144 (538)
T ss_pred             CceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---------------
Confidence            44899999999 56999999987 57899999999999999999999999999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc-CCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                  ....+||+|||+|+.+.+ ....+.++.|.||+|||++ ..+.|+.++||||+|||++|+.+-++.|.
T Consensus       145 ------------~~~~iKiaDFGLARev~S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP  211 (538)
T KOG0661|consen  145 ------------GNDVIKIADFGLAREVRS-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP  211 (538)
T ss_pred             ------------ccceeEeccccccccccc-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence                        466799999999998865 3445678889999999986 56779999999999999999999999997


Q ss_pred             CCCCCCCCHhHHHH---------------HhhCCccCCCC-------cccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         244 SNHGQAISPGMKNR---------------IRLGQFDFPNP-------EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       244 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~-------~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      +.+..+...++..-               ...-.+.+|..       .....+.++.+||.+||.+||.+||||.|+|+|
T Consensus       212 G~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  212 GASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             CCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            76544332222111               11112222221       123478999999999999999999999999999


Q ss_pred             CccccCC
Q psy3151         302 KWISQFN  308 (372)
Q Consensus       302 p~~~~~~  308 (372)
                      |||+...
T Consensus       292 pffq~~~  298 (538)
T KOG0661|consen  292 PFFQVGR  298 (538)
T ss_pred             ccccccc
Confidence            9998643

>KOG0660|consensus

Probab=100.00  E-value=6.9e-54  Score=380.56  Aligned_cols=277  Identities=27%  Similarity=0.481  Sum_probs=224.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeee-ecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYEN-IYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~-~~~~   84 (372)
                      +..+|.. .+.||.|+||.|+.|.++.||+.||||.+.+       ..++.||+.. ++.++|+||+.+.+++.. ....
T Consensus        20 i~~~y~~-~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElkl-Lr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   20 IPRYYVL-IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKL-LRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             ccceecc-cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHH-HHHhcCCCcceEEeecccccccc
Confidence            5566665 3779999999999999999999999999862       3567899988 677789999999999975 3345


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      .+.+|+|+|+| +.+|...++...  .++++.++.+++||++||.|+|+.||+||||||.|+|++               
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---------------  159 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---------------  159 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---------------
Confidence            67899999999 669999998753  399999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeecccccccccc--CCCcccccccCCCcCCCccc-CCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVS--NKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .+..+||+|||+|+....  .....+.++.|.||+|||++ ....|+.++||||+|||++||++|++.
T Consensus       160 ------------~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkpl  227 (359)
T KOG0660|consen  160 ------------ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPL  227 (359)
T ss_pred             ------------cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCC
Confidence                        566689999999998754  34456778889999999986 457799999999999999999999999


Q ss_pred             CCCCCCCCCC-----------HhHHHHHh-------hCCc-cCCCC----cccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         242 FFSNHGQAIS-----------PGMKNRIR-------LGQF-DFPNP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       242 f~~~~~~~~~-----------~~~~~~~~-------~~~~-~~~~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |.+.+.....           .....++.       ..+. ..|..    .+.+.++++.||+.+||..||.+|+|++|+
T Consensus       228 FpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA  307 (359)
T KOG0660|consen  228 FPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA  307 (359)
T ss_pred             CCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH
Confidence            9776543221           11111111       0011 11111    135688999999999999999999999999


Q ss_pred             hcCCccccCCCCCCCCCcccccc
Q psy3151         299 MENKWISQFNQVPQTPLCTGKML  321 (372)
Q Consensus       299 l~hp~~~~~~~~~~~~~~~~~~~  321 (372)
                      |.|||+..+.....+|.+.....
T Consensus       308 L~hPYl~~~hdp~dEP~~~~~~~  330 (359)
T KOG0660|consen  308 LAHPYLAPYHDPEDEPVCQPIFD  330 (359)
T ss_pred             hcChhhhhhcCCccCCCCCCCCc
Confidence            99999999998888886655433

>KOG0599|consensus

Probab=100.00  E-value=6.1e-55  Score=372.80  Aligned_cols=258  Identities=35%  Similarity=0.658  Sum_probs=230.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------------hhhHHHHHHHHHhcCCCCEeEEeEee
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------------VKARREVELQLAVGSHKHIVNIKDVY   78 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~ni~~~~~~~   78 (372)
                      .+.+.|+- .++||.|..++|.++.++.||+.+|+|++...             ...++|+.++.++..||||+.+.++|
T Consensus        14 ~fy~~y~p-keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   14 GFYAKYEP-KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hHHhhcCh-HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            36677887 58899999999999999999999999998521             23467899989999999999999999


Q ss_pred             eeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          79 ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      +.    +.++++|+|.|+.|.|.+++.+.-.  +||.+.++|++|++.|+.|||.++||||||||+|||++         
T Consensus        93 es----~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld---------  157 (411)
T KOG0599|consen   93 ES----DAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD---------  157 (411)
T ss_pred             cC----cchhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec---------
Confidence            87    7899999999999999999987654  99999999999999999999999999999999999998         


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC------CCCCCCccchhhHHHHH
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG------PDKYDKSCDIWSLGVIM  232 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il  232 (372)
                                        ++.+++|+|||+|..+.. .......||||+|+|||.+.      ...|+..+|+||+|+++
T Consensus       158 ------------------dn~~i~isDFGFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVIm  218 (411)
T KOG0599|consen  158 ------------------DNMNIKISDFGFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIM  218 (411)
T ss_pred             ------------------cccceEEeccceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHH
Confidence                              788899999999998865 45677899999999999873      35689999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       233 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      |.|+.|.+||+....    ..+...+..|++.+..++|.++|.+++|||++||++||.+|+|++|+|.||||.++.
T Consensus       219 yTLLaGcpPFwHRkQ----mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~  290 (411)
T KOG0599|consen  219 YTLLAGCPPFWHRKQ----MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA  290 (411)
T ss_pred             HHHHcCCCchhHHHH----HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence            999999999975432    235677888999999999999999999999999999999999999999999997653

>KOG0659|consensus

Probab=100.00  E-value=3.6e-53  Score=360.77  Aligned_cols=257  Identities=28%  Similarity=0.437  Sum_probs=214.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|.. .+.||+|+||.||+|++..||+.||||.+..       ...+.||+.. ++.++|+||+.++++|-.    ...
T Consensus         2 ~rY~~-~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~-Lqel~h~nIi~LiD~F~~----~~~   75 (318)
T KOG0659|consen    2 DRYEK-LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKL-LQELKHPNIIELIDVFPH----KSN   75 (318)
T ss_pred             chhhh-hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHH-HHHccCcchhhhhhhccC----CCc
Confidence            68887 4779999999999999999999999999962       3468899998 677789999999999976    677


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +.+|+||++ .+|...|+... ..++...++.++.++++||+|||++.|+||||||.|+||+                  
T Consensus        76 l~lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis------------------  135 (318)
T KOG0659|consen   76 LSLVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS------------------  135 (318)
T ss_pred             eEEEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc------------------
Confidence            999999995 49999888754 5799999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .+|.+||+|||+|+...+........+-|.||+|||.+ ....|+..+||||.|||+.||+.|.+.|.+.+
T Consensus       136 ---------~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s  206 (318)
T KOG0659|consen  136 ---------SDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS  206 (318)
T ss_pred             ---------CCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence                     78899999999999988766665556789999999987 45679999999999999999999998887766


Q ss_pred             CCCCCHhHHHHHhhC------------------CccCCCC--cccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         247 GQAISPGMKNRIRLG------------------QFDFPNP--EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~------------------~~~~~~~--~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      +-+....+...+...                  .++.+..  .+...+.++.||+.+||..||.+|+|+.|+|+|+||+.
T Consensus       207 DidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  207 DIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             hHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence            543322222221111                  1111111  12446788999999999999999999999999999987

>KOG0032|consensus

Probab=100.00  E-value=4e-52  Score=390.13  Aligned_cols=266  Identities=40%  Similarity=0.703  Sum_probs=237.7

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ...+.+.|++ .+.||.|.||.||+|+++.||+.+|+|++.+.        ....+|+.++..+..||||+.+.+.|++ 
T Consensus        30 ~~~~~~~Y~l-~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-  107 (382)
T KOG0032|consen   30 SEDIKEKYEL-GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-  107 (382)
T ss_pred             cccccccEEe-hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-
Confidence            4567889999 57899999999999999999999999999632        3567899996666569999999999997 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         ...+|+|||+|.||+|.+.+...   .++|..+..++.|++.+++|||+.||+||||||+|+|+....+        
T Consensus       108 ---~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~--------  173 (382)
T KOG0032|consen  108 ---PDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDE--------  173 (382)
T ss_pred             ---CCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccC--------
Confidence               67899999999999999999886   2999999999999999999999999999999999999985432        


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                     ..+.+|++|||+|..... .......||||.|+|||++...+|+..+||||+|+++|.|++|.+|
T Consensus       174 ---------------~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~P  237 (382)
T KOG0032|consen  174 ---------------GSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPP  237 (382)
T ss_pred             ---------------CCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCC
Confidence                           356899999999998876 6677889999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVP  311 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~  311 (372)
                      |.+.+..    .....+..+.+.++.+.|..++..+++||++||..||.+|+||.++|+|||++.....+
T Consensus       238 F~~~~~~----~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~  303 (382)
T KOG0032|consen  238 FWGETEF----EIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT  303 (382)
T ss_pred             CcCCChh----HHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence            9876543    34568888999999999999999999999999999999999999999999998764443

>KOG0600|consensus

Probab=100.00  E-value=1.1e-52  Score=385.91  Aligned_cols=260  Identities=23%  Similarity=0.421  Sum_probs=214.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      -.+.|+.+ +.||+|+||.||+|++..||+.||+|.+...       ....|||.+ ++.++||||+++.++..+.  ..
T Consensus       115 ~~~~feki-~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~I-Lr~l~HpNIikL~eivt~~--~~  190 (560)
T KOG0600|consen  115 RADSFEKI-EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKI-LRRLDHPNIIKLEEIVTSK--LS  190 (560)
T ss_pred             chHHHHHH-HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHH-HHhcCCCcccceeeEEEec--CC
Confidence            35678886 5699999999999999999999999998632       356799998 7888999999999998652  34


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+|+|||+. ||.-++..- .-.|++.+++.++.||+.||+|||++||+|||||.+||||+                
T Consensus       191 ~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid----------------  252 (560)
T KOG0600|consen  191 GSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID----------------  252 (560)
T ss_pred             ceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc----------------
Confidence            689999999965 998888653 24699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                 ..|.+||+|||+|+....... ..+..+.|.||+|||++.+ ..|+.++|+||.||||.||++|++.|.
T Consensus       253 -----------n~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~  321 (560)
T KOG0600|consen  253 -----------NNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ  321 (560)
T ss_pred             -----------CCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence                       688899999999997765443 3666778999999998755 679999999999999999999999998


Q ss_pred             CCCCCCCCHhHHHHHhhCCc------cCCC---------------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQF------DFPN---------------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~------~~~~---------------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      +.+..+....+.+......-      .+|.               .....++..+.+|+..||..||.+|.||.++|+|+
T Consensus       322 G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se  401 (560)
T KOG0600|consen  322 GRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE  401 (560)
T ss_pred             CccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence            87765544444333221110      1110               11345788999999999999999999999999999


Q ss_pred             ccc
Q psy3151         303 WIS  305 (372)
Q Consensus       303 ~~~  305 (372)
                      ||.
T Consensus       402 yF~  404 (560)
T KOG0600|consen  402 YFT  404 (560)
T ss_pred             ccc
Confidence            994

>KOG0591|consensus

Probab=100.00  E-value=5.9e-54  Score=368.17  Aligned_cols=247  Identities=28%  Similarity=0.484  Sum_probs=210.9

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeE-eeeeec
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKD-VYENIY   82 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~-~~~~~~   82 (372)
                      .+-...|.|+ +.||.|+||+||+|.+..+|+.+|.|.+.-       ......|+.+ ++.++||||+++++ .|..  
T Consensus        15 ~~~l~~y~Il-~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~l-LkQL~HpNIVqYy~~~f~~--   90 (375)
T KOG0591|consen   15 QKTLADYQIL-KKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISL-LKQLNHPNIVQYYAHSFIE--   90 (375)
T ss_pred             cccHHHHHHH-HHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHH-HHhcCCchHHHHHHHhhhc--
Confidence            3344679985 779999999999999999999999998851       2234578877 78889999999888 4432  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCceeeecCCCCCc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHD--QN--IAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~--~~--ivHrDlkp~NIli~~~~~~~~  156 (372)
                       +...+++|||||.+|||..+|+.  .....++|..+|.++.|++.||.++|+  ..  |+||||||.||+++       
T Consensus        91 -~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-------  162 (375)
T KOG0591|consen   91 -DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-------  162 (375)
T ss_pred             -cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-------
Confidence             24459999999999999999986  334579999999999999999999999  45  99999999999998       


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  236 (372)
                                          .+|.+|++|||+++.+........+.+|||.||+||.+.+.+|+.++||||+||++|||+
T Consensus       163 --------------------~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMc  222 (375)
T KOG0591|consen  163 --------------------ANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMC  222 (375)
T ss_pred             --------------------CCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence                                788999999999999988777788899999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI  295 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~  295 (372)
                      .-++||.+..    ...+..++..+.++  +.--..+|.++..||..|+.+||++||+.
T Consensus       223 aL~~PF~g~n----~~~L~~KI~qgd~~--~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  223 ALQSPFYGDN----LLSLCKKIEQGDYP--PLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hcCCCccccc----HHHHHHHHHcCCCC--CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            9999998763    34556667766553  21125789999999999999999999985

>KOG0663|consensus

Probab=100.00  E-value=2.3e-52  Score=366.08  Aligned_cols=260  Identities=27%  Similarity=0.445  Sum_probs=215.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +.|+.+ ..|++|+||.||+|+|+.|++.||+|.++..       ....||+.++++. +|||||.+-++..-  .+-+.
T Consensus        76 ~efe~l-nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG--~~~d~  151 (419)
T KOG0663|consen   76 EEFEKL-NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVG--SNMDK  151 (419)
T ss_pred             HHHHHH-hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEec--cccce
Confidence            467776 5699999999999999999999999999742       3578999995555 69999999998753  23456


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+|||||+. ||..++...+ .+|+..+++.++.|++.||+|||.+.|+||||||+|+|++                  
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~------------------  211 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS------------------  211 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec------------------
Confidence            9999999965 9999998765 5799999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               ..|.+||+|||+|+...++....+..+.|.||+|||++.+ ..|+.++||||+|||+.||+++.+.|.+..
T Consensus       212 ---------~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s  282 (419)
T KOG0663|consen  212 ---------HKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS  282 (419)
T ss_pred             ---------cCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence                     6888999999999999887777788888999999999865 569999999999999999999999998776


Q ss_pred             CCCCCHhHHHHHhhCC-------ccCC--------C-------Ccc--cccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         247 GQAISPGMKNRIRLGQ-------FDFP--------N-------PEW--EHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~-------~~~~--------~-------~~~--~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      ..+....+...+....       ..+|        .       ..+  ..+++...+|+..+|.+||.+|.||+|+|+|+
T Consensus       283 E~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~  362 (419)
T KOG0663|consen  283 EIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE  362 (419)
T ss_pred             hHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence            5544333333221110       0011        0       001  12568999999999999999999999999999


Q ss_pred             ccccC
Q psy3151         303 WISQF  307 (372)
Q Consensus       303 ~~~~~  307 (372)
                      ||...
T Consensus       363 ~F~e~  367 (419)
T KOG0663|consen  363 YFRET  367 (419)
T ss_pred             ccccC
Confidence            99874

>KOG0585|consensus

Probab=100.00  E-value=2.1e-52  Score=381.14  Aligned_cols=265  Identities=28%  Similarity=0.529  Sum_probs=219.1

Q ss_pred             cCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------------------hhhHHHHHHHHHh
Q psy3151           5 FKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------------------VKARREVELQLAV   65 (372)
Q Consensus         5 ~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------------~~~~~e~~~~~~~   65 (372)
                      |.+.......+.|++. +-||+|.||+|.+|.+..+++.||||++.+.                   .+..+|+++ ++.
T Consensus        87 ~~~~~~~k~lNqy~l~-~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIai-lKk  164 (576)
T KOG0585|consen   87 YDDDQDRKQLNQYELI-KEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAI-LKK  164 (576)
T ss_pred             ecCcccceehhheehh-hhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHH-HHh
Confidence            3444555567899996 5599999999999999999999999999632                   256789998 778


Q ss_pred             cCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy3151          66 GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA-FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE  144 (372)
Q Consensus        66 ~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~-l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~  144 (372)
                      +.|||||+++++..+  ....++|+|+|||..|.+...--   .++ +++.+++.|++.++.||+|||.+|||||||||+
T Consensus       165 l~H~nVV~LiEvLDD--P~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPs  239 (576)
T KOG0585|consen  165 LHHPNVVKLIEVLDD--PESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPS  239 (576)
T ss_pred             cCCcCeeEEEEeecC--cccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence            899999999999976  45678999999999888755332   234 999999999999999999999999999999999


Q ss_pred             ceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccc-----cCCCcccccccCCCcCCCcccCCCC-
Q psy3151         145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV-----SNKASLQTPCYTPYYVAPEVLGPDK-  218 (372)
Q Consensus       145 NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~-  218 (372)
                      |+|++                           .+|++||+|||.+....     +........+|||.|+|||.+.++. 
T Consensus       240 NLLl~---------------------------~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~  292 (576)
T KOG0585|consen  240 NLLLS---------------------------SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS  292 (576)
T ss_pred             heEEc---------------------------CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC
Confidence            99998                           67899999999988652     2223345588999999999986632 


Q ss_pred             ---CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh
Q psy3151         219 ---YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI  295 (372)
Q Consensus       219 ---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~  295 (372)
                         .+.+.||||+||+||.|+.|+.||.+...    ..+..+|....+.+|.  ...+..+++|||.+||++||++|++.
T Consensus       293 ~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~~l~~KIvn~pL~fP~--~pe~~e~~kDli~~lL~KdP~~Ri~l  366 (576)
T KOG0585|consen  293 FSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----LELFDKIVNDPLEFPE--NPEINEDLKDLIKRLLEKDPEQRITL  366 (576)
T ss_pred             ccccchhhhhhhhhhhHHHhhhccCCcccchH----HHHHHHHhcCcccCCC--cccccHHHHHHHHHHhhcChhheeeh
Confidence               35789999999999999999999976554    3456666666666553  23678999999999999999999999


Q ss_pred             hHHhcCCccccCCC
Q psy3151         296 DQVMENKWISQFNQ  309 (372)
Q Consensus       296 ~eil~hp~~~~~~~  309 (372)
                      .++..|||...-..
T Consensus       367 ~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  367 PDIKLHPWVTRDGD  380 (576)
T ss_pred             hhheecceeccCCC
Confidence            99999999987543

>KOG0694|consensus

Probab=100.00  E-value=6.2e-52  Score=393.83  Aligned_cols=252  Identities=31%  Similarity=0.553  Sum_probs=221.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|.++ ++||+|+||+|++|..+.+++.||||++.+.        .....|..++....+||-+++++.+|++    .
T Consensus       367 l~~F~~l-~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT----~  441 (694)
T KOG0694|consen  367 LDDFRLL-AVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT----K  441 (694)
T ss_pred             ccceEEE-EEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc----C
Confidence            3567774 8899999999999999999999999999643        3456677775555579999999999987    8


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      .++|+||||+.||++..+.+.   +.|++..++.|++.|+.||.|||++|||+||||.+|||+|                
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD----------------  502 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD----------------  502 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc----------------
Confidence            899999999999995544432   4599999999999999999999999999999999999999                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 ..|.+||+|||+++..........|.||||.|+|||++.+..|+.++|.|||||+||||+.|..||.++
T Consensus       503 -----------~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd  571 (694)
T KOG0694|consen  503 -----------TEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD  571 (694)
T ss_pred             -----------ccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence                       788899999999998876777889999999999999999999999999999999999999999999877


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccCC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQFN  308 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~~  308 (372)
                      +..    ++...|......+|.    .+|.++.++|++||..+|++|..     +++|..||||+.++
T Consensus       572 dEe----e~FdsI~~d~~~yP~----~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  572 DEE----EVFDSIVNDEVRYPR----FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             CHH----HHHHHHhcCCCCCCC----cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            654    456777776666664    89999999999999999999996     57899999999764

>KOG0607|consensus

Probab=100.00  E-value=1.8e-52  Score=364.61  Aligned_cols=274  Identities=37%  Similarity=0.702  Sum_probs=236.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      .|.+-|++.+++||+|+|+.|--+....||+.||||++++.     .+.+||++.......|+||+.++++|++    +.
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd----d~  149 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED----DT  149 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc----cc
Confidence            38889999999999999999999999999999999999753     4678999998899999999999999997    78


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+|||-|.||+|...|+++..  |+|.++.+++..|+.||++||.+||.||||||+|||...+.+...+||+||++..
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence            89999999999999999998754  9999999999999999999999999999999999999877766666666666532


Q ss_pred             ccccccCCCCCCCCeeee-ccccccccccCCCcccccccCCCcCCCccc-----CCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         167 PENLLYTKPGDGGILKLT-DFGFAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~-Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                      .             +|+. |..     ........++||+..|||||+.     ....|+.++|.||||+|+|.|++|++
T Consensus       228 g-------------~k~~~~~s-----pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYp  289 (463)
T KOG0607|consen  228 G-------------IKLNNDCS-----PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYP  289 (463)
T ss_pred             c-------------cccCCCCC-----CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCC
Confidence            1             1111 111     1123346778999999999975     33569999999999999999999999


Q ss_pred             CCCCCCCCCC-----------CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         241 PFFSNHGQAI-----------SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       241 pf~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      ||.+..+.+.           ...+.+.|..|.+++|..+|..+|.+++|||+.+|..|+.+|.+|.++++|||++....
T Consensus       290 PFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  290 PFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             CccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            9988766442           24567889999999999999999999999999999999999999999999999988643

>KOG0198|consensus

Probab=100.00  E-value=2.9e-51  Score=370.57  Aligned_cols=259  Identities=29%  Similarity=0.416  Sum_probs=207.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ..+|.. .+.||+|+||+||++.+..+|..+|||.+...     ....+|+.+ +..++|||||++++.....  .+..+
T Consensus        16 ~~~~~~-~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~i-L~~l~~p~IV~~~G~~~~~--~~~~~   91 (313)
T KOG0198|consen   16 ISNWSK-GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRI-LSRLNHPNIVQYYGSSSSR--ENDEY   91 (313)
T ss_pred             cchhhh-hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHH-HHhCCCCCEEeeCCccccc--cCeee
Confidence            345766 68899999999999999999999999999753     335788888 5555699999999974431  11378


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      +++|||+.+|+|.+++.+.++ .+++..++.+.+||+.||+|||++||||+||||+|||++.                  
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~------------------  152 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP------------------  152 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC------------------
Confidence            999999999999999998764 7999999999999999999999999999999999999982                  


Q ss_pred             ccccCCCCCCCCeeeecccccccccc---CCCcccccccCCCcCCCcccCCCC-CCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVS---NKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                              .++.+||+|||++.....   .........|||.|||||++..+. .++++|||||||++.||+||..||..
T Consensus       153 --------~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  153 --------SNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             --------CCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence                    157899999999987763   112234578999999999998533 33599999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      .  ... ....-.+.... ..| .....+|.++++||.+|+..||++||||+++|.|||..+-.
T Consensus       225 ~--~~~-~~~~~~ig~~~-~~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  225 F--FEE-AEALLLIGRED-SLP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             h--cch-HHHHHHHhccC-CCC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            3  111 11112222222 112 23346999999999999999999999999999999997743

>KOG0578|consensus

Probab=100.00  E-value=1.6e-51  Score=383.84  Aligned_cols=254  Identities=31%  Similarity=0.472  Sum_probs=219.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      .....|+.. +.||+|+.|.||.|....+++.||||.+...     ...+.|+.+ ++-.+|+|||++++.|..    +.
T Consensus       270 dP~~~y~~~-~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~V-m~~~~H~NiVnfl~Sylv----~d  343 (550)
T KOG0578|consen  270 DPRSKYTDF-KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILV-MRDLHHPNIVNFLDSYLV----GD  343 (550)
T ss_pred             Chhhhhcch-hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHH-HHhccchHHHHHHHHhcc----cc
Confidence            345678775 4599999999999999999999999999743     345678877 677799999999999876    57


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+++||||++||+|.+.+....   ++|.++..+.++++.||+|||.+||+|||||.+|||+.                 
T Consensus       344 eLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~-----------------  403 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT-----------------  403 (550)
T ss_pred             eeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec-----------------
Confidence            8999999999999999987653   99999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .+|.+||+|||++..+........+.+|||+|||||++....|++++||||||++++||+-|.+||...+
T Consensus       404 ----------~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~  473 (550)
T KOG0578|consen  404 ----------MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN  473 (550)
T ss_pred             ----------cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC
Confidence                      6777999999999998877777888999999999999999999999999999999999999999997533


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      .   ...+..-...+...+.  .++.+|++++||+.+||+.|+.+|+||.++|+||||+.
T Consensus       474 P---lrAlyLIa~ng~P~lk--~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  474 P---LRALYLIATNGTPKLK--NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             h---HHHHHHHhhcCCCCcC--CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            2   2223333333333333  34589999999999999999999999999999999954

>KOG0597|consensus

Probab=100.00  E-value=1e-51  Score=383.20  Aligned_cols=249  Identities=33%  Similarity=0.586  Sum_probs=219.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhh-------hHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|.+. +.||+|+||.||+|+.+.|.+.||||.+.+..+       .++|+++ ++.++||||+.++++|++    ..+
T Consensus         2 e~yhv~-e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i-~r~lkHpniv~m~esfEt----~~~   75 (808)
T KOG0597|consen    2 EQYHVY-EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRI-LRSLKHPNIVEMLESFET----SAH   75 (808)
T ss_pred             cchhHH-HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHH-HHhcCCcchhhHHHhhcc----cce
Confidence            578884 789999999999999999999999999975432       5678888 778899999999999987    789


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +++|.||+.| +|..++...  +.++|+.++.++.|++.||.|||+.+|+|||+||.|||+.                  
T Consensus        76 ~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~------------------  134 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE------------------  134 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec------------------
Confidence            9999999976 999999865  5699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               ..+.+|+||||+|+....+....+..-|||.|||||++.+++|+..+|+||+||++|||++|++||...+-
T Consensus       135 ---------~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si  205 (808)
T KOG0597|consen  135 ---------KGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI  205 (808)
T ss_pred             ---------CCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH
Confidence                     78889999999999887766667777899999999999999999999999999999999999999965432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                          ..+.+.|......+|.    ..|.++++|+..+|.+||.+|+|+.+++.|||.++-
T Consensus       206 ----~~Lv~~I~~d~v~~p~----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  206 ----TQLVKSILKDPVKPPS----TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             ----HHHHHHHhcCCCCCcc----cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                2334455555444443    789999999999999999999999999999998763

>KOG0582|consensus

Probab=100.00  E-value=3.1e-50  Score=364.74  Aligned_cols=261  Identities=28%  Similarity=0.440  Sum_probs=216.1

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+-.+.|++. +.||.|..++||+|+...+++.||||+++-.      ...++|+.. +++.+||||+.++.+|..    
T Consensus        22 p~n~~~YeL~-e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~-msl~~HPNIv~~~~sFvv----   95 (516)
T KOG0582|consen   22 PLNAKDYELQ-EVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQT-MSLIDHPNIVTYHCSFVV----   95 (516)
T ss_pred             CCCccceeEE-EEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHH-hhhcCCCCcceEEEEEEe----
Confidence            3456889995 7799999999999999999999999999632      345677776 889999999999999987    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +..+|+||.||.+|++.++++..-...++|..+..|++++++||.|||++|.||||||+.||||+               
T Consensus        96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~---------------  160 (516)
T KOG0582|consen   96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID---------------  160 (516)
T ss_pred             cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc---------------
Confidence            78899999999999999999986555699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCc----ccccccCCCcCCCcccC--CCCCCCccchhhHHHHHHHHHhC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS----LQTPCYTPYYVAPEVLG--PDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                  .+|.|||+|||.+..+......    ..+.+|||+|||||++.  ...|+.|+||||||++..||.+|
T Consensus       161 ------------~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G  228 (516)
T KOG0582|consen  161 ------------SDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHG  228 (516)
T ss_pred             ------------CCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcC
Confidence                        6788999999988766554332    25568999999999963  35799999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCcc------CCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFD------FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      ..||........   +...+. +..+      ++......++..++.+|..||..||.+||||+++|+|+||++..
T Consensus       229 ~aPf~k~pPmkv---Ll~tLq-n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  229 HAPFSKYPPMKV---LLLTLQ-NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             CCCcccCChHHH---HHHHhc-CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            999965543221   112221 2221      12222345778899999999999999999999999999998764

>KOG0611|consensus

Probab=100.00  E-value=5e-51  Score=365.56  Aligned_cols=251  Identities=34%  Similarity=0.639  Sum_probs=224.5

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      +..+.-||++. +.||+|+||+|.+|.+...|+.||||.+++.        ...++|+++ +..++||||+.++++|++ 
T Consensus        48 khnlkHRyE~~-etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeI-MSsLNHPhII~IyEVFEN-  124 (668)
T KOG0611|consen   48 KHNLKHRYEIT-ETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEI-MSSLNHPHIIQIYEVFEN-  124 (668)
T ss_pred             ccchhhHHHHH-HHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHH-HhhcCCCceeehhhhhcC-
Confidence            44578899995 7899999999999999999999999998632        246899999 778899999999999997 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         ...+++||||..+|+|++++....  .|+|.+++.+++||+.|+.|+|.++++|||||.+|||++            
T Consensus       125 ---kdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD------------  187 (668)
T KOG0611|consen  125 ---KDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD------------  187 (668)
T ss_pred             ---CceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec------------
Confidence               778999999999999999998764  599999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCC-CccchhhHHHHHHHHHhCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~  240 (372)
                                     +++.+||+|||++..... .....+.||+|-|++||++.+.+|. +.+|.||||++||.|+.|..
T Consensus       188 ---------------~N~NiKIADFGLSNly~~-~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtM  251 (668)
T KOG0611|consen  188 ---------------QNNNIKIADFGLSNLYAD-KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTM  251 (668)
T ss_pred             ---------------CCCCeeeeccchhhhhcc-ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccc
Confidence                           788899999999987643 5668899999999999999999986 89999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      ||++.+.    ..+...+..|.+..|.     -+.++.-||+.||.+||++|.|++++..|-|++
T Consensus       252 PFDG~Dh----k~lvrQIs~GaYrEP~-----~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  252 PFDGRDH----KRLVRQISRGAYREPE-----TPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ccCCchH----HHHHHHhhcccccCCC-----CCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence            9987653    3456777777776653     478899999999999999999999999998875

>KOG4717|consensus

Probab=100.00  E-value=4.1e-50  Score=368.87  Aligned_cols=261  Identities=35%  Similarity=0.591  Sum_probs=230.9

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      -.+.+=|++ ++.||+|.|++|.+|+|..||+.||||++.+.       ...++|++. +++.+|||||+++++...   
T Consensus        14 gkIAGLYDL-ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRC-MKLVQHpNiVRLYEViDT---   88 (864)
T KOG4717|consen   14 GKIAGLYDL-EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRC-MKLVQHPNIVRLYEVIDT---   88 (864)
T ss_pred             cceeeeehh-hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHH-HHHhcCcCeeeeeehhcc---
Confidence            347788998 89999999999999999999999999999754       246789998 788999999999999876   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ...+|+|+|.-.+|+|+++|.++.. .+.|+.++.+++||+.|+.|+|+.++|||||||+|+.+..             
T Consensus        89 -QTKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-------------  153 (864)
T KOG4717|consen   89 -QTKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-------------  153 (864)
T ss_pred             -cceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-------------
Confidence             6789999999999999999999874 5999999999999999999999999999999999999873             


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCC-CccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .-|-||++|||++..+.+ .....+.||+..|.|||++.+..|+ +++||||||||||-|++|++||
T Consensus       154 -------------KlGlVKLTDFGFSNkf~P-G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF  219 (864)
T KOG4717|consen  154 -------------KLGLVKLTDFGFSNKFQP-GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF  219 (864)
T ss_pred             -------------ecCceEeeeccccccCCC-cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc
Confidence                         668899999999988765 5567889999999999999999998 7899999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT  313 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~  313 (372)
                      ....+.+.    ...+....+..|.    .+|.+++|||..||..||.+|.|.++|..|+|++.....+.+
T Consensus       220 qeANDSET----LTmImDCKYtvPs----hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT  282 (864)
T KOG4717|consen  220 QEANDSET----LTMIMDCKYTVPS----HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST  282 (864)
T ss_pred             ccccchhh----hhhhhcccccCch----hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence            77665554    3445556666664    789999999999999999999999999999999987665544

>KOG0610|consensus

Probab=100.00  E-value=1.9e-49  Score=356.88  Aligned_cols=279  Identities=27%  Similarity=0.424  Sum_probs=225.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++++++ +.||.|.-|+||+|....++..+|+|++.+.        .++..|.++ +..++||-++.++..|+.    +.
T Consensus        77 ~~f~ll-k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eI-L~~lDHPFlPTLYa~fet----~~  150 (459)
T KOG0610|consen   77 RHFRLL-KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREI-LSLLDHPFLPTLYASFET----DK  150 (459)
T ss_pred             HHHHHH-HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHH-HHhcCCCccchhhheeec----cc
Confidence            466775 6799999999999999999999999999743        244556667 788899999999999987    88


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      +.|++||||.||+|..+.+++.++.|++..++.++..|+.||+|||-.|||.|||||+||||.   +++.+-++||+++.
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr---edGHIMLsDFDLS~  227 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR---EDGHIMLSDFDLSL  227 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe---cCCcEEeeeccccc
Confidence            999999999999999999999989999999999999999999999999999999999999998   56679999999876


Q ss_pred             ccccccCC--------CCCCCCee---eeccccc-----c--------------cc--ccCCCcccccccCCCcCCCccc
Q psy3151         167 PENLLYTK--------PGDGGILK---LTDFGFA-----K--------------KI--VSNKASLQTPCYTPYYVAPEVL  214 (372)
Q Consensus       167 ~~~~~~~~--------~~~~~~~k---i~Dfg~a-----~--------------~~--~~~~~~~~~~~gt~~y~aPE~~  214 (372)
                      .....++-        .+....+.   ++-|...     +              ..  ..........+||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            44321110        00101111   1222111     0              00  1112234457899999999999


Q ss_pred             CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC
Q psy3151         215 GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT  294 (372)
Q Consensus       215 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s  294 (372)
                      .+..-+.++|.|+||+++|||+.|..||.+.+..+.    ...+......+|..  ..++..++|||+++|.+||.+|..
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----l~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg  381 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----LRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLG  381 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----HHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhc
Confidence            999999999999999999999999999988776554    45555555555543  268899999999999999999998


Q ss_pred             ----hhHHhcCCccccCC
Q psy3151         295 ----IDQVMENKWISQFN  308 (372)
Q Consensus       295 ----~~eil~hp~~~~~~  308 (372)
                          |+||.+||||++++
T Consensus       382 ~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  382 SKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             cccchHHhhcCccccCCC
Confidence                99999999999875

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.4e-49  Score=369.60  Aligned_cols=244  Identities=35%  Similarity=0.646  Sum_probs=206.8

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      ++||+|+||+||+|.+..+|+.||||++...        ....+|+.+ +..++||||+++++++..    +..+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~hp~i~~~~~~~~~----~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRV-LQNTRHPFLTALKYSFQT----HDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHH-HHhCCCCCCCCEEEEEEc----CCEEEEEEe
Confidence            3599999999999999999999999998642        123456666 566799999999999876    678999999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      |+.+++|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+|||++                        
T Consensus        76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~------------------------  129 (323)
T cd05571          76 YANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD------------------------  129 (323)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC------------------------
Confidence            99999999998764  4599999999999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHh
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG  253 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  253 (372)
                         .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.    ..
T Consensus       130 ---~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~  202 (323)
T cd05571         130 ---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EK  202 (323)
T ss_pred             ---CCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH----HH
Confidence               56779999999987644333444557899999999999989999999999999999999999999965432    23


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      ....+..+...+|.    .+++++.+||.+||+.||++||     ++.++++||||.+.
T Consensus       203 ~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         203 LFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             HHHHHHcCCCCCCC----CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            34445445554443    6899999999999999999999     89999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0594|consensus

Probab=100.00  E-value=1.6e-49  Score=353.65  Aligned_cols=265  Identities=29%  Similarity=0.467  Sum_probs=212.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCC-EeEEeEeeeeec--C
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKH-IVNIKDVYENIY--N   83 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~n-i~~~~~~~~~~~--~   83 (372)
                      ...|..+ +.||+|+||+||+|+++.+|+.||+|.++..       ..+.+|+-+ ++.++|+| |+++++++....  .
T Consensus        10 ~~~~~~~-eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisl-lk~L~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKV-EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISL-LKRLSHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHH-HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHH-HHHhCCCcceEEEEeeeeeccccc
Confidence            4557776 4599999999999999999999999999633       246899987 67779999 999999987511  1


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKED--GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~--~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                      ....+|+||||+. -+|..++.....  ..++...++.+++||+.||+|||++||+||||||+||||+            
T Consensus        88 ~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~------------  154 (323)
T KOG0594|consen   88 GIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS------------  154 (323)
T ss_pred             ccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC------------
Confidence            2338999999995 599999987653  2588899999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                     ..|.+||+|||+|+...-+....+..++|.||+|||++.+. .|+..+||||+|||++||+++++
T Consensus       155 ---------------~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~  219 (323)
T KOG0594|consen  155 ---------------SSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP  219 (323)
T ss_pred             ---------------CCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence                           67889999999999776555666777889999999998665 79999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhC------------CccCCCCcc----------cccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         241 PFFSNHGQAISPGMKNRIRLG------------QFDFPNPEW----------EHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~----------~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      .|.+....+....+...+...            .+..+.+.|          ...++++.+++.+||+.+|.+|.||+.+
T Consensus       220 LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a  299 (323)
T KOG0594|consen  220 LFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA  299 (323)
T ss_pred             CCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH
Confidence            997766533322222222111            011011111          2234689999999999999999999999


Q ss_pred             hcCCccccCC
Q psy3151         299 MENKWISQFN  308 (372)
Q Consensus       299 l~hp~~~~~~  308 (372)
                      |.||||....
T Consensus       300 l~h~yf~~~~  309 (323)
T KOG0594|consen  300 LTHPYFSELP  309 (323)
T ss_pred             hcChhhcccc
Confidence            9999998763

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.9e-49  Score=360.16  Aligned_cols=253  Identities=28%  Similarity=0.482  Sum_probs=208.9

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      |++. +.||+|+||+||+|.+..+|+.||||.+....        ...+|+.+ +..++|+||+.+.+++..    ++.+
T Consensus         2 f~~~-~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i-l~~l~~~~iv~~~~~~~~----~~~~   75 (285)
T cd05631           2 FRHY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI-LEKVNSRFVVSLAYAYET----KDAL   75 (285)
T ss_pred             ceEE-EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHH-HHhcCCCcEEEEEEEEcc----CCeE
Confidence            6664 77999999999999999999999999986321        23456766 666799999999998875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+.+|+|.+++.......+++..+..++.|++.||+|||+.||+||||||+|||++                   
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~-------------------  136 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD-------------------  136 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC-------------------
Confidence            9999999999999888765445699999999999999999999999999999999999997                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++|+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       137 --------~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~  207 (285)
T cd05631         137 --------DRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER  207 (285)
T ss_pred             --------CCCCEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence                    5677999999998765322 2234457899999999999999999999999999999999999999766543


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      .....+...+......++    ..++.++.+||++||+.||.+|||     ++++++||||.+.
T Consensus       208 ~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         208 VKREEVDRRVKEDQEEYS----EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             hhHHHHHHHhhcccccCC----ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            332333333333322222    368999999999999999999997     8999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0658|consensus

Probab=100.00  E-value=2.2e-50  Score=358.89  Aligned_cols=268  Identities=27%  Similarity=0.465  Sum_probs=217.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEec-chhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC-ceEEEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVGSHKHIVNIKDVYENIYNG-SRCLLV   90 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~-~~~~~l   90 (372)
                      ..-.|.- .+++|+|+||.||.|....+++.||||.+- +..-..+|+.+ ++.++|||||++..+|...... .-++.+
T Consensus        22 ~~i~~~~-~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~i-m~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   22 VEISYEA-VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQI-MRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             eEEEEEe-eEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHH-HHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3445666 488999999999999999999999999885 34455689988 5688999999999999765544 336778


Q ss_pred             EEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          91 IMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ||||++. +|.+.++..  .+..++...++-+++||++||.|||+.||+||||||.|+|+|.                  
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~------------------  160 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP------------------  160 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC------------------
Confidence            9999975 999999852  2356999999999999999999999999999999999999994                  


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                              +.|.+||||||.|+.+..+... .++..|..|+|||.+ ....|+.+.||||.||+++||+-|++.|.+.+.
T Consensus       161 --------~tg~LKicDFGSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~  231 (364)
T KOG0658|consen  161 --------DTGVLKICDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS  231 (364)
T ss_pred             --------CCCeEEeccCCcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence                    6799999999999998765544 566679999999986 456799999999999999999999999988776


Q ss_pred             CCCCHhHHHHHhh--------C-----CccCCC---C-----cccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         248 QAISPGMKNRIRL--------G-----QFDFPN---P-----EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       248 ~~~~~~~~~~~~~--------~-----~~~~~~---~-----~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      .+....+.+.+..        .     .+.+|.   .     .....++++.+|+.++|.++|.+|.|+.|+|.||||..
T Consensus       232 ~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde  311 (364)
T KOG0658|consen  232 VDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE  311 (364)
T ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence            5443333222111        0     111111   1     12457899999999999999999999999999999998


Q ss_pred             CCCC
Q psy3151         307 FNQV  310 (372)
Q Consensus       307 ~~~~  310 (372)
                      .+..
T Consensus       312 lr~~  315 (364)
T KOG0658|consen  312 LRDP  315 (364)
T ss_pred             hhCc
Confidence            7654

>KOG0580|consensus

Probab=100.00  E-value=2e-50  Score=339.23  Aligned_cols=250  Identities=36%  Similarity=0.601  Sum_probs=224.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|++ ++.||+|-||.||+|+.++++-.||+|++.+.        ...++|+++ ..-++||||++++++|.+    .
T Consensus        21 l~dfei-gr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEI-qs~L~hpnilrlY~~fhd----~   94 (281)
T KOG0580|consen   21 LDDFEI-GRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEI-QSHLRHPNILRLYGYFHD----S   94 (281)
T ss_pred             hhhccc-cccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEe-ecccCCccHHhhhhheec----c
Confidence            367888 89999999999999999999999999999743        356788888 677799999999999987    7


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+++||..+|+|+..++......+++..++.++.|++.||.|+|..+|+||||||+|+|++                
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg----------------  158 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG----------------  158 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC----------------
Confidence            8899999999999999999976667899999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 ..+.+||+|||-+....  .....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||.+.
T Consensus       159 -----------~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~  225 (281)
T KOG0580|consen  159 -----------SAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ  225 (281)
T ss_pred             -----------CCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence                       67789999999987653  45567899999999999999999999999999999999999999999765


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      .    ......++....+.+|    ..++.++.|||.+||.++|.+|.+..|++.|||+..
T Consensus       226 ~----~~etYkrI~k~~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  226 S----HSETYKRIRKVDLKFP----STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             h----hHHHHHHHHHccccCC----cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            5    3455777777777776    379999999999999999999999999999999864

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.3e-49  Score=367.25  Aligned_cols=249  Identities=35%  Similarity=0.615  Sum_probs=211.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      -.++|++ .+.||+|+||+||+|.+..+|+.||||++....        ...+|+.+ ++.++||||+++++++..    
T Consensus        16 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~----   89 (329)
T PTZ00263         16 KLSDFEM-GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI-LMELSHPFIVNMMCSFQD----   89 (329)
T ss_pred             CchheEE-EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHH-HHhCCCCCCCcEEEEEEc----
Confidence            3478998 477999999999999999999999999986321        24567776 566799999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ++.+|+||||+.+|+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~---------------  152 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD---------------  152 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC---------------
Confidence            67899999999999999999765  4599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.+||+|||++.....   ...+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+
T Consensus       153 ------------~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  217 (329)
T PTZ00263        153 ------------NKGHVKVTDFGFAKKVPD---RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD  217 (329)
T ss_pred             ------------CCCCEEEeeccCceEcCC---CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence                        567799999999886533   22346789999999999988899999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      ...    ......+..+...+|.    .++.++++||.+||+.||.+|++     +++++.||||.+.
T Consensus       218 ~~~----~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        218 DTP----FRIYEKILAGRLKFPN----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             CCH----HHHHHHHhcCCcCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            432    2334555555555443    57899999999999999999997     7999999999874

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-49  Score=360.70  Aligned_cols=247  Identities=37%  Similarity=0.669  Sum_probs=209.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||+|+||+||+|.+..+|+.||||++...        ....+|+.+ ++.++||||+++++++.+    +.
T Consensus         1 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~----~~   74 (291)
T cd05612           1 DDLERI-KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRV-LKEVSHPFIIRLFWTEHD----QR   74 (291)
T ss_pred             CCceee-eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHH-HHhCCCCcHhhhHhhhcc----CC
Confidence            478885 7799999999999999999999999998532        123457766 677799999999988765    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+||||+.+|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                 
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~-----------------  135 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD-----------------  135 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC-----------------
Confidence            899999999999999999765  4599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus       136 ----------~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  202 (291)
T cd05612         136 ----------KEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN  202 (291)
T ss_pred             ----------CCCCEEEEecCcchhccC---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                      567799999999876533   2234578999999999998889999999999999999999999996644


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      .    ......+..+...++.    .++..+++||++||+.||.+|++     ++++++||||..+
T Consensus       203 ~----~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         203 P----FGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             H----HHHHHHHHhCCcCCCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence            2    3344555555555543    56899999999999999999995     9999999999864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.5e-48  Score=362.25  Aligned_cols=244  Identities=32%  Similarity=0.551  Sum_probs=206.0

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .||+|+||+||+|.++.+++.||||++...        .....|..++....+||||+++++++..    ...+|+||||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~----~~~~~iv~Ey   77 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT----PDRLFFVMEF   77 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc----CCEEEEEEcC
Confidence            599999999999999999999999998632        1234566665556689999999999876    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +++|+|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+|||++                         
T Consensus        78 ~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~-------------------------  130 (320)
T cd05590          78 VNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD-------------------------  130 (320)
T ss_pred             CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC-------------------------
Confidence            9999999988765  4599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhH
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM  254 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  254 (372)
                        .++.++|+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.    ..+
T Consensus       131 --~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~  204 (320)
T cd05590         131 --HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDL  204 (320)
T ss_pred             --CCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHH
Confidence              56779999999987643333344556789999999999988999999999999999999999999965442    233


Q ss_pred             HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh------hHHhcCCccccC
Q psy3151         255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI------DQVMENKWISQF  307 (372)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~------~eil~hp~~~~~  307 (372)
                      ...+..+....+    ..++.++.+||++||+.||.+|+++      ++++.||||..+
T Consensus       205 ~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         205 FEAILNDEVVYP----TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             HHHHhcCCCCCC----CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            444544444433    2589999999999999999999998      899999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.4e-48  Score=357.06  Aligned_cols=255  Identities=25%  Similarity=0.443  Sum_probs=202.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|.++ +.||.|+||+||+|.+..+++.||+|++...      ....+|+.+ ++.++||||+++++++..    +...
T Consensus         5 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~----~~~~   78 (288)
T cd07871           5 ETYVKL-DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSL-LKNLKHANIVTLHDIIHT----ERCL   78 (288)
T ss_pred             ccceEe-eEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHH-HHhCCCCCEeeEEEEEcC----CCeE
Confidence            579985 7799999999999999999999999998632      244578887 667799999999999875    6689


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++                   
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~-------------------  137 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-------------------  137 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC-------------------
Confidence            999999964 9999887653 4589999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                              .++.+||+|||++..............+|+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.
T Consensus       138 --------~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~  209 (288)
T cd07871         138 --------EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV  209 (288)
T ss_pred             --------CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence                    5677999999998765443334445678999999998865 5689999999999999999999999966543


Q ss_pred             CCCCHhHHHHHhh---------------CCccCCC-------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         248 QAISPGMKNRIRL---------------GQFDFPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       248 ~~~~~~~~~~~~~---------------~~~~~~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .+....+......               ..+.++.       .....++.++++||.+||++||.+|||++|+|+||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         210 KEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             HHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            2211111110000               0000110       0013468899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.2e-48  Score=358.82  Aligned_cols=257  Identities=26%  Similarity=0.449  Sum_probs=203.1

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .++|+++ +.||.|+||+||+|.+..+|+.||||++...      ....+|+.+ ++.++||||+++++++..    +..
T Consensus         4 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~----~~~   77 (303)
T cd07869           4 ADSYEKL-EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASL-LKGLKHANIVLLHDIIHT----KET   77 (303)
T ss_pred             cccceEe-eeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHH-HhhCCCCCcCeEEEEEec----CCe
Confidence            3789995 7799999999999999999999999998632      234577777 667799999999999875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+. ++|.+++.... +.+++..++.++.||+.||+|||+.||+||||||+|||++                  
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~------------------  137 (303)
T cd07869          78 LTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS------------------  137 (303)
T ss_pred             EEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC------------------
Confidence            999999995 68888887643 4699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.+||+|||++.............+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+..
T Consensus       138 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  208 (303)
T cd07869         138 ---------DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK  208 (303)
T ss_pred             ---------CCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence                     5677999999998765433334455678999999999854 558899999999999999999999996543


Q ss_pred             CCCCCHhHHHHHhh-C-------------------CccC-CCCc------ccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         247 GQAISPGMKNRIRL-G-------------------QFDF-PNPE------WEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       247 ~~~~~~~~~~~~~~-~-------------------~~~~-~~~~------~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      ...  ..+...... +                   .+.. .+..      ....++++.+||.+||+.||++|||+.|+|
T Consensus       209 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l  286 (303)
T cd07869         209 DIQ--DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL  286 (303)
T ss_pred             cHH--HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence            210  011100000 0                   0000 0000      012457899999999999999999999999


Q ss_pred             cCCccccC
Q psy3151         300 ENKWISQF  307 (372)
Q Consensus       300 ~hp~~~~~  307 (372)
                      +||||+++
T Consensus       287 ~h~~f~~~  294 (303)
T cd07869         287 SHEYFSDL  294 (303)
T ss_pred             cCcccccC
Confidence            99999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.3e-48  Score=367.65  Aligned_cols=253  Identities=31%  Similarity=0.536  Sum_probs=198.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||+|+||+||+|.+..+++.||||++....        ...+|+.+ +..++||||+++++.+.+    +.
T Consensus         1 ~~y~~~-~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~i-l~~~~~~~iv~~~~~~~~----~~   74 (363)
T cd05628           1 EDFESL-KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI-LVEADSLWVVKMFYSFQD----KL   74 (363)
T ss_pred             CCceEe-EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHH-HHhCCCCCcceEEEEEec----CC
Confidence            478885 77999999999999999999999999996421        23456666 566799999999999876    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+||||++||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++                 
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~-----------------  135 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD-----------------  135 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC-----------------
Confidence            899999999999999999765  4599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccC-----------------------------------CCcccccccCCCcCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSN-----------------------------------KASLQTPCYTPYYVAP  211 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~-----------------------------------~~~~~~~~gt~~y~aP  211 (372)
                                .++.+||+|||++......                                   .......+||+.|+||
T Consensus       136 ----------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP  205 (363)
T cd05628         136 ----------SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAP  205 (363)
T ss_pred             ----------CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCH
Confidence                      3344555555554432110                                   0012346899999999


Q ss_pred             cccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCC-
Q psy3151         212 EVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPS-  290 (372)
Q Consensus       212 E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~-  290 (372)
                      |++.+..++.++|+|||||++|+|++|..||.+....    .....+.........+....+++++++||.+|+. +|. 
T Consensus       206 E~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~  280 (363)
T cd05628         206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ----ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEH  280 (363)
T ss_pred             HHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Chhh
Confidence            9999899999999999999999999999999654432    2333343322221112223578999999999876 444 


Q ss_pred             --CCCChhHHhcCCccccC
Q psy3151         291 --ERLTIDQVMENKWISQF  307 (372)
Q Consensus       291 --~R~s~~eil~hp~~~~~  307 (372)
                        .||+++|+++||||++.
T Consensus       281 r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         281 RIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             cCCCCCHHHHhCCCCCCCC
Confidence              46899999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.2e-48  Score=360.92  Aligned_cols=246  Identities=30%  Similarity=0.531  Sum_probs=205.5

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      +.||+|+||.||+|.+..+|+.||+|++...        .....|..++....+||||+++++++..    ++++|+|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~~lv~E   76 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT----KEHLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe----CCEEEEEEC
Confidence            3599999999999999999999999998642        1234566665556799999999999876    678999999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      |+.+|+|.+++...  +.+++..+..++.||+.||+|||++||+||||||+|||++                        
T Consensus        77 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~------------------------  130 (316)
T cd05620          77 FLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD------------------------  130 (316)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC------------------------
Confidence            99999999998764  4599999999999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHh
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG  253 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  253 (372)
                         .++.++|+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.    ..
T Consensus       131 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~----~~  203 (316)
T cd05620         131 ---RDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE----DE  203 (316)
T ss_pred             ---CCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HH
Confidence               56779999999887543333344567889999999999989999999999999999999999999965543    23


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh-hHHhcCCccccCC
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-DQVMENKWISQFN  308 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~-~eil~hp~~~~~~  308 (372)
                      +...+......++    ..++.++++||.+||+.||++|+++ +++++||||....
T Consensus       204 ~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         204 LFESIRVDTPHYP----RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             HHHHHHhCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence            3444444433333    2579999999999999999999998 5888999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-48  Score=359.09  Aligned_cols=242  Identities=33%  Similarity=0.603  Sum_probs=204.3

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      ||+|+||+||+|.+..+++.||+|++...        ....+|+.+ +..++||||+++++++..    +..+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTV-LAQVNCPFIVPLKFSFQS----PEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH-HHhCCCCcEeceeeEEec----CCeEEEEEcCC
Confidence            79999999999999999999999998632        123456666 566799999999998875    67899999999


Q ss_pred             CCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151          96 HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus        96 ~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                      ++|+|.+++...  +.+++..++.++.||+.||.|||+.||+||||||+|||++                          
T Consensus        76 ~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~--------------------------  127 (312)
T cd05585          76 NGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD--------------------------  127 (312)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC--------------------------
Confidence            999999999764  4599999999999999999999999999999999999998                          


Q ss_pred             CCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHH
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK  255 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  255 (372)
                       .++.++|+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+...    ....
T Consensus       128 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~~~~  202 (312)
T cd05585         128 -YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----NEMY  202 (312)
T ss_pred             -CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----HHHH
Confidence             56779999999987644333334556799999999999999999999999999999999999999965432    2334


Q ss_pred             HHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC---ChhHHhcCCccccC
Q psy3151         256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL---TIDQVMENKWISQF  307 (372)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~---s~~eil~hp~~~~~  307 (372)
                      ..+......++    ..+++++.+||.+||..||.+||   ++.+++.||||.+.
T Consensus       203 ~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         203 RKILQEPLRFP----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHHcCCCCCC----CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            44444444444    36899999999999999999997   57999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.5e-48  Score=360.84  Aligned_cols=248  Identities=30%  Similarity=0.516  Sum_probs=204.9

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      +||+|+||+||+|.+..+++.||||++....        ...+|..++..+.+||||++++++|..    .+.+|+||||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~----~~~~~lv~e~   77 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT----ESRLFFVIEF   77 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc----CCEEEEEEeC
Confidence            5999999999999999999999999996321        234566665556689999999999876    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +++|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                         
T Consensus        78 ~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~-------------------------  130 (329)
T cd05588          78 VSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD-------------------------  130 (329)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC-------------------------
Confidence            9999999988764  4599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC-----
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA-----  249 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----  249 (372)
                        .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.......     
T Consensus       131 --~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~  208 (329)
T cd05588         131 --AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN  208 (329)
T ss_pred             --CCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccccc
Confidence              5677999999998754333334456789999999999999999999999999999999999999996322111     


Q ss_pred             CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC------hhHHhcCCccccC
Q psy3151         250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT------IDQVMENKWISQF  307 (372)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s------~~eil~hp~~~~~  307 (372)
                      ........+.......|    ..++.++.+||.+||+.||.+|+|      ++++++||||...
T Consensus       209 ~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         209 TEDYLFQVILEKQIRIP----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             chHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            11223344444444444    367899999999999999999997      7899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.2e-48  Score=361.73  Aligned_cols=244  Identities=32%  Similarity=0.551  Sum_probs=206.2

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      +||+|+||+||+|.+..+++.||||++....        ....|.+++....+||||++++++|..    +..+|+||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~----~~~~~lv~E~   77 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT----KDRLFFVMEY   77 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----CCeEEEEEeC
Confidence            5999999999999999999999999986421        234566665556689999999999976    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +++++|...+...  +.+++..++.++.||+.||.|||+.||+||||||+|||++                         
T Consensus        78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~-------------------------  130 (321)
T cd05591          78 VNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD-------------------------  130 (321)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC-------------------------
Confidence            9999999988765  4599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhH
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM  254 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  254 (372)
                        .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.    ...
T Consensus       131 --~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~  204 (321)
T cd05591         131 --AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDL  204 (321)
T ss_pred             --CCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----HHH
Confidence              56779999999987654434444556789999999999988999999999999999999999999965543    233


Q ss_pred             HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-------ChhHHhcCCccccC
Q psy3151         255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-------TIDQVMENKWISQF  307 (372)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-------s~~eil~hp~~~~~  307 (372)
                      ...+..+....|.    .++.++.+||.+||+.||++|+       +++++++||||..+
T Consensus       205 ~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         205 FESILHDDVLYPV----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             HHHHHcCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            4445444444442    5789999999999999999999       89999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-48  Score=368.33  Aligned_cols=253  Identities=34%  Similarity=0.597  Sum_probs=202.1

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||.|+||+||+|++..+|+.||||++....        ...+|+.+ +..++||||++++++|..    +.
T Consensus         1 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~i-l~~l~h~~iv~~~~~~~~----~~   74 (364)
T cd05599           1 DDFESI-KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI-LAEADNPWVVKLYYSFQD----EN   74 (364)
T ss_pred             CCceEE-EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH-HHhCCCCCCcceEEEEEc----CC
Confidence            478885 77999999999999999999999999996421        23457766 566789999999999886    77


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ++|+||||+.+|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                 
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~-----------------  135 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD-----------------  135 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC-----------------
Confidence            899999999999999999765  4599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCC--------------------------------------CcccccccCCCc
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNK--------------------------------------ASLQTPCYTPYY  208 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--------------------------------------~~~~~~~gt~~y  208 (372)
                                .++.++|+|||++.......                                      ......+||+.|
T Consensus       136 ----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  205 (364)
T cd05599         136 ----------AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDY  205 (364)
T ss_pred             ----------CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccc
Confidence                      34445555555554321100                                      011235799999


Q ss_pred             CCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCC
Q psy3151         209 VAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVD  288 (372)
Q Consensus       209 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~d  288 (372)
                      +|||++....++.++|||||||++|+|++|..||.+.+..    .....+......+..+....+++++++||.+||. +
T Consensus       206 ~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~  280 (364)
T cd05599         206 IAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ----ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-E  280 (364)
T ss_pred             cCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHH----HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-C
Confidence            9999999899999999999999999999999999755432    2223333222222223334679999999999997 9


Q ss_pred             CCCCCC---hhHHhcCCccccC
Q psy3151         289 PSERLT---IDQVMENKWISQF  307 (372)
Q Consensus       289 P~~R~s---~~eil~hp~~~~~  307 (372)
                      |.+|++   +++++.||||++.
T Consensus       281 p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         281 AERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             HhhcCCCCCHHHHhcCCCcCCC
Confidence            999998   9999999999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.2e-48  Score=361.20  Aligned_cols=245  Identities=37%  Similarity=0.662  Sum_probs=205.7

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      ++||+|+||.||+|.+..+|+.||+|++....        ...+|+.+ ++.++||||++++++|..    +..+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~i~~~~~~~~~----~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV-LQNTRHPFLTALKYAFQT----HDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHH-HHhCCCCCCcceeeEEec----CCEEEEEEe
Confidence            35999999999999999999999999986421        22356665 667799999999999876    678999999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      |+.+|+|..++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                        
T Consensus        76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~------------------------  129 (323)
T cd05595          76 YANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD------------------------  129 (323)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc------------------------
Confidence            99999999888764  3599999999999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHh
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG  253 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  253 (372)
                         .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.    ..
T Consensus       130 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~  202 (323)
T cd05595         130 ---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ER  202 (323)
T ss_pred             ---CCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH----HH
Confidence               56779999999987643333344556789999999999888999999999999999999999999965443    22


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccCC
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFN  308 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~~  308 (372)
                      ....+......+|.    .+++++.+||.+||..||.+|+     ++.++++||||.+..
T Consensus       203 ~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         203 LFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             HHHHHhcCCCCCCC----CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            33444444444443    6799999999999999999998     899999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.2e-48  Score=360.36  Aligned_cols=243  Identities=34%  Similarity=0.648  Sum_probs=205.0

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      +||+|+||.||+|.+..+|+.||||++....        ...+|+.+ ++.++||||+++++++..    +..+|+||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~----~~~~~lv~Ey   76 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRV-LKNTRHPFLTSLKYSFQT----KDRLCFVMEY   76 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH-HHhCCCCCCcceEEEEEc----CCEEEEEEeC
Confidence            5899999999999999999999999996421        23456665 677799999999998875    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +++|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                         
T Consensus        77 ~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~-------------------------  129 (328)
T cd05593          77 VNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD-------------------------  129 (328)
T ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC-------------------------
Confidence            9999999888764  4599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhH
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM  254 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  254 (372)
                        .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.    ...
T Consensus       130 --~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~  203 (328)
T cd05593         130 --KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL  203 (328)
T ss_pred             --CCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----HHH
Confidence              56779999999987644333344556899999999999888999999999999999999999999965432    223


Q ss_pred             HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      ...+......+|.    .++.++.+||.+||..||.+|+     ++.++++||||...
T Consensus       204 ~~~~~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         204 FELILMEDIKFPR----TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             HHHhccCCccCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            3444444444443    6799999999999999999997     89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.1e-48  Score=360.18  Aligned_cols=248  Identities=29%  Similarity=0.507  Sum_probs=204.9

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      +||+|+||+||+|.+..+++.||+|++...        ....+|+.++....+||||+++++++..    ++.+|+||||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~----~~~~~lv~E~   77 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ESRLFFVIEY   77 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe----CCEEEEEEeC
Confidence            599999999999999999999999998642        1234566665666799999999999876    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +++|+|..++...  +.+++..++.++.||+.||+|||++||+||||||+||+++                         
T Consensus        78 ~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~-------------------------  130 (329)
T cd05618          78 VNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD-------------------------  130 (329)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC-------------------------
Confidence            9999999888764  4599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC-----
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA-----  249 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----  249 (372)
                        .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.......     
T Consensus       131 --~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~  208 (329)
T cd05618         131 --SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN  208 (329)
T ss_pred             --CCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccc
Confidence              5677999999998754333333455688999999999999999999999999999999999999995322111     


Q ss_pred             CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh------hHHhcCCccccC
Q psy3151         250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI------DQVMENKWISQF  307 (372)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~------~eil~hp~~~~~  307 (372)
                      ....+...+......+|    ..++.++.+||.+||+.||.+|+|+      +++++||||++.
T Consensus       209 ~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         209 TEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             cHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            11123333444444444    3678999999999999999999984      799999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-47  Score=357.19  Aligned_cols=244  Identities=32%  Similarity=0.558  Sum_probs=203.7

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .||+|+||+||+|.+..+++.||||++....        ....|...+....+||||+++++++..    +..+|+||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e~   77 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT----KEHLFFVMEY   77 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc----CCEEEEEEcC
Confidence            5999999999999999999999999986321        233455555556689999999999875    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      ++||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                         
T Consensus        78 ~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~-------------------------  130 (316)
T cd05592          78 LNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD-------------------------  130 (316)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC-------------------------
Confidence            9999999998765  4599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhH
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM  254 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  254 (372)
                        .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.    ..+
T Consensus       131 --~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~  204 (316)
T cd05592         131 --KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DEL  204 (316)
T ss_pred             --CCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHH
Confidence              56779999999987654434444566899999999999988899999999999999999999999976543    223


Q ss_pred             HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh-hHHhcCCccccC
Q psy3151         255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-DQVMENKWISQF  307 (372)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~-~eil~hp~~~~~  307 (372)
                      ...+......+|    ..++.++.+||.+||+.||.+||++ .++++||||...
T Consensus       205 ~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         205 FDSILNDRPHFP----RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             HHHHHcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence            334433333333    3579999999999999999999986 588899999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-48  Score=362.49  Aligned_cols=251  Identities=29%  Similarity=0.525  Sum_probs=207.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||+|+||.||+|.+..+|+.||||++...        ....+|+.+ +..++||||+++++++..    +.
T Consensus         1 ~~y~~~-~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~~~h~~iv~~~~~~~~----~~   74 (333)
T cd05600           1 KDFQIL-TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDI-LTTTKSEWLVKLLYAFQD----DE   74 (333)
T ss_pred             CCcEEE-EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHH-HHhCCCCCCccEEEEEEc----CC
Confidence            478885 7799999999999999999999999998632        123456666 566689999999999876    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..|+||||+++++|.+++...  +.+++..++.++.||+.||.|||+.||+||||||+|||++                 
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~-----------------  135 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID-----------------  135 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC-----------------
Confidence            899999999999999999765  4599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                ..+.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus       136 ----------~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  202 (333)
T cd05600         136 ----------ASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST  202 (333)
T ss_pred             ----------CCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence                      567799999999876533   3345678999999999988899999999999999999999999996554


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcc----cccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEW----EHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ..+    ....+.........+..    ..++.++.+||.+||..+|.+|||+++++.||||.+.
T Consensus       203 ~~~----~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         203 PNE----TWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHH----HHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            322    22222221111111111    2568999999999999999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589|consensus

Probab=100.00  E-value=1.2e-48  Score=362.39  Aligned_cols=255  Identities=30%  Similarity=0.498  Sum_probs=222.2

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      .++|..+ +.+|+|+||.+++++++.+++.+|+|.++-.       ..+..|..+ +..+.||||+.+.+.|+.   ++.
T Consensus         3 m~~Ye~~-~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~l-is~~~hP~iv~y~ds~~~---~~~   77 (426)
T KOG0589|consen    3 MDNYEVL-RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDL-LSKLLHPNIVEYKDSFEE---DGQ   77 (426)
T ss_pred             cchhhhh-hhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHH-HHhccCCCeeeeccchhc---CCc
Confidence            4688885 7799999999999999999999999999632       356677776 566899999999999976   355


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .++|||+||+||+|.+.|...++..++|+.+..++.|++.|+.|||+++|+|||||+.|||++                 
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt-----------------  140 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT-----------------  140 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc-----------------
Confidence            599999999999999999988767899999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.|+|+|||+|+..........+.+|||.|++||++.+.+|+.++|||||||++|||++-+++|...+
T Consensus       141 ----------k~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~  210 (426)
T KOG0589|consen  141 ----------KDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN  210 (426)
T ss_pred             ----------ccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence                      4556899999999998877667788999999999999999999999999999999999999999996655


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      -    ..+..++..+.+.   |....++.+++.||+.||..+|..||++.++|.+|.+...
T Consensus       211 m----~~Li~ki~~~~~~---Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  211 M----SELILKINRGLYS---PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             h----HHHHHHHhhccCC---CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            3    3445555555532   2224789999999999999999999999999999988743

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.4e-48  Score=368.20  Aligned_cols=276  Identities=28%  Similarity=0.466  Sum_probs=201.7

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +|+++ +.||+|+||+||+|++..+++.||+|++....        ...+|+.+ ++.++||||+++++.|.+    +..
T Consensus         2 ~f~~~-~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~i-l~~~~h~~iv~~~~~~~~----~~~   75 (382)
T cd05625           2 MFVKI-KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDI-LAEADNEWVVRLYYSFQD----KDN   75 (382)
T ss_pred             CcEEE-EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHH-HHhCCCCcCCeEEEEEEe----CCE
Confidence            68885 77999999999999999999999999986432        23456666 667799999999999976    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+++|+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++.   .+.++++|||.+..
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~---~g~~kL~DFGla~~  150 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCTG  150 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCCEEEeECCCCcc
Confidence            99999999999999998765  45899999999999999999999999999999999999983   33456666665432


Q ss_pred             cccccC----CCCCCCCeeeecccccc-----------------cc--ccCCCcccccccCCCcCCCcccCCCCCCCccc
Q psy3151         168 ENLLYT----KPGDGGILKLTDFGFAK-----------------KI--VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCD  224 (372)
Q Consensus       168 ~~~~~~----~~~~~~~~ki~Dfg~a~-----------------~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  224 (372)
                      ......    ..++...-...+|....                 ..  ........+.+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            110000    00000000000000000                 00  00000122357899999999999899999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC---hhHHhcC
Q psy3151         225 IWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT---IDQVMEN  301 (372)
Q Consensus       225 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s---~~eil~h  301 (372)
                      ||||||++|+|++|..||.+.+..    .....+.........+....+++++.+||.+|+ .+|.+|++   +++++.|
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQTPL----ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCCHH----HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            999999999999999999764432    122223222222333334578999999999987 59999997   9999999


Q ss_pred             CccccC
Q psy3151         302 KWISQF  307 (372)
Q Consensus       302 p~~~~~  307 (372)
                      |||+..
T Consensus       306 p~f~~~  311 (382)
T cd05625         306 PFFKTI  311 (382)
T ss_pred             CCcCCc
Confidence            999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.4e-48  Score=362.67  Aligned_cols=250  Identities=30%  Similarity=0.547  Sum_probs=210.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCC-cEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTS-EVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      -.++|++. +.||+|+||.||+|.+..++ ..||+|++...        ....+|+.+ +..++||||+++++++..   
T Consensus        28 ~~~~y~~~-~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~Iv~~~~~~~~---  102 (340)
T PTZ00426         28 KYEDFNFI-RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKI-LNYINHPFCVNLYGSFKD---  102 (340)
T ss_pred             ChhhcEEE-EEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHH-HHhCCCCCCcceEEEEEe---
Confidence            35789985 77999999999999976655 78999998532        123457766 677799999999999976   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       +..+|+||||+.+|+|.+++...  +.+++..++.++.||+.||.|||+.||+||||||+|||++              
T Consensus       103 -~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~--------------  165 (340)
T PTZ00426        103 -ESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD--------------  165 (340)
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC--------------
Confidence             67899999999999999999765  3599999999999999999999999999999999999997              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   .++.+||+|||++.....   ...+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus       166 -------------~~~~ikL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~  229 (340)
T PTZ00426        166 -------------KDGFIKMTDFGFAKVVDT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY  229 (340)
T ss_pred             -------------CCCCEEEecCCCCeecCC---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence                         567899999999876532   2345678999999999988889999999999999999999999997


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFN  308 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~~  308 (372)
                      +.+.    ......+..+...+|.    .+++++.++|++||+.||++|+     |++++++||||.++.
T Consensus       230 ~~~~----~~~~~~i~~~~~~~p~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        230 ANEP----LLIYQKILEGIIYFPK----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             CCCH----HHHHHHHhcCCCCCCC----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            6442    2334555555554443    5789999999999999999996     899999999998753

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.9e-48  Score=360.27  Aligned_cols=245  Identities=33%  Similarity=0.580  Sum_probs=204.9

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      ++||+|+||+||+|.+..+|+.||||++....        ....|...+++.++||||+++++.+..    +...|+|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~----~~~~~lv~e   76 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----ADKLYFVLD   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe----CCEEEEEEc
Confidence            35999999999999999999999999986321        223454555677899999999999876    678999999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      |+++|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                        
T Consensus        77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~------------------------  130 (323)
T cd05575          77 YVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD------------------------  130 (323)
T ss_pred             CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC------------------------
Confidence            99999999998764  4599999999999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHh
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG  253 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  253 (372)
                         .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.    ..
T Consensus       131 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~  203 (323)
T cd05575         131 ---SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----AE  203 (323)
T ss_pred             ---CCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH----HH
Confidence               56779999999987643333344556789999999999988999999999999999999999999975432    23


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh----hHHhcCCccccC
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI----DQVMENKWISQF  307 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~----~eil~hp~~~~~  307 (372)
                      +...+.......+    ..++.++.++|.+||+.||.+||++    .++++||||..+
T Consensus       204 ~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         204 MYDNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             HHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            3444444444333    3579999999999999999999998    599999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-47  Score=357.25  Aligned_cols=245  Identities=29%  Similarity=0.526  Sum_probs=204.4

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .||+|+||+||+|.+..+++.||||++...        .....|...+....+||||+++++++..    ...+|+||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~----~~~~~lv~ey   77 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT----KENLFFVMEY   77 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe----CCEEEEEEeC
Confidence            599999999999999999999999998643        1234566665556799999999999876    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++                         
T Consensus        78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~-------------------------  130 (316)
T cd05619          78 LNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD-------------------------  130 (316)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC-------------------------
Confidence            9999999999764  3599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhH
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM  254 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  254 (372)
                        .++.+||+|||++.............+||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.    ...
T Consensus       131 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~  204 (316)
T cd05619         131 --TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EEL  204 (316)
T ss_pred             --CCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHH
Confidence              56679999999987543333334456789999999999988999999999999999999999999965442    233


Q ss_pred             HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChh-HHhcCCccccCC
Q psy3151         255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID-QVMENKWISQFN  308 (372)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~-eil~hp~~~~~~  308 (372)
                      ...+......++    ..++.++.+||.+||+.||.+||++. ++++||||+...
T Consensus       205 ~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         205 FQSIRMDNPCYP----RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             HHHHHhCCCCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence            344443333333    25789999999999999999999996 899999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.4e-47  Score=357.96  Aligned_cols=250  Identities=31%  Similarity=0.552  Sum_probs=206.3

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +|+++ +.||+|+||.||+|.+..+++.||||++...        .....|..++..+..|++|+.++++|..    .+.
T Consensus         1 ~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~   75 (324)
T cd05587           1 DFNFL-MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----MDR   75 (324)
T ss_pred             CceEE-EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCE
Confidence            47774 7799999999999999999999999998632        1234566664444345678899988875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+++|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                  
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~------------------  135 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD------------------  135 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc------------------
Confidence            99999999999999998765  4599999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.+||+|||++.............+||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.
T Consensus       136 ---------~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~  206 (324)
T cd05587         136 ---------AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE  206 (324)
T ss_pred             ---------CCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence                     56779999999987543333344556799999999999999999999999999999999999999965542


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh-----hHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-----DQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~-----~eil~hp~~~~~  307 (372)
                          ......+......+|    ..++.++.+++.+||..||.+|+++     +++++||||...
T Consensus       207 ----~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         207 ----DELFQSIMEHNVSYP----KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             ----HHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                233444444444444    3689999999999999999999986     899999999875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-47  Score=349.31  Aligned_cols=248  Identities=28%  Similarity=0.452  Sum_probs=202.8

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      ||+|+||+||+|.+..+|+.||||.+....        ....|+.+ ++.++||||+++.+++..    +..+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i-l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI-LAKVHSRFIVSLAYAFQT----KTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHH-HHhCCCCcEeeeeEEEcC----CCeEEEEEeCC
Confidence            799999999999999999999999986321        22456666 667799999999998875    67799999999


Q ss_pred             CCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          96 HGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        96 ~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      ++|+|.+.+...  ....+++..++.++.||+.||+|||+.||+||||||+||+++                        
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~------------------------  131 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD------------------------  131 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC------------------------
Confidence            999998887542  234699999999999999999999999999999999999997                        


Q ss_pred             CCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHh
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG  253 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  253 (372)
                         .++.++|+|||++..............||+.|+|||++.+..++.++|+|||||++|+|++|..||...........
T Consensus       132 ---~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~  208 (280)
T cd05608         132 ---NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE  208 (280)
T ss_pred             ---CCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence               56779999999987665443334456789999999999999999999999999999999999999975443322222


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      ....+.......    ...++.++.+++.+||+.||++||     |++++++||||++.
T Consensus       209 ~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         209 LKQRILNDSVTY----PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             HHHhhcccCCCC----cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            223222222222    236899999999999999999999     88999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-47  Score=365.50  Aligned_cols=278  Identities=26%  Similarity=0.418  Sum_probs=199.1

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .|+++ +.||+|+||+||+|.+..+++.||||++....        ...+|+.+ ++.++||||+++++++.+    +.+
T Consensus         2 ~f~~~-~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~h~~iv~l~~~~~~----~~~   75 (381)
T cd05626           2 MFVKI-KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDI-LAEADNEWVVKLYYSFQD----KDN   75 (381)
T ss_pred             CceEE-EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHH-HHhcCCCCeeeeEEEEec----CCE
Confidence            57875 66999999999999999999999999996421        23456666 667799999999999976    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+++|+|.+++.+.  +.+++..++.++.||+.||+|||+.||+||||||+|||++.   .+.++++|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~---~~~~kL~DFGl~~~  150 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL---DGHIKLTDFGLCTG  150 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC---CCCEEEeeCcCCcc
Confidence            99999999999999999765  35999999999999999999999999999999999999973   23455555554432


Q ss_pred             cccccCC-CCCCC---------------Ceeeeccccc-------cccccCCCcccccccCCCcCCCcccCCCCCCCccc
Q psy3151         168 ENLLYTK-PGDGG---------------ILKLTDFGFA-------KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCD  224 (372)
Q Consensus       168 ~~~~~~~-~~~~~---------------~~ki~Dfg~a-------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  224 (372)
                      ....... ....+               .+-.+.++..       ...........+.+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            1100000 00000               0000000000       00000000123457999999999998888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccC--CCCCCCChhHHhcCC
Q psy3151         225 IWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCV--DPSERLTIDQVMENK  302 (372)
Q Consensus       225 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~--dP~~R~s~~eil~hp  302 (372)
                      ||||||++|+|++|..||...+...    ....+.........+....+++++.+||.+|+..  +|..|+|+++++.||
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp  306 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTE----TQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP  306 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHH----HHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence            9999999999999999997654322    1222222121222233346899999999996654  555599999999999


Q ss_pred             ccccCC
Q psy3151         303 WISQFN  308 (372)
Q Consensus       303 ~~~~~~  308 (372)
                      ||+++.
T Consensus       307 ~f~~~~  312 (381)
T cd05626         307 FFSEVD  312 (381)
T ss_pred             ccCCCC
Confidence            998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-47  Score=357.67  Aligned_cols=250  Identities=30%  Similarity=0.544  Sum_probs=209.0

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +|+++ +.||+|+||+||+|.+..+++.||||++....        ....|..++.....|++|+.+++++..    ...
T Consensus         1 df~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~   75 (323)
T cd05616           1 DFNFL-MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT----MDR   75 (323)
T ss_pred             CceEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec----CCE
Confidence            47774 77999999999999999999999999986421        233455554555678999999999876    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+++|+|.+.+...  +.+++..+..++.||+.||+|||++||+||||||+|||++                  
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~------------------  135 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD------------------  135 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC------------------
Confidence            99999999999999998765  3599999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.
T Consensus       136 ---------~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~  206 (323)
T cd05616         136 ---------SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE  206 (323)
T ss_pred             ---------CCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence                     56779999999987654333344556789999999999999999999999999999999999999975443


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh-----hHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-----DQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~-----~eil~hp~~~~~  307 (372)
                          ..+...+......+|.    .++.++.+|+.+||+.||.+|+++     .++++||||+..
T Consensus       207 ----~~~~~~i~~~~~~~p~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         207 ----DELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             ----HHHHHHHHhCCCCCCC----cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence                2334445555544443    689999999999999999999984     899999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.4e-47  Score=357.52  Aligned_cols=254  Identities=30%  Similarity=0.535  Sum_probs=206.2

Q ss_pred             ceeeccccccccCCeEEEEEEEc---CCCcEEEEEEecch---------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          16 DYDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHDT---------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      +|+++ +.||+|+||+||+|++.   .+|+.||+|++...         ....+|+.++..+.+||||+.+++++..   
T Consensus         1 ~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---   76 (332)
T cd05614           1 NFELL-KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---   76 (332)
T ss_pred             CceEE-EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec---
Confidence            47884 77999999999999874   47899999998632         1234577775555579999999998875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       +..+|+||||+.+|+|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+|||++              
T Consensus        77 -~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~--------------  139 (332)
T cd05614          77 -EAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD--------------  139 (332)
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC--------------
Confidence             67899999999999999998765  3599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                   .++.+||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus       140 -------------~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  206 (332)
T cd05614         140 -------------SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP  206 (332)
T ss_pred             -------------CCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCC
Confidence                         56779999999987653322 223346789999999998764 478999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      |...........+...+......++    ..+++.+.+||.+||+.||++||     +++++++||||++.
T Consensus       207 f~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         207 FTLEGERNTQSEVSRRILKCDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9755443333334444433333333    36899999999999999999999     78899999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-47  Score=358.25  Aligned_cols=264  Identities=28%  Similarity=0.484  Sum_probs=204.1

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec-CCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY-NGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~-~~~~~   87 (372)
                      +|++ .+.||+|+||.||+|.+..+|+.||||.+...       ....+|+.+ ++.++||||+++++++.... .....
T Consensus         1 ry~i-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL-LRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEE-EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHH-HHhCCCCCEeeecceEeccCCCCCce
Confidence            6888 47899999999999999999999999998531       234578877 66779999999999875321 12346


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++                  
T Consensus        79 ~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~------------------  137 (338)
T cd07859          79 IYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN------------------  137 (338)
T ss_pred             EEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC------------------
Confidence            89999999 56999988765  3599999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCC--CCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                               .++.+||+|||++........   .....+||+.|+|||++.+  ..++.++|||||||++|+|++|++||
T Consensus       138 ---------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf  208 (338)
T cd07859         138 ---------ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF  208 (338)
T ss_pred             ---------CCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC
Confidence                     567799999999876432211   2234678999999999865  67899999999999999999999999


Q ss_pred             CCCCCCCCC-----------HhHHHHHhhC-------Cc--cCCC---CcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         243 FSNHGQAIS-----------PGMKNRIRLG-------QF--DFPN---PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       243 ~~~~~~~~~-----------~~~~~~~~~~-------~~--~~~~---~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .+.+.....           ......+...       ..  ..+.   ..+..+++++.++|.+||+.||++|||+++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l  288 (338)
T cd07859         209 PGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL  288 (338)
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence            654321110           0000000000       00  0000   11235678899999999999999999999999


Q ss_pred             cCCccccCCCCC
Q psy3151         300 ENKWISQFNQVP  311 (372)
Q Consensus       300 ~hp~~~~~~~~~  311 (372)
                      +||||++.....
T Consensus       289 ~hp~f~~~~~~~  300 (338)
T cd07859         289 ADPYFKGLAKVE  300 (338)
T ss_pred             cCchhhhcCccc
Confidence            999998876543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.1e-48  Score=366.76  Aligned_cols=277  Identities=26%  Similarity=0.460  Sum_probs=200.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||+|+||+||+|++..+++.||||++...        ....+|+++ ++.++||||+++++.|..    ++
T Consensus         1 ~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i-l~~l~h~~iv~~~~~~~~----~~   74 (376)
T cd05598           1 SMFVKI-KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI-LAEADNEWVVKLYYSFQD----KD   74 (376)
T ss_pred             CCceEE-EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHH-HHhCCCCCcceEEEEEEc----CC
Confidence            368886 6799999999999999999999999998632        223467776 667799999999999876    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+||||+++|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++.   .+.++|+|||.+.
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~---~~~ikL~DFG~a~  149 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCT  149 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC---CCCEEEEeCCCCc
Confidence            899999999999999999765  45899999999999999999999999999999999999983   2234444444432


Q ss_pred             ccccccC----CCCCCCCeeeecccc-----c----------cccccCCCcccccccCCCcCCCcccCCCCCCCccchhh
Q psy3151         167 PENLLYT----KPGDGGILKLTDFGF-----A----------KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWS  227 (372)
Q Consensus       167 ~~~~~~~----~~~~~~~~ki~Dfg~-----a----------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  227 (372)
                      .......    ...........+...     .          .............+||+.|+|||++.+..++.++||||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  229 (376)
T cd05598         150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  229 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence            1100000    000000000000000     0          00000000112357999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC---ChhHHhcCCcc
Q psy3151         228 LGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL---TIDQVMENKWI  304 (372)
Q Consensus       228 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~---s~~eil~hp~~  304 (372)
                      |||++|+|++|..||.+....+    ....+.........+....+++++.+||.+|+ .+|.+|+   |+.++++||||
T Consensus       230 lGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~  304 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAE----TQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF  304 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHH----HHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence            9999999999999997654322    22223322222233334568999999999987 5999999   99999999999


Q ss_pred             ccC
Q psy3151         305 SQF  307 (372)
Q Consensus       305 ~~~  307 (372)
                      +++
T Consensus       305 ~~~  307 (376)
T cd05598         305 KGI  307 (376)
T ss_pred             CCC
Confidence            875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-47  Score=365.96  Aligned_cols=272  Identities=28%  Similarity=0.498  Sum_probs=198.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||.|+||+||+|.+..+|+.||||++....        ...+|+.+ ++.++||||++++++|.+    +.
T Consensus         1 ~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hp~iv~~~~~~~~----~~   74 (377)
T cd05629           1 EDFHTV-KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV-LAESDSPWVVSLYYSFQD----AQ   74 (377)
T ss_pred             CCceEe-EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHH-HHhCCCCCcceEEEEEEc----CC
Confidence            478885 77999999999999999999999999985321        23456666 566799999999999976    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ++|+||||+++|+|.+++...  +.+++..++.++.|++.||+|||+.||+||||||+|||++.   .+.++++|||+++
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~---~~~~kl~DfGla~  149 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR---GGHIKLSDFGLST  149 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC---CCCEEEeeccccc
Confidence            899999999999999999765  45999999999999999999999999999999999999973   2345555555443


Q ss_pred             ccccccC-----C--CCC--------CCCe-------------eeeccccccccccCCCcccccccCCCcCCCcccCCCC
Q psy3151         167 PENLLYT-----K--PGD--------GGIL-------------KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK  218 (372)
Q Consensus       167 ~~~~~~~-----~--~~~--------~~~~-------------ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  218 (372)
                      .......     .  ...        ...+             ++.+++.+.     .......+||+.|+|||++.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~  224 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNR-----RLMAYSTVGTPDYIAPEIFLQQG  224 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc-----cccccccCCCccccCHHHHccCC
Confidence            1100000     0  000        0000             000000000     00011357899999999998889


Q ss_pred             CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCC---CCh
Q psy3151         219 YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER---LTI  295 (372)
Q Consensus       219 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R---~s~  295 (372)
                      ++.++|||||||++|+|++|..||.+....    .....+.........+....++.++.+||.+||. +|.+|   +|+
T Consensus       225 ~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         225 YGQECDWWSLGAIMFECLIGWPPFCSENSH----ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             CCCceeeEecchhhhhhhcCCCCCCCCCHH----HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            999999999999999999999999654432    2223333222222223334579999999999998 77765   599


Q ss_pred             hHHhcCCccccC
Q psy3151         296 DQVMENKWISQF  307 (372)
Q Consensus       296 ~eil~hp~~~~~  307 (372)
                      .+++.||||++.
T Consensus       300 ~~~l~hp~~~~~  311 (377)
T cd05629         300 HEIKSHPFFRGV  311 (377)
T ss_pred             HHHhcCCCcCCC
Confidence            999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-47  Score=358.69  Aligned_cols=244  Identities=36%  Similarity=0.654  Sum_probs=204.5

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      ++||+|+||+||+|.+..+|+.||+|++....        ...+|+.+ +..++||||+++++++..    ...+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~-l~~~~hp~i~~~~~~~~~----~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV-LQNSRHPFLTALKYSFQT----HDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH-HHhCCCCCCCceEEEEEc----CCEEEEEEe
Confidence            35999999999999999999999999996421        22345555 566799999999998876    678999999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      |+.+|+|.+++...  +.+++..++.++.||+.||+|||+ .||+||||||+|||++                       
T Consensus        76 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~-----------------------  130 (325)
T cd05594          76 YANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-----------------------  130 (325)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC-----------------------
Confidence            99999999888764  359999999999999999999997 7999999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCH
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP  252 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  252 (372)
                          .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.    .
T Consensus       131 ----~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----~  202 (325)
T cd05594         131 ----KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----E  202 (325)
T ss_pred             ----CCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----H
Confidence                56779999999987544333344456789999999999888999999999999999999999999965432    2


Q ss_pred             hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      .....+......+|.    .+++++.+||.+||+.||++|+     ++.++++||||.+.
T Consensus       203 ~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         203 KLFELILMEEIRFPR----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             HHHHHHhcCCCCCCC----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            334444444444443    6799999999999999999997     89999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-47  Score=356.50  Aligned_cols=244  Identities=32%  Similarity=0.574  Sum_probs=205.0

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .||+|+||+||+|.+..+++.||||++...        ....+|+.++....+||||+++++++..    ...+|+||||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~----~~~~~lv~e~   77 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT----KDRLFFVMEY   77 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----CCEEEEEEcC
Confidence            599999999999999999999999998642        1234566665555589999999999876    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +.+|+|..++.+.  +.+++..+..++.||+.||.|||+.||+||||||+||+++                         
T Consensus        78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~-------------------------  130 (318)
T cd05570          78 VNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD-------------------------  130 (318)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC-------------------------
Confidence            9999999988765  3599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhH
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM  254 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  254 (372)
                        .++.++|+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.    ...
T Consensus       131 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~----~~~  204 (318)
T cd05570         131 --SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----DEL  204 (318)
T ss_pred             --CCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH----HHH
Confidence              56779999999887543333334456789999999999999999999999999999999999999965442    223


Q ss_pred             HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh-----hHHhcCCccccC
Q psy3151         255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-----DQVMENKWISQF  307 (372)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~-----~eil~hp~~~~~  307 (372)
                      ...+......++    ..++.++.+||.+||+.||.+|||+     .+++.||||+..
T Consensus       205 ~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         205 FQSILEDEVRYP----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             HHHHHcCCCCCC----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            344444444433    3579999999999999999999999     999999999875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.1e-47  Score=355.60  Aligned_cols=249  Identities=30%  Similarity=0.522  Sum_probs=206.2

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHH--HHhcCCCCEeEEeEeeeeecCCce
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQ--LAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~--~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      |+++ +.||+|+||.||+|.+..+|+.||||++....        ...+|+.++  +..++||||+++++++..    +.
T Consensus         1 y~i~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~----~~   75 (324)
T cd05589           1 FRCL-AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT----ED   75 (324)
T ss_pred             CeEE-EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc----CC
Confidence            6674 77999999999999999999999999996321        223444432  234579999999999876    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..|+||||+.+++|...+..   +.+++..++.++.||+.||+|||++||+||||||+||+++                 
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~-----------------  135 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD-----------------  135 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC-----------------
Confidence            89999999999999888754   3599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+
T Consensus       136 ----------~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~  205 (324)
T cd05589         136 ----------TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD  205 (324)
T ss_pred             ----------CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence                      5677999999988764433344456789999999999998899999999999999999999999996554


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccCC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFN  308 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~~  308 (372)
                      .    ......+.......|    ..++.++.+||.+||+.||.+||     ++.++++||||++..
T Consensus       206 ~----~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         206 E----EEVFDSIVNDEVRYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             H----HHHHHHHHhCCCCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            3    223344444444443    36799999999999999999999     699999999998753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-47  Score=361.29  Aligned_cols=251  Identities=37%  Similarity=0.657  Sum_probs=206.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|.++ +.||+|+||+||+|.+..+|+.||||++....        ...+|+.+ +..++||||+++++++.+    +.
T Consensus         1 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----~~   74 (350)
T cd05573           1 DDFEVI-KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI-LADADSPWIVKLYYSFQD----EE   74 (350)
T ss_pred             CCceEE-EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHH-HHhcCCCCccchhhheec----CC
Confidence            479985 77999999999999999999999999986321        23456665 667789999999998875    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ++|+||||+.+++|.+++.+.  +.+++..++.++.||+.||+|||+.||+||||||+|||++                 
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~-----------------  135 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID-----------------  135 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC-----------------
Confidence            899999999999999999875  4699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCC-----------------------------CcccccccCCCcCCCcccCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNK-----------------------------ASLQTPCYTPYYVAPEVLGPD  217 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~  217 (372)
                                .++.+||+|||++.......                             ......+||+.|+|||++.+.
T Consensus       136 ----------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  205 (350)
T cd05573         136 ----------ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT  205 (350)
T ss_pred             ----------CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence                      45567777777776543322                             123446789999999999999


Q ss_pred             CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhh--CCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-
Q psy3151         218 KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL--GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-  294 (372)
Q Consensus       218 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-  294 (372)
                      .++.++|||||||++|+|++|..||......    .....+..  .....|  ....+++++.+||.+||. ||.+|++ 
T Consensus       206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~~~p--~~~~~~~~~~~li~~ll~-dp~~R~~s  278 (350)
T cd05573         206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ----ETYNKIINWKESLRFP--PDPPVSPEAIDLICRLLC-DPEDRLGS  278 (350)
T ss_pred             CCCCceeeEecchhhhhhccCCCCCCCCCHH----HHHHHHhccCCcccCC--CCCCCCHHHHHHHHHHcc-ChhhcCCC
Confidence            9999999999999999999999999765422    22333333  222222  223479999999999998 9999999 


Q ss_pred             hhHHhcCCccccC
Q psy3151         295 IDQVMENKWISQF  307 (372)
Q Consensus       295 ~~eil~hp~~~~~  307 (372)
                      ++++++||||+++
T Consensus       279 ~~~ll~hp~~~~~  291 (350)
T cd05573         279 FEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHhcCCCcCCC
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.8e-47  Score=361.02  Aligned_cols=254  Identities=30%  Similarity=0.522  Sum_probs=208.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|+++ +.||+|+||+||+|.+..+++.||+|++....        ...+|+.+ ++.++||||+++++++.+    +
T Consensus        42 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i-l~~~~h~~iv~~~~~~~~----~  115 (370)
T cd05596          42 AEDFDVI-KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI-MAHANSEWIVQLHYAFQD----D  115 (370)
T ss_pred             HHHcEEE-EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHH-HHhCCCCCcceEEEEEec----C
Confidence            4689985 77999999999999999999999999986321        12356665 677899999999998876    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +.+|+||||+.+|+|.+++...   .+++..+..++.||+.||+|||+.||+||||||+|||++                
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----------------  176 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----------------  176 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc----------------
Confidence            7899999999999999988653   489999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCC----CCCCccchhhHHHHHHHHHhCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPD----KYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                 .++.+||+|||++........ .....+||+.|+|||++.+.    .++.++|+|||||++|+|++|..
T Consensus       177 -----------~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~  245 (370)
T cd05596         177 -----------KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT  245 (370)
T ss_pred             -----------CCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCC
Confidence                       567899999999876543222 23456799999999998543    47899999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCC--CCChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE--RLTIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~--R~s~~eil~hp~~~~~  307 (372)
                      ||.+.+.    ......+.........+....+|.++.+||.+||..+|.+  |+|++++++||||++.
T Consensus       246 Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         246 PFYADSL----VGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CcCCCCH----HHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            9976543    2233444333322222333468999999999999999988  9999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0667|consensus

Probab=100.00  E-value=4.4e-48  Score=367.17  Aligned_cols=262  Identities=26%  Similarity=0.392  Sum_probs=208.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCC-----CCEeEEeEeeeeec
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSH-----KHIVNIKDVYENIY   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h-----~ni~~~~~~~~~~~   82 (372)
                      -+.-||.|+ ++||+|+||.|.+|.+..|++.||||+++...    ++..|+.++..+..|     -|+|+++++|..  
T Consensus       183 ~i~~rY~V~-e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--  259 (586)
T KOG0667|consen  183 HIAYRYEVL-EVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--  259 (586)
T ss_pred             eeEEEEEEE-EEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--
Confidence            355699994 99999999999999999999999999998654    445567665444423     489999999976  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        .+++|||+|.+ +.+|+++++.+....|+...++.++.||+.||.+||+.||||.||||+|||+...           
T Consensus       260 --r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-----------  325 (586)
T KOG0667|consen  260 --RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-----------  325 (586)
T ss_pred             --ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-----------
Confidence              78999999999 6699999999888889999999999999999999999999999999999999842           


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    ....|||+|||+|.....   ...+++.+..|+|||++.+.+|+.+.||||||||++||++|.+.|
T Consensus       326 --------------~r~~vKVIDFGSSc~~~q---~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  326 --------------KRSRIKVIDFGSSCFESQ---RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             --------------CcCceeEEecccccccCC---cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence                          234799999999987532   233788899999999999999999999999999999999999988


Q ss_pred             CCCCCCCCCHhHHHHH------------------h------------------------------hCCccCCCC--c---
Q psy3151         243 FSNHGQAISPGMKNRI------------------R------------------------------LGQFDFPNP--E---  269 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~------------------~------------------------------~~~~~~~~~--~---  269 (372)
                      .+.+..+....+.+-+                  .                              ......|+.  .   
T Consensus       389 pG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~  468 (586)
T KOG0667|consen  389 PGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLES  468 (586)
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccch
Confidence            6654322111110000                  0                              000001100  0   


Q ss_pred             -cc-ccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         270 -WE-HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       270 -~~-~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                       .. .....+.|||++||.+||.+|+|+.++|+||||...
T Consensus       469 ~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  469 GLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             hcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence             01 122457899999999999999999999999999853

>KOG0201|consensus

Probab=100.00  E-value=2.8e-49  Score=358.15  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=216.4

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+....|+.+ +.||+|+||.||+|.+..+++.||||++.-.      ....+|+.. +...+++||.++++.|..    
T Consensus         9 ~~~~~~~~~~-~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~-Ls~~~~~~it~yygsyl~----   82 (467)
T KOG0201|consen    9 IDPELLYTKL-ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISV-LSQCDSPNITEYYGSYLK----   82 (467)
T ss_pred             CCcccccccc-hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHH-HHhcCcchHHhhhhheee----
Confidence            3455678885 7799999999999999999999999999632      234567766 677789999999999886    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +..++++||||.||++.+.++..  +.+.|.++..++++++.||.|||+++.+|||||+.|||+.               
T Consensus        83 g~~LwiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---------------  145 (467)
T KOG0201|consen   83 GTKLWIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---------------  145 (467)
T ss_pred             cccHHHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---------------
Confidence            78899999999999999999764  3459999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  ..|.+|++|||.+...........+.+|||.|||||++....|+.++||||||++.+||++|.+||..
T Consensus       146 ------------~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~  213 (467)
T KOG0201|consen  146 ------------ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK  213 (467)
T ss_pred             ------------ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence                        45789999999999887766666889999999999999988999999999999999999999999976


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      .+......    .+  .. ..|+.....+|+.+++||..||.+||+.||||.++|+|+|++.
T Consensus       214 ~hPmrvlf----lI--pk-~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  214 LHPMRVLF----LI--PK-SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             cCcceEEE----ec--cC-CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            65532210    01  01 1233333478999999999999999999999999999999986

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.8e-47  Score=353.66  Aligned_cols=249  Identities=29%  Similarity=0.533  Sum_probs=205.9

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .||+|+||+||+|.+..+++.||+|++....        ...+|+.++..+.+||||+.+++++..    .+.+|+||||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~   77 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT----TSRLFLVIEY   77 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe----CCEEEEEEeC
Confidence            5999999999999999999999999996421        234666665666689999999999876    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +++|+|..++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                         
T Consensus        78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~-------------------------  130 (327)
T cd05617          78 VNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD-------------------------  130 (327)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe-------------------------
Confidence            9999999988765  3599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC---CC
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA---IS  251 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~  251 (372)
                        .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.......   ..
T Consensus       131 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~  208 (327)
T cd05617         131 --ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTE  208 (327)
T ss_pred             --CCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccH
Confidence              5677999999998754333334456789999999999999999999999999999999999999996433221   11


Q ss_pred             HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh------hHHhcCCccccCC
Q psy3151         252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI------DQVMENKWISQFN  308 (372)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~------~eil~hp~~~~~~  308 (372)
                      ......+.......|    ..++..+.++|.+||..||.+|+++      ++++.||||+...
T Consensus       209 ~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         209 DYLFQVILEKPIRIP----RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HHHHHHHHhCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            223333433333333    3678999999999999999999985      6999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.1e-47  Score=349.23  Aligned_cols=255  Identities=27%  Similarity=0.447  Sum_probs=200.0

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|++. +.||+|+||+||+|++..+++.||||++...       ....+|+.. ++.++||||+++++++..    +..
T Consensus         1 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~   74 (287)
T cd07848           1 NKFEVL-GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKM-LRTLKQENIVELKEAFRR----RGK   74 (287)
T ss_pred             CCceEE-EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHH-HHhCCCccccchhhhEec----CCE
Confidence            479985 7799999999999999999999999998632       234567776 677799999999999875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+.++.+..+... . ..+++..++.++.||+.||.|||+.||+||||||+||+++                  
T Consensus        75 ~~lv~e~~~~~~l~~~~~~-~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~------------------  134 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEM-P-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS------------------  134 (287)
T ss_pred             EEEEEecCCCCHHHHHHhc-C-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc------------------
Confidence            9999999988766544432 2 4599999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.+||+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+
T Consensus       135 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         135 ---------HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             ---------CCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence                     56779999999988654322 22334578999999999988889999999999999999999999996543


Q ss_pred             CCCCCHhHHHHH------------h---hCCccCCCC---------cccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         247 GQAISPGMKNRI------------R---LGQFDFPNP---------EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       247 ~~~~~~~~~~~~------------~---~~~~~~~~~---------~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      ..+....+....            .   ......+..         ....+|.++.+||++||++||++|||++++|+||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp  285 (287)
T cd07848         206 EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP  285 (287)
T ss_pred             HHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence            221110000000            0   000011110         0123688999999999999999999999999999


Q ss_pred             cc
Q psy3151         303 WI  304 (372)
Q Consensus       303 ~~  304 (372)
                      ||
T Consensus       286 ~f  287 (287)
T cd07848         286 AF  287 (287)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.2e-47  Score=359.88  Aligned_cols=255  Identities=29%  Similarity=0.507  Sum_probs=206.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..++|+++ +.||+|+||.||+|.+..+++.+|+|++...        ....+|+.+ ++.++||||+++++++..    
T Consensus        41 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i-~~~~~hp~iv~~~~~~~~----  114 (370)
T cd05621          41 KAEDYDVV-KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI-MAFANSPWVVQLFCAFQD----  114 (370)
T ss_pred             CHHHCeEE-EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHH-HHhCCCCCEeeEEEEEEc----
Confidence            45789995 7799999999999999999999999998532        123355555 677899999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +..+|+||||+++|+|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~---------------  176 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD---------------  176 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---------------
Confidence            77899999999999999998653   489999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCC----CCCCccchhhHHHHHHHHHhCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPD----KYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~  239 (372)
                                  .++.+||+|||+|........ ...+.+||+.|+|||++...    .++.++|+||+||++|+|++|.
T Consensus       177 ------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~  244 (370)
T cd05621         177 ------------KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD  244 (370)
T ss_pred             ------------CCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCC
Confidence                        567799999999986643222 23466899999999998653    3789999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCC--CCChhHHhcCCccccC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE--RLTIDQVMENKWISQF  307 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~--R~s~~eil~hp~~~~~  307 (372)
                      .||...+.    ......+.........+....++..+++++.+||..++.+  |+|++++++||||+..
T Consensus       245 ~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         245 TPFYADSL----VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CCCCCCCH----HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            99975542    2233344333222223333467999999999999865543  8999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.2e-47  Score=355.59  Aligned_cols=244  Identities=32%  Similarity=0.557  Sum_probs=204.2

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .||+|+||+||+|.+..+|+.||+|++....        ....|...+++.++||||+++++.+..    +..+|+||||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~----~~~~~lv~e~   77 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----TEKLYFVLDF   77 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec----CCEEEEEEcC
Confidence            5999999999999999999999999986421        223455555677899999999998876    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +.+|+|..++...  +.+++..++.++.||+.||+|||+.||+||||||+|||++                         
T Consensus        78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~-------------------------  130 (325)
T cd05604          78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD-------------------------  130 (325)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC-------------------------
Confidence            9999999888764  4599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhH
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM  254 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  254 (372)
                        .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.    ..+
T Consensus       131 --~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~  204 (325)
T cd05604         131 --SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV----AEM  204 (325)
T ss_pred             --CCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH----HHH
Confidence              56779999999987644333444566789999999999999999999999999999999999999976542    233


Q ss_pred             HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh----hHHhcCCccccC
Q psy3151         255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI----DQVMENKWISQF  307 (372)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~----~eil~hp~~~~~  307 (372)
                      ...+.......++    ..+.++.++|.+||+.||.+||++    .+++.||||...
T Consensus       205 ~~~~~~~~~~~~~----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         205 YDNILHKPLVLRP----GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             HHHHHcCCccCCC----CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            3444444333332    578999999999999999999987    489999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-47  Score=361.63  Aligned_cols=260  Identities=23%  Similarity=0.329  Sum_probs=204.4

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      ..+|.++ +.||+|+||.||+|.+..+++.||+|.... ....+|+.+ ++.++||||++++++|..    +...++|+|
T Consensus        91 ~~~y~~~-~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-~~~~~E~~i-l~~l~HpnIv~~~~~~~~----~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSIL-ETFTPGAEGFAFACIDNKTCEHVVIKAGQR-GGTATEAHI-LRAINHPSIIQLKGTFTY----NKFTCLILP  163 (391)
T ss_pred             cCCcEEE-EEEcCCCCeEEEEEEECCCCCEEEEechhh-hhhHHHHHH-HHhCCCCCCCCEeEEEEE----CCeeEEEEe
Confidence            3579995 779999999999999999999999997643 456788887 677799999999999976    678899999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      ++. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++                        
T Consensus       164 ~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~------------------------  216 (391)
T PHA03212        164 RYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN------------------------  216 (391)
T ss_pred             cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc------------------------
Confidence            994 6898888765  3589999999999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccC-CCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC--
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSN-KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI--  250 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--  250 (372)
                         ..+.+||+|||+|...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||........  
T Consensus       217 ---~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~  293 (391)
T PHA03212        217 ---HPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC  293 (391)
T ss_pred             ---CCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccC
Confidence               5667999999998653321 2223446789999999999988999999999999999999999988765432110  


Q ss_pred             -CHhHHHHH--------------------------hhCCc--cCCCCcc---cccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         251 -SPGMKNRI--------------------------RLGQF--DFPNPEW---EHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       251 -~~~~~~~~--------------------------~~~~~--~~~~~~~---~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                       .......+                          .....  ....+.|   ..++.++.+||.+||++||.+||||+|+
T Consensus       294 ~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~el  373 (391)
T PHA03212        294 DSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEAL  373 (391)
T ss_pred             chhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHH
Confidence             00000000                          00000  0001111   1346789999999999999999999999


Q ss_pred             hcCCccccCCCC
Q psy3151         299 MENKWISQFNQV  310 (372)
Q Consensus       299 l~hp~~~~~~~~  310 (372)
                      |+||||+.+...
T Consensus       374 L~hp~f~~~~~~  385 (391)
T PHA03212        374 LDFAAFQDIPDP  385 (391)
T ss_pred             hcChhhccCCCC
Confidence            999999876443

>KOG0986|consensus

Probab=100.00  E-value=1.5e-48  Score=354.01  Aligned_cols=268  Identities=29%  Similarity=0.457  Sum_probs=231.8

Q ss_pred             ccCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEe
Q psy3151           4 TFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIK   75 (372)
Q Consensus         4 ~~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~   75 (372)
                      +|++.+..|+..++....++||+|+||.||.++-+.||+-||+|.+.+..        .+..|..+ +...+.+-||.+-
T Consensus       173 QWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~i-L~kV~s~FiVsla  251 (591)
T KOG0986|consen  173 QWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQI-LEKVSSPFIVSLA  251 (591)
T ss_pred             HHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHH-HHHhccCcEEEEe
Confidence            46677777887777666788999999999999999999999999986432        34566666 6666889999999


Q ss_pred             EeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCC
Q psy3151          76 DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGG  155 (372)
Q Consensus        76 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~  155 (372)
                      ..|++    ...+++|+..|+||||.-+|.+..++.|++..++.++.+|+.||++||+.+||.|||||+|||+|      
T Consensus       252 YAfeT----kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD------  321 (591)
T KOG0986|consen  252 YAFET----KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD------  321 (591)
T ss_pred             eeecC----CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec------
Confidence            99987    77899999999999999999888777899999999999999999999999999999999999998      


Q ss_pred             ceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHH
Q psy3151         156 ILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       156 ~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  235 (372)
                                           +.|+++|+|+|+|..+.. .......+||.+|||||++.+..|+..+|.|||||+||+|
T Consensus       322 ---------------------d~GhvRISDLGLAvei~~-g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYem  379 (591)
T KOG0986|consen  322 ---------------------DHGHVRISDLGLAVEIPE-GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEM  379 (591)
T ss_pred             ---------------------cCCCeEeeccceEEecCC-CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHH
Confidence                                 788999999999998755 3344556999999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccCC
Q psy3151         236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQFN  308 (372)
Q Consensus       236 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~~  308 (372)
                      +.|+.||.......-..++..++......++    +..|+++++|.+.+|+.||++|..     ++++.+||||+.++
T Consensus       380 i~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln  453 (591)
T KOG0986|consen  380 IAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN  453 (591)
T ss_pred             HcccCchhhhhhhhhHHHHHHHHhcchhhcc----cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence            9999999766555544556666665555555    479999999999999999999985     77999999999764

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.9e-47  Score=347.42  Aligned_cols=260  Identities=24%  Similarity=0.400  Sum_probs=201.0

Q ss_pred             cceeeccccccccCCeEEEEEEEcC-CCcEEEEEEecch-------hhhHHHHHHHHHh--cCCCCEeEEeEeeeee-cC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKK-TSEVYALKVLHDT-------VKARREVELQLAV--GSHKHIVNIKDVYENI-YN   83 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~-------~~~~~e~~~~~~~--~~h~ni~~~~~~~~~~-~~   83 (372)
                      ++|+++ +.||+|+||+||+|.+.. +|+.||+|.+...       ....+|+.++..+  .+||||+++++++... ..
T Consensus         1 ~~Y~~~-~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECV-AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCccee-eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479985 679999999999999864 5788999988532       2344566654333  4799999999988532 12


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ....+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++              
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~--------------  144 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT--------------  144 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc--------------
Confidence            3557899999995 6999999876555699999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   .++.+||+|||++...... .......||+.|+|||++.+..++.++|+|||||++|+|++|.+||.
T Consensus       145 -------------~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~  210 (290)
T cd07862         145 -------------SSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  210 (290)
T ss_pred             -------------CCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence                         5677999999998765432 23345678999999999988889999999999999999999999997


Q ss_pred             CCCCCCCCHhHHHHHhhC---Cc----cCCC------------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         244 SNHGQAISPGMKNRIRLG---QF----DFPN------------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~---~~----~~~~------------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      +....+....+.......   .+    ..+.            .....++..+++||.+||+.||++|||+.++|+||||
T Consensus       211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            654332211111111000   00    0000            0012468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.7e-47  Score=352.43  Aligned_cols=244  Identities=34%  Similarity=0.573  Sum_probs=203.3

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      +||+|+||+||+|++..+|+.||+|++....        ...+|...+++.++||||+++++++..    .+..|+||||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~----~~~~~lv~e~   77 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT----AEKLYFVLDY   77 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc----CCEEEEEEcC
Confidence            5999999999999999999999999986321        233454445677899999999998875    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +++++|...+...  ..+++..++.++.||+.||.|||+.||+||||||+||+++                         
T Consensus        78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~-------------------------  130 (321)
T cd05603          78 VNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD-------------------------  130 (321)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC-------------------------
Confidence            9999999888764  4599999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhH
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM  254 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  254 (372)
                        .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.    ..+
T Consensus       131 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~  204 (321)
T cd05603         131 --SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----SQM  204 (321)
T ss_pred             --CCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----HHH
Confidence              56779999999987543333334456789999999999888999999999999999999999999976532    233


Q ss_pred             HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChh----HHhcCCccccC
Q psy3151         255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID----QVMENKWISQF  307 (372)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~----eil~hp~~~~~  307 (372)
                      ...+.......+.    ..+.++.++|.+||+.||.+|+++.    ++++|+||...
T Consensus       205 ~~~i~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         205 YDNILHKPLQLPG----GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             HHHHhcCCCCCCC----CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            4444444444442    5789999999999999999999864    99999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.8e-47  Score=355.84  Aligned_cols=255  Identities=33%  Similarity=0.564  Sum_probs=206.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|.+. +.||+|+||+||+|.+..+|+.||||++....        ...+|+.+ ++..+||||+++++++..    +.
T Consensus         1 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i-~~~~~~~~i~~~~~~~~~----~~   74 (330)
T cd05601           1 KDFDVK-SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDI-LSISNSPWIPQLQYAFQD----KD   74 (330)
T ss_pred             CCceEE-EEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH-HHhCCCCCCcceeeEEec----CC
Confidence            468884 77999999999999999999999999996432        23345555 677899999999998875    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+||||+++|+|.+++.+.. +.+++..++.++.||+.||+|||+.||+||||||+|||++                 
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~-----------------  136 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID-----------------  136 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC-----------------
Confidence            8999999999999999998753 4699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccC------CCCCCCccchhhHHHHHHHHHhCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLG------PDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                .++.+||+|||++........ .....+||+.|+|||++.      ...++.++|||||||++|+|++|.
T Consensus       137 ----------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~  206 (330)
T cd05601         137 ----------RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR  206 (330)
T ss_pred             ----------CCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCC
Confidence                      567899999999986643322 223457899999999986      456889999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      .||......    .....+.........+....+++++.+||.+||. +|.+|||+++++.||||....
T Consensus       207 ~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         207 SPFHEGTSA----KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             CCCCCCCHH----HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            999654322    2223332221111112223579999999999998 999999999999999998753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.3e-47  Score=360.50  Aligned_cols=251  Identities=31%  Similarity=0.569  Sum_probs=198.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      +.|+++ +.||+|+||+||+|.+..+++.||||++....        ...+|+.+ +..++||||+++++.|.+    +.
T Consensus         1 ~~f~~~-~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~iv~~~~~~~~----~~   74 (360)
T cd05627           1 DDFESL-KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI-LVEADGAWVVKMFYSFQD----KR   74 (360)
T ss_pred             CCceEE-EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHH-HHhCCCCCEeeEEEEEEc----CC
Confidence            468885 77999999999999999999999999996321        23456665 566699999999999876    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ++|+||||++||+|.+++.+.  +.+++..++.++.|++.||+|||+.||+||||||+|||++                 
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~-----------------  135 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD-----------------  135 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC-----------------
Confidence            899999999999999999765  4599999999999999999999999999999999999997                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccC-----------------------------------CCcccccccCCCcCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSN-----------------------------------KASLQTPCYTPYYVAP  211 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~-----------------------------------~~~~~~~~gt~~y~aP  211 (372)
                                .++.++|+|||++......                                   .......+||+.|+||
T Consensus       136 ----------~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  205 (360)
T cd05627         136 ----------AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAP  205 (360)
T ss_pred             ----------CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCH
Confidence                      3344555555554432110                                   0112245799999999


Q ss_pred             cccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhC--CccCCCCcccccCHHHHHHHHHhccCCC
Q psy3151         212 EVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG--QFDFPNPEWEHVSQEAKTLIKNMLCVDP  289 (372)
Q Consensus       212 E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~ll~~dP  289 (372)
                      |++.+..++.++|+|||||++|+|++|..||.+.+..    .....+...  ...+|.  ...+++++++||.+|+. ||
T Consensus       206 E~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~~-~p  278 (360)
T cd05627         206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ----ETYRKVMNWKETLVFPP--EVPISEKAKDLILRFCT-DS  278 (360)
T ss_pred             HHHcCCCCCCcceeccccceeeecccCCCCCCCCCHH----HHHHHHHcCCCceecCC--CCCCCHHHHHHHHHhcc-Ch
Confidence            9999999999999999999999999999999765432    223333322  222332  23478999999999874 99


Q ss_pred             CCCCC---hhHHhcCCccccC
Q psy3151         290 SERLT---IDQVMENKWISQF  307 (372)
Q Consensus       290 ~~R~s---~~eil~hp~~~~~  307 (372)
                      .+|++   ++++++||||.++
T Consensus       279 ~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         279 ENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             hhcCCCCCHHHHhcCCCCCCC
Confidence            99984   7999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=345.39  Aligned_cols=254  Identities=28%  Similarity=0.468  Sum_probs=208.7

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .|+++ +.||+|+||+||+|.+..+++.||||++...        ....+|+.+ ++.++||||+.+++++..    +..
T Consensus         1 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~   74 (285)
T cd05605           1 TFRHY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI-LEKVNSRFVVSLAYAYET----KDA   74 (285)
T ss_pred             CceEE-EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHH-HHhcCCCCEeeeeeeecC----CCe
Confidence            47774 7799999999999999999999999998632        123457776 566699999999998875    568


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +++||||+.+|+|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++                  
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~------------------  136 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD------------------  136 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC------------------
Confidence            99999999999999888765445699999999999999999999999999999999999997                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               +++.++|+|||++...... ......+|++.|+|||++.+..++.++|+||+||++|+|++|..||.+...
T Consensus       137 ---------~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~  206 (285)
T cd05605         137 ---------DYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE  206 (285)
T ss_pred             ---------CCCCEEEeeCCCceecCCC-CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence                     5677999999998765332 222345789999999999888899999999999999999999999976544


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      ......+...+.......+    ..++..+.+||.+||..||.+||     +++++++||||...
T Consensus       207 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         207 KVKREEVERRVKEDQEEYS----EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             hhHHHHHHHHhhhcccccC----cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            3322223333333222222    35899999999999999999999     89999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0192|consensus

Probab=100.00  E-value=1.1e-46  Score=350.62  Aligned_cols=240  Identities=28%  Similarity=0.454  Sum_probs=198.0

Q ss_pred             cccccccCCeEEEEEEEcCCCcE-EEEEEecchh-------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce-EEEEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEV-YALKVLHDTV-------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR-CLLVI   91 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~-vaiK~~~~~~-------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~-~~~lv   91 (372)
                      .+.||.|+||+||+|...  |.. ||||++....       ...+|+.+ +..++|||||.+++++..    .. .+.+|
T Consensus        46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~i-l~~l~HpNIV~f~G~~~~----~~~~~~iV  118 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASL-LSRLRHPNIVQFYGACTS----PPGSLCIV  118 (362)
T ss_pred             hhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHH-HHhCCCCCeeeEEEEEcC----CCCceEEE
Confidence            456999999999999986  555 9999997532       56778887 666899999999999875    23 68999


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~-ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      |||+++|+|.+++.......++...+..++.||++||+|||+++ ||||||||+|||++                     
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---------------------  177 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---------------------  177 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---------------------
Confidence            99999999999998744467999999999999999999999999 99999999999998                     


Q ss_pred             ccCCCCCCC-CeeeeccccccccccCCCcccccccCCCcCCCcccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         171 LYTKPGDGG-ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG--PDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       171 ~~~~~~~~~-~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                            ..+ ++||+|||+++.............||+.|||||++.  ...|+.++|+||||+++|||+||..||.+...
T Consensus       178 ------~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  178 ------LKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             ------CCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence                  454 899999999987654334444578999999999999  56999999999999999999999999976654


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..    ....+.......+.+  ..+++.+..||.+||..||++||+..+++.
T Consensus       252 ~~----~~~~v~~~~~Rp~~p--~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  252 VQ----VASAVVVGGLRPPIP--KECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HH----HHHHHHhcCCCCCCC--ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            22    222222222211111  248999999999999999999999999865

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.8e-47  Score=354.41  Aligned_cols=244  Identities=33%  Similarity=0.593  Sum_probs=203.3

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .||+|+||+||+|.+..+++.||+|++....        ....|...+++.++||||+++++++..    +..+|+||||
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~----~~~~~lv~e~   77 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----ADKLYFVLDY   77 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc----CCeEEEEEeC
Confidence            5999999999999999999999999986321        223444444677899999999999875    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +.+++|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+|||++                         
T Consensus        78 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~-------------------------  130 (325)
T cd05602          78 INGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD-------------------------  130 (325)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC-------------------------
Confidence            9999999998764  4589999999999999999999999999999999999998                         


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhH
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM  254 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  254 (372)
                        .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..    ..
T Consensus       131 --~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~  204 (325)
T cd05602         131 --SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EM  204 (325)
T ss_pred             --CCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH----HH
Confidence              567799999999876544344445678999999999999999999999999999999999999999754432    23


Q ss_pred             HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChh----HHhcCCccccC
Q psy3151         255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID----QVMENKWISQF  307 (372)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~----eil~hp~~~~~  307 (372)
                      ...+.......+    ..++.++.++|.+||+.||.+|+++.    ++++|+||..+
T Consensus       205 ~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         205 YDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             HHHHHhCCcCCC----CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence            333333333332    36899999999999999999999976    89999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.9e-47  Score=366.60  Aligned_cols=267  Identities=24%  Similarity=0.421  Sum_probs=204.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-hhhHHHHHHHHHhcCCCCEeEEeEeeeeec----CCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARREVELQLAVGSHKHIVNIKDVYENIY----NGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~----~~~~~   87 (372)
                      ...+|++ .+.||+|+||+||+|.+..+++.||||.+... ....+|+.+ ++.++||||++++++|....    ....+
T Consensus        64 ~~~~y~~-~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~i-l~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         64 PNKSYKL-GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI-MKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             cCCeEEE-eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHH-HHhcCCCCCcceeeeEeecccccCCCceE
Confidence            3468998 58899999999999999999999999988543 334567777 67779999999998874321    12346


Q ss_pred             EEEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          88 LLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +++||||+. ++|.+++..  .....+++..++.++.||+.||+|||+.||+||||||+|||++.               
T Consensus       142 l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~---------------  205 (440)
T PTZ00036        142 LNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP---------------  205 (440)
T ss_pred             EEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC---------------
Confidence            789999996 478777653  22356999999999999999999999999999999999999973               


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                 ..+.+||+|||+|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+
T Consensus       206 -----------~~~~vkL~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  273 (440)
T PTZ00036        206 -----------NTHTLKLCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG  273 (440)
T ss_pred             -----------CCCceeeeccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                       34569999999998664322 2334678999999998755 4699999999999999999999999976


Q ss_pred             CCCCCCCHhHHHHHh-------------hCCccCCCCc--------ccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         245 NHGQAISPGMKNRIR-------------LGQFDFPNPE--------WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~--------~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      ....+....+.....             ...+.++...        ....++++++||.+||++||.+|||+.|+|+|||
T Consensus       274 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        274 QSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             CChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence            543222111111100             0011111100        1246789999999999999999999999999999


Q ss_pred             cccCCC
Q psy3151         304 ISQFNQ  309 (372)
Q Consensus       304 ~~~~~~  309 (372)
                      |..+..
T Consensus       354 f~~~~~  359 (440)
T PTZ00036        354 FDDLRD  359 (440)
T ss_pred             HHhhhc
Confidence            987654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-46  Score=350.57  Aligned_cols=244  Identities=35%  Similarity=0.609  Sum_probs=204.3

Q ss_pred             ccccccCCeEEEEEEEc---CCCcEEEEEEecchh---------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          22 EILGLGINGKVLQIVEK---KTSEVYALKVLHDTV---------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +.||+|+||.||+|.+.   .+++.||||++....         ...+|+.+ ++.++||||++++++|..    +..+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hp~iv~~~~~~~~----~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI-LEAVKHPFIVDLIYAFQT----GGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHH-HHhCCCCchhceeeEEec----CCeEE
Confidence            46999999999999874   478999999986321         23456766 677799999999999876    67899


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+.+++|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                    
T Consensus        77 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~--------------------  134 (323)
T cd05584          77 LILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD--------------------  134 (323)
T ss_pred             EEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC--------------------
Confidence            999999999999998765  4589999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA  249 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  249 (372)
                             .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.  
T Consensus       135 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--  205 (323)
T cd05584         135 -------AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--  205 (323)
T ss_pred             -------CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--
Confidence                   56789999999987554333334456789999999999888899999999999999999999999965432  


Q ss_pred             CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                        ......+..+....|.    .+++++.+||.+||+.||++||     ++++++.||||...
T Consensus       206 --~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         206 --KKTIDKILKGKLNLPP----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             --HHHHHHHHcCCCCCCC----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence              2234444445544443    5789999999999999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-47  Score=355.60  Aligned_cols=244  Identities=33%  Similarity=0.615  Sum_probs=202.8

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhc--CCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG--SHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~--~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      ||+|+||+||+|++..+|+.||||++....        ....|..++....  +||||+.++++|..    ...+|+|||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~----~~~~~lv~e   76 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT----DSDLYLVTD   76 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec----CCeEEEEEc
Confidence            799999999999999999999999986321        1223445544444  89999999999876    678999999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      |+.+|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                        
T Consensus        77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~------------------------  130 (330)
T cd05586          77 YMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD------------------------  130 (330)
T ss_pred             CCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC------------------------
Confidence            99999999998764  4599999999999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCH
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP  252 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  252 (372)
                         .++.++|+|||++.............+||+.|+|||++.+. .++.++|||||||++|+|++|..||.....    .
T Consensus       131 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~  203 (330)
T cd05586         131 ---ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----Q  203 (330)
T ss_pred             ---CCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH----H
Confidence               56779999999987654434444567899999999998654 589999999999999999999999965432    3


Q ss_pred             hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC----ChhHHhcCCccccC
Q psy3151         253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL----TIDQVMENKWISQF  307 (372)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~----s~~eil~hp~~~~~  307 (372)
                      .+...+..+...++.   ..+++++.+||++||..||.+||    +++++++||||...
T Consensus       204 ~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         204 QMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             HHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            344555555555543   35789999999999999999998    68999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.7e-46  Score=354.10  Aligned_cols=263  Identities=26%  Similarity=0.418  Sum_probs=203.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--   82 (372)
                      .+.++|+++ +.||+|+||.||+|.+..+|+.||||++...       ....+|+.+ ++.++||||++++++|....  
T Consensus        18 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQL-KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVL-LKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEE-EEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHH-HHhCCCCCEeeeeeeeccCCCc
Confidence            578999995 7799999999999999999999999998532       234567776 67779999999999986321  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      .....+|+||||+.+ +|.+.+..    .+++..++.++.||+.||+|||+.||+||||||+|||++             
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~-------------  157 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-------------  157 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC-------------
Confidence            123468999999965 67776642    389999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    .++.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       158 --------------~~~~~kl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf  222 (359)
T cd07876         158 --------------SDCTLKILDFGLARTACT-NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF  222 (359)
T ss_pred             --------------CCCCEEEecCCCcccccc-CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence                          567899999999875432 22234467899999999999889999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHH------------------HHhhCCccCCC----------------CcccccCHHHHHHHHHhccCC
Q psy3151         243 FSNHGQAISPGMKN------------------RIRLGQFDFPN----------------PEWEHVSQEAKTLIKNMLCVD  288 (372)
Q Consensus       243 ~~~~~~~~~~~~~~------------------~~~~~~~~~~~----------------~~~~~~s~~~~~li~~ll~~d  288 (372)
                      .+.+.......+..                  .........+.                ......++++++||.+||+.|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d  302 (359)
T cd07876         223 QGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID  302 (359)
T ss_pred             CCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccC
Confidence            76542211000000                  00000000000                001124678999999999999


Q ss_pred             CCCCCChhHHhcCCccccCCC
Q psy3151         289 PSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       289 P~~R~s~~eil~hp~~~~~~~  309 (372)
                      |++|||+.|+|+||||..+..
T Consensus       303 P~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         303 PDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             cccCCCHHHHhcCchhhhhcC
Confidence            999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-46  Score=351.75  Aligned_cols=250  Identities=30%  Similarity=0.549  Sum_probs=206.5

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      |++. +.||+|+||+||+|.++.+|+.||||++....        ....|..++....+|++|+++++++..    ...+
T Consensus         2 f~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~   76 (323)
T cd05615           2 FNFL-MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT----VDRL   76 (323)
T ss_pred             ceEE-EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec----CCEE
Confidence            5663 77999999999999999999999999986321        234566664445567888899998876    6689


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+++|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                   
T Consensus        77 ~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~-------------------  135 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD-------------------  135 (323)
T ss_pred             EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC-------------------
Confidence            9999999999999998765  4599999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.+||+|||++.............+||+.|+|||++.+..++.++|+||+||++|+|++|..||.+... 
T Consensus       136 --------~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-  206 (323)
T cd05615         136 --------SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-  206 (323)
T ss_pred             --------CCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-
Confidence                    56779999999987654333334456789999999999888999999999999999999999999966542 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccCC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQFN  308 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~~  308 (372)
                         ......+......+|    ..++.++.+++.+||+.||.+|++     .+++++||||+.+.
T Consensus       207 ---~~~~~~i~~~~~~~p----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         207 ---DELFQSIMEHNVSYP----KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             ---HHHHHHHHhCCCCCC----ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence               233444444444444    367899999999999999999998     47899999998753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.5e-46  Score=340.81  Aligned_cols=248  Identities=27%  Similarity=0.433  Sum_probs=201.6

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      ||+|+||+||++.+..+|+.||+|.+...        .....|+++ ++.++||||++++++++.    +.++|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~i-l~~l~hp~i~~~~~~~~~----~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-LEKVNSPFIVNLAYAFES----KTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHH-HHhcCCCcEEEEEEEEec----CCeEEEEEecC
Confidence            79999999999999999999999998532        123457776 566699999999999875    67899999999


Q ss_pred             CCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151          96 HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus        96 ~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                      .|++|.+++.......+++..+..++.||+.||+|||+.||+||||||+||+++                          
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~--------------------------  129 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD--------------------------  129 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc--------------------------
Confidence            999999988765545689999999999999999999999999999999999998                          


Q ss_pred             CCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHH
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK  255 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  255 (372)
                       .++.++|+|||++...... .......||+.|+|||++.+..++.++|+||+||++|+|++|..||...........+.
T Consensus       130 -~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~  207 (277)
T cd05607         130 -DQGNCRLSDLGLAVELKDG-KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK  207 (277)
T ss_pred             -CCCCEEEeeceeeeecCCC-ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH
Confidence             5667999999998765432 22234568999999999988889999999999999999999999996543222112222


Q ss_pred             HHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh----hHHhcCCccccC
Q psy3151         256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI----DQVMENKWISQF  307 (372)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~----~eil~hp~~~~~  307 (372)
                      ..........+   ...+++++++||.+||+.||.+||++    ++++.||||+.+
T Consensus       208 ~~~~~~~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         208 RRTLEDEVKFE---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             HHhhccccccc---cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence            33222222222   13679999999999999999999999    678899999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0612|consensus

Probab=100.00  E-value=3.7e-48  Score=383.76  Aligned_cols=253  Identities=33%  Similarity=0.594  Sum_probs=216.1

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      .++|.|+ ++||+|+||.|.+++++.|++.||+|++++.       ...++|.+-.+...+.+-|+.++..|.+    ++
T Consensus        74 ~~Dfeil-KvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD----~~  148 (1317)
T KOG0612|consen   74 AEDFEIL-KVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD----ER  148 (1317)
T ss_pred             HHhhHHH-HHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC----cc
Confidence            3689996 8999999999999999999999999999742       1223444333777889999999999987    89


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ++|+||||++||||..++.+..  +++++.++.|+..|+.||+-||+.|+|||||||+|||++                 
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld-----------------  209 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD-----------------  209 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec-----------------
Confidence            9999999999999999998875  699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccc-cCCCcccccccCCCcCCCcccC----C-CCCCCccchhhHHHHHHHHHhCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIV-SNKASLQTPCYTPYYVAPEVLG----P-DKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~-~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                ..|++|++|||.+-... ++.......+|||.|+|||++.    + +.|++.+|.||+||++|||+.|..
T Consensus       210 ----------~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T  279 (1317)
T KOG0612|consen  210 ----------KSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET  279 (1317)
T ss_pred             ----------ccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence                      67889999999988776 4455677889999999999983    3 679999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhC--CccCCCCcccccCHHHHHHHHHhccCCCCCCCC---hhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLG--QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT---IDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s---~~eil~hp~~~~~  307 (372)
                      ||+..+-.+.    ..+|...  .+.+|..  ..+|.++++||.++++ +|+.|..   ++++..||||.+.
T Consensus       280 PFYadslveT----Y~KIm~hk~~l~FP~~--~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  280 PFYADSLVET----YGKIMNHKESLSFPDE--TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             cchHHHHHHH----HHHHhchhhhcCCCcc--cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence            9976654333    4444443  4556622  3599999999999998 8999998   9999999999875

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.6e-46  Score=350.34  Aligned_cols=255  Identities=24%  Similarity=0.391  Sum_probs=205.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .++|+++ +.||+|+||.||+|.+..+|..+|+|++...      ....+|+.. ++.++||||+++++++..    +..
T Consensus         4 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~   77 (331)
T cd06649           4 DDDFERI-SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQV-LHECNSPYIVGFYGAFYS----DGE   77 (331)
T ss_pred             cccceEE-EeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHH-HHHCCCCCCCeEEEEEEE----CCE
Confidence            5789995 6799999999999999999999999998632      235577776 566799999999999876    668


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .++||||+++++|.+++....  .+++..++.++.|++.||.|||+. +|+||||||+|||++                 
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-----------------  138 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN-----------------  138 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc-----------------
Confidence            999999999999999997653  599999999999999999999986 699999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.++|+|||++.....  ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+
T Consensus       139 ----------~~~~~kl~Dfg~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         139 ----------SRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             ----------CCCcEEEccCcccccccc--cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence                      567799999999876532  22334578999999999998899999999999999999999999996433


Q ss_pred             CCCCCHh------------------------------------------HHHHHhhCCccCCCCcccccCHHHHHHHHHh
Q psy3151         247 GQAISPG------------------------------------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNM  284 (372)
Q Consensus       247 ~~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~l  284 (372)
                      ..+....                                          ....+...  ..+......+++++++||.+|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~  284 (331)
T cd06649         207 AKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNE--PPPKLPNGVFTPDFQEFVNKC  284 (331)
T ss_pred             HHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhC--CCcCCCCccccHHHHHHHHHH
Confidence            2111000                                          00000000  001111124788999999999


Q ss_pred             ccCCCCCCCChhHHhcCCccccC
Q psy3151         285 LCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       285 l~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |++||++|||+.++++||||+..
T Consensus       285 L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         285 LIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccCCcccCCCHHHHhcChHHhhc
Confidence            99999999999999999999763

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.7e-46  Score=354.64  Aligned_cols=251  Identities=27%  Similarity=0.427  Sum_probs=200.8

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .++|+++ +.||.|+||+||+|.+..+|+.||||++...      ....+|+++ ++.++|+||+++++++..    +..
T Consensus        73 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~  146 (353)
T PLN00034         73 LSELERV-NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEI-LRDVNHPNVVKCHDMFDH----NGE  146 (353)
T ss_pred             HHHHhhh-hhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHH-HHhCCCCCcceeeeEecc----CCe
Confidence            4678875 6799999999999999999999999998532      234577777 677799999999999875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+.+++|...      ...++..+..++.||+.||+|||++||+||||||+|||++                  
T Consensus       147 ~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~------------------  202 (353)
T PLN00034        147 IQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN------------------  202 (353)
T ss_pred             EEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc------------------
Confidence            9999999999998643      2367888999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-----CCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-----DKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                               .++.+||+|||++.............+||..|+|||++..     ...+.++|||||||++|+|++|..||
T Consensus       203 ---------~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf  273 (353)
T PLN00034        203 ---------SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF  273 (353)
T ss_pred             ---------CCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCC
Confidence                     5677999999998876443333445678999999998743     23456899999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ......+. ......+...   .+......++.++++||.+||+.||++|||+.|+++||||.+.
T Consensus       274 ~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        274 GVGRQGDW-ASLMCAICMS---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             CCCCCccH-HHHHHHHhcc---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            74333222 1122222111   1122224678999999999999999999999999999999874

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.6e-46  Score=353.20  Aligned_cols=264  Identities=25%  Similarity=0.402  Sum_probs=204.0

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec-
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY-   82 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~-   82 (372)
                      ..+.++|++. +.||+|+||.||+|.+..+++.||||++...       ....+|+.+ ++.++||||+++++++.... 
T Consensus        20 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~ii~~~~~~~~~~~   97 (364)
T cd07875          20 FTVLKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL-MKCVNHKNIIGLLNVFTPQKS   97 (364)
T ss_pred             hchhcceeEE-EEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHH-HHhcCCCCccccceeeccccc
Confidence            3477999995 7799999999999999999999999998532       234567766 67779999999999885321 


Q ss_pred             -CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          83 -NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        83 -~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                       ......|+||||+. ++|.+.+..    .+++..++.++.|++.||+|||++||+||||||+|||++            
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~------------  160 (364)
T cd07875          98 LEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK------------  160 (364)
T ss_pred             ccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC------------
Confidence             22356899999996 478777753    389999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                     .++.+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       161 ---------------~~~~~kL~DfG~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p  224 (364)
T cd07875         161 ---------------SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL  224 (364)
T ss_pred             ---------------CCCcEEEEeCCCccccCC-CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCC
Confidence                           567799999999976533 2223445789999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHh------------------hCC----------------ccCCCCcccccCHHHHHHHHHhccC
Q psy3151         242 FFSNHGQAISPGMKNRIR------------------LGQ----------------FDFPNPEWEHVSQEAKTLIKNMLCV  287 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~------------------~~~----------------~~~~~~~~~~~s~~~~~li~~ll~~  287 (372)
                      |.+.+..+....+.....                  ...                ++.........+.++++||.+||+.
T Consensus       225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  304 (364)
T cd07875         225 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI  304 (364)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCc
Confidence            966543211111100000                  000                0000011122457899999999999


Q ss_pred             CCCCCCChhHHhcCCccccCCC
Q psy3151         288 DPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       288 dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      ||.+|||+.++|+||||..+..
T Consensus       305 dP~~R~t~~e~L~hp~~~~~~~  326 (364)
T cd07875         305 DASKRISVDEALQHPYINVWYD  326 (364)
T ss_pred             CcccCCCHHHHhcCcccccccC
Confidence            9999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.8e-46  Score=354.20  Aligned_cols=254  Identities=30%  Similarity=0.520  Sum_probs=205.4

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|++. +.||+|+||.||+|.+..+++.||+|++....        ...+|+.+ ++.++||||+++++++..    +
T Consensus        42 ~~~y~i~-~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i-~~~~~hp~iv~~~~~~~~----~  115 (371)
T cd05622          42 AEDYEVV-KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI-MAFANSPWVVQLFYAFQD----D  115 (371)
T ss_pred             hhhcEEE-EEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHH-HHhCCCCCCCeEEEEEEc----C
Confidence            4799995 77999999999999999999999999985321        12345554 677899999999999875    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      .++|+||||+.+|+|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~----------------  176 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----------------  176 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC----------------
Confidence            7899999999999999998653   489999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCC----CCCCccchhhHHHHHHHHHhCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPD----KYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                 .++.+||+|||++........ .....+||+.|+|||++...    .++.++|||||||++|+|++|..
T Consensus       177 -----------~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~  245 (371)
T cd05622         177 -----------KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT  245 (371)
T ss_pred             -----------CCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCC
Confidence                       567799999999886643221 23456799999999998653    37899999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCC--CCChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE--RLTIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~--R~s~~eil~hp~~~~~  307 (372)
                      ||...+.    ......+.......+.+....++.++++||.+||..++.+  |++++++++||||++.
T Consensus       246 Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         246 PFYADSL----VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CCCCCCH----HHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            9975442    2233444333222223334578999999999999844433  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG4236|consensus

Probab=100.00  E-value=6.8e-48  Score=355.07  Aligned_cols=260  Identities=35%  Similarity=0.597  Sum_probs=230.5

Q ss_pred             Ccccceee-ccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          12 PIQDDYDI-STEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        12 ~~~~~Y~i-~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      .|..-|+| -+++||+|.||+||-|+++++|+.||||++.+       ....+.|+++ +..+.||.||.+--.|+.   
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaI-Lq~l~HPGiV~le~M~ET---  634 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAI-LQNLHHPGIVNLECMFET---  634 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHH-HHhcCCCCeeEEEEeecC---
Confidence            36667777 46789999999999999999999999999963       3456789988 677799999999998886   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ...+++|||-+ .|++.++|.....+++++..-+.++.||+.||.|||.++|+|.||||+|||+.+.+           
T Consensus       635 -~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-----------  701 (888)
T KOG4236|consen  635 -PERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-----------  701 (888)
T ss_pred             -CceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-----------
Confidence             67899999999 56898999888888999999999999999999999999999999999999998654           


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   +...+||||||+|+.+.. .......+|||.|+|||++....|+..-||||.|+|+|--+.|..||.
T Consensus       702 -------------~FPQvKlCDFGfARiIgE-ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  702 -------------PFPQVKLCDFGFARIIGE-KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             -------------CCCceeeccccceeecch-hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence                         456689999999988754 455678899999999999999999999999999999999999999994


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      .  +    +.+...+....|-+|+..|..++.++.|||..+|++.-.+|.|.+..|.|||++++.
T Consensus       768 E--d----EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  768 E--D----EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             C--c----cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            3  2    235677888889999999999999999999999999999999999999999998864

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.5e-46  Score=341.60  Aligned_cols=259  Identities=25%  Similarity=0.422  Sum_probs=200.9

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHh--cCCCCEeEEeEeeeeec-CCc
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAV--GSHKHIVNIKDVYENIY-NGS   85 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~--~~h~ni~~~~~~~~~~~-~~~   85 (372)
                      +|+++ +.||+|+||+||+|.+..+|+.||+|.+...       ....+|+..+..+  .+||||+++++++.... ...
T Consensus         1 ~y~~~-~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPV-AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEe-eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            58885 6799999999999999999999999998632       1344666664333  47999999999886422 234


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+++||||+. ++|.+++.......+++..++.++.||+.||+|||+.||+||||||+||+++                
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----------------  142 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----------------  142 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----------------
Confidence            57899999996 5899988775555699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||++...... .......||+.|+|||++.+..++.++||||+||++|+|++|.+||...
T Consensus       143 -----------~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         143 -----------SGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             -----------CCCCEEECccCccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence                       5677999999998765432 2233456799999999998888999999999999999999999999654


Q ss_pred             CCCCCCHhHHHHHhh-------CCcc-----CCC-------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         246 HGQAISPGMKNRIRL-------GQFD-----FPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~-------~~~~-----~~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ........+......       ....     +..       .....++.++.+||.+||+.||++|||+.+++.||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            332211111111100       0000     000       0113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0690|consensus

Probab=100.00  E-value=1.2e-47  Score=335.31  Aligned_cols=253  Identities=35%  Similarity=0.641  Sum_probs=221.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhh-hHHH-------HHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARRE-------VELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~e-------~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      -.++|+.+ ++||+|.||+|.+|+.+.+|+.||||++++..- +..|       -+. +...+||.+..+...|+.    
T Consensus       166 Tm~dFdfL-KvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RV-L~~~~HPFLt~LKYsFQt----  239 (516)
T KOG0690|consen  166 TMEDFDFL-KVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRV-LQNCRHPFLTSLKYSFQT----  239 (516)
T ss_pred             ccchhhHH-HHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHH-HHhccCcHHHHhhhhhcc----
Confidence            34667775 889999999999999999999999999975432 2233       333 556689999998888876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+++||||.+||.|.-.+.+..  .++|...+.+-..|+.||.|||+++||.||||.+|+|++               
T Consensus       240 ~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD---------------  302 (516)
T KOG0690|consen  240 QDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD---------------  302 (516)
T ss_pred             CceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec---------------
Confidence            778999999999999999887653  599999999999999999999999999999999999999               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .+|.+||+|||+++..........+.||||.|+|||++....|+.++|.|.+||++|||++|+.||..
T Consensus       303 ------------kDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  303 ------------KDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             ------------cCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence                        67889999999998877777778899999999999999999999999999999999999999999987


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccCC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQFN  308 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~~  308 (372)
                      .+.    ..+...+..+.+.+|.    .++++++.|+..+|.+||.+|..     |.++.+|+||..++
T Consensus       371 ~dh----~kLFeLIl~ed~kFPr----~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  371 KDH----EKLFELILMEDLKFPR----TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             cch----hHHHHHHHhhhccCCc----cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence            664    4456777777888875    78999999999999999999985     88999999998764

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5e-46  Score=351.75  Aligned_cols=262  Identities=26%  Similarity=0.417  Sum_probs=202.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--   82 (372)
                      .+.++|+++ +.||+|+||.||+|.+..+++.||||.+...       ....+|+.+ ++.++||||++++++|....  
T Consensus        14 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL-MKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEE-EEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHH-HHHhCCCchhceeeeeeccccc
Confidence            478999995 7799999999999999999999999998632       234567766 67779999999999886321  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ......|+||||+.+ +|.+.+..    .+++..++.++.|++.||+|||++||+||||||+|||++             
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~-------------  153 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-------------  153 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC-------------
Confidence            123468999999964 77777653    389999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    .++.+||+|||+++.... .......+||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       154 --------------~~~~~kl~Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  218 (355)
T cd07874         154 --------------SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF  218 (355)
T ss_pred             --------------CCCCEEEeeCcccccCCC-ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                          567799999999876533 22234467899999999999889999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHH-------------------Hhh----CCccCC-----------CCcccccCHHHHHHHHHhccCC
Q psy3151         243 FSNHGQAISPGMKNR-------------------IRL----GQFDFP-----------NPEWEHVSQEAKTLIKNMLCVD  288 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~-------------------~~~----~~~~~~-----------~~~~~~~s~~~~~li~~ll~~d  288 (372)
                      .+.+...........                   ...    ....++           .......+.++++||.+||..|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d  298 (355)
T cd07874         219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID  298 (355)
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCC
Confidence            654321110000000                   000    000000           0111234678899999999999


Q ss_pred             CCCCCChhHHhcCCccccCC
Q psy3151         289 PSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       289 P~~R~s~~eil~hp~~~~~~  308 (372)
                      |++|||+.|+|+||||..+.
T Consensus       299 P~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         299 PAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             chhcCCHHHHhcCcchhccc
Confidence            99999999999999998664

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-45  Score=343.51  Aligned_cols=257  Identities=27%  Similarity=0.444  Sum_probs=193.7

Q ss_pred             cccccccCCeEEEEEEEc--CCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          21 TEILGLGINGKVLQIVEK--KTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      +..||+|+||+||+|.+.  .+++.||+|.+...   ....+|+.+ ++.++||||++++++|..  ..+...|++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~--~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIAL-LRELKHPNVISLQKVFLS--HADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHH-HHhcCCCCCcceeeeEec--CCCcEEEEEEecc
Confidence            456999999999999975  47799999998643   346678887 677799999999998854  2356789999999


Q ss_pred             CCCchhHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          96 HGGELFQRIQQKE-------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        96 ~~g~L~~~i~~~~-------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      . ++|.+++....       ...+++..++.++.||+.||+|||++||+||||||+|||+..+++               
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~---------------  146 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP---------------  146 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCC---------------
Confidence            5 58888876421       125899999999999999999999999999999999999964322               


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCC---CcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNK---ASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                              ..+.+||+|||+|.......   ......+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||..
T Consensus       147 --------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         147 --------ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             --------CcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence                    56789999999997654322   12345678999999999866 4589999999999999999999999965


Q ss_pred             CCCCCC-----CHhHHHHHhh-CC------------cc-------------CC--------CCcccccCHHHHHHHHHhc
Q psy3151         245 NHGQAI-----SPGMKNRIRL-GQ------------FD-------------FP--------NPEWEHVSQEAKTLIKNML  285 (372)
Q Consensus       245 ~~~~~~-----~~~~~~~~~~-~~------------~~-------------~~--------~~~~~~~s~~~~~li~~ll  285 (372)
                      ......     .......+.. ..            .+             ..        .......+.++.+||.+||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  298 (317)
T cd07868         219 RQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL  298 (317)
T ss_pred             CcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHh
Confidence            432110     0000000000 00            00             00        0000123567999999999


Q ss_pred             cCCCCCCCChhHHhcCCcc
Q psy3151         286 CVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       286 ~~dP~~R~s~~eil~hp~~  304 (372)
                      ++||.+|||++|+|+||||
T Consensus       299 ~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         299 TMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ccCcccCCCHHHHhcCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.3e-46  Score=344.89  Aligned_cols=260  Identities=25%  Similarity=0.430  Sum_probs=205.2

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|.++ +.||+|+||+||+|.+..+++.||+|.+...      ....+|+.+ ++.++||||+++++++..    +...
T Consensus         6 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~~   79 (309)
T cd07872           6 ETYIKL-EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSL-LKDLKHANIVTLHDIVHT----DKSL   79 (309)
T ss_pred             CceEEE-EEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHH-HHhCCCCCcceEEEEEee----CCeE
Confidence            679885 7799999999999999999999999998632      234567776 666799999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++                   
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~-------------------  138 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN-------------------  138 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-------------------
Confidence            999999964 8888886643 4589999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                              ..+.+||+|||++..............+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.
T Consensus       139 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  210 (309)
T cd07872         139 --------ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV  210 (309)
T ss_pred             --------CCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                    5677999999998765443333445567999999998754 5688999999999999999999999966543


Q ss_pred             CCCCHhHHHHHh---------------hCCccCCC-------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         248 QAISPGMKNRIR---------------LGQFDFPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       248 ~~~~~~~~~~~~---------------~~~~~~~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      .+....+.....               ......+.       .....++.++++||.+||+.||.+|||++|+++||||+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         211 EDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             HHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence            221111111000               00011111       01134788999999999999999999999999999998


Q ss_pred             cCCC
Q psy3151         306 QFNQ  309 (372)
Q Consensus       306 ~~~~  309 (372)
                      ....
T Consensus       291 ~~~~  294 (309)
T cd07872         291 SLGT  294 (309)
T ss_pred             hccc
Confidence            7643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-46  Score=347.98  Aligned_cols=244  Identities=31%  Similarity=0.581  Sum_probs=203.4

Q ss_pred             ccccccCCeEEEEEEEc---CCCcEEEEEEecchh-------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          22 EILGLGINGKVLQIVEK---KTSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      +.||+|+||.||++.+.   .+|+.||+|++....       ...+|+++ ++.++||||+++++++..    +..+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~----~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDI-LAEVNHPFIVKLHYAFQT----EGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHhCCCCCcccEEEEEEc----CCEEEEE
Confidence            46999999999999873   578999999996421       23457766 667799999999999876    6789999


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      |||+.+|+|.+++.+.  ..+++..++.++.||+.||+|||+.||+||||||+|||++                      
T Consensus        77 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----------------------  132 (318)
T cd05582          77 LDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----------------------  132 (318)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----------------------
Confidence            9999999999998654  4599999999999999999999999999999999999998                      


Q ss_pred             cCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q psy3151         172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS  251 (372)
Q Consensus       172 ~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  251 (372)
                           .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.    
T Consensus       133 -----~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----  203 (318)
T cd05582         133 -----EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----  203 (318)
T ss_pred             -----CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----
Confidence                 56779999999987654443344556789999999999888899999999999999999999999965432    


Q ss_pred             HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      ......+......+|    ..+++++.+||++||+.||++|||     +++++.||||...
T Consensus       204 ~~~~~~i~~~~~~~p----~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         204 KETMTMILKAKLGMP----QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            223334444444444    257999999999999999999999     6779999999875

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-46  Score=347.69  Aligned_cols=254  Identities=30%  Similarity=0.584  Sum_probs=202.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||+|+||+||+|.+..+++.||||++....        ...+|+.+ +..++|+||+.++++|..    +.
T Consensus         1 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----~~   74 (331)
T cd05597           1 DDFEIL-KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV-LVNGDRRWITNLHYAFQD----EN   74 (331)
T ss_pred             CCceEE-EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHH-HHhCCCCCCCceEEEEec----CC
Confidence            478885 77999999999999999999999999986321        13345555 666799999999999876    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ++|+||||+.+|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++                 
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~-----------------  136 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD-----------------  136 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC-----------------
Confidence            8999999999999999997643 4699999999999999999999999999999999999997                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCC-----CCCCCccchhhHHHHHHHHHhCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGP-----DKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                .++.+||+|||++........ .....+||+.|+|||++..     ..++.++|+||+||++|+|++|..
T Consensus       137 ----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~  206 (331)
T cd05597         137 ----------KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET  206 (331)
T ss_pred             ----------CCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCC
Confidence                      567799999999876543222 2233568999999999853     457889999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhC--CccCCCCcccccCHHHHHHHHHhccCCCCC--CCChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLG--QFDFPNPEWEHVSQEAKTLIKNMLCVDPSE--RLTIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~ll~~dP~~--R~s~~eil~hp~~~~~  307 (372)
                      ||......    .....+...  .+.++. ....++.++++||++||..++.+  |++++++++||||.+.
T Consensus       207 Pf~~~~~~----~~~~~i~~~~~~~~~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         207 PFYAESLV----ETYGKIMNHKEHFQFPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CCCCCCHH----HHHHHHHcCCCcccCCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            99654322    122223221  122222 22358999999999999764443  7899999999999875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.2e-45  Score=336.88  Aligned_cols=253  Identities=30%  Similarity=0.493  Sum_probs=204.3

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      |++ .+.||+|+||.||+|.+..+++.||||.+...        ....+|+.+ ++.++|+||+.+++.+..    +..+
T Consensus         2 f~~-~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i-l~~l~~~~i~~~~~~~~~----~~~~   75 (285)
T cd05630           2 FRQ-YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI-LEKVNSRFVVSLAYAYET----KDAL   75 (285)
T ss_pred             cee-eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHH-HHhCCCCCeeeeeEEEec----CCEE
Confidence            666 47799999999999999999999999998532        123457776 666799999999998875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++                   
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~-------------------  136 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD-------------------  136 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC-------------------
Confidence            9999999999999988765445699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++|+|||++....... ......||+.|+|||++.+..++.++|+||+||++|+|++|..||......
T Consensus       137 --------~~~~~~l~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~  207 (285)
T cd05630         137 --------DHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK  207 (285)
T ss_pred             --------CCCCEEEeeccceeecCCCc-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc
Confidence                    56679999999887653322 223457899999999998889999999999999999999999999754322


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      ...............    .....+++++.+|+.+||+.||++|||     ++++++||||++.
T Consensus       208 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         208 IKREEVERLVKEVQE----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             chHHHHHhhhhhhhh----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            111111111111111    112467899999999999999999999     8999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.9e-45  Score=332.48  Aligned_cols=260  Identities=26%  Similarity=0.408  Sum_probs=208.7

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC--C
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYN--G   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~--~   84 (372)
                      .+..++|++. +.||.|+||.||+|.+..+++.||+|++...    ....+|+..+.++.+|+||+++++++.....  .
T Consensus         2 ~~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELV-ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHH-HheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            3567899995 7799999999999999999999999998632    3456777776666689999999999864221  1


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+|++|||+.+++|.+++.......+++..++.++.|++.||+|||+.||+||||||+||+++               
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~---------------  145 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---------------  145 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---------------
Confidence            35789999999999999999875545699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                  .++.++|+|||++..............|++.|+|||++.     ...++.++|+||+||++|+|++|.
T Consensus       146 ------------~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~  213 (272)
T cd06637         146 ------------ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA  213 (272)
T ss_pred             ------------CCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCC
Confidence                        566799999999876544333445567899999999985     346888999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .||.......   . .....  ....+......++.++.+|+.+||..||.+|||+.+++.||||
T Consensus       214 ~p~~~~~~~~---~-~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         214 PPLCDMHPMR---A-LFLIP--RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCccccCHHH---H-HHHHh--cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            9996433211   1 11111  1111122223578999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-45  Score=347.76  Aligned_cols=263  Identities=23%  Similarity=0.421  Sum_probs=204.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--   82 (372)
                      .+.++|.++ +.||.|+||+||+|.+..+++.||||.+...       ....+|+.+ ++.++||||++++++|....  
T Consensus        12 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          12 EVPERYQNL-TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRL-LKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhh-eecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHH-HHhcCCCchhhhhhhhcccccc
Confidence            367899995 7799999999999999999999999998632       234567777 66779999999999885321  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ......|++++++ +++|.+++..   +.+++..++.++.||+.||.|||++||+||||||+||+++             
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~-------------  152 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN-------------  152 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC-------------
Confidence            1234579999998 7799887754   3599999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                    .++.+||+|||++.....   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus       153 --------------~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  215 (343)
T cd07878         153 --------------EDCELRILDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL  215 (343)
T ss_pred             --------------CCCCEEEcCCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCC
Confidence                          567799999999886533   2345578999999999866 5689999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHH-----------HHhh-------CCcc-CCCC----cccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         242 FFSNHGQAISPGMKN-----------RIRL-------GQFD-FPNP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       242 f~~~~~~~~~~~~~~-----------~~~~-------~~~~-~~~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |.+.+..+....+..           .+..       ...+ .+..    .+...++.+.+||.+||..||.+|||+.++
T Consensus       216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el  295 (343)
T cd07878         216 FPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA  295 (343)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            965432111100000           0000       0000 0110    112457789999999999999999999999


Q ss_pred             hcCCccccCCCC
Q psy3151         299 MENKWISQFNQV  310 (372)
Q Consensus       299 l~hp~~~~~~~~  310 (372)
                      |.||||......
T Consensus       296 l~hp~~~~~~~~  307 (343)
T cd07878         296 LAHPYFSQYHDP  307 (343)
T ss_pred             hcCcchhccCCC
Confidence            999999886543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-45  Score=361.37  Aligned_cols=275  Identities=23%  Similarity=0.335  Sum_probs=200.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHh-----cCCCCEeEEeEeeeeecCC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAV-----GSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~-----~~h~ni~~~~~~~~~~~~~   84 (372)
                      .++|+++ +.||+|+||+||+|.+..+++.||||++....    ....|+.++..+     ..|.++++++++|..   +
T Consensus       128 ~~~y~i~-~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~---~  203 (467)
T PTZ00284        128 TQRFKIL-SLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN---E  203 (467)
T ss_pred             CCcEEEE-EEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc---C
Confidence            4789995 77999999999999999999999999996422    233455543222     245668899888864   3


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ..++|+|||++ +++|.+++.+.  +.+++..++.++.||+.||+|||+ .||+||||||+|||++.++..     .+++
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~-----~~~~  275 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV-----VDPV  275 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcc-----cccc
Confidence            46799999998 77999988765  459999999999999999999998 599999999999999854321     1111


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                      ...      ..+...+.+||+|||.+....   ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus       276 ~~~------~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        276 TNR------ALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             ccc------ccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            110      111245579999999876432   22345688999999999999999999999999999999999999997


Q ss_pred             CCCCCCCCHhHHHHH-------------------hh--CCcc--CCCC-----------cccccCHHHHHHHHHhccCCC
Q psy3151         244 SNHGQAISPGMKNRI-------------------RL--GQFD--FPNP-----------EWEHVSQEAKTLIKNMLCVDP  289 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~-------------------~~--~~~~--~~~~-----------~~~~~s~~~~~li~~ll~~dP  289 (372)
                      +.+..+....+...+                   ..  +.+.  ..+.           .....++.+.|||.+||++||
T Consensus       347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  426 (467)
T PTZ00284        347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR  426 (467)
T ss_pred             CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence            654322111110000                   00  0000  0000           000124667899999999999


Q ss_pred             CCCCChhHHhcCCccccCCC
Q psy3151         290 SERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       290 ~~R~s~~eil~hp~~~~~~~  309 (372)
                      ++|||++|+|+||||.++..
T Consensus       427 ~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        427 QKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             hhCCCHHHHhcCccccccCC
Confidence            99999999999999988543

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.7e-45  Score=344.99  Aligned_cols=254  Identities=29%  Similarity=0.562  Sum_probs=202.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||+|+||+||++.+..+++.+|+|++....        ...+|+.+ +...+|+||+++++++..    ..
T Consensus         1 ~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----~~   74 (332)
T cd05623           1 EDFEIL-KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV-LVNGDNQWITTLHYAFQD----EN   74 (332)
T ss_pred             CCceEE-EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHH-HhhCCCCCEeeEEEEEec----CC
Confidence            478885 77999999999999999999999999986321        12344444 566799999999999875    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+||||+.+|+|.+++.+.. ..+++..++.++.||+.||+|||+.||+||||||+|||++                 
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~-----------------  136 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD-----------------  136 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC-----------------
Confidence            8999999999999999997643 4599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                .++.+||+|||++........ .....+||+.|+|||++.     ...++.++|+|||||++|+|++|..
T Consensus       137 ----------~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~  206 (332)
T cd05623         137 ----------MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET  206 (332)
T ss_pred             ----------CCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCC
Confidence                      567799999999876533222 223457899999999985     3568899999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCC--ccCCCCcccccCHHHHHHHHHhccCCCCC--CCChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQ--FDFPNPEWEHVSQEAKTLIKNMLCVDPSE--RLTIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~ll~~dP~~--R~s~~eil~hp~~~~~  307 (372)
                      ||...+..    .....+....  +.+|. ....++.++++||++||..++.+  |++++++++||||.++
T Consensus       207 Pf~~~~~~----~~~~~i~~~~~~~~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         207 PFYAESLV----ETYGKIMNHKERFQFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             CCCCCCHH----HHHHHHhCCCccccCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            99654322    2233333222  22221 22467999999999999765544  7899999999999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.4e-45  Score=358.54  Aligned_cols=257  Identities=31%  Similarity=0.490  Sum_probs=210.4

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCC-CcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKT-SEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+....|.+ .+.||.|++|.||+|.+..+ ++.||+|.+...     ....+|+.. +..++||||+++++++..    
T Consensus        63 ~~~~~~y~~-~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~-l~~l~Hpniv~~~~~~~~----  136 (478)
T PTZ00267         63 NPREHMYVL-TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHC-LAACDHFGIVKHFDDFKS----  136 (478)
T ss_pred             CCcceeEEE-EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHH-HHhCCCCCEeEEEEEEEE----
Confidence            345566998 58899999999999999887 788999976421     234567776 677799999999999976    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      +..+|+||||+++|+|.+++...  ....+++.++..++.||+.||+|||+.||+||||||+|||++             
T Consensus       137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-------------  203 (478)
T PTZ00267        137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM-------------  203 (478)
T ss_pred             CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC-------------
Confidence            67899999999999999887642  234689999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                    ..+.+||+|||++........  .....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       204 --------------~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~  269 (478)
T PTZ00267        204 --------------PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR  269 (478)
T ss_pred             --------------CCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence                          567799999999986543221  2345679999999999998999999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ||.....    ..+...+..+....   ....++.++.+||.+||..||++|||+++++.|+|++.+
T Consensus       270 Pf~~~~~----~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        270 PFKGPSQ----REIMQQVLYGKYDP---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CCCCCCH----HHHHHHHHhCCCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            9965432    22333443333321   113678999999999999999999999999999998754

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.6e-45  Score=342.10  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=203.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .++|++. +.||.|+||.||+|.+..++..+|+|++...      ....+|+.+ ++.++||||++++++|..    ++.
T Consensus         4 ~~~y~~~-~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~   77 (333)
T cd06650           4 DDDFEKI-SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQV-LHECNSPYIVGFYGAFYS----DGE   77 (333)
T ss_pred             hhhhhee-ccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHH-HHHCCCCcccceeEEEEE----CCE
Confidence            5789995 7799999999999999999999999988632      235577777 566689999999999986    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      +|+||||+.+++|.+++...  +.+++..++.++.|++.||.|||+. +|+||||||+|||++                 
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~-----------------  138 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-----------------  138 (333)
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc-----------------
Confidence            99999999999999999764  4589999999999999999999985 799999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.+||+|||++......  .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus       139 ----------~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         139 ----------SRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             ----------CCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence                      5667999999998755321  2234568999999999988889999999999999999999999996443


Q ss_pred             CCCCCHh----------------------------------------HHHHHhhCCccCCCCcccccCHHHHHHHHHhcc
Q psy3151         247 GQAISPG----------------------------------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC  286 (372)
Q Consensus       247 ~~~~~~~----------------------------------------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~  286 (372)
                      .......                                        +...+...  ..+......++.++++||.+||+
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~  284 (333)
T cd06650         207 AKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE--PPPKLPSGVFGAEFQDFVNKCLI  284 (333)
T ss_pred             hhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcC--CCccCCCCCcCHHHHHHHHHhcc
Confidence            2111000                                        00000000  00000012367899999999999


Q ss_pred             CCCCCCCChhHHhcCCccccC
Q psy3151         287 VDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       287 ~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +||++|||+++++.||||+..
T Consensus       285 ~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         285 KNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             CCcccCcCHHHHhhCHHHhcC
Confidence            999999999999999999763

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-45  Score=349.98  Aligned_cols=258  Identities=23%  Similarity=0.375  Sum_probs=206.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEc--CCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEK--KTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      +..+|.++ +.||.|+||.||+|...  .+++.||+|.+.......+|+.+ ++.++||||++++++|..    ....|+
T Consensus        90 ~~~~y~i~-~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~i-l~~l~h~~iv~~~~~~~~----~~~~~l  163 (392)
T PHA03207         90 VRMQYNIL-SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDI-LKTISHRAIINLIHAYRW----KSTVCM  163 (392)
T ss_pred             ccCceEEE-EeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHH-HHhcCCCCccceeeeEee----CCEEEE
Confidence            45679995 77999999999999764  45788999999776667789988 667799999999999875    678999


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      |||++. ++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++                     
T Consensus       164 v~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~---------------------  219 (392)
T PHA03207        164 VMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---------------------  219 (392)
T ss_pred             EehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---------------------
Confidence            999995 6899988543  4699999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                            ..+.++|+|||++........  .....+||+.|+|||++....|+.++|||||||++|+|++|..||.+....
T Consensus       220 ------~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~  293 (392)
T PHA03207        220 ------EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK  293 (392)
T ss_pred             ------CCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence                  567799999999876543222  223457899999999999889999999999999999999999999776543


Q ss_pred             CCCHhHHHHHh---hCCcc-----------------------CCCCc---ccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         249 AISPGMKNRIR---LGQFD-----------------------FPNPE---WEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       249 ~~~~~~~~~~~---~~~~~-----------------------~~~~~---~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .....+...+.   .....                       +..+.   ...++.++++||++||..||.+|||+.++|
T Consensus       294 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l  373 (392)
T PHA03207        294 SSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL  373 (392)
T ss_pred             CcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHh
Confidence            22111111110   00000                       00000   124577899999999999999999999999


Q ss_pred             cCCcccc
Q psy3151         300 ENKWISQ  306 (372)
Q Consensus       300 ~hp~~~~  306 (372)
                      .||||.+
T Consensus       374 ~~p~f~~  380 (392)
T PHA03207        374 SLPLFTK  380 (392)
T ss_pred             hCchhhc
Confidence            9999976

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.4e-45  Score=342.03  Aligned_cols=254  Identities=30%  Similarity=0.560  Sum_probs=203.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|.+. +.||+|+||+||+|++..+++.||+|++....        ...+|..+ +..++|+||+.+++++..    ++
T Consensus         1 d~y~i~-~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~l~~~~~~----~~   74 (331)
T cd05624           1 DDFEII-KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV-LVNGDCQWITTLHYAFQD----EN   74 (331)
T ss_pred             CCceEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHH-HHhCCCCCEeeEEEEEEc----CC
Confidence            578985 77999999999999999999999999986421        12334444 677799999999999876    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..|+||||+.||+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++                 
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~-----------------  136 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD-----------------  136 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc-----------------
Confidence            8999999999999999997643 4699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCC-----CCCCCccchhhHHHHHHHHHhCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGP-----DKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                .++.+||+|||++........ .....+||+.|+|||++.+     ..++.++|+|||||++|+|++|..
T Consensus       137 ----------~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~  206 (331)
T cd05624         137 ----------MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET  206 (331)
T ss_pred             ----------CCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCC
Confidence                      567799999999876543222 2234578999999999865     568899999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCC--ccCCCCcccccCHHHHHHHHHhccCCCCC--CCChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQ--FDFPNPEWEHVSQEAKTLIKNMLCVDPSE--RLTIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~ll~~dP~~--R~s~~eil~hp~~~~~  307 (372)
                      ||...+..    .....+....  +.+| .....++.++++||.+||..++.+  |++++++++||||+..
T Consensus       207 Pf~~~~~~----~~~~~i~~~~~~~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         207 PFYAESLV----ETYGKIMNHEERFQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CccCCCHH----HHHHHHHcCCCcccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            99654322    2233333222  2222 223457999999999999976654  5689999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0603|consensus

Probab=100.00  E-value=1.6e-45  Score=348.24  Aligned_cols=249  Identities=37%  Similarity=0.651  Sum_probs=218.9

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ..++.+.|++. ..+|.|+||.|-.+.+..+++.+++|++.+. ....+|+.+.+...+||||+++.+.+.+    +.+.
T Consensus       317 ~~~~~~~y~~~-~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~----~~~~  391 (612)
T KOG0603|consen  317 TAPFTESYEFR-EELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYED----GKEI  391 (612)
T ss_pred             cCCcchhhccc-cccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecC----Ccee
Confidence            44688899984 5599999999999999999999999999866 5677888888899999999999999986    7899


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+|||.+.|+.+.+.+.....  +. .++..|++||+.|+.|||++|||||||||+|||++.                  
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~------------------  450 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDG------------------  450 (612)
T ss_pred             eeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecC------------------
Confidence            999999999999999887542  33 888899999999999999999999999999999951                  


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              ..++++|+|||.+......   +.+.|-|..|.|||++....|++++|+||||++||+|++|+.||......
T Consensus       451 --------~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  451 --------SAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             --------CCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence                    6788999999999876443   55677899999999999999999999999999999999999999776554


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                         ..+..++..+.+.      ..+|.+++|||++||++||.+|+++.+++.||||
T Consensus       520 ---~ei~~~i~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  520 ---IEIHTRIQMPKFS------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ---HHHHHhhcCCccc------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence               3456666655543      5799999999999999999999999999999999

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-45  Score=344.85  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=198.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      ..+|.++ +.||+|+||.||+|.+..+++.||+|+... .....|+.+ ++.++||||+++++++..    +...++|||
T Consensus        65 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~~~lv~e  137 (357)
T PHA03209         65 SLGYTVI-KTLTPGSEGRVFVATKPGQPDPVVLKIGQK-GTTLIEAML-LQNVNHPSVIRMKDTLVS----GAITCMVLP  137 (357)
T ss_pred             hcCcEEE-EEecCCCCeEEEEEEECCCCceEEEEeCCc-cccHHHHHH-HHhCCCCCCcChhheEEe----CCeeEEEEE
Confidence            3469995 779999999999999999999999998643 344567776 677799999999999876    667899999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      ++. ++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++                        
T Consensus       138 ~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~------------------------  191 (357)
T PHA03209        138 HYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN------------------------  191 (357)
T ss_pred             ccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC------------------------
Confidence            995 68988887643 4699999999999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC--
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS--  251 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--  251 (372)
                         ..+.++|+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|+++..++.........  
T Consensus       192 ---~~~~~kl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~  267 (357)
T PHA03209        192 ---DVDQVCIGDLGAAQFPVV-APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY  267 (357)
T ss_pred             ---CCCCEEEecCcccccccc-CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHH
Confidence               567799999999875432 22233457899999999999889999999999999999999865554332211100  


Q ss_pred             -----HhHHHHHhh-C--CccCC--------------------------CCcccccCHHHHHHHHHhccCCCCCCCChhH
Q psy3151         252 -----PGMKNRIRL-G--QFDFP--------------------------NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQ  297 (372)
Q Consensus       252 -----~~~~~~~~~-~--~~~~~--------------------------~~~~~~~s~~~~~li~~ll~~dP~~R~s~~e  297 (372)
                           ..+...+.. +  .-.++                          ......++.++.+||.+||+.||++||||.|
T Consensus       268 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e  347 (357)
T PHA03209        268 VKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEE  347 (357)
T ss_pred             HHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHH
Confidence                 000000000 0  00000                          0111245778889999999999999999999


Q ss_pred             HhcCCcccc
Q psy3151         298 VMENKWISQ  306 (372)
Q Consensus       298 il~hp~~~~  306 (372)
                      +|+||||++
T Consensus       348 ~l~hp~f~~  356 (357)
T PHA03209        348 ILNYPMFAQ  356 (357)
T ss_pred             HhcCchhcc
Confidence            999999976

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-44  Score=334.72  Aligned_cols=259  Identities=23%  Similarity=0.421  Sum_probs=203.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|.++ +.||.|+||.||+|.+..+++.||+|.+...      ....+|+.. ++.++||||+++++++..    +...
T Consensus         6 ~~y~~~-~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~nI~~~~~~~~~----~~~~   79 (301)
T cd07873           6 ETYIKL-DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSL-LKDLKHANIVTLHDIIHT----EKSL   79 (301)
T ss_pred             cceEEe-eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHH-HHhcCCCCcceEEEEEec----CCeE
Confidence            679985 6799999999999999999999999998632      234567777 667799999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++                   
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~-------------------  138 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-------------------  138 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC-------------------
Confidence            99999996 58988887643 4589999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                              .++.++|+|||++..............+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.
T Consensus       139 --------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~  210 (301)
T cd07873         139 --------ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV  210 (301)
T ss_pred             --------CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence                    5677999999998765433333344567889999998754 4578899999999999999999999965543


Q ss_pred             CCCCHhHHHHH---------------hhCCccCCC-------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         248 QAISPGMKNRI---------------RLGQFDFPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       248 ~~~~~~~~~~~---------------~~~~~~~~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      .+....+....               ....+..+.       .....+++++++||.+||+.||.+|||++++++||||+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         211 EEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             HHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            21110000000               000011110       01135788999999999999999999999999999998


Q ss_pred             cCC
Q psy3151         306 QFN  308 (372)
Q Consensus       306 ~~~  308 (372)
                      .+.
T Consensus       291 ~~~  293 (301)
T cd07873         291 CLG  293 (301)
T ss_pred             ccc
Confidence            764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-44  Score=332.01  Aligned_cols=253  Identities=30%  Similarity=0.462  Sum_probs=206.3

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      |++. +.||.|+||+||+|.+..+++.+|+|.+...        ....+|+.+ ++.++|+||+.+.+.+..    ++..
T Consensus         2 ~~~~-~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~i-l~~l~~~~i~~~~~~~~~----~~~~   75 (285)
T cd05632           2 FRQY-RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI-LEKVNSQFVVNLAYAYET----KDAL   75 (285)
T ss_pred             ceEE-EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHH-HHHcCCcCceeEEEEEec----CCEE
Confidence            6664 6799999999999999999999999998532        123467777 566799999999998875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++                   
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~-------------------  136 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD-------------------  136 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC-------------------
Confidence            9999999999999888765545699999999999999999999999999999999999997                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++|+|||++...... .......|++.|+|||.+.+..++.++|+||+||++|+|++|..||......
T Consensus       137 --------~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~  207 (285)
T cd05632         137 --------DYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK  207 (285)
T ss_pred             --------CCCCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                    5667999999988765322 2223457899999999998888999999999999999999999999754332


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      .....+...+......+    ...++.++.+|+.+||..||++|||     +++++.|+||+..
T Consensus       208 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         208 VKREEVDRRVLETEEVY----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHHHHHHhhhcccccc----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            22122222222222222    2367899999999999999999999     8899999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2e-44  Score=327.46  Aligned_cols=253  Identities=24%  Similarity=0.390  Sum_probs=202.0

Q ss_pred             cccceeecccc-ccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          13 IQDDYDISTEI-LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        13 ~~~~Y~i~~~~-lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      +.+.|++...+ ||.|+||.||++.++.++..+|+|++........|+.......+||||+++++.|..    ++..|+|
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~----~~~~~iv   87 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTT----LKGHVLI   87 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEec----CCeeEEE
Confidence            45677775443 599999999999999999999999987543333344332233479999999999876    5689999


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      |||+++++|.+++....  .+++..++.++.||+.||.|||+.|++||||||+||+++                      
T Consensus        88 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----------------------  143 (267)
T PHA03390         88 MDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD----------------------  143 (267)
T ss_pred             EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe----------------------
Confidence            99999999999997653  699999999999999999999999999999999999998                      


Q ss_pred             cCCCCCCC-CeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q psy3151         172 YTKPGDGG-ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI  250 (372)
Q Consensus       172 ~~~~~~~~-~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  250 (372)
                           ..+ .++|+|||++......    ....+++.|+|||++.+..++.++|+||+||++|+|++|..||........
T Consensus       144 -----~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~  214 (267)
T PHA03390        144 -----RAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL  214 (267)
T ss_pred             -----CCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence                 334 7899999988765322    234578899999999888899999999999999999999999975544332


Q ss_pred             CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-hhHHhcCCcccc
Q psy3151         251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-IDQVMENKWISQ  306 (372)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-~~eil~hp~~~~  306 (372)
                      ...........    +.+....+++.+.+||.+||+.||.+|++ ++++|+||||.+
T Consensus       215 ~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        215 DLESLLKRQQK----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             hHHHHHHhhcc----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            21111111111    12223468999999999999999999996 599999999963

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-44  Score=355.22  Aligned_cols=261  Identities=28%  Similarity=0.480  Sum_probs=209.9

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ....++|.+ .+.||+|+||+||+|.+..+|+.||||++...       ....+|+.. +...+|+||+++++.+.....
T Consensus        28 ~~~~~rY~i-~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~-l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         28 KEQAKKYWI-SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCC-LLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccCCCEEE-EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHH-HhcCCCCcEEEeecceecccc
Confidence            446789999 58899999999999999999999999998532       233456665 556689999999887753211


Q ss_pred             ----CceEEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          84 ----GSRCLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        84 ----~~~~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                          ....+++||||+++|+|.+++...  ....+++..++.++.|++.||+|||+.||+||||||+|||++        
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~--------  177 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC--------  177 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe--------
Confidence                122578999999999999998753  224699999999999999999999999999999999999998        


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccC--CCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHH
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN--KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  235 (372)
                                         .++.+||+|||+++.....  .......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus       178 -------------------~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeL  238 (496)
T PTZ00283        178 -------------------SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYEL  238 (496)
T ss_pred             -------------------CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence                               5677999999998765332  1223456799999999999988999999999999999999


Q ss_pred             HhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       236 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ++|..||.+.+.    ..+...+..+...   +....+++++.+|+.+||+.||.+|||+.+++.|||++.+
T Consensus       239 ltG~~Pf~~~~~----~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        239 LTLKRPFDGENM----EEVMHKTLAGRYD---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             HHCCCCCCCCCH----HHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            999999965432    2233333333322   1123689999999999999999999999999999998764

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.4e-45  Score=346.82  Aligned_cols=259  Identities=25%  Similarity=0.407  Sum_probs=200.0

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC-CceEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN-GSRCL   88 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~-~~~~~   88 (372)
                      |++ .+.||+|+||+||+|.+..+|+.||||.+...       ....+|+.+ ++.++||||+++++++..... ....+
T Consensus         2 ~~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           2 VEP-DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKM-LCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             Ccc-cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHH-HHhCCCCCcCCHhheecCCCccccceE
Confidence            566 47799999999999999999999999988532       245678777 666799999999999875211 11378


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+. ++|.+.+...  +.+++..++.++.||+.||+|||+.||+||||||+|||++                   
T Consensus        80 ~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~-------------------  137 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN-------------------  137 (372)
T ss_pred             EEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC-------------------
Confidence            99999995 5888888654  4599999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                              .++.+||+|||++....... .......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+
T Consensus       138 --------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         138 --------SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             --------CCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence                    56779999999987653322 223345678999999998764 58899999999999999999999997654


Q ss_pred             CCCCCHhHHH-------------------HHhhCCccCCC-----CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         247 GQAISPGMKN-------------------RIRLGQFDFPN-----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       247 ~~~~~~~~~~-------------------~~~~~~~~~~~-----~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      .......+..                   .+.......+.     ......++++.+||.+||+.||.+|||+.++|.||
T Consensus       210 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         210 PIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             HHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence            3221111100                   01001111110     11134588999999999999999999999999999


Q ss_pred             ccccC
Q psy3151         303 WISQF  307 (372)
Q Consensus       303 ~~~~~  307 (372)
                      ||.+.
T Consensus       290 ~~~~~  294 (372)
T cd07853         290 YLDEG  294 (372)
T ss_pred             hhCCC
Confidence            99874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-45  Score=331.39  Aligned_cols=252  Identities=33%  Similarity=0.564  Sum_probs=201.6

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhh-------hHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      |+++ +.||+|+||+||+|.+..+++.||+|++.....       ..+|+..+ +.++||||+++++++..    ....+
T Consensus         1 y~~~-~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~-~~l~~~~i~~~~~~~~~----~~~~~   74 (260)
T PF00069_consen    1 YRLV-KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKIL-RRLRHPNIVQILDVFQD----DNYLY   74 (260)
T ss_dssp             EEEE-EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHH-HHHTBTTBCHEEEEEEE----SSEEE
T ss_pred             CEEe-EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcc-ccccccccccccccccc----ccccc
Confidence            7774 779999999999999999999999999974321       23466664 44499999999999986    67899


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+.+++|.+++...  +.+++..++.++.||+.||++||+.||+|+||||+||+++                    
T Consensus        75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~--------------------  132 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD--------------------  132 (260)
T ss_dssp             EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES--------------------
T ss_pred             cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc--------------------
Confidence            999999999999999844  4599999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-PDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                             .++.++|+|||.+..............+|+.|+|||++. +..++.++|+||||+++|+|++|..||......
T Consensus       133 -------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~  205 (260)
T PF00069_consen  133 -------ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD  205 (260)
T ss_dssp             -------TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH
T ss_pred             -------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence                   567789999999876433334455667899999999998 788999999999999999999999999654111


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .. ......................+.++.++|.+||+.||++|||+.++++||||
T Consensus       206 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  206 DQ-LEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HH-HHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             hh-hhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            11 11111111111111111111234899999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-44  Score=338.99  Aligned_cols=250  Identities=23%  Similarity=0.400  Sum_probs=196.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .++|++ .+.||.|+||.||+|.+.     .+++.||||++...      ....+|+.++..+.+||||+++++++..  
T Consensus         6 ~~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--   82 (338)
T cd05102           6 RDRLRL-GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK--   82 (338)
T ss_pred             hhHcee-eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC--
Confidence            478998 578999999999999752     34678999998632      2356788886666699999999998753  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhcc------------------------------------------------------
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKE------------------------------------------------------  108 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~------------------------------------------------------  108 (372)
                       .+..+++||||+++|+|.+++....                                                      
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence             2456899999999999999987532                                                      


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCee
Q psy3151         109 ------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK  182 (372)
Q Consensus       109 ------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~k  182 (372)
                            ...+++..+..++.||+.||+|||++||+||||||+|||++                           .++.+|
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---------------------------~~~~~k  214 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---------------------------ENNVVK  214 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---------------------------CCCcEE
Confidence                  12478889999999999999999999999999999999998                           566799


Q ss_pred             eeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHh
Q psy3151         183 LTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIR  259 (372)
Q Consensus       183 i~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~  259 (372)
                      |+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....   ......+.
T Consensus       215 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~~  291 (338)
T cd05102         215 ICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN---EEFCQRLK  291 (338)
T ss_pred             EeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHh
Confidence            999999876533221  1122345678999999988889999999999999999997 99999654322   22233333


Q ss_pred             hCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       260 ~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .+.....   ...+++++.+|+.+||..||.+|||+.++++
T Consensus       292 ~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         292 DGTRMRA---PENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             cCCCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            3222111   1367899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.2e-44  Score=333.86  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=191.9

Q ss_pred             cccccccCCeEEEEEEEcC--CCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          21 TEILGLGINGKVLQIVEKK--TSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      +..||+|+||+||+|.+..  ++..||+|.+...   ....+|+.+ ++.++||||+++++++..  ..+...|+||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~--~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIAL-LRELKHPNVIALQKVFLS--HSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHH-HHhCCCCCeeeEEEEEec--cCCCeEEEEEeee
Confidence            4569999999999999653  6789999998643   245678877 677799999999998853  2356789999999


Q ss_pred             CCCchhHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          96 HGGELFQRIQQK-------EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        96 ~~g~L~~~i~~~-------~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      . ++|.+++...       ....+++..++.++.||+.||.|||+.||+||||||+|||+..+++               
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~---------------  146 (317)
T cd07867          83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP---------------  146 (317)
T ss_pred             C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCC---------------
Confidence            5 5888877532       1235899999999999999999999999999999999999964322               


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                              ..+.+||+|||+++.......   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..
T Consensus       147 --------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         147 --------ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             --------CCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence                    567899999999876543221   2334578999999999866 4588999999999999999999999965


Q ss_pred             CCCCCC-----CHhHHHHHhh----------------CCc----------cCC--------CCcccccCHHHHHHHHHhc
Q psy3151         245 NHGQAI-----SPGMKNRIRL----------------GQF----------DFP--------NPEWEHVSQEAKTLIKNML  285 (372)
Q Consensus       245 ~~~~~~-----~~~~~~~~~~----------------~~~----------~~~--------~~~~~~~s~~~~~li~~ll  285 (372)
                      ......     .......+..                ..+          ...        .......+..+.+||.+||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l  298 (317)
T cd07867         219 RQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL  298 (317)
T ss_pred             ccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHh
Confidence            432110     0000000000                000          000        0000124567899999999


Q ss_pred             cCCCCCCCChhHHhcCCcc
Q psy3151         286 CVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       286 ~~dP~~R~s~~eil~hp~~  304 (372)
                      +.||.+|||++|+|+||||
T Consensus       299 ~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         299 TMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ccCcccccCHHHHhcCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0586|consensus

Probab=100.00  E-value=2.8e-45  Score=344.92  Aligned_cols=254  Identities=33%  Similarity=0.559  Sum_probs=224.7

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +-.+.|.+. +.||+|.|++|.+|.+..++..||||++++.       .+..+|+.+ +..++||||++++.+.+.    
T Consensus        53 ~~vg~y~i~-~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~i-mk~l~HPnIvkl~~v~~t----  126 (596)
T KOG0586|consen   53 NSVGLYVII-KTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDI-MKSLNHPNIVKLFSVIET----  126 (596)
T ss_pred             ccccceeee-eeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHH-HHhcCCcceeeeeeeeee----
Confidence            345678884 7799999999999999999999999999743       346889998 677899999999999986    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+|+||||+.+|.+++++.++.  .+.+.+++.++.|++.|++|||+++|||||||++|||++               
T Consensus       127 ~~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~---------------  189 (596)
T KOG0586|consen  127 EATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD---------------  189 (596)
T ss_pred             cceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc---------------
Confidence            778999999999999999999874  588899999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCC-CccchhhHHHHHHHHHhCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                  .+..+||+|||++..+. ......+.||+|.|+|||++.+..|+ +++|+||+|+++|.|+.|..||+
T Consensus       190 ------------~~mnikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD  256 (596)
T KOG0586|consen  190 ------------ENMNIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD  256 (596)
T ss_pred             ------------cccceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence                        66779999999999886 45667889999999999999888775 89999999999999999999997


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      +..-..    +..++..+.+..|.    .++.++.+||+++|.++|.+|++.+++..|.|......
T Consensus       257 G~~lk~----Lr~rvl~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  257 GQNLKE----LRPRVLRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             Cccccc----ccchheeeeecccc----eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence            765443    45666677776664    68999999999999999999999999999999976543

>KOG0666|consensus

Probab=100.00  E-value=1.1e-45  Score=321.11  Aligned_cols=265  Identities=27%  Similarity=0.462  Sum_probs=206.1

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCC----cEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTS----EVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ...|+++++ ||+|+||.||+|..+.++    +.+|||.++..       ..+.||+.. ++-+.||||+.+..+|... 
T Consensus        23 l~~ye~ig~-Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL-~REl~h~nvi~Lv~Vfl~~-   99 (438)
T KOG0666|consen   23 LFEYEGIGK-IGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIAL-LRELKHPNVISLVKVFLSH-   99 (438)
T ss_pred             HHHhhccce-ecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHH-HHHhcCCcchhHHHHHhcc-
Confidence            457888754 999999999999776654    37899999643       467899987 7888999999999999752 


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKED---GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~---~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                        +..+++++||.+. +|.+.|+-+..   ..++...++.|+.||+.|+.|||++-|+||||||.|||+..++.      
T Consensus       100 --d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgp------  170 (438)
T KOG0666|consen  100 --DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGP------  170 (438)
T ss_pred             --CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCC------
Confidence              6789999999976 99999875322   45999999999999999999999999999999999999986553      


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHH
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l  235 (372)
                                       ..|+|||+|||+|+.+...-..   ....+.|.||+|||.+.+ ..|++++|+||+|||+.||
T Consensus       171 -----------------erG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaEl  233 (438)
T KOG0666|consen  171 -----------------ERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAEL  233 (438)
T ss_pred             -----------------ccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHH
Confidence                             5799999999999987654332   344667999999998755 5699999999999999999


Q ss_pred             HhCCCCCCCCCCC-----CCCHhHHHHHhh--CCc---cCCC----Cc------------------------ccccCHHH
Q psy3151         236 LCGFPPFFSNHGQ-----AISPGMKNRIRL--GQF---DFPN----PE------------------------WEHVSQEA  277 (372)
Q Consensus       236 l~g~~pf~~~~~~-----~~~~~~~~~~~~--~~~---~~~~----~~------------------------~~~~s~~~  277 (372)
                      ++..+.|.+....     ........++..  |..   .+|.    |+                        +..-++.+
T Consensus       234 Ltl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a  313 (438)
T KOG0666|consen  234 LTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSA  313 (438)
T ss_pred             HccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchH
Confidence            9999999654211     111111111110  000   0000    00                        12234568


Q ss_pred             HHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         278 KTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       278 ~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .+|+.+||++||.+|+|++++|+|+||..-
T Consensus       314 ~~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  314 LDLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             HHHHHHHhccCchhhccHHHHhcccccccC
Confidence            999999999999999999999999999875

>KOG0579|consensus

Probab=100.00  E-value=1.5e-46  Score=352.46  Aligned_cols=256  Identities=29%  Similarity=0.435  Sum_probs=215.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ...+.|.|+++ ||.|+||+||+|.++.++-..|.|++...     ....-|+++ +...+||+|+++++.|..    ++
T Consensus        29 nP~d~WeIiGE-LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeI-La~CdHP~ivkLl~ayy~----en  102 (1187)
T KOG0579|consen   29 NPRDHWEIIGE-LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEI-LAECDHPVIVKLLSAYYF----EN  102 (1187)
T ss_pred             CHHHHHHHHhh-hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhh-hhcCCChHHHHHHHHHhc----cC
Confidence            35678899877 99999999999999999999999998632     356678888 666689999999998865    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+++..|||.||-...++...+ ..|++.+++.+.+|++.||.|||+++|||||||..|||++                 
T Consensus       103 kLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T-----------------  164 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT-----------------  164 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE-----------------
Confidence            8999999999999988888776 4699999999999999999999999999999999999999                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc-----CCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                .+|.++++|||.+...........+.+|||+|||||+.     ...+|+.++||||||++|.+|..+.+|
T Consensus       165 ----------ldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP  234 (1187)
T KOG0579|consen  165 ----------LDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP  234 (1187)
T ss_pred             ----------ecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC
Confidence                      56669999999998776666677889999999999975     568899999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ....+...    +.-++...  +.|. .....++..+.|++.+||.+||..||+++++|+||||++.
T Consensus       235 HhelnpMR----VllKiaKS--ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  235 HHELNPMR----VLLKIAKS--EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             ccccchHH----HHHHHhhc--CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            85443321    12222222  1111 1124678999999999999999999999999999999875

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.5e-44  Score=328.13  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=207.0

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeec--CCc
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIY--NGS   85 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--~~~   85 (372)
                      +..++|++. +.||.|+||.||+|.+..+++.+|+|++....    ....|+..+.+..+|+||+++++++....  ...
T Consensus        13 ~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          13 DPAGIFELV-EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             Chhhhhhhh-eeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            456899995 77999999999999999999999999986432    34456666566668999999999985321  125


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|++|||+.+|+|.+++.......+++..++.++.||+.||+|||+.||+||||||+||+++                
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~----------------  155 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----------------  155 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----------------
Confidence            6889999999999999999876556689999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                 +++.++|+|||++..............|++.|+|||.+.     ...++.++|+|||||++|+|++|..
T Consensus       156 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~  224 (282)
T cd06636         156 -----------ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP  224 (282)
T ss_pred             -----------CCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCC
Confidence                       566799999998876543333344567899999999875     3568889999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ||........   ... +..  ...+......++.++.+||.+||..||.+|||+.++++||||
T Consensus       225 p~~~~~~~~~---~~~-~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         225 PLCDMHPMRA---LFL-IPR--NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CccccCHHhh---hhh-Hhh--CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            9965432111   111 111  111111224578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9e-44  Score=320.71  Aligned_cols=250  Identities=26%  Similarity=0.467  Sum_probs=205.1

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .|++. +.||.|++|.||+|.+..+++.||+|.+...       ....+|++. ++.++|+|++++++.+..   .+..+
T Consensus         1 ~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~---~~~~~   75 (257)
T cd08223           1 AYCFV-RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQL-LSQLKHPNIVAYRESWEG---EDGLL   75 (257)
T ss_pred             CceEE-EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHH-HHhCCCCCeeeeeeeecC---CCCEE
Confidence            48884 7799999999999999999999999998532       123456655 667799999999987753   24578


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |++|||+++++|.+++.......+++.+++.++.|++.||++||+.|++||||||+||+++                   
T Consensus        76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~-------------------  136 (257)
T cd08223          76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT-------------------  136 (257)
T ss_pred             EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe-------------------
Confidence            9999999999999999875545699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++|+|||++..............+++.|+|||++.+..++.++|+||+||++|+|++|..||...+. 
T Consensus       137 --------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-  207 (257)
T cd08223         137 --------RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-  207 (257)
T ss_pred             --------cCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-
Confidence                    56789999999988765433334456788999999999888899999999999999999999999964332 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                         ......+..+....   ....+++++.+++.+||+.||.+|||+.+++.||||
T Consensus       208 ---~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         208 ---NSLVYRIIEGKLPP---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ---HHHHHHHHhcCCCC---CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence               12222333332211   123688999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-44  Score=328.25  Aligned_cols=255  Identities=26%  Similarity=0.411  Sum_probs=198.4

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|+++ +.||.|++|.||+|.+..+++.||||.+...       ....+|+.. ++.++||||+++++++..    +...
T Consensus         1 ~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~   74 (285)
T cd07861           1 DYTKI-EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISL-LKELQHPNIVCLQDVLMQ----ESRL   74 (285)
T ss_pred             CceEe-eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHH-HHhcCCCCEeeeEEEEee----CCeE
Confidence            47885 6799999999999999999999999998532       234567776 666689999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          89 LVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      |+||||+. ++|.+++..... ..+++..++.++.||+.||+|||+.||+||||||+||+++                  
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~------------------  135 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID------------------  135 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc------------------
Confidence            99999996 689888875432 5699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.++|+|||++..............+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+..
T Consensus       136 ---------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~  206 (285)
T cd07861         136 ---------NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS  206 (285)
T ss_pred             ---------CCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence                     5677999999988765433333334566889999998754 457899999999999999999999996543


Q ss_pred             CCCCCHhHHHHH-----------------hh--CCc--cCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         247 GQAISPGMKNRI-----------------RL--GQF--DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       247 ~~~~~~~~~~~~-----------------~~--~~~--~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ............                 ..  ...  .........+++++.+||.+||+.||.+|||+.+++.||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         207 EIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            211100000000                 00  000  00001123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG4279|consensus

Probab=100.00  E-value=1.3e-45  Score=349.16  Aligned_cols=254  Identities=28%  Similarity=0.476  Sum_probs=212.0

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh-----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCC
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV-----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHG   97 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~   97 (372)
                      +||+|+||+||.|+|..|....|||.+....     -..+|+.. .+.+.|.|||++++++..    +.++-|+||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaL-H~~LrHkNIVrYLGs~se----nGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIAL-HSTLRHKNIVRYLGSVSE----NGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHH-HHHHhhHhHHHHhhccCC----CCeEEEEeecCCC
Confidence            6999999999999999999999999996432     23456655 777899999999999754    6789999999999


Q ss_pred             CchhHHHHhccCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151          98 GELFQRIQQKEDGAF--TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus        98 g~L~~~i~~~~~~~l--~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                      |+|.++++..- |++  .|..+-.+.+||+.||.|||.+.|||||||-+|+||+.                         
T Consensus       657 GSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-------------------------  710 (1226)
T KOG4279|consen  657 GSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-------------------------  710 (1226)
T ss_pred             CcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-------------------------
Confidence            99999999865 567  88999999999999999999999999999999999983                         


Q ss_pred             CCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHh
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG  253 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  253 (372)
                       -.|.+||+|||-++++..-..-..+..||..|||||++..  ..|+.++|||||||++.||.||++||.......    
T Consensus       711 -ySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----  785 (1226)
T KOG4279|consen  711 -YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----  785 (1226)
T ss_pred             -ccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----
Confidence             5688999999999888665555677889999999999854  459999999999999999999999995432211    


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCC
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT  313 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~  313 (372)
                       ..-...|.+..-++....+|.+++.||.+|+.+||.+||+|.++|..||++.-+..+..
T Consensus       786 -AAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~  844 (1226)
T KOG4279|consen  786 -AAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRP  844 (1226)
T ss_pred             -HhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCC
Confidence             12223344444444456899999999999999999999999999999999876444433

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-44  Score=346.76  Aligned_cols=258  Identities=22%  Similarity=0.294  Sum_probs=202.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      ....|.+ .+.||+|+||.||+|.+..+++.||||.... ....+|+.+ ++.++|+||+++++++..    +...++||
T Consensus       167 ~~~gy~i-~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-~~~~~E~~i-L~~L~HpnIv~l~~~~~~----~~~~~lv~  239 (461)
T PHA03211        167 AGLGFAI-HRALTPGSEGCVFESSHPDYPQRVVVKAGWY-ASSVHEARL-LRRLSHPAVLALLDVRVV----GGLTCLVL  239 (461)
T ss_pred             ccCCeEE-EEEEccCCCeEEEEEEECCCCCEEEEecccc-cCHHHHHHH-HHHCCCCCCCcEEEEEEE----CCEEEEEE
Confidence            3557998 4779999999999999999999999996532 345678887 677799999999998875    66789999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      |++. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++                       
T Consensus       240 e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~-----------------------  294 (461)
T PHA03211        240 PKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN-----------------------  294 (461)
T ss_pred             EccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC-----------------------
Confidence            9994 68988887643 4699999999999999999999999999999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC-
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA-  249 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-  249 (372)
                          ..+.++|+|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..|+....... 
T Consensus       295 ----~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~  370 (461)
T PHA03211        295 ----GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE  370 (461)
T ss_pred             ----CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence                566799999999876533221  1234578999999999998899999999999999999999887654332111 


Q ss_pred             ---CCHhHHHHHhhCCcc---------------------------CCCCcc---cccCHHHHHHHHHhccCCCCCCCChh
Q psy3151         250 ---ISPGMKNRIRLGQFD---------------------------FPNPEW---EHVSQEAKTLIKNMLCVDPSERLTID  296 (372)
Q Consensus       250 ---~~~~~~~~~~~~~~~---------------------------~~~~~~---~~~s~~~~~li~~ll~~dP~~R~s~~  296 (372)
                         ....+...+......                           ...+.|   ..++.++.+||.+||+.||.+|||+.
T Consensus       371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~  450 (461)
T PHA03211        371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAA  450 (461)
T ss_pred             cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHH
Confidence               111122222211110                           011112   13567899999999999999999999


Q ss_pred             HHhcCCcccc
Q psy3151         297 QVMENKWISQ  306 (372)
Q Consensus       297 eil~hp~~~~  306 (372)
                      |+|+||||+.
T Consensus       451 elL~hp~f~~  460 (461)
T PHA03211        451 ELLRLPLFQS  460 (461)
T ss_pred             HHhhCcccCC
Confidence            9999999964

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.7e-44  Score=330.07  Aligned_cols=260  Identities=26%  Similarity=0.426  Sum_probs=210.9

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ......+|+++ +.||.|++|.||+|.+..+++.||+|.+...     ....+|+.. ++.++|+||+++++++..    
T Consensus        14 ~~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~----   87 (297)
T cd06656          14 VGDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV-MRENKNPNIVNYLDSYLV----   87 (297)
T ss_pred             cCChhhhceee-eeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHH-HHhCCCCCEeeEEEEEec----
Confidence            34567899995 7799999999999999999999999998632     234456665 677799999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...|+||||+++++|.+++.+.   .+++..+..++.|++.||.|||+.|++||||||+||+++               
T Consensus        88 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~---------------  149 (297)
T cd06656          88 GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG---------------  149 (297)
T ss_pred             CCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---------------
Confidence            67899999999999999998653   489999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.++|+|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||..
T Consensus       150 ------------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~  217 (297)
T cd06656         150 ------------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (297)
T ss_pred             ------------CCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                        56779999999887654433333445678999999999888899999999999999999999999966


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV  310 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~  310 (372)
                      .+.....   ......+...  ......++..+.+|+.+||..||++|||++++++||||+.....
T Consensus       218 ~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         218 ENPLRAL---YLIATNGTPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             CCcchhe---eeeccCCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence            4432211   1111111111  11123578899999999999999999999999999999876443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-43  Score=319.60  Aligned_cols=249  Identities=28%  Similarity=0.416  Sum_probs=206.8

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .|.+ .+.||+|++|.||+|.+..+++.|++|.+...       ....+|+.. ++.++||||+++++++..    +...
T Consensus         1 ~~~~-~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~   74 (256)
T cd08529           1 DFEI-LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARV-LAKLDSSYIIRYYESFLD----KGKL   74 (256)
T ss_pred             CceE-eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHH-HHhcCCCCeehheeeecc----CCEE
Confidence            4777 47799999999999999999999999998521       234456665 666799999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||+++                   
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~-------------------  135 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD-------------------  135 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe-------------------
Confidence            9999999999999999876456799999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++++|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|..||..... 
T Consensus       136 --------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-  206 (256)
T cd08529         136 --------AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-  206 (256)
T ss_pred             --------CCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-
Confidence                    56779999999988765544444456788999999999888899999999999999999999999965442 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                         ......+..+.++..   ...++.++.++|.+||+.+|++||++.++++|||+
T Consensus       207 ---~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         207 ---GALILKIIRGVFPPV---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ---HHHHHHHHcCCCCCC---ccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence               222233333322211   12678999999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=321.32  Aligned_cols=249  Identities=25%  Similarity=0.433  Sum_probs=202.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +.|.+ .+.||.|++|.||.|.+..+++.+|+|.+...          ....+|+.. ++.++||||++++++++.    
T Consensus         2 ~~~~~-~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----   75 (263)
T cd06625           2 TNWRR-GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQL-LKNLQHERIVQYYGCLRD----   75 (263)
T ss_pred             Ccccc-cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHH-HHhCCCCCeeeeEEEEcc----
Confidence            46887 68899999999999999999999999988522          134557766 566799999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +..+|+|+||+++++|.+++...  +.+++..++.++.|++.||.|||+.||+||||+|+||+++               
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~---------------  138 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD---------------  138 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---------------
Confidence            56899999999999999998765  3599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.++|+|||++.........   .....|++.|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus       139 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  206 (263)
T cd06625         139 ------------SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP  206 (263)
T ss_pred             ------------CCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence                        5667999999988755322111   1334678899999999888899999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      |......    ...........  .......++.++.++|.+||..+|.+|||+.+++.||||
T Consensus       207 ~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         207 WAEFEAM----AAIFKIATQPT--NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ccccchH----HHHHHHhccCC--CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9654321    11112221111  112224688999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-44  Score=336.46  Aligned_cols=251  Identities=19%  Similarity=0.263  Sum_probs=190.9

Q ss_pred             cccccc--CCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          22 EILGLG--INGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        22 ~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      ++||+|  +|++||++.++.+|+.||+|.+...       ....+|+.+ ++.++||||+++++++..    ++..|+||
T Consensus         4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~-l~~l~hpniv~~~~~~~~----~~~~~lv~   78 (327)
T cd08227           4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHV-SKLFNHPNIVPYRATFIA----DNELWVVT   78 (327)
T ss_pred             hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHH-HHhcCCCCeeeEEEEEEE----CCEEEEEE
Confidence            679999  6789999999999999999999632       123356655 677799999999999976    67899999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      ||+++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++                       
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~-----------------------  135 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-----------------------  135 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe-----------------------
Confidence            999999999999765445699999999999999999999999999999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCC--CCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                          .++.++++||+.+........       ......++..|+|||++.+  ..++.++|||||||++|+|++|..||.
T Consensus       136 ----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  211 (327)
T cd08227         136 ----VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  211 (327)
T ss_pred             ----cCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence                344566666654332211100       0112345778999999865  468999999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCcc------------------------------------------CCCCcccccCHHHHHHH
Q psy3151         244 SNHGQAISPGMKNRIRLGQFD------------------------------------------FPNPEWEHVSQEAKTLI  281 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~s~~~~~li  281 (372)
                      ........   ... ..+..+                                          ...+....+++++.+||
T Consensus       212 ~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  287 (327)
T cd08227         212 DMPATQML---LEK-LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFV  287 (327)
T ss_pred             CcchhHHH---HHH-hcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHH
Confidence            43321110   000 000000                                          00011224578999999


Q ss_pred             HHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         282 KNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       282 ~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      .+||+.||++|||++++++||||++..
T Consensus       288 ~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         288 EQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             HHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            999999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.3e-44  Score=328.27  Aligned_cols=256  Identities=26%  Similarity=0.444  Sum_probs=208.8

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      -....+|+++ +.||.|++|.||+|.+..+++.+|+|.+...     ....+|+.. ++.++|+||+++++.+..    +
T Consensus        16 ~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~-l~~~~h~~v~~~~~~~~~----~   89 (296)
T cd06654          16 GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV-MRENKNPNIVNYLDSYLV----G   89 (296)
T ss_pred             CCcccceeeE-EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHH-HHhCCCCCEeeEEEEEEe----C
Confidence            3456899995 6799999999999999999999999988632     244567776 566799999999999875    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...|+||||+.+++|.+++...   .+++.++..++.|++.||+|||+.||+||||||+||+++                
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~----------------  150 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----------------  150 (296)
T ss_pred             CEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----------------
Confidence            6899999999999999998643   489999999999999999999999999999999999997                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.++|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus       151 -----------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~  219 (296)
T cd06654         151 -----------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (296)
T ss_pred             -----------CCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence                       566799999998876543333334457889999999998888999999999999999999999999655


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .....   .......+....  .....++..+.+||.+||..||.+|||+.+++.||||...
T Consensus       220 ~~~~~---~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         220 NPLRA---LYLIATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             CHHHh---HHHHhcCCCCCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            43211   111111111111  1224678999999999999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.4e-44  Score=324.22  Aligned_cols=251  Identities=28%  Similarity=0.461  Sum_probs=202.4

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .++|.+. +.||.|+||.||+|.+..+++.||+|++....     ...+|+.. ++.++||||+++++.+..    +...
T Consensus         8 ~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~-~~~l~h~~ii~~~~~~~~----~~~~   81 (267)
T cd06645           8 QEDFELI-QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM-MKDCKHSNIVAYFGSYLR----RDKL   81 (267)
T ss_pred             HHHHHHH-HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHH-HHhCCCCCeeeEEEEEEe----CCEE
Confidence            4689985 77999999999999999999999999986321     23456665 677799999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+++|.+++...  +.+++..++.++.|++.||+|||+.|++|+||||+||+++                   
T Consensus        82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~-------------------  140 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT-------------------  140 (267)
T ss_pred             EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-------------------
Confidence            9999999999999998765  4599999999999999999999999999999999999997                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                              ..+.++|+|||++..............|++.|+|||.+.   ...++.++|+|||||++|+|++|..||...
T Consensus       141 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~  212 (267)
T cd06645         141 --------DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             --------CCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence                    566799999999876544333334567899999999874   456889999999999999999999998654


Q ss_pred             CCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      .....    ........+..+. .....++..+.++|.+||..+|++|||++++++|||
T Consensus       213 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         213 HPMRA----LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             cchhh----HHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            32211    1111111221111 111246789999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.1e-43  Score=324.76  Aligned_cols=259  Identities=28%  Similarity=0.392  Sum_probs=206.7

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-----KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ...+.|+++ +.||.|+||.||+|.+..+++.+|+|++....     ...+|+.. ++.++||||+++++.+..    +.
T Consensus         9 ~~~~~y~i~-~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~   82 (292)
T cd06644           9 DPNEVWEII-GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEI-LATCNHPYIVKLLGAFYW----DG   82 (292)
T ss_pred             Ccchhhhhh-heecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHH-HHhCCCCcEeeeEEEEEe----CC
Confidence            356889996 66999999999999999999999999986322     23456665 667789999999999875    66


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..|+||||+.+++|..++.+.. ..+++..++.++.|++.||.|||+.|++||||||+||+++                 
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~-----------------  144 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT-----------------  144 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc-----------------
Confidence            8999999999999988876543 4599999999999999999999999999999999999997                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                .++.++|+|||++..............+++.|+|||.+.     ...++.++|+|||||++|+|++|..|
T Consensus       145 ----------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p  214 (292)
T cd06644         145 ----------LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP  214 (292)
T ss_pred             ----------CCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence                      566799999998876543333334456788999999874     34578899999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      |...+..    ...........+ .......++.++.++|.+||..||++||+++++++||||..+..
T Consensus       215 ~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         215 HHELNPM----RVLLKIAKSEPP-TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             CccccHH----HHHHHHhcCCCc-cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            9654321    112222211111 11112357889999999999999999999999999999987644

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0574|consensus

Probab=100.00  E-value=4.9e-47  Score=328.43  Aligned_cols=254  Identities=28%  Similarity=0.465  Sum_probs=217.8

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc---hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +...-|+|+++ ||+|+||.||+|.|+.+|+.+|||.+..   -....+|+.+ +.....|+||++++.|..    ...+
T Consensus        30 ~PEEVFDi~~K-LGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISI-MQQC~S~yVVKYYGSYFK----~sDL  103 (502)
T KOG0574|consen   30 PPEEVFDIVGK-LGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISI-MQQCKSKYVVKYYGSYFK----HSDL  103 (502)
T ss_pred             ChHHHHHHHHH-hcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHH-HHHcCCchhhhhhhhhcc----CCce
Confidence            34567888754 9999999999999999999999999863   3456788888 455588999999998864    6779


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++|||||..|++.+.++.+. +.++|+++..+++.-+.||+|||...-+|||||..|||++                   
T Consensus       104 WIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN-------------------  163 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN-------------------  163 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc-------------------
Confidence            99999999999999998654 6799999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .+|..|++|||.|..+.+.-...++.+|||.|||||++..-.|+.++||||||++..||..|++||.+-...
T Consensus       164 --------T~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM  235 (502)
T KOG0574|consen  164 --------TDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM  235 (502)
T ss_pred             --------ccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc
Confidence                    788899999999999888777888999999999999999999999999999999999999999999765432


Q ss_pred             CCCHhHHHHHhhCCccCCCCcc---cccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEW---EHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .-      ...  -..-|+|++   +..|.++-|||++||.++|++|-||-++++|||+++.
T Consensus       236 RA------IFM--IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  236 RA------IFM--IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             ce------eEe--ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            21      000  011122322   4578999999999999999999999999999999864

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.3e-43  Score=325.86  Aligned_cols=248  Identities=35%  Similarity=0.696  Sum_probs=208.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++. +.||.|++|.||+|.+..+++.+|+|++...        ....+|++. ++.++||||+++++++..    +.
T Consensus         1 ~~y~~~-~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~   74 (290)
T cd05580           1 DDFEFI-KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRI-LQSIRHPFLVNLYGSFQD----DS   74 (290)
T ss_pred             CceEEE-EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH-HHhCCCCCccceeeEEEc----CC
Confidence            478884 7899999999999999999999999998532        234467776 566689999999999876    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+||||+++++|.+++...  +.+++..++.++.||+.||.|||+.||+||||+|+||+++                 
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~-----------------  135 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD-----------------  135 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC-----------------
Confidence            899999999999999999775  4599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.+||+|||++......   ....+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus       136 ----------~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         136 ----------SDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             ----------CCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence                      5677999999998876433   334568999999999988888999999999999999999999996544


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccCC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFN  308 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~~  308 (372)
                      .    ......+..+...++.    .++..++++|.+||..||.+|+     ++++++.||||..+.
T Consensus       203 ~----~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         203 P----IQIYEKILEGKVRFPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             H----HHHHHHHhcCCccCCc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            1    2233444444444442    5689999999999999999999     899999999997653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.3e-44  Score=328.53  Aligned_cols=251  Identities=27%  Similarity=0.440  Sum_probs=197.6

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|+++ +.||.|+||+||+|.+..+|+.+|+|.+...       ....+|+.. ++.++||||+++++++.+    ...+
T Consensus         1 ~y~~~-~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~-l~~l~h~~i~~~~~~~~~----~~~~   74 (284)
T cd07839           1 KYEKL-EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL-LKELKHKNIVRLYDVLHS----DKKL   74 (284)
T ss_pred             CceeE-EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHH-HHhcCCCCeeeHHHHhcc----CCce
Confidence            58885 6799999999999999999999999998532       234567777 566799999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+|+||+. ++|.+++.... +.+++..++.++.||+.||.|||++||+||||||+||+++                   
T Consensus        75 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~-------------------  133 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN-------------------  133 (284)
T ss_pred             EEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc-------------------
Confidence            99999996 58888876543 4699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                              .++.++|+|||++..............+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.....
T Consensus       134 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~  205 (284)
T cd07839         134 --------KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND  205 (284)
T ss_pred             --------CCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC
Confidence                    56679999999887654433333445678899999988654 478999999999999999999888654322


Q ss_pred             CCCCHhHHHHHhh-------------------CCccCCC------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         248 QAISPGMKNRIRL-------------------GQFDFPN------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       248 ~~~~~~~~~~~~~-------------------~~~~~~~------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      ..   .....+..                   ..+....      .....+++++.+||.+||+.||.+|||+++++.||
T Consensus       206 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         206 VD---DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             HH---HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            11   11111100                   0000000      01124789999999999999999999999999999


Q ss_pred             cc
Q psy3151         303 WI  304 (372)
Q Consensus       303 ~~  304 (372)
                      ||
T Consensus       283 ~f  284 (284)
T cd07839         283 YF  284 (284)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-43  Score=323.65  Aligned_cols=251  Identities=26%  Similarity=0.368  Sum_probs=201.1

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|+++ +.||.|+||+||+|.+..+++.||+|++...      ....+|+.+ +..++||||+++++.+..    .+..
T Consensus         1 ~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~~   74 (279)
T cd06619           1 QDIQYQ-EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEI-LYKCDSPYIIGFYGAFFV----ENRI   74 (279)
T ss_pred             Ccchhe-eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHH-HHhCCCCCeeeEEEEEEE----CCEE
Confidence            357775 7799999999999999999999999998532      234467776 566799999999999986    6778


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+++++|..+      ..+++..+..++.|++.||+|||+.||+|+||||+||+++                   
T Consensus        75 ~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~-------------------  129 (279)
T cd06619          75 SICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN-------------------  129 (279)
T ss_pred             EEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC-------------------
Confidence            999999999988654      2378999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++|+|||++......  .....+||+.|+|||.+.+..++.++|+|||||++|+|++|..||......
T Consensus       130 --------~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~  199 (279)
T cd06619         130 --------TRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN  199 (279)
T ss_pred             --------CCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccc
Confidence                    5677999999998765332  233457899999999998888999999999999999999999999653322


Q ss_pred             CC---CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         249 AI---SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       249 ~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      ..   .......+.....  +.......++++.++|.+||+.||.+||+++++++||||....
T Consensus       200 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         200 QGSLMPLQLLQCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             ccccchHHHHHHHhccCC--CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            11   1111222211111  1111235788999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.3e-43  Score=325.29  Aligned_cols=256  Identities=26%  Similarity=0.437  Sum_probs=208.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ...+|+++ +.||.|++|.||+|.+..+|+.||+|.+...     ....+|+.. ++.++||||+++++++..    +..
T Consensus        17 ~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~----~~~   90 (296)
T cd06655          17 PKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV-MKELKNPNIVNFLDSFLV----GDE   90 (296)
T ss_pred             CcceEEEE-EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHH-HHhcCCCceeeeeeeEec----Cce
Confidence            45789985 7799999999999999999999999988532     234456666 667799999999999875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+|+||+.+++|.+++...   .+++.++..++.|++.||+|||+.|++||||||+||+++                  
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~------------------  149 (296)
T cd06655          91 LFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG------------------  149 (296)
T ss_pred             EEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC------------------
Confidence            99999999999999988653   489999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.++|+|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus       150 ---------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~  220 (296)
T cd06655         150 ---------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP  220 (296)
T ss_pred             ---------CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                     56779999999887654433333445678899999999888899999999999999999999999965442


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      ..   .. ..+..... .+......+++.+.++|.+||..||.+|||+.+++.||||+....
T Consensus       221 ~~---~~-~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         221 LR---AL-YLIATNGT-PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HH---HH-HHHHhcCC-cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            11   11 11111111 111122467899999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0671|consensus

Probab=100.00  E-value=2.7e-45  Score=327.08  Aligned_cols=278  Identities=25%  Similarity=0.433  Sum_probs=214.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCC-C----CEeEEeEeeeeecC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSH-K----HIVNIKDVYENIYN   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h-~----ni~~~~~~~~~~~~   83 (372)
                      +.+||.|+ ..+|+|+||+|..+.+..++..||||+++...    .+.-|++.+.++..+ |    -++.+.++|+-   
T Consensus        87 l~~Ry~i~-~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy---  162 (415)
T KOG0671|consen   87 LTNRYEIV-DLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY---  162 (415)
T ss_pred             cccceehh-hhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc---
Confidence            68999996 77999999999999999999999999997443    344567766666433 2    36788888876   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       .+++++|+|.+ |-++++++..++-.+++...++.+.+||+.++++||+.+++|.||||+|||+.+..   ..++.+-+
T Consensus       163 -rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~---~~~~~~~k  237 (415)
T KOG0671|consen  163 -RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSE---YFKTYNPK  237 (415)
T ss_pred             -cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccc---eEEEeccC
Confidence             77899999999 77999999987777899999999999999999999999999999999999997422   22222222


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                      ..    ..+.++.....++++|||.|+....   ...+.+.|..|+|||++.+-+++.++|+||+||||+|+.+|...|.
T Consensus       238 ~~----~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  238 KK----VCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             Cc----cceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence            11    1222334677899999999987533   3466778999999999999999999999999999999999999998


Q ss_pred             CCCCCCCCHhHHHHHhh------------------CCccCCCCccc---------------------ccCHHHHHHHHHh
Q psy3151         244 SNHGQAISPGMKNRIRL------------------GQFDFPNPEWE---------------------HVSQEAKTLIKNM  284 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~---------------------~~s~~~~~li~~l  284 (372)
                      ..++.+-. .+.+++..                  +.++++.....                     ..-.++.|||++|
T Consensus       311 tHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  311 THENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             cCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            77644321 12222211                  11222211100                     0113588999999


Q ss_pred             ccCCCCCCCChhHHhcCCccccC
Q psy3151         285 LCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       285 l~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |.+||.+|+|+.|+|.||||+..
T Consensus       390 L~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  390 LEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HccCccccccHHHHhcCHHhhcC
Confidence            99999999999999999999864

>KOG0662|consensus

Probab=100.00  E-value=7.9e-45  Score=293.40  Aligned_cols=258  Identities=28%  Similarity=0.465  Sum_probs=207.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +.|+.. +.||+|.||+||+|++..+++.||+|.++-       ...+.+|+.+ ++.+.|.||++++++...    ++.
T Consensus         2 ~~ydkm-ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicl-lkelkhknivrl~dvlhs----dkk   75 (292)
T KOG0662|consen    2 QKYDKM-EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICL-LKELKHKNIVRLHDVLHS----DKK   75 (292)
T ss_pred             cchHHH-HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHH-HHHhhhcceeehhhhhcc----Cce
Confidence            457765 559999999999999999999999999862       2367899987 777899999999998875    788


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +.+|+||| ..+|..+..+.. +.++.+.++.++.|+++||.++|+.++.||||||.|+||+                  
T Consensus        76 ltlvfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin------------------  135 (292)
T KOG0662|consen   76 LTLVFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN------------------  135 (292)
T ss_pred             eEEeHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec------------------
Confidence            99999999 459988887764 6799999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLC-GFPPFFSN  245 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~  245 (372)
                               .+|.+|++|||+|+.+.-+-.-....+.|.||++|.++.+ .-|+...|+||.||++.|+.. |++.|.+.
T Consensus       136 ---------~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~  206 (292)
T KOG0662|consen  136 ---------RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_pred             ---------cCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence                     6778999999999987654433445566999999998755 568999999999999999986 77878766


Q ss_pred             CCCCCCHhHHHHHhhCC-ccCC--------------CC--cc----cccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         246 HGQAISPGMKNRIRLGQ-FDFP--------------NP--EW----EHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~-~~~~--------------~~--~~----~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      +..+....+...+.... -.+|              ++  .|    ..++...+||++++|..+|.+|++|+.+++||||
T Consensus       207 dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf  286 (292)
T KOG0662|consen  207 DVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF  286 (292)
T ss_pred             cHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence            54443322222221110 0011              00  11    2344567899999999999999999999999999


Q ss_pred             ccC
Q psy3151         305 SQF  307 (372)
Q Consensus       305 ~~~  307 (372)
                      ..+
T Consensus       287 ~d~  289 (292)
T KOG0662|consen  287 SDF  289 (292)
T ss_pred             ccc
Confidence            875

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=324.01  Aligned_cols=256  Identities=29%  Similarity=0.402  Sum_probs=207.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ..++|+++ +.||.|+||.||+|.+..+++.+|+|++...     ....+|+.. ++.++||||+++++.+..    +..
T Consensus         3 ~~~~~~i~-~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~   76 (280)
T cd06611           3 PNDIWEII-GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDI-LSECKHPNIVGLYEAYFY----ENK   76 (280)
T ss_pred             chhHHHHH-HHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHH-HHhCCCCceeEEEEEEec----CCe
Confidence            35789995 6699999999999999999999999998632     234467776 566689999999999875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++                  
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~------------------  137 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT------------------  137 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC------------------
Confidence            999999999999999987653 4699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                               .++.++|+|||++..............+|+.|+|||.+.     ...++.++|+|||||++|+|++|..||
T Consensus       138 ---------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~  208 (280)
T cd06611         138 ---------LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH  208 (280)
T ss_pred             ---------CCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCc
Confidence                     567799999998876544333344567899999999874     345778999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ...+..    .....+..+..+. ......++.++.++|.+||+.+|.+|||++++++||||.+.
T Consensus       209 ~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         209 HELNPM----RVLLKILKSEPPT-LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             ccCCHH----HHHHHHhcCCCCC-cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            654322    1122222221110 01123578999999999999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-43  Score=323.30  Aligned_cols=248  Identities=31%  Similarity=0.457  Sum_probs=202.0

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      ||+|+||+||+|.+..+|+.||+|.+...        ....+|+++ ++.++||||++++++++.    ....|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI-LEKVSSRFIVSLAYAFET----KDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHH-HHhCCCCCEeeeeeEEec----CCeEEEEEecC
Confidence            69999999999999999999999998532        123457766 667789999999999875    67899999999


Q ss_pred             CCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151          96 HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus        96 ~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                      ++++|.+++.+.....+++..++.++.|++.||.|||+.|++||||+|+||+++                          
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~--------------------------  129 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD--------------------------  129 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC--------------------------
Confidence            999999999876544699999999999999999999999999999999999998                          


Q ss_pred             CCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHH
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK  255 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  255 (372)
                       .++.++|+|||.+..... ........++..|+|||.+.+..++.++|+||+||++|+|++|..||...........+.
T Consensus       130 -~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  207 (277)
T cd05577         130 -DHGNVRISDLGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK  207 (277)
T ss_pred             -CCCCEEEccCcchhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH
Confidence             567799999998876533 222334456888999999988889999999999999999999999996654422222222


Q ss_pred             HHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccCC
Q psy3151         256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFN  308 (372)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~~  308 (372)
                      ......    +......+++++.++|.+||+.||.+||     ++.+++.||||..+.
T Consensus       208 ~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         208 RRTLEM----AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             hccccc----cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence            222222    2222235799999999999999999999     888899999997653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-44  Score=323.88  Aligned_cols=260  Identities=25%  Similarity=0.401  Sum_probs=207.0

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--CCc
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIY--NGS   85 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--~~~   85 (372)
                      +..++|++. +.||.|++|.||+|.+..+++.+|+|++...    ....+|+..+.++.+|+||+++++++....  ..+
T Consensus         3 ~~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELV-EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             Cchhheehe-eeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            456999995 7899999999999999999999999998643    345567777566668999999999987533  235


Q ss_pred             eEEEEEEeccCCCchhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKE--DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~--~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ..+|+||||+.+++|.+++....  +..+++..++.++.|++.||.|||+.|++|+||+|+||+++              
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~--------------  147 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT--------------  147 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc--------------
Confidence            67899999999999999887533  45699999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-----CCCCCccchhhHHHHHHHHHhC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-----DKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g  238 (372)
                                   .++.++++|||++..............|++.|+|||.+..     ..++.++|+|||||++|+|++|
T Consensus       148 -------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g  214 (275)
T cd06608         148 -------------KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG  214 (275)
T ss_pred             -------------cCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC
Confidence                         5677999999988765443333445668899999998743     3477899999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ..||.......    ....+...... .......++.++++||.+||..||++|||+.++++|||+
T Consensus       215 ~~p~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         215 KPPLCDMHPMR----ALFKIPRNPPP-TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCccccchHH----HHHHhhccCCC-CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            99996433211    11122211111 111112468899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-43  Score=328.25  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=202.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|++. +.||+|+||.||+|.+..+|..+|+|.+...      ....+|+++ ++.++||||+++++++..    +..+
T Consensus         1 ~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~~   74 (308)
T cd06615           1 DDFEKL-GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKV-LHECNSPYIVGFYGAFYS----DGEI   74 (308)
T ss_pred             CCceEE-eeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEee----CCEE
Confidence            468885 7799999999999999999999999998632      235578877 555699999999999976    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      |+||||+++++|.+++.+.  +.+++..+..++.||+.||.|||+ .+++||||||+||+++                  
T Consensus        75 ~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~------------------  134 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN------------------  134 (308)
T ss_pred             EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe------------------
Confidence            9999999999999999765  459999999999999999999998 5999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.++|+|||++......  .....+|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus       135 ---------~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~  203 (308)
T cd06615         135 ---------SRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA  203 (308)
T ss_pred             ---------cCCcEEEccCCCccccccc--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence                     5667999999988654321  22445788999999999888899999999999999999999999864332


Q ss_pred             CCCCHhH--------------------------------HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh
Q psy3151         248 QAISPGM--------------------------------KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI  295 (372)
Q Consensus       248 ~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~  295 (372)
                      .......                                ...+....  .+......++.++.+||.+||..||++|||+
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  281 (308)
T cd06615         204 KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP--PPKLPSGAFSDEFQDFVDKCLKKNPKERADL  281 (308)
T ss_pred             hhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCC--CccCcCcccCHHHHHHHHHHccCChhhCcCH
Confidence            2110000                                00000000  0000012368899999999999999999999


Q ss_pred             hHHhcCCccccC
Q psy3151         296 DQVMENKWISQF  307 (372)
Q Consensus       296 ~eil~hp~~~~~  307 (372)
                      .++++||||.+.
T Consensus       282 ~~ll~~~~~~~~  293 (308)
T cd06615         282 KELTKHPFIKRA  293 (308)
T ss_pred             HHHhcChhhhhc
Confidence            999999999775

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-43  Score=321.86  Aligned_cols=251  Identities=28%  Similarity=0.457  Sum_probs=207.0

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|++. +.||.|++|.||+|.+..+++.+|+|++....      ...+|+.. ++.++|+||+++++++..    +..+
T Consensus         1 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~   74 (274)
T cd06609           1 ELFTLL-ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQF-LSQCRSPYITKYYGSFLK----GSKL   74 (274)
T ss_pred             Chhhhh-hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHH-HHHcCCCCeeeeeEEEEE----CCeE
Confidence            578885 77999999999999999999999999986321      33466665 667789999999998875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+|+||+.+++|.+++...   .+++..++.++.|++.||.|||+.+++|+||+|+||+++                   
T Consensus        75 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~-------------------  132 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS-------------------  132 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC-------------------
Confidence            9999999999999998764   599999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++++|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..
T Consensus       133 --------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~  204 (274)
T cd06609         133 --------EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM  204 (274)
T ss_pred             --------CCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH
Confidence                    567799999999987754433344567788999999998888999999999999999999999999654422


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                          .....+.....+  ......++.++.+++.+||..||++|||++++++||||.+.
T Consensus       205 ----~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         205 ----RVLFLIPKNNPP--SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             ----HHHHHhhhcCCC--CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence                122222222111  11111278999999999999999999999999999999774

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.9e-43  Score=321.88  Aligned_cols=246  Identities=28%  Similarity=0.448  Sum_probs=194.6

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHH--HHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVEL--QLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~--~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      +||+|+||.||+|.+..+++.+|+|.+....        ...+|...  .+....||||+.+++.+..    ++..|+||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~   76 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT----PDKLCFIL   76 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec----CCeEEEEE
Confidence            4899999999999999999999999885321        12223222  1233479999999998875    56799999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      ||+.+++|.+++...  +.+++..+..++.|++.||+|||+.||+||||||+||+++                       
T Consensus        77 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~-----------------------  131 (279)
T cd05633          77 DLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD-----------------------  131 (279)
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC-----------------------
Confidence            999999999988765  4599999999999999999999999999999999999997                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-PDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS  251 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  251 (372)
                          .++.++++|||++......  ......||+.|+|||.+. +..++.++|+||+||++|+|++|..||........ 
T Consensus       132 ----~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-  204 (279)
T cd05633         132 ----EHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-  204 (279)
T ss_pred             ----CCCCEEEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-
Confidence                5667999999988755332  223356899999999986 45688999999999999999999999965543221 


Q ss_pred             HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccCC
Q psy3151         252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFN  308 (372)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~~  308 (372)
                      ........    ..+......++.++.++|.+||..||.+|+     |++++++||||++.+
T Consensus       205 ~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         205 HEIDRMTL----TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHHHHHhh----cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            11111111    111122246889999999999999999999     699999999998853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.2e-43  Score=320.48  Aligned_cols=256  Identities=27%  Similarity=0.399  Sum_probs=203.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +-|+++ +.||.|+||.||+|.+..++..+|+|.+...     ....+|+++ ++.++||||+++++.+..    ++..|
T Consensus         5 ~~~~i~-~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~-l~~l~h~~ii~~~~~~~~----~~~~~   78 (282)
T cd06643           5 EFWEII-GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDI-LASCDHPNIVKLLDAFYY----ENNLW   78 (282)
T ss_pred             HHHHHH-hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHH-HHHCCCCCeeeEEEEEee----CCEEE
Confidence            347775 6699999999999999999999999998632     233457766 666799999999999875    67899


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +|+||+.+++|..++.+.. ..+++..++.++.|++.||.|||+.|++||||||+||+++                    
T Consensus        79 ~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~--------------------  137 (282)
T cd06643          79 ILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT--------------------  137 (282)
T ss_pred             EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc--------------------
Confidence            9999999999988876533 4699999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                             .++.++++|||++..............+|+.|+|||++.     ...++.++|+||+||++|+|++|.+||..
T Consensus       138 -------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  210 (282)
T cd06643         138 -------LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE  210 (282)
T ss_pred             -------cCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence                   567799999998876544333334456899999999873     34578899999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      .+..    .....+...... .......++.++.+||.+||..||.+|||++++++||||.....
T Consensus       211 ~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         211 LNPM----RVLLKIAKSEPP-TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             cCHH----HHHHHHhhcCCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            4321    111222211111 11112357899999999999999999999999999999986533

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-43  Score=328.66  Aligned_cols=255  Identities=29%  Similarity=0.495  Sum_probs=202.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++. +.||.|++|+||+|.+..+++.||+|.+....        ...+|++. ++.++||||+++++.+..    +.
T Consensus         1 ~~y~~~-~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~   74 (316)
T cd05574           1 KHFKKI-KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI-LATLDHPFLPTLYASFQT----ET   74 (316)
T ss_pred             CceEEe-eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHH-HHhCCCCCchhheeeeec----CC
Confidence            478885 77999999999999999999999999986321        23456665 677789999999999875    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..|+||||+.+++|.+++.......+++..++.++.|++.||+|||+.|++|+||||+||+++.                
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~----------------  138 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE----------------  138 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC----------------
Confidence            8999999999999999998655567999999999999999999999999999999999999983                


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccC-----------------------------CCcccccccCCCcCCCcccCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSN-----------------------------KASLQTPCYTPYYVAPEVLGPD  217 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~  217 (372)
                                 ++.++|+|||++......                             ........||..|+|||++.+.
T Consensus       139 -----------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  207 (316)
T cd05574         139 -----------SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD  207 (316)
T ss_pred             -----------CCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC
Confidence                       334555555544332110                             1112234678899999999888


Q ss_pred             CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC---
Q psy3151         218 KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT---  294 (372)
Q Consensus       218 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s---  294 (372)
                      .++.++|||||||++|+|++|..||.+.+...    ....+......++.  ...++.++.++|.+||..||++|||   
T Consensus       208 ~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~  281 (316)
T cd05574         208 GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE----TFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKR  281 (316)
T ss_pred             CCCchHHHHHHHHHHHHHhhCCCCCCCCchHH----HHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchh
Confidence            89999999999999999999999996554321    22222322333222  2237899999999999999999999   


Q ss_pred             -hhHHhcCCccccCC
Q psy3151         295 -IDQVMENKWISQFN  308 (372)
Q Consensus       295 -~~eil~hp~~~~~~  308 (372)
                       ++++|.||||++..
T Consensus       282 ~~~~ll~~~~~~~~~  296 (316)
T cd05574         282 GAAEIKQHPFFRGVN  296 (316)
T ss_pred             hHHHHHcCchhhcCC
Confidence             99999999998753

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.3e-43  Score=321.99  Aligned_cols=255  Identities=27%  Similarity=0.478  Sum_probs=200.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|+++ +.||+|++|.||+|.+..+|+.||+|++...       ....+|+.+ ++.++||||+++++++..    +..
T Consensus         1 ~~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~----~~~   74 (286)
T cd07847           1 EKYEKL-SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRM-LKQLKHPNLVNLIEVFRR----KRK   74 (286)
T ss_pred             Cceeee-eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHH-HHhCCCCCEeeeeeEEee----CCE
Confidence            579985 7799999999999999999999999988532       123467776 666789999999999876    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .++||||+++++|..++...  ..+++..++.++.||+.||.|||+.|++||||||+||+++                  
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~------------------  134 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT------------------  134 (286)
T ss_pred             EEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc------------------
Confidence            99999999988887776543  3599999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.++|+|||++..............++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+..
T Consensus       135 ---------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         135 ---------KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             ---------CCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     5667999999998876544333344567889999999865 568899999999999999999999997554


Q ss_pred             CCCCCHhHHHHHh-----------hC----CccCCCC--------cccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         247 GQAISPGMKNRIR-----------LG----QFDFPNP--------EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       247 ~~~~~~~~~~~~~-----------~~----~~~~~~~--------~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      ..+....+.....           ..    ....+.+        ....++.++.+||.+||+.||++|||+.+++.|||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~  285 (286)
T cd07847         206 DVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY  285 (286)
T ss_pred             hHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence            3221111110000           00    0001111        12356889999999999999999999999999999


Q ss_pred             c
Q psy3151         304 I  304 (372)
Q Consensus       304 ~  304 (372)
                      |
T Consensus       286 f  286 (286)
T cd07847         286 F  286 (286)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0197|consensus

Probab=100.00  E-value=6.6e-44  Score=331.91  Aligned_cols=239  Identities=25%  Similarity=0.436  Sum_probs=197.1

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecc----hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHD----TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHG   97 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~   97 (372)
                      +.||+|.||+|+.|.... ...||+|.+..    .....+|+.+ ++.++|+|||++++++..    +.-+|||||||..
T Consensus       212 ~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~i-Mk~L~H~~lV~l~gV~~~----~~piyIVtE~m~~  285 (468)
T KOG0197|consen  212 RELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQI-MKKLRHEKLVKLYGVCTK----QEPIYIVTEYMPK  285 (468)
T ss_pred             HHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHH-HHhCcccCeEEEEEEEec----CCceEEEEEeccc
Confidence            459999999999999963 44799999863    2345578888 788899999999999875    4469999999999


Q ss_pred             CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCC
Q psy3151          98 GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD  177 (372)
Q Consensus        98 g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  177 (372)
                      |+|.++++...++.+...+...++.||+.|++||+++++|||||..+||||+                           .
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---------------------------~  338 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---------------------------E  338 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---------------------------c
Confidence            9999999986667899999999999999999999999999999999999998                           6


Q ss_pred             CCCeeeeccccccccccCCCcccccccCC-CcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHH
Q psy3151         178 GGILKLTDFGFAKKIVSNKASLQTPCYTP-YYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMK  255 (372)
Q Consensus       178 ~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~-~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~  255 (372)
                      +..+||+|||+|+...++.-.......-| -|.|||.+..+.++.++|+||||++||||+| |+.||.+.+..+    ..
T Consensus       339 ~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----v~  414 (468)
T KOG0197|consen  339 DLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----VL  414 (468)
T ss_pred             CceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----HH
Confidence            77899999999995443222222222223 4999999999999999999999999999999 999997665433    34


Q ss_pred             HHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +.+..| +.+|.|  ..+++++.++|..||+.+|++|||++.+..
T Consensus       415 ~~le~G-yRlp~P--~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  415 ELLERG-YRLPRP--EGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHhcc-CcCCCC--CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            444443 344444  379999999999999999999999986643

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.4e-43  Score=320.82  Aligned_cols=260  Identities=28%  Similarity=0.444  Sum_probs=204.2

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeee-cCCce
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENI-YNGSR   86 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~-~~~~~   86 (372)
                      ...++|+++ +.||+|+||+||+|.+..+++.+|+|++...    ....+|+.++.++.+||||+++++++... ...+.
T Consensus        15 ~~~~~~~~~-~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          15 DPSDTWEII-ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             Ccccceeee-eeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            467899995 6799999999999999999999999998632    23456777755555899999999987422 12356


Q ss_pred             EEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ..|+||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+++||||||+||+++               
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---------------  158 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---------------  158 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---------------
Confidence            899999999999999987632  234689999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                  ..+.++++|||++..............|++.|+|||++.     ...++.++|+||+||++|+|++|.
T Consensus       159 ------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~  226 (286)
T cd06638         159 ------------TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD  226 (286)
T ss_pred             ------------CCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCC
Confidence                        566799999999876644333334456899999999874     345789999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .||........   .. ...... .........++.++.+||.+||+.||++|||+.++++|+||
T Consensus       227 ~p~~~~~~~~~---~~-~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         227 PPLADLHPMRA---LF-KIPRNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCCCCchhHH---Hh-hccccC-CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            99965432111   11 111111 11111112467899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.8e-43  Score=321.22  Aligned_cols=255  Identities=25%  Similarity=0.357  Sum_probs=202.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|+++ +.||+|+||.||+|.+..+|+.||||++...      .....|+...++..+||||+++++++..    +...
T Consensus         1 ~~~~~~-~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~----~~~~   75 (283)
T cd06617           1 DDLEVI-EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR----EGDV   75 (283)
T ss_pred             CCceEE-EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec----CCcE
Confidence            478885 6799999999999999999999999998632      2345566666788899999999999875    5679


Q ss_pred             EEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          89 LVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      |++|||++ ++|.+++...  ....+++..++.++.||+.||+|||++ +++||||||+||+++                
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~----------------  138 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN----------------  138 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----------------
Confidence            99999996 6888877642  224699999999999999999999997 999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC----CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP----DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                 .++.+||+|||++...... .......|+..|+|||.+.+    ..++.++|+|||||++|+|++|..|
T Consensus       139 -----------~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  206 (283)
T cd06617         139 -----------RNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP  206 (283)
T ss_pred             -----------CCCCEEEeecccccccccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence                       5677999999998765332 12233567889999998854    4578899999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      |.....  ....+...........+.   ..++.++.++|.+||..+|.+|||++++++||||.+..
T Consensus       207 ~~~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         207 YDSWKT--PFQQLKQVVEEPSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             CCcccc--CHHHHHHHHhcCCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            954221  112222222211222221   35789999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.8e-43  Score=319.47  Aligned_cols=252  Identities=29%  Similarity=0.447  Sum_probs=201.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ..++|++. +.||+|+||.||+|.+..+++.||+|++...     ....+|+.. +..++||||+++++++..    +..
T Consensus         7 ~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~-l~~~~h~~ii~~~~~~~~----~~~   80 (267)
T cd06646           7 PQHDYELI-QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM-VKECKHCNIVAYFGSYLS----REK   80 (267)
T ss_pred             chhhcchh-heeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHH-HHhcCCCCeeeeeEEEEe----CCE
Confidence            35789995 6799999999999999999999999998632     234467766 677799999999999875    668


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+.+++|.+++...  +.+++..+..++.|++.||.|||+.||+||||||+||+++                  
T Consensus        81 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~------------------  140 (267)
T cd06646          81 LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT------------------  140 (267)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC------------------
Confidence            89999999999999988754  4589999999999999999999999999999999999997                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC---CCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                               .++.++|+|||++..............|++.|+|||.+.   ...++.++|+||+||++|+|++|..||..
T Consensus       141 ---------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~  211 (267)
T cd06646         141 ---------DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             ---------CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence                     566799999999876643333334456788999999874   45578899999999999999999999864


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      .......    ..+....+..+. .....++.++.+||.+||..||++|||++++++|+|
T Consensus       212 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         212 LHPMRAL----FLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             cchhhhh----eeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            4322110    111111111111 111346899999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG1989|consensus

Probab=100.00  E-value=4.5e-44  Score=349.86  Aligned_cols=248  Identities=31%  Similarity=0.450  Sum_probs=202.6

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-----hhhhHHHHHHHHHhcCCCCEeEEeE-eeeee-cCC-ceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-----TVKARREVELQLAVGSHKHIVNIKD-VYENI-YNG-SRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~ni~~~~~-~~~~~-~~~-~~~   87 (372)
                      +++| +++|.+|||+.||+|++...|..||+|++-.     .....+|+.++..+-+|+|||.+++ ..... ..+ .-.
T Consensus        38 ~v~V-~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   38 RVTV-EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEE-EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4555 7899999999999999998889999998742     2345789999777778999999999 33221 222 235


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~--ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      .+|.||||.||.|.+++..+-...|+|.++.+|+.|+++|+.+||...  |||||||-+||||+                
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls----------------  180 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS----------------  180 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc----------------
Confidence            678899999999999998755556999999999999999999999998  99999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCccc---------ccccCCCcCCCccc---CCCCCCCccchhhHHHHHH
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ---------TPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~---------~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~  233 (372)
                                 .++.+||||||.|.-.........         ...-|+.|+|||++   .+.+.++|+|||||||+||
T Consensus       181 -----------~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLY  249 (738)
T KOG1989|consen  181 -----------ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLY  249 (738)
T ss_pred             -----------CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHH
Confidence                       677899999998875433221100         11238899999975   7788999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      -||....||.....        ..|..+.|.+|+.  ..++..+.+||+.||+.||.+||++.|++.+
T Consensus       250 kLCy~t~PFe~sg~--------laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  250 KLCYFTTPFEESGK--------LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             HHHHhCCCcCcCcc--------eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            99999999965432        3456677777763  4789999999999999999999999999873

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-42  Score=313.61  Aligned_cols=249  Identities=29%  Similarity=0.462  Sum_probs=208.2

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|+++ +.||.|+||.||.+++..+++.+++|.+...       ....+|++. ++.++|+||+++++++..    ...+
T Consensus         1 ~y~~~-~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~----~~~~   74 (256)
T cd08221           1 HYIPI-RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVI-LSLLQHPNIIAYYNHFMD----DNTL   74 (256)
T ss_pred             CceEe-eEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHH-HHhCCCCCeeEEEeEEec----CCeE
Confidence            68885 7799999999999999999999999987532       245577777 566799999999999976    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      +++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++                   
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~-------------------  135 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT-------------------  135 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe-------------------
Confidence            9999999999999999876445699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.+||+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..||..... 
T Consensus       136 --------~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-  206 (256)
T cd08221         136 --------KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-  206 (256)
T ss_pred             --------CCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-
Confidence                    56679999999887664433334456789999999999888899999999999999999999999965432 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                         ......+..+.+...   ...++.++.++|.+||..+|.+|||+.++++|||+
T Consensus       207 ---~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         207 ---LNLVVKIVQGNYTPV---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             ---HHHHHHHHcCCCCCC---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence               223333333333221   14678999999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.5e-43  Score=315.80  Aligned_cols=252  Identities=29%  Similarity=0.434  Sum_probs=205.8

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .++|++. +.||.|+||.||+|.+..+++.+|+|.+...   ....+|+.. ++.++||||+++++++..    +...|+
T Consensus         2 ~~~y~~~-~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~-~~~l~~~~i~~~~~~~~~----~~~~~l   75 (256)
T cd06612           2 EEVFDIL-EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISI-LKQCDSPYIVKYYGSYFK----NTDLWI   75 (256)
T ss_pred             cccchhh-hhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHH-HHhCCCCcEeeeeeeeec----CCcEEE
Confidence            4789985 7799999999999999999999999998743   245567776 566699999999999876    578999


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ++||+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++||||+|+||+++                     
T Consensus        76 ~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---------------------  133 (256)
T cd06612          76 VMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---------------------  133 (256)
T ss_pred             EEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---------------------
Confidence            999999999999987643 4689999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI  250 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  250 (372)
                            .++.++|+|||++..............++..|+|||++.+..++.++|+|||||++|+|++|..||........
T Consensus       134 ------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~  207 (256)
T cd06612         134 ------EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA  207 (256)
T ss_pred             ------CCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh
Confidence                  56679999999988765433333445578899999999888899999999999999999999999965433221


Q ss_pred             CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                          ...+.... .........++.++.++|.+||+.||.+|||+.++|.||||
T Consensus       208 ----~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         208 ----IFMIPNKP-PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ----hhhhccCC-CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                11111100 00011113567899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-42  Score=319.86  Aligned_cols=261  Identities=26%  Similarity=0.430  Sum_probs=204.7

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC-Cce
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYN-GSR   86 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~-~~~   86 (372)
                      ...++|.+. +.||.|+||.||+|.+..+++.+|+|++...    ....+|+.++.++.+|||++++++++..... ...
T Consensus        19 ~~~~~y~~~-~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          19 DPTDTWEII-ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCCCeEEE-EEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            467899995 6799999999999999999999999998632    2345677775666689999999999864221 235


Q ss_pred             EEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ..|+||||+++++|.+++...  ....+++..++.++.|++.||+|||+.|++||||||+||+++               
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---------------  162 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---------------  162 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---------------
Confidence            789999999999999988641  234689999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-----CCCCccchhhHHHHHHHHHhCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-----KYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~  239 (372)
                                  .++.++|+|||++..............|+..|+|||.+...     .++.++|+|||||++|+|++|+
T Consensus       163 ------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~  230 (291)
T cd06639         163 ------------TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD  230 (291)
T ss_pred             ------------CCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCC
Confidence                        56679999999887654433333445678899999987543     3688999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      .||.......   .. ..+...... ........+.++.+||.+||+.+|++|||+.++++||||+
T Consensus       231 ~p~~~~~~~~---~~-~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         231 PPLFDMHPVK---TL-FKIPRNPPP-TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCCCcHHH---HH-HHHhcCCCC-CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            9996543211   11 112111110 0011134678899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-43  Score=358.33  Aligned_cols=276  Identities=28%  Similarity=0.451  Sum_probs=210.6

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ..+.++|.++ +.||.|+||+||+|.+..+++.||+|++...       ....+|+.+ +..++||||++++++|..  .
T Consensus         9 e~~l~~YeIl-~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~I-L~~L~HPNIVrl~d~f~d--e   84 (1021)
T PTZ00266          9 ESRLNEYEVI-KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNV-MRELKHKNIVRYIDRFLN--K   84 (1021)
T ss_pred             ccccCCEEEE-EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHH-HHHcCCCCcCeEEEEEEe--c
Confidence            3466899995 7799999999999999999999999998632       234568877 677799999999998854  2


Q ss_pred             CceEEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCceeeecCCCC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQ-------NIAHRDVKPENLLYTKPGDG  154 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~-------~ivHrDlkp~NIli~~~~~~  154 (372)
                      ....+|+||||+.+++|.++|...  ..+.+++..++.|+.||+.||.|||+.       +||||||||+||||+.... 
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~-  163 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR-  163 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc-
Confidence            346799999999999999998753  224699999999999999999999985       4999999999999974221 


Q ss_pred             CceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC--CCCCCccchhhHHHHH
Q psy3151         155 GILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLGVIM  232 (372)
Q Consensus       155 ~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il  232 (372)
                      ....+.++..         .....+.+||+|||++...... ......+||+.|+|||++..  ..++.++|||||||+|
T Consensus       164 ~lg~i~~~~~---------n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL  233 (1021)
T PTZ00266        164 HIGKITAQAN---------NLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII  233 (1021)
T ss_pred             cccccccccc---------ccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence            0001111110         0114567999999999865332 22334578999999999853  4588999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       233 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      |+|++|..||......   ..+...+... ..++   ....+.++.+||..||..+|.+|||+.|+|.|||+....
T Consensus       234 YELLTGk~PF~~~~~~---~qli~~lk~~-p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        234 YELCSGKTPFHKANNF---SQLISELKRG-PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHHHHCCCCCCcCCcH---HHHHHHHhcC-CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            9999999999643321   1222222221 1222   235789999999999999999999999999999998654

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.8e-43  Score=315.35  Aligned_cols=249  Identities=28%  Similarity=0.525  Sum_probs=205.7

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|+++ +.||.|+||.||++.+..+|+.||+|.+...       ....+|+.. ++.++||||+++++++..    .++.
T Consensus         1 ~y~~~-~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~   74 (256)
T cd08218           1 KYVKV-KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAV-LSNMKHPNIVQYQESFEE----NGNL   74 (256)
T ss_pred             CceEE-EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHH-HHhCCCCCeeeeEeeecC----CCeE
Confidence            58885 7799999999999999999999999998532       234567766 677799999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+|+||+.+++|.+.+.......+++..+..++.|++.||.|||++|++|+||+|+||+++                   
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~-------------------  135 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-------------------  135 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc-------------------
Confidence            9999999999999998765444689999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++++|||.+..............|++.|+|||++.+..++.++|+|||||++|+|++|..||..... 
T Consensus       136 --------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-  206 (256)
T cd08218         136 --------KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-  206 (256)
T ss_pred             --------CCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-
Confidence                    56679999999887654433333345678889999999888899999999999999999999999964332 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                         ......+..+.....   ...++.++.++|.+||+.+|.+||++.++++||||
T Consensus       207 ---~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         207 ---KNLVLKIIRGSYPPV---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ---HHHHHHHhcCCCCCC---cccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence               222333333333211   23678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-43  Score=316.25  Aligned_cols=245  Identities=29%  Similarity=0.519  Sum_probs=201.3

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      +.||.|+||.||+|.+..+|+.||+|++....        ....|...+....+|+||+++++++..    ++.+|+|+|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e   77 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS----KDYLYLVME   77 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc----CCeEEEEEe
Confidence            45999999999999999999999999986432        123344444556689999999999875    678999999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      |+++++|.+++...  +.+++..+..++.||+.||.|||+.|++||||+|+||+++                        
T Consensus        78 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~------------------------  131 (260)
T cd05611          78 YLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID------------------------  131 (260)
T ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC------------------------
Confidence            99999999999765  3599999999999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHh
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG  253 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  253 (372)
                         .++.++|+|||++.....    .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.    ..
T Consensus       132 ---~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~  200 (260)
T cd05611         132 ---QTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DA  200 (260)
T ss_pred             ---CCCcEEEeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HH
Confidence               566799999998875432    2334578899999999888889999999999999999999999965432    23


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh---hHHhcCCccccC
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI---DQVMENKWISQF  307 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~---~eil~hp~~~~~  307 (372)
                      ....+.......+......+++++.++|.+||+.||++|||+   +|++.||||++.
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         201 VFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence            344444444444443344689999999999999999999955   799999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.2e-43  Score=324.84  Aligned_cols=263  Identities=25%  Similarity=0.381  Sum_probs=200.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC-Cce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN-GSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~-~~~   86 (372)
                      ++|++. +.||.|+||.||+|.+..+|+.||||.+...       ....+|+.++..+.+||||+++++++..... +..
T Consensus         1 ~~y~~~-~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKL-EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEe-eEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            578885 7799999999999999999999999988532       2356788876666578999999998865222 233


Q ss_pred             EEEEEEeccCCCchhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKE---DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~---~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ..|+||||+.+ +|.+++....   ...+++..++.++.||+.||.|||++||+||||||+||+++.             
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~-------------  145 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK-------------  145 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-------------
Confidence            48999999975 8988886532   235899999999999999999999999999999999999982             


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .++.++|+|||++..............+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||
T Consensus       146 -------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~  212 (295)
T cd07837         146 -------------QKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF  212 (295)
T ss_pred             -------------CCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC
Confidence                         2677999999988765433333334466889999998754 45789999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhC------------------Ccc--CCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         243 FSNHGQAISPGMKNRIRLG------------------QFD--FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~------------------~~~--~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      .+.+.......+...+...                  .+.  ........++.++.+||.+||..||.+|||+.+++.||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~  292 (295)
T cd07837         213 PGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP  292 (295)
T ss_pred             CCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCC
Confidence            6543221111111100000                  000  00001134789999999999999999999999999999


Q ss_pred             ccc
Q psy3151         303 WIS  305 (372)
Q Consensus       303 ~~~  305 (372)
                      ||+
T Consensus       293 ~~~  295 (295)
T cd07837         293 YFD  295 (295)
T ss_pred             CcC
Confidence            984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-43  Score=322.81  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=203.0

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|+++ +.||+|+||.||+|.+..+|+.||+|.+...      ....+|+.. ++.++||||+++++.+..    ++.+
T Consensus         1 ~~~~~~-~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----~~~~   74 (286)
T cd06622           1 DEIEVL-DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDI-LHKAVSPYIVDFYGAFFI----EGAV   74 (286)
T ss_pred             Chhhhh-hhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHH-HHhcCCCcHHhhhhheec----CCeE
Confidence            478885 6799999999999999999999999988532      234567776 566799999999998875    6789


Q ss_pred             EEEEeccCCCchhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          89 LVIMECMHGGELFQRIQQKE-DGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~-~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      |+||||+++++|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+||+++                 
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-----------------  137 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN-----------------  137 (286)
T ss_pred             EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC-----------------
Confidence            99999999999998887531 2359999999999999999999997 5999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC------CCCCccchhhHHHHHHHHHhCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD------KYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                .++.++|+|||++......  ......+++.|+|||.+.+.      .++.++|+|||||++|+|++|..
T Consensus       138 ----------~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~  205 (286)
T cd06622         138 ----------GNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY  205 (286)
T ss_pred             ----------CCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC
Confidence                      5667999999988755322  22345678899999998543      35789999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      ||.......... ....+..+.   +......++.++.+||.+||..+|.+||++++++.||||.....
T Consensus       206 pf~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         206 PYPPETYANIFA-QLSAIVDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             CCCCcchhhHHH-HHHHHhhcC---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            996543222111 111122111   11222358999999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.4e-43  Score=316.21  Aligned_cols=254  Identities=25%  Similarity=0.457  Sum_probs=204.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|++. +.||.|+||+||+|.+..++..+|+|++...      ....+|++. ++.++|+||+++++.+..    ++..
T Consensus         1 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~   74 (267)
T cd06610           1 DDYELI-EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQA-MSQCNHPNVVKYYTSFVV----GDEL   74 (267)
T ss_pred             Ccceee-eeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHH-HHhcCCCCEEEEEEEEee----CCEE
Confidence            478884 7799999999999999999999999998532      234567765 677799999999998875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          89 LVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      |+|||++++++|.+++..... ..+++..++.++.|++.||.|||+.|++||||+|+||+++                  
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~------------------  136 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG------------------  136 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc------------------
Confidence            999999999999999976432 4689999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCc----ccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKAS----LQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                               +++.++|+|||++.........    ....+|++.|+|||.+... .++.++|+|||||++|+|++|..||
T Consensus       137 ---------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~  207 (267)
T cd06610         137 ---------EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY  207 (267)
T ss_pred             ---------CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCc
Confidence                     5667899999988766443222    2334678899999998766 7889999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ...+....   ...........++. ..+..+++++.+++.+||..||++|||+++++.||||
T Consensus       208 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         208 SKYPPMKV---LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccChhhh---HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            65543322   11111111111111 1123678999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.7e-43  Score=317.43  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=202.0

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +|++ ++.||+|++|.||+|.+..+++.+|+|++...           ....+|+.. ++.++|+||+++++++..    
T Consensus         1 ~~~~-~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~----   74 (268)
T cd06630           1 EWLK-GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRL-MARLNHPHIIRMLGATCE----   74 (268)
T ss_pred             Cccc-cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHH-HHHcCCCceehhhceecc----
Confidence            4777 68899999999999999999999999998632           234567766 566799999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      .+..++||||+.+++|.+++.+.  +.+++..++.++.||+.||.|||++|++|+||+|+||+++.              
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--------------  138 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--------------  138 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--------------
Confidence            67899999999999999999764  45899999999999999999999999999999999999973              


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                  ....++|+|||.+........    ......||..|+|||.+.+..++.++|+||+||++|+|++|..
T Consensus       139 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~  206 (268)
T cd06630         139 ------------TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP  206 (268)
T ss_pred             ------------CCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCC
Confidence                        223588999998876543211    1223467889999999988889999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      ||.......... ..........  .......+++++.+++.+||..+|.+|||+.++++||||+
T Consensus       207 p~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         207 PWNAEKHSNHLA-LIFKIASATT--APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCCCCCCcchHH-HHHHHhccCC--CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            996543322211 1111111111  1112235789999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.5e-43  Score=315.93  Aligned_cols=247  Identities=25%  Similarity=0.414  Sum_probs=199.3

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      +|.+ +..||.|++|.||+|.+..+++.+|+|.+...              ....+|+.+ ++.++||||+++++++.. 
T Consensus         1 ~~~~-~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~-   77 (267)
T cd06628           1 KWIK-GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIAL-LKELQHENIVQYLGSSLD-   77 (267)
T ss_pred             Cccc-cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHH-HHhcCCCCeeeEEEEEEe-
Confidence            4666 58899999999999999999999999988521              123456665 666799999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         ..+.++||||+++++|.+++...  +.+++..++.++.|++.||+|||+.|++||||+|+||+++            
T Consensus        78 ---~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~------------  140 (267)
T cd06628          78 ---ADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD------------  140 (267)
T ss_pred             ---CCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc------------
Confidence               67889999999999999999765  4589999999999999999999999999999999999997            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCC------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHH
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  235 (372)
                                     +++.++|+|||.+........      ......|++.|+|||.+.+..++.++|+||+||++|+|
T Consensus       141 ---------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l  205 (267)
T cd06628         141 ---------------NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM  205 (267)
T ss_pred             ---------------CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHH
Confidence                           566788888888776542111      11234578899999999888899999999999999999


Q ss_pred             HhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       236 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ++|..||......   ..+. .+.....   +.....++.++.++|++||+.||.+||++.++++||||
T Consensus       206 ~~g~~p~~~~~~~---~~~~-~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         206 LTGKHPFPDCTQL---QAIF-KIGENAS---PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             hhCCCCCCCccHH---HHHH-HHhccCC---CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999654321   1111 1111111   11113578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.5e-43  Score=325.21  Aligned_cols=261  Identities=26%  Similarity=0.445  Sum_probs=203.0

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      .++|++. +.||.|+||.||+|.+..+|+.||+|.+...       ....+|+.+ ++.++|+||+++++++..  ....
T Consensus         6 ~~~y~~~-~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~--~~~~   81 (309)
T cd07845           6 VTEFEKL-NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITL-LLNLRHPNIVELKEVVVG--KHLD   81 (309)
T ss_pred             ccceeEe-eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHH-HHhCCCCCCcceEEEEec--CCCC
Confidence            4679985 7799999999999999999999999998532       123468777 567799999999999864  2235


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+||+++                 
T Consensus        82 ~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~-----------------  142 (309)
T cd07845          82 SIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-----------------  142 (309)
T ss_pred             eEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-----------------
Confidence            6899999996 58888887643 4699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                ..+.++|+|||.+..............+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...
T Consensus       143 ----------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         143 ----------DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             ----------CCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence                      5677999999998876543333344455888999998854 56889999999999999999999999655


Q ss_pred             CCCCCCHhHHHHHh---------------hCCccCCCC-------cccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         246 HGQAISPGMKNRIR---------------LGQFDFPNP-------EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       246 ~~~~~~~~~~~~~~---------------~~~~~~~~~-------~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      +.......+.....               .+.+..+..       .....++++.+||.+||+.||++|||+.+++.|||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~  292 (309)
T cd07845         213 SEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY  292 (309)
T ss_pred             CHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence            43222111111100               001111100       01235889999999999999999999999999999


Q ss_pred             cccC
Q psy3151         304 ISQF  307 (372)
Q Consensus       304 ~~~~  307 (372)
                      |++.
T Consensus       293 f~~~  296 (309)
T cd07845         293 FKEK  296 (309)
T ss_pred             hccC
Confidence            9864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=313.89  Aligned_cols=252  Identities=31%  Similarity=0.487  Sum_probs=204.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .++|++. +.||.|+||.||+|.+..+++.+|+|++...     ....+|+.. ++.++||||+++++++..    +..+
T Consensus         2 ~~~~~~~-~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~----~~~~   75 (262)
T cd06613           2 QEDYELI-QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISM-LKECRHPNIVAYFGSYLR----RDKL   75 (262)
T ss_pred             ccceEEE-EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHH-HHhCCCCChhceEEEEEe----CCEE
Confidence            5789985 7799999999999999999999999998632     345567776 667799999999998875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+.||+|+||||+||+++                   
T Consensus        76 ~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~-------------------  135 (262)
T cd06613          76 WIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT-------------------  135 (262)
T ss_pred             EEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC-------------------
Confidence            99999999999999887642 4599999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC---CCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD---KYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                              .++.++|+|||.+..............++..|+|||.+...   .++.++|+|||||++|+|++|..||...
T Consensus       136 --------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~  207 (262)
T cd06613         136 --------EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL  207 (262)
T ss_pred             --------CCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence                    56679999999987664433333445678899999998766   7899999999999999999999999654


Q ss_pred             CCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      +...    .........+..+. .....++.++.++|.+||..+|..|||+.+++.|+|
T Consensus       208 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         208 HPMR----ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             CHHH----HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            3221    11112222111111 112346788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2e-43  Score=325.14  Aligned_cols=256  Identities=27%  Similarity=0.454  Sum_probs=206.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +.+.|... ..||.|+||.||++.+..++..||||.+...     ....+|+.. ++.++|+||+++++.+..    +..
T Consensus        20 ~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~-l~~l~h~~ii~~~~~~~~----~~~   93 (292)
T cd06658          20 PREYLDSF-IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVI-MRDYHHENVVDMYNSYLV----GDE   93 (292)
T ss_pred             hHHHHhhh-hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHH-HHhCCCCcHHHHHHheec----CCe
Confidence            44566653 5699999999999999999999999998532     234567776 566799999999998875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+++++|.+++..   +.+++.+++.++.||+.||+|||+.||+||||||+||+++                  
T Consensus        94 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~------------------  152 (292)
T cd06658          94 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT------------------  152 (292)
T ss_pred             EEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc------------------
Confidence            9999999999999998754   3489999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.++|+|||++..............|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.
T Consensus       153 ---------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~  223 (292)
T cd06658         153 ---------SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP  223 (292)
T ss_pred             ---------CCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                     56779999999887654333333446789999999999888899999999999999999999999965432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      ..    ....+... .....+....++..+.+++.+||..||.+|||++++++||||.....
T Consensus       224 ~~----~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         224 LQ----AMRRIRDN-LPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HH----HHHHHHhc-CCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence            21    11222211 11111222357889999999999999999999999999999987544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.2e-43  Score=322.94  Aligned_cols=259  Identities=28%  Similarity=0.437  Sum_probs=202.3

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----------KARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      +|++. +.||.|++|.||+|.+..+|+.||||.+....          ....|+.. ++.++|+||+++++++..    +
T Consensus         1 ~y~~~-~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~----~   74 (298)
T cd07841           1 RYEKG-KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKL-LQELKHPNIIGLLDVFGH----K   74 (298)
T ss_pred             Cceee-eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHH-HhhcCCCCChhhhheeec----C
Confidence            58884 77999999999999999999999999986432          23456766 566789999999999876    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++                
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~----------------  136 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----------------  136 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc----------------
Confidence            7899999999 889999997654 3699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                 .++.++|+|||++..............+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+
T Consensus       137 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         137 -----------SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             -----------CCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence                       5677999999999876544333344456888999998854 5678999999999999999999887765


Q ss_pred             CCCCCCCHhHHHHHhhC---------Cc-------cCCC----CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         245 NHGQAISPGMKNRIRLG---------QF-------DFPN----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~---------~~-------~~~~----~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ....+............         ..       ..+.    ......+.++.++|.+||..||++|||+.+++.||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~  285 (298)
T cd07841         206 DSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF  285 (298)
T ss_pred             CccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccc
Confidence            44322111111100000         00       0000    0113457889999999999999999999999999999


Q ss_pred             ccCCC
Q psy3151         305 SQFNQ  309 (372)
Q Consensus       305 ~~~~~  309 (372)
                      ++...
T Consensus       286 ~~~~~  290 (298)
T cd07841         286 SNDPA  290 (298)
T ss_pred             cCCCC
Confidence            88543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.9e-42  Score=316.29  Aligned_cols=246  Identities=28%  Similarity=0.465  Sum_probs=196.1

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHH--HHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVEL--QLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~--~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      +||+|+||.||+|.+..+++.||+|++....        ....|...  .+....||||+.+++.+..    ...+|+||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~   76 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----PDKLSFIL   76 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec----CCEEEEEE
Confidence            4899999999999999999999999985321        11222222  2344689999999999875    66899999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      ||+.|++|.+++...  +.+++..++.++.|++.||+|||+.+|+||||||+||+++                       
T Consensus        77 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~-----------------------  131 (278)
T cd05606          77 DLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-----------------------  131 (278)
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC-----------------------
Confidence            999999999988654  4599999999999999999999999999999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS  251 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  251 (372)
                          .++.++|+|||++......  .....+|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||........ 
T Consensus       132 ----~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-  204 (278)
T cd05606         132 ----EHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-  204 (278)
T ss_pred             ----CCCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-
Confidence                5667999999988755332  2234578999999999864 4689999999999999999999999976533221 


Q ss_pred             HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccCC
Q psy3151         252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFN  308 (372)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~~  308 (372)
                      ..............+    ..++.++.+++.+||..+|.+|+     ++.++++||||+...
T Consensus       205 ~~~~~~~~~~~~~~~----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         205 HEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HHHHHHhhccCCCCC----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            122222222222222    35689999999999999999999     999999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.2e-43  Score=322.40  Aligned_cols=263  Identities=27%  Similarity=0.428  Sum_probs=202.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|++. +.||.|++|+||+|.+..+|+.||+|.+...       ....+|+.. ++.++||||+++++++..    +..
T Consensus         2 ~~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~   75 (294)
T PLN00009          2 DQYEKV-EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISL-LKEMQHGNIVRLQDVVHS----EKR   75 (294)
T ss_pred             CceEEE-EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHH-HHhccCCCEeeEEEEEec----CCe
Confidence            579985 7799999999999999999999999988532       234567776 566699999999999875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+. ++|.+.+.......+++..++.++.||+.||+|||++|++||||+|+||+++.                 
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~-----------------  137 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-----------------  137 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC-----------------
Confidence            999999995 58888887655445789999999999999999999999999999999999973                 


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.+||+|||++..............+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+
T Consensus       138 ---------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~  208 (294)
T PLN00009        138 ---------RTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS  208 (294)
T ss_pred             ---------CCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                     3456899999998765433333344567889999998755 457899999999999999999999996543


Q ss_pred             CCCCCHhHHHHHhhC----------------Cc-cCCCC----cccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         247 GQAISPGMKNRIRLG----------------QF-DFPNP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~----------------~~-~~~~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      ..+....+.......                .. .++..    ....+++++.++|.+||+.||++||++.+++.||||.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        209 EIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             HHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence            221111110000000                00 00000    0134688999999999999999999999999999998


Q ss_pred             cCCCC
Q psy3151         306 QFNQV  310 (372)
Q Consensus       306 ~~~~~  310 (372)
                      ++...
T Consensus       289 ~~~~~  293 (294)
T PLN00009        289 DLGDA  293 (294)
T ss_pred             HHhcC
Confidence            86543

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=319.22  Aligned_cols=256  Identities=25%  Similarity=0.437  Sum_probs=197.6

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .++|++. +.||.|++|+||+|.+..+++.||||.+...      ....+|+.+ ++.++|+||+++++++..    +.+
T Consensus         4 ~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~~~   77 (291)
T cd07844           4 LETYKKL-DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASL-LKDLKHANIVTLHDIIHT----KKT   77 (291)
T ss_pred             ccceeEE-EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHH-HhhCCCcceeeEEEEEec----CCe
Confidence            3789985 7799999999999999999999999998532      234568877 566699999999999875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++                  
T Consensus        78 ~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~------------------  137 (291)
T cd07844          78 LTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS------------------  137 (291)
T ss_pred             EEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc------------------
Confidence            999999997 49999887654 3689999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.++|+|||++..............+++.|+|||++.+ ..++.++|+||+||++|+|++|..||....
T Consensus       138 ---------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         138 ---------ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             ---------CCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence                     5677999999988754332222233456888999998865 558899999999999999999999996543


Q ss_pred             CCCC-CHhHHHHHh---------------hCCccC----CC---CcccccC--HHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         247 GQAI-SPGMKNRIR---------------LGQFDF----PN---PEWEHVS--QEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       247 ~~~~-~~~~~~~~~---------------~~~~~~----~~---~~~~~~s--~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .... ...+.....               ......    +.   .....++  .++.+++.+||+.||++|||+.+++.|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         209 DVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            1100 000000000               000000    00   0011234  889999999999999999999999999


Q ss_pred             Ccc
Q psy3151         302 KWI  304 (372)
Q Consensus       302 p~~  304 (372)
                      |||
T Consensus       289 ~~f  291 (291)
T cd07844         289 PYF  291 (291)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1e-42  Score=328.87  Aligned_cols=263  Identities=27%  Similarity=0.432  Sum_probs=203.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--   82 (372)
                      .+.++|+++ +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||++++++|....  
T Consensus        13 ~~~~~y~~~-~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          13 TVLKRYQNL-KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVL-MKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhhcceEEE-EEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHH-HHhcCCCCCcceeeeeccCCCc
Confidence            367999995 7799999999999999999999999998531       234567776 66779999999999886321  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      .+....|+||||+. ++|.+.+...    +++..++.++.|++.||+|||++||+||||||+||+++             
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~-------------  152 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-------------  152 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC-------------
Confidence            22356899999995 5888887542    89999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    .++.+||+|||++...... .......+|+.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       153 --------------~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf  217 (353)
T cd07850         153 --------------SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF  217 (353)
T ss_pred             --------------CCCCEEEccCccceeCCCC-CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCC
Confidence                          5677999999998765432 2233456788999999999899999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHH-----------HH-------hhCCc--------------cCCCCc---ccccCHHHHHHHHHhccC
Q psy3151         243 FSNHGQAISPGMKN-----------RI-------RLGQF--------------DFPNPE---WEHVSQEAKTLIKNMLCV  287 (372)
Q Consensus       243 ~~~~~~~~~~~~~~-----------~~-------~~~~~--------------~~~~~~---~~~~s~~~~~li~~ll~~  287 (372)
                      ...+.......+..           ..       .....              .++...   ....+.++++||.+||+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  297 (353)
T cd07850         218 PGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI  297 (353)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCC
Confidence            65432111000000           00       00000              000000   123467789999999999


Q ss_pred             CCCCCCChhHHhcCCccccCCC
Q psy3151         288 DPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       288 dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      ||++|||+.|+|.||||+.+..
T Consensus       298 dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         298 DPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             ChhhCcCHHHHhcChhHhhccC
Confidence            9999999999999999987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-42  Score=321.20  Aligned_cols=253  Identities=29%  Similarity=0.537  Sum_probs=202.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||.|+||.||+|.+..+++.||+|.+....        ...+|+.+ ++.++||||+++++.+..    +.
T Consensus         1 ~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----~~   74 (305)
T cd05609           1 EDFETI-KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI-LTFAENPFVVSMFCSFET----KR   74 (305)
T ss_pred             CCceEe-eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHH-HHhCCCCCeeeeEEEEec----CC
Confidence            468885 77999999999999999999999999986321        23356665 667799999999998875    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ++|+||||+.|++|.+++...  +.+++..++.++.|++.||+|||+.|++||||||+||+++                 
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~-----------------  135 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-----------------  135 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC-----------------
Confidence            899999999999999999765  4599999999999999999999999999999999999997                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccC---------------CCcccccccCCCcCCCcccCCCCCCCccchhhHHHH
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSN---------------KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI  231 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  231 (372)
                                ..+.++++|||+++.....               ........++..|+|||.+....++.++|+|||||+
T Consensus       136 ----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~v  205 (305)
T cd05609         136 ----------SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGII  205 (305)
T ss_pred             ----------CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHH
Confidence                      4556777777766531100               001112456888999999988889999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC---hhHHhcCCccccC
Q psy3151         232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT---IDQVMENKWISQF  307 (372)
Q Consensus       232 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s---~~eil~hp~~~~~  307 (372)
                      +|+|++|..||.+...    .........+....+... ..++.++.++|.+||+.||++|||   +.++++||||...
T Consensus       206 l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         206 LYEFLVGCVPFFGDTP----EELFGQVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             HHHHHhCCCCCCCCCH----HHHHHHHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            9999999999975432    233444444443333322 257899999999999999999998   7999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7e-43  Score=316.33  Aligned_cols=255  Identities=28%  Similarity=0.438  Sum_probs=204.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|++. +.||.|++|.||+|.+..+++.+|+|.+...      ....+|+.. ++.+.||||+++++.+..    +...
T Consensus         1 ~~~~~~-~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----~~~~   74 (265)
T cd06605           1 DDLEYL-GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDI-LHKCNSPYIVGFYGAFYN----NGDI   74 (265)
T ss_pred             CcchHH-HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHH-HHHCCCCchhhhheeeec----CCEE
Confidence            467774 7799999999999999999999999998643      234567766 455679999999998876    5789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      ++++||+.+++|.+++.... ..+++..++.++.|++.||+|||+ .|++|+||||+||+++                  
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~------------------  135 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN------------------  135 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC------------------
Confidence            99999999999999998653 469999999999999999999999 9999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.++|+|||.+........  ....++..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus       136 ---------~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  204 (265)
T cd06605         136 ---------SRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND  204 (265)
T ss_pred             ---------CCCCEEEeecccchhhHHHHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Confidence                     567799999998876533221  125678899999999888999999999999999999999999965432


Q ss_pred             CC-CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 QA-ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .. ..............  +......++.++.++|.+||..||++|||+.+++.||||+++
T Consensus       205 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         205 PPDGIFELLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             ccccHHHHHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            11 11112222222111  111111278999999999999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.3e-43  Score=329.80  Aligned_cols=272  Identities=26%  Similarity=0.456  Sum_probs=209.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      +.++|++ .+.||.|++|.||+|.+..+|+.||+|++...       ....+|+.+ ++.++||||++++++|.......
T Consensus         3 ~~~~y~~-~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           3 VGSRYKP-IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKI-LRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhhceee-eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHH-HHhcCCCCccCHHHhccccCCCC
Confidence            4588998 47899999999999999999999999998632       234567776 66678999999999887544446


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+||||+. ++|.+++...  +.+++..++.++.||+.||.|||+.||+||||||+||+++                
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----------------  141 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----------------  141 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----------------
Confidence            78999999995 6898888654  3599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                 .++.+||+|||++........    .....+|+.+|+|||.+.+ ..++.++|+|||||++|+|++|..
T Consensus       142 -----------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~  210 (334)
T cd07855         142 -----------EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ  210 (334)
T ss_pred             -----------CCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCC
Confidence                       567799999998876543221    1234577899999998755 468899999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHH----------------HHh--hCCccCC-CC----cccccCHHHHHHHHHhccCCCCCCCChhH
Q psy3151         241 PFFSNHGQAISPGMKN----------------RIR--LGQFDFP-NP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQ  297 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~----------------~~~--~~~~~~~-~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~e  297 (372)
                      ||.+.+.......+..                .+.  ...+... ..    .....+.++.++|.+||+.+|.+|||+++
T Consensus       211 pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  290 (334)
T cd07855         211 LFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ  290 (334)
T ss_pred             ccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9965432211000000                000  0001100 00    01346899999999999999999999999


Q ss_pred             HhcCCccccCCCCCCCCCc
Q psy3151         298 VMENKWISQFNQVPQTPLC  316 (372)
Q Consensus       298 il~hp~~~~~~~~~~~~~~  316 (372)
                      ++.||||.+.......+.+
T Consensus       291 ~l~~~~~~~~~~~~~~~~~  309 (334)
T cd07855         291 ALQHPFLAQYHDPDDEPTC  309 (334)
T ss_pred             HHhChhhhhccCCcccccC
Confidence            9999999987665555444

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.5e-42  Score=312.66  Aligned_cols=246  Identities=31%  Similarity=0.525  Sum_probs=202.6

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +|++. +.||.|+||.||++.+..+++.+|+|.+...      ....+|+.+ ++.++|+||+++++.+..    +..+|
T Consensus         1 ~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~   74 (255)
T cd08219           1 QYNVL-RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL-LAKMKHPNIVAFKESFEA----DGHLY   74 (255)
T ss_pred             CceEE-EEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHH-HHhCCCCCcceEEEEEEE----CCEEE
Confidence            57884 7799999999999999999999999998532      234456665 677799999999999876    67899


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      ++|||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++                    
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~--------------------  134 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT--------------------  134 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC--------------------
Confidence            999999999999998765555689999999999999999999999999999999999997                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA  249 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  249 (372)
                             +++.++++|||.+..............|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.  
T Consensus       135 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--  205 (255)
T cd08219         135 -------QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--  205 (255)
T ss_pred             -------CCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--
Confidence                   56779999999987664433333445688999999999888899999999999999999999999965432  


Q ss_pred             CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                        ......+..+.....   ...++.++.+||.+||+.||++|||+.+++.-
T Consensus       206 --~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         206 --KNLILKVCQGSYKPL---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --HHHHHHHhcCCCCCC---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              122233333332211   13578899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0696|consensus

Probab=100.00  E-value=1.5e-44  Score=324.65  Aligned_cols=250  Identities=32%  Similarity=0.557  Sum_probs=217.7

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +|..+ .+||+|+||+|-+|..+.+.+.||||++.+.        .....|.+.+.-...-|-++.++.+|+.    -..
T Consensus       350 DFnFl-~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----mDR  424 (683)
T KOG0696|consen  350 DFNFL-MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----MDR  424 (683)
T ss_pred             ccceE-EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh----hhh
Confidence            45554 6899999999999999999999999998643        2334566663333456788999999986    567


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||++||+|.-.|++.  +++-|..+..++..|+.||-+||++||+.||||.+|||++                  
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd------------------  484 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD------------------  484 (683)
T ss_pred             eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec------------------
Confidence            99999999999999999886  4699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               ..|.+||+|||+++..........+.||||.|+|||++..++|+.++|.||+||+||||+.|++||++.+.
T Consensus       485 ---------~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE  555 (683)
T KOG0696|consen  485 ---------SEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE  555 (683)
T ss_pred             ---------cCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence                     67889999999999877777788899999999999999999999999999999999999999999987765


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh-----hHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-----DQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~-----~eil~hp~~~~~  307 (372)
                      .    .+...+......+|.    .+|.++.++.+.+|.+.|.+|..+     .++-.||||+.+
T Consensus       556 ~----elF~aI~ehnvsyPK----slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i  612 (683)
T KOG0696|consen  556 D----ELFQAIMEHNVSYPK----SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI  612 (683)
T ss_pred             H----HHHHHHHHccCcCcc----cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence            4    456777777777764    789999999999999999999864     679999999865

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.1e-43  Score=320.69  Aligned_cols=255  Identities=26%  Similarity=0.401  Sum_probs=199.2

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|+++ +.||.|++|.||+|.+..+|+.||||.+...       ....+|++. ++.++||||+++++++..    +...
T Consensus         1 ~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~~~~   74 (284)
T cd07860           1 NFQKV-EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVKLLDVIHT----ENKL   74 (284)
T ss_pred             Cceee-eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHH-HHhcCCCCCcchhhhccc----CCcE
Confidence            47775 6699999999999999999999999988632       235568877 666799999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+. ++|.+++.......+++..++.++.|++.||+|||+.|++||||+|+||+++                   
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~-------------------  134 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN-------------------  134 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-------------------
Confidence            99999995 6899988776556799999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                              .++.++++|||++..............+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.
T Consensus       135 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~  206 (284)
T cd07860         135 --------TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE  206 (284)
T ss_pred             --------CCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence                    567799999998876544333334456688999999886544 68899999999999999999999965432


Q ss_pred             CCCCHhHHHHHhh--------------CCccCC---C----CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         248 QAISPGMKNRIRL--------------GQFDFP---N----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       248 ~~~~~~~~~~~~~--------------~~~~~~---~----~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .............              ....++   .    .....++.+++++|.+||+.||.+|||+++++.||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         207 IDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            1111000000000              000000   0    0012467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-42  Score=321.95  Aligned_cols=254  Identities=20%  Similarity=0.244  Sum_probs=192.0

Q ss_pred             ccceeeccccccccCCeEEEEEEEcC----------------CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKK----------------TSEVYALKVLHDT------VKARREVELQLAVGSHKHI   71 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni   71 (372)
                      .++|++ .+.||+|+||.||+|.+..                ++..||+|++...      ....+|+.. +..++||||
T Consensus         4 ~~~~~~-~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~ni   81 (304)
T cd05096           4 RGHLLF-KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI-LSRLKDPNI   81 (304)
T ss_pred             hhhCee-eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHH-HhhcCCCCe
Confidence            478988 5779999999999998632                3457999998632      234567776 566799999


Q ss_pred             eEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccC-----------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q psy3151          72 VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-----------------GAFTEREAAIIMNEICSAIKFLHDQ  134 (372)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~-----------------~~l~~~~~~~i~~qil~~l~~LH~~  134 (372)
                      +++++++..    ....++||||+.+++|.+++.....                 ..+++..++.++.||+.||.|||+.
T Consensus        82 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~  157 (304)
T cd05096          82 IRLLGVCVD----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL  157 (304)
T ss_pred             eEEEEEEec----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            999999875    5678999999999999999865321                 2467889999999999999999999


Q ss_pred             CceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCc
Q psy3151         135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPE  212 (372)
Q Consensus       135 ~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE  212 (372)
                      ||+||||||+|||++                           .++.+||+|||++........  ......++..|+|||
T Consensus       158 ~ivH~dlkp~Nill~---------------------------~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE  210 (304)
T cd05096         158 NFVHRDLATRNCLVG---------------------------ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE  210 (304)
T ss_pred             CccccCcchhheEEc---------------------------CCccEEECCCccceecccCceeEecCcCCCCccccCHH
Confidence            999999999999998                           567799999999876533221  112234577899999


Q ss_pred             ccCCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCC
Q psy3151         213 VLGPDKYDKSCDIWSLGVIMYILLC--GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPS  290 (372)
Q Consensus       213 ~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~  290 (372)
                      ++....++.++|+|||||++|+|++  +..||...+..+.......................++..+.+||.+||..||+
T Consensus       211 ~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  290 (304)
T cd05096         211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCR  290 (304)
T ss_pred             HHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCch
Confidence            9988889999999999999999986  56788654433221111111111111111111135789999999999999999


Q ss_pred             CCCChhHHhc
Q psy3151         291 ERLTIDQVME  300 (372)
Q Consensus       291 ~R~s~~eil~  300 (372)
                      +|||++++.+
T Consensus       291 ~RPs~~~i~~  300 (304)
T cd05096         291 ERPSFSDIHA  300 (304)
T ss_pred             hCcCHHHHHH
Confidence            9999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0584|consensus

Probab=100.00  E-value=7.5e-44  Score=335.77  Aligned_cols=257  Identities=20%  Similarity=0.322  Sum_probs=215.4

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc---------hhhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---------TVKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      .+..+||-...++||+|+|-+||+|.|..+|..||.-.+..         ..+...|++. ++.++||||+++++.+.+.
T Consensus        35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~l-LKsL~H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHL-LKSLKHPNIIRFYDSWVDT  113 (632)
T ss_pred             cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHH-HccCCCCceeeeeeheecC
Confidence            34678898888899999999999999999999999765531         1345567766 7889999999999999763


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCceeeecCCCCCceee
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ--NIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~--~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                        ....+.+|+|.+..|+|..++++.+  .++...++.|++||+.||.|||++  -|+|||||.+||||+          
T Consensus       114 --~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin----------  179 (632)
T KOG0584|consen  114 --DNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN----------  179 (632)
T ss_pred             --CCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc----------
Confidence              3467899999999999999998874  599999999999999999999998  499999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                      |..|.|||+|+|+|......  .....+|||.|||||++. ..|+..+||||||+++.||+|+.
T Consensus       180 ----------------G~~G~VKIGDLGLAtl~r~s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~e  240 (632)
T KOG0584|consen  180 ----------------GNLGEVKIGDLGLATLLRKS--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSE  240 (632)
T ss_pred             ----------------CCcCceeecchhHHHHhhcc--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhcc
Confidence                            47899999999999876432  233478999999999997 78999999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .||.....   ...+.+++..|.-+..  ...--.+++++||.+||.. .+.|+|+.|+|.||||..-
T Consensus       241 YPYsEC~n---~AQIYKKV~SGiKP~s--l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  241 YPYSECTN---PAQIYKKVTSGIKPAA--LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             CChhhhCC---HHHHHHHHHcCCCHHH--hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            99955433   2446677766654311  1123478999999999998 9999999999999999863

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.5e-43  Score=321.73  Aligned_cols=253  Identities=28%  Similarity=0.455  Sum_probs=205.3

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      +.+.|+++ +.||.|+||.||+|.+..+++.||+|.+....      ...+|+.. ++.++||||+++++++..    +.
T Consensus         2 ~~~~y~~~-~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~   75 (277)
T cd06642           2 PEELFTKL-ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITV-LSQCDSPYITRYYGSYLK----GT   75 (277)
T ss_pred             hHHHHHHH-HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHH-HHcCCCCccHhhhccccc----CC
Confidence            34678875 67999999999999999999999999986321      34567766 566799999999999875    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..|+||||+.+++|.+++..   +.+++..++.++.||+.||.|||++|++|+||+|+||+++                 
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~-----------------  135 (277)
T cd06642          76 KLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS-----------------  135 (277)
T ss_pred             ceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe-----------------
Confidence            89999999999999998864   3589999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.++++|||++..............|+..|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus       136 ----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06642         136 ----------EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH  205 (277)
T ss_pred             ----------CCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence                      5667999999998766443333334567889999999988889999999999999999999999986443


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      ....    ...+....   ++.....++.++.++|.+||..+|.+|||+.+++.||||..+.
T Consensus       206 ~~~~----~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         206 PMRV----LFLIPKNS---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             hhhH----HhhhhcCC---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            2221    11111111   1111135788999999999999999999999999999997753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.5e-42  Score=316.71  Aligned_cols=251  Identities=29%  Similarity=0.462  Sum_probs=205.1

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ...|+++ +.||.|+||.||+|.+..+++.||||++....      ...+|+.. ++.++||||+++++++..    +..
T Consensus         3 ~~~y~~~-~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~   76 (277)
T cd06640           3 EELFTKL-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITV-LSQCDSPYVTKYYGSYLK----GTK   76 (277)
T ss_pred             HHhhhhh-hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEEE----CCE
Confidence            4578875 66999999999999999999999999986321      23456665 566799999999999876    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+.+++|.+++..   +++++..+..++.|++.||+|||+.+++|+||+|+||+++                  
T Consensus        77 ~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~------------------  135 (277)
T cd06640          77 LWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS------------------  135 (277)
T ss_pred             EEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc------------------
Confidence            9999999999999998865   3589999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.++++|||++..............++..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus       136 ---------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~  206 (277)
T cd06640         136 ---------EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP  206 (277)
T ss_pred             ---------CCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh
Confidence                     56679999999987665433333445678899999999888899999999999999999999999965433


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ...    ...+...   .++.....++.++.+++.+||..+|.+|||+++++.|+||.+.
T Consensus       207 ~~~----~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         207 MRV----LFLIPKN---NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             HhH----hhhhhcC---CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence            221    1111111   1122223578899999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.8e-42  Score=329.61  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=194.5

Q ss_pred             cceeeccccccccCCeEEEEEEE-----cCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVE-----KKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ++|++ .+.||+|+||+||+|.+     ..++..||||++...      ....+|+.++..+.+||||+++++++..   
T Consensus        35 ~~~~~-~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~---  110 (375)
T cd05104          35 NRLSF-GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV---  110 (375)
T ss_pred             HHeeh-hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence            47998 68899999999999974     356779999998632      2345788875555589999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhcc-------------------------------------------------------
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKE-------------------------------------------------------  108 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~-------------------------------------------------------  108 (372)
                       +...|+||||+++|+|.+++....                                                       
T Consensus       111 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         111 -GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             -CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence             667899999999999999987532                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151         109 ------------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus       109 ------------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                                        ...+++..+..++.||+.||+|||+.||+||||||+|||++                     
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---------------------  248 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---------------------  248 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---------------------
Confidence                              12478889999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                            .++.+||+|||++.........  .....++..|+|||++.+..++.++|+|||||++|+|++ |..||.....
T Consensus       249 ------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~  322 (375)
T cd05104         249 ------HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV  322 (375)
T ss_pred             ------CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence                  5667899999998765432211  112234567999999998999999999999999999998 8899865432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .   ......+..+. ...  .....+.++.+||.+||+.||++|||+.++++.
T Consensus       323 ~---~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         323 D---SKFYKMIKEGY-RML--SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             h---HHHHHHHHhCc-cCC--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            2   12222233221 111  113568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.4e-42  Score=310.09  Aligned_cols=249  Identities=28%  Similarity=0.453  Sum_probs=203.4

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|+++ +.||.|++|.||+|.+..+++.+|||.+...       ....+|+.. ++.++||||+++++.+..    +...
T Consensus         1 ~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----~~~~   74 (256)
T cd08220           1 KYEKI-RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQV-LKLLSHPNIIEYYENFLE----DKAL   74 (256)
T ss_pred             CceEE-EEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHH-HhhCCCCchhheeeeEec----CCEE
Confidence            58885 7799999999999999999999999998632       234456666 666799999999998865    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+++++|.+++.......+++..++.++.|++.||+|||++|++|+||||+||+++.                  
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~------------------  136 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK------------------  136 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC------------------
Confidence            99999999999999998755456899999999999999999999999999999999999973                  


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++++|||.+....... ......|++.|+|||.+....++.++|+||+|+++|+|++|..||...+..
T Consensus       137 --------~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~  207 (256)
T cd08220         137 --------HKMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP  207 (256)
T ss_pred             --------CCCEEEEccCCCceecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH
Confidence                    34468899999887664322 223456788999999998888999999999999999999999999654322


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                          .....+..+...   +....++.++.+++.+||..||.+|||+.++++||||
T Consensus       208 ----~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         208 ----ALVLKIMSGTFA---PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ----HHHHHHHhcCCC---CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                222222222221   1113578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.3e-43  Score=320.38  Aligned_cols=256  Identities=24%  Similarity=0.362  Sum_probs=197.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|... +.||+|+||.||++.+..+|+.+|+|.+...      ....+|+..+.+..+|+||+++++++..    +...
T Consensus         4 ~~~~~~-~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~----~~~~   78 (288)
T cd06616           4 EDLKDL-GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR----EGDC   78 (288)
T ss_pred             HHhHHH-HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec----CCcE
Confidence            356663 6799999999999999999999999998632      2345677776666679999999998865    5678


Q ss_pred             EEEEeccCCCchhHHH---HhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          89 LVIMECMHGGELFQRI---QQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i---~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +++|||+. +++.++.   .....+.+++..+..++.|++.||+|||+. |++||||||+||+++               
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---------------  142 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---------------  142 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---------------
Confidence            89999985 4554433   223335699999999999999999999985 999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC---CCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD---KYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  ..+.++|+|||++....... ......|++.|+|||.+...   .++.++|+||+||++|+|++|..|
T Consensus       143 ------------~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  209 (288)
T cd06616         143 ------------RNGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP  209 (288)
T ss_pred             ------------cCCcEEEeecchhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCC
Confidence                        56679999999987654322 22334678899999998765   688999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |....  .....+ .....+. ...+...+..++.++.+||.+||..||++|||+++++.||||+..
T Consensus       210 ~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         210 YPKWN--SVFDQL-TQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             chhcc--hHHHHH-hhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            95432  111111 1111111 122222234588999999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.5e-42  Score=319.44  Aligned_cols=257  Identities=27%  Similarity=0.447  Sum_probs=208.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ..++|+++ +.||+|+||.||+|.+..+++.||+|.+...     ....+|+.. ++.++||||+++++.+..    ++.
T Consensus        17 ~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~-l~~l~hp~i~~~~~~~~~----~~~   90 (293)
T cd06647          17 PKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV-MRENKHPNIVNYLDSYLV----GDE   90 (293)
T ss_pred             chhhceee-eEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHH-HhhcCCCCeeehhheeee----CCc
Confidence            35899996 7799999999999999999999999998532     234567766 566789999999999875    667


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+|+||+++++|.+++.+.   .+++..+..++.|++.||.|||++|++||||||+||+++                  
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~------------------  149 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG------------------  149 (293)
T ss_pred             EEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc------------------
Confidence            89999999999999998753   489999999999999999999999999999999999997                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.++|+|||++..............|++.|+|||.+....++.++|+|||||++|++++|..||...+.
T Consensus       150 ---------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~  220 (293)
T cd06647         150 ---------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP  220 (293)
T ss_pred             ---------CCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence                     56679999999887654433333445678899999999888899999999999999999999999965443


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV  310 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~  310 (372)
                      ....   ......+...+  .....++..+.++|.+||..+|.+||++.+++.|+||+..+..
T Consensus       221 ~~~~---~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~  278 (293)
T cd06647         221 LRAL---YLIATNGTPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL  278 (293)
T ss_pred             hhhe---eehhcCCCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence            2211   11111111111  1223578899999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.3e-42  Score=317.58  Aligned_cols=254  Identities=28%  Similarity=0.440  Sum_probs=196.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .++|.++ +.||+|+||.||+|.+..+|+.||+|++...      ....+|+.. ++.++|+||+++++++..    +..
T Consensus         4 ~~~y~~~-~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~----~~~   77 (291)
T cd07870           4 ATSYLNL-EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASL-LKGLKHANIVLLHDIIHT----KET   77 (291)
T ss_pred             cceeEEE-EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHH-HHhcCCCCEeEEEEEEec----CCe
Confidence            3689985 7799999999999999999999999998532      134567776 666799999999999875    668


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+. ++|.+.+.... +.+++..++.++.||+.||.|||+.||+|+||||+||+++                  
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~------------------  137 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS------------------  137 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc------------------
Confidence            999999995 68877776543 4588999999999999999999999999999999999997                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.++|+|||++..............+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||....
T Consensus       138 ---------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         138 ---------YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             ---------CCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence                     5667999999988765433333344567889999999865 457889999999999999999999996543


Q ss_pred             CCCCCHhHHHHHh---------------hCC-----cc--CCCC---cc--cccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         247 GQAISPGMKNRIR---------------LGQ-----FD--FPNP---EW--EHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       247 ~~~~~~~~~~~~~---------------~~~-----~~--~~~~---~~--~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      ...  ..+.....               ...     +.  .+..   .+  ...+.++.+++.+||..||++|||+.+++
T Consensus       209 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l  286 (291)
T cd07870         209 DVF--EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL  286 (291)
T ss_pred             hHH--HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence            210  00000000               000     00  0000   00  12367899999999999999999999999


Q ss_pred             cCCcc
Q psy3151         300 ENKWI  304 (372)
Q Consensus       300 ~hp~~  304 (372)
                      .||||
T Consensus       287 ~h~~~  291 (291)
T cd07870         287 LHPYF  291 (291)
T ss_pred             cCCCC
Confidence            99997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-42  Score=326.65  Aligned_cols=271  Identities=25%  Similarity=0.420  Sum_probs=208.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec-CC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY-NG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~-~~   84 (372)
                      +.++|.+. +.||.|+||+||+|.+..+|+.||||.+...       ....+|+.. ++.++|+||+++++++.... ..
T Consensus         3 ~~~~y~~~-~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPI-KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKL-LRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEE-EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHH-HHhcCCCCccchHHheecccccc
Confidence            56789995 7799999999999999999999999988531       234567776 56679999999999876421 12


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ....|+|+||+. ++|.+++...  +.+++..++.++.||+.||.|||+.|++||||||+||+++               
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---------------  142 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---------------  142 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---------------
Confidence            246899999995 6899888754  4599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                  .++.+||+|||++..............++..|+|||.+.. ..++.++|+|||||++|+|++|..||.
T Consensus       143 ------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  210 (337)
T cd07858         143 ------------ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP  210 (337)
T ss_pred             ------------CCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence                        5677999999998866443333445567889999998754 568899999999999999999999996


Q ss_pred             CCCCCCCCH--------------------hHHHHHhh-CCccCC--CCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         244 SNHGQAISP--------------------GMKNRIRL-GQFDFP--NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       244 ~~~~~~~~~--------------------~~~~~~~~-~~~~~~--~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +.+......                    .....+.. .....+  ......+++++.+||++||+.||++|||++++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~  290 (337)
T cd07858         211 GKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA  290 (337)
T ss_pred             CCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence            543211000                    00000000 000000  0112357899999999999999999999999999


Q ss_pred             CCccccCCCCCCCCC
Q psy3151         301 NKWISQFNQVPQTPL  315 (372)
Q Consensus       301 hp~~~~~~~~~~~~~  315 (372)
                      ||||..+......+.
T Consensus       291 h~~~~~~~~~~~~~~  305 (337)
T cd07858         291 HPYLASLHDPSDEPV  305 (337)
T ss_pred             CcchhhhcCcccCcc
Confidence            999998766544443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0596|consensus

Probab=100.00  E-value=1.9e-43  Score=327.78  Aligned_cols=251  Identities=27%  Similarity=0.448  Sum_probs=194.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEec-c------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-D------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ..|+++ +.||+||-++||++..... ..||+|.+. .      ......|++.+.++-.|.+|+.++++-..    +.+
T Consensus       361 ~~Yeil-k~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~----d~~  434 (677)
T KOG0596|consen  361 REYEIL-KQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT----DGY  434 (677)
T ss_pred             chhhHH-HhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc----Cce
Confidence            458886 6699999999999998654 445555543 1      13457899998888899999999997543    889


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||- ..||..++++... .++.-.++.+..|++.|+.++|..||||-||||.|+|+-                  
T Consensus       435 lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV------------------  494 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV------------------  494 (677)
T ss_pred             EEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE------------------
Confidence            99999997 5699999987653 345459999999999999999999999999999999995                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCC-----------CCCCccchhhHHHHHHH
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPD-----------KYDKSCDIWSLGVIMYI  234 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~~  234 (372)
                                .|.+||+|||+|..+..+...  ....+||+.|||||.+...           ..++++||||||||||+
T Consensus       495 ----------kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYq  564 (677)
T KOG0596|consen  495 ----------KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQ  564 (677)
T ss_pred             ----------eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHH
Confidence                      688999999999987654432  4557999999999998432           25679999999999999


Q ss_pred             HHhCCCCCCCCCCCCCCHhHHHHHhhCC--ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         235 LLCGFPPFFSNHGQAISPGMKNRIRLGQ--FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       235 ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |+.|++||..-...   ......+....  .++|...   -..++.++++.||+.||.+|||+.++|+|||++.+
T Consensus       565 MvYgktPf~~~~n~---~aKl~aI~~P~~~Iefp~~~---~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  565 MVYGKTPFGQIINQ---IAKLHAITDPNHEIEFPDIP---ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             HHhcCCchHHHHHH---HHHHHhhcCCCccccccCCC---CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            99999999532110   11122222221  1232210   12339999999999999999999999999999763

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-42  Score=318.61  Aligned_cols=255  Identities=29%  Similarity=0.505  Sum_probs=199.6

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|++. +.||.|++|.||+|.+..+|+.||+|++...       ....+|+.. ++.++||||+++++++..    +...
T Consensus         1 ~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----~~~~   74 (286)
T cd07832           1 RYKIL-GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA-LQACQHPYVVKLLDVFPH----GSGF   74 (286)
T ss_pred             CceEE-eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHH-HHhCCCCCCcceeeEEec----CCee
Confidence            58885 7799999999999999999999999998632       234567776 566689999999999876    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++                   
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~-------------------  133 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS-------------------  133 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc-------------------
Confidence            9999999 999999987654 5699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                              ..+.++++|||++........ ......|+..|+|||.+.+ ..++.++||||+||++|+|++|.+||.+..
T Consensus       134 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  205 (286)
T cd07832         134 --------ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN  205 (286)
T ss_pred             --------CCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence                    567799999998876644321 2334568899999998854 446899999999999999999988885543


Q ss_pred             CCCCCHhHHHHHhh---------------CCccCCC-------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         247 GQAISPGMKNRIRL---------------GQFDFPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       247 ~~~~~~~~~~~~~~---------------~~~~~~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ..............               ....++.       ......+.++.+||.+||..||.+|||+++++.||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         206 DIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             HHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence            21111001000000               0000000       0112467899999999999999999999999999998


Q ss_pred             c
Q psy3151         305 S  305 (372)
Q Consensus       305 ~  305 (372)
                      .
T Consensus       286 ~  286 (286)
T cd07832         286 T  286 (286)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-42  Score=329.65  Aligned_cols=248  Identities=24%  Similarity=0.402  Sum_probs=193.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCC-----CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKT-----SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ++|++ .+.||+|+||.||+|.+..+     ++.||||++...      ....+|+.++..+.+|+||+++++.+..   
T Consensus        38 ~~~~~-~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~---  113 (374)
T cd05106          38 DNLQF-GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH---  113 (374)
T ss_pred             HHcee-hheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC---
Confidence            45888 58899999999999986544     457999998632      2345788875555589999999998865   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhcc-------------------------------------------------------
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKE-------------------------------------------------------  108 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~-------------------------------------------------------  108 (372)
                       ....|+||||+.+|+|.+++....                                                       
T Consensus       114 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         114 -GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             -CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence             567899999999999999986531                                                       


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151         109 -------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus       109 -------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                                   ..++++..++.++.||+.||.|||++||+||||||+|||++                          
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~--------------------------  246 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT--------------------------  246 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe--------------------------
Confidence                         12478899999999999999999999999999999999998                          


Q ss_pred             CCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCH
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISP  252 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  252 (372)
                       +++.+||+|||++.........  ..+..+++.|+|||++....++.++|+|||||++|+|++ |..||.......   
T Consensus       247 -~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---  322 (374)
T cd05106         247 -DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---  322 (374)
T ss_pred             -CCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---
Confidence             5667999999998765332211  112234567999999988899999999999999999997 999996543321   


Q ss_pred             hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .....+.. ....+.  ....++++.+++.+||+.||.+|||+.++++
T Consensus       323 ~~~~~~~~-~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         323 KFYKMVKR-GYQMSR--PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHc-ccCccC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            12222222 122111  1346899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.3e-42  Score=311.63  Aligned_cols=243  Identities=37%  Similarity=0.652  Sum_probs=200.7

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      ||.|++|.||+|.+..+++.+|+|++...        ....+|+.. ++.++||||+++++.+..    +...|+++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI-LEECNHPFIVKLYRTFKD----KKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHH-HHhCCCCCEeeeeeeEEc----CCccEEEEecC
Confidence            69999999999999999999999998632        224456665 566799999999998875    67899999999


Q ss_pred             CCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151          96 HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus        96 ~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                      ++++|.+++.+.  ..+++..+..++.||+.||+|||++|++|+||+|+||+++                          
T Consensus        76 ~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~--------------------------  127 (262)
T cd05572          76 LGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD--------------------------  127 (262)
T ss_pred             CCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc--------------------------
Confidence            999999999765  3489999999999999999999999999999999999998                          


Q ss_pred             CCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHH
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK  255 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  255 (372)
                       .++.++|+|||++....... ......+++.|+|||.+....++.++|+||+|+++|+|++|..||......  .....
T Consensus       128 -~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~  203 (262)
T cd05572         128 -SNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PMEIY  203 (262)
T ss_pred             -CCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHH
Confidence             56779999999988664432 223456789999999998888999999999999999999999999765431  12233


Q ss_pred             HHHhh--CCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         256 NRIRL--GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       256 ~~~~~--~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      ..+..  .....|    ...++++.++|.+||+.||.+|||     ++|+++||||+.+
T Consensus       204 ~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         204 NDILKGNGKLEFP----NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             HHHhccCCCCCCC----cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence            33332  222222    245899999999999999999999     9999999999875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.8e-42  Score=314.27  Aligned_cols=251  Identities=24%  Similarity=0.426  Sum_probs=197.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..|++ .+.||+|+||.||+|.+..++..||+|.+...          ....+|+.+ ++.++||||+++++++..  ..
T Consensus         2 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~--~~   77 (266)
T cd06651           2 INWRR-GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQL-LKNLQHERIVQYYGCLRD--RA   77 (266)
T ss_pred             CCccc-cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHH-HHHcCCCCeeeEEEEEEc--CC
Confidence            46777 58899999999999999999999999988521          234567776 566699999999998864  22


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +..+++++||+++++|.+++...  +.+++..++.++.|++.||+|||+.||+||||||+||+++               
T Consensus        78 ~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~---------------  140 (266)
T cd06651          78 EKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD---------------  140 (266)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---------------
Confidence            46789999999999999999765  3489999999999999999999999999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccC---CCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSN---KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.++|+|||++......   ........++..|+|||.+.+..++.++|+||+||++|+|++|..|
T Consensus       141 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~p  208 (266)
T cd06651         141 ------------SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP  208 (266)
T ss_pred             ------------CCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCC
Confidence                        5567899999988754321   1112234578899999999888899999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      |.....   ...+.......   ..+.....+++.+++++ +||..+|++|||+++++.||||+
T Consensus       209 f~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         209 WAEYEA---MAAIFKIATQP---TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ccccch---HHHHHHHhcCC---CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            964422   11122111111   11111135788899999 57778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=326.66  Aligned_cols=270  Identities=25%  Similarity=0.418  Sum_probs=204.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee-cCC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI-YNG   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~-~~~   84 (372)
                      .+.++|++. +.||+|+||.||+|.+..+|+.||||++...      ....+|+.. ++.++||||+++++++... ...
T Consensus         2 ~~~~~y~i~-~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           2 DVGPRYQNL-SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKI-LRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccccceEEE-EEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHH-HHhCCCCCcCchhheeecccccc
Confidence            367899994 7899999999999999999999999998521      234457776 5666899999999887532 223


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ....|+++||+. ++|.+.+..   ..+++..++.++.||+.||+|||+.||+||||||+||+++               
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~---------------  140 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---------------  140 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---------------
Confidence            456899999995 588887754   3599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                  .++.++|+|||++........   .....+||+.|+|||.+.+ ..++.++|+||+||++|+|++|+.
T Consensus       141 ------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~  208 (336)
T cd07849         141 ------------TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP  208 (336)
T ss_pred             ------------CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence                        567799999998876533221   1233567999999998644 568899999999999999999999


Q ss_pred             CCCCCCCCCCCH-----------hHHHHHhh-------CCccCC-CC----cccccCHHHHHHHHHhccCCCCCCCChhH
Q psy3151         241 PFFSNHGQAISP-----------GMKNRIRL-------GQFDFP-NP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQ  297 (372)
Q Consensus       241 pf~~~~~~~~~~-----------~~~~~~~~-------~~~~~~-~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~e  297 (372)
                      ||.+.+......           .....+..       ...+.. ..    .....+.++.+||.+||+.||++|||+.+
T Consensus       209 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e  288 (336)
T cd07849         209 LFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE  288 (336)
T ss_pred             CCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence            996543211000           00000000       000000 00    01246788999999999999999999999


Q ss_pred             HhcCCccccCCCCCCCC
Q psy3151         298 VMENKWISQFNQVPQTP  314 (372)
Q Consensus       298 il~hp~~~~~~~~~~~~  314 (372)
                      +++||||+.+......+
T Consensus       289 ~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         289 ALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             HhcCccccccCCCCCcc
Confidence            99999999876544433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-42  Score=312.43  Aligned_cols=248  Identities=27%  Similarity=0.439  Sum_probs=198.0

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +|++ .+.||.|+||+||+|.+ .+|+.+|+|.+...           ....+|+.. ++.++|+||+++++++..    
T Consensus         1 ~~~~-~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----   73 (265)
T cd06631           1 EWTK-GEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDL-LKSLKHVNIVQYLGTCLD----   73 (265)
T ss_pred             Cccc-cceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHH-HHhcCCCCEeeEeeEeec----
Confidence            4777 57899999999999987 47899999988521           224457766 566789999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ....++++||+++++|.+++.+.  +.+++..++.++.|++.||+|||+.||+|+||+|+||+++               
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---------------  136 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM---------------  136 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC---------------
Confidence            67899999999999999999765  3589999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccC------CCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSN------KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                  .++.++|+|||++......      ........|+..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus       137 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  204 (265)
T cd06631         137 ------------PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG  204 (265)
T ss_pred             ------------CCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhC
Confidence                        5667888898887654211      1112334678899999999888899999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ..||...+...   .. ..+.......+ .....++.++.++|++||..+|.+|||+.+++.||||
T Consensus       205 ~~p~~~~~~~~---~~-~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         205 KPPLASMDRLA---AM-FYIGAHRGLMP-RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCccccCChHH---HH-HHhhhccCCCC-CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            99996533211   11 11111111111 1223688999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.6e-42  Score=312.50  Aligned_cols=246  Identities=27%  Similarity=0.427  Sum_probs=194.9

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      ..||+|+||.||+|.+..++..||+|.+...     ....+|+.. ++.++|+||+++++++..    +...++|+||+.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~   88 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIAL-HSYLKHRNIVQYLGSDSE----NGFFKIFMEQVP   88 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHH-HHhcCCCCeeeeeeeecc----CCEEEEEEecCC
Confidence            3599999999999999999999999988632     234567766 677799999999998875    678999999999


Q ss_pred             CCchhHHHHhccCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          97 GGELFQRIQQKEDGAF--TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        97 ~g~L~~~i~~~~~~~l--~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +++|.+++.... ..+  ++..+..++.||+.||+|||+.||+||||||+||+++.                        
T Consensus        89 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~------------------------  143 (268)
T cd06624          89 GGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT------------------------  143 (268)
T ss_pred             CCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC------------------------
Confidence            999999997643 235  88899999999999999999999999999999999973                        


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCH
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK--YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP  252 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  252 (372)
                        +.+.++|+|||.+..............|++.|+|||.+....  ++.++|+||+|+++|+|++|..||........  
T Consensus       144 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--  219 (268)
T cd06624         144 --YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--  219 (268)
T ss_pred             --CCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--
Confidence              356799999998876543333333445788999999986543  78999999999999999999999964322111  


Q ss_pred             hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ........   ...+.....+++++++|+.+||+.+|.+|||+.+++.||||
T Consensus       220 ~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         220 AMFKVGMF---KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             hHhhhhhh---ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            11111110   11111123578999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.8e-42  Score=322.32  Aligned_cols=271  Identities=26%  Similarity=0.427  Sum_probs=206.1

Q ss_pred             ceeeccccccccCCeEEEEEEEcCC--CcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKT--SEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      +|++ .+.||.|+||.||+|.+..+  ++.||||.+...       ....+|+.++.++.+||||+++++..........
T Consensus         1 ~y~~-~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYEL-IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceE-EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            5787 47799999999999999888  999999988531       2346788876666689999999987653223345


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..|++++|+. ++|.+++...  ..+++..++.++.||+.||+|||+.||+||||||+||+++                 
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~-----------------  139 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN-----------------  139 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc-----------------
Confidence            6889999995 6899988654  4599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                .++.++|+|||++........    ......||+.|+|||.+.+ ..++.++|+||+||++|+|++|.+|
T Consensus       140 ----------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~p  209 (332)
T cd07857         140 ----------ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV  209 (332)
T ss_pred             ----------CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcC
Confidence                      566799999998876543211    1233568999999998754 5689999999999999999999999


Q ss_pred             CCCCCCCCCCH-----------hHHHHHhh----------CCccCC--CCcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         242 FFSNHGQAISP-----------GMKNRIRL----------GQFDFP--NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       242 f~~~~~~~~~~-----------~~~~~~~~----------~~~~~~--~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |...+......           .....+..          ...+..  ...+...+.++.+|+.+||+.||.+|||+.++
T Consensus       210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l  289 (332)
T cd07857         210 FKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA  289 (332)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            96543211100           00000000          000000  01123468899999999999999999999999


Q ss_pred             hcCCccccCCCCCCCCCcc
Q psy3151         299 MENKWISQFNQVPQTPLCT  317 (372)
Q Consensus       299 l~hp~~~~~~~~~~~~~~~  317 (372)
                      +.|||++.++.....+.|.
T Consensus       290 l~~~~~~~~~~~~~~~~~~  308 (332)
T cd07857         290 LEHPYLAIWHDPDDEPVCQ  308 (332)
T ss_pred             hcChhhhhhcCcccccccc
Confidence            9999999988765666553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.4e-42  Score=310.63  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=208.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|.+. +.||.|++|.||+|.+..+++.||||++...      ....+|+.. +..++|+||+++++++..    +...
T Consensus         1 ~~~~~~-~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~   74 (264)
T cd06623           1 SDLERV-KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKT-LRSCESPYVVKCYGAFYK----EGEI   74 (264)
T ss_pred             Ccceee-eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHH-HHhcCCCCeeeEEEEEcc----CCeE
Confidence            468884 7899999999999999999999999998643      234566666 555679999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||+|||+ .|++||||+|+||+++                  
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~------------------  134 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN------------------  134 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC------------------
Confidence            9999999999999999765  459999999999999999999999 9999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.++++|||.+..............++..|+|||.+....++.++|+||||+++|+|++|..||.....
T Consensus       135 ---------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~  205 (264)
T cd06623         135 ---------SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ  205 (264)
T ss_pred             ---------CCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence                     56779999999988765444333455678899999999888899999999999999999999999966542


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccc-cCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .. .......+.....  +. .... ++..+.++|.+||..+|++|||+.++++|||++.+
T Consensus       206 ~~-~~~~~~~~~~~~~--~~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         206 PS-FFELMQAICDGPP--PS-LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             cC-HHHHHHHHhcCCC--CC-CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            11 1222233322111  11 1123 78999999999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.5e-42  Score=315.73  Aligned_cols=255  Identities=28%  Similarity=0.451  Sum_probs=206.1

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ..+|.. .+.||.|++|.||+|.+..+++.+|+|.+...     ....+|+.+ ++.++||||+++++++..    ++..
T Consensus        18 ~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~-l~~~~h~~vv~~~~~~~~----~~~~   91 (285)
T cd06648          18 RSYLDN-FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVI-MRDYQHPNIVEMYSSYLV----GDEL   91 (285)
T ss_pred             hHhhhc-ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHH-HHHcCCCChheEEEEEEc----CCeE
Confidence            345665 36799999999999999999999999988532     234567766 667799999999998875    6778


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++++||+.+++|.+++..   +.+++..++.++.|++.||+|||++|++||||+|+||+++                   
T Consensus        92 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~-------------------  149 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT-------------------  149 (285)
T ss_pred             EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc-------------------
Confidence            999999999999999876   3589999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++++|||.+..............|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+..
T Consensus       150 --------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~  221 (285)
T cd06648         150 --------SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL  221 (285)
T ss_pred             --------CCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH
Confidence                    567799999998876543333334456899999999998888999999999999999999999999654321


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                          .....+....... ......++..+.++|.+||+.+|++|||+.++++||||++...
T Consensus       222 ----~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         222 ----QAMKRIRDNLPPK-LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             ----HHHHHHHhcCCCC-CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                1222232221111 1111237899999999999999999999999999999988653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-42  Score=320.94  Aligned_cols=254  Identities=28%  Similarity=0.451  Sum_probs=205.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ....|+.. ..||.|+||.||+|.+..+++.||+|++...     ....+|+.. +..++||||+++++++..    +..
T Consensus        19 ~~~~~~~~-~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~-l~~l~hp~i~~~~~~~~~----~~~   92 (297)
T cd06659          19 PRSLLENY-IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVI-MRDYQHQNVVEMYKSYLV----GEE   92 (297)
T ss_pred             chhhHHhh-hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHH-HHhCCCCchhhhhhheee----CCe
Confidence            33445553 4699999999999999999999999998532     234566666 566789999999999876    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+++++|.+++..   ..+++..++.++.|++.||+|||++|++||||||+||+++                  
T Consensus        93 ~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~------------------  151 (297)
T cd06659          93 LWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT------------------  151 (297)
T ss_pred             EEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc------------------
Confidence            9999999999999987754   3489999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.++|+|||++.............+|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus       152 ---------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  222 (297)
T cd06659         152 ---------LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP  222 (297)
T ss_pred             ---------cCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                     56779999999987654433334456789999999999888899999999999999999999999965432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .    .....+..... ........++.++.++|.+||+.+|.+|||++++++||||.+.
T Consensus       223 ~----~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         223 V----QAMKRLRDSPP-PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             H----HHHHHHhccCC-CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence            1    11222222111 1112234578899999999999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.3e-42  Score=324.17  Aligned_cols=263  Identities=25%  Similarity=0.428  Sum_probs=202.9

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-------------------hhHHHHHHHHHhcCCCCE
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------------------KARREVELQLAVGSHKHI   71 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------------~~~~e~~~~~~~~~h~ni   71 (372)
                      ..+.+||..+.+.||.|+||+||+|.+..+++.||||++....                   ...+|+.. ++.++|+||
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i   82 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI-MNEIKHENI   82 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHH-HHhCCCcce
Confidence            3578999887888999999999999999999999999985321                   24567776 666799999


Q ss_pred             eEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecC
Q psy3151          72 VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP  151 (372)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~  151 (372)
                      +++++++..    +...|+||||+. ++|.+++...  ..+++..+..++.||+.||+|||+.||+|+||+|+||+++  
T Consensus        83 v~~~~~~~~----~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~--  153 (335)
T PTZ00024         83 MGLVDVYVE----GDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN--  153 (335)
T ss_pred             eeeeEEEec----CCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC--
Confidence            999999875    678999999996 6999988754  3599999999999999999999999999999999999998  


Q ss_pred             CCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccc--------------cCCCcccccccCCCcCCCcccCCC
Q psy3151         152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV--------------SNKASLQTPCYTPYYVAPEVLGPD  217 (372)
Q Consensus       152 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~--------------~~~~~~~~~~gt~~y~aPE~~~~~  217 (372)
                                               ..+.++++|||.+....              ..........+++.|+|||.+.+.
T Consensus       154 -------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  208 (335)
T PTZ00024        154 -------------------------SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA  208 (335)
T ss_pred             -------------------------CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC
Confidence                                     45567777777776543              111122234568889999988654


Q ss_pred             -CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCC-ccCC---------------C----CcccccCHH
Q psy3151         218 -KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ-FDFP---------------N----PEWEHVSQE  276 (372)
Q Consensus       218 -~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---------------~----~~~~~~s~~  276 (372)
                       .++.++|+|||||++|+|++|..||.+.+..+....+........ ..++               +    ......+.+
T Consensus       209 ~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (335)
T PTZ00024        209 EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDD  288 (335)
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChH
Confidence             478999999999999999999999976543221111111110000 0000               0    001245788


Q ss_pred             HHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         277 AKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       277 ~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      +.++|.+||+.+|++|||++++|.||||+...
T Consensus       289 ~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        289 AIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            99999999999999999999999999998753

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.2e-42  Score=312.61  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=199.4

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---------------hhhHHHHHHHHHhcCCCCEeEEeEeeee
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---------------VKARREVELQLAVGSHKHIVNIKDVYEN   80 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------------~~~~~e~~~~~~~~~h~ni~~~~~~~~~   80 (372)
                      +|.+ .+.||.|++|.||+|.+..+|+.+|+|.+...               ....+|+.. ++.++||||+++++++..
T Consensus         2 ~~~~-~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~   79 (272)
T cd06629           2 KWVK-GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET-LKDLDHLNIVQYLGFETT   79 (272)
T ss_pred             ceee-cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHH-HHhcCCCCcceEEEEecc
Confidence            5777 68899999999999999999999999987521               123456665 667799999999998865


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                          ....++||||+.+++|.+++...  +.+++..++.++.||+.||.|||++|++||||+|+||+++           
T Consensus        80 ----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~-----------  142 (272)
T cd06629          80 ----EEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD-----------  142 (272)
T ss_pred             ----CCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc-----------
Confidence                67899999999999999999765  4699999999999999999999999999999999999998           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCC--CCCccchhhHHHHHHHHH
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDK--YDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll  236 (372)
                                      .++.++++|||++.......  .......|+..|+|||.+....  ++.++|+||||+++|+|+
T Consensus       143 ----------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~  206 (272)
T cd06629         143 ----------------ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF  206 (272)
T ss_pred             ----------------CCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH
Confidence                            56779999999887543211  1123345788999999986654  789999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHH-hhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRI-RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      +|..||......   ....... .......+......++.++.++|.+||..+|.+|||++++++||||
T Consensus       207 ~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         207 AGRRPWSDEEAI---AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             hCCCCCcCcchH---HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            999999543221   1111111 1111222322334578999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG2345|consensus

Probab=100.00  E-value=1.4e-43  Score=299.40  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=200.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-----hhhhHHHHHHHHHhcCCCCEeEEeEeeeee-cCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-----TVKARREVELQLAVGSHKHIVNIKDVYENI-YNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~-~~~~~~   87 (372)
                      ..||+|. +.||+|||+.||++++..+++.||+|.+..     ...+.+|++. .++.+||||+++++..... .++...
T Consensus        20 ~~Ryri~-~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~-~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   20 NKRYRIQ-RLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDN-HRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             CceEEEe-eeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHH-HHhhCCcchHHHHHHHHHhhccCcee
Confidence            4699995 779999999999999999999999999852     3467888887 6778999999998876422 224567


Q ss_pred             EEEEEeccCCCchhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          88 LLVIMECMHGGELFQRIQQKE--DGAFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~--~~~l~~~~~~~i~~qil~~l~~LH~~~--ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      .|++++|...|+|.+.+....  +..++|.++..|+.+|++||++||+..  ++||||||.|||++              
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls--------------  163 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS--------------  163 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec--------------
Confidence            999999999999999988632  235999999999999999999999998  99999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCc---------ccccccCCCcCCCcccC---CCCCCCccchhhHHHH
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---------LQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVI  231 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  231 (372)
                                   +.+.++|.|||.++...-....         ......|..|+|||.+.   +...+.++|||||||+
T Consensus       164 -------------~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCt  230 (302)
T KOG2345|consen  164 -------------DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCT  230 (302)
T ss_pred             -------------CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHH
Confidence                         5677889999988754321110         11123388899999983   4456799999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       232 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ||+|+.|..||...-.+-  ..+.-.+..+++.+|..  ..+|..+.+||+.||+.||.+||++.+++.+
T Consensus       231 LYa~mf~~sPfe~~~~~G--gSlaLAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  231 LYAMMFGESPFERIYQQG--GSLALAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             HHHHHHcCCcchHHhhcC--CeEEEeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            999999999994321110  11122334445555543  3489999999999999999999999999874

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.4e-42  Score=309.41  Aligned_cols=251  Identities=31%  Similarity=0.472  Sum_probs=206.1

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|+++ +.||.|+||.||+|.+..+|+.||+|++...       .....|+.. ++.++||||+++++.+..  ..+...
T Consensus         1 ~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~--~~~~~~   76 (265)
T cd08217           1 DYEVL-ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNI-LRELKHPNIVRYYDRIID--RSNQTL   76 (265)
T ss_pred             Cceee-eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHH-HHhcCCCccceeeeeeec--CCCCEE
Confidence            47885 7799999999999999999999999998532       123346655 677799999999997753  235678


Q ss_pred             EEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          89 LVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLH-----DQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH-----~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                      |++|||+++++|.+++...  ....+++..++.++.||+.||+|||     +.+++|+||||+||+++            
T Consensus        77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~------------  144 (265)
T cd08217          77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD------------  144 (265)
T ss_pred             EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe------------
Confidence            9999999999999998763  2356999999999999999999999     89999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                     .++.++++|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus       145 ---------------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p  209 (265)
T cd08217         145 ---------------ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP  209 (265)
T ss_pred             ---------------cCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCc
Confidence                           56789999999988765544334456789999999999888899999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      |...+.    ..+...+..+....   ....++.++.+++.+||..+|.+|||+.++++|||+
T Consensus       210 ~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         210 FTARNQ----LQLASKIKEGKFRR---IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCcCH----HHHHHHHhcCCCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            965442    23334444333321   123678999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-42  Score=313.74  Aligned_cols=251  Identities=30%  Similarity=0.487  Sum_probs=202.0

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhc--CCCCEeEEeEeeeeecCCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVG--SHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~--~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .|+++ +.||.|+||.||+|.+..+++.||+|.+...      ....+|+.++..+.  .|||++++++++..    +..
T Consensus         2 ~y~~~-~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~----~~~   76 (277)
T cd06917           2 LYQRL-ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK----GPR   76 (277)
T ss_pred             hhhhh-hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee----CCE
Confidence            57775 6799999999999999999999999998532      23456776644443  49999999998875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+++++|.+++...   .+++..++.++.|++.||.|||+.||+|+||+|+||+++                  
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~------------------  135 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT------------------  135 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc------------------
Confidence            99999999999999988653   599999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               ..+.++++|||++..............|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||....
T Consensus       136 ---------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  206 (277)
T cd06917         136 ---------NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD  206 (277)
T ss_pred             ---------CCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence                     5677999999998876554444445578899999998864 457899999999999999999999996543


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ....    ...+...  ..+......++.++.+++.+||..||.+|||+.+++.|+||++.
T Consensus       207 ~~~~----~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         207 AFRA----MMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             hhhh----hhccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            2211    1111111  11111112378899999999999999999999999999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG1290|consensus

Probab=100.00  E-value=3.1e-42  Score=315.43  Aligned_cols=293  Identities=23%  Similarity=0.343  Sum_probs=218.7

Q ss_pred             cc-cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc----hhhhHHHHHHHHHhcCC-------CCEeEEeEeeee
Q psy3151          13 IQ-DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD----TVKARREVELQLAVGSH-------KHIVNIKDVYEN   80 (372)
Q Consensus        13 ~~-~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h-------~ni~~~~~~~~~   80 (372)
                      |. +||.++ +.||.|.|++||+|.|.++.+.||+|+.+.    +..+..||.++.+...+       .+||++++.|..
T Consensus        75 F~~gRY~v~-rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   75 FNGGRYHVQ-RKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ccCceEEEE-EeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            55 899986 669999999999999999999999999963    45678899987666533       479999999999


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCC-------
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPG-------  152 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~-------  152 (372)
                      ...++.++++|+|++ |.+|..+|....-+.++...++.|++||+.||.|||.. ||||.||||+|||+..+.       
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~  232 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA  232 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence            999999999999999 78999999987777899999999999999999999976 999999999999996431       


Q ss_pred             -------------CCCceee--------------ec--------------------cC-------------------CCC
Q psy3151         153 -------------DGGILKL--------------TD--------------------FG-------------------DVK  166 (372)
Q Consensus       153 -------------~~~~~~~--------------~d--------------------~~-------------------~~~  166 (372)
                                   ....++-              .+                    +|                   ...
T Consensus       233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~  312 (590)
T KOG1290|consen  233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN  312 (590)
T ss_pred             hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence                         0000000              00                    00                   000


Q ss_pred             ------------------------cc--------------------------ccc----------------cCCCCCCCC
Q psy3151         167 ------------------------PE--------------------------NLL----------------YTKPGDGGI  180 (372)
Q Consensus       167 ------------------------~~--------------------------~~~----------------~~~~~~~~~  180 (372)
                                              ..                          ...                ...+.....
T Consensus       313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~  392 (590)
T KOG1290|consen  313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR  392 (590)
T ss_pred             ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence                                    00                          000                001334567


Q ss_pred             eeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhH--HHH-
Q psy3151         181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM--KNR-  257 (372)
Q Consensus       181 ~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~--~~~-  257 (372)
                      |||+|||-|...   ....+..+.|..|+|||++.+..|+..+||||++|++|||+||...|...++......-  ... 
T Consensus       393 vKIaDlGNACW~---~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i  469 (590)
T KOG1290|consen  393 VKIADLGNACWV---HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI  469 (590)
T ss_pred             EEEeeccchhhh---hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence            899999998865   33455667799999999999999999999999999999999999999766554422110  000 


Q ss_pred             -----------HhhCCc---------cCCC----Ccc-------------cccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         258 -----------IRLGQF---------DFPN----PEW-------------EHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       258 -----------~~~~~~---------~~~~----~~~-------------~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                                 ...|.+         .+..    ..|             ..-..++.||+.-||+.+|++||||.++|+
T Consensus       470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence                       000100         0000    000             112356779999999999999999999999


Q ss_pred             CCccccCCCC
Q psy3151         301 NKWISQFNQV  310 (372)
Q Consensus       301 hp~~~~~~~~  310 (372)
                      |||+..+...
T Consensus       550 hPwLn~~~~~  559 (590)
T KOG1290|consen  550 HPWLNPVAGP  559 (590)
T ss_pred             CccccCCCCC
Confidence            9999876544

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.9e-42  Score=312.42  Aligned_cols=248  Identities=27%  Similarity=0.501  Sum_probs=203.6

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +|++ .+.||.|+||.||+|.+..+++.||+|++...        ....+|+.. ++.++||||+++++++..    +..
T Consensus         1 ~y~~-~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~   74 (258)
T cd05578           1 HFEL-LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRI-LQELNHPFLVNLWYSFQD----EEN   74 (258)
T ss_pred             CceE-EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHH-HHhCCCCChHHHHHhhcC----CCe
Confidence            4788 47799999999999999999999999998632        234566665 666799999999998865    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+|+||+.+++|.+++...  ..+++..+..++.||+.||.|||++|++|+||+|+||+++                  
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~------------------  134 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD------------------  134 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc------------------
Confidence            99999999999999999765  4699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.++|+|||++....... ......|+..|+|||.+....++.++|+||||+++|+|++|..||...+.
T Consensus       135 ---------~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  204 (258)
T cd05578         135 ---------EQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR  204 (258)
T ss_pred             ---------CCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence                     56678999999887654322 23345678889999999888899999999999999999999999976543


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh--hHHhcCCcc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI--DQVMENKWI  304 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~--~eil~hp~~  304 (372)
                      .. ...............+    ..++.++.++|.+||..||.+||++  ++++.||||
T Consensus       205 ~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         205 TI-RDQIRAKQETADVLYP----ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             cH-HHHHHHHhccccccCc----ccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            21 1222222221222222    3578999999999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.7e-42  Score=314.55  Aligned_cols=238  Identities=16%  Similarity=0.204  Sum_probs=192.9

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      ..||+|++|.||+|..  +|+.||||.+...        ....+|+.+ +..++||||+++++++.+...+...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKN-LRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHH-HHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            4599999999999997  6899999998642        223478877 6667999999999998653334567899999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      |+++|+|.+++.+.  +.+++.....++.|++.||.|||+. +++||||||+||+++                       
T Consensus       103 y~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~-----------------------  157 (283)
T PHA02988        103 YCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT-----------------------  157 (283)
T ss_pred             eCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC-----------------------
Confidence            99999999999765  3589999999999999999999984 999999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI  250 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  250 (372)
                          .++.+||+|||++......   .....||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+.+..  
T Consensus       158 ----~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--  228 (283)
T PHA02988        158 ----ENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--  228 (283)
T ss_pred             ----CCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--
Confidence                5678999999998765332   234567899999999866  67999999999999999999999999754322  


Q ss_pred             CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                        .+...+.......+.+  ..+++++.+||.+||+.||++|||++++++
T Consensus       229 --~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        229 --EIYDLIINKNNSLKLP--LDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             --HHHHHHHhcCCCCCCC--CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence              2333332222222221  257899999999999999999999999986

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-42  Score=314.63  Aligned_cols=260  Identities=27%  Similarity=0.378  Sum_probs=203.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|+.+ +.||.|++|.||+|.+..+++.+|+|.+...      ....+|++. ++.++||||++++++|..  .....+
T Consensus         1 ~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~--~~~~~~   76 (287)
T cd06621           1 EKIVEL-SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEI-NKSCKSPYIVKYYGAFLD--ESSSSI   76 (287)
T ss_pred             CceEEE-EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHH-HHhCCCCCeeeeeeEEEc--cCCCeE
Confidence            468885 6799999999999999999999999998632      245678776 566799999999998854  234578


Q ss_pred             EEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          89 LVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      |+||||+++++|.+++..  .....+++..+..++.||+.||.|||+.|++|+||+|+||+++                 
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~-----------------  139 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT-----------------  139 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe-----------------
Confidence            999999999999888754  2234689999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                ..+.++|+|||++.......  .....++..|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus       140 ----------~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (287)
T cd06621         140 ----------RKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG  207 (287)
T ss_pred             ----------cCCeEEEeeccccccccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence                      55678999999886543221  123456788999999988899999999999999999999999997553


Q ss_pred             CCC-CCHhHHHHHhhCCc-cCC--CCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         247 GQA-ISPGMKNRIRLGQF-DFP--NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       247 ~~~-~~~~~~~~~~~~~~-~~~--~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ... ........+..... ..+  .......++++.++|.+||..+|.+|||+.|++.||||++.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         208 EPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            211 11122222222111 111  11112356889999999999999999999999999999664

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-42  Score=319.12  Aligned_cols=261  Identities=24%  Similarity=0.464  Sum_probs=198.8

Q ss_pred             ceeeccccccccCCeEEEEEEEcC--CCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKK--TSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      +|+++ +.||+|++|.||+|.+..  +++.||+|.+...        ....+|+.+ +..++||||+++++++..  ..+
T Consensus         1 ~y~~~-~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~--~~~   76 (316)
T cd07842           1 KYEIE-GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIAL-LRELKHENVVSLVEVFLE--HAD   76 (316)
T ss_pred             CceEE-EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHH-HHhcCCCCccceEEEEeC--CCC
Confidence            58885 669999999999999988  8999999998752        245667776 666799999999999875  223


Q ss_pred             eEEEEEEeccCCCchhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKE---DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~---~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ..+|+||||+.+ +|.+.+....   ...+++..++.++.||+.||+|||+.||+||||||+||+++.+++         
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~---------  146 (316)
T cd07842          77 KSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGP---------  146 (316)
T ss_pred             ceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCC---------
Confidence            689999999964 7777765422   236899999999999999999999999999999999999985332         


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g  238 (372)
                                    ..+.+||+|||++........   .....++|+.|+|||.+.+ ..++.++|+|||||++|+|++|
T Consensus       147 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~  212 (316)
T cd07842         147 --------------ERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL  212 (316)
T ss_pred             --------------ccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc
Confidence                          477899999998876543222   2234567889999998765 4588999999999999999999


Q ss_pred             CCCCCCCCCCCCC------HhHHHHH-------------------------hhCCccCCC-------CcccccCHHHHHH
Q psy3151         239 FPPFFSNHGQAIS------PGMKNRI-------------------------RLGQFDFPN-------PEWEHVSQEAKTL  280 (372)
Q Consensus       239 ~~pf~~~~~~~~~------~~~~~~~-------------------------~~~~~~~~~-------~~~~~~s~~~~~l  280 (372)
                      .+||.+.......      ..+...+                         .......+.       ..+...+.++.++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (316)
T cd07842         213 EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL  292 (316)
T ss_pred             CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence            9999765433200      0000000                         000000110       0011567889999


Q ss_pred             HHHhccCCCCCCCChhHHhcCCcc
Q psy3151         281 IKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       281 i~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      +.+||+.||++|||+.+++.||||
T Consensus       293 i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         293 LRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhcCCcccCcCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.3e-41  Score=308.40  Aligned_cols=251  Identities=25%  Similarity=0.437  Sum_probs=198.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..|++ .+.||+|+||.||+|.+..+|+.||||.+...          ....+|+.+ ++.+.||||+++++++.+.  .
T Consensus         2 ~~~~~-~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~--~   77 (265)
T cd06652           2 TNWRL-GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQL-LKNLLHERIVQYYGCLRDP--M   77 (265)
T ss_pred             CcceE-eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHH-HHhcCCCCeeeEEeEeccC--C
Confidence            57888 58899999999999999999999999987421          133457776 6666999999999987541  2


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+|++|||+++++|.+++.+.  +.+++..+..++.|++.||+|||+.||+|+||||+||+++               
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---------------  140 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---------------  140 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---------------
Confidence            35788999999999999998765  3489999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCC---CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNK---ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.++|+|||.+.......   .......|+..|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus       141 ------------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  208 (265)
T cd06652         141 ------------SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP  208 (265)
T ss_pred             ------------CCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCC
Confidence                        56678999998887543211   122334678899999999888899999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      |......   .... .......  .+......+..+.++|.+|+. +|++|||++++++|||+.
T Consensus       209 ~~~~~~~---~~~~-~~~~~~~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         209 WAEFEAM---AAIF-KIATQPT--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CCccchH---HHHH-HHhcCCC--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9643211   1111 1211111  111123578889999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.3e-42  Score=316.90  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=199.2

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +.|++. +.||.|+||.||+|.+..+++.+|+|.+....       ...+|+.. ++.++||||+++++++..  .+...
T Consensus         5 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~--~~~~~   80 (293)
T cd07843           5 DEYEKL-NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINI-LLKLQHPNIVTVKEVVVG--SNLDK   80 (293)
T ss_pred             hhhhhh-hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHH-HHhcCCCCEEEEEEEEEe--cCCCc
Confidence            578885 77999999999999999999999999985321       23567776 566689999999998864  12378


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++                  
T Consensus        81 ~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~------------------  140 (293)
T cd07843          81 IYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN------------------  140 (293)
T ss_pred             EEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC------------------
Confidence            999999996 59999887644 3599999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.++|+|||++..............+++.|+|||.+.+. .++.++|+||+||++|+|++|..||....
T Consensus       141 ---------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         141 ---------NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             ---------CCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                     56779999999888765543334445678899999988654 46899999999999999999999996544


Q ss_pred             CCCCCHhHHHHHh--------------h---CCccC-----CCCcccc--cCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         247 GQAISPGMKNRIR--------------L---GQFDF-----PNPEWEH--VSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       247 ~~~~~~~~~~~~~--------------~---~~~~~-----~~~~~~~--~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      .......+.....              .   .....     .......  +++.+.++|++||+.||++|||+.|++.||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~  291 (293)
T cd07843         212 EIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP  291 (293)
T ss_pred             hHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCC
Confidence            3211111110000              0   00000     0001112  488899999999999999999999999999


Q ss_pred             cc
Q psy3151         303 WI  304 (372)
Q Consensus       303 ~~  304 (372)
                      ||
T Consensus       292 ~f  293 (293)
T cd07843         292 YF  293 (293)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.4e-42  Score=309.52  Aligned_cols=250  Identities=31%  Similarity=0.531  Sum_probs=203.5

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|.+ .+.||.|+||.||+|.+..+|..+|+|.+...       ....+|+.. ++.++|+||+++++.+..    +...
T Consensus         1 ~~~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~-l~~~~h~~i~~~~~~~~~----~~~~   74 (257)
T cd08225           1 RYEI-IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL-LAKMKHPNIVTFFASFQE----NGRL   74 (257)
T ss_pred             CceE-EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHH-HHhCCCCChhhhhheecc----CCeE
Confidence            5788 47799999999999999999999999998532       234567776 677799999999998875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+|+||+.+++|.+++.......+++..+..++.|++.||.|||+.+++|+||||+||+++.                  
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~------------------  136 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK------------------  136 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC------------------
Confidence            99999999999999997755446899999999999999999999999999999999999973                  


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              ....++++|||.+..............|++.|+|||.+....++.++|+|||||++|+|++|..||......
T Consensus       137 --------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  208 (257)
T cd08225         137 --------NGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH  208 (257)
T ss_pred             --------CCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence                    223468999998876654333333456788999999998888999999999999999999999999644321


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                          ............   +....++.++.++|.+||..+|++|||+.+++.||||
T Consensus       209 ----~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         209 ----QLVLKICQGYFA---PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ----HHHHHHhcccCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                122222222221   1113578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.5e-42  Score=315.56  Aligned_cols=254  Identities=29%  Similarity=0.510  Sum_probs=195.9

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      |+++ +.||.|+||.||+|.+..+++.||+|++...      ....+|+..+.++.+|+||+++++++.+.  ..+.+++
T Consensus         1 y~~~-~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~~~~l   77 (282)
T cd07831           1 YKIL-GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR--KTGRLAL   77 (282)
T ss_pred             CceE-eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC--CCCcEEE
Confidence            5664 6699999999999999999999999998642      12346777756666799999999998751  2267899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+. ++|.+.+.... ..+++..++.++.||+.||+|||+.|++||||||+||+++                     
T Consensus        78 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---------------------  134 (282)
T cd07831          78 VFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---------------------  134 (282)
T ss_pred             EEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---------------------
Confidence            999996 58888887643 4689999999999999999999999999999999999997                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-PDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA  249 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  249 (372)
                            . +.+||+|||++....... ......+++.|+|||.+. +..++.++|+||+||++|+|++|..||.+.+..+
T Consensus       135 ------~-~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~  206 (282)
T cd07831         135 ------D-DILKLADFGSCRGIYSKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD  206 (282)
T ss_pred             ------C-CCeEEEecccccccccCC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH
Confidence                  4 779999999887654322 223346788999999764 4567899999999999999999999996544321


Q ss_pred             CCHhHHH-----------HHhh---CCccCCCCc-------ccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         250 ISPGMKN-----------RIRL---GQFDFPNPE-------WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       250 ~~~~~~~-----------~~~~---~~~~~~~~~-------~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .......           ....   ..+.++...       ...++.++.+||.+||..||++|||++++++||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         207 QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1111100           0000   011111100       12468999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9e-42  Score=307.53  Aligned_cols=247  Identities=30%  Similarity=0.507  Sum_probs=200.0

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      +|+. .+.||.|++|+||+|.+..+++.||+|.+...          ....+|+.. ++.++|+||+++++++..    +
T Consensus         1 ~~~~-~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~----~   74 (258)
T cd06632           1 RWRK-GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIAL-LSKLQHPNIVQYLGTERE----E   74 (258)
T ss_pred             Cccc-cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHH-HHhcCCCCchheeeeEec----C
Confidence            5777 58899999999999999989999999988532          134466665 566799999999998865    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...|+++||+++++|.+++.+.  +.+++..++.++.||+.||+|||+.||+|+||+|+||+++                
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~----------------  136 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD----------------  136 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----------------
Confidence            7899999999999999999765  3589999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC-CCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                 .++.+||+|||.+....... ......|++.|+|||.+.... ++.++|+|||||++|+|++|..||..
T Consensus       137 -----------~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~  204 (258)
T cd06632         137 -----------TNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ  204 (258)
T ss_pred             -----------CCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence                       56679999999887654322 234456788999999987666 89999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ....   ............  + .....+++++.+++.+||..+|.+|||+.+++.|||+
T Consensus       205 ~~~~---~~~~~~~~~~~~--~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         205 LEGV---AAVFKIGRSKEL--P-PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             CcHH---HHHHHHHhcccC--C-CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            4321   111111111111  1 1123578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.2e-42  Score=310.13  Aligned_cols=249  Identities=26%  Similarity=0.457  Sum_probs=201.0

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++ .+.||.|+||.||+|.+..+++.||||.+...        ....+|+++ ++.++||||+++++++..    .+
T Consensus         2 ~~~~i-~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~   75 (267)
T cd08228           2 ANFQI-EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDL-LKQLNHPNVIKYLDSFIE----DN   75 (267)
T ss_pred             cceee-eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHH-HHhCCCcceeeeeeeEEE----CC
Confidence            57998 57799999999999999999999999987421        123567776 677799999999999875    56


Q ss_pred             EEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ..++|+||+.+++|.+++...  ....+++..++.++.||+.||.|||++|++|+||||+||+++               
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---------------  140 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---------------  140 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---------------
Confidence            889999999999999888642  224589999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.++|+|||++..............|++.|+|||.+.+..++.++|+||+|+++|+|++|..||..
T Consensus       141 ------------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~  208 (267)
T cd08228         141 ------------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             ------------CCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence                        56679999999887664433333445678899999999888899999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ....  .......+....  .++.....++.++.++|.+||..+|++|||+.++++
T Consensus       209 ~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         209 DKMN--LFSLCQKIEQCD--YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             cccc--HHHHHHHHhcCC--CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence            4321  122333333222  222222457889999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-41  Score=307.10  Aligned_cols=250  Identities=27%  Similarity=0.461  Sum_probs=201.5

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ||.+. +.||.|++|.||+|.+..+++.||+|.+...       ....+|+.. ++.++|+||+++++++..    .+..
T Consensus         1 ~y~~~-~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-~~~l~~~~i~~~~~~~~~----~~~~   74 (264)
T cd06626           1 RWQRG-NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKV-LELLKHPNLVKYYGVEVH----REKV   74 (264)
T ss_pred             Cceee-eEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHH-HHhCCCCChhheeeeEec----CCEE
Confidence            68884 7799999999999999999999999998632       234567766 666799999999998765    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++|+||+.+++|.+++...  +.+++..++.++.|++.||.|||+.||+|+||+|+||+++                   
T Consensus        75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~-------------------  133 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD-------------------  133 (264)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-------------------
Confidence            9999999999999998764  3589999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcc----cccccCCCcCCCcccCCCC---CCCccchhhHHHHHHHHHhCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASL----QTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p  241 (372)
                              .++.+||+|||++..........    ....+++.|+|||.+....   ++.++|+|||||++|+|++|..|
T Consensus       134 --------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~p  205 (264)
T cd06626         134 --------HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP  205 (264)
T ss_pred             --------CCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCC
Confidence                    56779999999887764432221    2346788999999987765   88999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      |......   ......+..+ .....+.+..++..+.++|.+||+.+|.+|||+.+++.|||+
T Consensus       206 f~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         206 WSELDNE---FQIMFHVGAG-HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ccCCcch---HHHHHHHhcC-CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9644311   1122222221 111222334568999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-42  Score=313.53  Aligned_cols=253  Identities=26%  Similarity=0.370  Sum_probs=202.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|+++ +.||+|+||+||+|.+..+|+.||+|++...      ....+|+++ ++.++||||+++++.+..    ...+
T Consensus         5 ~~~~~~-~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~~~~   78 (284)
T cd06620           5 EDLETI-SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQI-MHECRSPYIVSFYGAFLN----ENNI   78 (284)
T ss_pred             HHHHHH-HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHH-HHHcCCCCcceEeeeEec----CCEE
Confidence            678885 6799999999999999999999999987532      234567776 556699999999999876    5789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      |+||||+++++|.+++...  +.+++..++.++.|++.||.|||+ .|++||||||+||+++                  
T Consensus        79 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~------------------  138 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN------------------  138 (284)
T ss_pred             EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC------------------
Confidence            9999999999999988764  459999999999999999999997 5999999999999997                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.++|+|||++......  .....+|+..|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus       139 ---------~~~~~~l~d~gl~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~  207 (284)
T cd06620         139 ---------SRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI  207 (284)
T ss_pred             ---------CCCcEEEccCCcccchhhh--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence                     5677999999988654321  12345789999999999888899999999999999999999999975443


Q ss_pred             CC----CCHhH---HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         248 QA----ISPGM---KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       248 ~~----~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      ..    ....+   ...+....  .+......++.++.+|+.+||..||.+|||+.++++|+||.+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         208 DDDGQDDPMGILDLLQQIVQEP--PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             hhhhhhhhhHHHHHHHHHhhcc--CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            21    11111   11111111  111111237889999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0577|consensus

Probab=100.00  E-value=3e-43  Score=328.23  Aligned_cols=247  Identities=27%  Similarity=0.426  Sum_probs=207.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc--------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD--------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ..|.-+.+ ||.|+||.||-|.+..+.+.||||.+..        -.+...|+.. ++.+.|||++.+.+||..    +.
T Consensus        26 klf~dLrE-IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrF-L~~l~HPntieYkgCyLr----e~   99 (948)
T KOG0577|consen   26 KLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRF-LRQLRHPNTIEYKGCYLR----EH   99 (948)
T ss_pred             HHHHHHHH-hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHH-HHhccCCCcccccceeec----cc
Confidence            34554545 9999999999999999999999999863        2356788887 777899999999999975    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..++|||||- |+-.+++.-.+ +++-+.++..|..+.+.||+|||+.+.||||||..|||++                 
T Consensus       100 TaWLVMEYCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs-----------------  160 (948)
T KOG0577|consen  100 TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS-----------------  160 (948)
T ss_pred             hHHHHHHHHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec-----------------
Confidence            7899999995 58888887665 5699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc---CCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                +.|.||++|||.|....    ...+.+|||.|||||++   ..+.|+-++||||||+++.||...++|++
T Consensus       161 ----------e~g~VKLaDFGSAsi~~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF  226 (948)
T KOG0577|consen  161 ----------EPGLVKLADFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  226 (948)
T ss_pred             ----------CCCeeeeccccchhhcC----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence                      78889999999987643    35678999999999987   45789999999999999999999999987


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      +.+.      +.......+-+.|.......|..+++||..||++-|..|||.+++|.|+|+..
T Consensus       227 nMNA------MSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  227 NMNA------MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             CchH------HHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence            6543      22233333333333333457899999999999999999999999999999865

>KOG4721|consensus

Probab=100.00  E-value=3.1e-43  Score=326.90  Aligned_cols=237  Identities=26%  Similarity=0.428  Sum_probs=198.5

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchh
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELF  101 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~  101 (372)
                      +-||+|+.|.||+|+..  ++.||||.++.  ...-+|. .++.++||||+.+.+++..    ...++||||||..|.|+
T Consensus       130 eWlGSGaQGAVF~Grl~--netVAVKKV~e--lkETdIK-HLRkLkH~NII~FkGVCtq----sPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH--NETVAVKKVRE--LKETDIK-HLRKLKHPNIITFKGVCTQ----SPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhccCcccceeeeecc--CceehhHHHhh--hhhhhHH-HHHhccCcceeeEeeeecC----CceeEEeeeccccccHH
Confidence            45999999999999975  89999997752  1222343 3788899999999999865    67899999999999999


Q ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCe
Q psy3151         102 QRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL  181 (372)
Q Consensus       102 ~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  181 (372)
                      +.++..  ..++......|..+|+.|++|||...|||||||.-||||+                           .+..|
T Consensus       201 ~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---------------------------~~d~V  251 (904)
T KOG4721|consen  201 EVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---------------------------YDDVV  251 (904)
T ss_pred             HHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---------------------------ccceE
Confidence            999865  4599999999999999999999999999999999999998                           56679


Q ss_pred             eeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhC
Q psy3151         182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG  261 (372)
Q Consensus       182 ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  261 (372)
                      ||+|||-++..... ......+||..|||||++...+.+.++|||||||+||||+||..||.+-+...+..++-    ..
T Consensus       252 KIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG----sN  326 (904)
T KOG4721|consen  252 KISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG----SN  326 (904)
T ss_pred             EeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc----CC
Confidence            99999988876543 44556899999999999999999999999999999999999999997665544433322    22


Q ss_pred             CccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         262 QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       262 ~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      .+.+|.|  ..+++-++=||++||.-.|..|||+.++|.|-=
T Consensus       327 sL~LpvP--stcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  327 SLHLPVP--STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             cccccCc--ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            2334433  378899999999999999999999999999843

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-42  Score=317.71  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=199.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|+++ +.||.|+||.||+|.+..+++.||+|.+...       ....+|+++ ++.++||||+++++++..    +..
T Consensus         1 ~~y~~~-~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~   74 (286)
T cd07846           1 EKYENL-GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRM-LKQLRHENLVNLIEVFRR----KKR   74 (286)
T ss_pred             CceeEe-eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHH-HHhcCCcchhhHHHhccc----CCe
Confidence            478885 7799999999999999999999999987532       234567776 566799999999999875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+.+++|.++....  ..+++..++.++.||+.||+|||+.|++|+||+|+||+++                  
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~------------------  134 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS------------------  134 (286)
T ss_pred             EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC------------------
Confidence            99999999998888776543  3489999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.++++|||++..............++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||....
T Consensus       135 ---------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~  205 (286)
T cd07846         135 ---------QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS  205 (286)
T ss_pred             ---------CCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence                     5677999999998876443333444567889999998865 457889999999999999999999986543


Q ss_pred             CCCCCHhHHHHH----------hh-----CCccCCC--------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         247 GQAISPGMKNRI----------RL-----GQFDFPN--------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       247 ~~~~~~~~~~~~----------~~-----~~~~~~~--------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      ..+....+....          ..     .....+.        .....++..+.+|+.+||..+|++|||+.++++|||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         206 DIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             hHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence            211100000000          00     0000000        012357889999999999999999999999999999


Q ss_pred             c
Q psy3151         304 I  304 (372)
Q Consensus       304 ~  304 (372)
                      |
T Consensus       286 ~  286 (286)
T cd07846         286 F  286 (286)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.3e-42  Score=321.31  Aligned_cols=251  Identities=22%  Similarity=0.389  Sum_probs=197.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .++|++. +.||.|+||.||+|.+.     .+++.||+|++...      ....+|+..+.++.+|+||+++++++..  
T Consensus         6 ~~~~~i~-~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~--   82 (337)
T cd05054           6 RDRLKLG-KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK--   82 (337)
T ss_pred             HHHhhhh-cccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec--
Confidence            5799994 88999999999999754     34689999998632      2345688876666689999999998753  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccC-----------------------------------------------------
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKED-----------------------------------------------------  109 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~-----------------------------------------------------  109 (372)
                       .+..++++|||+.+++|.+++.....                                                     
T Consensus        83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence             25678999999999999999865321                                                     


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeee
Q psy3151         110 ------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL  183 (372)
Q Consensus       110 ------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki  183 (372)
                            ..+++..+..++.||+.||+|||++||+||||||+||+++                           .++.++|
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---------------------------~~~~vkL  214 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---------------------------ENNVVKI  214 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---------------------------CCCcEEE
Confidence                  2588999999999999999999999999999999999998                           5667999


Q ss_pred             eccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhh
Q psy3151         184 TDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL  260 (372)
Q Consensus       184 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~  260 (372)
                      +|||++.........  .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+   .....+..
T Consensus       215 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~  291 (337)
T cd05054         215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKE  291 (337)
T ss_pred             eccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhc
Confidence            999999876432221  222344668999999988999999999999999999998 999996543221   22222222


Q ss_pred             CCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       261 ~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      +.....   ....++++.+++.+||+.+|++|||+.++++|
T Consensus       292 ~~~~~~---~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         292 GTRMRA---PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             cCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            221111   13578999999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-42  Score=314.55  Aligned_cols=255  Identities=33%  Similarity=0.519  Sum_probs=199.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|++. +.||.|++|.||+|.+..+++.||||++...       ....+|++. ++.++|+||+++++++..    ++.
T Consensus         1 ~~y~~~-~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~   74 (288)
T cd07833           1 NKYEVL-GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKV-LRQLRHENIVNLKEAFRR----KGR   74 (288)
T ss_pred             CceeEE-EEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHH-HHhcCCCCeeehhheEEE----CCE
Confidence            479985 7799999999999999999999999988532       245677777 566689999999999976    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .++||||+.++.+..+..+.  ..+++..++.++.||+.||.|||+.|++|+||+|+||+++                  
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~------------------  134 (288)
T cd07833          75 LYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS------------------  134 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC------------------
Confidence            99999999876665555433  4599999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                               .++.++|+|||++........ ......++..|+|||++.+. .++.++|+||||+++|+|++|..||.+.
T Consensus       135 ---------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         135 ---------ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             ---------CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                     567799999999887654332 33446778999999999777 7899999999999999999999999654


Q ss_pred             CCCCCCHhHHHHH----------h--hC---CccCCCC---------cccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         246 HGQAISPGMKNRI----------R--LG---QFDFPNP---------EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       246 ~~~~~~~~~~~~~----------~--~~---~~~~~~~---------~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ...+.........          .  ..   ...++..         ....++.++.+||++||..+|++|||+++++.|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         206 SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             CHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            3211100000000          0  00   0000000         011348899999999999999999999999999


Q ss_pred             Ccc
Q psy3151         302 KWI  304 (372)
Q Consensus       302 p~~  304 (372)
                      |||
T Consensus       286 ~~f  288 (288)
T cd07833         286 PYF  288 (288)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-42  Score=313.71  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=197.8

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      |+++ +.||.|++|.||+|.+..+|..||+|++...       ....+|+.. ++.++|||++++++++..    +...|
T Consensus         1 y~~~-~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~-l~~l~~~~iv~~~~~~~~----~~~~~   74 (283)
T cd07835           1 YQKV-EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISL-LKELNHPNIVRLLDVVHS----ENKLY   74 (283)
T ss_pred             Cchh-eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHH-HHhcCCCCccCHhheecc----CCeEE
Confidence            5664 6799999999999999999999999998632       234568776 667789999999999875    67899


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      ++|||++ ++|.+++.......+++..++.++.|++.||+|||+.+++||||+|+||+++                    
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~--------------------  133 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID--------------------  133 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc--------------------
Confidence            9999995 6999998775534699999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                             .++.++|+|||++..............+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..
T Consensus       134 -------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  206 (283)
T cd07835         134 -------REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI  206 (283)
T ss_pred             -------CCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                   5667899999988765433323334456889999998755 45789999999999999999999999654321


Q ss_pred             CCCHhHHHH---------------------HhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNR---------------------IRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~---------------------~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .....+...                     ...............++.++.++|.+||+.||.+|||+++++.||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         207 DQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            110000000                     00000000011123577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.7e-42  Score=311.09  Aligned_cols=245  Identities=20%  Similarity=0.340  Sum_probs=194.0

Q ss_pred             cceeeccccccccCCeEEEEEEEc---CCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ++|++ .+.||+|+||.||+|.+.   ..+..||+|.+....      ...+|+.. +..++||||+++++++..    +
T Consensus         5 ~~~~~-~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~----~   78 (266)
T cd05064           5 KSIKI-ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALT-LGQFDHSNIVRLEGVITR----G   78 (266)
T ss_pred             HHeEE-eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHH-HhcCCCCCcCeEEEEEec----C
Confidence            56888 588999999999999875   456799999986431      23456665 556799999999999875    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...++||||+.+|+|.+++.... +.+++..++.++.||+.||+|||++|++||||||+||+++                
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~----------------  141 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN----------------  141 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc----------------
Confidence            78999999999999999987643 4689999999999999999999999999999999999997                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFF  243 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~  243 (372)
                                 .++.++++|||.+......... .....++..|+|||.+.+..++.++|||||||++|++++ |..||.
T Consensus       142 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~  210 (266)
T cd05064         142 -----------SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             -----------CCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence                       5667889999876654221111 112234568999999988999999999999999999775 999997


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .....    .+...+..+ ...+.  ...++..+.+++.+||+.+|.+|||++++++
T Consensus       211 ~~~~~----~~~~~~~~~-~~~~~--~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         211 DMSGQ----DVIKAVEDG-FRLPA--PRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             cCCHH----HHHHHHHCC-CCCCC--CCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            65432    223333322 12222  2468899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-41  Score=309.93  Aligned_cols=250  Identities=28%  Similarity=0.461  Sum_probs=203.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +-|+++ +.||.|+||.||+|.+..+++.||||++...      ....+|+.. +..++||||+++++++..    +...
T Consensus         4 ~~~~~~-~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~----~~~~   77 (277)
T cd06641           4 ELFTKL-EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV-LSQCDSPYVTKYYGSYLK----DTKL   77 (277)
T ss_pred             Hhhhhh-eeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHH-HHhcCCCCEeEEEEEEEe----CCeE
Confidence            456675 6699999999999999999999999997532      134456665 566799999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+++|.+++..   +.+++..+..++.|++.|+.+||+.|++|+||||+||+++                   
T Consensus        78 ~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~-------------------  135 (277)
T cd06641          78 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS-------------------  135 (277)
T ss_pred             EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC-------------------
Confidence            999999999999998864   3589999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++|+|||++..............++..|+|||.+.+..++.++|+|||||++|+|++|..||......
T Consensus       136 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  207 (277)
T cd06641         136 --------EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM  207 (277)
T ss_pred             --------CCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH
Confidence                    566799999998876544333334456788999999998888899999999999999999999999643321


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                          .....+.....+   .....++.++.+++.+||..+|.+||++.+++.||||.+.
T Consensus       208 ----~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         208 ----KVLFLIPKNNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ----HHHHHHhcCCCC---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                122222222111   1123578999999999999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.9e-42  Score=323.51  Aligned_cols=266  Identities=26%  Similarity=0.432  Sum_probs=200.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG--   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~--   84 (372)
                      .+.++|.+. +.||.|+||+||+|.+..+|+.||+|.+...     ....+|+++ ++.++||||+++++++......  
T Consensus         2 ~~~~~y~~~-~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~-l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           2 DLGSRYMDL-RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKI-IRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             CcCcceEEE-EEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHH-HHhcCCCcchhhHhhhcccccccc
Confidence            367899995 7799999999999999999999999998532     234567777 5667999999999887642211  


Q ss_pred             --------ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCc
Q psy3151          85 --------SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        85 --------~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                              ....|+||||+. ++|.+++..   +.+++..++.++.||+.||.|||+.||+||||||+||+++.      
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~------  149 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT------  149 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC------
Confidence                    236899999996 589888754   35999999999999999999999999999999999999973      


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC---CcccccccCCCcCCCcccCC-CCCCCccchhhHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK---ASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIM  232 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il  232 (372)
                                          .++.++++|||.+.......   .......++..|+|||.+.. ..++.++|+|||||++
T Consensus       150 --------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil  209 (342)
T cd07854         150 --------------------EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF  209 (342)
T ss_pred             --------------------CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHH
Confidence                                34568899999887653211   11223457889999998644 5688999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCHhHHH-------------------HHh--hCCccCCC-CcccccCHHHHHHHHHhccCCCC
Q psy3151         233 YILLCGFPPFFSNHGQAISPGMKN-------------------RIR--LGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPS  290 (372)
Q Consensus       233 ~~ll~g~~pf~~~~~~~~~~~~~~-------------------~~~--~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~  290 (372)
                      |+|++|..||..............                   ...  ......+. .....++.++.+||.+||+.||.
T Consensus       210 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  289 (342)
T cd07854         210 AEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM  289 (342)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCch
Confidence            999999999965432111000000                   000  00000000 00124788999999999999999


Q ss_pred             CCCChhHHhcCCccccCCC
Q psy3151         291 ERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       291 ~R~s~~eil~hp~~~~~~~  309 (372)
                      +|||+.+++.||||+.+..
T Consensus       290 ~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         290 DRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             hccCHHHHhCCCccccccC
Confidence            9999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-41  Score=319.52  Aligned_cols=269  Identities=28%  Similarity=0.484  Sum_probs=205.9

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ..+.++|++. +.||.|+||.||+|.+..+|+.+|+|.+...       ....+|+..+.++.+||||+++++++..  .
T Consensus         3 ~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~--~   79 (337)
T cd07852           3 KHILRKYEIL-QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA--E   79 (337)
T ss_pred             chhhhHHHHh-HhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc--C
Confidence            3578899994 7899999999999999999999999987421       2345678774444499999999998753  2


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      +....|+||||+. ++|..++...   .+++..++.++.||+.||.|||+.||+||||||+||+++              
T Consensus        80 ~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~--------------  141 (337)
T cd07852          80 NDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN--------------  141 (337)
T ss_pred             CCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc--------------
Confidence            2457899999996 5999888653   589999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCC-----CcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHh
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-----ASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~  237 (372)
                                   .++.+||+|||++.......     .......||+.|+|||.+.+ ..++.++|+|||||++|+|++
T Consensus       142 -------------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t  208 (337)
T cd07852         142 -------------SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL  208 (337)
T ss_pred             -------------CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh
Confidence                         56779999999887654322     12234567899999998754 567899999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHH-----------------------HHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC
Q psy3151         238 GFPPFFSNHGQAISPGMKN-----------------------RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT  294 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s  294 (372)
                      |+.||.+.........+..                       .+..............++.++.++|.+||+.||++|||
T Consensus       209 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps  288 (337)
T cd07852         209 GKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT  288 (337)
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC
Confidence            9999965432211000000                       00000000001112347899999999999999999999


Q ss_pred             hhHHhcCCccccCCCCCCC
Q psy3151         295 IDQVMENKWISQFNQVPQT  313 (372)
Q Consensus       295 ~~eil~hp~~~~~~~~~~~  313 (372)
                      +.++++|||++++......
T Consensus       289 ~~~il~~~~~~~~~~~~~~  307 (337)
T cd07852         289 AEEALEHPYVAQFHNPSDE  307 (337)
T ss_pred             HHHHhhChhhhhhccCCCC
Confidence            9999999999988654433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-41  Score=311.66  Aligned_cols=255  Identities=28%  Similarity=0.480  Sum_probs=198.6

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +|+++ +.||.|++|.||+|.+..+|+.||||++...      ....+|+.. ++.++||||+++++++..    .+..+
T Consensus         1 ~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~~~~~   74 (284)
T cd07836           1 NFKQL-EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISL-MKELKHENIVRLHDVIHT----ENKLM   74 (284)
T ss_pred             CceEe-eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHH-HHhhcCCCEeeeeeeEee----CCcEE
Confidence            47885 6799999999999999999999999998632      344577776 556699999999999876    57789


Q ss_pred             EEEeccCCCchhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          90 VIMECMHGGELFQRIQQKE-DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~-~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      +||||+.+ +|.+++.... ...+++..+..++.||+.||+|||+.|++||||||+||+++                   
T Consensus        75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~-------------------  134 (284)
T cd07836          75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN-------------------  134 (284)
T ss_pred             EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC-------------------
Confidence            99999975 8988887543 24589999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                              .++.++++|||++..............+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.
T Consensus       135 --------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  206 (284)
T cd07836         135 --------KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN  206 (284)
T ss_pred             --------CCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence                    5677999999988765433333344567889999998755 4578999999999999999999999976543


Q ss_pred             CCCCHhHHHH-----------Hhh-CCc--cCCCC-------cccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         248 QAISPGMKNR-----------IRL-GQF--DFPNP-------EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       248 ~~~~~~~~~~-----------~~~-~~~--~~~~~-------~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .+....+...           +.. ..+  ..+..       .....+.+++++|.+||+.||.+|||++++++||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         207 EDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             HHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            2211111100           000 000  00000       012457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-42  Score=339.58  Aligned_cols=261  Identities=20%  Similarity=0.272  Sum_probs=189.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCC-cEEEEE------------------Eecc----hhhhHHHHHHHHHhcCCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTS-EVYALK------------------VLHD----TVKARREVELQLAVGSHK   69 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~----~~~~~~e~~~~~~~~~h~   69 (372)
                      +.++|+++ +.||+|+||+||+|..+... ...++|                  .+..    .....+|+.+ +..++||
T Consensus       146 ~~~~Y~ii-~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~i-l~~l~Hp  223 (501)
T PHA03210        146 FLAHFRVI-DDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILA-LGRLNHE  223 (501)
T ss_pred             hhhccEEE-eEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHH-HHhCCCC
Confidence            56789996 66999999999998764322 222222                  1111    1223567776 6677999


Q ss_pred             CEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q psy3151          70 HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE---DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENL  146 (372)
Q Consensus        70 ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~---~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NI  146 (372)
                      ||+++++++..    ....|+|++++ +++|.+++....   ........++.++.||+.||+|||++||+||||||+||
T Consensus       224 nIv~l~~~~~~----~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI  298 (501)
T PHA03210        224 NILKIEEILRS----EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI  298 (501)
T ss_pred             CcCcEeEEEEE----CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            99999999976    56789999999 458888775422   12245677889999999999999999999999999999


Q ss_pred             eeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccch
Q psy3151         147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDI  225 (372)
Q Consensus       147 li~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di  225 (372)
                      |++                           .++.+||+|||++........ .....+||+.|+|||++.+..++.++||
T Consensus       299 Ll~---------------------------~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  351 (501)
T PHA03210        299 FLN---------------------------CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDI  351 (501)
T ss_pred             EEC---------------------------CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHH
Confidence            998                           567799999999987644322 2234678999999999998999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhC---CccCCC----------------------C--cccccCHHHH
Q psy3151         226 WSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG---QFDFPN----------------------P--EWEHVSQEAK  278 (372)
Q Consensus       226 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~----------------------~--~~~~~s~~~~  278 (372)
                      |||||++|+|++|..++...........+...+...   ...++.                      .  ....++.++.
T Consensus       352 wSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  431 (501)
T PHA03210        352 WSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFE  431 (501)
T ss_pred             HHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHH
Confidence            999999999999876543322211111111111100   000000                      0  0123567888


Q ss_pred             HHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         279 TLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       279 ~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ++|.+||++||.+|||+.|+|.||||...
T Consensus       432 ~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        432 YPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            99999999999999999999999999764

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-42  Score=319.54  Aligned_cols=267  Identities=27%  Similarity=0.438  Sum_probs=207.0

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec-CCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY-NGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~-~~~~~   87 (372)
                      +|++ .+.||.|++|.||+|.+..+|+.||||.+...       ....+|+.. ++.++|+||+++.+++.... .....
T Consensus         1 ~y~i-~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYEL-LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKL-LRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             Ccee-eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHH-HHhcCCcchhhhhhhhcccCcccccc
Confidence            6888 47899999999999999999999999988642       245567777 56668999999999886522 12347


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|++|||+. ++|.+++...  ..+++..++.++.||+.||+|||+.||+||||||+||+++                  
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~------------------  137 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN------------------  137 (330)
T ss_pred             eEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc------------------
Confidence            899999996 5898888654  3699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCC---CcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNK---ASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                               .++.++|+|||++.......   .......+|+.|+|||.+.+. .++.++|+|||||++|+|++|.+||.
T Consensus       138 ---------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~  208 (330)
T cd07834         138 ---------SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP  208 (330)
T ss_pred             ---------CCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence                     56789999999988765433   123445678899999999777 78999999999999999999999996


Q ss_pred             CCCCCCCCHhHHHH--------------------HhhCCccCCC---CcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         244 SNHGQAISPGMKNR--------------------IRLGQFDFPN---PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       244 ~~~~~~~~~~~~~~--------------------~~~~~~~~~~---~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +....+....+...                    +.......+.   .....++.++.+||.+||+++|.+|||+++++.
T Consensus       209 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         209 GRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             CCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            65432111111000                    0000000000   001236889999999999999999999999999


Q ss_pred             CCccccCCCCCCCC
Q psy3151         301 NKWISQFNQVPQTP  314 (372)
Q Consensus       301 hp~~~~~~~~~~~~  314 (372)
                      ||||+++...+..+
T Consensus       289 ~~~~~~~~~~~~~~  302 (330)
T cd07834         289 HPYLAQLHDPEDEP  302 (330)
T ss_pred             CccHHhhcccccCC
Confidence            99999887654443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.4e-42  Score=312.13  Aligned_cols=247  Identities=23%  Similarity=0.368  Sum_probs=198.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCC-----cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTS-----EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ++|+++ +.||+|+||.||+|.+...+     ..+|+|.+...      ....+|+.. +..++||||+++++++..   
T Consensus         5 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~-l~~l~h~~i~~~~~~~~~---   79 (283)
T cd05048           5 SAVRFL-EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL-MSDLQHPNIVCLLGVCTK---   79 (283)
T ss_pred             HHcchh-hcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHH-HHhcCCcccceEEEEEcC---
Confidence            478885 67999999999999986655     78999998632      123567776 566799999999998875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeee
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKED--------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYT  149 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~--------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~  149 (372)
                       ....|++|||+.+++|.+++.....              ..+++..++.++.||+.||.|||+.|++||||||+||+++
T Consensus        80 -~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 -EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG  158 (283)
T ss_pred             -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence             5678999999999999999976421              4588999999999999999999999999999999999998


Q ss_pred             cCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhh
Q psy3151         150 KPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWS  227 (372)
Q Consensus       150 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  227 (372)
                                                 +++.++|+|||++........  ......+++.|+|||.+.+..++.++|+||
T Consensus       159 ---------------------------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s  211 (283)
T cd05048         159 ---------------------------EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWS  211 (283)
T ss_pred             ---------------------------CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHH
Confidence                                       566799999999876533221  123345678899999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         228 LGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       228 lG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||++|+|++ |..||.+....    .+...+..+...   +....++.++.+|+.+||+.||.+|||+.+++++
T Consensus       212 lG~il~el~~~g~~p~~~~~~~----~~~~~i~~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         212 FGVVLWEIFSYGLQPYYGFSNQ----EVIEMIRSRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHH----HHHHHHHcCCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999998 99999765432    233334333222   1124689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.8e-41  Score=314.17  Aligned_cols=261  Identities=26%  Similarity=0.423  Sum_probs=196.8

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC-
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN-   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~-   83 (372)
                      ...++|++. +.||.|+||.||+|.+..+++.||||.+...       ....+|+.. ++.++||||+++++++..... 
T Consensus         9 ~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865           9 DEVSKYEKL-AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKI-LQLLKHENVVNLIEICRTKATP   86 (310)
T ss_pred             chhhheEEE-EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHH-HHhCCCCCccceEEEEeccccc
Confidence            355789995 7799999999999999999999999988532       123567776 667799999999998764211 


Q ss_pred             ---CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          84 ---GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        84 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                         .....|+||||+. ++|.+.+.... ..+++.+++.++.||+.||.|||+.|++|+||||+||+++           
T Consensus        87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~-----------  153 (310)
T cd07865          87 YNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT-----------  153 (310)
T ss_pred             ccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC-----------
Confidence               1346799999995 58888876543 4689999999999999999999999999999999999998           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHH
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l  235 (372)
                                      .++.+||+|||++........    ......++..|+|||.+.+. .++.++|+||||+++|+|
T Consensus       154 ----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el  217 (310)
T cd07865         154 ----------------KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM  217 (310)
T ss_pred             ----------------CCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHH
Confidence                            567799999998876533221    12334568889999987654 478899999999999999


Q ss_pred             HhCCCCCCCCCCCCCCHhHHHHHhh----------------CCccCCCCc---------ccccCHHHHHHHHHhccCCCC
Q psy3151         236 LCGFPPFFSNHGQAISPGMKNRIRL----------------GQFDFPNPE---------WEHVSQEAKTLIKNMLCVDPS  290 (372)
Q Consensus       236 l~g~~pf~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~---------~~~~s~~~~~li~~ll~~dP~  290 (372)
                      ++|..||.+.+...... ....+..                .....+...         ....+..+.+||.+||..||.
T Consensus       218 ~t~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~  296 (310)
T cd07865         218 WTRSPIMQGNTEQHQLT-LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA  296 (310)
T ss_pred             HhCCCCCCCCCHHHHHH-HHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChh
Confidence            99999996543221100 0000000                000011000         012357788999999999999


Q ss_pred             CCCChhHHhcCCcc
Q psy3151         291 ERLTIDQVMENKWI  304 (372)
Q Consensus       291 ~R~s~~eil~hp~~  304 (372)
                      +|||++++++||||
T Consensus       297 ~R~t~~e~l~h~~f  310 (310)
T cd07865         297 KRIDADTALNHDFF  310 (310)
T ss_pred             hccCHHHHhcCCCC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.4e-41  Score=307.09  Aligned_cols=244  Identities=32%  Similarity=0.556  Sum_probs=199.6

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      ||.|+||.||+|.+..+|+.+|+|++....        ...+|+.. ++.++||||+++++.+..    +...|+++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI-LSQAQSPYVVKLYYSFQG----KKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHH-HHhCCCcchhHHHHheec----CcEEEEEEecC
Confidence            689999999999999999999999986322        34456665 566689999999988865    67899999999


Q ss_pred             CCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151          96 HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus        96 ~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                      .+++|.+++.+..  .+++..++.++.||+.||.|||+.|++|+||+|+||+++                          
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~--------------------------  127 (265)
T cd05579          76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID--------------------------  127 (265)
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc--------------------------
Confidence            9999999997653  599999999999999999999999999999999999998                          


Q ss_pred             CCCCCeeeeccccccccccCCC--------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKA--------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                       .++.++|+|||++........        ......+++.|+|||.+....++.++|+||||+++|+|++|..||.....
T Consensus       128 -~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~  206 (265)
T cd05579         128 -SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP  206 (265)
T ss_pred             -CCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence             566788888888775433211        22334678889999999888899999999999999999999999965432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh---hHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI---DQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~---~eil~hp~~~~~  307 (372)
                          ......+..+....+.  ...++.++.+++.+||+.+|.+|||+   .++|+||||+++
T Consensus       207 ----~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         207 ----EEIFQNILNGKIEWPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             ----HHHHHHHhcCCcCCCc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence                2333444444443332  12358999999999999999999999   999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.8e-41  Score=310.24  Aligned_cols=254  Identities=30%  Similarity=0.559  Sum_probs=202.6

Q ss_pred             ceeeccccccccCCeEEEEEEEc---CCCcEEEEEEecch---------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          16 DYDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHDT---------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      .|++ .+.||.|+||.||+|.+.   .+|+.||+|++...         ....+|+.++..+.+|+||+.++++|+.   
T Consensus         1 ~y~~-~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---   76 (290)
T cd05613           1 NFEL-LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---   76 (290)
T ss_pred             Ccee-eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec---
Confidence            4777 477999999999999885   47899999998632         2234577775555579999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       +...|+||||+++++|.+++...  ..+++..+..++.||+.||.|||+.|++||||+|+||+++              
T Consensus        77 -~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~--------------  139 (290)
T cd05613          77 -DTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD--------------  139 (290)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC--------------
Confidence             67899999999999999999765  3589999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCC--CCCCCccchhhHHHHHHHHHhCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                   .++.++|+|||++....... .......|+..|+|||.+..  ..++.++|+|||||++|+|++|..
T Consensus       140 -------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~  206 (290)
T cd05613         140 -------------SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS  206 (290)
T ss_pred             -------------CCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCC
Confidence                         56779999999887653322 12234567889999999864  347789999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      ||...........+...+.....+.+    ..+++.+.+++.+||..||++||     ++++++.||||+..
T Consensus       207 p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         207 PFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             CCCcCCccccHHHHHHHhhccCCCCC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            99644332222233333333322222    35789999999999999999997     89999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-41  Score=307.54  Aligned_cols=249  Identities=25%  Similarity=0.456  Sum_probs=200.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++ .+.||.|++|.||+|.+..+|+.+|||.+...        ....+|+.+ ++.++||||+++++++..    +.
T Consensus         2 ~~y~~-~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~----~~   75 (267)
T cd08229           2 ANFRI-EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDL-LKQLNHPNVIKYYASFIE----DN   75 (267)
T ss_pred             chhhh-hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHH-HHHccCCchhhhhheeEe----CC
Confidence            57888 47799999999999999999999999987531        133456766 566799999999999875    67


Q ss_pred             EEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ..+++|||+++++|.+++...  ....+++..++.++.||+.||.|||++|++|+||||+||+++               
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---------------  140 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---------------  140 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---------------
Confidence            899999999999999988742  224689999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.++++|||++..............|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+
T Consensus       141 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  208 (267)
T cd08229         141 ------------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             ------------CCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence                        56779999999887664433333445788999999999888899999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .....  ......+...  ..++.....++.++.+++.+||..||.+|||+.++++
T Consensus       209 ~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         209 DKMNL--YSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ccchH--HHHhhhhhcC--CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            43211  1222222222  2222223468899999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4e-41  Score=302.80  Aligned_cols=249  Identities=33%  Similarity=0.570  Sum_probs=205.9

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|.+. +.||.|++|.||+|.+..+++.||+|++...       ....+|++. ++.++|||++++.+.+..    +...
T Consensus         1 ~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~~~~~~~~~~~----~~~~   74 (258)
T cd08215           1 KYEII-KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKI-LKKLNHPNIIKYYESFEE----KGKL   74 (258)
T ss_pred             CceEE-eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHH-HHhcCCCChhheEEEEec----CCEE
Confidence            58884 7799999999999999999999999998632       234567766 566689999999998875    5789


Q ss_pred             EEEEeccCCCchhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          89 LVIMECMHGGELFQRIQQKE--DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~--~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ++|+||+++++|.+++....  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++                 
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~-----------------  137 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT-----------------  137 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc-----------------
Confidence            99999999999999998743  35699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.++|+|||.+..............|++.|+|||.+....++.++|+||+|+++++|++|..||....
T Consensus       138 ----------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  207 (258)
T cd08215         138 ----------SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN  207 (258)
T ss_pred             ----------CCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence                      5677999999998776544333444578899999999988889999999999999999999999995443


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .    ..+..........   +....++.++.+++.+||..+|++|||+.++|+||||
T Consensus       208 ~----~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         208 L----LELALKILKGQYP---PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             H----HHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            2    2223333222221   1113678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.5e-41  Score=310.11  Aligned_cols=254  Identities=25%  Similarity=0.397  Sum_probs=202.2

Q ss_pred             CccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151           8 FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus         8 ~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      +....+..+|.+. +.||+|+||+||+|.+..+|+.||+|++...        ....+|++. ++.++||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~-~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~h~niv~~~~~~~   85 (307)
T cd06607           8 FSKDDPEKLFTDL-REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRF-LQQLRHPNTIEYKGCYL   85 (307)
T ss_pred             hcCCCcchhhhhh-eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHH-HHhCCCCCEEEEEEEEE
Confidence            3445567889985 7799999999999999999999999988521        234567776 66679999999999987


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      .    +...|+||||+. |++.+.+.... +.+++..+..++.||+.||.|||+.||+||||+|+||+++          
T Consensus        86 ~----~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~----------  149 (307)
T cd06607          86 R----EHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT----------  149 (307)
T ss_pred             e----CCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC----------
Confidence            6    667899999996 57777776543 4599999999999999999999999999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC---CCCCCCccchhhHHHHHHHHH
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll  236 (372)
                                       +++.++|+|||++.....    .....+++.|+|||++.   ...++.++|+||||+++|+|+
T Consensus       150 -----------------~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~  208 (307)
T cd06607         150 -----------------EPGTVKLADFGSASLVSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  208 (307)
T ss_pred             -----------------CCCCEEEeecCcceecCC----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHH
Confidence                             567799999998875432    23346788999999873   456889999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      +|..||.+.....    ....+...  ..+......++.++.++|.+||..||.+|||+.+++.||||..
T Consensus       209 tg~~p~~~~~~~~----~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         209 ERKPPLFNMNAMS----ALYHIAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             cCCCCCCCccHHH----HHHHHhcC--CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            9999996543211    11111111  1111112346889999999999999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.4e-41  Score=307.74  Aligned_cols=258  Identities=29%  Similarity=0.469  Sum_probs=210.3

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .....+.|++. +.||.|++|.||+|.+..+++.+|+|++....    ...+|++. ++.++|+||+++++.+..    +
T Consensus        14 ~~~~~~~~~~~-~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~   87 (286)
T cd06614          14 EGDPRELYKNL-EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILI-MKDCKHPNIVDYYDSYLV----G   87 (286)
T ss_pred             CCCccccchHh-HhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHH-HHHCCCCCeeEEEEEEEE----C
Confidence            34577889885 78999999999999999899999999997432    45567776 677799999999999876    5


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...|+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++                
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~----------------  150 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS----------------  150 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc----------------
Confidence            78999999999999999998764 3699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.++|+|||.+..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus       151 -----------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~  219 (286)
T cd06614         151 -----------KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE  219 (286)
T ss_pred             -----------CCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence                       566799999998776544333334445788999999998888999999999999999999999999643


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      ....    ....+..... .+......++.++.++|.+||+.+|.+|||+.+++.|+||.+
T Consensus       220 ~~~~----~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         220 PPLR----ALFLITTKGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             CHHH----HHHHHHhcCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            3211    1111111111 111122347899999999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-41  Score=309.92  Aligned_cols=248  Identities=32%  Similarity=0.546  Sum_probs=200.1

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|.+ .+.||.|++|.||+|.+..+|+.||+|++...        ....+|..++.++.+||||+++++++..    ++
T Consensus         1 ~~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~   75 (280)
T cd05581           1 DDFKF-GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD----EE   75 (280)
T ss_pred             CCceE-eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC----Cc
Confidence            46888 47799999999999999999999999998642        2344566664444349999999998865    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..++|||++.+++|.+++.+..  .+++..++.++.|++.||.+||+.|++|+||+|+||+++                 
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~-----------------  136 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD-----------------  136 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC-----------------
Confidence            8999999999999999998753  599999999999999999999999999999999999997                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCC--------------------CcccccccCCCcCCCcccCCCCCCCccchh
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNK--------------------ASLQTPCYTPYYVAPEVLGPDKYDKSCDIW  226 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  226 (372)
                                .++.++++|||++.......                    .......++..|+|||++....++.++|+|
T Consensus       137 ----------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~  206 (280)
T cd05581         137 ----------KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLW  206 (280)
T ss_pred             ----------CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHH
Confidence                      45567777777766543221                    112234568889999999888899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh----hHHhcCC
Q psy3151         227 SLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI----DQVMENK  302 (372)
Q Consensus       227 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~----~eil~hp  302 (372)
                      ||||+++++++|..||.....    ......+......++    ..+++.+.+||.+||+.||.+|||+    ++++.||
T Consensus       207 slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         207 ALGCIIYQMLTGKPPFRGSNE----YLTFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             HHHHHHHHHHhCCCCCCCccH----HHHHHHHHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence            999999999999999965442    122233333333333    2568999999999999999999999    9999999


Q ss_pred             cc
Q psy3151         303 WI  304 (372)
Q Consensus       303 ~~  304 (372)
                      ||
T Consensus       279 ~~  280 (280)
T cd05581         279 FF  280 (280)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.3e-41  Score=302.59  Aligned_cols=249  Identities=25%  Similarity=0.459  Sum_probs=201.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc--------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD--------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++ .+.||.|++|.||+|.+..+|+.||+|.+..        .....+|++. ++.++|+||+++++++..    ++
T Consensus         2 ~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~-l~~~~~~~i~~~~~~~~~----~~   75 (267)
T cd08224           2 GNFKI-EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDL-LKQLDHPNVIKYLASFIE----NN   75 (267)
T ss_pred             Cceee-eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHH-HHhCCCCCeeeeeeeeec----CC
Confidence            68998 5789999999999999999999999998852        2234567776 566799999999999875    56


Q ss_pred             EEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.||+||||+|+||+++               
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~---------------  140 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT---------------  140 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC---------------
Confidence            789999999999999998752  234589999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.++++|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||..
T Consensus       141 ------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         141 ------------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             ------------CCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence                        56779999999887654433333445678899999999888899999999999999999999999954


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ....  .......+..+...  +.....++.++.++|.+||..+|++|||+.++++
T Consensus       209 ~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         209 DKMN--LYSLCKKIEKCDYP--PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             CCcc--HHHHHhhhhcCCCC--CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4311  11222233222221  1112367889999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.5e-41  Score=342.19  Aligned_cols=249  Identities=26%  Similarity=0.342  Sum_probs=193.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++. +.||+|+||.||+|.+..+|+.||||++...        .+..+|+.+ ++.++||||+++++++..    ++
T Consensus         2 grYeIi-~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~I-Ls~L~HPNIVkl~~v~~d----~~   75 (932)
T PRK13184          2 QRYDII-RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKI-AADLIHPGIVPVYSICSD----GD   75 (932)
T ss_pred             CCeEEE-EEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHH-HHhCCCcCcCeEEEEEee----CC
Confidence            689995 7799999999999999999999999998532        234567776 667799999999999875    67


Q ss_pred             EEEEEEeccCCCchhHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          87 CLLVIMECMHGGELFQRIQQKE---------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~---------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      ..|+||||++|++|.+++....         ...++...+..++.||+.||+|||++||+||||||+||+++        
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd--------  147 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG--------  147 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc--------
Confidence            8999999999999999886421         12356678899999999999999999999999999999998        


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccC------------------CCcccccccCCCcCCCcccCCCCC
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN------------------KASLQTPCYTPYYVAPEVLGPDKY  219 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~  219 (372)
                                         .++.++|+|||++......                  .......+||+.|+|||++.+..+
T Consensus       148 -------------------~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~  208 (932)
T PRK13184        148 -------------------LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA  208 (932)
T ss_pred             -------------------CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC
Confidence                               4556777777777654110                  011123578999999999999999


Q ss_pred             CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         220 DKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       220 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      +.++|||||||++|+|++|..||.........   .......  +.....+..+++.+.+++.+||+.||++|++..+.+
T Consensus       209 S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~---~~~~i~~--P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        209 SESTDIYALGVILYQMLTLSFPYRRKKGRKIS---YRDVILS--PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             CcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh---hhhhccC--hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999999999999999764432221   1110000  001111246789999999999999999999876666


Q ss_pred             cC
Q psy3151         300 EN  301 (372)
Q Consensus       300 ~h  301 (372)
                      .+
T Consensus       284 l~  285 (932)
T PRK13184        284 KQ  285 (932)
T ss_pred             HH
Confidence            54

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.1e-41  Score=309.70  Aligned_cols=247  Identities=26%  Similarity=0.451  Sum_probs=200.2

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      ..||.|+||.||++.+..+|+.||||.+...     ....+|+.. ++.++|+||+++++.+..    +.+.++||||++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~  100 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVI-MRDYQHENVVEMYNSYLV----GDELWVVMEFLE  100 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHH-HHhcCCcchhheeeEEEe----CCEEEEEEecCC
Confidence            4599999999999999999999999998532     234567765 667799999999999876    678999999999


Q ss_pred             CCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCC
Q psy3151          97 GGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG  176 (372)
Q Consensus        97 ~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~  176 (372)
                      +++|.+++..   +.+++..++.++.|++.||+|||+.|++||||+|+||+++                           
T Consensus       101 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---------------------------  150 (292)
T cd06657         101 GGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---------------------------  150 (292)
T ss_pred             CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---------------------------
Confidence            9999988754   3489999999999999999999999999999999999998                           


Q ss_pred             CCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHH
Q psy3151         177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN  256 (372)
Q Consensus       177 ~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~  256 (372)
                      .++.++|+|||++..............|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.....    ...
T Consensus       151 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~----~~~  226 (292)
T cd06657         151 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMK  226 (292)
T ss_pred             CCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH
Confidence            5567899999987765433333344567899999999988889999999999999999999999996543221    111


Q ss_pred             HHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       257 ~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      .+.. ..+........++.++.+++.+||..||.+||++.+++.||||....
T Consensus       227 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         227 MIRD-NLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHHh-hCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            1111 11111112235789999999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0695|consensus

Probab=100.00  E-value=2.9e-42  Score=302.81  Aligned_cols=255  Identities=30%  Similarity=0.539  Sum_probs=219.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ .+||+|+|++|.++++++|.+.||+|++.+.        .....|........+||.+|.++.+|+.    ++
T Consensus       250 ~df~ll-~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt----es  324 (593)
T KOG0695|consen  250 QDFDLL-RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT----ES  324 (593)
T ss_pred             ccceee-eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc----cc
Confidence            568885 8899999999999999999999999998632        1233455555566789999999999987    78


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+++|.||++||+|.-.++++.  +++|+.++.+...|+.||.|||++||+.||||.+|+|++                 
T Consensus       325 rlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld-----------------  385 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD-----------------  385 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc-----------------
Confidence            9999999999999999998764  599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC--
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS--  244 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--  244 (372)
                                ..|.+|++|+|+++....+.....+.||||.|+|||++.+..|+..+|.|+||++++||+.|+.||+-  
T Consensus       386 ----------aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  386 ----------AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             ----------cCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence                      67889999999998876667778899999999999999999999999999999999999999999942  


Q ss_pred             --CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC------hhHHhcCCccccC
Q psy3151         245 --NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT------IDQVMENKWISQF  307 (372)
Q Consensus       245 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s------~~eil~hp~~~~~  307 (372)
                        +........+...+...+...|.    .+|-.+..+++..|.+||.+|..      .+++..|+||+.+
T Consensus       456 m~n~d~ntedylfqvilekqiripr----slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i  522 (593)
T KOG0695|consen  456 MDNPDMNTEDYLFQVILEKQIRIPR----SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI  522 (593)
T ss_pred             CCCcccchhHHHHHHHhhhcccccc----eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence              22333334556666666777664    67888889999999999999975      6899999999864

>KOG0983|consensus

Probab=100.00  E-value=3.5e-42  Score=294.66  Aligned_cols=252  Identities=24%  Similarity=0.401  Sum_probs=200.8

Q ss_pred             eeccccccccCCeEEEEEEEcCCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          18 DISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        18 ~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      +++ ..||+|+.|.|+++..+.+|...|||.+.+..      +....+.+.+..-+.|.||+.+++|..    +...++.
T Consensus        95 ~~l-~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~----n~dV~Ic  169 (391)
T KOG0983|consen   95 ENL-GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT----NTDVFIC  169 (391)
T ss_pred             hhH-HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee----CchHHHH
Confidence            344 34999999999999999999999999997543      344455555555568999999999976    5567888


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||.| +.-+..++++- .++++|.-+-.+...++.||.||..+ ||+|||+||+|||++                     
T Consensus       170 MelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD---------------------  226 (391)
T KOG0983|consen  170 MELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---------------------  226 (391)
T ss_pred             HHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc---------------------
Confidence            9998 33444444443 36799999999999999999999976 899999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP---DKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                            ..|.+|+||||++.++.+.. ..+...|-+.|||||.+..   ..|+.++|+||||++++||.||+.||.+.+.
T Consensus       227 ------e~GniKlCDFGIsGrlvdSk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t  299 (391)
T KOG0983|consen  227 ------ERGNIKLCDFGISGRLVDSK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT  299 (391)
T ss_pred             ------cCCCEEeecccccceeeccc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence                  78899999999999886643 3445677889999999843   4689999999999999999999999976543


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      .   ..+...+.....+. .+....+|+++++|+..||++|+.+||-..++|+|||+..+.
T Consensus       300 d---Fe~ltkvln~ePP~-L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  300 D---FEVLTKVLNEEPPL-LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             c---HHHHHHHHhcCCCC-CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            2   23444444322211 122245899999999999999999999999999999998763

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-41  Score=318.37  Aligned_cols=264  Identities=25%  Similarity=0.438  Sum_probs=203.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC--
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN--   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~--   83 (372)
                      +.++|+++ +.||+|+||.||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++.....  
T Consensus        13 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          13 VPDRYRDL-KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL-LKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             cccceEEE-EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHH-HHhcCCCCccceeeeecCCcccc
Confidence            67899995 7799999999999999999999999998531       234567776 677799999999999864211  


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      .....++||||+ +++|.+++..   ..+++..++.++.||+.||+|||+.||+||||||+||+++              
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~--------------  152 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN--------------  152 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--------------
Confidence            123568999999 7799888764   3599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .++.++++|||++.....   ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||
T Consensus       153 -------------~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  216 (343)
T cd07880         153 -------------EDCELKILDFGLARQTDS---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF  216 (343)
T ss_pred             -------------CCCCEEEeeccccccccc---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                         567799999999876532   2233456889999998865 45889999999999999999999999


Q ss_pred             CCCCCCCCCHhH-----------HHHHhhC-------Ccc-CC----CCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         243 FSNHGQAISPGM-----------KNRIRLG-------QFD-FP----NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       243 ~~~~~~~~~~~~-----------~~~~~~~-------~~~-~~----~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .+.+.......+           ...+...       ... ..    ...+..+++++.++|.+||+.||.+|||+.+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         217 KGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence            654321110000           0000000       000 00    001235788899999999999999999999999


Q ss_pred             cCCccccCCCCCC
Q psy3151         300 ENKWISQFNQVPQ  312 (372)
Q Consensus       300 ~hp~~~~~~~~~~  312 (372)
                      .||||+.+.....
T Consensus       297 ~~~~~~~~~~~~~  309 (343)
T cd07880         297 AHPYFEEFHDPED  309 (343)
T ss_pred             cCccHhhhcCccc
Confidence            9999998865433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.5e-41  Score=316.25  Aligned_cols=253  Identities=19%  Similarity=0.277  Sum_probs=189.5

Q ss_pred             cccccc--CCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          22 EILGLG--INGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        22 ~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      +.||.|  +||+||+|.+..+|+.||+|++...       ....+|+.+ ++.++||||++++++|..    +...++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~-~~~l~h~niv~~~~~~~~----~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVL-SHFFRHPNIMTSWTVFTT----GSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHH-HHhCCCCCcceEeeeEec----CCceEEEE
Confidence            347777  9999999999999999999998632       123345544 667899999999999976    67799999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      ||+.+++|.+++.+.....+++..++.++.||+.||+|||+.||+||||||+||+++                       
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~-----------------------  135 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS-----------------------  135 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe-----------------------
Confidence            999999999999875445699999999999999999999999999999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCCc-------ccccccCCCcCCCcccCCC--CCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKAS-------LQTPCYTPYYVAPEVLGPD--KYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                          .++.++++||+.+.........       .....++..|+|||++.+.  .++.++|+||+||++|+|++|..||.
T Consensus       136 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  211 (328)
T cd08226         136 ----GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ  211 (328)
T ss_pred             ----CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                4456777777644322111100       0112345679999998663  47899999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCC------------------------------------------ccCCCCcccccCHHHHHHH
Q psy3151         244 SNHGQAISPGMKNRIRLGQ------------------------------------------FDFPNPEWEHVSQEAKTLI  281 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~s~~~~~li  281 (372)
                      .......   ....+....                                          .....+....++.++.+||
T Consensus       212 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (328)
T cd08226         212 DMLRTQM---LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV  288 (328)
T ss_pred             CcChHHH---HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHH
Confidence            5432110   101000000                                          0000111234678899999


Q ss_pred             HHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         282 KNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       282 ~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      ++||+.||++|||++++|+||||.+..+
T Consensus       289 ~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         289 ELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             HHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence            9999999999999999999999987644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2e-41  Score=309.41  Aligned_cols=247  Identities=24%  Similarity=0.376  Sum_probs=198.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcC-----CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKK-----TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .++|.+. +.||+|+||.||+|.+..     +++.||||.+...      ....+|+++ +..+.|+||+++++++..  
T Consensus         4 ~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~--   79 (280)
T cd05049           4 RDTIVLK-RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL-LTNFQHENIVKFYGVCTE--   79 (280)
T ss_pred             hHHhhHH-hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHH-HHhcCCCCchheeeEEec--
Confidence            3568885 779999999999998753     4688999998632      244567776 666799999999999876  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeec
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKE------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTK  150 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~  150 (372)
                        +...++||||+++++|.+++....            ...+++..+..++.|++.||.|||++|++||||||+||+++ 
T Consensus        80 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~-  156 (280)
T cd05049          80 --GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG-  156 (280)
T ss_pred             --CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc-
Confidence              577999999999999999997542            23588999999999999999999999999999999999998 


Q ss_pred             CCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhH
Q psy3151         151 PGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSL  228 (372)
Q Consensus       151 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  228 (372)
                                                .++.++|+|||++........  ......+++.|+|||++.+..++.++|||||
T Consensus       157 --------------------------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  210 (280)
T cd05049         157 --------------------------YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF  210 (280)
T ss_pred             --------------------------CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHH
Confidence                                      567799999998875432211  1223345778999999998999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         229 GVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       229 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||++|+|++ |..||......    .....+..+....++   ..++.++.+++.+||..||.+|||++|+++
T Consensus       211 G~il~e~~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         211 GVVLWEIFTYGKQPWYGLSNE----EVIECITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            999999998 99999665432    233444444333222   368899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.9e-41  Score=307.06  Aligned_cols=246  Identities=22%  Similarity=0.373  Sum_probs=197.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      ..|.+ .+.||.|++|.||+|.+..+++.||+|.+....    ...+|++. ++.++||||+++++++..    +..+++
T Consensus         6 ~~~~~-~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~l   79 (263)
T cd05052           6 TDITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV-MKEIKHPNLVQLLGVCTR----EPPFYI   79 (263)
T ss_pred             HHeEE-eeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHH-HHhCCCCChhheEEEEcC----CCCcEE
Confidence            45777 477999999999999999999999999986432    34567776 556799999999998865    567899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      +|||+.+++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++                     
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---------------------  138 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---------------------  138 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---------------------
Confidence            99999999999999775545689999999999999999999999999999999999997                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcc-cccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASL-QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  248 (372)
                            +++.+||+|||++.......... ....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..
T Consensus       139 ------~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~  212 (263)
T cd05052         139 ------ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  212 (263)
T ss_pred             ------CCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence                  56779999999887654322111 11223567999999988889999999999999999998 99998654322


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                          .....+..+ +.  ......++.++.++|.+||..||++|||+.++++
T Consensus       213 ----~~~~~~~~~-~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         213 ----QVYELLEKG-YR--MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ----HHHHHHHCC-CC--CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                222333222 11  1222468899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-41  Score=318.18  Aligned_cols=267  Identities=25%  Similarity=0.425  Sum_probs=203.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--   82 (372)
                      .+.++|.++ +.||+|+||.||+|.+..+|+.||+|++...       ....+|+.+ ++.++||||+++++++....  
T Consensus        14 ~~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~-l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          14 EVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL-LKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             hccCceEEE-EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHH-HHHcCCCcccceeeeeeecccc
Confidence            367999995 7799999999999999999999999998532       234467766 66679999999999886321  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ......|++++++ +++|.+++...   .+++..++.++.||+.||+|||++||+||||||+||+++             
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~-------------  154 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-------------  154 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc-------------
Confidence            1234578889887 78998887543   499999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                    .++.++|+|||++.....   ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..|
T Consensus       155 --------------~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  217 (345)
T cd07877         155 --------------EDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  217 (345)
T ss_pred             --------------CCCCEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCC
Confidence                          567799999999875432   2234567889999998765 5688999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHh------------------hCCc-cCCCC----cccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         242 FFSNHGQAISPGMKNRIR------------------LGQF-DFPNP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~------------------~~~~-~~~~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |...+.......+.....                  .... ..+..    .....++++.+||.+||+.||.+|||+.++
T Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~  297 (345)
T cd07877         218 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  297 (345)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH
Confidence            964432111000000000                  0000 00000    112468899999999999999999999999


Q ss_pred             hcCCccccCCCCCCCC
Q psy3151         299 MENKWISQFNQVPQTP  314 (372)
Q Consensus       299 l~hp~~~~~~~~~~~~  314 (372)
                      +.||||+++......+
T Consensus       298 l~h~~f~~~~~~~~~~  313 (345)
T cd07877         298 LAHAYFAQYHDPDDEP  313 (345)
T ss_pred             hcChhhhhcCCCCccc
Confidence            9999999876654444

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.7e-41  Score=301.50  Aligned_cols=229  Identities=26%  Similarity=0.453  Sum_probs=187.6

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHh
Q psy3151          27 GINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ  106 (372)
Q Consensus        27 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~  106 (372)
                      |.+|+||+|++..+|+.||+|.+.......+|... .....||||+++++++..    ....++||||+.+|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLT-IIPHCVPNMVCLHKYIVS----EDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhhhhHHHH-HHhcCCCceeehhhheec----CCeEEEEEecCCCCCHHHHHHH
Confidence            89999999999999999999999765545555444 334469999999999875    6789999999999999999876


Q ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeecc
Q psy3151         107 KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF  186 (372)
Q Consensus       107 ~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Df  186 (372)
                      ..  .+++..+..++.|++.||+|||+.||+||||||+||+++                           .++.++++||
T Consensus        79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---------------------------~~~~~~l~df  129 (237)
T cd05576          79 FL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---------------------------DRGHIQLTYF  129 (237)
T ss_pred             hc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---------------------------CCCCEEEecc
Confidence            53  499999999999999999999999999999999999998                           5667999999


Q ss_pred             ccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCC
Q psy3151         187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFP  266 (372)
Q Consensus       187 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  266 (372)
                      |.+......   .....++..|+|||.+....++.++|+||+||++|+|++|..||...... .    .   .......|
T Consensus       130 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~----~---~~~~~~~~  198 (237)
T cd05576         130 SRWSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I----N---THTTLNIP  198 (237)
T ss_pred             cchhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c----c---cccccCCc
Confidence            987655331   22344577899999998888999999999999999999999887532211 0    0   00111222


Q ss_pred             CCcccccCHHHHHHHHHhccCCCCCCCCh-----hHHhcCCcc
Q psy3151         267 NPEWEHVSQEAKTLIKNMLCVDPSERLTI-----DQVMENKWI  304 (372)
Q Consensus       267 ~~~~~~~s~~~~~li~~ll~~dP~~R~s~-----~eil~hp~~  304 (372)
                          ..+++++.++|.+||+.||++|+|+     ++++.||||
T Consensus       199 ----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         199 ----EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ----ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence                2578999999999999999999996     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.5e-40  Score=298.95  Aligned_cols=251  Identities=29%  Similarity=0.468  Sum_probs=203.5

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|++ .+.||+|++|.||+|.+..+++.+++|++....       ...+|+.. ++.++||||+++++.+...  .....
T Consensus         1 ~~~~-~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~--~~~~~   76 (260)
T cd06606           1 EWTR-GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRI-LSSLQHPNIVRYYGSERDE--EKNTL   76 (260)
T ss_pred             Ccee-eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHH-HHHcCCCCEeeEEEEEecC--CCCeE
Confidence            4777 478999999999999999999999999986433       34566666 6677899999999988751  12789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++++||+.+++|.+++.+..  .+++..++.++.|++.||.|||+.|++|+||+|+||+++                   
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~-------------------  135 (260)
T cd06606          77 NIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD-------------------  135 (260)
T ss_pred             EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc-------------------
Confidence            99999999999999998754  699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                              .++.++|+|||.+........  ......++..|+|||.+....++.++|+||||+++|+|++|..||....
T Consensus       136 --------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         136 --------SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             --------CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                    567799999998887654332  1344567889999999988889999999999999999999999996554


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .  . ......+...  ..........+.++.++|.+||+.||.+|||+.+++.||||
T Consensus       208 ~--~-~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         208 N--P-MAALYKIGSS--GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             c--h-HHHHHhcccc--CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            1  1 1111111110  11111223568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.4e-41  Score=308.20  Aligned_cols=255  Identities=19%  Similarity=0.297  Sum_probs=197.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcC-----CCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKK-----TSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      -.++|++. +.||+|+||.||+|.++.     .+..||+|.+....      ...+|+.. ++.++||||+++++++.. 
T Consensus         4 ~~~~~~i~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~-   80 (288)
T cd05061           4 SREKITLL-RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV-MKGFTCHHVVRLLGVVSK-   80 (288)
T ss_pred             cHHHceee-eeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEcC-
Confidence            35789995 779999999999997652     35689999875322      23456655 666789999999998865 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKE--------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~--------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                         ....|+||||+.+|+|.+++....        ...++...+..++.||+.||.|||++||+||||||+||+++    
T Consensus        81 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~----  153 (288)
T cd05061          81 ---GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA----  153 (288)
T ss_pred             ---CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc----
Confidence               567899999999999999997532        13356788999999999999999999999999999999998    


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHH
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI  231 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  231 (372)
                                             .++.++++|||+++........  .....++..|+|||.+.+..++.++|+|||||+
T Consensus       154 -----------------------~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~  210 (288)
T cd05061         154 -----------------------HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV  210 (288)
T ss_pred             -----------------------CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHH
Confidence                                   5667899999988755332211  112234667999999988889999999999999


Q ss_pred             HHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc------CCcc
Q psy3151         232 MYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME------NKWI  304 (372)
Q Consensus       232 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~------hp~~  304 (372)
                      +|+|++ |..||.+....    .....+..+....   .....++++.+++.+||+.||.+|||+.++++      ||||
T Consensus       211 l~el~~~~~~p~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~  283 (288)
T cd05061         211 LWEITSLAEQPYQGLSNE----QVLKFVMDGGYLD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF  283 (288)
T ss_pred             HHHHHhCCCCCCCCCCHH----HHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence            999998 78898654322    2333333222211   11356899999999999999999999999987      8988


Q ss_pred             ccC
Q psy3151         305 SQF  307 (372)
Q Consensus       305 ~~~  307 (372)
                      .++
T Consensus       284 ~~~  286 (288)
T cd05061         284 PEV  286 (288)
T ss_pred             CCC
Confidence            764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0669|consensus

Probab=100.00  E-value=6e-44  Score=302.25  Aligned_cols=263  Identities=25%  Similarity=0.408  Sum_probs=204.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC-
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYNG-   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~-   84 (372)
                      ..+.|..+ ..||+|.||.||+|+.+.+|+.||+|++-.       ...+.+|+.+ +..+.|+|++++++++...... 
T Consensus        15 ~~~~yek~-~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreiki-L~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   15 EVSKYEKL-AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKI-LQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             cchHHHHH-HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHH-HHHhcchhHHHHHHHHhhccCCc
Confidence            34567765 569999999999999999999999997632       2467899998 7888999999999988633222 


Q ss_pred             ---ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          85 ---SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        85 ---~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         ...+|+||.+|+. +|..++.... .+++..+++.++.+++.||.|+|++.|+|||+||.|+||+            
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt------------  158 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT------------  158 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc------------
Confidence               3459999999965 8988886542 4699999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCC----CcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHH
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK----ASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll  236 (372)
                                     .+|.+||+|||+++.+....    ...+..+.|.||++||.+.+ ..|+++.|||+.||++.+|+
T Consensus       159 ---------------~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw  223 (376)
T KOG0669|consen  159 ---------------KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW  223 (376)
T ss_pred             ---------------CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH
Confidence                           67889999999997664322    22344566999999998754 67999999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhh---------------CCccCCC-Cc--c---------cccCHHHHHHHHHhccCCC
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRL---------------GQFDFPN-PE--W---------EHVSQEAKTLIKNMLCVDP  289 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~-~~--~---------~~~s~~~~~li~~ll~~dP  289 (372)
                      ++.+.|.+++.+.....+......               ...+.++ +.  .         -.-++++.||+.+||..||
T Consensus       224 trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP  303 (376)
T KOG0669|consen  224 TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDP  303 (376)
T ss_pred             ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCc
Confidence            999999877654332211111100               0011110 00  0         0124689999999999999


Q ss_pred             CCCCChhHHhcCCcccc
Q psy3151         290 SERLTIDQVMENKWISQ  306 (372)
Q Consensus       290 ~~R~s~~eil~hp~~~~  306 (372)
                      .+|++++++|.|.||..
T Consensus       304 ~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  304 TKRIDADQALNHDFFWK  320 (376)
T ss_pred             ccCcchHhhhchhhhhc
Confidence            99999999999999965

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=299.68  Aligned_cols=247  Identities=30%  Similarity=0.499  Sum_probs=203.6

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|++ .+.||+|++|.||+|.+..+++.||+|.+....       ...+|++. ++.++|||++++++++..    ++..
T Consensus         1 ~y~~-~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~   74 (254)
T cd06627           1 NYQL-GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDL-LKNLKHPNIVKYIGSIET----SDSL   74 (254)
T ss_pred             Ccee-eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHH-HHhCCCCCccEEEEEEEe----CCEE
Confidence            5788 477999999999999999999999999986432       24566666 566689999999999875    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      +++|||+.+++|.+++...  +.+++..++.++.|++.||.+||+.||+||||||+||+++                   
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~-------------------  133 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT-------------------  133 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC-------------------
Confidence            9999999999999998765  4599999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||......
T Consensus       134 --------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~  205 (254)
T cd06627         134 --------KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM  205 (254)
T ss_pred             --------CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH
Confidence                    567799999999887655443334556788999999988777899999999999999999999999654321


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                         ..............    ...++.++.+++.+||..+|++|||+.+++.||||
T Consensus       206 ---~~~~~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         206 ---AALFRIVQDDHPPL----PEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ---HHHHHHhccCCCCC----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence               11111111111111    23678999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.2e-41  Score=313.49  Aligned_cols=265  Identities=25%  Similarity=0.436  Sum_probs=205.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+.++|++. +.||.|+||.||+|.+..+|+.||||.+..       .....+|+++ ++.++||||+++.++|..   .
T Consensus         7 ~~~~~y~~~-~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~---~   81 (328)
T cd07856           7 EITNRYVDL-QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKL-LKHLRHENIISLSDIFIS---P   81 (328)
T ss_pred             ccccceEEE-EeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHH-HHhcCCCCeeeEeeeEec---C
Confidence            367899995 789999999999999999999999998742       1234567776 667799999999998864   2


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...|+++||+ +++|.+++..   ..+++..++.++.||+.||+|||+.||+||||+|+||+++               
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~---------------  142 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---------------  142 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---------------
Confidence            45689999999 6689888764   3489999999999999999999999999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                  .++.++|+|||.+.....   ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.
T Consensus       143 ------------~~~~~~l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~  207 (328)
T cd07856         143 ------------ENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP  207 (328)
T ss_pred             ------------CCCCEEeCccccccccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                        567799999998875432   2234466888999998755 568999999999999999999999996


Q ss_pred             CCCCCCCC-----------HhHHHHH---------hhCC--ccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         244 SNHGQAIS-----------PGMKNRI---------RLGQ--FDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       244 ~~~~~~~~-----------~~~~~~~---------~~~~--~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ........           .......         ....  ...+. .....++.++.++|.+||+.+|++|||+++++.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         208 GKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            54321100           0000000         0000  00010 011346889999999999999999999999999


Q ss_pred             CCccccCCCCCCCCC
Q psy3151         301 NKWISQFNQVPQTPL  315 (372)
Q Consensus       301 hp~~~~~~~~~~~~~  315 (372)
                      ||||......+..+.
T Consensus       288 ~~~~~~~~~~~~~~~  302 (328)
T cd07856         288 HPYLAPYHDPTDEPV  302 (328)
T ss_pred             CCccccccCCccccC
Confidence            999998776655544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.1e-41  Score=313.84  Aligned_cols=260  Identities=25%  Similarity=0.408  Sum_probs=195.8

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec----
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY----   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~----   82 (372)
                      .++|++. +.||.|+||.||+|.+..+++.+|||++...       ....+|++. ++.++||||+++++++....    
T Consensus         7 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEIL-GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKI-LKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEE-EEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHH-HHhcCCCCccchhhheeccccccc
Confidence            6899995 7799999999999999999999999988521       234678876 66779999999999875322    


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      .....+|+|+||+. ++|...+.... ..+++..++.++.||+.||+|||++||+||||||+||+++             
T Consensus        85 ~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~-------------  149 (311)
T cd07866          85 RKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID-------------  149 (311)
T ss_pred             ccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC-------------
Confidence            12456899999995 47777776432 4699999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC-----------cccccccCCCcCCCcccCC-CCCCCccchhhHHH
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-----------SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGV  230 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~  230 (372)
                                    .++.++|+|||++........           ......+++.|+|||.+.+ ..++.++|+|||||
T Consensus       150 --------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  215 (311)
T cd07866         150 --------------NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGC  215 (311)
T ss_pred             --------------CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHH
Confidence                          556678888887765432111           1223456888999998754 45889999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCHhHHHHHhh------------CC-------ccCCC---CcccccCHHHHHHHHHhccCC
Q psy3151         231 IMYILLCGFPPFFSNHGQAISPGMKNRIRL------------GQ-------FDFPN---PEWEHVSQEAKTLIKNMLCVD  288 (372)
Q Consensus       231 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------~~-------~~~~~---~~~~~~s~~~~~li~~ll~~d  288 (372)
                      ++|+|++|.+||.+.+.......+......            ..       ...+.   ..+...++++.++|.+||..|
T Consensus       216 il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  295 (311)
T cd07866         216 VFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD  295 (311)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccC
Confidence            999999999999654432211111110000            00       00000   011245578999999999999


Q ss_pred             CCCCCChhHHhcCCcc
Q psy3151         289 PSERLTIDQVMENKWI  304 (372)
Q Consensus       289 P~~R~s~~eil~hp~~  304 (372)
                      |.+|||+.+++.||||
T Consensus       296 p~~R~t~~ell~~~~f  311 (311)
T cd07866         296 PYKRLTASDALEHPYF  311 (311)
T ss_pred             cccCcCHHHHhcCCCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-40  Score=304.42  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=192.2

Q ss_pred             cccce-eeccccccccCCeEEEEEE----EcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDY-DISTEILGLGINGKVLQIV----EKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y-~i~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      |.+|| +++ +.||.|+||+||++.    ...+++.||+|++...      ....+|+.. ++.++||||+++++++.. 
T Consensus         1 ~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~-   77 (283)
T cd05080           1 FHKRYLKKI-RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINI-LKTLYHENIVKYKGCCSE-   77 (283)
T ss_pred             CChhhceec-eecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHH-HHhCCCCCEeeEEEEEec-
Confidence            46788 664 779999999998865    3457889999998632      233567776 666799999999998753 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                       .+...+|++|||+++++|.+++...   .+++..++.++.|++.||+|||++||+||||||+||+++            
T Consensus        78 -~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~------------  141 (283)
T cd05080          78 -QGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD------------  141 (283)
T ss_pred             -CCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc------------
Confidence             2345789999999999999998764   499999999999999999999999999999999999997            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                     .++.++|+|||++.........   .....++..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus       142 ---------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg  206 (283)
T cd05080         142 ---------------NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH  206 (283)
T ss_pred             ---------------CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhC
Confidence                           5667899999988765432211   1122345679999999888899999999999999999999


Q ss_pred             CCCCCCCCCCCC-----------CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         239 FPPFFSNHGQAI-----------SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       239 ~~pf~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..||........           .......+.. ....+  ....++.++.+++.+||+.||++|||++++++
T Consensus       207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         207 CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER-GMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCcchhhhhhcccccccchhhhhhhhhc-CCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            999854322100           0000011111 11111  12357899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0608|consensus

Probab=100.00  E-value=5e-42  Score=322.15  Aligned_cols=276  Identities=28%  Similarity=0.469  Sum_probs=207.3

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhH--------HHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR--------REVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .|..+ +.||-|+||+|+++.-..|...||+|.+++.+...        .|..+ +.-.+.+-||+++..|.+    +..
T Consensus       630 mFvki-k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDI-LAEADn~WVVrLyySFQD----kdn  703 (1034)
T KOG0608|consen  630 MFVKI-KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDI-LAEADNEWVVRLYYSFQD----KDN  703 (1034)
T ss_pred             ceEEE-eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhh-HhhcCCcceEEEEEEecc----CCc
Confidence            45554 77999999999999999999999999997544322        24444 566688999999999987    788


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||+|++||++..++.+.  +.|+|+.++.++..+.+|+++.|..|.|||||||+|||||.   ++.+|++|||+|.+
T Consensus       704 LYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr---dGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCTG  778 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc---CCceeeeecccccc
Confidence            99999999999999999876  56999999999999999999999999999999999999994   44578888887765


Q ss_pred             cccccC-C-CCCCCCeeeecccccccccc----------------CCCcccccccCCCcCCCcccCCCCCCCccchhhHH
Q psy3151         168 ENLLYT-K-PGDGGILKLTDFGFAKKIVS----------------NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG  229 (372)
Q Consensus       168 ~~~~~~-~-~~~~~~~ki~Dfg~a~~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  229 (372)
                      ..-... + .+.....+.-.+..+.....                ........+||+.|+|||++....|+..+|.||.|
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG  858 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence            442111 1 11111122111111111000                00112236799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC---hhHHhcCCcccc
Q psy3151         230 VIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT---IDQVMENKWISQ  306 (372)
Q Consensus       230 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s---~~eil~hp~~~~  306 (372)
                      ||||||+.|++||......+....+.+-...-.+    +.-.++|.++.+||.++.+ +++.|+.   ++|+..||||+.
T Consensus       859 vil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~----~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQYKVINWRNFLHI----PYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcceeeeeehhhcccc----ccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence            9999999999999877665543333322222122    2224789999999998865 8888885   788999999987


Q ss_pred             C
Q psy3151         307 F  307 (372)
Q Consensus       307 ~  307 (372)
                      +
T Consensus       934 I  934 (1034)
T KOG0608|consen  934 I  934 (1034)
T ss_pred             c
Confidence            5

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-41  Score=305.93  Aligned_cols=246  Identities=22%  Similarity=0.400  Sum_probs=199.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ...|++. +.||.|+||.||+|.+.. ++.+|+|++...     ....+|+.. ++.++||||+++++++..    ....
T Consensus         5 ~~~y~~~-~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~   77 (261)
T cd05148           5 REEFTLE-RKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQA-LKRLRHKHLISLFAVCSV----GEPV   77 (261)
T ss_pred             HHHHHHh-hhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHH-HhcCCCcchhheeeeEec----CCCe
Confidence            4578884 779999999999999987 899999998633     234567766 667799999999998875    5678


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++                   
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~-------------------  138 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG-------------------  138 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc-------------------
Confidence            9999999999999999876556799999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                              .++.+||+|||.+..............++..|+|||.+....++.++|+|||||++|+|++ |..||...+.
T Consensus       139 --------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~  210 (261)
T cd05148         139 --------EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN  210 (261)
T ss_pred             --------CCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence                    5677999999988765432222223344667999999988889999999999999999998 8999965442


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .+    ....+..+ ...+  ....+++++.++|.+||..||.+|||+.++++
T Consensus       211 ~~----~~~~~~~~-~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         211 HE----VYDQITAG-YRMP--CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HH----HHHHHHhC-CcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            22    22223221 2212  12367899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.4e-41  Score=310.54  Aligned_cols=247  Identities=20%  Similarity=0.365  Sum_probs=193.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcE--EEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEV--YALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++ .+.||+|+||.||+|.+..++..  +|+|.+...      ....+|++.+.++.+||||+++++++..    ++
T Consensus         7 ~~~~~-~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----~~   81 (303)
T cd05088           7 NDIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RG   81 (303)
T ss_pred             hhcee-eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC----CC
Confidence            57888 47899999999999999887764  577766531      1345688876666699999999999875    66


Q ss_pred             EEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~  152 (372)
                      ..|+||||+++++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++   
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~---  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec---
Confidence            7999999999999999997542              13589999999999999999999999999999999999998   


Q ss_pred             CCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHH
Q psy3151         153 DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM  232 (372)
Q Consensus       153 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  232 (372)
                                              .++.+||+|||++....... ......++..|+|||.+....++.++|||||||++
T Consensus       159 ------------------------~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  213 (303)
T cd05088         159 ------------------------ENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL  213 (303)
T ss_pred             ------------------------CCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence                                    56679999999886432111 11112235679999999888899999999999999


Q ss_pred             HHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         233 YILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       233 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |+|++ |..||...+..    .....+..+ .  ........++++.+|+.+||+.+|++|||+++++.+
T Consensus       214 ~ellt~g~~p~~~~~~~----~~~~~~~~~-~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         214 WEIVSLGGTPYCGMTCA----ELYEKLPQG-Y--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHHhcCCCCcccCChH----HHHHHHhcC-C--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99998 99999654432    222222221 1  111223578999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-41  Score=314.82  Aligned_cols=262  Identities=26%  Similarity=0.466  Sum_probs=200.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--   82 (372)
                      .+.++|.+ .+.||.|+||.||+|.+..+|+.||||.+...       ....+|+.. ++.++||||+++++++....  
T Consensus        12 ~~~~~y~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~   89 (342)
T cd07879          12 ELPERYTS-LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL-LKHMQHENVIGLLDVFTSAVSG   89 (342)
T ss_pred             ccccceEE-EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHH-HHhcCCCCccchhheecccccC
Confidence            35789998 47899999999999999999999999998532       234567776 56679999999999986421  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      .....+|+|+||+. .+|..++.    ..+++..++.++.|++.||+|||+.||+||||||+||+++             
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~-------------  151 (342)
T cd07879          90 DEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN-------------  151 (342)
T ss_pred             CCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-------------
Confidence            12245799999995 47766542    3489999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                    .++.++++|||++.....   ......+|+.|+|||.+.+ ..++.++|+|||||++|+|++|+.|
T Consensus       152 --------------~~~~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~p  214 (342)
T cd07879         152 --------------EDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTL  214 (342)
T ss_pred             --------------CCCCEEEeeCCCCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCC
Confidence                          567799999999875422   2234567889999999865 4688999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHH-----------HHh-------hCCcc-CCCC----cccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         242 FFSNHGQAISPGMKN-----------RIR-------LGQFD-FPNP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       242 f~~~~~~~~~~~~~~-----------~~~-------~~~~~-~~~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |.+.+.......+..           ...       ....+ .+..    .+...+.++.+||.+||+.||.+|||++++
T Consensus       215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~  294 (342)
T cd07879         215 FKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA  294 (342)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            975432111000000           000       00000 0110    012467889999999999999999999999


Q ss_pred             hcCCccccCCCC
Q psy3151         299 MENKWISQFNQV  310 (372)
Q Consensus       299 l~hp~~~~~~~~  310 (372)
                      +.||||..+...
T Consensus       295 l~h~~f~~~~~~  306 (342)
T cd07879         295 LEHPYFDSFRDA  306 (342)
T ss_pred             hcCcchhhcccc
Confidence            999999988654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.5e-41  Score=313.16  Aligned_cols=246  Identities=19%  Similarity=0.274  Sum_probs=187.6

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCch
Q psy3151          28 INGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGEL  100 (372)
Q Consensus        28 ~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  100 (372)
                      ++|.||.+++..+++.||||++...       ....+|+.. ++.++|+||++++++|..    ....|++|||+.+++|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~-l~~l~h~~i~~~~~~~~~----~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIIT-SRQLQHPNILPYVTSFIV----DSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHH-HHhcCCcchhhhhheeec----CCeEEEEEeccCCCCH
Confidence            5566777777779999999998532       245577776 566789999999999875    6778999999999999


Q ss_pred             hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCC
Q psy3151         101 FQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI  180 (372)
Q Consensus       101 ~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~  180 (372)
                      .+++.......+++..++.++.||+.||+|||+.||+||||||+||+++                           .++.
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---------------------------~~~~  139 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---------------------------GDGK  139 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---------------------------cCCc
Confidence            9999875445699999999999999999999999999999999999998                           4566


Q ss_pred             eeeeccccccccccCCC-------cccccccCCCcCCCcccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q psy3151         181 LKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS  251 (372)
Q Consensus       181 ~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  251 (372)
                      ++|+|||.+........       ......++..|+|||++..  ..++.++|+||+||++|+|++|..||........ 
T Consensus       140 ~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-  218 (314)
T cd08216         140 VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-  218 (314)
T ss_pred             eEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            78888877754432111       1123345778999999865  4588999999999999999999999965432111 


Q ss_pred             HhHHHHHhhC--------C---------------------ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         252 PGMKNRIRLG--------Q---------------------FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       252 ~~~~~~~~~~--------~---------------------~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                        ....+...        .                     ...+......++.++.+|+.+||..||++|||++++|+||
T Consensus       219 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         219 --LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             --HHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence              11111100        0                     0000111123457899999999999999999999999999


Q ss_pred             ccccCC
Q psy3151         303 WISQFN  308 (372)
Q Consensus       303 ~~~~~~  308 (372)
                      ||++..
T Consensus       297 ~~~~~~  302 (314)
T cd08216         297 FFKQCK  302 (314)
T ss_pred             hHhhhc
Confidence            998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.9e-41  Score=301.23  Aligned_cols=238  Identities=22%  Similarity=0.397  Sum_probs=188.2

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      .||+|+||.||+|.+..+++.+|+|.+...      ....+|+++ ++.++||||+++++++..    ....|+||||+.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~   76 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARI-LKQYSHPNIVRLIGVCTQ----KQPIYIVMELVQ   76 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHH-HHhCCCCCcceEEEEEcC----CCCeEEEEeecc
Confidence            599999999999999999999999987532      245677776 566799999999999875    567999999999


Q ss_pred             CCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCC
Q psy3151          97 GGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG  176 (372)
Q Consensus        97 ~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~  176 (372)
                      +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++                           
T Consensus        77 ~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---------------------------  128 (252)
T cd05084          77 GGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---------------------------  128 (252)
T ss_pred             CCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---------------------------
Confidence            999999987543 4589999999999999999999999999999999999998                           


Q ss_pred             CCCCeeeeccccccccccCCCcc--cccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHh
Q psy3151         177 DGGILKLTDFGFAKKIVSNKASL--QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPG  253 (372)
Q Consensus       177 ~~~~~ki~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  253 (372)
                      .++.+|++|||++..........  ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||......    .
T Consensus       129 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----~  204 (252)
T cd05084         129 EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----Q  204 (252)
T ss_pred             CCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----H
Confidence            55678888888876543211110  11122346999999988889999999999999999997 88888544321    1


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ....+... ...  +....++..+.+|+.+||+.||++|||+.++++
T Consensus       205 ~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         205 TREAIEQG-VRL--PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHHcC-CCC--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22222211 111  122367899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=309.18  Aligned_cols=253  Identities=30%  Similarity=0.482  Sum_probs=198.2

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      |+++ +.||.|++|.||+|.+..+|+.+|+|.+...       ....+|+.. ++.++|+||+++++++..    +...|
T Consensus         1 y~~~-~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~~   74 (283)
T cd05118           1 YQKL-GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKL-LKELNHPNIIKLLDVFRH----KGDLY   74 (283)
T ss_pred             Cccc-eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHH-HHHhcCCCcchHHHhhcc----CCCEE
Confidence            5665 6699999999999999999999999998632       234567766 566689999999998875    57899


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +|+||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++                    
T Consensus        75 ~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~--------------------  132 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN--------------------  132 (283)
T ss_pred             EEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC--------------------
Confidence            99999965 8988887653 4699999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                             .++.++|+|||.+..............++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..
T Consensus       133 -------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~  205 (283)
T cd05118         133 -------TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI  205 (283)
T ss_pred             -------CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                   56779999999887765433233335578889999998766 7899999999999999999999999654432


Q ss_pred             CCCHhHHHHHh---------------hCCccCC-------CCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIR---------------LGQFDFP-------NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~---------------~~~~~~~-------~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      +....+.....               .....++       ...+..++.++.++|.+||..||.+||++.+++.||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         206 DQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            11111110000               0000000       01123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=299.33  Aligned_cols=239  Identities=37%  Similarity=0.645  Sum_probs=200.8

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      ||.|+||.||+|.+..+++.+|+|++....        ....|+.. ++.++||||+++++.++.    +...|+||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNI-LSRINHPFIVKLHYAFQT----EEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHH-HHHcCCCcHHHHHHHeec----CCeeEEEEecC
Confidence            699999999999999899999999986421        34566765 677789999999998875    77899999999


Q ss_pred             CCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151          96 HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus        96 ~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                      .+++|.+++....  .+++..++.++.|++.||.|||+.+++|+||+|+||+++                          
T Consensus        76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~--------------------------  127 (250)
T cd05123          76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD--------------------------  127 (250)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc--------------------------
Confidence            9999999997653  489999999999999999999999999999999999998                          


Q ss_pred             CCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHH
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK  255 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  255 (372)
                       ..+.++|+|||.+..............++..|+|||.+.+...+.++|+||||+++|+|++|..||...+.    ....
T Consensus       128 -~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~  202 (250)
T cd05123         128 -ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIY  202 (250)
T ss_pred             -CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHH
Confidence             56679999999987764433334455678899999999888889999999999999999999999965432    2333


Q ss_pred             HHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh---hHHhcCCcc
Q psy3151         256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI---DQVMENKWI  304 (372)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~---~eil~hp~~  304 (372)
                      ..+......++.    ..+.++.++|++||..||++|||+   ++++.||||
T Consensus       203 ~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         203 EKILKDPLRFPE----FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHhcCCCCCCC----CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            444334444332    568999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=299.36  Aligned_cols=250  Identities=24%  Similarity=0.416  Sum_probs=198.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+|++ .+.||+|+||.||+|.+..+++.||+|.+...          ....+|++. ++.++|+||+++++++.+  ..
T Consensus         2 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~-l~~l~h~~i~~~~~~~~~--~~   77 (264)
T cd06653           2 VNWRL-GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQL-LKNLRHDRIVQYYGCLRD--PE   77 (264)
T ss_pred             Cceee-eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHH-HHHcCCCCcceEEEEEEc--CC
Confidence            47888 58899999999999999999999999987421          134457776 666699999999998854  22


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+++++||+++++|.+++...  +.+++..++.++.||+.||.|||+.|++|+||||+||+++               
T Consensus        78 ~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---------------  140 (264)
T cd06653          78 EKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---------------  140 (264)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---------------
Confidence            45688999999999999998764  3489999999999999999999999999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccC---CCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSN---KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.++|+|||++......   ........++..|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus       141 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  208 (264)
T cd06653         141 ------------SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP  208 (264)
T ss_pred             ------------CCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence                        5667899999988765321   1112334678899999999888899999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      |......   ..+.. +...  +.++.....+++++.++|.+||. +|..|||+.+++.|||.
T Consensus       209 ~~~~~~~---~~~~~-~~~~--~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         209 WAEYEAM---AAIFK-IATQ--PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CCccCHH---HHHHH-HHcC--CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            9643221   11222 1111  11112224688999999999999 67999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-41  Score=318.11  Aligned_cols=267  Identities=25%  Similarity=0.447  Sum_probs=205.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--   82 (372)
                      .+.++|++. ..||.|++|.||+|.+..+++.||||++...       ....+|+.+ ++.+.||||+++.+++....  
T Consensus        12 ~~~~~y~~~-~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          12 EVPDRYQNL-SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL-LKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             cccCceEEE-EEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHH-HHhccCCCHHHHHHHhhccccc
Confidence            377899995 7799999999999999999999999998531       234567776 56679999999998875411  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ......|+|+||+ +++|.+++..   ..+++..++.++.||+.||+|||+.||+||||||+||+++             
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~-------------  152 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-------------  152 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC-------------
Confidence            1234589999999 6799998865   3599999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                    .++.++|+|||++......   .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.|
T Consensus       153 --------------~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p  215 (343)
T cd07851         153 --------------EDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL  215 (343)
T ss_pred             --------------CCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence                          5677999999998765322   334567889999998754 4678999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHH-----------Hhh-------CCcc-CCC----CcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         242 FFSNHGQAISPGMKNR-----------IRL-------GQFD-FPN----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~-----------~~~-------~~~~-~~~----~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |...........+...           +..       .... ...    ......++++.+||.+||..||.+|||+.++
T Consensus       216 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el  295 (343)
T cd07851         216 FPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA  295 (343)
T ss_pred             CCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH
Confidence            9654322110000000           000       0000 000    0012468999999999999999999999999


Q ss_pred             hcCCccccCCCCCCCC
Q psy3151         299 MENKWISQFNQVPQTP  314 (372)
Q Consensus       299 l~hp~~~~~~~~~~~~  314 (372)
                      +.||||.++......+
T Consensus       296 l~h~~~~~~~~~~~~~  311 (343)
T cd07851         296 LAHPYLAEYHDPEDEP  311 (343)
T ss_pred             hcCCCccccCCCcccc
Confidence            9999999886654433

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.6e-40  Score=300.41  Aligned_cols=246  Identities=22%  Similarity=0.386  Sum_probs=196.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|+++ +.||.|++|.||+|.+. ++..||+|.+...    ....+|+.+ ++.++|+||+++++++..    ++..|
T Consensus         5 ~~~~~~~-~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~   77 (261)
T cd05072           5 RESIKLV-KKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANL-MKTLQHDKLVRLYAVVTK----EEPIY   77 (261)
T ss_pred             hHHeEEe-eecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHH-HHhCCCCCeeeEEEEEcC----CCCcE
Confidence            3688986 66999999999999975 5678999987532    234567776 566799999999998865    66789


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      ++|||+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++                    
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~--------------------  137 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS--------------------  137 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec--------------------
Confidence            999999999999999876556789999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                             .++.++|+|||++......... .....++..|+|||.+....++.++|+|||||++|+|++ |..||.....
T Consensus       138 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~  210 (261)
T cd05072         138 -------ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN  210 (261)
T ss_pred             -------CCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence                   5677999999998765432211 122234567999999988889999999999999999998 9999965432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .    .....+..+ ...  +....++.++.+++.+||..+|++|||++++++
T Consensus       211 ~----~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         211 S----DVMSALQRG-YRM--PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             H----HHHHHHHcC-CCC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            2    223333222 222  223468899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=304.99  Aligned_cols=258  Identities=26%  Similarity=0.414  Sum_probs=196.3

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHh--cCCCCEeEEeEeeeeecC-Cce
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAV--GSHKHIVNIKDVYENIYN-GSR   86 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~--~~h~ni~~~~~~~~~~~~-~~~   86 (372)
                      |++. +.||.|+||.||+|.+..+++.||+|.+...       ....+|+..+.++  ++||||+++++++..... +..
T Consensus         1 y~~~-~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEEL-AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEE-EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            5664 6799999999999999989999999999622       1233566554333  469999999999875321 223


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .++++|||+. ++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++                 
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~-----------------  141 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT-----------------  141 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc-----------------
Confidence            5899999996 4899988765444699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.++|+|||++...... .......++..|+|||.+.+..++.++|+|||||++|+|++|.+||.+..
T Consensus       142 ----------~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         142 ----------SDGQVKIADFGLARIYSFE-MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             ----------cCCCEEEeccCcceeccCC-cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence                      5677999999988765432 22233456888999999988889999999999999999999999996544


Q ss_pred             CCCCCHhHHHHHhh-CCccCC------------------CCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         247 GQAISPGMKNRIRL-GQFDFP------------------NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       247 ~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ..+....+...... ....++                  ......++..+.++|.+||+.||.+||++++++.||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            32211111111000 000000                  00012356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.8e-41  Score=312.67  Aligned_cols=245  Identities=18%  Similarity=0.293  Sum_probs=193.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcE----EEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEV----YALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+|++. +.||+|+||+||+|.+..+++.    ||+|++...      ....+|+.+ ++.++||||+++++++..    
T Consensus         7 ~~f~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~g~~~~----   80 (316)
T cd05108           7 TEFKKI-KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV-MASVDNPHVCRLLGICLT----   80 (316)
T ss_pred             hhceee-eeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEcC----
Confidence            568885 7799999999999998766654    899998532      233456665 677799999999998863    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                       ...++++||+.+|+|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+|||++               
T Consensus        81 -~~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~---------------  143 (316)
T cd05108          81 -STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK---------------  143 (316)
T ss_pred             -CCceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---------------
Confidence             34679999999999999998754 4589999999999999999999999999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcc--cccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL--QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                  .++.+||+|||+++.........  ....++..|+|||.+....++.++|||||||++|+|++ |..|
T Consensus       144 ------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p  211 (316)
T cd05108         144 ------------TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  211 (316)
T ss_pred             ------------CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence                        56679999999998664322211  12233567999999998999999999999999999997 9999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |.+....    .+...+.. ....+.  ...++.++.+++.+||..||.+|||+.+++.+
T Consensus       212 ~~~~~~~----~~~~~~~~-~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         212 YDGIPAS----EISSILEK-GERLPQ--PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCCHH----HHHHHHhC-CCCCCC--CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9654322    12222222 222222  23578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-40  Score=297.71  Aligned_cols=248  Identities=31%  Similarity=0.484  Sum_probs=201.3

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .|++ .+.||.|++|.||+|.+..+++.+++|++....     ...+|++. ++.++|+||+.+++++..    +...++
T Consensus         1 ~y~~-~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~~l   74 (253)
T cd05122           1 LFEI-LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQI-LKKCKHPNIVKYYGSYLK----KDELWI   74 (253)
T ss_pred             Ccee-eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHH-HHhCCCCCEeEEEEEEec----CCeEEE
Confidence            3777 477999999999999999999999999986432     45567776 666789999999999876    577899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ++||+.+++|.+++.... ..+++..++.++.|++.||.+||+.|++||||+|+||+++                     
T Consensus        75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---------------------  132 (253)
T cd05122          75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---------------------  132 (253)
T ss_pred             EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---------------------
Confidence            999999999999987753 4699999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI  250 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  250 (372)
                            +++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+... 
T Consensus       133 ------~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-  204 (253)
T cd05122         133 ------SDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-  204 (253)
T ss_pred             ------cCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-
Confidence                  567799999998877654322 344567889999999988889999999999999999999999996543211 


Q ss_pred             CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                        .............+  ....++.++.++|.+||+.||++|||+.++++|||
T Consensus       205 --~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         205 --ALFKIATNGPPGLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             --HHHHHHhcCCCCcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence              11111111111111  11234889999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1e-40  Score=306.17  Aligned_cols=254  Identities=32%  Similarity=0.560  Sum_probs=200.7

Q ss_pred             ceeeccccccccCCeEEEEEEEc---CCCcEEEEEEecch---------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          16 DYDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHDT---------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      +|++ .+.||.|++|.||+|.+.   .+++.||||++...         ....+|+..+.++.+||||+++++.+..   
T Consensus         1 ~~~~-~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---   76 (288)
T cd05583           1 NFEL-LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---   76 (288)
T ss_pred             CceE-EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec---
Confidence            4777 477999999999999864   46789999998632         1234677775666689999999998875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       +...|+||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.|++||||||+||+++              
T Consensus        77 -~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~--------------  139 (288)
T cd05583          77 -DTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD--------------  139 (288)
T ss_pred             -CCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC--------------
Confidence             67899999999999999998764  3589999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCC--CCCccchhhHHHHHHHHHhCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDK--YDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~  240 (372)
                                   .++.++++|||++......... ....+|++.|+|||.+.+..  .+.++|+||||+++|+|++|..
T Consensus       140 -------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~  206 (288)
T cd05583         140 -------------SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS  206 (288)
T ss_pred             -------------CCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCC
Confidence                         5667999999988765432221 22346788999999986654  7889999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC---hhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT---IDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s---~~eil~hp~~~~~  307 (372)
                      ||...........+...+.......+    ..++.++.++|.+||+.||++|||   +.++|+||||+.+
T Consensus       207 p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         207 PFTVDGEQNSQSEISRRILKSKPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             CcccCcccchHHHHHHHHHccCCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            99644332222233333333322222    357899999999999999999998   5677999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.3e-40  Score=318.27  Aligned_cols=249  Identities=24%  Similarity=0.417  Sum_probs=193.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCC-----CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKT-----SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .++|.+ .+.||.|+||.||+|.+...     +..||||++...      ....+|+.++.++..||||+++++++..  
T Consensus        36 ~~~~~~-~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--  112 (400)
T cd05105          36 RDGLVL-GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--  112 (400)
T ss_pred             ccceeh-hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence            466777 58899999999999987533     457999999632      2345788875555469999999999865  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhcc------------------------------------------------------
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKE------------------------------------------------------  108 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~------------------------------------------------------  108 (372)
                        ....|+|||||++|+|.+++....                                                      
T Consensus       113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         113 --SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             --CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence              667999999999999999886531                                                      


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceee
Q psy3151         109 ----------------------------------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY  148 (372)
Q Consensus       109 ----------------------------------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli  148 (372)
                                                              ...+++..+..++.||+.||+|||+.||+||||||+|||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill  270 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence                                                    1247888999999999999999999999999999999999


Q ss_pred             ecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchh
Q psy3151         149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIW  226 (372)
Q Consensus       149 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  226 (372)
                      +                           .++.+||+|||++........  ......+++.|+|||.+.+..++.++|||
T Consensus       271 ~---------------------------~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  323 (400)
T cd05105         271 A---------------------------QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW  323 (400)
T ss_pred             e---------------------------CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHH
Confidence            8                           566799999999876533221  12234467789999999888899999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         227 SLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       227 slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||||++|+|++ |..||......   ......+..+ ...+  ....++.++.+++.+||..||++|||+.++.+
T Consensus       324 SlGvil~ellt~g~~P~~~~~~~---~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         324 SYGILLWEIFSLGGTPYPGMIVD---STFYNKIKSG-YRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHHHHHHCCCCCCcccchh---HHHHHHHhcC-CCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            99999999997 99998643221   1222223222 1111  12367899999999999999999999998866

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.1e-40  Score=304.31  Aligned_cols=246  Identities=24%  Similarity=0.385  Sum_probs=195.8

Q ss_pred             cceeeccccccccCCeEEEEEEE-----cCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVE-----KKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +.|.+ .+.||.|+||+||++.+     ..++..+|+|.+...     ....+|+.. ++.++||||+++++++..    
T Consensus         5 ~~~~~-~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   78 (288)
T cd05093           5 HNIVL-KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL-LTNLQHEHIVKFYGVCVE----   78 (288)
T ss_pred             HHeee-ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHH-HHhCCCCCcceEEEEEec----
Confidence            56777 57899999999999985     345677999998642     234567776 566689999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKE-----------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~-----------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                      +...++||||+++++|.+++....           ...+++..++.++.||+.||+|||+.|++||||||+||+++    
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~----  154 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----  154 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc----
Confidence            678999999999999999997542           12489999999999999999999999999999999999998    


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHH
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI  231 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  231 (372)
                                             +++.++++|||++........  ......+++.|+|||.+.+..++.++|+|||||+
T Consensus       155 -----------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~i  211 (288)
T cd05093         155 -----------------------ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV  211 (288)
T ss_pred             -----------------------cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHH
Confidence                                   567799999999876533221  1223345678999999988889999999999999


Q ss_pred             HHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         232 MYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       232 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +|+|++ |..||.....    ......+..+.....   ....+.++.+|+.+||+.||.+|||+.+++.
T Consensus       212 l~~l~t~g~~p~~~~~~----~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         212 LWEIFTYGKQPWYQLSN----NEVIECITQGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHHhCCCCCCCCCCH----HHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999998 8999865442    223344444332211   1357899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-40  Score=313.96  Aligned_cols=251  Identities=22%  Similarity=0.401  Sum_probs=195.6

Q ss_pred             ccceeeccccccccCCeEEEEEEE-----cCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVE-----KKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .++|++ .+.||.|+||+||+|.+     ..+++.||||++...      ....+|+..+.++.+||||+++++++..  
T Consensus         6 ~~~~~~-~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--   82 (343)
T cd05103           6 RDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--   82 (343)
T ss_pred             hhHhcc-cccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec--
Confidence            478998 57899999999999985     356789999998632      2355788887777689999999998753  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccC-----------------------------------------------------
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKED-----------------------------------------------------  109 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~-----------------------------------------------------  109 (372)
                       .+..++++|||+.+|+|.+++.....                                                     
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence             24578999999999999999875321                                                     


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCC
Q psy3151         110 ------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD  177 (372)
Q Consensus       110 ------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  177 (372)
                                  ..++...+..++.||+.||+|||++||+||||||+||+++                           .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---------------------------~  214 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------E  214 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---------------------------C
Confidence                        2367888899999999999999999999999999999998                           5


Q ss_pred             CCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhH
Q psy3151         178 GGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGM  254 (372)
Q Consensus       178 ~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~  254 (372)
                      ++.+||+|||++.........  .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||......   ...
T Consensus       215 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~  291 (343)
T cd05103         215 NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEF  291 (343)
T ss_pred             CCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc---HHH
Confidence            667999999988765332211  112334567999999988889999999999999999997 99998653321   122


Q ss_pred             HHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ...+..+.. .+.+  ...++++.+++.+||+.||.+|||+.++++|
T Consensus       292 ~~~~~~~~~-~~~~--~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         292 CRRLKEGTR-MRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHhccCC-CCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222222221 1111  2468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.1e-40  Score=306.46  Aligned_cols=250  Identities=25%  Similarity=0.418  Sum_probs=196.7

Q ss_pred             cccceeeccccccccCCeEEEEEEE-----cCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVE-----KKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..++|.+ .+.||+|+||.||+|.+     ..++..+|+|.+...      ....+|+..+.++.+||||+++++++.. 
T Consensus        33 ~~~~~~~-~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  110 (302)
T cd05055          33 PRNNLSF-GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-  110 (302)
T ss_pred             cHHHeEE-cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-
Confidence            4568888 58899999999999975     345678999988632      2345688875555589999999998875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         ....|+||||+.+++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++            
T Consensus       111 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~------------  175 (302)
T cd05055         111 ---GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT------------  175 (302)
T ss_pred             ---CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc------------
Confidence               56789999999999999999765444589999999999999999999999999999999999997            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-G  238 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g  238 (372)
                                     .++.++++|||++........  ......+++.|+|||.+.+..++.++||||+||++|+|++ |
T Consensus       176 ---------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g  240 (302)
T cd05055         176 ---------------HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG  240 (302)
T ss_pred             ---------------CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCC
Confidence                           566789999998876543221  1122334678999999988889999999999999999998 9


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..||......   ......+..+ ...  ......++++.+++.+||..+|++|||+.++++
T Consensus       241 ~~p~~~~~~~---~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         241 SNPYPGMPVD---SKFYKLIKEG-YRM--AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCcCCCCch---HHHHHHHHcC-CcC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9998654322   1122222222 111  112356899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.7e-41  Score=302.06  Aligned_cols=246  Identities=21%  Similarity=0.347  Sum_probs=197.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +.+.|+++ +.||+|+||.||+|... +++.||+|.+...    ....+|+.. ++.++|+||+++++++.     ....
T Consensus         4 ~~~~~~~~-~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~-----~~~~   75 (260)
T cd05067           4 PRETLKLV-KKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANL-MKQLQHPRLVRLYAVVT-----QEPI   75 (260)
T ss_pred             chHHceee-eeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHH-HHhcCCcCeeeEEEEEc-----cCCc
Confidence            46789985 77999999999999864 6788999998642    344567776 66679999999998864     3458


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |++|||+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++                   
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~-------------------  136 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS-------------------  136 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc-------------------
Confidence            9999999999999999876556799999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  246 (372)
                              +++.++++|||++........ ......++..|+|||.+....++.++|+|||||++|+|++ |..||.+.+
T Consensus       137 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  208 (260)
T cd05067         137 --------ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT  208 (260)
T ss_pred             --------CCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence                    567799999998876542221 1122334668999999988889999999999999999998 999996544


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..    .....+..+ ...  +.....+.++.++|.+||..+|++|||+++++.
T Consensus       209 ~~----~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         209 NP----EVIQNLERG-YRM--PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             hH----HHHHHHHcC-CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            32    222222222 111  222467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.9e-40  Score=297.93  Aligned_cols=244  Identities=21%  Similarity=0.381  Sum_probs=194.1

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      ++|++. +.||+|+||.||+|... ++..+|+|.+...    ....+|+.. ++.++||||+++++++..    ....++
T Consensus         4 ~~~~~~-~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~i   76 (256)
T cd05114           4 SELTFM-KELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKV-MMKLSHPKLVQLYGVCTQ----QKPLYI   76 (256)
T ss_pred             HHcEEe-eEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHH-HHHCCCCCceeEEEEEcc----CCCEEE
Confidence            568885 66999999999999875 4668999987632    345567776 667799999999998875    567899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+++|+|.+++.... +.+++..++.++.|++.||+|||+.||+||||||+||+++                     
T Consensus        77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---------------------  134 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---------------------  134 (256)
T ss_pred             EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---------------------
Confidence            999999999999987643 4589999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcc-cccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASL-QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  248 (372)
                            .++.++++|||.+.......... ....++..|+|||.+....++.++|+|||||++|+|++ |+.||...+..
T Consensus       135 ------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~  208 (256)
T cd05114         135 ------STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY  208 (256)
T ss_pred             ------CCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence                  56678999999887653322111 12223557999999988889999999999999999999 89999654432


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                          .....+..+.....   ....+.++.+++.+||+.+|.+|||++++++
T Consensus       209 ----~~~~~i~~~~~~~~---~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         209 ----EVVEMISRGFRLYR---PKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ----HHHHHHHCCCCCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                22333333322111   1346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-40  Score=304.18  Aligned_cols=249  Identities=21%  Similarity=0.381  Sum_probs=194.2

Q ss_pred             cceeeccccccccCCeEEEEEEEcC-----CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKK-----TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      +.|.+. +.||+|++|.||+|.+..     ++..||+|.+...      ....+|+.. ++.++|+||+++++++..   
T Consensus         6 ~~~~~~-~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~---   80 (277)
T cd05036           6 DSITLL-RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI-MSKFNHQNIVRLIGVSFE---   80 (277)
T ss_pred             HHcEee-eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEcc---
Confidence            678885 779999999999999987     7889999988532      124556665 566799999999998765   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKED-----GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                       ....++||||+.+++|.+++.....     ..+++..+..++.||+.||+|||++|++||||||+||+++.++      
T Consensus        81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~------  153 (277)
T cd05036          81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG------  153 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC------
Confidence             4567999999999999999976532     2489999999999999999999999999999999999998433      


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHH
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  236 (372)
                                        ....+|++|||++.........  ......+..|+|||++.+..++.++|||||||++|+|+
T Consensus       154 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~  215 (277)
T cd05036         154 ------------------PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF  215 (277)
T ss_pred             ------------------CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence                              2345788888887765321111  11222345799999998888999999999999999999


Q ss_pred             h-CCCCCCCCCCCCCCHhHHHHHhhC-CccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         237 C-GFPPFFSNHGQAISPGMKNRIRLG-QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       237 ~-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      + |..||...+..    .....+... ....+    ..++..+.+++.+||+.+|++|||+.++++|
T Consensus       216 ~~g~~pf~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         216 SLGYMPYPGRTNQ----EVMEFVTGGGRLDPP----KGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCCCCCCCCCCHH----HHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            7 99999654432    222222222 12222    3578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-40  Score=299.80  Aligned_cols=246  Identities=24%  Similarity=0.414  Sum_probs=196.2

Q ss_pred             cceeeccccccccCCeEEEEEEEcCC---CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKT---SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ++|++ .+.||+|+||+||+|.+..+   ...||||.+...      ....+|+.. ++.++||||+++++++..    +
T Consensus         4 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~   77 (266)
T cd05033           4 SYVTI-EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASI-MGQFDHPNIIRLEGVVTK----S   77 (266)
T ss_pred             HHcee-eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHH-HHhCCCCCcceEeEEEec----C
Confidence            67888 57799999999999998654   468999988632      123457766 667799999999998865    5


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...+++|||+.+++|.+++.... +.+++..++.++.|++.||.|||++||+|+||||+||+++                
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~----------------  140 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN----------------  140 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----------------
Confidence            67899999999999999997654 4699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCccc--ccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ--TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPF  242 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  242 (372)
                                 .++.++++|||++...........  ...+++.|+|||.+....++.++|+|||||++|+|++ |..||
T Consensus       141 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~  209 (266)
T cd05033         141 -----------SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY  209 (266)
T ss_pred             -----------CCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCC
Confidence                       567799999999887642222111  2233567999999988889999999999999999998 99999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ......    .....+..+ ...+.  ...++.++.+|+.+||+.+|++|||+.+++++
T Consensus       210 ~~~~~~----~~~~~~~~~-~~~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         210 WDMSNQ----DVIKAVEDG-YRLPP--PMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCCCHH----HHHHHHHcC-CCCCC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            654322    223333322 11122  23678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.5e-41  Score=302.03  Aligned_cols=248  Identities=29%  Similarity=0.471  Sum_probs=197.9

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc----------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD----------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ||.+ .+.||+|+||+||+|.+..++..+++|++..          .....+|+.. ++.++||||+++++++..    .
T Consensus         1 ~y~i-~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~   74 (260)
T cd08222           1 RYIL-QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQL-LSKLDHPAIVKFHASFLE----R   74 (260)
T ss_pred             Ccee-eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHH-HHhCCCCcHHHHHHHHhc----C
Confidence            6888 4779999999999999988888787777642          1133456665 667799999999998865    5


Q ss_pred             eEEEEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ...++|+||+.+++|.+++..  .....+++..++.++.|++.||.|||+.|++|+||||+||+++              
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~--------------  140 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK--------------  140 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee--------------
Confidence            678999999999999998864  2234699999999999999999999999999999999999996              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                    .+.++++|||.+..............|++.|+|||.+....++.++|+||+|+++|+|++|..||.
T Consensus       141 --------------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~  206 (260)
T cd08222         141 --------------NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE  206 (260)
T ss_pred             --------------cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                          234889999888765443333344567889999999988889999999999999999999999995


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ....    ......+..+...   .....++.++.++|.+||..||++||++.++++||||
T Consensus       207 ~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         207 GQNF----LSVVLRIVEGPTP---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             CccH----HHHHHHHHcCCCC---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            4321    2222233222211   1123678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=300.20  Aligned_cols=241  Identities=22%  Similarity=0.409  Sum_probs=195.9

Q ss_pred             ccccccCCeEEEEEEEcCC---CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          22 EILGLGINGKVLQIVEKKT---SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      +.||+|+||.||+|.+...   +..+|+|++...      ....+|+.. +..++|+||+++++++..    +...++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARV-MKKLGHPNVVRLLGVCTE----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHH-HhhcCCCChheeeeeecC----CCceEEEE
Confidence            3599999999999999866   999999998632      244567776 555679999999998875    67899999


Q ss_pred             eccCCCchhHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          93 ECMHGGELFQRIQQKE-------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~-------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ||+++++|.+++....       ...+++..++.++.|++.||+|||++|++||||||+||+++                
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~----------------  139 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG----------------  139 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC----------------
Confidence            9999999999998751       25699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPF  242 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  242 (372)
                                 .++.++|+|||.+.......  .......+++.|+|||.+....++.++|+|||||++|+|++ |..||
T Consensus       140 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  208 (262)
T cd00192         140 -----------EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY  208 (262)
T ss_pred             -----------CCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence                       56779999999988765432  22334456888999999988889999999999999999999 69999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ......    .+...+..+.. .  .....++.++.+++.+||..+|.+|||+.+++++
T Consensus       209 ~~~~~~----~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         209 PGLSNE----EVLEYLRKGYR-L--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CCCCHH----HHHHHHHcCCC-C--CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            665322    23333332211 1  1123679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-40  Score=301.74  Aligned_cols=245  Identities=20%  Similarity=0.332  Sum_probs=193.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|++. +.||+|+||.||+|.+..+ ..||+|++...    ....+|+.. ++.++||||+++++.+.     ....|
T Consensus         5 ~~~~~~~-~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~-l~~l~~~~i~~~~~~~~-----~~~~~   76 (262)
T cd05071           5 RESLRLE-VKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQV-MKKLRHEKLVQLYAVVS-----EEPIY   76 (262)
T ss_pred             hHHeeEe-eecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHH-HHhCCCCCcceEEEEEC-----CCCcE
Confidence            4789994 7799999999999998765 45999998642    234567776 56678999999998764     34579


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++                    
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~--------------------  136 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG--------------------  136 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc--------------------
Confidence            999999999999999865445689999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                             .++.++|+|||.+......... .....++..|+|||......++.++|+|||||++|+|++ |..||.....
T Consensus       137 -------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~  209 (262)
T cd05071         137 -------ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN  209 (262)
T ss_pred             -------CCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence                   5667999999988765432221 112334667999999988889999999999999999999 8888865432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .    .....+..+ ...+  ....++..+.+++.+||+.||++|||++++++
T Consensus       210 ~----~~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         210 R----EVLDQVERG-YRMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             H----HHHHHHhcC-CCCC--CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            2    223333222 1111  12367899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.3e-40  Score=302.22  Aligned_cols=249  Identities=18%  Similarity=0.297  Sum_probs=193.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..++|++. +.||+|+||.||+|.+.     .++..||||.+....      ...+|+.+ ++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~-~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~-l~~l~~~~iv~~~~~~~~-   80 (277)
T cd05062           4 AREKITMS-RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV-MKEFNCHHVVRLLGVVSQ-   80 (277)
T ss_pred             cHHHceee-eeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEcC-
Confidence            45789995 77999999999999865     245789999885321      23466666 566799999999998865 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKED--------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~--------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                         +...++||||+.+++|.+++.+...        ..++...+..++.|++.||+|||+.|++||||||+||+++    
T Consensus        81 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~----  153 (277)
T cd05062          81 ---GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----  153 (277)
T ss_pred             ---CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc----
Confidence               6678999999999999999876321        2357788999999999999999999999999999999998    


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHH
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI  231 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  231 (372)
                                             .++.++++|||++.........  .....+++.|+|||++.+..++.++|+|||||+
T Consensus       154 -----------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~  210 (277)
T cd05062         154 -----------------------EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV  210 (277)
T ss_pred             -----------------------CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHH
Confidence                                   5667899999988755332211  112344678999999988889999999999999


Q ss_pred             HHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         232 MYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       232 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      +|+|++ |..||.+...    ......+........   ....+..+.+++.+||+.||++|||+.+++++
T Consensus       211 l~el~~~~~~p~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         211 LWEIATLAEQPYQGMSN----EQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHHHcCCCCCCCCCCH----HHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999998 7888865432    222232322222111   13578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-40  Score=306.99  Aligned_cols=261  Identities=28%  Similarity=0.482  Sum_probs=198.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--   82 (372)
                      ...++|++. +.||.|+||.||+|.+..+|+.||+|.+...       ....+|+.. ++.++||||+++++++....  
T Consensus         4 ~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~-~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           4 RCVDKFDII-GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKI-LRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhhee-eeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHH-HHhCCCCCeeeeeheecCcchh
Confidence            356789984 7799999999999999999999999998632       123467776 56669999999999886421  


Q ss_pred             ----CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          83 ----NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        83 ----~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                          .....+|+|+||+.+ ++...+.... ..+++..++.++.||+.||+|||+.||+||||||+||+++         
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---------  150 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---------  150 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---------
Confidence                113379999999975 7777776542 4699999999999999999999999999999999999998         


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHH
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll  236 (372)
                                        .++.+||+|||++........ ......+++.|+|||.+.+ ..++.++|+|||||++|+|+
T Consensus       151 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~  212 (302)
T cd07864         151 ------------------NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF  212 (302)
T ss_pred             ------------------CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHH
Confidence                              567799999999876543221 1222345778999998754 45789999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCcc--CC---------------------CCcccccCHHHHHHHHHhccCCCCCCC
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFD--FP---------------------NPEWEHVSQEAKTLIKNMLCVDPSERL  293 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~---------------------~~~~~~~s~~~~~li~~ll~~dP~~R~  293 (372)
                      +|++||...........+.... .+..+  ++                     ...+..++..+.++|.+||..||.+||
T Consensus       213 ~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  291 (302)
T cd07864         213 TKKPIFQANQELAQLELISRLC-GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC  291 (302)
T ss_pred             hCCCCCCCCChHHHHHHHHHHh-CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC
Confidence            9999996543221111111110 00000  00                     011234689999999999999999999


Q ss_pred             ChhHHhcCCcc
Q psy3151         294 TIDQVMENKWI  304 (372)
Q Consensus       294 s~~eil~hp~~  304 (372)
                      |+++++.||||
T Consensus       292 ~~~~il~~~~~  302 (302)
T cd07864         292 TAEEALNSPWL  302 (302)
T ss_pred             CHHHHhcCCCC
Confidence            99999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=303.64  Aligned_cols=247  Identities=21%  Similarity=0.342  Sum_probs=196.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCC-----CcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKT-----SEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..++|.+. +.||.|+||.||+|.+...     +..+|+|.+....      ...+|+.. +..++||||+++++++.. 
T Consensus         4 ~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~-   80 (277)
T cd05032           4 PREKITLI-RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV-MKEFNCHHVVRLLGVVST-   80 (277)
T ss_pred             chHHeeEE-eEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHH-HHhCCCCceeEEEEEEcC-
Confidence            35789984 7799999999999998654     4889999986332      23456665 566799999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKE--------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~--------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                         +...|+||||+.+++|.+++....        ...+++..+..++.||+.||.|||+.||+||||||+||+++    
T Consensus        81 ---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~----  153 (277)
T cd05032          81 ---GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA----  153 (277)
T ss_pred             ---CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc----
Confidence               577999999999999999987532        12478889999999999999999999999999999999998    


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHH
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI  231 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  231 (372)
                                             .++.+||+|||+++.......  ......++..|+|||.+.+..++.++|+|||||+
T Consensus       154 -----------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  210 (277)
T cd05032         154 -----------------------EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVV  210 (277)
T ss_pred             -----------------------CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHH
Confidence                                   567799999998876533221  1233455778999999988889999999999999


Q ss_pred             HHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         232 MYILLC-GFPPFFSNHGQAISPGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       232 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +|+|++ |..||...+..    .....+..+. ...|    ..++.++.+++.+||+.+|++|||+.+++.
T Consensus       211 l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         211 LWEMATLAEQPYQGLSNE----EVLKFVIDGGHLDLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHHhhccCCCCCccCCHH----HHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            999998 99998654332    2223333222 2222    246899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4645|consensus

Probab=100.00  E-value=9.8e-43  Score=349.34  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=208.1

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---h----hhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---V----KARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ..+.-|+.- +-.||.|.||.||-|.+..||+..|+|.+.-.   .    ..-+|..+ +..++|||+|+++++=.+   
T Consensus      1231 snV~~rWqr-g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~v-lE~lnHpNlV~YyGVEvH--- 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQR-GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKV-LEGLNHPNLVRYYGVEVH--- 1305 (1509)
T ss_pred             ccceeeecc-ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHH-HHhccCccccccCceeec---
Confidence            346667776 57799999999999999999999999988522   1    22355555 788899999999998654   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ....||.||||.+|+|.+.+...  +..+|...+.+..|++.|++|||+.|||||||||.||+++              
T Consensus      1306 -Rekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld-------------- 1368 (1509)
T KOG4645|consen 1306 -REKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD-------------- 1368 (1509)
T ss_pred             -HHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee--------------
Confidence             56789999999999999999764  3478888899999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCCCC---CCCccchhhHHHHHHHHH
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll  236 (372)
                                   .+|.+|.+|||.|..+..+..    ......|||.|||||++.+..   -..++|||||||++.||+
T Consensus      1369 -------------~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~ 1435 (1509)
T KOG4645|consen 1369 -------------FNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMA 1435 (1509)
T ss_pred             -------------cCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEee
Confidence                         677899999999988765432    344578999999999996644   457899999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCcc-CCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFD-FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      ||+.||...+..   ..+.-.+..|.-+ +|    +.+|++.+|||.+||..||++|+++.|+|+|-|-+.
T Consensus      1436 tGkrPW~~~dne---~aIMy~V~~gh~Pq~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1436 TGKRPWAELDNE---WAIMYHVAAGHKPQIP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             cCCCchhhccch---hHHHhHHhccCCCCCc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            999999654432   2333334444332 22    359999999999999999999999999999998654

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.5e-40  Score=305.12  Aligned_cols=247  Identities=21%  Similarity=0.378  Sum_probs=193.0

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCc--EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSE--VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++ .++||.|+||.||+|.+..++.  .+++|.+...      ....+|+..+.++.+||||+++++++..    ..
T Consensus         2 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~   76 (297)
T cd05089           2 EDIKF-EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN----RG   76 (297)
T ss_pred             cccee-eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc----CC
Confidence            67888 5889999999999999987765  4688887631      2345677776666689999999998865    56


Q ss_pred             EEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~  152 (372)
                      ..|+||||+++++|.+++....              .+.+++..++.++.|++.||+|||+.||+||||||+|||++   
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~---  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC---
Confidence            7899999999999999997532              12488999999999999999999999999999999999997   


Q ss_pred             CCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHH
Q psy3151         153 DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM  232 (372)
Q Consensus       153 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  232 (372)
                                              .++.+||+|||++....... .......+..|+|||.+....++.++|||||||++
T Consensus       154 ------------------------~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il  208 (297)
T cd05089         154 ------------------------ENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLL  208 (297)
T ss_pred             ------------------------CCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHH
Confidence                                    56678999999886432111 11112224569999999888899999999999999


Q ss_pred             HHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         233 YILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       233 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |+|++ |..||......    .....+..+ ...+  ....++.++.+|+.+||..+|.+|||++++++.
T Consensus       209 ~el~t~g~~pf~~~~~~----~~~~~~~~~-~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         209 WEIVSLGGTPYCGMTCA----ELYEKLPQG-YRME--KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             HHHHcCCCCCCCCCCHH----HHHHHHhcC-CCCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99997 99999654322    222222222 1111  123588999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.3e-40  Score=305.15  Aligned_cols=254  Identities=25%  Similarity=0.398  Sum_probs=199.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .+.|++. +.||.|++|.||+|.+..+++.||||.+....      ...+|+..+.+..+||||+++++++..    +..
T Consensus        14 ~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~   88 (296)
T cd06618          14 LNDLENL-GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT----DSD   88 (296)
T ss_pred             cchheee-eEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec----CCe
Confidence            4778885 77999999999999999999999999986321      234566655666679999999999875    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .|++|||+. ++|.+++.... +.+++..+..++.||+.||+|||+ .||+||||+|+||+++                 
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~-----------------  149 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD-----------------  149 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc-----------------
Confidence            999999984 57777766543 469999999999999999999997 5999999999999997                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC----CCCccchhhHHHHHHHHHhCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK----YDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                .++.++|+|||++....... ......+++.|+|||.+.+..    ++.++|+||||+++|+|++|..||
T Consensus       150 ----------~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  218 (296)
T cd06618         150 ----------ASGNVKLCDFGISGRLVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY  218 (296)
T ss_pred             ----------CCCCEEECccccchhccCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCC
Confidence                      56779999999987654322 223345678899999986543    788999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCc-cCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQF-DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ......   ......+..... ..+  ....++.++.+|+.+||..||.+|||+++++.||||...
T Consensus       219 ~~~~~~---~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         219 KNCKTE---FEVLTKILQEEPPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CcchhH---HHHHHHHhcCCCCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            543211   112222222221 111  112478999999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-40  Score=298.91  Aligned_cols=246  Identities=21%  Similarity=0.355  Sum_probs=195.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ..++|+++ +.||+|+||.||+|.+. ++..+|+|.+...    ....+|+.+ ++.++|+|++++++++.     ....
T Consensus         4 ~~~~~~~~-~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~-l~~l~~~~i~~~~~~~~-----~~~~   75 (260)
T cd05070           4 PRESLQLI-KKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQI-MKKLRHDKLVQLYAVVS-----EEPI   75 (260)
T ss_pred             chHHhhhh-heeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHH-HHhcCCCceEEEEeEEC-----CCCc
Confidence            45789995 67999999999999875 5677999998632    345578777 56679999999998774     3457


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |++|||+.+++|.+++.......+++..++.++.|++.||.|||+.||+||||||+||+++                   
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~-------------------  136 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-------------------  136 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe-------------------
Confidence            8999999999999999875555689999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  246 (372)
                              +++.++|+|||++......... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+
T Consensus       137 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  208 (260)
T cd05070         137 --------DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN  208 (260)
T ss_pred             --------CCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence                    5667999999998765332211 112234557999999988889999999999999999999 899996543


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..    .....+..+ ...+  .....+.++.+|+.+||..+|.+|||++++++
T Consensus       209 ~~----~~~~~~~~~-~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         209 NR----EVLEQVERG-YRMP--CPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HH----HHHHHHHcC-CCCC--CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            22    222333221 1212  22467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=300.28  Aligned_cols=245  Identities=20%  Similarity=0.390  Sum_probs=194.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .+|++ .+.||.|+||.||+|.+. ++..+|+|++...    ....+|+.. ++.++||||+++++++..    ....|+
T Consensus         4 ~~~~~-~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~~l   76 (256)
T cd05059           4 SELTF-LKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKV-MMKLSHPNLVQLYGVCTK----QRPIFI   76 (256)
T ss_pred             HHcch-hhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHH-HHhCCCCCEEEEEEEEcC----CCceEE
Confidence            35777 477999999999999886 5678999998642    244567776 566799999999998865    567899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+++++|.+++.... +.+++..++.++.||+.||+|||+.|++||||||+||+++                     
T Consensus        77 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---------------------  134 (256)
T cd05059          77 VTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---------------------  134 (256)
T ss_pred             EEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---------------------
Confidence            999999999999997654 3689999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcc-cccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASL-QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  248 (372)
                            .++.+||+|||+++......... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..
T Consensus       135 ------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  208 (256)
T cd05059         135 ------EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS  208 (256)
T ss_pred             ------CCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence                  56779999999887654321111 11122447999999988899999999999999999998 89999654432


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      +    ....+..+ ...+  ....++.++.+++.+||..+|++|||+.++++.
T Consensus       209 ~----~~~~~~~~-~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         209 E----VVESVSAG-YRLY--RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             H----HHHHHHcC-CcCC--CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            2    22333222 1111  123579999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.3e-40  Score=303.17  Aligned_cols=247  Identities=21%  Similarity=0.364  Sum_probs=194.6

Q ss_pred             cceeeccccccccCCeEEEEEEE----cCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVE----KKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +.|++. +.||+|+||+||+|..    ..+++.+|+|.+...      ....+|+.. ++.++||||+++++++..    
T Consensus         5 ~~~~~~-~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~----   78 (283)
T cd05090           5 SAVRFM-EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL-MAELHHPNIVCLLGVVTQ----   78 (283)
T ss_pred             hhceee-eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHH-HhhCCCCCeeeEEEEEec----
Confidence            567884 6799999999999985    345689999998631      234567776 666799999999998865    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeee
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKE---------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYT  149 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~---------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~  149 (372)
                      +...|+||||+.+++|.+++....               ...+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~  158 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence            567899999999999999985321               12478899999999999999999999999999999999998


Q ss_pred             cCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhh
Q psy3151         150 KPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWS  227 (372)
Q Consensus       150 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  227 (372)
                                                 .++.+||+|||+++.......  ......++..|+|||.+.+..++.++|+||
T Consensus       159 ---------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  211 (283)
T cd05090         159 ---------------------------EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS  211 (283)
T ss_pred             ---------------------------CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHH
Confidence                                       566789999999876533221  122334466799999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         228 LGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       228 lG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||++|+|++ |..||.+....    .+...+..... .  +....+++++.+++.+||+.||++||++.+++++
T Consensus       212 lG~il~el~~~g~~p~~~~~~~----~~~~~~~~~~~-~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         212 FGVVLWEIFSFGLQPYYGFSNQ----EVIEMVRKRQL-L--PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHH----HHHHHHHcCCc-C--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            9999999998 99999654321    22333332221 1  1224678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.7e-40  Score=296.67  Aligned_cols=247  Identities=28%  Similarity=0.467  Sum_probs=203.0

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +|++. +.||.|++|.||+|.+..+++.+|+|.+...       ....+|+.. ++.++|+||+++++++..    +...
T Consensus         1 ~y~~~-~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~   74 (256)
T cd08530           1 DFKVL-KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRI-LASVNHPNIISYKEAFLD----GNKL   74 (256)
T ss_pred             CceEe-eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHH-HHhCCCCCchhhhhhhcc----CCEE
Confidence            58884 7799999999999999999999999998632       133456665 566689999999998875    5789


Q ss_pred             EEEEeccCCCchhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          89 LVIMECMHGGELFQRIQQKE--DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~--~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      |+||||+++++|.+++....  ...+++..++.++.|++.||+|||+.|++|+||+|+||+++                 
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~-----------------  137 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV-----------------  137 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe-----------------
Confidence            99999999999999887621  24589999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                ..+.++++|||++......  ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus       138 ----------~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  205 (256)
T cd08530         138 ----------ANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS  205 (256)
T ss_pred             ----------cCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                      5667999999998766443  2334567889999999988889999999999999999999999996544


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .    ......+..+.++..   ...++.++.+++.+||..+|.+|||+.++++||++
T Consensus       206 ~----~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         206 M----QDLRYKVQRGKYPPI---PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             H----HHHHHHHhcCCCCCC---chhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            2    223333333333211   13678999999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2e-40  Score=305.28  Aligned_cols=250  Identities=22%  Similarity=0.279  Sum_probs=193.4

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCC----------------cEEEEEEecch------hhhHHHHHHHHHhcCCCCE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTS----------------EVYALKVLHDT------VKARREVELQLAVGSHKHI   71 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni   71 (372)
                      .++|+++ +.||+|+||.||+|.+..++                ..||+|.+...      ....+|+.+ +..++||||
T Consensus         4 ~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFV-EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI-LSRLSDPNI   81 (296)
T ss_pred             hhhCccc-ccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHH-HHhcCCCCE
Confidence            3689985 77999999999999876544                56899998632      233467777 566699999


Q ss_pred             eEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy3151          72 VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE---------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK  142 (372)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~---------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlk  142 (372)
                      +++++++..    +...+++|||+.+++|.+++....         ...+++..++.++.|++.||+|||+.||+|||||
T Consensus        82 ~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk  157 (296)
T cd05051          82 ARLLGVCTV----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA  157 (296)
T ss_pred             eEEEEEEec----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            999999875    578999999999999999997643         1258999999999999999999999999999999


Q ss_pred             CCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCC
Q psy3151         143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYD  220 (372)
Q Consensus       143 p~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~  220 (372)
                      |+||+++                           ..+.++|+|||++........  ......+++.|+|||.+....++
T Consensus       158 p~Nili~---------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  210 (296)
T cd05051         158 TRNCLVG---------------------------KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT  210 (296)
T ss_pred             hhceeec---------------------------CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC
Confidence            9999998                           567799999998876533221  12234457789999999888899


Q ss_pred             CccchhhHHHHHHHHHh--CCCCCCCCCCCCCCHhHHHHHhhC----CccCCCCcccccCHHHHHHHHHhccCCCCCCCC
Q psy3151         221 KSCDIWSLGVIMYILLC--GFPPFFSNHGQAISPGMKNRIRLG----QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT  294 (372)
Q Consensus       221 ~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s  294 (372)
                      .++|||||||++|+|++  +..||......+    ........    ......+....++.++.+++.+||+.||.+|||
T Consensus       211 ~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt  286 (296)
T cd05051         211 TKSDVWAFGVTLWEILTLCREQPYEHLTDQQ----VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT  286 (296)
T ss_pred             ccchhhhhHHHHHHHHhcCCCCCCCCcChHH----HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC
Confidence            99999999999999998  677885443222    11211111    111111112356799999999999999999999


Q ss_pred             hhHHhc
Q psy3151         295 IDQVME  300 (372)
Q Consensus       295 ~~eil~  300 (372)
                      +.++++
T Consensus       287 ~~el~~  292 (296)
T cd05051         287 FREIHL  292 (296)
T ss_pred             HHHHHH
Confidence            999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.5e-40  Score=303.33  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=196.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCC-----CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKT-----SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      -.++|++. +.||+|+||.||++.+...     ...+|+|.+...      ....+|+..+.++.+|+||+++++++.. 
T Consensus        10 ~~~~~~~~-~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   87 (293)
T cd05053          10 PRDRLTLG-KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-   87 (293)
T ss_pred             CHhHeEEe-eEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-
Confidence            34789885 7899999999999988643     378999988632      1345677775555589999999998865 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcee
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQK--------------EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL  147 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~--------------~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIl  147 (372)
                         +..++++|||+.+|+|.+++...              ..+.+++..+..++.|++.||+|||+.||+||||||+||+
T Consensus        88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence               56799999999999999998652              2346899999999999999999999999999999999999


Q ss_pred             eecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccch
Q psy3151         148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDI  225 (372)
Q Consensus       148 i~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di  225 (372)
                      ++                           +++.+|++|||+++........  .....++..|+|||.+.+..++.++||
T Consensus       165 ~~---------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  217 (293)
T cd05053         165 VT---------------------------EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDV  217 (293)
T ss_pred             Ec---------------------------CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccce
Confidence            98                           5677999999998765432211  112233567999999988889999999


Q ss_pred             hhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         226 WSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       226 wslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||||++|+|++ |..||.....    ......+..+.. .+  .....+.++.+|+.+||..||.+|||+.+++++
T Consensus       218 ~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         218 WSFGVLLWEIFTLGGSPYPGIPV----EELFKLLKEGYR-ME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             eehhhHHHHHhcCCCCCCCCCCH----HHHHHHHHcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            999999999997 9999865432    222333332221 11  113578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.1e-40  Score=334.55  Aligned_cols=143  Identities=31%  Similarity=0.504  Sum_probs=124.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..++|.++ +.||.|+||+||+|.+..+++.||||++...        ....+|+.+ +..++||||+++++++..    
T Consensus         2 ~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~-l~~l~hp~Iv~~~~~~~~----   75 (669)
T cd05610           2 SIEEFVIV-KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDA-LALSKSPFIVHLYYSLQS----   75 (669)
T ss_pred             ccCCEEEE-EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHH-HHhcCCCCcCeEEEEEEE----
Confidence            35789995 7799999999999999999999999999642        234456655 677899999999988875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ..++|+||||+.+++|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+|||++.   .+.++|+|||+
T Consensus        76 ~~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~---~g~vkL~DFGl  150 (669)
T cd05610          76 ANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN---EGHIKLTDFGL  150 (669)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC---CCCEEEEeCCC
Confidence            67899999999999999999765  35899999999999999999999999999999999999974   45799999998


Q ss_pred             CC
Q psy3151         165 VK  166 (372)
Q Consensus       165 ~~  166 (372)
                      ++
T Consensus       151 s~  152 (669)
T cd05610         151 SK  152 (669)
T ss_pred             Cc
Confidence            75

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.6e-40  Score=296.85  Aligned_cols=245  Identities=20%  Similarity=0.364  Sum_probs=193.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      ++|++. +.||+|+||+||+|.+. .+..+|||.+...    ....+|+.. ++.++||||+++++++..    ....|+
T Consensus         4 ~~~~~~-~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~l   76 (256)
T cd05113           4 KDLTFL-KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKV-MMKLSHEKLVQLYGVCTK----QRPIYI   76 (256)
T ss_pred             HHeEEe-eEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHH-HhcCCCCCeeeEEEEEcc----CCCcEE
Confidence            578885 66999999999999875 3556999988642    234567776 666789999999999865    556899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+.+++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++                     
T Consensus        77 v~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---------------------  134 (256)
T cd05113          77 VTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---------------------  134 (256)
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---------------------
Confidence            999999999999997654 3689999999999999999999999999999999999997                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  248 (372)
                            .++.+||+|||.+......... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||..... 
T Consensus       135 ------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-  207 (256)
T cd05113         135 ------DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-  207 (256)
T ss_pred             ------CCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-
Confidence                  5667999999988765332211 111223567999999988889999999999999999998 9999854432 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                         ......+..+.....   ....+..+.+++.+||..||.+|||+.+++.+
T Consensus       208 ---~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         208 ---SETVEKVSQGLRLYR---PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ---HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence               222333333222211   13568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG1035|consensus

Probab=100.00  E-value=2.4e-41  Score=337.84  Aligned_cols=255  Identities=29%  Similarity=0.468  Sum_probs=197.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee-------
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI-------   81 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~-------   81 (372)
                      .+|+.+ ++||+||||.||+|+++-+|+.||||.+.-.      .+..+|+.. +..++|||||+++..+...       
T Consensus       479 ~DFEEL-~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~-LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  479 NDFEEL-ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKL-LARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhHHH-HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHH-HhhcCCcceeeeehhhhccCCccccc
Confidence            345554 7899999999999999999999999998643      356788887 7888999999987665211       


Q ss_pred             -----------------------------------------------c--------C-----------------------
Q psy3151          82 -----------------------------------------------Y--------N-----------------------   83 (372)
Q Consensus        82 -----------------------------------------------~--------~-----------------------   83 (372)
                                                                     .        .                       
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                           0        0                       


Q ss_pred             -----------------------C-------ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy3151          84 -----------------------G-------SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD  133 (372)
Q Consensus        84 -----------------------~-------~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~  133 (372)
                                             +       ...+||=||||+..++.+++.++... -....+|++++||+.||.|+|+
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHh
Confidence                                   0       03479999999987777777664311 1488999999999999999999


Q ss_pred             CCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccc------------------cC
Q psy3151         134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV------------------SN  195 (372)
Q Consensus       134 ~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~------------------~~  195 (372)
                      +|||||||||.|||++                           ..+.|||+|||+|+...                  ..
T Consensus       716 ~giIHRDLKP~NIFLd---------------------------~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~  768 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLD---------------------------SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSN  768 (1351)
T ss_pred             CceeeccCCcceeEEc---------------------------CCCCeeecccccchhhhhhhhhHhhccCccccccCCC
Confidence            9999999999999998                           56679999999987621                  11


Q ss_pred             CCcccccccCCCcCCCcccCCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccc
Q psy3151         196 KASLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEH  272 (372)
Q Consensus       196 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (372)
                      ....+..+||.-|+|||++.+..   |+.|+||||||++++||+.   ||...  .+ ...+...++.+.++.+...+..
T Consensus       769 ~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--ME-Ra~iL~~LR~g~iP~~~~f~~~  842 (1351)
T KOG1035|consen  769 DGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--ME-RASILTNLRKGSIPEPADFFDP  842 (1351)
T ss_pred             CcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch--HH-HHHHHHhcccCCCCCCcccccc
Confidence            22456678999999999996654   9999999999999999984   56321  11 1234555666666666323334


Q ss_pred             cCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         273 VSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       273 ~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      --+.-..+|++||+.||++||||.|+|.+.||-
T Consensus       843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  843 EHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             cchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            446677899999999999999999999999985

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.9e-40  Score=300.33  Aligned_cols=244  Identities=17%  Similarity=0.293  Sum_probs=191.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCc----EEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSE----VYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ++|+++ +.||.|+||+||+|.+..+|+    .||+|++....      ...+|+.+ +...+||||+++++++..    
T Consensus         7 ~~~~~~-~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----   80 (279)
T cd05109           7 TELKKV-KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV-MAGVGSPYVCRLLGICLT----   80 (279)
T ss_pred             hheeee-eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHH-HHhcCCCCCceEEEEEcC----
Confidence            678885 779999999999999877776    48999985321      23345555 566789999999998753    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                       ...++++||+++|+|.+++.... +.+++..+..++.||+.||+|||++||+||||||+|||++               
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---------------  143 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---------------  143 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---------------
Confidence             34678999999999999987643 4699999999999999999999999999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                  +.+.+||+|||+++........  .....+++.|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus       144 ------------~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p  211 (279)
T cd05109         144 ------------SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ------------CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence                        5567899999998766432221  112233567999999988889999999999999999998 8999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |.....    ......+..+...   +....++.++.+++.+||..||++|||+.+++.
T Consensus       212 ~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         212 YDGIPA----REIPDLLEKGERL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCCCCH----HHHHHHHHCCCcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            854332    1222333322211   112367899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-40  Score=298.08  Aligned_cols=236  Identities=24%  Similarity=0.367  Sum_probs=187.0

Q ss_pred             cccccCCeEEEEEEE--cCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          23 ILGLGINGKVLQIVE--KKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      .||+|+||+||+|.+  ..+++.+|+|++...       ....+|+.+ ++.++||||+++++++.     +...++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~-----~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANV-MQQLDNPYIVRMIGICE-----AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHH-HHhCCCCCcceEEEEEc-----CCCcEEEEe
Confidence            389999999999964  567899999998532       123456665 66779999999999874     345789999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      |+.+++|.+++...  +.+++..+..++.|++.||+|||++||+||||||+||+++                        
T Consensus        76 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~------------------------  129 (257)
T cd05116          76 LAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV------------------------  129 (257)
T ss_pred             cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc------------------------
Confidence            99999999999764  3599999999999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQA  249 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  249 (372)
                         .++.++|+|||++.........   .....+++.|+|||.+....++.++|+|||||++|+|++ |..||...... 
T Consensus       130 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  205 (257)
T cd05116         130 ---TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-  205 (257)
T ss_pred             ---CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence               5667999999998765433221   112233578999999988889999999999999999998 99999654332 


Q ss_pred             CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                         .....+..+.. .+  ....+++++.++|.+||+.||.+|||+++|.+
T Consensus       206 ---~~~~~i~~~~~-~~--~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         206 ---EVTQMIESGER-ME--CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ---HHHHHHHCCCC-CC--CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence               22333333322 11  11368999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.6e-40  Score=304.84  Aligned_cols=250  Identities=22%  Similarity=0.368  Sum_probs=195.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcC-------CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKK-------TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      ..++|.+ .+.||+|+||.||+|.+..       ++..+|+|.+...      ....+|+..+..+.+||||+++++++.
T Consensus        16 ~~~~~~i-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          16 PRDRLVL-GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             ehHHeEE-eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            4588988 5779999999999998743       3357999998632      134567777555658999999999987


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKED--------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN  145 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~--------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~N  145 (372)
                      .    +...|+||||+.+++|.+++.....              ..++...+..++.|++.||+|||+.|++||||||+|
T Consensus        95 ~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  170 (307)
T cd05098          95 Q----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN  170 (307)
T ss_pred             c----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence            5    5678999999999999999976421              248889999999999999999999999999999999


Q ss_pred             eeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcc--cccccCCCcCCCcccCCCCCCCcc
Q psy3151         146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL--QTPCYTPYYVAPEVLGPDKYDKSC  223 (372)
Q Consensus       146 Ili~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~  223 (372)
                      |+++                           .++.++|+|||.+..........  ....+++.|+|||++.+..++.++
T Consensus       171 ill~---------------------------~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  223 (307)
T cd05098         171 VLVT---------------------------EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS  223 (307)
T ss_pred             eEEc---------------------------CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHH
Confidence            9998                           56678999999887653221111  112235679999999888899999


Q ss_pred             chhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         224 DIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       224 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |+|||||++|+|++ |..||.....    ..+...+..+.. .  .....++.++.+|+.+||..+|.+|||+.+++++
T Consensus       224 DvwslG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         224 DVWSFGVLLWEIFTLGGSPYPGVPV----EELFKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            99999999999998 8888854332    223333333221 1  1123678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.5e-40  Score=294.93  Aligned_cols=242  Identities=20%  Similarity=0.356  Sum_probs=193.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh---hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV---KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      ++|++. +.||+|+||.||+|...  |..+|+|.+....   ...+|+.. ++.++|+|++++++++..   .++..|++
T Consensus         6 ~~~~~~-~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~---~~~~~~lv   78 (256)
T cd05082           6 KELKLL-QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASV-MTQLRHSNLVQLLGVIVE---EKGGLYIV   78 (256)
T ss_pred             HhCeee-eeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHH-HHhCCCCCeeeEEEEEEc---CCCceEEE
Confidence            478884 77999999999999764  8889999986432   34567776 667799999999987642   25678999


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      |||+++++|.+++.+.....+++..+..++.||+.||+|||++|++||||||+||+++                      
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----------------------  136 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS----------------------  136 (256)
T ss_pred             EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc----------------------
Confidence            9999999999999876545689999999999999999999999999999999999998                      


Q ss_pred             cCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCC
Q psy3151         172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAI  250 (372)
Q Consensus       172 ~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  250 (372)
                           +++.+|++|||++.......   ....++..|+|||++....++.++|+|||||++|+|++ |..||.....   
T Consensus       137 -----~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---  205 (256)
T cd05082         137 -----EDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---  205 (256)
T ss_pred             -----CCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---
Confidence                 56789999999887543321   22334567999999988889999999999999999997 9999854332   


Q ss_pred             CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                       ......+..+.   +......+++.+.+++.+||+.+|++|||+.++++
T Consensus       206 -~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         206 -KDVVPRVEKGY---KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -HHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             22223332221   11122467899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.7e-40  Score=301.39  Aligned_cols=246  Identities=25%  Similarity=0.392  Sum_probs=196.0

Q ss_pred             cceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+|.+ .+.||+|+||.||+|.+.     .++..+++|.+...     ....+|+.. ++.++|+||+++++++..    
T Consensus         5 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   78 (291)
T cd05094           5 RDIVL-KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL-LTNLQHEHIVKFYGVCGD----   78 (291)
T ss_pred             HHeEE-eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHH-HhcCCCCCcceEEEEEcc----
Confidence            46887 477999999999999854     35677999998632     245567776 666799999999998875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeec
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTK  150 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~  150 (372)
                      +...++||||+++++|.+++....              .+.+++..++.++.||+.||+|||++||+||||||+||+++ 
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~-  157 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-  157 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc-
Confidence            567899999999999999997542              13489999999999999999999999999999999999998 


Q ss_pred             CCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhH
Q psy3151         151 PGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSL  228 (372)
Q Consensus       151 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  228 (372)
                                                .++.++|+|||++........  ......+++.|+|||.+.+..++.++|||||
T Consensus       158 --------------------------~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  211 (291)
T cd05094         158 --------------------------ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF  211 (291)
T ss_pred             --------------------------cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence                                      567799999998876533221  1223455778999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         229 GVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       229 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||++|+|++ |..||......    .....+..+.....   ....+.++.+++.+||+.||++|||+.++++
T Consensus       212 G~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         212 GVILWEIFTYGKQPWFQLSNT----EVIECITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHHHHhCCCCCCCCCCHH----HHHHHHhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            999999998 99998654432    22333333332211   1356889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.1e-40  Score=300.39  Aligned_cols=244  Identities=16%  Similarity=0.298  Sum_probs=190.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCc----EEEEEEecch--hhhHH----HHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSE----VYALKVLHDT--VKARR----EVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~--~~~~~----e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ++|++. +.||.|+||+||+|.+..+|+    .+++|.+...  .....    |+.. +..++||||+++++++.     
T Consensus         7 ~~~~~~-~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~-l~~l~h~~iv~~~~~~~-----   79 (279)
T cd05111           7 TELRKL-KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA-MGSLDHAYIVRLLGICP-----   79 (279)
T ss_pred             hhceec-cccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHH-HhcCCCCCcceEEEEEC-----
Confidence            678884 779999999999999987776    4777777532  12222    2223 45668999999999864     


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...++++||+.+|+|.+++.... +.+++..+..++.||+.||+|||+.|++||||||+||+++               
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~---------------  143 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK---------------  143 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---------------
Confidence            345788999999999999997643 4689999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                  .++.+||+|||+++.......  ......++..|+|||.+....++.++|+|||||++|||++ |..|
T Consensus       144 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p  211 (279)
T cd05111         144 ------------SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP  211 (279)
T ss_pred             ------------CCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence                        567799999999876543222  1223445678999999988889999999999999999998 9999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |.+....    .....+..+... +.  ...++.++.+++.+||..||++|||+.++++
T Consensus       212 ~~~~~~~----~~~~~~~~~~~~-~~--~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         212 YAGMRPH----EVPDLLEKGERL-AQ--PQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCCCHH----HHHHHHHCCCcC-CC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9654322    222223322221 11  1356788999999999999999999999977

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=302.88  Aligned_cols=254  Identities=31%  Similarity=0.481  Sum_probs=196.1

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      |++ .+.||.|++|+||+|....+++.||||.+....      ...+|+..+.++.+|+||+++++++..    +...|+
T Consensus         1 y~~-~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~----~~~~~l   75 (283)
T cd07830           1 YKV-IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE----NDELYF   75 (283)
T ss_pred             Cee-heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc----CCcEEE
Confidence            566 467999999999999999999999999986431      234577764444449999999999876    678999


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+ +++|.+.+.......+++..+..++.|++.+|.|||++|++|+||+|+||+++                     
T Consensus        76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~---------------------  133 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS---------------------  133 (283)
T ss_pred             EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---------------------
Confidence            99999 78999988876545689999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-PDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA  249 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  249 (372)
                            +.+.++|+|||.+...... .......++..|+|||++. ...++.++|+||||+++++|++|.+||......+
T Consensus       134 ------~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~  206 (283)
T cd07830         134 ------GPEVVKIADFGLAREIRSR-PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID  206 (283)
T ss_pred             ------CCCCEEEeecccceeccCC-CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH
Confidence                  5678999999998765432 2233456788999999874 4557899999999999999999999996543221


Q ss_pred             CCHhHHH------------H---HhhCCccCCC-------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         250 ISPGMKN------------R---IRLGQFDFPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       250 ~~~~~~~------------~---~~~~~~~~~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .......            .   ........+.       ......+.++.++|++||+.||++|||++|++.||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         207 QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             HHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            1000000            0   0000000000       0011236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-40  Score=299.82  Aligned_cols=255  Identities=28%  Similarity=0.505  Sum_probs=196.3

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      |+++ +.||.|++|.||+|.+..+|+.+|+|.+...       ....+|+.+ ++.++|+|++++++++...  .....+
T Consensus         1 y~~~-~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~--~~~~~~   76 (287)
T cd07840           1 YEKI-AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKL-LQKLRHPNIVRLKEIVTSK--GKGSIY   76 (287)
T ss_pred             Ceee-EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHH-HHhccCCCeeeheeeEecC--CCCcEE
Confidence            6675 6699999999999999999999999999643       234567776 5666899999999998751  136899


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++                    
T Consensus        77 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~--------------------  134 (287)
T cd07840          77 MVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN--------------------  134 (287)
T ss_pred             EEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc--------------------
Confidence            9999996 48988887653 4699999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                             +++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.....
T Consensus       135 -------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~  207 (287)
T cd07840         135 -------NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE  207 (287)
T ss_pred             -------CCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                   567899999999887644321 2333456888999997654 5688999999999999999999999965443


Q ss_pred             CCCCHhHHHHHhhCC-ccCC--------------C-------Ccccc-cCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         248 QAISPGMKNRIRLGQ-FDFP--------------N-------PEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~-~~~~--------------~-------~~~~~-~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ......+........ ..++              .       ..... ++.++.+++.+||..+|.+|||++++++||||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         208 LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            211111111000000 0000              0       00112 38899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.6e-40  Score=302.65  Aligned_cols=254  Identities=19%  Similarity=0.282  Sum_probs=191.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEcC----------------CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKK----------------TSEVYALKVLHDT------VKARREVELQLAVGSHKHI   71 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni   71 (372)
                      .++|++. +.||+|+||+||+|.+..                ++..+|+|.+...      ....+|+.. ++.++|+||
T Consensus         4 ~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~-l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFK-EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI-MSRLKDPNI   81 (296)
T ss_pred             hhhceee-eeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHH-HHhCCCCCc
Confidence            4689994 779999999999986432                3557999998632      234567776 566799999


Q ss_pred             eEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy3151          72 VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED---------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK  142 (372)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlk  142 (372)
                      +++++++..    +...++||||+.+++|.+++.....         ..+++..+..++.||+.||+|||+.|++|||||
T Consensus        82 ~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk  157 (296)
T cd05095          82 IRLLAVCIT----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA  157 (296)
T ss_pred             ceEEEEEec----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            999999875    5678999999999999999876431         236788999999999999999999999999999


Q ss_pred             CCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCC
Q psy3151         143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYD  220 (372)
Q Consensus       143 p~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~  220 (372)
                      |+||+++                           .++.++++|||++........  ......+++.|+|||....+.++
T Consensus       158 p~Nili~---------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~  210 (296)
T cd05095         158 TRNCLVG---------------------------KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT  210 (296)
T ss_pred             hheEEEc---------------------------CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc
Confidence            9999997                           566789999998876533221  11223335679999998888899


Q ss_pred             CccchhhHHHHHHHHHh--CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         221 KSCDIWSLGVIMYILLC--GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       221 ~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      .++|+|||||++|+|++  |..||...+..+..................+....+++.+.+|+.+||+.||.+|||+.++
T Consensus       211 ~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  290 (296)
T cd05095         211 TASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI  290 (296)
T ss_pred             chhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            99999999999999998  7788865443322111111111110011111123577999999999999999999999998


Q ss_pred             hc
Q psy3151         299 ME  300 (372)
Q Consensus       299 l~  300 (372)
                      ++
T Consensus       291 ~~  292 (296)
T cd05095         291 HA  292 (296)
T ss_pred             HH
Confidence            65

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=301.95  Aligned_cols=253  Identities=29%  Similarity=0.469  Sum_probs=197.9

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      |++. +.||.|++|.||+|.+..+++.||+|++...       .....|+.. ++.++|+||+++++++..    ....+
T Consensus         1 y~~~-~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~----~~~~~   74 (282)
T cd07829           1 YEKL-EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISL-LKELKHPNIVKLLDVIHT----ERKLY   74 (282)
T ss_pred             Ceee-hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHH-HHhcCCCCHHHHHhhhhc----CCceE
Confidence            5664 6799999999999999999999999998643       233567776 566689999999999875    57899


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+. ++|.+++.+.. ..+++..++.++.|++.||+|||++||+||||+|+||+++                    
T Consensus        75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~--------------------  132 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN--------------------  132 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc--------------------
Confidence            9999997 59999998753 3599999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                             .++.++|+|||++..............++..|+|||.+.+. .++.++|+|||||++|+|++|..||......
T Consensus       133 -------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~  205 (282)
T cd07829         133 -------RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI  205 (282)
T ss_pred             -------CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence                   56779999999987664433333444567889999998665 7899999999999999999999999654321


Q ss_pred             CCCHhHHHHHh------------h--CCccCCC-------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         249 AISPGMKNRIR------------L--GQFDFPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       249 ~~~~~~~~~~~------------~--~~~~~~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      .....+.....            .  ....++.       ......+.++.++|.+||..||++||++++++.||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         206 DQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            11100000000            0  0000000       0112357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5e-40  Score=297.16  Aligned_cols=245  Identities=21%  Similarity=0.348  Sum_probs=194.0

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|.+ .+.||+|++|.||+|.+..+ ..+|+|.+...    ....+|+.+ ++.++|||++++++++.     ....+
T Consensus         5 ~~~~~~-~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~-----~~~~~   76 (260)
T cd05069           5 RESLRL-DVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQI-MKKLRHDKLVPLYAVVS-----EEPIY   76 (260)
T ss_pred             hHHeee-eeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHH-HHhCCCCCeeeEEEEEc-----CCCcE
Confidence            478998 47799999999999988654 46999987642    234567776 56679999999998874     34578


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      ++|||+.+++|.+++.......+++..+..++.||+.||.|||+.|++|+||||+||+++                    
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~--------------------  136 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG--------------------  136 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc--------------------
Confidence            999999999999999875545689999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                             +++.++|+|||.+......... .....++..|+|||...+..++.++|+|||||++|+|++ |..||.+...
T Consensus       137 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  209 (260)
T cd05069         137 -------DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN  209 (260)
T ss_pred             -------CCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence                   5677999999998765332211 112234667999999988889999999999999999999 8999965432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .    .....+... +..  +.....+..+.+++++||..||.+|||++++++
T Consensus       210 ~----~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         210 R----EVLEQVERG-YRM--PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             H----HHHHHHHcC-CCC--CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            2    222222222 221  222467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=9.6e-40  Score=297.00  Aligned_cols=246  Identities=19%  Similarity=0.285  Sum_probs=189.9

Q ss_pred             cccccccCCeEEEEEEEcCCCc--EEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC--CceEEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTSE--VYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN--GSRCLL   89 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~--~~~~~~   89 (372)
                      ++.||+|+||.||+|.+..++.  .+|+|.+...       ....+|+.. ++.++||||+++++++.....  .....+
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVC-MKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHH-HHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            5789999999999999987775  6999987532       233456666 566799999999987642211  223578


Q ss_pred             EEEeccCCCchhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          90 VIMECMHGGELFQRIQQK----EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~----~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ++|||+.+|+|.+++...    ....+++..+..++.||+.||+|||+.||+||||||+|||++                
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----------------  146 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN----------------  146 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc----------------
Confidence            999999999999887532    123489999999999999999999999999999999999997                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPF  242 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  242 (372)
                                 .++.++|+|||++.........  .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||
T Consensus       147 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~  215 (272)
T cd05075         147 -----------ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY  215 (272)
T ss_pred             -----------CCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence                       5677999999998765432211  122334678999999998899999999999999999999 88998


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .+...    ......+..+...   +....++..+.++|.+||+.||.+|||+.+++++
T Consensus       216 ~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         216 PGVEN----SEIYDYLRQGNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCH----HHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            65432    2233334333221   1113578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=303.53  Aligned_cols=254  Identities=19%  Similarity=0.272  Sum_probs=191.0

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCC--------------cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTS--------------EVYALKVLHDT------VKARREVELQLAVGSHKHIVN   73 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~   73 (372)
                      .++|++. +.||+|+||.||+|.+..++              ..||+|.+...      ....+|++. ++.++|+||++
T Consensus         4 ~~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~-l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLK-EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI-MSRLKNPNIIR   81 (295)
T ss_pred             hHhCeeh-hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHH-HHhCCCCCcCe
Confidence            3689995 77999999999999875432              35899998632      234567776 66779999999


Q ss_pred             EeEeeeeecCCceEEEEEEeccCCCchhHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q psy3151          74 IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED----------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKP  143 (372)
Q Consensus        74 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp  143 (372)
                      +++++..    .+..++||||+.+++|.+++.....          ..+++..+..++.|++.||+|||+.|++||||||
T Consensus        82 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp  157 (295)
T cd05097          82 LLGVCVS----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT  157 (295)
T ss_pred             EEEEEcC----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence            9999865    6678999999999999999865321          2368899999999999999999999999999999


Q ss_pred             CceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCC
Q psy3151         144 ENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDK  221 (372)
Q Consensus       144 ~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  221 (372)
                      +||+++                           .++.+|++|||++........  ......+++.|+|||.+....++.
T Consensus       158 ~Nill~---------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  210 (295)
T cd05097         158 RNCLVG---------------------------NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT  210 (295)
T ss_pred             hhEEEc---------------------------CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCc
Confidence            999998                           556789999998875533211  112223466899999998888999


Q ss_pred             ccchhhHHHHHHHHHh--CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         222 SCDIWSLGVIMYILLC--GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       222 ~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      ++|+|||||++|+|++  +..||...............................++.+.+|+.+||..||++|||+++++
T Consensus       211 ~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~  290 (295)
T cd05097         211 ASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH  290 (295)
T ss_pred             hhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            9999999999999988  66788654332211111111111001111111235789999999999999999999999996


Q ss_pred             c
Q psy3151         300 E  300 (372)
Q Consensus       300 ~  300 (372)
                      +
T Consensus       291 ~  291 (295)
T cd05097         291 H  291 (295)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-40  Score=295.55  Aligned_cols=246  Identities=20%  Similarity=0.333  Sum_probs=195.6

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|++. +.||.|++|.||+|.+. +++.||+|.+...    ....+|+.. ++.++||||+++++++..    ++..|
T Consensus         5 ~~~~~~~-~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~   77 (261)
T cd05068           5 RTSIQLL-RKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQI-MKKLRHPKLIQLYAVCTL----EEPIY   77 (261)
T ss_pred             hhheeeE-EEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHH-HHHCCCCCccceeEEEec----CCCee
Confidence            3678884 77999999999999975 4678999998642    335567776 566689999999998865    56789


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      ++|||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++                    
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~--------------------  137 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG--------------------  137 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc--------------------
Confidence            999999999999999875544699999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                             .++.++|+|||++......... ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+...
T Consensus       138 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  210 (261)
T cd05068         138 -------ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN  210 (261)
T ss_pred             -------CCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence                   5677999999998876432111 111122347999999988889999999999999999999 9999965432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .    .....+... ...+.  ....+..+.+++.+||+.+|.+||++.++++
T Consensus       211 ~----~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         211 A----EVLQQVDQG-YRMPC--PPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             H----HHHHHHHcC-CCCCC--CCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            2    223333222 22222  1357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG4250|consensus

Probab=100.00  E-value=4.6e-41  Score=320.68  Aligned_cols=216  Identities=30%  Similarity=0.476  Sum_probs=179.3

Q ss_pred             cCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc------hhhhHHHHHHHHHhcCCCCEeEEeEee
Q psy3151           5 FKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD------TVKARREVELQLAVGSHKHIVNIKDVY   78 (372)
Q Consensus         5 ~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~ni~~~~~~~   78 (372)
                      |.|..+..-..-+.- .+.||+|+||.||+++++.+|+.||||.++.      .....+|+++ ++.++|+|||+++++=
T Consensus         3 ~~~~l~~~~~y~W~~-~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~Eiei-lkKLnh~NIVk~f~ie   80 (732)
T KOG4250|consen    3 YPPVLTSGENYLWEM-DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEI-LKKLNHPNIVKLFDIE   80 (732)
T ss_pred             CCcccccCCCcceee-hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHH-HHHcCchhhhhhcccC
Confidence            455555555566666 6889999999999999999999999999864      3456789999 6666799999999986


Q ss_pred             eeec--CCceEEEEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCC
Q psy3151          79 ENIY--NGSRCLLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGG  155 (372)
Q Consensus        79 ~~~~--~~~~~~~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~  155 (372)
                      +...  .-...-.+|||||.||||...+.+-.+ ..|++.++..++..+..||.|||++||+||||||.||++....+  
T Consensus        81 e~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ged--  158 (732)
T KOG4250|consen   81 ETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGED--  158 (732)
T ss_pred             CccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCC--
Confidence            5422  012346899999999999999986221 35999999999999999999999999999999999999975333  


Q ss_pred             ceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHH
Q psy3151         156 ILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYI  234 (372)
Q Consensus       156 ~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~  234 (372)
                                           .....||+|||.|+.+..+. .....+||+.|.+||++.. ..|+..+|.|||||++|+
T Consensus       159 ---------------------gq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~  216 (732)
T KOG4250|consen  159 ---------------------GQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYE  216 (732)
T ss_pred             ---------------------CceEEeeecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHH
Confidence                                 34457999999999886644 6788899999999999984 889999999999999999


Q ss_pred             HHhCCCCCCCCC
Q psy3151         235 LLCGFPPFFSNH  246 (372)
Q Consensus       235 ll~g~~pf~~~~  246 (372)
                      .+||..||....
T Consensus       217 caTG~lPF~p~~  228 (732)
T KOG4250|consen  217 CATGELPFIPFG  228 (732)
T ss_pred             HhccCCCCCcCC
Confidence            999999995543

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.2e-40  Score=302.08  Aligned_cols=246  Identities=20%  Similarity=0.299  Sum_probs=193.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCC-----CcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKT-----SEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      .+|.++ +.||.|+||+||+|.+..+     ++.||||++....      ...+|+.+ +..++||||+++++++..   
T Consensus         5 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~h~~iv~~~~~~~~---   79 (283)
T cd05091           5 STVRFM-EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMM-RSRLQHPNIVCLLGVVTK---   79 (283)
T ss_pred             HHHHHH-HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHH-HhcCCCCCcCeEEEEEcC---
Confidence            457775 6699999999999987543     5889999996332      22345544 667799999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeee
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYT  149 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~  149 (372)
                       ....++++||+.+++|.+++....              ...+++..++.++.|++.||.|||+.||+||||||+||+++
T Consensus        80 -~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~  158 (283)
T cd05091          80 -EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF  158 (283)
T ss_pred             -CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence             567899999999999999985321              13488899999999999999999999999999999999997


Q ss_pred             cCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhh
Q psy3151         150 KPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWS  227 (372)
Q Consensus       150 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  227 (372)
                                                 +++.+||+|||+++.......  ......+++.|+|||.+....++.++|+||
T Consensus       159 ---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  211 (283)
T cd05091         159 ---------------------------DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWS  211 (283)
T ss_pred             ---------------------------CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHH
Confidence                                       566799999998876533221  122344577899999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         228 LGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       228 lG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |||++|+|++ |..||.+...    ......+.......   ....++.++.+|+.+||+.+|.+|||+++++.
T Consensus       212 lG~~l~el~~~g~~p~~~~~~----~~~~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         212 YGVVLWEVFSYGLQPYCGYSN----QDVIEMIRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHHHHHHHcCCCCCCCCCCH----HHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            9999999998 8888865433    22344444433221   12468999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.7e-39  Score=301.96  Aligned_cols=250  Identities=26%  Similarity=0.399  Sum_probs=198.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +.+.|... +.||+|+||+||+|.+..+|+.||+|.+...        ....+|+.. ++.++|||++++++++..    
T Consensus        19 ~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----   92 (313)
T cd06633          19 PEEIFVGL-HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKF-LQQLKHPNTIEYKGCYLK----   92 (313)
T ss_pred             HHHHhhcc-eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHH-HHhCCCCCCccEEEEEEe----
Confidence            44556664 5599999999999999999999999998521        123467766 666799999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++               
T Consensus        93 ~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~---------------  155 (313)
T cd06633          93 EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---------------  155 (313)
T ss_pred             CCEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---------------
Confidence            678999999995 58888776543 4689999999999999999999999999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC---CCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.++|+|||++....    ......|+..|+|||.+.   ...++.++|+|||||++|+|++|..|
T Consensus       156 ------------~~~~~kL~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p  219 (313)
T cd06633         156 ------------EPGQVKLADFGSASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  219 (313)
T ss_pred             ------------CCCCEEEeecCCCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence                        56679999999876432    223456788999999973   45688999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |........   ... +...  ..+......++..+++|+.+||+.+|.+|||+.+++.||||+..
T Consensus       220 ~~~~~~~~~---~~~-~~~~--~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         220 LFNMNAMSA---LYH-IAQN--DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             CCCCChHHH---HHH-HHhc--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            965432211   111 1111  11222223567889999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-40  Score=297.19  Aligned_cols=249  Identities=21%  Similarity=0.288  Sum_probs=192.2

Q ss_pred             eeeccccccccCCeEEEEEEEcCC---CcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--CC
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKT---SEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--NG   84 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--~~   84 (372)
                      |++ .+.||+|+||.||+|.+..+   +..||+|.+...       ....+|+.. ++.++||||+++++++....  ..
T Consensus         1 ~~~-~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKL-GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAAC-MKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             Ccc-ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHH-HHhCCCCCeeeEEeeeccCCcccc
Confidence            456 57899999999999987653   488999998632       234567765 66679999999999875321  12


Q ss_pred             ceEEEEEEeccCCCchhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKE----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~----~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                      ....+++|||+++++|.+++....    ...+++..++.++.|++.||.|||+.|++||||||+||+++           
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~-----------  147 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR-----------  147 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC-----------
Confidence            345799999999999999885431    23589999999999999999999999999999999999997           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-  237 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-  237 (372)
                                      .++.+||+|||+++........  .....++..|+|||.+....++.++|+|||||++|+|++ 
T Consensus       148 ----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~  211 (273)
T cd05035         148 ----------------EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR  211 (273)
T ss_pred             ----------------CCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhC
Confidence                            5667999999998765432221  111233567999999988889999999999999999999 


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |..||.+....    .....+..+...   .....++.++.+++.+||+.||.+|||+.+++++
T Consensus       212 g~~p~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         212 GQTPYPGVENH----EIYDYLRHGNRL---KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCCCCCHH----HHHHHHHcCCCC---CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            88998654332    223333332211   1123678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.4e-39  Score=302.55  Aligned_cols=249  Identities=23%  Similarity=0.392  Sum_probs=194.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcC-------CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKK-------TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      ..++|.+ .+.||+|+||.||+|.+..       ++..+|+|.+...      ....+|+.++..+.+||||+++++++.
T Consensus        10 ~~~~~~~-~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          10 PRDRLVL-GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             cHHHeee-eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            5689998 5789999999999998642       3567999988632      134567777555557999999999886


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN  145 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~N  145 (372)
                      .    +...|++|||+.+|+|.+++....              ...++...+..++.||+.||.|||++||+||||||+|
T Consensus        89 ~----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  164 (314)
T cd05099          89 Q----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN  164 (314)
T ss_pred             c----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence            5    567899999999999999997642              1358899999999999999999999999999999999


Q ss_pred             eeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCcc
Q psy3151         146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSC  223 (372)
Q Consensus       146 Ili~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~  223 (372)
                      |+++                           .++.+||+|||+++........  .....+++.|+|||.+.+..++.++
T Consensus       165 ill~---------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  217 (314)
T cd05099         165 VLVT---------------------------EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS  217 (314)
T ss_pred             EEEc---------------------------CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccc
Confidence            9998                           5667999999998765322111  1122234679999999888899999


Q ss_pred             chhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         224 DIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       224 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |+|||||++|+|++ |..||.....    ......+..+.. .  .....++.++.+++.+||..||++|||+.++++
T Consensus       218 DiwslG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         218 DVWSFGILMWEIFTLGGSPYPGIPV----EELFKLLREGHR-M--DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             hhhHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCC-C--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999 8899855432    223333333221 1  111367889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.8e-40  Score=301.48  Aligned_cols=252  Identities=15%  Similarity=0.176  Sum_probs=186.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCC---CcEEEEEEecchh-hhHH------------HHHH--HHHhcCCCCEeEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKT---SEVYALKVLHDTV-KARR------------EVEL--QLAVGSHKHIVNI   74 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~------------e~~~--~~~~~~h~ni~~~   74 (372)
                      ..++|.+ .+.||+|+||+||+|.+..+   +..+|+|+..... ....            ++..  ......|+||+++
T Consensus        10 ~~~~y~i-~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882         10 TGKEWKI-DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             CCCceEE-eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4578999 58899999999999999877   7778888653211 1111            1111  1334589999999


Q ss_pred             eEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCC
Q psy3151          75 KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDG  154 (372)
Q Consensus        75 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~  154 (372)
                      +++.........+.+++++++. .++.+.+...  ...++..++.++.|++.||+|||+.+|+||||||+|||++     
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~-----  160 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD-----  160 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-----
Confidence            9876543222335678888874 4676666543  2368899999999999999999999999999999999997     


Q ss_pred             CceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC-------CcccccccCCCcCCCcccCCCCCCCccchhh
Q psy3151         155 GILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-------ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWS  227 (372)
Q Consensus       155 ~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  227 (372)
                                            ..+.++|+|||+|+......       .......||+.|+|||++.+..++.++||||
T Consensus       161 ----------------------~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwS  218 (294)
T PHA02882        161 ----------------------GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLES  218 (294)
T ss_pred             ----------------------CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHH
Confidence                                  55678899999987653221       1122346899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCC-CH----hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         228 LGVIMYILLCGFPPFFSNHGQAI-SP----GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       228 lG~il~~ll~g~~pf~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |||++|+|++|..||.+...... ..    ....++..+....     ...+.++.+++..|+..+|++||+++++++
T Consensus       219 lG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        219 LGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            99999999999999976532211 10    1122222222222     356899999999999999999999999875

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-40  Score=296.78  Aligned_cols=247  Identities=20%  Similarity=0.354  Sum_probs=197.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ..++|.+ .+.||.|+||.||+|.+. +++.+|||.+...    ....+|+.. ++.++|+||+++++++..    +...
T Consensus         4 ~~~~~~i-~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~   76 (261)
T cd05034           4 PRESLKL-ERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQI-MKKLRHDKLVQLYAVCSE----EEPI   76 (261)
T ss_pred             chhheee-eeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHH-HhhCCCCCEeeeeeeeec----CCce
Confidence            3578998 578999999999999975 5688999998642    345567776 566789999999998865    5678


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++                   
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~-------------------  137 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG-------------------  137 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc-------------------
Confidence            9999999999999999876545699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  246 (372)
                              +++.++++|||++........ ......++..|+|||.+.+..++.++|+||+||++|+|++ |+.||.+..
T Consensus       138 --------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  209 (261)
T cd05034         138 --------ENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT  209 (261)
T ss_pred             --------CCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence                    567799999998876542111 1112223567999999988889999999999999999998 999996543


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..    .....+..+ +..+  .....+.++.+++.+||..+|.+|||++++++
T Consensus       210 ~~----~~~~~~~~~-~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         210 NR----EVLEQVERG-YRMP--RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HH----HHHHHHHcC-CCCC--CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            22    223333222 2212  12356899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-39  Score=294.89  Aligned_cols=235  Identities=27%  Similarity=0.423  Sum_probs=185.8

Q ss_pred             ccccCCeEEEEEEEc--CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          24 LGLGINGKVLQIVEK--KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        24 lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      ||+|+||.||+|.+.  .++..||+|++...      ....+|+.. ++.++||||++++++++.     ...++||||+
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~-l~~l~h~~ii~~~~~~~~-----~~~~lv~e~~   76 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEI-MHQLDNPYIVRMIGVCEA-----EALMLVMEMA   76 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHH-HHhcCCCCeEEEEEEEcC-----CCeEEEEEeC
Confidence            899999999999775  45667999998632      124467776 566799999999998753     4689999999


Q ss_pred             CCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151          96 HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus        96 ~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                      ++++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++                          
T Consensus        77 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~--------------------------  129 (257)
T cd05115          77 SGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV--------------------------  129 (257)
T ss_pred             CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc--------------------------
Confidence            9999999987543 4699999999999999999999999999999999999997                          


Q ss_pred             CCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCC
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAIS  251 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  251 (372)
                       .++.+||+|||++.........   .....+++.|+|||.+....++.++|+|||||++|+|++ |..||......+  
T Consensus       130 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--  206 (257)
T cd05115         130 -NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--  206 (257)
T ss_pred             -CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--
Confidence             5667999999988755332221   111223567999999988889999999999999999996 999996554322  


Q ss_pred             HhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         252 PGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       252 ~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                        ....+..+. ...+    ...++++.++|.+||..||++||++.++.+
T Consensus       207 --~~~~~~~~~~~~~~----~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         207 --VMSFIEQGKRLDCP----AECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             --HHHHHHCCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              222332222 1222    357899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-39  Score=297.28  Aligned_cols=252  Identities=25%  Similarity=0.385  Sum_probs=192.3

Q ss_pred             ccceeeccccccccCCeEEEEEE----EcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIV----EKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..+|+++ +.||+|+||+||+|.    +..+++.||+|.+...     ....+|++. +..++||||+++++++..  .+
T Consensus         3 ~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~--~~   78 (284)
T cd05081           3 ERHLKFI-QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI-LKSLQHDNIVKYKGVCYS--AG   78 (284)
T ss_pred             cccceee-eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHH-HHhCCCCCeeEEEEEEcc--CC
Confidence            3578885 779999999999997    4567899999998632     234567777 566799999999997643  23


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++               
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~---------------  142 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE---------------  142 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC---------------
Confidence            456899999999999999997643 4589999999999999999999999999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.++|+|||++.........   .....++..|+|||.+.+..++.++|+|||||++|+|++|..+
T Consensus       143 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~  210 (284)
T cd05081         143 ------------SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK  210 (284)
T ss_pred             ------------CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence                        5667999999998865432221   1111224459999999888899999999999999999998777


Q ss_pred             CCCCCCCC------------CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQA------------ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +.......            ....+...+.. ....+  ....++.++.+|+.+||..+|++|||+.+++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         211 SCSPPAEFMRMMGNDKQGQMIVYHLIELLKN-NGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             CCCcchhhhhhcccccccccchHHHHHHHhc-CCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            64322110            00011111111 11111  12367899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-39  Score=301.27  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=197.0

Q ss_pred             CcccceeeccccccccCCeEEEEEEEc-------CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEee
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEK-------KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVY   78 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~   78 (372)
                      .-.++|.+ .+.||+|+||.||+|.+.       .++..+|+|.+...      ....+|+..+..+.+||||+++++++
T Consensus        12 ~~~~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          12 FSRDKLTL-GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             ccHHHeee-cceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            35688998 588999999999999753       24568999988532      23556777754454899999999998


Q ss_pred             eeecCCceEEEEEEeccCCCchhHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy3151          79 ENIYNGSRCLLVIMECMHGGELFQRIQQKED--------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE  144 (372)
Q Consensus        79 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~--------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~  144 (372)
                      ..    ....|+||||+.+++|.+++.+...              ..++...+..++.||+.||.|||++||+||||||+
T Consensus        91 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  166 (304)
T cd05101          91 TQ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR  166 (304)
T ss_pred             ec----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence            75    5678999999999999999976421              24788899999999999999999999999999999


Q ss_pred             ceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCc
Q psy3151         145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKS  222 (372)
Q Consensus       145 NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~  222 (372)
                      ||+++                           .++.+||+|||++.........  .....+++.|+|||++.+..++.+
T Consensus       167 Nili~---------------------------~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  219 (304)
T cd05101         167 NVLVT---------------------------ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ  219 (304)
T ss_pred             eEEEc---------------------------CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch
Confidence            99998                           5677999999998766432211  222344678999999988889999


Q ss_pred             cchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         223 CDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       223 ~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      +|||||||++|+|++ |..||...+.    ..+...+..+... .  ....++.++.+|+.+||..+|.+|||+.++++.
T Consensus       220 ~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         220 SDVWSFGVLMWEIFTLGGSPYPGIPV----EELFKLLKEGHRM-D--KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             hhHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            999999999999998 7888854432    2333333332211 1  123678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.9e-40  Score=297.04  Aligned_cols=245  Identities=23%  Similarity=0.405  Sum_probs=194.2

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCc---EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSE---VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ++|++ .+.||+|+||.||+|.+..++.   .+|+|.+...      ....+|+.. ++.++||||+++++++..    +
T Consensus         4 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~   77 (267)
T cd05066           4 SCIKI-EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASI-MGQFDHPNIIHLEGVVTK----S   77 (267)
T ss_pred             HHeEe-eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHH-HHhCCCCCcceEEEEEec----C
Confidence            67888 5889999999999999875543   7999988532      233456665 556699999999999865    5


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...|+||||+++++|.+++.... +.+++.++..++.|++.||+|||+.|++||||||+||+++                
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~----------------  140 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN----------------  140 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC----------------
Confidence            67899999999999999997654 4689999999999999999999999999999999999997                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccc---cccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT---PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                 .++.++++|||++............   ..++..|+|||.+.+..++.++|+|||||++|++++ |..|
T Consensus       141 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p  209 (267)
T cd05066         141 -----------SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP  209 (267)
T ss_pred             -----------CCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCC
Confidence                       5667999999988765433221111   222457999999988889999999999999999886 9999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |......+    ....+..+ ...  +....+++++.+++.+||+.+|.+|||+.++++
T Consensus       210 ~~~~~~~~----~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         210 YWEMSNQD----VIKAIEEG-YRL--PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             cccCCHHH----HHHHHhCC-CcC--CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            96554322    22333222 222  222367899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-39  Score=310.60  Aligned_cols=250  Identities=22%  Similarity=0.395  Sum_probs=194.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .++|.+ .+.||+|+||.||+|.+.     .+++.||+|++...      ....+|+.++.++..||||+++++++..  
T Consensus        36 ~~~~~~-~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--  112 (401)
T cd05107          36 RDNLVL-GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--  112 (401)
T ss_pred             HHHeeh-hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence            356777 578999999999999853     45678999999642      1345688875555459999999998865  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccC-----------------------------------------------------
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKED-----------------------------------------------------  109 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~-----------------------------------------------------  109 (372)
                        ....++||||+.+|+|.+++.....                                                     
T Consensus       113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence              5679999999999999999975321                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q psy3151         110 -------------------------------------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENL  146 (372)
Q Consensus       110 -------------------------------------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NI  146 (372)
                                                                 ..+++..++.++.||+.||+|||+.||+||||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni  270 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV  270 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence                                                       2367778899999999999999999999999999999


Q ss_pred             eeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccc
Q psy3151         147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCD  224 (372)
Q Consensus       147 li~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~D  224 (372)
                      |++                           ..+.+||+|||+++.......  ......+++.|+|||.+....++.++|
T Consensus       271 Ll~---------------------------~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  323 (401)
T cd05107         271 LIC---------------------------EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSD  323 (401)
T ss_pred             EEe---------------------------CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhH
Confidence            998                           566789999999876532211  122345678899999998888999999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         225 IWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       225 iwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      +|||||++|||++ |..||......   ......+..+ ...+  ....++.++.+|+.+||..+|.+||+++++++.
T Consensus       324 vwslGvil~e~l~~g~~P~~~~~~~---~~~~~~~~~~-~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         324 VWSFGILLWEIFTLGGTPYPELPMN---EQFYNAIKRG-YRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCCch---HHHHHHHHcC-CCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999998 88998544322   1122222222 2111  123578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=292.20  Aligned_cols=236  Identities=22%  Similarity=0.372  Sum_probs=187.6

Q ss_pred             cccccCCeEEEEEEEcCCC---cEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          23 ILGLGINGKVLQIVEKKTS---EVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      .||+|+||.||+|.+..++   ..+|+|.+....      ...+|+.. ++.++||||+++++++.     ....++|||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~-----~~~~~~v~e   75 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASV-MAQLDHPCIVRLIGVCK-----GEPLMLVME   75 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHH-HHhcCCCCeeeEEEEEc-----CCceEEEEE
Confidence            5999999999999876655   889999986322      34466666 56679999999999765     345799999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      |+.+++|.+++....  .+++..+..++.|++.||+|||+.|++||||||+||+++                        
T Consensus        76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~------------------------  129 (257)
T cd05060          76 LAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV------------------------  129 (257)
T ss_pred             eCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc------------------------
Confidence            999999999997654  599999999999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccCCCcccc---cccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKASLQT---PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQA  249 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  249 (372)
                         .++.+||+|||+++...........   ..++..|+|||.+....++.++|+|||||++|+|++ |..||...+.. 
T Consensus       130 ---~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-  205 (257)
T cd05060         130 ---NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-  205 (257)
T ss_pred             ---CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence               5667899999988766433222111   122457999999988889999999999999999998 99999654332 


Q ss_pred             CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                         .....+..... .  +....++..+.++|.+||..+|++|||+.++++
T Consensus       206 ---~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         206 ---EVIAMLESGER-L--PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ---HHHHHHHcCCc-C--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence               22333332221 1  122467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=296.79  Aligned_cols=240  Identities=20%  Similarity=0.370  Sum_probs=187.4

Q ss_pred             ccccccCCeEEEEEEEcCCCc--EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          22 EILGLGINGKVLQIVEKKTSE--VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      ++||+|+||.||+|.+..++.  .+|+|.+...      ....+|+..+.++.+||||+++++++..    .+..|+|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec----CCCceEEEE
Confidence            359999999999999988876  4688887631      2345677776666689999999999875    567899999


Q ss_pred             ccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          94 CMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      |+++++|.+++....              ...+++..++.++.|++.||+|||+.|++||||||+||+++          
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~----------  146 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----------  146 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc----------
Confidence            999999999997532              12478999999999999999999999999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-G  238 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g  238 (372)
                                       .++.+|++|||++....... .......+..|+|||++....++.++|+|||||++|+|++ |
T Consensus       147 -----------------~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g  208 (270)
T cd05047         147 -----------------ENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG  208 (270)
T ss_pred             -----------------CCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence                             56779999999875332111 1111223567999999988889999999999999999997 9


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..||.+.+..    .....+... ...  .....++.++.+|+.+||..||.+|||+.+++.
T Consensus       209 ~~pf~~~~~~----~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         209 GTPYCGMTCA----ELYEKLPQG-YRL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCccccCHH----HHHHHHhCC-CCC--CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            9999654322    222222221 111  112357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0665|consensus

Probab=100.00  E-value=6.7e-41  Score=292.62  Aligned_cols=295  Identities=26%  Similarity=0.420  Sum_probs=220.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeee--ec
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYEN--IY   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~--~~   82 (372)
                      .+..||.-+ ..+|.|.. .|..|.|..++++||+|.+..       ..++.+|... +..++|+||++++.+|..  ..
T Consensus        14 tv~~Ry~nL-~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l-~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   14 TVPKRYVNL-KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKL-MKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeeeee-cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhh-hhhhcccceeeeeeccCccccH
Confidence            356788886 67999999 899999999999999998742       3467788877 677799999999999952  12


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ......|+|||+| ..+|...+..    .++.+.++.++.|+++|++|||+.||+||||||+||++.             
T Consensus        91 ~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~-------------  152 (369)
T KOG0665|consen   91 EEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN-------------  152 (369)
T ss_pred             HHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec-------------
Confidence            2345689999999 5699998873    389999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    .++.+||.|||+|+..... -..+.++.|..|.|||++.+..|.+.+||||+||++.||++|...|
T Consensus       153 --------------~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf  217 (369)
T KOG0665|consen  153 --------------SDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF  217 (369)
T ss_pred             --------------chhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence                          6788999999999875443 3566678899999999998888999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhh-------------------------CCc--cCCCCcc-------cccCHHHHHHHHHhccCC
Q psy3151         243 FSNHGQAISPGMKNRIRL-------------------------GQF--DFPNPEW-------EHVSQEAKTLIKNMLCVD  288 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~-------------------------~~~--~~~~~~~-------~~~s~~~~~li~~ll~~d  288 (372)
                      .+.+.-+....+......                         ..+  .+|...|       ..-+..++||+.+||..|
T Consensus       218 ~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~  297 (369)
T KOG0665|consen  218 PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVID  297 (369)
T ss_pred             cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccC
Confidence            655432211111110000                         000  0111111       123466899999999999


Q ss_pred             CCCCCChhHHhcCCccccC---CCCCCCC-CccccccccCCCCchhhHHHHHHHHHHh
Q psy3151         289 PSERLTIDQVMENKWISQF---NQVPQTP-LCTGKMLKEGEETWPEVQDEMTRSLATM  342 (372)
Q Consensus       289 P~~R~s~~eil~hp~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~  342 (372)
                      |++|.|++++|.|||++-|   ...+..+ ....+.+..+..+..|..+++.+.+...
T Consensus       298 pe~Risv~daL~HPY~~vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f  355 (369)
T KOG0665|consen  298 PEKRISVDDALRHPYIKVWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRF  355 (369)
T ss_pred             hhhcccHHHHhcCCeeeeecccccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhh
Confidence            9999999999999999832   2221111 1122344455556666667666655543

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-39  Score=291.74  Aligned_cols=241  Identities=22%  Similarity=0.400  Sum_probs=195.0

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      +.|++ .+.||.|+||.||+|...  |+.||+|.+....    ...+|+.+ ++.++|+||+++++++..    +...++
T Consensus         6 ~~~~~-~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~~~   77 (256)
T cd05039           6 KELKL-GATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASV-MTTLRHPNLVQLLGVVLQ----GNPLYI   77 (256)
T ss_pred             hhccc-eeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHH-HHhcCCcceeeeEEEEcC----CCCeEE
Confidence            57887 577999999999999875  8899999997543    34567776 666689999999999875    567899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++                     
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---------------------  136 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---------------------  136 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---------------------
Confidence            99999999999999876544699999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQA  249 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  249 (372)
                            .++.++|+|||.+.......   ....++..|+|||.+....++.++|+|||||++|+|++ |..||.....  
T Consensus       137 ------~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--  205 (256)
T cd05039         137 ------EDLVAKVSDFGLAKEASQGQ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--  205 (256)
T ss_pred             ------CCCCEEEccccccccccccc---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence                  66779999999988663221   12233557999999988889999999999999999997 9999854432  


Q ss_pred             CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                        ..+...+... +..  .....+++++.++|.+||..+|++|||+.+++.
T Consensus       206 --~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         206 --KDVVPHVEKG-YRM--EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             --HHHHHHHhcC-CCC--CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence              2222332222 111  112357899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-39  Score=297.84  Aligned_cols=250  Identities=25%  Similarity=0.376  Sum_probs=191.9

Q ss_pred             eeeccccccccCCeEEEEEEE----cCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          17 YDISTEILGLGINGKVLQIVE----KKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      |+++ +.||+|+||.||+|..    ..+++.||+|.+...      ....+|+.. ++.++||||+++.+++..  .+..
T Consensus         6 ~~~~-~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~--~~~~   81 (284)
T cd05079           6 LKRI-RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI-LRNLYHENIVKYKGICTE--DGGN   81 (284)
T ss_pred             hhhc-eecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHH-HHhCCCCCeeeeeeEEec--CCCC
Confidence            4665 6699999999999974    467899999998622      234567776 667799999999998864  2245


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..++||||+++++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+||+++                 
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~-----------------  143 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE-----------------  143 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc-----------------
Confidence            6899999999999999987643 3589999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                .++.++|+|||++.........   .....++..|+|||.+.+..++.++|||||||++|+|+++..|+.
T Consensus       144 ----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~  213 (284)
T cd05079         144 ----------SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES  213 (284)
T ss_pred             ----------CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence                      5667899999988765432221   123445667999999988889999999999999999999877653


Q ss_pred             CCCC----------CCCC-HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         244 SNHG----------QAIS-PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       244 ~~~~----------~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ....          .+.. ......+..+. .  .+....++.++.+|+.+||+.||.+|||+++++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         214 SPMTLFLKMIGPTHGQMTVTRLVRVLEEGK-R--LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cccchhhhhcccccccccHHHHHHHHHcCc-c--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            2211          0000 11111111111 1  12234688999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.6e-39  Score=297.21  Aligned_cols=246  Identities=26%  Similarity=0.405  Sum_probs=192.4

Q ss_pred             cceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+|.+. +.||+|+||.||+|...     .++..+|+|.+...     ....+|++. ++.++|+||+++++++..    
T Consensus         5 ~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   78 (280)
T cd05092           5 RDIVLK-WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL-LTVLQHQHIVRFYGVCTE----   78 (280)
T ss_pred             Hhceec-cccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHH-HhcCCCCCCceEEEEEec----
Confidence            467774 67999999999999743     35778999988632     245567776 566799999999998875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKED-------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP  151 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~-------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~  151 (372)
                      +...+++|||+.+++|.+++.....             ..+++..++.++.||+.||+|||+.|++||||||+|||++  
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~--  156 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG--  156 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc--
Confidence            5678999999999999999976431             2488999999999999999999999999999999999997  


Q ss_pred             CCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHH
Q psy3151         152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG  229 (372)
Q Consensus       152 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  229 (372)
                                               +++.++|+|||++........  ......+++.|+|||.+.+..++.++|+||||
T Consensus       157 -------------------------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  211 (280)
T cd05092         157 -------------------------QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG  211 (280)
T ss_pred             -------------------------CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHH
Confidence                                     567799999998875432211  11223346789999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         230 VIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       230 ~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |++|+|++ |.+||......    .....+..+..   ......+++++.++|.+||+.||.+||+++++++
T Consensus       212 ~il~el~~~g~~p~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         212 VVLWEIFTYGKQPWYQLSNT----EAIECITQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHHcCCCCCCccCCHH----HHHHHHHcCcc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            99999998 89998544322    12222222211   1112367899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.6e-39  Score=299.54  Aligned_cols=249  Identities=25%  Similarity=0.377  Sum_probs=197.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +...|... +.||+|+||.||+|.+..+|+.+|+|.+...        ....+|++. ++.++|||++++++++..    
T Consensus        23 ~~~~f~~~-~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~----   96 (317)
T cd06635          23 PEKLFTDL-REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF-LQRIKHPNSIEYKGCYLR----   96 (317)
T ss_pred             chhhhhhh-heeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHH-HHhCCCCCEEEEEEEEee----
Confidence            44557774 6699999999999999999999999998532        134467766 566789999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...|+||||+. |+|.+.+.... .++++..+..++.||+.||.|||+.||+||||+|+||+++               
T Consensus        97 ~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~---------------  159 (317)
T cd06635          97 EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---------------  159 (317)
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC---------------
Confidence            667899999996 48877776543 4699999999999999999999999999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC---CCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.++|+|||++.....    .....|++.|+|||.+.   .+.++.++|+|||||++|+|++|..|
T Consensus       160 ------------~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p  223 (317)
T cd06635         160 ------------EPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  223 (317)
T ss_pred             ------------CCCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence                        566799999998765422    23446788999999873   45688999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      |.......   ............   .....+++.+.++|.+||+.+|.+|||+.++++|+|+..
T Consensus       224 ~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         224 LFNMNAMS---ALYHIAQNESPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             CCCccHHH---HHHHHHhccCCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            96543221   112222211111   112357889999999999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.2e-40  Score=327.00  Aligned_cols=265  Identities=19%  Similarity=0.230  Sum_probs=178.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCC----CcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeee-e-cCCce
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKT----SEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYEN-I-YNGSR   86 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~-~-~~~~~   86 (372)
                      -.++|.+ .+.||+|+||+||+|.+..+    +..||||.+.............++...+.++..+...|.. . ...+.
T Consensus       130 ~~~~y~l-~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        130 KKDDFVL-GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             ccCCeEE-eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCC
Confidence            3468998 57899999999999999998    9999999886432211111111111122333332222211 0 12356


Q ss_pred             EEEEEEeccCCCchhHHHHhccCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceee
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDG------------------AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY  148 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~------------------~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli  148 (372)
                      .+++|+||+.+++|.+++......                  ...+..++.++.||+.||+|||++||+||||||+|||+
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl  288 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF  288 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence            789999999999999998754210                  12234577899999999999999999999999999999


Q ss_pred             ecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCC----------
Q psy3151         149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPD----------  217 (372)
Q Consensus       149 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------  217 (372)
                      +.                          +.+.+||+|||+|....... ......++|+.|+|||.+...          
T Consensus       289 ~~--------------------------~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~  342 (566)
T PLN03225        289 SE--------------------------GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP  342 (566)
T ss_pred             eC--------------------------CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCcccc
Confidence            72                          35679999999997653322 223456789999999975322          


Q ss_pred             ------------CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCcc-----------CCC------C
Q psy3151         218 ------------KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFD-----------FPN------P  268 (372)
Q Consensus       218 ------------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~------~  268 (372)
                                  .++.++|||||||++|||+++..++....     ......+......           ...      .
T Consensus       343 ~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~-----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  417 (566)
T PLN03225        343 VATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL-----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFE  417 (566)
T ss_pred             ccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHH-----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhh
Confidence                        24456799999999999999776653210     0011111100000           000      0


Q ss_pred             cccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         269 EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       269 ~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      .....+.++.+||.+||++||++|||+.++|+||||++...
T Consensus       418 ~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        418 VLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             hccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence            01122345679999999999999999999999999987543

>KOG1026|consensus

Probab=100.00  E-value=1.1e-40  Score=324.91  Aligned_cols=238  Identities=26%  Similarity=0.458  Sum_probs=201.5

Q ss_pred             ccccccCCeEEEEEEEcC-----CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          22 EILGLGINGKVLQIVEKK-----TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      +.||+|+||+||+|+-..     +...||||.+++.      ...+||++. +..++|||||++++++..    ++-+|+
T Consensus       492 ~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeL-la~l~H~nIVrLlGVC~~----~~P~~M  566 (774)
T KOG1026|consen  492 EELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAEL-LAELQHPNIVRLLGVCRE----GDPLCM  566 (774)
T ss_pred             hhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHH-HHhccCCCeEEEEEEEcc----CCeeEE
Confidence            459999999999997643     4578999999743      245678876 788899999999999976    778999


Q ss_pred             EEeccCCCchhHHHHhccC------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          91 IMECMHGGELFQRIQQKED------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      |+|||..|||.++++....            ++|+..+...|+.||+.|++||-++..|||||-.+|+||.         
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---------  637 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---------  637 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---------
Confidence            9999999999999986422            2388999999999999999999999999999999999997         


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCccc--ccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHH
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ--TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  236 (372)
                                        +...|||+|||+++.+.+.+-..-  ...-...|||||.+..+.|+.++||||+||+|||++
T Consensus       638 ------------------e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIF  699 (774)
T KOG1026|consen  638 ------------------ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIF  699 (774)
T ss_pred             ------------------cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhh
Confidence                              788899999999998755332211  111133699999999999999999999999999999


Q ss_pred             h-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         237 C-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       237 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      + |..||.+...++    +.+.+..++. ++.|  ++++.++.+||..||+.+|.+|||+.||
T Consensus       700 syG~QPy~glSn~E----VIe~i~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  700 SYGKQPYYGLSNQE----VIECIRAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             ccccCcccccchHH----HHHHHHcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            8 999998877644    5777888877 6655  4899999999999999999999999997

>KOG0587|consensus

Probab=100.00  E-value=1.1e-39  Score=316.98  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=218.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeec-CCce
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIY-NGSR   86 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~-~~~~   86 (372)
                      ...+.+.| .++||.|.+|.||++++..+|+..|+|+.....    ....|.++++..-.|||++.++++|.-.. ..+.
T Consensus        16 dp~d~~ei-~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   16 DPADIFEI-IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCccEE-EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            35677887 688999999999999999999999999987443    34445556666778999999999986332 3467


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .++||||||.||+.-|+++...+..+.|+.+..|++.++.||.|||.+.++|||||=.|||++                 
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT-----------------  157 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT-----------------  157 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe-----------------
Confidence            899999999999999999987778899999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-----CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-----DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                .++.||++|||++..+........+.+|||.|||||++..     ..|+..+|+||||++..||.-|.+|
T Consensus       158 ----------~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PP  227 (953)
T KOG0587|consen  158 ----------ENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPP  227 (953)
T ss_pred             ----------ccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCC
Confidence                      6788999999999999888888899999999999999833     3478899999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCc---ccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPE---WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      +.+.....      .....  ..-|+|.   +...+.++.++|..||.+|.++||+..++|+|||+.
T Consensus       228 l~DmHPmr------aLF~I--pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  228 LCDMHPMR------ALFLI--PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             ccCcchhh------hhccC--CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            96654321      11111  1222222   467899999999999999999999999999999997

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-39  Score=292.71  Aligned_cols=240  Identities=23%  Similarity=0.308  Sum_probs=181.3

Q ss_pred             cccccCCeEEEEEEEcC------------CCcEEEEEEecchh-----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          23 ILGLGINGKVLQIVEKK------------TSEVYALKVLHDTV-----KARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~-----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .||+|+||.||+|....            ....+|+|++....     ...+|+. .+..++||||+++++++..    +
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~-~l~~l~hp~iv~~~~~~~~----~   76 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETAS-MMRQVSHKHIVLLYGVCVR----D   76 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHH-HHHhCCCCCEeeEEEEEec----C
Confidence            58999999999998532            23468999875322     2233444 4777899999999998865    5


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...++||||+++++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++...          
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~----------  145 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDG----------  145 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccC----------
Confidence            66799999999999988876543 4699999999999999999999999999999999999997433100          


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-CCCCCCccchhhHHHHHHHHH-hCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-PDKYDKSCDIWSLGVIMYILL-CGFPPFF  243 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll-~g~~pf~  243 (372)
                                .....++++|||++.....    .....++..|+|||.+. ...++.++|||||||++|+|+ +|..||.
T Consensus       146 ----------~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  211 (262)
T cd05077         146 ----------ECGPFIKLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK  211 (262)
T ss_pred             ----------CCCceeEeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence                      0233489999998865432    12345688899999886 467899999999999999998 5888875


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .....+     ............    ...+.++.+||.+||+.||.+||++.+++++
T Consensus       212 ~~~~~~-----~~~~~~~~~~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         212 DKTLAE-----KERFYEGQCMLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CcchhH-----HHHHHhcCccCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            432211     112222222222    1346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-39  Score=295.23  Aligned_cols=245  Identities=23%  Similarity=0.415  Sum_probs=193.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCc---EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSE---VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ++|++ .+.||+|+||.||+|.+..+++   .||||++...      .....|+.. ++.++||||+++++++..    +
T Consensus         4 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~----~   77 (269)
T cd05065           4 SCVKI-EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI-MGQFDHPNIIHLEGVVTK----S   77 (269)
T ss_pred             HHeEE-EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHH-HHhCCCcCcceEEEEECC----C
Confidence            46887 5889999999999999987765   5999998632      133456665 566799999999998865    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...++||||+.+++|.+++.... +.+++..++.++.|++.||+|||++|++|+||||+||+++                
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~----------------  140 (269)
T cd05065          78 RPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN----------------  140 (269)
T ss_pred             CceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc----------------
Confidence            67899999999999999987653 4689999999999999999999999999999999999997                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCc--ccccc---cCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPC---YTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF  239 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  239 (372)
                                 .++.++++|||++.........  .....   .+..|+|||.+....++.++|+||+||++|||++ |.
T Consensus       141 -----------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~  209 (269)
T cd05065         141 -----------SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE  209 (269)
T ss_pred             -----------CCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCC
Confidence                       5667899999988655332211  11111   1346999999988899999999999999999886 99


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .||...+..    .....+.. ....+  ....++.++.+++.+||..+|.+||++++++.
T Consensus       210 ~p~~~~~~~----~~~~~i~~-~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         210 RPYWDMSNQ----DVINAIEQ-DYRLP--PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCCCCCCHH----HHHHHHHc-CCcCC--CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999654432    22333322 22222  22467899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0668|consensus

Probab=100.00  E-value=5.3e-41  Score=280.73  Aligned_cols=261  Identities=26%  Similarity=0.425  Sum_probs=207.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEec--chhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--DTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      -+++|+|+ ..+|+|-|+.||.|.+..++++++||++.  +..+..||+.++..+..||||++++++..+  +......+
T Consensus        36 ~~ddYeiv-rk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D--p~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIV-RKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD--PESKTPSL  112 (338)
T ss_pred             ccchHHHH-HHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC--ccccCchh
Confidence            46889996 56999999999999999999999999997  456788999998888889999999999865  33566789


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      |+||+++.+...+-.     .++.-.++.++.+++.||.|||++||+|||+||.|++|+.                    
T Consensus       113 iFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--------------------  167 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--------------------  167 (338)
T ss_pred             HhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--------------------
Confidence            999999877766553     3899999999999999999999999999999999999984                    


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCC-CCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSN-HGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~  248 (372)
                            ....++++|+|+|.+.-++ ..-+..+.+..|--||.+.. ..|+.+-|+|||||++..|+..+-||+-. +..
T Consensus       168 ------~~rkLrlIDWGLAEFYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~  240 (338)
T KOG0668|consen  168 ------ELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY  240 (338)
T ss_pred             ------hhceeeeeecchHhhcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH
Confidence                  4567999999999876443 33445566888999998854 56899999999999999999999887533 222


Q ss_pred             CCCHhH---------HHHHhhCCccCC-------------------CCcc-cccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         249 AISPGM---------KNRIRLGQFDFP-------------------NPEW-EHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       249 ~~~~~~---------~~~~~~~~~~~~-------------------~~~~-~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      +....+         ..-+..-...++                   +++. ..+++++.||+.++|..|..+|+||.|++
T Consensus       241 DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam  320 (338)
T KOG0668|consen  241 DQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM  320 (338)
T ss_pred             HHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence            211111         011111111111                   1111 23569999999999999999999999999


Q ss_pred             cCCccccCC
Q psy3151         300 ENKWISQFN  308 (372)
Q Consensus       300 ~hp~~~~~~  308 (372)
                      .||||....
T Consensus       321 ~HpyF~~~~  329 (338)
T KOG0668|consen  321 AHPYFAPVR  329 (338)
T ss_pred             cCchHHHHH
Confidence            999997653

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.4e-39  Score=291.57  Aligned_cols=246  Identities=22%  Similarity=0.390  Sum_probs=194.4

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCc---EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSE---VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .++|+. .+.||+|+||.||+|.+..+++   .+|+|.+...      .....|++. +..++||||+++.+++..    
T Consensus         4 ~~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   77 (268)
T cd05063           4 PSHITK-QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASI-MGQFSHHNIIRLEGVVTK----   77 (268)
T ss_pred             hHHceE-eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHH-HhcCCCCCeeEEEEEEcc----
Confidence            357887 5789999999999999976665   7999988532      123456665 566799999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ....|+||||+.+++|.+++.... +.+++..+..++.|++.||+|||+.|++||||||+||+++               
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---------------  141 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---------------  141 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---------------
Confidence            567899999999999999987643 5689999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccc---cccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT---PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFP  240 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  240 (372)
                                  .++.++++|||++............   ...++.|+|||.+....++.++|+|||||++|+|++ |..
T Consensus       142 ------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~  209 (268)
T cd05063         142 ------------SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER  209 (268)
T ss_pred             ------------CCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCC
Confidence                        5667899999988765432221111   112456999999988889999999999999999997 999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||.....    ......+..+ ...  +....++.++.+++.+||+.+|.+||++.++++
T Consensus       210 p~~~~~~----~~~~~~i~~~-~~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         210 PYWDMSN----HEVMKAINDG-FRL--PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCcCCH----HHHHHHHhcC-CCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9965443    2233333322 122  222467899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.4e-39  Score=298.43  Aligned_cols=251  Identities=25%  Similarity=0.399  Sum_probs=199.5

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ....+|+.+ +.||.|++|.||+|.+..+++.+|+|.+...        ....+|+.. ++.++|+|++++.+++..   
T Consensus        12 ~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~---   86 (308)
T cd06634          12 DPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF-LQKLRHPNTIQYRGCYLR---   86 (308)
T ss_pred             CcHHHHHHH-HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHH-HHhCCCCCcccEEEEEEc---
Confidence            355678875 6699999999999999999999999998521        123467766 566799999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       +...++||||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.|++||||||+||+++              
T Consensus        87 -~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~--------------  149 (308)
T cd06634          87 -EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--------------  149 (308)
T ss_pred             -CCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC--------------
Confidence             567899999996 58887776543 4589999999999999999999999999999999999997              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC---CCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                   .++.++++|||++.....    .....+++.|+|||.+.   ...++.++|||||||++|+|++|..
T Consensus       150 -------------~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  212 (308)
T cd06634         150 -------------EPGLVKLGDFGSASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  212 (308)
T ss_pred             -------------CCCcEEECCcccceeecC----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCC
Confidence                         567799999998875432    23346788999999874   3567889999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ||.......   ... .+.....  +......++..+.+||.+||..+|.+||++++++.|||+...
T Consensus       213 p~~~~~~~~---~~~-~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         213 PLFNMNAMS---ALY-HIAQNES--PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             CCccccHHH---HHH-HHhhcCC--CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            986543211   111 1111111  111123578899999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1151|consensus

Probab=100.00  E-value=5.5e-41  Score=304.06  Aligned_cols=262  Identities=27%  Similarity=0.423  Sum_probs=211.5

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEec--chh----------hhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--DTV----------KARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~~----------~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      .+.+||-++ .+||+|+|+.||+|.|....+.||||+-.  +.+          -+.+|..+ .+.++||.||+++++|.
T Consensus       460 tLn~RYLlL-hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrI-HKeLDHpRIVKlYDyfs  537 (775)
T KOG1151|consen  460 TLNDRYLLL-HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRI-HKELDHPRIVKLYDYFS  537 (775)
T ss_pred             chHHHHHHH-HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhh-hhccCcceeeeeeeeee
Confidence            378899885 88999999999999999999999999864  211          24577777 67779999999999996


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCceeeecCCCCCce
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ--NIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~--~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      .   +...++-|+|||+|.+|..+++.+.  .++|.+++.|+.||+.||.||...  -|||-||||.|||+....     
T Consensus       538 l---DtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt-----  607 (775)
T KOG1151|consen  538 L---DTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT-----  607 (775)
T ss_pred             e---ccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc-----
Confidence            4   2456889999999999999998764  599999999999999999999976  699999999999997422     


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCC----CCCCCccchh
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGP----DKYDKSCDIW  226 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~~Diw  226 (372)
                                         ..|.+||+|||+++...+...       -.....||.||++||.+.-    ...+.++|+|
T Consensus       608 -------------------acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVW  668 (775)
T KOG1151|consen  608 -------------------ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVW  668 (775)
T ss_pred             -------------------ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeE
Confidence                               578899999999987754322       1344678999999998733    3467899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         227 SLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       227 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      |+|||+|..+.|+.||..+..+.........+....+.+|+.  .-+++++++||++||++.-++|....++..||||..
T Consensus       669 SvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  669 SVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             eeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            999999999999999965543332222222333444455543  368999999999999999999999999999999964

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.8e-39  Score=288.63  Aligned_cols=241  Identities=23%  Similarity=0.393  Sum_probs=193.3

Q ss_pred             cccccccCCeEEEEEEEcCCC----cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTS----EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .+.||.|+||.||+|.+..++    ..+|+|++...      .....|+.. +..++|+||+++++++..    .+..|+
T Consensus         4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~~~   78 (258)
T smart00219        4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARI-MRKLDHPNIVKLLGVCTE----EEPLMI   78 (258)
T ss_pred             cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHH-HHhcCCCchheEEEEEcC----CCeeEE
Confidence            467999999999999998776    99999999632      244567776 445599999999999876    578999


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      +|||+++++|.+++.......+++..++.++.|++.||++||+.|++|+||||+||+++                     
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~---------------------  137 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---------------------  137 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc---------------------
Confidence            99999999999999765433389999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCccc-ccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQ-TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  248 (372)
                            .++.++++|||++........... ...+++.|+|||.+.+..++.++|+||+||++|+|++ |..||...+. 
T Consensus       138 ------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-  210 (258)
T smart00219      138 ------ENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-  210 (258)
T ss_pred             ------cCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence                  566799999998876644322111 1235788999999988889999999999999999998 8888865332 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                         ......+.......   ....++.++.+++.+||..||++|||+.++++
T Consensus       211 ---~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      211 ---EEVLEYLKKGYRLP---KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ---HHHHHHHhcCCCCC---CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence               22233333332221   11347999999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.6e-39  Score=288.49  Aligned_cols=245  Identities=20%  Similarity=0.380  Sum_probs=194.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .+|++. +.||.|+||.||+|.+. ++..+|+|.+...    ....+|++. ++.++||||+++++++..    ....++
T Consensus         4 ~~~~~~-~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~~~   76 (256)
T cd05112           4 SELTLV-QEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQV-MMKLSHPKLVQLYGVCTE----RSPICL   76 (256)
T ss_pred             hHeEEE-eeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHH-HHhCCCCCeeeEEEEEcc----CCceEE
Confidence            478884 77999999999999885 4778999988642    345678876 666799999999998875    567899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+.+++|.+++.... +.++++.++.++.|++.||+|||+.|++||||||+||+++                     
T Consensus        77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---------------------  134 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---------------------  134 (256)
T ss_pred             EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---------------------
Confidence            999999999999987643 4589999999999999999999999999999999999997                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  248 (372)
                            .++.++|+|||.+......... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||..... 
T Consensus       135 ------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-  207 (256)
T cd05112         135 ------ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-  207 (256)
T ss_pred             ------CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence                  5667999999988765332111 112233567999999988889999999999999999998 9999964432 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                         ..+...+..+.....+   ...+.++.+|+.+||+.+|++|||+.+++++
T Consensus       208 ---~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         208 ---SEVVETINAGFRLYKP---RLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---HHHHHHHhCCCCCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence               2223333322111111   2468999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.5e-39  Score=291.16  Aligned_cols=247  Identities=26%  Similarity=0.429  Sum_probs=197.3

Q ss_pred             ceeeccccccccCCeEEEEEEEcC-CCcEEEEEEecch---------------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKK-TSEVYALKVLHDT---------------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      .|++. +.||+|+||.||+|.+.. +++.+|+|.+...               ....+|+..+.+..+||||+++++++.
T Consensus         1 ~y~~~-~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   79 (269)
T cd08528           1 EYAVL-EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL   79 (269)
T ss_pred             Cchhh-hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence            37774 779999999999999987 7899999987421               123456666556679999999999987


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCc
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                      .    +...+++|||+.+++|.+++..  .....+++..++.++.|++.||.|||+ .|++|+||+|+||+++       
T Consensus        80 ~----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~-------  148 (269)
T cd08528          80 E----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-------  148 (269)
T ss_pred             c----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC-------
Confidence            5    6789999999999999988754  223469999999999999999999996 6899999999999998       


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  236 (372)
                                          ..+.++|+|||.+....... ......|+..|+|||.+.+..++.++|+||||+++|+|+
T Consensus       149 --------------------~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~  207 (269)
T cd08528         149 --------------------EDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC  207 (269)
T ss_pred             --------------------CCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHH
Confidence                                56779999999987654432 334556788999999998888999999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      +|..||.....    ......+......  +.....++.++.++|.+||+.||++|||+.|+..+
T Consensus       208 ~g~~p~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         208 TLQPPFYSTNM----LSLATKIVEAVYE--PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             hCCCcccccCH----HHHHHHHhhccCC--cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            99999954432    1222233322222  11123578999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-40  Score=297.17  Aligned_cols=241  Identities=27%  Similarity=0.472  Sum_probs=185.7

Q ss_pred             cccccccCCeEEEEEEEc----CCCcEEEEEEecc------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          21 TEILGLGINGKVLQIVEK----KTSEVYALKVLHD------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .+.||.|.||.||+|...    ..+..|+||.+..      .....+|+.. ++.++||||+++++++..    ....++
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~-l~~l~h~ni~~~~g~~~~----~~~~~l   78 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQI-LRKLRHPNIVKLYGFCIE----NEPLFL   78 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHH-HHTHSBTTBE-EEEEEES----SSSEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccc-cccccccccccccccccc----cccccc
Confidence            467999999999999988    4578899999953      2345667776 455599999999999874    445899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      |+||+++|+|.+++.......+++..+..++.||+.||.|||+++++|+||+|+||+++                     
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---------------------  137 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---------------------  137 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---------------------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------------------
Confidence            99999999999999987445699999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                            .++.+||+|||++........  ......+...|+|||.+....++.++||||||+++|||++ |..||...+.
T Consensus       138 ------~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~  211 (259)
T PF07714_consen  138 ------SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN  211 (259)
T ss_dssp             ------TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred             ------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence                  567899999999887632211  1122334567999999988889999999999999999999 7899855432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                          ..+...+..+.. .+.  ...++..+.++|.+||..||.+|||+.++++
T Consensus       212 ----~~~~~~~~~~~~-~~~--~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  212 ----EEIIEKLKQGQR-LPI--PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ----HHHHHHHHTTEE-TTS--BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ----cccccccccccc-cee--ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                223344433322 111  2368999999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.8e-39  Score=301.01  Aligned_cols=250  Identities=22%  Similarity=0.380  Sum_probs=194.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCC-------CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKT-------SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      ...+|++ .+.||+|+||.||+|.+...       +..+|+|.+...      ....+|+..+.++.+||||+++++++.
T Consensus        10 ~~~~~~i-~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          10 SRTRLTL-GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             CHhHeee-cceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            3457988 57899999999999986432       346899988632      234567777555558999999999886


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN  145 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~N  145 (372)
                      .    +..+|++|||+.+|+|.+++.+..              ...++...+..++.||+.||.|||++||+||||||+|
T Consensus        89 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          89 Q----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             c----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            5    567899999999999999997632              1247888999999999999999999999999999999


Q ss_pred             eeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCcc
Q psy3151         146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSC  223 (372)
Q Consensus       146 Ili~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~  223 (372)
                      |+++                           .++.+||+|||+++........  .....++..|+|||++.+..++.++
T Consensus       165 ill~---------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  217 (334)
T cd05100         165 VLVT---------------------------EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS  217 (334)
T ss_pred             EEEc---------------------------CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchh
Confidence            9997                           5667999999988765432211  1122335679999999888999999


Q ss_pred             chhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         224 DIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       224 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||||||++|+|++ |..||...+.    ......+..+.. .  .....++.++.+|+.+||+.+|.+|||+.+++.+
T Consensus       218 Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         218 DVWSFGVLLWEIFTLGGSPYPGIPV----EELFKLLKEGHR-M--DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             hhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCC-C--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            99999999999998 8889865432    223333332211 1  1123578899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.2e-39  Score=293.64  Aligned_cols=240  Identities=21%  Similarity=0.316  Sum_probs=181.8

Q ss_pred             cccccCCeEEEEEEEcCC------------------------CcEEEEEEecchh-----hhHHHHHHHHHhcCCCCEeE
Q psy3151          23 ILGLGINGKVLQIVEKKT------------------------SEVYALKVLHDTV-----KARREVELQLAVGSHKHIVN   73 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~-----~~~~e~~~~~~~~~h~ni~~   73 (372)
                      .||+|+||.||+|....+                        ...||+|++....     ...+|+.+ ++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~-~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASL-MSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHH-HhcCCCCCeee
Confidence            499999999999975332                        2458899886322     22344444 67789999999


Q ss_pred             EeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          74 IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        74 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                      +++++..    +...++||||+++|+|..++.... +.+++..+..++.||+.||+|||++||+||||||+||+++..+.
T Consensus        81 ~~~~~~~----~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          81 VHGVCVR----GSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEEe----CCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence            9999875    567899999999999998886543 56899999999999999999999999999999999999984321


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHH
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIM  232 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il  232 (372)
                      ..                    .....++++|||.+.....    .....++..|+|||.+.+ ..++.++|+|||||++
T Consensus       156 ~~--------------------~~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l  211 (274)
T cd05076         156 AE--------------------GTSPFIKLSDPGVSFTALS----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTL  211 (274)
T ss_pred             cc--------------------CccceeeecCCcccccccc----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHH
Confidence            00                    0234589999998764322    122356788999998865 5689999999999999


Q ss_pred             HHHH-hCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         233 YILL-CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       233 ~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |+|+ +|..||......+.    . .........+.    ..++++.++|.+||+.+|++|||+.+++++
T Consensus       212 ~el~~~g~~p~~~~~~~~~----~-~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         212 LEICFDGEVPLKERTPSEK----E-RFYEKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHhCCCCCccccChHHH----H-HHHHhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            9985 69999965433221    1 11111222222    346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-39  Score=293.43  Aligned_cols=242  Identities=21%  Similarity=0.314  Sum_probs=184.8

Q ss_pred             ccccccCCeEEEEEEEcCCCc-------EEEEEEecchh-----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          22 EILGLGINGKVLQIVEKKTSE-------VYALKVLHDTV-----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~-----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +.||.|+||.||+|.+..++.       .+|+|.+....     ...+|... ++.++||||+++++++..    +...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~-l~~~~h~~iv~~~~~~~~----~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASM-MSQLSHKHLVLNYGVCVC----GDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHH-HHhCCCCChhheeeEEEe----CCCcE
Confidence            359999999999999866554       48888875332     22344444 677899999999999875    56789


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+.+|+|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++..   +.          
T Consensus        76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~---~~----------  141 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDR---KT----------  141 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEeccccc---cc----------
Confidence            9999999999999997654 358999999999999999999999999999999999999854321   11          


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCC-CCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGF-PPFFSNHG  247 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~  247 (372)
                            +..+.++++|||++.....    .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|. .||...+.
T Consensus       142 ------~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~  211 (258)
T cd05078         142 ------GNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS  211 (258)
T ss_pred             ------CCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence                  1334589999998865432    233457888999999876 45889999999999999999984 56543222


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .     ............|.    ..+.++.+||.+||+.||++|||++++++.
T Consensus       212 ~-----~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         212 Q-----KKLQFYEDRHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             H-----HHHHHHHccccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            1     11112222233332    456889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.2e-39  Score=289.43  Aligned_cols=240  Identities=22%  Similarity=0.388  Sum_probs=192.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      ++|++ .+.||+|+||.||++..  +++.+|+|.+...   ....+|+.. ++.++||||+++++++..     +..|++
T Consensus         6 ~~~~~-~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~-----~~~~~v   76 (254)
T cd05083           6 QKLTL-GEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAV-MTKLHHKNLVRLLGVILH-----NGLYIV   76 (254)
T ss_pred             HHcee-eeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHH-HHhCCCCCcCeEEEEEcC-----CCcEEE
Confidence            57888 58899999999999864  6889999998632   234567776 667799999999998753     347999


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      |||+.+++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++                      
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~----------------------  134 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS----------------------  134 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----------------------
Confidence            9999999999999876545689999999999999999999999999999999999997                      


Q ss_pred             cCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCC
Q psy3151         172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAI  250 (372)
Q Consensus       172 ~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  250 (372)
                           .++.++|+|||++......   ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..  
T Consensus       135 -----~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--  204 (254)
T cd05083         135 -----EDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--  204 (254)
T ss_pred             -----CCCcEEECCCccceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--
Confidence                 5677999999988754321   112223567999999988889999999999999999997 99999654322  


Q ss_pred             CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                        .....+..+ ...+.  ...++.++.+++.+||+.+|.+|||+++++.
T Consensus       205 --~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         205 --EVKECVEKG-YRMEP--PEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             --HHHHHHhCC-CCCCC--CCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              223333322 11111  2367899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.7e-39  Score=294.54  Aligned_cols=245  Identities=22%  Similarity=0.381  Sum_probs=191.7

Q ss_pred             ceeeccccccccCCeEEEEEEEcC-----CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKK-----TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +|++ .+.||+|+||+||+|.+..     ....+|+|.+...      ....+|+.. ++.++||||+++++.+..    
T Consensus         1 ~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----   74 (290)
T cd05045           1 NLVL-GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNL-LKQVNHPHVIKLYGACSQ----   74 (290)
T ss_pred             Cccc-cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHH-HhhCCCCCEeeEEEEEec----
Confidence            4666 5789999999999998753     3367999987532      234567776 567799999999998865    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKE----------------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK  142 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~----------------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlk  142 (372)
                      +...++++||+.+++|.+++....                      ...+++..++.++.|++.||.|||+.||+|||||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik  154 (290)
T cd05045          75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA  154 (290)
T ss_pred             CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence            567899999999999999886421                      1347899999999999999999999999999999


Q ss_pred             CCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCC
Q psy3151         143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYD  220 (372)
Q Consensus       143 p~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~  220 (372)
                      |+||+++                           +++.++|+|||++........  ......++..|+|||.+.+..++
T Consensus       155 p~nill~---------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~  207 (290)
T cd05045         155 ARNVLVA---------------------------EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT  207 (290)
T ss_pred             hheEEEc---------------------------CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc
Confidence            9999997                           566799999999876533221  11223446689999999888899


Q ss_pred             CccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         221 KSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       221 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .++|||||||++|+|++ |..||.+....    .+....... ...+.  ...++.++.+++.+||+.+|.+|||+++++
T Consensus       208 ~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~-~~~~~--~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~  280 (290)
T cd05045         208 TQSDVWSFGVLLWEIVTLGGNPYPGIAPE----RLFNLLKTG-YRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADIS  280 (290)
T ss_pred             hHhHHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHhCC-CCCCC--CCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            99999999999999998 99999654322    223333222 22221  246789999999999999999999999997


Q ss_pred             c
Q psy3151         300 E  300 (372)
Q Consensus       300 ~  300 (372)
                      +
T Consensus       281 ~  281 (290)
T cd05045         281 K  281 (290)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-39  Score=287.00  Aligned_cols=237  Identities=24%  Similarity=0.419  Sum_probs=188.8

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      .||.|++|.||+|.+.. ++.||+|.+...      ....+|+.+ ++.++|+||+++++++..    ....++||||+.
T Consensus         2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~----~~~~~~v~e~~~   75 (251)
T cd05041           2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEI-LKQYDHPNIVKLIGVCVQ----KQPIYIVMELVP   75 (251)
T ss_pred             ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHH-HHhCCCCCeEEEEEEEec----CCCeEEEEEcCC
Confidence            59999999999999987 999999987632      234566665 677799999999998875    667899999999


Q ss_pred             CCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCC
Q psy3151          97 GGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG  176 (372)
Q Consensus        97 ~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~  176 (372)
                      +++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++                           
T Consensus        76 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~---------------------------  127 (251)
T cd05041          76 GGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG---------------------------  127 (251)
T ss_pred             CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc---------------------------
Confidence            999999987643 4589999999999999999999999999999999999998                           


Q ss_pred             CCCCeeeeccccccccccCCCcc--cccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHh
Q psy3151         177 DGGILKLTDFGFAKKIVSNKASL--QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPG  253 (372)
Q Consensus       177 ~~~~~ki~Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  253 (372)
                      .++.++|+|||.+..........  ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||......    .
T Consensus       128 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~  203 (251)
T cd05041         128 ENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----Q  203 (251)
T ss_pred             CCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----H
Confidence            56678999999887553211111  11223556999999988889999999999999999999 88888554322    2


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ....+... ...+  ....++.++.+++.+||..+|.+|||+.++++
T Consensus       204 ~~~~~~~~-~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         204 TRERIESG-YRMP--APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHHhcC-CCCC--CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            22222221 1111  12467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0614|consensus

Probab=100.00  E-value=1.2e-41  Score=312.72  Aligned_cols=250  Identities=33%  Similarity=0.585  Sum_probs=210.3

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .+++ ..||-|+||.|=++........+|+|++++.        .-...|..+++.. ..|.||+++..|.+    +.+.
T Consensus       422 l~~i-aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd----~kyv  495 (732)
T KOG0614|consen  422 LKRI-ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD----SKYV  495 (732)
T ss_pred             hhhh-hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc----chhh
Confidence            3443 5699999999999988766666999988632        1234567775444 68999999998876    8899


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+.||-|-||.|+..++.+  +.|++..++.++..++.|++|||+.|||.|||||+|.+++                   
T Consensus       496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd-------------------  554 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD-------------------  554 (732)
T ss_pred             hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec-------------------
Confidence            9999999999999999876  5699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .+|-+||.|||+|+.+.. .....+.||||.|.|||++.+..-+.++|.||||+++|||++|.+||.+.+..
T Consensus       555 --------~~Gy~KLVDFGFAKki~~-g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm  625 (732)
T KOG0614|consen  555 --------NRGYLKLVDFGFAKKIGS-GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM  625 (732)
T ss_pred             --------cCCceEEeehhhHHHhcc-CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence                    678899999999998865 44567899999999999999999999999999999999999999999887765


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccCC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQFN  308 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~~  308 (372)
                      .....+.+.+.  .+.+|    ..++..+.+||+++...+|.+|..     +.+|.+|.||.++.
T Consensus       626 ktYn~ILkGid--~i~~P----r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  626 KTYNLILKGID--KIEFP----RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             HHHHHHHhhhh--hhhcc----cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence            44333333322  23344    378999999999999999999987     89999999999864

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-39  Score=295.32  Aligned_cols=248  Identities=21%  Similarity=0.320  Sum_probs=194.8

Q ss_pred             ccceeeccccccccCCeEEEEEEEcC----CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKK----TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      .++|.+ .++||+|+||.||+|.+..    +++.||+|.+...      ....+|+.. ++.++||||+++++++..   
T Consensus         5 ~~~~~~-~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~---   79 (280)
T cd05043           5 RDRVTL-SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCL-LYGLSHQNILPILHVCIE---   79 (280)
T ss_pred             hhheEE-eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEec---
Confidence            478998 5889999999999999876    3688999988632      224466666 566699999999998653   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKED------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      .+...+++++|+.+++|.+++.....      ..+++..++.++.||+.||+|||+.+++||||||+||+++        
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~--------  151 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID--------  151 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc--------
Confidence            24568899999999999999876422      3589999999999999999999999999999999999997        


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHH
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  235 (372)
                                         +++.+||+|||+++........  .....++..|+|||.+.+..++.++|||||||++|++
T Consensus       152 -------------------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el  212 (280)
T cd05043         152 -------------------EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL  212 (280)
T ss_pred             -------------------CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHH
Confidence                               5677899999998755322111  1122345679999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         236 LC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       236 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ++ |..||......    .+...+..+ ...+  ....+++++.+++.+||..||++|||+.++++
T Consensus       213 ~~~g~~p~~~~~~~----~~~~~~~~~-~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         213 MTLGQTPYVEIDPF----EMAAYLKDG-YRLA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             hcCCCCCcCcCCHH----HHHHHHHcC-CCCC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            98 99999654322    223333222 2212  22357899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.7e-39  Score=290.27  Aligned_cols=246  Identities=20%  Similarity=0.358  Sum_probs=195.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ..++|.+ .+.||+|+||.||+|.+. .+..+|+|.+...    ....+|+.+ ++.++|+||+++++++..     ...
T Consensus         4 ~~~~~~~-~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~-----~~~   75 (260)
T cd05073           4 PRESLKL-EKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANV-MKTLQHDKLVKLHAVVTK-----EPI   75 (260)
T ss_pred             cccceeE-EeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHH-HHhcCCCCcceEEEEEcC-----CCe
Confidence            5678998 577999999999999865 4567999988632    245567776 566799999999998753     457


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |++|||+++++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||+++                   
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~-------------------  136 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS-------------------  136 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc-------------------
Confidence            9999999999999999876555689999999999999999999999999999999999997                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  246 (372)
                              ..+.++|+|||.+......... .....++..|+|||.+....++.++|+|||||++|++++ |..||...+
T Consensus       137 --------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~  208 (260)
T cd05073         137 --------ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS  208 (260)
T ss_pred             --------CCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence                    5677999999988765432211 122234567999999988889999999999999999998 999996543


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..    .....+..+ +..+  .....+.++.+++.+||+.+|++||++.+++.
T Consensus       209 ~~----~~~~~~~~~-~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         209 NP----EVIRALERG-YRMP--RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HH----HHHHHHhCC-CCCC--CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            22    222332222 2222  22467899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.6e-39  Score=290.09  Aligned_cols=240  Identities=20%  Similarity=0.324  Sum_probs=189.3

Q ss_pred             ccccccCCeEEEEEEEcC-CC--cEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          22 EILGLGINGKVLQIVEKK-TS--EVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      +.||.|++|.||+|.+.. ++  ..+|||.+....      ...+|+.. ++.++||||+++++.+..     ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~-----~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAI-MHSLDHENLIRLYGVVLT-----HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHH-HhhcCCCCccceeEEEcC-----CeEEEEE
Confidence            358999999999999865 33  369999986432      34457766 666799999999998763     6789999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      ||+++++|.+++.......+++..++.++.|++.||+|||++|++|+||||+||+++                       
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~-----------------------  131 (257)
T cd05040          75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA-----------------------  131 (257)
T ss_pred             EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe-----------------------
Confidence            999999999999875434689999999999999999999999999999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ  248 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  248 (372)
                          .++.+||+|||++.........   .....++..|+|||.+....++.++|+|||||++|+|++ |..||...+..
T Consensus       132 ----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  207 (257)
T cd05040         132 ----SDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS  207 (257)
T ss_pred             ----cCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence                5577999999988766432211   112345778999999988889999999999999999998 99999644332


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +    +...+.......+.  ....+.++.+++.+||..+|++|||+.++++
T Consensus       208 ~----~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         208 Q----ILKKIDKEGERLER--PEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             H----HHHHHHhcCCcCCC--CccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            2    22222211111111  1357899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.7e-39  Score=295.85  Aligned_cols=247  Identities=20%  Similarity=0.387  Sum_probs=193.6

Q ss_pred             ccceeeccccccccCCeEEEEEEEcC-----CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKK-----TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .++|++. +.||.|+||.||+|.+..     ++..+|+|++...      ....+|+.. ++.++||||+++++++..  
T Consensus         4 ~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~-l~~l~h~~iv~~~~~~~~--   79 (288)
T cd05050           4 RNNIEYV-RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL-MAEFDHPNIVKLLGVCAV--   79 (288)
T ss_pred             hHhceec-ccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHH-HHhcCCCchheEEEEEcC--
Confidence            4678885 669999999999998753     6789999998632      234456766 666799999999998875  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhcc--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKE--------------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK  142 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~--------------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlk  142 (372)
                        +...+++|||+.+++|.+++....                    ...+++..++.++.||+.||+|||++|++|||||
T Consensus        80 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~  157 (288)
T cd05050          80 --GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA  157 (288)
T ss_pred             --CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence              567899999999999999997432                    1247889999999999999999999999999999


Q ss_pred             CCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCC
Q psy3151         143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYD  220 (372)
Q Consensus       143 p~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~  220 (372)
                      |+||+++                           .++.++|+|||++........  .......+..|+|||.+.+..++
T Consensus       158 p~nil~~---------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  210 (288)
T cd05050         158 TRNCLVG---------------------------ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT  210 (288)
T ss_pred             HhheEec---------------------------CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC
Confidence            9999997                           567789999998875432211  11222335679999999888899


Q ss_pred             CccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         221 KSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       221 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .++|+|||||++|+|++ |..||.+....    .....+..+... +.  ...++.++.+|+.+||+.||.+|||+.|++
T Consensus       211 ~~~Dv~slG~il~el~~~~~~p~~~~~~~----~~~~~~~~~~~~-~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~el~  283 (288)
T cd05050         211 TESDVWAYGVVLWEIFSYGMQPYYGMAHE----EVIYYVRDGNVL-SC--PDNCPLELYNLMRLCWSKLPSDRPSFASIN  283 (288)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhcCCCC-CC--CCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            99999999999999997 88888654322    223333333321 11  135789999999999999999999999987


Q ss_pred             c
Q psy3151         300 E  300 (372)
Q Consensus       300 ~  300 (372)
                      +
T Consensus       284 ~  284 (288)
T cd05050         284 R  284 (288)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.4e-38  Score=285.75  Aligned_cols=238  Identities=21%  Similarity=0.397  Sum_probs=188.0

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      ++||.|+||.||+|... ++..+|+|.+...      ....+|+.. ++.++||||+++++++..    ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARI-LKQYDHPNIVKLIGVCTQ----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHH-HHhCCCCCcCeEEEEEec----CCccEEEEECC
Confidence            36999999999999864 6889999987532      134467776 566799999999998875    56789999999


Q ss_pred             CCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151          96 HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus        96 ~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                      .+++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++                          
T Consensus        75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~--------------------------  127 (250)
T cd05085          75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG--------------------------  127 (250)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc--------------------------
Confidence            9999999987643 4589999999999999999999999999999999999997                          


Q ss_pred             CCCCCeeeeccccccccccCCCcc-cccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHh
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKASL-QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPG  253 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~  253 (372)
                       .++.++++|||++.......... ....+++.|+|||.+....++.++|+|||||++|++++ |..||......    .
T Consensus       128 -~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~  202 (250)
T cd05085         128 -ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----Q  202 (250)
T ss_pred             -CCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----H
Confidence             56678999999886543221111 11233567999999988889999999999999999998 99999654322    2


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ....+..+ ...  .....++.++.+++.+||..+|++|||+.++++
T Consensus       203 ~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         203 AREQVEKG-YRM--SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             HHHHHHcC-CCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            22233222 111  112357899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-38  Score=289.95  Aligned_cols=242  Identities=20%  Similarity=0.274  Sum_probs=182.3

Q ss_pred             cccccCCeEEEEEEEc--CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEK--KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .||+|+||.||+|...  .++..+|+|.+...      ....+|+.. ++.++||||+++++++..    ....++||||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~~~lv~e~   76 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQP-YRSLQHSNLLQCLGQCTE----VTPYLLVMEF   76 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHH-HHhCCCCCEeeEEEEEcC----CCCcEEEEEC
Confidence            4899999999999754  45678999988632      134456665 667799999999998865    5568999999


Q ss_pred             cCCCchhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          95 MHGGELFQRIQQKE---DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        95 ~~~g~L~~~i~~~~---~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      +++|+|.+++....   ....++..++.++.|++.||+|||+.|++||||||+||+++                      
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~----------------------  134 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT----------------------  134 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----------------------
Confidence            99999999997532   12467788889999999999999999999999999999998                      


Q ss_pred             cCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCC-------CCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         172 YTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPD-------KYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       172 ~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                           ..+.++++|||.+........  ......+++.|+|||++...       .++.++|+|||||++|+|++ |..|
T Consensus       135 -----~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p  209 (269)
T cd05087         135 -----ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP  209 (269)
T ss_pred             -----CCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC
Confidence                 566799999998865432221  12234567889999988532       35789999999999999996 9999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcc-cccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEW-EHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |......+.   ....+.......+.+.. ...+..+.+++..|+ .+|++|||+++++.
T Consensus       210 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         210 YRHLSDEQV---LTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCCChHHH---HHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            965432221   11122222222332221 246788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0193|consensus

Probab=100.00  E-value=2.9e-40  Score=309.84  Aligned_cols=240  Identities=23%  Similarity=0.359  Sum_probs=189.6

Q ss_pred             ccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          20 STEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        20 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      +.+.||+|.||+||+|++-  | .||||+++..       .....|+.. ++..+|.||+-+.+++..    ... .||+
T Consensus       396 l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~-lkkTRH~NIlLFMG~~~~----p~~-AIiT  466 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAV-LKKTRHENILLFMGACMN----PPL-AIIT  466 (678)
T ss_pred             ccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHH-HhhcchhhheeeehhhcC----Cce-eeee
Confidence            4678999999999999985  3 5999999732       223456665 788899999999999864    343 8999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      -+|+|-+|+.++...+ .+|.....+.|++||++|+.|||.++|||||||..|||+.                       
T Consensus       467 qwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~-----------------------  522 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH-----------------------  522 (678)
T ss_pred             hhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc-----------------------
Confidence            9999999999998765 4699999999999999999999999999999999999997                       


Q ss_pred             CCCCCCCCeeeecccccccccc--CCCcccccccCCCcCCCcccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVS--NKASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                          .++.|||+|||++..-.-  ........-|...|||||++.   ..+|++.+|+|||||++|||++|..||.....
T Consensus       523 ----~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~  598 (678)
T KOG0193|consen  523 ----EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR  598 (678)
T ss_pred             ----cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence                568899999999875432  222334455667799999984   45799999999999999999999999974433


Q ss_pred             CCCCHhHHHHHhhCCccC-CCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDF-PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..+.    -.+..|.... ......+++.++++|+..||.+++++||++.++|.
T Consensus       599 dqIi----fmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  599 DQII----FMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hheE----EEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            3221    1122221111 11123467789999999999999999999999887

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.2e-39  Score=291.40  Aligned_cols=242  Identities=22%  Similarity=0.304  Sum_probs=181.7

Q ss_pred             cccccCCeEEEEEEEcC--CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKK--TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .||+|+||+||+|....  ....+|+|.+...      ....+|+.. ++.++||||+++++.+..    ....|+||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~-~~~l~h~nii~~~~~~~~----~~~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQP-YRELNHPNVLQCLGQCIE----SIPYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHH-HHhCCCCCcceEEEEECC----CCceEEEEEe
Confidence            48999999999996532  4567899987532      123456665 566799999999998865    5678999999


Q ss_pred             cCCCchhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          95 MHGGELFQRIQQKED---GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~---~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      +.+|+|.+++.....   ...++..++.++.||+.||+|||++||+||||||+|||++                      
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----------------------  134 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT----------------------  134 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec----------------------
Confidence            999999999976432   2356788999999999999999999999999999999998                      


Q ss_pred             cCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccC-------CCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         172 YTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLG-------PDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       172 ~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                           .++.+||+|||++........  ......+++.|+|||++.       ...++.++|||||||++|+|++ |..|
T Consensus       135 -----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p  209 (269)
T cd05042         135 -----ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP  209 (269)
T ss_pred             -----CCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCC
Confidence                 567799999998865432211  112234467799999863       2456789999999999999999 7888


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCc-ccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPE-WEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |......+   .....+.......+.+. ...++..+.+++..|+ .||++|||++++++
T Consensus       210 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         210 YPDLSDEQ---VLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCcCCHHH---HHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            85443221   12222333333333322 2357888999999998 59999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.7e-39  Score=291.62  Aligned_cols=248  Identities=22%  Similarity=0.419  Sum_probs=196.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcC-----CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKK-----TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ++|+++ +.||.|+||+||+|..+.     +.+.+|+|.+...      ....+|+.+ ++.++|+||+++++++..   
T Consensus         5 ~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~---   79 (275)
T cd05046           5 SNLQEI-TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM-FRKLSHKNVVRLLGLCRE---   79 (275)
T ss_pred             Hhceee-eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHH-HHhcCCcceeeeEEEECC---
Confidence            678885 669999999999999754     4578999988632      235667777 566699999999998865   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCc
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKED-------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~-------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                       ....|+||||+++++|.+++.....       ..+++..+..++.||+.||+|||+.||+||||||+||+++       
T Consensus        80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~-------  151 (275)
T cd05046          80 -AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS-------  151 (275)
T ss_pred             -CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe-------
Confidence             5678999999999999999976541       1589999999999999999999999999999999999998       


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  235 (372)
                                          ..+.++++|||++....... .......+++.|+|||.+.+..++.++|+|||||++|+|
T Consensus       152 --------------------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  211 (275)
T cd05046         152 --------------------SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV  211 (275)
T ss_pred             --------------------CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHH
Confidence                                56678899998876543211 122233456779999998888889999999999999999


Q ss_pred             Hh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         236 LC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       236 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ++ |..||.....    .........+...++.+  ..++..+.+++.+||..+|.+|||+.+++.+
T Consensus       212 ~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         212 FTQGELPFYGLSD----EEVLNRLQAGKLELPVP--EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HhCCCCCccccch----HHHHHHHHcCCcCCCCC--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            98 8889854332    22333444333333222  3578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.9e-39  Score=290.24  Aligned_cols=245  Identities=22%  Similarity=0.350  Sum_probs=192.1

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCC---CcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKT---SEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .++|.+ .+.||.|+||.||+|.+..+   ...+|||......      ...+|+.. ++.++||||+++++++.+    
T Consensus         5 ~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~-l~~~~h~~i~~~~~~~~~----   78 (270)
T cd05056           5 REDITL-GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI-MRQFDHPHIVKLIGVITE----   78 (270)
T ss_pred             hhhcee-eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHH-HHhCCCCchhceeEEEcC----
Confidence            356887 57899999999999987644   4578999875321      34456665 666789999999998763    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                       ...|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||+++               
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---------------  141 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---------------  141 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---------------
Confidence             44789999999999999997643 3589999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPF  242 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  242 (372)
                                  ..+.++++|||++......... .....+++.|+|||.+....++.++|+|||||++|+|++ |..||
T Consensus       142 ------------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf  209 (270)
T cd05056         142 ------------SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF  209 (270)
T ss_pred             ------------cCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCC
Confidence                        5667999999988765433211 112233467999999988889999999999999999986 99999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ......+    ....+..+...   +....++.++.++|.+||..+|.+|||+.+++.
T Consensus       210 ~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         210 QGVKNND----VIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             CCCCHHH----HHHHHHcCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6554322    22222222211   112467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG1187|consensus

Probab=100.00  E-value=7.6e-39  Score=299.86  Aligned_cols=253  Identities=26%  Similarity=0.346  Sum_probs=191.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-----hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce-E
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-----TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSR-C   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~-~   87 (372)
                      ++.|.- ..+||+|+||.||+|.-.. |..||||.+..     ......|+++ +..++|||++++++++.+    ++ .
T Consensus        74 T~~Fs~-~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~-ls~l~H~Nlv~LlGyC~e----~~~~  146 (361)
T KOG1187|consen   74 TNNFSE-SNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEI-LSRLRHPNLVKLLGYCLE----GGEH  146 (361)
T ss_pred             HhCCch-hcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHH-HhcCCCcCcccEEEEEec----CCce
Confidence            345554 4679999999999999864 48999998864     2346678887 566679999999999975    44 6


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN---IAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~---ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      .++|+||+.+|+|.+++.......+++....+|+.+++.||+|||...   |+||||||+|||+|               
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD---------------  211 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD---------------  211 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC---------------
Confidence            999999999999999998754327899999999999999999999864   99999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCccccc-ccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                  .+...||+|||+|+..........+. .||.+|+|||....+..+.++||||||+++.||++|+.+.+
T Consensus       212 ------------~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d  279 (361)
T KOG1187|consen  212 ------------EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVD  279 (361)
T ss_pred             ------------CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccC
Confidence                        67789999999996543212222222 78999999999988999999999999999999999998886


Q ss_pred             CCCCC-C--CCHhHHHHHhhCCcc-CCCCcc--cccC--HH---HHHHHHHhccCCCCCCCChhHHhc
Q psy3151         244 SNHGQ-A--ISPGMKNRIRLGQFD-FPNPEW--EHVS--QE---AKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       244 ~~~~~-~--~~~~~~~~~~~~~~~-~~~~~~--~~~s--~~---~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..... +  +.......+..+.+. +..+..  ..++  .+   +..+..+|++.+|..||++.|+++
T Consensus       280 ~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  280 QSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            54311 1  111112222222111 111111  1223  23   446677999999999999999754

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=290.99  Aligned_cols=245  Identities=20%  Similarity=0.325  Sum_probs=194.0

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCc----EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSE----VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      .++|++. +.||+|+||+||+|.+..+|+    .+|+|.+...      ....+|+.. +..++||||+++++++..   
T Consensus         6 ~~~~~~~-~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~---   80 (279)
T cd05057           6 ETELEKI-KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV-MASVDHPHVVRLLGICLS---   80 (279)
T ss_pred             HHHcEEc-ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHH-HHhCCCCCcceEEEEEec---
Confidence            3788884 779999999999999877665    5899987532      233466666 566799999999998863   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                        ...++||||+.+|+|.+++.+.. ..+++..+..++.||+.||+|||+.|++||||||+||+++              
T Consensus        81 --~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~--------------  143 (279)
T cd05057          81 --SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK--------------  143 (279)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc--------------
Confidence              46899999999999999997654 4599999999999999999999999999999999999997              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCccc--ccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ--TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFP  240 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  240 (372)
                                   .++.+||+|||.+...........  ...++..|+|||.+....++.++|+|||||++|++++ |..
T Consensus       144 -------------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~  210 (279)
T cd05057         144 -------------TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK  210 (279)
T ss_pred             -------------CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCC
Confidence                         566789999998876543222111  1223567999999988889999999999999999998 999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||.+....    .+...+..+.. .+.  ....+.++.+++.+||..||..|||+.++++
T Consensus       211 p~~~~~~~----~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         211 PYEGIPAV----EIPDLLEKGER-LPQ--PPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCCCHH----HHHHHHhCCCC-CCC--CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99655432    23333333221 111  1357889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.5e-38  Score=287.63  Aligned_cols=239  Identities=19%  Similarity=0.286  Sum_probs=182.4

Q ss_pred             cccccCCeEEEEEEEcC---CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          23 ILGLGINGKVLQIVEKK---TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      .||+|+||.||+|.+..   ++..+|||.+...      ....+|+.. ++.++||||+++++++..   .+...+++||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~---~~~~~~lv~e   77 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGII-MKDFSHPNVLSLLGICLP---SEGSPLVVLP   77 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHH-HccCCCCCcceEEEEeec---CCCCcEEEEe
Confidence            58999999999998653   3567999988532      233456665 677799999999997643   2456789999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      |+.+++|.+++.... ..+++..+..++.||+.||+|||+.+++||||||+|||++                        
T Consensus        78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~------------------------  132 (262)
T cd05058          78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD------------------------  132 (262)
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc------------------------
Confidence            999999999997643 3478888899999999999999999999999999999998                        


Q ss_pred             CCCCCCCeeeeccccccccccCC----CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCC
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNK----ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG-FPPFFSNHGQ  248 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~  248 (372)
                         .++.+||+|||++.......    .......+++.|+|||.+....++.++|||||||++|+|++| .+||..... 
T Consensus       133 ---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-  208 (262)
T cd05058         133 ---ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-  208 (262)
T ss_pred             ---CCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence               56678999999887543211    111223346689999999888899999999999999999995 566643322 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                         ......+..+.. .+  .....+..+.+++.+||..+|++||++.+++.
T Consensus       209 ---~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         209 ---FDITVYLLQGRR-LL--QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             ---HHHHHHHhcCCC-CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence               122222222211 11  11356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0194|consensus

Probab=100.00  E-value=1.2e-39  Score=307.77  Aligned_cols=240  Identities=23%  Similarity=0.397  Sum_probs=193.8

Q ss_pred             cccccccCCeEEEEEEEcCCCc---E-EEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTSE---V-YALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~---~-vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .+.||+|+||.||+|..+..+.   . ||||.....        ....+|.++ ++.++||||++++++...    ..-+
T Consensus       162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArv-Mr~l~H~NVVr~yGVa~~----~~Pl  236 (474)
T KOG0194|consen  162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARV-MRQLNHPNVVRFYGVAVL----EEPL  236 (474)
T ss_pred             cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHH-HHhCCCCCEEEEEEEEcC----CCcc
Confidence            4789999999999998876432   3 899988631        234577777 566899999999998865    6779


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+|||+|+||+|.+++++.+ +.++..+...++.+.+.||+|||+++++||||-.+|+|++                   
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~-------------------  296 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS-------------------  296 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec-------------------
Confidence            99999999999999999875 3599999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCccccccc-CCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY-TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  246 (372)
                              .++.+||+|||+++....... ....+- ...|+|||.+....|+.++|||||||++||+++ |..||.+..
T Consensus       297 --------~~~~vKISDFGLs~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~  367 (474)
T KOG0194|consen  297 --------KKGVVKISDFGLSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK  367 (474)
T ss_pred             --------CCCeEEeCccccccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence                    456689999999876531111 111111 236999999999999999999999999999998 888997765


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..    .+...+....+..+.+  ...+.++..++.+|+..||++|||+.++.+
T Consensus       368 ~~----~v~~kI~~~~~r~~~~--~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  368 NY----EVKAKIVKNGYRMPIP--SKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HH----HHHHHHHhcCccCCCC--CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            43    3455554444444433  367899999999999999999999999866

>KOG1027|consensus

Probab=100.00  E-value=2.6e-40  Score=319.86  Aligned_cols=253  Identities=29%  Similarity=0.409  Sum_probs=200.8

Q ss_pred             eccccccccCCeE-EEEEEEcCCCcEEEEEEecc--hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          19 ISTEILGLGINGK-VLQIVEKKTSEVYALKVLHD--TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        19 i~~~~lG~G~~g~-V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      .-.+++|.|+-|+ ||+|...  |+.||||.+-.  ...+.+|+..+...-.||||++++..-.+    .+++||..|.|
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d----~qF~YIalELC  585 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQD----RQFLYIALELC  585 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccC----CceEEEEehHh
Confidence            3467899999987 6999874  88999998853  35788999998889999999998886543    78999999999


Q ss_pred             CCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccC
Q psy3151          96 HGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT  173 (372)
Q Consensus        96 ~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~  173 (372)
                      . .+|.+++...  +.........+.++.|++.||+|||+.+||||||||.||||+.++..                   
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~-------------------  645 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSAD-------------------  645 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCC-------------------
Confidence            5 5999999873  21112225678899999999999999999999999999999854311                   


Q ss_pred             CCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCC
Q psy3151         174 KPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG-FPPFFSNHGQA  249 (372)
Q Consensus       174 ~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~  249 (372)
                         ...+++|+|||+++....+...   ..+..||-+|+|||++....-+.++|||||||++|+.++| .+||.+.-.. 
T Consensus       646 ---~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-  721 (903)
T KOG1027|consen  646 ---GTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-  721 (903)
T ss_pred             ---cceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-
Confidence               3467899999999988665443   4456789999999999988888999999999999998885 9999654322 


Q ss_pred             CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                           ...+..+.+.+..... ....++.|||.+|+.++|..||+|.++|.||+|...
T Consensus       722 -----~~NIl~~~~~L~~L~~-~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  722 -----QANILTGNYTLVHLEP-LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             -----hhhhhcCccceeeecc-CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence                 2344555544332111 111289999999999999999999999999999764

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-38  Score=294.55  Aligned_cols=245  Identities=19%  Similarity=0.330  Sum_probs=191.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCc----EEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSE----VYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ++|++. +.||+|+||.||+|.+..+|+    .+|+|.+....      ...+|+.+ ++.++||||+++++++..    
T Consensus         7 ~~~~~~-~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~h~niv~~~~~~~~----   80 (303)
T cd05110           7 TELKRV-KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI-MASMDHPHLVRLLGVCLS----   80 (303)
T ss_pred             hhceec-cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHH-HHhCCCCCcccEEEEEcC----
Confidence            567774 779999999999999987776    57888876321      23456665 667799999999998753    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                       ...++++||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++               
T Consensus        81 -~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---------------  143 (303)
T cd05110          81 -PTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---------------  143 (303)
T ss_pred             -CCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---------------
Confidence             23678999999999999987653 3589999999999999999999999999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                  .++.+||+|||+++........  .....++..|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus       144 ------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p  211 (303)
T cd05110         144 ------------SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP  211 (303)
T ss_pred             ------------CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence                        5567899999998765432221  222344678999999988889999999999999999997 8899


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |.+.....    ....+..+ ...+.  ....+.++.+++.+||..+|++||+++++++.
T Consensus       212 ~~~~~~~~----~~~~~~~~-~~~~~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         212 YDGIPTRE----IPDLLEKG-ERLPQ--PPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCCCHHH----HHHHHHCC-CCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            86543211    22222222 11221  23578899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.3e-38  Score=289.04  Aligned_cols=244  Identities=26%  Similarity=0.399  Sum_probs=187.1

Q ss_pred             cccccCCeEEEEEEEcCCC------cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          23 ILGLGINGKVLQIVEKKTS------EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .||.|+||.||+|.+...+      +.+|||.+...      ....+|+.. ++.++||||+++++++..    ....++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~~   76 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHL-MSNFNHPNIVKLLGVCLL----NEPQYI   76 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHH-HHhcCCCCeeeEeeeecC----CCCeEE
Confidence            5899999999999986544      78999987532      234466665 677799999999998865    567899


Q ss_pred             EEeccCCCchhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          91 IMECMHGGELFQRIQQKE-----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~-----~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ||||+++++|.+++....     ...+++..+..++.||+.||.|||+.+++|+||||+||+++.++.+           
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~-----------  145 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYD-----------  145 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCC-----------
Confidence            999999999999997532     2348899999999999999999999999999999999999843210           


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPF  242 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  242 (372)
                                 ....++++|||++........  ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||
T Consensus       146 -----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~  214 (269)
T cd05044         146 -----------ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY  214 (269)
T ss_pred             -----------CCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCC
Confidence                       123688889888865432211  1122344678999999988889999999999999999998 99999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ......    .....+..+.. .  .....++.++.++|.+||..+|.+|||++++++
T Consensus       215 ~~~~~~----~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         215 PALNNQ----EVLQHVTAGGR-L--QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccCHH----HHHHHHhcCCc-c--CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            544321    22222222111 1  112367899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1095|consensus

Probab=100.00  E-value=3.9e-39  Score=324.48  Aligned_cols=241  Identities=22%  Similarity=0.405  Sum_probs=195.6

Q ss_pred             cccccccCCeEEEEEEEcCCCc-----EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTSE-----VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      ...||+|+||.||.|.......     .||||.+.+.      ....+|..+ +..++||||++++++..+    ....+
T Consensus       697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~-m~~f~HpNiv~liGv~l~----~~~~~  771 (1025)
T KOG1095|consen  697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALL-MSKFDHPNIVSLIGVCLD----SGPPL  771 (1025)
T ss_pred             eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHH-HhcCCCcceeeEEEeecC----CCCcE
Confidence            5789999999999998865433     3899988643      233455554 788899999999999875    55688


Q ss_pred             EEEeccCCCchhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          90 VIMECMHGGELFQRIQQKE-----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~-----~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +++|||+||||..+|++..     ...++......++.||++|++||++++.|||||-.+|+|++               
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---------------  836 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---------------  836 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---------------
Confidence            9999999999999999751     24699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccC--CCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT--PYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt--~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                  ....|||+|||+|+.+....-......+.  ..|||||.+..+.++.++|||||||++||+++ |..|
T Consensus       837 ------------~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P  904 (1025)
T KOG1095|consen  837 ------------ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP  904 (1025)
T ss_pred             ------------ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence                        56789999999999664433222222222  35999999999999999999999999999998 9999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |.+.+..++   +..-...+.++.|    ..++..+.++|.+||+.+|++||++..+++
T Consensus       905 Y~~~~n~~v---~~~~~~ggRL~~P----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  905 YPSRSNFEV---LLDVLEGGRLDPP----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCcchHHH---HHHHHhCCccCCC----CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            977665443   2223444444444    378999999999999999999999999987

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-38  Score=290.14  Aligned_cols=251  Identities=26%  Similarity=0.412  Sum_probs=194.1

Q ss_pred             cceeeccccccccCCeEEEEEEEc----CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK----KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..|+++ +.||+|+||.||+|...    .+++.+|||++...      ....+|+.. ++.+.||||+++++++..  .+
T Consensus         4 ~~~~~~-~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~-l~~l~~~~i~~~~~~~~~--~~   79 (284)
T cd05038           4 RHLKFI-KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEI-LRTLDHENIVKYKGVCEK--PG   79 (284)
T ss_pred             hhchhh-eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHH-HHhCCCCChheEEeeeec--CC
Confidence            467775 77999999999999864    35899999998633      234567766 566799999999998754  23


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ....+++|||+++++|.+++.... ..+++..+..++.||+.||+|||+.|++||||||+||+++               
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---------------  143 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---------------  143 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---------------
Confidence            567899999999999999997654 3599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.++|+|||.+.........   .....++..|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus       144 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p  211 (284)
T cd05038         144 ------------SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP  211 (284)
T ss_pred             ------------CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCC
Confidence                        5577999999988876432211   1112335569999999888899999999999999999999999


Q ss_pred             CCCCCCCCC-----------CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAI-----------SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |........           .......+.. ....+.  ...++.++.+|+.+||..+|.+|||+.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         212 SQSPPAEFLRMIGIAQGQMIVTRLLELLKE-GERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cccccchhccccccccccccHHHHHHHHHc-CCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            865432221           1111122211 111111  2356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.7e-38  Score=284.28  Aligned_cols=239  Identities=22%  Similarity=0.301  Sum_probs=183.1

Q ss_pred             ccccccCCeEEEEEEEcCCC----------cEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          22 EILGLGINGKVLQIVEKKTS----------EVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~----------~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +.||+|+||.||+|.+..++          ..+++|++...    ....+|+.. ++.++||||+++++++..     ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~-----~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASL-MSQLSHKHLVKLYGVCVR-----DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHH-HHcCCCcchhheeeEEec-----CC
Confidence            35899999999999998777          45888887532    233455555 677799999999998754     34


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++..             
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~-------------  140 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN-------------  140 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc-------------
Confidence            689999999999999998754 268999999999999999999999999999999999999843310             


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC--CCCCccchhhHHHHHHHHHh-CCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD--KYDKSCDIWSLGVIMYILLC-GFPPFFS  244 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~-g~~pf~~  244 (372)
                             .+....++++|||++.....    .....++..|+|||.+...  .++.++|+|||||++|+|++ |..||..
T Consensus       141 -------~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~  209 (259)
T cd05037         141 -------EGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST  209 (259)
T ss_pred             -------cCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence                   00233699999999876533    2233456789999998766  78999999999999999999 5777755


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .+....    ..... .....+.    ....++.++|.+||..+|.+|||+.++++
T Consensus       210 ~~~~~~----~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         210 LSSSEK----ERFYQ-DQHRLPM----PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCchhH----HHHHh-cCCCCCC----CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            432211    11111 1111222    12378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.3e-38  Score=285.33  Aligned_cols=242  Identities=19%  Similarity=0.277  Sum_probs=178.8

Q ss_pred             cccccCCeEEEEEEEcCC--CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKKT--SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .||+|+||+||+|....+  ...+++|.+...      ....+|+.. ++.++||||+++++.+..    ....|+||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~-~~~l~h~~iv~~~~~~~~----~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDP-YRILQHPNILQCLGQCVE----AIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHH-HhccCCcchhheEEEecC----CCccEEEEec
Confidence            499999999999975433  345667776532      234455555 567799999999999875    5678999999


Q ss_pred             cCCCchhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          95 MHGGELFQRIQQKE--DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        95 ~~~g~L~~~i~~~~--~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      +.+|+|.+++.+..  ...+++..++.++.||+.||+|||+.+++||||||+|||++                       
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~-----------------------  133 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT-----------------------  133 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc-----------------------
Confidence            99999999997642  13467788899999999999999999999999999999997                       


Q ss_pred             CCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCC-------CCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGP-------DKYDKSCDIWSLGVIMYILLC-GFPPF  242 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~pf  242 (372)
                          .++.++|+|||++.......  ......+++..|+|||++..       ..++.++|+|||||++|+|++ |..||
T Consensus       134 ----~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  209 (268)
T cd05086         134 ----SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY  209 (268)
T ss_pred             ----CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence                56779999999876432211  12234567889999998743       245789999999999999997 56787


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCc-ccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPE-WEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ......+.   ....+.......+.+. ...+++.+.+++..|| .+|.+|||++++++
T Consensus       210 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         210 SHLSDREV---LNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCCHHHH---HHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            54332211   1121222222222221 2347889999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0670|consensus

Probab=100.00  E-value=5.8e-40  Score=302.34  Aligned_cols=263  Identities=23%  Similarity=0.420  Sum_probs=207.1

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcC-----CCCEeEEeEeeee
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGS-----HKHIVNIKDVYEN   80 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~-----h~ni~~~~~~~~~   80 (372)
                      .+-|.+||.+. ...|+|-||+|..|.+..-|+.||||++...    ....+|++++.++..     .-|+++++..|..
T Consensus       427 gE~LD~RY~V~-~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  427 GELLDSRYEVQ-GYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhcceeEEE-eccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            34588999996 6699999999999999999999999999754    356789998655542     3488998888876


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                          .+++|+|||.+ ..+|.+++++.+. -.|....++.++.|++.||.+|-..||+|.||||+|||++.         
T Consensus       506 ----knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE---------  571 (752)
T KOG0670|consen  506 ----KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE---------  571 (752)
T ss_pred             ----cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc---------
Confidence                78999999999 5699999988543 24889999999999999999999999999999999999983         


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                       ....+||||||.|.....+  ..+.+..+..|.|||++.+.+|+...|+||.||+||||.||+
T Consensus       572 -----------------~k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGk  632 (752)
T KOG0670|consen  572 -----------------SKNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGK  632 (752)
T ss_pred             -----------------CcceeeeccCccccccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccc
Confidence                             5678999999999876432  334445566799999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHH--------HHHhhCCcc---C-------------------------CCCcc---------c---
Q psy3151         240 PPFFSNHGQAISPGMK--------NRIRLGQFD---F-------------------------PNPEW---------E---  271 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~--------~~~~~~~~~---~-------------------------~~~~~---------~---  271 (372)
                      ..|.+.+...+.....        .-+..++|.   +                         ..|+.         .   
T Consensus       633 IlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~  712 (752)
T KOG0670|consen  633 ILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLP  712 (752)
T ss_pred             eecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCC
Confidence            9997766543321110        011111110   0                         00000         0   


Q ss_pred             ----ccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         272 ----HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       272 ----~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                          ..-..+++|+.+||..||++|.|..|+|.||||..
T Consensus       713 deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  713 DEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             chhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                11246889999999999999999999999999964

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.6e-38  Score=285.08  Aligned_cols=247  Identities=21%  Similarity=0.329  Sum_probs=188.6

Q ss_pred             eeeccccccccCCeEEEEEEEc---CCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc-
Q psy3151          17 YDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS-   85 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~-   85 (372)
                      |.+ .++||+|+||+||+|.+.   .+++.+|||++...       ....+|+.. ++.++||||+++++++......+ 
T Consensus         1 ~~~-~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTL-GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAAC-MKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             Ccc-hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHH-HhcCCCCCcceEEEEEccCCCCCc
Confidence            556 578999999999999864   46799999988632       134567765 67779999999999875422111 


Q ss_pred             -eEEEEEEeccCCCchhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          86 -RCLLVIMECMHGGELFQRIQQKE----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        86 -~~~~lv~e~~~~g~L~~~i~~~~----~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                       ...+++++|+.+|+|.+++....    ...+++..++.++.||+.||+|||+.||+||||||+||+++           
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~-----------  147 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN-----------  147 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc-----------
Confidence             23578899999999988875321    12478999999999999999999999999999999999997           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-  237 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-  237 (372)
                                      .++.+|++|||+++.......  ......+++.|++||.+....++.++|+|||||++|+|++ 
T Consensus       148 ----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~  211 (273)
T cd05074         148 ----------------ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR  211 (273)
T ss_pred             ----------------CCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhC
Confidence                            566789999998876533221  1122334567999999988889999999999999999999 


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |.+||...+..    .....+.... ...+    ...+.++.+++.+||..+|++|||+.+++.
T Consensus       212 g~~p~~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         212 GQTPYAGVENS----EIYNYLIKGNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             CCCCCCCCCHH----HHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            88988654322    2222222221 1111    257889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1006|consensus

Probab=100.00  E-value=3.7e-40  Score=281.16  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=198.7

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecc------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHD------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      .||.|+||+|++..|+.+|+..|||.++.      ..+...|.+..++..+.||||++++....    +..-++.||.| 
T Consensus        71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~----EGdcWiCMELM-  145 (361)
T KOG1006|consen   71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS----EGDCWICMELM-  145 (361)
T ss_pred             HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc----CCceeeeHHHH-
Confidence            49999999999999999999999999963      23556777777888899999999998654    56689999999 


Q ss_pred             CCchhHHHH---hccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          97 GGELFQRIQ---QKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        97 ~g~L~~~i~---~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      +.+|..+-+   ......++|+-+-.|....+.||+||-.. +|+|||+||+|||++                       
T Consensus       146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld-----------------------  202 (361)
T KOG1006|consen  146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD-----------------------  202 (361)
T ss_pred             hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe-----------------------
Confidence            556644332   22234599999999999999999999865 899999999999999                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG--PDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI  250 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  250 (372)
                          ..|.+|+||||++..+... -..+...|-..|||||.+.  ...|+.++|+||||++|||+.||..||...+.   
T Consensus       203 ----r~G~vKLCDFGIcGqLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---  274 (361)
T KOG1006|consen  203 ----RHGDVKLCDFGICGQLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---  274 (361)
T ss_pred             ----cCCCEeeecccchHhHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---
Confidence                5677999999999887542 2334456777899999884  34699999999999999999999999965432   


Q ss_pred             CHhHHHHHhhCCccC--CCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         251 SPGMKNRIRLGQFDF--PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       251 ~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      .......+..+..+.  .......++..+..+|..||.+|-+.||...+++.+||++.+..
T Consensus       275 vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  275 VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            112223334444332  11222358899999999999999999999999999999987643

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=294.00  Aligned_cols=262  Identities=18%  Similarity=0.226  Sum_probs=181.0

Q ss_pred             ccceeeccccccccCCeEEEEEEEc----------------CCCcEEEEEEecchhh-------------------hHHH
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEK----------------KTSEVYALKVLHDTVK-------------------ARRE   58 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~-------------------~~~e   58 (372)
                      .++|++ .+.||+|+||+||+|.+.                ..++.||||.+.....                   ...|
T Consensus       144 ~d~F~i-~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        144 SDDFQL-RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             ccCceE-eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            468998 588999999999999752                3457899999853211                   1123


Q ss_pred             HHHHHHhcCCCC-----EeEEeEeeeeecC----CceEEEEEEeccCCCchhHHHHhccC--------------------
Q psy3151          59 VELQLAVGSHKH-----IVNIKDVYENIYN----GSRCLLVIMECMHGGELFQRIQQKED--------------------  109 (372)
Q Consensus        59 ~~~~~~~~~h~n-----i~~~~~~~~~~~~----~~~~~~lv~e~~~~g~L~~~i~~~~~--------------------  109 (372)
                      +.. +..+.|.+     +++++++|.....    .....++||||+.+++|.+++.....                    
T Consensus       223 ~~~-l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYM-CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHH-HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            333 23334443     4666666643211    13458999999999999998864210                    


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccc
Q psy3151         110 --GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG  187 (372)
Q Consensus       110 --~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg  187 (372)
                        ..+++..++.++.|++.||.|||+.+|+||||||+|||++                           .++.+||+|||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---------------------------~~~~~kL~DFG  354 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---------------------------VDGQVKIIDFG  354 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---------------------------CCCcEEEEeCc
Confidence              1245678899999999999999999999999999999998                           55679999999


Q ss_pred             cccccccCCC-cccccccCCCcCCCcccCCCC--------------------CC--CccchhhHHHHHHHHHhCCC-CCC
Q psy3151         188 FAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDK--------------------YD--KSCDIWSLGVIMYILLCGFP-PFF  243 (372)
Q Consensus       188 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--------------------~~--~~~DiwslG~il~~ll~g~~-pf~  243 (372)
                      ++........ ......+|+.|+|||.+....                    |+  .++|+||+||++|+|++|.. ||.
T Consensus       355 la~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        355 AAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             CccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            9875433211 111233488999999875322                    22  24799999999999999875 664


Q ss_pred             CCCCCCCC-------HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCC---CCCCChhHHhcCCcccc
Q psy3151         244 SNHGQAIS-------PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDP---SERLTIDQVMENKWISQ  306 (372)
Q Consensus       244 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP---~~R~s~~eil~hp~~~~  306 (372)
                      ........       ...........+.++  .+...+++++||+.+||..+|   .+|+|++|+|+||||..
T Consensus       435 ~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        435 NIRLFNTELRQYDNDLNRWRMYKGQKYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             chhhhhhHHhhccchHHHHHhhcccCCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            32111000       001111222233332  355689999999999999866   68999999999999954

>KOG0664|consensus

Probab=100.00  E-value=2.3e-39  Score=277.39  Aligned_cols=256  Identities=27%  Similarity=0.458  Sum_probs=198.0

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC-ceEEEEEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYNG-SRCLLVIM   92 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~-~~~~~lv~   92 (372)
                      .+-||.|+||+||.+.|..+|+.||+|.+..       ..+.++|+.. +...+|.|++..+++......+ .+.+|+++
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~km-LcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKM-LSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHH-HHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            5679999999999999999999999998852       3467889886 7888999999988877532111 23378899


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      |.|. .+|..+|.+-  ..++.+.++-+++||++||.|||+.||.||||||.|+|++                       
T Consensus       137 ELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN-----------------------  190 (449)
T KOG0664|consen  137 ELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN-----------------------  190 (449)
T ss_pred             HHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec-----------------------
Confidence            9995 4898888753  4699999999999999999999999999999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI  250 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  250 (372)
                          .+..+||||||+|+....... .++..+.|.+|+|||++.+ ..|+.++||||.|||+.|++..+..|......+.
T Consensus       191 ----SNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ  266 (449)
T KOG0664|consen  191 ----SNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ  266 (449)
T ss_pred             ----cCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH
Confidence                678899999999987654332 3445567999999999855 5699999999999999999999999865443222


Q ss_pred             CH------------hHH-------HHHhhCCccCCCC--c-----ccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         251 SP------------GMK-------NRIRLGQFDFPNP--E-----WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       251 ~~------------~~~-------~~~~~~~~~~~~~--~-----~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ..            .+.       ..+..+....|..  .     ...-..++.+++.+||..||.+|.+.++++.|++.
T Consensus       267 L~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  267 LQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            11            111       1111111111110  0     01223568899999999999999999999999998


Q ss_pred             ccC
Q psy3151         305 SQF  307 (372)
Q Consensus       305 ~~~  307 (372)
                      ...
T Consensus       347 ~e~  349 (449)
T KOG0664|consen  347 EEG  349 (449)
T ss_pred             ccc
Confidence            764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.3e-35  Score=263.80  Aligned_cols=238  Identities=38%  Similarity=0.621  Sum_probs=194.0

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchh
Q psy3151          28 INGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELF  101 (372)
Q Consensus        28 ~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~  101 (372)
                      +||.||+|.+..+|+.+|+|++...      ....+|+.. ++.++|+||+++++++..    +...++++||+.+++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~-~~~l~~~~i~~~~~~~~~----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISI-LKKLKHPNIVRLYDVFED----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHH-HHhCCCCcHHHHHhheee----CCEEEEEEeCCCCCCHH
Confidence            5899999999999999999998632      345677776 566699999999998875    57889999999999999


Q ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCe
Q psy3151         102 QRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL  181 (372)
Q Consensus       102 ~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  181 (372)
                      +++....  .++...++.++.+++.++.+||+.|++|+||+|+||+++                           .++.+
T Consensus        76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---------------------------~~~~~  126 (244)
T smart00220       76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---------------------------EDGHV  126 (244)
T ss_pred             HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---------------------------CCCcE
Confidence            9987653  389999999999999999999999999999999999998                           55779


Q ss_pred             eeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhC
Q psy3151         182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG  261 (372)
Q Consensus       182 ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  261 (372)
                      +++|||.+....... ......++..|+|||.+....++.++|+||+|+++++|++|..||......   ..........
T Consensus       127 ~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---~~~~~~~~~~  202 (244)
T smart00220      127 KLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKP  202 (244)
T ss_pred             EEccccceeeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhcc
Confidence            999999988764322 334556788999999998888999999999999999999999999653211   2233333333


Q ss_pred             CccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         262 QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       262 ~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ...... ....++.++.+++.+||..+|++||++.++++||||
T Consensus       203 ~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      203 KPPFPP-PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CCCCcc-ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            222211 111278999999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0199|consensus

Probab=100.00  E-value=8.5e-37  Score=289.89  Aligned_cols=245  Identities=23%  Similarity=0.391  Sum_probs=199.1

Q ss_pred             cccccccCCeEEEEEEEcCC-C--cEEEEEEecc------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          21 TEILGLGINGKVLQIVEKKT-S--EVYALKVLHD------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~-~--~~vaiK~~~~------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      .|.||+|.||+|++|.++.. |  -.||||++..      .....+|+.. +..++|+|++++|++..     +.-+.+|
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~-M~~L~H~hliRLyGvVl-----~qp~mMV  188 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASH-MLKLQHPHLIRLYGVVL-----DQPAMMV  188 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHH-HHhccCcceeEEeeeec-----cchhhHH
Confidence            46799999999999988653 3  4589999963      2466789988 56669999999999976     3568899


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      ||.++.|+|.+.+.+.....|.......++.||+.|+.||.++++|||||-.+|+|+.                      
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla----------------------  246 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA----------------------  246 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec----------------------
Confidence            9999999999999985567799999999999999999999999999999999999998                      


Q ss_pred             cCCCCCCCCeeeeccccccccccCCCcccc--cc-cCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         172 YTKPGDGGILKLTDFGFAKKIVSNKASLQT--PC-YTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       172 ~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~--~~-gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                           ....|||+|||+.+.+..+......  .. --..|+|||.+....++.++|+|++||++|||++ |..||-+..+
T Consensus       247 -----sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g  321 (1039)
T KOG0199|consen  247 -----SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG  321 (1039)
T ss_pred             -----ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence                 4557999999999988654433211  11 1235999999999999999999999999999998 8999988776


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      ..+    .+++..+. .++.+  +.+++++.+++..||..+|.+|||+..|.+.-+..
T Consensus       322 ~qI----L~~iD~~e-rLpRP--k~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  322 IQI----LKNIDAGE-RLPRP--KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             HHH----HHhccccc-cCCCC--CCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            544    34444222 12222  47899999999999999999999999886544443

>KOG4257|consensus

Probab=100.00  E-value=2.4e-36  Score=283.68  Aligned_cols=238  Identities=24%  Similarity=0.431  Sum_probs=193.8

Q ss_pred             ccccccccCCeEEEEEEEcCC--C--cEEEEEEec------chhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          20 STEILGLGINGKVLQIVEKKT--S--EVYALKVLH------DTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        20 ~~~~lG~G~~g~V~~~~~~~~--~--~~vaiK~~~------~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +.++||.|.||.||.|.....  |  --||||.-+      +..+...|.-+ ++..+||||+++++++.     ++-++
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~i-MrnfdHphIikLIGv~~-----e~P~W  466 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASI-MRNFDHPHIIKLIGVCV-----EQPMW  466 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHH-HHhCCCcchhheeeeee-----cccee
Confidence            346799999999999987543  3  337777654      23455667766 78889999999999997     46799


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +|||.++-|.|..+++.++ ..++......+..||..||.|||+...|||||-.+|||++                    
T Consensus       467 ivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs--------------------  525 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS--------------------  525 (974)
T ss_pred             EEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec--------------------
Confidence            9999999999999999865 4699999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCC-CcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP-YYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~-~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                             ....||++|||+++.+.+......+...-| -|||||.+.-..++.++|+|.|||++||++. |..||.+-..
T Consensus       526 -------Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN  598 (974)
T KOG4257|consen  526 -------SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN  598 (974)
T ss_pred             -------CcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence                   567899999999998876544433322222 5999999988999999999999999999886 9999988766


Q ss_pred             CCCCHhHHHHHhhC-CccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         248 QAISPGMKNRIRLG-QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .+..    ..+..| .++.|    .++++.+..|+.+||+++|.+||++.++.
T Consensus       599 sDVI----~~iEnGeRlP~P----~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  599 SDVI----GHIENGERLPCP----PNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             cceE----EEecCCCCCCCC----CCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            5542    222222 33333    48999999999999999999999987753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9e-36  Score=315.95  Aligned_cols=244  Identities=18%  Similarity=0.243  Sum_probs=181.1

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhh-hHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEe
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      ..|.. ..+||+|+||.||+|.+..+|+.||||.+..... ..+|++. ++.++||||+++++++..    +...|+|||
T Consensus       690 ~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~-l~~l~HpnIv~~~~~~~~----~~~~~lv~E  763 (968)
T PLN00113        690 SSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-MGKLQHPNIVKLIGLCRS----EKGAYLIHE  763 (968)
T ss_pred             hhCCc-ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHH-HhhCCCCCcceEEEEEEc----CCCCEEEEe
Confidence            34554 4679999999999999999999999999864332 3445655 667799999999999975    567899999


Q ss_pred             ccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          94 CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH---DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        94 ~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH---~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      |+++|+|.+++..     +++..+..++.||+.||+|||   +.+|+||||||+||+++.                    
T Consensus       764 y~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~--------------------  818 (968)
T PLN00113        764 YIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG--------------------  818 (968)
T ss_pred             CCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC--------------------
Confidence            9999999999852     899999999999999999999   679999999999999973                    


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI  250 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  250 (372)
                             .+..++. ||.+.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       819 -------~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~  886 (968)
T PLN00113        819 -------KDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG  886 (968)
T ss_pred             -------CCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence                   3334443 444332211    1223678999999999988999999999999999999999999954322211


Q ss_pred             CHhHHHHHhhC----------CccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         251 SPGMKNRIRLG----------QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       251 ~~~~~~~~~~~----------~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ......+....          ......+.......++.+++.+||+.||++|||++|+++.
T Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            11101110000          0000000001123467789999999999999999999874

>KOG0196|consensus

Probab=100.00  E-value=3.1e-37  Score=296.21  Aligned_cols=248  Identities=24%  Similarity=0.406  Sum_probs=207.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCC---cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTS---EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      +.-.|-.++++||.|.||.||+|+.+..|   ..||||.++..      .....|..+ +-..+||||+++.++...   
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsI-MGQFdHPNIIrLEGVVTk---  701 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASI-MGQFDHPNIIRLEGVVTK---  701 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhh-cccCCCCcEEEEEEEEec---
Confidence            33344446899999999999999998776   66999999632      234466766 566799999999999865   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       .+-..||.|||++|+|..++++++ +.|+..++..+++.|+.|+.||-+.|+|||||-.+|||++              
T Consensus       702 -s~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN--------------  765 (996)
T KOG0196|consen  702 -SKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN--------------  765 (996)
T ss_pred             -CceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec--------------
Confidence             667899999999999999999887 6699999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCccccccc---CCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY---TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF  239 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  239 (372)
                                   .+-.+|++|||+++.+.++.....+..|   ...|.|||.+.-.+++.++|+||+|+++||.++ |.
T Consensus       766 -------------snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGE  832 (996)
T KOG0196|consen  766 -------------SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE  832 (996)
T ss_pred             -------------cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCC
Confidence                         6788999999999988766544333333   236999999999999999999999999999775 99


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .||++.+.++.    .+.+..+ +.+|+|  .+++..+..||..||++|-.+||.+.||+.
T Consensus       833 RPYWdmSNQdV----IkaIe~g-yRLPpP--mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  833 RPYWDMSNQDV----IKAIEQG-YRLPPP--MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             CcccccchHHH----HHHHHhc-cCCCCC--CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            99998877654    3444332 444444  489999999999999999999999999876

>KOG2052|consensus

Probab=100.00  E-value=1.2e-35  Score=269.75  Aligned_cols=255  Identities=23%  Similarity=0.343  Sum_probs=193.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEec--chhhhHHHHHHHHH-hcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--DTVKARREVELQLA-VGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~e~~~~~~-~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +...-.+ .+.||+|.||.||+|...  |+.||||+|.  +....++|.+++.. +++|+||+.++..-...-..-..++
T Consensus       209 iarqI~L-~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  209 IARQIVL-QEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hhheeEE-EEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            4445555 478999999999999997  9999999996  44567888888754 5699999998876432112245799


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCceeeecCCCCCceeeec
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ--------NIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~--------~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                      ||.+|.+.|||+|++.+.   .++.+...+++..++.||+|||-.        .|.|||||..|||+.            
T Consensus       286 LvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK------------  350 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK------------  350 (513)
T ss_pred             EeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc------------
Confidence            999999999999999874   399999999999999999999942        599999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccC----CCcccccccCCCcCCCcccCCCC----C--CCccchhhHHHH
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN----KASLQTPCYTPYYVAPEVLGPDK----Y--DKSCDIWSLGVI  231 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwslG~i  231 (372)
                                     .++++.|+|+|+|......    ....+..+||..|||||++.+.-    +  -..+||||||.+
T Consensus       351 ---------------kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV  415 (513)
T KOG2052|consen  351 ---------------KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV  415 (513)
T ss_pred             ---------------cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence                           6788999999999876443    22356789999999999986532    2  257899999999


Q ss_pred             HHHHHhC----------CCCCCCCCCCCCCH-hHHHHHhhCCccCCCC-cccccC--HHHHHHHHHhccCCCCCCCChhH
Q psy3151         232 MYILLCG----------FPPFFSNHGQAISP-GMKNRIRLGQFDFPNP-EWEHVS--QEAKTLIKNMLCVDPSERLTIDQ  297 (372)
Q Consensus       232 l~~ll~g----------~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~s--~~~~~li~~ll~~dP~~R~s~~e  297 (372)
                      +||++..          ++||.+-.+.+... .+.+-+-..++..+.+ .|...+  ..+..+|+-||..+|.-|.||-.
T Consensus       416 lWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALr  495 (513)
T KOG2052|consen  416 LWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALR  495 (513)
T ss_pred             HHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence            9998743          68887765555443 3333333333332222 232211  23557899999999999999866


Q ss_pred             Hhc
Q psy3151         298 VME  300 (372)
Q Consensus       298 il~  300 (372)
                      +.+
T Consensus       496 iKK  498 (513)
T KOG2052|consen  496 IKK  498 (513)
T ss_pred             HHH
Confidence            543

>KOG1094|consensus

Probab=100.00  E-value=1.1e-35  Score=277.48  Aligned_cols=253  Identities=20%  Similarity=0.267  Sum_probs=195.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ..++-.+ .+.||+|.||.|.+|.-. .+.+||+|.++.      .....+|++++.++ +||||+.+++++..    ++
T Consensus       536 PRs~L~~-~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~----De  608 (807)
T KOG1094|consen  536 PRSRLRF-KEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQ----DD  608 (807)
T ss_pred             chhheeh-hhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeec----CC
Confidence            3445555 577999999999999864 369999999963      23456899985555 99999999999875    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      -+++|+||+++|+|.+++..+.-..+......+|+.||+.|++||.+.++|||||.++|+|++                 
T Consensus       609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~-----------------  671 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD-----------------  671 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec-----------------
Confidence            799999999999999999987543345566777999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCccc--ccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHH--hCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ--TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL--CGFPPF  242 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll--~g~~pf  242 (372)
                                .++++||+|||+++.+.++.....  ..+-...|||||.+..++++.++|+|+||+++||++  +...||
T Consensus       672 ----------~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py  741 (807)
T KOG1094|consen  672 ----------GEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPY  741 (807)
T ss_pred             ----------CcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCch
Confidence                      778899999999997755433211  122245799999999999999999999999999975  578999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      ...++.+..+..-.....+....-.+...-++..+.+||.+||..|-++|||++++-
T Consensus       742 ~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  742 SQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             hhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            665544332211111111111111111235789999999999999999999999983

>KOG1167|consensus

Probab=100.00  E-value=6e-35  Score=264.16  Aligned_cols=281  Identities=21%  Similarity=0.346  Sum_probs=203.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcC---CCcEEEEEEecc---hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKK---TSEVYALKVLHD---TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      +.+.|.++ +.||.|.|++||++.+..   .++.||+|.+..   ..+...|++.+..+..+.||+++.+++..    +.
T Consensus        34 ~~~~~~~v-~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn----nd  108 (418)
T KOG1167|consen   34 ISNAYKVV-NKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN----ND  108 (418)
T ss_pred             hhhhhhhh-ccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc----CC
Confidence            56677774 779999999999999887   789999999863   45778899998899999999999999976    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ...+|+||++..+-.++...     ++..+++.+++.++.||.++|.+|||||||||+|+|.+.  ..+...++|||++.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechhHH
Confidence            78999999999888887754     789999999999999999999999999999999999985  44566788999875


Q ss_pred             -ccccc-----------cCCCCCCCCeeeecccccc---c-------cccCCCcccccccCCCcCCCcccCC-CCCCCcc
Q psy3151         167 -PENLL-----------YTKPGDGGILKLTDFGFAK---K-------IVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSC  223 (372)
Q Consensus       167 -~~~~~-----------~~~~~~~~~~ki~Dfg~a~---~-------~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  223 (372)
                       .+.-.           ...+. .|.. .-.+..+.   .       ....+.......||++|+|||++.. ...+.++
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~-~g~~-~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPA-MGKD-VHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCcc-ccCc-ccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence             11111           00110 1100 01111111   0       0111222344689999999999854 4578999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCCCCCCCCH----------hHHH----------------------HHhhCCc--------
Q psy3151         224 DIWSLGVIMYILLCGFPPFFSNHGQAISP----------GMKN----------------------RIRLGQF--------  263 (372)
Q Consensus       224 DiwslG~il~~ll~g~~pf~~~~~~~~~~----------~~~~----------------------~~~~~~~--------  263 (372)
                      ||||.|+|+.-++++..||..........          .+.+                      ......+        
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            99999999999999999995443221100          0000                      0000000        


Q ss_pred             c---CCCCc-ccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         264 D---FPNPE-WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       264 ~---~~~~~-~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +   ..... .+..+..+.||+.+||+.||.+|+||+++|+||||...
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence            0   00011 12345689999999999999999999999999999753

>KOG4278|consensus

Probab=100.00  E-value=3.2e-35  Score=276.02  Aligned_cols=237  Identities=22%  Similarity=0.377  Sum_probs=196.7

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      ...||.|.||.||.|.+++..-.||||.+...    .....|.++ ++-+.|||+|++++++..    +.-+|||.|||.
T Consensus       272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAv-MKeikHpNLVqLLGVCT~----EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV-MKEIKHPNLVQLLGVCTH----EPPFYIITEFMC  346 (1157)
T ss_pred             eeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHH-HHhhcCccHHHHhhhhcc----CCCeEEEEeccc
Confidence            34699999999999999999999999999743    244567766 677799999999999975    566999999999


Q ss_pred             CCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCC
Q psy3151          97 GGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG  176 (372)
Q Consensus        97 ~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~  176 (372)
                      .|+|.++++...+..++.-....++.||..|++||..++.|||||-.+|+|+.                           
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---------------------------  399 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---------------------------  399 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---------------------------
Confidence            99999999998777788888999999999999999999999999999999997                           


Q ss_pred             CCCCeeeeccccccccccCCCccccccc---CCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCH
Q psy3151         177 DGGILKLTDFGFAKKIVSNKASLQTPCY---TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISP  252 (372)
Q Consensus       177 ~~~~~ki~Dfg~a~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  252 (372)
                      .+..||++|||+++....+...  ...|   ..-|.|||-+.-..++.++|+|+|||+|||+.| |..||.+-+-.    
T Consensus       400 EnhiVKvADFGLsRlMtgDTYT--AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----  473 (1157)
T KOG4278|consen  400 ENHIVKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----  473 (1157)
T ss_pred             ccceEEeeccchhhhhcCCcee--cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----
Confidence            6778999999999987543221  1222   224999999988889999999999999999998 88999665422    


Q ss_pred             hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      .+...+.. .+.+..|  +.+++.+.+||+.||+++|.+||+++|+
T Consensus       474 qVY~LLEk-gyRM~~P--eGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  474 QVYGLLEK-GYRMDGP--EGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHHHHhc-cccccCC--CCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence            22333322 2333332  5899999999999999999999999998

>KOG0576|consensus

Probab=100.00  E-value=6.6e-36  Score=282.79  Aligned_cols=265  Identities=30%  Similarity=0.460  Sum_probs=215.3

Q ss_pred             CCccCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeE
Q psy3151           2 TPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKD   76 (372)
Q Consensus         2 ~~~~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~   76 (372)
                      +|..+.... ...++|+++ ..+|+|+||.||+|+|+.+++..|+|+++..     ....+|+-+ ++-.+||||+.+++
T Consensus         3 ~~~~disrr-nP~ddyell-qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~-~~dc~h~nivay~g   79 (829)
T KOG0576|consen    3 SPKSDISRR-NPQDDYELL-QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGM-LRDCRHPNIVAYFG   79 (829)
T ss_pred             Cccchhhhc-CCccchhhe-eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceee-eecCCCcChHHHHh
Confidence            344444444 778999996 6799999999999999999999999999632     233456554 77789999999999


Q ss_pred             eeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCc
Q psy3151          77 VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        77 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                      .|..    ...++++||||.||+|.+.-.  ..++++|.++....+..+.||+|||++|-+|||||=.||+++       
T Consensus        80 sylr----~dklwicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt-------  146 (829)
T KOG0576|consen   80 SYLR----RDKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT-------  146 (829)
T ss_pred             hhhh----hcCcEEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec-------
Confidence            8764    567999999999999988653  457899999999999999999999999999999999999998       


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc---CCCCCCCccchhhHHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~  233 (372)
                                          +.|.+|++|||.+..+...-.......|||.|||||+-   ..+.|+..+|+|++|++..
T Consensus       147 --------------------d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAi  206 (829)
T KOG0576|consen  147 --------------------DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAI  206 (829)
T ss_pred             --------------------ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchh
Confidence                                66779999999998887666667778999999999975   5678999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCC-cccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNP-EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      |+-.-++|.+.......    ........+..|.. .....++.+-+|++.+|.++|++|||++.+|.|||..+
T Consensus       207 el~eLqpplfdlhpmr~----l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  207 ELGELQPPLFDLHPMRA----LFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             hhhhcCCcccccchHHH----HHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            99988888654433221    11122222322221 12357888999999999999999999999999999865

>KOG0984|consensus

Probab=100.00  E-value=1.6e-34  Score=238.43  Aligned_cols=191  Identities=26%  Similarity=0.384  Sum_probs=158.3

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      +.||+|++|.|=+.++..+|...|+|.+...      .+..+|+.+.++...+|.+|.+++.+..    ....++.||.|
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r----egdvwIcME~M  127 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR----EGDVWICMELM  127 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc----cccEEEeHHHh
Confidence            3499999999999999999999999998632      3455677776777889999999997654    66799999999


Q ss_pred             CCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          96 HGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        96 ~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                       ..+|..+-.+  ..++.++|..+-+|+..++.||.|||++ .|+|||+||+||||+                       
T Consensus       128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn-----------------------  183 (282)
T KOG0984|consen  128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN-----------------------  183 (282)
T ss_pred             -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc-----------------------
Confidence             4577655443  3346799999999999999999999987 899999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC----CCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG----PDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                          ..|+|||||||++..+.+.-. .+...|-..|+|||.+.    ...|+.++||||||++++||.+++.||...
T Consensus       184 ----~~GqVKiCDFGIsG~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  184 ----YDGQVKICDFGISGYLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ----cCCcEEEcccccceeehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence                678899999999988765322 23345667799999873    346999999999999999999999999543

>KOG1345|consensus

Probab=100.00  E-value=4.2e-35  Score=250.94  Aligned_cols=265  Identities=25%  Similarity=0.372  Sum_probs=200.6

Q ss_pred             CCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151           7 PFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus         7 ~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      +.+.-.|.+.|+| .+.||+|.||++-+|.|+.++..+++|.+....    ...+|..--..+..|.||+.-+++-   +
T Consensus        16 el~kv~l~d~y~I-~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va---F   91 (378)
T KOG1345|consen   16 ELKKVDLEDVYTI-NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVA---F   91 (378)
T ss_pred             cccccchhhhhhH-HHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHH---h
Confidence            3455668999999 588999999999999999999999999998654    3445655546677899998876652   2


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      .....+++++||++-|+|.+-+...   .+.|...+.++.|++.|+.|||+.++||||||.+||||-..           
T Consensus        92 qt~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-----------  157 (378)
T KOG1345|consen   92 QTSDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-----------  157 (378)
T ss_pred             hcCceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-----------
Confidence            2356888999999999998877553   38999999999999999999999999999999999999732           


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC---C--CCCCccchhhHHHHHHHHHh
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP---D--KYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~~ll~  237 (372)
                                    +..++|+||||.++..+..-..   .-.+..|.+||.+..   +  ..++.+|+|.||+++|.++|
T Consensus       158 --------------df~rvKlcDFG~t~k~g~tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt  220 (378)
T KOG1345|consen  158 --------------DFYRVKLCDFGLTRKVGTTVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT  220 (378)
T ss_pred             --------------CccEEEeeecccccccCceehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeec
Confidence                          3457999999988765321111   112455899997632   2  25688999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCC---CChhHHhcCCcccc
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER---LTIDQVMENKWISQ  306 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R---~s~~eil~hp~~~~  306 (372)
                      |.+||......+....-...-..+...--+..+..+++.+..+.++-|..+|++|   .++.......|...
T Consensus       221 G~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  221 GKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             CCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            9999974433332222222222222222233456789999999999999999999   77888777888754

>KOG0200|consensus

Probab=100.00  E-value=2.5e-33  Score=280.42  Aligned_cols=243  Identities=25%  Similarity=0.420  Sum_probs=195.4

Q ss_pred             cccccccCCeEEEEEEEcC-------CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          21 TEILGLGINGKVLQIVEKK-------TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .+.||+|+||.|++|.-..       ....||||.+...      .....|++.+..+..|+||+.++++...    ...
T Consensus       301 ~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~----~~~  376 (609)
T KOG0200|consen  301 GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ----DGP  376 (609)
T ss_pred             cceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----CCc
Confidence            4589999999999986431       2567999998632      3456899998899999999999998865    677


Q ss_pred             EEEEEeccCCCchhHHHHhcc------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          88 LLVIMECMHGGELFQRIQQKE------------D--GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~------------~--~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                      +++|+||+..|+|..+++.+.            .  ..++......++.||+.|++||++.++|||||-.+|||+.    
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~----  452 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT----  452 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec----
Confidence            999999999999999998765            0  1389999999999999999999999999999999999998    


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcc-cccccCC--CcCCCcccCCCCCCCccchhhHHH
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL-QTPCYTP--YYVAPEVLGPDKYDKSCDIWSLGV  230 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~-~~~~gt~--~y~aPE~~~~~~~~~~~DiwslG~  230 (372)
                                             .+..+||+|||+|+......... ....|+.  .|||||.+....|+.++|+||+|+
T Consensus       453 -----------------------~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI  509 (609)
T KOG0200|consen  453 -----------------------KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGI  509 (609)
T ss_pred             -----------------------CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHH
Confidence                                   56789999999999654433322 2222222  399999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         231 IMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       231 il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +|||+++ |..||.+-.   ....+.+.+..|.-. ..|  ..+++++.++|+.||+.+|++||++.++.+
T Consensus       510 ~L~EifsLG~~PYp~~~---~~~~l~~~l~~G~r~-~~P--~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  510 LLWEIFTLGGTPYPGIP---PTEELLEFLKEGNRM-EQP--EHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHhhCCCCCCCCCC---cHHHHHHHHhcCCCC-CCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            9999998 889996522   123344455554432 222  467999999999999999999999999866

>KOG3653|consensus

Probab=100.00  E-value=4.2e-34  Score=261.52  Aligned_cols=247  Identities=19%  Similarity=0.254  Sum_probs=182.7

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecchh--hhHHHHHHH-HHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCC
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--KARREVELQ-LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHG   97 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~e~~~~-~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~   97 (372)
                      .++||+|.||.||+|+..  ++.||||++....  ....|.+++ +-.+.|+||++++..-+........++||++|.+.
T Consensus       215 ~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k  292 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK  292 (534)
T ss_pred             HHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence            378999999999999975  7999999997543  333454443 34668999999988755322224478999999999


Q ss_pred             CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          98 GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ---------NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        98 g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~---------~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+|.+++..+-   +++....+++..+++||+|||+.         .|+|||||..||||.                   
T Consensus       293 GsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-------------------  350 (534)
T KOG3653|consen  293 GSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-------------------  350 (534)
T ss_pred             CcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-------------------
Confidence            99999998764   99999999999999999999963         599999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCC-CCC-----CccchhhHHHHHHHHHhCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPD-KYD-----KSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DiwslG~il~~ll~g~~  240 (372)
                              .++++.|+|||+|..+.....  .....+||..|||||++.+. ++.     .+.||||+|.+||||++...
T Consensus       351 --------~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~  422 (534)
T KOG3653|consen  351 --------NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT  422 (534)
T ss_pred             --------cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence                    678899999999998865332  33447899999999998553 222     47899999999999998754


Q ss_pred             CCC-CCC------------CCCCCHhHHHHHhhCCcc-CCCCcccc--cCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         241 PFF-SNH------------GQAISPGMKNRIRLGQFD-FPNPEWEH--VSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       241 pf~-~~~------------~~~~~~~~~~~~~~~~~~-~~~~~~~~--~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      -++ +..            .....+.+...+...+.. .-+..|..  .-.-+++.+..||+.||+.|+||.=+-
T Consensus       423 ~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  423 DADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             cccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence            442 111            111223343333322211 11122221  235578999999999999999986553

>KOG1152|consensus

Probab=100.00  E-value=2e-34  Score=268.83  Aligned_cols=192  Identities=34%  Similarity=0.571  Sum_probs=167.0

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-------------hhHHHHHHHHHhcC---CCCEeEEeEeee
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------------KARREVELQLAVGS---HKHIVNIKDVYE   79 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~e~~~~~~~~~---h~ni~~~~~~~~   79 (372)
                      .|..+ +.+|.|+||.|++|.|+.+...|+||.+.+.+             ..-.|+.++ ..++   |+||++++++|+
T Consensus       562 ~yttl-q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIl-a~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  562 DYTTL-QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQIL-ATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cceee-eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHH-HHhhhcCccchhhhhheee
Confidence            47776 56999999999999999999999999986432             233688884 4444   999999999999


Q ss_pred             eecCCceEEEEEEecc-CCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          80 NIYNGSRCLLVIMECM-HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~-~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      +    +.++|++||.. +|.+|.++|..+.  .++|.+++.|++||+.|+++||++||||||||-+|+.++         
T Consensus       640 d----dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd---------  704 (772)
T KOG1152|consen  640 D----DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD---------  704 (772)
T ss_pred             c----CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEe---------
Confidence            7    78999999986 4579999998875  499999999999999999999999999999999999998         


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHHHHHh
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~  237 (372)
                                        .+|.+||+|||.|....+  ....+.+||..|+|||++.+.+| +.+-|||++|++||.++.
T Consensus       705 ------------------~~g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy  764 (772)
T KOG1152|consen  705 ------------------SNGFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY  764 (772)
T ss_pred             ------------------cCCeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe
Confidence                              688999999999876543  44677899999999999999887 588999999999999999


Q ss_pred             CCCCCCC
Q psy3151         238 GFPPFFS  244 (372)
Q Consensus       238 g~~pf~~  244 (372)
                      ...||+.
T Consensus       765 kenpyyn  771 (772)
T KOG1152|consen  765 KENPYYN  771 (772)
T ss_pred             ccCCCcC
Confidence            9999853

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=3.1e-34  Score=297.18  Aligned_cols=222  Identities=14%  Similarity=0.229  Sum_probs=165.9

Q ss_pred             CC-CCEeEEeEeeeeec---CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy3151          67 SH-KHIVNIKDVYENIY---NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK  142 (372)
Q Consensus        67 ~h-~ni~~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlk  142 (372)
                      +| +||+++++.|....   .....++++||++ +++|.+++.... ..+++.+++.++.||+.||+|||++||+|||||
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            44 57888888773221   1234678889988 669999997532 459999999999999999999999999999999


Q ss_pred             CCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC----------------CcccccccCC
Q psy3151         143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK----------------ASLQTPCYTP  206 (372)
Q Consensus       143 p~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~----------------~~~~~~~gt~  206 (372)
                      |+||||+.   .+.+++.|||.+....     ....+.+|++|||+++......                ......+||+
T Consensus       108 P~NiLl~~---~~~~k~~d~~~~~~~~-----~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        108 PSCFVMSS---FNHVSFIESASCSDSG-----SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             chhEEEcc---cCcEEEeeccccCccc-----ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            99999984   4459999999876421     1245789999999997532100                0112246899


Q ss_pred             CcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhcc
Q psy3151         207 YYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC  286 (372)
Q Consensus       207 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~  286 (372)
                      +|+|||++.+..|+.++|||||||+||||++|.+|+....      .....+.....  ++ ......+++.+++.+||+
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~L~  250 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHRVL--PP-QILLNWPKEASFCLWLLH  250 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHhhc--Ch-hhhhcCHHHHHHHHHhCC
Confidence            9999999998999999999999999999999988874211      11111111111  11 111235567899999999


Q ss_pred             CCCCCCCChhHHhcCCccccC
Q psy3151         287 VDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       287 ~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +||.+|||+.|+++||||...
T Consensus       251 ~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        251 PEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             CChhhCcChHHHhhchhhhhh
Confidence            999999999999999999764

>KOG1025|consensus

Probab=100.00  E-value=1.6e-33  Score=271.78  Aligned_cols=239  Identities=22%  Similarity=0.366  Sum_probs=194.2

Q ss_pred             cccccccCCeEEEEEEEcCCC----cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTS----EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .++||.|+||+||+|..-..|    -+||||++...      ....+|+-. +..++|||+++++++...     +.+.|
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~-masldHpnl~RLLgvc~~-----s~~ql  774 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALR-MASLDHPNLLRLLGVCML-----STLQL  774 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHH-HhcCCCchHHHHhhhccc-----chHHH
Confidence            357999999999999886555    46888888532      233455544 778899999999999874     34889


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      |++|++.|.|.++++.++ .++-......|..||++|+.|||.+++|||||-.+|+|+.                     
T Consensus       775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---------------------  832 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---------------------  832 (1177)
T ss_pred             HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---------------------
Confidence            999999999999999865 5799999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCccccccc--CCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                            ....+||.|||+|+.+...........|  .+-|||=|.+....|+.++|+||+||++||++| |..||++...
T Consensus       833 ------sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~  906 (1177)
T KOG1025|consen  833 ------SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA  906 (1177)
T ss_pred             ------CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence                  4556999999999987665544444443  335999999999999999999999999999998 9999988776


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .++.    +.+..+.- ++.|  ..++.++.-+|.+||..|+..||+++++..
T Consensus       907 ~eI~----dlle~geR-LsqP--piCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  907 EEIP----DLLEKGER-LSQP--PICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHhh----HHHhcccc-CCCC--CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            6553    33333221 2222  378999999999999999999999988754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3e-31  Score=230.12  Aligned_cols=207  Identities=40%  Similarity=0.641  Sum_probs=178.3

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCC
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHG   97 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~   97 (372)
                      ||.|++|.||++.+..+|+.+++|++...      ....+|+.. ++.+.|++|+++++++..    ....++++|++.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~-~~~l~~~~i~~~~~~~~~----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEI-LKKLNHPNIVKLYGVFED----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHH-HHhcCCCCeeeEeeeeec----CCeEEEEEecCCC
Confidence            68999999999999888999999999754      346678776 566789999999999875    4688999999998


Q ss_pred             CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCC
Q psy3151          98 GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD  177 (372)
Q Consensus        98 g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  177 (372)
                      ++|.+++.... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++                           .
T Consensus        76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---------------------------~  127 (215)
T cd00180          76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---------------------------S  127 (215)
T ss_pred             CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---------------------------C
Confidence            99999987652 3589999999999999999999999999999999999998                           4


Q ss_pred             -CCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHH
Q psy3151         178 -GGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK  255 (372)
Q Consensus       178 -~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  255 (372)
                       .+.++|+|||.+..............+...|++||.+... .++.++|+|++|+++++|                    
T Consensus       128 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------  187 (215)
T cd00180         128 DNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------  187 (215)
T ss_pred             CCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------
Confidence             5679999999887654332223334567889999998776 788999999999999999                    


Q ss_pred             HHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                                         ..+.+++.+|+..||.+||+++++++|+
T Consensus       188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                               6688999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=1.5e-30  Score=221.30  Aligned_cols=164  Identities=23%  Similarity=0.294  Sum_probs=127.1

Q ss_pred             CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCC
Q psy3151          98 GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD  177 (372)
Q Consensus        98 g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  177 (372)
                      |+|.+++...+ ..+++..++.++.||+.||+|||+++      ||+|||++                           .
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---------------------------~   46 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---------------------------W   46 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---------------------------C
Confidence            68999997643 46999999999999999999999999      99999997                           5


Q ss_pred             CCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHH
Q psy3151         178 GGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNR  257 (372)
Q Consensus       178 ~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~  257 (372)
                      ++.+++  ||++......     ...||+.|+|||++.+..|+.++|||||||++|+|++|..||.......   .....
T Consensus        47 ~~~~~~--fG~~~~~~~~-----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~  116 (176)
T smart00750       47 DGLLKL--DGSVAFKTPE-----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEI  116 (176)
T ss_pred             ccceee--ccceEeeccc-----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHH
Confidence            667888  9988765331     2367999999999999999999999999999999999999996543211   11111


Q ss_pred             HhhCCccC-C--CCcccccCH--HHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         258 IRLGQFDF-P--NPEWEHVSQ--EAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       258 ~~~~~~~~-~--~~~~~~~s~--~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      +....... +  .+....++.  ++.++|.+||..||.+|||+.++++|+|+.
T Consensus       117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      117 LLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            11111111 0  011123344  699999999999999999999999999975

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=6e-29  Score=218.85  Aligned_cols=194  Identities=42%  Similarity=0.691  Sum_probs=163.0

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      |++ .+.||.|++|.||+|.+..+++.+|+|.+...      ....+|++. ++.++|+|++++++++..    ....++
T Consensus         1 ~~~-~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~-~~~~~~~~i~~~~~~~~~----~~~~~~   74 (225)
T smart00221        1 YEL-GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRI-LKKLKHPNIVKLYGVFED----PEPLYL   74 (225)
T ss_pred             Cce-eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHH-HHhCCCCChhhheeeeec----CCceEE
Confidence            455 46799999999999999988999999999742      344567776 556699999999998765    567899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ++|++.+++|.+++..... .+++..++.++.|++.++.+||+.+++|+||+|.||+++                     
T Consensus        75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---------------------  132 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---------------------  132 (225)
T ss_pred             EEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---------------------
Confidence            9999999999999976532 289999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                            ..+.++|+|||.+....... .......++..|++||.+ ....++.++|+||||+++++|++|+.||..
T Consensus       133 ------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      133 ------MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ------CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                  55779999999888764432 122345678889999998 777788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0590|consensus

Probab=99.96  E-value=9.7e-31  Score=258.91  Aligned_cols=262  Identities=28%  Similarity=0.429  Sum_probs=197.6

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---h--------hhHHHHHHHHHhcCCCCEeEEeEeeee
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---V--------KARREVELQLAVGSHKHIVNIKDVYEN   80 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~   80 (372)
                      .+.+.|-..+.++|.|++|.|+.+......+.++.|.+...   .        ....|..+ -..+.|||++..+..+..
T Consensus       314 ~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i-~~~l~h~~~~e~l~~~~~  392 (601)
T KOG0590|consen  314 GFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCI-GSSLSHPNIIETLDIVQE  392 (601)
T ss_pred             ccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheee-cccccCCchhhhHHHHhh
Confidence            35677877778999999999999888887777777765411   0        01122222 445689998776666554


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                          ....+-+||||++ +|..++...  +.++..++..++.|++.|++|||+.||.|||+||+|+++.           
T Consensus       393 ----~~~~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~-----------  454 (601)
T KOG0590|consen  393 ----IDGILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT-----------  454 (601)
T ss_pred             ----cccchhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe-----------
Confidence                2223444999998 999999875  3599999999999999999999999999999999999998           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCC----CcccccccCCCcCCCcccCCCCCCC-ccchhhHHHHHHHH
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK----ASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVIMYIL  235 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l  235 (372)
                                      ..|.+||+|||.+.....+.    ......+|+..|+|||++.+..|++ .+||||.|+++..|
T Consensus       455 ----------------~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m  518 (601)
T KOG0590|consen  455 ----------------ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICM  518 (601)
T ss_pred             ----------------cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEE
Confidence                            56789999999887654322    2345678999999999999999984 78999999999999


Q ss_pred             HhCCCCCCCCCCCCCCH-hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         236 LCGFPPFFSNHGQAISP-GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       236 l~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      .+|+.||......+... ............-+...+..++.+.+.+|.+||++||.+|.|+++|++.+||+...
T Consensus       519 ~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  519 ILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             ecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            99999996554433210 00000000011112233456788999999999999999999999999999998764

>KOG1024|consensus

Probab=99.96  E-value=2.9e-29  Score=224.90  Aligned_cols=248  Identities=18%  Similarity=0.302  Sum_probs=186.0

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCC-----CcEEEEEEecchhh------hHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKT-----SEVYALKVLHDTVK------ARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~------~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .+|.+. ..++-+|.||.||.|.....     .+.|-+|.+.....      ...|- .++.-..|||+..+.++...  
T Consensus       283 r~Rv~l-~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es-~lly~~sH~nll~V~~V~ie--  358 (563)
T KOG1024|consen  283 RCRVRL-SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQES-MLLYGASHPNLLSVLGVSIE--  358 (563)
T ss_pred             hhheec-hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHH-HHHhcCcCCCccceeEEEee--
Confidence            356665 47799999999999966532     23344555532211      11222 23555689999999888653  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKE------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                       +....++++.++.-|+|..+++..+      .+.++..+...++.|++.|++|||+.||||.||-.+|.+|+       
T Consensus       359 -~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId-------  430 (563)
T KOG1024|consen  359 -DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID-------  430 (563)
T ss_pred             -ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh-------
Confidence             2456778899998899999998432      13477788889999999999999999999999999999998       


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccc-c-CCCcCCCcccCCCCCCCccchhhHHHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPC-Y-TPYYVAPEVLGPDKYDKSCDIWSLGVIMYI  234 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~-g-t~~y~aPE~~~~~~~~~~~DiwslG~il~~  234 (372)
                                          +.-++||+|=.+++.+.+..-.+-..- . ...|||||.+....|+.++|+||||+++||
T Consensus       431 --------------------d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWE  490 (563)
T KOG1024|consen  431 --------------------DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWE  490 (563)
T ss_pred             --------------------hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHH
Confidence                                667899999999998765433322111 1 235999999999999999999999999999


Q ss_pred             HHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         235 LLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       235 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |+| |+.||..-++.+    +..-+..| +.+..|  .++++++..+|.-||+.+|++||+.+|+..
T Consensus       491 Lmtlg~~PyaeIDPfE----m~~ylkdG-yRlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  491 LMTLGKLPYAEIDPFE----MEHYLKDG-YRLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHhcCCCCccccCHHH----HHHHHhcc-ceecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            998 999996655433    33333333 222222  379999999999999999999999999876

>KOG1164|consensus

Probab=99.94  E-value=1.4e-25  Score=209.03  Aligned_cols=256  Identities=20%  Similarity=0.232  Sum_probs=187.8

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCC-cEEEEEEecchh-----hhHHHHHHHHHhc---CCCCEeEEeEeeeeecCCce
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTS-EVYALKVLHDTV-----KARREVELQLAVG---SHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~-----~~~~e~~~~~~~~---~h~ni~~~~~~~~~~~~~~~   86 (372)
                      +|.+ .+.||+|+||.||+|.+..++ ..+|+|+.....     ....|...+..+.   .-+|+..+++...   ..+.
T Consensus        19 ~~~i-~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~---~~~~   94 (322)
T KOG1164|consen   19 RYKL-GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR---STED   94 (322)
T ss_pred             ceEE-eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc---CCCc
Confidence            8999 577999999999999998775 678888875321     3456777655554   2368888888773   2367


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      +-|+||+.+ |.+|.++......+.++...+..++.|++.+|++||+.|++||||||+|+++...+..            
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~------------  161 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRS------------  161 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCc------------
Confidence            889999999 8899998877666789999999999999999999999999999999999999843210            


Q ss_pred             ccccccCCCCCCCCeeeecccccc--ccccCC-----C--c-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHH
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAK--KIVSNK-----A--S-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~--~~~~~~-----~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  236 (372)
                                ....+.+.|||+|+  ......     .  . .....||..|+++.+..+...+++.|+||++.++.+++
T Consensus       162 ----------~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~  231 (322)
T KOG1164|consen  162 ----------EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELL  231 (322)
T ss_pred             ----------ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHh
Confidence                      12457777888777  321111     0  1 12345899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .|..||.......................   .....+.++..+...+-..+...+|....+...
T Consensus       232 ~g~LPW~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  232 KGSLPWEALEMTDLKSKFEKDPRKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             cCCCCCccccccchHHHHHHHhhhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            99999965543322111211111111110   112345677777777777899999998777553

>KOG0603|consensus

Probab=99.94  E-value=8.6e-28  Score=228.16  Aligned_cols=234  Identities=31%  Similarity=0.560  Sum_probs=195.8

Q ss_pred             cccccCCeEEEEEEE---cCCCcEEEEEEecchh-------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          23 ILGLGINGKVLQIVE---KKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~~-------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      ++|.|+||.|+++.-   ...|+.+|+|+..+..       ....|..++....+||.++++...|+.    +..+|+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt----~~kl~l~l   76 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT----DGKLYLIL   76 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc----ccchhHhh
Confidence            379999999987643   3468889999886321       223344554556669999999999987    78899999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      ++..||+|...+.+..  .+.+...+.+...++.+++++|+.||+|||+|++||+++                       
T Consensus        77 d~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld-----------------------  131 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL-----------------------  131 (612)
T ss_pred             hhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec-----------------------
Confidence            9999999998887654  489999999999999999999999999999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCH
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP  252 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  252 (372)
                          ..|.+++.|||+++........    |||..|||||++.  ....++|.||+|++.|+|++|..||..        
T Consensus       132 ----~~Ghi~~tdfglske~v~~~~~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------  193 (612)
T KOG0603|consen  132 ----LEGHIKLTDFGLSKEAVKEKIA----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------  193 (612)
T ss_pred             ----ccCccccCCchhhhHhHhhhhc----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------
Confidence                6788999999999877543332    9999999999997  577899999999999999999999965        


Q ss_pred             hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh-----hHHhcCCccccC
Q psy3151         253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-----DQVMENKWISQF  307 (372)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~-----~eil~hp~~~~~  307 (372)
                      ....++....+.+|.    .++.++++++..++..+|..|..+     .++++|+||+..
T Consensus       194 ~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  194 DTMKRILKAELEMPR----ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             HHHHHHhhhccCCch----hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence            345666666666664    789999999999999999999864     789999999864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=1.2e-24  Score=200.89  Aligned_cols=255  Identities=34%  Similarity=0.550  Sum_probs=192.7

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCC-CEeEEeEeeeeecCCceE
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHK-HIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~-ni~~~~~~~~~~~~~~~~   87 (372)
                      |.+ .+.||.|+||.||++.+.   ..+|+|.+...        ....+|+.. ...+.|+ +|+.+.+.+..    ...
T Consensus         2 ~~~-~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~-~~~~~~~~~i~~~~~~~~~----~~~   72 (384)
T COG0515           2 YRI-LRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQI-LASLNHPPNIVKLYDFFQD----EGS   72 (384)
T ss_pred             cee-EEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHH-HHHccCCcceeeEEEEEec----CCE
Confidence            666 467999999999999997   88899998532        234566665 4555666 79999999854    445


Q ss_pred             EEEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          88 LLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+++++++.++++.+++..... ..+++..+..++.|++.++.|+|+.|++|||+||+||+++                 
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~-----------------  135 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD-----------------  135 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec-----------------
Confidence            8999999999999977765421 1599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCC-CeeeeccccccccccCCC------cccccccCCCcCCCcccCC---CCCCCccchhhHHHHHHHHH
Q psy3151         167 PENLLYTKPGDGG-ILKLTDFGFAKKIVSNKA------SLQTPCYTPYYVAPEVLGP---DKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       167 ~~~~~~~~~~~~~-~~ki~Dfg~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll  236 (372)
                                ..+ .++++|||.+........      .....+||..|+|||.+.+   ..++...|+||+|+++++++
T Consensus       136 ----------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~  205 (384)
T COG0515         136 ----------RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL  205 (384)
T ss_pred             ----------CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHH
Confidence                      334 689999998875543221      3466788999999999977   57889999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCcc-CCCCccccc----CHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFD-FPNPEWEHV----SQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +|..||...............+...... .........    ...+.+++..++..+|..|.+..+...++|....
T Consensus       206 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         206 TGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             hCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            9999975544311112233333332222 111111111    2578999999999999999999999888776554

>KOG1165|consensus

Probab=99.93  E-value=1.5e-25  Score=197.49  Aligned_cols=208  Identities=20%  Similarity=0.340  Sum_probs=177.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEec---chhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH---DTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~---~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +.-+|++ ++.||+|+||+.+.|.+.-++++||||.-.   +....+.|...+..+...++|...+.+-..    +.+-.
T Consensus        26 VG~hyrV-GkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqe----G~~Ni  100 (449)
T KOG1165|consen   26 VGPHYRV-GKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE----GKYNI  100 (449)
T ss_pred             eccccee-ccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccc----cchhh
Confidence            5668998 788999999999999999999999999754   334667888887778888999998876544    77888


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +|+|.+ |-+|.|+..-++ ..|+...+..++.|++.-++|+|+.++|.|||||+|+||..++..               
T Consensus       101 LVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k---------------  163 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTK---------------  163 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCC---------------
Confidence            999999 889999888776 469999999999999999999999999999999999999865531               


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                             +...+.|+|||+|+..-+...       ......||..||+--...+...+.+.|+=|||-++++.+-|..||
T Consensus       164 -------~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPW  236 (449)
T KOG1165|consen  164 -------DANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW  236 (449)
T ss_pred             -------CCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcc
Confidence                   556789999999987754332       133457899999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q psy3151         243 FSNHGQA  249 (372)
Q Consensus       243 ~~~~~~~  249 (372)
                      .+.....
T Consensus       237 QGLKA~t  243 (449)
T KOG1165|consen  237 QGLKADT  243 (449)
T ss_pred             ccccCcc
Confidence            8765443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=7.4e-26  Score=211.02  Aligned_cols=171  Identities=19%  Similarity=0.185  Sum_probs=127.4

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcC-CCcEEEEEEecch----------hhhHHHHHHHHHhcCCCCEeE-EeEe
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKK-TSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVN-IKDV   77 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~ni~~-~~~~   77 (372)
                      -.++.++|.+ .+.||+|+||+||+|.+.. +++.+|||++...          ....+|+++ +..++|+|++. +++ 
T Consensus        13 ~~~~~~~Y~~-~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~i-L~~L~h~~iv~~l~~-   89 (365)
T PRK09188         13 IPALSARFVE-TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRA-LKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccCCceE-ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHH-HHhccCCCCCcEEEE-
Confidence            3458899999 5889999999999999876 7888899986421          234678887 56678999885 433 


Q ss_pred             eeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCceeeecCCCCCc
Q psy3151          78 YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV-KPENLLYTKPGDGGI  156 (372)
Q Consensus        78 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDl-kp~NIli~~~~~~~~  156 (372)
                      +       ...|+||||+.|++|.. +.  .   ..   ...++.|++.||.|||++||+|||| ||+|||++       
T Consensus        90 ~-------~~~~LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~-------  146 (365)
T PRK09188         90 T-------GKDGLVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG-------  146 (365)
T ss_pred             c-------CCcEEEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc-------
Confidence            1       23699999999999963 21  1   11   1467899999999999999999999 99999997       


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC--------CcccccccCCCcCCCcccCCCC------CCCc
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--------ASLQTPCYTPYYVAPEVLGPDK------YDKS  222 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~------~~~~  222 (372)
                                          .++.++|+|||+|.......        ....+.++++.|.|||.+....      .+..
T Consensus       147 --------------------~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~  206 (365)
T PRK09188        147 --------------------PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLP  206 (365)
T ss_pred             --------------------CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccc
Confidence                                45668888888887654321        1123566788999999985432      2344


Q ss_pred             cchh
Q psy3151         223 CDIW  226 (372)
Q Consensus       223 ~Diw  226 (372)
                      +|-|
T Consensus       207 ~dgW  210 (365)
T PRK09188        207 SRIW  210 (365)
T ss_pred             cCcE
Confidence            6666

>KOG1163|consensus

Probab=99.93  E-value=4.3e-25  Score=186.73  Aligned_cols=252  Identities=18%  Similarity=0.206  Sum_probs=191.4

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      -+.+.|.++ +.||+|+||-+|+|.+..+|+.||||+-...   .....|..++..+..-..|+.+..++.+    ..+-
T Consensus        12 iv~gky~lv-rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e----~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLV-RKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE----KDYN   86 (341)
T ss_pred             eeccceEEE-EeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc----cccc
Confidence            367899997 5599999999999999999999999987543   3456777776666666778777776654    6788


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      .+||+.+ |-+|.++..-.. ..++...+.-++.|++.-++|+|.++.+||||||+|+|+....                
T Consensus        87 vlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr----------------  148 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR----------------  148 (341)
T ss_pred             eeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc----------------
Confidence            9999999 889999887665 4699999999999999999999999999999999999997432                


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                              -...+.++|||+|+..-+...       .-....||..|++--...+...+.+.|+=|+|.+|.+..-|..|
T Consensus       149 --------h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LP  220 (341)
T KOG1163|consen  149 --------HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLP  220 (341)
T ss_pred             --------ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCc
Confidence                    345678889998877643221       12335689999998888777888999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCC-cccccCHHHHHHHHHhccCCCCCCCCh
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNP-EWEHVSQEAKTLIKNMLCVDPSERLTI  295 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~ll~~dP~~R~s~  295 (372)
                      |.+...... ....+.+.......+.. .-.+++.|+.-.+.-|-..--++-|..
T Consensus       221 WQglka~tk-~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  221 WQGLKAATK-KQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             ccccchhhH-HHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            987654432 12233333333332221 124567787777777766655666664

>KOG0606|consensus

Probab=99.92  E-value=1.5e-25  Score=222.91  Aligned_cols=227  Identities=30%  Similarity=0.544  Sum_probs=169.1

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ...|-...|..+ ++|-.|+||.||+++|+.+.+.+|+|+ ++.....|            ||..+.+         + .
T Consensus        77 ~~~p~e~df~~I-klisngAygavylvrh~~trqrfa~ki-Nkq~lilR------------nilt~a~---------n-p  132 (1205)
T KOG0606|consen   77 RRAPSESDFNTI-KLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILR------------NILTFAG---------N-P  132 (1205)
T ss_pred             ccCCCcccccee-EeeccCCCCceeeeeccccccchhhcc-cccchhhh------------ccccccC---------C-c
Confidence            445677888885 889999999999999999999999953 33222211            2332211         1 1


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      +.|      ||-...++.-  +.++.+.        +.+++|||+-||+|||+||+|.+|.                   
T Consensus       133 fvv------gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT-------------------  177 (1205)
T KOG0606|consen  133 FVV------GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLIT-------------------  177 (1205)
T ss_pred             cee------chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceee-------------------
Confidence            222      4555555443  3466544        8899999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccC---------------CCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHH
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSN---------------KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  233 (372)
                              .-|.+|++|||++......               ...-...||||.|+|||++....|+..+|.|+||+|+|
T Consensus       178 --------~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIly  249 (1205)
T KOG0606|consen  178 --------SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILY  249 (1205)
T ss_pred             --------ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHH
Confidence                    6778888898887643210               00122369999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC---ChhHHhcCCccccC
Q psy3151         234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL---TIDQVMENKWISQF  307 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~---s~~eil~hp~~~~~  307 (372)
                      +.+.|..||++...+++    ...+......+|.. ...+.+|+++++.+||+.+|..|.   .+-++.+|+||+.+
T Consensus       250 eFLVgcvpffGdtpeel----fg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  250 EFLVGCVPFFGDTPEEL----FGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             HHheeeeeccCCCHHHH----Hhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            99999999988766544    44444444445543 346889999999999999999997   46778899999864

>KOG1240|consensus

Probab=99.92  E-value=5.3e-26  Score=226.31  Aligned_cols=246  Identities=24%  Similarity=0.346  Sum_probs=169.0

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh---------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV---------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      .|.. .+.||++.|=+|.+|++.. |. |+||++-+..         +..+|+.  ..++++||++.+.-+.+.    +.
T Consensus        24 e~~~-~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t----~k   94 (1431)
T KOG1240|consen   24 ECHY-VENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVT----DK   94 (1431)
T ss_pred             ceee-ecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHh----hH
Confidence            5665 4679999999999999964 54 8999985432         1223333  678899999997776554    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..|+|-+|... +|+|++..+  +.+..-+.+.|+.||+.||.-+|..||+|||||.+||||++=.   =+.++||...+
T Consensus        95 AAylvRqyvkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN---W~~LtDFAsFK  168 (1431)
T KOG1240|consen   95 AAYLVRQYVKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN---WLYLTDFASFK  168 (1431)
T ss_pred             HHHHHHHHHhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec---hhhhhcccccC
Confidence            78999999965 999999765  3488999999999999999999999999999999999998411   13455555443


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC----------CC-CCCccchhhHHHHHHHH
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP----------DK-YDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~~DiwslG~il~~l  235 (372)
                      +.=..+..|        +||+.=         ..+......|+|||.+-.          .+ .+++-||||+||+++||
T Consensus       169 PtYLPeDNP--------adf~fF---------FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaEL  231 (1431)
T KOG1240|consen  169 PTYLPEDNP--------ADFTFF---------FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAEL  231 (1431)
T ss_pred             CccCCCCCc--------ccceEE---------EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHH
Confidence            322211111        222211         111111335999998733          12 56789999999999999


Q ss_pred             Hh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcc-cccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         236 LC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEW-EHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       236 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ++ |++||...       .+ -..+.+.-..+.... .--+..+++||..|++.||++|.||++.|+.
T Consensus       232 f~Eg~PlF~LS-------QL-~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  232 FLEGRPLFTLS-------QL-LAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HhcCCCcccHH-------HH-HhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            98 78998321       11 111111100000000 1124579999999999999999999999984

>KOG4158|consensus

Probab=99.91  E-value=2e-24  Score=194.56  Aligned_cols=203  Identities=21%  Similarity=0.357  Sum_probs=144.9

Q ss_pred             hcCCCCEeEEeEeeeee-----------------------cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHH
Q psy3151          65 VGSHKHIVNIKDVYENI-----------------------YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM  121 (372)
Q Consensus        65 ~~~h~ni~~~~~~~~~~-----------------------~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~  121 (372)
                      +..||||+.+...|.+.                       ...+..+|+||.-+. .+|.+++..+.   .+.....-++
T Consensus       272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~l  347 (598)
T KOG4158|consen  272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVIL  347 (598)
T ss_pred             cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHH
Confidence            34699999999888432                       224567999999985 59999998754   7888999999


Q ss_pred             HHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC-----
Q psy3151         122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-----  196 (372)
Q Consensus       122 ~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-----  196 (372)
                      .|+++|+.|||.+||.|||+|.+|||+..++|                       ....+.|+|||.+-......     
T Consensus       348 aQlLEav~hL~~hgvAhRDlKSDNiL~ElddD-----------------------~~P~LVvaDFGCcLAd~~hGlqlpy  404 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDDD-----------------------EIPQLVVADFGCCLADDNHGLQLPY  404 (598)
T ss_pred             HHHHHHHHHHHHccchhhcccccceEEEecCC-----------------------CCcEEEEcccceeeecccccccccc
Confidence            99999999999999999999999999987654                       22334555666543221110     


Q ss_pred             -CcccccccCCCcCCCcccCCCC-----CC-CccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCc
Q psy3151         197 -ASLQTPCYTPYYVAPEVLGPDK-----YD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPE  269 (372)
Q Consensus       197 -~~~~~~~gt~~y~aPE~~~~~~-----~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (372)
                       ...-...|...-||||+....+     .+ .++|.|+.|.+.||+++...||++.....+..  .. ....+++   +.
T Consensus       405 ~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~--r~-Yqe~qLP---al  478 (598)
T KOG4158|consen  405 ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT--RT-YQESQLP---AL  478 (598)
T ss_pred             ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech--hh-hhhhhCC---CC
Confidence             0111223466689999985432     12 58999999999999999999998743322211  11 2222222   22


Q ss_pred             ccccCHHHHHHHHHhccCCCCCCCCh---hHHhc
Q psy3151         270 WEHVSQEAKTLIKNMLCVDPSERLTI---DQVME  300 (372)
Q Consensus       270 ~~~~s~~~~~li~~ll~~dP~~R~s~---~eil~  300 (372)
                      .+.+++.+++|+..+|+.||++|+++   +.+|+
T Consensus       479 p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  479 PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             cccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            25789999999999999999999994   44554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=5.6e-23  Score=184.08  Aligned_cols=230  Identities=21%  Similarity=0.349  Sum_probs=138.9

Q ss_pred             ccccccccCCeEEEEEEEcCCCcEEEEEEecchh-------hhHHHHHHHHHhcC----------CCCEeEEeEeee---
Q psy3151          20 STEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGS----------HKHIVNIKDVYE---   79 (372)
Q Consensus        20 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~e~~~~~~~~~----------h~ni~~~~~~~~---   79 (372)
                      .++.||.|+++.||.+.|..||+.+|+|++....       ...+|.........          |-.++..++...   
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            3678999999999999999999999999985211       11111111011100          112222222221   


Q ss_pred             -----eecCCceE-----EEEEEeccCCCchhHHHHh---ccCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy3151          80 -----NIYNGSRC-----LLVIMECMHGGELFQRIQQ---KEDG--AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE  144 (372)
Q Consensus        80 -----~~~~~~~~-----~~lv~e~~~~g~L~~~i~~---~~~~--~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~  144 (372)
                           ....+.+.     .+++|+-+ .+||.+++..   ....  .+.......+..|+++.+++||+.|+||+||+|+
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~  174 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPE  174 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccccee
Confidence                 00111122     36778888 4688887653   2211  1222333456689999999999999999999999


Q ss_pred             ceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC--------
Q psy3151         145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP--------  216 (372)
Q Consensus       145 NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------  216 (372)
                      |++++                           .+|.+.++||+.....+...   .....+..|.+||....        
T Consensus       175 nfll~---------------------------~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~  224 (288)
T PF14531_consen  175 NFLLD---------------------------QDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNN  224 (288)
T ss_dssp             GEEE----------------------------TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSE
T ss_pred             eEEEc---------------------------CCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCccc
Confidence            99998                           67889999998776543311   11233567999997632        


Q ss_pred             CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCC
Q psy3151         217 DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER  292 (372)
Q Consensus       217 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R  292 (372)
                      ..++.+.|.|+||+++|.|+|+..||...........     .....       .++++.++.||..||+.||.+|
T Consensus       225 ~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----~f~~C-------~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  225 APYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----DFSRC-------RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             EEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----GGTTS-------S---HHHHHHHHHHT-SSGGGS
T ss_pred             ceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----cchhc-------CCcCHHHHHHHHHHccCCcccC
Confidence            3578899999999999999999999975543322211     11111       2578999999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=2e-23  Score=181.66  Aligned_cols=170  Identities=18%  Similarity=0.212  Sum_probs=126.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hh----------hHHHHHHHHHhcCCCCEeEEeEee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VK----------ARREVELQLAVGSHKHIVNIKDVY   78 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~----------~~~e~~~~~~~~~h~ni~~~~~~~   78 (372)
                      +.++|+++ ++||.|+||.||++.+  ++..+|||+++..    ..          ..+|+.. +..+.|+||..+.+++
T Consensus        29 l~~~y~~~-~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~-l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         29 LSYNIKTI-KVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQ-TDRVRSEGLASLNDFY  104 (232)
T ss_pred             hhCceEEE-EEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHH-HHHHHHCCCCcceEee
Confidence            78999995 8899999999999655  4778999999622    11          2456555 4555999999999887


Q ss_pred             eeecC----CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCC
Q psy3151          79 ENIYN----GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDG  154 (372)
Q Consensus        79 ~~~~~----~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~  154 (372)
                      .....    .....+++|||++|.+|.++..      +++.    ...+++.+|..||+.|++|||+||+||+++     
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~-----  169 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVS-----  169 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEe-----
Confidence            64211    1235789999999999977631      4443    456999999999999999999999999997     


Q ss_pred             CceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHH
Q psy3151         155 GILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI  234 (372)
Q Consensus       155 ~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  234 (372)
                                            +++ ++++|||.+........ .           ...+....|+.++|+||||+++..
T Consensus       170 ----------------------~~g-i~liDfg~~~~~~e~~a-~-----------d~~vler~y~~~~di~~lg~~~~~  214 (232)
T PRK10359        170 ----------------------KNG-LRIIDLSGKRCTAQRKA-K-----------DRIDLERHYGIKNEIKDLGYYLLI  214 (232)
T ss_pred             ----------------------CCC-EEEEECCCcccccchhh-H-----------HHHHHHhHhcccccccceeEeehH
Confidence                                  455 89999987764421110 0           113345567789999999999876


Q ss_pred             HH
Q psy3151         235 LL  236 (372)
Q Consensus       235 ll  236 (372)
                      +.
T Consensus       215 ~~  216 (232)
T PRK10359        215 YK  216 (232)
T ss_pred             HH
Confidence            54

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=1.3e-22  Score=174.12  Aligned_cols=134  Identities=17%  Similarity=0.244  Sum_probs=100.4

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecchh--------------h-----------------hHHHHHHHHHhcCCC
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------------K-----------------ARREVELQLAVGSHK   69 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~-----------------~~~e~~~~~~~~~h~   69 (372)
                      .+.||+|++|.||+|.+. +|+.||||+++...              +                 ..+|+..+ ..+.++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNL-KRLVTA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHH-HHHHHC
Confidence            367999999999999997 89999999985321              0                 11366663 444556


Q ss_pred             CEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCceee
Q psy3151          70 HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL-HDQNIAHRDVKPENLLY  148 (372)
Q Consensus        70 ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~L-H~~~ivHrDlkp~NIli  148 (372)
                      ++.....+..     .. .++||||++|+++...+...  +.+++..+..++.|++.+|.+| |+.||+||||||+|||+
T Consensus        80 ~v~~p~~~~~-----~~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli  151 (190)
T cd05147          80 GIPCPEPILL-----KS-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCCcEEEe-----cC-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence            6533222211     11 38999999887776554332  4699999999999999999999 79999999999999999


Q ss_pred             ecCCCCCceeeeccCCCCccccccCCCCCCCCeeeecccccccc
Q psy3151         149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI  192 (372)
Q Consensus       149 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~  192 (372)
                      +                            ++.++++|||+|...
T Consensus       152 ~----------------------------~~~v~LiDFG~a~~~  167 (190)
T cd05147         152 H----------------------------DGKLYIIDVSQSVEH  167 (190)
T ss_pred             E----------------------------CCcEEEEEccccccC
Confidence            6                            245899999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.8e-21  Score=168.79  Aligned_cols=123  Identities=18%  Similarity=0.257  Sum_probs=95.8

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecc-----hhhhHHHHHHHHHhc----CCCCEeEEeEeeeeecCCceE-EEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHD-----TVKARREVELQLAVG----SHKHIVNIKDVYENIYNGSRC-LLV   90 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~----~h~ni~~~~~~~~~~~~~~~~-~~l   90 (372)
                      .+.||+|+||.||.  +..++.. +||++..     .....+|+..+..+.    .||||+++++++++... ... +.+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-~g~v~~~   82 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-TGYVYDV   82 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-CeEEEEE
Confidence            35799999999995  7777776 6998863     345778998855542    68999999999986322 234 347


Q ss_pred             EEec--cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCceeeecCC
Q psy3151          91 IMEC--MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI-KFLHDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus        91 v~e~--~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l-~~LH~~~ivHrDlkp~NIli~~~~  152 (372)
                      |+||  +.+++|.+++.+.   .+++.  ..++.|++.++ +|||+++|+||||||+|||++..+
T Consensus        83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~  142 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRIS  142 (210)
T ss_pred             EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccC
Confidence            8999  5579999999653   36666  36688888888 999999999999999999998543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.1e-21  Score=167.43  Aligned_cols=180  Identities=16%  Similarity=0.162  Sum_probs=132.9

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecchh---------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDTV---------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      ...|++|+||+|+.+..  .+.+++.+.+....         .+.+|++++.++..|++|++++++.        ..|++
T Consensus         7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------~~~lv   76 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------GRHLD   76 (218)
T ss_pred             ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------CEEEE
Confidence            46799999999997775  68888877775321         3568999976666778899998852        25899


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV-KPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDl-kp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      |||+.|.+|.+.+..        . ...++.|++.+|.++|++||+|||| ||+|||++                     
T Consensus        77 meyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---------------------  126 (218)
T PRK12274         77 RSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---------------------  126 (218)
T ss_pred             EeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---------------------
Confidence            999999888654311        1 1357889999999999999999999 79999997                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCc----c---------cccccCCCcCCCcccCC-CCCC-CccchhhHHHHHHHH
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKAS----L---------QTPCYTPYYVAPEVLGP-DKYD-KSCDIWSLGVIMYIL  235 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~----~---------~~~~gt~~y~aPE~~~~-~~~~-~~~DiwslG~il~~l  235 (372)
                            .++.++|+|||+|.........    .         ....+++.|++|+...- ...+ ...+.++.|+-+|.+
T Consensus       127 ------~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~  200 (218)
T PRK12274        127 ------EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRF  200 (218)
T ss_pred             ------CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHH
Confidence                  4567889999988754332210    0         01225788899975321 1223 566888999999999


Q ss_pred             HhCCCCCCCCC
Q psy3151         236 LCGFPPFFSNH  246 (372)
Q Consensus       236 l~g~~pf~~~~  246 (372)
                      +|+..+++++.
T Consensus       201 ~~~~~~~~~~~  211 (218)
T PRK12274        201 VTRRVLHWEDN  211 (218)
T ss_pred             HhccCCccccC
Confidence            99999886653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.2e-21  Score=168.56  Aligned_cols=135  Identities=16%  Similarity=0.181  Sum_probs=102.0

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecchh-------------------------------hhHHHHHHHHHhcCCC
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------------------------------KARREVELQLAVGSHK   69 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------------------------~~~~e~~~~~~~~~h~   69 (372)
                      .+.||+|++|.||+|.+. +|+.||||+++...                               ...+|... +..+.|+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRN-LKRLYEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHH-HHHHHhC
Confidence            357999999999999987 89999999986321                               01245555 4445677


Q ss_pred             CEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceee
Q psy3151          70 HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLY  148 (372)
Q Consensus        70 ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli  148 (372)
                      ++.....+...      ..|+||||++|+++.......  ..+++..+..++.|++.+|.+||+ .||+||||||+||++
T Consensus        80 ~i~~p~~~~~~------~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll  151 (190)
T cd05145          80 GVPVPEPILLK------KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY  151 (190)
T ss_pred             CCCCceEEEec------CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE
Confidence            77444333221      138999999887654432222  358899999999999999999999 999999999999999


Q ss_pred             ecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccc
Q psy3151         149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV  193 (372)
Q Consensus       149 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~  193 (372)
                      +                            ++.++|+|||+|....
T Consensus       152 ~----------------------------~~~~~liDFG~a~~~~  168 (190)
T cd05145         152 H----------------------------DGKPYIIDVSQAVELD  168 (190)
T ss_pred             E----------------------------CCCEEEEEcccceecC
Confidence            6                            3458899999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195|consensus

Probab=99.85  E-value=1.1e-21  Score=168.95  Aligned_cols=233  Identities=19%  Similarity=0.296  Sum_probs=173.7

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      .|.....|..|+|+..  |..+++|++...      .+.+.|.--.+++..||||+.+++.+..    ..++.++..||+
T Consensus       197 kl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns----ppnlv~isq~mp  270 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS----PPNLVIISQYMP  270 (448)
T ss_pred             hhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC----CCCceEeeeecc
Confidence            3778888999999987  455677887522      1223333333788899999999998875    567899999999


Q ss_pred             CCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          97 GGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        97 ~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~--ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      .|+|+..+....+-..+..++.+++..+++|++|||+..  |.---|....++|+.+                       
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-----------------------  327 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-----------------------  327 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-----------------------
Confidence            999999998766556788899999999999999999974  4444688889999721                       


Q ss_pred             CCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCC---CccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q psy3151         175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD---KSCDIWSLGVIMYILLCGFPPFFSNHGQAIS  251 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  251 (372)
                        -..++-++|--++...       ......|.|++||.+...+-+   .++|+|||++++||+.|...||.+.+..+. 
T Consensus       328 --ltarismad~kfsfqe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-  397 (448)
T KOG0195|consen  328 --LTARISMADTKFSFQE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-  397 (448)
T ss_pred             --hhhheecccceeeeec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-
Confidence              1223334443333221       223448899999999776544   689999999999999999999987766554 


Q ss_pred             HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                       +++-.+..-....|+    +++..+..|+.-|+..||.+||.++.++
T Consensus       398 -gmkialeglrv~ipp----gis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  398 -GMKIALEGLRVHIPP----GISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -hhhhhhccccccCCC----CccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence             333333333344454    7899999999999999999999987763

>KOG1033|consensus

Probab=99.84  E-value=8.9e-22  Score=184.02  Aligned_cols=179  Identities=25%  Similarity=0.393  Sum_probs=138.1

Q ss_pred             eEEEEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      .++|+.|++|...+|.+++..... ...+......++.|+..|++|   +|.+|||+||.||+..               
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---------------  390 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---------------  390 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---------------
Confidence            368999999999999999975332 346778899999999999999   9999999999999997               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCC------CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNK------ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-  237 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-  237 (372)
                                  .+..+||+|||+........      ...+...||.+||+||.+.+..|+.++||||||++|+|++. 
T Consensus       391 ------------~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~  458 (516)
T KOG1033|consen  391 ------------DDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ  458 (516)
T ss_pred             ------------cchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH
Confidence                        56679999999987654432      24566789999999999999999999999999999999997 


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      -...|..       ......+..+.+  |+..+.++ ++-.+|+.+||...|.+||++.+.-.|+|.
T Consensus       459 f~T~~er-------~~t~~d~r~g~i--p~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  459 FSTQFER-------IATLTDIRDGII--PPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hccHHHH-------HHhhhhhhcCCC--ChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2222210       111222333333  33233333 445689999999999999988887777764

>KOG1166|consensus

Probab=99.84  E-value=8.2e-21  Score=192.46  Aligned_cols=198  Identities=20%  Similarity=0.250  Sum_probs=149.0

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhh----hHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK----ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      ..|.| .+.||.|+||+||+|.+.. |+.||+|+=.-...    .-.++..-++..--+.|..+..++.-    .+.-++
T Consensus       698 ~~~~I-~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~----~~~S~l  771 (974)
T KOG1166|consen  698 EKFCI-SKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVF----QNASVL  771 (974)
T ss_pred             eeEEE-EeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHcc----CCccee
Confidence            46777 5779999999999999987 99999997642211    11222111111122344444333321    334578


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      |+||.+.|+|.+++...  +.+++..+..++.|++..+++||..||||+||||+|+||...-..      |         
T Consensus       772 v~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~------~---------  834 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA------D---------  834 (974)
T ss_pred             eeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC------C---------
Confidence            99999999999999743  569999999999999999999999999999999999999742211      0         


Q ss_pred             ccCCCCCCCCeeeecccccccccc--CCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVS--NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                           .+...++|+|||.|-....  ........++|-.+-.+|+..+.+|++++|.|.|+.+++-|+.|+.
T Consensus       835 -----~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  835 -----SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             -----CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence                 0244589999998876532  3345666788999999999999999999999999999999999864

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2e-19  Score=159.55  Aligned_cols=137  Identities=16%  Similarity=0.168  Sum_probs=102.6

Q ss_pred             eeeccccccccCCeEEEEEE-EcCCCcEEEEEEecchh-----------------------------hhHHHHHHHHHhc
Q psy3151          17 YDISTEILGLGINGKVLQIV-EKKTSEVYALKVLHDTV-----------------------------KARREVELQLAVG   66 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~~~-----------------------------~~~~e~~~~~~~~   66 (372)
                      |.+ .+.||.|++|.||+|. +..+|+.||||++....                             ...+|+..+.++.
T Consensus        30 ~~i-~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       30 SAI-GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             HHh-CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            667 5789999999999999 77899999999986321                             1235776654443


Q ss_pred             C-CCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCC
Q psy3151          67 S-HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN-IAHRDVKPE  144 (372)
Q Consensus        67 ~-h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~-ivHrDlkp~  144 (372)
                      . ...++.+++.        ...++||||+.|.+|.......  ..+....+..++.||+.+|.+||+.| |+||||||+
T Consensus       109 ~~~i~~p~~~~~--------~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~  178 (237)
T smart00090      109 EAGVPVPKPIAW--------RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY  178 (237)
T ss_pred             hcCCCCCeeeEe--------cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence            2 1223333331        1248999999988887654332  34677788899999999999999999 999999999


Q ss_pred             ceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeecccccccc
Q psy3151         145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI  192 (372)
Q Consensus       145 NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~  192 (372)
                      ||+++                            ++.++++|||.|...
T Consensus       179 NIli~----------------------------~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH----------------------------DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE----------------------------CCCEEEEEChhhhcc
Confidence            99996                            245889999987643

>KOG0590|consensus

Probab=99.80  E-value=6.8e-21  Score=189.00  Aligned_cols=258  Identities=26%  Similarity=0.469  Sum_probs=196.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEcC-CCcEEEEEEecchh-------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKK-TSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ...|.++ +.||+|+|+.|-++.... +...+|.|.+....       ....|..+....-+|+|++.+++....    .
T Consensus        19 ~~~~~~~-~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~----~   93 (601)
T KOG0590|consen   19 NSQYKLS-RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS----P   93 (601)
T ss_pred             ccccccc-ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC----C
Confidence            5567875 559999999999887743 45666777664332       223355553333349999999997765    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-DQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH-~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+++++|..|+++.+.+........+...+..++.|+..++.|+| ..++.|||+||+|.+++               
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---------------  158 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---------------  158 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---------------
Confidence            78899999999999999884322225788899999999999999999 99999999999999998               


Q ss_pred             CCccccccCCCCCCC-Ceeeecccccccccc-C--CCccccccc-CCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhC
Q psy3151         165 VKPENLLYTKPGDGG-ILKLTDFGFAKKIVS-N--KASLQTPCY-TPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~-~~ki~Dfg~a~~~~~-~--~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g  238 (372)
                                  ..+ .+++.|||+|..... .  .......+| ++.|+|||.+.+. ...+..|+||+|+++.-+++|
T Consensus       159 ------------~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g  226 (601)
T KOG0590|consen  159 ------------ESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTG  226 (601)
T ss_pred             ------------cCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccC
Confidence                        344 789999999887644 2  223455788 9999999999774 456899999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      ..|+...........  ..... ...+-...|..++..+.+++.+++..+|..|.+.+++..+||+..
T Consensus       227 ~~p~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  227 ELPWDFPSRKDGRYS--SWKSN-KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CCCccccccccccce--eeccc-ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            999966544332100  00100 011122345688999999999999999999999999999999988

>KOG1023|consensus

Probab=99.80  E-value=3.7e-19  Score=169.34  Aligned_cols=205  Identities=21%  Similarity=0.280  Sum_probs=155.5

Q ss_pred             HhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCC
Q psy3151          64 AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI-AHRDVK  142 (372)
Q Consensus        64 ~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~i-vHrDlk  142 (372)
                      +.+.|.|+.++++...+    +..+++|.+||..|+|.+.+.... ..++......+++.|+.||.|||...| .|+.++
T Consensus         2 ~~l~h~n~~~f~g~~~~----~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~   76 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVD----GPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK   76 (484)
T ss_pred             cccchhhhhhheeeEec----CCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence            34689999999999876    578999999999999999998743 568899999999999999999998866 999999


Q ss_pred             CCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccC--CCcccccccCCCcCCCcccCCCC--
Q psy3151         143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN--KASLQTPCYTPYYVAPEVLGPDK--  218 (372)
Q Consensus       143 p~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~--  218 (372)
                      ..|.+++                           ....+|++|||+.......  ........-..-|.|||.+....  
T Consensus        77 s~nClvd---------------------------~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~  129 (484)
T KOG1023|consen   77 SSNCLVD---------------------------SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQ  129 (484)
T ss_pred             cccceee---------------------------eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccc
Confidence            9999999                           5677999999988766321  01111111134599999986532  


Q ss_pred             -----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhh-CCccCCCCcc--cccCHHHHHHHHHhccCCCC
Q psy3151         219 -----YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL-GQFDFPNPEW--EHVSQEAKTLIKNMLCVDPS  290 (372)
Q Consensus       219 -----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~s~~~~~li~~ll~~dP~  290 (372)
                           -+.+.|+||+|++++|+++...||..........++...+.. +.-.+.+..+  ....+++..++.+||..+|.
T Consensus       130 ~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~  209 (484)
T KOG1023|consen  130 SLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPE  209 (484)
T ss_pred             cccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChh
Confidence                 356799999999999999999999765444333344444444 2222221111  14556799999999999999


Q ss_pred             CCCChhHHhc
Q psy3151         291 ERLTIDQVME  300 (372)
Q Consensus       291 ~R~s~~eil~  300 (372)
                      .||+++++-.
T Consensus       210 ~rPs~~~i~~  219 (484)
T KOG1023|consen  210 KRPSIEQIRS  219 (484)
T ss_pred             hCccHHHHHh
Confidence            9999998854

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=4.5e-18  Score=147.39  Aligned_cols=131  Identities=19%  Similarity=0.197  Sum_probs=98.2

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh---------------------------hhHHHHHHHHHhcCCC
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV---------------------------KARREVELQLAVGSHK   69 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------------~~~~e~~~~~~~~~h~   69 (372)
                      |.+ .+.||.|+||.||+|.+. +|+.||||++....                           ...+|...+ ..+.|+
T Consensus        17 ~~~-~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~~~   93 (198)
T cd05144          17 ESL-GNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL-KALYEE   93 (198)
T ss_pred             hhc-CCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH-HHHHHc
Confidence            666 588999999999999885 89999999864211                           133455553 333555


Q ss_pred             C--EeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcee
Q psy3151          70 H--IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL  147 (372)
Q Consensus        70 n--i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIl  147 (372)
                      +  ++..++        ....++||||++|++|.....        ......++.+++.++.++|+.||+||||||+||+
T Consensus        94 ~i~v~~~~~--------~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nil  157 (198)
T cd05144          94 GFPVPKPID--------WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNIL  157 (198)
T ss_pred             CCCCCceee--------cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEE
Confidence            3  333332        123589999999988866432        1345678899999999999999999999999999


Q ss_pred             eecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccc
Q psy3151         148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV  193 (372)
Q Consensus       148 i~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~  193 (372)
                      ++                           .++.++|+|||++....
T Consensus       158 l~---------------------------~~~~~~liDfg~~~~~~  176 (198)
T cd05144         158 VD---------------------------DDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             Ec---------------------------CCCcEEEEECCccccCC
Confidence            98                           56779999999986553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=9.7e-18  Score=146.71  Aligned_cols=129  Identities=20%  Similarity=0.294  Sum_probs=100.9

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch-------------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT-------------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +.||+|++|.||+|.+  +|..+++|+....             ....+|+.. +..+.|+||.....++..    ....
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~~~~i~~p~~~~~~----~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARI-MSRARKAGVNVPAVYFVD----PENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHH-HHHHHHCCCCCCeEEEEe----CCCC
Confidence            4699999999999987  6788999976421             123456666 455577887665555543    3457


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      +++|||++|++|.+.+...     .. ....++.+++.+|.+||+.|++|+|++|.||+++                   
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-------------------  129 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-------------------  129 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-------------------
Confidence            8999999999999988643     22 8889999999999999999999999999999996                   


Q ss_pred             ccccCCCCCCCCeeeeccccccc
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKK  191 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~  191 (372)
                               .+.++++|||.+..
T Consensus       130 ---------~~~~~liDf~~a~~  143 (211)
T PRK14879        130 ---------GGKIYLIDFGLAEF  143 (211)
T ss_pred             ---------CCCEEEEECCcccC
Confidence                     24578888887764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=9.9e-18  Score=145.28  Aligned_cols=125  Identities=20%  Similarity=0.224  Sum_probs=92.9

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecch-------------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDT-------------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +||+|++|+||+|..  +|..+++|+....             .+..+|++. +..+.|+++.....++..    ....+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~~~~i~~p~~~~~~----~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARL-LSRARKAGVNTPVVYDVD----PDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHH-HHHHHHCCCCCCEEEEEE----CCCCE
Confidence            489999999999984  5788999986421             223457766 444556654333222222    33468


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||++|++|.+.+....   .      .++.|++.+|.+||+.|++|||++|.||+++                    
T Consensus        74 lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~--------------------  124 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR--------------------  124 (199)
T ss_pred             EEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE--------------------
Confidence            9999999999998875421   1      7899999999999999999999999999996                    


Q ss_pred             cccCCCCCCCCeeeeccccccc
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKK  191 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~  191 (372)
                              .+.+++.|||++..
T Consensus       125 --------~~~~~liDfg~a~~  138 (199)
T TIGR03724       125 --------DDKLYLIDFGLGKY  138 (199)
T ss_pred             --------CCcEEEEECCCCcC
Confidence                    34588888888764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=6.8e-17  Score=160.58  Aligned_cols=131  Identities=18%  Similarity=0.220  Sum_probs=98.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEec-c------------hhhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-D------------TVKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~------------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..|.. .+.||+|+||+||+|.+...  .+++|+.. .            .....+|+.. +..++|++++....+... 
T Consensus       333 ~~~~~-~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~~~~i~~p~~~~~~-  407 (535)
T PRK09605        333 RRKIP-DHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARL-LSEARRAGVPTPVIYDVD-  407 (535)
T ss_pred             cccCc-cceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHH-HHhhcccCCCeeEEEEEe-
Confidence            33433 57899999999999987543  34444321 1            0123467776 566689998876655443 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         ....++||||++|++|.+++.          ....++.|++.+|.+||+.|++||||||+||+++            
T Consensus       408 ---~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~------------  462 (535)
T PRK09605        408 ---PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR------------  462 (535)
T ss_pred             ---CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE------------
Confidence               345689999999999998874          3467899999999999999999999999999994            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccc
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKK  191 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~  191 (372)
                                      ++.++|+|||+++.
T Consensus       463 ----------------~~~~~liDFGla~~  476 (535)
T PRK09605        463 ----------------DDRLYLIDFGLGKY  476 (535)
T ss_pred             ----------------CCcEEEEeCccccc
Confidence                            34688999998874

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.1e-16  Score=140.50  Aligned_cols=139  Identities=18%  Similarity=0.200  Sum_probs=99.6

Q ss_pred             ceeecccccc-ccCCeEEEEEEEcCCCcEEEEEEecch------------------hhhHHHHHHHHHhcCCCCE--eEE
Q psy3151          16 DYDISTEILG-LGINGKVLQIVEKKTSEVYALKVLHDT------------------VKARREVELQLAVGSHKHI--VNI   74 (372)
Q Consensus        16 ~Y~i~~~~lG-~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------~~~~~e~~~~~~~~~h~ni--~~~   74 (372)
                      .+.....+|| .|+.|+||.+...  +..++||.+...                  .+..+|++. +..+.|++|  +..
T Consensus        31 ~~~~~~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~l-l~~L~~~gi~vP~p  107 (239)
T PRK01723         31 FWQQQARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRL-LAQLYEAGLPVPRP  107 (239)
T ss_pred             HHhhcCceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHH-HHHHHhCCCCCcee
Confidence            3333345688 8999999998874  788999987421                  234567776 455567664  666


Q ss_pred             eEeeeeecCCceEEEEEEeccCC-CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          75 KDVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        75 ~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                      +.+...........++|||+++| .+|.+++..   ..+++..    +.||+.+|.+||+.||+||||||.|||++    
T Consensus       108 l~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~----  176 (239)
T PRK01723        108 IAARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD----  176 (239)
T ss_pred             EeeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc----
Confidence            66543211111123599999997 688888754   2366553    57899999999999999999999999998    


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccc
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK  191 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~  191 (372)
                                             .++.++|+|||.+..
T Consensus       177 -----------------------~~~~v~LIDfg~~~~  191 (239)
T PRK01723        177 -----------------------PDGKFWLIDFDRGEL  191 (239)
T ss_pred             -----------------------CCCCEEEEECCCccc
Confidence                                   445789999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.8e-16  Score=134.75  Aligned_cols=131  Identities=16%  Similarity=0.227  Sum_probs=90.3

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecchhhh-----------------------------HHHHHHHHHhcCC-CC
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA-----------------------------RREVELQLAVGSH-KH   70 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------------~~e~~~~~~~~~h-~n   70 (372)
                      .+.||+|+||+||+|.+. +|+.||||++......                             ..|...+..+..+ -.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            367999999999999986 8999999988632110                             1222222222111 12


Q ss_pred             EeEEeEeeeeecCCceEEEEEEeccCCCchhHH-HHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceee
Q psy3151          71 IVNIKDVYENIYNGSRCLLVIMECMHGGELFQR-IQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLY  148 (372)
Q Consensus        71 i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli  148 (372)
                      +...+.+        ...++||||++++++... +....   .. ..++.++.+++.++.++|+ .||+||||||+||++
T Consensus        81 ~~~~~~~--------~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili  148 (187)
T cd05119          81 VPKPIDL--------NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV  148 (187)
T ss_pred             CCceEec--------CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence            3333332        125899999998554322 21111   11 6788999999999999999 999999999999999


Q ss_pred             ecCCCCCceeeeccCCCCccccccCCCCCCCCeeeecccccccc
Q psy3151         149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI  192 (372)
Q Consensus       149 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~  192 (372)
                      +                            ++.++++|||.+...
T Consensus       149 ~----------------------------~~~~~liDfg~a~~~  164 (187)
T cd05119         149 D----------------------------DGKVYIIDVPQAVEI  164 (187)
T ss_pred             E----------------------------CCcEEEEECcccccc
Confidence            6                            345888899888654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601|consensus

Probab=99.68  E-value=9e-17  Score=153.27  Aligned_cols=253  Identities=26%  Similarity=0.294  Sum_probs=189.3

Q ss_pred             cccceeeccccccc--cCCeEEEEEEE--cCCCcEEEEEEec-------chhhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGL--GINGKVLQIVE--KKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~--G~~g~V~~~~~--~~~~~~vaiK~~~-------~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      +..++.+. +.+|.  |.+|.||.+..  ..+++.+|+|.-.       ......+|......+-.|+|.++.+..++. 
T Consensus       112 ~~~~~~~~-~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-  189 (524)
T KOG0601|consen  112 FDQRFPIS-SRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-  189 (524)
T ss_pred             hhhhcccc-cccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-
Confidence            45566664 66999  99999999988  8899999999743       223445677776777789999996666654 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS----AIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~----~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                         .+.+|+-+|++ +.+|.++...-. ..+++..++..+.+...    ||.++|+.+++|-|+||.||++..++     
T Consensus       190 ---~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-----  259 (524)
T KOG0601|consen  190 ---SGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-----  259 (524)
T ss_pred             ---CCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-----
Confidence               78899999999 568877776532 34899999999999999    99999999999999999999997321     


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCccc-----ccccCCCcCCCcccCCCCCCCccchhhHHHHH
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ-----TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM  232 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  232 (372)
                                           ..++++|||+...+....-...     ...|...|++||... +.++...|++++|.++
T Consensus       260 ---------------------~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~  317 (524)
T KOG0601|consen  260 ---------------------TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVI  317 (524)
T ss_pred             ---------------------ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhh
Confidence                                 5677777777766544332111     124566799999875 5688999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       233 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      .+-.++..++.......+     ..+..+  ..+.......+.++...+..|++.+|..|++++.++.|+++..
T Consensus       318 l~~~l~~~~~~~g~~~~W-----~~~r~~--~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  318 LEAILGSHLPSVGKNSSW-----SQLRQG--YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             HhhHhhcccccCCCCCCc-----cccccc--cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            999988777644311111     111111  1232333456778888999999999999999999999999864

>KOG0606|consensus

Probab=99.61  E-value=7.2e-16  Score=154.52  Aligned_cols=284  Identities=22%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHH----HHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARR----EVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      =.+.+.+. +-+-+|+++.++.+.-..+|...++|+......+..    .+........||+.......+.. ..-....
T Consensus       802 S~d~~~i~-~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-~~~rsP~  879 (1205)
T KOG0606|consen  802 SPDGFEIT-KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-FPCRSPL  879 (1205)
T ss_pred             CCccceec-ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-CCCCCCc
Confidence            34556664 468999999999999888898888887654333222    11111111122333333333322 1224568


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      +++++|+++++|...+++.  +..+++.++..+..+..++++||+..+.|||++|.|+++..   .+...+.+|++.+..
T Consensus       880 ~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~---~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY---DGHRPLTDFGTLSKV  954 (1205)
T ss_pred             chhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcc---cCCcccCcccccccc
Confidence            9999999999999999765  45888999999999999999999999999999999999984   445677788766554


Q ss_pred             ccccCCCCCCCCe---eeeccccccccccCC----CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         169 NLLYTKPGDGGIL---KLTDFGFAKKIVSNK----ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       169 ~~~~~~~~~~~~~---ki~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                      ..++.-.+..|..   -..+++.+.....-.    .......||+.|.+||.+.+..-...+|.|+.|+++++.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            4332221111111   111222222211111    112335689999999999998899999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChh---HHhcCCccccCC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID---QVMENKWISQFN  308 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~---eil~hp~~~~~~  308 (372)
                      |.....+.    +...+..+...+|.. ....+.++++++..+|..+|.+|..+.   ++-.|+||+...
T Consensus      1035 ~na~tpq~----~f~ni~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1035 FNAETPQQ----IFENILNRDIPWPEG-PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             CCCcchhh----hhhccccCCCCCCCC-ccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            96655443    345555555544432 246789999999999999999999987   889999998653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=5.3e-15  Score=121.50  Aligned_cols=128  Identities=25%  Similarity=0.375  Sum_probs=101.5

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh---hhHHHHHHHHHhcCC-CCEeEEeEeeeeecCCceEEEEEEeccCC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV---KARREVELQLAVGSH-KHIVNIKDVYENIYNGSRCLLVIMECMHG   97 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~e~~~~~~~~~h-~ni~~~~~~~~~~~~~~~~~~lv~e~~~~   97 (372)
                      +.||.|.++.||++....  ..+++|......   ...+|+..+..+..+ .++++++..+..    .+..+++|||+.+
T Consensus         4 ~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~----~~~~~~v~e~~~g   77 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES----DGWSYLLMEWIEG   77 (155)
T ss_pred             eecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC----CCccEEEEEecCC
Confidence            569999999999999853  789999986543   466788775555444 688888877654    4578999999988


Q ss_pred             CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          98 GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ---NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        98 g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~---~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      +++..+         +......++.+++.+|.+||..   +++|+|++|+||+++                         
T Consensus        78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-------------------------  123 (155)
T cd05120          78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-------------------------  123 (155)
T ss_pred             eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-------------------------
Confidence            766543         5566677889999999999985   799999999999998                         


Q ss_pred             CCCCCCeeeeccccccc
Q psy3151         175 PGDGGILKLTDFGFAKK  191 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~  191 (372)
                        ..+.+++.|||.+..
T Consensus       124 --~~~~~~l~Df~~~~~  138 (155)
T cd05120         124 --DGKILGIIDWEYAGY  138 (155)
T ss_pred             --CCcEEEEEecccccC
Confidence              456688999987763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601|consensus

Probab=99.51  E-value=1.6e-14  Score=138.02  Aligned_cols=246  Identities=22%  Similarity=0.236  Sum_probs=179.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEc-CCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEK-KTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ...++..+ ..||.|.|+.|+.+.-. .++..|++|.+..       ......|+.+...+..|.|+++....+..    
T Consensus       263 ~~~df~~v-~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~----  337 (524)
T KOG0601|consen  263 KLTDFGLV-SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ----  337 (524)
T ss_pred             ecCCccee-EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc----
Confidence            34556665 45999999999987755 7889999998752       23456777777778889999987776643    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ....|+--|||+++++...+.-.  ..+.+...+++..|++.++.++|+...+|+|+||+||++..              
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~--------------  401 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN--------------  401 (524)
T ss_pred             cccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc--------------
Confidence            45677999999999887766433  34899999999999999999999999999999999999974              


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcC--CCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV--APEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                  +.+..+++|||.+..+...   .....++.++.  +++......+..++|++|||..+.+..++...-
T Consensus       402 ------------~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  402 ------------DGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             ------------chhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence                        2256788888887643211   11111233333  555556667889999999999999999986543


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      .....       ...+..+..+..    ...+.++..+.+.++..++..|+++.++..|.-|.
T Consensus       467 ~~~~~-------~~~i~~~~~p~~----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  467 ESGVQ-------SLTIRSGDTPNL----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ccccc-------ceeeecccccCC----CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            22111       122333333222    23458888999999999999999999998887554

>KOG1266|consensus

Probab=99.50  E-value=2.6e-14  Score=126.81  Aligned_cols=206  Identities=16%  Similarity=0.192  Sum_probs=140.6

Q ss_pred             HhcCCCCEeEEeEeeeeecC-CceEEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC--Ccee
Q psy3151          64 AVGSHKHIVNIKDVYENIYN-GSRCLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQ--NIAH  138 (372)
Q Consensus        64 ~~~~h~ni~~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~--~ivH  138 (372)
                      -.+.|.||++++.++.+... +.....++.||+..|+|.+++++.  ....+....-++|..||+.||.|||+.  -|+|
T Consensus       122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih  201 (458)
T KOG1266|consen  122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH  201 (458)
T ss_pred             HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence            33469999999998865433 455678899999999999999862  224588888999999999999999987  5999


Q ss_pred             cCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeecccccc--cccc--CCCcccccccCCCcCCCccc
Q psy3151         139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK--KIVS--NKASLQTPCYTPYYVAPEVL  214 (372)
Q Consensus       139 rDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~--~~~~--~~~~~~~~~gt~~y~aPE~~  214 (372)
                      +++..+.|++.                           .+|-+||+--.-..  ....  .........+-++|.|||.-
T Consensus       202 gnlTc~tifiq---------------------------~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg  254 (458)
T KOG1266|consen  202 GNLTCDTIFIQ---------------------------HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG  254 (458)
T ss_pred             CCcchhheeec---------------------------CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC
Confidence            99999999998                           34445543211000  0000  00111123346789999987


Q ss_pred             CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC
Q psy3151         215 GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT  294 (372)
Q Consensus       215 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s  294 (372)
                      .....+-++|||++|....+|..+..--........   ....+....+...       ..--++++.+||+-.|..||+
T Consensus       255 ~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~---~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~  324 (458)
T KOG1266|consen  255 TTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVE---VEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPD  324 (458)
T ss_pred             cccccccchhhhhhhHHHHHHHHheeccCCCcceee---hhhhhhhheeecc-------CccccCcCcccccCCCCCCcc
Confidence            777788899999999999999887643211111100   1111111111111       122347899999999999999


Q ss_pred             hhHHhcCCcccc
Q psy3151         295 IDQVMENKWISQ  306 (372)
Q Consensus       295 ~~eil~hp~~~~  306 (372)
                      +.+++.||.+-+
T Consensus       325 ar~llfHpllfe  336 (458)
T KOG1266|consen  325 ARLLLFHPLLFE  336 (458)
T ss_pred             hhhhhcCceeee
Confidence            999999998644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.48  E-value=6.6e-13  Score=113.33  Aligned_cols=133  Identities=16%  Similarity=0.207  Sum_probs=96.0

Q ss_pred             ccccccCCeEEEEEEEcC------CCcEEEEEEecch-------------------------------hhhHHHHHHHHH
Q psy3151          22 EILGLGINGKVLQIVEKK------TSEVYALKVLHDT-------------------------------VKARREVELQLA   64 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~-------------------------------~~~~~e~~~~~~   64 (372)
                      ..||.|--+.||.|....      .+..+|||+....                               ..+.+|...+.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            469999999999998654      3589999987410                               012367776555


Q ss_pred             hcCC-CCEeEEeEeeeeecCCceEEEEEEeccCCCchhH-HHHhccCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCC
Q psy3151          65 VGSH-KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQ-RIQQKEDGAFTEREAAIIMNEICSAIKFL-HDQNIAHRDV  141 (372)
Q Consensus        65 ~~~h-~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~i~~~~~~~l~~~~~~~i~~qil~~l~~L-H~~~ivHrDl  141 (372)
                      +... -+++.++.+.        .-++||||+.+..+.. .+..   ..++++.+..+..|++.+|..| |..||||+||
T Consensus        83 l~~~Gv~vP~pi~~~--------~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVLK--------KHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEec--------CCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            4432 4566666542        2478999997654432 2222   2367777888899999999999 8999999999


Q ss_pred             CCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccc
Q psy3151         142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV  193 (372)
Q Consensus       142 kp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~  193 (372)
                      +|.||++.                            ++.+.++|||.|....
T Consensus       152 s~~NIL~~----------------------------~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH----------------------------DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE----------------------------CCcEEEEECCCceeCC
Confidence            99999996                            3458899999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=5.1e-13  Score=128.95  Aligned_cols=137  Identities=18%  Similarity=0.220  Sum_probs=91.3

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh---------------------------------------------hhH
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV---------------------------------------------KAR   56 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------------------------------~~~   56 (372)
                      +.||.|++|.||+|+.. +|+.||||+.+...                                             ...
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            46999999999999874 79999999974210                                             011


Q ss_pred             HHHHHHHH---hcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHH-HHHHHH
Q psy3151          57 REVELQLA---VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS-AIKFLH  132 (372)
Q Consensus        57 ~e~~~~~~---~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~-~l~~LH  132 (372)
                      +|...+.+   ...+.+-+.+-.++...   .+.-++||||++|++|.+....... ..+   ...++.+++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~---~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDR---TSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhh---cCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHH
Confidence            12222111   12222223333344321   2336899999999999887654221 122   3345556655 478899


Q ss_pred             HCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccc
Q psy3151         133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV  193 (372)
Q Consensus       133 ~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~  193 (372)
                      ..|++|+|+||.||+++                           .++.++++|||++....
T Consensus       275 ~~g~~H~D~hPgNilv~---------------------------~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVL---------------------------KDGKIIALDFGIVGRLS  308 (437)
T ss_pred             hCCceeCCCCcccEEEC---------------------------CCCcEEEEeCCCeeECC
Confidence            99999999999999997                           56779999999887653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243|consensus

Probab=99.43  E-value=2.5e-12  Score=124.36  Aligned_cols=182  Identities=20%  Similarity=0.290  Sum_probs=130.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhh----hHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK----ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      --|+|  +..+-++.+..-.|..+.++.++.|........    ..++....++.++||||+++++.++.    +..+|+
T Consensus        13 fpY~l--e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~----~~~~yl   86 (690)
T KOG1243|consen   13 FPYDL--EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE----EGTLYL   86 (690)
T ss_pred             CCccc--ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc----cCceEE
Confidence            34665  224444444333567778899999998864332    12333334888999999999999886    668999


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH-~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      |+|-+.  .|..++.+     ++...+...+.||+.||.+|| ..+++|++|.-+.|+|+                    
T Consensus        87 vTErV~--Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn--------------------  139 (690)
T KOG1243|consen   87 VTERVR--PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN--------------------  139 (690)
T ss_pred             Eeeccc--cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc--------------------
Confidence            999984  67777765     568888999999999999998 56899999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                             ..|.-||++|..+..............---.|..|+......  -..|.|.|||++++++.|
T Consensus       140 -------~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  140 -------ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -------CCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence                   677799999988765433221111111112366666543222  357999999999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=8e-13  Score=129.24  Aligned_cols=146  Identities=19%  Similarity=0.257  Sum_probs=94.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----------------------------------------
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----------------------------------------   53 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------------------------   53 (372)
                      ...|+.  +.||+|++|.|++|+.+.+|+.||||+.+...                                        
T Consensus       119 F~~fd~--~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        119 FDDFDI--KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHhcCh--hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            345665  56999999999999998889999999985210                                        


Q ss_pred             -----hhHHHHHHHH---HhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCC----CCCHHHHHHHH
Q psy3151          54 -----KARREVELQL---AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG----AFTEREAAIIM  121 (372)
Q Consensus        54 -----~~~~e~~~~~---~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~----~l~~~~~~~i~  121 (372)
                           ...+|.....   ....+.+.+.+-.+|.+.   .+..++||||+.|+++.+...-...+    .+.+..+..++
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~  273 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF  273 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence                 0112222111   112233444444444432   23468999999999997743211112    25555566666


Q ss_pred             HHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeecccccccccc
Q psy3151         122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS  194 (372)
Q Consensus       122 ~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~  194 (372)
                      .|++       ..|++|+|+||.||+++.++.                       ..+.+++.|||++..+..
T Consensus       274 ~Qif-------~~GffHaDpHPGNIlv~~~g~-----------------------~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVF-------RDGFFHADMHPGNIFVSYDPP-----------------------ENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------hCCeeeCCCChHHeEEecCCC-----------------------CCCeEEEEecceEEECCH
Confidence            6665       589999999999999984331                       234788889998876643

>KOG3741|consensus

Probab=99.41  E-value=1.3e-11  Score=116.20  Aligned_cols=231  Identities=16%  Similarity=0.239  Sum_probs=162.3

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+.+.+=|.+  +..+.-.-.+.|+|....+|..|++|.++-.     .+...=+++ ++.+.|+|||.+.++|....-+
T Consensus       272 v~~~~~L~pl--~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~-wkkl~h~NvV~frevf~t~tF~  348 (655)
T KOG3741|consen  272 VESFVNLYPL--ELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEA-WKKLCHTNVVPFREVFLTYTFG  348 (655)
T ss_pred             hhhhhceeec--ccccccccceeEeeeeccCCceeeeeeeccccccCcccchHHHHH-HHHhccCceeehhhhhhhhccC
Confidence            3334454544  3233224467899999999999999999522     122233343 7788999999999999855556


Q ss_pred             ceEEEEEEeccCC-CchhHHHHhc-------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeec
Q psy3151          85 SRCLLVIMECMHG-GELFQRIQQK-------------EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTK  150 (372)
Q Consensus        85 ~~~~~lv~e~~~~-g~L~~~i~~~-------------~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~  150 (372)
                      +..+++|++|.++ ++|.++--..             .+.+.+|..+|.++.||..||.++|+.|+.-+-|.|.+|+++ 
T Consensus       349 D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~-  427 (655)
T KOG3741|consen  349 DLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT-  427 (655)
T ss_pred             cceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee-
Confidence            7889999999986 5776654221             124588999999999999999999999999999999999998 


Q ss_pred             CCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHH
Q psy3151         151 PGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGV  230 (372)
Q Consensus       151 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  230 (372)
                                                .+.+++|...|+...+..++.              |.+   .-..+-|.=.||.
T Consensus       428 --------------------------G~~RIriS~C~i~Dvl~~d~~--------------~~l---e~~Qq~D~~~lG~  464 (655)
T KOG3741|consen  428 --------------------------GKMRIRISGCGIMDVLQEDPT--------------EPL---ESQQQNDLRDLGL  464 (655)
T ss_pred             --------------------------CcceEEEecccceeeecCCCC--------------cch---hHHhhhhHHHHHH
Confidence                                      455788888887766544320              111   1224678889999


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         231 IMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       231 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ++..|.||..--...+.  ........+.           ..+|.+++++|.-+...+++. -++.+++.+
T Consensus       465 ll~aLAt~~~ns~~~d~--~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  465 LLLALATGTENSNRTDS--TQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHhhcccccccccc--hHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            99999999543111110  0011112221           367999999999999988886 677788765

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=2.8e-12  Score=107.97  Aligned_cols=110  Identities=19%  Similarity=0.274  Sum_probs=78.3

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHG   97 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~   97 (372)
                      +.|+.|.++.||++...  ++.|++|+.....    ...+|...+..+.....+++++....      ..-++|||+++|
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~------~~~~lv~e~i~G   75 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP------ETGVLITEFIEG   75 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC------CCCeEEEEecCC
Confidence            45899999999999875  7889999975432    34567766444433323445554432      124789999999


Q ss_pred             CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCceeee
Q psy3151          98 GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI-----AHRDVKPENLLYT  149 (372)
Q Consensus        98 g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~i-----vHrDlkp~NIli~  149 (372)
                      .++.+.    .   .   ....++.+++.+|+.||+.++     +|+|++|.||+++
T Consensus        76 ~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~  122 (170)
T cd05151          76 SELLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD  122 (170)
T ss_pred             Cccccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE
Confidence            877543    0   1   123456799999999999985     9999999999997

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087|consensus

Probab=99.17  E-value=5.7e-10  Score=92.12  Aligned_cols=124  Identities=19%  Similarity=0.236  Sum_probs=85.0

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEec-c------------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLH-D------------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~------------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|-+|+-+.|+++...  |+...||.-. +            ..+..+|+..+.++.. -.|.-..-+|.+    ...-
T Consensus        13 ~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~-~GI~~P~l~~~D----~~~~   85 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRA-LGIPAPRLIFID----TYGG   85 (229)
T ss_pred             eeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHH-hCCCCceEEEEe----cCCC
Confidence            67889999999998875  8888888642 1            1234466666443322 233322223333    1223


Q ss_pred             EEEEeccCC-CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCC
Q psy3151          89 LVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus        89 ~lv~e~~~~-g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~  152 (372)
                      .++|||++| .++.+++...-......+....++.+|-..+.-||.++|+|+||..+||++.+++
T Consensus        86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~  150 (229)
T KOG3087|consen   86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG  150 (229)
T ss_pred             eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC
Confidence            577999966 4788888775433334444478889999999999999999999999999998644

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=3.1e-10  Score=94.04  Aligned_cols=126  Identities=19%  Similarity=0.278  Sum_probs=87.7

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEec-------------chhhhHHHHHHHHHhcC-CCCEeEEeEeeeeecCCceE
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLH-------------DTVKARREVELQLAVGS-HKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-------------~~~~~~~e~~~~~~~~~-h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ..+++|+-+.++.+...  |.++++|.=-             ...+..+|..++.+.-. --+++-++++.      ...
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD------~~~   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD------PDN   73 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc------CCC
Confidence            35889999999998653  5557777531             11244567766432211 12334444433      334


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      ..++|||++|..|.+.+...         ...++..+-.-+.-||..||+|+||.++||++.                  
T Consensus        74 ~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~------------------  126 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS------------------  126 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe------------------
Confidence            67899999998888888653         145667777788899999999999999999996                  


Q ss_pred             cccccCCCCCCCCeeeecccccccc
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKI  192 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~  192 (372)
                                .+.+.++|||++...
T Consensus       127 ----------~~~i~~IDfGLg~~s  141 (204)
T COG3642         127 ----------GGRIYFIDFGLGEFS  141 (204)
T ss_pred             ----------CCcEEEEECCccccc
Confidence                      344899999998743

>KOG2137|consensus

Probab=99.16  E-value=1.8e-11  Score=119.02  Aligned_cols=154  Identities=23%  Similarity=0.391  Sum_probs=108.8

Q ss_pred             HHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc---
Q psy3151         123 EICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---  198 (372)
Q Consensus       123 qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---  198 (372)
                      +++.|+.++|.. ++||+.|.|++|.++                           ..+..||+.|+.+....++...   
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n---------------------------a~~~wkl~Gf~f~v~~~~~~~~p~~  159 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVN---------------------------ANGDWKLAGFSFCVNANGPTEYPFS  159 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeec---------------------------cCcceeeccchhhhccCCCCccccc
Confidence            344899999965 999999999999998                           4455666666665443321110   


Q ss_pred             -----c-cccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHH-hCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCccc
Q psy3151         199 -----L-QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL-CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWE  271 (372)
Q Consensus       199 -----~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (372)
                           . ........|.|||++.....+.++|+||+||++|.+. .|+..+..................+.+.+.    .
T Consensus       160 ~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s----~  235 (700)
T KOG2137|consen  160 EYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS----N  235 (700)
T ss_pred             cCCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc----c
Confidence                 0 0011244699999998888889999999999999998 566666544333221111222222223333    3


Q ss_pred             ccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         272 HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       272 ~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .+++++++=+.+++..++..||++..++..|||.+.
T Consensus       236 ~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  236 NLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            688999999999999999999999999999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.12  E-value=6.2e-10  Score=94.69  Aligned_cols=121  Identities=22%  Similarity=0.266  Sum_probs=76.8

Q ss_pred             EEEEEEcCCCcEEEEEEecch-------------------------------hhhHHHHHHHHHhcCC-CCEeEEeEeee
Q psy3151          32 VLQIVEKKTSEVYALKVLHDT-------------------------------VKARREVELQLAVGSH-KHIVNIKDVYE   79 (372)
Q Consensus        32 V~~~~~~~~~~~vaiK~~~~~-------------------------------~~~~~e~~~~~~~~~h-~ni~~~~~~~~   79 (372)
                      ||.|.. .+|..+|||+....                               ..+.+|.+.+.++... -++++++.+..
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~   80 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR   80 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence            788887 46789999987410                               1234677775444333 25666665432


Q ss_pred             eecCCceEEEEEEeccC--CCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCceeeecCCCCCc
Q psy3151          80 NIYNGSRCLLVIMECMH--GGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF-LHDQNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~--~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~-LH~~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                              -++||||+.  |..+..+....    ++.+....++.+++..+.. +|..||+|+||.+.||+++       
T Consensus        81 --------~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~-------  141 (188)
T PF01163_consen   81 --------NVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD-------  141 (188)
T ss_dssp             --------TEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE-------
T ss_pred             --------CEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee-------
Confidence                    269999998  65555443321    3356677788888885555 5799999999999999997       


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccc
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV  193 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~  193 (372)
                                           .+.+.|+|||.+....
T Consensus       142 ---------------------~~~~~iIDf~qav~~~  157 (188)
T PF01163_consen  142 ---------------------DGKVYIIDFGQAVDSS  157 (188)
T ss_dssp             ---------------------TTCEEE--GTTEEETT
T ss_pred             ---------------------cceEEEEecCcceecC
Confidence                                 2379999999887653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=2e-09  Score=97.03  Aligned_cols=126  Identities=17%  Similarity=0.131  Sum_probs=84.2

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh----------------hhHHHHHHHHHhcCCCCE--eEEeEeeeeecC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV----------------KARREVELQLAVGSHKHI--VNIKDVYENIYN   83 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~e~~~~~~~~~h~ni--~~~~~~~~~~~~   83 (372)
                      +++-......|+++..  .|+.|.||......                .+.+|...+.++.. .+|  +.++.+++....
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~-~GIptP~pVa~~e~~~~  104 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHE-VGVDTMTGVAFGERGSN  104 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHH-cCCCCCCeeEEEEecCC
Confidence            4444444445666543  57889999763211                35677776444422 232  233334432111


Q ss_pred             C-ceEEEEEEeccCCC-chhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeec
Q psy3151          84 G-SRCLLVIMECMHGG-ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTK  150 (372)
Q Consensus        84 ~-~~~~~lv~e~~~~g-~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~  150 (372)
                      . ...-++|+|++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++.
T Consensus       105 ~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~  173 (268)
T PRK15123        105 PATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHL  173 (268)
T ss_pred             CccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEec
Confidence            1 23468999999875 7888886432234677888899999999999999999999999999999974

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.10  E-value=5.6e-09  Score=96.44  Aligned_cols=246  Identities=16%  Similarity=0.189  Sum_probs=149.1

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecchhh--hHHHHHHHHHhcCCCCEeEEeEeee---eecCCceEEEEEEecc
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK--ARREVELQLAVGSHKHIVNIKDVYE---NIYNGSRCLLVIMECM   95 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~e~~~~~~~~~h~ni~~~~~~~~---~~~~~~~~~~lv~e~~   95 (372)
                      +.-||+|+-+.+|-.-.-  +. -+.|+++...-  ..+..+.+...-.||-+..-+-+=.   ....++..+-+.|..+
T Consensus        16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v   92 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV   92 (637)
T ss_pred             CccccCCccceeeecchh--hc-hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence            456999999999854322  22 24588864322  1222333334445554432111110   0112334477888888


Q ss_pred             CCCch-hHHHH----hccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          96 HGGEL-FQRIQ----QKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        96 ~~g~L-~~~i~----~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      .|..- ..+..    ++.-....+..+.+..+.|+.+.+.||..|.+-+|++++|+|++   |...|.++|-+.      
T Consensus        93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsDs------  163 (637)
T COG4248          93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSDS------  163 (637)
T ss_pred             CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcccc------
Confidence            76422 11111    12223477899999999999999999999999999999999998   334455544222      


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhC-CCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCG-FPPFFS  244 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g-~~pf~~  244 (372)
                                +.|+         .+.....+.+|.+.|.+||.-.     +-.-+...|.|.||+++|+++.| ++||.+
T Consensus       164 ----------fqi~---------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         164 ----------FQIN---------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             ----------eeec---------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence                      1222         2233345567888899999743     33455789999999999999886 999976


Q ss_pred             CCCCCCCHh-HHHHHhhCCccC----------CC--CcccccCHHHHHHHHHhccC--CCCCCCChhH
Q psy3151         245 NHGQAISPG-MKNRIRLGQFDF----------PN--PEWEHVSQEAKTLIKNMLCV--DPSERLTIDQ  297 (372)
Q Consensus       245 ~~~~~~~~~-~~~~~~~~~~~~----------~~--~~~~~~s~~~~~li~~ll~~--dP~~R~s~~e  297 (372)
                      -........ ....|..+.|.+          ++  ..|.-++++++-|..+|+..  ++.-|||++-
T Consensus       225 I~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         225 IPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             ccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            432211111 111222222211          11  22456789999999999986  4668999653

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.07  E-value=1e-09  Score=96.37  Aligned_cols=107  Identities=14%  Similarity=0.145  Sum_probs=73.2

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcC-CCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGS-HKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~-h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      +.||.|..+.||++... +|+.+++|+....      ....+|.+.+..+.. +.++++++.+..... .....++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-VLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-ccCCceEEEEE
Confidence            45899999999999874 3688999987642      345677777444333 234566666544211 01356899999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD  133 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~  133 (372)
                      ++|.++.+.+..   ..++++....++.+++.+|..||+
T Consensus        82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~  117 (223)
T cd05154          82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALHS  117 (223)
T ss_pred             eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            999888775532   237777888888888888888883

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=2.5e-08  Score=86.79  Aligned_cols=97  Identities=23%  Similarity=0.254  Sum_probs=69.8

Q ss_pred             hhHHHHHHHHHhcC-CCCEeEEeEeeeeecCCceEEEEEEeccCC-CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy3151          54 KARREVELQLAVGS-HKHIVNIKDVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL  131 (372)
Q Consensus        54 ~~~~e~~~~~~~~~-h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~L  131 (372)
                      ++.+|...+..+.. .=.++..+.+.+.........++|+|++++ .+|.+++.....  .+......++.+++..+.-|
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHH
Confidence            56677776444432 122344444444322223456899999987 479998876432  67888899999999999999


Q ss_pred             HHCCceecCCCCCceeeecCC
Q psy3151         132 HDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus       132 H~~~ivHrDlkp~NIli~~~~  152 (372)
                      |..||+|+|++|.|||++.++
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~  155 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDD  155 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCC
Confidence            999999999999999998543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.87  E-value=1.7e-08  Score=88.70  Aligned_cols=130  Identities=21%  Similarity=0.254  Sum_probs=97.0

Q ss_pred             ccccccccCCeEEEEEEEcCCCcEEEEEEecc---------------------------hhhhHHHHHHHHHhcCC-CCE
Q psy3151          20 STEILGLGINGKVLQIVEKKTSEVYALKVLHD---------------------------TVKARREVELQLAVGSH-KHI   71 (372)
Q Consensus        20 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---------------------------~~~~~~e~~~~~~~~~h-~ni   71 (372)
                      ++..||-|--|.||.|.+. .|.++|||.=+.                           ...+.+|.+++.++-.+ -.|
T Consensus        95 iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4678999999999999986 688999996320                           12356788886666443 356


Q ss_pred             eEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecC
Q psy3151          72 VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP  151 (372)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~  151 (372)
                      ++.++.        +.-.+|||+++|-.|...-       ++.+.+..++..|+.-+..+-..||||+|+.+-||+++  
T Consensus       174 P~P~~~--------nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~--  236 (304)
T COG0478         174 PKPIAW--------NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT--  236 (304)
T ss_pred             CCcccc--------ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe--
Confidence            665553        3457899999886664321       34666777777788888777799999999999999998  


Q ss_pred             CCCCceeeeccCCCCccccccCCCCCCCCeeeecccccccc
Q psy3151         152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI  192 (372)
Q Consensus       152 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~  192 (372)
                                               ++|.+.++||-.+...
T Consensus       237 -------------------------~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         237 -------------------------EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             -------------------------cCCCEEEEeCcccccC
Confidence                                     5677999999776543

>KOG0576|consensus

Probab=98.84  E-value=6.8e-10  Score=107.18  Aligned_cols=256  Identities=20%  Similarity=0.171  Sum_probs=174.0

Q ss_pred             CccCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCC-EeEEeEeeeee
Q psy3151           3 PTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKH-IVNIKDVYENI   81 (372)
Q Consensus         3 ~~~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~n-i~~~~~~~~~~   81 (372)
                      +.|.|.....-..-|....+ +++|+++++++.+...+...+ .+.+......+-+++. +...+||| .+..++-+   
T Consensus       230 S~~qpp~lkDk~kws~~fh~-fvK~altknpKkRptaeklL~-h~fvs~~l~~rl~~eL-LdK~n~P~~~v~~~~d~---  303 (829)
T KOG0576|consen  230 SGFQPPTLKDKTKWSEFFHN-FVKGALTKNPKKRPTAEKLLQ-HPFVSQTLSRRLAIEL-LDKVNNPNPVVRYLEDY---  303 (829)
T ss_pred             cCCCCCcccCCccchHHHHH-HHHHHhcCCCccCCChhhhee-ceeeccchhhHHHHHH-HHHccCCCCcccccccC---
Confidence            56777777766666776544 899999999999988776665 7877666555556665 77779999 44444433   


Q ss_pred             cCCceEEEEEEeccCCC-chhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          82 YNGSRCLLVIMECMHGG-ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g-~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                       ..+.+..++++++.++ +....+.... -.+.+-+...+.+.-.++++++|+.-=+|||    ||+.+           
T Consensus       304 -~~E~~~~i~~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-----------  366 (829)
T KOG0576|consen  304 -DGEDYLWIPMRICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-----------  366 (829)
T ss_pred             -CcccccchhhhhhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-----------
Confidence             3477899999999776 2211111000 1133344455666777889999998778998    88875           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                       .+..+..||+.+..+.... ..++..+|+.++|||+.....+....|.|++|.--.+|.-|.+
T Consensus       367 -----------------~~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~p  428 (829)
T KOG0576|consen  367 -----------------EEEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLP  428 (829)
T ss_pred             -----------------ccccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCC
Confidence                             4568899999887765432 4566788999999999999999999999999998888888877


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCC--ccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQ--FDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |-........      .+..+.  ..+.. ..|..  .+-.++...|+..-|..|+....++.|.+|.+.
T Consensus       429 Pr~~P~~~~~------~~g~~p~s~~L~~~~aw~~--~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  429 PRSSPPAVLP------MIGNGPNSPMLTDKSAWSP--VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             CCCCCccccC------CCCCCCCccccchhhhcCc--ccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            7543211100      000000  00000 11111  111257788999999999999999999999875

>PRK09902 hypothetical protein; Provisional

Probab=98.71  E-value=7.4e-07  Score=76.55  Aligned_cols=122  Identities=15%  Similarity=0.116  Sum_probs=85.8

Q ss_pred             cccCCeEEEEEEEcCCCcEEEEEEecc-----------hhhhHHHHHHHHHhcCC-CCEeEEeEeeee-ecCCceEEEEE
Q psy3151          25 GLGINGKVLQIVEKKTSEVYALKVLHD-----------TVKARREVELQLAVGSH-KHIVNIKDVYEN-IYNGSRCLLVI   91 (372)
Q Consensus        25 G~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~e~~~~~~~~~h-~ni~~~~~~~~~-~~~~~~~~~lv   91 (372)
                      |.||-|-|+.....  |+.+-+|.-..           .....+|...+..+... -.++.++ ++.. .....-..+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            56899999987653  55688887541           13456788775444321 1244444 3321 11223456889


Q ss_pred             EeccCC-CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeee
Q psy3151          92 MECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYT  149 (372)
Q Consensus        92 ~e~~~~-g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~  149 (372)
                      +|-+.| .+|.+++......+.++.....++.+++.++.-||+.|+.|+|+-+.||+++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~  162 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVK  162 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeec
Confidence            997754 6888888765434568888899999999999999999999999999999997

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.57  E-value=6.4e-07  Score=78.13  Aligned_cols=140  Identities=18%  Similarity=0.189  Sum_probs=93.1

Q ss_pred             cccceeecccc---ccccCCeEEEEEEEcCCCcEEEEEEecch-----------------------------hhhHHHHH
Q psy3151          13 IQDDYDISTEI---LGLGINGKVLQIVEKKTSEVYALKVLHDT-----------------------------VKARREVE   60 (372)
Q Consensus        13 ~~~~Y~i~~~~---lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~e~~   60 (372)
                      +..++.| .++   |.+|--+.||+|.. .++..+|+|++...                             ....+|..
T Consensus        43 L~~rg~i-~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~  120 (268)
T COG1718          43 LLSRGVI-TELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFR  120 (268)
T ss_pred             HhcCCce-eeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHH
Confidence            3444444 343   55666777999887 46899999998521                             11234555


Q ss_pred             HHHHhc-CCCCEeEEeEeeeeecCCceEEEEEEeccCCCch-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q psy3151          61 LQLAVG-SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGEL-FQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIA  137 (372)
Q Consensus        61 ~~~~~~-~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L-~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~iv  137 (372)
                      .+.++. .+=.+++.+.++.        -.+||||+..... .-.+..   -.+..+++..+..+++..+.-|-. .|+|
T Consensus       121 NL~R~~eAGVrvP~Pi~~~~--------nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LV  189 (268)
T COG1718         121 NLKRAYEAGVRVPEPIAFRN--------NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLV  189 (268)
T ss_pred             HHHHHHHcCCCCCCceeecC--------CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcc
Confidence            543332 2344556565543        3789999954311 111111   224455788899999999999887 8999


Q ss_pred             ecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccc
Q psy3151         138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV  193 (372)
Q Consensus       138 HrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~  193 (372)
                      |+||..-|||+.                            .+.+.|+|||.|....
T Consensus       190 HgDLSEyNiL~~----------------------------~~~p~iID~~QaV~~~  217 (268)
T COG1718         190 HGDLSEYNILVH----------------------------DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccchhhheEEE----------------------------CCeEEEEECccccccC
Confidence            999999999995                            4568999999887653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.48  E-value=3.1e-06  Score=73.05  Aligned_cols=124  Identities=21%  Similarity=0.272  Sum_probs=72.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhh--------------hHHHHHHHHHhc--CCCCEeEEeE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK--------------ARREVELQLAVG--SHKHIVNIKD   76 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~e~~~~~~~~--~h~ni~~~~~   76 (372)
                      +.++|.++ +++-......|.+-.  .+|+.+++|..+...+              +.+.+....++.  ..-..+.++-
T Consensus        29 ~~~~~~~~-kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   29 LDNNYKII-KVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HhCCceEE-EeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            45667763 556665555555443  4688999998853211              122222222221  1112222222


Q ss_pred             eeeee-cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeee
Q psy3151          77 VYENI-YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYT  149 (372)
Q Consensus        77 ~~~~~-~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~  149 (372)
                      +.+-. ..-....+++|||++|..|.+...      +++.    +...|..++.-||..|++|+|..|.|++++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~  169 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVS  169 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEE
Confidence            22111 111234568999999988866532      3432    445677789999999999999999999997

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=8.8e-07  Score=86.58  Aligned_cols=138  Identities=22%  Similarity=0.272  Sum_probs=86.4

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch---------------------------------------------hhhH
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT---------------------------------------------VKAR   56 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------------------------------------------~~~~   56 (372)
                      +-|+.++-|.|++|+.. +|+.||||+.+-.                                             -..+
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            56899999999999986 4999999997410                                             0012


Q ss_pred             HHHHHHHHh---c-CCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy3151          57 REVELQLAV---G-SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH  132 (372)
Q Consensus        57 ~e~~~~~~~---~-~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH  132 (372)
                      +|...+.+.   . +.+++ .+-.+|.+.   .+.-+++|||++|..+.+...... ..++...+.....++.  +..+=
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~---t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~  282 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEY---TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLL  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-Eeceeehhc---cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHH
Confidence            233222111   1 23443 333444321   234689999999999988743322 2355433333222221  23333


Q ss_pred             HCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeecccccccccc
Q psy3151         133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS  194 (372)
Q Consensus       133 ~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~  194 (372)
                      ..|.+|.|.+|.||+++                           .++.+.+.|||+...+..
T Consensus       283 ~dgffHaDpHpGNi~v~---------------------------~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 RDGFFHADPHPGNILVR---------------------------SDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             hcCccccCCCccceEEe---------------------------cCCcEEEEcCcceecCCH
Confidence            48999999999999998                           556788888888776543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.33  E-value=9e-06  Score=71.71  Aligned_cols=69  Identities=23%  Similarity=0.200  Sum_probs=44.9

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecc---hhhhHHHHHHHHHhcCC-CCEeEEeEeeeeecCCceEEEEEEeccCCC
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGSH-KHIVNIKDVYENIYNGSRCLLVIMECMHGG   98 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h-~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g   98 (372)
                      .||.|..+.||+.    .|..+++|....   .....+|.+.+..+... -.+.+.+.+.+.    ++...+|||+++|.
T Consensus         8 ~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~----~~~~glv~e~i~G~   79 (226)
T TIGR02172         8 QTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVED----GGRLGLIYELIVGK   79 (226)
T ss_pred             eecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEec----CCeeeeeeeecCCc
Confidence            4899999999983    255678998864   23456777775444322 123455555433    44567899999886


Q ss_pred             c
Q psy3151          99 E   99 (372)
Q Consensus        99 ~   99 (372)
                      +
T Consensus        80 ~   80 (226)
T TIGR02172        80 R   80 (226)
T ss_pred             c
Confidence            3

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.33  E-value=9e-06  Score=71.63  Aligned_cols=78  Identities=18%  Similarity=0.239  Sum_probs=51.5

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCC-CCEeEEeEeeeeecCCceEEEEEEeccCC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSH-KHIVNIKDVYENIYNGSRCLLVIMECMHG   97 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h-~ni~~~~~~~~~~~~~~~~~~lv~e~~~~   97 (372)
                      +.|+.|..+.||++....  ..+++|.....   ....+|...+..+..+ ..+..++..... .......+++|++++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~-~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTS-DEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE-TEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeeccc-ccccccceEEEEEecc
Confidence            458999999999999864  48999998765   4556677665444333 235566553321 1223457999999998


Q ss_pred             CchhH
Q psy3151          98 GELFQ  102 (372)
Q Consensus        98 g~L~~  102 (372)
                      ..+..
T Consensus        80 ~~~~~   84 (239)
T PF01636_consen   80 RPLDD   84 (239)
T ss_dssp             EEHHH
T ss_pred             ccccc
Confidence            87766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1035|consensus

Probab=98.29  E-value=1.6e-06  Score=89.63  Aligned_cols=200  Identities=18%  Similarity=0.192  Sum_probs=131.3

Q ss_pred             HHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy3151          63 LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK  142 (372)
Q Consensus        63 ~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlk  142 (372)
                      +....|+|++.++.+-......+-.+.+..++|..-++...++..  +.++.+.++.+..++++||+|+|+....|.-|.
T Consensus       236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~  313 (1351)
T KOG1035|consen  236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLSLEHVVLS  313 (1351)
T ss_pred             HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhccceeEEe
Confidence            566789999998877542211122344556888888888888775  458999999999999999999999844443332


Q ss_pred             CCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeee--ccccccccccCCCcccccccCCCcCCCcccCCCCCC
Q psy3151         143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT--DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD  220 (372)
Q Consensus       143 p~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~--Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  220 (372)
                      .+-..-.                        .....+.+.++  ||+.+........... ..-+..+.|||......+.
T Consensus       314 ~s~~~~~------------------------~~~~e~~~~~sl~~~~ss~~l~d~~~~~~-~~~~~~~~~~e~~~~~~~~  368 (1351)
T KOG1035|consen  314 ASSSKES------------------------TVDGEGVVAISLSDFDSSKPLPDNEKSFS-DLLAEIRNADEDLKENTAK  368 (1351)
T ss_pred             ccccccc------------------------ccCccceeecchhhhcccccCCCcccchh-hcCccccccccccccccch
Confidence            2211110                        00144556666  8887776644332222 2225568889988766665


Q ss_pred             C--ccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         221 K--SCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       221 ~--~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      .  ..|+|.+|..+..+..|..+-...       .....+.      +    .....+..+++.+|+.-++++|+++.++
T Consensus       369 ~~r~~dL~~lgll~~~~~~~~~i~~~~-------~~~~~~l------~----~~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  369 KSRLTDLWCLGLLLLQLSQGEDISEKS-------AVPVSLL------D----VLSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             hhhhhHHHHHHHHHhhhhhcCcccccc-------cchhhhh------c----cccchhhhhhhhhhcchhhhhccchhhh
Confidence            4  479999999999998875442100       0000000      0    0111267889999999999999999999


Q ss_pred             hcCCcccc
Q psy3151         299 MENKWISQ  306 (372)
Q Consensus       299 l~hp~~~~  306 (372)
                      +.|+|.+-
T Consensus       432 l~~~f~~~  439 (1351)
T KOG1035|consen  432 LTHPFLRF  439 (1351)
T ss_pred             hhchhccc
Confidence            99999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.14  E-value=2.9e-05  Score=69.28  Aligned_cols=73  Identities=14%  Similarity=0.095  Sum_probs=48.2

Q ss_pred             ccccCC-eEEEEEEEcCCCcEEEEEEecch--hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCch
Q psy3151          24 LGLGIN-GKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGEL  100 (372)
Q Consensus        24 lG~G~~-g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  100 (372)
                      |-.|.. +.||++...  +..+.+|+....  ....+|++.+..+..+--+++++.+...    +...++|||+++|.+|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD----DGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec----CCccEEEEEeeCCccH
Confidence            444555 889998753  467889988644  3566788775555444445566665543    2457889999998776


Q ss_pred             hH
Q psy3151         101 FQ  102 (372)
Q Consensus       101 ~~  102 (372)
                      ..
T Consensus        80 ~~   81 (244)
T cd05150          80 AA   81 (244)
T ss_pred             hH
Confidence            53

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235|consensus

Probab=98.11  E-value=3.4e-05  Score=75.43  Aligned_cols=153  Identities=19%  Similarity=0.187  Sum_probs=93.4

Q ss_pred             CCcccceeec-cccccccCCeEEEEEEEcCCCcEEEEEEecchh------------------------------------
Q psy3151          11 TPIQDDYDIS-TEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------------------------------------   53 (372)
Q Consensus        11 ~~~~~~Y~i~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------------   53 (372)
                      .|+.+-|.-. .+.||.-+.|.|++|+.+. |+.||||+=+...                                    
T Consensus       155 ~~ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~  233 (538)
T KOG1235|consen  155 APIEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAK  233 (538)
T ss_pred             CCHHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHh
Confidence            3444545443 3679999999999999975 9999999864110                                    


Q ss_pred             ------hhHHHHHHH---HHhcCCCC---EeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHH
Q psy3151          54 ------KARREVELQ---LAVGSHKH---IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM  121 (372)
Q Consensus        54 ------~~~~e~~~~---~~~~~h~n---i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~  121 (372)
                            ...+|.+..   .+...|-+   -+.+-.+|.+.   ...-+++||||+|..+.+.-.-.+ ..++...+..-+
T Consensus       234 ~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l  309 (538)
T KOG1235|consen  234 SLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKL  309 (538)
T ss_pred             hhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHH
Confidence                  011222111   22233444   22233344321   335789999999987755432222 236766554443


Q ss_pred             HHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccc
Q psy3151         122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV  193 (372)
Q Consensus       122 ~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~  193 (372)
                      .+..  ++-|=..|.+|.|-+|.||++..+++                       .++.+.+.|||+...+.
T Consensus       310 ~~~~--~~qIf~~GffHaDPHPGNilv~~~~~-----------------------~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  310 VEAY--LEQIFKTGFFHADPHPGNILVRPNPE-----------------------GDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHH--HHHHHhcCCccCCCCCCcEEEecCCC-----------------------CCccEEEEccccccccc
Confidence            3322  22233578999999999999985432                       46778889999887654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.91  E-value=0.00046  Score=59.34  Aligned_cols=118  Identities=19%  Similarity=0.306  Sum_probs=81.1

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch---------------------hhhHHHHHHHHHhc-----CCCCEeEEe
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT---------------------VKARREVELQLAVG-----SHKHIVNIK   75 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------------------~~~~~e~~~~~~~~-----~h~ni~~~~   75 (372)
                      ..||+|+.-.||.  |. ......||+....                     ....+|+..+..+.     .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            5699999999996  43 3444678988532                     23455665543332     477899999


Q ss_pred             EeeeeecCCceEEEEEEeccCC------CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeee
Q psy3151          76 DVYENIYNGSRCLLVIMECMHG------GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYT  149 (372)
Q Consensus        76 ~~~~~~~~~~~~~~lv~e~~~~------g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~  149 (372)
                      ++.++    +.-+-+|+|.+.+      -+|.+++.+.   .+++ .+...   +-.-.+||-+.+|+.+|++|.||++.
T Consensus        84 G~veT----~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVET----NLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEec----CCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEE
Confidence            99886    4456777877642      3677777543   3666 44443   44456788899999999999999998


Q ss_pred             cCCC
Q psy3151         150 KPGD  153 (372)
Q Consensus       150 ~~~~  153 (372)
                      ..++
T Consensus       153 ~~~~  156 (199)
T PF10707_consen  153 RRDS  156 (199)
T ss_pred             ecCC
Confidence            6554

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.87  E-value=0.00041  Score=59.30  Aligned_cols=115  Identities=23%  Similarity=0.305  Sum_probs=76.4

Q ss_pred             cceeeccccccccCC-eEEEEEEEcCCCcEEEEEEecc-----h-----hh----------------hHHHHHHH--HHh
Q psy3151          15 DDYDISTEILGLGIN-GKVLQIVEKKTSEVYALKVLHD-----T-----VK----------------ARREVELQ--LAV   65 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~-g~V~~~~~~~~~~~vaiK~~~~-----~-----~~----------------~~~e~~~~--~~~   65 (372)
                      ..++.+ +.||.|.. |.||++.-  +|+.||+|++..     .     ..                ...|-+..  ++.
T Consensus        37 ~~I~fl-efLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   37 DDIEFL-EFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CcEeee-eecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            577776 77999999 99999986  488999999421     0     00                11233332  334


Q ss_pred             cCCCCE--eEEeEeeeeec--------------CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy3151          66 GSHKHI--VNIKDVYENIY--------------NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK  129 (372)
Q Consensus        66 ~~h~ni--~~~~~~~~~~~--------------~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~  129 (372)
                      ..+.++  +++++++.-..              .......||.||.....           .++...    +.+|++-+.
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHH
Confidence            455566  88888874221              11223467888775532           133333    456777788


Q ss_pred             HHHHCCceecCCCCCcee
Q psy3151         130 FLHDQNIAHRDVKPENLL  147 (372)
Q Consensus       130 ~LH~~~ivHrDlkp~NIl  147 (372)
                      .+|..||+-+|+++.|..
T Consensus       179 ~~~k~gI~~~Dv~~~ny~  196 (207)
T PF13095_consen  179 ILHKLGIVPRDVKPRNYR  196 (207)
T ss_pred             HHHHCCeeeccCcccccc
Confidence            999999999999999987

>PLN02876 acyl-CoA dehydrogenase

Probab=97.83  E-value=0.00017  Score=75.80  Aligned_cols=77  Identities=17%  Similarity=0.229  Sum_probs=50.3

Q ss_pred             ccccccCCeEEEEEEEcCCC--cEEEEEEecc------hhhhHHHHHHHHHhcCCCCE--eEEeEeeeeecCCceEEEEE
Q psy3151          22 EILGLGINGKVLQIVEKKTS--EVYALKVLHD------TVKARREVELQLAVGSHKHI--VNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~--~~vaiK~~~~------~~~~~~e~~~~~~~~~h~ni--~~~~~~~~~~~~~~~~~~lv   91 (372)
                      +.++.|.++.+|+......+  ..+++|+...      .....+|...+..+..|.++  ++++.++.+... ....|+|
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v-~G~~flV  122 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV-IGTAFYI  122 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc-CCCceEE
Confidence            44899999999998765432  4678887632      23466888885555446665  666665543211 2346899


Q ss_pred             EeccCCCc
Q psy3151          92 MECMHGGE   99 (372)
Q Consensus        92 ~e~~~~g~   99 (372)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.75  E-value=0.00027  Score=58.74  Aligned_cols=123  Identities=19%  Similarity=0.145  Sum_probs=80.3

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeE-EeEeeeeecCCceEEEEEEeccC
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVN-IKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~-~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      .+.||+|++|.||+|...  |..+|+|+-+..   .....|.++ +.++.-.++.. ++.+-+        ..+.|||+.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEaki-Leil~g~~~~p~vy~yg~--------~~i~me~i~   95 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKI-LEILAGEGVTPEVYFYGE--------DFIRMEYID   95 (201)
T ss_pred             hhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHH-HHHhhhcCCCceEEEech--------hhhhhhhhc
Confidence            356999999999999975  678999976532   234567766 45555555543 333322        245599998


Q ss_pred             CCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-C-CceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          97 GGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK-P-ENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        97 ~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlk-p-~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      |-.|.+.-..     .+..    -+..++..-.-|-..||-|..|. | .||++.                         
T Consensus        96 G~~L~~~~~~-----~~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-------------------------  141 (201)
T COG2112          96 GRPLGKLEIG-----GDRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-------------------------  141 (201)
T ss_pred             Ccchhhhhhc-----ccHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEec-------------------------
Confidence            8777665421     1222    33445666666778899999886 3 455553                         


Q ss_pred             CCCCCCeeeeccccccc
Q psy3151         175 PGDGGILKLTDFGFAKK  191 (372)
Q Consensus       175 ~~~~~~~ki~Dfg~a~~  191 (372)
                         ++.+.|+||..|+.
T Consensus       142 ---~~~~~iIDFd~At~  155 (201)
T COG2112         142 ---DRDVYIIDFDSATF  155 (201)
T ss_pred             ---CCcEEEEEccchhh
Confidence               34688999988764

>KOG1826|consensus

Probab=97.69  E-value=1.8e-06  Score=91.23  Aligned_cols=202  Identities=15%  Similarity=0.058  Sum_probs=132.7

Q ss_pred             cCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-----Ccee
Q psy3151          66 GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQ-----NIAH  138 (372)
Q Consensus        66 ~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~-----~ivH  138 (372)
                      ..|+++.....-..  .......|.+++|+.+|.+.+.|.+.  +...+.+..+.....+.+.+..-+|++     -.+|
T Consensus      1286 ~~h~~~~~~p~rI~--ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~ 1363 (2724)
T KOG1826|consen 1286 AKHYLTEVDPLRIP--PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVS 1363 (2724)
T ss_pred             hhceeeecccccCC--CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchh
Confidence            46887776444332  23345678999999999999998763  223455555555555658888888865     2699


Q ss_pred             cCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC
Q psy3151         139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK  218 (372)
Q Consensus       139 rDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  218 (372)
                      ++||+.|.+|.                           .+..++++++|+.+.............+++.|++|++...-.
T Consensus      1364 ~~Lkf~lpmIV---------------------------tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik 1416 (2724)
T KOG1826|consen 1364 KSLKFTLPMIV---------------------------TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK 1416 (2724)
T ss_pred             hhhhhhcccee---------------------------cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh
Confidence            99999999998                           567799999999984433334445566788899999988888


Q ss_pred             CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCc-cCCCCcccccCHHHHHHHHHhccCCCCCCCChhH
Q psy3151         219 YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQF-DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQ  297 (372)
Q Consensus       219 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~e  297 (372)
                      ++.++|+|..|+-+|....|..+|-..    ....+...+..+.+ ..+    ...+.++-.....+|-+.-..||.-..
T Consensus      1417 ~t~rsdilr~s~~ly~rs~~n~~fi~f----lq~~Lkgiidn~tf~sIe----~l~pgdaNve~~~~Ll~K~~~rp~q~i 1488 (2724)
T KOG1826|consen 1417 FTKRSDILRRSLSLYLRSDGNAYFIFF----LQPALKGIIDNHTFFSIE----KLKPGDANVEALHRLLWKYMERPGQYI 1488 (2724)
T ss_pred             hhhHHHHHHHHHHHHHHhcccHHHHHH----HHHHHcCccccccccccc----ccCCCcccHHHHHHHHHHhhhcchhhh
Confidence            988899999999999999888877211    00111111111111 111    122333333444444455567787777


Q ss_pred             HhcCCcc
Q psy3151         298 VMENKWI  304 (372)
Q Consensus       298 il~hp~~  304 (372)
                      .+.-+.+
T Consensus      1489 sls~d~~ 1495 (2724)
T KOG1826|consen 1489 SLSRDHF 1495 (2724)
T ss_pred             hcccccc
Confidence            7665555

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.56  E-value=0.0014  Score=57.94  Aligned_cols=71  Identities=17%  Similarity=0.332  Sum_probs=44.0

Q ss_pred             ccccccCCeEEEEEEEcC-CCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          22 EILGLGINGKVLQIVEKK-TSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      +.|..|-...+|++.... .++.|++|+.....    ...+|..++..+..+--+++++..+.     +   .++|||++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-----~---~~l~e~i~   75 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-----N---GLIYEFIP   75 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-----C---cEEEEeeC
Confidence            457888899999987543 35788999875322    22357766444433333344444332     1   37999998


Q ss_pred             CCch
Q psy3151          97 GGEL  100 (372)
Q Consensus        97 ~g~L  100 (372)
                      |.++
T Consensus        76 G~~l   79 (235)
T cd05157          76 GRTL   79 (235)
T ss_pred             CCcC
Confidence            8665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.52  E-value=0.0012  Score=63.01  Aligned_cols=72  Identities=14%  Similarity=0.109  Sum_probs=48.0

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEec------------chhhhHHHHHHHHHhcCC--CCEeEEeEeeeeecCCceE
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLH------------DTVKARREVELQLAVGSH--KHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~------------~~~~~~~e~~~~~~~~~h--~ni~~~~~~~~~~~~~~~~   87 (372)
                      +.||.|.+..||++.+..+++.++||.-.            ...+...|.+.+.....+  .++++++.+-      ...
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D------~~~  105 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD------EEL  105 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC------CCC
Confidence            34999999999999986544689999842            112345666664443332  4567776653      234


Q ss_pred             EEEEEeccCCCc
Q psy3151          88 LLVIMECMHGGE   99 (372)
Q Consensus        88 ~~lv~e~~~~g~   99 (372)
                      -++|||++++..
T Consensus       106 ~~lVME~L~~~~  117 (401)
T PRK09550        106 AVTVMEDLSDHK  117 (401)
T ss_pred             CEEEEecCCCcc
Confidence            679999997643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.43  E-value=0.001  Score=59.03  Aligned_cols=74  Identities=11%  Similarity=0.098  Sum_probs=40.1

Q ss_pred             ccccccCCe-EEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCC--CEeEEeEeeeeecCCceEEEEEEecc
Q psy3151          22 EILGLGING-KVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHK--HIVNIKDVYENIYNGSRCLLVIMECM   95 (372)
Q Consensus        22 ~~lG~G~~g-~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~--ni~~~~~~~~~~~~~~~~~~lv~e~~   95 (372)
                      +.|+.|+.. .||+.     +..+++|.....   ....+|.+.+..+..+-  -+..++..... .......+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~-~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEP-GEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCC-ccCCCcceEEEEee
Confidence            347766665 58875     235778886542   24566777644443321  23333332211 11112457889999


Q ss_pred             CCCchh
Q psy3151          96 HGGELF  101 (372)
Q Consensus        96 ~~g~L~  101 (372)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            886663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.41  E-value=0.00096  Score=59.99  Aligned_cols=67  Identities=15%  Similarity=0.187  Sum_probs=40.6

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecchh-----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCC
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDTV-----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGG   98 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g   98 (372)
                      +..|-.+.+|+..  .+++.+++|......     ...+|.+++..+..+--.++++....        -++||||++|.
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--------~~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--------HWLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--------CEEEEEeccCc
Confidence            5678888999887  457788999864321     23567666444433311233333321        25899999886


Q ss_pred             ch
Q psy3151          99 EL  100 (372)
Q Consensus        99 ~L  100 (372)
                      .+
T Consensus        74 ~~   75 (256)
T TIGR02721        74 VI   75 (256)
T ss_pred             cc
Confidence            54

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.33  E-value=0.00098  Score=56.93  Aligned_cols=82  Identities=16%  Similarity=0.124  Sum_probs=60.2

Q ss_pred             HHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHH---HHhccCCCCCHHHHHHHHHHHHHHHHHHHH-
Q psy3151          58 EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQR---IQQKEDGAFTEREAAIIMNEICSAIKFLHD-  133 (372)
Q Consensus        58 e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~---i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-  133 (372)
                      |..++..+-..++++++++.+..        ++|.||...+++...   +.+.  -..++..+..|+.+++..+++++. 
T Consensus         9 E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    9 EPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             HHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcC
Confidence            55553334344799999998843        567899976666421   1111  126899999999999999999997 


Q ss_pred             --CCceecCCCCCceeee
Q psy3151         134 --QNIAHRDVKPENLLYT  149 (372)
Q Consensus       134 --~~ivHrDlkp~NIli~  149 (372)
                        ..+.-.|++|+|+-++
T Consensus        79 ~~~~~~lcDv~~~nfgv~   96 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVN   96 (188)
T ss_pred             CCCcEEEeecchHHeEEe
Confidence              3577789999999998

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.26  E-value=0.0021  Score=59.07  Aligned_cols=77  Identities=13%  Similarity=0.100  Sum_probs=43.3

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch--hhhHHHHHHHHHhcCC-CCEeEEeEeeee--ecCCceEEEEEEeccC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSH-KHIVNIKDVYEN--IYNGSRCLLVIMECMH   96 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h-~ni~~~~~~~~~--~~~~~~~~~lv~e~~~   96 (372)
                      +.|..|....+|++..  ++..+++|+....  .....|++.+..+..+ -.+++++..-..  ....++..++++++++
T Consensus        20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~   97 (296)
T cd05153          20 EGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA   97 (296)
T ss_pred             ecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence            3477888889999865  3457899988632  2334566553333222 124444332110  0011335688999998


Q ss_pred             CCch
Q psy3151          97 GGEL  100 (372)
Q Consensus        97 ~g~L  100 (372)
                      |..+
T Consensus        98 G~~~  101 (296)
T cd05153          98 GEHL  101 (296)
T ss_pred             CCCC
Confidence            8664

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268|consensus

Probab=97.18  E-value=0.00034  Score=63.65  Aligned_cols=128  Identities=17%  Similarity=0.229  Sum_probs=87.6

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecch---------------------------hhhHHHHHHHHHhcCCC-CEe
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDT---------------------------VKARREVELQLAVGSHK-HIV   72 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------------------------~~~~~e~~~~~~~~~h~-ni~   72 (372)
                      +..||-|--+-+|.+-+. .|.+.++|.=+-.                           ..+.+|...+..+-.|- -|+
T Consensus        97 GnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVP  175 (465)
T KOG2268|consen   97 GNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVP  175 (465)
T ss_pred             ccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCC
Confidence            678999999999999885 5888899853200                           12346666654444432 234


Q ss_pred             EEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCC
Q psy3151          73 NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~  152 (372)
                      +.+++        +.-++|||++.|-.|...-.        ...+..+...+..-+--|-..|+||+|..--||++.   
T Consensus       176 kpiD~--------~RH~Vvmelv~g~Pl~~v~~--------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---  236 (465)
T KOG2268|consen  176 KPIDH--------NRHCVVMELVDGYPLRQVRH--------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---  236 (465)
T ss_pred             Ccccc--------cceeeHHHhhcccceeeeee--------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEe---
Confidence            44443        34578999998877765432        122334455566667778899999999999999998   


Q ss_pred             CCCceeeeccCCCCccccccCCCCCCCCeeeecccccccc
Q psy3151         153 DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI  192 (372)
Q Consensus       153 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~  192 (372)
                                              +++.++++||-.....
T Consensus       237 ------------------------dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  237 ------------------------DDDKIVVIDFPQMVST  252 (465)
T ss_pred             ------------------------cCCCEEEeechHhhcc
Confidence                                    5667889999766544

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.08  E-value=0.0043  Score=57.22  Aligned_cols=71  Identities=14%  Similarity=0.176  Sum_probs=43.4

Q ss_pred             cccccCCeEEEEEEEcC------CCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          23 ILGLGINGKVLQIVEKK------TSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      .|..|-...+|++....      +++.+++|+....    ....+|.+++..+..+--.++++.++..        .+|+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--------~~v~   76 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN--------GRIE   76 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC--------Cchh
Confidence            46777788999987643      2688999997643    2345666664444333223445554421        2578


Q ss_pred             eccCCCchh
Q psy3151          93 ECMHGGELF  101 (372)
Q Consensus        93 e~~~~g~L~  101 (372)
                      ||++|..+.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            998876653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270|consensus

Probab=97.03  E-value=0.005  Score=57.19  Aligned_cols=116  Identities=16%  Similarity=0.280  Sum_probs=76.5

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch-------------------------------hhhHHHHHHHHHhcCCCC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT-------------------------------VKARREVELQLAVGSHKH   70 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------------------------~~~~~e~~~~~~~~~h~n   70 (372)
                      ..|..|--+.||.|.. .+|..+|||++...                               ..+..|++.+.++ +...
T Consensus       150 GCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~~aG  227 (520)
T KOG2270|consen  150 GCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-NNAG  227 (520)
T ss_pred             cccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-HhcC
Confidence            4577888888999877 46888999987411                               1234555554333 3334


Q ss_pred             EeEEeEeeeeecCCceEEEEEEeccCCCchh--HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcee
Q psy3151          71 IVNIKDVYENIYNGSRCLLVIMECMHGGELF--QRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLL  147 (372)
Q Consensus        71 i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~--~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIl  147 (372)
                      |.-.-.+..      ..-+|||+++. .+=+  -.++.   -.++...+..+-.|++.-+.-|-+ .++||.||.--|+|
T Consensus       228 IP~PePIlL------k~hVLVM~FlG-rdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L  297 (520)
T KOG2270|consen  228 IPCPEPILL------KNHVLVMEFLG-RDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL  297 (520)
T ss_pred             CCCCCceee------ecceEeeeecc-CCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence            432222221      12368999994 3322  22222   348888899998999988888865 59999999999999


Q ss_pred             ee
Q psy3151         148 YT  149 (372)
Q Consensus       148 i~  149 (372)
                      +.
T Consensus       298 yh  299 (520)
T KOG2270|consen  298 YH  299 (520)
T ss_pred             EE
Confidence            95

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.96  E-value=0.012  Score=55.13  Aligned_cols=68  Identities=18%  Similarity=0.193  Sum_probs=44.0

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecc------------hhhhHHHHHHHHHhcCC-C-CEeEEeEeeeeecCCceEEE
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHD------------TVKARREVELQLAVGSH-K-HIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~------------~~~~~~e~~~~~~~~~h-~-ni~~~~~~~~~~~~~~~~~~   89 (372)
                      ||.|....||++.+..+++.++||.-..            ..+...|.+.+...... | ++++++.+-      .....
T Consensus         3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D------~e~~~   76 (370)
T TIGR01767         3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD------TEMAV   76 (370)
T ss_pred             CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc------cccce
Confidence            7999999999999865457899997531            12345566665443332 3 455555432      34456


Q ss_pred             EEEeccCC
Q psy3151          90 VIMECMHG   97 (372)
Q Consensus        90 lv~e~~~~   97 (372)
                      +|||++..
T Consensus        77 ~vMEdL~~   84 (370)
T TIGR01767        77 TVMEDLSH   84 (370)
T ss_pred             ehHhhCcc
Confidence            89999954

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK05231 homoserine kinase; Provisional

Probab=96.89  E-value=0.024  Score=52.61  Aligned_cols=76  Identities=9%  Similarity=0.033  Sum_probs=39.4

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecc--hhhhHHHHHHHHHhcCC-CCEeEEeEeeee--ecCCceEEEEEEeccCC
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHD--TVKARREVELQLAVGSH-KHIVNIKDVYEN--IYNGSRCLLVIMECMHG   97 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h-~ni~~~~~~~~~--~~~~~~~~~lv~e~~~~   97 (372)
                      .|+.|....+|++... +| .+++|+++.  ......|...+..+..+ -.+++.+..-..  ...-++..+++++|++|
T Consensus        29 ~l~~G~~n~~y~v~t~-~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~G  106 (319)
T PRK05231         29 GIAEGIENSNFFLTTT-QG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLEG  106 (319)
T ss_pred             hhccccccceEEEEeC-CC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecCC
Confidence            4677888899998754 33 688998852  12223344433222111 123333321100  00013456889999988


Q ss_pred             Cch
Q psy3151          98 GEL  100 (372)
Q Consensus        98 g~L  100 (372)
                      ..+
T Consensus       107 ~~~  109 (319)
T PRK05231        107 KWP  109 (319)
T ss_pred             CCC
Confidence            643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.86  E-value=0.013  Score=54.15  Aligned_cols=77  Identities=8%  Similarity=0.085  Sum_probs=42.1

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCC-CCEeEEeEeeee--ecCCceEEEEEEecc
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSH-KHIVNIKDVYEN--IYNGSRCLLVIMECM   95 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h-~ni~~~~~~~~~--~~~~~~~~~lv~e~~   95 (372)
                      +.++.|....+|++... +| .+++|+.+..   .....|.+.+..+.++ -.+++++..-..  ....++..+++++|+
T Consensus        28 ~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTD-VG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             cccCCccccceEEEEeC-CC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            44778878899998653 34 6788987542   3334455543333211 124444432110  001134568999999


Q ss_pred             CCCch
Q psy3151          96 HGGEL  100 (372)
Q Consensus        96 ~~g~L  100 (372)
                      +|.++
T Consensus       106 ~G~~~  110 (307)
T TIGR00938       106 QGLSV  110 (307)
T ss_pred             CCCCC
Confidence            88543

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1093|consensus

Probab=96.61  E-value=0.0077  Score=58.25  Aligned_cols=82  Identities=16%  Similarity=0.141  Sum_probs=53.4

Q ss_pred             CccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCC---------cccccCHHHHHHHHHhccCCCCC
Q psy3151         221 KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNP---------EWEHVSQEAKTLIKNMLCVDPSE  291 (372)
Q Consensus       221 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~s~~~~~li~~ll~~dP~~  291 (372)
                      +++||||+|.++.++..|...+......+....    +.. -+..+..         ..-.++.-..++..+|+...|..
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~----i~k-~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~i  184 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLEI----LLK-YYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPII  184 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHH----HHH-hccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccc
Confidence            599999999999999988766532221111000    000 0000000         00134566778999999999999


Q ss_pred             CCChhHHhcCCccccC
Q psy3151         292 RLTIDQVMENKWISQF  307 (372)
Q Consensus       292 R~s~~eil~hp~~~~~  307 (372)
                      ||...++.+++-|...
T Consensus       185 r~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  185 RPLPMELSKRCSFTEV  200 (725)
T ss_pred             ccchhHHhcCccHHHH
Confidence            9999999999998765

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.35  E-value=0.062  Score=51.32  Aligned_cols=68  Identities=18%  Similarity=0.150  Sum_probs=45.0

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEec------------chhhhHHHHHHHHHhcC--CCCEeEEeEeeeeecCCceE
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLH------------DTVKARREVELQLAVGS--HKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~------------~~~~~~~e~~~~~~~~~--h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +.||.|....||++.+.  ++.++||.-.            ...+...|.+.+.....  ..++++++.+.+      ..
T Consensus        38 ~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------d~  109 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------TM  109 (418)
T ss_pred             EEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------CC
Confidence            34899999999998873  4568999764            22344556655433322  246777777654      23


Q ss_pred             EEEEEeccCC
Q psy3151          88 LLVIMECMHG   97 (372)
Q Consensus        88 ~~lv~e~~~~   97 (372)
                      -+++||++++
T Consensus       110 ~vlvME~L~~  119 (418)
T PLN02756        110 ALIGMRYLEP  119 (418)
T ss_pred             CEEEEeecCC
Confidence            5778999976

>PLN02236 choline kinase

Probab=96.25  E-value=0.062  Score=50.59  Aligned_cols=70  Identities=16%  Similarity=0.177  Sum_probs=42.1

Q ss_pred             cccccCCeEEEEEEEcC----CCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          23 ILGLGINGKVLQIVEKK----TSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      .|-.|-...+|++....    +++.|++|+.....    ...+|..++..+..+---.++++.+..    +    .|.+|
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~----g----~v~ef  114 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN----G----RVEEF  114 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC----c----eEEEe
Confidence            46668889999987432    34789999875321    224566664444333223455555532    2    47888


Q ss_pred             cCCCch
Q psy3151          95 MHGGEL  100 (372)
Q Consensus        95 ~~~g~L  100 (372)
                      +++.+|
T Consensus       115 i~g~~l  120 (344)
T PLN02236        115 IHARTL  120 (344)
T ss_pred             eCCCCC
Confidence            877665

>PRK10593 hypothetical protein; Provisional

Probab=96.23  E-value=0.045  Score=50.36  Aligned_cols=103  Identities=10%  Similarity=0.023  Sum_probs=70.2

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCC--CCEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSH--KHIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h--~ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      +-||.|..+.||..... ++ .+.+|.....   .....|.+.+..+..+  -.++++++++... ...+.-++|||+++
T Consensus        20 ~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~-~~~g~~~LVmE~i~   96 (297)
T PRK10593         20 ECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE-QSPGPDVLLLERLR   96 (297)
T ss_pred             eecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC-CcCCCeEEEEeccC
Confidence            45999999999998653 23 4677876542   3556788875555443  3577777765431 11345799999999


Q ss_pred             CCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy3151          97 GGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ  134 (372)
Q Consensus        97 ~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~  134 (372)
                      |+++.+.       ..+......+..+++.+|+-||+.
T Consensus        97 G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         97 GVSVEAP-------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             CEecCCC-------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            9877651       134455667778889999999985

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.18  E-value=0.038  Score=50.25  Aligned_cols=42  Identities=14%  Similarity=0.171  Sum_probs=24.6

Q ss_pred             cccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcC
Q psy3151          25 GLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGS   67 (372)
Q Consensus        25 G~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~   67 (372)
                      ++|....|+.+.+ .+|+.+++|.-...   ....+|.+.+..+..
T Consensus        20 ~~g~~~~v~~i~~-~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~   64 (276)
T cd05152          20 ESGLDFQVVFAKD-TDGVPWVLRIPRRPDVSERAAAEKRVLALVRK   64 (276)
T ss_pred             CCcceeEEEEEEc-CCCCeEEEEecCCHHHHHHHHHHHHHHHHHHh
Confidence            4444445555432 35788999987542   345678877544433

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.18  E-value=0.033  Score=52.91  Aligned_cols=69  Identities=14%  Similarity=0.067  Sum_probs=45.5

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEec-----------chhhhHHHHHHHHHhcCC-C-CEeEEeEeeeeecCCceEEE
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLH-----------DTVKARREVELQLAVGSH-K-HIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~-----------~~~~~~~e~~~~~~~~~h-~-ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .||.|.-..||++.+..+++.++||.-.           ...+..-|.+.+...... | ++++++.+-      .....
T Consensus        36 eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D------~e~~~  109 (409)
T PRK12396         36 EIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD------SVMNC  109 (409)
T ss_pred             EcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC------cHHhh
Confidence            4899999999999985456789999753           123456677665443332 3 456665542      34456


Q ss_pred             EEEeccCC
Q psy3151          90 VIMECMHG   97 (372)
Q Consensus        90 lv~e~~~~   97 (372)
                      +|||+++.
T Consensus       110 ~vMEdL~~  117 (409)
T PRK12396        110 CVMEDLSD  117 (409)
T ss_pred             HHHHhCcc
Confidence            89999954

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.13  E-value=0.042  Score=50.74  Aligned_cols=15  Identities=33%  Similarity=0.638  Sum_probs=14.1

Q ss_pred             CceecCCCCCceeee
Q psy3151         135 NIAHRDVKPENLLYT  149 (372)
Q Consensus       135 ~ivHrDlkp~NIli~  149 (372)
                      .++|+|+.+.||+++
T Consensus       199 ~lvHGD~~~gNlii~  213 (321)
T COG3173         199 VLVHGDYRPGNLIID  213 (321)
T ss_pred             eeeeCCcccCCEEEe
Confidence            489999999999998

>KOG1236|consensus

Probab=95.93  E-value=0.025  Score=53.33  Aligned_cols=63  Identities=17%  Similarity=0.174  Sum_probs=47.2

Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCceeeecC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-DQNIAHRDVKPENLLYTKP  151 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH-~~~ivHrDlkp~NIli~~~  151 (372)
                      ....++-+|..|.++..++...+   .+|+..+.++.-...|+.-+- -.+.+|.|+.|.||++...
T Consensus       318 ~~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  318 TDLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ccceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            34678888999999998887654   567677777666666654443 4589999999999999743

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.71  E-value=0.13  Score=48.01  Aligned_cols=70  Identities=17%  Similarity=0.285  Sum_probs=41.1

Q ss_pred             ccccccCCeEEEEEEEcCC---CcEEEEEEecch----hhhHHHHHHHHHhcCCCCE-eEEeEeeeeecCCceEEEEEEe
Q psy3151          22 EILGLGINGKVLQIVEKKT---SEVYALKVLHDT----VKARREVELQLAVGSHKHI-VNIKDVYENIYNGSRCLLVIME   93 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni-~~~~~~~~~~~~~~~~~~lv~e   93 (372)
                      +.|..|-...+|++.....   +..|++|+....    ....+|..++..+ ..-++ ++++.++..    +    +|.+
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l-~~~gl~P~~l~~~~~----G----~i~~   90 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYL-SAAGFGAKLLGVFGN----G----MIQS   90 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHH-HhcCCCCceeEEeCC----c----Eeeh
Confidence            4466688899999875432   347899987532    1234666664333 33333 345555432    2    4788


Q ss_pred             ccCCCch
Q psy3151          94 CMHGGEL  100 (372)
Q Consensus        94 ~~~~g~L  100 (372)
                      |++|.+|
T Consensus        91 fi~g~~l   97 (330)
T PLN02421         91 FINARTL   97 (330)
T ss_pred             hhcCCCC
Confidence            8876554

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.35  E-value=0.14  Score=47.75  Aligned_cols=72  Identities=11%  Similarity=0.135  Sum_probs=38.1

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCC-----EeEEeEeeeeecCCceEEEEEEeccCCCc
Q psy3151          28 INGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKH-----IVNIKDVYENIYNGSRCLLVIMECMHGGE   99 (372)
Q Consensus        28 ~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~n-----i~~~~~~~~~~~~~~~~~~lv~e~~~~g~   99 (372)
                      .-..||++... +|+. ++|+.+..   .....|.+.+..+..+.-     +...-+-......+..+.+-+++|++|..
T Consensus        37 ~eN~~f~~~~~-~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~  114 (331)
T COG2334          37 EENSNFRVQTE-DGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP  114 (331)
T ss_pred             ccCceEEEEec-CCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence            45678888764 3444 99998764   222334444444433311     22222222111111246778899998877


Q ss_pred             hh
Q psy3151         100 LF  101 (372)
Q Consensus       100 L~  101 (372)
                      +.
T Consensus       115 ~~  116 (331)
T COG2334         115 LE  116 (331)
T ss_pred             cC
Confidence            76

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.34  E-value=0.066  Score=49.55  Aligned_cols=83  Identities=18%  Similarity=0.239  Sum_probs=40.3

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhH-HHHHHH--HHhcCCCCEeEEeEeeee--ecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR-REVELQ--LAVGSHKHIVNIKDVYEN--IYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~e~~~~--~~~~~h~ni~~~~~~~~~--~~~~~~~   87 (372)
                      +...|.+--.-+ .|.-+.||++...  +..+++|.+....... .....+  +....-++++.++..-..  ....++.
T Consensus         4 vl~~Y~l~v~~i-~~~~~~v~~v~T~--~G~~~Lk~~~~~~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~~~~~~   80 (309)
T TIGR02904         4 VLEHYGLQPEEM-EQVTGKLFKVYTD--QGVFALKKLYADRNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYLFHGHF   80 (309)
T ss_pred             hHhhcCCCceee-ecccCcEEEEEeC--CCCEEEEEeccchHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeeeEECCE
Confidence            445566511223 3335789988763  3458899987443221 222222  222223445554332110  0011334


Q ss_pred             EEEEEeccCCC
Q psy3151          88 LLVIMECMHGG   98 (372)
Q Consensus        88 ~~lv~e~~~~g   98 (372)
                      .|++|++++|.
T Consensus        81 ~~~L~~wi~G~   91 (309)
T TIGR02904        81 LYYLMPWLDIE   91 (309)
T ss_pred             EEEEeCCcccc
Confidence            58899998773

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PHA03111 Ser/Thr kinase; Provisional

Probab=95.22  E-value=0.056  Score=49.63  Aligned_cols=70  Identities=23%  Similarity=0.253  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHHHH----HCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccc
Q psy3151         114 EREAAIIMNEICSAIKFLH----DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA  189 (372)
Q Consensus       114 ~~~~~~i~~qil~~l~~LH----~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a  189 (372)
                      .+-++.++.||+.-.-.+-    ..+.+|-||||+||||-...+.-.+++.+-...      +.   ..-.+++.||.+|
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~v------F~---Epi~~~LnDFDfS  348 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYV------FN---EPIKACLNDFDFS  348 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEE------ec---cchhhhhcccCHH
Confidence            3567788889887654443    346899999999999985543333343331111      11   3446788999988


Q ss_pred             ccc
Q psy3151         190 KKI  192 (372)
Q Consensus       190 ~~~  192 (372)
                      ...
T Consensus       349 qv~  351 (444)
T PHA03111        349 QVA  351 (444)
T ss_pred             HHc
Confidence            754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.97  E-value=0.1  Score=45.25  Aligned_cols=52  Identities=19%  Similarity=0.227  Sum_probs=26.5

Q ss_pred             CcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCch
Q psy3151          41 SEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGEL  100 (372)
Q Consensus        41 ~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  100 (372)
                      ++.|+|++.-..    .....|..++..+..+-.-+++++.+.+     .   .|.+|++|.+|
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~-----g---~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN-----G---RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT-----E---EEEE--SSEE-
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC-----C---cEEEEeccccc
Confidence            467888887543    3344566664444344334566666542     1   45688866554

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.80  E-value=0.095  Score=48.90  Aligned_cols=88  Identities=18%  Similarity=0.226  Sum_probs=61.8

Q ss_pred             CEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceee
Q psy3151          70 HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLY  148 (372)
Q Consensus        70 ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli  148 (372)
                      .++.+...+.....+..+.|++|++- |+.|. .+.     .-..+++..++.+-+..++-+... ..-|||+.-+||||
T Consensus       283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI  355 (488)
T COG5072         283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI  355 (488)
T ss_pred             cchhhhcceEEecCCceEEEEEEecC-Cceee-eee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee
Confidence            33333333332234567889999986 55553 332     245778888888887777777655 68999999999999


Q ss_pred             ecCCCCCceeeeccCCCCccccccCCCCCCCCeeeecccccccc
Q psy3151         149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI  192 (372)
Q Consensus       149 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~  192 (372)
                      +                            .|.|-|+||-+++..
T Consensus       356 d----------------------------~GnvtLIDfklsRl~  371 (488)
T COG5072         356 D----------------------------EGNVTLIDFKLSRLS  371 (488)
T ss_pred             e----------------------------cCceEEEEeeeeecc
Confidence            5                            567999999998843

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.71  E-value=0.053  Score=50.02  Aligned_cols=71  Identities=21%  Similarity=0.217  Sum_probs=43.8

Q ss_pred             HHHHHHHHHHHHHHHHHHH----HCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccc
Q psy3151         114 EREAAIIMNEICSAIKFLH----DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA  189 (372)
Q Consensus       114 ~~~~~~i~~qil~~l~~LH----~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a  189 (372)
                      .+-++.++.||+.-.--+-    ..+.+|-||||+|||+-...+.-.++..+-...      +.   ..-.+++.||.+|
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~v------F~---Epi~~~LnDFDfS  344 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYV------FK---EPIRCCLNDFDFS  344 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEE------ec---ccceeeecccCHH
Confidence            3566777778765442221    346899999999999986544444444331111      11   3345789999988


Q ss_pred             cccc
Q psy3151         190 KKIV  193 (372)
Q Consensus       190 ~~~~  193 (372)
                      ...+
T Consensus       345 qv~~  348 (434)
T PF05445_consen  345 QVAN  348 (434)
T ss_pred             Hhcc
Confidence            7543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK06148 hypothetical protein; Provisional

Probab=94.36  E-value=0.62  Score=50.34  Aligned_cols=32  Identities=31%  Similarity=0.474  Sum_probs=22.8

Q ss_pred             CCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151         134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus       134 ~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      .++||+|+.+.|||++.++.....=|.|||.+
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa  234 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDA  234 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccc
Confidence            47999999999999985443233336666654

>PTZ00384 choline kinase; Provisional

Probab=93.60  E-value=1.2  Score=42.54  Aligned_cols=71  Identities=14%  Similarity=0.224  Sum_probs=41.8

Q ss_pred             ccccccCCeEEEEEEEcCC-CcE-----EEEEEecc----hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          22 EILGLGINGKVLQIVEKKT-SEV-----YALKVLHD----TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~-~~~-----vaiK~~~~----~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      +.|..|-...+|++..... +..     |.+++...    .....+|..++..+..+---.++++.|..        +++
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~--------g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD--------FTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC--------EEE
Confidence            4466788999999875432 222     44443211    12335677774444444444666676642        588


Q ss_pred             EeccCCCch
Q psy3151          92 MECMHGGEL  100 (372)
Q Consensus        92 ~e~~~~g~L  100 (372)
                      .||++|.+|
T Consensus       128 ~efIeGr~l  136 (383)
T PTZ00384        128 QEWVEGNTM  136 (383)
T ss_pred             EEEeccccC
Confidence            999988665

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=92.93  E-value=0.21  Score=46.07  Aligned_cols=68  Identities=16%  Similarity=0.117  Sum_probs=34.2

Q ss_pred             EEEEEEEcCCCcEEEEEEecch-hhhHHHHHHHHHhcCC-CCEeEEeEeeee--ecCCceEEEEEEeccCCCch
Q psy3151          31 KVLQIVEKKTSEVYALKVLHDT-VKARREVELQLAVGSH-KHIVNIKDVYEN--IYNGSRCLLVIMECMHGGEL  100 (372)
Q Consensus        31 ~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h-~ni~~~~~~~~~--~~~~~~~~~lv~e~~~~g~L  100 (372)
                      .||++... .| .+++|+++.. .....+...+..+..+ -.++.++..-..  ....++..++++++++|.++
T Consensus        11 ~v~~v~t~-~g-~~~LK~~~~~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~   82 (313)
T TIGR02906        11 NVYKVETD-SG-NKCLKKINYPPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC   82 (313)
T ss_pred             cEEEEEeC-CC-CeEEEEcCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence            47887643 33 6889988643 2333344443222211 134444432110  00013467899999987544

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=92.22  E-value=2.2  Score=38.98  Aligned_cols=71  Identities=15%  Similarity=0.109  Sum_probs=40.0

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh--hhHHHHHHHHHh--cCCCCEeEEeEeeeeecCCceEEEEEEeccCC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV--KARREVELQLAV--GSHKHIVNIKDVYENIYNGSRCLLVIMECMHG   97 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~e~~~~~~~--~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~   97 (372)
                      +.++.|..+.+|+..  .+++.+.||+-....  ....|.+-+..+  ..--.+++++.+...    ++.-|+||||++.
T Consensus        23 ~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~----~~~~fLlle~l~~   96 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY----DDDAFLLLEFLEM   96 (288)
T ss_dssp             EEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-----SSCCEEEEE----
T ss_pred             EecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee----cCCceEEEEeecC
Confidence            348889999999877  678889999886432  345666664444  233456677776543    2234899999976


Q ss_pred             C
Q psy3151          98 G   98 (372)
Q Consensus        98 g   98 (372)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            5

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00296 choline kinase; Provisional

Probab=90.73  E-value=3.4  Score=40.28  Aligned_cols=70  Identities=16%  Similarity=0.238  Sum_probs=40.9

Q ss_pred             ccccccCCeEEEEEEEcC--------CCcEEEEEEecchh----hhHHHHHHHHHhcCCCCE-eEEeEeeeeecCCceEE
Q psy3151          22 EILGLGINGKVLQIVEKK--------TSEVYALKVLHDTV----KARREVELQLAVGSHKHI-VNIKDVYENIYNGSRCL   88 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni-~~~~~~~~~~~~~~~~~   88 (372)
                      +.|..|-.-.+|++....        +++.|.+++.-...    ....|..+...+ ...+| .++++.+.     +   
T Consensus       111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~l-s~~gi~P~l~~~f~-----g---  181 (442)
T PTZ00296        111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTM-SKYRIAPQLLNTFS-----G---  181 (442)
T ss_pred             EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHH-HHCCCCCceEEEeC-----C---
Confidence            457788888999987542        25689999874321    234466553333 33333 34555553     1   


Q ss_pred             EEEEeccCCCch
Q psy3151          89 LVIMECMHGGEL  100 (372)
Q Consensus        89 ~lv~e~~~~g~L  100 (372)
                      +.|.+|++|.+|
T Consensus       182 g~I~efi~g~~l  193 (442)
T PTZ00296        182 GRIEEWLYGDPL  193 (442)
T ss_pred             CEEEEeeCCccC
Confidence            346888887644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	372
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-124
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-124
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-124
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-119
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-119
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-117
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-117
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-116
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-115
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-115
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-115
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-115
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-115
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-115
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-100
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-51
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-50
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-48
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-47
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-46
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-46
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-45
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-42
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-42
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-42
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-42
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-42
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-41
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-41
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-40
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-40
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-40
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-40
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-39
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-39
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-39
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-38
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-38
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-38
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-38
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-37
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-37
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-37
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-37
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-36
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-36
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-36
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-36
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-35
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-35
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-35
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-35
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-35
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-35
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-35
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-34
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-34
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-33
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-33
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-33
3soa_A	444	Full-Length Human Camkii Length = 444		3e-33
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-32
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-32
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-32
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-32
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-32
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-32
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-32
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-32
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-32
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-31
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-31
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-31
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-31
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-30
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-30
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-30
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-30
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-30
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-30
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-30
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-29
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-29
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-29
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-29
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-29
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-29
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-29
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-29
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-29
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-29
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-29
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-29
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-29
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-29
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-29
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-29
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-28
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-28
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-28
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-28
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-28
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-28
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-28
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-28
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-28
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-28
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-28
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-28
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-28
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-28
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-28
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-28
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-28
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-28
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-28
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-28
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-28
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-28
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-28
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-28
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-28
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-28
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-28
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-28
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-28
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-28
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-28
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-28
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-28
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-28
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-28
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-28
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-28
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-28
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-28
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-28
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-28
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-28
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-28
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-28
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-28
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-28
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-28
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-28
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-28
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-28
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-28
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-28
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-28
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-28
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-28
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-28
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-28
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-28
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-28
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-28
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-28
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-28
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-28
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-28
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-28
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-27
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-27
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-27
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-27
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-27
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-27
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-27
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-27
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-27
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-27
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-27
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-27
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-27
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-27
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-27
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-27
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-27
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-27
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-27
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-27
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-27
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-27
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-27
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-27
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-27
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-27
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-27
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-27
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-27
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-27
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-27
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-27
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-27
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-27
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-26
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-26
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-26
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-26
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-26
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-26
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-26
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-26
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-26
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-26
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-26
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-25
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-25
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-25
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-25
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-25
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-25
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-25
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-25
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-25
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-25
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-25
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-25
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-25
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-24
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-24
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-24
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-24
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-24
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-23
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-23
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-23
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-23
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-23
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-23
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-23
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-23
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-23
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-23
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-23
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-23
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-23
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-23
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-23
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-22
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-22
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-22
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-22
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-22
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-22
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-22
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-22
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-21
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-21
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-21
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-20
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-20
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-20
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-20
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-20
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-19
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-19
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-19
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-19
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-19
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-19
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-19
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-19
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-18
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-18
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-18
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-18
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-18
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-18
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-18
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-18
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-18
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-18
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-18
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-18
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-18
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-18
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-18
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-18
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-18
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-18
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-17
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-16
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-16
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-16
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-16
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-14
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-14
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-14
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-14
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-14
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-14
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-14
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-12
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-12
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-11
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		8e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-11
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		8e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-11
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		9e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-10
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		4e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-10
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-09
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-09
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		9e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-07
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-07
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-07
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-07
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-07
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-07
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-07
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-07
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-07
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-07
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		4e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-07
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-07
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-07
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-07
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-07
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-07
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-07
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-07
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-07
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-07
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-07
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-07
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-07
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		6e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-06
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-06
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-05
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-05
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-05
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-05
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-05
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-05
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-05
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		8e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-05
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-04
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-04
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-04
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-04
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-04
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-04
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		3e-04
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		3e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-04
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		3e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-04
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-04
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-04
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-04

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  442 bits (1138), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 214/355 (60%), Positives = 261/355 (73%), Gaps = 25/355 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 118
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 179 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 214
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 215 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 274 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 333
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           TPL T ++LKE +E W +V++EMT +LATMRVDY+QI IK + ++ NPLL KRRK
Sbjct: 334 TPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRK 388

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  442 bits (1138), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 214/355 (60%), Positives = 261/355 (73%), Gaps = 25/355 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 65  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 124
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 125 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 184
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 185 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 220
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 221 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 279
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 280 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 339
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           TPL T ++LKE +E W +V++EMT +LATMRVDY+QI IK + ++ NPLL KRRK
Sbjct: 340 TPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRK 394

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  442 bits (1136), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 214/355 (60%), Positives = 261/355 (73%), Gaps = 25/355 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 74
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 135 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 170
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 171 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 229
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 230 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 289
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           TPL T ++LKE +E W +V++EMT +LATMRVDY+QI IK + ++ NPLL KRRK
Sbjct: 290 TPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRK 344

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  424 bits (1089), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 208/355 (58%), Positives = 251/355 (70%), Gaps = 25/355 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK L D  KARREVEL        HIV
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQCPHIV 118
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++ EC+ GGELF RIQ + D AFTEREA+ I   I  AI++LH
Sbjct: 119 RIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH 178
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 179 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 214
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD WSLGVI YILLCG+PPF+SNHG AISP
Sbjct: 215 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISP 273
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           G K RIR GQ++FPNPEW  VS+E K LI+N+L  +P++R TI +   + WI Q  +VPQ
Sbjct: 274 GXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQ 333
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           TPL T ++LKE +E W +V++E T +LATMRVDY+QI IK + ++ NPLL KRRK
Sbjct: 334 TPLHTSRVLKEDKERWEDVKEEXTSALATMRVDYEQIKIKKIEDASNPLLLKRRK 388

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  423 bits (1088), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 204/337 (60%), Positives = 248/337 (73%), Gaps = 25/337 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 74
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 135 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 170
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 171 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 229
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 230 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 289
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQI 349
           TPL T ++LKE +E W +V++EMT +LATMRVDY+QI
Sbjct: 290 TPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQI 326

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  418 bits (1075), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 203/337 (60%), Positives = 249/337 (73%), Gaps = 26/337 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           + DDY +S ++LGLG+NGKVL+   ++T +  ALK+L+D+ KAR+EV+         HIV
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIV 85
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+++G RCLL+IMECM GGELF RIQ++ D AFTEREAA IM +I +AI+FLH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      +LKLTDFGFAK+ 
Sbjct: 146 SHNIAHRDVKPE------------------------NLLYTSKEKDAVLKLTDFGFAKET 181
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
             N  +LQTPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCGFPPF+SN GQAISP
Sbjct: 182 TQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIRLGQ+ FPNPEW  VS++AK LI+ +L  DP+ERLTI Q M + WI+Q   VPQ
Sbjct: 240 GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQI 349
           TPL T ++L+E ++ W EV++EMT +LATMRVDYDQ+
Sbjct: 300 TPLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQV 336

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  418 bits (1074), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 203/337 (60%), Positives = 249/337 (73%), Gaps = 26/337 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           + DDY +S ++LGLG+NGKVL+   ++T +  ALK+L+D+ KAR+EV+         HIV
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIV 66
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+++G RCLL+IMECM GGELF RIQ++ D AFTEREAA IM +I +AI+FLH
Sbjct: 67  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      +LKLTDFGFAK+ 
Sbjct: 127 SHNIAHRDVKPE------------------------NLLYTSKEKDAVLKLTDFGFAKET 162
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
             N  +LQTPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCGFPPF+SN GQAISP
Sbjct: 163 TQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 220
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIRLGQ+ FPNPEW  VS++AK LI+ +L  DP+ERLTI Q M + WI+Q   VPQ
Sbjct: 221 GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 280
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQI 349
           TPL T ++L+E ++ W EV++EMT +LATMRVDYDQ+
Sbjct: 281 TPLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQV 317

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  414 bits (1064), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 200/333 (60%), Positives = 243/333 (72%), Gaps = 25/333 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 13  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 72
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 133 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 168
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL  PCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 169 TSHN-SLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 227
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 228 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 287
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMRVD 345
           TPL T ++LKE +E W +V++EMT +LATMRVD
Sbjct: 288 TPLHTSRVLKEDKERWEDVKEEMTSALATMRVD 320

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  412 bits (1060), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 199/331 (60%), Positives = 242/331 (73%), Gaps = 25/331 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 13  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 72
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 133 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 168
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 169 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 227
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 228 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 287
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
           TPL T ++LKE +E W +V++EMT +LATMR
Sbjct: 288 TPLHTSRVLKEDKERWEDVKEEMTSALATMR 318

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  412 bits (1060), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 199/331 (60%), Positives = 242/331 (73%), Gaps = 25/331 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 20  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 79
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 80  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 139
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 140 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 175
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 176 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 234
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 235 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 294
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
           TPL T ++LKE +E W +V++EMT +LATMR
Sbjct: 295 TPLHTSRVLKEDKERWEDVKEEMTSALATMR 325

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  412 bits (1060), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 199/331 (60%), Positives = 242/331 (73%), Gaps = 25/331 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 19  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 78
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 79  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 138
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 139 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 174
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 175 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 233
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 234 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 293
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
           TPL T ++LKE +E W +V++EMT +LATMR
Sbjct: 294 TPLHTSRVLKEDKERWEDVKEEMTSALATMR 324

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  412 bits (1060), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 199/331 (60%), Positives = 242/331 (73%), Gaps = 25/331 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 29  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 88
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 89  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 148
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 149 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 184
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 185 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 243
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 244 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 303
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
           TPL T ++LKE +E W +V++EMT +LATMR
Sbjct: 304 TPLHTSRVLKEDKERWEDVKEEMTSALATMR 334

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  412 bits (1060), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 199/331 (60%), Positives = 242/331 (73%), Gaps = 25/331 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 14  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 73
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 74  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 133
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 134 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 169
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 170 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 228
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 229 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 288
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
           TPL T ++LKE +E W +V++EMT +LATMR
Sbjct: 289 TPLHTSRVLKEDKERWEDVKEEMTSALATMR 319

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  412 bits (1059), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 199/331 (60%), Positives = 242/331 (73%), Gaps = 25/331 (7%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 21  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 80
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 81  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 140
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 141 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 176
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 177 TSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 235
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 236 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 295
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
           TPL T ++LKE +E W +V++EMT +LATMR
Sbjct: 296 TPLHTSRVLKEDKERWEDVKEEMTSALATMR 326

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  362 bits (929), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 180/331 (54%), Positives = 222/331 (67%), Gaps = 46/331 (13%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIV 72
           I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL        HIV
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 74
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  AI++LH
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             NIAHRDVKPE                        NLLYT      ILKLTDFGFAK+ 
Sbjct: 135 SINIAHRDVKPE------------------------NLLYTSKRPNAILKLTDFGFAKET 170
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
                                   +KYDKSCD+WSLGVIMYILLCG+PPF+SNHG AISP
Sbjct: 171 TG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           GMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q  +VPQ
Sbjct: 209 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268
Query: 313 TPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
           TPL T ++LKE +E W +V++EMT +LATMR
Sbjct: 269 TPLHTSRVLKEDKERWEDVKEEMTSALATMR 299

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  197 bits (500), Expect = 9e-51,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 172/299 (57%), Gaps = 33/299 (11%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARREVELQLAVGSHKHIVNIKDV 77
           +  E +G+G   +  + V K T+  YA+KV+  + +    E+E+ L  G H +I+ +KDV
Sbjct: 30  VVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDV 89
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y++     + + ++ E M GGEL  +I +++   F+EREA+ +++ I   +++LH Q + 
Sbjct: 90  YDD----GKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+KP N+LY                         + G+   L++ DFGFAK++ +   
Sbjct: 144 HRDLKPSNILYVD-----------------------ESGNPECLRICDFGFAKQLRAENG 180
Query: 198 SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP-GMKN 256
            L TPCYT  +VAPEVL    YD+ CDIWSLG+++Y +L G+ PF   +G + +P  +  
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF--ANGPSDTPEEILT 238
Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPL 315
           RI  G+F      W  VS+ AK L+  ML VDP +RLT  QV+++ W++Q +++PQ+ L
Sbjct: 239 RIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQL 297

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 107/305 (35%), Positives = 174/305 (57%), Gaps = 34/305 (11%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARREVELQLAVGSHKHI 71
             D Y +  E +G+G   +  + V K T+  YA+KV+  + +    E+E+ L  G H +I
Sbjct: 25  FSDGY-VVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNI 83
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           + +KDVY++     + + ++ E M GGEL  +I +++   F+EREA+ +++ I   +++L
Sbjct: 84  ITLKDVYDD----GKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVEYL 137
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H Q + HRD+KP N+LY                         + G+   L++ DFGFAK+
Sbjct: 138 HSQGVVHRDLKPSNILYVD-----------------------ESGNPECLRICDFGFAKQ 174
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           + +    L TPCYT  +VAPEVL    YD+ CDIWSLG+++Y +L G+ PF   +G + +
Sbjct: 175 LRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF--ANGPSDT 232
Query: 252 P-GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV 310
           P  +  RI  G+F      W  VS+ AK L+  ML VDP +RLT  QV+++ W++Q +++
Sbjct: 233 PEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKL 292
Query: 311 PQTPL 315
           PQ+ L
Sbjct: 293 PQSQL 297

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 110/313 (35%), Positives = 180/313 (57%), Gaps = 39/313 (12%)
Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVE---LQLAVGSHKHIV 72
           D D+  + LG G      + V KK+++ +A+K++   ++A  + E   L+L  G H +IV
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG-HPNIV 69
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            + +V+ +  +      ++ME ++GGELF+RI++K+   F+E EA+ IM ++ SA+  +H
Sbjct: 70  KLHEVFHDQLH----TFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMH 123
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           D  + HRD+KPEN                        LL+T   D   +K+ DFGFA+  
Sbjct: 124 DVGVVHRDLKPEN------------------------LLFTDENDNLEIKIIDFGFARLK 159
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
             +   L+TPC+T +Y APE+L  + YD+SCD+WSLGVI+Y +L G  PF S H ++++ 
Sbjct: 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS-HDRSLTC 218
Query: 253 G----MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
                +  +I+ G F F    W++VSQEAK LI+ +L VDP++RL +  +  N+W+   +
Sbjct: 219 TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278
Query: 309 QVPQTPLCTGKML 321
           Q+   PL T  +L
Sbjct: 279 QLSSNPLMTPDIL 291

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 165/302 (54%), Gaps = 32/302 (10%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARREVELQLAVGSHKHIVN 73
           D Y++  +I G+G      + + K T+  +A+K++  + +    E+E+ L  G H +I+ 
Sbjct: 22  DGYEVKEDI-GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +KDVY++     + + V+ E M GGEL  +I +++   F+EREA+ ++  I   +++LH 
Sbjct: 81  LKDVYDD----GKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA 134
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           Q + HRD+KP N+LY                         + G+   +++ DFGFAK++ 
Sbjct: 135 QGVVHRDLKPSNILYVD-----------------------ESGNPESIRICDFGFAKQLR 171
Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
           +    L TPCYT  +VAPEVL    YD +CDIWSLGV++Y +L G+ P F+N        
Sbjct: 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP-FANGPDDTPEE 230
Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT 313
           +  RI  G+F      W  VS  AK L+  ML VDP +RLT   V+ + WI  ++Q+PQ 
Sbjct: 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290
Query: 314 PL 315
            L
Sbjct: 291 QL 292

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 102/290 (35%), Positives = 166/290 (57%), Gaps = 40/290 (13%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR-REVELQLAVGS---HKHIVNI 74
           I  E+LG G   +V  + ++ T +++ALK +  +   R   +E ++AV     H++IV +
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           +D+YE+  +      ++M+ + GGELF RI ++  G +TE++A++++ ++ SA+K+LH+ 
Sbjct: 72  EDIYESTTH----YYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KPENLLY  P +   + +TDFG  K E          GI              
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--------NGI-------------- 163
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
               + T C TP YVAPEVL    Y K+ D WS+GVI YILLCG+PPF+    +     +
Sbjct: 164 ----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY----EETESKL 215
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
             +I+ G ++F +P W+ +S+ AK  I ++L  DP+ER T ++ + + WI
Sbjct: 216 FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 102/302 (33%), Positives = 162/302 (53%), Gaps = 32/302 (10%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARREVELQLAVGSHKHIVN 73
           D Y++  +I G+G      + + K T+  +A+K++  + +    E+E+ L  G H +I+ 
Sbjct: 22  DGYEVKEDI-GVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +KDVY++     + + V+ E   GGEL  +I +++   F+EREA+ ++  I   +++LH 
Sbjct: 81  LKDVYDD----GKYVYVVTELXKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA 134
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           Q + HRD+KP N+LY                         + G+   +++ DFGFAK++ 
Sbjct: 135 QGVVHRDLKPSNILYVD-----------------------ESGNPESIRICDFGFAKQLR 171
Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
           +    L TPCYT  +VAPEVL    YD +CDIWSLGV++Y  L G+ P F+N        
Sbjct: 172 AENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP-FANGPDDTPEE 230
Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT 313
           +  RI  G+F      W  VS  AK L+   L VDP +RLT   V+ + WI  ++Q+PQ 
Sbjct: 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290
Query: 314 PL 315
            L
Sbjct: 291 QL 292

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 163/296 (55%), Gaps = 39/296 (13%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK---ARREVELQLAVGSHK 69
           + D +++ +E LG G    V +  +K T + YALKVL  TV     R E+ + L + SH 
Sbjct: 51  LSDFFEVESE-LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHP 108
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           +I+ +K+++E     S    +++E + GGELF RI +K  G ++ER+AA  + +I  A+ 
Sbjct: 109 NIIKLKEIFETPTEIS----LVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVA 162
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           +LH+  I HRD+KPEN                        LLY  P     LK+ DFG +
Sbjct: 163 YLHENGIVHRDLKPEN------------------------LLYATPAPDAPLKIADFGLS 198
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
           K IV ++  ++T C TP Y APE+L    Y    D+WS+G+I YILLCGF PF+   G  
Sbjct: 199 K-IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ 257
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
               M  RI   ++ F +P W+ VS  AK L++ ++ +DP +RLT  Q +++ W++
Sbjct: 258 F---MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 162/298 (54%), Gaps = 41/298 (13%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVG-----S 67
           I+D YD   ++LG G   +V+   +K+T ++ A+K +       +E  ++  +       
Sbjct: 16  IRDIYDFR-DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 74
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +IV + D+YE+       L +IM+ + GGELF RI +K  G +TER+A+ ++ ++  A
Sbjct: 75  HPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDA 128
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +K+LHD  I HRD+KPEN                        LLY    +   + ++DFG
Sbjct: 129 VKYLHDLGIVHRDLKPEN------------------------LLYYSLDEDSKIMISDFG 164
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
            +K +    + L T C TP YVAPEVL    Y K+ D WS+GVI YILLCG+PPF+  + 
Sbjct: 165 LSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN- 222
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
                 +  +I   +++F +P W+ +S  AK  I++++  DP +R T +Q +++ WI+
Sbjct: 223 ---DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 165/298 (55%), Gaps = 41/298 (13%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE--VELQLAVG---S 67
           I+D YD   ++LG G   +V+   +K+T ++ A+K +       +E  +E ++AV     
Sbjct: 16  IRDIYDFR-DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +IV + D+YE+       L +IM+ + GGELF RI +K  G +TER+A+ ++ ++  A
Sbjct: 75  HPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDA 128
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +K+LHD  I HRD+KPEN                        LLY    +   + ++DFG
Sbjct: 129 VKYLHDLGIVHRDLKPEN------------------------LLYYSLDEDSKIMISDFG 164
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
            +K +    + L T C TP YVAPEVL    Y K+ D WS+GVI YILLCG+PPF+  + 
Sbjct: 165 LSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN- 222
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
                 +  +I   +++F +P W+ +S  AK  I++++  DP +R T +Q +++ WI+
Sbjct: 223 ---DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 165/298 (55%), Gaps = 41/298 (13%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE--VELQLAVG---S 67
           I+D YD   ++LG G   +V+   +K+T ++ A+K +       +E  +E ++AV     
Sbjct: 16  IRDIYDFR-DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +IV + D+YE+       L +IM+ + GGELF RI +K  G +TER+A+ ++ ++  A
Sbjct: 75  HPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDA 128
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +K+LHD  I HRD+KPEN                        LLY    +   + ++DFG
Sbjct: 129 VKYLHDLGIVHRDLKPEN------------------------LLYYSLDEDSKIMISDFG 164
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
            +K +    + L T C TP YVAPEVL    Y K+ D WS+GVI YILLCG+PPF+  + 
Sbjct: 165 LSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN- 222
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
                 +  +I   +++F +P W+ +S  AK  I++++  DP +R T +Q +++ WI+
Sbjct: 223 ---DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 165/298 (55%), Gaps = 41/298 (13%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE--VELQLAVG---S 67
           I+D YD   ++LG G   +V+   +K+T ++ A+K +       +E  +E ++AV     
Sbjct: 16  IRDIYDFR-DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +IV + D+YE+       L +IM+ + GGELF RI +K  G +TER+A+ ++ ++  A
Sbjct: 75  HPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDA 128
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +K+LHD  I HRD+KPEN                        LLY    +   + ++DFG
Sbjct: 129 VKYLHDLGIVHRDLKPEN------------------------LLYYSLDEDSKIMISDFG 164
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
            +K +    + L T C TP YVAPEVL    Y K+ D WS+GVI YILLCG+PPF+  + 
Sbjct: 165 LSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN- 222
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
                 +  +I   +++F +P W+ +S  AK  I++++  DP +R T +Q +++ WI+
Sbjct: 223 ---DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 103/290 (35%), Positives = 155/290 (53%), Gaps = 44/290 (15%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNIKD 76
           LG G  G+VL   +K T    A+K++  T        K   EV + L +  H +I+ + D
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAV-LKLLDHPNIMKLYD 103
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            +E+     R   ++MEC  GGELF  I  +    F E +AA+I+ ++ S + +LH  NI
Sbjct: 104 FFED----KRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KPENL                       LL +K  D  ++K+ DFG +  +  N+
Sbjct: 158 VHRDLKPENL-----------------------LLESKEKD-ALIKIVDFGLS-AVFENQ 192
Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
             ++    T YY+APEVL   KYD+ CD+WS+GVI++ILL G+PPF     Q I      
Sbjct: 193 KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL----R 247
Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           ++  G++ F +PEW++VS+ AK LIK ML  D   R++  Q +E+ WI +
Sbjct: 248 KVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 96/289 (33%), Positives = 157/289 (54%), Gaps = 40/289 (13%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE--VELQLAVG---SHKHIVNIKD 76
           E LG G   +V+   EK T +++A+K +       +E  +E ++AV     H++IV ++D
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALED 87
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           +YE+       L ++M+ + GGELF RI +K  G +TE++A+ ++ ++  A+ +LH   I
Sbjct: 88  IYES----PNHLYLVMQLVSGGELFDRIVEK--GFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KPEN                        LLY    +   + ++DFG +K +    
Sbjct: 142 VHRDLKPEN------------------------LLYYSQDEESKIMISDFGLSK-MEGKG 176
Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
             + T C TP YVAPEVL    Y K+ D WS+GVI YILLCG+PPF+  +   +      
Sbjct: 177 DVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLF----E 232
Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
           +I   +++F +P W+ +S  AK  I+N++  DP++R T +Q   + WI+
Sbjct: 233 QILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIA 281

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 103/288 (35%), Positives = 149/288 (51%), Gaps = 37/288 (12%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHD----TVKARREVELQLAVGSHKHIVNIKDVYE 79
           LG G  G+VL   +K T    A+K++      T      +  ++AV       NI  +YE
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
             +   R   ++ME   GGELF  I  ++   F+E +AA+IM ++ S   +LH  NI HR
Sbjct: 72  -FFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVIMKQVLSGTTYLHKHNIVHR 128
Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+KPENL                       LL +K  D  ++K+ DFG +         +
Sbjct: 129 DLKPENL-----------------------LLESKSRDA-LIKIVDFGLSAHFEVG-GKM 163
Query: 200 QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIR 259
           +    T YY+APEVL   KYD+ CD+WS GVI+YILLCG+PPF     Q I      R+ 
Sbjct: 164 KERLGTAYYIAPEVL-RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEIL----KRVE 218
Query: 260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            G+F F  P+W  VS EAK L+K ML  +PS+R++ ++ + + WI +F
Sbjct: 219 KGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKF 266

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 103/288 (35%), Positives = 149/288 (51%), Gaps = 37/288 (12%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHD----TVKARREVELQLAVGSHKHIVNIKDVYE 79
           LG G  G+VL   +K T    A+K++      T      +  ++AV       NI  +YE
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
             +   R   ++ME   GGELF  I  ++   F+E +AA+IM ++ S   +LH  NI HR
Sbjct: 89  -FFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVIMKQVLSGTTYLHKHNIVHR 145
Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+KPENL                       LL +K  D  ++K+ DFG +         +
Sbjct: 146 DLKPENL-----------------------LLESKSRDA-LIKIVDFGLSAHFEVG-GKM 180
Query: 200 QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIR 259
           +    T YY+APEVL   KYD+ CD+WS GVI+YILLCG+PPF     Q I      R+ 
Sbjct: 181 KERLGTAYYIAPEVL-RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEIL----KRVE 235
Query: 260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            G+F F  P+W  VS EAK L+K ML  +PS+R++ ++ + + WI +F
Sbjct: 236 KGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKF 283

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 102/326 (31%), Positives = 167/326 (51%), Gaps = 56/326 (17%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-----HDTVKARREVELQLAVGS 67
            +D Y +++E+LG G   KV   V  +  + YA+K++     H   +  REVE       
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQG 69
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           +K+I+ + + +E+    +R  LV  E + GG +   IQ+++   F EREA+ ++ ++ +A
Sbjct: 70  NKNILELIEFFED---DTRFYLV-FEKLQGGSILAHIQKQKH--FNEREASRVVRDVAAA 123
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + FLH + IAHRD+KPEN+L   P     +K+ DF                      D G
Sbjct: 124 LDFLHTKGIAHRDLKPENILCESPEKVSPVKICDF----------------------DLG 161
Query: 188 FAKKIVSN-----KASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLC 237
              K+ ++        L TPC +  Y+APEV+         YDK CD+WSLGV++YI+L 
Sbjct: 162 SGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLS 221
Query: 238 GFPPFFSNHG-----------QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
           G+PPF  + G           +     +   I+ G+++FP+ +W H+S EAK LI  +L 
Sbjct: 222 GYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLV 281
Query: 287 VDPSERLTIDQVMENKWISQFNQVPQ 312
            D  +RL+  QV+++ W+    Q P+
Sbjct: 282 RDAKQRLSAAQVLQHPWVQ--GQAPE 305

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/313 (33%), Positives = 161/313 (51%), Gaps = 44/313 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-----HDTVKARREVELQLAVGS 67
            +D Y +  ++LG G + +V   +   TS+ YA+K++     H   +  REVE+      
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG 69
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H+   N+ ++ E      R  LV  E M GG +   I ++    F E EA++++ ++ SA
Sbjct: 70  HR---NVLELIEFFEEEDRFYLV-FEKMRGGSILSHIHKRRH--FNELEASVVVQDVASA 123
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + FLH++ IAHRD+KPEN+L   P     +K+ DF             G G  +KL   G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDF-------------GLGSGIKLN--G 168
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
               I  +   L TPC +  Y+APEV+         YDK CD+WSLGVI+YILL G+PPF
Sbjct: 169 DCSPI--STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226
Query: 243 FSNHGQ-------AISPGMKN----RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
               G           P  +N     I+ G+++FP+ +W H+S  AK LI  +L  D  +
Sbjct: 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQ 286
Query: 292 RLTIDQVMENKWI 304
           RL+  QV+++ W+
Sbjct: 287 RLSAAQVLQHPWV 299

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 159/299 (53%), Gaps = 46/299 (15%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNIK 75
           +LG G  G+VL+  ++ T + YA+KV++       DT    REVEL L    H +I+ + 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL-LKKLDHPNIMKLF 87
Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
           ++ E+    S    ++ E   GGELF  I +++   F+E +AA I+ ++ S I ++H  N
Sbjct: 88  EILED----SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN 141
Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I HRD+KPEN+L                       L +K  D  I K+ DFG +     N
Sbjct: 142 IVHRDLKPENIL-----------------------LESKEKDCDI-KIIDFGLSTCFQQN 177
Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
              ++    T YY+APEVL    YD+ CD+WS GVI+YILL G PPF+  +   I     
Sbjct: 178 -TKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK--- 232
Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
            R+  G++ F  P+W  +S +AK LI+ ML   PS R+T  Q +E+ WI +++   +TP
Sbjct: 233 -RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS--SETP 288

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 44/293 (15%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNIK 75
           +LG G  G+VL+  ++ T + YA+KV++       DT    REVEL L    H +I+ + 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL-LKKLDHPNIMKLF 87
Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
           ++ E+    S    ++ E   GGELF  I +++   F+E +AA I+ ++ S I ++H  N
Sbjct: 88  EILED----SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN 141
Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I HRD+KPEN+L                       L +K  D  I K+ DFG +     N
Sbjct: 142 IVHRDLKPENIL-----------------------LESKEKDCDI-KIIDFGLSTCFQQN 177
Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
              ++    T YY+APEVL    YD+ CD+WS GVI+YILL G PPF+  +   I     
Sbjct: 178 -TKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---- 231
Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
            R+  G++ F  P+W  +S +AK LI+ ML   PS R+T  Q +E+ WI +++
Sbjct: 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 105/313 (33%), Positives = 162/313 (51%), Gaps = 44/313 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-----HDTVKARREVELQLAVGS 67
            +D Y +  ++LG G + +V   +   TS+ YA+K++     H   +  REVE+      
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG 69
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H+   N+ ++ E      R  LV  E M GG +   I ++    F E EA++++ ++ SA
Sbjct: 70  HR---NVLELIEFFEEEDRFYLV-FEKMRGGSILSHIHKRRH--FNELEASVVVQDVASA 123
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + FLH++ IAHRD+KPEN+L   P     +K+ DF D+            G  +KL   G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDF-DL------------GSGIKLN--G 168
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
               I  +   L TPC +  Y+APEV+         YDK CD+WSLGVI+YILL G+PPF
Sbjct: 169 DCSPI--STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226
Query: 243 FSNHGQ-------AISPGMKN----RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
               G           P  +N     I+ G+++FP+ +W H+S  AK LI  +L  D  +
Sbjct: 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQ 286
Query: 292 RLTIDQVMENKWI 304
           RL+  QV+++ W+
Sbjct: 287 RLSAAQVLQHPWV 299

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 156/293 (53%), Gaps = 44/293 (15%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNIK 75
           +LG G  G+VL+  ++ T + YA+KV++       DT    REVEL L    H +I+ + 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL-LKKLDHPNIMKLF 87
Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
           ++ E+    S    ++ E   GGELF  I +++   F+E +AA I+ ++ S I ++H  N
Sbjct: 88  EILED----SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN 141
Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I HRD+KPEN+L                       L +K  D  I K+ DFG +     N
Sbjct: 142 IVHRDLKPENIL-----------------------LESKEKDCDI-KIIDFGLSTCFQQN 177
Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
              ++    T YY+APEVL    YD+ CD+WS GVI+YILL G PPF+  +   I     
Sbjct: 178 -TKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---- 231
Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
            R+  G++ F  P+W  +S +AK LI+ ML   PS R+T  Q +E+ WI +++
Sbjct: 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/296 (34%), Positives = 158/296 (53%), Gaps = 44/296 (14%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALK-----VLHDTVKARREVELQLAVGSHKHIVNIKDVY 78
           +G G  G+V   V+K T    A K      + D  + ++E+E+  ++  H +I+ + + +
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETF 92
Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
           E+  +    + ++ME   GGELF+R+  K    F E +AA IM ++ SA+ + H  N+AH
Sbjct: 93  EDNTD----IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAH 146
Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+KPEN L+          LTD  D                LKL DFG A +    K  
Sbjct: 147 RDLKPENFLF----------LTDSPD--------------SPLKLIDFGLAARFKPGKM- 181
Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
           ++T   TPYYV+P+VL    Y   CD WS GV+MY+LLCG+PPF +     +      +I
Sbjct: 182 MRTKVGTPYYVSPQVL-EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM----LKI 236
Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
           R G F FP  +W +VS +A++LI+ +L   P +R+T  Q +E++W  +  Q+  +P
Sbjct: 237 REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK--QLSSSP 290

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 98/304 (32%), Positives = 159/304 (52%), Gaps = 45/304 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGS 67
           DDY +  E LG G    V + V+K  ++ YA K+++       D  K  RE  +   +  
Sbjct: 31  DDYQLFEE-LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI-CRLLK 88
Query: 68  HKHIVNIKD-VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           H +IV + D + E  ++      ++ + + GGELF+ I  +E   ++E +A+  +++I  
Sbjct: 89  HPNIVRLHDSISEEGFH-----YLVFDLVTGGELFEDIVARE--YYSEADASHCIHQILE 141
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           ++  +H  +I HRD+KPEN                        LL      G  +KL DF
Sbjct: 142 SVNHIHQHDIVHRDLKPEN------------------------LLLASKCKGAAVKLADF 177
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G A ++   + +      TP Y++PEVL  D Y K  DIW+ GVI+YILL G+PPF+   
Sbjct: 178 GLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDED 237
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
                  +  +I+ G +DFP+PEW+ V+ EAK LI  ML ++P++R+T DQ +++ W+ Q
Sbjct: 238 QHK----LYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQ 293
Query: 307 FNQV 310
            + V
Sbjct: 294 RSTV 297

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 158/298 (53%), Gaps = 43/298 (14%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALK-----VLHDTVKARREVELQLAVGSHKHIVNIKDVY 78
           +G G  G+V   V+K T    A K      + D  + ++E+E+  ++  H +I+ + + +
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETF 75
Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
           E+  +    + ++ME   GGELF+R+  K    F E +AA IM ++ SA+ + H  N+AH
Sbjct: 76  EDNTD----IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAH 129
Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+KPEN L+          LTD  D                LKL DFG A +    K  
Sbjct: 130 RDLKPENFLF----------LTDSPD--------------SPLKLIDFGLAARFKPGKM- 164
Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
           ++T   TPYYV+P+VL    Y   CD WS GV+MY+LLCG+PPF +     +      +I
Sbjct: 165 MRTKVGTPYYVSPQVL-EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM----LKI 219
Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS-QFNQVPQTPL 315
           R G F FP  +W +VS +A++LI+ +L   P +R+T  Q +E++W   Q +  P+  L
Sbjct: 220 REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 277

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 107/315 (33%), Positives = 159/315 (50%), Gaps = 59/315 (18%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTV--KAR----------------REVELQLAV 65
           LG G  G+VL   EK      A+KV+  +   K R                 E+ L L  
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL-LKS 102
Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
             H +I+ + DV+E+     +   ++ E   GGELF++I  +    F E +AA IM +I 
Sbjct: 103 LDHPNIIKLFDVFED----KKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQIL 156
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
           S I +LH  NI HRD+KPEN+L                 ++ +N L         +K+ D
Sbjct: 157 SGICYLHKHNIVHRDIKPENIL-----------------LENKNSLLN-------IKIVD 192
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
           FG +    S    L+    T YY+APEVL   KY++ CD+WS GVIMYILLCG+PPF   
Sbjct: 193 FGLSS-FFSKDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
           + Q I      ++  G++ F   +W+++S EAK LIK ML  D ++R T ++ + ++WI 
Sbjct: 251 NDQDIIK----KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306
Query: 306 QF----NQVPQTPLC 316
           ++    N+  Q  LC
Sbjct: 307 KYANNINKSDQKTLC 321

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 159/306 (51%), Gaps = 46/306 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAV 65
             D+YD+  E LG G    V + V K T   +A K+++       D  K  RE  +   +
Sbjct: 27  FSDNYDVKEE-LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 66  GSHKHIVNIKD-VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
             H +IV + D + E  ++      ++ + + GGELF+ I  +E   ++E +A+  + +I
Sbjct: 86  -QHPNIVRLHDSIQEESFH-----YLVFDLVTGGELFEDIVARE--FYSEADASHCIQQI 137
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
             +I + H   I HR++KPENL                       LL +K   G  +KL 
Sbjct: 138 LESIAYCHSNGIVHRNLKPENL-----------------------LLASK-AKGAAVKLA 173
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A + V++  +      TP Y++PEVL  D Y K  DIW+ GVI+YILL G+PPF+ 
Sbjct: 174 DFGLAIE-VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                +      +I+ G +D+P+PEW+ V+ EAK+LI +ML V+P +R+T DQ ++  WI
Sbjct: 233 EDQHRLYA----QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288
Query: 305 SQFNQV 310
               +V
Sbjct: 289 CNRERV 294

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 159/306 (51%), Gaps = 46/306 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAV 65
             D+YD+  E LG G    V + V K T   +A K+++       D  K  RE  +   +
Sbjct: 4   FSDNYDVKEE-LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 66  GSHKHIVNIKD-VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
             H +IV + D + E  ++      ++ + + GGELF+ I  +E   ++E +A+  + +I
Sbjct: 63  -QHPNIVRLHDSIQEESFH-----YLVFDLVTGGELFEDIVARE--FYSEADASHCIQQI 114
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
             +I + H   I HR++KPENL                       LL +K   G  +KL 
Sbjct: 115 LESIAYCHSNGIVHRNLKPENL-----------------------LLASK-AKGAAVKLA 150
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A + V++  +      TP Y++PEVL  D Y K  DIW+ GVI+YILL G+PPF+ 
Sbjct: 151 DFGLAIE-VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                    +  +I+ G +D+P+PEW+ V+ EAK+LI +ML V+P +R+T DQ ++  WI
Sbjct: 210 EDQHR----LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
Query: 305 SQFNQV 310
               +V
Sbjct: 266 CNRERV 271

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 101/306 (33%), Positives = 159/306 (51%), Gaps = 46/306 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAV 65
             D+YD+  E LG G    V + V K T   +A K+++       D  K  RE  +   +
Sbjct: 3   FSDNYDVKEE-LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 66  GSHKHIVNIKD-VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
             H +IV + D + E  ++      ++ + + GGELF+ I  +E   ++E +A+  + +I
Sbjct: 62  -QHPNIVRLHDSIQEESFH-----YLVFDLVTGGELFEDIVARE--FYSEADASHCIQQI 113
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
             +I + H   I HR++KPENL                       LL +K   G  +KL 
Sbjct: 114 LESIAYCHSNGIVHRNLKPENL-----------------------LLASK-AKGAAVKLA 149
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A + V++  +      TP Y++PEVL  D Y K  DIW+ GVI+YILL G+PPF+ 
Sbjct: 150 DFGLAIE-VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 208
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                    +  +I+ G +D+P+PEW+ V+ EAK+LI +ML V+P +R+T DQ ++  WI
Sbjct: 209 EDQHR----LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264
Query: 305 SQFNQV 310
               +V
Sbjct: 265 CNRERV 270

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 100/300 (33%), Positives = 157/300 (52%), Gaps = 46/300 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAV 65
             D+YD+  E LG G    V + V K T   +A K+++       D  K  RE  +   +
Sbjct: 4   FSDNYDVKEE-LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 66  GSHKHIVNIKD-VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
             H +IV + D + E  ++      ++ + + GGELF+ I  +E   ++E +A+  + +I
Sbjct: 63  -QHPNIVRLHDSIQEESFH-----YLVFDLVTGGELFEDIVARE--FYSEADASHCIQQI 114
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
             +I + H   I HR++KPENL                       LL +K   G  +KL 
Sbjct: 115 LESIAYCHSNGIVHRNLKPENL-----------------------LLASK-AKGAAVKLA 150
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A + V++  +      TP Y++PEVL  D Y K  DIW+ GVI+YILL G+PPF+ 
Sbjct: 151 DFGLAIE-VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                    +  +I+ G +D+P+PEW+ V+ EAK+LI +ML V+P +R+T DQ ++  WI
Sbjct: 210 EDQHR----LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 95/309 (30%), Positives = 161/309 (52%), Gaps = 55/309 (17%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGS-- 67
           ++D+Y I ++ LG G  G+V    E+KT +  A+K++      + + RE +  L V +  
Sbjct: 7   LRDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 65
Query: 68  -------HKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
                  H  I+ IK+ +  E+ Y       +++E M GGELF ++    +    E    
Sbjct: 66  EILKKLNHPCIIKIKNFFDAEDYY-------IVLELMEGGELFDKVVG--NKRLKEATCK 116
Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           +   ++  A+++LH+  I HRD+KPEN+L +   +  ++K+TDFG               
Sbjct: 117 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH-------------- 162
Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYIL 235
                       KI+   + ++T C TP Y+APEVL   G   Y+++ D WSLGVI++I 
Sbjct: 163 -----------SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 211
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           L G+PP FS H   +S  +K++I  G+++F    W  VS++A  L+K +L VDP  R T 
Sbjct: 212 LSGYPP-FSEHRTQVS--LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT 268
Query: 296 DQVMENKWI 304
           ++ + + W+
Sbjct: 269 EEALRHPWL 277

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 95/309 (30%), Positives = 161/309 (52%), Gaps = 55/309 (17%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGS-- 67
           ++D+Y I ++ LG G  G+V    E+KT +  A+K++      + + RE +  L V +  
Sbjct: 8   LRDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 68  -------HKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
                  H  I+ IK+ +  E+ Y       +++E M GGELF ++    +    E    
Sbjct: 67  EILKKLNHPCIIKIKNFFDAEDYY-------IVLELMEGGELFDKVVG--NKRLKEATCK 117
Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           +   ++  A+++LH+  I HRD+KPEN+L +   +  ++K+TDFG               
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH-------------- 163
Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYIL 235
                       KI+   + ++T C TP Y+APEVL   G   Y+++ D WSLGVI++I 
Sbjct: 164 -----------SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           L G+PP FS H   +S  +K++I  G+++F    W  VS++A  L+K +L VDP  R T 
Sbjct: 213 LSGYPP-FSEHRTQVS--LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT 269
Query: 296 DQVMENKWI 304
           ++ + + W+
Sbjct: 270 EEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 95/309 (30%), Positives = 161/309 (52%), Gaps = 55/309 (17%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGS-- 67
           ++D+Y I ++ LG G  G+V    E+KT +  A+K++      + + RE +  L V +  
Sbjct: 8   LRDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 68  -------HKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
                  H  I+ IK+ +  E+ Y       +++E M GGELF ++    +    E    
Sbjct: 67  EILKKLNHPCIIKIKNFFDAEDYY-------IVLELMEGGELFDKVVG--NKRLKEATCK 117
Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           +   ++  A+++LH+  I HRD+KPEN+L +   +  ++K+TDFG               
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH-------------- 163
Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYIL 235
                       KI+   + ++T C TP Y+APEVL   G   Y+++ D WSLGVI++I 
Sbjct: 164 -----------SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           L G+PP FS H   +S  +K++I  G+++F    W  VS++A  L+K +L VDP  R T 
Sbjct: 213 LSGYPP-FSEHRTQVS--LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT 269
Query: 296 DQVMENKWI 304
           ++ + + W+
Sbjct: 270 EEALRHPWL 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 95/309 (30%), Positives = 161/309 (52%), Gaps = 55/309 (17%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGS-- 67
           ++D+Y I ++ LG G  G+V    E+KT +  A+K++      + + RE +  L V +  
Sbjct: 8   LRDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 68  -------HKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
                  H  I+ IK+ +  E+ Y       +++E M GGELF ++    +    E    
Sbjct: 67  EILKKLNHPCIIKIKNFFDAEDYY-------IVLELMEGGELFDKVVG--NKRLKEATCK 117
Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           +   ++  A+++LH+  I HRD+KPEN+L +   +  ++K+TDFG               
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH-------------- 163
Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYIL 235
                       KI+   + ++T C TP Y+APEVL   G   Y+++ D WSLGVI++I 
Sbjct: 164 -----------SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           L G+PP FS H   +S  +K++I  G+++F    W  VS++A  L+K +L VDP  R T 
Sbjct: 213 LSGYPP-FSEHRTQVS--LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT 269
Query: 296 DQVMENKWI 304
           ++ + + W+
Sbjct: 270 EEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 95/309 (30%), Positives = 161/309 (52%), Gaps = 55/309 (17%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGS-- 67
           ++D+Y I ++ LG G  G+V    E+KT +  A+K++      + + RE +  L V +  
Sbjct: 14  LRDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 72
Query: 68  -------HKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
                  H  I+ IK+ +  E+ Y       +++E M GGELF ++    +    E    
Sbjct: 73  EILKKLNHPCIIKIKNFFDAEDYY-------IVLELMEGGELFDKVVG--NKRLKEATCK 123
Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           +   ++  A+++LH+  I HRD+KPEN+L +   +  ++K+TDFG               
Sbjct: 124 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH-------------- 169
Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYIL 235
                       KI+   + ++T C TP Y+APEVL   G   Y+++ D WSLGVI++I 
Sbjct: 170 -----------SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 218
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           L G+PP FS H   +S  +K++I  G+++F    W  VS++A  L+K +L VDP  R T 
Sbjct: 219 LSGYPP-FSEHRTQVS--LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT 275
Query: 296 DQVMENKWI 304
           ++ + + W+
Sbjct: 276 EEALRHPWL 284

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 147/304 (48%), Gaps = 57/304 (18%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------------ARREVELQLAVGSH 68
           +++G G++  V + V + T   +A+K++  T +              RRE  +   V  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            HI+ + D YE+    S  + ++ + M  GELF  + +K   A +E+E   IM  +  A+
Sbjct: 160 PHIITLIDSYES----SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAV 213
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            FLH  NI HRD+KPEN+L                             D   ++L+DFGF
Sbjct: 214 SFLHANNIVHRDLKPENILL---------------------------DDNMQIRLSDFGF 246
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDK------YDKSCDIWSLGVIMYILLCGFPPF 242
           +  +   +  L+  C TP Y+APE+L          Y K  D+W+ GVI++ LL G PPF
Sbjct: 247 SCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
           +  H + I   M   I  GQ+ F +PEW+  S   K LI  +L VDP  RLT +Q +++ 
Sbjct: 306 W--HRRQIL--MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361
Query: 303 WISQ 306
           +  +
Sbjct: 362 FFER 365

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 156/306 (50%), Gaps = 45/306 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAV 65
           + D+Y +  E LG G    V + ++  T + YA K+++       D  K  RE  +   +
Sbjct: 2   MTDEYQLFEE-LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARI-CRL 59
Query: 66  GSHKHIVNIKD-VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
             H +IV + D + E  ++      ++ + + GGELF+ I  +E   ++E +A+  + +I
Sbjct: 60  LKHPNIVRLHDSISEEGFH-----YLVFDLVTGGELFEDIVARE--YYSEADASHCIQQI 112
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
             ++   H   I HRD+KPEN                        LL      G  +KL 
Sbjct: 113 LESVNHCHLNGIVHRDLKPEN------------------------LLLASKSKGAAVKLA 148
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A ++  ++ +      TP Y++PEVL  D Y K  D+W+ GVI+YILL G+PPF+ 
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD 208
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                    +  +I+ G +DFP+PEW+ V+ EAK LI  ML ++P++R+T  + +++ WI
Sbjct: 209 EDQHR----LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264
Query: 305 SQFNQV 310
            Q + V
Sbjct: 265 CQRSTV 270

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 156/306 (50%), Gaps = 45/306 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAV 65
           + D+Y +  E LG G    V + ++  T + YA K+++       D  K  RE  +   +
Sbjct: 2   MTDEYQLFEE-LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARI-CRL 59
Query: 66  GSHKHIVNIKD-VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
             H +IV + D + E  ++      ++ + + GGELF+ I  +E   ++E +A+  + +I
Sbjct: 60  LKHPNIVRLHDSISEEGFH-----YLVFDLVTGGELFEDIVARE--YYSEADASHCIQQI 112
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
             ++   H   I HRD+KPEN                        LL      G  +KL 
Sbjct: 113 LESVNHCHLNGIVHRDLKPEN------------------------LLLASKSKGAAVKLA 148
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A ++  ++ +      TP Y++PEVL  D Y K  D+W+ GVI+YILL G+PPF+ 
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD 208
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                    +  +I+ G +DFP+PEW+ V+ EAK LI  ML ++P++R+T  + +++ WI
Sbjct: 209 EDQHR----LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264
Query: 305 SQFNQV 310
            Q + V
Sbjct: 265 CQRSTV 270

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 94/309 (30%), Positives = 161/309 (52%), Gaps = 55/309 (17%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGS-- 67
           ++D+Y I ++ LG G  G+V    E+KT +  A++++      + + RE +  L V +  
Sbjct: 147 LRDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 205
Query: 68  -------HKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
                  H  I+ IK+ +  E+ Y       +++E M GGELF ++    +    E    
Sbjct: 206 EILKKLNHPCIIKIKNFFDAEDYY-------IVLELMEGGELFDKVVG--NKRLKEATCK 256
Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           +   ++  A+++LH+  I HRD+KPEN+L +   +  ++K+TDFG               
Sbjct: 257 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH-------------- 302
Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYIL 235
                       KI+   + ++T C TP Y+APEVL   G   Y+++ D WSLGVI++I 
Sbjct: 303 -----------SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 351
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           L G+PP FS H   +S  +K++I  G+++F    W  VS++A  L+K +L VDP  R T 
Sbjct: 352 LSGYPP-FSEHRTQVS--LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT 408
Query: 296 DQVMENKWI 304
           ++ + + W+
Sbjct: 409 EEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 94/309 (30%), Positives = 161/309 (52%), Gaps = 55/309 (17%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGS-- 67
           ++D+Y I ++ LG G  G+V    E+KT +  A++++      + + RE +  L V +  
Sbjct: 133 LRDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 68  -------HKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
                  H  I+ IK+ +  E+ Y       +++E M GGELF ++    +    E    
Sbjct: 192 EILKKLNHPCIIKIKNFFDAEDYY-------IVLELMEGGELFDKVVG--NKRLKEATCK 242
Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           +   ++  A+++LH+  I HRD+KPEN+L +   +  ++K+TDFG               
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH-------------- 288
Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYIL 235
                       KI+   + ++T C TP Y+APEVL   G   Y+++ D WSLGVI++I 
Sbjct: 289 -----------SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           L G+PP FS H   +S  +K++I  G+++F    W  VS++A  L+K +L VDP  R T 
Sbjct: 338 LSGYPP-FSEHRTQVS--LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTT 394
Query: 296 DQVMENKWI 304
           ++ + + W+
Sbjct: 395 EEALRHPWL 403

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 155/306 (50%), Gaps = 45/306 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAV 65
           + D+Y +  +I G G    V + V+  T   YA K+++       D  K  RE  +   +
Sbjct: 2   MTDEYQLYEDI-GKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARI-CRL 59
Query: 66  GSHKHIVNIKD-VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
             H +IV + D + E  ++      ++ + + GGELF+ I  +E   ++E +A+  + +I
Sbjct: 60  LKHSNIVRLHDSISEEGFH-----YLVFDLVTGGELFEDIVARE--YYSEADASHCIQQI 112
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
             A+   H   + HRD+KPEN                        LL      G  +KL 
Sbjct: 113 LEAVLHCHQMGVVHRDLKPEN------------------------LLLASKCKGAAVKLA 148
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A ++  ++ +      TP Y++PEVL  + Y K  DIW+ GVI+YILL G+PPF+ 
Sbjct: 149 DFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWD 208
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                    +  +I+ G +DFP+PEW+ V+ EAK LI  ML ++P++R+T  + +++ W+
Sbjct: 209 EDQHK----LYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264
Query: 305 SQFNQV 310
            Q + V
Sbjct: 265 CQRSTV 270

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 95/296 (32%), Positives = 146/296 (49%), Gaps = 42/296 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNI 74
           E LG G    V + V+    + YA K+++       D  K  RE  +   +  H +IV +
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARI-CRLLKHPNIVRL 86
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            D       G   L  I + + GGELF+ I  +E   ++E +A+  + +I  A+   H  
Sbjct: 87  HDSISE--EGHHYL--IFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM 140
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+KPEN                        LL      G  +KL DFG A ++  
Sbjct: 141 GVVHRDLKPEN------------------------LLLASKLKGAAVKLADFGLAIEVEG 176
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            + +      TP Y++PEVL  D Y K  D+W+ GVI+YILL G+PPF+          +
Sbjct: 177 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR----L 232
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV 310
             +I+ G +DFP+PEW+ V+ EAK LI  ML ++PS+R+T  + +++ WIS  + V
Sbjct: 233 YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTV 288

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 150/295 (50%), Gaps = 45/295 (15%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVGSHKHIVNI 74
           +LG G  G+V+   +K T +  A+KV+         D     REV+L L    H +I+ +
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL-LKQLDHPNIMKL 114
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            + +E+         ++ E   GGELF  I  ++   F+E +AA I+ ++ S I ++H  
Sbjct: 115 YEFFED----KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN 168
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KPENL                       LL +K  D  I ++ DFG +    +
Sbjct: 169 KIVHRDLKPENL-----------------------LLESKSKDANI-RIIDFGLSTHFEA 204
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +K  ++    T YY+APEVL    YD+ CD+WS GVI+YILL G PPF      A    +
Sbjct: 205 SK-KMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPF----NGANEYDI 258
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
             ++  G++ F  P+W+ VS+ AK LI+ ML   PS R++    ++++WI  + +
Sbjct: 259 LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 313

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 150/295 (50%), Gaps = 45/295 (15%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVGSHKHIVNI 74
           +LG G  G+V+   +K T +  A+KV+         D     REV+L L    H +I+ +
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL-LKQLDHPNIMKL 115
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            + +E+         ++ E   GGELF  I  ++   F+E +AA I+ ++ S I ++H  
Sbjct: 116 YEFFED----KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN 169
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KPENL                       LL +K  D  I ++ DFG +    +
Sbjct: 170 KIVHRDLKPENL-----------------------LLESKSKDANI-RIIDFGLSTHFEA 205
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +K  ++    T YY+APEVL    YD+ CD+WS GVI+YILL G PPF      A    +
Sbjct: 206 SK-KMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPF----NGANEYDI 259
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
             ++  G++ F  P+W+ VS+ AK LI+ ML   PS R++    ++++WI  + +
Sbjct: 260 LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 314

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 150/295 (50%), Gaps = 45/295 (15%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVGSHKHIVNI 74
           +LG G  G+V+   +K T +  A+KV+         D     REV+L L    H +I+ +
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL-LKQLDHPNIMKL 91
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            + +E+         ++ E   GGELF  I  ++   F+E +AA I+ ++ S I ++H  
Sbjct: 92  YEFFED----KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN 145
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KPENL                       LL +K  D  I ++ DFG +    +
Sbjct: 146 KIVHRDLKPENL-----------------------LLESKSKDANI-RIIDFGLSTHFEA 181
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +K  ++    T YY+APEVL    YD+ CD+WS GVI+YILL G PPF      A    +
Sbjct: 182 SK-KMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPF----NGANEYDI 235
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
             ++  G++ F  P+W+ VS+ AK LI+ ML   PS R++    ++++WI  + +
Sbjct: 236 LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 150/295 (50%), Gaps = 45/295 (15%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVGSHKHIVNI 74
           +LG G  G+V+   +K T +  A+KV+         D     REV+L L    H +I+ +
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL-LKQLDHPNIMKL 97
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            + +E+         ++ E   GGELF  I  ++   F+E +AA I+ ++ S I ++H  
Sbjct: 98  YEFFED----KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN 151
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KPENL                       LL +K  D  I ++ DFG +    +
Sbjct: 152 KIVHRDLKPENL-----------------------LLESKSKDANI-RIIDFGLSTHFEA 187
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +K  ++    T YY+APEVL    YD+ CD+WS GVI+YILL G PPF      A    +
Sbjct: 188 SK-KMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPF----NGANEYDI 241
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
             ++  G++ F  P+W+ VS+ AK LI+ ML   PS R++    ++++WI  + +
Sbjct: 242 LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 296

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 96/303 (31%), Positives = 152/303 (50%), Gaps = 43/303 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGS 67
           ++Y +  E LG G    V + V+    + YA  +++       D  K  RE  +   +  
Sbjct: 11  EEYQLFEE-LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI-CRLLK 68
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +IV + D       G   L  I + + GGELF+ I  +E   ++E +A+  + +I  A
Sbjct: 69  HPNIVRLHDSISE--EGHHYL--IFDLVTGGELFEDIVARE--YYSEADASHCIQQILEA 122
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +   H   + HR++KPENL                       LL +K   G  +KL DFG
Sbjct: 123 VLHCHQMGVVHRNLKPENL-----------------------LLASKL-KGAAVKLADFG 158
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
            A ++   + +      TP Y++PEVL  D Y K  D+W+ GVI+YILL G+PPF+    
Sbjct: 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
                 +  +I+ G +DFP+PEW+ V+ EAK LI  ML ++PS+R+T  + +++ WIS  
Sbjct: 219 HR----LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274
Query: 308 NQV 310
           + V
Sbjct: 275 STV 277

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 154/304 (50%), Gaps = 50/304 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNI 74
           +D+D   ++LG G  GKV+ + EK T   YA+K+L   V   ++ E+   V   + + N 
Sbjct: 5   NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNT 62
Query: 75  KDVY----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +  +    +  +     L  +ME  +GGELF  + ++    FTE  A     EI SA+++
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEY 120
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH +++ +RD+K ENL+  K G                            +K+TDFG  K
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGH---------------------------IKITDFGLCK 153
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQA 249
           + +S+ A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H + 
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWI 304
               +   IR     FP      +S EAK+L+  +L  DP +RL        +VME+++ 
Sbjct: 214 FELILMEEIR-----FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 305 SQFN 308
              N
Sbjct: 265 LSIN 268

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 154/304 (50%), Gaps = 50/304 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNI 74
           +D+D   ++LG G  GKV+ + EK T   YA+K+L   V   ++ E+   V   + + N 
Sbjct: 8   NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNT 65
Query: 75  KDVY----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +  +    +  +     L  +ME  +GGELF  + ++    FTE  A     EI SA+++
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEY 123
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH +++ +RD+K ENL+  K G                            +K+TDFG  K
Sbjct: 124 LHSRDVVYRDIKLENLMLDKDGH---------------------------IKITDFGLCK 156
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQA 249
           + +S+ A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H + 
Sbjct: 157 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 216
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWI 304
               +   IR     FP      +S EAK+L+  +L  DP +RL        +VME+++ 
Sbjct: 217 FELILMEEIR-----FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267
Query: 305 SQFN 308
              N
Sbjct: 268 LSIN 271

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 154/304 (50%), Gaps = 50/304 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNI 74
           +D+D   ++LG G  GKV+ + EK T   YA+K+L   V   ++ E+   V   + + N 
Sbjct: 5   NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNT 62
Query: 75  KDVY----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +  +    +  +     L  +ME  +GGELF  + ++    FTE  A     EI SA+++
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEY 120
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH +++ +RD+K ENL+  K G                            +K+TDFG  K
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGH---------------------------IKITDFGLCK 153
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQA 249
           + +S+ A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H + 
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWI 304
               +   IR     FP      +S EAK+L+  +L  DP +RL        +VME+++ 
Sbjct: 214 FELILMEEIR-----FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 305 SQFN 308
              N
Sbjct: 265 LSIN 268

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 152/307 (49%), Gaps = 49/307 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQ 62
            +D Y++  E++G G    V + + ++T + +A+K++            T   +RE  + 
Sbjct: 22  FEDVYEL-CEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI--I 120
             +  H HIV + + Y    +    L ++ E M G +L   I ++ D  F   EA     
Sbjct: 81  HML-KHPHIVELLETY----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
           M +I  A+++ HD NI HRDVKPEN+L     +   +KL DFG       +  + G+ G+
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFG-------VAIQLGESGL 188
Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
           +     G                 TP+++APEV+  + Y K  D+W  GVI++ILL G  
Sbjct: 189 VAGGRVG-----------------TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNP-EWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
           PF+    +     +K + ++      NP +W H+S+ AK L++ ML +DP+ER+T+ + +
Sbjct: 232 PFYGTKERLFEGIIKGKYKM------NPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285
Query: 300 ENKWISQ 306
            + W+ +
Sbjct: 286 NHPWLKE 292

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 94/295 (31%), Positives = 146/295 (49%), Gaps = 45/295 (15%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVGSHKHIVNI 74
           +LG G  G+V+   +K T +  A+KV+         D     REV+L L    H +I  +
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL-LKQLDHPNIXKL 91
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            + +E+         ++ E   GGELF  I  ++   F+E +AA I+ ++ S I + H  
Sbjct: 92  YEFFED----KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYXHKN 145
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KPENL                       LL +K  D  I ++ DFG +    +
Sbjct: 146 KIVHRDLKPENL-----------------------LLESKSKDANI-RIIDFGLSTHFEA 181
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +K   +    T YY+APEVL    YD+ CD+WS GVI+YILL G PPF      A    +
Sbjct: 182 SKKX-KDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPF----NGANEYDI 235
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
             ++  G++ F  P+W+ VS+ AK LI+  L   PS R++    ++++WI  + +
Sbjct: 236 LKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTYTK 290

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 93/304 (30%), Positives = 153/304 (50%), Gaps = 50/304 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNI 74
           +D+D   ++LG G  GKV+ + EK T   YA+K+L   V   ++ E+   V   + + N 
Sbjct: 10  NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNT 67
Query: 75  KDVY----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +  +    +  +     L  +ME  +GGELF  + ++    FTE  A     EI SA+++
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEY 125
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH +++ +RD+K ENL+  K G                            +K+TDFG  K
Sbjct: 126 LHSRDVVYRDIKLENLMLDKDGH---------------------------IKITDFGLCK 158
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQA 249
           + +S+ A+++  C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H + 
Sbjct: 159 EGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 218
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWI 304
               +   IR     FP      +S EAK+L+  +L  DP +RL        +VME+++ 
Sbjct: 219 FELILMEEIR-----FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269
Query: 305 SQFN 308
              N
Sbjct: 270 LSIN 273

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 93/304 (30%), Positives = 153/304 (50%), Gaps = 50/304 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNI 74
           +D+D   ++LG G  GKV+ + EK T   YA+K+L   V   ++ E+   V   + + N 
Sbjct: 5   NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNT 62
Query: 75  KDVY----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +  +    +  +     L  +ME  +GGELF  + ++    FTE  A     EI SA+++
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEY 120
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH +++ +RD+K ENL+  K G                            +K+TDFG  K
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGH---------------------------IKITDFGLCK 153
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQA 249
           + +S+ A+++  C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H + 
Sbjct: 154 EGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWI 304
               +   IR     FP      +S EAK+L+  +L  DP +RL        +VME+++ 
Sbjct: 214 FELILMEEIR-----FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 305 SQFN 308
              N
Sbjct: 265 LSIN 268

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 93/304 (30%), Positives = 153/304 (50%), Gaps = 50/304 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNI 74
           +D+D   ++LG G  GKV+ + EK T   YA+K+L   V   ++ E+   V   + + N 
Sbjct: 5   NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNT 62
Query: 75  KDVY----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +  +    +  +     L  +ME  +GGELF  + ++    FTE  A     EI SA+++
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEY 120
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH +++ +RD+K ENL+  K G                            +K+TDFG  K
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGH---------------------------IKITDFGLCK 153
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQA 249
           + +S+ A+++  C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H + 
Sbjct: 154 EGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWI 304
               +   IR     FP      +S EAK+L+  +L  DP +RL        +VME+++ 
Sbjct: 214 FELILMEEIR-----FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 305 SQFN 308
              N
Sbjct: 265 LSIN 268

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 93/304 (30%), Positives = 153/304 (50%), Gaps = 50/304 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNI 74
           +D+D   ++LG G  GKV+ + EK T   YA+K+L   V   ++ E+   V   + + N 
Sbjct: 5   NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNT 62
Query: 75  KDVY----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +  +    +  +     L  +ME  +GGELF  + ++    FTE  A     EI SA+++
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEY 120
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH +++ +RD+K ENL+  K G                            +K+TDFG  K
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGH---------------------------IKITDFGLCK 153
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQA 249
           + +S+ A+++  C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H + 
Sbjct: 154 EGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWI 304
               +   IR     FP      +S EAK+L+  +L  DP +RL        +VME+++ 
Sbjct: 214 FELILMEEIR-----FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 305 SQFN 308
              N
Sbjct: 265 LSIN 268

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 142/306 (46%), Gaps = 58/306 (18%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT---------VKARRE-----VELQLAVGS 67
           EILG G++  V + + K T + YA+K++  T         V+  RE     V++   V  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +I+ +KD YE     +    ++ + M  GELF  + +K     +E+E   IM  +   
Sbjct: 83  HPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEV 136
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I  LH  NI HRD+KPEN+L                             D   +KLTDFG
Sbjct: 137 ICALHKLNIVHRDLKPENILL---------------------------DDDMNIKLTDFG 169
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL------GPDKYDKSCDIWSLGVIMYILLCGFPP 241
           F+ ++   +  L++ C TP Y+APE++          Y K  D+WS GVIMY LL G PP
Sbjct: 170 FSCQLDPGE-KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           F+          M   I  G + F +PEW+  S   K L+   L V P +R T ++ + +
Sbjct: 229 FWHRKQML----MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284
Query: 302 KWISQF 307
            +  Q+
Sbjct: 285 PFFQQY 290

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 141/306 (46%), Gaps = 58/306 (18%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT---------VKARRE-----VELQLAVGS 67
           EILG G++  V + + K T + YA+K++  T         V+  RE     V++   V  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +I+ +KD YE     +    ++ + M  GELF  + +K     +E+E   IM  +   
Sbjct: 83  HPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEV 136
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I  LH  NI HRD+KPEN+L                             D   +KLTDFG
Sbjct: 137 ICALHKLNIVHRDLKPENILL---------------------------DDDMNIKLTDFG 169
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL------GPDKYDKSCDIWSLGVIMYILLCGFPP 241
           F+ ++   +  L+  C TP Y+APE++          Y K  D+WS GVIMY LL G PP
Sbjct: 170 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           F+          M   I  G + F +PEW+  S   K L+   L V P +R T ++ + +
Sbjct: 229 FWHRKQML----MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284
Query: 302 KWISQF 307
            +  Q+
Sbjct: 285 PFFQQY 290

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 141/306 (46%), Gaps = 58/306 (18%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT---------VKARRE-----VELQLAVGS 67
           EILG G++  V + + K T + YA+K++  T         V+  RE     V++   V  
Sbjct: 10  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 69
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +I+ +KD YE     +    ++ + M  GELF  + +K     +E+E   IM  +   
Sbjct: 70  HPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEV 123
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I  LH  NI HRD+KPEN+L                             D   +KLTDFG
Sbjct: 124 ICALHKLNIVHRDLKPENILL---------------------------DDDMNIKLTDFG 156
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL------GPDKYDKSCDIWSLGVIMYILLCGFPP 241
           F+ ++   +  L+  C TP Y+APE++          Y K  D+WS GVIMY LL G PP
Sbjct: 157 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           F+          M   I  G + F +PEW+  S   K L+   L V P +R T ++ + +
Sbjct: 216 FWHRKQML----MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 271
Query: 302 KWISQF 307
            +  Q+
Sbjct: 272 PFFQQY 277

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 95/329 (28%), Positives = 159/329 (48%), Gaps = 47/329 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL---HDTVKARREVELQ-LAVGSH 68
           + D YDI  E LG G  G V ++ E+ T   +A K +   H++ K     E+Q ++V  H
Sbjct: 49  VLDHYDIHEE-LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 107
Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
             +VN+ D +E+       +++I E M GGELF+++   E    +E EA   M ++C  +
Sbjct: 108 PTLVNLHDAFED----DNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGL 162
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
             +H+ N  H D+KPEN+++T                       TK  +   LKL DFG 
Sbjct: 163 CHMHENNYVHLDLKPENIMFT-----------------------TKRSNE--LKLIDFGL 197
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
              +   K S++    T  + APEV          D+WS+GV+ YILL G  PF    G+
Sbjct: 198 TAHL-DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF---GGE 253
Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
                ++N ++   ++  +  +  +S++ K  I+ +L  DP+ R+TI Q +E+ W++  N
Sbjct: 254 NDDETLRN-VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 312
Query: 309 ------QVPQTPLCTGK-MLKEGEETWPE 330
                 Q+P +     +  +K   + WPE
Sbjct: 313 APGRDSQIPSSRYTKIRDSIKTKYDAWPE 341

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/329 (28%), Positives = 158/329 (48%), Gaps = 47/329 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL---HDTVKARREVELQ-LAVGSH 68
           + D YDI  E LG G  G V ++ E+ T   +A K +   H++ K     E+Q ++V  H
Sbjct: 155 VLDHYDIHEE-LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
             +VN+ D +E+       +++I E M GGELF+++   E    +E EA   M ++C  +
Sbjct: 214 PTLVNLHDAFED----DNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGL 268
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
             +H+ N  H D+KPEN+++T                K  N L          KL DFG 
Sbjct: 269 CHMHENNYVHLDLKPENIMFT---------------TKRSNEL----------KLIDFGL 303
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
              +   K S++    T  + APEV          D+WS+GV+ YILL G  PF    G+
Sbjct: 304 TAHL-DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF---GGE 359
Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
                ++N ++   ++  +  +  +S++ K  I+ +L  DP+ R+TI Q +E+ W++  N
Sbjct: 360 NDDETLRN-VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418
Query: 309 ------QVPQTPLCTGK-MLKEGEETWPE 330
                 Q+P +     +  +K   + WPE
Sbjct: 419 APGRDSQIPSSRYTKIRDSIKTKYDAWPE 447

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 148/302 (49%), Gaps = 45/302 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAV 65
           ++D Y++  E LG G    V +  +K T + YA K +            +R E+E ++ +
Sbjct: 3   VEDHYEMGEE-LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 66  GS---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                H +I+ + D++EN  +    +++I+E + GGELF  + +KE  + TE EA   + 
Sbjct: 62  LREIRHPNIITLHDIFENKTD----VVLILELVSGGELFDFLAEKE--SLTEDEATQFLK 115
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I   + +LH + IAH D+KPEN++           L D     P             +K
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIM-----------LLDKNVPNPR------------IK 152
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           L DFG A KI +     +    TP +VAPE++  +      D+WS+GVI YILL G  PF
Sbjct: 153 LIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
               G+     + N I    +DF    + + S+ AK  I+ +L  DP  R+TI Q +E+ 
Sbjct: 212 L---GETKQETLTN-ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267
Query: 303 WI 304
           WI
Sbjct: 268 WI 269

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 147/303 (48%), Gaps = 45/303 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAV 65
           ++D YDI  E LG G    V +  EK T   YA K +            +R E+E ++++
Sbjct: 10  VEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 66  GS---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                H +++ + DVYEN  +    +++I+E + GGELF  + QKE  + +E EA   + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTD----VVLILELVSGGELFDFLAQKE--SLSEEEATSFIK 122
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I   + +LH + IAH D+KPEN++           L D     P             +K
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIM-----------LLDKNIPIPH------------IK 159
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           L DFG A +I  +    +    TP +VAPE++  +      D+WS+GVI YILL G  PF
Sbjct: 160 LIDFGLAHEI-EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
             +  Q     + +      +DF    + H S+ AK  I+ +L  +  +RLTI + + + 
Sbjct: 219 LGDTKQETLANITS----VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 303 WIS 305
           WI+
Sbjct: 275 WIT 277

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 147/303 (48%), Gaps = 45/303 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAV 65
           ++D YDI  E LG G    V +  EK T   YA K +            +R E+E ++++
Sbjct: 10  VEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 66  GS---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                H +++ + DVYEN  +    +++I+E + GGELF  + QKE  + +E EA   + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTD----VVLILELVSGGELFDFLAQKE--SLSEEEATSFIK 122
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I   + +LH + IAH D+KPEN++           L D     P             +K
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIM-----------LLDKNIPIPH------------IK 159
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           L DFG A +I  +    +    TP +VAPE++  +      D+WS+GVI YILL G  PF
Sbjct: 160 LIDFGLAHEI-EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
             +  Q     + +      +DF    + H S+ AK  I+ +L  +  +RLTI + + + 
Sbjct: 219 LGDTKQETLANITSV----SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 303 WIS 305
           WI+
Sbjct: 275 WIT 277

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 147/303 (48%), Gaps = 45/303 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAV 65
           ++D YDI  E LG G    V +  EK T   YA K +            +R E+E ++++
Sbjct: 10  VEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 66  GS---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                H +++ + DVYEN  +    +++I+E + GGELF  + QKE  + +E EA   + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTD----VVLILELVSGGELFDFLAQKE--SLSEEEATSFIK 122
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I   + +LH + IAH D+KPEN++           L D     P             +K
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIM-----------LLDKNIPIPH------------IK 159
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           L DFG A +I  +    +    TP +VAPE++  +      D+WS+GVI YILL G  PF
Sbjct: 160 LIDFGLAHEI-EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
             +  Q     + +      +DF    + H S+ AK  I+ +L  +  +RLTI + + + 
Sbjct: 219 LGDTKQETLANITS----VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 303 WIS 305
           WI+
Sbjct: 275 WIT 277

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 151/310 (48%), Gaps = 49/310 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQ 62
            +D Y++  E++G G    V + + ++T + +A+K++            T   +RE  + 
Sbjct: 24  FEDVYEL-CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 82
Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI--I 120
             +  H HIV + + Y +       L ++ E M G +L   I ++ D  F   EA     
Sbjct: 83  HML-KHPHIVELLETYSS----DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 137
Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
           M +I  A+++ HD NI HRDVKP  +L     +   +KL  FG       +  + G+ G+
Sbjct: 138 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG-------VAIQLGESGL 190
Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
           +     G                 TP+++APEV+  + Y K  D+W  GVI++ILL G  
Sbjct: 191 VAGGRVG-----------------TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 233
Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNP-EWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
           PF+    +     +K + ++      NP +W H+S+ AK L++ ML +DP+ER+T+ + +
Sbjct: 234 PFYGTKERLFEGIIKGKYKM------NPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 287
Query: 300 ENKWISQFNQ 309
            + W+ + ++
Sbjct: 288 NHPWLKERDR 297

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 149/307 (48%), Gaps = 49/307 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQ 62
            +D Y++  E++G G    V + + ++T + +A+K++            T   +RE  + 
Sbjct: 22  FEDVYEL-CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI--I 120
             +  H HIV + + Y    +    L ++ E M G +L   I ++ D  F   EA     
Sbjct: 81  HML-KHPHIVELLETY----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
           M +I  A+++ HD NI HRDVKP  +L     +   +KL  FG       +  + G+ G+
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG-------VAIQLGESGL 188
Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
           +     G                 TP+++APEV+  + Y K  D+W  GVI++ILL G  
Sbjct: 189 VAGGRVG-----------------TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNP-EWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
           PF+    +     +K + ++      NP +W H+S+ AK L++ ML +DP+ER+T+ + +
Sbjct: 232 PFYGTKERLFEGIIKGKYKM------NPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285
Query: 300 ENKWISQ 306
            + W+ +
Sbjct: 286 NHPWLKE 292

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 161/343 (46%), Gaps = 62/343 (18%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----DTVKARREVELQLAVGS 67
           + D YDI  E LG G  G V + VEK T  V+  K ++     D    + E+ +   +  
Sbjct: 49  VYDYYDILEE-LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-H 106
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H  ++N+ D +E+ Y     +++I+E + GGELF RI   ED   +E E    M + C  
Sbjct: 107 HPKLINLHDAFEDKYE----MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEG 161
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +K +H+ +I H D+KPEN++  +      +K+ DFG       L TK     I+K+T   
Sbjct: 162 LKHMHEHSIVHLDIKPENIM-CETKKASSVKIIDFG-------LATKLNPDEIVKVT--- 210
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
                            T  + APE++  +      D+W++GV+ Y+LL G  PF    G
Sbjct: 211 ---------------TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF---AG 252
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI--- 304
           +     ++N ++   ++F    +  VS EAK  IKN+L  +P +RLT+   +E+ W+   
Sbjct: 253 EDDLETLQN-VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311
Query: 305 ----------SQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTR 337
                     S++N++ Q        +KE    WP  Q  + R
Sbjct: 312 HSNLTSRIPSSRYNKIRQK-------IKEKYADWPAPQPAIGR 347

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 92/302 (30%), Positives = 147/302 (48%), Gaps = 45/302 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAV 65
           ++D Y++  E LG G    V +  +K T + YA K +            +R E+E ++ +
Sbjct: 24  VEDHYEMGEE-LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNI 82
Query: 66  GS---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                H +I+ + D++EN  +    +++I+E + GGELF  + +KE  + TE EA   + 
Sbjct: 83  LREIRHPNIITLHDIFENKTD----VVLILELVSGGELFDFLAEKE--SLTEDEATQFLK 136
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I   + +LH + IAH D+KPEN++           L D     P             +K
Sbjct: 137 QILDGVHYLHSKRIAHFDLKPENIM-----------LLDKNVPNPR------------IK 173
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           L DFG A KI +     +    TP +VAPE++  +      D+WS+GVI YILL G  PF
Sbjct: 174 LIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
               G+     + N I    +DF    + + S+ AK  I+ +L  DP  R+ I Q +E+ 
Sbjct: 233 L---GETKQETLTN-ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHS 288
Query: 303 WI 304
           WI
Sbjct: 289 WI 290

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 149/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 13  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 67
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    GE+++ +Q+     F E+  A  + E+ +
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYL-ILEYAPRGEVYKELQKL--SKFDEQRTATYITELAN 124
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 157
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 158 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 216 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267
Query: 307 FNQVP 311
            +  P
Sbjct: 268 NSSKP 272

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 149/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D+DI    LG G  G V    E+++  + ALKVL  T         + RREVE+Q    
Sbjct: 12  EDFDIGRP-LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ---- 66
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SRFDEQRTATYITELAN 123
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 124 ALSYCHSKRVIHRDIKPENLLL---------------------------GSNGELKIADF 156
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF ++ 
Sbjct: 157 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  + S+RLT+ +V+E+ WI  
Sbjct: 215 YQETY----RRISRVEFTFPD----FVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKA 266
Query: 307 FNQVP 311
            +  P
Sbjct: 267 NSSKP 271

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 92/302 (30%), Positives = 147/302 (48%), Gaps = 45/302 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAV 65
           ++D Y++  E LG G    V +  +K T + YA K +            +R E+E ++ +
Sbjct: 10  VEDHYEMGEE-LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 66  GS---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                H +I+ + D++EN  +    +++I+E + GGELF  + +KE  + TE EA   + 
Sbjct: 69  LREIRHPNIITLHDIFENKTD----VVLILELVSGGELFDFLAEKE--SLTEDEATQFLK 122
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I   + +LH + IAH D+KPEN++           L D     P             +K
Sbjct: 123 QILDGVHYLHSKRIAHFDLKPENIM-----------LLDKNVPNPR------------IK 159
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           L DFG A KI +     +    TP +VAPE++  +      D+WS+GVI YILL G  PF
Sbjct: 160 LIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
               G+     + N I    +DF    + + S+ AK  I+ +L  DP  R+ I Q +E+ 
Sbjct: 219 L---GETKQETLTN-ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHS 274
Query: 303 WI 304
           WI
Sbjct: 275 WI 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 147/300 (49%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G+   V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 45/303 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAV 65
           ++D YDI  E LG G    V +  EK T   YA K +            +R E+E ++++
Sbjct: 10  VEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 66  GS---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                H +++ + DVYEN  +    +++I+E + GGELF  + QKE  + +E EA   + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTD----VVLILELVSGGELFDFLAQKE--SLSEEEATSFIK 122
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I   + +LH + IAH D+KPEN++           L D     P             +K
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIM-----------LLDKNIPIPH------------IK 159
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           L DFG A +I  +    +    TP +VAPE++  +      D+WS+GVI YILL G  PF
Sbjct: 160 LIDFGLAHEI-EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
             +  Q         I    +DF    +   S+ AK  I+ +L  +  +RLTI + + + 
Sbjct: 219 LGDTKQETLAN----ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 303 WIS 305
           WI+
Sbjct: 275 WIT 277

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 92/303 (30%), Positives = 145/303 (47%), Gaps = 45/303 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAV 65
           ++D YDI  E LG G    V +  EK T   YA K +            +R E+E ++++
Sbjct: 10  VEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 66  GS---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                H +++ + DVYEN  +    +++I+E + GGELF  + QKE  + +E EA   + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTD----VVLILELVSGGELFDFLAQKE--SLSEEEATSFIK 122
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I   + +LH + IAH D+KPEN++           L D     P             +K
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIM-----------LLDKNIPIPH------------IK 159
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           L DFG A +I  +    +    TP +VAPE++  +      D+WS+GVI YILL G  PF
Sbjct: 160 LIDFGLAHEI-EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
             +  Q         I    +DF    +   S+ AK  I+ +L  +  +RLTI + + + 
Sbjct: 219 LGDTKQETLAN----ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 303 WIS 305
           WI+
Sbjct: 275 WIT 277

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 94/303 (31%), Positives = 147/303 (48%), Gaps = 45/303 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAV 65
           ++D YDI  E LG G    V +  EK T   YA K +    +  +RR     E+E ++++
Sbjct: 10  VEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 66  GS---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                H +I+ + DVYEN  +    +++I+E + GGELF  + QKE  + +E EA   + 
Sbjct: 69  LRQVLHPNIITLHDVYENRTD----VVLILELVSGGELFDFLAQKE--SLSEEEATSFIK 122
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I   + +LH + IAH D+KPEN++           L D     P             +K
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIM-----------LLDKNIPIPH------------IK 159
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           L DFG A +I  +    +    TP +VAPE++  +      D+WS+GVI YILL G  PF
Sbjct: 160 LIDFGLAHEI-EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
             +  Q         I    +DF    +   S+ AK  I+ +L  +  +RLTI + + + 
Sbjct: 219 LGDTKQETLAN----ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 303 WIS 305
           WI+
Sbjct: 275 WIT 277

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 148/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D+DI    LG G  G V    E+++  + ALKVL  T         + RREVE+Q    
Sbjct: 12  EDFDIGRP-LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ---- 66
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SRFDEQRTATYITELAN 123
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 124 ALSYCHSKRVIHRDIKPENLLL---------------------------GSNGELKIADF 156
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++    T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF ++ 
Sbjct: 157 GWSVHAPSSRRD--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  + S+RLT+ +V+E+ WI  
Sbjct: 215 YQETY----RRISRVEFTFPD----FVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKA 266
Query: 307 FNQVP 311
            +  P
Sbjct: 267 NSSKP 271

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 141/292 (48%), Gaps = 44/292 (15%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH----DTVKARREVELQLAVGSHKHIVNIKD 76
            E LG G  G V + VE  + + Y  K +     D V  ++E+ + L +  H++I+++ +
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISI-LNIARHRNILHLHE 68
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAF--TEREAAIIMNEICSAIKFLHDQ 134
            +E++      L++I E + G ++F+RI      AF   ERE    ++++C A++FLH  
Sbjct: 69  SFESMEE----LVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
           NI H D++PEN++Y +      +K+ +FG  +       KPGD   L  T          
Sbjct: 122 NIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQ-----LKPGDNFRLLFT---------- 165
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
                      P Y APEV   D    + D+WSLG ++Y+LL G  PF +   Q I   +
Sbjct: 166 ----------APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            N     ++ F    ++ +S EA   +  +L  +   R+T  + +++ W+ Q
Sbjct: 216 MN----AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 151/299 (50%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 62  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 178
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 179 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 211
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K +  T C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++  Q I 
Sbjct: 212 V---KGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQ 266
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
             +  +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 267 --IYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 319

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 140/281 (49%), Gaps = 51/281 (18%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAV------GSHKHIVNI 74
           ++LG G  GKV+ + EK T   YA+K+L  + + A+ EV   L          H  +  +
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-D 133
           K  ++        L  +ME  +GGELF  + ++    F+E  A     EI SA+ +LH +
Sbjct: 217 KYSFQT----HDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSE 270
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           +N+ +RD+K ENL+  K G                            +K+TDFG  K+ +
Sbjct: 271 KNVVYRDLKLENLMLDKDGH---------------------------IKITDFGLCKEGI 303
Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISP 252
            + A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H +    
Sbjct: 304 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 363
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            +   IR     FP      +  EAK+L+  +L  DP +RL
Sbjct: 364 ILMEEIR-----FPRT----LGPEAKSLLSGLLKKDPKQRL 395

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 140/281 (49%), Gaps = 51/281 (18%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAV------GSHKHIVNI 74
           ++LG G  GKV+ + EK T   YA+K+L  + + A+ EV   L          H  +  +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-D 133
           K  ++        L  +ME  +GGELF  + ++    F+E  A     EI SA+ +LH +
Sbjct: 214 KYSFQT----HDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSE 267
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           +N+ +RD+K ENL+  K G                            +K+TDFG  K+ +
Sbjct: 268 KNVVYRDLKLENLMLDKDGH---------------------------IKITDFGLCKEGI 300
Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISP 252
            + A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H +    
Sbjct: 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            +   IR     FP      +  EAK+L+  +L  DP +RL
Sbjct: 361 ILMEEIR-----FPRT----LGPEAKSLLSGLLKKDPKQRL 392

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 148/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 34  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 88
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 145
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 146 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 178
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 179 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 237 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288
Query: 307 FNQVP 311
            +  P
Sbjct: 289 NSSKP 293

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 148/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 25  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 79
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 136
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 137 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 169
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 170 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 227
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 228 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 279
Query: 307 FNQVP 311
            +  P
Sbjct: 280 NSSKP 284

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 148/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 7   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 61
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 118
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 119 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 151
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 152 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 209
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 210 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 261
Query: 307 FNQVP 311
            +  P
Sbjct: 262 NSSKP 266

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 148/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 13  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 67
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 124
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 157
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 158 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 216 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267
Query: 307 FNQVP 311
            +  P
Sbjct: 268 NSSKP 272

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 148/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 11  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 65
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 122
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 155
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 156 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 214 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265
Query: 307 FNQVP 311
            +  P
Sbjct: 266 NSSKP 270

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 148/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 12  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 66
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKLSK--FDEQRTATYITELAN 123
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 124 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 156
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 157 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 214
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 215 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 266
Query: 307 FNQVP 311
            +  P
Sbjct: 267 NSSKP 271

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 148/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 8   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 62
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 119
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 152
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 153 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 211 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262
Query: 307 FNQVP 311
            +  P
Sbjct: 263 NSSKP 267

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 94/294 (31%), Positives = 140/294 (47%), Gaps = 52/294 (17%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-------DTV-KARREVELQLAVGSHKHIVN 73
           + LG+G  GKV     + T    A+K+L+       D V K +RE++  L +  H HI+ 
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ-NLKLFRHPHIIK 75
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +  V     +      ++ME + GGELF  I +   G   E EA  +  +I SA+ + H 
Sbjct: 76  LYQVISTPTD----FFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHR 129
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             + HRD+KPEN+L     +                            K+ DFG +  ++
Sbjct: 130 HMVVHRDLKPENVLLDAHMNA---------------------------KIADFGLS-NMM 161
Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           S+   L+T C +P Y APEV+    Y     DIWS GVI+Y LLCG  PF   H     P
Sbjct: 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----VP 217
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            +  +IR G F  P    E++++   TL+ +ML VDP +R TI  + E++W  Q
Sbjct: 218 TLFKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 69  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 122
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 159
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 160 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 219 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 69  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 122
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 159
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 160 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 219 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 13  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 67
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 124
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 157
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE +    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 158 GWSVHAPSSRRT--TLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANT 215
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 216 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPXLREVLEHPWITA 267
Query: 307 FNQVP 311
            +  P
Sbjct: 268 NSSKP 272

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I+E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 139/281 (49%), Gaps = 51/281 (18%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAV------GSHKHIVNI 74
           ++LG G  GKV+ + EK T   YA+K+L  + + A+ EV   L          H  +  +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 73
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-D 133
           K  ++        L  +ME  +GGELF  + ++    F+E  A     EI SA+ +LH +
Sbjct: 74  KYSFQT----HDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSE 127
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           +N+ +RD+K ENL+  K G                            +K+TDFG  K+ +
Sbjct: 128 KNVVYRDLKLENLMLDKDGH---------------------------IKITDFGLCKEGI 160
Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISP 252
            + A+++  C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H +    
Sbjct: 161 KDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 220
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            +   IR     FP      +  EAK+L+  +L  DP +RL
Sbjct: 221 ILMEEIR-----FPRT----LGPEAKSLLSGLLKKDPKQRL 252

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 146/299 (48%), Gaps = 53/299 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 11  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 65
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 122
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 155
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 156 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+
Sbjct: 214 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 143/290 (49%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 168 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIXNHKWFA 299

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 139/281 (49%), Gaps = 51/281 (18%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAV------GSHKHIVNI 74
           ++LG G  GKV+ + EK T   YA+K+L  + + A+ EV   L          H  +  +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-D 133
           K  ++        L  +ME  +GGELF  + ++    F+E  A     EI SA+ +LH +
Sbjct: 75  KYSFQT----HDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSE 128
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           +N+ +RD+K ENL+  K G                            +K+TDFG  K+ +
Sbjct: 129 KNVVYRDLKLENLMLDKDGH---------------------------IKITDFGLCKEGI 161
Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISP 252
            + A+++  C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H +    
Sbjct: 162 KDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 221
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            +   IR     FP      +  EAK+L+  +L  DP +RL
Sbjct: 222 ILMEEIR-----FPRT----LGPEAKSLLSGLLKKDPKQRL 253

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 139/281 (49%), Gaps = 51/281 (18%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAV------GSHKHIVNI 74
           ++LG G  GKV+ + EK T   YA+K+L  + + A+ EV   L          H  +  +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-D 133
           K  ++        L  +ME  +GGELF  + ++    F+E  A     EI SA+ +LH +
Sbjct: 76  KYSFQT----HDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSE 129
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           +N+ +RD+K ENL+  K G                            +K+TDFG  K+ +
Sbjct: 130 KNVVYRDLKLENLMLDKDGH---------------------------IKITDFGLCKEGI 162
Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISP 252
            + A+++  C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H +    
Sbjct: 163 KDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 222
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            +   IR     FP      +  EAK+L+  +L  DP +RL
Sbjct: 223 ILMEEIR-----FPRT----LGPEAKSLLSGLLKKDPKQRL 254

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 9   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 63
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 120
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 153
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++    T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 154 GWSVHAPSSRRD--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 212 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
Query: 307 FNQVP 311
            +  P
Sbjct: 264 NSSKP 268

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 143/290 (49%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 168 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 145/290 (50%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 187
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  + G                            +++TDFGFAK++   K    
Sbjct: 188 LKPENLLIDQQG---------------------------YIQVTDFGFAKRV---KGRTW 217
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++  Q I   +  +I  
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQ--IYEKIVS 273
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 274 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 319

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 147/299 (49%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 147/299 (49%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 42  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 158
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 159 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 191
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 192 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 249 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 143/290 (49%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 168 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 143/290 (49%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 159
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 160 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 189
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 245
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 246 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 291

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 142/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME   GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENL+  + G                            +K+TDFGFAK++   K    
Sbjct: 168 LKPENLMIDQQG---------------------------YIKVTDFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 143/290 (49%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 168 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
           T C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 198 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 147/299 (49%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 28  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 86
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 144
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL                             + G +++TDFGFAK+
Sbjct: 145 HSLDLIYRDLKPENLLID---------------------------EQGYIQVTDFGFAKR 177
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 178 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 234
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 235 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 285

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 143/290 (49%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 152
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 153 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 182
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
           T C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 183 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 238
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 239 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFA 284

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 147/299 (49%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 148/295 (50%), Gaps = 42/295 (14%)
Query: 17  YDIS-TEILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARREVELQLAVGS---HKHI 71
           Y +S TEILG G  G+V +  E  T    A K++    +K + EV+ +++V +   H ++
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           + + D +E+  +    ++++ME + GGELF RI   E    TE +  + M +IC  I+ +
Sbjct: 149 IQLYDAFESKND----IVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHM 203
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I H D+KPEN+L                             D   +K+ DFG A++
Sbjct: 204 HQMYILHLDLKPENILCVNR-------------------------DAKQIKIIDFGLARR 238
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAI 250
               +  L+    TP ++APEV+  D      D+WS+GVI Y+LL G  PF   N  + +
Sbjct: 239 -YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297
Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
                N I   ++D  + E++ +S+EAK  I  +L  + S R++  + +++ W+S
Sbjct: 298 -----NNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 147/299 (49%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLPNGVNDIKNHKWFA 298

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 147/299 (49%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 147/299 (49%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 148/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 11  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 65
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 122
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ +F
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIANF 155
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 156 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 214 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265
Query: 307 FNQVP 311
            +  P
Sbjct: 266 NSSKP 270

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 8   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 62
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 119
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 152
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +    C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 153 GWSVHAPSSRRA--ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 211 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262
Query: 307 FNQVP 311
            +  P
Sbjct: 263 NSSKP 267

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 148/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 10  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 64
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 121
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ +F
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIANF 154
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 155 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 213 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264
Query: 307 FNQVP 311
            +  P
Sbjct: 265 NSSKP 269

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFAEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 145/299 (48%), Gaps = 53/299 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK+   + ALKVL            + RREVE+Q    
Sbjct: 5   EDFEIGRP-LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 59
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 116
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 117 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 149
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 150 GWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 207
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+
Sbjct: 208 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 258

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 11  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 65
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKLSK--FDEQRTATYITELAN 122
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 155
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +    C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 156 GWSVHAPSSRRA--ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 214 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265
Query: 307 FNQVP 311
            +  P
Sbjct: 266 NSSKP 270

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 142/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F E  A     +I    ++LH  ++ +RD
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 159
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 160 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 189
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 245
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 246 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 291

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 145/300 (48%), Gaps = 44/300 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKARR-----EVELQLAVG- 66
           DDY  + E LG G    V +  EK T   YA K +    T  +RR     ++E ++++  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 67  --SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +++ + +VYEN  +    +++I E + GGELF  + +KE  + TE EA   + +I
Sbjct: 70  EIQHPNVITLHEVYENKTD----VILIGELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + + +LH   IAH D+KPEN++           L D    KP             +K+ 
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIM-----------LLDRNVPKPR------------IKII 160
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL G  PF  
Sbjct: 161 DFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI   +++ WI
Sbjct: 220 DTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 8   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 62
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 119
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 152
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +    C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 153 GWSVHAPSSRRTXL--CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 211 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262
Query: 307 FNQVP 311
            +  P
Sbjct: 263 NSSKP 267

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 144/290 (49%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   YA+K+L    V   +++E  L     +  VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L +++E   GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +K+ DFGFAK++   K    
Sbjct: 168 LKPENLLIDQQ---------------------------GYIKVADFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++  Q I   +  +I  
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQ--IYEKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 148/299 (49%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 62  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F E  A     +I    ++L
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYL 178
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 179 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 211
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++  Q I 
Sbjct: 212 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQ 266
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
             +  +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 267 --IYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 319

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 36  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F E  A     +I    ++L
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYL 152
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 153 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 185
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 186 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 242
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 243 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 293

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 8   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 62
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 119
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 152
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +    C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 153 GWSVHAPSSRRT--ELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 211 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262
Query: 307 FNQVP 311
            +  P
Sbjct: 263 NSSKP 267

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 145/290 (50%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   +A+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++  Q I   +  +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQ--IYEKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 143/290 (49%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   +A+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 145/290 (50%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +  K+T   +A+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++  Q I   +  +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQ--IYEKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 8   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 62
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 119
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 152
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +    C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 153 GWSVHAPSSRRT--DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 211 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262
Query: 307 FNQVP 311
            +  P
Sbjct: 263 NSSKP 267

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 147/299 (49%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENL+  + G                            +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLIIDQQG---------------------------YIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 146/305 (47%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 34  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 88
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 145
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 146 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 178
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++      C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 179 GWSVHAPSSRRD--DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 237 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288
Query: 307 FNQVP 311
            +  P
Sbjct: 289 NSSKP 293

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 9   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 63
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 120
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 153
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +    C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 154 GWSVHAPSSRRT--DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 212 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
Query: 307 FNQVP 311
            +  P
Sbjct: 264 NSSKP 268

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 13  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 67
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 124
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 157
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +    C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 158 GWSVHAPSSRRT--DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 216 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267
Query: 307 FNQVP 311
            +  P
Sbjct: 268 NSSKP 272

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 139/294 (47%), Gaps = 52/294 (17%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-------DTV-KARREVELQLAVGSHKHIVN 73
           + LG+G  GKV     + T    A+K+L+       D V K +RE++  L +  H HI+ 
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ-NLKLFRHPHIIK 75
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +  V     +      ++ME + GGELF  I +   G   E EA  +  +I SA+ + H 
Sbjct: 76  LYQVISTPTD----FFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHR 129
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             + HRD+KPEN+L     +                            K+ DFG +  ++
Sbjct: 130 HMVVHRDLKPENVLLDAHMNA---------------------------KIADFGLS-NMM 161
Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           S+   L+  C +P Y APEV+    Y     DIWS GVI+Y LLCG  PF   H     P
Sbjct: 162 SDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----VP 217
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            +  +IR G F  P    E++++   TL+ +ML VDP +R TI  + E++W  Q
Sbjct: 218 TLFKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 8   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 62
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 119
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 152
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +    C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 153 GWSVHAPSSRRT--DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 211 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262
Query: 307 FNQVP 311
            +  P
Sbjct: 263 NSSKP 267

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 146/305 (47%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 8   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 62
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 119
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 152
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++      C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 153 GWSVHAPSSRRXXL--CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 211 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262
Query: 307 FNQVP 311
            +  P
Sbjct: 263 NSSKP 267

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 146/305 (47%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 10  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 64
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 121
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 154
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++      C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 155 GWSVHAPSSRRX--XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 213 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264
Query: 307 FNQVP 311
            +  P
Sbjct: 265 NSSKP 269

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 146/305 (47%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 11  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 65
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 122
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 155
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++      C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 156 GWSVHAPSSRRD--DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 214 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265
Query: 307 FNQVP 311
            +  P
Sbjct: 266 NSSKP 270

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 146/305 (47%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK +  + ALKVL            + RREVE+Q    
Sbjct: 8   EDFEIGRP-LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 62
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 119
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 120 ALSYCHSKKVIHRDIKPENLLL---------------------------GSAGELKIADF 152
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +    C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 153 GWSVHAPSSRRA--ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 211 YQ----DTYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262
Query: 307 FNQVP 311
            +  P
Sbjct: 263 NSSKP 267

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME   GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENL+  + G                            +K+TDFGFAK++   K    
Sbjct: 168 LKPENLMIDQQG---------------------------YIKVTDFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 146/305 (47%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 13  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 67
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    GE+++ +Q+     F E+  A  + E+ +
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYL-ILEYAPRGEVYKELQKL--SKFDEQRTATYITELAN 124
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 157
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++        T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 158 GWSVHAPSSRRXXLXG--TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 216 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267
Query: 307 FNQVP 311
            +  P
Sbjct: 268 NSSKP 272

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 136/278 (48%), Gaps = 53/278 (19%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR-REVE------LQLAVGSHKHIVNIKD 76
           LG G  G+V  I  +     YA+KVL   +  R ++VE      L L++ +H  I+ +  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            +++    ++ + +IM+ + GGELF  +++ +   F    A     E+C A+++LH ++I
Sbjct: 74  TFQD----AQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            +RD+KPEN+L  K                            G +K+TDFGFAK +    
Sbjct: 128 IYRDLKPENILLDK---------------------------NGHIKITDFGFAKYVPDVT 160
Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF-SNHGQAISPGMK 255
             L   C TP Y+APEV+    Y+KS D WS G+++Y +L G+ PF+ SN  +     + 
Sbjct: 161 YXL---CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217
Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             +R   F          +++ K L+  ++  D S+RL
Sbjct: 218 AELRFPPF---------FNEDVKDLLSRLITRDLSQRL 246

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME   GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENL+  + G                            +K+TDFGFAK++   K    
Sbjct: 168 LKPENLMIDQQG---------------------------YIKVTDFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+AP ++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME   GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENL+  + G                            +K+TDFGFAK++   K    
Sbjct: 167 LKPENLMIDQQG---------------------------YIKVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/299 (30%), Positives = 144/299 (48%), Gaps = 53/299 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 11  EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 65
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 122
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 123 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 155
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++      C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 156 GWSVHAPSSRRX--XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+
Sbjct: 214 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 168 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 92/305 (30%), Positives = 147/305 (48%), Gaps = 53/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+Q    
Sbjct: 9   EDFEIGRP-LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ---- 63
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH    NI  +Y   ++ +R  L I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 120
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL                            G  G LK+ DF
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLL---------------------------GSAGELKIADF 153
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++ +  T   T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 154 GWSCHAPSSRRT--TLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ WI+ 
Sbjct: 212 YQETY----KRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
Query: 307 FNQVP 311
            +  P
Sbjct: 264 NSSKP 268

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++        ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKAFGNLKNGVNDIKNHKWFA 298

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 140/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME   GGE+F  +++   G F E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENL+  + G                            +K+TDFGFAK++   K    
Sbjct: 168 LKPENLMIDQQG---------------------------YIKVTDFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 140/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME   GGE+F  +++   G F E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENL+  + G                            +K+TDFGFAK++   K    
Sbjct: 167 LKPENLMIDQQG---------------------------YIKVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +      L     TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 VKGRTWXLXG---TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F E  A     +I    ++LH  ++ +RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +++TDFGFAK++   K    
Sbjct: 168 LKPENLLIDQQ---------------------------GYIQVTDFGFAKRV---KGRTW 197
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 253
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 254 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 141/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           +G G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME M GG++F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +K+ DFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIKVADFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 141/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           +G G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME M GG++F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +K+ DFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIKVADFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K        TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 140/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +E+E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME   GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENL+  + G                            +K+TDFG AK++   K    
Sbjct: 167 LKPENLMIDQQG---------------------------YIKVTDFGLAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 146/299 (48%), Gaps = 49/299 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E  L        VN
Sbjct: 41  DQFD-RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 74  IKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
              +   E  +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYL 157
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H  ++ +RD+KPENLL  +                            G +++TDFGFAK+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQ---------------------------GYIQVTDFGFAKR 190
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +   K      C TP  +APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I 
Sbjct: 191 V---KGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
                +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 248 ----EKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 141/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME   GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENL+  + G                            +++TDFGFAK++   K    
Sbjct: 167 LKPENLMIDQQG---------------------------YIQVTDFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 141/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           +G G  G+V+ +   +T   YA+K+L    V   +++E  L        VN   +   E 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME + GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENLL  +                            G +K+ DFGFAK++   K    
Sbjct: 167 LKPENLLIDQQ---------------------------GYIKVADFGFAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 108/365 (29%), Positives = 170/365 (46%), Gaps = 66/365 (18%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTV-KARREVELQLAVGSHKH 70
           I  + LG+G  GKV     + T    A+K+L+       D V K RRE++  L +  H H
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ-NLKLFRHPH 77
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           I+ +   Y+ I   S   +V ME + GGELF  I +  +G   E+E+  +  +I S + +
Sbjct: 78  IIKL---YQVISTPSDIFMV-MEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDY 131
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+KPEN+L     +                            K+ DFG + 
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNA---------------------------KIADFGLS- 163
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
            ++S+   L+  C +P Y APEV+    Y     DIWS GVI+Y LLCG  PF  +H   
Sbjct: 164 NMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--- 220
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ--- 306
             P +  +I  G F  P    ++++    +L+K+ML VDP +R TI  + E++W  Q   
Sbjct: 221 -VPTLFKKICDGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275
Query: 307 FNQVPQTPLCTGKM-----LKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPL 361
               P+ P  +  M     LKE  E +   ++E+   L      Y++ H   L  + + +
Sbjct: 276 KYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCL------YNRNHQDPLAVAYHLI 329
Query: 362 LNKRR 366
           ++ RR
Sbjct: 330 IDNRR 334

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 140/290 (48%), Gaps = 48/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVNIKDV--YEN 80
           LG G  G+V+ +   +T   YA+K+L    V   +E+E  L        VN   +   E 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
            +  +  L ++ME   GGE+F  +++   G F+E  A     +I    ++LH  ++ +RD
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KPENL+  + G                            +++TDFG AK++   K    
Sbjct: 167 LKPENLMIDQQG---------------------------YIQVTDFGLAKRV---KGRTW 196
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL 260
             C TP Y+APE++    Y+K+ D W+LGV++Y +  G+PPFF++    I      +I  
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS 252
Query: 261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWIS 305
           G+  FP+    H S + K L++N+L VD ++R       ++ +  +KW +
Sbjct: 253 GKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 138/287 (48%), Gaps = 44/287 (15%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVY--- 78
           +++G G  GKVL    K     YA+KVL      +++ E  +    +  + N+K  +   
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 79  -ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
               +  +  L  +++ ++GGELF  +Q++    F E  A     EI SA+ +LH  NI 
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           +RD+KPEN+L    G                            + LTDFG  K+ + + +
Sbjct: 162 YRDLKPENILLDSQGH---------------------------IVLTDFGLCKENIEHNS 194
Query: 198 SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNR 257
           +  T C TP Y+APEVL    YD++ D W LG ++Y +L G PPF+S +   +   + N+
Sbjct: 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254
Query: 258 -IRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-DQVMENK 302
            ++L     PN     ++  A+ L++ +L  D ++RL   D  ME K
Sbjct: 255 PLQLK----PN-----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 136/294 (46%), Gaps = 45/294 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQL----AVGSHKH 70
           DD+DI    LG G  G V    EK+   + ALKVL  +   +  VE QL     + SH  
Sbjct: 15  DDFDIGRP-LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
             NI  +Y N ++  + + +++E    GEL++ +Q+   G F E+ +A  M E+  A+ +
Sbjct: 74  HPNILRMY-NYFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHY 130
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H++ + HRD+KPENLL                            G  G LK+ DFG++ 
Sbjct: 131 CHERKVIHRDIKPENLLM---------------------------GYKGELKIADFGWSV 163
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
              S +      C T  Y+ PE++    +D+  D+W  GV+ Y  L G PPF S      
Sbjct: 164 HAPSLRRRXM--CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS------ 215
Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
               +   R+   D   P +  +S  +K LI  +L   P +RL +  VME+ W+
Sbjct: 216 PSHTETHRRIVNVDLKFPPF--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 136/294 (46%), Gaps = 45/294 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQL----AVGSHKH 70
           DD+DI    LG G  G V    EK+   + ALKVL  +   +  VE QL     + SH  
Sbjct: 14  DDFDI-VRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
             NI  +Y N ++  + + +++E    GEL++ +Q+   G F E+ +A  M E+  A+ +
Sbjct: 73  HPNILRMY-NYFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHY 129
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H++ + HRD+KPENLL                            G  G LK+ DFG++ 
Sbjct: 130 CHERKVIHRDIKPENLLM---------------------------GYKGELKIADFGWSV 162
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
              S +      C T  Y+ PE++    +D+  D+W  GV+ Y  L G PPF S      
Sbjct: 163 HAPSLRRRXM--CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS------ 214
Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
               +   R+   D   P +  +S  +K LI  +L   P +RL +  VME+ W+
Sbjct: 215 PSHTETHRRIVNVDLKFPPF--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 92/304 (30%), Positives = 144/304 (47%), Gaps = 52/304 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ--------LAVG 66
           DD  I    LG G  G V  +VE+++S +   +V+    K R +V ++        L   
Sbjct: 21  DDLFIFKRKLGSGAFGDV-HLVEERSSGLE--RVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRI--QQKEDGAFTEREAAIIMNEI 124
            H +I+ I +V+E+ +N    + ++ME   GGEL +RI   Q    A +E   A +M ++
Sbjct: 78  DHPNIIKIFEVFEDYHN----MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            +A+ + H Q++ H+D+KPEN+L              F D  P +           +K+ 
Sbjct: 134 MNALAYFHSQHVVHKDLKPENIL--------------FQDTSPHS----------PIKII 169
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A+   S++ S      T  Y+APEV   D   K CDIWS GV+MY LL G  PF  
Sbjct: 170 DFGLAELFKSDEHSTNAAG-TALYMAPEVFKRDVTFK-CDIWSAGVVMYFLLTGCLPFTG 227
Query: 245 NHGQAISPGMKNRIRLGQFDFPN--PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
              + +        +   +  PN   E   ++ +A  L+K ML  DP  R +  QV+ ++
Sbjct: 228 TSLEEVQ-------QKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
Query: 303 WISQ 306
           W  Q
Sbjct: 281 WFKQ 284

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 99/347 (28%), Positives = 151/347 (43%), Gaps = 83/347 (23%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQ 62
           +Q  Y +   I G G  G V   +E +T  + A+K+++          D  + + EV L 
Sbjct: 24  LQKKYHLKGAI-GQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ---------------- 106
             +    H  NI  +YE +Y   + + ++ME  HGG L  ++                  
Sbjct: 83  KKL----HHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 107 --------------------KEDGAFTEREAAI--IMNEICSAIKFLHDQNIAHRDVKPE 144
                               +E   F +RE  I  IM +I SA+ +LH+Q I HRD+KPE
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N L++      I KL DFG  K     + K  +G    +T                T   
Sbjct: 198 NFLFSTNKSFEI-KLVDFGLSKE----FYKLNNGEYYGMT----------------TKAG 236
Query: 205 TPYYVAPEVLGP--DKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISPGMKNRIRLG 261
           TPY+VAPEVL    + Y   CD WS GV++++LL G  PF   N    IS  +  ++   
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL--- 293
Query: 262 QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
              F NP +  +S  A+ L+ N+L  +  ER    + +++ WISQF+
Sbjct: 294 --CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 130/254 (51%), Gaps = 46/254 (18%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           K  REV + + V +H +IV + +V E      + L ++ME   GGE+F  +     G   
Sbjct: 59  KLFREVRI-MKVLNHPNIVKLFEVIET----EKTLYLVMEYASGGEVFDYLVAH--GRMK 111
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E+EA     +I SA+++ H + I HRD+K ENLL     +                    
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN-------------------- 151
Query: 174 KPGDGGILKLTDFGFAKKIV-SNKASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVI 231
                  +K+ DFGF+ +    NK  L T C +P Y APE+    KYD    D+WSLGVI
Sbjct: 152 -------IKIADFGFSNEFTFGNK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVI 202
Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           +Y L+ G  PF    GQ +   ++ R+  G++  P     ++S + + L+K  L ++PS+
Sbjct: 203 LYTLVSGSLPF---DGQNLKE-LRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSK 254
Query: 292 RLTIDQVMENKWIS 305
           R T++Q+M+++W++
Sbjct: 255 RGTLEQIMKDRWMN 268

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 127/253 (50%), Gaps = 44/253 (17%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           K  REV + + + +H +IV + +V E      + L +IME   GGE+F  +     G   
Sbjct: 57  KLFREVRI-MKILNHPNIVKLFEVIET----EKTLYLIMEYASGGEVFDYLVAH--GRMK 109
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E+EA     +I SA+++ H + I HRD+K ENLL     +                    
Sbjct: 110 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN-------------------- 149
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVIM 232
                  +K+ DFGF+ +       L T C +P Y APE+    KYD    D+WSLGVI+
Sbjct: 150 -------IKIADFGFSNEFTVG-GKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 201
Query: 233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
           Y L+ G  PF    GQ +   ++ R+  G++  P     ++S + + L+K  L ++P +R
Sbjct: 202 YTLVSGSLPF---DGQNLKE-LRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKR 253
Query: 293 LTIDQVMENKWIS 305
            T++Q+M+++WI+
Sbjct: 254 GTLEQIMKDRWIN 266

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 130/254 (51%), Gaps = 46/254 (18%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           K  REV + + V +H +IV + +V E      + L ++ME   GGE+F  +     G   
Sbjct: 59  KLFREVRI-MKVLNHPNIVKLFEVIET----EKTLYLVMEYASGGEVFDYLVAH--GRMK 111
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E+EA     +I SA+++ H + I HRD+K ENLL     +                    
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN-------------------- 151
Query: 174 KPGDGGILKLTDFGFAKKIV-SNKASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVI 231
                  +K+ DFGF+ +    NK  L T C +P Y APE+    KYD    D+WSLGVI
Sbjct: 152 -------IKIADFGFSNEFTFGNK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVI 202
Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           +Y L+ G  PF    GQ +   ++ R+  G++  P     ++S + + L+K  L ++PS+
Sbjct: 203 LYTLVSGSLPF---DGQNLKE-LRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSK 254
Query: 292 RLTIDQVMENKWIS 305
           R T++Q+M+++W++
Sbjct: 255 RGTLEQIMKDRWMN 268

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 130/254 (51%), Gaps = 46/254 (18%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           K  REV + + V +H +IV + +V E      + L ++ME   GGE+F  +     G   
Sbjct: 59  KLFREVRI-MKVLNHPNIVKLFEVIET----EKTLYLVMEYASGGEVFDYLVAH--GRMK 111
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E+EA     +I SA+++ H + I HRD+K ENLL     +                    
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN-------------------- 151
Query: 174 KPGDGGILKLTDFGFAKKIV-SNKASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVI 231
                  +K+ DFGF+ +    NK  L T C +P Y APE+    KYD    D+WSLGVI
Sbjct: 152 -------IKIADFGFSNEFTFGNK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVI 202
Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           +Y L+ G  PF    GQ +   ++ R+  G++  P     ++S + + L+K  L ++PS+
Sbjct: 203 LYTLVSGSLPF---DGQNLKE-LRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSK 254
Query: 292 RLTIDQVMENKWIS 305
           R T++Q+M+++W++
Sbjct: 255 RGTLEQIMKDRWMN 268

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 142/295 (48%), Gaps = 41/295 (13%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK----ARREVELQLAVGSHKH 70
           D Y++  +I G G  G    + +K+ +E+ A+K +    K     +RE+    ++  H +
Sbjct: 19  DRYELVKDI-GAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSL-RHPN 76
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IV  K+V     +    L ++ME   GGELF+RI     G F+E EA     ++ S + +
Sbjct: 77  IVRFKEVILTPTH----LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSY 130
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   +AHRD+K EN L               G   P             LK+ DFG++K
Sbjct: 131 AHAMQVAHRDLKLENTLLD-------------GSPAPR------------LKIADFGYSK 165
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
             V + +  ++   TP Y+APEVL   +YD K  D+WS GV +Y++L G  PF     + 
Sbjct: 166 ASVLH-SQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF--EDPEE 222
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                K   R+    +  P++ H+S E + LI  +   DP++R++I ++  ++W 
Sbjct: 223 PKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 130/254 (51%), Gaps = 46/254 (18%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           K  REV + + V +H +IV + +V E      + L ++ME   GGE+F  +     G   
Sbjct: 52  KLFREVRI-MKVLNHPNIVKLFEVIET----EKTLYLVMEYASGGEVFDYLVAH--GWMK 104
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E+EA     +I SA+++ H + I HRD+K ENLL     +                    
Sbjct: 105 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN-------------------- 144
Query: 174 KPGDGGILKLTDFGFAKKIV-SNKASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVI 231
                  +K+ DFGF+ +    NK  L T C +P Y APE+    KYD    D+WSLGVI
Sbjct: 145 -------IKIADFGFSNEFTFGNK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVI 195
Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           +Y L+ G  PF    GQ +   ++ R+  G++  P     ++S + + L+K  L ++PS+
Sbjct: 196 LYTLVSGSLPF---DGQNLKE-LRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSK 247
Query: 292 RLTIDQVMENKWIS 305
           R T++Q+M+++W++
Sbjct: 248 RGTLEQIMKDRWMN 261

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 129/254 (50%), Gaps = 46/254 (18%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           K  REV + + V +H +IV + +V E      + L ++ME   GGE+F  +     G   
Sbjct: 59  KLFREVRI-MKVLNHPNIVKLFEVIET----EKTLYLVMEYASGGEVFDYLVAH--GRMK 111
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E+EA     +I SA+++ H + I HRD+K ENLL     +                    
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN-------------------- 151
Query: 174 KPGDGGILKLTDFGFAKKIV-SNKASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVI 231
                  +K+ DFGF+ +    NK  L   C +P Y APE+    KYD    D+WSLGVI
Sbjct: 152 -------IKIADFGFSNEFTFGNK--LDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVI 202
Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           +Y L+ G  PF    GQ +   ++ R+  G++  P     ++S + + L+K  L ++PS+
Sbjct: 203 LYTLVSGSLPF---DGQNLKE-LRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSK 254
Query: 292 RLTIDQVMENKWIS 305
           R T++Q+M+++W++
Sbjct: 255 RGTLEQIMKDRWMN 268

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 128/254 (50%), Gaps = 46/254 (18%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           K  REV + + V +H +IV + +V E      + L ++ME   GGE+F  +     G   
Sbjct: 59  KLFREVRI-MKVLNHPNIVKLFEVIET----EKTLYLVMEYASGGEVFDYLVAH--GRMK 111
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E+EA     +I SA+++ H + I HRD+K ENLL     +                    
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN-------------------- 151
Query: 174 KPGDGGILKLTDFGFAKKIV-SNKASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVI 231
                  +K+ DFGF+ +    NK  L   C  P Y APE+    KYD    D+WSLGVI
Sbjct: 152 -------IKIADFGFSNEFTFGNK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVI 202
Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           +Y L+ G  PF    GQ +   ++ R+  G++  P     ++S + + L+K  L ++PS+
Sbjct: 203 LYTLVSGSLPF---DGQNLKE-LRERVLRGKYRIPF----YMSTDCENLLKKFLILNPSK 254
Query: 292 RLTIDQVMENKWIS 305
           R T++Q+M+++W++
Sbjct: 255 RGTLEQIMKDRWMN 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/288 (30%), Positives = 140/288 (48%), Gaps = 51/288 (17%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ-------LAVGSHKHIVNIKD 76
           LG G  GKV       T +  ALK+++  V A+ +++ +       L +  H HI+ + D
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V   I +    ++VI     G ELF  I Q++    +E+EA     +I SA+++ H   I
Sbjct: 81  V---IKSKDEIIMVIEYA--GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KPENLL  +  +                           +K+ DFG +  I+++ 
Sbjct: 134 VHRDLKPENLLLDEHLN---------------------------VKIADFGLS-NIMTDG 165
Query: 197 ASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
             L+T C +P Y APEV+    Y     D+WS GVI+Y++LC   PF     ++I    K
Sbjct: 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLFK 222
Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           N I  G +  P    + +S  A  LIK ML V+P  R++I ++M++ W
Sbjct: 223 N-ISNGVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 89/288 (30%), Positives = 140/288 (48%), Gaps = 51/288 (17%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ-------LAVGSHKHIVNIKD 76
           LG G  GKV       T +  ALK+++  V A+ +++ +       L +  H HI+ + D
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V   I +    ++VI     G ELF  I Q++    +E+EA     +I SA+++ H   I
Sbjct: 82  V---IKSKDEIIMVIEYA--GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KPENLL  +  +                           +K+ DFG +  I+++ 
Sbjct: 135 VHRDLKPENLLLDEHLN---------------------------VKIADFGLS-NIMTDG 166
Query: 197 ASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
             L+T C +P Y APEV+    Y     D+WS GVI+Y++LC   PF     ++I    K
Sbjct: 167 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLFK 223
Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           N I  G +  P    + +S  A  LIK ML V+P  R++I ++M++ W
Sbjct: 224 N-ISNGVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 266

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 139/295 (47%), Gaps = 41/295 (13%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD----TVKARREVELQLAVGSHKH 70
           D Y++  +I G G  G    + +K+++E+ A+K +          +RE+    ++  H +
Sbjct: 19  DRYELVKDI-GSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSL-RHPN 76
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IV  K+V     +    L ++ME   GGELF+RI     G F+E EA     ++ S + +
Sbjct: 77  IVRFKEVILTPTH----LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSY 130
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+K EN L               G   P             LK+ DFG++K
Sbjct: 131 CHAMQVCHRDLKLENTLLD-------------GSPAPR------------LKICDFGYSK 165
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
             V +     T   TP Y+APEVL   +YD K  D+WS GV +Y++L G  PF     + 
Sbjct: 166 SSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF--EDPEE 222
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                K   R+    +  P++ H+S E + LI  +   DP++R++I ++  ++W 
Sbjct: 223 PKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 125/253 (49%), Gaps = 44/253 (17%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           K  REV + + + +H +IV + +V E      + L +IME   GGE+F  +     G   
Sbjct: 60  KLFREVRI-MKILNHPNIVKLFEVIET----EKTLYLIMEYASGGEVFDYLVAH--GRMK 112
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E+EA     +I SA+++ H + I HRD+K ENLL     +                    
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN-------------------- 152
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVIM 232
                  +K+ DFGF+ +       L   C  P Y APE+    KYD    D+WSLGVI+
Sbjct: 153 -------IKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
           Y L+ G  PF    GQ +   ++ R+  G++  P     ++S + + L+K  L ++P +R
Sbjct: 205 YTLVSGSLPF---DGQNLKE-LRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKR 256
Query: 293 LTIDQVMENKWIS 305
            T++Q+M+++WI+
Sbjct: 257 GTLEQIMKDRWIN 269

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 89/288 (30%), Positives = 140/288 (48%), Gaps = 51/288 (17%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ-------LAVGSHKHIVNIKD 76
           LG G  GKV       T +  ALK+++  V A+ +++ +       L +  H HI+ + D
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V   I +    ++VI     G ELF  I Q++    +E+EA     +I SA+++ H   I
Sbjct: 72  V---IKSKDEIIMVIEYA--GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KPENLL  +  +                           +K+ DFG +  I+++ 
Sbjct: 125 VHRDLKPENLLLDEHLN---------------------------VKIADFGLS-NIMTDG 156
Query: 197 ASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
             L+T C +P Y APEV+    Y     D+WS GVI+Y++LC   PF     ++I    K
Sbjct: 157 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLFK 213
Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           N I  G +  P    + +S  A  LIK ML V+P  R++I ++M++ W
Sbjct: 214 N-ISNGVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 256

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 89/288 (30%), Positives = 140/288 (48%), Gaps = 51/288 (17%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ-------LAVGSHKHIVNIKD 76
           LG G  GKV       T +  ALK+++  V A+ +++ +       L +  H HI+ + D
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V   I +    ++VI     G ELF  I Q++    +E+EA     +I SA+++ H   I
Sbjct: 76  V---IKSKDEIIMVIEYA--GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KPENLL  +  +                           +K+ DFG +  I+++ 
Sbjct: 129 VHRDLKPENLLLDEHLN---------------------------VKIADFGLS-NIMTDG 160
Query: 197 ASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
             L+T C +P Y APEV+    Y     D+WS GVI+Y++LC   PF     ++I    K
Sbjct: 161 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLFK 217
Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           N I  G +  P    + +S  A  LIK ML V+P  R++I ++M++ W
Sbjct: 218 N-ISNGVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 260

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 136/284 (47%), Gaps = 56/284 (19%)
Query: 23  ILGLGINGKVLQIVE---KKTSEVYALKVLH---------DTVKARREVELQLAVGSHKH 70
           +LG G  GKV Q+ +     T +++A+KVL          DT   + E  +   V  H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPF 82
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IV++  +Y     G   L +I+E + GGELF ++++  +G F E  A   + EI  A+  
Sbjct: 83  IVDL--IYAFQTGGK--LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGH 136
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH + I +RD+KPEN++    G                            +KLTDFG  K
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGH---------------------------VKLTDFGLCK 169
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQA 249
           + + +     T C T  Y+APE+L    ++++ D WSLG +MY +L G PPF   N  + 
Sbjct: 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           I   +K ++ L  +         ++QEA+ L+K +L  + + RL
Sbjct: 230 IDKILKCKLNLPPY---------LTQEARDLLKKLLKRNAASRL 264

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 141/295 (47%), Gaps = 41/295 (13%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK----ARREVELQLAVGSHKH 70
           D Y++  +I G G  G    + +K+++E+ A+K +    K     +RE+    ++  H +
Sbjct: 18  DRYELVKDI-GSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL-RHPN 75
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IV  K+V   I   +  L ++ME   GGELF+RI     G F+E EA     ++ S + +
Sbjct: 76  IVRFKEV---ILTPTH-LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSY 129
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+K EN L               G   P             LK+ DFG++K
Sbjct: 130 CHAMQVCHRDLKLENTLLD-------------GSPAPR------------LKICDFGYSK 164
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
             V +     T   TP Y+APEVL   +YD K  D+WS GV +Y++L G  PF     + 
Sbjct: 165 SSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF--EDPEE 221
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                K   R+    +  P++ H+S E + LI  +   DP++R++I ++  ++W 
Sbjct: 222 PKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 143/301 (47%), Gaps = 44/301 (14%)
Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA---RREVELQLAV----GSHK 69
           Y ++++ LG G    V Q + K T + YA K L    +    R E+  ++AV     S  
Sbjct: 30  YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
            ++N+ +VYEN    +  +++I+E   GGE+F     +     +E +   ++ +I   + 
Sbjct: 90  RVINLHEVYEN----TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           +LH  NI H D+KP+N+L +         +   GD+                K+ DFG +
Sbjct: 146 YLHQNNIVHLDLKPQNILLS--------SIYPLGDI----------------KIVDFGMS 181
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
           +KI  +   L+    TP Y+APE+L  D    + D+W++G+I Y+LL    PF     Q 
Sbjct: 182 RKI-GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ- 239
Query: 250 ISPGMKNRIRLGQ--FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
                +  + + Q   D+    +  VSQ A   I+++L  +P +R T +  + + W+ Q+
Sbjct: 240 -----ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
Query: 308 N 308
           +
Sbjct: 295 D 295

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 135/284 (47%), Gaps = 56/284 (19%)
Query: 23  ILGLGINGKVLQIVE---KKTSEVYALKVLH---------DTVKARREVELQLAVGSHKH 70
           +LG G  GKV Q+ +     T +++A+KVL          DT   + E  +   V  H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPF 82
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IV++  +Y     G   L +I+E + GGELF ++++  +G F E  A   + EI  A+  
Sbjct: 83  IVDL--IYAFQTGGK--LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGH 136
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH + I +RD+KPEN++    G                            +KLTDFG  K
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGH---------------------------VKLTDFGLCK 169
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQA 249
           + + +       C T  Y+APE+L    ++++ D WSLG +MY +L G PPF   N  + 
Sbjct: 170 ESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           I   +K ++ L  +         ++QEA+ L+K +L  + + RL
Sbjct: 230 IDKILKCKLNLPPY---------LTQEARDLLKKLLKRNAASRL 264

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 131/278 (47%), Gaps = 47/278 (16%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVGSHKHIVNIKDVYENI 81
           +LG G  GKV+    K+T ++YA+KVL  D +    +VE  +   + K I+++   +  +
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRILSLARNHPFL 86
Query: 82  YNGSRC------LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
                C      L  +ME ++GG+L   IQ+     F E  A     EI SA+ FLHD+ 
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG 144
Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I +RD+K +N+L    G                             KL DFG  K+ + N
Sbjct: 145 IIYRDLKLDNVLLDHEGH---------------------------CKLADFGMCKEGICN 177
Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
             +  T C TP Y+APE+L    Y  + D W++GV++Y +LCG  PF + +   +   + 
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           N       +   P W H  ++A  ++K+ +  +P+ RL
Sbjct: 238 ND------EVVYPTWLH--EDATGILKSFMTKNPTMRL 267

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 139/295 (47%), Gaps = 41/295 (13%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK----ARREVELQLAVGSHKH 70
           D Y++  +I G G  G    + +K+++E+ A+K +    K     +RE+    ++  H +
Sbjct: 19  DRYELVKDI-GSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL-RHPN 76
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IV  K+V     +    L ++ME   GGELF+RI     G F+E EA     ++ S + +
Sbjct: 77  IVRFKEVILTPTH----LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSY 130
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+K EN L               G   P             LK+  FG++K
Sbjct: 131 CHAMQVCHRDLKLENTLLD-------------GSPAPR------------LKICAFGYSK 165
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
             V +     T   TP Y+APEVL   +YD K  D+WS GV +Y++L G  PF     + 
Sbjct: 166 SSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF--EDPEE 222
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                K   R+    +  P++ H+S E + LI  +   DP++R++I ++  ++W 
Sbjct: 223 PKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 139/295 (47%), Gaps = 41/295 (13%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK----ARREVELQLAVGSHKH 70
           D Y++  +I G G  G    + +K+++E+ A+K +    K     +RE+    ++  H +
Sbjct: 19  DRYELVKDI-GSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL-RHPN 76
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           IV  K+V     +    L ++ME   GGELF+RI     G F+E EA     ++ S + +
Sbjct: 77  IVRFKEVILTPTH----LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSY 130
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+K EN L               G   P             LK+  FG++K
Sbjct: 131 CHAMQVCHRDLKLENTLLD-------------GSPAPR------------LKICAFGYSK 165
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
             V +     T   TP Y+APEVL   +YD K  D+WS GV +Y++L G  PF     + 
Sbjct: 166 SSVLHSQPKDT-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF--EDPEE 222
Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                K   R+    +  P++ H+S E + LI  +   DP++R++I ++  ++W 
Sbjct: 223 PKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 135/295 (45%), Gaps = 51/295 (17%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ-------LAVGSHKHI 71
           I  E LG G  GKV      KT +  ALK +   +  + ++ ++       L +  H HI
Sbjct: 12  IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           + + DV   I   +  ++VI     GGELF  I +K+    TE E      +I  AI++ 
Sbjct: 72  IKLYDV---ITTPTDIVMVIEYA--GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYC 124
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I HRD+KPENLL                             D   +K+ DFG +  
Sbjct: 125 HRHKIVHRDLKPENLLL---------------------------DDNLNVKIADFGLS-N 156
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
           I+++   L+T C +P Y APEV+    Y     D+WS G+++Y++L G  PF        
Sbjct: 157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF----DDEF 212
Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
            P +  ++    +  P+     +S  A++LI+ M+  DP +R+TI ++  + W +
Sbjct: 213 IPNLFKKVNSCVYVMPD----FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 143/292 (48%), Gaps = 50/292 (17%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNIKD 76
           +G G  GK + +   +    Y +K ++       +  ++RREV + LA   H +IV  ++
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV-LANMKHPNIVQYRE 90
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            +E   NGS  L ++M+   GG+LF+RI  ++   F E +      +IC A+K +HD+ I
Sbjct: 91  SFEE--NGS--LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI 146
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+K +N+  TK                            G ++L DFG A +++++ 
Sbjct: 147 LHRDIKSQNIFLTK---------------------------DGTVQLGDFGIA-RVLNST 178
Query: 197 ASLQTPCY-TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
             L   C  TPYY++PE+     Y+   DIW+LG ++Y  LC     F       +  MK
Sbjct: 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLY-ELCTLKHAFE------AGSMK 231
Query: 256 NRI-RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           N + ++    FP P   H S + ++L+  +   +P +R +++ ++E  +I++
Sbjct: 232 NLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 94/299 (31%), Positives = 139/299 (46%), Gaps = 55/299 (18%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           DD++I    LG G  G V    EKK+  + ALKVL  +         + RRE+E+Q    
Sbjct: 23  DDFEIGRP-LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ---- 77
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           +H H  NI  +Y   Y+  R  L I+E    GEL++ +Q+     F E+  A IM E+  
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYL-ILEYAPRGELYKELQK--SCTFDEQRTATIMEELAD 134
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL    G+  I                            DF
Sbjct: 135 ALMYCHGKKVIHRDIKPENLLLGLKGELKI---------------------------ADF 167
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-N 245
           G++    S +   +T C T  Y+ PE++    +++  D+W +GV+ Y LL G PPF S +
Sbjct: 168 GWSVHAPSLRR--KTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESAS 225
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           H +        RI      FP      V   A+ LI  +L  +PSERL + QV  + W+
Sbjct: 226 HNETY-----RRIVKVDLKFPAS----VPTGAQDLISKLLRHNPSERLPLAQVSAHPWV 275

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 136/292 (46%), Gaps = 50/292 (17%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVL--------HDTVKARREVELQLAVGSHKHIVNI 74
            LG G   K  +I +  T EV+A K++        H   K   E+ +  ++ +H+H+V  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGF 82
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              +E+    +  + V++E      L +    K   A TE EA   + +I    ++LH  
Sbjct: 83  HGFFED----NDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+K  NL   +             D++              +K+ DFG A K+  
Sbjct: 137 RVIHRDLKLGNLFLNE-------------DLE--------------VKIGDFGLATKVEY 169
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +    +T C TP Y+APEVL    +    D+WS+G IMY LL G PPF ++  +      
Sbjct: 170 DGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--- 226
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             RI+  ++  P    +H++  A +LI+ ML  DP+ R TI++++ +++ + 
Sbjct: 227 -LRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 273

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 136/292 (46%), Gaps = 50/292 (17%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVL--------HDTVKARREVELQLAVGSHKHIVNI 74
            LG G   K  +I +  T EV+A K++        H   K   E+ +  ++ +H+H+V  
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGF 86
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              +E+    +  + V++E      L +    K   A TE EA   + +I    ++LH  
Sbjct: 87  HGFFED----NDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+K  NL   +             D++              +K+ DFG A K+  
Sbjct: 141 RVIHRDLKLGNLFLNE-------------DLE--------------VKIGDFGLATKVEY 173
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +    +T C TP Y+APEVL    +    D+WS+G IMY LL G PPF ++  +      
Sbjct: 174 DGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--- 230
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             RI+  ++  P    +H++  A +LI+ ML  DP+ R TI++++ +++ + 
Sbjct: 231 -LRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 277

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 136/292 (46%), Gaps = 50/292 (17%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVL--------HDTVKARREVELQLAVGSHKHIVNI 74
            LG G   K  +I +  T EV+A K++        H   K   E+ +  ++ +H+H+V  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGF 82
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              +E+    +  + V++E      L +    K   A TE EA   + +I    ++LH  
Sbjct: 83  HGFFED----NDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+K  NL   +             D++              +K+ DFG A K+  
Sbjct: 137 RVIHRDLKLGNLFLNE-------------DLE--------------VKIGDFGLATKVEY 169
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +    +T C TP Y+APEVL    +    D+WS+G IMY LL G PPF ++  +      
Sbjct: 170 DGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--- 226
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             RI+  ++  P    +H++  A +LI+ ML  DP+ R TI++++ +++ + 
Sbjct: 227 -LRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 273

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 142/310 (45%), Gaps = 63/310 (20%)
Query: 22  EILGLGINGKVL---QIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVY 78
           ++LG G  GKV    +I    T ++YA+KVL      ++         + +H    + V 
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-------AKTTEHTRTERQVL 112
Query: 79  ENI------------YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           E+I            +     L +I++ ++GGELF  + Q+E   FTE E  I + EI  
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVL 170
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A++ LH   I +RD+K EN+L    G                            + LTDF
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGH---------------------------VVLTDF 203
Query: 187 GFAKKIVSNKASLQTP-CYTPYYVAPEVL--GPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
           G +K+ V+++       C T  Y+AP+++  G   +DK+ D WSLGV+MY LL G  PF 
Sbjct: 204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263
Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQV 298
            +  +     +  RI   +  +P    + +S  AK LI+ +L  DP +RL       D++
Sbjct: 264 VDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319
Query: 299 MENKWISQFN 308
            E+ +  + N
Sbjct: 320 KEHLFFQKIN 329

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSHKHIVNIKDV-Y 78
             LG G   K  +I +  T EV+A KV+  +  +K  ++ ++   +  HK + N   V +
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
              +     + V++E      L +    K   A TE EA   M +    +++LH+  + H
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIH 165
Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  NL            L D  DVK                + DFG A KI  +   
Sbjct: 166 RDLKLGNLF-----------LNDDMDVK----------------IGDFGLATKIEFDGER 198
Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
            +T C TP Y+APEVL    +    DIWSLG I+Y LL G PPF        S   +  I
Sbjct: 199 KKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF------ETSCLKETYI 252
Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           R+ + ++  P   H++  A  LI+ ML  DP+ R ++ +++ +++ + 
Sbjct: 253 RIKKNEYSVP--RHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 135/292 (46%), Gaps = 50/292 (17%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVL--------HDTVKARREVELQLAVGSHKHIVNI 74
            LG G   K  +I +  T EV+A K++        H   K   E+ +  ++ +H+H+V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGF 106
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              +E+    +  + V++E      L +    K   A TE EA   + +I    ++LH  
Sbjct: 107 HGFFED----NDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+K  NL   +             D++              +K+ DFG A K+  
Sbjct: 161 RVIHRDLKLGNLFLNE-------------DLE--------------VKIGDFGLATKVEY 193
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +    +  C TP Y+APEVL    +    D+WS+G IMY LL G PPF ++  +      
Sbjct: 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--- 250
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             RI+  ++  P    +H++  A +LI+ ML  DP+ R TI++++ +++ + 
Sbjct: 251 -LRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 135/292 (46%), Gaps = 50/292 (17%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVL--------HDTVKARREVELQLAVGSHKHIVNI 74
            LG G   K  +I +  T EV+A K++        H   K   E+ +  ++ +H+H+V  
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGF 104
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              +E+    +  + V++E      L +    K   A TE EA   + +I    ++LH  
Sbjct: 105 HGFFED----NDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+K  NL   +             D++              +K+ DFG A K+  
Sbjct: 159 RVIHRDLKLGNLFLNE-------------DLE--------------VKIGDFGLATKVEY 191
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +    +  C TP Y+APEVL    +    D+WS+G IMY LL G PPF ++  +      
Sbjct: 192 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--- 248
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             RI+  ++  P    +H++  A +LI+ ML  DP+ R TI++++ +++ + 
Sbjct: 249 -LRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 295

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 135/292 (46%), Gaps = 50/292 (17%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVL--------HDTVKARREVELQLAVGSHKHIVNI 74
            LG G   K  +I +  T EV+A K++        H   K   E+ +  ++ +H+H+V  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGF 80
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              +E+    +  + V++E      L +    K   A TE EA   + +I    ++LH  
Sbjct: 81  HGFFED----NDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+K  NL   +             D++              +K+ DFG A K+  
Sbjct: 135 RVIHRDLKLGNLFLNE-------------DLE--------------VKIGDFGLATKVEY 167
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +    +  C TP Y+APEVL    +    D+WS+G IMY LL G PPF ++  +      
Sbjct: 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--- 224
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             RI+  ++  P    +H++  A +LI+ ML  DP+ R TI++++ +++ + 
Sbjct: 225 -LRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 122/252 (48%), Gaps = 46/252 (18%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           K  REV +   V +H +IV + +V E      + L ++ E   GGE+F  +     G   
Sbjct: 59  KLFREVRIX-KVLNHPNIVKLFEVIET----EKTLYLVXEYASGGEVFDYLVAH--GRXK 111
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E+EA     +I SA+++ H + I HRD+K ENLL     +                    
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXN-------------------- 151
Query: 174 KPGDGGILKLTDFGFAKKIV-SNKASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVI 231
                  +K+ DFGF+ +    NK  L   C  P Y APE+    KYD    D+WSLGVI
Sbjct: 152 -------IKIADFGFSNEFTFGNK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVI 202
Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           +Y L+ G  PF    GQ +   ++ R+  G++  P     + S + + L+K  L ++PS+
Sbjct: 203 LYTLVSGSLPF---DGQNLKE-LRERVLRGKYRIPF----YXSTDCENLLKKFLILNPSK 254
Query: 292 RLTIDQVMENKW 303
           R T++Q+ +++W
Sbjct: 255 RGTLEQIXKDRW 266

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 146/302 (48%), Gaps = 56/302 (18%)
Query: 22  EILGLGINGKVL---QIVEKKTSEVYALKVL-------HDTVKARREVELQLAVGSHKHI 71
           ++LG G  GKV    +I      ++YA+KVL        D V+ + E ++ + V +H  I
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFI 89
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           V +   ++        L +I++ + GG+LF R+ +  +  FTE +    + E+  A+  L
Sbjct: 90  VKLHYAFQT----EGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHL 143
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I +RD+KPEN+L  + G                            +KLTDFG +K+
Sbjct: 144 HSLGIIYRDLKPENILLDEEGH---------------------------IKLTDFGLSKE 176
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAI 250
            + ++    + C T  Y+APEV+    + +S D WS GV+M+ +L G  PF   +  + +
Sbjct: 177 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 236
Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI--DQVMENKWISQFN 308
           +  +K ++ + QF         +S EA++L++ +   +P+ RL    D V E K  S F+
Sbjct: 237 TMILKAKLGMPQF---------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 287
Query: 309 QV 310
            +
Sbjct: 288 TI 289

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 49/290 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAV--GSHKHIVNIKDVYENI 81
           +G G  G V    EK +    A+K++    + RRE+     V    ++H  N+ ++Y++ 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF-NVVEMYKSY 111
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
             G   L V+ME + GG L   + Q       E + A +   +  A+ +LH Q + HRD+
Sbjct: 112 LVGEE-LWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT 201
           K +++L T  G                            +KL+DFGF  +I  +    + 
Sbjct: 168 KSDSILLTLDGR---------------------------VKLSDFGFCAQISKDVPKRKX 200
Query: 202 PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP--GMKNRIR 259
              TPY++APEV+    Y    DIWSLG+++  ++ G PP+FS+     SP   MK R+R
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD-----SPVQAMK-RLR 254
Query: 260 LGQFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               D P P+ ++   VS   +  ++ ML  DP ER T  +++++ ++ Q
Sbjct: 255 ----DSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 146/302 (48%), Gaps = 56/302 (18%)
Query: 22  EILGLGINGKVL---QIVEKKTSEVYALKVL-------HDTVKARREVELQLAVGSHKHI 71
           ++LG G  GKV    +I      ++YA+KVL        D V+ + E ++ + V +H  I
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFI 88
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           V +   ++        L +I++ + GG+LF R+ +  +  FTE +    + E+  A+  L
Sbjct: 89  VKLHYAFQT----EGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHL 142
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I +RD+KPEN+L  + G                            +KLTDFG +K+
Sbjct: 143 HSLGIIYRDLKPENILLDEEGH---------------------------IKLTDFGLSKE 175
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAI 250
            + ++    + C T  Y+APEV+    + +S D WS GV+M+ +L G  PF   +  + +
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI--DQVMENKWISQFN 308
           +  +K ++ + QF         +S EA++L++ +   +P+ RL    D V E K  S F+
Sbjct: 236 TMILKAKLGMPQF---------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286
Query: 309 QV 310
            +
Sbjct: 287 TI 288

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 146/302 (48%), Gaps = 56/302 (18%)
Query: 22  EILGLGINGKVL---QIVEKKTSEVYALKVL-------HDTVKARREVELQLAVGSHKHI 71
           ++LG G  GKV    +I      ++YA+KVL        D V+ + E ++ + V +H  I
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFI 88
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           V +   ++        L +I++ + GG+LF R+ +  +  FTE +    + E+  A+  L
Sbjct: 89  VKLHYAFQT----EGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHL 142
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I +RD+KPEN+L  + G                            +KLTDFG +K+
Sbjct: 143 HSLGIIYRDLKPENILLDEEGH---------------------------IKLTDFGLSKE 175
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAI 250
            + ++    + C T  Y+APEV+    + +S D WS GV+M+ +L G  PF   +  + +
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI--DQVMENKWISQFN 308
           +  +K ++ + QF         +S EA++L++ +   +P+ RL    D V E K  S F+
Sbjct: 236 TMILKAKLGMPQF---------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286
Query: 309 QV 310
            +
Sbjct: 287 TI 288

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 133/254 (52%), Gaps = 46/254 (18%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           K  REV + + + +H +IV + +V E      + L ++ME   GGE+F  +     G   
Sbjct: 60  KLFREVRI-MKILNHPNIVKLFEVIET----EKTLYLVMEYASGGEVFDYLVAH--GRMK 112
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E+EA     +I SA+++ H + I HRD+K ENLL               GD+        
Sbjct: 113 EKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLD-------------GDMN------- 152
Query: 174 KPGDGGILKLTDFGFAKKI-VSNKASLQTPCYTPYYVAPEVLGPDKYDK-SCDIWSLGVI 231
                  +K+ DFGF+ +  V NK  L T C +P Y APE+    KYD    D+WSLGVI
Sbjct: 153 -------IKIADFGFSNEFTVGNK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVI 203
Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           +Y L+ G  PF    GQ +   ++ R+  G++  P     ++S + + L+K +L ++P +
Sbjct: 204 LYTLVSGSLPF---DGQNLKE-LRERVLRGKYRIPF----YMSTDCENLLKKLLVLNPIK 255
Query: 292 RLTIDQVMENKWIS 305
           R +++Q+M+++W++
Sbjct: 256 RGSLEQIMKDRWMN 269

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSHKHIVNIKDV-Y 78
             LG G   K  +I +  T EV+A KV+  +  +K  ++ ++   +  HK + N   V +
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
              +     + V++E      L +    K   A TE EA   M +    +++LH+  + H
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIH 165
Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  NL            L D  DVK                + DFG A KI  +   
Sbjct: 166 RDLKLGNLF-----------LNDDMDVK----------------IGDFGLATKIEFDGER 198
Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
            +  C TP Y+APEVL    +    DIWSLG I+Y LL G PPF        S   +  I
Sbjct: 199 KKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF------ETSCLKETYI 252
Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           R+ + ++  P   H++  A  LI+ ML  DP+ R ++ +++ +++ + 
Sbjct: 253 RIKKNEYSVP--RHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSHKHIVNIKDV-Y 78
             LG G   K  +I +  T EV+A KV+  +  +K  ++ ++   +  HK + N   V +
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
              +     + V++E      L +    K   A TE EA   M +    +++LH+  + H
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIH 165
Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  NL            L D  DVK                + DFG A KI  +   
Sbjct: 166 RDLKLGNLF-----------LNDDMDVK----------------IGDFGLATKIEFDGER 198
Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
            +  C TP Y+APEVL    +    DIWSLG I+Y LL G PPF        S   +  I
Sbjct: 199 KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF------ETSCLKETYI 252
Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           R+ + ++  P   H++  A  LI+ ML  DP+ R ++ +++ +++ + 
Sbjct: 253 RIKKNEYSVP--RHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSHKHIVNIKDV-Y 78
             LG G   K  +I +  T EV+A KV+  +  +K  ++ ++   +  HK + N   V +
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
              +     + V++E      L +    K   A TE EA   M +    +++LH+  + H
Sbjct: 92  HGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIH 149
Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  NL            L D  DVK                + DFG A KI  +   
Sbjct: 150 RDLKLGNLF-----------LNDDMDVK----------------IGDFGLATKIEFDGER 182
Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
            +  C TP Y+APEVL    +    DIWSLG I+Y LL G PPF        S   +  I
Sbjct: 183 KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF------ETSCLKETYI 236
Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           R+ + ++  P   H++  A  LI+ ML  DP+ R ++ +++ +++ + 
Sbjct: 237 RIKKNEYSVP--RHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 282

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 96/340 (28%), Positives = 146/340 (42%), Gaps = 57/340 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHI 71
           D YD   +I G G  G    + +K T E+ A+K +         V+ ++       H +I
Sbjct: 20  DRYDFVKDI-GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           V  K+V     +    L +IME   GGEL++RI     G F+E EA     ++ S + + 
Sbjct: 79  VRFKEVILTPTH----LAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYC 132
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I HRD+K EN L               G   P             LK+ DFG++K 
Sbjct: 133 HSMQICHRDLKLENTLLD-------------GSPAPR------------LKICDFGYSKS 167
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
            V +     T   TP Y+APEVL   +YD K  D+WS GV +Y++L G  PF     +  
Sbjct: 168 SVLHSQPKST-VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEP 224
Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI------ 304
               K   R+    +  P+   +S E   LI  +   DP+ R++I ++  + W       
Sbjct: 225 RDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA 284
Query: 305 ---------SQFNQVPQTPLCTGKMLKE--GEETWPEVQD 333
                    SQF Q P+ P+ +   + +   E T P V++
Sbjct: 285 DLMNESNTGSQF-QEPEQPMQSLDTIMQIISEATIPAVRN 323

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 135/282 (47%), Gaps = 52/282 (18%)
Query: 22  EILGLGINGKVL---QIVEKKTSEVYALKVLHD-TVKARREVELQ-----LAVGSHKHIV 72
           ++LG G  GKV    ++    +  +YA+KVL   T+K R  V  +     LA  +H  +V
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +   ++        L +I++ + GG+LF R+ +  +  FTE +    + E+   +  LH
Sbjct: 94  KLHYAFQT----EGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALGLDHLH 147
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I +RD+KPEN+L  + G                            +KLTDFG +K+ 
Sbjct: 148 SLGIIYRDLKPENILLDEEGH---------------------------IKLTDFGLSKEA 180
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAIS 251
           + ++    + C T  Y+APEV+    +  S D WS GV+M+ +L G  PF   +  + ++
Sbjct: 181 IDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMT 240
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             +K ++ + QF         +S EA++L++ +   +P+ RL
Sbjct: 241 LILKAKLGMPQF---------LSTEAQSLLRALFKRNPANRL 273

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 133/290 (45%), Gaps = 52/290 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VG 66
           +D+++  ++LG G  GKV     KKT++ +A+K L  D V    +VE  +          
Sbjct: 18  EDFELH-KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
            H  + ++   ++   N    L  +ME ++GG+L   IQ      F    A     EI  
Sbjct: 77  EHPFLTHMFCTFQTKEN----LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIIL 130
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            ++FLH + I +RD+K +N+L  K G                            +K+ DF
Sbjct: 131 GLQFLHSKGIVYRDLKLDNILLDKDGH---------------------------IKIADF 163
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G  K+ +   A     C TP Y+APE+L   KY+ S D WS GV++Y +L G  PF   H
Sbjct: 164 GMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF---H 220
Query: 247 GQAISPGMKNRIRLGQFDFP-NPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           GQ     + + IR+   D P  P W  + +EAK L+  +   +P +RL +
Sbjct: 221 GQD-EEELFHSIRM---DNPFYPRW--LEKEAKDLLVKLFVREPEKRLGV 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 129/286 (45%), Gaps = 51/286 (17%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VGSHKH 70
           I  ++LG G  GKV     KKT++ +A+K L  D V    +VE  +           H  
Sbjct: 20  ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           + ++   ++   N    L  +ME ++GG+L   IQ      F    A     EI   ++F
Sbjct: 80  LTHMFCTFQTKEN----LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQF 133
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH + I +RD+K +N+L  K G                            +K+ DFG  K
Sbjct: 134 LHSKGIVYRDLKLDNILLDKDGH---------------------------IKIADFGMCK 166
Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
           + +   A     C TP Y+APE+L   KY+ S D WS GV++Y +L G  PF   HGQ  
Sbjct: 167 ENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF---HGQD- 222
Query: 251 SPGMKNRIRLGQFDFP-NPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
              + + IR+   D P  P W  + +EAK L+  +   +P +RL +
Sbjct: 223 EEELFHSIRM---DNPFYPRW--LEKEAKDLLVKLFVREPEKRLGV 263

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 49/279 (17%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVGSHKHIVNIKDVYENI 81
           +LG G  GKV+    K T E+YA+K+L  D V    +VE  +     K ++ + D    +
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMV---EKRVLALLDKPPFL 82
Query: 82  YNGSRC------LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
                C      L  +ME ++GG+L   IQQ   G F E +A     EI   + FLH + 
Sbjct: 83  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISIGLFFLHKRG 140
Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I +RD+K +N++    G                            +K+ DFG  K+ + +
Sbjct: 141 IIYRDLKLDNVMLDSEGH---------------------------IKIADFGMCKEHMMD 173
Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAISPGM 254
             + +  C TP Y+APE++    Y KS D W+ GV++Y +L G PPF   +  +     M
Sbjct: 174 GVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 233
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           ++ +      +P    + +S+EA ++ K ++   P++RL
Sbjct: 234 EHNV-----SYP----KSLSKEAVSICKGLMTKHPAKRL 263

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 36/227 (15%)
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
           N +  S  + +++E  H GE+  R  +     F+E EA   M++I + + +LH   I HR
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+   NLL T+  +                           +K+ DFG A ++       
Sbjct: 137 DLTLSNLLLTRNMN---------------------------IKIADFGLATQLKMPHEKH 169
Query: 200 QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIR 259
            T C TP Y++PE+     +    D+WSLG + Y LL G PPF ++          N++ 
Sbjct: 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD----TVKNTLNKVV 225
Query: 260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           L  ++ P+     +S EAK LI  +L  +P++RL++  V+++ ++S+
Sbjct: 226 LADYEMPS----FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 137/293 (46%), Gaps = 55/293 (18%)
Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQLAV 65
           D+D+   ++G G   KVL +  KKT  +YA++V+           D V+  + V  Q + 
Sbjct: 53  DFDL-LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS- 110
Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
            +H  +V +   ++     SR   VI E ++GG+L   +Q++      E  A     EI 
Sbjct: 111 -NHPFLVGLHSCFQT---ESRLFFVI-EYVNGGDLMFHMQRQR--KLPEEHARFYSAEIS 163
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
            A+ +LH++ I +RD+K +N+L    G    +KLTD+G  K E L   +PGD        
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCK-EGL---RPGD-------- 208
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF--- 242
                       +  T C TP Y+APE+L  + Y  S D W+LGV+M+ ++ G  PF   
Sbjct: 209 ------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256
Query: 243 --FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
               N  Q     +   I   Q   P      +S +A +++K+ L  DP ERL
Sbjct: 257 GSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERL 305

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 136/293 (46%), Gaps = 55/293 (18%)
Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQLAV 65
           D+D+   ++G G   KVL +  KKT  +YA+KV+           D V+  + V  Q + 
Sbjct: 21  DFDL-LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS- 78
Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
            +H  +V +   ++     SR   VI E ++GG+L   +Q++      E  A     EI 
Sbjct: 79  -NHPFLVGLHSCFQT---ESRLFFVI-EYVNGGDLMFHMQRQR--KLPEEHARFYSAEIS 131
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
            A+ +LH++ I +RD+K +N+L    G    +KLTD+G  K E L   +PGD        
Sbjct: 132 LALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCK-EGL---RPGD-------- 176
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF--- 242
                       +    C TP Y+APE+L  + Y  S D W+LGV+M+ ++ G  PF   
Sbjct: 177 ------------TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 224
Query: 243 --FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
               N  Q     +   I   Q   P      +S +A +++K+ L  DP ERL
Sbjct: 225 GSSDNPDQNTEDYLFQVILEKQIRIPRS----MSVKAASVLKSFLNKDPKERL 273

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 136/293 (46%), Gaps = 55/293 (18%)
Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQLAV 65
           D+D+   ++G G   KVL +  KKT  +YA+KV+           D V+  + V  Q + 
Sbjct: 6   DFDL-LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS- 63
Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
            +H  +V +   ++     SR   VI E ++GG+L   +Q++      E  A     EI 
Sbjct: 64  -NHPFLVGLHSCFQT---ESRLFFVI-EYVNGGDLMFHMQRQR--KLPEEHARFYSAEIS 116
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
            A+ +LH++ I +RD+K +N+L    G    +KLTD+G  K E L   +PGD        
Sbjct: 117 LALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCK-EGL---RPGD-------- 161
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF--- 242
                       +    C TP Y+APE+L  + Y  S D W+LGV+M+ ++ G  PF   
Sbjct: 162 ------------TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 209
Query: 243 --FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
               N  Q     +   I   Q   P      +S +A +++K+ L  DP ERL
Sbjct: 210 GSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAASVLKSFLNKDPKERL 258

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 136/293 (46%), Gaps = 55/293 (18%)
Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----------DTVKARREVELQLAV 65
           D+D+   ++G G   KVL +  KKT  +YA+KV+           D V+  + V  Q + 
Sbjct: 10  DFDL-LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS- 67
Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
            +H  +V +   ++     SR   VI E ++GG+L   +Q++      E  A     EI 
Sbjct: 68  -NHPFLVGLHSCFQT---ESRLFFVI-EYVNGGDLMFHMQRQR--KLPEEHARFYSAEIS 120
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
            A+ +LH++ I +RD+K +N+L    G    +KLTD+G  K E L   +PGD        
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCK-EGL---RPGD-------- 165
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF--- 242
                       +    C TP Y+APE+L  + Y  S D W+LGV+M+ ++ G  PF   
Sbjct: 166 ------------TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213
Query: 243 --FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
               N  Q     +   I   Q   P      +S +A +++K+ L  DP ERL
Sbjct: 214 GSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERL 262

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 43/302 (14%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYENIY 82
           +G G  G V    EK T +  A+K +    + RRE+   ++ +    H  N+ D+Y +  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 83  NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK 142
            G   L V+ME + GG L   +         E + A +   +  A+ +LH+Q + HRD+K
Sbjct: 113 VGDE-LWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP 202
            +++L T  G                            +KL+DFGF  ++       +  
Sbjct: 169 SDSILLTSDGR---------------------------IKLSDFGFCAQVSKEVPKRKXL 201
Query: 203 CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ 262
             TPY++APEV+    Y    DIWSLG+++  ++ G PP+F+       P ++   R+  
Sbjct: 202 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE------PPLQAMRRIRD 255
Query: 263 FDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKML 321
              P  +  H VS   +  +  ML  +PS+R T  +++ +     F ++   P C   ++
Sbjct: 256 SLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHP----FLKLAGPPSCIVPLM 311
Query: 322 KE 323
           ++
Sbjct: 312 RQ 313

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 46/288 (15%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIVNIKDVYE 79
           E +G G  G+V + ++ +T +V A+K+  L +      +++ ++ V S      +   Y 
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
           +   GS+ L +IME + GG     ++    G F E + A ++ EI   + +LH +   HR
Sbjct: 89  SYLKGSK-LWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHR 144
Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+K  N+L ++ GD                           +KL DFG A ++   +   
Sbjct: 145 DIKAANVLLSEQGD---------------------------VKLADFGVAGQLTDTQIKR 177
Query: 200 QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI---SPGMKN 256
            T   TP+++APEV+    YD   DIWSLG+    L  G PP    H   +    P    
Sbjct: 178 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP 237
Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
              +G F          ++  K  I   L  DPS R T  +++++K+I
Sbjct: 238 PTLVGDF----------TKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 49/286 (17%)
Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAV 65
           ++D++I  +++G G  G+V  +  K T  +YA+K+L+        +T   R E ++ L  
Sbjct: 89  REDFEI-IKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV-LVN 146
Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
           G  + I  +   +++       L ++M+   GG+L   + + ED    E  A   + E+ 
Sbjct: 147 GDCQWITALHYAFQD----ENHLYLVMDYYVGGDLLTLLSKFED-KLPEDMARFYIGEMV 201
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
            AI  +H  +  HRD+KP+N+L    G    ++L DFG                 LK+ D
Sbjct: 202 LAIDSIHQLHYVHRDIKPDNVLLDVNGH---IRLADFG---------------SCLKMND 243
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFP 240
            G  +  V+          TP Y++PE+L     G  KY   CD WSLGV MY +L G  
Sbjct: 244 DGTVQSSVA--------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 295
Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
           PF++         + N     +F FP+   + VS+EAK LI+ ++C
Sbjct: 296 PFYAESLVETYGKIMNHEE--RFQFPSHVTD-VSEEAKDLIQRLIC 338

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 132/302 (43%), Gaps = 56/302 (18%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARR-------EVELQLAVGS 67
           +DY++  +++G G  G+V  +  K T +VYA+K+L      +R       E    +A  +
Sbjct: 74  EDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              +V +   +++     R L ++ME M GG+L   +   +     E+ A     E+  A
Sbjct: 133 SPWVVQLFYAFQD----DRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLA 185
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H     HRDVKP+N+L  K                            G LKL DFG
Sbjct: 186 LDAIHSMGFIHRDVKPDNMLLDK---------------------------SGHLKLADFG 218
Query: 188 FAKKIVSNKASL---QTPCYTPYYVAPEVL----GPDKYDKSCDIWSLGVIMYILLCGFP 240
              K+  NK  +    T   TP Y++PEVL    G   Y + CD WS+GV +Y +L G  
Sbjct: 219 TCMKM--NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 276
Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF+++        + N      F    P+   +S+EAK LI   L  D   RL  + V E
Sbjct: 277 PFYADSLVGTYSKIMNHKNSLTF----PDDNDISKEAKNLICAFL-TDREVRLGRNGVEE 331
Query: 301 NK 302
            K
Sbjct: 332 IK 333

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 132/302 (43%), Gaps = 56/302 (18%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARR-------EVELQLAVGS 67
           +DY++  +++G G  G+V  +  K T +VYA+K+L      +R       E    +A  +
Sbjct: 69  EDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              +V +   +++     R L ++ME M GG+L   +   +     E+ A     E+  A
Sbjct: 128 SPWVVQLFYAFQD----DRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLA 180
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H     HRDVKP+N+L  K                            G LKL DFG
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDK---------------------------SGHLKLADFG 213
Query: 188 FAKKIVSNKASL---QTPCYTPYYVAPEVL----GPDKYDKSCDIWSLGVIMYILLCGFP 240
              K+  NK  +    T   TP Y++PEVL    G   Y + CD WS+GV +Y +L G  
Sbjct: 214 TCMKM--NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF+++        + N      F    P+   +S+EAK LI   L  D   RL  + V E
Sbjct: 272 PFYADSLVGTYSKIMNHKNSLTF----PDDNDISKEAKNLICAFL-TDREVRLGRNGVEE 326
Query: 301 NK 302
            K
Sbjct: 327 IK 328

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 49/286 (17%)
Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAV 65
           ++D++I  +++G G  G+V  +  K T  +YA+K+L+        +T   R E ++ L  
Sbjct: 73  REDFEI-IKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV-LVN 130
Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
           G  + I  +   +++       L ++M+   GG+L   + + ED    E  A   + E+ 
Sbjct: 131 GDCQWITALHYAFQD----ENHLYLVMDYYVGGDLLTLLSKFED-KLPEDMARFYIGEMV 185
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
            AI  +H  +  HRD+KP+N+L    G    ++L DFG                 LK+ D
Sbjct: 186 LAIDSIHQLHYVHRDIKPDNVLLDVNGH---IRLADFG---------------SCLKMND 227
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFP 240
            G  +  V+          TP Y++PE+L     G  KY   CD WSLGV MY +L G  
Sbjct: 228 DGTVQSSVA--------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 279
Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
           PF++         + N     +F FP+   + VS+EAK LI+ ++C
Sbjct: 280 PFYAESLVETYGKIMNHEE--RFQFPSHVTD-VSEEAKDLIQRLIC 322

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 132/302 (43%), Gaps = 56/302 (18%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARR-------EVELQLAVGS 67
           +DY++  +++G G  G+V  +  K T +VYA+K+L      +R       E    +A  +
Sbjct: 74  EDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              +V +   +++     R L ++ME M GG+L   +   +     E+ A     E+  A
Sbjct: 133 SPWVVQLFYAFQD----DRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLA 185
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H     HRDVKP+N+L  K                            G LKL DFG
Sbjct: 186 LDAIHSMGFIHRDVKPDNMLLDK---------------------------SGHLKLADFG 218
Query: 188 FAKKIVSNKASL---QTPCYTPYYVAPEVL----GPDKYDKSCDIWSLGVIMYILLCGFP 240
              K+  NK  +    T   TP Y++PEVL    G   Y + CD WS+GV +Y +L G  
Sbjct: 219 TCMKM--NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 276
Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF+++        + N      F    P+   +S+EAK LI   L  D   RL  + V E
Sbjct: 277 PFYADSLVGTYSKIMNHKNSLTF----PDDNDISKEAKNLICAFL-TDREVRLGRNGVEE 331
Query: 301 NK 302
            K
Sbjct: 332 IK 333

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 134/286 (46%), Gaps = 49/286 (17%)
Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAV 65
           ++D++I  +++G G  G+V  +  K   +V+A+K+L+        +T   R E ++ L  
Sbjct: 73  REDFEI-LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV-LVN 130
Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
           G  K I  +   +++  N    L ++M+   GG+L   + + ED    E  A   + E+ 
Sbjct: 131 GDSKWITTLHYAFQDDNN----LYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYLAEMV 185
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
            AI  +H  +  HRD+KP+N+L       G ++L DFG                 LKL +
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDM---NGHIRLADFG---------------SCLKLME 227
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFP 240
            G  +  V+          TP Y++PE+L     G  +Y   CD WSLGV MY +L G  
Sbjct: 228 DGTVQSSVAVG--------TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
           PF++         + N     +F FP  +   VS+ AK LI+ ++C
Sbjct: 280 PFYAESLVETYGKIMNHKE--RFQFPT-QVTDVSENAKDLIRRLIC 322

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 51/280 (18%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VGSHKHIVNI 74
           +LG G  GKV+    K T E+YA+K+L  D V    +VE  +         G    +  +
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              ++ +      L  +ME ++GG+L   IQQ   G F E  A     EI   + FL  +
Sbjct: 87  HSCFQTMDR----LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K +N++    G                            +K+ DFG  K+ + 
Sbjct: 141 GIIYRDLKLDNVMLDSEGH---------------------------IKIADFGMCKENIW 173
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAISPG 253
           +  + +  C TP Y+APE++    Y KS D W+ GV++Y +L G  PF   +  +     
Sbjct: 174 DGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233
Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           M++ +      +P    + +S+EA  + K ++   P +RL
Sbjct: 234 MEHNVA-----YP----KSMSKEAVAICKGLMTKHPGKRL 264

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 51/280 (18%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VGSHKHIVNI 74
           +LG G  GKV+    K T E+YA+K+L  D V    +VE  +         G    +  +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              ++ +      L  +ME ++GG+L   IQQ   G F E  A     EI   + FL  +
Sbjct: 408 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K +N++    G                            +K+ DFG  K+ + 
Sbjct: 462 GIIYRDLKLDNVMLDSEGH---------------------------IKIADFGMCKENIW 494
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAISPG 253
           +  + +  C TP Y+APE++    Y KS D W+ GV++Y +L G  PF   +  +     
Sbjct: 495 DGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554
Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           M++ +      +P    + +S+EA  + K ++   P +RL
Sbjct: 555 MEHNVA-----YP----KSMSKEAVAICKGLMTKHPGKRL 585

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 135/292 (46%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 95
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 96  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 146
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 147 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 179
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A   +   T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 180 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 239
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 240 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 283

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 92
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 93  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 143
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 144 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 176
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 177 AKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 237 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 280

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 133/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 94
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I++   G+F E        EI SA+
Sbjct: 95  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSAL 145
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 178
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 179 AKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGN 238
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I       I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 239 EGLI---FAKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 136/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ + +  +  
Sbjct: 7   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 123 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 155
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 216 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 7   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 123 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 155
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 216 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 135/292 (46%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 91
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 92  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 142
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 143 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 175
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A   +   T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 176 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 235
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 236 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 279

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 94
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 95  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 145
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 178
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 179 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 239 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 94
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 95  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 145
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 178
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 179 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 239 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 92
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 93  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 143
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 144 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 176
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 177 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 237 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 280

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 94
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 95  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 145
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 178
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 179 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 239 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 95
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 96  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 146
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 147 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 179
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 180 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 239
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 240 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 283

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 92
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 93  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 143
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 144 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 176
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 177 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 237 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 280

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 7   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 123 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 155
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 216 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 7   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 123 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 155
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 216 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 7   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 123 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 155
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 216 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 5   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 121 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 153
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 214 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 69
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I++   G+F E        EI SA+
Sbjct: 70  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSAL 120
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 121 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 153
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 154 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 213
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 214 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 257

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 130/285 (45%), Gaps = 40/285 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIVNIKDVYE 79
           E +G G  G+V + ++ +T +V A+K+  L +      +++ ++ V S      +   Y 
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
           +    ++ L +IME + GG     +   E G   E + A I+ EI   + +LH +   HR
Sbjct: 73  SYLKDTK-LWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+K  N+L           L++ G+VK                L DFG A ++   +   
Sbjct: 129 DIKAANVL-----------LSEHGEVK----------------LADFGVAGQLTDTQIKR 161
Query: 200 QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIR 259
            T   TP+++APEV+    YD   DIWSLG+    L  G PP    H       MK    
Sbjct: 162 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------PMKVLFL 215
Query: 260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           + + + P  E  + S+  K  ++  L  +PS R T  +++++K+I
Sbjct: 216 IPKNNPPTLEGNY-SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 70
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 71  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 121
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 122 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 154
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 155 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 215 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 258

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 99
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I++   G+F E        EI SA+
Sbjct: 100 VKLYFCFQDDEKLYFG-------LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSAL 150
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 151 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 183
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 184 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 243
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 244 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 287

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 7   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 123 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 155
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 216 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 72
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 73  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 123
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 124 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 156
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 157 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 216
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 217 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 260

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 133/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 94
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I++   G+F E        EI SA+
Sbjct: 95  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSAL 145
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 178
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 179 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I       I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 239 EGLI---FAKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 71
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 72  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 122
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 123 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 155
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 156 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 215
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 216 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 259

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 91
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 92  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 142
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 143 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 175
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 176 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 235
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 236 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 279

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 7   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 123 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 155
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 216 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 130/285 (45%), Gaps = 40/285 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIVNIKDVYE 79
           E +G G  G+V + ++ +T +V A+K+  L +      +++ ++ V S      +   Y 
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
           +    ++ L +IME + GG     +   E G   E + A I+ EI   + +LH +   HR
Sbjct: 93  SYLKDTK-LWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIHR 148
Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+K  N+L           L++ G+VK                L DFG A ++   +   
Sbjct: 149 DIKAANVL-----------LSEHGEVK----------------LADFGVAGQLTDTQIKR 181
Query: 200 QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIR 259
            T   TP+++APEV+    YD   DIWSLG+    L  G PP    H       MK    
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------PMKVLFL 235
Query: 260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           + + + P  E  + S+  K  ++  L  +PS R T  +++++K+I
Sbjct: 236 IPKNNPPTLEGNY-SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 76
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 77  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 127
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 128 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 160
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 161 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 220
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 221 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 264

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 94
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     G L + I  ++ G+F E        EI SA+
Sbjct: 95  VKLYFTFQDDEKLYFG-------LSYAKNGCLLKYI--RKIGSFDETCTRFYTAEIVSAL 145
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 146 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 178
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A   +   T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGN 238
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 239 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 282

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 133/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G     +   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 92
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 93  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 143
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 144 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 176
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 177 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP    E    +A+ L++ +L +D ++RL  +++
Sbjct: 237 EYLI---FQKIIKL-EYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 280

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 62/292 (21%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHI 71
           +ILG G    V+   E  TS  YA+K+L             V   R+V  +L    H   
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---DHPFF 97
Query: 72  VNIKDVY---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           V +   +   E +Y G       +     GEL + I  ++ G+F E        EI SA+
Sbjct: 98  VKLYFTFQDDEKLYFG-------LSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSAL 148
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           ++LH + I HRD+KPEN+L  +             D+               +++TDFG 
Sbjct: 149 EYLHGKGIIHRDLKPENILLNE-------------DMH--------------IQITDFGT 181
Query: 189 AKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           AK +   S +A       T  YV+PE+L      KS D+W+LG I+Y L+ G PPF + +
Sbjct: 182 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 241
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
              I    +  I+L ++DFP   +     +A+ L++ +L +D ++RL  +++
Sbjct: 242 EYLI---FQKIIKL-EYDFPAAFF----PKARDLVEKLLVLDATKRLGCEEM 285

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 40/288 (13%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIVNIKDVYENI 81
           +G G  G+V + ++  T EV A+K+  L +      +++ ++ V S      I   Y   
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR-YFGS 85
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
           Y  S  L +IME + GG     ++    G   E   A I+ EI   + +LH +   HRD+
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDI 142
Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT 201
           K  N+L ++ GD                           +KL DFG A ++   +     
Sbjct: 143 KAANVLLSEQGD---------------------------VKLADFGVAGQLTDTQIKRNX 175
Query: 202 PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG 261
              TP+++APEV+    YD   DIWSLG+    L  G PP    H       M+    + 
Sbjct: 176 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH------PMRVLFLIP 229
Query: 262 QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
           +   P  E +H S+  K  ++  L  DP  R T  +++++K+I+++ +
Sbjct: 230 KNSPPTLEGQH-SKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK 276

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 52/300 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARR-------EVELQLAVGS 67
           +DYD+  +++G G  G+V  +  K + +VYA+K+L      +R       E    +A  +
Sbjct: 75  EDYDV-VKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              +V +   +++     + L ++ME M GG+L   +   +     E+ A     E+  A
Sbjct: 134 SPWVVQLFCAFQD----DKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLA 186
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H   + HRDVKP+N+L  K                            G LKL DFG
Sbjct: 187 LDAIHSMGLIHRDVKPDNMLLDKH---------------------------GHLKLADFG 219
Query: 188 FAKKI-VSNKASLQTPCYTPYYVAPEVL----GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
              K+  +      T   TP Y++PEVL    G   Y + CD WS+GV ++ +L G  PF
Sbjct: 220 TCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
           +++       G  ++I   +     PE   +S+ AK LI   L  D   RL  + V E K
Sbjct: 280 YADS----LVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFL-TDREVRLGRNGVEEIK 334

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 129/285 (45%), Gaps = 40/285 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIVNIKDVYE 79
           E +G G  G+V + ++ +T +V A+K+  L +      +++ ++ V S      +   Y 
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
           +    ++ L +IME + GG     +   E G   E + A I+ EI   + +LH +   HR
Sbjct: 88  SYLKDTK-LWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIHR 143
Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+K  N+L           L++ G+VK                L DFG A ++   +   
Sbjct: 144 DIKAANVL-----------LSEHGEVK----------------LADFGVAGQLTDTQIKR 176
Query: 200 QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIR 259
                TP+++APEV+    YD   DIWSLG+    L  G PP    H       MK    
Sbjct: 177 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------PMKVLFL 230
Query: 260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           + + + P  E  + S+  K  ++  L  +PS R T  +++++K+I
Sbjct: 231 IPKNNPPTLEGNY-SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 129/285 (45%), Gaps = 40/285 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIVNIKDVYE 79
           E +G G  G+V + ++ +T +V A+K+  L +      +++ ++ V S      +   Y 
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
           +    ++ L +IME + GG     +   E G   E + A I+ EI   + +LH +   HR
Sbjct: 73  SYLKDTK-LWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+K  N+L           L++ G+VK                L DFG A ++   +   
Sbjct: 129 DIKAANVL-----------LSEHGEVK----------------LADFGVAGQLTDTQIKR 161
Query: 200 QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIR 259
                TP+++APEV+    YD   DIWSLG+    L  G PP    H       MK    
Sbjct: 162 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------PMKVLFL 215
Query: 260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
           + + + P  E  + S+  K  ++  L  +PS R T  +++++K+I
Sbjct: 216 IPKNNPPTLEGNY-SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYEN 80
           E +G G +G V   ++  T +  A++ ++   + ++E+ + ++ V       NI +  ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
              G   L V+ME + GG L   + +       E + A +  E   A++FLH   + HRD
Sbjct: 86  YLVGDE-LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +K +N+L                            G  G +KLTDFGF  +I   ++   
Sbjct: 142 IKSDNILL---------------------------GMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           T   TPY++APEV+    Y    DIWSLG++   ++ G PP+ + +
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 45/279 (16%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNI 74
           +LG G  G+V     + T ++YA K L             A  E ++   V S + +V++
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSL 249
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              YE        L +++  M+GG+L   I       F E  A     EIC  ++ LH +
Sbjct: 250 AYAYET----KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+KPEN+L                             D G ++++D G A  +  
Sbjct: 306 RIVYRDLKPENILLD---------------------------DHGHIRISDLGLAVHVPE 338
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            + +++    T  Y+APEV+  ++Y  S D W+LG ++Y ++ G  PF     +     +
Sbjct: 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           +  ++    + P    E  S +A++L   +LC DP+ERL
Sbjct: 398 ERLVK----EVPEEYSERFSPQARSLCSQLLCKDPAERL 432

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 45/279 (16%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNI 74
           +LG G  G+V     + T ++YA K L             A  E ++   V S + +V++
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSL 249
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              YE     + CL++ +  M+GG+L   I       F E  A     EIC  ++ LH +
Sbjct: 250 AYAYET--KDALCLVLTL--MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+KPEN+L                             D G ++++D G A  +  
Sbjct: 306 RIVYRDLKPENILLD---------------------------DHGHIRISDLGLAVHVPE 338
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            + +++    T  Y+APEV+  ++Y  S D W+LG ++Y ++ G  PF     +     +
Sbjct: 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397
Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           +  ++    + P    E  S +A++L   +LC DP+ERL
Sbjct: 398 ERLVK----EVPEEYSERFSPQARSLCSQLLCKDPAERL 432

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L     T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSX 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L     T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 7   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 123 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 155
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L     T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 156 RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 216 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L     T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 45/299 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHIV 72
           +D+D+  + LG G  G+V   V + T E  A+K+  +   V     ++ ++ +    +  
Sbjct: 6   EDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           N+   Y +   G+   L +  C  GGELF RI+   D    E +A    +++ + + +LH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYC-SGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL  +  +                           LK++DFG A   
Sbjct: 122 GIGITHRDIKPENLLLDERDN---------------------------LKISDFGLATVF 154
Query: 193 VSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFF--SNHG 247
             N     L     T  YVAPE+L   ++  +  D+WS G+++  +L G  P+   S+  
Sbjct: 155 RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 214
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           Q  S   + +  L      NP W+ +      L+  +L  +PS R+TI  + +++W ++
Sbjct: 215 QEYSDWKEKKTYL------NP-WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYEN 80
           E +G G +G V   ++  T +  A++ ++   + ++E+ + ++ V       NI +  ++
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
              G   L V+ME + GG L   + +       E + A +  E   A++FLH   + HR+
Sbjct: 87  YLVGDE-LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRN 142
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +K +N+L                            G  G +KLTDFGF  +I   ++   
Sbjct: 143 IKSDNILL---------------------------GMDGSVKLTDFGFCAQITPEQSKRS 175
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           T   TPY++APEV+    Y    DIWSLG++   ++ G PP+ + +
Sbjct: 176 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 221

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 47/277 (16%)
Query: 43  VYALKVLHDTVK----------ARREVELQLAVGSHKHIVNIKDV-YENIYNGSRCLLVI 91
           VYA + L + V+          +R    L   +  HKH+ +   V Y   ++ +  + + 
Sbjct: 38  VYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAI--IMNEICSAIKFLHDQNIAHRDVKPENLLYT 149
           ME + GG L   ++ K  G   + E  I     +I   +K+LHD  I HRD+K +N+L  
Sbjct: 98  MEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN 156
Query: 150 KPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV 209
                                 Y+     G+LK++DFG +K++       +T   T  Y+
Sbjct: 157 ---------------------TYS-----GVLKISDFGTSKRLAGINPCTETFTGTLQYM 190
Query: 210 APEVL--GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           APE++  GP  Y K+ DIWSLG  +  +  G PPF+      +        ++G F    
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE-----LGEPQAAMFKVGMFKVHP 245
Query: 268 PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
              E +S EAK  I      DP +R   + ++ ++++
Sbjct: 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYEN 80
           E +G G +G V   ++  T +  A++ ++   + ++E+ + ++ V       NI +  ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
              G   L V+ME + GG L   + +       E + A +  E   A++FLH   + HRD
Sbjct: 86  YLVGDE-LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +K +N+L                            G  G +KLTDFGF  +I   ++   
Sbjct: 142 IKSDNILL---------------------------GMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
               TPY++APEV+    Y    DIWSLG++   ++ G PP+ + +
Sbjct: 175 XMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYEN 80
           E +G G +G V   ++  T +  A++ ++   + ++E+ + ++ V       NI +  ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
              G   L V+ME + GG L   + +       E + A +  E   A++FLH   + HRD
Sbjct: 86  YLVGDE-LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +K +N+L                            G  G +KLTDFGF  +I   ++   
Sbjct: 142 IKSDNILL---------------------------GMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
               TPY++APEV+    Y    DIWSLG++   ++ G PP+ + +
Sbjct: 175 EMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYEN 80
           E +G G +G V   ++  T +  A++ ++   + ++E+ + ++ V       NI +  ++
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
              G   L V+ME + GG L   + +       E + A +  E   A++FLH   + HRD
Sbjct: 87  YLVGDE-LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRD 142
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +K +N+L                            G  G +KLTDFGF  +I   ++   
Sbjct: 143 IKSDNILL---------------------------GMDGSVKLTDFGFCAQITPEQSKRS 175
Query: 201 TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
               TPY++APEV+    Y    DIWSLG++   ++ G PP+ + +
Sbjct: 176 XMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 221

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAV--GSHKHIVNIKDVYENI 81
           +G G  G V     + + ++ A+K +    + RRE+     V    ++H  N+ ++Y + 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSY 97
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
             G   L V+ME + GG L   +         E + A +   +  A+  LH Q + HRD+
Sbjct: 98  LVGDE-LWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGVIHRDI 153
Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT 201
           K +++L T  G                            +KL+DFGF  ++       + 
Sbjct: 154 KSDSILLTHDGR---------------------------VKLSDFGFCAQVSKEVPRRKX 186
Query: 202 PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG 261
              TPY++APE++    Y    DIWSLG+++  ++ G PP+F+       P +K  +++ 
Sbjct: 187 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKA-MKMI 239
Query: 262 QFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           + + P P  ++   VS   K  +  +L  DP++R T  +++++ ++++
Sbjct: 240 RDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 286

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAV--GSHKHIVNIKDVYENI 81
           +G G  G V     + + ++ A+K +    + RRE+     V    ++H  N+ ++Y + 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSY 90
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
             G   L V+ME + GG L   +         E + A +   +  A+  LH Q + HRD+
Sbjct: 91  LVGDE-LWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGVIHRDI 146
Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT 201
           K +++L T  G                            +KL+DFGF  ++       + 
Sbjct: 147 KSDSILLTHDGR---------------------------VKLSDFGFCAQVSKEVPRRKX 179
Query: 202 PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG 261
              TPY++APE++    Y    DIWSLG+++  ++ G PP+F+       P +K  +++ 
Sbjct: 180 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKA-MKMI 232
Query: 262 QFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           + + P P  ++   VS   K  +  +L  DP++R T  +++++ ++++
Sbjct: 233 RDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 279

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAV--GSHKHIVNIKDVYENI 81
           +G G  G V     + + ++ A+K +    + RRE+     V    ++H  N+ ++Y + 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSY 217
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
             G   L V+ME + GG L   +         E + A +   +  A+  LH Q + HRD+
Sbjct: 218 LVGDE-LWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGVIHRDI 273
Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT 201
           K +++L T                             G +KL+DFGF  ++       + 
Sbjct: 274 KSDSILLTH---------------------------DGRVKLSDFGFCAQVSKEVPRRKX 306
Query: 202 PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG 261
              TPY++APE++    Y    DIWSLG+++  ++ G PP+F+       P +K  +++ 
Sbjct: 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKA-MKMI 359
Query: 262 QFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           + + P P  ++   VS   K  +  +L  DP++R T  +++++ ++++
Sbjct: 360 RDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAV--GSHKHIVNIKDVYENI 81
           +G G  G V     + + ++ A+K +    + RRE+     V    ++H  N+ ++Y + 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSY 140
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
             G   L V+ME + GG L   +         E + A +   +  A+  LH Q + HRD+
Sbjct: 141 LVGDE-LWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGVIHRDI 196
Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT 201
           K +++L T  G                            +KL+DFGF  ++       + 
Sbjct: 197 KSDSILLTHDGR---------------------------VKLSDFGFCAQVSKEVPRRKX 229
Query: 202 PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG 261
              TPY++APE++    Y    DIWSLG+++  ++ G PP+F+       P +K  +++ 
Sbjct: 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKA-MKMI 282
Query: 262 QFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           + + P P  ++   VS   K  +  +L  DP++R T  +++++ ++++
Sbjct: 283 RDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAV--GSHKHIVNIKDVYENI 81
           +G G  G V     + + ++ A+K +    + RRE+     V    ++H  N+ ++Y + 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSY 95
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
             G   L V+ME + GG L   +         E + A +   +  A+  LH Q + HRD+
Sbjct: 96  LVGDE-LWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGVIHRDI 151
Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT 201
           K +++L T  G                            +KL+DFGF  ++       + 
Sbjct: 152 KSDSILLTHDGR---------------------------VKLSDFGFCAQVSKEVPRRKX 184
Query: 202 PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG 261
              TPY++APE++    Y    DIWSLG+++  ++ G PP+F+       P +K  +++ 
Sbjct: 185 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKA-MKMI 237
Query: 262 QFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           + + P P  ++   VS   K  +  +L  DP++R T  +++++ ++++
Sbjct: 238 RDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 284

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAV--GSHKHIVNIKDVYENI 81
           +G G  G V     + + ++ A+K +    + RRE+     V    ++H  N+ ++Y + 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSY 86
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
             G   L V+ME + GG L   +         E + A +   +  A+  LH Q + HRD+
Sbjct: 87  LVGDE-LWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGVIHRDI 142
Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT 201
           K +++L T  G                            +KL+DFGF  ++       + 
Sbjct: 143 KSDSILLTHDGR---------------------------VKLSDFGFCAQVSKEVPRRKX 175
Query: 202 PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG 261
              TPY++APE++    Y    DIWSLG+++  ++ G PP+F+       P +K  +++ 
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKA-MKMI 228
Query: 262 QFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           + + P P  ++   VS   K  +  +L  DP++R T  +++++ ++++
Sbjct: 229 RDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 117/233 (50%), Gaps = 35/233 (15%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVG-SHKHIVNIKD 76
           E LG G  G VL+ + + T E  A+K     +    + R  +E+Q+    +H ++V+ ++
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 77  VYENIYN--GSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAIIMNEICSAIKFLHD 133
           V + +     +   L+ ME   GG+L + + Q E+     E     ++++I SA+++LH+
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             I HRD+KPEN++  +PG              P+ L++         K+ D G+AK++ 
Sbjct: 140 NRIIHRDLKPENIVL-QPG--------------PQRLIH---------KIIDLGYAKEL- 174
Query: 194 SNKASLQTPCY-TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
            ++  L T    T  Y+APE+L   KY  + D WS G + +  + GF PF  N
Sbjct: 175 -DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 117/233 (50%), Gaps = 35/233 (15%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVG-SHKHIVNIKD 76
           E LG G  G VL+ + + T E  A+K     +    + R  +E+Q+    +H ++V+ ++
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 77  VYENIYN--GSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAIIMNEICSAIKFLHD 133
           V + +     +   L+ ME   GG+L + + Q E+     E     ++++I SA+++LH+
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 140
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             I HRD+KPEN++  +PG              P+ L++         K+ D G+AK++ 
Sbjct: 141 NRIIHRDLKPENIVL-QPG--------------PQRLIH---------KIIDLGYAKEL- 175
Query: 194 SNKASLQTPCY-TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
            ++  L T    T  Y+APE+L   KY  + D WS G + +  + GF PF  N
Sbjct: 176 -DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 47/277 (16%)
Query: 43  VYALKVLHDTVK----------ARREVELQLAVGSHKHIVNIKDV-YENIYNGSRCLLVI 91
           VYA + L + V+          +R    L   +  HKH+ +   V Y   ++ +  + + 
Sbjct: 24  VYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 83
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAI--IMNEICSAIKFLHDQNIAHRDVKPENLLYT 149
           ME + GG L   ++ K  G   + E  I     +I   +K+LHD  I HRD+K +N+L  
Sbjct: 84  MEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN 142
Query: 150 KPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV 209
                                 Y+     G+LK++DFG +K++       +T   T  Y+
Sbjct: 143 T---------------------YS-----GVLKISDFGTSKRLAGINPCTETFTGTLQYM 176
Query: 210 APEVL--GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           APE++  GP  Y K+ DIWSLG  +  +  G PPF+      +        ++G F    
Sbjct: 177 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE-----LGEPQAAMFKVGMFKVHP 231
Query: 268 PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
              E +S EAK  I      DP +R   + ++ ++++
Sbjct: 232 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE------VELQLAVGSH 68
           +D+ +   +LG G  G+V     K T ++YA K L+     +R+      VE ++    H
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 69  -KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEIC 125
            + IV++   +E   +    L ++M  M+GG++   I    +++  F E  A     +I 
Sbjct: 244 SRFIVSLAYAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
           S ++ LH +NI +RD+KPEN+L                             D G ++++D
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLD---------------------------DDGNVRISD 332
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
            G A ++ + +   +    TP ++APE+L  ++YD S D ++LGV +Y ++    PF + 
Sbjct: 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             +  +  +K R+      +P+      S  +K   + +L  DP +RL
Sbjct: 393 GEKVENKELKQRVLEQAVTYPD----KFSPASKDFCEALLQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE------VELQLAVGSH 68
           +D+ +   +LG G  G+V     K T ++YA K L+     +R+      VE ++    H
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 69  -KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEIC 125
            + IV++   +E   +    L ++M  M+GG++   I    +++  F E  A     +I 
Sbjct: 244 SRFIVSLAYAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
           S ++ LH +NI +RD+KPEN+L                             D G ++++D
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLD---------------------------DDGNVRISD 332
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
            G A ++ + +   +    TP ++APE+L  ++YD S D ++LGV +Y ++    PF + 
Sbjct: 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             +  +  +K R+      +P+      S  +K   + +L  DP +RL
Sbjct: 393 GEKVENKELKQRVLEQAVTYPD----KFSPASKDFCEALLQKDPEKRL 436

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE------VELQLAVGSH 68
           +D+ +   +LG G  G+V     K T ++YA K L+     +R+      VE ++    H
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 69  -KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEIC 125
            + IV++   +E   +    L ++M  M+GG++   I    +++  F E  A     +I 
Sbjct: 244 SRFIVSLAYAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
           S ++ LH +NI +RD+KPEN+L                             D G ++++D
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLD---------------------------DDGNVRISD 332
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
            G A ++ + +   +    TP ++APE+L  ++YD S D ++LGV +Y ++    PF + 
Sbjct: 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             +  +  +K R+      +P+      S  +K   + +L  DP +RL
Sbjct: 393 GEKVENKELKQRVLEQAVTYPD----KFSPASKDFCEALLQKDPEKRL 436

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE------VELQLAVGSH 68
           +D+ +   +LG G  G+V     K T ++YA K L+     +R+      VE ++    H
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 69  -KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEIC 125
            + IV++   +E   +    L ++M  M+GG++   I    +++  F E  A     +I 
Sbjct: 244 SRFIVSLAYAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
           S ++ LH +NI +RD+KPEN+L                             D G ++++D
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLD---------------------------DDGNVRISD 332
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
            G A ++ + +   +    TP ++APE+L  ++YD S D ++LGV +Y ++    PF + 
Sbjct: 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             +  +  +K R+      +P+      S  +K   + +L  DP +RL
Sbjct: 393 GEKVENKELKQRVLEQAVTYPD----KFSPASKDFCEALLQKDPEKRL 436

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/327 (24%), Positives = 134/327 (40%), Gaps = 51/327 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLA 64
           + D Y++  EILG G   +V    + +     A+KVL   +        + RRE +   A
Sbjct: 10  LSDRYELG-EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
           + +H  IV + D  E          ++ME + G  L   +    +G  T + A  ++ + 
Sbjct: 69  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADA 125
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
           C A+ F H   I HRDVKP N+L +                               +K+ 
Sbjct: 126 CQALNFSHQNGIIHRDVKPANILISA---------------------------TNAVKVV 158
Query: 185 DFGFAKKIVSNKASL-QTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           DFG A+ I  +  S+ QT     T  Y++PE    D  D   D++SLG ++Y +L G PP
Sbjct: 159 DFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           F  +   +++      +R      P+   E +S +   ++   L  +P  R      M  
Sbjct: 219 FTGDSPVSVA---YQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
Query: 302 KWISQFN-QVPQTPLCTGKMLKEGEET 327
             +   N + P+ P    K+L + E T
Sbjct: 275 DLVRVHNGEPPEAP----KVLTDAERT 297

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 127/294 (43%), Gaps = 44/294 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQL-AVGSHKHIVNIKDVY-- 78
           E++G G  G+V +    KT ++ A+KV+  T     E++ ++  +  + H  NI   Y  
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 79  ---ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
              +N       L ++ME    G +   I+  +     E   A I  EI   +  LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           + HRD+K +N+L T+  +                           +KL DFG + ++   
Sbjct: 150 VIHRDIKGQNVLLTENAE---------------------------VKLVDFGVSAQLDRT 182
Query: 196 KASLQTPCYTPYYVAPEVLGPDK-----YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
                T   TPY++APEV+  D+     YD   D+WSLG+    +  G PP    H    
Sbjct: 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---- 238
Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
              M+    + +   P  + +  S++ ++ I++ L  + S+R   +Q+M++ +I
Sbjct: 239 --PMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 134/327 (40%), Gaps = 51/327 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLA 64
           + D Y++  EILG G   +V    + +     A+KVL   +        + RRE +   A
Sbjct: 10  LSDRYELG-EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
           + +H  IV + D  E          ++ME + G  L   +    +G  T + A  ++ + 
Sbjct: 69  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADA 125
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
           C A+ F H   I HRDVKP N++ +                               +K+ 
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISA---------------------------TNAVKVM 158
Query: 185 DFGFAKKIVSNKASL-QTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           DFG A+ I  +  S+ QT     T  Y++PE    D  D   D++SLG ++Y +L G PP
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           F  +   +++      +R      P+   E +S +   ++   L  +P  R      M  
Sbjct: 219 FTGDSPDSVA---YQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
Query: 302 KWISQFN-QVPQTPLCTGKMLKEGEET 327
             +   N + P+ P    K+L + E T
Sbjct: 275 DLVRVHNGEPPEAP----KVLTDAERT 297

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 129/299 (43%), Gaps = 54/299 (18%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE---VELQ-LAVGSHKHIVNIKDVYE 79
           LG G  GKV +   K+T  + A KV+    +   E   VE++ LA   H +IV +   Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY- 77
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
             Y+  +  ++I  C  G      I  + D   TE +  ++  ++  A+ FLH + I HR
Sbjct: 78  --YHDGKLWIMIEFCPGGA--VDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR 133
Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+K  N+L T  GD                           ++L DFG + K +      
Sbjct: 134 DLKAGNVLMTLEGD---------------------------IRLADFGVSAKNLKTLQKR 166
Query: 200 QTPCYTPYYVAPEV-----LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            +   TPY++APEV     +    YD   DIWSLG+ +  +    PP        ++P M
Sbjct: 167 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-----HELNP-M 220
Query: 255 KNRIRLGQFDFPN----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
           +  +++ + D P      +W   S E +  +K  L  +P  R +  Q++E+ ++S    
Sbjct: 221 RVLLKIAKSDPPTLLTPSKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 276

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 129/299 (43%), Gaps = 54/299 (18%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE---VELQ-LAVGSHKHIVNIKDVYE 79
           LG G  GKV +   K+T  + A KV+    +   E   VE++ LA   H +IV +   Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY- 85
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
             Y+  +  ++I  C  G      I  + D   TE +  ++  ++  A+ FLH + I HR
Sbjct: 86  --YHDGKLWIMIEFCPGGA--VDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR 141
Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+K  N+L T  GD                           ++L DFG + K +      
Sbjct: 142 DLKAGNVLMTLEGD---------------------------IRLADFGVSAKNLKTLQKR 174
Query: 200 QTPCYTPYYVAPEV-----LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
            +   TPY++APEV     +    YD   DIWSLG+ +  +    PP        ++P M
Sbjct: 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-----HELNP-M 228
Query: 255 KNRIRLGQFDFPN----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
           +  +++ + D P      +W   S E +  +K  L  +P  R +  Q++E+ ++S    
Sbjct: 229 RVLLKIAKSDPPTLLTPSKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 88  LLVIMECMHGGELFQRIQ--QKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN 145
           L +++E    G+L + I+  +K+     ER       ++CSA++ +H + + HRD+KP N
Sbjct: 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166
Query: 146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT 205
           +  T                             G++KL D G  +   S   +  +   T
Sbjct: 167 VFITA---------------------------TGVVKLGDLGLGRFFSSKTTAAHSLVGT 199
Query: 206 PYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDF 265
           PYY++PE +  + Y+   DIWSLG ++Y +     PF+ +     S   K    + Q D+
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEQCDY 255
Query: 266 PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           P    +H S+E + L+   +  DP +R  +  V +
Sbjct: 256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 134/327 (40%), Gaps = 51/327 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLA 64
           + D Y++  EILG G   +V    + +     A+KVL   +        + RRE +   A
Sbjct: 10  LSDRYELG-EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
           + +H  IV + D  E          ++ME + G  L   +    +G  T + A  ++ + 
Sbjct: 69  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADA 125
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
           C A+ F H   I HRDVKP N++ +                               +K+ 
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISA---------------------------TNAVKVM 158
Query: 185 DFGFAKKIVSNKASL-QTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           DFG A+ I  +  S+ QT     T  Y++PE    D  D   D++SLG ++Y +L G PP
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           F  +   +++      +R      P+   E +S +   ++   L  +P  R      M  
Sbjct: 219 FTGDSPVSVA---YQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
Query: 302 KWISQFN-QVPQTPLCTGKMLKEGEET 327
             +   N + P+ P    K+L + E T
Sbjct: 275 DLVRVHNGEPPEAP----KVLTDAERT 297

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 134/327 (40%), Gaps = 51/327 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLA 64
           + D Y++  EILG G   +V    + +     A+KVL   +        + RRE +   A
Sbjct: 10  LSDRYELG-EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
           + +H  IV + D  E          ++ME + G  L   +    +G  T + A  ++ + 
Sbjct: 69  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADA 125
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
           C A+ F H   I HRDVKP N++ +                               +K+ 
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISA---------------------------TNAVKVM 158
Query: 185 DFGFAKKIVSNKASL-QTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           DFG A+ I  +  S+ QT     T  Y++PE    D  D   D++SLG ++Y +L G PP
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           F  +   +++      +R      P+   E +S +   ++   L  +P  R      M  
Sbjct: 219 FTGDSPVSVA---YQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
Query: 302 KWISQFN-QVPQTPLCTGKMLKEGEET 327
             +   N + P+ P    K+L + E T
Sbjct: 275 DLVRVHNGEPPEAP----KVLTDAERT 297

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 111/286 (38%), Gaps = 75/286 (26%)
Query: 55  ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTE 114
           A RE+ L L    H +IV++ DV     +  RCL ++ E M      +++  +      +
Sbjct: 66  AIREISL-LKELHHPNIVSLIDVI----HSERCLTLVFEFMEKD--LKKVLDENKTGLQD 118
Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
            +  I + ++   +   H   I HRD+KP+NLL                           
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS------------------------ 154
Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMY 233
               G LKL DFG A+       S      T +Y AP+VL G  KY  S DIWS+G I  
Sbjct: 155 ---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211
Query: 234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQ----FDFPNP-EWEHVS-------------- 274
            ++ G P F         PG+ +  +L +       PNP EW  V               
Sbjct: 212 EMITGKPLF---------PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFE 262
Query: 275 ------------QEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
                       QE   L+ NMLC DP++R++    M + +    +
Sbjct: 263 KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 131/318 (41%), Gaps = 65/318 (20%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAVGSHKHIVNIKD 76
           +G G  G V +   + T ++ A+K   ++         A RE+ + L    H ++VN+ +
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRM-LKQLKHPNLVNLLE 69
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V+       R  LV   C H   +   + + + G   E     I  +   A+ F H  N 
Sbjct: 70  VFRR---KRRLHLVFEYCDHT--VLHELDRYQRGV-PEHLVKSITWQTLQAVNFCHKHNC 123
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRDVKPEN+L TK                             ++KL DFGFA+ +    
Sbjct: 124 IHRDVKPENILITK---------------------------HSVIKLCDFGFARLLTGPS 156
Query: 197 ASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFP--PFFSNHGQA---- 249
                   T +Y +PE+L G  +Y    D+W++G +   LL G P  P  S+  Q     
Sbjct: 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216
Query: 250 -----ISPGMKNRIRLGQF----DFPNPE--------WEHVSQEAKTLIKNMLCVDPSER 292
                + P  +      Q+      P+PE        + ++S  A  L+K  L +DP+ER
Sbjct: 217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER 276
Query: 293 LTIDQVMENKWISQFNQV 310
           LT +Q++ + +     ++
Sbjct: 277 LTCEQLLHHPYFENIREI 294

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 111/286 (38%), Gaps = 75/286 (26%)
Query: 55  ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTE 114
           A RE+ L L    H +IV++ DV     +  RCL ++ E M      +++  +      +
Sbjct: 66  AIREISL-LKELHHPNIVSLIDVI----HSERCLTLVFEFMEKD--LKKVLDENKTGLQD 118
Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
            +  I + ++   +   H   I HRD+KP+NLL                           
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN------------------------- 153
Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMY 233
               G LKL DFG A+       S      T +Y AP+VL G  KY  S DIWS+G I  
Sbjct: 154 --SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211
Query: 234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQ----FDFPNP-EWEHVS-------------- 274
            ++ G P F         PG+ +  +L +       PNP EW  V               
Sbjct: 212 EMITGKPLF---------PGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFE 262
Query: 275 ------------QEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
                       QE   L+ NMLC DP++R++    M + +    +
Sbjct: 263 KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 36/198 (18%)
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
            +E +A     ++   I++LH Q I HRD+KP NLL                        
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV----------------------- 170
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSL 228
               G+ G +K+ DFG + +   + A L     TP ++APE L   +     K+ D+W++
Sbjct: 171 ----GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAM 226
Query: 229 GVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVD 288
           GV +Y  + G  PF           + ++I+    +FP+     ++++ K LI  ML  +
Sbjct: 227 GVTLYCFVFGQCPFMDERIMC----LHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKN 280
Query: 289 PSERLTIDQVMENKWISQ 306
           P  R+ + ++  + W+++
Sbjct: 281 PESRIVVPEIKLHPWVTR 298

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 133/305 (43%), Gaps = 54/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS------- 67
           +DY++   I G G  G+  +I  K   ++   K L     +  E E Q+ V         
Sbjct: 6   EDYEVLYTI-GTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLREL 62
Query: 68  -HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEI 124
            H +IV   D   +  N +  L ++ME   GG+L   I +  KE     E     +M ++
Sbjct: 63  KHPNIVRYYDRIIDRTNTT--LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 125 CSAIKFLHDQN-----IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
             A+K  H ++     + HRD+KP N+               F D K             
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANV---------------FLDGKQN----------- 154
Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
            +KL DFG A+ +  + +  +T   TPYY++PE +    Y++  DIWSLG ++Y L    
Sbjct: 155 -VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
           PPF +   + ++     +IR G+F      +   S E   +I  ML +    R ++++++
Sbjct: 214 PPFTAFSQKELA----GKIREGKFRRIPYRY---SDELNEIITRMLNLKDYHRPSVEEIL 266
Query: 300 ENKWI 304
           EN  I
Sbjct: 267 ENPLI 271

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 68/303 (22%)
Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVG 66
           +DD++I  +++G G   +V  +  K+T +VYA+K+++         V   RE    L  G
Sbjct: 60  RDDFEI-LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER----EAAIIMN 122
             + I  +   +++       L ++ME   GG+L   + +     F ER     A   + 
Sbjct: 119 DRRWITQLHFAFQD----ENYLYLVMEYYVGGDLLTLLSK-----FGERIPAEMARFYLA 169
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           EI  AI  +H     HRD+KP+N+L  + G    ++L DFG                 LK
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGH---IRLADFGSC---------------LK 211
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-------DKYDKSCDIWSLGVIMYIL 235
           L   G  + +V+          TP Y++PE+L           Y   CD W+LGV  Y +
Sbjct: 212 LRADGTVRSLVAVG--------TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
Query: 236 LCGFPPFFSN-----HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPS 290
             G  PF+++     +G+ +    K  + L   D      E V +EA+  I+ +LC  P 
Sbjct: 264 FYGQTPFYADSTAETYGKIVH--YKEHLSLPLVD------EGVPEEARDFIQRLLC-PPE 314
Query: 291 ERL 293
            RL
Sbjct: 315 TRL 317

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 133/327 (40%), Gaps = 51/327 (15%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLA 64
           + D Y++  EILG G   +V    + +     A+KVL   +        + RRE +   A
Sbjct: 10  LSDRYELG-EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
           + +H  IV +    E          ++ME + G  L   +    +G  T + A  ++ + 
Sbjct: 69  L-NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADA 125
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
           C A+ F H   I HRDVKP N++ +                               +K+ 
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISA---------------------------TNAVKVM 158
Query: 185 DFGFAKKIVSNKASL-QTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           DFG A+ I  +  S+ QT     T  Y++PE    D  D   D++SLG ++Y +L G PP
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           F  +   +++      +R      P+   E +S +   ++   L  +P  R      M  
Sbjct: 219 FTGDSPVSVA---YQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
Query: 302 KWISQFN-QVPQTPLCTGKMLKEGEET 327
             +   N + P+ P    K+L + E T
Sbjct: 275 DLVRVHNGEPPEAP----KVLTDAERT 297

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 131/305 (42%), Gaps = 54/305 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS------- 67
           +DY++   I G G  G+  +I  K   ++   K L     +  E E Q+ V         
Sbjct: 6   EDYEVLYTI-GTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLREL 62
Query: 68  -HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEI 124
            H +IV   D   +  N +  L ++ME   GG+L   I +  KE     E     +M ++
Sbjct: 63  KHPNIVRYYDRIIDRTNTT--LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 125 CSAIKFLHDQN-----IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
             A+K  H ++     + HRD+KP N+      +   +KL DFG  +  N          
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILN---------- 167
Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
                D  FAK  V           TPYY++PE +    Y++  DIWSLG ++Y L    
Sbjct: 168 ----HDTSFAKAFVG----------TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
           PPF +   + ++     +IR G+F      +   S E   +I  ML +    R ++++++
Sbjct: 214 PPFTAFSQKELA----GKIREGKFRRIPYRY---SDELNEIITRMLNLKDYHRPSVEEIL 266
Query: 300 ENKWI 304
           EN  I
Sbjct: 267 ENPLI 271

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 54/259 (20%)
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           NI  +Y+ I+   R +LV     H  +  +++    +G      A   + ++ + I + H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFE---HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           D+ + HRD+KP+NLL  + G+                           LK+ DFG A+  
Sbjct: 118 DRRVLHRDLKPQNLLINREGE---------------------------LKIADFGLARAF 150
Query: 193 VSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF--------- 242
                       T +Y AP+VL G  KY  + DIWS+G I   ++ G P F         
Sbjct: 151 GIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQL 210
Query: 243 ---FSNHGQAISPGMKNRIRLGQFDFPNPE------WEH----VSQEAKTLIKNMLCVDP 289
              F   G   S    N   L ++D PN        WE     + +    L+  ML +DP
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 290 SERLTIDQVMENKWISQFN 308
           ++R+T  Q +E+ +  + N
Sbjct: 270 NQRITAKQALEHAYFKENN 288

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 54/259 (20%)
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           NI  +Y+ I+   R +LV     H  +  +++    +G      A   + ++ + I + H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFE---HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           D+ + HRD+KP+NLL  + G+                           LK+ DFG A+  
Sbjct: 118 DRRVLHRDLKPQNLLINREGE---------------------------LKIADFGLARAF 150
Query: 193 VSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF--------- 242
                       T +Y AP+VL G  KY  + DIWS+G I   ++ G P F         
Sbjct: 151 GIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
Query: 243 ---FSNHGQAISPGMKNRIRLGQFDFPNPE------WEH----VSQEAKTLIKNMLCVDP 289
              F   G   S    N   L ++D PN        WE     + +    L+  ML +DP
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 290 SERLTIDQVMENKWISQFN 308
           ++R+T  Q +E+ +  + N
Sbjct: 270 NQRITAKQALEHAYFKENN 288

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 124/307 (40%), Gaps = 46/307 (14%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLA 64
           + D Y++  EILG G   +V    + +     A+KVL   +        + RRE +   A
Sbjct: 27  LSDRYELG-EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 85
Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
           + +H  IV + D  E          ++ME + G  L   +    +G  T + A  ++ + 
Sbjct: 86  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADA 142
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
           C A+ F H   I HRDVKP N++ +                               +K+ 
Sbjct: 143 CQALNFSHQNGIIHRDVKPANIMISAT---------------------------NAVKVM 175
Query: 185 DFGFAKKIVSNKASL-QTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           DFG A+ I  +  S+ QT     T  Y++PE    D  D   D++SLG ++Y +L G PP
Sbjct: 176 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           F  +   +++      +R      P+   E +S +   ++   L  +P  R      M  
Sbjct: 236 FTGDSPVSVA---YQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 291
Query: 302 KWISQFN 308
             +   N
Sbjct: 292 DLVRVHN 298

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 54/259 (20%)
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           NI  +Y+ I+   R +LV     H  +  +++    +G      A   + ++ + I + H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFE---HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           D+ + HRD+KP+NLL  + G+                           LK+ DFG A+  
Sbjct: 118 DRRVLHRDLKPQNLLINREGE---------------------------LKIADFGLARAF 150
Query: 193 VSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF--------- 242
                       T +Y AP+VL G  KY  + DIWS+G I   ++ G P F         
Sbjct: 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
Query: 243 ---FSNHGQAISPGMKNRIRLGQFDFPNPE------WEH----VSQEAKTLIKNMLCVDP 289
              F   G   S    N   L ++D PN        WE     + +    L+  ML +DP
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 290 SERLTIDQVMENKWISQFN 308
           ++R+T  Q +E+ +  + N
Sbjct: 270 NQRITAKQALEHAYFKENN 288

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS------H 68
           +DY++   I G G  G+  +I  K   ++   K L     +  E E Q+ V         
Sbjct: 6   EDYEVLYTI-GTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLREL 62
Query: 69  KHIVNIKDVYENIYNGSRC-LLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEIC 125
           KH  NI   Y+ I + +   L ++ME   GG+L   I +  KE     E     +M ++ 
Sbjct: 63  KH-PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 126 SAIKFLHDQN-----IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
            A+K  H ++     + HRD+KP N+      +   +KL DFG  +  N           
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILN----------- 167
Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
               D  FAK+ V           TPYY++PE +    Y++  DIWSLG ++Y L    P
Sbjct: 168 ---HDEDFAKEFVG----------TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF +   + ++     +IR G+F      +   S E   +I  ML +    R ++++++E
Sbjct: 215 PFTAFSQKELA----GKIREGKFRRIPYRY---SDELNEIITRMLNLKDYHRPSVEEILE 267
Query: 301 NKWI 304
           N  I
Sbjct: 268 NPLI 271

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 50/290 (17%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREV-----ELQLAVG-S 67
           D ++I   I G G  GKV  + +  T ++YA+K ++      R EV     ELQ+  G  
Sbjct: 15  DHFEILRAI-GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H  +VN+   +++       + ++++ + GG+L   +QQ  +  F E    + + E+  A
Sbjct: 74  HPFLVNLWYSFQD----EEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMA 127
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +L +Q I HRD+KP+N+L                             + G + +TDF 
Sbjct: 128 LDYLQNQRIIHRDMKPDNILL---------------------------DEHGHVHITDFN 160
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYILLCGFPPFFS 244
            A  ++  +  + T   T  Y+APE+    K   Y  + D WSLGV  Y LL G  P+  
Sbjct: 161 IA-AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
               + S  + +        +P+  W   SQE  +L+K +L  +P +R +
Sbjct: 220 RSSTS-SKEIVHTFETTVVTYPSA-W---SQEMVSLLKKLLEPNPDQRFS 264

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/350 (22%), Positives = 147/350 (42%), Gaps = 65/350 (18%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVE-KKTSEVYALKVLHDTVKARREVELQLAV------ 65
           +Q+ Y+I +  LG G  G+V+Q V+ ++     ALK++ +  K +    L++ V      
Sbjct: 31  LQERYEIVS-TLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINE 89
Query: 66  ---GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
               +    V + D ++  Y+G  C  +  E + G   F  ++      +   +   +  
Sbjct: 90  KDPDNKNLCVQMFDWFD--YHGHMC--ISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAF 144
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++C A+KFLHD  + H D+KPEN+L+          L    D         +      ++
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRD--------ERSVKSTAVR 196
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           + DFG A     +     T   T +Y APEV+    + + CD+WS+G I++    GF   
Sbjct: 197 VVDFGSA---TFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGF-TL 252
Query: 243 FSNHGQAISPGMKNRI------RL------------GQFDFP-------------NPEWE 271
           F  H       M  RI      R+            G+ D+               P   
Sbjct: 253 FQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRR 312
Query: 272 HVSQEAKT------LIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPL 315
           +++ EA+       LI++ML  +P++RLT+ + +++ + ++    P   L
Sbjct: 313 YLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKL 362

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 136/304 (44%), Gaps = 53/304 (17%)
Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE---VELQ-LAVGSHK 69
           +D ++I  E LG G  GKV +   K+TS + A KV+    +   E   VE+  LA   H 
Sbjct: 36  EDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 70  HIVNIKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           +IV + D   YEN       L +++E   GG +   +  + +   TE +  ++  +   A
Sbjct: 95  NIVKLLDAFYYEN------NLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDA 147
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +LHD  I HRD+K  N+L+T  GD                           +KL DFG
Sbjct: 148 LNYLHDNKIIHRDLKAGNILFTLDGD---------------------------IKLADFG 180
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL----GPDK-YDKSCDIWSLGVIMYILLCGFPPF 242
            + K         +   TPY++APEV+      D+ YD   D+WSLG+ +  +    PP 
Sbjct: 181 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 240
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
                  ++P M+  +++ + + P   +    S   K  +K  L  +   R T  Q++++
Sbjct: 241 -----HELNP-MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 294
Query: 302 KWIS 305
            +++
Sbjct: 295 PFVT 298

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 136/304 (44%), Gaps = 53/304 (17%)
Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE---VELQ-LAVGSHK 69
           +D ++I  E LG G  GKV +   K+TS + A KV+    +   E   VE+  LA   H 
Sbjct: 36  EDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 70  HIVNIKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           +IV + D   YEN       L +++E   GG +   +  + +   TE +  ++  +   A
Sbjct: 95  NIVKLLDAFYYEN------NLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDA 147
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +LHD  I HRD+K  N+L+T  GD                           +KL DFG
Sbjct: 148 LNYLHDNKIIHRDLKAGNILFTLDGD---------------------------IKLADFG 180
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL----GPDK-YDKSCDIWSLGVIMYILLCGFPPF 242
            + K         +   TPY++APEV+      D+ YD   D+WSLG+ +  +    PP 
Sbjct: 181 VSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 240
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
                  ++P M+  +++ + + P   +    S   K  +K  L  +   R T  Q++++
Sbjct: 241 -----HELNP-MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 294
Query: 302 KWIS 305
            +++
Sbjct: 295 PFVT 298

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/322 (24%), Positives = 134/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L + V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVL-MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVIQMELD-- 124
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
                 + ++ ++   IK LH   I HRD+KP N++                 VK +   
Sbjct: 125 --HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+GV
Sbjct: 163 -------ATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGV 213
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPKIPDKQLDEREHTIEEWKEL 355

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 52/279 (18%)
Query: 41  SEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYENIYNGSRCLLVIMECMHG 97
           + V     L D+V    EV L   VG+   H  ++ + D +E        +LV+   +  
Sbjct: 67  NRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEG---FMLVLERPLPA 123
Query: 98  GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL 157
            +LF  I +K  G   E  +     ++ +AI+  H + + HRD+K EN+L       G  
Sbjct: 124 QDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCA 179
Query: 158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD 217
           KL DFG      LL+ +P        TDF   +                 Y  PE +   
Sbjct: 180 KLIDFGS---GALLHDEP-------YTDFDGTR----------------VYSPPEWISRH 213
Query: 218 KYDK-SCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQE 276
           +Y      +WSLG+++Y ++CG  PF  +            I   +  FP     HVS +
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERD----------QEILEAELHFPA----HVSPD 259
Query: 277 AKTLIKNMLCVDPSERLTIDQVMENKWI-SQFNQVPQTP 314
              LI+  L   PS R ++++++ + W+ +    VP  P
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNP 298

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 135/304 (44%), Gaps = 53/304 (17%)
Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE---VELQ-LAVGSHK 69
           +D ++I  E LG G  GKV +   K+TS + A KV+    +   E   VE+  LA   H 
Sbjct: 36  EDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 70  HIVNIKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           +IV + D   YEN       L +++E   GG +   +  + +   TE +  ++  +   A
Sbjct: 95  NIVKLLDAFYYEN------NLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDA 147
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +LHD  I HRD+K  N+L+T  GD                           +KL DFG
Sbjct: 148 LNYLHDNKIIHRDLKAGNILFTLDGD---------------------------IKLADFG 180
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL----GPDK-YDKSCDIWSLGVIMYILLCGFPPF 242
            + K             TPY++APEV+      D+ YD   D+WSLG+ +  +    PP 
Sbjct: 181 VSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 240
Query: 243 FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
                  ++P M+  +++ + + P   +    S   K  +K  L  +   R T  Q++++
Sbjct: 241 -----HELNP-MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 294
Query: 302 KWIS 305
            +++
Sbjct: 295 PFVT 298

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/322 (24%), Positives = 134/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L + V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVL-MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVIQMELD-- 124
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
                 + ++ ++   IK LH   I HRD+KP N++                 VK +   
Sbjct: 125 --HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+GV
Sbjct: 163 -------ATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGV 213
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPKIPDKQLDEREHTIEEWKEL 355

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 118/288 (40%), Gaps = 45/288 (15%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALK---VLHDTVKARREVELQLAVGSHKHIVNIKDVY 78
           E LG G  G V + + K+T ++ A+K   V  D  +  +E+ +     S  H+V     Y
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS-PHVVK----Y 89
Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
              Y  +  L ++ME    G +   I+ + +   TE E A I+      +++LH     H
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIH 148
Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+K  N+L    G                             KL DFG A ++    A 
Sbjct: 149 RDIKAGNILLNTEGHA---------------------------KLADFGVAGQLTDXMAK 181
Query: 199 LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG-QAISPGMKNR 257
                 TP+++APEV+    Y+   DIWSLG+    +  G PP+   H  +AI     N 
Sbjct: 182 RNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN- 240
Query: 258 IRLGQFDFPNPE-WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
                  F  PE W   S      +K  L   P +R T  Q++++ ++
Sbjct: 241 ---PPPTFRKPELW---SDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 38/192 (19%)
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH++IV++ DV E       C  ++ME + G  L + I+    G  +   A    N+I  
Sbjct: 69  SHQNIVSMIDVDEE----DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILD 122
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            IK  HD  I HRD+KP+N+L                                 LK+ DF
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDS---------------------------NKTLKIFDF 155
Query: 187 GFAKKIVSNKASLQTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           G AK + S  +  QT     T  Y +PE    +  D+  DI+S+G+++Y +L G PPF  
Sbjct: 156 GIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF-- 212
Query: 245 NHGQAISPGMKN 256
           N   A+S  +K+
Sbjct: 213 NGETAVSIAIKH 224

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 72/289 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSDX-- 163
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 164 --------TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 214 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+
Sbjct: 274 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 135/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L + V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVL-MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 163 -------ATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPKIPDKQLDEREHTIEEWKEL 355

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 70  RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELDH- 126
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 127 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 163
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 164 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 214
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 215 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 274
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 275 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 334
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 335 PPQIYDKQLDEREHTIEEWKEL 356

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 107 RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELDH- 163
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 164 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 200
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 201 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 252 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 311
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 312 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 371
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 372 PPQIYDKQLDEREHTIEEWKEL 393

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 68  RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELDH- 124
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 125 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 161
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 162 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 212
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 213 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 272
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 273 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 332
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 333 PPQIYDKQLDEREHTIEEWKEL 354

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 163 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 214 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 274 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 333
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPQIYDKQLDEREHTIEEWKEL 355

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 163 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 214 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 274 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 333
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPQIYDKQLDEREHTIEEWKEL 355

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 70  RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELDH- 126
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 127 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 163
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 164 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 214
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 215 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 274
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 275 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 334
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 335 PPQIYDKQLDEREHTIEEWKEL 356

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 107 RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH- 163
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 164 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 200
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 201 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 252 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 311
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 312 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 371
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 372 PPQIYDKQLDEREHTIEEWKEL 393

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 44/236 (18%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENI 81
           +++G G  G V Q    ++ EV   KVL D     RE+++ + +  H ++V++K  + + 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQI-MRIVKHPNVVDLKAFFYS- 103
Query: 82  YNGSR----CLLVIMECM-----HGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            NG +     L +++E +          + +++Q       +    + M ++  ++ ++H
Sbjct: 104 -NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIK----LYMYQLLRSLAYIH 158
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL   P                           G+LKL DFG AK +
Sbjct: 159 SIGICHRDIKPQNLLLDPPS--------------------------GVLKLIDFGSAKIL 192
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           ++ + ++   C + YY APE + G   Y  + DIWS G +M  L+ G P F    G
Sbjct: 193 IAGEPNVSXIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 63  RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELDH- 119
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 120 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 156
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 157 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 207
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 208 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 267
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 268 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 327
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 328 PPQIYDKQLDEREHTIEEWKEL 349

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 62  RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH- 118
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 119 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 155
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 156 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 266
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 267 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 326
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 327 PPQIYDKQLDEREHTIEEWKEL 348

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 63  RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH- 119
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 120 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 156
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 157 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 207
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 208 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 267
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 268 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 327
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 328 PPQIYDKQLDEREHTIEEWKEL 349

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 81/322 (25%), Positives = 137/322 (42%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVIQMELD-- 124
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
                 + ++ ++   IK LH   I HRD+KP N++                 VK +   
Sbjct: 125 --HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIV-----------------VKSDX-- 163
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 164 --------TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IM------YILLCGF-----------------PPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 214 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 274 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 333
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPQIYDKQLDEREHTIEEWKEL 355

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 72/289 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSDX-- 163
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 164 --------TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 214 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+
Sbjct: 274 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/322 (25%), Positives = 137/322 (42%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVIQMELD-- 124
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
                 + ++ ++   IK LH   I HRD+KP N++                 VK +   
Sbjct: 125 --HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIV-----------------VKSDX-- 163
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 164 --------TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 214 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 274 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 333
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPQIYDKQLDEREHTIEEWKEL 355

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/322 (25%), Positives = 137/322 (42%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+++ +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 62  RAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELD-- 117
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
                 + ++ ++   IK LH   I HRD+KP N++                 VK +   
Sbjct: 118 --HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIV-----------------VKSDX-- 156
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 157 --------TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 231 IM------YILLCG-----------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM       IL  G                  P F       +   ++NR +     FP 
Sbjct: 207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 266
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT--- 313
                    + EH    + +A+ L+  ML +DP++R+++D  +++ +I+ +    +    
Sbjct: 267 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 326
Query: 314 -PLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 327 PPQIYDKQLDEREHTIEEWKEL 348

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 134/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 163 -------ATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPKIPDKQLDEREHTIEEWKEL 355

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/322 (24%), Positives = 133/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L + V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVL-MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVIQMELD-- 124
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
                 + ++ ++   IK LH   I HRD+KP N++                 VK +   
Sbjct: 125 --HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 163 -------ATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPKIPDKQLDEREHTIEEWKEL 355

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 126/300 (42%), Gaps = 54/300 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVYE 79
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 83
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNEICSAIKFLHDQNI 136
           +       + + +   +  E   R+ +    A        +   M ++  ++ ++H   I
Sbjct: 84  SSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KP+NLL                             D  +LKL DFG AK++V  +
Sbjct: 144 CHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQLVRGE 177
Query: 197 ASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG-------- 247
            ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G        
Sbjct: 178 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 248 QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPSERLT 294
           + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+ RLT
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 52/242 (21%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKHIVNI 74
           ++ILG G    V +   KKT +++A+KV ++    R      RE E+ L   +HK+IV +
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV-LKKLNHKNIVKL 72
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAIIMNEICSAIKFLHD 133
             + E     +R  ++IME    G L+  +++  +     E E  I++ ++   +  L +
Sbjct: 73  FAIEEE--TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             I HR++KP N++     DG                         + KLTDFG A+++ 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQ-----------------------SVYKLTDFGAARELE 167
Query: 194 SNKASLQTPCYTPYYVAPEVLGPD-------------KYDKSCDIWSLGVIMYILLCGFP 240
            ++       +   Y   E L PD             KY  + D+WS+GV  Y    G  
Sbjct: 168 DDEQ------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
Query: 241 PF 242
           PF
Sbjct: 222 PF 223

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 35/275 (12%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNIKD 76
           LG G  G V + ++++T EV A+K + D         +  RE+ +   +  H++IVN+ +
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V     +  R + ++ + M   +L   I+              ++ ++   IK+LH   +
Sbjct: 77  VLR--ADNDRDVYLVFDYMET-DLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KP N+L         +K+ DFG     + +  +     I  L+     +    ++
Sbjct: 131 LHRDMKPSNILLNAECH---VKVADFG--LSRSFVNIRRVTNNI-PLSINENTENFDDDQ 184
Query: 197 ASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
             L     T +Y APE+L G  KY K  D+WSLG I+  +LCG P F         PG  
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF---------PGSS 235
Query: 256 NRIRL----GQFDFP-NPEWEHV-SQEAKTLIKNM 284
              +L    G  DFP N + E + S  AKT+I+++
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESL 270

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 72/309 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIK---- 75
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++    
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 117
Query: 76  -------DVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSA 127
                  +VY N+      L  + E ++     + R +Q     + +    + M ++  +
Sbjct: 118 SSGEKKDEVYLNL-----VLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRS 168
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + ++H   I HRD+KP+NLL                             D  +LKL DFG
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFG 202
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
            AK++V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + 
Sbjct: 203 SAKQLVRGEPNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261
Query: 247 G--------QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNML 285
           G        + +    + +IR       +F FP  +   W  V +     EA  L   +L
Sbjct: 262 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 321
Query: 286 CVDPSERLT 294
              P+ RLT
Sbjct: 322 EYTPTARLT 330

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/329 (24%), Positives = 134/329 (40%), Gaps = 63/329 (19%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 95
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 151
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 152 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 185
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 186 VRGEPNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 244
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 245 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 304
Query: 291 ERLTIDQVMENKWISQFNQVPQTPLCTGK 319
            RLT  +   + +  +    P   L  G+
Sbjct: 305 ARLTPLEACAHSFFDELRD-PNVKLPNGR 332

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 91
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 147
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 148 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 181
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 182 VRGEPNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 240
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 241 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 300
Query: 291 ERLT 294
            RLT
Sbjct: 301 ARLT 304

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 102
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 158
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 159 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 192
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 193 VRGEPNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 251
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 252 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 311
Query: 291 ERLT 294
            RLT
Sbjct: 312 ARLT 315

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 95
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 151
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 152 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 185
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 186 VRGEPNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 244
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 245 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 304
Query: 291 ERLT 294
            RLT
Sbjct: 305 ARLT 308

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 52/242 (21%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKHIVNI 74
           ++ILG G    V +   KKT +++A+KV ++    R      RE E+ L   +HK+IV +
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV-LKKLNHKNIVKL 72
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAIIMNEICSAIKFLHD 133
             + E     +R  ++IME    G L+  +++  +     E E  I++ ++   +  L +
Sbjct: 73  FAIEEE--TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             I HR++KP N++     DG                         + KLTDFG A+++ 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQ-----------------------SVYKLTDFGAARELE 167
Query: 194 SNKASLQTPCYTPYYVAPEVLGPD-------------KYDKSCDIWSLGVIMYILLCGFP 240
            ++       +   Y   E L PD             KY  + D+WS+GV  Y    G  
Sbjct: 168 DDEQ------FVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
Query: 241 PF 242
           PF
Sbjct: 222 PF 223

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 84
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 140
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 141 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 174
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 175 VRGEPNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 233
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 234 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 293
Query: 291 ERLT 294
            RLT
Sbjct: 294 ARLT 297

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 83
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 139
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 140 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 173
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 174 VRGEPNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 291 ERLT 294
            RLT
Sbjct: 293 ARLT 296

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 83
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 139
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 140 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 173
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 174 VRGEPNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 291 ERLT 294
            RLT
Sbjct: 293 ARLT 296

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/329 (24%), Positives = 134/329 (40%), Gaps = 63/329 (19%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 87
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 88  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 143
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 144 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 177
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 178 VRGEPNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 236
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 237 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 296
Query: 291 ERLTIDQVMENKWISQFNQVPQTPLCTGK 319
            RLT  +   + +  +    P   L  G+
Sbjct: 297 ARLTPLEACAHSFFDELRD-PNVKLPNGR 324

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 72/309 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIK---- 75
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++    
Sbjct: 104 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 162
Query: 76  -------DVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSA 127
                  +VY N+      L  + E ++     + R +Q     + +    + M ++  +
Sbjct: 163 SSGEKKDEVYLNL-----VLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRS 213
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + ++H   I HRD+KP+NLL                             D  +LKL DFG
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFG 247
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
            AK++V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + 
Sbjct: 248 SAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 306
Query: 247 G--------QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNML 285
           G        + +    + +IR       +F FP  +   W  V +     EA  L   +L
Sbjct: 307 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 366
Query: 286 CVDPSERLT 294
              P+ RLT
Sbjct: 367 EYTPTARLT 375

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 134/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 163 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPKIPDKQLDEREHTIEEWKEL 355

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 72/309 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIK---- 75
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++    
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 117
Query: 76  -------DVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSA 127
                  +VY N+      L  + E ++     + R +Q     + +    + M ++  +
Sbjct: 118 SSGEKKDEVYLNL-----VLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRS 168
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + ++H   I HRD+KP+NLL                             D  +LKL DFG
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFG 202
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
            AK++V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + 
Sbjct: 203 SAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261
Query: 247 G--------QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNML 285
           G        + +    + +IR       +F FP  +   W  V +     EA  L   +L
Sbjct: 262 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 321
Query: 286 CVDPSERLT 294
              P+ RLT
Sbjct: 322 EYTPTARLT 330

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 72/309 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIK---- 75
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++    
Sbjct: 61  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 119
Query: 76  -------DVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSA 127
                  +VY N+      L  + E ++     + R +Q     + +    + M ++  +
Sbjct: 120 SSGEKKDEVYLNL-----VLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRS 170
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + ++H   I HRD+KP+NLL                             D  +LKL DFG
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFG 204
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
            AK++V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + 
Sbjct: 205 SAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 263
Query: 247 G--------QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNML 285
           G        + +    + +IR       +F FP  +   W  V +     EA  L   +L
Sbjct: 264 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 323
Query: 286 CVDPSERLT 294
              P+ RLT
Sbjct: 324 EYTPTARLT 332

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 134/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LSQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 163 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPKIPDKQLDEREHTIEEWKEL 355

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 72/309 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIK---- 75
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++    
Sbjct: 30  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 88
Query: 76  -------DVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSA 127
                  +VY N+      L  + E ++     + R +Q     + +    + M ++  +
Sbjct: 89  SSGEKKDEVYLNL-----VLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRS 139
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + ++H   I HRD+KP+NLL                             D  +LKL DFG
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFG 173
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
            AK++V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + 
Sbjct: 174 SAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 232
Query: 247 G--------QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNML 285
           G        + +    + +IR       +F FP  +   W  V +     EA  L   +L
Sbjct: 233 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 292
Query: 286 CVDPSERLT 294
              P+ RLT
Sbjct: 293 EYTPTARLT 301

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/322 (25%), Positives = 134/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 74  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELDH- 130
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 131 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 167
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ D+WS+G 
Sbjct: 168 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGC 218
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++C                         P F       +   ++NR +   + F  
Sbjct: 219 IMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 278
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 279 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 338
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 339 PPKIPDKQLDEREHTIEEWKEL 360

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 72/309 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIK---- 75
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++    
Sbjct: 63  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 121
Query: 76  -------DVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSA 127
                  +VY N+      L  + E ++     + R +Q     + +    + M ++  +
Sbjct: 122 SSGEKKDEVYLNL-----VLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRS 172
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + ++H   I HRD+KP+NLL                             D  +LKL DFG
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFG 206
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
            AK++V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + 
Sbjct: 207 SAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 265
Query: 247 G--------QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNML 285
           G        + +    + +IR       +F FP  +   W  V +     EA  L   +L
Sbjct: 266 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 325
Query: 286 CVDPSERLT 294
              P+ RLT
Sbjct: 326 EYTPTARLT 334

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 96
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 152
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 153 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 186
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 187 VRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 245
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 246 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 305
Query: 291 ERLT 294
            RLT
Sbjct: 306 ARLT 309

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 72/309 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIK---- 75
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++    
Sbjct: 53  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 111
Query: 76  -------DVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSA 127
                  +VY N+      L  + E ++     + R +Q     + +    + M ++  +
Sbjct: 112 SSGEKKDEVYLNL-----VLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRS 162
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + ++H   I HRD+KP+NLL                             D  +LKL DFG
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFG 196
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
            AK++V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + 
Sbjct: 197 SAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 255
Query: 247 G--------QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNML 285
           G        + +    + +IR       +F FP  +   W  V +     EA  L   +L
Sbjct: 256 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 315
Query: 286 CVDPSERLT 294
              P+ RLT
Sbjct: 316 EYTPTARLT 324

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/329 (24%), Positives = 134/329 (40%), Gaps = 63/329 (19%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL D     RE+++   +  H +IV ++  + 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 83
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 139
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 140 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 173
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 174 VRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 291 ERLTIDQVMENKWISQFNQVPQTPLCTGK 319
            RLT  +   + +  +    P   L  G+
Sbjct: 293 ARLTPLEACAHSFFDELRD-PNVKLPNGR 320

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 134/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 70  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELDH- 126
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 127 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 163
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 164 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 214
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 215 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 274
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 275 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 334
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 335 PPKIPDKQLDEREHTIEEWKEL 356

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/322 (25%), Positives = 134/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 63  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELDH- 119
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 120 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 156
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ D+WS+G 
Sbjct: 157 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGC 207
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++C                         P F       +   ++NR +   + F  
Sbjct: 208 IMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 267
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 268 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 327
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 328 PPKIPDKQLDEREHTIEEWKEL 349

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/317 (25%), Positives = 139/317 (43%), Gaps = 79/317 (24%)
Query: 26  LGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVY--ENIYN 83
           LGIN  V ++     ++ +A        +A RE+ L L   +HK+I+++ +V+  +    
Sbjct: 48  LGINVAVKKLSRPFQNQTHA-------KRAYRELVL-LKCVNHKNIISLLNVFTPQKTLE 99
Query: 84  GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKP 143
             + + ++ME M    L Q I  + D    ER + ++   +C  IK LH   I HRD+KP
Sbjct: 100 EFQDVYLVMELMDAN-LCQVIHMELDH---ERMSYLLYQMLC-GIKHLHSAGIIHRDLKP 154
Query: 144 ENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP- 202
            N++                 VK +            LK+ DFG A+   +N   + TP 
Sbjct: 155 SNIV-----------------VKSD----------CTLKILDFGLARTACTN--FMMTPY 185
Query: 203 CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-------------------F 243
             T YY APEV+    Y  + DIWS+G IM  L+ G   F                    
Sbjct: 186 VVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPS 245
Query: 244 SNHGQAISPGMKNRIRLG------QFDFPNPEWEHVSQ---------EAKTLIKNMLCVD 288
           +    A+ P ++N +         +F+   P+W   S+         +A+ L+  ML +D
Sbjct: 246 AEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVID 305
Query: 289 PSERLTIDQVMENKWIS 305
           P +R+++D+ + + +I+
Sbjct: 306 PDKRISVDEALRHPYIT 322

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 134/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 163 -------CTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPKIPDKQLDEREHTIEEWKEL 355

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/317 (25%), Positives = 139/317 (43%), Gaps = 79/317 (24%)
Query: 26  LGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVY--ENIYN 83
           LGIN  V ++     ++ +A        +A RE+ L L   +HK+I+++ +V+  +    
Sbjct: 46  LGINVAVKKLSRPFQNQTHA-------KRAYRELVL-LKCVNHKNIISLLNVFTPQKTLE 97
Query: 84  GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKP 143
             + + ++ME M    L Q I  + D    ER + ++   +C  IK LH   I HRD+KP
Sbjct: 98  EFQDVYLVMELMDAN-LCQVIHMELDH---ERMSYLLYQMLC-GIKHLHSAGIIHRDLKP 152
Query: 144 ENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP- 202
            N++                 VK +            LK+ DFG A+   +N   + TP 
Sbjct: 153 SNIV-----------------VKSD----------CTLKILDFGLARTASTN--FMMTPY 183
Query: 203 CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-------------------F 243
             T YY APEV+    Y ++ DIWS+G IM  L+ G   F                    
Sbjct: 184 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 243
Query: 244 SNHGQAISPGMKNRIRLG------QFDFPNPEWEHVSQ---------EAKTLIKNMLCVD 288
           +    A+ P ++N +          F+   P+W   S+         +A+ L+  ML +D
Sbjct: 244 AEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVID 303
Query: 289 PSERLTIDQVMENKWIS 305
           P +R+++D+ + + +I+
Sbjct: 304 PDKRISVDEALRHPYIT 320

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 134/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + + TP   T YY APEV+    Y ++ DIWS+G 
Sbjct: 163 -------CTLKILDFGLAR--TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 214 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 273
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 274 LFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 333
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 334 PPKIPDKQLDEREHTIEEWKEL 355

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 137/308 (44%), Gaps = 54/308 (17%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVL---------HDTVKARREVELQLAVGSHKHIV 72
           ++LG G  GKV ++++ +T    A+K+L         +     ++E++L L    HK+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL-LRRLRHKNVI 69
Query: 73  NIKDVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
            + DV  N     +  +V+  C+ G  E+   + +K    F   +A     ++   +++L
Sbjct: 70  QLVDVLYN-EEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGLEYL 125
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H Q I H+D+KP NLL T                            GG LK++  G A+ 
Sbjct: 126 HSQGIVHKDIKPGNLLLTT---------------------------GGTLKISALGVAEA 158
Query: 192 IVSNKA--SLQTPCYTPYYVAPEVL-GPDKYDK-SCDIWSLGVIMYILLCGFPPFFSNHG 247
           +    A  + +T   +P +  PE+  G D +     DIWS GV +Y +  G  PF    G
Sbjct: 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF---EG 215
Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
             I    +N I  G +  P      +S     L+K ML  +P++R +I Q+ ++ W  + 
Sbjct: 216 DNIYKLFEN-IGKGSYAIPGDCGPPLSD----LLKGMLEYEPAKRFSIRQIRQHSWFRKK 270
Query: 308 NQVPQTPL 315
           +   + P+
Sbjct: 271 HPPAEAPV 278

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 131/321 (40%), Gaps = 77/321 (23%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI 231
                    LK+ DFG A+        ++    T YY APEV+    Y ++ DIWS+G I
Sbjct: 163 -------CTLKILDFGLAR-TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCI 214
Query: 232 MYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN- 267
           M  ++C                         P F       +   ++NR +   + F   
Sbjct: 215 MGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVENRPKYAGYSFEKL 274
Query: 268 -------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQT 313
                   + EH    + +A+ L+  ML +D S+R+++D+ ++    N W          
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 314 PLCTGKMLKEGEET---WPEV 331
           P    K L E E T   W E+
Sbjct: 335 PKIPDKQLDEREHTIEEWKEL 355

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 62/304 (20%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL       RE+++   +  H +IV ++  + 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL-DHCNIVRLRYFFY 83
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 84  SSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 139
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 140 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 173
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 174 VRGEPNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 291 ERLT 294
            RLT
Sbjct: 293 ARLT 296

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 124/289 (42%), Gaps = 45/289 (15%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNI 74
           EI+G+G  GKV +       EV      HD       T++  R+     A+  H +I+ +
Sbjct: 13  EIIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           + V     N    L ++ME   GG L + +  K          A+   +I   + +LHD+
Sbjct: 72  RGVCLKEPN----LCLVMEFARGGPLNRVLSGKRIPPDILVNWAV---QIARGMNYLHDE 124
Query: 135 NIA---HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
            I    HRD+K  N+L        IL+  + GD+  +           ILK+TDFG A++
Sbjct: 125 AIVPIIHRDLKSSNIL--------ILQKVENGDLSNK-----------ILKITDFGLARE 165
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
                       Y   ++APEV+    + K  D+WS GV+++ LL G  PF    G A++
Sbjct: 166 WHRTTKMSAAGAYA--WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
            G    + + +   P P      +    L+++    DP  R +   +++
Sbjct: 224 YG----VAMNKLALPIP--STCPEPFAKLMEDCWNPDPHSRPSFTNILD 266

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 131/321 (40%), Gaps = 77/321 (23%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 69  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELDH- 125
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 126 --ERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 162
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI 231
                    LK+ DFG A+        ++    T YY APEV+    Y ++ D+WS+G I
Sbjct: 163 -------CTLKILDFGLAR-TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCI 214
Query: 232 MYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN- 267
           M  ++C                         P F       +   ++NR +   + F   
Sbjct: 215 MGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 274
Query: 268 -------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQT 313
                   + EH    + +A+ L+  ML +D S+R+++D+ ++    N W          
Sbjct: 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPP 334
Query: 314 PLCTGKMLKEGEET---WPEV 331
           P    K L E E T   W E+
Sbjct: 335 PKIPDKQLDEREHTIEEWKEL 355

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 42/297 (14%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK--ARREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  V A K++H  +K   R ++  +L V    +  
Sbjct: 25  DDFEKISE-LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 83
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + +L 
Sbjct: 84  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 173
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           ++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  +  G  P  S  G    
Sbjct: 174 LIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAI 231
Query: 252 PGMKNRIRLGQFDFPNPEWEH--VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             + + I     + P P+      S E +  +   L  +P+ER  + Q+M + +I +
Sbjct: 232 FELLDYI----VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 284

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 56/235 (23%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VK--ARREVELQLAVGSHKHIVNIK 75
           ++G G  G V++   K T  + A+K   ++     VK  A RE++L L    H+++VN+ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKL-LKQLRHENLVNLL 90
Query: 76  DV-------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +V       Y         +L  +E    G  +Q +Q+              + +I + I
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQK-------------YLFQIINGI 137
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            F H  NI HRD+KPEN+L ++                            G++KL DFGF
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQ---------------------------SGVVKLCDFGF 170
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           A+ + +          T +Y APE+L G  KY K+ D+W++G ++  +  G P F
Sbjct: 171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 62/304 (20%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL       RE+++   +  H +IV ++  + 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL-DHCNIVRLRYFFY 83
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 139
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 140 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 173
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 174 VRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 291 ERLT 294
            RLT
Sbjct: 293 ARLT 296

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 62/304 (20%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY- 78
           T+++G G  G V Q     + E+ A+K VL       RE+++   +  H +IV ++  + 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL-DHCNIVRLRYFFY 83
Query: 79  ------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                 + +Y       V          + R +Q     + +    + M ++  ++ ++H
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK----LYMYQLFRSLAYIH 139
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KP+NLL                             D  +LKL DFG AK++
Sbjct: 140 SFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFGSAKQL 173
Query: 193 VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---- 247
           V  + ++   C + YY APE + G   Y  S D+WS G ++  LL G P F  + G    
Sbjct: 174 VRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 248 ----QAISPGMKNRIR-----LGQFDFPNPE---WEHVSQ-----EAKTLIKNMLCVDPS 290
               + +    + +IR       +F FP  +   W  V +     EA  L   +L   P+
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 291 ERLT 294
            RLT
Sbjct: 293 ARLT 296

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/322 (25%), Positives = 133/322 (41%), Gaps = 79/322 (24%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
           +A RE+ L   V +HK+I+ + +V+  +      + + ++ME M    L Q IQ + D  
Sbjct: 71  RAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD-- 126
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER + ++   +C  IK LH   I HRD+KP N++                 VK +   
Sbjct: 127 -HERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV-----------------VKSD--- 164
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTP-CYTPYYVAPEVLGPDKYDKSCDIWSLGV 230
                    LK+ DFG A+   +  + +  P   T YY APEV+    Y ++ DIWS+G 
Sbjct: 165 -------CTLKILDFGLAR--TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGC 215
Query: 231 IMYILLCG-----------------------FPPFFSNHGQAISPGMKNRIRLGQFDFPN 267
           IM  ++ G                        P F       +   ++NR +   + F  
Sbjct: 216 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 275
Query: 268 --------PEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVME----NKWISQFNQVPQ 312
                    + EH    + +A+ L+  ML +D S+R+++D+ ++    N W         
Sbjct: 276 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 335
Query: 313 TPLCTGKMLKEGEET---WPEV 331
            P    K L E E T   W E+
Sbjct: 336 PPKIPDKQLDEREHTIEEWKEL 357

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 96  DLFDFITER--GALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDL--NRGELK 151
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 152 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 182
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 228
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 229 XECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 42/208 (20%)
Query: 120 IMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
           I  + C A++ +H Q   I HRD+K ENLL +   + G +KL DFG              
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATT---------- 187
Query: 178 GGILKLTDFGFA---KKIVSNKASLQTPCYTPYYVAPEVLGPDKYD-----KSCDIWSLG 229
             I    D+ ++   + +V  + +  T   TP Y  PE++  D Y      +  DIW+LG
Sbjct: 188 --ISHYPDYSWSAQRRALVEEEITRNT---TPMYRTPEII--DLYSNFPIGEKQDIWALG 240
Query: 230 VIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDP 289
            I+Y+L     PF          G K RI  G++  P  + ++      +LI+ ML V+P
Sbjct: 241 CILYLLCFRQHPF--------EDGAKLRIVNGKYSIPPHDTQYTV--FHSLIRAMLQVNP 290
Query: 290 SERLTIDQVME--NKWISQFNQVPQTPL 315
            ERL+I +V+    +  +  N  P++P+
Sbjct: 291 EERLSIAEVVHQLQEIAAARNVNPKSPI 318

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 131/310 (42%), Gaps = 47/310 (15%)
Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHI 71
           +DDY++  E++G G    V         E  A+K   L     +  E+  ++   S  H 
Sbjct: 9   RDDYELQ-EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 67
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQ------QKEDGAFTEREAAIIMNEIC 125
            NI   Y +       L ++M+ + GG +   I+      + + G   E   A I+ E+ 
Sbjct: 68  PNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +++LH     HRDVK  N+L    G+ G +++ DFG     +      GD        
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFG----VSAFLATGGD-------- 171
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFS 244
                 I  NK   +T   TP ++APEV+   + YD   DIWS G+    L  G  P+  
Sbjct: 172 ------ITRNKVR-KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 224
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEW-----EHVSQEAKTLIKNM-LCV--DPSERLTID 296
                  P MK  +   Q D P+ E      E + +  K+  K + LC+  DP +R T  
Sbjct: 225 Y------PPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA 278
Query: 297 QVMENKWISQ 306
           +++ +K+  +
Sbjct: 279 ELLRHKFFQK 288

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 122/289 (42%), Gaps = 52/289 (17%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ LA   H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 69  RTLREIKILLAF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 124
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +  +    
Sbjct: 125 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSD---LKICDFGLARVAD---- 177
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 178 -PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 220
Query: 233 YILLCGFPPFFSNH---------GQAISP-------GMKNRIRLGQFDFP-------NPE 269
             +L   P F   H         G   SP       G+  + R      P       N  
Sbjct: 221 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRL 280
Query: 270 WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
           + +   +A  L+  ML  +P +R+ ++Q + + +++Q+      P+   
Sbjct: 281 FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEA 329

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 131/310 (42%), Gaps = 47/310 (15%)
Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKV--LHDTVKARREVELQLAVGSHKHI 71
           +DDY++  E++G G    V         E  A+K   L     +  E+  ++   S  H 
Sbjct: 14  RDDYELQ-EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQ------QKEDGAFTEREAAIIMNEIC 125
            NI   Y +       L ++M+ + GG +   I+      + + G   E   A I+ E+ 
Sbjct: 73  PNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +++LH     HRDVK  N+L    G+ G +++ DFG     +      GD        
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFG----VSAFLATGGD-------- 176
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFS 244
                 I  NK   +T   TP ++APEV+   + YD   DIWS G+    L  G  P+  
Sbjct: 177 ------ITRNKVR-KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEW-----EHVSQEAKTLIKNM-LCV--DPSERLTID 296
                  P MK  +   Q D P+ E      E + +  K+  K + LC+  DP +R T  
Sbjct: 230 Y------PPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA 283
Query: 297 QVMENKWISQ 306
           +++ +K+  +
Sbjct: 284 ELLRHKFFQK 293

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 143 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 198
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 199 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 229
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 275
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 276 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 101 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 156
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 157 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 187
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 233
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 234 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 128 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 183
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 184 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 214
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 260
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 261 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 100 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 155
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 156 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 186
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 232
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 233 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 143 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 198
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 199 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 229
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 275
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 276 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 99  DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 154
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 155 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 185
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 231
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 232 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 101 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 156
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 157 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 187
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 233
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 234 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 115 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 170
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 171 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 201
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 247
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 248 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 100 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 155
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 156 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 186
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 232
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 233 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 126/296 (42%), Gaps = 60/296 (20%)
Query: 50  HDTVKARREVELQLAVG-SHKHIVNIKDVYE-NIYNGSRCLLVIMECMHGGELFQRIQQK 107
           H T   R   E+Q+ +   H++++ I+D+   +     R + ++ + M   +L++ ++ +
Sbjct: 81  HQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQ 139
Query: 108 EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK- 166
           +    +       + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  + 
Sbjct: 140 Q---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD---LKICDFGLARI 193
Query: 167 --PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSC 223
             PE+                 GF  + V+ +          +Y APE++   K Y KS 
Sbjct: 194 ADPEH--------------DHTGFLTEXVATR----------WYRAPEIMLNSKGYTKSI 229
Query: 224 DIWSLGVIMYILLCGFPPFFSNH---------GQAISPG---------MKNRIRLGQFDF 265
           DIWS+G I+  +L   P F   H         G   SP          MK R  L     
Sbjct: 230 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPS 289
Query: 266 PNP-EWEHV----SQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
                W  +      +A  L+  ML  +P++R+T+++ + + ++ Q+      P+ 
Sbjct: 290 KTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVA 345

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 133/321 (41%), Gaps = 74/321 (23%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKV--LHD-----TVKARREVELQLAVGSHKHIVNI 74
           E +G G  G V +   ++T E+ ALK   L D        A RE+ L L    HK+IV +
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL-LKELKHKNIVRL 66
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNEICSAIKFL 131
            DV   +++  +  LV   C       Q +++  D    + +  I+   + ++   + F 
Sbjct: 67  HDV---LHSDKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H +N+ HRD+KP+NLL  + G+                           LKL DFG A+ 
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGE---------------------------LKLADFGLARA 150
Query: 192 IVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
                        T +Y  P+VL G   Y  S D+WS G I   L     P F   G  +
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFP--GNDV 208
Query: 251 SPGMKNRIRL----GQFDFPN----PEWE----------------HVSQEAKTLIKNMLC 286
              +K   RL     +  +P+    P+++                 ++   + L++N+L 
Sbjct: 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLK 268
Query: 287 VDPSERLTIDQVMENKWISQF 307
            +P +R++ ++ +++ + S F
Sbjct: 269 CNPVQRISAEEALQHPYFSDF 289

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 96  DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 151
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 152 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 182
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 228
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 101 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 156
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 157 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 187
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 233
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 234 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 135 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 190
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 191 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 221
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 267
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 116 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 171
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 172 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 202
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 248
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 249 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 143 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 198
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 199 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 229
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 275
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 276 XECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 148 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 203
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 204 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 234
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 280
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 281 XECQHLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 116 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 171
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 172 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 202
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 248
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 249 XECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 123 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 178
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 179 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 209
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 255
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 256 XECQHLIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 115 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 170
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 171 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 201
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 247
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 248 XECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 120/293 (40%), Gaps = 57/293 (19%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKD----VYE 79
           +G G  G V    + + SEV A+K +  + K   E + Q  +   + +  ++      Y 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 80  NIYNGSRCLLVIME-CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
             Y       ++ME C+        + +K      E E A + +     + +LH  N+ H
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RDVK  N+L ++PG                           ++KL DFG         AS
Sbjct: 178 RDVKAGNILLSEPG---------------------------LVKLGDFG--------SAS 202
Query: 199 LQTPCY----TPYYVAPEV---LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +  P      TPY++APEV   +   +YD   D+WSLG+    L    PP F+ +     
Sbjct: 203 IMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----- 257
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
             M     + Q + P  +  H S+  +  + + L   P +R T + +++++++
Sbjct: 258 -AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 120/293 (40%), Gaps = 57/293 (19%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKD----VYE 79
           +G G  G V    + + SEV A+K +  + K   E + Q  +   + +  ++      Y 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 80  NIYNGSRCLLVIME-CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
             Y       ++ME C+        + +K      E E A + +     + +LH  N+ H
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RDVK  N+L ++PG                           ++KL DFG         AS
Sbjct: 139 RDVKAGNILLSEPG---------------------------LVKLGDFG--------SAS 163
Query: 199 LQTPCY----TPYYVAPEV---LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           +  P      TPY++APEV   +   +YD   D+WSLG+    L    PP F+ +     
Sbjct: 164 IMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----- 218
Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
             M     + Q + P  +  H S+  +  + + L   P +R T + +++++++
Sbjct: 219 -AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 128 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 183
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 184 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 214
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I          GQ  F     + VS
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIG--------GQVFFR----QRVS 260
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 261 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 128 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 183
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 184 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 214
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I          GQ  F     + VS
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIG--------GQVFFR----QRVS 260
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 261 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 96  DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 151
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 152 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 182
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I          GQ  F     + VS
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIG--------GQVFFR----QRVS 228
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 129 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 184
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 185 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 215
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I          GQ  F     + VS
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIG--------GQVFFR----QRVS 261
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 262 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 129 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 184
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 185 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 215
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I          GQ  F     + VS
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIG--------GQVFFR----QRVS 261
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 262 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 123/295 (41%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ LA   H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 69  RTLREIKILLAF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 124
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +  +    
Sbjct: 125 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVAD---- 177
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 178 -PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 220
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 221 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 280
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + +++Q+      P+   
Sbjct: 281 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEPIAEA 329

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 52/227 (22%)
Query: 108 EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP 167
           E G   E  A + M ++   +K++H  N+ HRD+KP NL                  +  
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF-----------------INT 155
Query: 168 ENLLYTKPGDGGILKLTDFGFAKKI---VSNKASLQTPCYTPYYVAPE-VLGPDKYDKSC 223
           E+L         +LK+ DFG A+ +    S+K  L     T +Y +P  +L P+ Y K+ 
Sbjct: 156 EDL---------VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI 206
Query: 224 DIWSLGVIMYILLCGFPPFFSNHG----QAISPGM-----KNRIRLGQF-------DFPN 267
           D+W+ G I   +L G   F   H     Q I   +     ++R  L          D   
Sbjct: 207 DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTE 266
Query: 268 PE------WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           P          +S+EA   ++ +L   P +RLT ++ + + ++S ++
Sbjct: 267 PHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 129 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 184
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 185 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 215
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I          GQ  F     + VS
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIG--------GQVFFR----QRVS 261
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 262 XECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 129 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 184
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 185 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 215
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I          GQ  F     + VS
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIG--------GQVFFR----QRVS 261
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 262 XECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + ++  + G +L++ ++ +     +
Sbjct: 87  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LS 142
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +       
Sbjct: 143 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLAR-----VA 194
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 195 DPDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 238
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 239 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 298
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 299 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 347

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/326 (24%), Positives = 124/326 (38%), Gaps = 67/326 (20%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVK--ARREVELQLAVGSHKHI 71
           + LG G    V +  +K T+++ A+K +         D +   A RE++L L   SH +I
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL-LQELSHPNI 74
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           + + D + +  N S    ++ + M      + I +      T       M      +++L
Sbjct: 75  IGLLDAFGHKSNIS----LVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I HRD+KP NLL                             + G+LKL DFG AK 
Sbjct: 129 HQHWILHRDLKPNNLLLD---------------------------ENGVLKLADFGLAKS 161
Query: 192 IVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFP---------- 240
             S   +      T +Y APE+L G   Y    D+W++G I+  LL   P          
Sbjct: 162 FGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 221
Query: 241 --PFFSNHGQAISPGMKNRIRLGQF----DFPNPEWEHVSQEAK----TLIKNMLCVDPS 290
               F   G        +   L  +     FP     H+   A      LI+ +   +P 
Sbjct: 222 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC 281
Query: 291 ERLTIDQVMENKWISQFNQVPQTPLC 316
            R+T  Q ++ K+ S  N+   TP C
Sbjct: 282 ARITATQALKMKYFS--NRPGPTPGC 305

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 128 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 183
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 184 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 214
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I          GQ  F     + VS
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIG--------GQVFFR----QRVS 260
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + PS+R T +++  + W+
Sbjct: 261 XECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 57/255 (22%)
Query: 59  VELQLAVGS---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
           V L++A+ S   H +I+ + D++EN        LV+ +   G +LF  I +       E 
Sbjct: 76  VTLEIAILSRVEHANIIKVLDIFEN---QGFFQLVMEKHGSGLDLFAFIDRHPR--LDEP 130
Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
            A+ I  ++ SA+ +L  ++I HRD+K EN++  +          DF             
Sbjct: 131 LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE----------DF------------- 167
Query: 176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYI 234
                +KL DFG A  +   K    T C T  Y APEVL  + Y     ++WSLGV +Y 
Sbjct: 168 ----TIKLIDFGSAAYLERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYT 222
Query: 235 LLCGFPPFF---SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           L+    PF         AI P                    VS+E  +L+  +L   P  
Sbjct: 223 LVFEENPFCELEETVEAAIHPPY-----------------LVSKELMSLVSGLLQPVPER 265
Query: 292 RLTIDQVMENKWISQ 306
           R T+++++ + W++Q
Sbjct: 266 RTTLEKLVTDPWVTQ 280

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/321 (23%), Positives = 133/321 (41%), Gaps = 74/321 (23%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKV--LHD-----TVKARREVELQLAVGSHKHIVNI 74
           E +G G  G V +   ++T E+ ALK   L D        A RE+ L L    HK+IV +
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL-LKELKHKNIVRL 66
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNEICSAIKFL 131
            DV   +++  +  LV   C       Q +++  D    + +  I+   + ++   + F 
Sbjct: 67  HDV---LHSDKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H +N+ HRD+KP+NLL  + G+                           LKL +FG A+ 
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGE---------------------------LKLANFGLARA 150
Query: 192 IVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
                        T +Y  P+VL G   Y  S D+WS G I   L     P F   G  +
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDV 208
Query: 251 SPGMKNRIRL----GQFDFPN----PEWE----------------HVSQEAKTLIKNMLC 286
              +K   RL     +  +P+    P+++                 ++   + L++N+L 
Sbjct: 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLK 268
Query: 287 VDPSERLTIDQVMENKWISQF 307
            +P +R++ ++ +++ + S F
Sbjct: 269 CNPVQRISAEEALQHPYFSDF 289

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 81/342 (23%), Positives = 135/342 (39%), Gaps = 83/342 (24%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD------TVKARREVELQLAVG 66
           I  D+ + + +LG G  G V     K T E+ A+K +         ++  RE+++ L   
Sbjct: 9   ISSDFQLKS-LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI-LKHF 66
Query: 67  SHKHIVNI-----KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM 121
            H++I+ I      D +EN       + +I E M   +L + I  +     ++      +
Sbjct: 67  KHENIITIFNIQRPDSFENFNE----VYIIQELMQT-DLHRVISTQ---MLSDDHIQYFI 118
Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
            +   A+K LH  N+ HRD+KP NLL     D                           L
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---------------------------L 151
Query: 182 KLTDFGFAKKIVSNKASLQTP----------CYTPYYVAPEV-LGPDKYDKSCDIWSLGV 230
           K+ DFG A+ I  + A    P            T +Y APEV L   KY ++ D+WS G 
Sbjct: 152 KVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGC 211
Query: 231 IMYILLCGFPPFFSN---------HGQAISPGMKNRIRLGQFD-----------FPNPEW 270
           I+  L    P F             G   +P   N +R  +             +P    
Sbjct: 212 ILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL 271
Query: 271 E----HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           E     V+ +   L++ ML  DP++R+T  + +E+ ++  ++
Sbjct: 272 EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/342 (22%), Positives = 144/342 (42%), Gaps = 69/342 (20%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK-------VLHDTVKARREVELQLAV 65
           + D+Y+I  E +G G  G V     + T +  A+K       V+ +  +  RE+++ L  
Sbjct: 52  VGDEYEI-IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI-LKH 109
Query: 66  GSHKHIVNIKDVYENI--YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
             H +I+ IKD+      Y   + + V+++ M   +L Q I   +    T       + +
Sbjct: 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQ--PLTLEHVRYFLYQ 166
Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +   +K++H   + HRD+KP NLL  +  +                           LK+
Sbjct: 167 LLRGLKYMHSAQVIHRDLKPSNLLVNENCE---------------------------LKI 199
Query: 184 TDFGFAKKIVSNKASLQ----TPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG 238
            DFG A+ + ++ A  Q        T +Y APE+ L   +Y ++ D+WS+G I   +L  
Sbjct: 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR 259
Query: 239 FPPF----FSNHGQAI-------SPGM-----KNRIRLGQFDFPNPE---WEHV----SQ 275
              F    + +  Q I       SP +       R+R      P  +   WE V     +
Sbjct: 260 RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADR 319
Query: 276 EAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCT 317
           +A +L+  ML  +PS R++    + + ++++++     P C 
Sbjct: 320 QALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCA 361

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/342 (23%), Positives = 135/342 (39%), Gaps = 83/342 (24%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD------TVKARREVELQLAVG 66
           I  D+ + + +LG G  G V     K T E+ A+K +         ++  RE+++ L   
Sbjct: 9   ISSDFQLKS-LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI-LKHF 66
Query: 67  SHKHIVNI-----KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM 121
            H++I+ I      D +EN       + +I E M   +L + I  +     ++      +
Sbjct: 67  KHENIITIFNIQRPDSFENFNE----VYIIQELMQT-DLHRVISTQ---MLSDDHIQYFI 118
Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
            +   A+K LH  N+ HRD+KP NLL     D                           L
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---------------------------L 151
Query: 182 KLTDFGFAKKIVSNKASLQTP----------CYTPYYVAPEV-LGPDKYDKSCDIWSLGV 230
           K+ DFG A+ I  + A    P            T +Y APEV L   KY ++ D+WS G 
Sbjct: 152 KVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGC 211
Query: 231 IMYILLCGFPPFFSN---------HGQAISPGMKNRIRLGQFD-----------FPNPEW 270
           I+  L    P F             G   +P   N +R  +             +P    
Sbjct: 212 ILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL 271
Query: 271 E----HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           E     V+ +   L++ ML  DP++R+T  + +E+ ++  ++
Sbjct: 272 EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 51/210 (24%)
Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
           +LF  I ++  GA  E  A     ++  A++  H+  + HRD+K EN+L     + G LK
Sbjct: 116 DLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELK 171
Query: 159 LTDFGDVKPENLLYTKPGDGGILK---LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG 215
           L DF             G G +LK    TDF              T  Y+P    PE + 
Sbjct: 172 LIDF-------------GSGALLKDTVYTDFD------------GTRVYSP----PEWIR 202
Query: 216 PDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVS 274
             +Y  +S  +WSLG+++Y ++CG  PF   H + I       IR GQ  F     + VS
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-------IR-GQVFFR----QRVS 248
Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            E + LI+  L + P +R T +++  + W+
Sbjct: 249 XECQHLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/342 (23%), Positives = 135/342 (39%), Gaps = 83/342 (24%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD------TVKARREVELQLAVG 66
           I  D+ + + +LG G  G V     K T E+ A+K +         ++  RE+++ L   
Sbjct: 9   ISSDFQLKS-LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI-LKHF 66
Query: 67  SHKHIVNI-----KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM 121
            H++I+ I      D +EN       + +I E M   +L + I  +     ++      +
Sbjct: 67  KHENIITIFNIQRPDSFENFNE----VYIIQELMQT-DLHRVISTQ---MLSDDHIQYFI 118
Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
            +   A+K LH  N+ HRD+KP NLL     D                           L
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---------------------------L 151
Query: 182 KLTDFGFAKKIVSNKASLQTP----------CYTPYYVAPEV-LGPDKYDKSCDIWSLGV 230
           K+ DFG A+ I  + A    P            T +Y APEV L   KY ++ D+WS G 
Sbjct: 152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGC 211
Query: 231 IMYILLCGFPPFFSN---------HGQAISPGMKNRIRLGQFD-----------FPNPEW 270
           I+  L    P F             G   +P   N +R  +             +P    
Sbjct: 212 ILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL 271
Query: 271 E----HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           E     V+ +   L++ ML  DP++R+T  + +E+ ++  ++
Sbjct: 272 EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 124/291 (42%), Gaps = 41/291 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARREVELQLAVGSHKHIVNIKDVYEN 80
           ++LG G  G ++        +V   ++L +    A REV+L      H +++     Y  
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR----YFC 85
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                +   + +E +    L + ++QK D A    E   ++ +  S +  LH  NI HRD
Sbjct: 86  TEKDRQFQYIAIE-LCAATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +KP N+L + P   G +K                        ++DFG  KK+   + S  
Sbjct: 144 LKPHNILISMPNAHGKIKAM----------------------ISDFGLCKKLAVGRHSFS 181
Query: 201 TPCYTP---YYVAPEVLGPDKYDK---SCDIWSLGVIMYILLC-GFPPFFSNHGQAISPG 253
                P    ++APE+L  D  +    + DI+S G + Y ++  G  PF    G+++   
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----GKSLQRQ 237
Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
               +     D  +PE +H    A+ LI+ M+ +DP +R +   V+++ + 
Sbjct: 238 ANILLGACSLDCLHPE-KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/342 (22%), Positives = 144/342 (42%), Gaps = 69/342 (20%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK-------VLHDTVKARREVELQLAV 65
           + D+Y+I  E +G G  G V     + T +  A+K       V+ +  +  RE+++ L  
Sbjct: 53  VGDEYEI-IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI-LKH 110
Query: 66  GSHKHIVNIKDVYENI--YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
             H +I+ IKD+      Y   + + V+++ M   +L Q I   +    T       + +
Sbjct: 111 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQ--PLTLEHVRYFLYQ 167
Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +   +K++H   + HRD+KP NLL  +  +                           LK+
Sbjct: 168 LLRGLKYMHSAQVIHRDLKPSNLLVNENCE---------------------------LKI 200
Query: 184 TDFGFAKKIVSNKASLQ----TPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG 238
            DFG A+ + ++ A  Q        T +Y APE+ L   +Y ++ D+WS+G I   +L  
Sbjct: 201 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR 260
Query: 239 FPPF----FSNHGQAI-------SPGM-----KNRIRLGQFDFPNPE---WEHV----SQ 275
              F    + +  Q I       SP +       R+R      P  +   WE V     +
Sbjct: 261 RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADR 320
Query: 276 EAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCT 317
           +A +L+  ML  +PS R++    + + ++++++     P C 
Sbjct: 321 QALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCA 362

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 129/304 (42%), Gaps = 50/304 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  V A K++H  +K   R ++  +L V    +  
Sbjct: 6   DDFEKISE-LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + +L 
Sbjct: 65  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 154
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           ++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  +  G  P      +  S
Sbjct: 155 LIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212
Query: 252 PGMKNRIRLGQFDF-------PNPEWEH--VSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
                R  +  F+        P P+      S E +  +   L  +P+ER  + Q+M + 
Sbjct: 213 -----RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 267
Query: 303 WISQ 306
           +I +
Sbjct: 268 FIKR 271

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 119/264 (45%), Gaps = 38/264 (14%)
Query: 41  SEVYALKVL-----HDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM 95
              YALK +      D  +A+RE ++   + +H +I+ +               +++   
Sbjct: 54  GHFYALKRILCHEQQDREEAQREADMH-RLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112
Query: 96  HGGELFQRIQQ-KEDGAF-TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD 153
             G L+  I++ K+ G F TE +   ++  IC  ++ +H +  AHRD+KP N+L    GD
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GD 169
Query: 154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEV 213
            G   L D G +  +  ++ + G    L L D+   +  +S             Y APE+
Sbjct: 170 EGQPVLMDLGSMN-QACIHVE-GSRQALTLQDWAAQRCTIS-------------YRAPEL 214
Query: 214 LGPDKY---DKSCDIWSLGVIMYILLCGFPPF--FSNHGQAISPGMKNRIRLGQFDFPNP 268
                +   D+  D+WSLG ++Y ++ G  P+      G +++  ++N++ +       P
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI-------P 267
Query: 269 EWEHVSQEAKTLIKNMLCVDPSER 292
           +    S     L+ +M+ VDP +R
Sbjct: 268 QSPRHSSALWQLLNSMMTVDPHQR 291

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 66/301 (21%)
Query: 50  HDTVKAR--REVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK 107
           H T   R  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +
Sbjct: 65  HQTYXQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ 123
Query: 108 EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP 167
                +       + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  + 
Sbjct: 124 H---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARV 177
Query: 168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIW 226
            +     P           GF  + V+          T +Y APE++   K Y KS DIW
Sbjct: 178 AD-----PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIW 216
Query: 227 SLGVIMYILLCGFPPFFSNH---------GQAISPGM--------------------KNR 257
           S+G I+  +L   P F   H         G   SP                      KN+
Sbjct: 217 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 276
Query: 258 IRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCT 317
           +   +  FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+  
Sbjct: 277 VPWNRL-FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAE 330
Query: 318 G 318
Sbjct: 331 A 331

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 91/238 (38%), Gaps = 38/238 (15%)
Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVEL--QLAVGS 67
           Y+   EI G+G  G V +  +  +    ALK +          +   REV L  +L    
Sbjct: 6   YEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H ++V + DV           + ++      +L   + +             +M +    
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + FLH   I HRD+KPEN+L T                            GG +KL DFG
Sbjct: 125 LDFLHANCIVHRDLKPENILVTS---------------------------GGTVKLADFG 157
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
            A +I S + +L     T +Y APEVL    Y    D+WS+G I   +    P F  N
Sbjct: 158 LA-RIYSYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 214

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 67  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 122
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +       
Sbjct: 123 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLAR-----VA 174
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 175 DPDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 218
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 219 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRL 278
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 279 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 327

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 91/238 (38%), Gaps = 38/238 (15%)
Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVEL--QLAVGS 67
           Y+   EI G+G  G V +  +  +    ALK +          +   REV L  +L    
Sbjct: 6   YEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H ++V + DV           + ++      +L   + +             +M +    
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + FLH   I HRD+KPEN+L T                            GG +KL DFG
Sbjct: 125 LDFLHANCIVHRDLKPENILVTS---------------------------GGTVKLADFG 157
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
            A +I S + +L     T +Y APEVL    Y    D+WS+G I   +    P F  N
Sbjct: 158 LA-RIYSYQMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 214

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/340 (22%), Positives = 143/340 (42%), Gaps = 75/340 (22%)
Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVY-ALKVLHDTVKARREVELQLAVGSHKHIVNIK 75
           Y+I  + LG G  GKV++ ++ K    + A+K++ +  +       ++ V  H +  +  
Sbjct: 16  YEI-VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 76  DVYENI-------YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI--IMNEICS 126
             +  +       ++G  C  ++ E + G   +  I  KE+G    R   I  +  +IC 
Sbjct: 75  STFRCVQMLEWFEHHGHIC--IVFELL-GLSTYDFI--KENGFLPFRLDHIRKMAYQICK 129
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD-----VKPENLLYTKPGDGGIL 181
           ++ FLH   + H D+KPEN+L+ +         +D+ +     +K +      P     +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQ---------SDYTEAYNPKIKRDERTLINPD----I 176
Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           K+ DFG A     + ++L +   T +Y APEV+    + + CD+WS+G I+     GF  
Sbjct: 177 KVVDFGSATYDDEHHSTLVS---TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF-T 232
Query: 242 FFSNHGQAISPGMKNRI-------------RLGQFDFPNPEWE-------HVSQEAK--- 278
            F  H       M  RI             +   F     +W+       +VS+  K   
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292
Query: 279 --------------TLIKNMLCVDPSERLTIDQVMENKWI 304
                          LI+ ML  DP++R+T+ + +++ + 
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 67  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 122
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +  +    
Sbjct: 123 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVAD---- 175
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 176 -PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 218
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 219 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRL 278
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 279 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 327

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 112/241 (46%), Gaps = 29/241 (12%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVE--KKTSEVYALKVLHDTVKARREVELQLAV----- 65
           +Q+ Y+I    LG G  GKV++ ++  +  S+V ALK++ +  K R    L++ V     
Sbjct: 17  LQERYEIVGN-LGEGTFGKVVECLDHARGKSQV-ALKIIRNVGKYREAARLEINVLKKIK 74
Query: 66  ---GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                +K +  +   + N ++G  C  +  E + G   F+ +++     +       +  
Sbjct: 75  EKDKENKFLCVLMSDWFN-FHGHMC--IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN-LLYTKPGDGGIL 181
           ++C A++FLH+  + H D+KPEN+L+           ++F  +  E+     K      +
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVN---------SEFETLYNEHKSCEEKSVKNTSI 181
Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           ++ DFG A     +     T   T +Y  PEV+    + + CD+WS+G I++    GF  
Sbjct: 182 RVADFGSA---TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238
Query: 242 F 242
           F
Sbjct: 239 F 239

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 67  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 122
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +       
Sbjct: 123 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLAR-----VA 174
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 175 DPDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 218
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 219 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 278
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 279 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 327

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 112/241 (46%), Gaps = 29/241 (12%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVE--KKTSEVYALKVLHDTVKARREVELQLAV----- 65
           +Q+ Y+I    LG G  GKV++ ++  +  S+V ALK++ +  K R    L++ V     
Sbjct: 49  LQERYEIVGN-LGEGTFGKVVECLDHARGKSQV-ALKIIRNVGKYREAARLEINVLKKIK 106
Query: 66  ---GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                +K +  +   + N ++G  C  +  E + G   F+ +++     +       +  
Sbjct: 107 EKDKENKFLCVLMSDWFN-FHGHMC--IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 162
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN-LLYTKPGDGGIL 181
           ++C A++FLH+  + H D+KPEN+L+           ++F  +  E+     K      +
Sbjct: 163 QLCHALRFLHENQLTHTDLKPENILFVN---------SEFETLYNEHKSCEEKSVKNTSI 213
Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           ++ DFG A     +     T   T +Y  PEV+    + + CD+WS+G I++    GF  
Sbjct: 214 RVADFGSA---TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 270
Query: 242 F 242
           F
Sbjct: 271 F 271

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 71  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 126
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +       
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLAR-----VA 178
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 179 DPDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 223 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 282
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 283 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 331

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 112/241 (46%), Gaps = 29/241 (12%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVE--KKTSEVYALKVLHDTVKARREVELQLAV----- 65
           +Q+ Y+I    LG G  GKV++ ++  +  S+V ALK++ +  K R    L++ V     
Sbjct: 26  LQERYEIVGN-LGEGTFGKVVECLDHARGKSQV-ALKIIRNVGKYREAARLEINVLKKIK 83
Query: 66  ---GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                +K +  +   + N ++G  C  +  E + G   F+ +++     +       +  
Sbjct: 84  EKDKENKFLCVLMSDWFN-FHGHMC--IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 139
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN-LLYTKPGDGGIL 181
           ++C A++FLH+  + H D+KPEN+L+           ++F  +  E+     K      +
Sbjct: 140 QLCHALRFLHENQLTHTDLKPENILFVN---------SEFETLYNEHKSCEEKSVKNTSI 190
Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           ++ DFG A     +     T   T +Y  PEV+    + + CD+WS+G I++    GF  
Sbjct: 191 RVADFGSA---TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 247
Query: 242 F 242
           F
Sbjct: 248 F 248

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 91/238 (38%), Gaps = 38/238 (15%)
Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVEL--QLAVGS 67
           Y+   EI G+G  G V +  +  +    ALK +          +   REV L  +L    
Sbjct: 6   YEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H ++V + DV           + ++      +L   + +             +M +    
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + FLH   I HRD+KPEN+L T                            GG +KL DFG
Sbjct: 125 LDFLHANCIVHRDLKPENILVTS---------------------------GGTVKLADFG 157
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
            A +I S + +L     T +Y APEVL    Y    D+WS+G I   +    P F  N
Sbjct: 158 LA-RIYSYQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 214

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 75  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 130
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +       
Sbjct: 131 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLAR-----VA 182
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 183 DPDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 226
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 227 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 286
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 287 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 335

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 67  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 122
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +       
Sbjct: 123 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLAR-----VA 174
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 175 DPDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 218
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 219 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 278
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 279 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 327

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/331 (22%), Positives = 132/331 (39%), Gaps = 70/331 (21%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKAR--REVELQLAVGSHKHIVNIKDV 77
           +G G  G V    +       A+K +    H T   R  RE+++ L    H++I+ I D+
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDI 109
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
                      + I++ +   +L++ ++ +     +       + +I   +K++H  N+ 
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVL 166
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+KP NLL     D   LK+ DFG  +        P           GF  + V+   
Sbjct: 167 HRDLKPSNLLLNTTCD---LKICDFGLAR-----VADPDHDHT------GFLTEYVA--- 209
Query: 198 SLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFSNH---------G 247
                  T +Y APE++   K Y KS DIWS+G I+  +L   P F   H         G
Sbjct: 210 -------TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 262
Query: 248 QAISPGM--------------------KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCV 287
              SP                      KN++   +  FPN +      +A  L+  ML  
Sbjct: 263 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL-FPNAD-----SKALDLLDKMLTF 316
Query: 288 DPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
           +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 317 NPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 347

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 134/300 (44%), Gaps = 43/300 (14%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREV---ELQLAVGSHKHIVNIKDVYE 79
           +LG G  G+V++      S  YA+K +  T +    +    + LA  +H+++V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 80  NIYNGSR---------CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
              N  +          L + ME    G L+  I   E+      E   +  +I  A+ +
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSY 131
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           +H Q I HRD+KP N+   +  +   +K+ DFG  K  +    +  D  ILKL     ++
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRN---VKIGDFGLAKNVH----RSLD--ILKLD----SQ 178
Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
            +  +  +L +   T  YVA EVL G   Y++  D++SLG+I + ++  F          
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF---------- 228
Query: 250 ISPGMKN-----RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            S GM+      ++R    +FP    ++  +  K +I+ ++  DP++R     ++ + W+
Sbjct: 229 -STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 67  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 122
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +  +    
Sbjct: 123 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVAD---- 175
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 176 -PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 218
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 219 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 278
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 279 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 327

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/331 (22%), Positives = 133/331 (40%), Gaps = 70/331 (21%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKAR--REVELQLAVGSHKHIVNIKDV 77
           +G G  G V    +       A+K +    H T   R  RE+++ L    H++I+ I D+
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDI 91
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
                      + I++ +   +L++ ++ +     +       + +I   +K++H  N+ 
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVL 148
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+KP NLL     D   LK+ DFG  +  +     P           GF  + V+   
Sbjct: 149 HRDLKPSNLLLNTTCD---LKICDFGLARVAD-----PDHDHT------GFLTEYVA--- 191
Query: 198 SLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFSNH---------G 247
                  T +Y APE++   K Y KS DIWS+G I+  +L   P F   H         G
Sbjct: 192 -------TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 244
Query: 248 QAISPGM--------------------KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCV 287
              SP                      KN++   +  FPN +      +A  L+  ML  
Sbjct: 245 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL-FPNAD-----SKALDLLDKMLTF 298
Query: 288 DPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
           +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 299 NPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 329

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 65  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 120
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +  +    
Sbjct: 121 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVAD---- 173
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 174 -PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 216
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 217 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 276
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 277 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 325

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 72  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 127
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +  +    
Sbjct: 128 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVAD---- 180
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 181 -PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 223
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 224 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 283
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 284 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 332

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 73  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 128
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +  +    
Sbjct: 129 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVAD---- 181
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 182 -PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 224
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 225 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 284
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 285 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 333

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 64  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 119
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +  +    
Sbjct: 120 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVAD---- 172
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 173 -PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 215
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 216 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 275
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 276 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 324

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 71  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 126
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +  +    
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVAD---- 179
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 180 -PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 223 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 282
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 283 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 331

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 71  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 126
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +  +    
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVAD---- 179
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 180 -PDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 223 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 282
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 283 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 331

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 128/306 (41%), Gaps = 71/306 (23%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVY-- 78
           E++G G  G+V +   +   + Y ++ V ++  KA REV+  LA   H +IV+    +  
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVK-ALAKLDHVNIVHYNGCWDG 76
Query: 79  -------------------ENIYNGSR----CLLVIMECMHGGELFQRIQQKEDGAFTER 115
                              EN  N SR    CL + ME    G L Q I+++      + 
Sbjct: 77  FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 136
Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
            A  +  +I   + ++H + + HRD+KP N+      D   +K+ DFG      L+ +  
Sbjct: 137 LALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV---DTKQVKIGDFG------LVTSLK 187
Query: 176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL 235
            DG            K   +K +L+       Y++PE +    Y K  D+++LG+I+  L
Sbjct: 188 NDG------------KRTRSKGTLR-------YMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 236 L--CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           L  C      S     +  G+ + I    FD          ++ KTL++ +L   P +R 
Sbjct: 229 LHVCDTAFETSKFFTDLRDGIISDI----FD----------KKEKTLLQKLLSKKPEDRP 274
Query: 294 TIDQVM 299
              +++
Sbjct: 275 NTSEIL 280

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 77/262 (29%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVYEN-- 80
           LG G  G V ++ + ++ + +ALK VL D     RE+++ + V  H +I+ + D +    
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDI-MKVLDHVNIIKLVDYFYTTG 73
Query: 81  ------------------------------IYNGS--RCLLVIMECMHGGELFQRIQQKE 108
                                         I N S  + L VIME +   +   ++ +  
Sbjct: 74  DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV--PDTLHKVLK-- 129
Query: 109 DGAFTEREAAIIMN-------EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD 161
             +F     +I MN       ++  A+ F+H   I HRD+KP+NLL              
Sbjct: 130 --SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN------------ 175
Query: 162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYD 220
                              LKL DFG AKK++ ++ S+   C + +Y APE+ LG  +Y 
Sbjct: 176 --------------SKDNTLKLCDFGSAKKLIPSEPSVAXIC-SRFYRAPELMLGATEYT 220
Query: 221 KSCDIWSLGVIMYILLCGFPPF 242
            S D+WS+G +   L+ G P F
Sbjct: 221 PSIDLWSIGCVFGELILGKPLF 242

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 91/241 (37%), Gaps = 41/241 (17%)
Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVEL--QLA 64
           Y+   EI G+G  G V +  +  +    ALK +             +   REV L  +L 
Sbjct: 11  YEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H ++V + DV           + ++      +L   + +             +M + 
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              + FLH   I HRD+KPEN+L T                            GG +KL 
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTS---------------------------GGTVKLA 162
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG A +I S + +L     T +Y APEVL    Y    D+WS+G I   +    P F  
Sbjct: 163 DFGLA-RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221
Query: 245 N 245
           N
Sbjct: 222 N 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 71  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 126
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +       
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLAR-----VA 178
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 179 DPDHDHT------GFLXEXVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 223 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 282
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 283 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 331

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 72  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 127
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +       
Sbjct: 128 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLAR-----VA 179
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 180 DPDHDHT------GFLXEXVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 223
Query: 233 YILLCGFPPFFSNH---------GQAISPGM--------------------KNRIRLGQF 263
             +L   P F   H         G   SP                      KN++   + 
Sbjct: 224 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 283
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 284 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 332

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/295 (22%), Positives = 119/295 (40%), Gaps = 64/295 (21%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+++ L    H++I+ I D+           + I++ +   +L++ ++ +     +
Sbjct: 65  RTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LS 120
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                  + +I   +K++H  N+ HRD+KP NLL     D   LK+ DFG  +       
Sbjct: 121 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLAR-----VA 172
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
            P           GF  + V+          T +Y APE++   K Y KS DIWS+G I+
Sbjct: 173 DPDHDHT------GFLTEYVA----------TRWYRAPEIMLNSKGYTKSIDIWSVGCIL 216
Query: 233 YILLCGFPPFFSNH-----------------------------GQAISPGMKNRIRLGQF 263
             +L   P F   H                                +S   KN++   + 
Sbjct: 217 AEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRL 276
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
            FPN +      +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 277 -FPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 325

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 54/234 (23%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHI 71
           +S   +G G  G V   ++K++ E  A+K L           +A RE+ L L    H+++
Sbjct: 45  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL-LLLKHMQHENV 103
Query: 72  VNIKDVY------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
           + + DV+       N Y+      ++M  M      Q+I   E   F+E +   ++ ++ 
Sbjct: 104 IGLLDVFTPASSLRNFYD----FYLVMPFMQTD--LQKIMGME---FSEEKIQYLVYQML 154
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +K++H   + HRD+KP NL   +  +                           LK+ D
Sbjct: 155 KGLKYIHSAGVVHRDLKPGNLAVNEDCE---------------------------LKILD 187
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG 238
           FG A+      A +     T +Y APEV L    Y+++ DIWS+G IM  +L G
Sbjct: 188 FGLAR---HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 68
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 69  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KPENLL                               G +KL DFG A
Sbjct: 120 FCHSHRVLHRDLKPENLLINT---------------------------EGAIKLADFGLA 152
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 153 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 212
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 213 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 269
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 270 LHYDPNKRISAKAALAHPFF 289

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 127/293 (43%), Gaps = 58/293 (19%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKHIVNIKDVYEN 80
           E++G G  G+V +   +   + Y +K V ++  KA REV+  LA   H +IV+    ++ 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK-ALAKLDHVNIVHYNGCWDG 75
Query: 81  I--------YNGSR----CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
                     N SR    CL + ME    G L Q I+++      +  A  +  +I   +
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            ++H + + +RD+KP N+      D   +K+ DFG      L+ +   DG          
Sbjct: 136 DYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFG------LVTSLKNDG---------- 176
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL--CGFPPFFSNH 246
             K   +K +L+       Y++PE +    Y K  D+++LG+I+  LL  C      S  
Sbjct: 177 --KRXRSKGTLR-------YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 227
Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
              +  G+ + I    FD          ++ KTL++ +L   P +R    +++
Sbjct: 228 FTDLRDGIISDI----FD----------KKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 67
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 68  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KPENLL    G                            +KL DFG A
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEG---------------------------AIKLADFGLA 151
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 152 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 212 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 268
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 269 LHYDPNKRISAKAALAHPFF 288

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 73
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 74  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 125 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 157
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 158 RAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 217
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 218 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 274
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 275 LHYDPNKRISAKAALAHPFF 294

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/331 (22%), Positives = 132/331 (39%), Gaps = 70/331 (21%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKAR--REVELQLAVGSHKHIVNIKDV 77
           +G G  G V    +       A+K +    H T   R  RE+++ L    H++I+ I D+
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDI 93
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
                      + I++ +   +L++ ++ +     +       + +I   +K++H  N+ 
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQH---LSNDHICYFLYQILRGLKYIHSANVL 150
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+KP NLL     D   LK+ DFG  +        P           GF  + V+   
Sbjct: 151 HRDLKPSNLLLNTTCD---LKICDFGLAR-----VADPDHDHT------GFLTEYVA--- 193
Query: 198 SLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFSNH---------G 247
                  T +Y APE++   K Y KS DIWS+G I+  +L   P F   H         G
Sbjct: 194 -------TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246
Query: 248 QAISPGM--------------------KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCV 287
              SP                      KN++   +  FPN +      +A  L+  ML  
Sbjct: 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL-FPNAD-----SKALDLLDKMLTF 300
Query: 288 DPSERLTIDQVMENKWISQFNQVPQTPLCTG 318
           +P +R+ ++Q + + ++ Q+      P+   
Sbjct: 301 NPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 331

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 66
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 67  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 118 FCHSHRVLHRDLKPQNLLI---------------------------NTEGAIKLADFGLA 150
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 151 RAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 267
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 268 LHYDPNKRISAKAALAHPFF 287

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 60/304 (19%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  V A K++H  +K   R ++  +L V    +  
Sbjct: 9   DDFEKISE-LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 67
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + +L 
Sbjct: 68  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 157
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
           ++   A+      T  Y++PE L    Y    DIWS+G+ +  +  G  P          
Sbjct: 158 LIDEMAN--EFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP---------- 205
Query: 252 PGMKNRIRLGQFDF-------PNPEWEHV--SQEAKTLIKNMLCVDPSERLTIDQVMENK 302
                R  +  F+        P P+      S E +  +   L  +P+ER  + Q+M + 
Sbjct: 206 -----RPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 260
Query: 303 WISQ 306
           +I +
Sbjct: 261 FIKR 264

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 36/231 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  V A K++H  +K   R ++  +L V    +  
Sbjct: 68  DDFEKISE-LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 126
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + +L 
Sbjct: 127 YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 216
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           ++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  +  G  P 
Sbjct: 217 LIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  V A K++H  +K   R ++  +L V    +  
Sbjct: 33  DDFEKISE-LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + +L 
Sbjct: 92  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 181
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           ++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  +  G  P
Sbjct: 182 LIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 128/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 66
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q ++   D  A T     +I   + ++   + 
Sbjct: 67  LLDV---IHTENKLYLV-FEFLH-----QDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KPENLL                               G +KL DFG A
Sbjct: 118 FCHSHRVLHRDLKPENLLINT---------------------------EGAIKLADFGLA 150
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 151 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 267
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 268 LHYDPNKRISAKAALAHPFF 287

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVL--HDTVKAR---REVELQLAVGSHKHIVN 73
           I  E+LG G  G+ +++  ++T EV  +K L   D    R   +EV++   +  H +++ 
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLK 71
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
              V   +Y   R L  I E + GG L + I +  D  +   +      +I S + +LH 
Sbjct: 72  FIGV---LYKDKR-LNFITEYIKGGTL-RGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
            NI HRD+   N L  +  +   + + DFG  +      T+P     LK  D      +V
Sbjct: 127 MNIIHRDLNSHNCLVRENKN---VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM 232
            N          PY++APE++    YD+  D++S G+++
Sbjct: 184 GN----------PYWMAPEMINGRSYDEKVDVFSFGIVL 212

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 66
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 67  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL    G                            +KL DFG A
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEG---------------------------AIKLADFGLA 150
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 151 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 267
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 268 LHYDPNKRISAKAALAHPFF 287

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  V A K++H  +K   R ++  +L V    +  
Sbjct: 6   DDFEKISE-LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + +L 
Sbjct: 65  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 154
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           ++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  +  G  P
Sbjct: 155 LIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  V A K++H  +K   R ++  +L V    +  
Sbjct: 6   DDFEKISE-LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + +L 
Sbjct: 65  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 154
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           ++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  +  G  P
Sbjct: 155 LIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  V A K++H  +K   R ++  +L V    +  
Sbjct: 6   DDFEKISE-LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + +L 
Sbjct: 65  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 154
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           ++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  +  G  P
Sbjct: 155 LIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  K +  V A K++H  +K   R ++  +L V    +  
Sbjct: 6   DDFEKISE-LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + +L 
Sbjct: 65  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 154
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           ++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  +  G  P
Sbjct: 155 LIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 66
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 67  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLS 117
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 118 FCHSHRVLHRDLKPQNLLI---------------------------NTEGAIKLADFGLA 150
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 151 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 267
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 268 LHYDPNKRISAKAALAHPFF 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 73
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 74  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 125 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 157
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 158 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 217
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 218 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 274
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 275 LHYDPNKRISAKAALAHPFF 294

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 70
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 71  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 122 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 154
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 155 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 214
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 215 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 271
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 272 LHYDPNKRISAKAALAHPFF 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 70
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 71  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 122 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 154
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 155 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 214
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 215 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 271
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 272 LHYDPNKRISAKAALAHPFF 291

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 65
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 66  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 117 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 149
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 150 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 267 LHYDPNKRISAKAALAHPFF 286

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 66
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 67  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 118 FCHSHRVLHRDLKPQNLLI---------------------------NTEGAIKLADFGLA 150
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 151 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 267
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 268 LHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 65
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 66  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 117 FCHSHRVLHRDLKPQNLLI---------------------------NTEGAIKLADFGLA 149
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 267 LHYDPNKRISAKAALAHPFF 286

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 67
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 68  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL    G                            +KL DFG A
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEG---------------------------AIKLADFGLA 151
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 152 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 212 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 268
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 269 LHYDPNKRISAKAALAHPFF 288

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 69
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 70  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 121 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 153
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 154 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 214 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 270
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 271 LHYDPNKRISAKAALAHPFF 290

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 116/251 (46%), Gaps = 49/251 (19%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA----RREVELQLAVG-----SHKHIV 72
           +++G G  G+V + + K +S    + V   T+KA    ++ V+     G     SH +I+
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E + +  + +++I E M  G L + +++K DG F+  +   ++  I + +K+L 
Sbjct: 110 RL----EGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           + N  HRD+   N+L                     NL         + K++DFG ++ +
Sbjct: 165 NMNYVHRDLAARNILVN------------------SNL---------VCKVSDFGLSRVL 197
Query: 193 VSNKASLQTPCYTPY---YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFF--SNH 246
             +  +  T         + APE +   K+  + D+WS G++M+ ++  G  P++  SNH
Sbjct: 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257
Query: 247 G--QAISPGMK 255
              +AI+ G +
Sbjct: 258 EVMKAINDGFR 268

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 65
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 66  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 117 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 149
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 150 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 267 LHYDPNKRISAKAALAHPFF 286

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 66
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 67  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 118 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 150
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 151 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 267
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 268 LHYDPNKRISAKAALAHPFF 287

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 66
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 67  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 118 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 150
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 151 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 267
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 268 LHYDPNKRISAKAALAHPFF 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 69
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 70  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 121 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 153
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 154 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 214 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 270
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 271 LHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 68
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 69  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 120 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 152
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 153 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 212
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 213 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 269
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 270 LHYDPNKRISAKAALAHPFF 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 66
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 67  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 118 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 150
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 151 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 267
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 268 LHYDPNKRISAKAALAHPFF 287

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 68
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 69  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 120 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 152
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 153 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 212
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 213 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 269
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 270 LHYDPNKRISAKAALAHPFF 289

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 39/235 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           +D+ +   I+G G  G+V    +  T ++YA+K L    +K ++   L L       +V+
Sbjct: 189 NDFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 74  IKDV-----YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
             D          ++    L  I++ M+GG+L   + Q   G F+E +      EI   +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGL 305
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           + +H++ + +RD+KP N+L  + G                            ++++D G 
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGH---------------------------VRISDLGL 338
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPF 242
           A      K        T  Y+APEVL     YD S D +SLG +++ LL G  PF
Sbjct: 339 ACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 39/235 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           +D+ +   I+G G  G+V    +  T ++YA+K L    +K ++   L L       +V+
Sbjct: 189 NDFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 74  IKDV-----YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
             D          ++    L  I++ M+GG+L   + Q   G F+E +      EI   +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGL 305
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           + +H++ + +RD+KP N+L  + G                            ++++D G 
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGH---------------------------VRISDLGL 338
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPF 242
           A      K        T  Y+APEVL     YD S D +SLG +++ LL G  PF
Sbjct: 339 ACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 39/235 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           +D+ +   I+G G  G+V    +  T ++YA+K L    +K ++   L L       +V+
Sbjct: 189 NDFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 74  IKDV-----YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
             D          ++    L  I++ M+GG+L   + Q   G F+E +      EI   +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGL 305
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           + +H++ + +RD+KP N+L  + G                            ++++D G 
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGH---------------------------VRISDLGL 338
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPF 242
           A      K        T  Y+APEVL     YD S D +SLG +++ LL G  PF
Sbjct: 339 ACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 39/235 (16%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHIVN 73
           +D+ +   I+G G  G+V    +  T ++YA+K L    +K ++   L L       +V+
Sbjct: 188 NDFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 246
Query: 74  IKDV-----YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
             D          ++    L  I++ M+GG+L   + Q   G F+E +      EI   +
Sbjct: 247 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGL 304
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           + +H++ + +RD+KP N+L  + G                            ++++D G 
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGH---------------------------VRISDLGL 337
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPF 242
           A      K        T  Y+APEVL     YD S D +SLG +++ LL G  PF
Sbjct: 338 ACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/340 (22%), Positives = 141/340 (41%), Gaps = 75/340 (22%)
Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVY-ALKVLHDTVKARREVELQLAVGSHKHIVNIK 75
           Y+I  + LG G  GKV++ ++ K    + A+K++ +  +       ++ V  H +  +  
Sbjct: 16  YEI-VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 76  DVYENI-------YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI--IMNEICS 126
             +  +       ++G  C  ++ E + G   +  I  KE+G    R   I  +  +IC 
Sbjct: 75  STFRCVQMLEWFEHHGHIC--IVFELL-GLSTYDFI--KENGFLPFRLDHIRKMAYQICK 129
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD-----VKPENLLYTKPGDGGIL 181
           ++ FLH   + H D+KPEN+L+ +         +D+ +     +K +      P     +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQ---------SDYTEAYNPKIKRDERTLINPD----I 176
Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           K+ DFG A     + ++L       +Y APEV+    + + CD+WS+G I+     GF  
Sbjct: 177 KVVDFGSATYDDEHHSTL---VXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF-T 232
Query: 242 FFSNHGQAISPGMKNRI-------------RLGQFDFPNPEWE-------HVSQEAK--- 278
            F  H       M  RI             +   F     +W+       +VS+  K   
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292
Query: 279 --------------TLIKNMLCVDPSERLTIDQVMENKWI 304
                          LI+ ML  DP++R+T+ + +++ + 
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 66
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 67  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL    G                            +KL DFG A
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEG---------------------------AIKLADFGLA 150
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 151 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 267
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 268 LHYDPNKRISAKAALAHPFF 287

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 65
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 66  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 117 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 149
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 267 LHYDPNKRISAKAALAHPFF 286

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 67
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 68  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL    G                            +KL DFG A
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEG---------------------------AIKLADFGLA 151
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 152 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 212 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 268
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 269 LHYDPNKRISAKAALAHPFF 288

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 67
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 68  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL    G                            +KL DFG A
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEG---------------------------AIKLADFGLA 151
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 152 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 211
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 212 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 268
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 269 LHYDPNKRISAKAALAHPFF 288

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 39/229 (17%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQL---AVGSHKHIVNIKDVYEN 80
           +G G  G V ++V K + ++ A+K +  TV  + + +L +    V        I   Y  
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 81  IYNGSRCLLVIMECMHGG--ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIA 137
           ++    C  + ME M     + ++ +    D    E     I      A+  L +   I 
Sbjct: 90  LFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII 148
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRD+KP N+L  + G+                           +KL DFG + ++V + A
Sbjct: 149 HRDIKPSNILLDRSGN---------------------------IKLCDFGISGQLVDSIA 181
Query: 198 SLQTPCYTPYYVAPEVLGPDK----YDKSCDIWSLGVIMYILLCGFPPF 242
             +     P Y+APE + P      YD   D+WSLG+ +Y L  G  P+
Sbjct: 182 KTRDAGCRP-YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYAL-KVLHDT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV AL K+  DT        A RE+ L L   +H +IV 
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 66
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 67  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 118 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 150
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 151 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 210
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 211 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 267
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 268 LHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 129/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYAL-KVLHDT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV AL K+  DT        A RE+ L L   +H +IV 
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 65
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q +++  D  A T     +I   + ++   + 
Sbjct: 66  LLDV---IHTENKLYLV-FEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 117 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 149
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 267 LHYDPNKRISAKAALAHPFF 286

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 54/234 (23%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHI 71
           +S   +G G  G V   ++K++ E  A+K L           +A RE+ L L    H+++
Sbjct: 27  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL-LLLKHMQHENV 85
Query: 72  VNIKDVY------ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
           + + DV+       N Y+      ++M  M        +Q+     F+E +   ++ ++ 
Sbjct: 86  IGLLDVFTPASSLRNFYD----FYLVMPFMQTD-----LQKIMGLKFSEEKIQYLVYQML 136
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +K++H   + HRD+KP NL   +  +                           LK+ D
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCE---------------------------LKILD 169
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG 238
           FG A+      A +     T +Y APEV L    Y+++ DIWS+G IM  +L G
Sbjct: 170 FGLAR---HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 128/320 (40%), Gaps = 76/320 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 69
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFTEREAAII---MNEICSAIK 129
           + DV   I+  ++  LV  E +H     Q ++   D  A T     +I   + ++   + 
Sbjct: 70  LLDV---IHTENKLYLV-FEFLH-----QDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           F H   + HRD+KP+NLL                               G +KL DFG A
Sbjct: 121 FCHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLA 153
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP----- 240
           +       +      T +Y APE+L G   Y  + DIWSLG I   M      FP     
Sbjct: 154 RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 213
Query: 241 ----PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNM 284
                 F   G   + + PG+ +   +  +    P+W           + ++ ++L+  M
Sbjct: 214 DQLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 270
Query: 285 LCVDPSERLTIDQVMENKWI 304
           L  DP++R++    + + + 
Sbjct: 271 LHYDPNKRISAKAALAHPFF 290

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 49/237 (20%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQ--LAVGSHKHIVNIKDVY 78
            + G G  G V    EK T    A+K V+ D     RE+++   LAV  H +IV ++  +
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYF 88
Query: 79  ENIYNGSR---CLLVIMECMHGGELFQRIQQKEDGAFTEREAA-------IIMNEICSAI 128
             +    R    L V+ME  +  +   R  +     +  R+ A       + + ++  +I
Sbjct: 89  YTLGERDRRDIYLNVVME--YVPDTLHRCCRN----YYRRQVAPPPILIKVFLFQLIRSI 142
Query: 129 KFLH--DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
             LH    N+ HRD+KP N+L  +  DG                          LKL DF
Sbjct: 143 GCLHLPSVNVCHRDIKPHNVLVNE-ADG-------------------------TLKLCDF 176
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           G AKK+  ++ ++   C + YY APE + G   Y  + DIWS+G I   ++ G P F
Sbjct: 177 GSAKKLSPSEPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 124/319 (38%), Gaps = 74/319 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 65
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNEICSAIKF 130
           + DV   I+  ++  LV        + F      +  A T     +I   + ++   + F
Sbjct: 66  LLDV---IHTENKLYLVFEHVHQDLKTFM-----DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+KP+NLL                               G +KL DFG A+
Sbjct: 118 CHSHRVLHRDLKPQNLLI---------------------------NTEGAIKLADFGLAR 150
Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP------ 240
                  +      T +Y APE+L G   Y  + DIWSLG I   M      FP      
Sbjct: 151 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210
Query: 241 ---PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNML 285
                F   G   + + PG+ +   +  +    P+W           + ++ ++L+  ML
Sbjct: 211 QLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 286 CVDPSERLTIDQVMENKWI 304
             DP++R++    + + + 
Sbjct: 268 HYDPNKRISAKAALAHPFF 286

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 75/326 (23%), Positives = 131/326 (40%), Gaps = 72/326 (22%)
Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK--ARREVELQLAVGSHKHI 71
           QDDY +  + LG G   +V + +    +E   +K+L    K   +RE+++   +    +I
Sbjct: 36  QDDYQLVRK-LGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNI 94
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           + + D+ ++    SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + 
Sbjct: 95  ITLADIVKD--PVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYC 147
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I HRDVKP N++     +   L+L D+G  +     +  PG    +++        
Sbjct: 148 HSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA------- 193
Query: 192 IVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ-- 248
                        + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H    
Sbjct: 194 -------------SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 240
Query: 249 -----------------------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAK 278
                                   + P      G  +R R  +  F + E +H VS EA 
Sbjct: 241 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEAL 298
Query: 279 TLIKNMLCVDPSERLTIDQVMENKWI 304
             +  +L  D   RLT  + ME+ + 
Sbjct: 299 DFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 131/298 (43%), Gaps = 48/298 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYE 79
           +G G  G+V ++  +KT  V A+K +  +       R  ++L + + SH     ++    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN-IAH 138
            I N    + + ME M  G   ++++++  G   ER    +   I  A+ +L +++ + H
Sbjct: 93  FITNTD--VFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148
Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RDVKP N+L  + G                            +KL DFG + ++V +KA 
Sbjct: 149 RDVKPSNILLDERGQ---------------------------IKLCDFGISGRLVDDKAK 181
Query: 199 LQTPCYTPYYVAPEVLGP-----DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
            ++      Y+APE + P       YD   D+WSLG+ +  L  G  P+     +     
Sbjct: 182 DRS-AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY-----KNCKTD 235
Query: 254 MKNRIRLGQFDFP-NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV 310
            +   ++ Q + P  P     S + ++ +K+ L  D  +R   ++++E+ +I ++  +
Sbjct: 236 FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL 293

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 131/300 (43%), Gaps = 43/300 (14%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREV---ELQLAVGSHKHIVNIKDVYE 79
           +LG G  G+V++      S  YA+K +  T +    +    + LA  +H+++V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 80  NIYNGSR---------CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
              N  +          L + ME      L+  I   E+      E   +  +I  A+ +
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHS-ENLNQQRDEYWRLFRQILEALSY 131
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           +H Q I HRD+KP N+   +  +   +K+ DFG  K  +          ILKL     ++
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRN---VKIGDFGLAKNVH------RSLDILKLD----SQ 178
Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
            +  +  +L +   T  YVA EVL G   Y++  D++SLG+I + ++  F          
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF---------- 228
Query: 250 ISPGMKN-----RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            S GM+      ++R    +FP    ++  +  K +I+ ++  DP++R     ++ + W+
Sbjct: 229 -STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 116/258 (44%), Gaps = 56/258 (21%)
Query: 22  EILGLGINGKV----LQIVEKKTSEVY-ALKVLHD--TVKARREVELQLAVGS---HKHI 71
           +++G G  G+V    L++  K+  E++ A+K L    T K RR+   + ++     H ++
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKR--EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           +++    E +   S  +++I E M  G L   ++Q  DG FT  +   ++  I + +K+L
Sbjct: 97  IHL----EGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYL 151
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
            D N  HRD+   N+L                     NL         + K++DFG ++ 
Sbjct: 152 ADMNYVHRDLAARNILVNS------------------NL---------VCKVSDFGLSRF 184
Query: 192 IVSNKASLQTPCYTPY--------YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
           +  + +    P YT          + APE +   K+  + D+WS G++M+ ++  G  P+
Sbjct: 185 LEDDTSD---PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 241
Query: 243 FSNHGQAISPGMKNRIRL 260
           +    Q +   ++   RL
Sbjct: 242 WDMTNQDVINAIEQDYRL 259

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARHT 175
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
               A       T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 176 DDEMAGF---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 36/231 (15%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVGSHKHIV 72
           DD++  +E LG G  G V ++  + +  + A K++H  +K   R ++  +L V    +  
Sbjct: 16  DDFERISE-LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 74
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            I   Y   Y+    + + ME M GG L Q +  KE     E     +   +   + +L 
Sbjct: 75  YIVGFYGAFYSDGE-ISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 133 DQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           +++ I HRDVKP N+L    G+                           +KL DFG + +
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQ 164
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           ++ + A+  +   T  Y+APE L    Y    DIWS+G+ +  L  G  P 
Sbjct: 165 LIDSMAN--SFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 86  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 138
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 139 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARHT 171
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
               A       T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 172 DDEMAGF---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 226
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 227 QLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFAN-VFIGANPLAVDLLEKML 285
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 286 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 316

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARHT 175
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
               A       T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 176 DDEMAGF---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 38/226 (16%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH------KHIVNIK 75
           +++G G  G+V++  + K  +  ALK++ +  +  R+   ++ +  H       + +N+ 
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 76  DVYENI-YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            + EN  +    C+   +  M+   L++ I++ +   F+        + I   +  LH  
Sbjct: 163 HMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I H                         D+KPEN+L  + G  GI K+ DFG +     
Sbjct: 220 RIIH------------------------CDLKPENILLKQQGRSGI-KVIDFGSS---CY 251
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
               + T   + +Y APEV+   +Y    D+WSLG I+  LL G+P
Sbjct: 252 EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 38/226 (16%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH------KHIVNIK 75
           +++G G  G+V++  + K  +  ALK++ +  +  R+   ++ +  H       + +N+ 
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 76  DVYENI-YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            + EN  +    C+   +  M+   L++ I++ +   F+        + I   +  LH  
Sbjct: 163 HMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I H                         D+KPEN+L  + G  GI K+ DFG +     
Sbjct: 220 RIIH------------------------CDLKPENILLKQQGRSGI-KVIDFGSS---CY 251
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
               + T   + +Y APEV+   +Y    D+WSLG I+  LL G+P
Sbjct: 252 EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 113/259 (43%), Gaps = 58/259 (22%)
Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHD--TVKARREVELQLAVGS---HKHIV 72
           E++G G  G+V    L+   KK S V A+K L    T + RRE   + ++     H +I+
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCV-AIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGEL--FQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
            ++ V  N    S  ++++ E M  G L  F R+    DG FT  +   ++  I S +++
Sbjct: 79  RLEGVVTN----SMPVMILTEFMENGALDSFLRLN---DGQFTVIQLVGMLRGIASGMRY 131
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           L + +  HRD+   N+L                     NL         + K++DFG ++
Sbjct: 132 LAEMSYVHRDLAARNILVNS------------------NL---------VCKVSDFGLSR 164
Query: 191 KIVSNKASLQTPCYTP--------YYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
            +  N +    P YT          + APE +   K+  + D WS G++M+ ++  G  P
Sbjct: 165 FLEENSSD---PTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221
Query: 242 FFSNHGQAISPGMKNRIRL 260
           ++    Q +   ++   RL
Sbjct: 222 YWDMSNQDVINAIEQDYRL 240

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 51/113 (45%), Gaps = 28/113 (24%)
Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           +M ++   + FLH   + HRD+KP+N+L T  G                           
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-------------------------- 158
Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM 232
            +KL DFG A +I S + +L +   T +Y APEVL    Y    D+WS+G I 
Sbjct: 159 -IKLADFGLA-RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 209

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 54/123 (43%), Gaps = 28/123 (22%)
Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           +M ++   + FLH   + HRD+KP+N+L T  G                           
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-------------------------- 158
Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
            +KL DFG A +I S + +L +   T +Y APEVL    Y    D+WS+G I   +    
Sbjct: 159 -IKLADFGLA-RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
Query: 240 PPF 242
           P F
Sbjct: 217 PLF 219

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 99/233 (42%), Gaps = 46/233 (19%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALK-VLHDTVK-----ARREVELQLAVGSHKHIVNIK 75
           E LG G    V + + K T    ALK V  D+ +     A RE+ L   +  H++IV + 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLY 69
Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEICSAIKF 130
           DV   I+  ++  LV  E M   +L + +  +  G  T R   +        ++   + F
Sbjct: 70  DV---IHTENKLTLVF-EFM-DNDLKKYMDSRTVGN-TPRGLELNLVKYFQWQLLQGLAF 123
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H+  I HRD+KP+NLL  K G                            LKL DFG A+
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQ---------------------------LKLGDFGLAR 156
Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
                  +  +   T +Y AP+VL G   Y  S DIWS G I+  ++ G P F
Sbjct: 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 54/123 (43%), Gaps = 28/123 (22%)
Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           +M ++   + FLH   + HRD+KP+N+L T  G                           
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-------------------------- 158
Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
            +KL DFG A +I S + +L +   T +Y APEVL    Y    D+WS+G I   +    
Sbjct: 159 -IKLADFGLA-RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
Query: 240 PPF 242
           P F
Sbjct: 217 PLF 219

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 79/319 (24%), Positives = 124/319 (38%), Gaps = 74/319 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 69
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNEICSAIKF 130
           + DV   I+  ++  LV        + F      +  A T     +I   + ++   + F
Sbjct: 70  LLDV---IHTENKLYLVFEFLSMDLKKFM-----DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+KPENLL                               G +KL DFG A+
Sbjct: 122 CHSHRVLHRDLKPENLLINT---------------------------EGAIKLADFGLAR 154
Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP------ 240
                  +      T +Y APE+L G   Y  + DIWSLG I   M      FP      
Sbjct: 155 AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 214
Query: 241 ---PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNML 285
                F   G   + + PG+ +   +  +    P+W           + ++ ++L+  ML
Sbjct: 215 QLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 286 CVDPSERLTIDQVMENKWI 304
             DP++R++    + + + 
Sbjct: 272 HYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 79/319 (24%), Positives = 124/319 (38%), Gaps = 74/319 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 67
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNEICSAIKF 130
           + DV   I+  ++  LV        + F      +  A T     +I   + ++   + F
Sbjct: 68  LLDV---IHTENKLYLVFEFLSMDLKKFM-----DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+KPENLL    G                            +KL DFG A+
Sbjct: 120 CHSHRVLHRDLKPENLLINTEG---------------------------AIKLADFGLAR 152
Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP------ 240
                  +      T +Y APE+L G   Y  + DIWSLG I   M      FP      
Sbjct: 153 AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 212
Query: 241 ---PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNML 285
                F   G   + + PG+ +   +  +    P+W           + ++ ++L+  ML
Sbjct: 213 QLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 269
Query: 286 CVDPSERLTIDQVMENKWI 304
             DP++R++    + + + 
Sbjct: 270 HYDPNKRISAKAALAHPFF 288

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 56/289 (19%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYEN 80
           E++G G  G V +  + +  +V   ++  ++ +    VEL QL+  +H +IV +     N
Sbjct: 14  EVVGRGAFGVVCK-AKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS-AIKFLHD---QNI 136
                 CL  +ME   GG L+  +   E   +     A+     CS  + +LH    + +
Sbjct: 73  ----PVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI---- 192
            HRD+KP NLL                              G +LK+ DFG A  I    
Sbjct: 127 IHRDLKPPNLLLV--------------------------AGGTVLKICDFGTACDIQTHM 160
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            +NK S         ++APEV     Y + CD++S G+I++ ++    PF    G A   
Sbjct: 161 TNNKGSAA-------WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-- 211
Query: 253 GMKNRIRLGQFDFPNPEW-EHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
               RI     +   P   +++ +  ++L+      DPS+R +++++++
Sbjct: 212 ----RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 124/319 (38%), Gaps = 74/319 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 69
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNEICSAIKF 130
           + DV   I+  ++  LV        + F      +  A T     +I   + ++   + F
Sbjct: 70  LLDV---IHTENKLYLVFEHVDQDLKKFM-----DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+KP+NLL                               G +KL DFG A+
Sbjct: 122 CHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLAR 154
Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP------ 240
                  +      T +Y APE+L G   Y  + DIWSLG I   M      FP      
Sbjct: 155 AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 214
Query: 241 ---PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNML 285
                F   G   + + PG+ +   +  +    P+W           + ++ ++L+  ML
Sbjct: 215 QLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 286 CVDPSERLTIDQVMENKWI 304
             DP++R++    + + + 
Sbjct: 272 HYDPNKRISAKAALAHPFF 290

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 56/289 (19%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL-QLAVGSHKHIVNIKDVYEN 80
           E++G G  G V +  + +  +V   ++  ++ +    VEL QL+  +H +IV +     N
Sbjct: 15  EVVGRGAFGVVCK-AKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS-AIKFLHD---QNI 136
                 CL  +ME   GG L+  +   E   +     A+     CS  + +LH    + +
Sbjct: 74  ----PVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI---- 192
            HRD+KP NLL                              G +LK+ DFG A  I    
Sbjct: 128 IHRDLKPPNLLLV--------------------------AGGTVLKICDFGTACDIQTHM 161
Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
            +NK S         ++APEV     Y + CD++S G+I++ ++    PF    G A   
Sbjct: 162 TNNKGSAA-------WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-- 212
Query: 253 GMKNRIRLGQFDFPNPEW-EHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
               RI     +   P   +++ +  ++L+      DPS+R +++++++
Sbjct: 213 ----RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKXQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDXE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 45/212 (21%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 37  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 94
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIM----NEICSAIKFLHDQNIAHRDVKPENLL 147
           ME +  G L   +Q     A  ER   I +    ++IC  +++L  +   HRD+   N+L
Sbjct: 95  MEYLPYGSLRDYLQ-----AHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL 149
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYT 205
                            V+ EN +          K+ DFG  K +  +K    ++ P  +
Sbjct: 150 -----------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 206 P-YYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
           P ++ APE L   K+  + D+WS GV++Y L 
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 131/303 (43%), Gaps = 44/303 (14%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARREVELQLAVGSHKHIVNIKDV 77
           +S +ILG G +G V+     +   V   ++L D    A  E++L      H +++     
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIR---- 73
Query: 78  YENIYNGSRCLLVIMEC--MHGGELFQRIQQKEDGAFTEREAAII--MNEICSAIKFLHD 133
           Y       R L + +E   ++  +L +     ++    ++E   I  + +I S +  LH 
Sbjct: 74  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             I HRD+KP+N+L +        + T       ENL          + ++DFG  KK+ 
Sbjct: 134 LKIIHRDLKPQNILVSTSS-----RFTADQQTGAENLR---------ILISDFGLCKKLD 179
Query: 194 SNKASLQT----PCYTPYYVAPEVLGPD-------KYDKSCDIWSLGVIMYILLC-GFPP 241
           S ++S +T    P  T  + APE+L          +  +S DI+S+G + Y +L  G  P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQV 298
           F   + +       N IR G F     +  H   +  EA  LI  M+  DP +R T  +V
Sbjct: 240 FGDKYSRE-----SNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
Query: 299 MEN 301
           + +
Sbjct: 294 LRH 296

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 110 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 162
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 163 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 194
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 195 --TDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 250
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 251 QLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKML 309
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 310 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 340

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/324 (22%), Positives = 135/324 (41%), Gaps = 68/324 (20%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNIKD 76
           +G G  G V   V+ +T    A+K L+          +A RE+ L L    H++++ + D
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL-LKHMRHENVIGLLD 91
Query: 77  VY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           V+  +   +      ++M  M G +L + ++ ++ G   E     ++ ++   ++++H  
Sbjct: 92  VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLG---EDRIQFLVYQMLKGLRYIHAA 147
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KP NL   +  +                           LK+ DFG A++  S
Sbjct: 148 GIIHRDLKPGNLAVNEDCE---------------------------LKILDFGLARQADS 180
Query: 195 NKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNHGQAI-- 250
               +     T +Y APEV L   +Y ++ DIWS+G IM  ++ G   F  S+H   +  
Sbjct: 181 E---MXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 237
Query: 251 ------SPGMKNRIRLGQFDFPN-----PEWE---------HVSQEAKTLIKNMLCVDPS 290
                 +P  +   RL   +  N     PE E         + S  A  L++ ML +D  
Sbjct: 238 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 297
Query: 291 ERLTIDQVMENKWISQFNQVPQTP 314
           +R+T  + + + +    +     P
Sbjct: 298 QRVTAGEALAHPYFESLHDTEDEP 321

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 37  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 94
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L + +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 95  MEFLPYGSLREYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 149
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 150 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 92  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 144
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 145 SADIIHRDLKPSNLAVNEDSE---------------------------LKILDFGLARH- 176
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 177 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 232
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 233 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 291
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 292 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 322

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 96  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 148
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 149 SADIIHRDLKPSNLAVNEDSE---------------------------LKILDFGLARH- 180
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 181 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 236
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 237 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 295
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 296 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 326

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALK-VLHDT------VKARREVELQLAVGSHKHIVNIKD 76
           +G G  G+V +   +KT +  ALK VL +       + A RE+++ L +  H+++VN+ +
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLKHENVVNLIE 84
Query: 77  VYE---NIYNGSRC----LLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +     + YN  RC     LV   C H    L   +  K    FT  E   +M  + + +
Sbjct: 85  ICRTKASPYN--RCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGL 138
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            ++H   I HRD+K  N+L T+    G+LKL DFG  +                   F  
Sbjct: 139 YYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARA------------------FSL 177
Query: 189 AKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIM 232
           AK    N+        T +Y  PE +LG   Y    D+W  G IM
Sbjct: 178 AKNSQPNR--YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 38/227 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL---HDTV----KARREVELQLAVGSHKHIVNIKD 76
           LG G  G+V + ++  T+E  A+K +   H+       A REV L L    H++I+ +K 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSL-LKELQHRNIIELKS 100
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V   I++  R  L+     +  +L + + +  D +   R     + ++ + + F H +  
Sbjct: 101 V---IHHNHRLHLIFEYAEN--DLKKYMDKNPDVSM--RVIKSFLYQLINGVNFCHSRRC 153
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KP+NLL         L ++D  +               +LK+ DFG A+      
Sbjct: 154 LHRDLKPQNLL---------LSVSDASETP-------------VLKIGDFGLARAFGIPI 191
Query: 197 ASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
                   T +Y  PE+L G   Y  S DIWS+  I   +L   P F
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKXQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 109 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 161
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 162 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 193
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 194 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 249
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 250 QLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKML 308
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 309 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 339

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 110 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 162
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 163 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 194
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 195 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 250
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 251 QLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKML 309
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 310 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 340

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 100 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 152
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 153 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 184
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 185 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 240
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 241 QLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKML 299
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 300 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 330

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 86  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 138
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 139 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 170
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 171 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 226
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 227 QLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFAN-VFIGANPLAVDLLEKML 285
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 286 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 316

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 139/331 (41%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 97  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 149
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 150 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARHT 182
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                       T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 183 ADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 237
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 296
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 297 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 327

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 95  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 147
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 148 SADIIHRDLKPSNLAVNEDXE---------------------------LKILDFGLARH- 179
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 180 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 235
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 236 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 294
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 295 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 325

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 38/226 (16%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH------KHIVNIK 75
           +++G G  G+V++  + K  +  ALK++ +  +  R+   ++ +  H       + +N+ 
Sbjct: 103 KVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 76  DVYENI-YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            + EN  +    C+   +  M+   L++ I++ +   F+        + I   +  LH  
Sbjct: 163 HMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I H                         D+KPEN+L  + G  GI K+ DFG +     
Sbjct: 220 RIIH------------------------CDLKPENILLKQQGRSGI-KVIDFGSS---CY 251
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
               +     + +Y APEV+   +Y    D+WSLG I+  LL G+P
Sbjct: 252 EHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 139/331 (41%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 97  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 149
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 150 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARHT 182
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                       T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 183 ADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 237
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 296
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 297 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 327

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 139/331 (41%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 97  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 149
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 150 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARHT 182
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                       T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 183 ADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 237
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 296
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 297 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 327

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 129/299 (43%), Gaps = 40/299 (13%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARREVELQLAVGSHKHIVNIKDV 77
           +S +ILG G +G V+     +   V   ++L D    A  E++L      H +++     
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIR---- 91
Query: 78  YENIYNGSRCLLVIMEC--MHGGELFQRIQQKEDGAFTEREAAII--MNEICSAIKFLHD 133
           Y       R L + +E   ++  +L +     ++    ++E   I  + +I S +  LH 
Sbjct: 92  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             I HRD+KP+N+L +        + T       ENL          + ++DFG  KK+ 
Sbjct: 152 LKIIHRDLKPQNILVSTSS-----RFTADQQTGAENLR---------ILISDFGLCKKLD 197
Query: 194 SN----KASLQTPCYTPYYVAPEVLGPD---KYDKSCDIWSLG-VIMYILLCGFPPFFSN 245
           S     + +L  P  T  + APE+L      +  +S DI+S+G V  YIL  G  PF   
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 257
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           + +       N IR G F     +  H   +  EA  LI  M+  DP +R T  +V+ +
Sbjct: 258 YSRE-----SNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 41  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 98
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 99  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 153
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 154 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 190
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 191 YAPESLTESKFSVASDVWSFGVVLYELF 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 101 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 153
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 154 SADIIHRDLKPSNLAVNEDXE---------------------------LKILDFGLARH- 185
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 186 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 241
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 242 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 300
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 301 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 331

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 65  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 122
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 123 MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 177
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 178 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 214
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELF 242

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 34  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 91
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 92  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 146
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 147 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 37  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 94
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 95  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 149
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 150 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 129/299 (43%), Gaps = 40/299 (13%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARREVELQLAVGSHKHIVNIKDV 77
           +S +ILG G +G V+     +   V   ++L D    A  E++L      H +++     
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIR---- 91
Query: 78  YENIYNGSRCLLVIMEC--MHGGELFQRIQQKEDGAFTEREAAII--MNEICSAIKFLHD 133
           Y       R L + +E   ++  +L +     ++    ++E   I  + +I S +  LH 
Sbjct: 92  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             I HRD+KP+N+L +        + T       ENL          + ++DFG  KK+ 
Sbjct: 152 LKIIHRDLKPQNILVSTSS-----RFTADQQTGAENLR---------ILISDFGLCKKLD 197
Query: 194 SN----KASLQTPCYTPYYVAPEVLGPD---KYDKSCDIWSLG-VIMYILLCGFPPFFSN 245
           S     + +L  P  T  + APE+L      +  +S DI+S+G V  YIL  G  PF   
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 257
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           + +       N IR G F     +  H   +  EA  LI  M+  DP +R T  +V+ +
Sbjct: 258 YSRE-----SNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 310

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 96  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 148
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 149 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 180
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 181 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 236
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 237 QLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKML 295
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 296 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 326

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/331 (21%), Positives = 139/331 (41%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKSQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG  +  
Sbjct: 143 SADIIHRDLKPSNLAVNEDSE---------------------------LKILDFGLCRH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALK-VLHDT------VKARREVELQLAVGSHKHIVNIKD 76
           +G G  G+V +   +KT +  ALK VL +       + A RE+++ L +  H+++VN+ +
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLKHENVVNLIE 83
Query: 77  VYE---NIYNGSRC----LLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +     + YN  RC     LV   C H    L   +  K    FT  E   +M  + + +
Sbjct: 84  ICRTKASPYN--RCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGL 137
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            ++H   I HRD+K  N+L T+    G+LKL DFG  +                   F  
Sbjct: 138 YYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARA------------------FSL 176
Query: 189 AKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIM 232
           AK    N+        T +Y  PE +LG   Y    D+W  G IM
Sbjct: 177 AKNSQPNR--YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALK-VLHDT------VKARREVELQLAVGSHKHIVNIKD 76
           +G G  G+V +   +KT +  ALK VL +       + A RE+++ L +  H+++VN+ +
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLKHENVVNLIE 84
Query: 77  VYE---NIYNGSRC----LLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +     + YN  RC     LV   C H    L   +  K    FT  E   +M  + + +
Sbjct: 85  ICRTKASPYN--RCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGL 138
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            ++H   I HRD+K  N+L T+    G+LKL DFG  +                   F  
Sbjct: 139 YYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARA------------------FSL 177
Query: 189 AKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIM 232
           AK    N+        T +Y  PE +LG   Y    D+W  G IM
Sbjct: 178 AKNSQPNR--YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 39  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 96
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 97  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 151
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 152 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 188
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 189 YAPESLTESKFSVASDVWSFGVVLYELF 216

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 124/319 (38%), Gaps = 74/319 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 69
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNEICSAIKF 130
           + DV   I+  ++  LV        + F      +  A T     +I   + ++   + F
Sbjct: 70  LLDV---IHTENKLYLVFEFLSMDLKDFM-----DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+KP+NLL                               G +KL DFG A+
Sbjct: 122 CHSHRVLHRDLKPQNLLINT---------------------------EGAIKLADFGLAR 154
Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP------ 240
                  +      T +Y APE+L G   Y  + DIWSLG I   M      FP      
Sbjct: 155 AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 214
Query: 241 ---PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNML 285
                F   G   + + PG+ +   +  +    P+W           + ++ ++L+  ML
Sbjct: 215 QLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 271
Query: 286 CVDPSERLTIDQVMENKWI 304
             DP++R++    + + + 
Sbjct: 272 HYDPNKRISAKAALAHPFF 290

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 52  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 109
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 110 MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 164
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 165 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 202 YAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 52  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 109
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 110 MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 164
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 165 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 202 YAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALK-VLHDT------VKARREVELQLAVGSHKHIVNIKD 76
           +G G  G+V +   +KT +  ALK VL +       + A RE+++ L +  H+++VN+ +
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLKHENVVNLIE 84
Query: 77  VYE---NIYNGSRC----LLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           +     + YN  RC     LV   C H    L   +  K    FT  E   +M  + + +
Sbjct: 85  ICRTKASPYN--RCKASIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGL 138
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            ++H   I HRD+K  N+L T+    G+LKL DFG  +                   F  
Sbjct: 139 YYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARA------------------FSL 177
Query: 189 AKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIM 232
           AK    N+        T +Y  PE +LG   Y    D+W  G IM
Sbjct: 178 AKNSQPNR--YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 42/238 (17%)
Query: 16  DYDISTEI--------LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS 67
           DY+   E+        LG G  G+V ++ +K+T    A+K +   ++  R  EL    G 
Sbjct: 85  DYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR--LEVFRAEELMACAGL 142
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
                 I  +Y  +  G   + + ME + GG L Q +  KE G   E  A   + +    
Sbjct: 143 TS--PRIVPLYGAVREGP-WVNIFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQALEG 197
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +++LH + I H DVK +N+L +   DG    L DFG                 + L   G
Sbjct: 198 LEYLHSRRILHGDVKADNVLLSS--DGSHAALCDFGHA---------------VCLQPDG 240
Query: 188 FAKKIVSNKASLQTPCYTP---YYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
             K +++         Y P    ++APEV+     D   D+WS   +M  +L G  P+
Sbjct: 241 LGKSLLTGD-------YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 95  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 147
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 148 SADIIHRDLKPSNLAVNEDXE---------------------------LKILDFGLARH- 179
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 180 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 235
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 236 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 294
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 295 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 325

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 34  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 91
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 92  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 146
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 147 -------------VENENRV----------KIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 34  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 91
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 92  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 146
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 147 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 40  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 97
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 98  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 152
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 153 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 189
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 190 YAPESLTESKFSVASDVWSFGVVLYELF 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 32  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 89
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 90  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 144
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 145 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 181
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 182 YAPESLTESKFSVASDVWSFGVVLYELF 209

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/331 (22%), Positives = 141/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +  IL                   DGG+ + TD      +
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKIL-------------------DGGLARHTDDEMTGYV 183
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                       T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 184 A-----------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 38  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 95
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 96  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 150
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 151 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 187
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 188 YAPESLTESKFSVASDVWSFGVVLYELF 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 33  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 90
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HRD+   N+L    
Sbjct: 91  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---- 145
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 146 -------------VENENRV----------KIGDFGLTKVLPQDKEXXKVKEPGESPIFW 182
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 183 YAPESLTESKFSVASDVWSFGVVLYELF 210

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 102 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 154
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 155 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 186
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 187 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 242
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 243 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 301
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 302 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 332

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 109 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 161
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 162 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 193
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 194 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 249
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 250 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 308
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 309 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 339

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 124/319 (38%), Gaps = 74/319 (23%)
Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLH-DT------VKARREVELQLAVGSHKHIVN 73
            E +G G  G V +   K T EV ALK +  DT        A RE+ L L   +H +IV 
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVK 68
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII---MNEICSAIKF 130
           + DV   I+  ++  LV        + F      +  A T     +I   + ++   + F
Sbjct: 69  LLDV---IHTENKLYLVFEFLSMDLKDFM-----DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   + HRD+KP+NLL    G                            +KL DFG A+
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEG---------------------------AIKLADFGLAR 153
Query: 191 KIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVI---MYILLCGFP------ 240
                  +      T +Y APE+L G   Y  + DIWSLG I   M      FP      
Sbjct: 154 AFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 213
Query: 241 ---PFFSNHG---QAISPGMKNRIRLGQFDFPNPEWEH---------VSQEAKTLIKNML 285
                F   G   + + PG+ +   +  +    P+W           + ++ ++L+  ML
Sbjct: 214 QLFRIFRTLGTPDEVVWPGVTS---MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 270
Query: 286 CVDPSERLTIDQVMENKWI 304
             DP++R++    + + + 
Sbjct: 271 HYDPNKRISAKAALAHPFF 289

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 139/331 (41%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++  +    T+     ++ +I   +K++H
Sbjct: 86  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCAK---LTDDHVQFLIYQILRGLKYIH 138
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 139 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 170
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 171 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 226
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 227 QLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFAN-VFIGANPLAVDLLEKML 285
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 286 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 316

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 110 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 162
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 163 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 194
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 195 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 250
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 251 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 309
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 310 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 340

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 92  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 144
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 145 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 176
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 177 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 232
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 233 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 291
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 292 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 322

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 92  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 144
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 145 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 176
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 177 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 232
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 233 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 291
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 292 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 322

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 101 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 153
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 154 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 185
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 186 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 241
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 242 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 300
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 301 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 331

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 102 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 154
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 155 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 186
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 187 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 242
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 243 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 301
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 302 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 332

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 102 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 154
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 155 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 186
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 187 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 242
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 243 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 301
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 302 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 332

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 96  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 148
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 149 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 180
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 181 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 236
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 237 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 295
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 296 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 326

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 87  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 139
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 140 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 171
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 172 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 227
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 228 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 286
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 287 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 317

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 113 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 165
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 166 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 197
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 198 --TDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 253
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 254 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 312
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 313 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 343

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 88  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 140
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 141 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 172
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 173 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 228
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 229 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKML 287
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 288 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 318

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 42/238 (17%)
Query: 16  DYDISTEI--------LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS 67
           DY+   E+        LG G  G+V ++ +K+T    A+K +   ++  R  EL    G 
Sbjct: 66  DYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVR--LEVFRAEELMACAGL 123
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
                 I  +Y  +  G   + + ME + GG L Q +  KE G   E  A   + +    
Sbjct: 124 TS--PRIVPLYGAVREGP-WVNIFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQALEG 178
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +++LH + I H DVK +N+L +   DG    L DFG                 + L   G
Sbjct: 179 LEYLHSRRILHGDVKADNVLLSS--DGSHAALCDFGHA---------------VCLQPDG 221
Query: 188 FAKKIVSNKASLQTPCYTP---YYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
             K +++         Y P    ++APEV+     D   D+WS   +M  +L G  P+
Sbjct: 222 LGKDLLTGD-------YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 101/243 (41%), Gaps = 52/243 (21%)
Query: 16  DYDISTEI--------LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREV----ELQL 63
           DY+   E+        LG G  G+V ++ +K+T    A+K      K R EV    EL  
Sbjct: 64  DYEYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVK------KVRLEVFRVEELVA 117
Query: 64  AVG-SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
             G S   IV +   Y  +  G   + + ME + GG L Q I+Q   G   E  A   + 
Sbjct: 118 CAGLSSPRIVPL---YGAVREGPW-VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLG 171
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +    +++LH + I H DVK +N+L +   DG    L DFG                 L 
Sbjct: 172 QALEGLEYLHTRRILHGDVKADNVLLSS--DGSRAALCDFGHA---------------LC 214
Query: 183 LTDFGFAKKIVSNKASLQTPCYTP---YYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
           L   G  K       SL T  Y P    ++APEV+     D   DIWS   +M  +L G 
Sbjct: 215 LQPDGLGK-------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 267
Query: 240 PPF 242
            P+
Sbjct: 268 HPW 270

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 92  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 144
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 145 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 176
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 177 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 232
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 233 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 291
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 292 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 322

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 95  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 147
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 148 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 179
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 180 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 235
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 236 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 294
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 295 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 325

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 95  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 147
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 148 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 179
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 180 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 235
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 236 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 294
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 295 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 325

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 89  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 141
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 142 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 173
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 174 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 229
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 230 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 288
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 289 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 319

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 113 F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 165
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 166 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 197
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 198 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 253
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 254 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 312
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 313 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 343

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 86  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 138
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 139 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 170
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 171 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 226
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 227 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKML 285
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 286 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 316

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 87  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 139
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 140 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 171
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 172 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 227
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 228 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 286
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 287 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 317

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 97  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 149
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 150 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 181
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 182 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 237
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 296
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 297 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 327

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 16/222 (7%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ------LAVGSHKHIVNIKDV 77
           +G G  G+VL        + YA+KV+ +  K  R  +++      +      +   +K  
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
            + +Y    CL  I E + G  L++ I +     F   +  +   EI  A+ +L   ++ 
Sbjct: 103 GKFMYYDHMCL--IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLT 159
Query: 138 HRDVKPENLLYTKP-GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
           H D+KPEN+L   P  +  ++ +    D K   +  TK      +KL DFG A       
Sbjct: 160 HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG---IKLIDFGCATFKSDYH 216
Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG 238
            S+     T  Y APEV+    +D S D+WS G ++  L  G
Sbjct: 217 GSIIN---TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 96  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 148
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DFG A+  
Sbjct: 149 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFGLARH- 180
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 181 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 236
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 237 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 295
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 296 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 326

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 52/208 (25%)
Query: 120 IMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           I+  + ++  ++H++ NI HRDVKP N+L  K    G +KL+DFG+              
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMDK---NGRVKLSDFGE-------------- 198
Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKS-CDIWSLGVIMYILL 236
                +++   KKI  ++ + +       ++ PE    +  Y+ +  DIWSLG+ +Y++ 
Sbjct: 199 -----SEYMVDKKIKGSRGTYE-------FMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
Query: 237 CGFPPFFSNHGQAIS-PGMKNRIRLGQFDFP---------------NPEWEHVSQEAKTL 280
               PF       IS   + N IR    ++P                     +S E    
Sbjct: 247 YNVVPF----SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF 302
Query: 281 IKNMLCVDPSERLTIDQVMENKWISQFN 308
           +K  L  +P+ER+T +  ++++W++  N
Sbjct: 303 LKLFLRKNPAERITSEDALKHEWLADTN 330

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 109/253 (43%), Gaps = 48/253 (18%)
Query: 22  EILGLGINGKVLQ---IVEKKTSEVYALKVLHD--TVKARREVELQLAVGS---HKHIVN 73
           +++G+G  G+V      V  K     A+K L    T K RR+   + ++     H +I++
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +    E +    + +++I E M  G L     +K DG FT  +   ++  I S +K+L D
Sbjct: 95  L----EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD 149
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-----PENLLYTKPGDGGILKLTDFGF 188
            +  HRD+   N+L        + K++DFG  +     PE    T+   GG + +     
Sbjct: 150 MSAVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTR---GGKIPIR---- 199
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHG 247
                              + APE +   K+  + D+WS G++M+ ++  G  P++    
Sbjct: 200 -------------------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 240
Query: 248 QAISPGMKNRIRL 260
           Q +   ++   RL
Sbjct: 241 QDVIKAIEEGYRL 253

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 115/258 (44%), Gaps = 56/258 (21%)
Query: 22  EILGLGINGKV----LQIVEKKTSEVY-ALKVLHD--TVKARREVELQLAVGS---HKHI 71
           +++G G  G+V    L++  K+  E++ A+K L    T K RR+   + ++     H ++
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKR--EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           +++    E +   S  +++I E M  G L   ++Q  DG FT  +   ++  I + +K+L
Sbjct: 71  IHL----EGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYL 125
Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
            D N  HR +   N+L                     NL         + K++DFG ++ 
Sbjct: 126 ADMNYVHRALAARNILVN------------------SNL---------VCKVSDFGLSRF 158
Query: 192 IVSNKASLQTPCYTPY--------YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
           +  + +    P YT          + APE +   K+  + D+WS G++M+ ++  G  P+
Sbjct: 159 LEDDTSD---PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 215
Query: 243 FSNHGQAISPGMKNRIRL 260
           +    Q +   ++   RL
Sbjct: 216 WDMTNQDVINAIEQDYRL 233

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 111/251 (44%), Gaps = 46/251 (18%)
Query: 23  ILGLGINGKV----LQIVEKKTSEVYALKVLH--DTVKARREVELQLAVGS---HKHIVN 73
           ++G G  G+V    L++  K+   V A+K L    T K RR+   + ++     H ++V+
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAV-AIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +    E +    + +++++E M  G L     +K DG FT  +   ++  I + +++L D
Sbjct: 109 L----EGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLAD 163
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
               HRD+   N+L                     NL         + K++DFG ++ I 
Sbjct: 164 MGYVHRDLAARNILVNS------------------NL---------VCKVSDFGLSRVIE 196
Query: 194 SNKASLQTPC---YTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQA 249
            +  ++ T         + APE +   K+  + D+WS G++M+ ++  G  P++    Q 
Sbjct: 197 DDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 256
Query: 250 ISPGMKNRIRL 260
           +   ++   RL
Sbjct: 257 VIKAIEEGYRL 267

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 109/253 (43%), Gaps = 48/253 (18%)
Query: 22  EILGLGINGKVLQ---IVEKKTSEVYALKVLHD--TVKARREVELQLAVGS---HKHIVN 73
           +++G+G  G+V      V  K     A+K L    T K RR+   + ++     H +I++
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +    E +    + +++I E M  G L     +K DG FT  +   ++  I S +K+L D
Sbjct: 74  L----EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD 128
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-----PENLLYTKPGDGGILKLTDFGF 188
            +  HRD+   N+L        + K++DFG  +     PE    T+   GG + +     
Sbjct: 129 MSYVHRDLAARNILVN---SNLVCKVSDFGMSRVLEDDPEAAYTTR---GGKIPIR---- 178
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHG 247
                              + APE +   K+  + D+WS G++M+ ++  G  P++    
Sbjct: 179 -------------------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 219
Query: 248 QAISPGMKNRIRL 260
           Q +   ++   RL
Sbjct: 220 QDVIKAIEEGYRL 232

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 109/253 (43%), Gaps = 48/253 (18%)
Query: 22  EILGLGINGKVLQ---IVEKKTSEVYALKVLHD--TVKARREVELQLAVGS---HKHIVN 73
           +++G+G  G+V      V  K     A+K L    T K RR+   + ++     H +I++
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +    E +    + +++I E M  G L     +K DG FT  +   ++  I S +K+L D
Sbjct: 80  L----EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD 134
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-----PENLLYTKPGDGGILKLTDFGF 188
            +  HRD+   N+L        + K++DFG  +     PE    T+   GG + +     
Sbjct: 135 MSYVHRDLAARNILVN---SNLVCKVSDFGMSRVLEDDPEAAYTTR---GGKIPIR---- 184
Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHG 247
                              + APE +   K+  + D+WS G++M+ ++  G  P++    
Sbjct: 185 -------------------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 225
Query: 248 QAISPGMKNRIRL 260
           Q +   ++   RL
Sbjct: 226 QDVIKAIEEGYRL 238

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/333 (21%), Positives = 136/333 (40%), Gaps = 86/333 (25%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + +  +  A+K L       + ARR   EL+L     H++++ + DV
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 78  YE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           +    +I + S   LV    + G +L   ++ +   A ++     ++ ++   +K++H  
Sbjct: 96  FTPATSIEDFSEVYLVT--TLMGADLNNIVKSQ---ALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KP N+   +  +                           L++ DFG A++   
Sbjct: 151 GIIHRDLKPSNVAVNEDSE---------------------------LRILDFGLARQ--- 180
Query: 195 NKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
               +     T +Y APE+ L    Y+++ DIWS+G IM  LL          G+A+ PG
Sbjct: 181 ADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL---------QGKALFPG 231
Query: 254 MKNRIRLGQF----DFPNPE--WEHVSQEAKTLIKN------------------------ 283
                +L +       P+PE   +  S+ A+T I++                        
Sbjct: 232 SDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLL 291
Query: 284 --MLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
             ML +D  +R++  + + + + SQ++     P
Sbjct: 292 GRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 125/312 (40%), Gaps = 73/312 (23%)
Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVL----HDTVKARREVELQLA--VGSHKH 70
           + LG G  GKV++     +++   +   A+K+L    H T +     EL++   +G+H +
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-------- 122
           IVN+         G   L++   C +G +L   +++K D     + +  IM         
Sbjct: 112 IVNLLGA---CTIGGPTLVITEYCCYG-DLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 123 --------EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
                   ++   + FL  +N  HRD+   N+L T                         
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT------------------------- 202
Query: 175 PGDGGILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG 229
              G I K+ DFG A+ I ++     K + + P     ++APE +    Y    D+WS G
Sbjct: 203 --HGRITKICDFGLARHIKNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYG 257
Query: 230 VIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVD 288
           + ++ L   G  P+    G  +       I+ G F   +P  EH   E   ++K     D
Sbjct: 258 IFLWELFSLGSSPY---PGMPVDSKFYKMIKEG-FRMLSP--EHAPAEMYDIMKTCWDAD 311
Query: 289 PSERLTIDQVME 300
           P +R T  Q+++
Sbjct: 312 PLKRPTFKQIVQ 323

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 125/312 (40%), Gaps = 73/312 (23%)
Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVL----HDTVKARREVELQLA--VGSHKH 70
           + LG G  GKV++     +++   +   A+K+L    H T +     EL++   +G+H +
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-------- 122
           IVN+         G   L++   C +G +L   +++K D     + +  IM         
Sbjct: 112 IVNLLGA---CTIGGPTLVITEYCCYG-DLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 123 --------EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
                   ++   + FL  +N  HRD+   N+L T                         
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT------------------------- 202
Query: 175 PGDGGILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG 229
              G I K+ DFG A+ I ++     K + + P     ++APE +    Y    D+WS G
Sbjct: 203 --HGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYG 257
Query: 230 VIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVD 288
           + ++ L   G  P+    G  +       I+ G F   +P  EH   E   ++K     D
Sbjct: 258 IFLWELFSLGSSPY---PGMPVDSKFYKMIKEG-FRMLSP--EHAPAEMYDIMKTCWDAD 311
Query: 289 PSERLTIDQVME 300
           P +R T  Q+++
Sbjct: 312 PLKRPTFKQIVQ 323

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 125/312 (40%), Gaps = 73/312 (23%)
Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVL----HDTVKARREVELQLA--VGSHKH 70
           + LG G  GKV++     +++   +   A+K+L    H T +     EL++   +G+H +
Sbjct: 47  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 106
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-------- 122
           IVN+         G   L++   C +G +L   +++K D     + +  IM         
Sbjct: 107 IVNLLGA---CTIGGPTLVITEYCCYG-DLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 123 --------EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
                   ++   + FL  +N  HRD+   N+L T                         
Sbjct: 163 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH------------------------ 198
Query: 175 PGDGGILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG 229
              G I K+ DFG A+ I ++     K + + P     ++APE +    Y    D+WS G
Sbjct: 199 ---GRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYG 252
Query: 230 VIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVD 288
           + ++ L   G  P+    G  +       I+ G F   +P  EH   E   ++K     D
Sbjct: 253 IFLWELFSLGSSPY---PGMPVDSKFYKMIKEG-FRMLSP--EHAPAEMYDIMKTCWDAD 306
Query: 289 PSERLTIDQVME 300
           P +R T  Q+++
Sbjct: 307 PLKRPTFKQIVQ 318

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 125/312 (40%), Gaps = 73/312 (23%)
Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVL----HDTVKARREVELQLA--VGSHKH 70
           + LG G  GKV++     +++   +   A+K+L    H T +     EL++   +G+H +
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-------- 122
           IVN+         G   L++   C +G +L   +++K D     + +  IM         
Sbjct: 105 IVNLLGA---CTIGGPTLVITEYCCYG-DLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 123 --------EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
                   ++   + FL  +N  HRD+   N+L T                         
Sbjct: 161 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH------------------------ 196
Query: 175 PGDGGILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG 229
              G I K+ DFG A+ I ++     K + + P     ++APE +    Y    D+WS G
Sbjct: 197 ---GRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYG 250
Query: 230 VIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVD 288
           + ++ L   G  P+    G  +       I+ G F   +P  EH   E   ++K     D
Sbjct: 251 IFLWELFSLGSSPY---PGMPVDSKFYKMIKEG-FRMLSP--EHAPAEMYDIMKTCWDAD 304
Query: 289 PSERLTIDQVME 300
           P +R T  Q+++
Sbjct: 305 PLKRPTFKQIVQ 316

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 101/243 (41%), Gaps = 52/243 (21%)
Query: 16  DYDISTEI--------LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREV----ELQL 63
           DY+   E+        +G G  G+V ++ +K+T    A+K      K R EV    EL  
Sbjct: 50  DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK------KVRLEVFRVEELVA 103
Query: 64  AVG-SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
             G S   IV +   Y  +  G   + + ME + GG L Q I+Q   G   E  A   + 
Sbjct: 104 CAGLSSPRIVPL---YGAVREGPW-VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLG 157
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +    +++LH + I H DVK +N+L +   DG    L DFG                 L 
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSS--DGSRAALCDFGHA---------------LC 200
Query: 183 LTDFGFAKKIVSNKASLQTPCYTP---YYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
           L   G  K       SL T  Y P    ++APEV+     D   DIWS   +M  +L G 
Sbjct: 201 LQPDGLGK-------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
Query: 240 PPF 242
            P+
Sbjct: 254 HPW 256

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 42/247 (17%)
Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYA----LKVLHDTVKARR---EVELQLAV 65
           I D Y+I   ++G G  G V +  +K    V A    L+V  D +  +R   E+ + L  
Sbjct: 51  IPDRYEIR-HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI-LNR 108
Query: 66  GSHKHIVNIKDV--------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREA 117
            +H H+V + D+        ++ +Y       V++E       F+++  +     TE   
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELY-------VVLEIADSD--FKKLF-RTPVYLTELHI 158
Query: 118 AIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK----PEN---L 170
             ++  +   +K++H   I HRD+KP N L  +      +K+ DFG  +    PEN    
Sbjct: 159 KTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS---VKVCDFGLARTVDYPENGNSQ 215
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLG 229
           L   P +   + L  F   K +   K  L     T +Y APE +L  + Y ++ D+WS+G
Sbjct: 216 LPISPREDD-MNLVTFPHTKNL---KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
Query: 230 VIMYILL 236
            I   LL
Sbjct: 272 CIFAELL 278

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 44/303 (14%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-ARREVELQLAVGSHKHIVNIKDV 77
           +S +ILG G +G V+     +   V   ++L D    A  E++L      H +++     
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIR---- 73
Query: 78  YENIYNGSRCLLVIMEC--MHGGELFQRIQQKEDGAFTEREAAII--MNEICSAIKFLHD 133
           Y       R L + +E   ++  +L +     ++    ++E   I  + +I S +  LH 
Sbjct: 74  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
             I HRD+KP+N+L +        + T       ENL          + ++DFG  KK+ 
Sbjct: 134 LKIIHRDLKPQNILVSTSS-----RFTADQQTGAENLR---------ILISDFGLCKKLD 179
Query: 194 SN----KASLQTPCYTPYYVAPEVLGPD-------KYDKSCDIWSLGVIMYILLC-GFPP 241
           S     + +L  P  T  + APE+L          +  +S DI+S+G + Y +L  G  P
Sbjct: 180 SGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEH---VSQEAKTLIKNMLCVDPSERLTIDQV 298
           F   + +       N IR G F     +  H   +  EA  LI  M+  DP +R T  +V
Sbjct: 240 FGDKYSRE-----SNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
Query: 299 MEN 301
           + +
Sbjct: 294 LRH 296

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/312 (22%), Positives = 125/312 (40%), Gaps = 73/312 (23%)
Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVL----HDTVKARREVELQLA--VGSHKH 70
           + LG G  GKV++     +++   +   A+K+L    H T +     EL++   +G+H +
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-------- 122
           IVN+         G   L++   C +G +L   +++K D     + +  IM         
Sbjct: 89  IVNLLGA---CTIGGPTLVITEYCCYG-DLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 123 --------EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
                   ++   + FL  +N  HRD+   N+L T                         
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH------------------------ 180
Query: 175 PGDGGILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG 229
              G I K+ DFG A+ I ++     K + + P     ++APE +    Y    D+WS G
Sbjct: 181 ---GRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYG 234
Query: 230 VIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVD 288
           + ++ L   G  P+    G  +       I+ G F   +P  EH   E   ++K     D
Sbjct: 235 IFLWELFSLGSSPY---PGMPVDSKFYKMIKEG-FRMLSP--EHAPAEMYDIMKTCWDAD 288
Query: 289 PSERLTIDQVME 300
           P +R T  Q+++
Sbjct: 289 PLKRPTFKQIVQ 300

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 45/203 (22%)
Query: 111 AFTEREAAIIMN---EICSAIKFLHDQNIAHRDVKPENLLYT-----KPGDGGILKLTDF 162
           +  +RE  + ++   +I  A++FLH + + HRD+KP N+ +T     K GD G++   D 
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD- 215
Query: 163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKS 222
            D + + +L   P                     A+      T  Y++PE +  + Y   
Sbjct: 216 QDEEEQTVLTPMPA-------------------YATHXGQVGTKLYMSPEQIHGNNYSHK 256
Query: 223 CDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL----GQFDFPNPEWEHVSQEAK 278
            DI+SLG+I++ LL  F           S  M+ R+R+        FP    +   QE  
Sbjct: 257 VDIFSLGLILFELLYSF-----------STQME-RVRIITDVRNLKFPLLFTQKYPQE-H 303
Query: 279 TLIKNMLCVDPSERLTIDQVMEN 301
            ++++ML   P+ER     ++EN
Sbjct: 304 MMVQDMLSPSPTERPEATDIIEN 326

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 101/243 (41%), Gaps = 52/243 (21%)
Query: 16  DYDISTEI--------LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREV----ELQL 63
           DY+   E+        +G G  G+V ++ +K+T    A+K      K R EV    EL  
Sbjct: 66  DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK------KVRLEVFRVEELVA 119
Query: 64  AVG-SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
             G S   IV +   Y  +  G   + + ME + GG L Q I+Q   G   E  A   + 
Sbjct: 120 CAGLSSPRIVPL---YGAVREGPW-VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLG 173
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +    +++LH + I H DVK +N+L +   DG    L DFG                 L 
Sbjct: 174 QALEGLEYLHTRRILHGDVKADNVLLSS--DGSRAALCDFGHA---------------LC 216
Query: 183 LTDFGFAKKIVSNKASLQTPCYTP---YYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
           L   G  K       SL T  Y P    ++APEV+     D   DIWS   +M  +L G 
Sbjct: 217 LQPDGLGK-------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 269
Query: 240 PPF 242
            P+
Sbjct: 270 HPW 272

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 58/259 (22%)
Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHD--TVKARREVELQLAVGS---HKHIV 72
           E++G G  G+V    L+   KK S V A+K L    T + RRE   + ++     H +I+
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCV-AIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGEL--FQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
            ++ V  N    S  ++++ E M  G L  F R+    DG FT  +   ++  I S +++
Sbjct: 81  RLEGVVTN----SMPVMILTEFMENGALDSFLRLN---DGQFTVIQLVGMLRGIASGMRY 133
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           L + +  HRD+   N+L                     NL         + K++DFG ++
Sbjct: 134 LAEMSYVHRDLAARNILVNS------------------NL---------VCKVSDFGLSR 166
Query: 191 KIVSNKASLQTPCYTP--------YYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
            +  N +    P  T          + APE +   K+  + D WS G++M+ ++  G  P
Sbjct: 167 FLEENSSD---PTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223
Query: 242 FFSNHGQAISPGMKNRIRL 260
           ++    Q +   ++   RL
Sbjct: 224 YWDMSNQDVINAIEQDYRL 242

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/331 (21%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ D+G A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDYGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 36  VEKKTSEVYALKVL-HDTVKARREVELQLAVG---SHKHIVNIKDVYENIYNGSRCLLVI 91
           ++  T EV A+K L H T +  R+ E ++ +     H +IV  K V  +   G R L +I
Sbjct: 35  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLI 92
Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           ME +  G L   +Q+ ++      +     ++IC  +++L  +   HR++   N+L    
Sbjct: 93  MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNIL---- 147
Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTP-YY 208
                        V+ EN +          K+ DFG  K +  +K    ++ P  +P ++
Sbjct: 148 -------------VENENRV----------KIGDFGLTKVLPQDKEYYKVKEPGESPIFW 184
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            APE L   K+  + D+WS GV++Y L 
Sbjct: 185 YAPESLTESKFSVASDVWSFGVVLYELF 212

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 114/283 (40%), Gaps = 51/283 (18%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLA-VGSHKHI------VNIKD 76
           LG G  G+V ++  K+   +YA+K      +  ++   +LA VGSH+ +      V ++ 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            +E    G    L    C   G   Q+  +    +  E +    + +   A+  LH Q +
Sbjct: 125 AWEE---GGILYLQTELC---GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            H DVKP N+     G  G  KL DFG       L  + G  G  ++ +           
Sbjct: 179 VHLDVKPANIFL---GPRGRCKLGDFG-------LLVELGTAGAGEVQEG---------- 218
Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
                    P Y+APE+L    Y  + D++SLG+ +  + C            +  G + 
Sbjct: 219 --------DPRYMAPELL-QGSYGTAADVFSLGLTILEVACNM---------ELPHGGEG 260
Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
             +L Q   P      +S E ++++  ML  DP  R T + ++
Sbjct: 261 WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALL 303

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +  IL                   D G+ + TD      +
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKIL-------------------DAGLARHTDDEMTGYV 183
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                       T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 184 A-----------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/333 (21%), Positives = 136/333 (40%), Gaps = 86/333 (25%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + +  +  A+K L       + ARR   EL+L     H++++ + DV
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 78  YE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           +    +I + S   LV    + G +L   ++ +   A ++     ++ ++   +K++H  
Sbjct: 96  FTPATSIEDFSEVYLVT--TLMGADLNNIVKCQ---ALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KP N+   +  +                           L++ DFG A++   
Sbjct: 151 GIIHRDLKPSNVAVNEDSE---------------------------LRILDFGLARQ--- 180
Query: 195 NKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
               +     T +Y APE+ L    Y+++ DIWS+G IM  LL          G+A+ PG
Sbjct: 181 ADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL---------QGKALFPG 231
Query: 254 MKNRIRLGQF----DFPNPE--WEHVSQEAKTLIKN------------------------ 283
                +L +       P+PE   +  S+ A+T I++                        
Sbjct: 232 SDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLL 291
Query: 284 --MLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
             ML +D  +R++  + + + + SQ++     P
Sbjct: 292 GRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 37/196 (18%)
Query: 114 EREAAIIMN---EICSAIKFLHDQNIAHRDVKPENLLYT-----KPGDGGILKLTDFGDV 165
           ERE ++ ++   +I  A++FLH + + HRD+KP N+ +T     K GD G++   D  D 
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD-QDE 172
Query: 166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDI 225
           + + +L   P            +A+        L        Y++PE +  + Y    DI
Sbjct: 173 EEQTVLTPMP-----------AYARHTGQVGTKL--------YMSPEQIHGNSYSHKVDI 213
Query: 226 WSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
           +SLG+I++ LL  +P  FS   + +    +    +    FP P +         ++++ML
Sbjct: 214 FSLGLILFELL--YP--FSTQMERV----RTLTDVRNLKFP-PLFTQKYPCEYVMVQDML 264
Query: 286 CVDPSERLTIDQVMEN 301
              P ER     ++EN
Sbjct: 265 SPSPMERPEAINIIEN 280

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 110/252 (43%), Gaps = 46/252 (18%)
Query: 22  EILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++     H +I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 109
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 110 RL----EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           D    HRD+   N+L                     NL         + K++DFG A+ +
Sbjct: 165 DMGYVHRDLAARNILIN------------------SNL---------VCKVSDFGLARVL 197
Query: 193 VSNKASLQTP--CYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQ 248
             +  +  T      P  + +PE +   K+  + D+WS G++++ ++  G  P++    Q
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 249 AISPGMKNRIRL 260
            +   +    RL
Sbjct: 258 DVIKAVDEGYRL 269

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/331 (21%), Positives = 139/331 (41%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+ DF  A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILDFYLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 86/199 (43%), Gaps = 40/199 (20%)
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +I+++    E +   S+ ++++ E M  G L     +K DG FT  +   ++  I + 
Sbjct: 82  HPNIIHL----EGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAG 136
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-----PENLLYTKPGDGGILK 182
           +K+L D    HRD+   N+L        + K++DFG  +     PE    T+   GG + 
Sbjct: 137 MKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLSRVLEDDPEAAYTTR---GGKIP 190
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           +                        + APE +   K+  + D+WS G++M+ ++  G  P
Sbjct: 191 IR-----------------------WTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227
Query: 242 FFSNHGQAISPGMKNRIRL 260
           ++    Q +   ++   RL
Sbjct: 228 YWEMTNQDVIKAVEEGYRL 246

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I+E M  G L   +++      +      +  +I SA+++L  +N  HRD
Sbjct: 79  ----EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 134
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 135 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTXTAH 167
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 168 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 92/234 (39%), Gaps = 47/234 (20%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVL---HDT---VKARREVELQLAVGSHKHIV 72
           I  + LG G    V +   K T  + ALK +   H+      A REV L L    H +IV
Sbjct: 5   IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSL-LKDLKHANIV 63
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED---GAFTEREAAIIMNEICSAIK 129
            + D    I +  + L ++ E +      + ++Q  D            + + ++   + 
Sbjct: 64  TLHD----IIHTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           + H Q + HRD+KP+NLL  + G+                           LKL DFG A
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGE---------------------------LKLADFGLA 147
Query: 190 KKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           +       +      T +Y  P++ LG   Y    D+W +G I Y +  G P F
Sbjct: 148 RAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I+E M  G L   +++      +      +  +I SA+++L  +N  HRD
Sbjct: 81  ----EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 137 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 169
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 99/245 (40%), Gaps = 73/245 (29%)
Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           ++ +I   I +LH   + HRD+KP N+L    G+G            PE          G
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVM--GEG------------PER---------G 169
Query: 180 ILKLTDFGFAKKIVS---NKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGVIMYIL 235
            +K+ D GFA+   S     A L     T +Y APE +LG   Y K+ DIW++G I   L
Sbjct: 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFD-------FP-NPEWEHVSQ--EAKTLIKN-- 283
           L   P F   H +       N     Q D       FP + +WE + +  E  TL+K+  
Sbjct: 230 LTSEPIF---HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR 286
Query: 284 ------------------------------MLCVDPSERLTIDQVMENKWISQFNQVPQT 313
                                         +L +DP +R+T +Q M++ +  + + +P +
Sbjct: 287 RNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE-DPLPTS 345
Query: 314 PLCTG 318
            +  G
Sbjct: 346 DVFAG 350

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 61/243 (25%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA------RREVELQLAVGSHKHIV 72
           +     GLG    VL++         A+K+L  T  A        E+++   +G H++IV
Sbjct: 63  VEATAFGLGKEDAVLKV---------AVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGEL-FQRIQQ-----KEDGAFTE-REAAIIMNEIC 125
           N+        +G   L++   C +G  L F R +      KEDG   E R+     +++ 
Sbjct: 114 NLLGA---CTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             + FL  +N  HRDV   N+L T                           +G + K+ D
Sbjct: 171 QGMAFLASKNCIHRDVAARNVLLT---------------------------NGHVAKIGD 203
Query: 186 FGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGF 239
           FG A+ I+++     K + + P     ++APE +    Y    D+WS G++++ I   G 
Sbjct: 204 FGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 260
Query: 240 PPF 242
            P+
Sbjct: 261 NPY 263

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 134/296 (45%), Gaps = 35/296 (11%)
Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARR----EVELQLAVGSHKHIVNIKDVY 78
           +LG G  G+V++      S  YA+K +  T +       EV L LA  +H+++V     +
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXL-LASLNHQYVVRYYAAW 71
Query: 79  ENIYNGSR---------CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
               N  +          L +  E      L+  I   E+      E   +  +I  A+ 
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHS-ENLNQQRDEYWRLFRQILEALS 130
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           ++H Q I HR++KP N+   +  +   +K+ DFG  K  +    +  D  ILKL     +
Sbjct: 131 YIHSQGIIHRNLKPXNIFIDESRN---VKIGDFGLAKNVH----RSLD--ILKLD----S 177
Query: 190 KKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           + +  +  +L +   T  YVA EVL G   Y++  D +SLG+I +  +  +P  FS   +
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI--YP--FSTGXE 233
Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            ++  +  ++R    +FP    ++  +  K +I+ ++  DP++R     ++ + W+
Sbjct: 234 RVN--ILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 61/243 (25%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA------RREVELQLAVGSHKHIV 72
           +     GLG    VL++         A+K+L  T  A        E+++   +G H++IV
Sbjct: 55  VEATAFGLGKEDAVLKV---------AVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGEL-FQRIQQ-----KEDGAFTE-REAAIIMNEIC 125
           N+        +G   L++   C +G  L F R +      KEDG   E R+     +++ 
Sbjct: 106 NLLGA---CTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 162
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             + FL  +N  HRDV   N+L T                           +G + K+ D
Sbjct: 163 QGMAFLASKNCIHRDVAARNVLLT---------------------------NGHVAKIGD 195
Query: 186 FGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGF 239
           FG A+ I+++     K + + P     ++APE +    Y    D+WS G++++ I   G 
Sbjct: 196 FGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 252
Query: 240 PPF 242
            P+
Sbjct: 253 NPY 255

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I+E M  G L   +++      +      +  +I SA+++L  +N  HRD
Sbjct: 81  ----EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 137 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 169
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 140/331 (42%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +  IL                   D G+ + TD      +
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKIL-------------------DRGLARHTDDEMTGYV 183
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                       T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 184 A-----------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 108/254 (42%), Gaps = 50/254 (19%)
Query: 22  EILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++     H +I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 109
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 110 RL----EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTKPGDGGILKLTDFG 187
           D    HRD+   N+L        + K++DFG     +  PE    T+ G   I       
Sbjct: 165 DMGFVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI------- 214
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + +PE +   K+  + D+WS G++++ ++  G  P++   
Sbjct: 215 -------------------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 247 GQAISPGMKNRIRL 260
            Q +   +    RL
Sbjct: 256 NQDVIKAVDEGYRL 269

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 72/331 (21%), Positives = 139/331 (41%), Gaps = 78/331 (23%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + KT    A+K L       + A+R   EL+L     H++++ + DV
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 78  YENIYNGSRCL-----LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           +      +R L     + ++  + G +L   ++ ++    T+     ++ +I   +K++H
Sbjct: 90  F----TPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIH 142
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
             +I HRD+KP NL   +  +                           LK+  FG A+  
Sbjct: 143 SADIIHRDLKPSNLAVNEDCE---------------------------LKILGFGLARH- 174
Query: 193 VSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNHGQ 248
                 +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   FP   ++H  
Sbjct: 175 --TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--TDHID 230
Query: 249 AI--------SPG---------------MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
            +        +PG               +++  ++ + +F N  +   +  A  L++ ML
Sbjct: 231 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKML 289
Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            +D  +R+T  Q + + + +Q++     P+ 
Sbjct: 290 VLDSDKRITAAQALAHAYFAQYHDPDDEPVA 320

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I+E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 82  ----EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 137
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 138 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTXTAH 170
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 171 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 38/195 (19%)
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH+ +V +  V        R + +I E M  G L   +++     F  ++   +  ++C 
Sbjct: 77  SHEKLVQLYGVCTK----QRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCE 131
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+++L  +   HRD+   N L                             D G++K++DF
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVN---------------------------DQGVVKVSDF 164
Query: 187 GFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF-- 242
           G ++ ++ ++ +       P  +  PEVL   K+    DIW+ GV+M+ I   G  P+  
Sbjct: 165 GLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224
Query: 243 FSNHGQA--ISPGMK 255
           F+N   A  I+ G++
Sbjct: 225 FTNSETAEHIAQGLR 239

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/260 (22%), Positives = 114/260 (43%), Gaps = 47/260 (18%)
Query: 15  DDYDISTE-ILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS 67
           D  +IS + ++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMG 101
Query: 68  ---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +I+ +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I
Sbjct: 102 QFDHPNIIRL----EGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            S +K+L D    HRD+   N+L                     NL         + K++
Sbjct: 157 ASGMKYLSDMGAVHRDLAARNILIN------------------SNL---------VCKVS 189
Query: 185 DFGFAKKIVSNKASLQTP--CYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFP 240
           DFG ++ +  +  +  T      P  + +PE +   K+  + D+WS G++++ ++  G  
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 241 PFFSNHGQAISPGMKNRIRL 260
           P++    Q +   +    RL
Sbjct: 250 PYWEMSNQDVIKAVDEGYRL 269

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 38/195 (19%)
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH+ +V +  V        R + +I E M  G L   +++     F  ++   +  ++C 
Sbjct: 61  SHEKLVQLYGVC----TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCE 115
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+++L  +   HRD+   N L                             D G++K++DF
Sbjct: 116 AMEYLESKQFLHRDLAARNCL---------------------------VNDQGVVKVSDF 148
Query: 187 GFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF-- 242
           G ++ ++ ++ +       P  +  PEVL   K+    DIW+ GV+M+ I   G  P+  
Sbjct: 149 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 208
Query: 243 FSNHGQA--ISPGMK 255
           F+N   A  I+ G++
Sbjct: 209 FTNSETAEHIAQGLR 223

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 39/167 (23%)
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN---EI 124
           H +IV   D +E+   G +C++++ E    G L   +++     F   +  ++ +   +I
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKR-----FKVXKIKVLRSWCRQI 138
Query: 125 CSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
              ++FLH +   I HRD+K +N+  T P           G V        K GD G+  
Sbjct: 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPT----------GSV--------KIGDLGLAT 180
Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG 229
           L    FAK ++           TP + APE    +KYD+S D+++ G
Sbjct: 181 LKRASFAKAVIG----------TPEFXAPEXY-EEKYDESVDVYAFG 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 38/195 (19%)
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH+ +V +  V        R + +I E M  G L   +++     F  ++   +  ++C 
Sbjct: 62  SHEKLVQLYGVC----TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCE 116
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+++L  +   HRD+   N L                             D G++K++DF
Sbjct: 117 AMEYLESKQFLHRDLAARNCL---------------------------VNDQGVVKVSDF 149
Query: 187 GFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF-- 242
           G ++ ++ ++ +       P  +  PEVL   K+    DIW+ GV+M+ I   G  P+  
Sbjct: 150 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 209
Query: 243 FSNHGQA--ISPGMK 255
           F+N   A  I+ G++
Sbjct: 210 FTNSETAEHIAQGLR 224

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I+E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 86  ----EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 142 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 174
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 38/195 (19%)
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH+ +V +  V        R + +I E M  G L   +++     F  ++   +  ++C 
Sbjct: 57  SHEKLVQLYGVC----TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCE 111
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+++L  +   HRD+   N L                             D G++K++DF
Sbjct: 112 AMEYLESKQFLHRDLAARNCL---------------------------VNDQGVVKVSDF 144
Query: 187 GFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF-- 242
           G ++ ++ ++ +       P  +  PEVL   K+    DIW+ GV+M+ I   G  P+  
Sbjct: 145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204
Query: 243 FSNHGQA--ISPGMK 255
           F+N   A  I+ G++
Sbjct: 205 FTNSETAEHIAQGLR 219

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 108/254 (42%), Gaps = 50/254 (19%)
Query: 22  EILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++     H +I+
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 80
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 81  RL----EGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-----PENLLYTKPGDGGILKLTDFG 187
           D    HRD+   N+L        + K++DFG  +     PE    T+ G   I       
Sbjct: 136 DMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI------- 185
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + +PE +   K+  + D+WS G++++ ++  G  P++   
Sbjct: 186 -------------------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 226
Query: 247 GQAISPGMKNRIRL 260
            Q +   +    RL
Sbjct: 227 NQDVIKAVDEGYRL 240

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 110/254 (43%), Gaps = 50/254 (19%)
Query: 22  EILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++     H +I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 109
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 110 RL----EGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTKPGDGGILKLTDFG 187
           D    HRD+   N+L        + K++DFG     +  PE    T+   GG + +    
Sbjct: 165 DMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTR---GGKIPIR--- 215
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + +PE +   K+  + D+WS G++++ ++  G  P++   
Sbjct: 216 --------------------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 247 GQAISPGMKNRIRL 260
            Q +   +    RL
Sbjct: 256 NQDVIKAVDEGYRL 269

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 36/194 (18%)
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH+ +V +  V        R + +I E M  G L   +++     F  ++   +  ++C 
Sbjct: 62  SHEKLVQLYGVC----TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCE 116
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+++L  +   HRD+   N L     D G++K++DFG                   L+ +
Sbjct: 117 AMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFG-------------------LSRY 154
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF--F 243
               +  S++ S     ++P    PEVL   K+    DIW+ GV+M+ I   G  P+  F
Sbjct: 155 VLDDEYTSSRGSKFPVRWSP----PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 210
Query: 244 SNHGQA--ISPGMK 255
           +N   A  I+ G++
Sbjct: 211 TNSETAEHIAQGLR 224

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++      +      +  +I SA+++L  +N  HRD
Sbjct: 86  ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 142 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 174
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 38/195 (19%)
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH+ +V +  V        R + +I E M  G L   +++     F  ++   +  ++C 
Sbjct: 68  SHEKLVQLYGVCTK----QRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCE 122
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+++L  +   HRD+   N L                             D G++K++DF
Sbjct: 123 AMEYLESKQFLHRDLAARNCLVN---------------------------DQGVVKVSDF 155
Query: 187 GFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF-- 242
           G ++ ++ ++ +       P  +  PEVL   K+    DIW+ GV+M+ I   G  P+  
Sbjct: 156 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 215
Query: 243 FSNHGQA--ISPGMK 255
           F+N   A  I+ G++
Sbjct: 216 FTNSETAEHIAQGLR 230

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 38/195 (19%)
Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           SH+ +V +  V        R + +I E M  G L   +++     F  ++   +  ++C 
Sbjct: 77  SHEKLVQLYGVCTK----QRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCE 131
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+++L  +   HRD+   N L                             D G++K++DF
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVN---------------------------DQGVVKVSDF 164
Query: 187 GFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF-- 242
           G ++ ++ ++ +       P  +  PEVL   K+    DIW+ GV+M+ I   G  P+  
Sbjct: 165 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224
Query: 243 FSNHGQA--ISPGMK 255
           F+N   A  I+ G++
Sbjct: 225 FTNSETAEHIAQGLR 239

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++      +      +  +I SA+++L  +N  HRD
Sbjct: 81  ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 137 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 169
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 110/254 (43%), Gaps = 50/254 (19%)
Query: 22  EILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++     H +I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 109
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 110 RL----EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTKPGDGGILKLTDFG 187
           D    HRD+   N+L        + K++DFG     +  PE    T+   GG + +    
Sbjct: 165 DMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTR---GGKIPIR--- 215
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + +PE +   K+  + D+WS G++++ ++  G  P++   
Sbjct: 216 --------------------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 247 GQAISPGMKNRIRL 260
            Q +   +    RL
Sbjct: 256 NQDVIKAVDEGYRL 269

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 110/254 (43%), Gaps = 50/254 (19%)
Query: 22  EILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++     H +I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 109
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 110 RL----EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTKPGDGGILKLTDFG 187
           D    HRD+   N+L        + K++DFG     +  PE    T+   GG + +    
Sbjct: 165 DMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTR---GGKIPIR--- 215
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + +PE +   K+  + D+WS G++++ ++  G  P++   
Sbjct: 216 --------------------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 247 GQAISPGMKNRIRL 260
            Q +   +    RL
Sbjct: 256 NQDVIKAVDEGYRL 269

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++      +      +  +I SA+++L  +N  HRD
Sbjct: 79  ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 134
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 135 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTXTAH 167
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 168 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 86  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 142 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTXTAH 174
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/254 (22%), Positives = 109/254 (42%), Gaps = 50/254 (19%)
Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLH--DTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK   V A+K L    T K RR+   + ++     H +I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 110 RL----EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTKPGDGGILKLTDFG 187
           D    HRD+   N+L        + K++DFG     +  PE    T+   GG + +    
Sbjct: 165 DMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTR---GGKIPIR--- 215
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + +PE +   K+  + D+WS G++++ ++  G  P++   
Sbjct: 216 --------------------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 247 GQAISPGMKNRIRL 260
            Q +   +    RL
Sbjct: 256 NQDVIKAVDEGYRL 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++      +      +  +I SA+++L  +N  HRD
Sbjct: 81  ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 137 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 169
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 72/333 (21%), Positives = 136/333 (40%), Gaps = 86/333 (25%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREV-ELQLAVG-SHKHIVNIKDV 77
           +G G  G V    + +  +  A+K L       + ARR   EL+L     H++++ + DV
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 78  YE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
           +    +I + S   LV    + G +L   ++ +   A ++     ++ ++   +K++H  
Sbjct: 88  FTPATSIEDFSEVYLVT--TLMGADLNNIVKCQ---ALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I HRD+KP N+   +  +                           L++ DFG A++   
Sbjct: 143 GIIHRDLKPSNVAVNEDCE---------------------------LRILDFGLARQ--- 172
Query: 195 NKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
               +     T +Y APE+ L    Y+++ DIWS+G IM  LL          G+A+ PG
Sbjct: 173 ADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL---------QGKALFPG 223
Query: 254 MKNRIRLGQF----DFPNPE--WEHVSQEAKTLIKN------------------------ 283
                +L +       P+PE   +  S+ A+T I++                        
Sbjct: 224 SDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLL 283
Query: 284 --MLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
             ML +D  +R++  + + + + SQ++     P
Sbjct: 284 GRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 316

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 110/254 (43%), Gaps = 50/254 (19%)
Query: 22  EILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++     H +I+
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 107
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 108 RL----EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 162
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTKPGDGGILKLTDFG 187
           D    HRD+   N+L        + K++DFG     +  PE    T+   GG + +    
Sbjct: 163 DMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTR---GGKIPIR--- 213
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + +PE +   K+  + D+WS G++++ ++  G  P++   
Sbjct: 214 --------------------WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 253
Query: 247 GQAISPGMKNRIRL 260
            Q +   +    RL
Sbjct: 254 NQDVIKAVDEGYRL 267

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 108/254 (42%), Gaps = 50/254 (19%)
Query: 22  EILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++     H +I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 109
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 110 RL----EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTKPGDGGILKLTDFG 187
           D    HRD+   N+L        + K++DFG     +  PE    T+ G   I       
Sbjct: 165 DMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI------- 214
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + +PE +   K+  + D+WS G++++ ++  G  P++   
Sbjct: 215 -------------------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 247 GQAISPGMKNRIRL 260
            Q +   +    RL
Sbjct: 256 NQDVIKAVDEGYRL 269

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 108/254 (42%), Gaps = 50/254 (19%)
Query: 22  EILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++     H +I+
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 80
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 81  RL----EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-----PENLLYTKPGDGGILKLTDFG 187
           D    HRD+   N+L        + K++DFG  +     PE    T+ G   I       
Sbjct: 136 DMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI------- 185
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + +PE +   K+  + D+WS G++++ ++  G  P++   
Sbjct: 186 -------------------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 226
Query: 247 GQAISPGMKNRIRL 260
            Q +   +    RL
Sbjct: 227 NQDVIKAVDEGYRL 240

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 112/262 (42%), Gaps = 51/262 (19%)
Query: 15  DDYDISTE-ILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS 67
           D  +IS + ++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++  
Sbjct: 31  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMG 89
Query: 68  ---HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +I+ +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I
Sbjct: 90  QFDHPNIIRL----EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 144
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-----PENLLYTKPGDGG 179
            S +K+L D    HRD+   N+L        + K++DFG  +     PE    T+ G   
Sbjct: 145 ASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCG 238
           I                           + +PE +   K+  + D+WS G++++ ++  G
Sbjct: 202 I--------------------------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 235
Query: 239 FPPFFSNHGQAISPGMKNRIRL 260
             P++    Q +   +    RL
Sbjct: 236 ERPYWEMSNQDVIKAVDEGYRL 257

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++      +      +  +I SA+++L  +N  HRD
Sbjct: 79  ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 134
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 135 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTFTAH 167
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 168 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 86  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 142 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 174
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/254 (22%), Positives = 108/254 (42%), Gaps = 50/254 (19%)
Query: 22  EILGLGINGKV----LQIVEKK--TSEVYALKVLHDTVKARREVELQLAVGS---HKHIV 72
           +++G G  G+V    L++  KK  +  +  LKV + T K RR+   + ++     H +I+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 109
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +   S+ ++++ E M  G L     +K D  FT  +   ++  I S +K+L 
Sbjct: 110 RL----EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG-----DVKPENLLYTKPGDGGILKLTDFG 187
           D    HRD+   N+L        + K++DFG     +  PE    T+ G   I       
Sbjct: 165 DMGYVHRDLAARNILINS---NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI------- 214
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                               + +PE +   K+  + D+WS G++++ ++  G  P++   
Sbjct: 215 -------------------RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 247 GQAISPGMKNRIRL 260
            Q +   +    RL
Sbjct: 256 NQDVIKAVDEGYRL 269

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 85  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 140
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 141 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 173
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 86  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 141
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 142 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 174
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 175 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 83  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 139 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 171
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 101/273 (36%), Gaps = 67/273 (24%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 106 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 160
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 161 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 193
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 292 RLTIDQVMENKWISQFNQVPQTPLCTGKMLKEG 324
           RLT  + ME+ +     +    P     +L  G
Sbjct: 312 RLTAREAMEHPYFYPVVKEQSQPCADNAVLSSG 344

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 94  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 149
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 150 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 182
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 183 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 83  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 139 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 171
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 81  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 137 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 169
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 81  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 137 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 169
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T+ +    + E+  A+ + H Q I HRDVKP N++     D  + K            
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRK------------ 165
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLG 229
                     L+L D+G A+     K        + Y+  PE+L     YD S D+WSLG
Sbjct: 166 ----------LRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 214
Query: 230 VIMYILLCGFPPFF---SNHGQAI-------SPGM-----KNRIRLG------------- 261
            +   ++    PFF    NH Q +       + G+     K RI L              
Sbjct: 215 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRK 274
Query: 262 -QFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               F N + +H VS EA   +  +L  D  ERLT  + M + +  Q
Sbjct: 275 PWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 42/214 (19%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M+ G L   ++  E  A        +  ++ + + ++   N  HRD++  N+L
Sbjct: 78  IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANIL 137
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+G I K+ DFG A+ I  N+ + +     P 
Sbjct: 138 V---------------------------GNGLICKIADFGLARLIEDNEXTARQGAKFPI 170
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L+          G+   PGM NR  L Q    
Sbjct: 171 KWTAPEAALYGRFTIKSDVWSFGILLTELV--------TKGRVPYPGMNNREVLEQVERG 222
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID 296
           +  P P+   +S     L+ +    DP ER T +
Sbjct: 223 YRMPCPQDCPIS--LHELMIHCWKKDPEERPTFE 254

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 24  LGLGINGKV----LQIVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKHIVN 73
           LG G  GKV           T E+ A+K L +    +      RE+E+ L    H+HIV 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEI-LRTLYHEHIVK 75
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
            K   E+   G + + ++ME +  G L   + +   G     +  +   +IC  + +LH 
Sbjct: 76  YKGCCED--QGEKSVQLVMEYVPLGSLRDYLPRHCVGL---AQLLLFAQQICEGMAYLHA 130
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK--PENLLYTKPGDGGILKLTDFGFAKK 191
           Q+  HR +   N+L     +  ++K+ DFG  K  PE   Y +  + G            
Sbjct: 131 QHYIHRALAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG------------ 175
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
                    +P    ++ APE L   K+  + D+WS GV +Y LL
Sbjct: 176 --------DSPV---FWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T+ +    + E+  A+ + H Q I HRDVKP N++     D  + K            
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRK------------ 164
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLG 229
                     L+L D+G A+     K        + Y+  PE+L     YD S D+WSLG
Sbjct: 165 ----------LRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 213
Query: 230 VIMYILLCGFPPFF---SNHGQAI-------SPGM-----KNRIRLG------------- 261
            +   ++    PFF    NH Q +       + G+     K RI L              
Sbjct: 214 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRK 273
Query: 262 -QFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               F N + +H VS EA   +  +L  D  ERLT  + M + +  Q
Sbjct: 274 PWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T+ +    + E+  A+ + H Q I HRDVKP N++     D  + K            
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRK------------ 164
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLG 229
                     L+L D+G A+     K        + Y+  PE+L     YD S D+WSLG
Sbjct: 165 ----------LRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 213
Query: 230 VIMYILLCGFPPFF---SNHGQAI-------SPGM-----KNRIRLG------------- 261
            +   ++    PFF    NH Q +       + G+     K RI L              
Sbjct: 214 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRK 273
Query: 262 -QFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               F N + +H VS EA   +  +L  D  ERLT  + M + +  Q
Sbjct: 274 PWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T+ +    + E+  A+ + H Q I HRDVKP N++     D  + K            
Sbjct: 142 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRK------------ 185
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLG 229
                     L+L D+G A+     K        + Y+  PE+L     YD S D+WSLG
Sbjct: 186 ----------LRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 234
Query: 230 VIMYILLCGFPPFF---SNHGQAI-------SPGM-----KNRIRLG------------- 261
            +   ++    PFF    NH Q +       + G+     K RI L              
Sbjct: 235 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQLEALVGRHSRK 294
Query: 262 -QFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               F N + +H VS EA   +  +L  D  ERLT  + M + +  Q
Sbjct: 295 PWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 341

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T+ +    + E+  A+ + H Q I HRDVKP N++     D  + K            
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRK------------ 164
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLG 229
                     L+L D+G A+     K        + Y+  PE+L     YD S D+WSLG
Sbjct: 165 ----------LRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 213
Query: 230 VIMYILLCGFPPFF---SNHGQAI-------SPGM-----KNRIRLG------------- 261
            +   ++    PFF    NH Q +       + G+     K RI L              
Sbjct: 214 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRK 273
Query: 262 -QFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               F N + +H VS EA   +  +L  D  ERLT  + M + +  Q
Sbjct: 274 PWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 24  LGLGINGKV----LQIVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKHIVN 73
           LG G  GKV           T E+ A+K L +    +      RE+E+ L    H+HIV 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEI-LRTLYHEHIVK 74
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
            K   E+   G + + ++ME +  G L   + +   G     +  +   +IC  + +LH 
Sbjct: 75  YKGCCED--QGEKSVQLVMEYVPLGSLRDYLPRHCVGL---AQLLLFAQQICEGMAYLHA 129
Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK--PENLLYTKPGDGGILKLTDFGFAKK 191
           Q+  HR +   N+L     +  ++K+ DFG  K  PE   Y +  + G            
Sbjct: 130 QHYIHRALAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG------------ 174
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
                    +P    ++ APE L   K+  + D+WS GV +Y LL
Sbjct: 175 --------DSPV---FWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T+ +    + E+  A+ + H Q I HRDVKP N++     D  + K            
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRK------------ 164
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLG 229
                     L+L D+G A+     K        + Y+  PE+L     YD S D+WSLG
Sbjct: 165 ----------LRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 213
Query: 230 VIMYILLCGFPPFF---SNHGQAI-------SPGM-----KNRIRLG------------- 261
            +   ++    PFF    NH Q +       + G+     K RI L              
Sbjct: 214 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRK 273
Query: 262 -QFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               F N + +H VS EA   +  +L  D  ERLT  + M + +  Q
Sbjct: 274 PWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T+ +    + E+  A+ + H Q I HRDVKP N++     D  + K            
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRK------------ 165
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLG 229
                     L+L D+G A+     K        + Y+  PE+L     YD S D+WSLG
Sbjct: 166 ----------LRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 214
Query: 230 VIMYILLCGFPPFF---SNHGQAI-------SPGM-----KNRIRLG------------- 261
            +   ++    PFF    NH Q +       + G+     K RI L              
Sbjct: 215 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRK 274
Query: 262 -QFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               F N + +H VS EA   +  +L  D  ERLT  + M + +  Q
Sbjct: 275 PWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 33/171 (19%)
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H+HI+  K   E+   G + L ++ME +  G L   + +   G     +  +   +IC  
Sbjct: 75  HEHIIKYKGCCED--QGEKSLQLVMEYVPLGSLRDYLPRHSIGL---AQLLLFAQQICEG 129
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK--PENLLYTKPGDGGILKLTD 185
           + +LH Q+  HR++   N+L     +  ++K+ DFG  K  PE   Y +  + G      
Sbjct: 130 MAYLHSQHYIHRNLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG------ 180
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
                          +P    ++ APE L   K+  + D+WS GV +Y LL
Sbjct: 181 --------------DSPV---FWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T+ +    + E+  A+ + H Q I HRDVKP N++     D  + K            
Sbjct: 123 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRK------------ 166
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLG 229
                     L+L D+G A+     K        + Y+  PE+L     YD S D+WSLG
Sbjct: 167 ----------LRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 215
Query: 230 VIMYILLCGFPPFF---SNHGQAI-------SPGM-----KNRIRLG------------- 261
            +   ++    PFF    NH Q +       + G+     K RI L              
Sbjct: 216 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRK 275
Query: 262 -QFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               F N + +H VS EA   +  +L  D  ERLT  + M + +  Q
Sbjct: 276 PWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 322

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++      +      +  +I SA+++L  +N  HR+
Sbjct: 288 ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 344 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 376
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T+ +    + E+  A+ + H Q I HRDVKP N++     D  + K            
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRK------------ 164
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLG 229
                     L+L D+G A+     K        + Y+  PE+L     YD S D+WSLG
Sbjct: 165 ----------LRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 213
Query: 230 VIMYILLCGFPPFF---SNHGQAI-------SPGM-----KNRIRLG------------- 261
            +   ++    PFF    NH Q +       + G+     K RI L              
Sbjct: 214 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRK 273
Query: 262 -QFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               F N + +H VS EA   +  +L  D  ERLT  + M + +  Q
Sbjct: 274 PWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T+ +    + E+  A+ + H Q I HRDVKP N++     D  + K            
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRK------------ 164
Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLG 229
                     L+L D+G A+     K        + Y+  PE+L     YD S D+WSLG
Sbjct: 165 ----------LRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 213
Query: 230 VIMYILLCGFPPFF---SNHGQAI-------SPGM-----KNRIRLG------------- 261
            +   ++    PFF    NH Q +       + G+     K RI L              
Sbjct: 214 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRK 273
Query: 262 -QFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               F N + +H VS EA   +  +L  D  ERLT  + M + +  Q
Sbjct: 274 PWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 82  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 137
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 138 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAP 170
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 171 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/252 (21%), Positives = 109/252 (43%), Gaps = 46/252 (18%)
Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHD--TVKARREVELQLAVGS---HKHIV 72
           +I+G G +G+V    L++  ++   V A+K L    T + RR+   + ++     H +I+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPV-AIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +    R  +++ E M  G L     +  DG FT  +   ++  + + +++L 
Sbjct: 114 RL----EGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           D    HRD+   N+L                     NL         + K++DFG ++ +
Sbjct: 169 DLGYVHRDLAARNVLVDS------------------NL---------VCKVSDFGLSRVL 201
Query: 193 VS--NKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQ 248
               + A   T    P  + APE +    +  + D+WS GV+M+ +L  G  P+++   +
Sbjct: 202 EDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR 261
Query: 249 AISPGMKNRIRL 260
            +   ++   RL
Sbjct: 262 DVISSVEEGYRL 273

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HRD
Sbjct: 83  ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 138
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 139 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAP 171
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 101/247 (40%), Gaps = 65/247 (26%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA------RREVELQLAVGSHKHIV 72
           +     GLG    VL++         A+K+L  T  A        E+++   +G H++IV
Sbjct: 63  VEATAFGLGKEDAVLKV---------AVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGEL-FQRIQQK---EDGAF-------TEREAAIIM 121
           N+        +G   L++   C +G  L F R + +    D AF       + R+     
Sbjct: 114 NLLGA---CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
           +++   + FL  +N  HRDV   N+L T                           +G + 
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLT---------------------------NGHVA 203
Query: 182 KLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
           K+ DFG A+ I+++     K + + P     ++APE +    Y    D+WS G++++ I 
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
Query: 236 LCGFPPF 242
             G  P+
Sbjct: 261 SLGLNPY 267

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 33/171 (19%)
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H+HI+  K   E+   G + L ++ME +  G L   + +   G     +  +   +IC  
Sbjct: 75  HEHIIKYKGCCED--QGEKSLQLVMEYVPLGSLRDYLPRHSIGL---AQLLLFAQQICEG 129
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK--PENLLYTKPGDGGILKLTD 185
           + +LH Q+  HR++   N+L     +  ++K+ DFG  K  PE   Y +  + G      
Sbjct: 130 MAYLHAQHYIHRNLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG------ 180
Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
                          +P    ++ APE L   K+  + D+WS GV +Y LL
Sbjct: 181 --------------DSPV---FWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 96/248 (38%), Gaps = 53/248 (21%)
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H+HI+  K   E+   G+  L ++ME +  G L   + +   G     +  +   +IC  
Sbjct: 92  HEHIIKYKGCCED--AGAASLQLVMEYVPLGSLRDYLPRHSIGL---AQLLLFAQQICEG 146
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +LH Q+  HRD+   N+L                             +  ++K+ DFG
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLD---------------------------NDRLVKIGDFG 179
Query: 188 FAKKIVSNKASLQ------TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF-- 239
            AK +       +      +P +   + APE L   K+  + D+WS GV +Y LL     
Sbjct: 180 LAKAVPEGHEXYRVREDGDSPVF---WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS 236
Query: 240 ---PPFFSNHGQAISPGMKNRIRLGQF-----DFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
              PP        I+ G    +RL +        P P  +    E   L+KN    + S 
Sbjct: 237 SQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRP--DKCPAEVYHLMKNCWETEASF 294
Query: 292 RLTIDQVM 299
           R T + ++
Sbjct: 295 RPTFENLI 302

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 102/248 (41%), Gaps = 67/248 (27%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA------RREVELQLAVGSHKHIV 72
           +     GLG    VL++         A+K+L  T  A        E+++   +G H++IV
Sbjct: 63  VEATAFGLGKEDAVLKV---------AVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE-----DGAF-------TEREAAII 120
           N+        +G   L++   C +G +L   +++K      D AF       + R+    
Sbjct: 114 NLLGA---CTHGGPVLVITEYCCYG-DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
            +++   + FL  +N  HRDV   N+L T                           +G +
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLT---------------------------NGHV 202
Query: 181 LKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-I 234
            K+ DFG A+ I+++     K + + P     ++APE +    Y    D+WS G++++ I
Sbjct: 203 AKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEI 259
Query: 235 LLCGFPPF 242
              G  P+
Sbjct: 260 FSLGLNPY 267

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 45/239 (18%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHK- 69
           D Y+I + ++G G  G+V++  ++   E  A+K++ +      +A+ EV L   +  H  
Sbjct: 54  DRYEIDS-LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 70  ----HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
               +IV++K  +  ++    CL+  M   +  +L +    +       R+ A    ++C
Sbjct: 113 EMKYYIVHLKRHF--MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFA---QQMC 167
Query: 126 SAIKFLH--DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +A+ FL   + +I H D+KPEN+L   P    I                         K+
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRXAI-------------------------KI 202
Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
            DFG + ++      +     + +Y +PEVL    YD + D+WSLG I+  +  G P F
Sbjct: 203 VDFGSSCQL---GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 106 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 160
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L     +   L+L D+G  +     +  PG    +++                     
Sbjct: 161 NVLIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 193
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 312 RLTAREAMEHPYF 324

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 91/248 (36%), Gaps = 66/248 (26%)
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
            T+ +    M E+  A+ + H + I HRDVKP N++             D    K     
Sbjct: 129 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVM------------IDHQQKK----- 171
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGV 230
                    L+L D+G A+              + Y+  PE+L     YD S D+WSLG 
Sbjct: 172 ---------LRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 221
Query: 231 IMYILLCGFPPFFSNHGQ---------------------------AISP------GMKNR 257
           ++  ++    PFF  HGQ                            + P      G  +R
Sbjct: 222 MLASMIFRREPFF--HGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSR 279
Query: 258 IRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
            R    +F + E  H VS EA  L+  +L  D  +RLT  + ME+ +     +    P  
Sbjct: 280 KRWE--NFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSA 337
Query: 317 TGKMLKEG 324
              +L  G
Sbjct: 338 DNAVLSSG 345

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/252 (21%), Positives = 109/252 (43%), Gaps = 46/252 (18%)
Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHD--TVKARREVELQLAVGS---HKHIV 72
           +I+G G +G+V    L++  ++   V A+K L    T + RR+   + ++     H +I+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPV-AIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +    E +    R  +++ E M  G L     +  DG FT  +   ++  + + +++L 
Sbjct: 114 RL----EGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           D    HRD+   N+L                     NL         + K++DFG ++ +
Sbjct: 169 DLGYVHRDLAARNVLVDS------------------NL---------VCKVSDFGLSRVL 201
Query: 193 VS--NKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQ 248
               + A   T    P  + APE +    +  + D+WS GV+M+ +L  G  P+++   +
Sbjct: 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR 261
Query: 249 AISPGMKNRIRL 260
            +   ++   RL
Sbjct: 262 DVISSVEEGYRL 273

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V + V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                    +I E M  G L   +++             +  +I SA+++L  +N  HR+
Sbjct: 327 ----EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRN 382
Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ 200
           +   N L                            G+  ++K+ DFG ++ +  +  +  
Sbjct: 383 LAARNCLV---------------------------GENHLVKVADFGLSRLMTGDTYTAH 415
Query: 201 TPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
                P  + APE L  +K+    D+W+ GV+++ I   G  P+
Sbjct: 416 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 100/253 (39%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  + F++++Q      T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 106 SRTPALVFEHVNNTD-FKQLRQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 160
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 161 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 193
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 312 RLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 106 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 160
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 161 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 193
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 312 RLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 106 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 160
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 161 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 193
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 312 RLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 106 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 160
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 161 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 193
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 312 RLTAREAMEHPYF 324

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 46/229 (20%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS---HKHIVNIKDVYEN 80
           LG G  G+V   V KK S   A+K L +      E   + AV     H ++V +  V   
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV--- 96
Query: 81  IYNGSRCLL-----VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
                 C L     ++ E M  G L   +++      T      +  +I SA+++L  +N
Sbjct: 97  ------CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN 150
Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
             HRD+   N L                            G+  ++K+ DFG ++ +  +
Sbjct: 151 FIHRDLAARNCLV---------------------------GENHVVKVADFGLSRLMTGD 183
Query: 196 KASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
             +       P  + APE L  + +    D+W+ GV+++ I   G  P+
Sbjct: 184 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 106 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 160
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 161 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 193
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 312 RLTAREAMEHPYF 324

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/306 (21%), Positives = 127/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+        +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 95  IINLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 151 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLAR---------- 197
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +  + KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 198 -----DINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 245
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 246 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 298
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 299 KQLVED 304

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/306 (21%), Positives = 127/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+        +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 90  IINLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 146 LVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADFGLAR---------- 192
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +  + KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 193 -----DINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 240
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 241 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 293
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 294 KQLVED 299

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 105 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 159
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 160 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 192
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 310
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 311 RLTAREAMEHPYF 323

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 106 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 160
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 161 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 193
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 312 RLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 106 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 160
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 161 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 193
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 312 RLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 104 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 158
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 159 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 191
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 252 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 309
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 310 RLTAREAMEHPYF 322

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 106 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 160
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 161 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 193
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 194 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 253
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 254 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 311
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 312 RLTAREAMEHPYF 324

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/306 (21%), Positives = 127/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+        +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 149 IINLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLAR---------- 251
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +  + KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 252 -----DINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 300 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 352
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 353 KQLVED 358

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 105 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 159
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 160 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 192
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 310
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 311 RLTAREAMEHPYF 323

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/306 (21%), Positives = 127/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+        +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 92  IINLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 148 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLAR---------- 194
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +  + KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 195 -----DINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 242
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 243 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 295
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 296 KQLVED 301

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 34/153 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGA---FTEREAAIIMNEICSAIKFLHDQN--IAHRDVK 142
           L ++ E +  G L++ + +   GA     ER    +  ++   + +LH++N  I HR++K
Sbjct: 109 LSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK 166
Query: 143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP 202
             NLL  K                     YT       +K+ DFG ++   S   S ++ 
Sbjct: 167 SPNLLVDKK--------------------YT-------VKVCDFGLSRLKASTFLSSKSA 199
Query: 203 CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL 235
             TP ++APEVL  +  ++  D++S GVI++ L
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 67/253 (26%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + H   I HRDVKP 
Sbjct: 111 SRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 165
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N++     +   L+L D+G  +     +  PG    +++                     
Sbjct: 166 NVMIDH--EHRKLRLIDWGLAE-----FYHPGQEYNVRVA-------------------- 198
Query: 205 TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ--------------- 248
           + Y+  PE+L     YD S D+WSLG ++  ++    PFF  H                 
Sbjct: 199 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 258
Query: 249 ----------AISP------GMKNRIRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSE 291
                      + P      G  +R R  +  F + E +H VS EA   +  +L  D   
Sbjct: 259 LYDYIDKYNIELDPRFNDILGRHSRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQS 316
Query: 292 RLTIDQVMENKWI 304
           RLT  + ME+ + 
Sbjct: 317 RLTAREAMEHPYF 329

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 71/174 (40%), Gaps = 22/174 (12%)
Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG------DVKPENLLYTK 174
           M  +  A+K +H   I HRDVKP N LY +        L DFG      D K E L + +
Sbjct: 123 MLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKK--YALVDFGLAQGTHDTKIELLKFVQ 180
Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG--PDKYDKSCDIWSLGVIM 232
                  +          +S +  +     TP + APEVL   P++   + D+WS GVI 
Sbjct: 181 --SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQ-TTAIDMWSAGVIF 237
Query: 233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
             LL G  PF+       +      IR  +            Q AKT  K++LC
Sbjct: 238 LSLLSGRYPFYKASDDLTALAQIMTIRGSR---------ETIQAAKTFGKSILC 282

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/306 (20%), Positives = 127/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+        +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 103 IINLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++++ DFG  +          
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADFGLAR---------- 205
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +  + KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 206 -----DINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 307 KQLVED 312

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/306 (21%), Positives = 126/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D            E+E+   +G HK+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+        +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 103 IINLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLAR---------- 205
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +  + KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 206 -----DINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 307 KQLVED 312

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 86/228 (37%), Gaps = 66/228 (28%)
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
            T+ +    M E+  A+ + H + I HRDVKP N++             D    K     
Sbjct: 134 LTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVM------------IDHQQKK----- 176
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGV 230
                    L+L D+G A+              + Y+  PE+L     YD S D+WSLG 
Sbjct: 177 ---------LRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 226
Query: 231 IMYILLCGFPPFFSNHGQ---------------------------AISP------GMKNR 257
           ++  ++    PFF  HGQ                            + P      G  +R
Sbjct: 227 MLASMIFRREPFF--HGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSR 284
Query: 258 IRLGQFDFPNPEWEH-VSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            R    +F + E  H VS EA  L+  +L  D  +RLT  + ME+ + 
Sbjct: 285 KRWE--NFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 40/283 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNI 74
           E +G G  G V + V++    +YA+K          D   A REV     +G H H+V  
Sbjct: 13  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 71
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED--GAFTEREAAIIMNEICSAIKFLH 132
              Y + +     +L+  E  +GG L   I +       F E E   ++ ++   ++++H
Sbjct: 72  ---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 128
Query: 133 DQNIAHRDVKPENLLYTKPG-DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
             ++ H D+KP N+  ++        +  D  D     +++         K+ D G   +
Sbjct: 129 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF---------KIGDLGHVTR 179
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
           I    +S Q       ++A EVL  +  +    DI++L + + +   G  P   N  Q  
Sbjct: 180 I----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPLPRNGDQW- 233
Query: 251 SPGMKNRIRLGQFDFPNPEWEHV-SQEAKTLIKNMLCVDPSER 292
                + IR G+     P    V SQE   L+K M+  DP  R
Sbjct: 234 -----HEIRQGRL----PRIPQVLSQEFTELLKVMIHPDPERR 267

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/250 (21%), Positives = 100/250 (40%), Gaps = 69/250 (27%)
Query: 19  ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA------RREVELQLAVGSHKHIV 72
           +     GLG    VL++         A+K+L  T  A        E+++   +G H++IV
Sbjct: 63  VEATAFGLGKEDAVLKV---------AVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAA 118
           N+        +G   L++   C +G +L   +++K               +   + R+  
Sbjct: 114 NLLGA---CTHGGPVLVITEYCCYG-DLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
              +++   + FL  +N  HRDV   N+L T                           +G
Sbjct: 170 HFSSQVAQGMAFLASKNCIHRDVAARNVLLT---------------------------NG 202
Query: 179 GILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            + K+ DFG A+ I+++     K + + P     ++APE +    Y    D+WS G++++
Sbjct: 203 HVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLW 259
Query: 234 -ILLCGFPPF 242
            I   G  P+
Sbjct: 260 EIFSLGLNPY 269

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 40/283 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNI 74
           E +G G  G V + V++    +YA+K          D   A REV     +G H H+V  
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 73
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED--GAFTEREAAIIMNEICSAIKFLH 132
              Y + +     +L+  E  +GG L   I +       F E E   ++ ++   ++++H
Sbjct: 74  ---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 133 DQNIAHRDVKPENLLYTKPG-DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
             ++ H D+KP N+  ++        +  D  D     +++         K+ D G   +
Sbjct: 131 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF---------KIGDLGHVTR 181
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
           I    +S Q       ++A EVL  +  +    DI++L + + +   G  P   N  Q  
Sbjct: 182 I----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQW- 235
Query: 251 SPGMKNRIRLGQFDFPNPEWEHV-SQEAKTLIKNMLCVDPSER 292
                + IR G+     P    V SQE   L+K M+  DP  R
Sbjct: 236 -----HEIRQGRL----PRIPQVLSQEFTELLKVMIHPDPERR 269

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 40/283 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNI 74
           E +G G  G V + V++    +YA+K          D   A REV     +G H H+V  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 75
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED--GAFTEREAAIIMNEICSAIKFLH 132
              Y + +     +L+  E  +GG L   I +       F E E   ++ ++   ++++H
Sbjct: 76  ---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 133 DQNIAHRDVKPENLLYTKPG-DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
             ++ H D+KP N+  ++        +  D  D     +++         K+ D G   +
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF---------KIGDLGHVTR 183
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
           I    +S Q       ++A EVL  +  +    DI++L + + +   G  P   N  Q  
Sbjct: 184 I----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQW- 237
Query: 251 SPGMKNRIRLGQFDFPNPEWEHV-SQEAKTLIKNMLCVDPSER 292
                + IR G+     P    V SQE   L+K M+  DP  R
Sbjct: 238 -----HEIRQGRL----PRIPQVLSQEFTELLKVMIHPDPERR 271

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 109/259 (42%), Gaps = 51/259 (19%)
Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------- 108
           E+E+   +G HK+I+N+        +G   L VI+E    G L + +Q +E         
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQ--DGP--LYVIVEYASKGNLREYLQAREPPGLEYSYN 138
Query: 109 -----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                +   + ++      ++   +++L  +   HRD+   N+L T   +  ++K+ DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFG 195
Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             +                +    + KK  + +  ++       ++APE L    Y    
Sbjct: 196 LAR---------------DIHHIDYYKKTTNGRLPVK-------WMAPEALFDRIYTHQS 233
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           D+WS GV+++ I   G  P+     + +   +K   R+   D P+    + + E   +++
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS----NCTNELYMMMR 286
Query: 283 NMLCVDPSERLTIDQVMEN 301
           +     PS+R T  Q++E+
Sbjct: 287 DCWHAVPSQRPTFKQLVED 305

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 70/174 (40%), Gaps = 34/174 (19%)
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           H+V I D  E   +G   L V    ++G +L   ++++  G      A  I+ +I SA+ 
Sbjct: 95  HVVPIHDFGE--IDGQ--LYVDXRLINGVDLAAXLRRQ--GPLAPPRAVAIVRQIGSALD 148
Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
             H     HRDVKPEN+L                 V  ++  Y          L DFG A
Sbjct: 149 AAHAAGATHRDVKPENIL-----------------VSADDFAY----------LVDFGIA 181
Query: 190 KKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
                 K + L     T YY APE           DI++L  ++Y  L G PP+
Sbjct: 182 SATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPY 235

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 40/283 (14%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGSHKHIVNI 74
           E +G G  G V + V++    +YA+K          D   A REV     +G H H+V  
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 73
Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED--GAFTEREAAIIMNEICSAIKFLH 132
              Y + +     +L+  E  +GG L   I +       F E E   ++ ++   ++++H
Sbjct: 74  ---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 133 DQNIAHRDVKPENLLYTKPG-DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
             ++ H D+KP N+  ++        +  D  D     +++         K+ D G   +
Sbjct: 131 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF---------KIGDLGHVTR 181
Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
           I    +S Q       ++A EVL  +  +    DI++L + + +   G  P   N  Q  
Sbjct: 182 I----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQW- 235
Query: 251 SPGMKNRIRLGQFDFPNPEWEHV-SQEAKTLIKNMLCVDPSER 292
                + IR G+     P    V SQE   L+K M+  DP  R
Sbjct: 236 -----HEIRQGRL----PRIPQVLSQEFTELLKVMIHPDPERR 269

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/147 (20%), Positives = 62/147 (42%), Gaps = 29/147 (19%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +  G F       +  ++C  + +L + ++ HRD+   N L
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCL 135
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  ++K++DFG  + ++ ++ +  T    P 
Sbjct: 136 V---------------------------GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMY 233
            + +PEV    +Y    D+WS GV+M+
Sbjct: 169 KWASPEVFSFSRYSSKSDVWSFGVLMW 195

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/320 (22%), Positives = 125/320 (39%), Gaps = 87/320 (27%)
Query: 33  LQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENI-----YNGSRC 87
           L+I  KK S  +   ++H   +  RE+ L L    H++++ + DV+        +N    
Sbjct: 77  LKIAVKKLSRPFQ-SIIH-AKRTYRELRL-LKHMKHENVIGLLDVFTPATSLEEFNDVYL 133
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           +  +M    G +L   ++ ++    T+     ++ +I   +K++H  +I HRD+KP NL 
Sbjct: 134 VTHLM----GADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 186
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
             +  +                           LK+ DFG A+        +     T +
Sbjct: 187 VNEDCE---------------------------LKILDFGLARH---TDDEMTGYVATRW 216
Query: 208 YVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG---FPPFFSNH---------------GQ 248
           Y APE+ L    Y+ + DIWS+G IM  LL G   FP   ++H                 
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPG--TDHINQLQQIMRLTGTPPAS 274
Query: 249 AIS--------------PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
            IS              P M  R     F   NP        A  L++ ML +D  +R+T
Sbjct: 275 VISRMPSHEARNYINSLPQMPKRNFADVFIGANP-------LAVDLLEKMLVLDTDKRIT 327
Query: 295 IDQVMENKWISQFNQVPQTP 314
             + + + + SQ++     P
Sbjct: 328 ASEALAHPYFSQYHDPDDEP 347

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 125/307 (40%), Gaps = 66/307 (21%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+        +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 103 IINLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP-ENLLYTKP 175
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +   N+ Y K 
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKN 215
Query: 176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-I 234
              G L +                        ++APE L    Y    D+WS GV+M+ I
Sbjct: 216 TTNGRLPVK-----------------------WMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
              G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T
Sbjct: 253 FTLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPT 305
Query: 295 IDQVMEN 301
             Q++E+
Sbjct: 306 FKQLVED 312

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/306 (21%), Positives = 126/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+        +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 103 IINLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLAR---------- 205
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +    KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 206 -----DINNIDXXKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 307 KQLVED 312

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/306 (21%), Positives = 127/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+  +     +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 103 IINL--LGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLAR---------- 205
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +    KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 206 -----DINNIDXXKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 307 KQLVED 312

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 34/153 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGA---FTEREAAIIMNEICSAIKFLHDQN--IAHRDVK 142
           L ++ E +  G L++ + +   GA     ER    +  ++   + +LH++N  I HRD+K
Sbjct: 109 LSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLK 166
Query: 143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP 202
             NLL  K                     YT       +K+ DFG ++   S     +  
Sbjct: 167 SPNLLVDKK--------------------YT-------VKVCDFGLSRLKASXFLXSKXA 199
Query: 203 CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL 235
             TP ++APEVL  +  ++  D++S GVI++ L
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 104/257 (40%), Gaps = 72/257 (28%)
Query: 24  LGLGINGKVLQIV------EKKTSEVYALKVLHDTVKA------RREVELQLAVGSHKHI 71
           LG G  GKV++        E    +V A+K+L  T  A        E+++   +G H++I
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHADEKEALMSELKIMSHLGQHENI 97
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGEL-FQRIQQ------------------KEDGAF 112
           VN+        +G   L++   C +G  L F R +                   KEDG  
Sbjct: 98  VNLLGA---CTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 113 TE-REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
            E R+     +++   + FL  +N  HRDV   N+L T                      
Sbjct: 155 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---------------------- 192
Query: 172 YTKPGDGGILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIW 226
                +G + K+ DFG A+ I+++     K + + P     ++APE +    Y    D+W
Sbjct: 193 -----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVW 244
Query: 227 SLGVIMY-ILLCGFPPF 242
           S G++++ I   G  P+
Sbjct: 245 SYGILLWEIFSLGLNPY 261

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/321 (21%), Positives = 126/321 (39%), Gaps = 73/321 (22%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNIKDV 77
           +G G + KV Q++ +K  ++YA+K ++       T+ + R  E+       +H   I  +
Sbjct: 64  IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQHSDKIIRL 121
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y+      + + ++MEC   G +      K+  +    E       +  A+  +H   I 
Sbjct: 122 YDYEIT-DQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           H D+KP N L                               G+LKL DFG A ++  +  
Sbjct: 178 HSDLKPANFLIVD----------------------------GMLKLIDFGIANQMQPDTT 209
Query: 198 SL--QTPCYTPYYVAPEVLGPDKYDKS-----------CDIWSLGVIMYILLCGFPPF-- 242
           S+   +   T  Y+ PE +      +             D+WSLG I+Y +  G  PF  
Sbjct: 210 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
Query: 243 ----FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQ 297
                S     I P         + +FP+ PE     ++ + ++K  L  DP +R++I +
Sbjct: 270 IINQISKLHAIIDPNH-------EIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPE 317
Query: 298 VMENKWISQFNQVPQTPLCTG 318
           ++ + ++ Q    P   +  G
Sbjct: 318 LLAHPYV-QIQTHPVNQMAKG 337

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/321 (21%), Positives = 126/321 (39%), Gaps = 73/321 (22%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNIKDV 77
           +G G + KV Q++ +K  ++YA+K ++       T+ + R  E+       +H   I  +
Sbjct: 64  IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQHSDKIIRL 121
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y+      + + ++MEC   G +      K+  +    E       +  A+  +H   I 
Sbjct: 122 YDYEIT-DQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           H D+KP N L                               G+LKL DFG A ++  +  
Sbjct: 178 HSDLKPANFLIV----------------------------DGMLKLIDFGIANQMQPDTT 209
Query: 198 SL--QTPCYTPYYVAPEVLGPDKYDKS-----------CDIWSLGVIMYILLCGFPPF-- 242
           S+   +   T  Y+ PE +      +             D+WSLG I+Y +  G  PF  
Sbjct: 210 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
Query: 243 ----FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQ 297
                S     I P         + +FP+ PE     ++ + ++K  L  DP +R++I +
Sbjct: 270 IINQISKLHAIIDPNH-------EIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPE 317
Query: 298 VMENKWISQFNQVPQTPLCTG 318
           ++ + ++ Q    P   +  G
Sbjct: 318 LLAHPYV-QIQTHPVNQMAKG 337

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +++E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 87  IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 146
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 147 V---------------------------GENLVCKVADFGLARLIEDNEXTARQGAKFPI 179
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 231
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     DP ER T +
Sbjct: 232 YRMPCPP------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 43/238 (18%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHK- 69
           D Y+I + ++G G  G+V++  ++   E  A+K++ +      +A+ EV L   +  H  
Sbjct: 54  DRYEIDS-LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 70  ----HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
               +IV++K  +  ++    CL+  M   +  +L +    +       R+ A    ++C
Sbjct: 113 EMKYYIVHLKRHF--MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFA---QQMC 167
Query: 126 SAIKFLHDQNIAHRDVKPE-NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
           +A+ FL           PE ++++               D+KPEN+L   P    I K+ 
Sbjct: 168 TALLFL---------ATPELSIIHC--------------DLKPENILLCNPKRSAI-KIV 203
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           DFG + ++      +     + +Y +PEVL    YD + D+WSLG I+  +  G P F
Sbjct: 204 DFGSSCQL---GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/306 (20%), Positives = 127/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+++        +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 103 IIHLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLAR---------- 205
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +  + KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 206 -----DINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 307 KQLVED 312

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/306 (20%), Positives = 126/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+        +G   L VI+     G L + ++ +               +   T ++
Sbjct: 103 IINLLGACTQ--DGP--LYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLAR---------- 205
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +  + KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 206 -----DINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 307 KQLVED 312

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ME M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 87  IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 146
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 147 V---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 231
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     DP ER T +
Sbjct: 232 YRMPCPP------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 43/238 (18%)
Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHK- 69
           D Y+I + ++G G  G+V++  ++   E  A+K++ +      +A+ EV L   +  H  
Sbjct: 35  DRYEIDS-LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 93
Query: 70  ----HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
               +IV++K  +  ++    CL+  M   +  +L +    +       R+ A    ++C
Sbjct: 94  EMKYYIVHLKRHF--MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFA---QQMC 148
Query: 126 SAIKFLHDQNIAHRDVKPE-NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
           +A+ FL           PE ++++               D+KPEN+L   P    I K+ 
Sbjct: 149 TALLFL---------ATPELSIIHC--------------DLKPENILLCNPKRSAI-KIV 184
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           DFG + ++      +     + +Y +PEVL    YD + D+WSLG I+  +  G P F
Sbjct: 185 DFGSSCQL---GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLF 239

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/321 (21%), Positives = 126/321 (39%), Gaps = 73/321 (22%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNIKDV 77
           +G G + KV Q++ +K  ++YA+K ++       T+ + R  E+       +H   I  +
Sbjct: 36  IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQHSDKIIRL 93
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y+      + + ++MEC   G +      K+  +    E       +  A+  +H   I 
Sbjct: 94  YDYEIT-DQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           H D+KP N L                               G+LKL DFG A ++  +  
Sbjct: 150 HSDLKPANFLIV----------------------------DGMLKLIDFGIANQMQPDTT 181
Query: 198 SL--QTPCYTPYYVAPEVLGPDKYDKS-----------CDIWSLGVIMYILLCGFPPF-- 242
           S+   +   T  Y+ PE +      +             D+WSLG I+Y +  G  PF  
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
Query: 243 ----FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQ 297
                S     I P         + +FP+ PE     ++ + ++K  L  DP +R++I +
Sbjct: 242 IINQISKLHAIIDPN-------HEIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPE 289
Query: 298 VMENKWISQFNQVPQTPLCTG 318
           ++ + ++ Q    P   +  G
Sbjct: 290 LLAHPYV-QIQTHPVNQMAKG 309

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 45/231 (19%)
Query: 14  QDDYDISTEILGLGINGKVLQIV---EKKTSEVYALKVL-HDTVKARREVELQLAVGSHK 69
           +D+  I+   LG G  G V Q V    KK  +V A+KVL   T KA  E  ++ A   H+
Sbjct: 8   RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 70  ----HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
               +IV +  V +     +  L+++ME   GG L + +  K +        A +++++ 
Sbjct: 67  LDNPYIVRLIGVCQ-----AEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVS 120
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +K+L ++N  HRD+   N+L                     N  Y         K++D
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLV-------------------NRHYA--------KISD 153
Query: 186 FGFAKKIVSNKASLQTPCYTPY---YVAPEVLGPDKYDKSCDIWSLGVIMY 233
           FG +K + ++ +         +   + APE +   K+    D+WS GV M+
Sbjct: 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 204

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/306 (20%), Positives = 126/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+ +        +G   L VI+E    G L + ++ +               +   T ++
Sbjct: 103 IITLLGACTQ--DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLAR---------- 205
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +  + KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 206 -----DINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 307 KQLVED 312

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 82/184 (44%), Gaps = 34/184 (18%)
Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
           +RE+++  A+ S   IV  + V  +   G + L ++ME +  G L +   Q+        
Sbjct: 59  QREIQILKALHS-DFIVKYRGV--SYGPGRQSLRLVMEYLPSGCL-RDFLQRHRARLDAS 114
Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
              +  ++IC  +++L  +   HRD+   N+L                 V+ E       
Sbjct: 115 RLLLYSSQICKGMEYLGSRRCVHRDLAARNIL-----------------VESE------- 150
Query: 176 GDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YYVAPEVLGPDKYDKSCDIWSLGVIM 232
                +K+ DFG AK +  +K    ++ P  +P ++ APE L  + + +  D+WS GV++
Sbjct: 151 ---AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 207
Query: 233 YILL 236
           Y L 
Sbjct: 208 YELF 211

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/321 (21%), Positives = 126/321 (39%), Gaps = 73/321 (22%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNIKDV 77
           +G G + KV Q++ +K  ++YA+K ++       T+ + R  E+       +H   I  +
Sbjct: 17  IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQHSDKIIRL 74
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y+      + + ++MEC   G +      K+  +    E       +  A+  +H   I 
Sbjct: 75  YDYEIT-DQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 130
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           H D+KP N L                               G+LKL DFG A ++  +  
Sbjct: 131 HSDLKPANFLIV----------------------------DGMLKLIDFGIANQMQPDTT 162
Query: 198 SL--QTPCYTPYYVAPEVLGPDKYDKS-----------CDIWSLGVIMYILLCGFPPF-- 242
           S+   +   T  Y+ PE +      +             D+WSLG I+Y +  G  PF  
Sbjct: 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
Query: 243 ----FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQ 297
                S     I P         + +FP+ PE     ++ + ++K  L  DP +R++I +
Sbjct: 223 IINQISKLHAIIDPNH-------EIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPE 270
Query: 298 VMENKWISQFNQVPQTPLCTG 318
           ++ + ++ Q    P   +  G
Sbjct: 271 LLAHPYV-QIQTHPVNQMAKG 290

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/147 (20%), Positives = 61/147 (41%), Gaps = 29/147 (19%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +  G F       +  ++C  + +L +  + HRD+   N L
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 135
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  ++K++DFG  + ++ ++ +  T    P 
Sbjct: 136 V---------------------------GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMY 233
            + +PEV    +Y    D+WS GV+M+
Sbjct: 169 KWASPEVFSFSRYSSKSDVWSFGVLMW 195

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/321 (21%), Positives = 126/321 (39%), Gaps = 73/321 (22%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNIKDV 77
           +G G + KV Q++ +K  ++YA+K ++       T+ + R  E+       +H   I  +
Sbjct: 20  IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQHSDKIIRL 77
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y+      + + ++MEC   G +      K+  +    E       +  A+  +H   I 
Sbjct: 78  YDYEIT-DQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 133
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           H D+KP N L                               G+LKL DFG A ++  +  
Sbjct: 134 HSDLKPANFLIV----------------------------DGMLKLIDFGIANQMQPDTT 165
Query: 198 SL--QTPCYTPYYVAPEVLGPDKYDKS-----------CDIWSLGVIMYILLCGFPPF-- 242
           S+   +   T  Y+ PE +      +             D+WSLG I+Y +  G  PF  
Sbjct: 166 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 225
Query: 243 ----FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQ 297
                S     I P         + +FP+ PE     ++ + ++K  L  DP +R++I +
Sbjct: 226 IINQISKLHAIIDPN-------HEIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPE 273
Query: 298 VMENKWISQFNQVPQTPLCTG 318
           ++ + ++ Q    P   +  G
Sbjct: 274 LLAHPYV-QIQTHPVNQMAKG 293

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +++E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 87  IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 146
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 147 V---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 231
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     DP ER T +
Sbjct: 232 YRMPCPP------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/147 (20%), Positives = 61/147 (41%), Gaps = 29/147 (19%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +  G F       +  ++C  + +L +  + HRD+   N L
Sbjct: 75  ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 133
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  ++K++DFG  + ++ ++ +  T    P 
Sbjct: 134 V---------------------------GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMY 233
            + +PEV    +Y    D+WS GV+M+
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMW 193

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/321 (21%), Positives = 126/321 (39%), Gaps = 73/321 (22%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNIKDV 77
           +G G + KV Q++ +K  ++YA+K ++       T+ + R  E+       +H   I  +
Sbjct: 16  IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQHSDKIIRL 73
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y+      + + ++MEC   G +      K+  +    E       +  A+  +H   I 
Sbjct: 74  YDYEIT-DQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 129
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           H D+KP N L                               G+LKL DFG A ++  +  
Sbjct: 130 HSDLKPANFLIVD----------------------------GMLKLIDFGIANQMQPDTT 161
Query: 198 SL--QTPCYTPYYVAPEVLGPDKYDKS-----------CDIWSLGVIMYILLCGFPPF-- 242
           S+   +   T  Y+ PE +      +             D+WSLG I+Y +  G  PF  
Sbjct: 162 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 221
Query: 243 ----FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQ 297
                S     I P         + +FP+ PE     ++ + ++K  L  DP +R++I +
Sbjct: 222 IINQISKLHAIIDPN-------HEIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPE 269
Query: 298 VMENKWISQFNQVPQTPLCTG 318
           ++ + ++ Q    P   +  G
Sbjct: 270 LLAHPYV-QIQTHPVNQMAKG 289

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/147 (20%), Positives = 61/147 (41%), Gaps = 29/147 (19%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +  G F       +  ++C  + +L +  + HRD+   N L
Sbjct: 80  ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 138
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  ++K++DFG  + ++ ++ +  T    P 
Sbjct: 139 V---------------------------GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 171
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMY 233
            + +PEV    +Y    D+WS GV+M+
Sbjct: 172 KWASPEVFSFSRYSSKSDVWSFGVLMW 198

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 82/184 (44%), Gaps = 34/184 (18%)
Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
           +RE+++  A+ S   IV  + V  +   G + L ++ME +  G L +   Q+        
Sbjct: 72  QREIQILKALHS-DFIVKYRGV--SYGPGRQSLRLVMEYLPSGCL-RDFLQRHRARLDAS 127
Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
              +  ++IC  +++L  +   HRD+   N+L                 V+ E       
Sbjct: 128 RLLLYSSQICKGMEYLGSRRCVHRDLAARNIL-----------------VESE------- 163
Query: 176 GDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YYVAPEVLGPDKYDKSCDIWSLGVIM 232
                +K+ DFG AK +  +K    ++ P  +P ++ APE L  + + +  D+WS GV++
Sbjct: 164 ---AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220
Query: 233 YILL 236
           Y L 
Sbjct: 221 YELF 224

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/217 (20%), Positives = 86/217 (39%), Gaps = 48/217 (22%)
Query: 31  KVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV 90
           K+L++V+    +  A +     ++  R V + L +G               Y     L +
Sbjct: 64  KILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG---------------YMTKDNLAI 108
Query: 91  IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTK 150
           + +   G  L++ +  +E   F   +   I  +    + +LH +NI HRD+K  N+    
Sbjct: 109 VTQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH- 166
Query: 151 PGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA--KKIVSNKASLQTPCYTPYY 208
                                     +G  +K+ DFG A  K   S    ++ P  +  +
Sbjct: 167 --------------------------EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 209 VAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           +APEV+     + +    D++S G+++Y L+ G  P+
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/147 (20%), Positives = 61/147 (41%), Gaps = 29/147 (19%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +  G F       +  ++C  + +L +  + HRD+   N L
Sbjct: 97  ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 155
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  ++K++DFG  + ++ ++ +  T    P 
Sbjct: 156 V---------------------------GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 188
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMY 233
            + +PEV    +Y    D+WS GV+M+
Sbjct: 189 KWASPEVFSFSRYSSKSDVWSFGVLMW 215

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 82/184 (44%), Gaps = 34/184 (18%)
Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
           +RE+++  A+ S   IV  + V  +   G + L ++ME +  G L +   Q+        
Sbjct: 60  QREIQILKALHS-DFIVKYRGV--SYGPGRQSLRLVMEYLPSGCL-RDFLQRHRARLDAS 115
Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
              +  ++IC  +++L  +   HRD+   N+L                 V+ E       
Sbjct: 116 RLLLYSSQICKGMEYLGSRRCVHRDLAARNIL-----------------VESE------- 151
Query: 176 GDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YYVAPEVLGPDKYDKSCDIWSLGVIM 232
                +K+ DFG AK +  +K    ++ P  +P ++ APE L  + + +  D+WS GV++
Sbjct: 152 ---AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 208
Query: 233 YILL 236
           Y L 
Sbjct: 209 YELF 212

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 84  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 143
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 144 VS---------------------------DTLSCKIADFGLARLIEDNEXTAREGAKFPI 176
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 177 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 218

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 90  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 149
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 150 VS---------------------------DTLSCKIADFGLARLIEDNEXTAREGAKFPI 182
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 183 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 224

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 147
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 148 VS---------------------------DTLSCKIADFGLARLIEDNEXTAREGAKFPI 180
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 181 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 222

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 83  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 142
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 143 VS---------------------------DTLSCKIADFGLARLIEDNEXTAREGAKFPI 175
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 176 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 217

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 142 VS---------------------------DTLSCKIADFGLARLIEDNEXTAREGAKFPI 174
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/306 (20%), Positives = 126/306 (41%), Gaps = 64/306 (20%)
Query: 24  LGLGINGKVLQI----VEK---KTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           LG G  G+V+      ++K   K +   A+K+L D    +       E+E+   +G HK+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTERE 116
           I+N+        +G   L VI+     G L + ++ +               +   T ++
Sbjct: 103 IINLLGACTQ--DGP--LYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 ++   +++L  Q   HRD+   N+L T   +  ++K+ DFG  +          
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLAR---------- 205
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
                 + +  + KK  + +  ++       ++APE L    Y    D+WS GV+M+ I 
Sbjct: 206 -----DINNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P+     + +   +K   R+   D P     + + E   ++++     PS+R T 
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRM---DKP----ANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 296 DQVMEN 301
            Q++E+
Sbjct: 307 KQLVED 312

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 142 VS---------------------------DTLSCKIADFGLARLIEDNEXTAREGAKFPI 174
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 216

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/147 (20%), Positives = 61/147 (41%), Gaps = 29/147 (19%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +  G F       +  ++C  + +L +  + HRD+   N L
Sbjct: 78  ICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 136
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  ++K++DFG  + ++ ++ +  T    P 
Sbjct: 137 V---------------------------GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMY 233
            + +PEV    +Y    D+WS GV+M+
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMW 196

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 52/219 (23%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-EICSAIKFLHDQNIAHRDVKPENL 146
           + ++ E M+ G L   ++  E G +      + M+ +I S + ++   N  HRD++  N+
Sbjct: 84  IYIVTEYMNKGSLLDFLK-GETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANI 142
Query: 147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP 206
           L                            G+  + K+ DFG A+ I  N+ + +     P
Sbjct: 143 LV---------------------------GENLVCKVADFGLARLIEDNEWTARQGAKFP 175
Query: 207 Y-YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ--- 262
             + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q   
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVER 227
Query: 263 -FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
            +  P P       E    + +++C     +P ER T +
Sbjct: 228 GYRMPCPP------ECPESLHDLMCQCWRKEPEERPTFE 260

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 91  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 150
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 151 VS---------------------------DTLSCKIADFGLARLIEDNEXTAREGAKFPI 183
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 184 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 225

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 52/219 (23%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-EICSAIKFLHDQNIAHRDVKPENL 146
           + ++ E M+ G L   ++  E G +      + M+ +I S + ++   N  HRD++  N+
Sbjct: 84  IYIVTEYMNKGSLLDFLK-GETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANI 142
Query: 147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP 206
           L                            G+  + K+ DFG A+ I  N+ + +     P
Sbjct: 143 LV---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFP 175
Query: 207 Y-YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ--- 262
             + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q   
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVER 227
Query: 263 -FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
            +  P P       E    + +++C     +P ER T +
Sbjct: 228 GYRMPCPP------ECPESLHDLMCQCWRKEPEERPTFE 260

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/311 (21%), Positives = 127/311 (40%), Gaps = 53/311 (17%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNIKDV 77
           +G G + KV Q++ +K  ++YA+K ++       T+ + R  E+       +H   I  +
Sbjct: 36  IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQHSDKIIRL 93
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y+      + + ++MEC   G +      K+  +    E       +  A+  +H   I 
Sbjct: 94  YDYEIT-DQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
           H D+KP N L       G+LKL DFG    ++P+     K    G +        K + S
Sbjct: 150 HSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF------FSNHGQ 248
           ++ + ++                      D+WSLG I+Y +  G  PF       S    
Sbjct: 206 SRENGKSKSKI--------------SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251
Query: 249 AISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            I P         + +FP+ PE     ++ + ++K  L  DP +R++I +++ + ++ Q 
Sbjct: 252 IIDPN-------HEIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPELLAHPYV-QI 298
Query: 308 NQVPQTPLCTG 318
              P   +  G
Sbjct: 299 QTHPVNQMAKG 309

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/146 (20%), Positives = 58/146 (39%), Gaps = 30/146 (20%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           L ++ E M  G L   ++ +               ++C A+++L   N  HRD+   N+L
Sbjct: 75  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 134
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           +  + K++DFG  K+  S + + + P     
Sbjct: 135 VS---------------------------EDNVAKVSDFGLTKEASSTQDTGKLPVK--- 164
Query: 208 YVAPEVLGPDKYDKSCDIWSLGVIMY 233
           + APE L   K+    D+WS G++++
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLW 190

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 78  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 137
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 138 V---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFPI 170
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 171 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 222
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     DP ER T +
Sbjct: 223 YRMPCP------PECPESLHDLMCQCWRKDPEERPTFE 254

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/146 (20%), Positives = 58/146 (39%), Gaps = 30/146 (20%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           L ++ E M  G L   ++ +               ++C A+++L   N  HRD+   N+L
Sbjct: 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 321
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           +  + K++DFG  K+  S + + + P     
Sbjct: 322 VS---------------------------EDNVAKVSDFGLTKEASSTQDTGKLPVK--- 351
Query: 208 YVAPEVLGPDKYDKSCDIWSLGVIMY 233
           + APE L   K+    D+WS G++++
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLW 377

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/259 (20%), Positives = 108/259 (41%), Gaps = 51/259 (19%)
Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------- 108
           E+E+   +G HK+I+N+        +G   L VI+E    G L + +Q +          
Sbjct: 75  EMEMMKMIGKHKNIINLLGACTQ--DGP--LYVIVEYASKGNLREYLQARRPPGLEYSYN 130
Query: 109 -----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                +   + ++      ++   +++L  +   HRD+   N+L T   +  ++K+ DFG
Sbjct: 131 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFG 187
Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             +                +    + KK  + +  ++       ++APE L    Y    
Sbjct: 188 LAR---------------DIHHIDYYKKTTNGRLPVK-------WMAPEALFDRIYTHQS 225
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           D+WS GV+++ I   G  P+     + +   +K   R+   D P+    + + E   +++
Sbjct: 226 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS----NCTNELYMMMR 278
Query: 283 NMLCVDPSERLTIDQVMEN 301
           +     PS+R T  Q++E+
Sbjct: 279 DCWHAVPSQRPTFKQLVED 297

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/146 (20%), Positives = 58/146 (39%), Gaps = 30/146 (20%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           L ++ E M  G L   ++ +               ++C A+++L   N  HRD+   N+L
Sbjct: 90  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 149
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           +  + K++DFG  K+  S + + + P     
Sbjct: 150 VS---------------------------EDNVAKVSDFGLTKEASSTQDTGKLPVK--- 179
Query: 208 YVAPEVLGPDKYDKSCDIWSLGVIMY 233
           + APE L   K+    D+WS G++++
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLW 205

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/259 (20%), Positives = 108/259 (41%), Gaps = 51/259 (19%)
Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------- 108
           E+E+   +G HK+I+N+        +G   L VI+E    G L + +Q +          
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQ--DGP--LYVIVEYASKGNLREYLQARRPPGLEYSYN 138
Query: 109 -----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                +   + ++      ++   +++L  +   HRD+   N+L T   +  ++K+ DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFG 195
Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             +                +    + KK  + +  ++       ++APE L    Y    
Sbjct: 196 LAR---------------DIHHIDYYKKTTNGRLPVK-------WMAPEALFDRIYTHQS 233
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           D+WS GV+++ I   G  P+     + +   +K   R+   D P+    + + E   +++
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS----NCTNELYMMMR 286
Query: 283 NMLCVDPSERLTIDQVMEN 301
           +     PS+R T  Q++E+
Sbjct: 287 DCWHAVPSQRPTFKQLVED 305

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/259 (20%), Positives = 108/259 (41%), Gaps = 51/259 (19%)
Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------- 108
           E+E+   +G HK+I+N+        +G   L VI+E    G L + +Q +          
Sbjct: 72  EMEMMKMIGKHKNIINLLGACTQ--DGP--LYVIVEYASKGNLREYLQARRPPGLEYSYN 127
Query: 109 -----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                +   + ++      ++   +++L  +   HRD+   N+L T   +  ++K+ DFG
Sbjct: 128 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFG 184
Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             +                +    + KK  + +  ++       ++APE L    Y    
Sbjct: 185 LAR---------------DIHHIDYYKKTTNGRLPVK-------WMAPEALFDRIYTHQS 222
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           D+WS GV+++ I   G  P+     + +   +K   R+   D P+    + + E   +++
Sbjct: 223 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS----NCTNELYMMMR 275
Query: 283 NMLCVDPSERLTIDQVMEN 301
           +     PS+R T  Q++E+
Sbjct: 276 DCWHAVPSQRPTFKQLVED 294

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/234 (21%), Positives = 90/234 (38%), Gaps = 43/234 (18%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++  E       +      +I   + F+  +N  HRD++  N+L
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                              + K+ DFG A+ I  N+ + +     P 
Sbjct: 317 VSA---------------------------SLVCKIADFGLARVIEDNEYTAREGAKFPI 349
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGV-IMYILLCGFPPFFSNHGQAISPGMKNR--IRLGQF 263
            + APE +    +    D+WS G+ +M I+  G  P+         PGM N   IR  + 
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY---------PGMSNPEVIRALER 400
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLT---IDQVMENKWISQFNQVPQTP 314
            +  P  E+  +E   ++       P ER T   I  V+++ + +  +Q  + P
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQXEEIP 454

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 146
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 147 V---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 231
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     DP ER T +
Sbjct: 232 YRMPCPP------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 146
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 147 V---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 231
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     DP ER T +
Sbjct: 232 YRMPCPP------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/259 (20%), Positives = 108/259 (41%), Gaps = 51/259 (19%)
Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------- 108
           E+E+   +G HK+I+N+        +G   L VI+E    G L + +Q +          
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQ--DGP--LYVIVEYASKGNLREYLQARRPPGLEYCYN 123
Query: 109 -----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                +   + ++      ++   +++L  +   HRD+   N+L T   +  ++K+ DFG
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFG 180
Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             +                +    + KK  + +  ++       ++APE L    Y    
Sbjct: 181 LAR---------------DIHHIDYYKKTTNGRLPVK-------WMAPEALFDRIYTHQS 218
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           D+WS GV+++ I   G  P+     + +   +K   R+   D P+    + + E   +++
Sbjct: 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS----NCTNELYMMMR 271
Query: 283 NMLCVDPSERLTIDQVMEN 301
           +     PS+R T  Q++E+
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 147
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 148 VS---------------------------DTLSCKIADFGLARLIEDNEYTAREGAKFPI 180
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 181 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 222

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 87  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 146
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 147 VS---------------------------DTLSCKIADFGLARLIEDNEYTAREGAKFPI 179
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 180 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 221

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 76  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 135
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 136 V---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFPI 168
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 169 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 220
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     DP ER T +
Sbjct: 221 YRMPCP------PECPESLHDLMCQCWRKDPEERPTFE 252

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 142 VS---------------------------DTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 216

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/259 (20%), Positives = 108/259 (41%), Gaps = 51/259 (19%)
Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------- 108
           E+E+   +G HK+I+N+        +G   L VI+E    G L + +Q +          
Sbjct: 76  EMEMMKMIGKHKNIINLLGACTQ--DGP--LYVIVEYASKGNLREYLQARRPPGLEYSYN 131
Query: 109 -----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                +   + ++      ++   +++L  +   HRD+   N+L T   +  ++K+ DFG
Sbjct: 132 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFG 188
Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             +                +    + KK  + +  ++       ++APE L    Y    
Sbjct: 189 LAR---------------DIHHIDYYKKTTNGRLPVK-------WMAPEALFDRIYTHQS 226
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           D+WS GV+++ I   G  P+     + +   +K   R+   D P+    + + E   +++
Sbjct: 227 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS----NCTNELYMMMR 279
Query: 283 NMLCVDPSERLTIDQVMEN 301
           +     PS+R T  Q++E+
Sbjct: 280 DCWHAVPSQRPTFKQLVED 298

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 92  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 151
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 152 VS---------------------------DTLSCKIADFGLARLIEDNEYTAREGAKFPI 184
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 185 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 226

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/259 (20%), Positives = 108/259 (41%), Gaps = 51/259 (19%)
Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------- 108
           E+E+   +G HK+I+N+        +G   L VI+E    G L + +Q +          
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQ--DGP--LYVIVEYASKGNLREYLQARRPPGLEYCYN 138
Query: 109 -----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                +   + ++      ++   +++L  +   HRD+   N+L T   +  ++K+ DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFG 195
Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             +                +    + KK  + +  ++       ++APE L    Y    
Sbjct: 196 LAR---------------DIHHIDYYKKTTNGRLPVK-------WMAPEALFDRIYTHQS 233
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           D+WS GV+++ I   G  P+     + +   +K   R+   D P+    + + E   +++
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS----NCTNELYMMMR 286
Query: 283 NMLCVDPSERLTIDQVMEN 301
           +     PS+R T  Q++E+
Sbjct: 287 DCWHAVPSQRPTFKQLVED 305

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 77  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 136
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 137 VS---------------------------DTLSCKIADFGLARLIEDNEYTAREGAKFPI 169
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 170 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 211

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 87  IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 146
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 147 V---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 231
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     DP ER T +
Sbjct: 232 YRMPCPP------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/259 (20%), Positives = 108/259 (41%), Gaps = 51/259 (19%)
Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------- 108
           E+E+   +G HK+I+N+        +G   L VI+E    G L + +Q +          
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQ--DGP--LYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 109 -----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                +   + ++      ++   +++L  +   HRD+   N+L T   +  ++K+ DFG
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFG 236
Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             +                +    + KK  + +  ++       ++APE L    Y    
Sbjct: 237 LAR---------------DIHHIDYYKKTTNGRLPVK-------WMAPEALFDRIYTHQS 274
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           D+WS GV+++ I   G  P+     + +   +K   R+   D P+    + + E   +++
Sbjct: 275 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS----NCTNELYMMMR 327
Query: 283 NMLCVDPSERLTIDQVMEN 301
           +     PS+R T  Q++E+
Sbjct: 328 DCWHAVPSQRPTFKQLVED 346

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 58/133 (43%), Gaps = 17/133 (12%)
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
            TE+    I+  +    KF+H+  I HRD+KP N L  +      +K+ DFG      L 
Sbjct: 128 LTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCS---VKICDFG------LA 178
Query: 172 YTKPGDGGILKLTDFGFAKKIV-------SNKASLQTPCYTPYYVAPE-VLGPDKYDKSC 223
            T   D  I  + D    ++         + K  L +   T +Y APE +L  + Y  S 
Sbjct: 179 RTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSI 238
Query: 224 DIWSLGVIMYILL 236
           DIWS G I   LL
Sbjct: 239 DIWSTGCIFAELL 251

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/181 (19%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +   +++ME    G L + +QQ       ++    +++++   +K+L + N  HRD+   
Sbjct: 83  AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 140
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                       L T+       K++DFG +K + +++   +   +
Sbjct: 141 NVL-----------------------LVTQH----YAKISDFGLSKALRADENXYKAQTH 173
Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
             +   + APE +   K+    D+WS GV+M+     G  P+    G  ++  ++   R+
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 233
Query: 261 G 261
           G
Sbjct: 234 G 234

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/321 (21%), Positives = 125/321 (38%), Gaps = 73/321 (22%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVGSHKHIVNIKDV 77
           +G G + KV Q++ +K  ++YA+K ++       T+ + R  E+       +H   I  +
Sbjct: 64  IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQHSDKIIRL 121
Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIA 137
           Y+      + + ++MEC   G +      K+  +    E       +  A+  +H   I 
Sbjct: 122 YDYEIT-DQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           H D+KP N L                               G+LKL DFG A ++  +  
Sbjct: 178 HSDLKPANFLIVD----------------------------GMLKLIDFGIANQMQPDTT 209
Query: 198 SL--QTPCYTPYYVAPEVLGPDKYDKS-----------CDIWSLGVIMYILLCGFPPF-- 242
           S+   +      Y+ PE +      +             D+WSLG I+Y +  G  PF  
Sbjct: 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
Query: 243 ----FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQ 297
                S     I P         + +FP+ PE     ++ + ++K  L  DP +R++I +
Sbjct: 270 IINQISKLHAIIDPNH-------EIEFPDIPE-----KDLQDVLKCCLKRDPKQRISIPE 317
Query: 298 VMENKWISQFNQVPQTPLCTG 318
           ++ + ++ Q    P   +  G
Sbjct: 318 LLAHPYV-QIQTHPVNQMAKG 337

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/218 (20%), Positives = 83/218 (38%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 77  IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 136
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 137 V---------------------------GENLVCKVADFGLARLIEDNEXTARQGAKFPI 169
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 170 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 221
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     +P ER T +
Sbjct: 222 YRMPCP------PECPESLHDLMCQCWRKEPEERPTFE 253

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/249 (21%), Positives = 97/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 33  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 91
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   ++ME M GG+L   +++           A+     +  +I
Sbjct: 92  HQNIVRCIGVSLQSLPR--FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 185
Query: 185 DFGFAKKIVSNKASLQTPCYT-PY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C   P  ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 246 YPSKSNQEV 254

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/181 (19%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +   +++ME    G L + +QQ       ++    +++++   +K+L + N  HRD+   
Sbjct: 77  AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 134
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                       L T+       K++DFG +K + +++   +   +
Sbjct: 135 NVL-----------------------LVTQH----YAKISDFGLSKALRADENYYKAQTH 167
Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
             +   + APE +   K+    D+WS GV+M+     G  P+    G  ++  ++   R+
Sbjct: 168 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 227
Query: 261 G 261
           G
Sbjct: 228 G 228

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/181 (19%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +   +++ME    G L + +QQ       ++    +++++   +K+L + N  HRD+   
Sbjct: 89  AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 146
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                       L T+       K++DFG +K + +++   +   +
Sbjct: 147 NVL-----------------------LVTQH----YAKISDFGLSKALRADENYYKAQTH 179
Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
             +   + APE +   K+    D+WS GV+M+     G  P+    G  ++  ++   R+
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 239
Query: 261 G 261
           G
Sbjct: 240 G 240

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/181 (19%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +   +++ME    G L + +QQ       ++    +++++   +K+L + N  HRD+   
Sbjct: 79  AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 136
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                       L T+       K++DFG +K + +++   +   +
Sbjct: 137 NVL-----------------------LVTQH----YAKISDFGLSKALRADENYYKAQTH 169
Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
             +   + APE +   K+    D+WS GV+M+     G  P+    G  ++  ++   R+
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 229
Query: 261 G 261
           G
Sbjct: 230 G 230

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 52/219 (23%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-EICSAIKFLHDQNIAHRDVKPENL 146
           + ++ E M  G L   ++  E G +      + M  +I S + ++   N  HRD++  N+
Sbjct: 253 IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311
Query: 147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP 206
           L                            G+  + K+ DFG A+ I  N+ + +     P
Sbjct: 312 LV---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 207 Y-YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ--- 262
             + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q   
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVER 396
Query: 263 -FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
            +  P P       E    + +++C     +P ER T +
Sbjct: 397 GYRMPCPP------ECPESLHDLMCQCWRKEPEERPTFE 429

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/181 (19%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +   +++ME    G L + +QQ       ++    +++++   +K+L + N  HRD+   
Sbjct: 99  AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 156
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                       L T+       K++DFG +K + +++   +   +
Sbjct: 157 NVL-----------------------LVTQ----HYAKISDFGLSKALRADENYYKAQTH 189
Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
             +   + APE +   K+    D+WS GV+M+     G  P+    G  ++  ++   R+
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 249
Query: 261 G 261
           G
Sbjct: 250 G 250

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/181 (19%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +   +++ME    G L + +QQ       ++    +++++   +K+L + N  HRD+   
Sbjct: 99  AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 156
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                       L T+       K++DFG +K + +++   +   +
Sbjct: 157 NVL-----------------------LVTQ----HYAKISDFGLSKALRADENYYKAQTH 189
Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
             +   + APE +   K+    D+WS GV+M+     G  P+    G  ++  ++   R+
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 249
Query: 261 G 261
           G
Sbjct: 250 G 250

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/181 (19%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +   +++ME    G L + +QQ       ++    +++++   +K+L + N  HRD+   
Sbjct: 97  AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 154
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                       L T+       K++DFG +K + +++   +   +
Sbjct: 155 NVL-----------------------LVTQ----HYAKISDFGLSKALRADENYYKAQTH 187
Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
             +   + APE +   K+    D+WS GV+M+     G  P+    G  ++  ++   R+
Sbjct: 188 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 247
Query: 261 G 261
           G
Sbjct: 248 G 248

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/181 (19%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +   +++ME    G L + +QQ       ++    +++++   +K+L + N  HRD+   
Sbjct: 83  AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 140
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                       L T+       K++DFG +K + +++   +   +
Sbjct: 141 NVL-----------------------LVTQH----YAKISDFGLSKALRADENYYKAQTH 173
Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
             +   + APE +   K+    D+WS GV+M+     G  P+    G  ++  ++   R+
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 233
Query: 261 G 261
           G
Sbjct: 234 G 234

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 96/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 48  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 106
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   ++ME M GG+L   +++           A+     +  +I
Sbjct: 107 HQNIVRCIGVSLQSLPR--FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 165 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 200
Query: 185 DFGFAKKIVSNKASLQTPC--YTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C      ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 201 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 260
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 261 YPSKSNQEV 269

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 52/219 (23%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-EICSAIKFLHDQNIAHRDVKPENL 146
           + ++ E M  G L   ++  E G +      + M  +I S + ++   N  HRD++  N+
Sbjct: 253 IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311
Query: 147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP 206
           L                            G+  + K+ DFG A+ I  N+ + +     P
Sbjct: 312 LV---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 207 Y-YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ--- 262
             + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q   
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVER 396
Query: 263 -FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
            +  P P       E    + +++C     +P ER T +
Sbjct: 397 GYRMPCPP------ECPESLHDLMCQCWRKEPEERPTFE 429

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/181 (19%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +   +++ME    G L + +QQ       ++    +++++   +K+L + N  HRD+   
Sbjct: 441 AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 498
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                       L T+       K++DFG +K + +++   +   +
Sbjct: 499 NVL-----------------------LVTQ----HYAKISDFGLSKALRADENYYKAQTH 531
Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
             +   + APE +   K+    D+WS GV+M+     G  P+    G  ++  ++   R+
Sbjct: 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 591
Query: 261 G 261
           G
Sbjct: 592 G 592

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 68/253 (26%)
Query: 54  KARREVELQL-AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAF 112
           K R E  +QL AV S + I  + +     Y    CLL  ++   G  L  R+ Q  D A 
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVTE-----YMSKGCLLDFLKGEMGKYL--RLPQLVDMA- 120
Query: 113 TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY 172
                     +I S + ++   N  HRD++  N+L                         
Sbjct: 121 ---------AQIASGMAYVERMNYVHRDLRAANILV------------------------ 147
Query: 173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVI 231
              G+  + K+ DFG A+ I  N+ + +     P  + APE     ++    D+WS G++
Sbjct: 148 ---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 204
Query: 232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQ----FDFPNPEWEHVSQEAKTLIKNMLCV 287
           +  L        +  G+   PGM NR  L Q    +  P P       E    + +++C 
Sbjct: 205 LTEL--------TTKGRVPYPGMVNREVLDQVERGYRMPCPP------ECPESLHDLMCQ 250
Query: 288 ----DPSERLTID 296
               DP ER T +
Sbjct: 251 CWRKDPEERPTFE 263

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/181 (19%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +   +++ME    G L + +QQ       ++    +++++   +K+L + N  HRD+   
Sbjct: 442 AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAAR 499
Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                       L T+       K++DFG +K + +++   +   +
Sbjct: 500 NVL-----------------------LVTQ----HYAKISDFGLSKALRADENYYKAQTH 532
Query: 205 TPY---YVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
             +   + APE +   K+    D+WS GV+M+     G  P+    G  ++  ++   R+
Sbjct: 533 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 592
Query: 261 G 261
           G
Sbjct: 593 G 593

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/214 (20%), Positives = 81/214 (37%), Gaps = 38/214 (17%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++  E       +      +I   + F+  +N  HRD++  N+L
Sbjct: 84  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 143
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                              + K+ DFG A+ I  N+ + +     P 
Sbjct: 144 VSA---------------------------SLVCKIADFGLARVIEDNEYTAREGAKFPI 176
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNR--IRLGQFD 264
            + APE +    +    D+WS G+++  ++         +G+   PGM N   IR  +  
Sbjct: 177 KWTAPEAINFGSFTIKSDVWSFGILLMEIV--------TYGRIPYPGMSNPEVIRALERG 228
Query: 265 FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
           +  P  E+  +E   ++       P ER T + +
Sbjct: 229 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYI 262

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/312 (20%), Positives = 124/312 (39%), Gaps = 84/312 (26%)
Query: 22  EILGLGINGKVLQIVEKKTSEV-----YALKVLHDTVKARR------EVELQLAVGSHKH 70
           ++LG G  GKV+       S+       A+K+L +   +        E+++   +GSH++
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELF--------------------QRIQQKED- 109
           IVN+          S  + +I E    G+L                     +R++++ED 
Sbjct: 111 IVNLLGAC----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 110 GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN 169
              T  +      ++   ++FL  ++  HRD+   N+L T                    
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH------------------- 207
Query: 170 LLYTKPGDGGILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCD 224
                   G ++K+ DFG A+ I+S+     + + + P     ++APE L    Y    D
Sbjct: 208 --------GKVVKICDFGLARDIMSDSNYVVRGNARLPVK---WMAPESLFEGIYTIKSD 256
Query: 225 IWSLGVIMY-ILLCGFPPFFSNHGQAISPGM---KNRIRLGQFDFPNPEWEHVSQEAKTL 280
           +WS G++++ I   G  P+         PG+    N  +L Q  F   +  + ++E   +
Sbjct: 257 VWSYGILLWEIFSLGVNPY---------PGIPVDANFYKLIQNGFKMDQPFYATEEIYII 307
Query: 281 IKNMLCVDPSER 292
           +++    D  +R
Sbjct: 308 MQSCWAFDSRKR 319

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 45/231 (19%)
Query: 14  QDDYDISTEILGLGINGKVLQIV---EKKTSEVYALKVL-HDTVKARREVELQLAVGSHK 69
           +D+  I+   LG G  G V Q V    KK  +V A+KVL   T KA  E  ++ A   H+
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 70  ----HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
               +IV +  V +     +  L+++ME   GG L + +  K +        A +++++ 
Sbjct: 393 LDNPYIVRLIGVCQ-----AEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVS 446
Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +K+L ++N  HR++   N+L                     N  Y K        ++D
Sbjct: 447 MGMKYLEEKNFVHRNLAARNVLLV-------------------NRHYAK--------ISD 479
Query: 186 FGFAKKIVSNKASLQTPCYTPY---YVAPEVLGPDKYDKSCDIWSLGVIMY 233
           FG +K + ++ +         +   + APE +   K+    D+WS GV M+
Sbjct: 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/218 (20%), Positives = 83/218 (38%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 80  IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 139
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 140 V---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFPI 172
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 173 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 224
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     +P ER T +
Sbjct: 225 YRMPCP------PECPESLHDLMCQCWRKEPEERPTFE 256

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/218 (21%), Positives = 82/218 (37%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +        +   +  +I S + ++   N  HRD+   N+L
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANIL 146
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG A+ I  N+ + +     P 
Sbjct: 147 V---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFPI 179
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 231
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     DP ER T +
Sbjct: 232 YRMPCPP------ECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/152 (22%), Positives = 63/152 (41%), Gaps = 31/152 (20%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           L ++ME +  G L +   Q+           +  ++IC  +++L  +   HRD+   N+L
Sbjct: 85  LRLVMEYLPSGCL-RDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 143
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYT 205
                                            +K+ DFG AK +  +K    ++ P  +
Sbjct: 144 VESEAH---------------------------VKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 206 P-YYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
           P ++ APE L  + + +  D+WS GV++Y L 
Sbjct: 177 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 102/262 (38%), Gaps = 57/262 (21%)
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
            TE     I+  +     F+H+  I HRD+KP N L  +      +K+ DFG  +  N  
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS---VKVCDFGLARTINSE 182
Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPE-VLGPDKYDKSCDIWSLGV 230
                   + +  + G   K +  K  L +   T +Y APE +L  + Y KS DIWS G 
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNL--KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240
Query: 231 IMYILL-----------CGFPPFFSNHGQAISPGM--------KNRIRLG---------- 261
           I   LL             FP F  +    +SP           NR +L           
Sbjct: 241 IFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT 300
Query: 262 QFDFPN---PE-------------------WEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
           + D  N   PE                   +  +S +   L+++ML  +P++R+TIDQ +
Sbjct: 301 EDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQAL 360
Query: 300 ENKWISQFNQVPQTPLCTGKML 321
           ++ ++    +       T K++
Sbjct: 361 DHPYLKDVRKKKLENFSTKKII 382

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/218 (20%), Positives = 82/218 (37%), Gaps = 50/218 (22%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + ++ E M  G L   ++ +        +   +  +I S + ++   N  HRD++  N+L
Sbjct: 254 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 313
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                                       G+  + K+ DFG  + I  N+ + +     P 
Sbjct: 314 V---------------------------GENLVCKVADFGLGRLIEDNEYTARQGAKFPI 346
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---- 262
            + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q    
Sbjct: 347 KWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVERG 398
Query: 263 FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
           +  P P       E    + +++C     DP ER T +
Sbjct: 399 YRMPCPP------ECPESLHDLMCQCWRKDPEERPTFE 430

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 86/219 (39%), Gaps = 52/219 (23%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-EICSAIKFLHDQNIAHRDVKPENL 146
           + ++ E M  G L   ++  E G +      + M  +I S + ++   N  HRD++  N+
Sbjct: 336 IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394
Query: 147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP 206
           L                    ENL         + K+ DFG A+ I  N+ + +     P
Sbjct: 395 LVG------------------ENL---------VCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 207 Y-YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ--- 262
             + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q   
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVER 479
Query: 263 -FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
            +  P P       E    + +++C     +P ER T +
Sbjct: 480 GYRMPCPP------ECPESLHDLMCQCWRKEPEERPTFE 512

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/232 (20%), Positives = 89/232 (38%), Gaps = 39/232 (16%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++  E G     +      +I   + ++  +N  HRD++  N+L
Sbjct: 83  IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVL 142
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                  E+L+          K+ DFG A+ I  N+ + +     P 
Sbjct: 143 VS------------------ESLM---------CKIADFGLARVIEDNEYTAREGAKFPI 175
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDF 265
            + APE +    +    D+WS G+++Y I+  G  P+       +   +    R+     
Sbjct: 176 KWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRM----- 230
Query: 266 PNPEWEHVSQEAKTLIKNMLCVDPSERLTID---QVMENKWISQFNQVPQTP 314
             P  E+   E   ++K        ER T D    V+++ + +   Q  Q P
Sbjct: 231 --PRVENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQP 280

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/237 (21%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENI 81
           ++ G+  +   LQ+  K   EVY+ +   D +    E  L ++  +H++IV    V  ++
Sbjct: 65  QVSGMPNDPSPLQVAVKTLPEVYSEQ---DELDFLMEA-LIISKFNHQNIVRCIGV--SL 118
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEICSAIKFLHDQNI 136
            +  R   +++E M GG+L   +++           A+     +  +I    ++L + + 
Sbjct: 119 QSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 176
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+   N L T P                        G G + K+ DFG A+ I    
Sbjct: 177 IHRDIAARNCLLTCP------------------------GPGRVAKIGDFGMARDIYRAS 212
Query: 197 ASLQTPC--YTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAI 250
              +  C      ++ PE      +    D WS GV+++ I   G+ P+ S   Q +
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 269

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 70/300 (23%)
Query: 16  DYDISTE------ILGLGINGKVLQ---IVEKKTSEVYALKVLHD-TVKARREVELQLAV 65
           DY+I  E       +G G  G V Q   +  +  +   A+K   + T  + RE  LQ A+
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 66  G----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
                 H HIV  I  + EN       + +IME    GEL   +Q ++   F+   A++I
Sbjct: 64  TMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK---FSLDLASLI 114
Query: 121 MN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           +   ++ +A+ +L  +   HRD+   N+L +                             
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVS---------------------------SN 147
Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILL 236
             +KL DFG ++ +  +     +    P  ++APE +   ++  + D+W  GV M+ IL+
Sbjct: 148 DCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 207
Query: 237 CGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSER 292
            G  PF          G+KN   +G+ +     P P   +      +L+      DPS R
Sbjct: 208 HGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSRR 256

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQ-LAVGSHKHIVNIKD 76
           E +G G  G+V     +  + + A+K   +T+    KA+   E + L   SH +IV +  
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V        + + ++ME + GG+ F    + E      +    ++ +  + +++L  +  
Sbjct: 180 VCTQ----KQPIYIVMELVQGGD-FLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+   N L T   +  +LK++DFG  + E                    A  + +  
Sbjct: 235 IHRDLAARNCLVT---EKNVLKISDFGMSREE--------------------ADGVXAAS 271
Query: 197 ASL-QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
             L Q P     + APE L   +Y    D+WS G++++
Sbjct: 272 GGLRQVPVK---WTAPEALNYGRYSSESDVWSFGILLW 306

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 52/219 (23%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN-EICSAIKFLHDQNIAHRDVKPENL 146
           + ++ E M  G L   ++  E G +      + M  +I S + ++   N  HRD++  N+
Sbjct: 253 IYIVGEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311
Query: 147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP 206
           L                            G+  + K+ DFG A+ I  N+ + +     P
Sbjct: 312 LV---------------------------GENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 207 Y-YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ--- 262
             + APE     ++    D+WS G+++  L        +  G+   PGM NR  L Q   
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTEL--------TTKGRVPYPGMVNREVLDQVER 396
Query: 263 -FDFPNPEWEHVSQEAKTLIKNMLCV----DPSERLTID 296
            +  P P       E    + +++C     +P ER T +
Sbjct: 397 GYRMPCPP------ECPESLHDLMCQCWRKEPEERPTFE 429

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 42/227 (18%)
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H HIV +  + E          +IME    GEL   +++ ++ +       +   +IC A
Sbjct: 72  HPHIVKLIGIIEE-----EPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKA 125
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +L   N  HRD+   N+L   P                             +KL DFG
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPE---------------------------CVKLGDFG 158
Query: 188 FAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSN 245
            ++ I        +    P  +++PE +   ++  + D+W   V M+ IL  G  PFF  
Sbjct: 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
             + +   ++   RL + D   P          TL+      DPS+R
Sbjct: 219 ENKDVIGVLEKGDRLPKPDLCPP-------VLYTLMTRCWDYDPSDR 258

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQ-LAVGSHKHIVNIKD 76
           E +G G  G+V     +  + + A+K   +T+    KA+   E + L   SH +IV +  
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V        + + ++ME + GG+ F    + E      +    ++ +  + +++L  +  
Sbjct: 180 VCTQ----KQPIYIVMELVQGGD-FLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+   N L T   +  +LK++DFG  + E                    A  + +  
Sbjct: 235 IHRDLAARNCLVT---EKNVLKISDFGMSREE--------------------ADGVYAAS 271
Query: 197 ASL-QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
             L Q P     + APE L   +Y    D+WS G++++
Sbjct: 272 GGLRQVPVK---WTAPEALNYGRYSSESDVWSFGILLW 306

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 42/227 (18%)
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H HIV +  + E          +IME    GEL   +++ ++ +       +   +IC A
Sbjct: 84  HPHIVKLIGIIEE-----EPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKA 137
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +L   N  HRD+   N+L   P                             +KL DFG
Sbjct: 138 MAYLESINCVHRDIAVRNILVASPE---------------------------CVKLGDFG 170
Query: 188 FAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSN 245
            ++ I        +    P  +++PE +   ++  + D+W   V M+ IL  G  PFF  
Sbjct: 171 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 230
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
             + +   ++   RL + D   P          TL+      DPS+R
Sbjct: 231 ENKDVIGVLEKGDRLPKPDLCPP-------VLYTLMTRCWDYDPSDR 270

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/170 (20%), Positives = 66/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HR+++  N+L
Sbjct: 78  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANIL 137
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I  N+ + +     P 
Sbjct: 138 VS---------------------------DTLSCKIADFGLARLIEDNEYTAREGAKFPI 170
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 171 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 212

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 97/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 50  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 108
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   +++E M GG+L   +++           A+     +  +I
Sbjct: 109 HQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 167 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 202
Query: 185 DFGFAKKIVSNKASLQTPCYT-PY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C   P  ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 203 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 262
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 263 YPSKSNQEV 271

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/146 (19%), Positives = 57/146 (39%), Gaps = 30/146 (20%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           L ++ E M  G L   ++ +               ++C A+++L   N  HRD+   N+L
Sbjct: 81  LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 140
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           +  + K++DFG  K+  S + + + P     
Sbjct: 141 VS---------------------------EDNVAKVSDFGLTKEASSTQDTGKLPVK--- 170
Query: 208 YVAPEVLGPDKYDKSCDIWSLGVIMY 233
           + APE L    +    D+WS G++++
Sbjct: 171 WTAPEALREAAFSTKSDVWSFGILLW 196

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 42/227 (18%)
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H HIV +  + E          +IME    GEL   +++ ++ +       +   +IC A
Sbjct: 68  HPHIVKLIGIIE-----EEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKA 121
Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +L   N  HRD+   N+L   P                             +KL DFG
Sbjct: 122 MAYLESINCVHRDIAVRNILVASPE---------------------------CVKLGDFG 154
Query: 188 FAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSN 245
            ++ I        +    P  +++PE +   ++  + D+W   V M+ IL  G  PFF  
Sbjct: 155 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 214
Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
             + +   ++   RL + D   P          TL+      DPS+R
Sbjct: 215 ENKDVIGVLEKGDRLPKPDLCPP-------VLYTLMTRCWDYDPSDR 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/259 (20%), Positives = 108/259 (41%), Gaps = 51/259 (19%)
Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------- 108
           E+E+   +G HK+I+N+  +     +G   L VI+E    G L + +Q +          
Sbjct: 83  EMEMMKMIGKHKNIINL--LGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEFSFN 138
Query: 109 -----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
                +   + ++      ++   +++L  +   HRD+   N+L T   +  ++K+ DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFG 195
Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
             +                +      KK  + +  ++       ++APE L    Y    
Sbjct: 196 LAR---------------DIHHIDXXKKTTNGRLPVK-------WMAPEALFDRIYTHQS 233
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           D+WS GV+++ I   G  P+     + +   +K   R+   D P+    + + E   +++
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS----NCTNELYMMMR 286
Query: 283 NMLCVDPSERLTIDQVMEN 301
           +     PS+R T  Q++E+
Sbjct: 287 DCWHAVPSQRPTFKQLVED 305

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 97/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 34  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 92
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   +++E M GG+L   +++           A+     +  +I
Sbjct: 93  HQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 151 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 186
Query: 185 DFGFAKKIVSNKASLQTPCYT-PY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C   P  ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 187 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 247 YPSKSNQEV 255

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/249 (20%), Positives = 96/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 40  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 98
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   +++E M GG+L   +++           A+     +  +I
Sbjct: 99  HQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 157 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 192
Query: 185 DFGFAKKIVSNKASLQTPC--YTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C      ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 193 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 252
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 253 YPSKSNQEV 261

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/249 (20%), Positives = 96/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 33  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 91
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   +++E M GG+L   +++           A+     +  +I
Sbjct: 92  HQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 185
Query: 185 DFGFAKKIVSNKASLQTPC--YTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C      ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 246 YPSKSNQEV 254

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/249 (20%), Positives = 96/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 60  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 118
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   +++E M GG+L   +++           A+     +  +I
Sbjct: 119 HQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 177 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 212
Query: 185 DFGFAKKIVSNKASLQTPC--YTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C      ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 213 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 272
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 273 YPSKSNQEV 281

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 97/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 25  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 83
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   +++E M GG+L   +++           A+     +  +I
Sbjct: 84  HQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 142 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 177
Query: 185 DFGFAKKIVSNKASLQTPCYT-PY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C   P  ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 178 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 237
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 238 YPSKSNQEV 246

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/233 (20%), Positives = 90/233 (38%), Gaps = 41/233 (17%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++  E G     +      +I   + ++  +N  HRD++  N+L
Sbjct: 82  IYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVL 141
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                  E+L+          K+ DFG A+ I  N+ + +     P 
Sbjct: 142 VS------------------ESLM---------CKIADFGLARVIEDNEYTAREGAKFPI 174
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFD-- 264
            + APE +    +    ++WS G+++Y ++         +G+   PG  N   +      
Sbjct: 175 KWTAPEAINFGCFTIKSNVWSFGILLYEIV--------TYGKIPYPGRTNADVMSALSQG 226
Query: 265 FPNPEWEHVSQEAKTLIKNMLCVDPSERLTID---QVMENKWISQFNQVPQTP 314
           +  P  E+   E   ++K        ER T D    V+++ + +   Q  Q P
Sbjct: 227 YRMPRMENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQP 279

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 123/300 (41%), Gaps = 70/300 (23%)
Query: 16  DYDISTE------ILGLGINGKVLQ---IVEKKTSEVYALKVLHD-TVKARREVELQLAV 65
           DY+I  E       +G G  G V Q   +  +  +   A+K   + T  + RE  LQ A+
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 66  G----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
                 H HIV  I  + EN       + +IME    GEL   +Q ++   F+   A++I
Sbjct: 64  TMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK---FSLDLASLI 114
Query: 121 MN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           +   ++ +A+ +L  +   HRD+   N+L +          TD                 
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVSA---------TD----------------- 148
Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILL 236
             +KL DFG ++ +  +     +    P  ++APE +   ++  + D+W  GV M+ IL+
Sbjct: 149 -CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 207
Query: 237 CGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSER 292
            G  PF          G+KN   +G+ +     P P   +      +L+      DPS R
Sbjct: 208 HGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSRR 256

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 64/170 (37%), Gaps = 32/170 (18%)
Query: 89  LVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEICSAIKFLHDQNIAHRDVKP 143
            +++E M GG+L   +++           A+     +  +I    ++L + +  HRD+  
Sbjct: 110 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 169
Query: 144 ENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPC 203
            N L T P                        G G + K+ DFG A+ I       +  C
Sbjct: 170 RNCLLTCP------------------------GPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 204 --YTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAI 250
                 ++ PE      +    D WS GV+++ I   G+ P+ S   Q +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 255

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/170 (20%), Positives = 65/170 (38%), Gaps = 36/170 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++       T  +   +  +I   + F+ ++N  HRD++  N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                           D    K+ DFG A+ I   + + +     P 
Sbjct: 142 VS---------------------------DTLSCKIADFGLARLIEDAEXTAREGAKFPI 174
Query: 208 -YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
            + APE +    +    D+WS G+++  ++         HG+   PGM N
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--------THGRIPYPGMTN 216

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/249 (20%), Positives = 96/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 51  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 109
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   +++E M GG+L   +++           A+     +  +I
Sbjct: 110 HQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 168 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 203
Query: 185 DFGFAKKIVSNKASLQTPC--YTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C      ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 204 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 263
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 264 YPSKSNQEV 272

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 97/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 34  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 92
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   +++E M GG+L   +++           A+     +  +I
Sbjct: 93  HQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 151 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 186
Query: 185 DFGFAKKIVSNKASLQTPCYT-PY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C   P  ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 187 DFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 246
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 247 YPSKSNQEV 255

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 99/248 (39%), Gaps = 61/248 (24%)
Query: 24  LGLGINGKVL-----QIVEKKTSEVYALKVLHD-TVKAR----REVELQLAVGSHKHIVN 73
           LG G  GKV       +   K   + A+K L D T+ AR    RE EL L    H+HIV 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL-LTNLQHEHIVK 81
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGEL--FQRIQ------------QKEDGAFTEREAAI 119
               +  +      L+++ E M  G+L  F R              ++  G     +   
Sbjct: 82  ----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPG 176
           I ++I S + +L  Q+  HRD+   N L    G   ++K+ DFG   DV   +  Y + G
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTD--YYRVG 192
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
              +L +                        ++ PE +   K+    D+WS GVI++ I 
Sbjct: 193 GHTMLPIR-----------------------WMPPESIMYRKFTTESDVWSFGVILWEIF 229
Query: 236 LCGFPPFF 243
             G  P+F
Sbjct: 230 TYGKQPWF 237

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 97/249 (38%), Gaps = 46/249 (18%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVEL---QLAVGSHK 69
           T I GLG +G   ++ E + S +         A+K L +    + E++     L +    
Sbjct: 74  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 132
Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMNEI 124
           H   ++ +  ++ +  R   +++E M GG+L   +++           A+     +  +I
Sbjct: 133 HQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
               ++L + +  HRD+   N L T P                        G G + K+ 
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAKIG 226
Query: 185 DFGFAKKIVSNKASLQTPCYT-PY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
           DFG A+ I       +  C   P  ++ PE      +    D WS GV+++ I   G+ P
Sbjct: 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 242 FFSNHGQAI 250
           + S   Q +
Sbjct: 287 YPSKSNQEV 295

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/251 (21%), Positives = 100/251 (39%), Gaps = 50/251 (19%)
Query: 21  TEILGLGINGKVLQIVEKKTSEV--------YALKVLHDTVKARREVE-----LQLAVGS 67
           T I GLG +G   ++ E + S +         A+K L +    + E++     L ++  +
Sbjct: 48  TLIRGLG-HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLN 106
Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-----IMN 122
           H++IV    V  ++ +  R   +++E M GG+L   +++           A+     +  
Sbjct: 107 HQNIVRCIGV--SLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I    ++L + +  HRD+   N L T P                        G G + K
Sbjct: 163 DIACGCQYLEENHFIHRDIAARNCLLTCP------------------------GPGRVAK 198
Query: 183 LTDFGFAKKIVSNKASLQTPC--YTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGF 239
           + DFG A+ I       +  C      ++ PE      +    D WS GV+++ I   G+
Sbjct: 199 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 258
Query: 240 PPFFSNHGQAI 250
            P+ S   Q +
Sbjct: 259 MPYPSKSNQEV 269

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 124/301 (41%), Gaps = 72/301 (23%)
Query: 16  DYDISTE------ILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-----ARREVELQLA 64
           DY+I  E       +G G  G V Q +   + E  AL V   T K     + RE  LQ A
Sbjct: 32  DYEIQRERIELGRCIGEGQFGDVHQGI-YMSPENPALAVAIKTCKNCTSDSVREKFLQEA 90
Query: 65  VG----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
           +      H HIV  I  + EN       + +IME    GEL   +Q ++   ++   A++
Sbjct: 91  LTMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK---YSLDLASL 141
Query: 120 IMN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-PENLLYTKPG 176
           I+   ++ +A+ +L  +   HRD+   N+L +       +KL DFG  +  E+  Y K  
Sbjct: 142 ILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKAS 198
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
            G                 K  ++       ++APE +   ++  + D+W  GV M+ IL
Sbjct: 199 KG-----------------KLPIK-------WMAPESINFRRFTSASDVWMFGVCMWEIL 234
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           + G  PF          G+KN   +G+ +     P P   +      +L+      DPS 
Sbjct: 235 MHGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSR 283
Query: 292 R 292
           R
Sbjct: 284 R 284

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 104/254 (40%), Gaps = 60/254 (23%)
Query: 52  TVKARREVELQLAVG----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ 106
           T  + RE  LQ A+      H HIV  I  + EN       + +IME    GEL   +Q 
Sbjct: 430 TSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQV 483
Query: 107 KEDGAFTEREAAIIMN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD 164
           ++   F+   A++I+   ++ +A+ +L  +   HRD+   N+L +       +KL DFG 
Sbjct: 484 RK---FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGL 537
Query: 165 VK-PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSC 223
            +  E+  Y K   G +                           ++APE +   ++  + 
Sbjct: 538 SRYMEDSTYYKASKGKL------------------------PIKWMAPESINFRRFTSAS 573
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAK 278
           D+W  GV M+ IL+ G  PF          G+KN   +G+ +     P P   +      
Sbjct: 574 DVWMFGVCMWEILMHGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLY 622
Query: 279 TLIKNMLCVDPSER 292
           +L+      DPS R
Sbjct: 623 SLMTKCWAYDPSRR 636

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 60/254 (23%)
Query: 52  TVKARREVELQLAVG----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ 106
           T  + RE  LQ A+      H HIV  I  + EN       + +IME    GEL   +Q 
Sbjct: 430 TSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQV 483
Query: 107 KEDGAFTEREAAIIMN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD 164
           ++   F+   A++I+   ++ +A+ +L  +   HRD+   N+L +          TD   
Sbjct: 484 RK---FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSA---------TD--- 528
Query: 165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSC 223
                           +KL DFG ++ +  +     +    P  ++APE +   ++  + 
Sbjct: 529 ---------------CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 224 DIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAK 278
           D+W  GV M+ IL+ G  PF          G+KN   +G+ +     P P   +      
Sbjct: 574 DVWMFGVCMWEILMHGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLY 622
Query: 279 TLIKNMLCVDPSER 292
           +L+      DPS R
Sbjct: 623 SLMTKCWAYDPSRR 636

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 124/301 (41%), Gaps = 72/301 (23%)
Query: 16  DYDISTE------ILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-----ARREVELQLA 64
           DY+I  E       +G G  G V Q +   + E  AL V   T K     + RE  LQ A
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGI-YMSPENPALAVAIKTCKNCTSDSVREKFLQEA 62
Query: 65  VG----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
           +      H HIV  I  + EN       + +IME    GEL   +Q ++   ++   A++
Sbjct: 63  LTMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK---YSLDLASL 113
Query: 120 IMN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-PENLLYTKPG 176
           I+   ++ +A+ +L  +   HRD+   N+L +       +KL DFG  +  E+  Y K  
Sbjct: 114 ILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKAS 170
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
            G                 K  ++       ++APE +   ++  + D+W  GV M+ IL
Sbjct: 171 KG-----------------KLPIK-------WMAPESINFRRFTSASDVWMFGVCMWEIL 206
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           + G  PF          G+KN   +G+ +     P P   +      +L+      DPS 
Sbjct: 207 MHGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSR 255
Query: 292 R 292
           R
Sbjct: 256 R 256

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 78/318 (24%), Positives = 124/318 (38%), Gaps = 78/318 (24%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIK---DVYEN 80
           LG G  G V ++    + ++ A+K +  TV ++ +  L + +      V+       Y  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 81  IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI--IMNEICSAIKFLHDQ-NIA 137
           ++     + + ME M    L +  +Q  D   T  E  +  I   I  A++ LH + ++ 
Sbjct: 119 LFREGD-VWICMELMDTS-LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 176
Query: 138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA 197
           HRDVKP N+L                     N L       G +K+ DFG +  +V + A
Sbjct: 177 HRDVKPSNVLI--------------------NAL-------GQVKMCDFGISGYLVDSVA 209
Query: 198 SLQTPCYTPYYVAPEVLGPD----KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
                   PY +APE + P+     Y    DIWSLG+ M                     
Sbjct: 210 KTIDAGCKPY-MAPERINPELNQKGYSVKSDIWSLGITM--------------------- 247
Query: 254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQT 313
               I L    FP   W    Q+ K +++     +PS +L  D     K+ ++F  V  T
Sbjct: 248 ----IELAILRFPYDSWGTPFQQLKQVVE-----EPSPQLPAD-----KFSAEF--VDFT 291
Query: 314 PLCTGKMLKEGEETWPEV 331
             C  K  KE   T+PE+
Sbjct: 292 SQCLKKNSKE-RPTYPEL 308

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 122/301 (40%), Gaps = 72/301 (23%)
Query: 16  DYDISTE------ILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-----ARREVELQLA 64
           DY+I  E       +G G  G V Q +   + E  AL V   T K     + RE  LQ A
Sbjct: 6   DYEIQRERIELGRCIGEGQFGDVHQGI-YMSPENPALAVAIKTCKNCTSDSVREKFLQEA 64
Query: 65  VG----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
           +      H HIV  I  + EN       + +IME    GEL   +Q ++   ++   A++
Sbjct: 65  LTMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK---YSLDLASL 115
Query: 120 IMN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-PENLLYTKPG 176
           I+   ++ +A+ +L  +   HRD+   N+L +       +KL DFG  +  E+  Y K  
Sbjct: 116 ILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKAS 172
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
            G +                           ++APE +   ++  + D+W  GV M+ IL
Sbjct: 173 KGKL------------------------PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           + G  PF          G+KN   +G+ +     P P   +      +L+      DPS 
Sbjct: 209 MHGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSR 257
Query: 292 R 292
           R
Sbjct: 258 R 258

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 124/301 (41%), Gaps = 72/301 (23%)
Query: 16  DYDISTE------ILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-----ARREVELQLA 64
           DY+I  E       +G G  G V Q +   + E  AL V   T K     + RE  LQ A
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVHQGI-YMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 65  VG----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
           +      H HIV  I  + EN       + +IME    GEL   +Q ++   ++   A++
Sbjct: 68  LTMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK---YSLDLASL 118
Query: 120 IMN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-PENLLYTKPG 176
           I+   ++ +A+ +L  +   HRD+   N+L +       +KL DFG  +  E+  Y K  
Sbjct: 119 ILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKAS 175
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
            G                 K  ++       ++APE +   ++  + D+W  GV M+ IL
Sbjct: 176 KG-----------------KLPIK-------WMAPESINFRRFTSASDVWMFGVCMWEIL 211
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           + G  PF          G+KN   +G+ +     P P   +      +L+      DPS 
Sbjct: 212 MHGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSR 260
Query: 292 R 292
           R
Sbjct: 261 R 261

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 122/301 (40%), Gaps = 72/301 (23%)
Query: 16  DYDISTE------ILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-----ARREVELQLA 64
           DY+I  E       +G G  G V Q +   + E  AL V   T K     + RE  LQ A
Sbjct: 7   DYEIQRERIELGRCIGEGQFGDVHQGI-YMSPENPALAVAIKTCKNCTSDSVREKFLQEA 65
Query: 65  VG----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
           +      H HIV  I  + EN       + +IME    GEL   +Q ++   ++   A++
Sbjct: 66  LTMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK---YSLDLASL 116
Query: 120 IMN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-PENLLYTKPG 176
           I+   ++ +A+ +L  +   HRD+   N+L +       +KL DFG  +  E+  Y K  
Sbjct: 117 ILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKAS 173
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
            G +                           ++APE +   ++  + D+W  GV M+ IL
Sbjct: 174 KGKL------------------------PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           + G  PF          G+KN   +G+ +     P P   +      +L+      DPS 
Sbjct: 210 MHGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSR 258
Query: 292 R 292
           R
Sbjct: 259 R 259

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 122/301 (40%), Gaps = 72/301 (23%)
Query: 16  DYDISTE------ILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-----ARREVELQLA 64
           DY+I  E       +G G  G V Q +   + E  AL V   T K     + RE  LQ A
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGI-YMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59
Query: 65  VG----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
           +      H HIV  I  + EN       + +IME    GEL   +Q ++   ++   A++
Sbjct: 60  LTMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK---YSLDLASL 110
Query: 120 IMN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-PENLLYTKPG 176
           I+   ++ +A+ +L  +   HRD+   N+L +       +KL DFG  +  E+  Y K  
Sbjct: 111 ILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKAS 167
Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
            G +                           ++APE +   ++  + D+W  GV M+ IL
Sbjct: 168 KGKL------------------------PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203
Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           + G  PF          G+KN   +G+ +     P P   +      +L+      DPS 
Sbjct: 204 MHGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSR 252
Query: 292 R 292
           R
Sbjct: 253 R 253

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/196 (21%), Positives = 90/196 (45%), Gaps = 33/196 (16%)
Query: 51  DTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG 110
           + ++  +E + ++ + S+ +  NI  +Y  ++N  R ++  + C   G+L+ R+  K   
Sbjct: 62  EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPC---GDLYHRLLDKAHP 118
Query: 111 AFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE 168
                +  ++++ I   I+++ +QN  I HRD++  N+            L    +  P 
Sbjct: 119 IKWSVKLRLMLD-IALGIEYMQNQNPPIVHRDLRSPNIF-----------LQSLDENAPV 166
Query: 169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK--YDKSCDIW 226
                        K+ DFG +++ V + + L        ++APE +G ++  Y +  D +
Sbjct: 167 -----------CAKVADFGLSQQSVHSVSGLLG---NFQWMAPETIGAEEESYTEKADTY 212
Query: 227 SLGVIMYILLCGFPPF 242
           S  +I+Y +L G  PF
Sbjct: 213 SFAMILYTILTGEGPF 228

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 70/300 (23%)
Query: 16  DYDISTE------ILGLGINGKVLQ---IVEKKTSEVYALKVLHD-TVKARREVELQLAV 65
           DY+I  E       +G G  G V Q   +  +  +   A+K   + T  + RE  LQ A+
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 66  G----SHKHIVN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
                 H HIV  I  + EN       + +IME    GEL   +Q ++   ++   A++I
Sbjct: 64  TMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK---YSLDLASLI 114
Query: 121 MN--EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK-PENLLYTKPGD 177
           +   ++ +A+ +L  +   HRD+   N+L +       +KL DFG  +  E+  Y K   
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 178 GGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILL 236
           G +                           ++APE +   ++  + D+W  GV M+ IL+
Sbjct: 172 GKL------------------------PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 207
Query: 237 CGFPPFFSNHGQAISPGMKNRIRLGQFD----FPNPEWEHVSQEAKTLIKNMLCVDPSER 292
            G  PF          G+KN   +G+ +     P P   +      +L+      DPS R
Sbjct: 208 HGVKPF---------QGVKNNDVIGRIENGERLPMP--PNCPPTLYSLMTKCWAYDPSRR 256

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/259 (22%), Positives = 110/259 (42%), Gaps = 48/259 (18%)
Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
           ++E+E+ L    H++IV  K +     +G   + +IME +  G L + + + ++    ++
Sbjct: 71  KKEIEI-LRNLYHENIVKYKGICTE--DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
           +    + +IC  + +L  +   HRD+   N+L                 V+ E+ +    
Sbjct: 128 QLKYAV-QICKGMDYLGSRQYVHRDLAARNVL-----------------VESEHQV---- 165
Query: 176 GDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YYVAPEVLGPDKYDKSCDIWSLGVIM 232
                 K+ DFG  K I ++K   +++    +P ++ APE L   K+  + D+WS GV +
Sbjct: 166 ------KIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
Query: 233 YILLCGFPPFFS-----------NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLI 281
           + LL       S            HGQ     + N ++ G+   P P   +   E   L+
Sbjct: 220 HELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK-RLPCP--PNCPDEVYQLM 276
Query: 282 KNMLCVDPSERLTIDQVME 300
           +      PS R +   ++E
Sbjct: 277 RKCWEFQPSNRTSFQNLIE 295

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/259 (22%), Positives = 110/259 (42%), Gaps = 48/259 (18%)
Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
           ++E+E+ L    H++IV  K +     +G   + +IME +  G L + + + ++    ++
Sbjct: 59  KKEIEI-LRNLYHENIVKYKGICTE--DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 115
Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
           +    + +IC  + +L  +   HRD+   N+L                 V+ E+ +    
Sbjct: 116 QLKYAV-QICKGMDYLGSRQYVHRDLAARNVL-----------------VESEHQV---- 153
Query: 176 GDGGILKLTDFGFAKKIVSNK--ASLQTPCYTP-YYVAPEVLGPDKYDKSCDIWSLGVIM 232
                 K+ DFG  K I ++K   +++    +P ++ APE L   K+  + D+WS GV +
Sbjct: 154 ------KIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 207
Query: 233 YILLCGFPPFFS-----------NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLI 281
           + LL       S            HGQ     + N ++ G+   P P   +   E   L+
Sbjct: 208 HELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK-RLPCP--PNCPDEVYQLM 264
Query: 282 KNMLCVDPSERLTIDQVME 300
           +      PS R +   ++E
Sbjct: 265 RKCWEFQPSNRTSFQNLIE 283

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 101/246 (41%), Gaps = 58/246 (23%)
Query: 24  LGLGINGKVL-----QIVEKKTSEVYALKVLHDTVKA-----RREVELQLAVGSHKHIVN 73
           LG G  GKV       ++ ++   + A+K L +  ++     +RE EL L +  H+HIV 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL-LTMLQHQHIVR 107
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGEL--FQR--------IQQKED---GAFTEREAAII 120
               +  +    R LL++ E M  G+L  F R        +   ED   G     +   +
Sbjct: 108 ----FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
            +++ + + +L   +  HRD+   N L                            G G +
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLV---------------------------GQGLV 196
Query: 181 LKLTDFGFAKKIVS-NKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLC 237
           +K+ DFG ++ I S +   +      P  ++ PE +   K+    D+WS GV+++ I   
Sbjct: 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY 256
Query: 238 GFPPFF 243
           G  P++
Sbjct: 257 GKQPWY 262

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 76/319 (23%), Positives = 123/319 (38%), Gaps = 80/319 (25%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYN 83
           LG G  G V ++    + ++ A+K +  TV ++ +  L + +      V+    +   + 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP--FTVTFY 72
Query: 84  GSRC----LLVIMECMHGGELFQRIQQKEDGAFTEREAAI--IMNEICSAIKFLHDQ-NI 136
           G+      + + ME M    L +  +Q  D   T  E  +  I   I  A++ LH + ++
Sbjct: 73  GALFREGDVWICMELMDTS-LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRDVKP N+L    G                            +K+ DFG +  +V + 
Sbjct: 132 IHRDVKPSNVLINALGQ---------------------------VKMCDFGISGYLVDDV 164
Query: 197 ASLQTPCYTPYYVAPEVLGPD----KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           A        PY +APE + P+     Y    DIWSLG+ M                    
Sbjct: 165 AKDIDAGCKPY-MAPERINPELNQKGYSVKSDIWSLGITM-------------------- 203
Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
                I L    FP   W    Q+ K +++     +PS +L  D     K+ ++F  V  
Sbjct: 204 -----IELAILRFPYDSWGTPFQQLKQVVE-----EPSPQLPAD-----KFSAEF--VDF 246
Query: 313 TPLCTGKMLKEGEETWPEV 331
           T  C  K  KE   T+PE+
Sbjct: 247 TSQCLKKNSKE-RPTYPEL 264

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 20/60 (33%), Positives = 37/60 (61%), Gaps = 2/60 (3%)
Query: 109 DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGG--ILKLTDFGDVK 166
           D  F+ +   +I  ++ S ++++H +N+ +RDVKPEN L  +PG+    ++ + DFG  K
Sbjct: 99  DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAK 158

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 101/235 (42%), Gaps = 60/235 (25%)
Query: 21  TEILGLGINGKV---LQIVEKKTSEV-YALKVLHDTVKARREVE-----LQLAVGSHKHI 71
            ++LG G  G V   + + E +T ++  A+K+L++T   +  VE     L +A   H H+
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN---EICSAI 128
           V +  V       S  + ++ + M  G L + + + +D   ++    +++N   +I   +
Sbjct: 103 VRLLGVCL-----SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQ----LLLNWCVQIAKGM 153
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF-------GDVKPENLLYTKPGDGGIL 181
            +L ++ + HRD+   N+L   P     +K+TDF       GD K  N       DGG +
Sbjct: 154 MYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYN------ADGGKM 204
Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            +                        ++A E +   K+    D+WS GV ++ L+
Sbjct: 205 PIK-----------------------WMALECIHYRKFTHQSDVWSYGVTIWELM 236

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 101/246 (41%), Gaps = 58/246 (23%)
Query: 24  LGLGINGKVL-----QIVEKKTSEVYALKVLHDTVKA-----RREVELQLAVGSHKHIVN 73
           LG G  GKV       ++ ++   + A+K L +  ++     +RE EL L +  H+HIV 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL-LTMLQHQHIVR 84
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGEL--FQR--------IQQKED---GAFTEREAAII 120
               +  +    R LL++ E M  G+L  F R        +   ED   G     +   +
Sbjct: 85  ----FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
            +++ + + +L   +  HRD+   N L                            G G +
Sbjct: 141 ASQVAAGMVYLAGLHFVHRDLATRNCLV---------------------------GQGLV 173
Query: 181 LKLTDFGFAKKIVS-NKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLC 237
           +K+ DFG ++ I S +   +      P  ++ PE +   K+    D+WS GV+++ I   
Sbjct: 174 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY 233
Query: 238 GFPPFF 243
           G  P++
Sbjct: 234 GKQPWY 239

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 101/235 (42%), Gaps = 60/235 (25%)
Query: 21  TEILGLGINGKV---LQIVEKKTSEV-YALKVLHDTVKARREVE-----LQLAVGSHKHI 71
            ++LG G  G V   + + E +T ++  A+K+L++T   +  VE     L +A   H H+
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN---EICSAI 128
           V +  V       S  + ++ + M  G L + + + +D   ++    +++N   +I   +
Sbjct: 80  VRLLGVCL-----SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQ----LLLNWCVQIAKGM 130
Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF-------GDVKPENLLYTKPGDGGIL 181
            +L ++ + HRD+   N+L   P     +K+TDF       GD K  N       DGG +
Sbjct: 131 MYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYN------ADGGKM 181
Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            +                        ++A E +   K+    D+WS GV ++ L+
Sbjct: 182 PIK-----------------------WMALECIHYRKFTHQSDVWSYGVTIWELM 213

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/196 (21%), Positives = 90/196 (45%), Gaps = 33/196 (16%)
Query: 51  DTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG 110
           + ++  +E + ++ + S+ +  NI  +Y  ++N  R ++  + C   G+L+ R+  K   
Sbjct: 62  EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPC---GDLYHRLLDKAHP 118
Query: 111 AFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE 168
                +  ++++ I   I+++ +QN  I HRD++  N+            L    +  P 
Sbjct: 119 IKWSVKLRLMLD-IALGIEYMQNQNPPIVHRDLRSPNIF-----------LQSLDENAPV 166
Query: 169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK--YDKSCDIW 226
                        K+ DFG +++ V + + L        ++APE +G ++  Y +  D +
Sbjct: 167 -----------CAKVADFGTSQQSVHSVSGLLG---NFQWMAPETIGAEEESYTEKADTY 212
Query: 227 SLGVIMYILLCGFPPF 242
           S  +I+Y +L G  PF
Sbjct: 213 SFAMILYTILTGEGPF 228

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 101/246 (41%), Gaps = 58/246 (23%)
Query: 24  LGLGINGKVL-----QIVEKKTSEVYALKVLHDTVKA-----RREVELQLAVGSHKHIVN 73
           LG G  GKV       ++ ++   + A+K L +  ++     +RE EL L +  H+HIV 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL-LTMLQHQHIVR 78
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGEL--FQR--------IQQKED---GAFTEREAAII 120
               +  +    R LL++ E M  G+L  F R        +   ED   G     +   +
Sbjct: 79  ----FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
            +++ + + +L   +  HRD+   N L                            G G +
Sbjct: 135 ASQVAAGMVYLAGLHFVHRDLATRNCLV---------------------------GQGLV 167
Query: 181 LKLTDFGFAKKIVS-NKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLC 237
           +K+ DFG ++ I S +   +      P  ++ PE +   K+    D+WS GV+++ I   
Sbjct: 168 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY 227
Query: 238 GFPPFF 243
           G  P++
Sbjct: 228 GKQPWY 233

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/55 (32%), Positives = 33/55 (60%)
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK 166
           F+ +   ++ +++ S I+++H +N  HRDVKP+N L      G ++ + DFG  K
Sbjct: 102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/55 (32%), Positives = 33/55 (60%)
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK 166
           F+ +   ++ +++ S I+++H +N  HRDVKP+N L      G ++ + DFG  K
Sbjct: 102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/55 (32%), Positives = 33/55 (60%)
Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK 166
           F+ +   ++ +++ S I+++H +N  HRDVKP+N L      G ++ + DFG  K
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/312 (22%), Positives = 124/312 (39%), Gaps = 80/312 (25%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED---------GAFTEREAAIIMN- 122
           N+             L+VI+E    G L   ++ K +           F   E  I  + 
Sbjct: 95  NLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++   ++FL  +   HRD+   N+L +                           +  ++K
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILLS---------------------------EKNVVK 184
Query: 183 LTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILL 236
           + DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++ I  
Sbjct: 185 IXDFGLARDIYKDPDYVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241
Query: 237 CGFPPFFSNHGQAISPGMKNRI----RLGQFDFPNPEWEHVSQEAKTLIKNML-CV--DP 289
            G  P+    G  I      R+    R+   D+  PE          + + ML C   +P
Sbjct: 242 LGASPY---PGVKIDEEFXRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEP 288
Query: 290 SERLTIDQVMEN 301
           S+R T  +++E+
Sbjct: 289 SQRPTFSELVEH 300

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/232 (20%), Positives = 88/232 (37%), Gaps = 49/232 (21%)
Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           + +I E M  G L   ++  E       +      +I   + F+  +N  HRD++  N+L
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 310
Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
            +                              + K+ DFG A+  V  K  ++       
Sbjct: 311 VSA---------------------------SLVCKIADFGLAR--VGAKFPIK------- 334
Query: 208 YVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNR--IRLGQFDF 265
           + APE +    +    D+WS G+++  ++         +G+   PGM N   IR  +  +
Sbjct: 335 WTAPEAINFGSFTIKSDVWSFGILLMEIV--------TYGRIPYPGMSNPEVIRALERGY 386
Query: 266 PNPEWEHVSQEAKTLIKNMLCVDPSERLT---IDQVMENKWISQFNQVPQTP 314
             P  E+  +E   ++       P ER T   I  V+++ + +  +Q  Q P
Sbjct: 387 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQXQQQP 438

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/166 (19%), Positives = 66/166 (39%), Gaps = 33/166 (19%)
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
           Y+ +  L ++ +   G  L+  +   E   F  ++   I  +    + +LH ++I HRD+
Sbjct: 88  YSTAPQLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA--KKIVSNKASL 199
           K  N+                              +   +K+ DFG A  K   S     
Sbjct: 147 KSNNIFLH---------------------------EDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 200 QTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           +    +  ++APEV+     + Y    D+++ G+++Y L+ G  P+
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 76/337 (22%), Positives = 133/337 (39%), Gaps = 77/337 (22%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVLHDTVKARR------EVELQLAVGSHKHIV 72
           LG G  GKV+Q     I +  T    A+K+L +   A        E+++   +G H ++V
Sbjct: 35  LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM----------- 121
           N+             L+VI+E    G L   ++ K D  F  ++AA+ M           
Sbjct: 95  NLLGA---CTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKKEKMEPGL 151
Query: 122 -------------NEICSAIKFLHDQNIAHRDVKPE---NLLYTKPGDGGILKLTDFG-- 163
                        +E  ++  F  D++++  DV+ E   +  Y +P     L    F   
Sbjct: 152 EQGKKPRLDSVTSSESFASSGFQEDKSLS--DVEEEEDSDGFYKEPITMEDLISYSFQVA 209
Query: 164 --------------DVKPENLLYTKPGDGGILKLTDFGFAKKIVSN-----KASLQTPCY 204
                         D+   N+L +   +  ++K+ DFG A+ I  N     K   + P  
Sbjct: 210 RGMEFLSSRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKNPDYVRKGDTRLPLK 266
Query: 205 TPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQF 263
              ++APE +    Y    D+WS GV+++ I   G  P+    G  +     +R+R G  
Sbjct: 267 ---WMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPY---PGVQMDEDFCSRLREG-M 319
Query: 264 DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
               PE+   + E   ++ +    DP ER    +++E
Sbjct: 320 RMRAPEYS--TPEIYQIMLDCWHRDPKERPRFAELVE 354

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 63/260 (24%)
Query: 68  HKHIVNIKDVYENI-YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           H  IV I +  E+   +G     ++ME + G  L +   QK   A    EA   + EI  
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA----EAIAYLLEILP 193
Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ +LH   + + D+KPEN++ T+      LKL D G V                ++  F
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAVS---------------RINSF 234
Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVL--GPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           G+                TP + APE++  GP     + DI+++G  +  L    P   +
Sbjct: 235 GYLYG-------------TPGFQAPEIVRTGP---TVATDIYTVGRTLAALTLDLP---T 275
Query: 245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW- 303
            +G+ +    ++   L  +D               L++  +  DP +R T  + M  +  
Sbjct: 276 RNGRYVDGLPEDDPVLKTYD-----------SYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324
Query: 304 ------ISQFNQVPQTPLCT 317
                 ++Q   VP+  L T
Sbjct: 325 GVLREVVAQDTGVPRPGLST 344

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/217 (18%), Positives = 81/217 (37%), Gaps = 48/217 (22%)
Query: 31  KVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV 90
           K+L +      ++ A K     ++  R V + L +G               Y+    L +
Sbjct: 40  KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG---------------YSTKPQLAI 84
Query: 91  IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTK 150
           + +   G  L+  +   E   F  ++   I  +    + +LH ++I HRD+K  N+    
Sbjct: 85  VTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH- 142
Query: 151 PGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA--KKIVSNKASLQTPCYTPYY 208
                                     +   +K+ DFG A  K   S     +    +  +
Sbjct: 143 --------------------------EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 176
Query: 209 VAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           +APEV+     + Y    D+++ G+++Y L+ G  P+
Sbjct: 177 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 68/313 (21%), Positives = 124/313 (39%), Gaps = 78/313 (24%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA--------IIMNEI 124
           N+             L+VI+E    G L   ++ K +     +EA          + + I
Sbjct: 97  NLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 125 C------SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           C        ++FL  +   HRD+   N+L +                           + 
Sbjct: 154 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------EK 186
Query: 179 GILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            ++K+ DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++
Sbjct: 187 NVVKICDFGLARDIYKDPDYVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLW 243
Query: 234 -ILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--D 288
            I   G  P+      +     +K   R+   D+  PE          + + ML C   +
Sbjct: 244 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGE 293
Query: 289 PSERLTIDQVMEN 301
           PS+R T  +++E+
Sbjct: 294 PSQRPTFSELVEH 306

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/166 (19%), Positives = 65/166 (39%), Gaps = 33/166 (19%)
Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
           Y+    L ++ +   G  L+  +   E   F  ++   I  +    + +LH ++I HRD+
Sbjct: 88  YSTKPQLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA--KKIVSNKASL 199
           K  N+                              +   +K+ DFG A  K   S     
Sbjct: 147 KSNNIFLH---------------------------EDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 200 QTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           +    +  ++APEV+     + Y    D+++ G+++Y L+ G  P+
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/246 (19%), Positives = 93/246 (37%), Gaps = 55/246 (22%)
Query: 13  IQDDYDISTEIL-----------GLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL 61
           + D++++S E +           G+   G    I++ +     A+K ++++   R  +E 
Sbjct: 8   VPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF 67
Query: 62  QLAVGSHK-----HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAF---- 112
                  K     H+V +  V        +  LV+ME M  G+L   ++     A     
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSK----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 113 ----TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP- 167
               T +E   +  EI   + +L+ +   HRD+   N +         +K+ DFG  +  
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDI 180
Query: 168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWS 227
               Y + G  G+L +                        ++APE L    +  S D+WS
Sbjct: 181 YETAYYRKGGKGLLPVR-----------------------WMAPESLKDGVFTTSSDMWS 217
Query: 228 LGVIMY 233
            GV+++
Sbjct: 218 FGVVLW 223

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/196 (20%), Positives = 89/196 (45%), Gaps = 33/196 (16%)
Query: 51  DTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG 110
           + ++  +E + ++ + S+ +  NI  +Y  ++N  R ++  + C   G+L+ R+  K   
Sbjct: 62  EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPC---GDLYHRLLDKAHP 118
Query: 111 AFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE 168
                +  ++++ I   I+++ +QN  I HRD++  N+            L    +  P 
Sbjct: 119 IKWSVKLRLMLD-IALGIEYMQNQNPPIVHRDLRSPNIF-----------LQSLDENAPV 166
Query: 169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK--YDKSCDIW 226
                        K+ DF  +++ V + + L        ++APE +G ++  Y +  D +
Sbjct: 167 -----------CAKVADFSLSQQSVHSVSGLLG---NFQWMAPETIGAEEESYTEKADTY 212
Query: 227 SLGVIMYILLCGFPPF 242
           S  +I+Y +L G  PF
Sbjct: 213 SFAMILYTILTGEGPF 228

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 67/309 (21%), Positives = 123/309 (39%), Gaps = 74/309 (23%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED---------GAFTEREAAIIMN- 122
           N+             L+VI+E    G L   ++ K +           F   E  I  + 
Sbjct: 95  NLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++   ++FL  +   HRD+   N+L +                           +  ++K
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILLS---------------------------EKNVVK 184
Query: 183 LTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILL 236
           + DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++ I  
Sbjct: 185 ICDFGLARDIYKDPDYVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241
Query: 237 CGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--DPSER 292
            G  P+      +     +K   R+   D+  PE          + + ML C   +PS+R
Sbjct: 242 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEPSQR 291
Query: 293 LTIDQVMEN 301
            T  +++E+
Sbjct: 292 PTFSELVEH 300

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 38/190 (20%)
Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           I  EI   + +LH + I H+D+K +N+ Y    D G + +TDFG      +L     +  
Sbjct: 135 IAQEIVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRRE-- 188
Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEV---LGPDK------YDKSCDIWSLGV 230
                          +K  +Q       ++APE+   L PD       + K  D+++LG 
Sbjct: 189 ---------------DKLRIQNGWLC--HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 231 IMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPS 290
           I Y L     PF +   +AI   M   ++      PN     + +E   ++      +  
Sbjct: 232 IWYELHAREWPFKTQPAEAIIWQMGTGMK------PNLSQIGMGKEISDILLFCWAFEQE 285
Query: 291 ERLTIDQVME 300
           ER T  ++M+
Sbjct: 286 ERPTFTKLMD 295

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 26/185 (14%)
Query: 89  LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY 148
           LV++  M  G+L   I+ +     T ++      ++   +KFL  +   HRD+   N + 
Sbjct: 106 LVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 164
Query: 149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYY 208
               +   +K+ DFG  +    +Y K  D               V NK   + P     +
Sbjct: 165 ---DEKFTVKVADFGLARD---MYDKEFDS--------------VHNKTGAKLPV---KW 201
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDF-P 266
           +A E L   K+    D+WS GV+++ L+  G PP+   +   I+  +    RL Q ++ P
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 261
Query: 267 NPEWE 271
           +P +E
Sbjct: 262 DPLYE 266

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 26/185 (14%)
Query: 89  LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY 148
           LV++  M  G+L   I+ +     T ++      ++   +KFL  +   HRD+   N + 
Sbjct: 109 LVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 167
Query: 149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYY 208
               +   +K+ DFG  +    +Y K  D               V NK   + P     +
Sbjct: 168 D---EKFTVKVADFGLARD---MYDKEFDS--------------VHNKTGAKLPV---KW 204
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDF-P 266
           +A E L   K+    D+WS GV+++ L+  G PP+   +   I+  +    RL Q ++ P
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 264
Query: 267 NPEWE 271
           +P +E
Sbjct: 265 DPLYE 269

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 62/144 (43%), Gaps = 38/144 (26%)
Query: 109 DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE 168
           D  FT +   +I  ++ S ++++H +N+ +RDVKPEN L  + G+            K E
Sbjct: 91  DRTFTLKTVLMIAIQLLSRMEYVHSKNLIYRDVKPENFLIGRQGN------------KKE 138
Query: 169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY--------- 219
           +          ++ + DFG AK+ +      +T  + PY     + G  +Y         
Sbjct: 139 H----------VIHIIDFGLAKEYIDP----ETKKHIPYREHKSLTGTARYMSINTHLGK 184
Query: 220 --DKSCDIWSLG-VIMYILLCGFP 240
              +  D+ +LG + MY L    P
Sbjct: 185 EQSRRDDLEALGHMFMYFLRGSLP 208

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/60 (31%), Positives = 36/60 (60%), Gaps = 2/60 (3%)
Query: 109 DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGG--ILKLTDFGDVK 166
           D  F+ +   +I  ++ S ++++H +N+ +RDVKPEN L  +PG+    ++ + DF   K
Sbjct: 99  DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 26/185 (14%)
Query: 89  LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY 148
           LV++  M  G+L   I+ +     T ++      ++   +KFL  +   HRD+   N + 
Sbjct: 108 LVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 166
Query: 149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYY 208
               +   +K+ DFG  +    +Y K  D               V NK   + P     +
Sbjct: 167 D---EKFTVKVADFGLARD---MYDKEFDS--------------VHNKTGAKLPV---KW 203
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDF-P 266
           +A E L   K+    D+WS GV+++ L+  G PP+   +   I+  +    RL Q ++ P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 263
Query: 267 NPEWE 271
           +P +E
Sbjct: 264 DPLYE 268

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/60 (31%), Positives = 36/60 (60%), Gaps = 2/60 (3%)
Query: 109 DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGG--ILKLTDFGDVK 166
           D  F+ +   +I  ++ S ++++H +N+ +RDVKPEN L  +PG+    ++ + DF   K
Sbjct: 120 DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 179

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 58/245 (23%)
Query: 24  LGLGINGKVL-----QIVEKKTSEVYALKVLHDTV-KAR----REVELQLAVGSHKHIVN 73
           LG G  GKV       +  ++   + A+K L D    AR    RE EL L    H+HIV 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL-LTNLQHEHIVK 79
Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA-----------FTEREAAIIMN 122
               Y     G   L+++ E M  G+L + ++     A            T+ +   I  
Sbjct: 80  F---YGVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGG 179
           +I + + +L  Q+  HRD+   N L    G+  ++K+ DFG   DV   +  Y + G   
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTD--YYRVGGHT 190
Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCG 238
           +L +                        ++ PE +   K+    D+WSLGV+++ I   G
Sbjct: 191 MLPIR-----------------------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYG 227
Query: 239 FPPFF 243
             P++
Sbjct: 228 KQPWY 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 26/185 (14%)
Query: 89  LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY 148
           LV++  M  G+L   I+ +     T ++      ++   +KFL  +   HRD+   N + 
Sbjct: 113 LVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 171
Query: 149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYY 208
               +   +K+ DFG  +    +Y K  D               V NK   + P     +
Sbjct: 172 D---EKFTVKVADFGLARD---MYDKEFDS--------------VHNKTGAKLPV---KW 208
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDF-P 266
           +A E L   K+    D+WS GV+++ L+  G PP+   +   I+  +    RL Q ++ P
Sbjct: 209 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 268
Query: 267 NPEWE 271
           +P +E
Sbjct: 269 DPLYE 273

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 26/185 (14%)
Query: 89  LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY 148
           LV++  M  G+L   I+ +     T ++      ++   +KFL  +   HRD+   N + 
Sbjct: 108 LVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 166
Query: 149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYY 208
               +   +K+ DFG  +    +Y K  D               V NK   + P     +
Sbjct: 167 D---EKFTVKVADFGLARD---MYDKEFDS--------------VHNKTGAKLPV---KW 203
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDF-P 266
           +A E L   K+    D+WS GV+++ L+  G PP+   +   I+  +    RL Q ++ P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 263
Query: 267 NPEWE 271
           +P +E
Sbjct: 264 DPLYE 268

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 67/311 (21%), Positives = 123/311 (39%), Gaps = 76/311 (24%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-----------GAFTEREAAIIM 121
           N+             L+VI+E    G L   ++ K +             F   E  I  
Sbjct: 97  NLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 122 N-EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
           + ++   ++FL  +   HRD+   N+L +                           +  +
Sbjct: 154 SFQVAKGMEFLASRKXIHRDLAARNILLS---------------------------EKNV 186
Query: 181 LKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-I 234
           +K+ DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++ I
Sbjct: 187 VKICDFGLARDIXKDPDXVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 235 LLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--DPS 290
              G  P+      +     +K   R+   D+  PE          + + ML C   +PS
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEPS 293
Query: 291 ERLTIDQVMEN 301
           +R T  +++E+
Sbjct: 294 QRPTFSELVEH 304

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/226 (20%), Positives = 86/226 (38%), Gaps = 48/226 (21%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHK-----HIVNIKDVY 78
            G+   G    I++ +     A+K ++++   R  +E        K     H+V +  V 
Sbjct: 30  FGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 89
Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAF--------TEREAAIIMNEICSAIKF 130
                  +  LV+ME M  G+L   ++     A         T +E   +  EI   + +
Sbjct: 90  SK----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 145
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGGILKLTDFG 187
           L+ +   HRD+   N +         +K+ DFG   D+   +  Y + G  G+L +    
Sbjct: 146 LNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETD--YYRKGGKGLLPVR--- 197
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
                               ++APE L    +  S D+WS GV+++
Sbjct: 198 --------------------WMAPESLKDGVFTTSSDMWSFGVVLW 223

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 26/117 (22%)
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + I FLH+ +  HRD+K  N+L     +    K++DFG                 L   
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFG-----------------LARA 182
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
              FA+ ++ ++        T  Y+APE L  +   KS DI+S GV++  ++ G P 
Sbjct: 183 SEKFAQTVMXSRI-----VGTTAYMAPEALRGEITPKS-DIYSFGVVLLEIITGLPA 233

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 67/312 (21%), Positives = 123/312 (39%), Gaps = 77/312 (24%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED------------GAFTEREAAII 120
           N+             L+VI+E    G L   ++ K +              F   E  I 
Sbjct: 96  NLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 121 MN-EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
            + ++   ++FL  +   HRD+   N+L +                           +  
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------EKN 185
Query: 180 ILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY- 233
           ++K+ DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++ 
Sbjct: 186 VVKICDFGLARDIXKDPDXVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLWE 242
Query: 234 ILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--DP 289
           I   G  P+      +     +K   R+   D+  PE          + + ML C   +P
Sbjct: 243 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEP 292
Query: 290 SERLTIDQVMEN 301
           S+R T  +++E+
Sbjct: 293 SQRPTFSELVEH 304

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 26/185 (14%)
Query: 89  LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY 148
           LV++  M  G+L   I+ +     T ++      ++   +KFL  +   HRD+   N + 
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225
Query: 149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYY 208
               +   +K+ DFG  +    +Y K  D               V NK   + P     +
Sbjct: 226 D---EKFTVKVADFGLARD---MYDKEFDS--------------VHNKTGAKLPV---KW 262
Query: 209 VAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDF-P 266
           +A E L   K+    D+WS GV+++ L+  G PP+   +   I+  +    RL Q ++ P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 322
Query: 267 NPEWE 271
           +P +E
Sbjct: 323 DPLYE 327

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/276 (20%), Positives = 103/276 (37%), Gaps = 55/276 (19%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+ L L    H +I+ ++D++ +    +   L ++  +   +L Q I  +     +
Sbjct: 75  RVLREIRL-LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVIS 132
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
            +     M  I   +  LH+  + HRD+ P N+L           L D  D+        
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL-----------LADNNDI-------- 173
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
                    + DF  A++  ++        +  +Y APE++   K + K  D+WS G +M
Sbjct: 174 --------TICDFNLAREDTADANKTHYVTHR-WYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 233 YILLCGFPPF----FSNHGQAI----------------SPGMKNRIRLGQFDFPNPEWEH 272
             +      F    F N    I                SP  ++ +R    + P   W  
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA 284
Query: 273 VSQEAK----TLIKNMLCVDPSERLTIDQVMENKWI 304
           V   A      LI  ML  +P  R++ +Q + + + 
Sbjct: 285 VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/276 (20%), Positives = 103/276 (37%), Gaps = 55/276 (19%)
Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           +  RE+ L L    H +I+ ++D++ +    +   L ++  +   +L Q I  +     +
Sbjct: 75  RVLREIRL-LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVIS 132
Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
            +     M  I   +  LH+  + HRD+ P N+L           L D  D+        
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL-----------LADNNDI-------- 173
Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIM 232
                    + DF  A++  ++        +  +Y APE++   K + K  D+WS G +M
Sbjct: 174 --------TICDFNLAREDTADANKTHYVTHR-WYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 233 YILLCGFPPF----FSNHGQAI----------------SPGMKNRIRLGQFDFPNPEWEH 272
             +      F    F N    I                SP  ++ +R    + P   W  
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA 284
Query: 273 VSQEAK----TLIKNMLCVDPSERLTIDQVMENKWI 304
           V   A      LI  ML  +P  R++ +Q + + + 
Sbjct: 285 VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/226 (20%), Positives = 86/226 (38%), Gaps = 48/226 (21%)
Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHK-----HIVNIKDVY 78
            G+   G    I++ +     A+K ++++   R  +E        K     H+V +  V 
Sbjct: 29  FGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 88
Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAF--------TEREAAIIMNEICSAIKF 130
                  +  LV+ME M  G+L   ++     A         T +E   +  EI   + +
Sbjct: 89  SK----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 144
Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGGILKLTDFG 187
           L+ +   HRD+   N +         +K+ DFG   D+   +  Y + G  G+L +    
Sbjct: 145 LNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETD--YYRKGGKGLLPVR--- 196
Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
                               ++APE L    +  S D+WS GV+++
Sbjct: 197 --------------------WMAPESLKDGVFTTSSDMWSFGVVLW 222

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 67/313 (21%), Positives = 123/313 (39%), Gaps = 78/313 (24%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-------------GAFTEREAAI 119
           N+             L+VI+E    G L   ++ K +               F   E  I
Sbjct: 95  NLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 120 IMN-EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             + ++   ++FL  +   HRD+   N+L +                           + 
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------EK 184
Query: 179 GILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            ++K+ DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 234 -ILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--D 288
            I   G  P+      +     +K   R+   D+  PE          + + ML C   +
Sbjct: 242 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGE 291
Query: 289 PSERLTIDQVMEN 301
           PS+R T  +++E+
Sbjct: 292 PSQRPTFSELVEH 304

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 67/313 (21%), Positives = 123/313 (39%), Gaps = 78/313 (24%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-------------GAFTEREAAI 119
           N+             L+VI+E    G L   ++ K +               F   E  I
Sbjct: 95  NLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 120 IMN-EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             + ++   ++FL  +   HRD+   N+L +                           + 
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------EK 184
Query: 179 GILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            ++K+ DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++
Sbjct: 185 NVVKICDFGLARDIYKDPDXVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 234 -ILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--D 288
            I   G  P+      +     +K   R+   D+  PE          + + ML C   +
Sbjct: 242 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGE 291
Query: 289 PSERLTIDQVMEN 301
           PS+R T  +++E+
Sbjct: 292 PSQRPTFSELVEH 304

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 67/313 (21%), Positives = 123/313 (39%), Gaps = 78/313 (24%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-------------GAFTEREAAI 119
           N+             L+VI+E    G L   ++ K +               F   E  I
Sbjct: 95  NLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 120 IMN-EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             + ++   ++FL  +   HRD+   N+L +                           + 
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------EK 184
Query: 179 GILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            ++K+ DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 234 -ILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--D 288
            I   G  P+      +     +K   R+   D+  PE          + + ML C   +
Sbjct: 242 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGE 291
Query: 289 PSERLTIDQVMEN 301
           PS+R T  +++E+
Sbjct: 292 PSQRPTFSELVEH 304

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 67/313 (21%), Positives = 123/313 (39%), Gaps = 78/313 (24%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-------------GAFTEREAAI 119
           N+             L+VI+E    G L   ++ K +               F   E  I
Sbjct: 86  NLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 120 IMN-EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             + ++   ++FL  +   HRD+   N+L +                           + 
Sbjct: 143 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------EK 175
Query: 179 GILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            ++K+ DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++
Sbjct: 176 NVVKICDFGLARDIXKDPDXVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLW 232
Query: 234 -ILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--D 288
            I   G  P+      +     +K   R+   D+  PE          + + ML C   +
Sbjct: 233 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGE 282
Query: 289 PSERLTIDQVMEN 301
           PS+R T  +++E+
Sbjct: 283 PSQRPTFSELVEH 295

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/117 (27%), Positives = 51/117 (43%), Gaps = 26/117 (22%)
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + I FLH+ +  HRD+K  N+L     +    K++DFG                 L   
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFG-----------------LARA 182
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
              FA+ ++  +        T  Y+APE L  +   KS DI+S GV++  ++ G P 
Sbjct: 183 SEKFAQTVMXXRI-----VGTTAYMAPEALRGEITPKS-DIYSFGVVLLEIITGLPA 233

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 67/313 (21%), Positives = 123/313 (39%), Gaps = 78/313 (24%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-------------GAFTEREAAI 119
           N+             L+VI+E    G L   ++ K +               F   E  I
Sbjct: 132 NLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 120 IMN-EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             + ++   ++FL  +   HRD+   N+L +                           + 
Sbjct: 189 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------EK 221
Query: 179 GILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            ++K+ DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++
Sbjct: 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLW 278
Query: 234 -ILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--D 288
            I   G  P+      +     +K   R+   D+  PE          + + ML C   +
Sbjct: 279 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGE 328
Query: 289 PSERLTIDQVMEN 301
           PS+R T  +++E+
Sbjct: 329 PSQRPTFSELVEH 341

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/117 (27%), Positives = 49/117 (41%), Gaps = 26/117 (22%)
Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            + I FLH+ +  HRD+K  N+L     +    K++DFG  +               K  
Sbjct: 137 ANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFGLARASE------------KFA 181
Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
                 +IV   A          Y+APE L  +   KS DI+S GV++  ++ G P 
Sbjct: 182 QXVMXXRIVGTTA----------YMAPEALRGEITPKS-DIYSFGVVLLEIITGLPA 227

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 40/192 (20%)
Query: 89  LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY 148
           LV++  M  G+L   I+ +     T ++      ++   +KFL  +   HRD+   N + 
Sbjct: 109 LVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 167
Query: 149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI-------VSNKASLQT 201
            +       K T                    +K+ DFG A+ +       V NK   + 
Sbjct: 168 DE-------KFT--------------------VKVADFGLARDMLDKEFDSVHNKTGAKL 200
Query: 202 PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRL 260
           P     ++A E L   K+    D+WS GV+++ L+  G PP+   +   I+  +    RL
Sbjct: 201 PV---KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 257
Query: 261 GQFDF-PNPEWE 271
            Q ++ P+P +E
Sbjct: 258 LQPEYCPDPLYE 269

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 67/313 (21%), Positives = 122/313 (38%), Gaps = 78/313 (24%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-------------GAFTEREAAI 119
           N+             L+VI E    G L   ++ K +               F   E  I
Sbjct: 86  NLLGA---CTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 120 IMN-EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             + ++   ++FL  +   HRD+   N+L +                           + 
Sbjct: 143 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------EK 175
Query: 179 GILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            ++K+ DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++
Sbjct: 176 NVVKICDFGLARDIYKDPDYVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLW 232
Query: 234 -ILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--D 288
            I   G  P+      +     +K   R+   D+  PE          + + ML C   +
Sbjct: 233 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGE 282
Query: 289 PSERLTIDQVMEN 301
           PS+R T  +++E+
Sbjct: 283 PSQRPTFSELVEH 295

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 67/313 (21%), Positives = 122/313 (38%), Gaps = 78/313 (24%)
Query: 24  LGLGINGKVLQ-----IVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGSHKHIV 72
           LG G  G+V++     I +  T    A+K+L     H   +A   E+++ + +G H ++V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-------------GAFTEREAAI 119
           N+             L+VI E    G L   ++ K +               F   E  I
Sbjct: 86  NLLGA---CTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 120 IMN-EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             + ++   ++FL  +   HRD+   N+L +                           + 
Sbjct: 143 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------EK 175
Query: 179 GILKLTDFGFAKKIVSN-----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            ++K+ DFG A+ I  +     K   + P     ++APE +    Y    D+WS GV+++
Sbjct: 176 NVVKICDFGLARDIXKDPDXVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLW 232
Query: 234 -ILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV--D 288
            I   G  P+      +     +K   R+   D+  PE          + + ML C   +
Sbjct: 233 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGE 282
Query: 289 PSERLTIDQVMEN 301
           PS+R T  +++E+
Sbjct: 283 PSQRPTFSELVEH 295

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	372
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-169
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-164
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-138
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-138
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-133
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-128
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-104
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-103
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-102
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-102
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-102
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-101
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-101
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-101
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-100
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-100
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-100
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-100
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-99
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-99
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-98
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-98
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-98
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-98
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-95
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-94
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-93
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-92
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-92
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-78
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-78
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-78
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-76
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-76
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-75
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-75
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-75
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-75
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-75
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-73
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-71
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-69
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-69
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-68
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-68
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-66
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-66
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-66
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-66
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-65
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-64
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-63
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-62
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-62
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-61
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-61
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-61
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-60
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-60
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-59
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-59
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-59
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-58
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-58
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-58
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-58
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-58
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-58
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-57
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-57
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-56
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-56
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-56
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-55
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-55
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-55
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-54
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-53
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-52
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-52
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-52
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-51
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-51
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-51
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-51
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-51
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-51
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-51
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-51
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-50
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-48
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-48
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-41
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-41
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-39
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-39
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-38
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-36
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-36
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-35
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-34
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-34
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-34
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-33
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-32
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-32
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-31
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-31
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-30
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-30
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-30
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-30
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-29
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-29
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-29
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-29
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-28
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-28
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-27
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-26
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-25
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-25
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-24
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-24
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-24
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-24
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-24
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-24
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-24
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-24
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-23
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-23
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-23
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-23
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-23
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-22
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-22
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-22
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-22
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-22
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-22
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-21
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-21
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-20
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-16
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-14
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-14
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-14
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-14
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-14
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-13
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-13
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-13
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-13
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-13
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-12
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-12
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-12
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-12
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-12
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-12
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-12
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-12
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-11
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-11
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-11
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-11
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-11
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-10
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-10
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-10
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-10
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-10
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-10
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-10
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-10
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-10
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-09
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-09
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-09
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-09
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-09
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-09
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-09
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-08
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-08
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-08
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-08
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-08
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-06
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-05
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-05
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-04

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  476 bits (1228), Expect = e-169
 Identities = 215/365 (58%), Positives = 262/365 (71%), Gaps = 25/365 (6%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS 67
            K   I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL      
Sbjct: 54  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ 113

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
             HIV I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  A
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I++LH  NIAHRDVKPENLLYT      ILKLTDFG                        
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG------------------------ 209

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           FAK+  S+  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG
Sbjct: 210 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q 
Sbjct: 269 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

Query: 308 NQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
            +VPQTPL T ++LKE +E W +V++EMT +LATMRVDY+QI IK + ++ NPLL KRRK
Sbjct: 329 TKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRK 388

Query: 368 NQSPS 372
                
Sbjct: 389 KARAL 393

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  462 bits (1190), Expect = e-164
 Identities = 204/341 (59%), Positives = 249/341 (73%), Gaps = 26/341 (7%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSH 68
           K   + DDY +S ++LGLG+NGKVL+   ++T +  ALK+L+D+ KAR+EV+        
Sbjct: 22  KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG 81

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            HIV I DVYEN+++G RCLL+IMECM GGELF RIQ++ D AFTEREAA IM +I +AI
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           +FLH  NIAHRDVKPENLLYT      +LKLTDFG                        F
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG------------------------F 177

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           AK+   N   LQTPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCGFPPF+SN GQ
Sbjct: 178 AKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
           AISPGMK RIRLGQ+ FPNPEW  VS++AK LI+ +L  DP+ERLTI Q M + WI+Q  
Sbjct: 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQI 349
            VPQTPL T ++L+E ++ W EV++EMT +LATMRVDYDQ+
Sbjct: 296 VVPQTPLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQV 336

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  397 bits (1021), Expect = e-138
 Identities = 110/360 (30%), Positives = 178/360 (49%), Gaps = 43/360 (11%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARREVELQLAVGS 67
            +    D Y++  E +G+G      + + K T+  +A+K++  +      E+E+ L  G 
Sbjct: 16  NSIQFTDGYEVK-EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ 74

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +I+ +KDVY++     + + V+ E M GGEL  +I ++    F+EREA+ ++  I   
Sbjct: 75  HPNIITLKDVYDD----GKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKT 128

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +++LH Q + HRD+KP N+LY                         + G+   +++ DFG
Sbjct: 129 VEYLHAQGVVHRDLKPSNILY-----------------------VDESGNPESIRICDFG 165

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           FAK++ +    L TPCYT  +VAPEVL    YD +CDIWSLGV++Y +L G+ PF  N  
Sbjct: 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA-NGP 224

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
                 +  RI  G+F      W  VS  AK L+  ML VDP +RLT   V+ + WI  +
Sbjct: 225 DDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284

Query: 308 NQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRK 367
           +Q+PQ  L         ++    V+  M  + + +  +   +    L       L +RR 
Sbjct: 285 DQLPQYQLNR-------QDAPHLVKGAMAATYSALNRNQSPV----LEPVGRSTLAQRRG 333

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  394 bits (1014), Expect = e-138
 Identities = 181/337 (53%), Positives = 222/337 (65%), Gaps = 46/337 (13%)

Query: 7   PFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVG 66
             K   I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL     
Sbjct: 9   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS 68

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
              HIV I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           AI++LH  NIAHRDVKPENLLYT      ILKLTDFG                       
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------------- 165

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
                                  A E  G +KYDKSCD+WSLGVIMYILLCG+PPF+SNH
Sbjct: 166 ----------------------FAKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202

Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
           G AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q
Sbjct: 203 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262

Query: 307 FNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMR 343
             +VPQTPL T ++LKE +E W +V++EMT +LATMR
Sbjct: 263 STKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 299

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  382 bits (984), Expect = e-133
 Identities = 108/322 (33%), Positives = 176/322 (54%), Gaps = 37/322 (11%)

Query: 9   KTTPIQDDYDI--STEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLA 64
           K +P    YD+    + LG G      + V KK+++ +A+K++   ++A  ++E+     
Sbjct: 2   KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKL 61

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H +IV + +V+ +         ++ME ++GGELF+RI++K    F+E EA+ IM ++
Sbjct: 62  CEGHPNIVKLHEVFHD----QLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKL 115

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            SA+  +HD  + HRD+KPENLL+T   D   +K+ DFG                     
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG--------------------- 154

Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
              FA+    +   L+TPC+T +Y APE+L  + YD+SCD+WSLGVI+Y +L G  PF S
Sbjct: 155 ---FARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211

Query: 245 NHGQ---AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           +        +  +  +I+ G F F    W++VSQEAK LI+ +L VDP++RL +  +  N
Sbjct: 212 HDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271

Query: 302 KWISQFNQVPQTPLCTGKMLKE 323
           +W+   +Q+   PL T  +L  
Sbjct: 272 EWLQDGSQLSSNPLMTPDILGS 293

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  370 bits (952), Expect = e-128
 Identities = 100/342 (29%), Positives = 162/342 (47%), Gaps = 60/342 (17%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKV-----LHDTVKARREVELQL 63
            +   +D Y +  ++LG G + +V   +   TS+ YA+K+      H   +  REVE+  
Sbjct: 6   FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLY 65

Query: 64  AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
               H++++ + + +E          ++ E M GG +   I ++    F E EA++++ +
Sbjct: 66  QCQGHRNVLELIEFFEE----EDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQD 119

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           + SA+ FLH++ IAHRD+KP                        EN+L   P     +K+
Sbjct: 120 VASALDFLHNKGIAHRDLKP------------------------ENILCEHPNQVSPVKI 155

Query: 184 TDFGFAKKIVSNKAS-------LQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVI 231
            DF     I  N          L TPC +  Y+APEV+         YDK CD+WSLGVI
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

Query: 232 MYILLCGFPPFFSNHG-----------QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTL 280
           +YILL G+PPF    G            A    +   I+ G+++FP+ +W H+S  AK L
Sbjct: 216 LYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDL 275

Query: 281 IKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLK 322
           I  +L  D  +RL+  QV+++ W+      P+  L T  +L+
Sbjct: 276 ISKLLVRDAKQRLSAAQVLQHPWVQ--GCAPENTLPTPMVLQ 315

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  308 bits (791), Expect = e-104
 Identities = 88/355 (24%), Positives = 144/355 (40%), Gaps = 89/355 (25%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL----------HDTVKARRE 58
               +Q  Y +    +G G  G V   +E +T  + A+K++           D  + + E
Sbjct: 20  SLLELQKKYHLK-GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78

Query: 59  VELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK----------- 107
           V L +    H +I  + +VYE+     + + ++ME  HGG L  ++              
Sbjct: 79  VRL-MKKLHHPNIARLYEVYED----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133

Query: 108 ---------------------------EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRD 140
                                       D    E+  + IM +I SA+ +LH+Q I HRD
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRD 193

Query: 141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS-- 198
           +KPEN L++      I                         KL DFG +K+         
Sbjct: 194 IKPENFLFSTNKSFEI-------------------------KLVDFGLSKEFYKLNNGEY 228

Query: 199 --LQTPCYTPYYVAPEVL--GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
             + T   TPY+VAPEVL    + Y   CD WS GV++++LL G  PF   +        
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA----DT 284

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
            +++   +  F NP +  +S  A+ L+ N+L  +  ER    + +++ WISQF+ 
Sbjct: 285 ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  304 bits (782), Expect = e-103
 Identities = 98/310 (31%), Positives = 153/310 (49%), Gaps = 44/310 (14%)

Query: 10  TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------HDTVKARREVELQ 62
           +T   D+YD+  E LG G    V + V K T   +A K++        D  K  RE  + 
Sbjct: 1   STKFSDNYDVK-EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 59

Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
             +  H +IV + D  +          ++ + + GGELF+ I  +    ++E +A+  + 
Sbjct: 60  RKL-QHPNIVRLHDSIQE----ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQ 112

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +I  +I + H   I HR++KPENLL      G  +KL DFG                   
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG------------------- 153

Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
                 A ++  ++A       TP Y++PEVL  D Y K  DIW+ GVI+YILL G+PPF
Sbjct: 154 -----LAIEVNDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
           +      +      +I+ G +D+P+PEW+ V+ EAK+LI +ML V+P +R+T DQ ++  
Sbjct: 208 WDEDQHRLY----AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263

Query: 303 WISQFNQVPQ 312
           WI    +V  
Sbjct: 264 WICNRERVAS 273

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  304 bits (780), Expect = e-102
 Identities = 78/318 (24%), Positives = 136/318 (42%), Gaps = 40/318 (12%)

Query: 2   TPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------HDTVK 54
           T            + Y ++++ LG G    V Q + K T + YA K L           +
Sbjct: 15  TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE 74

Query: 55  ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTE 114
              E+ +     S   ++N+ +VYEN    +  +++I+E   GGE+F     +     +E
Sbjct: 75  ILHEIAVLELAKSCPRVINLHEVYEN----TSEIILILEYAAGGEIFSLCLPELAEMVSE 130

Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
            +   ++ +I   + +LH  NI H D+KP                        +N+L + 
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKP------------------------QNILLSS 166

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI 234
               G +K+ DFG ++KI      L+    TP Y+APE+L  D    + D+W++G+I Y+
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYM 225

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
           LL    PF     Q       N I     D+    +  VSQ A   I+++L  +P +R T
Sbjct: 226 LLTHTSPFVGEDNQET---YLN-ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT 281

Query: 295 IDQVMENKWISQFNQVPQ 312
            +  + + W+ Q++    
Sbjct: 282 AEICLSHSWLQQWDFENL 299

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  307 bits (789), Expect = e-102
 Identities = 92/316 (29%), Positives = 147/316 (46%), Gaps = 43/316 (13%)

Query: 7   PFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------HDTVKARREV 59
               T   ++Y +  E LG G    V + V+    + YA  ++        D  K  RE 
Sbjct: 3   TITCTRFTEEYQLF-EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61

Query: 60  ELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
            +   +  H +IV + D             +I + + GGELF+ I  +    ++E +A+ 
Sbjct: 62  RICRLL-KHPNIVRLHDSISE----EGHHYLIFDLVTGGELFEDIVAR--EYYSEADASH 114

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
            + +I  A+   H   + HR++KPENLL      G  +KL DFG                
Sbjct: 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG---------------- 158

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
                    A ++   + +      TP Y++PEVL  D Y K  D+W+ GVI+YILL G+
Sbjct: 159 --------LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGY 210

Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
           PPF+      +      +I+ G +DFP+PEW+ V+ EAK LI  ML ++PS+R+T  + +
Sbjct: 211 PPFWDEDQHRLY----QQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266

Query: 300 ENKWISQFNQVPQTPL 315
           ++ WIS  + V     
Sbjct: 267 KHPWISHRSTVASCMH 282

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  304 bits (780), Expect = e-102
 Identities = 79/322 (24%), Positives = 145/322 (45%), Gaps = 47/322 (14%)

Query: 6   KPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL----------HDTVKA 55
                   +D Y++  E++G G    V + + ++T + +A+K++            T   
Sbjct: 15  MADDDVLFEDVYELC-EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73

Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--DGAFT 113
           +RE  +   +  H HIV + + Y +       L ++ E M G +L   I ++      ++
Sbjct: 74  KREASI-CHMLKHPHIVELLETYSS----DGMLYMVFEFMDGADLCFEIVKRADAGFVYS 128

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E  A+  M +I  A+++ HD NI HRDVKP  +L     +   +KL  FG          
Sbjct: 129 EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG---------- 178

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
                          A ++  +         TP+++APEV+  + Y K  D+W  GVI++
Sbjct: 179 --------------VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224

Query: 234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           ILL G  PF+          +   I  G++     +W H+S+ AK L++ ML +DP+ER+
Sbjct: 225 ILLSGCLPFYGT-----KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI 279

Query: 294 TIDQVMENKWISQFNQVPQTPL 315
           T+ + + + W+ + ++      
Sbjct: 280 TVYEALNHPWLKERDRYAYKIH 301

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  303 bits (778), Expect = e-101
 Identities = 99/320 (30%), Positives = 154/320 (48%), Gaps = 44/320 (13%)

Query: 3   PTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------HDTVKA 55
             F    +T   D+YD+  E LG G    V + V K T   +A K++        D  K 
Sbjct: 17  SEFMMNASTKFSDNYDVK-EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75

Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
            RE  +   +  H +IV + D  +          ++ + + GGELF+ I  +    ++E 
Sbjct: 76  EREARICRKL-QHPNIVRLHDSIQE----ESFHYLVFDLVTGGELFEDIVAR--EFYSEA 128

Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
           +A+  + +I  +I + H   I HR++KPENLL      G  +KL DFG            
Sbjct: 129 DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG------------ 176

Query: 176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL 235
                        A ++  ++A       TP Y++PEVL  D Y K  DIW+ GVI+YIL
Sbjct: 177 ------------LAIEVNDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 223

Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           L G+PPF+      +      +I+ G +D+P+PEW+ V+ EAK+LI +ML V+P +R+T 
Sbjct: 224 LVGYPPFWDEDQHRLY----AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA 279

Query: 296 DQVMENKWISQFNQVPQTPL 315
           DQ ++  WI    +V     
Sbjct: 280 DQALKVPWICNRERVASAIH 299

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  300 bits (771), Expect = e-101
 Identities = 99/313 (31%), Positives = 166/313 (53%), Gaps = 44/313 (14%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKV-----LHDTVKARREVELQ 62
            +TT I+  +    E+LG G   +V  + ++ T +++ALK               E+ + 
Sbjct: 2   MQTTNIRKTFIFM-EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60

Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
             +  H++IV ++D+YE+    +    ++M+ + GGELF RI ++  G +TE++A++++ 
Sbjct: 61  KKI-KHENIVTLEDIYES----TTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQ 113

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++ SA+K+LH+  I HRD+KPENLLY  P +   + +TDFG                   
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG------------------- 154

Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
                 +K   +    + T C TP YVAPEVL    Y K+ D WS+GVI YILLCG+PPF
Sbjct: 155 -----LSKMEQNGI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
           +          +  +I+ G ++F +P W+ +S+ AK  I ++L  DP+ER T ++ + + 
Sbjct: 208 YEETES----KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263

Query: 303 WISQFNQVPQTPL 315
           WI   N      +
Sbjct: 264 WIDG-NTALHRDI 275

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  298 bits (766), Expect = e-101
 Identities = 100/316 (31%), Positives = 154/316 (48%), Gaps = 49/316 (15%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKV-----LHDTVKARREVELQ 62
                I   Y +    +G G  G+V   V+K T    A K      + D  + ++E+E+ 
Sbjct: 2   STKGDINQYYTLE-NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 63  LAVGSHKHIVNIKDVYE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
            ++  H +I+ + + +E   +IY       ++ME   GGELF+R+  K    F E +AA 
Sbjct: 61  KSL-DHPNIIRLYETFEDNTDIY-------LVMELCTGGELFERVVHK--RVFRESDAAR 110

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           IM ++ SA+ + H  N+AHRD+KP                        EN L+       
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKP------------------------ENFLFLTDSPDS 146

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
            LKL DFG A +    K  ++T   TPYYV+P+VL    Y   CD WS GV+MY+LLCG+
Sbjct: 147 PLKLIDFGLAARFKPGK-MMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGY 204

Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
           PPF +     +      +IR G F FP  +W +VS +A++LI+ +L   P +R+T  Q +
Sbjct: 205 PPFSAPTDSEVM----LKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQAL 260

Query: 300 ENKWISQFNQVPQTPL 315
           E++W  +        L
Sbjct: 261 EHEWFEKQLSSSPRNL 276

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  299 bits (767), Expect = e-100
 Identities = 90/312 (28%), Positives = 158/312 (50%), Gaps = 57/312 (18%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------------DTVKARREV 59
           ++D+Y +S + LG G  G+V    E+KT +  A+K++                +    E+
Sbjct: 8   LRDEYIMS-KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 60  ELQLAVGSHKHIVNIKDVYE--NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREA 117
           E+   + +H  I+ IK+ ++  + Y       +++E M GGELF ++         E   
Sbjct: 67  EILKKL-NHPCIIKIKNFFDAEDYY-------IVLELMEGGELFDKVVGN--KRLKEATC 116

Query: 118 AIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
            +   ++  A+++LH+  I HRD+KP                        EN+L +   +
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKP------------------------ENVLLSSQEE 152

Query: 178 GGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYI 234
             ++K+TDFG + KI+   + ++T C TP Y+APEVL   G   Y+++ D WSLGVI++I
Sbjct: 153 DCLIKITDFGHS-KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI 211

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
            L G+PPF  +  Q     +K++I  G+++F    W  VS++A  L+K +L VDP  R T
Sbjct: 212 CLSGYPPFSEHRTQ---VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 268

Query: 295 IDQVMENKWISQ 306
            ++ + + W+  
Sbjct: 269 TEEALRHPWLQD 280

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  299 bits (767), Expect = e-100
 Identities = 94/323 (29%), Positives = 146/323 (45%), Gaps = 51/323 (15%)

Query: 6   KPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----------DTVK 54
           +PFK   ++D YDI  E LG G    V +  EK T   YA K +               +
Sbjct: 3   EPFKQQKVEDFYDIG-EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61

Query: 55  ARREVEL--QLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAF 112
             REV +  Q+    H +++ + DVYEN       +++I+E + GGELF  +   +  + 
Sbjct: 62  IEREVSILRQV---LHHNVITLHDVYEN----RTDVVLILELVSGGELFDFL--AQKESL 112

Query: 113 TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY 172
           +E EA   + +I   + +LH + IAH D+KPEN++                       L 
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM-----------------------LL 149

Query: 173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM 232
            K      +KL DFG A +I       +    TP +VAPE++  +      D+WS+GVI 
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

Query: 233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
           YILL G  PF  +  Q     + N I    +DF    + H S+ AK  I+ +L  +  +R
Sbjct: 209 YILLSGASPFLGDTKQET---LAN-ITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKR 264

Query: 293 LTIDQVMENKWISQFNQVPQTPL 315
           LTI + + + WI+  +       
Sbjct: 265 LTIQEALRHPWITPVDNQQAMVR 287

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  298 bits (764), Expect = e-100
 Identities = 93/326 (28%), Positives = 143/326 (43%), Gaps = 59/326 (18%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--------------HDTVK 54
            T    ++Y+   EILG G++  V + + K T + YA+K++                   
Sbjct: 11  STHGFYENYEPK-EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 55  ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTE 114
             +EV++   V  H +I+ +KD YE     +    ++ + M  GELF  + +K     +E
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEK--VTLSE 123

Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
           +E   IM  +   I  LH  NI HRD+KPEN+L                           
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLD------------------------- 158

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL------GPDKYDKSCDIWSL 228
             D   +KLTDFGF+ ++   +  L+  C TP Y+APE++          Y K  D+WS 
Sbjct: 159 --DDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215

Query: 229 GVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVD 288
           GVIMY LL G PPF+          M   I  G + F +PEW+  S   K L+   L V 
Sbjct: 216 GVIMYTLLAGSPPFWHRK----QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 271

Query: 289 PSERLTIDQVMENKWISQFNQVPQTP 314
           P +R T ++ + + +  Q+       
Sbjct: 272 PQKRYTAEEALAHPFFQQYVVEEVRH 297

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  297 bits (762), Expect = e-100
 Identities = 100/311 (32%), Positives = 155/311 (49%), Gaps = 51/311 (16%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVEL 61
                 + Y+I   +LG G  G+VL+  ++ T + YA+KV++       DT    REVEL
Sbjct: 16  FQGTFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL 74

Query: 62  QLAVGSHKHIVNIKDVYE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
              +  H +I+ + ++ E   + Y       ++ E   GGELF  I ++    F+E +AA
Sbjct: 75  LKKL-DHPNIMKLFEILEDSSSFY-------IVGELYTGGELFDEIIKR--KRFSEHDAA 124

Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
            I+ ++ S I ++H  NI HRD+KP                        EN+L       
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKP------------------------ENILLESKEKD 160

Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG 238
             +K+ DFG +     N   ++    T YY+APEVL    YD+ CD+WS GVI+YILL G
Sbjct: 161 CDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

Query: 239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
            PPF+  +   I      R+  G++ F  P+W  +S +AK LI+ ML   PS R+T  Q 
Sbjct: 219 TPPFYGKNEYDI----LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

Query: 299 MENKWISQFNQ 309
           +E+ WI +++ 
Sbjct: 275 LEHPWIQKYSS 285

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  298 bits (764), Expect = 1e-99
 Identities = 101/301 (33%), Positives = 157/301 (52%), Gaps = 39/301 (12%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH---DTVKARREVELQLAV 65
               + D +++    LG G    V +  +K T + YALKVL    D    R E+ + L +
Sbjct: 47  NRDALSDFFEVE-SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL 105

Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
            SH +I+ +K+++E        + +++E + GGELF RI +K  G ++ER+AA  + +I 
Sbjct: 106 -SHPNIIKLKEIFET----PTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQIL 158

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
            A+ +LH+  I HRD+KPENLLY  P     LK+ DFG                      
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG---------------------- 196

Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
              +K +      ++T C TP Y APE+L    Y    D+WS+G+I YILLCGF PF+  
Sbjct: 197 --LSKIVEHQVL-MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253

Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
            G      M  RI   ++ F +P W+ VS  AK L++ ++ +DP +RLT  Q +++ W++
Sbjct: 254 RGDQ---FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310

Query: 306 Q 306
            
Sbjct: 311 G 311

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  298 bits (765), Expect = 2e-99
 Identities = 92/320 (28%), Positives = 143/320 (44%), Gaps = 64/320 (20%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------------HDTVKA 55
                   YD   +++G G++  V + V + T   +A+K++                   
Sbjct: 88  AAKEFYQKYDPK-DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146

Query: 56  RREVELQLAVGSHKHIVNIKDVYE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAF 112
           RRE  +   V  H HI+ + D YE    ++       ++ + M  GELF  + +K   A 
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMF-------LVFDLMRKGELFDYLTEK--VAL 197

Query: 113 TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY 172
           +E+E   IM  +  A+ FLH  NI HRD+KPEN+L                         
Sbjct: 198 SEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL------------------------ 233

Query: 173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL------GPDKYDKSCDIW 226
               D   ++L+DFGF+  +   +  L+  C TP Y+APE+L          Y K  D+W
Sbjct: 234 ---DDNMQIRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289

Query: 227 SLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
           + GVI++ LL G PPF+          M   I  GQ+ F +PEW+  S   K LI  +L 
Sbjct: 290 ACGVILFTLLAGSPPFWHRR----QILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQ 345

Query: 287 VDPSERLTIDQVMENKWISQ 306
           VDP  RLT +Q +++ +  +
Sbjct: 346 VDPEARLTAEQALQHPFFER 365

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  297 bits (763), Expect = 2e-98
 Identities = 89/319 (27%), Positives = 159/319 (49%), Gaps = 57/319 (17%)

Query: 6   KPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------------DT 52
           +      ++D+Y +S + LG G  G+V    E+KT +  A++++                
Sbjct: 126 QSVYPKALRDEYIMS-KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPA 184

Query: 53  VKARREVELQLAVGSHKHIVNIKDVYE--NIYNGSRCLLVIMECMHGGELFQRIQQKEDG 110
           +    E+E+   + +H  I+ IK+ ++  + Y       +++E M GGELF ++      
Sbjct: 185 LNVETEIEILKKL-NHPCIIKIKNFFDAEDYY-------IVLELMEGGELFDKVVGN--K 234

Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
              E    +   ++  A+++LH+  I HRD+KP                        EN+
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP------------------------ENV 270

Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWS 227
           L +   +  ++K+TDFG + KI+   + ++T C TP Y+APEVL   G   Y+++ D WS
Sbjct: 271 LLSSQEEDCLIKITDFGHS-KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329

Query: 228 LGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCV 287
           LGVI++I L G+PPF  +  Q     +K++I  G+++F    W  VS++A  L+K +L V
Sbjct: 330 LGVILFICLSGYPPFSEHRTQ---VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 386

Query: 288 DPSERLTIDQVMENKWISQ 306
           DP  R T ++ + + W+  
Sbjct: 387 DPKARFTTEEALRHPWLQD 405

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  292 bits (750), Expect = 2e-98
 Identities = 93/317 (29%), Positives = 144/317 (45%), Gaps = 47/317 (14%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----------DTVKARREVEL 61
           ++D Y++  E LG G    V +  +K T + YA K +               +  REV +
Sbjct: 3   VEDHYEMG-EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 62  QLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM 121
            L    H +I+ + D++EN       +++I+E + GGELF  +   E  + TE EA   +
Sbjct: 62  -LREIRHPNIITLHDIFEN----KTDVVLILELVSGGELFDFL--AEKESLTEDEATQFL 114

Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
            +I   + +LH + IAH D+KPEN++                       L  K      +
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIM-----------------------LLDKNVPNPRI 151

Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           KL DFG A KI +     +    TP +VAPE++  +      D+WS+GVI YILL G  P
Sbjct: 152 KLIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
           F     Q     + N I    +DF    + + S+ AK  I+ +L  DP  R+TI Q +E+
Sbjct: 211 FLGETKQET---LTN-ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266

Query: 302 KWISQFNQVPQTPLCTG 318
            WI    +       +G
Sbjct: 267 SWIKAIRRRNVRGEDSG 283

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  295 bits (756), Expect = 4e-98
 Identities = 95/321 (29%), Positives = 144/321 (44%), Gaps = 51/321 (15%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----------DTVKAR 56
           FK   ++D YDI  E LG G    V +  EK T   YA K +               +  
Sbjct: 5   FKQQKVEDFYDIG-EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63

Query: 57  REVEL--QLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTE 114
           REV +  Q+    H +I+ + DVYEN       +++I+E + GGELF  + QK   + +E
Sbjct: 64  REVSILRQV---LHPNIITLHDVYEN----RTDVVLILELVSGGELFDFLAQK--ESLSE 114

Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
            EA   + +I   + +LH + IAH D+KPEN++                       L  K
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIM-----------------------LLDK 151

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI 234
                 +KL DFG A +I       +    TP +VAPE++  +      D+WS+GVI YI
Sbjct: 152 NIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYI 210

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
           LL G  PF  +  Q     + N I    +DF    +   S+ AK  I+ +L  +  +RLT
Sbjct: 211 LLSGASPFLGDTKQET---LAN-ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT 266

Query: 295 IDQVMENKWISQFNQVPQTPL 315
           I + + + WI+  +       
Sbjct: 267 IQEALRHPWITPVDTQQAMVR 287

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  293 bits (751), Expect = 6e-98
 Identities = 88/319 (27%), Positives = 141/319 (44%), Gaps = 51/319 (15%)

Query: 7   PFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----------DTVKA 55
            F+   + D YD   E LG G    V +  EK T   YA K +                 
Sbjct: 3   VFRQENVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61

Query: 56  RREVEL--QLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
            REV +  ++    H +++ + +VYEN       +++I+E + GGELF  +   E  + T
Sbjct: 62  EREVSILKEI---QHPNVITLHEVYEN----KTDVILILELVAGGELFDFL--AEKESLT 112

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E EA   + +I + + +LH   IAH D+KPEN++                       L  
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM-----------------------LLD 149

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
           +      +K+ DFG A KI       +    TP +VAPE++  +      D+WS+GVI Y
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208

Query: 234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           ILL G  PF  +  Q     + N +    ++F +  + + S  AK  I+ +L  DP +R+
Sbjct: 209 ILLSGASPFLGDTKQET---LAN-VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264

Query: 294 TIDQVMENKWISQFNQVPQ 312
           TI   +++ WI   +    
Sbjct: 265 TIQDSLQHPWIKPKDTQQA 283

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  286 bits (733), Expect = 1e-95
 Identities = 78/313 (24%), Positives = 136/313 (43%), Gaps = 45/313 (14%)

Query: 2   TPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKA 55
           +     +    I D +      LG G  G V  + E+ +     +K ++         + 
Sbjct: 9   SGRENLYFQGTIDDLFIFK-RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI 67

Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRI--QQKEDGAFT 113
             E+E+  ++  H +I+ I +V+E+       + ++ME   GGEL +RI   Q    A +
Sbjct: 68  EAEIEVLKSL-DHPNIIKIFEVFED----YHNMYIVMETCEGGELLERIVSAQARGKALS 122

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E   A +M ++ +A+ + H Q++ H+D+KP                        EN+L+ 
Sbjct: 123 EGYVAELMKQMMNALAYFHSQHVVHKDLKP------------------------ENILFQ 158

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
                  +K+ DFG A+   S++        T  Y+APEV         CDIWS GV+MY
Sbjct: 159 DTSPHSPIKIIDFGLAELFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMY 216

Query: 234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            LL G  PF     + +    + +    + ++   E   ++ +A  L+K ML  DP  R 
Sbjct: 217 FLLTGCLPFTGTSLEEV----QQKATYKEPNYA-VECRPLTPQAVDLLKQMLTKDPERRP 271

Query: 294 TIDQVMENKWISQ 306
           +  QV+ ++W  Q
Sbjct: 272 SAAQVLHHEWFKQ 284

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  289 bits (741), Expect = 1e-95
 Identities = 92/349 (26%), Positives = 157/349 (44%), Gaps = 52/349 (14%)

Query: 2   TPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----DTVKAR 56
            P     K   + D YDI  E LG G  G V + VEK T  V+  K ++     D    +
Sbjct: 38  VPQPVEVKQGSVYDYYDIL-EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK 96

Query: 57  REVEL--QLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTE 114
            E+ +  QL    H  ++N+ D +E+       +++I+E + GGELF RI  + D   +E
Sbjct: 97  NEISIMNQL---HHPKLINLHDAFED----KYEMVLILEFLSGGELFDRIAAE-DYKMSE 148

Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
            E    M + C  +K +H+ +I H D+KPEN++        +                  
Sbjct: 149 AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSV------------------ 190

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI 234
                  K+ DFG A K+  ++  ++    T  + APE++  +      D+W++GV+ Y+
Sbjct: 191 -------KIIDFGLATKLNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
           LL G  PF           ++N ++   ++F    +  VS EAK  IKN+L  +P +RLT
Sbjct: 243 LLSGLSPFAGEDDLET---LQN-VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298

Query: 295 IDQVMENKWISQFNQVPQTPLCTGKM------LKEGEETWPEVQDEMTR 337
           +   +E+ W+   +    + + + +       +KE    WP  Q  + R
Sbjct: 299 VHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGR 347

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  287 bits (737), Expect = 4e-95
 Identities = 85/312 (27%), Positives = 145/312 (46%), Gaps = 46/312 (14%)

Query: 9   KTTPIQDDYDI-STEILGLGINGKVLQIVEKKTSEVYALKVLH-----DTVKARREVEL- 61
           K   +   Y +  TEILG G  G+V +  E  T    A K++      D  + + E+ + 
Sbjct: 81  KQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVM 140

Query: 62  -QLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
            QL    H +++ + D +E+       ++++ME + GGELF RI  +     TE +  + 
Sbjct: 141 NQL---DHANLIQLYDAFES----KNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILF 192

Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
           M +IC  I+ +H   I H D+KPEN+L        I                        
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI------------------------ 228

Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
            K+ DFG A++    +  L+    TP ++APEV+  D      D+WS+GVI Y+LL G  
Sbjct: 229 -KIIDFGLARRYKPRE-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286

Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF  ++       + N I   ++D  + E++ +S+EAK  I  +L  + S R++  + ++
Sbjct: 287 PFLGDNDAET---LNN-ILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342

Query: 301 NKWISQFNQVPQ 312
           + W+S      +
Sbjct: 343 HPWLSDHKLHSR 354

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  291 bits (746), Expect = 5e-95
 Identities = 100/309 (32%), Positives = 156/309 (50%), Gaps = 45/309 (14%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVE 60
           +      + Y+I   +LG G  G+VL+  ++ T + YA+KV++       DT    REVE
Sbjct: 15  YFQGTFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73

Query: 61  LQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
           L   +  H +I+ + ++ E+    S    ++ E   GGELF  I ++    F+E +AA I
Sbjct: 74  LLKKL-DHPNIMKLFEILED----SSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARI 126

Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
           + ++ S I ++H  NI HRD+KP                        EN+L         
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKP------------------------ENILLESKEKDCD 162

Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
           +K+ DFG +     N   ++    T YY+APEVL    YD+ CD+WS GVI+YILL G P
Sbjct: 163 IKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTP 220

Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF+  +   I      R+  G++ F  P+W  +S +AK LI+ ML   PS R+T  Q +E
Sbjct: 221 PFYGKNEYDI----LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276

Query: 301 NKWISQFNQ 309
           + WI +++ 
Sbjct: 277 HPWIQKYSS 285

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  288 bits (738), Expect = 8e-94
 Identities = 100/319 (31%), Positives = 157/319 (49%), Gaps = 45/319 (14%)

Query: 4   TFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKAR 56
            F   K   + + Y    + LG G  G+VL   +K T    A+K++           K  
Sbjct: 26  MFITSKKGHLSEMYQRV-KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL 84

Query: 57  REVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTERE 116
            EV +   +  H +I+ + D +E+     R   ++MEC  GGELF  I  +    F E +
Sbjct: 85  EEVAVLKLL-DHPNIMKLYDFFED----KRNYYLVMECYKGGELFDEIIHR--MKFNEVD 137

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
           AA+I+ ++ S + +LH  NI HRD+KP                        ENLL     
Sbjct: 138 AAVIIKQVLSGVTYLHKHNIVHRDLKP------------------------ENLLLESKE 173

Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
              ++K+ DFG +    + K  ++    T YY+APEVL   KYD+ CD+WS+GVI++ILL
Sbjct: 174 KDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL 231

Query: 237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID 296
            G+PPF     Q     +  ++  G++ F +PEW++VS+ AK LIK ML  D   R++  
Sbjct: 232 AGYPPFGGQTDQ----EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ 287

Query: 297 QVMENKWISQFNQVPQTPL 315
           Q +E+ WI +     ++ +
Sbjct: 288 QALEHPWIKEMCSKKESGI 306

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  282 bits (723), Expect = 9e-94
 Identities = 78/308 (25%), Positives = 144/308 (46%), Gaps = 41/308 (13%)

Query: 12  PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----DTVKARREVELQLAVGS 67
            + + Y I+ E LG G  G V + VE  + + Y  K +     D V  ++E+ +      
Sbjct: 2   ELYEKYMIA-EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR- 59

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H++I+++ + +E+       L++I E + G ++F+RI         ERE    ++++C A
Sbjct: 60  HRNILHLHESFES----MEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEA 114

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           ++FLH  NI H D++PEN++Y       I                         K+ +FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTI-------------------------KIIEFG 149

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
            A+++     + +     P Y APEV   D    + D+WSLG ++Y+LL G  PF +   
Sbjct: 150 QARQLKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
           Q I   ++N I   ++ F    ++ +S EA   +  +L  +   R+T  + +++ W+ Q 
Sbjct: 209 QQI---IEN-IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

Query: 308 NQVPQTPL 315
            +   T +
Sbjct: 265 IERVSTKV 272

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  286 bits (735), Expect = 2e-93
 Identities = 94/319 (29%), Positives = 150/319 (47%), Gaps = 46/319 (14%)

Query: 4   TFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKA 55
            F    T    D Y     +LG G  G+V+   +K T +  A+KV+         D    
Sbjct: 15  MFVQHSTAIFSDRYKGQ-RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73

Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
            REV+L   +  H +I+ + + +E+         ++ E   GGELF  I  +    F+E 
Sbjct: 74  LREVQLLKQL-DHPNIMKLYEFFED----KGYFYLVGEVYTGGELFDEIISR--KRFSEV 126

Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
           +AA I+ ++ S I ++H   I HRD+KP                        ENLL    
Sbjct: 127 DAARIIRQVLSGITYMHKNKIVHRDLKP------------------------ENLLLESK 162

Query: 176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL 235
                +++ DFG +    ++K  ++    T YY+APEVL    YD+ CD+WS GVI+YIL
Sbjct: 163 SKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYIL 220

Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           L G PPF   +   I      ++  G++ F  P+W+ VS+ AK LI+ ML   PS R++ 
Sbjct: 221 LSGCPPFNGANEYDI----LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 276

Query: 296 DQVMENKWISQFNQVPQTP 314
              ++++WI  + +   + 
Sbjct: 277 RDALDHEWIQTYTKEQISV 295

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  285 bits (731), Expect = 1e-92
 Identities = 99/329 (30%), Positives = 153/329 (46%), Gaps = 56/329 (17%)

Query: 4   TFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------------- 50
            +   K   I + Y      LG G  G+VL   EK      A+KV+              
Sbjct: 25  MYVRKKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDN 83

Query: 51  -----DTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQ 105
                   +   E+ L  ++  H +I+ + DV+E+     +   ++ E   GGELF++I 
Sbjct: 84  KNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFED----KKYFYLVTEFYEGGELFEQII 138

Query: 106 QKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV 165
            +    F E +AA IM +I S I +LH  NI HRD+KP                      
Sbjct: 139 NR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKP---------------------- 174

Query: 166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDI 225
             EN+L         +K+ DFG +     +   L+    T YY+APEVL   KY++ CD+
Sbjct: 175 --ENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLK-KKYNEKCDV 230

Query: 226 WSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
           WS GVIMYILLCG+PPF   + Q     +  ++  G++ F   +W+++S EAK LIK ML
Sbjct: 231 WSCGVIMYILLCGYPPFGGQNDQ----DIIKKVEKGKYYFDFNDWKNISDEAKELIKLML 286

Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQTP 314
             D ++R T ++ + ++WI ++       
Sbjct: 287 TYDYNKRCTAEEALNSRWIKKYANNINKS 315

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  286 bits (734), Expect = 3e-92
 Identities = 86/328 (26%), Positives = 148/328 (45%), Gaps = 47/328 (14%)

Query: 3   PTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKV-----LHDTVKARR 57
           P     K   + D YDI  E LG G  G V ++ E+ T   +A K        D    R+
Sbjct: 145 PQPVEIKHDHVLDHYDIH-EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK 203

Query: 58  EVEL--QLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
           E++    L    H  +VN+ D +E+       +++I E M GGELF+++   E    +E 
Sbjct: 204 EIQTMSVL---RHPTLVNLHDAFED----DNEMVMIYEFMSGGELFEKVA-DEHNKMSED 255

Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
           EA   M ++C  +  +H+ N  H D+KPEN+++T      +                   
Sbjct: 256 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL------------------- 296

Query: 176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL 235
                 KL DFG    +   + S++    T  + APEV          D+WS+GV+ YIL
Sbjct: 297 ------KLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 349

Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           L G  PF   +       ++N ++   ++  +  +  +S++ K  I+ +L  DP+ R+TI
Sbjct: 350 LSGLSPFGGENDDET---LRN-VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 405

Query: 296 DQVMENKWISQFNQVPQ-TPLCTGKMLK 322
            Q +E+ W++  N   + + + + +  K
Sbjct: 406 HQALEHPWLTPGNAPGRDSQIPSSRYTK 433

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  242 bits (620), Expect = 3e-78
 Identities = 68/334 (20%), Positives = 126/334 (37%), Gaps = 64/334 (19%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVG 66
               + + ++ILG G    V +   KKT +++A+KV +            RE E+   + 
Sbjct: 7   SNHLWLL-SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL- 64

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE-DGAFTEREAAIIMNEIC 125
           +HK+IV +  + E     +R  ++IME    G L+  +++        E E  I++ ++ 
Sbjct: 65  NHKNIVKLFAIEEE--TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +  L +  I HR++KP N++     DG                         + KLTD
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDG-----------------------QSVYKLTD 159

Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVL--------GPDKYDKSCDIWSLGVIMYILLC 237
           FG A+++  ++    +   T  Y+ P++            KY  + D+WS+GV  Y    
Sbjct: 160 FGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

Query: 238 GFPPFFSNHGQAISPGMKNRIRLGQ-----------------FDFPNPEWEHVSQEAKT- 279
           G  PF    G   +  +  +I  G+                 +    P    +S+  +  
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL 278

Query: 280 ---LIKNMLCVDPSERLTIDQVMENKWISQFNQV 310
              ++ N+L  D  +    DQ             
Sbjct: 279 LTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  246 bits (629), Expect = 3e-78
 Identities = 70/326 (21%), Positives = 127/326 (38%), Gaps = 51/326 (15%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--DTVKARREVELQLAVGSHKH 70
           +++      +ILG G +G V+           A+K +       A  E++L      H +
Sbjct: 13  LKNLVVSE-KILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPN 70

Query: 71  IVNIKDVYENIYNGSRCLLVIME-CMHGGELFQRIQQKED-----GAFTEREAAIIMNEI 124
           ++             R L + +E C     L   ++ K           E     ++ +I
Sbjct: 71  VIRYYCSETT----DRFLYIALELC--NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
            S +  LH   I HRD+KP+N+L +        + T   +++              + ++
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR--------------ILIS 170

Query: 185 DFGFAKKIVSNKAS----LQTPCYTPYYVAPEVL-------GPDKYDKSCDIWSLGVIMY 233
           DFG  KK+ S ++S    L  P  T  + APE+L          +  +S DI+S+G + Y
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230

Query: 234 ILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPE---WEHVSQEAKTLIKNMLCVDP 289
            +L  G  PF   + +      ++ I  G F     +      +  EA  LI  M+  DP
Sbjct: 231 YILSKGKHPFGDKYSR------ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284

Query: 290 SERLTIDQVMENKWISQFNQVPQTPL 315
            +R T  +V+ +      ++  +  L
Sbjct: 285 LKRPTAMKVLRHPLFWPKSKKLEFLL 310

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  239 bits (613), Expect = 8e-78
 Identities = 87/310 (28%), Positives = 146/310 (47%), Gaps = 59/310 (19%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKA-------RREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL    ++        RREVE+Q  + 
Sbjct: 9   EDFEIG-RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL- 66

Query: 67  SHKHIVNIKDVYE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
            H +I+ +   +     +Y       +I+E    G +++ +Q+     F E+  A  + E
Sbjct: 67  RHPNILRLYGYFHDATRVY-------LILEYAPLGTVYRELQKL--SKFDEQRTATYITE 117

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           + +A+ + H + + HRD+KPENLL    G+                           LK+
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGE---------------------------LKI 150

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
            DFG++    S++      C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF 
Sbjct: 151 ADFGWSVHAPSSR--RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           +N  Q        RI   +F FP+     V++ A+ LI  +L  +PS+R  + +V+E+ W
Sbjct: 209 ANTYQE----TYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

Query: 304 ISQFNQVPQT 313
           I+  +  P  
Sbjct: 261 ITANSSKPSN 270

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  237 bits (606), Expect = 1e-76
 Identities = 89/312 (28%), Positives = 141/312 (45%), Gaps = 59/312 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKA-------RREVELQLAVG 66
           DD+DI    LG G  G V    EK+   + ALKVL    ++        RRE+E+Q  + 
Sbjct: 14  DDFDIG-RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL- 71

Query: 67  SHKHIVNIKDVYE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
            H +I+ + + +     IY       +++E    GEL++ +Q+   G F E+ +A  M E
Sbjct: 72  RHPNILRMYNYFHDRKRIY-------LMLEFAPRGELYKELQKH--GRFDEQRSATFMEE 122

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +  A+ + H++ + HRD+KPENLL    G+                           LK+
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGE---------------------------LKI 155

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
            DFG++    S +   +T C T  Y+ PE++    +D+  D+W  GV+ Y  L G PPF 
Sbjct: 156 ADFGWSVHAPSLR--RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           S            RI      FP      +S  +K LI  +L   P +RL +  VME+ W
Sbjct: 214 SPS----HTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265

Query: 304 ISQFNQVPQTPL 315
           +   ++    P+
Sbjct: 266 VKANSRRVLPPV 277

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  238 bits (609), Expect = 8e-76
 Identities = 73/365 (20%), Positives = 134/365 (36%), Gaps = 68/365 (18%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVG 66
               + +S +ILG G    V +   KKT +++A+KV +            RE E+   + 
Sbjct: 7   SNHLWLLS-DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL- 64

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE-DGAFTEREAAIIMNEIC 125
           +HK+IV +  + E     +R  ++IME    G L+  +++        E E  I++ ++ 
Sbjct: 65  NHKNIVKLFAIEEE--TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +  L +  I HR++KP N++     DG                         + KLTD
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDG-----------------------QSVYKLTD 159

Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVL--------GPDKYDKSCDIWSLGVIMYILLC 237
           FG A+++  ++    +   T  Y+ P++            KY  + D+WS+GV  Y    
Sbjct: 160 FGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

Query: 238 GFPPFFSNHGQAISPGMKNRIRLGQ-----------------FDFPNPEWEHVSQEAKT- 279
           G  PF    G   +  +  +I  G+                 +    P    +S+  +  
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL 278

Query: 280 ---LIKNMLCVDPSERLTIDQVMENKW-ISQFNQVPQTPLCTGKMLK---EGEETWPEVQ 332
              ++ N+L  D  +    DQ       I     +    L      K       T     
Sbjct: 279 LTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFH 338

Query: 333 DEMTR 337
           + + +
Sbjct: 339 ELVYK 343

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  235 bits (601), Expect = 1e-75
 Identities = 69/311 (22%), Positives = 130/311 (41%), Gaps = 36/311 (11%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREVELQLAVGSH 68
              D++    +LG G  G+V++      S  YA+K +            EV L LA  +H
Sbjct: 4   YASDFEE-IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVML-LASLNH 61

Query: 69  KHIVNIKDVYENIYNGSR---------CLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
           +++V     +    N  +          L + ME    G L+  I   E+      E   
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWR 120

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           +  +I  A+ ++H Q I HRD+KP N+   +  +   +K+ DFG       L        
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN---VKIGDFG-------LAKNVHRSL 170

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCG 238
            +   D   ++ +  +  +L +   T  YVA EVL G   Y++  D++SLG+I + ++  
Sbjct: 171 DILKLD---SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

Query: 239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
           F              +  ++R    +FP    ++  +  K +I+ ++  DP++R     +
Sbjct: 228 FSTGMERVN------ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281

Query: 299 MENKWISQFNQ 309
           + + W+   +Q
Sbjct: 282 LNSGWLPVKHQ 292

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  234 bits (599), Expect = 1e-75
 Identities = 74/303 (24%), Positives = 137/303 (45%), Gaps = 56/303 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--------HDTVKARREVELQLAVG 66
           +D+ +   +LG G    V +     T    A+K++            + + EV++   + 
Sbjct: 11  EDFKVG-NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL- 68

Query: 67  SHKHIVNIKDVYE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
            H  I+ + + +E    +Y       +++E  H GE+ + ++ +    F+E EA   M++
Sbjct: 69  KHPSILELYNYFEDSNYVY-------LVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQ 120

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           I + + +LH   I HRD+   NLL           LT   +                +K+
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLL-----------LTRNMN----------------IKI 153

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
            DFG A ++        T C TP Y++PE+     +    D+WSLG + Y LL G PPF 
Sbjct: 154 ADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           ++          N++ L  ++ P      +S EAK LI  +L  +P++RL++  V+++ +
Sbjct: 214 TDT----VKNTLNKVVLADYEMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265

Query: 304 ISQ 306
           +S+
Sbjct: 266 MSR 268

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  238 bits (610), Expect = 2e-75
 Identities = 75/360 (20%), Positives = 138/360 (38%), Gaps = 53/360 (14%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH--DTVKARREVELQLAVGSHKHIVNIKDVYE 79
           ++LG G  G ++       +   A+K +       A REV+L      H +++      +
Sbjct: 30  DVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK 88

Query: 80  NIYNGSRCLLVIME-CMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAH 138
           +     +   + +E C     L + ++QK D A    E   ++ +  S +  LH  NI H
Sbjct: 89  D----RQFQYIAIELC--AATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141

Query: 139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS 198
           RD+KP N+L + P   G +K                        ++DFG  KK+   + S
Sbjct: 142 RDLKPHNILISMPNAHGKIK----------------------AMISDFGLCKKLAVGRHS 179

Query: 199 ---LQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAIS 251
                    T  ++APE+L     +    + DI+S G + Y ++  G  PF  +      
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----- 234

Query: 252 PGMKNRIRLGQFDFPNPE-WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV 310
              +  I LG          +H    A+ LI+ M+ +DP +R +   V+++ +     + 
Sbjct: 235 -QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293

Query: 311 PQTPLCTGKMLKEGEETWPEVQDEM-TRSLATMRVDYDQIHIKSLINSKNPLLNKRRKNQ 369
            Q          E E     +  ++     A +++D+ +     L       L K R  +
Sbjct: 294 LQF-FQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTD----LRKFRTYK 348

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  234 bits (599), Expect = 2e-75
 Identities = 79/303 (26%), Positives = 135/303 (44%), Gaps = 57/303 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--------HDTVKARREVELQLAVG 66
             Y      LG G   K  +I +  T EV+A K++        H   K   E+ +  ++ 
Sbjct: 15  RRYVRG-RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL- 72

Query: 67  SHKHIVNIKDVYE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
           +H+H+V     +E    ++       V++E      L +  +++   A TE EA   + +
Sbjct: 73  AHQHVVGFHGFFEDNDFVF-------VVLELCRRRSLLELHKRR--KALTEPEARYYLRQ 123

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           I    ++LH   + HRD+K  NL            L +  +VK                +
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLF-----------LNEDLEVK----------------I 156

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
            DFG A K+  +    +  C TP Y+APEVL    +    D+WS+G IMY LL G PPF 
Sbjct: 157 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           ++           RI+  ++  P    +H++  A +LI+ ML  DP+ R TI++++ +++
Sbjct: 217 TSC----LKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEF 268

Query: 304 ISQ 306
            + 
Sbjct: 269 FTS 271

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  234 bits (598), Expect = 7e-75
 Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 57/303 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL--------HDTVKARREVELQLAVG 66
             Y      LG G   K  +I +  T EV+A K++        H   K   E+ +  ++ 
Sbjct: 41  RRYVRG-RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL- 98

Query: 67  SHKHIVNIKDVYE---NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
           +H+H+V     +E    ++       V++E      L +  +++   A TE EA   + +
Sbjct: 99  AHQHVVGFHGFFEDNDFVF-------VVLELCRRRSLLELHKRR--KALTEPEARYYLRQ 149

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           I    ++LH   + HRD+K  NL            L +  +                +K+
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLF-----------LNEDLE----------------VKI 182

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
            DFG A K+  +    +  C TP Y+APEVL    +    D+WS+G IMY LL G PPF 
Sbjct: 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
           ++           RI+  ++  P    +H++  A +LI+ ML  DP+ R TI++++ +++
Sbjct: 243 TSC----LKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEF 294

Query: 304 ISQ 306
            + 
Sbjct: 295 FTS 297

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  229 bits (587), Expect = 2e-73
 Identities = 65/332 (19%), Positives = 122/332 (36%), Gaps = 65/332 (19%)

Query: 6   KPFKTTPIQD-DYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------HDTVKARR 57
             F++  ++   Y I  + +G G + KV Q V  +  ++YA+K +             R 
Sbjct: 18  LYFQSMSVKGRIYSI-LKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRN 75

Query: 58  EVE-LQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTERE 116
           E+  L         I+ + D         + + ++MEC    +L   +++K   +    E
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEIT----DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWE 128

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                  +  A+  +H   I H D+KP N L                             
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-------------------------- 162

Query: 177 DGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVL-----------GPDKYDKSC 223
             G+LKL DFG A ++  +  S    +   T  Y+ PE +              K     
Sbjct: 163 --GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220

Query: 224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
           D+WSLG I+Y +  G  PF     Q     +     +   +      +   ++ + ++K 
Sbjct: 221 DVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKC 275

Query: 284 MLCVDPSERLTIDQVMENKWISQFNQVPQTPL 315
            L  DP +R++I +++ + ++ Q    P   +
Sbjct: 276 CLKRDPKQRISIPELLAHPYV-QIQTHPVNQM 306

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  224 bits (573), Expect = 5e-71
 Identities = 72/376 (19%), Positives = 135/376 (35%), Gaps = 64/376 (17%)

Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------HDTVKARREVE-LQLAVGS 67
            Y I  + +G G + KV Q V  +  ++YA+K +             R E+  L      
Sbjct: 10  IYSI-LKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              I+ + D         + + ++MEC    +L   +++K   +    E       +  A
Sbjct: 68  SDKIIRLYDYEIT----DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 120

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H   I H D+KP N L                               G+LKL DFG
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVD----------------------------GMLKLIDFG 152

Query: 188 FAKKIVSNKAS--LQTPCYTPYYVAPEVL-----------GPDKYDKSCDIWSLGVIMYI 234
            A ++  +  S    +   T  Y+ PE +              K     D+WSLG I+Y 
Sbjct: 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
           +  G  PF     Q     +     +   +      +   ++ + ++K  L  DP +R++
Sbjct: 213 MTYGKTPFQQIINQ-----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 267

Query: 295 IDQVMENKWI-SQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKS 353
           I +++ + ++  Q + V Q    T + +K        +    +   A   +       +S
Sbjct: 268 IPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGES 327

Query: 354 LINSKNPLLNKRRKNQ 369
             +S +    K+R  +
Sbjct: 328 HNSSSSKTFEKKRGKK 343

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  220 bits (562), Expect = 1e-69
 Identities = 68/314 (21%), Positives = 114/314 (36%), Gaps = 55/314 (17%)

Query: 2   TPTFKPFKTTPI-QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTV 53
           +P + P +     Q  +      LG G  G+V ++  K+   +YA+K          D  
Sbjct: 43  SPGYDPSRPESFFQQSFQR-LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA 101

Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME-CMHGGELFQRIQQKEDGAF 112
           +   EV     VG H   V ++  +E        L +  E C  G  L Q  +     + 
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQAWEE----GGILYLQTELC--GPSLQQHCE-AWGASL 154

Query: 113 TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY 172
            E +    + +   A+  LH Q + H DVKP N+                          
Sbjct: 155 PEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP---------------------- 192

Query: 173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM 232
                 G  KL DFG   ++     + +     P Y+APE+L    Y  + D++SLG+ +
Sbjct: 193 -----RGRCKLGDFGLLVEL-GTAGAGEVQEGDPRYMAPELL-QGSYGTAADVFSLGLTI 245

Query: 233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
             + C         G         ++R G    P      +S E ++++  ML  DP  R
Sbjct: 246 LEVACNMELPHGGEGW-------QQLRQG--YLPPEFTAGLSSELRSVLVMMLEPDPKLR 296

Query: 293 LTIDQVMENKWISQ 306
            T + ++    + Q
Sbjct: 297 ATAEALLALPVLRQ 310

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  220 bits (562), Expect = 8e-69
 Identities = 66/330 (20%), Positives = 122/330 (36%), Gaps = 64/330 (19%)

Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVE-LQLAVGS 67
            Y I  + +G G + KV Q V  +  ++YA+K ++            R E+  L      
Sbjct: 57  IYSI-LKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              I+ + D         + + ++MEC    +L   +++K   +    E       +  A
Sbjct: 115 SDKIIRLYDYEIT----DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 167

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H   I H D+KP N L                               G+LKL DFG
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVD----------------------------GMLKLIDFG 199

Query: 188 FAKKIVSNKAS--LQTPCYTPYYVAPEVL-----------GPDKYDKSCDIWSLGVIMYI 234
            A ++  +  S    +      Y+ PE +              K     D+WSLG I+Y 
Sbjct: 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
           +  G  PF     Q     +     +   +      +   ++ + ++K  L  DP +R++
Sbjct: 260 MTYGKTPFQQIINQ-----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 314

Query: 295 IDQVMENKWI-SQFNQVPQTPLCTGKMLKE 323
           I +++ + ++  Q + V Q    T + +K 
Sbjct: 315 IPELLAHPYVQIQTHPVNQMAKGTTEEMKY 344

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  215 bits (551), Expect = 2e-68
 Identities = 76/309 (24%), Positives = 129/309 (41%), Gaps = 52/309 (16%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGS 67
           +DY++    +G G  G+  +I  K   ++   K L        +      EV L L    
Sbjct: 6   EDYEV-LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL-LRELK 63

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEIC 125
           H +IV   D   +  N    L ++ME   GG+L   I +  KE     E     +M ++ 
Sbjct: 64  HPNIVRYYDRIIDRTNT--TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 126 SAIKFLHDQN-----IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
            A+K  H ++     + HRD+KP N+                                  
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDG---------------------------KQN 154

Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
           +KL DFG A+ +  + +  +T   TPYY++PE +    Y++  DIWSLG ++Y L    P
Sbjct: 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214

Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF +   + ++     +IR G+F          S E   +I  ML +    R ++++++E
Sbjct: 215 PFTAFSQKELA----GKIREGKFR---RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

Query: 301 NKWISQFNQ 309
           N  I + + 
Sbjct: 268 NPLILEHHH 276

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  226 bits (577), Expect = 3e-68
 Identities = 74/355 (20%), Positives = 134/355 (37%), Gaps = 52/355 (14%)

Query: 7   PFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVE 60
           P   T     +++  E LG G  G VL+ + + T E  A+K         +  +   E++
Sbjct: 6   PSLPTQTCGPWEM-KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQ 64

Query: 61  LQLAVGSHKHIVNIKDVYE--NIYNGSRCLLVIMECMHGGELFQRIQQKE-DGAFTEREA 117
           + +   +H ++V+ ++V +       +   L+ ME   GG+L + + Q E      E   
Sbjct: 65  I-MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123

Query: 118 AIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
             ++++I SA+++LH+  I HRD+KPEN++        I K+ D G              
Sbjct: 124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG-------------- 169

Query: 178 GGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC 237
                     +AK++   +        T  Y+APE+L   KY  + D WS G + +  + 
Sbjct: 170 ----------YAKELDQGEL-CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218

Query: 238 GFPPFFSNHGQA------------ISPGMKNRIRLGQFDFPNPEWEHVSQ----EAKTLI 281
           GF PF  N                      +     +F    P   H+S     + +  +
Sbjct: 219 GFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWL 278

Query: 282 KNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMT 336
           + ML     +R T  Q          + +    L +   +  G      V +   
Sbjct: 279 QCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENEN 333

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  212 bits (541), Expect = 2e-66
 Identities = 61/301 (20%), Positives = 111/301 (36%), Gaps = 35/301 (11%)

Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-----HDTVKARREVELQLAVGSHKH 70
            Y    + LG G    V  +        YALK +      D  +A+RE ++      H +
Sbjct: 30  HYLF-IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN-HPN 87

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAI 128
           I+ +               +++     G L+  I++   +    TE +   ++  IC  +
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           + +H +  AHRD+KP N+L       G   L D G +    +                  
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDE---GQPVLMDLGSMNQACI--------------HVEG 190

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKY---DKSCDIWSLGVIMYILLCGFPPFFSN 245
           +++ ++ +      C T  Y APE+     +   D+  D+WSLG ++Y ++ G  P+   
Sbjct: 191 SRQALTLQDWAAQRC-TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY--- 246

Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
                           Q     P+    S     L+ +M+ VDP +R  I  ++      
Sbjct: 247 DMVFQKGDSVALAVQNQLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

Query: 306 Q 306
           Q
Sbjct: 305 Q 305

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  210 bits (536), Expect = 4e-66
 Identities = 60/307 (19%), Positives = 119/307 (38%), Gaps = 55/307 (17%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-HDTVKARREVELQLAVGSHKHI 71
              D+    E++G G  G+V +   +   + Y +K + ++  KA REV+  LA   H +I
Sbjct: 9   FGMDFKE-IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKA-LAKLDHVNI 66

Query: 72  VNIKDVYE------------NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
           V+    ++            +  + ++CL + ME    G L Q I+++      +  A  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           +  +I   + ++H + + +RD+KP N+                                 
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVD---------------------------TK 159

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
            +K+ DFG    +  N         T  Y++PE +    Y K  D+++LG+I+  LL   
Sbjct: 160 QVKIGDFGLVTSL-KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC 218

Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
              F              +R G         +   ++ KTL++ +L   P +R    +++
Sbjct: 219 DTAFETS------KFFTDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

Query: 300 ENKWISQ 306
               + +
Sbjct: 267 RTLTVWK 273

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  212 bits (541), Expect = 4e-66
 Identities = 84/368 (22%), Positives = 158/368 (42%), Gaps = 55/368 (14%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGS 67
           + Y    + +G G  GK + +   +    Y +K ++       +  ++RREV + LA   
Sbjct: 24  EKYVRL-QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV-LANMK 81

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +IV  ++ +E     +  L ++M+   GG+LF+RI  ++   F E +      +IC A
Sbjct: 82  HPNIVQYRESFEE----NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +K +HD+ I HRD+K +N+  TK                            G ++L DFG
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTK---------------------------DGTVQLGDFG 170

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
            A+ + S     +    TPYY++PE+     Y+   DIW+LG ++Y L      F +   
Sbjct: 171 IARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
           + +      +I  G F  P     H S + ++L+  +   +P +R +++ ++E  +I++ 
Sbjct: 231 KNLV----LKIISGSFP-PVS--LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283

Query: 308 ------NQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPL 361
                  Q+     C     K G +  P  +    ++  ++     Q   K       PL
Sbjct: 284 IEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVM--PAQKITKPAAKYGIPL 341

Query: 362 LNKRRKNQ 369
             K+  ++
Sbjct: 342 AYKKYGDK 349

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  211 bits (540), Expect = 6e-66
 Identities = 63/343 (18%), Positives = 124/343 (36%), Gaps = 86/343 (25%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----------------------DT 52
           +DY I    L  G   K+  I+ +K ++ YALK                           
Sbjct: 31  NDYRI-IRTLNQGKFNKI--ILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 53  VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK----- 107
              + E+++   +  +++ +  + +  N       + +I E M    + +  +       
Sbjct: 88  DDFKNELQIITDI-KNEYCLTCEGIITN----YDEVYIIYEYMENDSILKFDEYFFVLDK 142

Query: 108 -EDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDV 165
                   +    I+  + ++  ++H++ NI HRDVKP N+L                  
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM----------------- 185

Query: 166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK--YDKSC 223
                        G +KL+DFG ++ +V  K  ++    T  ++ PE    +        
Sbjct: 186 ----------DKNGRVKLSDFGESEYMVDKK--IKGSRGTYEFMPPEFFSNESSYNGAKV 233

Query: 224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFP---------------NP 268
           DIWSLG+ +Y++     PF           + N IR    ++P                 
Sbjct: 234 DIWSLGICLYVMFYNVVPFSLKISL---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290

Query: 269 EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVP 311
               +S E    +K  L  +P+ER+T +  ++++W++  N   
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED 333

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  209 bits (534), Expect = 3e-65
 Identities = 88/343 (25%), Positives = 148/343 (43%), Gaps = 59/343 (17%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-------HDTVKARREVELQLAVGSHKHIVNIKD 76
           +G G   KV       T    A+K++           K  REV + + + +H +IV + +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRI-MKILNHPNIVKLFE 81

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V E      + L +IME   GGE+F  +     G   E+EA     +I SA+++ H + I
Sbjct: 82  VIET----EKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRI 135

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+K ENLL     +                           +K+ DFGF+ +     
Sbjct: 136 VHRDLKAENLLLDADMN---------------------------IKIADFGFSNEFTVGG 168

Query: 197 ASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
             L   C  P Y APE+    KYD    D+WSLGVI+Y L+ G  PF   +       ++
Sbjct: 169 K-LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN----LKELR 223

Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPL 315
            R+  G++  P     ++S + + L+K  L ++P +R T++Q+M+++WI+  ++  +   
Sbjct: 224 ERVLRGKYRIP----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP 279

Query: 316 CTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSK 358
                    E        +    +  M    ++I  +SL   K
Sbjct: 280 FV-------EPELDISDQKRIDIMVGMGYSQEEI-QESLSKMK 314

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  207 bits (527), Expect = 8e-64
 Identities = 55/337 (16%), Positives = 86/337 (25%), Gaps = 72/337 (21%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--------RREVELQ----------- 62
           E L +G    V  + + +  E +ALKV     +                           
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 63  ------------LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHG-----GELFQRIQ 105
                       +AV S      +    ++    +  LL  M                + 
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL--MPAASVDLELLFSTLDFVY 185

Query: 106 QKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV 165
               G        I+  ++      L  + + H    P+NL                   
Sbjct: 186 VFR-GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---------------- 228

Query: 166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK--YDKSC 223
                        G L L D     K+ +             Y   E L      +  + 
Sbjct: 229 -----------PDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHAL 274

Query: 224 DIWSLGVIMYILLCGFPPFF-SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIK 282
           + W LG+ +Y + C F PF     G   S    +    G           +    KTLI 
Sbjct: 275 NAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334

Query: 283 NMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGK 319
             L  D   RL   + ME     Q      + L TG+
Sbjct: 335 RFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  206 bits (526), Expect = 1e-63
 Identities = 82/286 (28%), Positives = 124/286 (43%), Gaps = 40/286 (13%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH----DTVKARREVELQLAVGSHKHIVNIKDVYE 79
           +G G  G    + +K T E+ A+K +          +RE+        H +IV  K+V  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN-HRSLRHPNIVRFKEVIL 86

Query: 80  NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR 139
                   L +IME   GGEL++RI     G F+E EA     ++ S + + H   I HR
Sbjct: 87  T----PTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHR 140

Query: 140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL 199
           D+K EN L                D  P   L          K+ DFG++K  V +    
Sbjct: 141 DLKLENTLL---------------DGSPAPRL----------KICDFGYSKSSVLHSQ-P 174

Query: 200 QTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRI 258
           ++   TP Y+APEVL   +YD K  D+WS GV +Y++L G  PF              RI
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234

Query: 259 RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
              ++  P+     +S E   LI  +   DP+ R++I ++  + W 
Sbjct: 235 LSVKYSIPDDIR--ISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  200 bits (510), Expect = 2e-62
 Identities = 73/306 (23%), Positives = 130/306 (42%), Gaps = 55/306 (17%)

Query: 11  TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLA 64
            P  +D+D+  + LG G  G+V   V + T E  A+K++            ++E+ +   
Sbjct: 3   VPFVEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NK 60

Query: 65  VGSHKHIVNIKDVYEN---IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM 121
           + +H+++V            Y       + +E   GGELF RI+        E +A    
Sbjct: 61  MLNHENVVKFYGHRREGNIQY-------LFLEYCSGGELFDRIEPD--IGMPEPDAQRFF 111

Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
           +++ + + +LH   I HRD+KPENLL           L +  +                L
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLL-----------LDERDN----------------L 144

Query: 182 KLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCG 238
           K++DFG A     N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

Query: 239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
             P+      + S    +  +  +       W+ +      L+  +L  +PS R+TI  +
Sbjct: 205 ELPW---DQPSDSCQEYSDWKEKKTYLN--PWKKIDSAPLALLHKILVENPSARITIPDI 259

Query: 299 MENKWI 304
            +++W 
Sbjct: 260 KKDRWY 265

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  200 bits (510), Expect = 5e-62
 Identities = 72/323 (22%), Positives = 120/323 (37%), Gaps = 66/323 (20%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-----------HDTVKARR 57
                + +Y +   +LG G  G V            A+KV+            D+V    
Sbjct: 25  DREAFEAEYRLG-PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83

Query: 58  EVELQLAV---GSHKHIVNIKDVYENIYNGSRCLLVIME-CMHGGELFQRIQQKEDGAFT 113
           EV L   V   G H  ++ + D +E         ++++E  +   +LF  I +K  G   
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFET----QEGFMLVLERPLPAQDLFDYITEK--GPLG 137

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
           E  +     ++ +AI+  H + + HRD+K EN+L                 +        
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENIL-----------------IDLRR---- 176

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIM 232
                G  KL DFG    +            T  Y  PE +   +Y      +WSLG+++
Sbjct: 177 -----GCAKLIDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILL 229

Query: 233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
           Y ++CG  PF               I   +  FP     HVS +   LI+  L   PS R
Sbjct: 230 YDMVCGDIPFER----------DQEILEAELHFPA----HVSPDCCALIRRCLAPKPSSR 275

Query: 293 LTIDQVMENKWISQ-FNQVPQTP 314
            ++++++ + W+      VP  P
Sbjct: 276 PSLEEILLDPWMQTPAEDVPLNP 298

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  198 bits (505), Expect = 1e-61
 Identities = 93/290 (32%), Positives = 133/290 (45%), Gaps = 52/290 (17%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVGSHKHIVNIK 75
           LG+G  GKV     + T    A+K+L+           K +RE++  L +  H HI+ + 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN-LKLFRHPHIIKLY 77

Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
            V            ++ME + GGELF  I +   G   E EA  +  +I SA+ + H   
Sbjct: 78  QVIST----PTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           + HRD+KPEN+L     +    K+ DFG       L     DG  L+             
Sbjct: 132 VVHRDLKPENVLLDAHMN---AKIADFG-------LSNMMSDGEFLR------------- 168

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
                T C +P Y APEV+    Y     DIWS GVI+Y LLCG  PF   H     P +
Sbjct: 169 -----TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----VPTL 219

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
             +IR G F  P    E++++   TL+ +ML VDP +R TI  + E++W 
Sbjct: 220 FKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  198 bits (505), Expect = 5e-61
 Identities = 73/306 (23%), Positives = 130/306 (42%), Gaps = 55/306 (17%)

Query: 11  TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLA 64
            P  +D+D+  + LG G  G+V   V + T E  A+K++            ++E+ +   
Sbjct: 3   VPFVEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NK 60

Query: 65  VGSHKHIVNIKDVYEN---IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM 121
           + +H+++V            Y       + +E   GGELF RI+        E +A    
Sbjct: 61  MLNHENVVKFYGHRREGNIQY-------LFLEYCSGGELFDRIEPD--IGMPEPDAQRFF 111

Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
           +++ + + +LH   I HRD+KPENLL           L +  +                L
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLL-----------LDERDN----------------L 144

Query: 182 KLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCG 238
           K++DFG A     N     L   C T  YVAPE+L   ++  +  D+WS G+++  +L G
Sbjct: 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

Query: 239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
             P+      + S    +  +  +       W+ +      L+  +L  +PS R+TI  +
Sbjct: 205 ELPW---DQPSDSCQEYSDWKEKKTYLN--PWKKIDSAPLALLHKILVENPSARITIPDI 259

Query: 299 MENKWI 304
            +++W 
Sbjct: 260 KKDRWY 265

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  197 bits (504), Expect = 7e-61
 Identities = 70/320 (21%), Positives = 123/320 (38%), Gaps = 63/320 (19%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-----------HDTVKARR 57
           +  P++  Y +   +LG G  G V   +    +   A+K +            +  +   
Sbjct: 37  EKEPLESQYQVG-PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95

Query: 58  EVE-LQLAVGSHKHIVNIKDVYENIYNGSRCLLVIME-CMHGGELFQRIQQKEDGAFTER 115
           EV  L+        ++ + D +E         ++I+E      +LF  I ++  GA  E 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFER----PDSFVLILERPEPVQDLFDFITER--GALQEE 149

Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
            A     ++  A++  H+  + HRD+K EN+L                       +    
Sbjct: 150 LARSFFWQVLEAVRHCHNCGVLHRDIKDENIL-----------------------IDLNR 186

Query: 176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYI 234
           G+   LKL DFG    +            T  Y  PE +   +Y  +S  +WSLG+++Y 
Sbjct: 187 GE---LKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 241

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
           ++CG  PF  +            I  GQ  F       VS E + LI+  L + PS+R T
Sbjct: 242 MVCGDIPFEHDE----------EIIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPT 287

Query: 295 IDQVMENKWISQFNQVPQTP 314
            +++  + W+       +T 
Sbjct: 288 FEEIQNHPWMQDVLLPQETA 307

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  199 bits (508), Expect = 7e-60
 Identities = 95/367 (25%), Positives = 151/367 (41%), Gaps = 68/367 (18%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVGSHKHIVNIK 75
           LG+G  GKV     + T    A+K+L+           K RRE++  L +  H HI+ + 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN-LKLFRHPHIIKLY 82

Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
            V          + ++ME + GGELF  I +   G   E+E+  +  +I S + + H   
Sbjct: 83  QVIST----PSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           + HRD+KPEN+L     +    K+ DFG       L     DG  L+             
Sbjct: 137 VVHRDLKPENVLLDAHMN---AKIADFG-------LSNMMSDGEFLR------------- 173

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
                T C +P Y APEV+    Y     DIWS GVI+Y LLCG  PF       + P +
Sbjct: 174 -----TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHV-PTL 224

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
             +I  G F  P    ++++    +L+K+ML VDP +R TI  + E++W  Q       P
Sbjct: 225 FKKICDGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFP 280

Query: 315 LCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNP---------LLNKR 365
                     ++      + +           +++ +  L N  +          +++ R
Sbjct: 281 EDPSYSSTMIDD------EALKEVCEKFECSEEEV-LSCLYNRNHQDPLAVAYHLIIDNR 333

Query: 366 RKNQSPS 372
           R      
Sbjct: 334 RIMNEAK 340

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  194 bits (496), Expect = 1e-59
 Identities = 91/370 (24%), Positives = 147/370 (39%), Gaps = 77/370 (20%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVGSHKHIVNIK 75
           LG G  GKV      KT +  ALK +           ++  RE+   L +  H HI+ + 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY-LKLLRHPHIIKLY 75

Query: 76  DVYEN---IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           DV      I        +++E   GGELF  I +K     TE E      +I  AI++ H
Sbjct: 76  DVITTPTDIV-------MVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCH 125

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+KPENLL     +                           +K+ DFG +  +
Sbjct: 126 RHKIVHRDLKPENLLLDDNLN---------------------------VKIADFGLSNIM 158

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
                 L+T C +P Y APEV+    Y     D+WS G+++Y++L G  PF     + I 
Sbjct: 159 TDGNF-LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF---DDEFI- 213

Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVP 311
           P +  ++    +  P    + +S  A++LI+ M+  DP +R+TI ++  + W +      
Sbjct: 214 PNLFKKVNSCVYVMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDY 269

Query: 312 QTPLCTGKMLKEGEETWPEVQDEMTRSLA-TMRVDYDQIHIKSLINSKNP--------LL 362
             P+         E         +   L   M    D I +++L + +N         L 
Sbjct: 270 LRPM--------EEVQGSYADSRIVSKLGEAMGFSEDYI-VEALRSDENNEVKEAYNLLH 320

Query: 363 NKRRKNQSPS 372
             +   +   
Sbjct: 321 ENQVIQEKLE 330

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  194 bits (494), Expect = 3e-59
 Identities = 77/358 (21%), Positives = 132/358 (36%), Gaps = 69/358 (19%)

Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------------HDTVKARREVELQ 62
            Y      LG G  G V   V+K+ ++   +K +                 K   E+ + 
Sbjct: 25  KYSTM-SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI- 82

Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIME-CMHGGELFQRIQQKEDGAFTEREAAIIM 121
           L+   H +I+ + D++EN         ++ME    G +LF  I +       E  A+ I 
Sbjct: 83  LSRVEHANIIKVLDIFEN----QGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIF 136

Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
            ++ SA+ +L  ++I HRD+K EN++           + +   +                
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIV-----------IAEDFTI---------------- 169

Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFP 240
           KL DFG A  +   K    T C T  Y APEVL  + Y     ++WSLGV +Y L+    
Sbjct: 170 KLIDFGSAAYLERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228

Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF                       P      VS+E  +L+  +L   P  R T+++++ 
Sbjct: 229 PFCE----------LEETVEAAIHPPY----LVSKELMSLVSGLLQPVPERRTTLEKLVT 274

Query: 301 NKWISQFNQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSK 358
           + W     Q       T + +    +    V    +  +    +  D    + L   +
Sbjct: 275 DPW---VTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLS-DVAQAQELCGGE 328

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  194 bits (495), Expect = 5e-59
 Identities = 40/330 (12%), Positives = 95/330 (28%), Gaps = 88/330 (26%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQL------------------ 63
            +LG       L+  +++T E + + V + T +       Q+                  
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 64  --------------AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK-- 107
                              K ++ ++    +++  SR  L      +     + +     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 108 EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP 167
              +        +  ++   +  LH   + H  ++P +++  + G               
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-------------- 244

Query: 168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD---------- 217
                        + LT F    +      +      +  +  PE+              
Sbjct: 245 -------------VFLTGFEHLVRD----GARVVSSVSRGFEPPELEARRATISYHRDRR 287

Query: 218 -KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQE 276
                S D W+LG+++Y + C   P   +            +   ++ F +   +++ Q 
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCADLPITKD----------AALGGSEWIFRSC--KNIPQP 335

Query: 277 AKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
            + L++  L     +RL   Q ME     Q
Sbjct: 336 VRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  190 bits (484), Expect = 3e-58
 Identities = 70/316 (22%), Positives = 121/316 (38%), Gaps = 41/316 (12%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL------HDTVKARREVELQLAVGSH 68
            D++   + LG G  G V +   K     YA+K +          K  REV+  LA   H
Sbjct: 5   TDFEP-IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA-LAKLEH 62

Query: 69  KHIVNIKDVYE--------NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI- 119
             IV   + +            +    L + M+      L   +  +      ER   + 
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           I  +I  A++FLH + + HRD+KP N+ +T      ++K+ DFG V   +          
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMD---------- 169

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF 239
             +  +       +   A       T  Y++PE +  + Y    DI+SLG+I++ LL   
Sbjct: 170 --QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225

Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
            PF +   +         +R  +F    P +         ++++ML   P ER     ++
Sbjct: 226 -PFSTQMERV---RTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278

Query: 300 ENKWISQFNQVPQTPL 315
           EN      +   +T L
Sbjct: 279 ENAVFEDLDFPGKTVL 294

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  190 bits (484), Expect = 3e-58
 Identities = 66/323 (20%), Positives = 130/323 (40%), Gaps = 85/323 (26%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL-------------------------------HDT 52
           +G G  G V     +  +  YA+KVL                                  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 53  VKARREVE-LQLAVGSHKHIVNIKDVYE-----NIYNGSRCLLVIMECMHGGELFQRIQQ 106
            +  +E+  L+     H ++V + +V +     ++Y       ++ E ++ G + +    
Sbjct: 81  EQVYQEIAILKKL--DHPNVVKLVEVLDDPNEDHLY-------MVFELVNQGPVMEVPT- 130

Query: 107 KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK 166
                 +E +A     ++   I++LH Q I HRD+KP NLL  + G              
Sbjct: 131 --LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH------------- 175

Query: 167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK--YD-KSC 223
                         +K+ DFG + +   + A L     TP ++APE L   +  +  K+ 
Sbjct: 176 --------------IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKAL 221

Query: 224 DIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKN 283
           D+W++GV +Y  + G  PF     + I   + ++I+    +FP  +   ++++ K LI  
Sbjct: 222 DVWAMGVTLYCFVFGQCPF---MDERI-MCLHSKIKSQALEFP--DQPDIAEDLKDLITR 275

Query: 284 MLCVDPSERLTIDQVMENKWISQ 306
           ML  +P  R+ + ++  + W+++
Sbjct: 276 MLDKNPESRIVVPEIKLHPWVTR 298

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  190 bits (484), Expect = 4e-58
 Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 66/301 (21%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL---------HDTVKARREVELQLAVGSHKHIVNI 74
           LG G  GKV ++++ +T    A+K+L         +     ++E++L L    HK+++ +
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL-LRRLRHKNVIQL 71

Query: 75  KDVYEN-----IYNGSRCLLVIMECMHGG--ELFQRIQQKEDGAFTEREAAIIMNEICSA 127
            DV  N     +Y       ++ME    G  E+   + +K    F   +A     ++   
Sbjct: 72  VDVLYNEEKQKMY-------MVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDG 121

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +++LH Q I H+D+KP NLL T  G                            LK++  G
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGT---------------------------LKISALG 154

Query: 188 FAKKIVSNKAS--LQTPCYTPYYVAPEVL-GPDKYD-KSCDIWSLGVIMYILLCGFPPFF 243
            A+ +    A    +T   +P +  PE+  G D +     DIWS GV +Y +  G  PF 
Sbjct: 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF- 213

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
              G  I   +   I  G +  P             L+K ML  +P++R +I Q+ ++ W
Sbjct: 214 --EGDNI-YKLFENIGKGSYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 304 I 304
            
Sbjct: 267 F 267

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  190 bits (485), Expect = 6e-58
 Identities = 75/311 (24%), Positives = 121/311 (38%), Gaps = 43/311 (13%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVL-----HDTVKARREVELQLAVGSHKHIVNIKD 76
            +L  G    V +  +  +   YALK L            +EV     +  H +IV    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 77  VY----ENIYNGSRCLLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFL 131
                 E    G    L++ E    G+L + +++ E  G  +      I  + C A++ +
Sbjct: 94  AASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 132 HDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           H Q   I HRD+K ENLL +  G    +KL DFG     +               D+ ++
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQG---TIKLCDFGSATTISHY------------PDYSWS 197

Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYILLCGFPPFFSNH 246
            +  +      T   TP Y  PE++         +  DIW+LG I+Y+L     PF    
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257

Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW--I 304
              I  G           +  P  +       +LI+ ML V+P ERL+I +V+       
Sbjct: 258 KLRIVNG----------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307

Query: 305 SQFNQVPQTPL 315
           +  N  P++P+
Sbjct: 308 AARNVNPKSPI 318

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  190 bits (486), Expect = 7e-58
 Identities = 81/306 (26%), Positives = 151/306 (49%), Gaps = 57/306 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVE------LQLAVGS 67
           D +D   + LG G  G+V+ +  K++   YA+K+L    V   +++E        L   +
Sbjct: 41  DQFDR-IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              +V ++  +++    +  L ++ME + GGE+F  +++   G F+E  A     +I   
Sbjct: 100 FPFLVKLEFSFKD----NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLT 153

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
            ++LH  ++ +RD+KPENLL  + G                            +++TDFG
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGY---------------------------IQVTDFG 186

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           FAK++     +L   C TP  +APE++    Y+K+ D W+LGV++Y +  G+PPFF++  
Sbjct: 187 FAKRVKGRTWTL---CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENK 302
                 +  +I  G+  FP+    H S + K L++N+L VD ++R       ++ +  +K
Sbjct: 244 I----QIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295

Query: 303 WISQFN 308
           W +  +
Sbjct: 296 WFATTD 301

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  189 bits (482), Expect = 9e-58
 Identities = 80/302 (26%), Positives = 131/302 (43%), Gaps = 55/302 (18%)

Query: 2   TPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVE 60
            P  +P K  P  +D+    +ILG G    V+   E  TS  YA+K+L    +    +V 
Sbjct: 19  QPPPQPRKKRP--EDFKF-GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75

Query: 61  ------LQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTE 114
                   ++   H   V +   +++       L   +     GEL + I++   G+F E
Sbjct: 76  YVTRERDVMSRLDHPFFVKLYFTFQD----DEKLYFGLSYAKNGELLKYIRKI--GSFDE 129

Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
                   EI SA+++LH + I HRD+KPEN+L  +                        
Sbjct: 130 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--------------------- 168

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTP--CYTPYYVAPEVLGPDKYDKSCDIWSLGVIM 232
                 +++TDFG AK +       +      T  YV+PE+L      KS D+W+LG I+
Sbjct: 169 ------IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCII 222

Query: 233 YILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           Y L+ G PPF + N        +  +I   ++DFP    E    +A+ L++ +L +D ++
Sbjct: 223 YQLVAGLPPFRAGNEYL-----IFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATK 273

Query: 292 RL 293
           RL
Sbjct: 274 RL 275

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  189 bits (481), Expect = 1e-57
 Identities = 65/314 (20%), Positives = 125/314 (39%), Gaps = 49/314 (15%)

Query: 2   TPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTV 53
               +P        ++ I  + +G G   +V +          ALK +            
Sbjct: 19  QKALRPDMGYNTLANFRI-EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA 77

Query: 54  KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQ--QKEDGA 111
              +E++L L   +H +++     +         L +++E    G+L + I+  +K+   
Sbjct: 78  DCIKEIDL-LKQLNHPNVIKYYASFIE----DNELNIVLELADAGDLSRMIKHFKKQKRL 132

Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
             ER       ++CSA++ +H + + HRD+KP N+  T                      
Sbjct: 133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--------------------- 171

Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI 231
                  G++KL D G  +   S   +  +   TPYY++PE +  + Y+   DIWSLG +
Sbjct: 172 ------TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 225

Query: 232 MYILLCGFPPFFSNHGQAIS-PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPS 290
           +Y +     PF   +G  ++   +  +I    +  P P  +H S+E + L+   +  DP 
Sbjct: 226 LYEMAALQSPF---YGDKMNLYSLCKKIEQCDYP-PLPS-DHYSEELRQLVNMCINPDPE 280

Query: 291 ERLTIDQVMENKWI 304
           +R  +  V +    
Sbjct: 281 KRPDVTYVYDVAKR 294

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  187 bits (476), Expect = 3e-57
 Identities = 63/307 (20%), Positives = 121/307 (39%), Gaps = 37/307 (12%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-------HDTVKARREVELQLAV 65
              ++    E +G G  G V + V++    +YA+K          D   A REV     +
Sbjct: 9   YTTEFHE-LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNE 123
           G H H+V     Y + +     +L+  E  +GG L   I +  +    F E E   ++ +
Sbjct: 68  GQHSHVVR----YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +   ++++H  ++ H D+KP N+  ++             D    N          + K+
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN--------KVMFKI 175

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPF 242
            D G   +I    +S Q       ++A EVL  +  +    DI++L + +       P  
Sbjct: 176 GDLGHVTRI----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
            +           + IR G+     P  + +SQE   L+K M+  DP  R +   ++++ 
Sbjct: 232 RNGD-------QWHEIRQGRLP-RIP--QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281

Query: 303 WISQFNQ 309
            +   ++
Sbjct: 282 VLLSASR 288

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  188 bits (480), Expect = 2e-56
 Identities = 81/304 (26%), Positives = 133/304 (43%), Gaps = 55/304 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQ------LAVGS 67
           +DY++  +++G G  G+V  +  K T +VYA+K+L    +  R +          +A  +
Sbjct: 69  EDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              +V +   +++     R L ++ME M GG+L   +    D    E+ A     E+  A
Sbjct: 128 SPWVVQLFYAFQD----DRYLYMVMEYMPGGDLVN-LMSNYD--VPEKWARFYTAEVVLA 180

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H     HRDVKP+N+L  K G                            LKL DFG
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGH---------------------------LKLADFG 213

Query: 188 FAKKIVSNKASL-QTPCYTPYYVAPEVL----GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
              K+         T   TP Y++PEVL    G   Y + CD WS+GV +Y +L G  PF
Sbjct: 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT---IDQVM 299
           +++       G  ++I   +     P+   +S+EAK LI   L  D   RL    ++++ 
Sbjct: 274 YADS----LVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIK 328

Query: 300 ENKW 303
            + +
Sbjct: 329 RHLF 332

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  185 bits (472), Expect = 3e-56
 Identities = 82/286 (28%), Positives = 139/286 (48%), Gaps = 52/286 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVE------LQLAVGS 67
            D+ I    LG G  G+V  I  +     YA+KVL  + V   ++VE      L L++ +
Sbjct: 6   QDFQI-LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H  I+ +   +++    ++ + +IM+ + GGELF  +++     F    A     E+C A
Sbjct: 65  HPFIIRMWGTFQD----AQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLA 118

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +++LH ++I +RD+KPEN+L  K G                            +K+TDFG
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGH---------------------------IKITDFG 151

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           FAK +     +L   C TP Y+APEV+    Y+KS D WS G+++Y +L G+ PF+ ++ 
Sbjct: 152 FAKYVPDVTYTL---CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
                    +I   +  FP       +++ K L+  ++  D S+RL
Sbjct: 209 M----KTYEKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRL 246

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  186 bits (475), Expect = 6e-56
 Identities = 76/301 (25%), Positives = 127/301 (42%), Gaps = 60/301 (19%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREV-----ELQ-LAVGSHKHIVNIKD 76
           +G G  GKV  + +  T ++YA+K ++      R EV     ELQ +    H  +VN+  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81

Query: 77  VY-----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
            Y     E+++       ++++ + GG+L   +QQ     F E    + + E+  A+ +L
Sbjct: 82  -YSFQDEEDMF-------MVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYL 131

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
            +Q I HRD+KP+N+L           L + G V                 +TDF  A  
Sbjct: 132 QNQRIIHRDMKPDNIL-----------LDEHGHV----------------HITDFNIAAM 164

Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           +      + T   T  Y+APE+    K   Y  + D WSLGV  Y LL G  P+      
Sbjct: 165 LPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST 223

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-TIDQVMENKWISQF 307
           +    + +        +P       SQE  +L+K +L  +P +R   +  V    +++  
Sbjct: 224 SSK-EIVHTFETTVVTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

Query: 308 N 308
           N
Sbjct: 279 N 279

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  187 bits (476), Expect = 2e-55
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 52/293 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQ------LAVGS 67
           +D++I  +++G G  G+V  +  K   +V+A+K+L+   +  R E          L  G 
Sbjct: 74  EDFEI-LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
            K I  +   +++       L ++M+   GG+L   +  K +    E  A   + E+  A
Sbjct: 133 SKWITTLHYAFQD----DNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMARFYLAEMVIA 187

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I  +H  +  HRD+KP+N+L    G                            ++L DFG
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGH---------------------------IRLADFG 220

Query: 188 FAKKIVSNKASL-QTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGFPP 241
              K++ +          TP Y++PE+L     G  +Y   CD WSLGV MY +L G  P
Sbjct: 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEW-EHVSQEAKTLIKNMLCVDPSERL 293
           F++            +I   +  F  P     VS+ AK LI+ ++C     RL
Sbjct: 281 FYAESLV----ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHRL 328

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  189 bits (481), Expect = 2e-55
 Identities = 76/299 (25%), Positives = 139/299 (46%), Gaps = 46/299 (15%)

Query: 5   FKPFKTTPI-QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQ 62
           +K  +  P+ +D +     +LG G  G+V     K T ++YA K L+   +K R+  +  
Sbjct: 174 WKWLEAQPMGEDWFLDFR-VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232

Query: 63  ------LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTE 114
                 LA    + IV++   +E   +    L ++M  M+GG++   I    +++  F E
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288

Query: 115 REAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
             A     +I S ++ LH +NI +RD+KPEN+L           L D G+V+        
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL-----------LDDDGNVR-------- 329

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI 234
                   ++D G A ++ + +   +    TP ++APE+L  ++YD S D ++LGV +Y 
Sbjct: 330 --------ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           ++    PF +   +  +  +K R+      +P    +  S  +K   + +L  DP +RL
Sbjct: 382 MIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRL 436

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  184 bits (470), Expect = 6e-55
 Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 54/295 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQ------LAVGS 67
           DD++I  +++G G   +V  +  K+T +VYA+K+++   +  R EV         L  G 
Sbjct: 61  DDFEI-LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
            + I  +   +++       L ++ME   GG+L   +  K         A   + EI  A
Sbjct: 120 RRWITQLHFAFQD----ENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLAEIVMA 174

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I  +H     HRD+KP+N+L  + G                            ++L DFG
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGH---------------------------IRLADFG 207

Query: 188 FAKKIVSNKASL-QTPCYTPYYVAPEVL-------GPDKYDKSCDIWSLGVIMYILLCGF 239
              K+ ++          TP Y++PE+L       G   Y   CD W+LGV  Y +  G 
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWE-HVSQEAKTLIKNMLCVDPSERL 293
            PF+++           +I   +     P  +  V +EA+  I+ +LC  P  RL
Sbjct: 268 TPFYADSTA----ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRL 317

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  186 bits (474), Expect = 4e-54
 Identities = 73/297 (24%), Positives = 131/297 (44%), Gaps = 45/297 (15%)

Query: 5   FKPFKTTPI-QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQ 62
           +K  +  P+ ++ +     +LG G  G+V     + T ++YA K L    +K R+   + 
Sbjct: 173 WKWLERQPVTKNTFRQ-YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231

Query: 63  ------LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTERE 116
                 L   + + +V++   YE        L +++  M+GG+L   I       F E  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDA----LCLVLTLMNGGDLKFHIYHMGQAGFPEAR 287

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
           A     EIC  ++ LH + I +RD+KPEN+L           L D G +           
Sbjct: 288 AVFYAAEICCGLEDLHRERIVYRDLKPENIL-----------LDDHGHI----------- 325

Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
                +++D G A  +   +   +    T  Y+APEV+  ++Y  S D W+LG ++Y ++
Sbjct: 326 -----RISDLGLAVHVPEGQTI-KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379

Query: 237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            G  PF     +     ++  ++    ++     E  S +A++L   +LC DP+ERL
Sbjct: 380 AGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLCSQLLCKDPAERL 432

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  178 bits (453), Expect = 4e-53
 Identities = 91/278 (32%), Positives = 142/278 (51%), Gaps = 50/278 (17%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQ------LAVGSHKHIVNIKD 76
           LG G  GKV+ + EK T   YA+K+L  + + A+ EV         L    H  +  +K 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            ++        L  +ME  +GGELF  + +  +  FTE  A     EI SA+++LH +++
Sbjct: 73  AFQT----HDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDV 126

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            +RD+K ENL+  K                          DG I K+TDFG  K+ +S+ 
Sbjct: 127 VYRDIKLENLMLDK--------------------------DGHI-KITDFGLCKEGISDG 159

Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAISPGMK 255
           A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +H +     + 
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LF 214

Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             I + +  FP      +S EAK+L+  +L  DP +RL
Sbjct: 215 ELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRL 248

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  175 bits (447), Expect = 2e-52
 Identities = 79/283 (27%), Positives = 129/283 (45%), Gaps = 58/283 (20%)

Query: 24  LGLGINGKVLQ---IVEKKTSEVYALKVLH-DTVKARREVELQ-----LAVGSHKHIVNI 74
           LG G  GKV     I      ++YA+KVL   T+K R  V  +     L   +H  IV +
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 75  KDVYENIY---NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
                  Y      + L +I++ + GG+LF R+ +  +  FTE +    + E+  A+  L
Sbjct: 92  H------YAFQTEGK-LYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHL 142

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I +RD+KPEN+L  +                          +G I KLTDFG +K+
Sbjct: 143 HSLGIIYRDLKPENILLDE--------------------------EGHI-KLTDFGLSKE 175

Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAI 250
            + ++    + C T  Y+APEV+    + +S D WS GV+M+ +L G  PF   +  +  
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-- 233

Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
                  I   +   P    + +S EA++L++ +   +P+ RL
Sbjct: 234 ---TMTMILKAKLGMP----QFLSPEAQSLLRMLFKRNPANRL 269

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  176 bits (448), Expect = 4e-52
 Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 63/285 (22%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVE--------LQLAVGSHKHIVNI 74
           +G G  GKVL    K     YA+KVL    +  ++E +        L   V  H  +V +
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGL 104

Query: 75  KDVY-----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
              +     + +Y        +++ ++GGELF  +Q+  +  F E  A     EI SA+ 
Sbjct: 105 H--FSFQTADKLY-------FVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALG 153

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           +LH  NI +RD+KPEN+L                              G I  LTDFG  
Sbjct: 154 YLHSLNIVYRDLKPENILLDS--------------------------QGHI-VLTDFGLC 186

Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQ 248
           K+ + + ++  T C TP Y+APEVL    YD++ D W LG ++Y +L G PPF+S N  +
Sbjct: 187 KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
                M + I             +++  A+ L++ +L  D ++RL
Sbjct: 247 -----MYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRL 282

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  176 bits (448), Expect = 8e-52
 Identities = 43/325 (13%), Positives = 97/325 (29%), Gaps = 79/325 (24%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--------RREVELQ----------- 62
            +LG       L+  +++T E + + V + T +         + EV              
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 63  -------------LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--K 107
                        +     K ++ ++    +++  SR  L      +     + +     
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 108 EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP 167
              +        +  ++   +  LH   + H  ++P +++                    
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD------------------ 245

Query: 168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY-TPYYVAPEVL-----GPDKYDK 221
                      G + LT F    +  ++  S     +  P   A  +L      P     
Sbjct: 246 ---------QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTF 296

Query: 222 SCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLI 281
           + D W+LG+ +Y + C   P   +            +   ++ F     +++ Q  + L+
Sbjct: 297 AFDTWTLGLAIYWIWCADLPNTDD----------AALGGSEWIF--RSCKNIPQPVRALL 344

Query: 282 KNMLCVDPSERLTIDQVMENKWISQ 306
           +  L     +RL   Q ME     Q
Sbjct: 345 EGFLRYPKEDRLLPLQAMETPEYEQ 369

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  174 bits (443), Expect = 1e-51
 Identities = 77/285 (27%), Positives = 128/285 (44%), Gaps = 52/285 (18%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVE--------LQLAVGSHKHIVN 73
           ++G G   KVL +  KKT  +YA+KV+  + V    +++         + A  +H  +V 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVG 74

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
           +   ++     SR L  ++E ++GG+L   +Q+       E  A     EI  A+ +LH+
Sbjct: 75  LHSCFQT---ESR-LFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE 128

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           + I +RD+K +N+L                             +G I KLTD+G  K+ +
Sbjct: 129 RGIIYRDLKLDNVLLDS--------------------------EGHI-KLTDYGMCKEGL 161

Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG 253
               +  T C TP Y+APE+L  + Y  S D W+LGV+M+ ++ G  PF           
Sbjct: 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221

Query: 254 -----MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
                +   I   Q   P      +S +A +++K+ L  DP ERL
Sbjct: 222 NTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERL 262

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  181 bits (461), Expect = 1e-51
 Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 51/282 (18%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VGSHKH--IV 72
           I+G G  G+V    +  T ++YA+K L    +K ++   L L        V +     IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +   +         L  I++ M+GG+L   + Q   G F+E +      EI   ++ +H
Sbjct: 256 CMSYAFHTPDK----LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH 309

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           ++ + +RD+KP N+L           L + G V                +++D G A   
Sbjct: 310 NRFVVYRDLKPANIL-----------LDEHGHV----------------RISDLGLACDF 342

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAIS 251
              K        T  Y+APEVL     YD S D +SLG +++ LL G  PF  +  +   
Sbjct: 343 SKKKP--HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-K 399

Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             +         + P    +  S E ++L++ +L  D + RL
Sbjct: 400 HEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRL 437

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  173 bits (442), Expect = 2e-51
 Identities = 83/279 (29%), Positives = 124/279 (44%), Gaps = 51/279 (18%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVE--------LQLAVGSHKHIVNI 74
           LG G  GKV     KKT++ +A+K L  D V    +VE        L LA   H  + ++
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHM 83

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              ++        L  +ME ++GG+L   IQ      F    A     EI   ++FLH +
Sbjct: 84  FCTFQT----KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK 137

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K +N+L  K                          DG I K+ DFG  K+ + 
Sbjct: 138 GIVYRDLKLDNILLDK--------------------------DGHI-KIADFGMCKENML 170

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
             A   T C TP Y+APE+L   KY+ S D WS GV++Y +L G  PF     +     +
Sbjct: 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----L 226

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            + IR+    +P      + +EAK L+  +   +P +RL
Sbjct: 227 FHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRL 261

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  173 bits (441), Expect = 3e-51
 Identities = 85/291 (29%), Positives = 131/291 (45%), Gaps = 64/291 (21%)

Query: 24  LGLGINGKVLQ---IVEKKTSEVYALKVLH-DTVKARRE-VELQLAVGSHKHIVNIKDVY 78
           LG G  GKV     I    T ++YA+KVL   T+  + +  E         H    + V 
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE---------HTRTERQVL 112

Query: 79  ENIYN-------------GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
           E+I                ++ L +I++ ++GGELF  + Q     FTE E  I + EI 
Sbjct: 113 EHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIV 169

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
            A++ LH   I +RD+K EN+L     +G +                          LTD
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDS--NGHV-------------------------VLTD 202

Query: 186 FGFAKKIVSNKASL-QTPCYTPYYVAPEVLGPDK--YDKSCDIWSLGVIMYILLCGFPPF 242
           FG +K+ V+++       C T  Y+AP+++      +DK+ D WSLGV+MY LL G  PF
Sbjct: 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             +  +     +  RI   +  +P    + +S  AK LI+ +L  DP +RL
Sbjct: 263 TVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRL 309

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  174 bits (444), Expect = 3e-51
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 50/284 (17%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VGSHKHIVNI 74
           ++G G   KVL +  KKT  +YA++V+  + V    +++             +H  +V +
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              ++     SR L  ++E ++GG+L   +Q+       E  A     EI  A+ +LH++
Sbjct: 119 HSCFQT---ESR-LFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER 172

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K +N+L                             +G I KLTD+G  K+ + 
Sbjct: 173 GIIYRDLKLDNVLLDS--------------------------EGHI-KLTDYGMCKEGLR 205

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG- 253
              +  T C TP Y+APE+L  + Y  S D W+LGV+M+ ++ G  PF            
Sbjct: 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265

Query: 254 ----MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
               +   I   Q   P      +S +A +++K+ L  DP ERL
Sbjct: 266 TEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERL 305

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  173 bits (440), Expect = 4e-51
 Identities = 79/282 (28%), Positives = 126/282 (44%), Gaps = 57/282 (20%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VGSHKHIVNIK 75
           LG G  GKV+    K+T ++YA+KVL  D +    +VE  +          +H  +  + 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 76  DVYENIY---NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
                        R L  +ME ++GG+L   IQ+     F E  A     EI SA+ FLH
Sbjct: 91  ------CCFQTPDR-LFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLH 141

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           D+ I +RD+K +N+L                             +G   KL DFG  K+ 
Sbjct: 142 DKGIIYRDLKLDNVLLDH--------------------------EGHC-KLADFGMCKEG 174

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQAIS 251
           + N  +  T C TP Y+APE+L    Y  + D W++GV++Y +LCG  PF + N      
Sbjct: 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--- 231

Query: 252 PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             +   I   +  +P      + ++A  ++K+ +  +P+ RL
Sbjct: 232 --LFEAILNDEVVYP----TWLHEDATGILKSFMTKNPTMRL 267

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  173 bits (440), Expect = 4e-51
 Identities = 77/278 (27%), Positives = 121/278 (43%), Gaps = 49/278 (17%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VGSHKHIVNIK 75
           LG G  GKV+    K T E+YA+K+L  D V    +VE  +         G    +  + 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 76  DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN 135
             ++      R L  +ME ++GG+L   IQQ   G F E  A     EI   + FL  + 
Sbjct: 88  SCFQT---MDR-LYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG 141

Query: 136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN 195
           I +RD+K +N++                             +G I K+ DFG  K+ + +
Sbjct: 142 IIYRDLKLDNVMLDS--------------------------EGHI-KIADFGMCKENIWD 174

Query: 196 KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK 255
             + +T C TP Y+APE++    Y KS D W+ GV++Y +L G  PF           + 
Sbjct: 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LF 230

Query: 256 NRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             I      +P    + +S+EA  + K ++   P +RL
Sbjct: 231 QSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRL 264

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  172 bits (438), Expect = 5e-51
 Identities = 83/290 (28%), Positives = 132/290 (45%), Gaps = 70/290 (24%)

Query: 24  LGLGINGKVLQ---IVEKKTSEVYALKVL--------HDTV---KARREVELQLAVGSHK 69
           LG G  GKV Q   +    T +++A+KVL               KA R +   L    H 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI---LEEVKHP 81

Query: 70  HIVNIKDVY-----ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
            IV++   Y       +Y       +I+E + GGELF ++++  +G F E  A   + EI
Sbjct: 82  FIVDLI--YAFQTGGKLY-------LILEYLSGGELFMQLER--EGIFMEDTACFYLAEI 130

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
             A+  LH + I +RD+KPEN++                              G + KLT
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNH--------------------------QGHV-KLT 163

Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           DFG  K+ + +     T C T  Y+APE+L    ++++ D WSLG +MY +L G PPF  
Sbjct: 164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

Query: 245 -NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            N  +       ++I   + + P     +++QEA+ L+K +L  + + RL
Sbjct: 224 ENRKK-----TIDKILKCKLNLP----PYLTQEARDLLKKLLKRNAASRL 264

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  172 bits (439), Expect = 5e-50
 Identities = 89/288 (30%), Positives = 145/288 (50%), Gaps = 52/288 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQ------LAVGS 67
           ++++    +LG G  GKV+ + EK T   YA+K+L  + + A+ EV         L    
Sbjct: 148 NEFEYLK-LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H  +  +K  ++        L  +ME  +GGELF  + +  +  F+E  A     EI SA
Sbjct: 207 HPFLTALKYSFQT----HDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSA 260

Query: 128 IKFLH-DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           + +LH ++N+ +RD+K ENL+  K                          DG I K+TDF
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDK--------------------------DGHI-KITDF 293

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS-N 245
           G  K+ + + A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++ +
Sbjct: 294 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353

Query: 246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
           H +     +   I + +  FP      +  EAK+L+  +L  DP +RL
Sbjct: 354 HEK-----LFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQRL 392

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  166 bits (422), Expect = 2e-48
 Identities = 50/322 (15%), Positives = 87/322 (27%), Gaps = 48/322 (14%)

Query: 3   PTFKPFKTTPI-QDDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDTVKAR 56
           P  KP     +      +   +LG G   +V +  +      K  + + LKV        
Sbjct: 52  PAIKPKTEFQLGSKLVYV-HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE 110

Query: 57  REVELQ----LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK---ED 109
             +  Q    L        +     +          +++ E    G L   I       +
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSAHLF----QNGSVLVGELYSYGTLLNAINLYKNTPE 166

Query: 110 GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN 169
               +         +   I+ +HD  I H D+KP+N +                      
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE--------------- 211

Query: 170 LLYTKPGDGGILKLTDFGFAK--KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWS 227
               +      L L D G +   K+          C T  +   E+L    ++   D + 
Sbjct: 212 -QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270

Query: 228 LGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCV 287
           +   +Y +L G      N G    P       L +       W             ML +
Sbjct: 271 VAATVYCMLFGTYMKVKNEGGECKP-----EGLFRRLPHLDMW-------NEFFHVMLNI 318

Query: 288 DPSERLTIDQVMENKWISQFNQ 309
                L    ++  K    F Q
Sbjct: 319 PDCHHLPSLDLLRQKLKKVFQQ 340

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  172 bits (437), Expect = 2e-48
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 49/279 (17%)

Query: 23  ILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLA-------VGSHKHIVNI 74
           +LG G  GKV+    K T E+YA+K+L  D V    +VE  +         G    +  +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              ++      R   V ME ++GG+L   IQQ   G F E  A     EI   + FL  +
Sbjct: 408 HSCFQT---MDRLYFV-MEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK 461

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            I +RD+K +N++                             +G I K+ DFG  K+ + 
Sbjct: 462 GIIYRDLKLDNVMLDS--------------------------EGHI-KIADFGMCKENIW 494

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGM 254
           +  + +T C TP Y+APE++    Y KS D W+ GV++Y +L G  PF           +
Sbjct: 495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----L 550

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
              I      +P    + +S+EA  + K ++   P +RL
Sbjct: 551 FQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRL 585

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  147 bits (372), Expect = 2e-41
 Identities = 47/228 (20%), Positives = 89/228 (39%), Gaps = 25/228 (10%)

Query: 78  YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI-IMNEICSAIKFLHDQNI 136
                +    L + M+      L   + ++      E    + I  +I  A++FLH + +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+KP N+ +T       +K+ DFG V   +            +  +       +   
Sbjct: 186 MHRDLKPSNIFFTMDDV---VKVGDFGLVTAMD------------QDEEEQTVLTPMPAY 230

Query: 197 ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN 256
           A+      T  Y++PE +  + Y    DI+SLG+I++ LL  F        + I      
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-QMERVRII-----T 284

Query: 257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            +R  +F      +     +   ++++ML   P+ER     ++EN   
Sbjct: 285 DVRNLKFP---LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  145 bits (368), Expect = 8e-41
 Identities = 61/291 (20%), Positives = 101/291 (34%), Gaps = 47/291 (16%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENI 81
             +G G  G+V ++ +K+T    A+K +   V    E+    A  S   IV         
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA-CAGLSSPRIVP----LYGA 118

Query: 82  YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV 141
                 + + ME + GG L Q I  K+ G   E  A   + +    +++LH + I H DV
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176

Query: 142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT 201
           K +N+L +                           DG    L DFG A  +  +      
Sbjct: 177 KADNVLLSS--------------------------DGSRAALCDFGHALCLQPDGLGKSL 210

Query: 202 PCY-----TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG-QAISPGMK 255
                   T  ++APEV+     D   DIWS   +M  +L G  P+              
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC----- 265

Query: 256 NRIRLGQFDFPNPEW-EHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
             +++     P  E     +      I+  L  +P  R +  ++      +
Sbjct: 266 --LKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  141 bits (357), Expect = 1e-39
 Identities = 74/299 (24%), Positives = 132/299 (44%), Gaps = 48/299 (16%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ----LAVGSHK 69
           +  Y    +I G G +G V   ++  T +  A++ ++   + ++E+ +     +    + 
Sbjct: 19  KKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77

Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           +IVN  D Y     G   L V+ME + GG L   + +       E + A +  E   A++
Sbjct: 78  NIVNYLDSY---LVGDE-LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           FLH   + HRD+K +N+L           L   G VK                LTDFGF 
Sbjct: 131 FLHSNQVIHRDIKSDNIL-----------LGMDGSVK----------------LTDFGFC 163

Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI-LLCGFPPFFSNHGQ 248
            +I   ++   T   TPY++APEV+    Y    DIWSLG IM I ++ G PP+ + +  
Sbjct: 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMIEGEPPYLNEN-- 220

Query: 249 AISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
              P ++    +     P     E +S   +  +   L +D  +R +  ++++++++  
Sbjct: 221 ---P-LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  140 bits (355), Expect = 6e-39
 Identities = 84/300 (28%), Positives = 132/300 (44%), Gaps = 50/300 (16%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ-----LAVGSH 68
           +   D   +I G G  G V    EK +    A+K++ D  K +R   L      +    H
Sbjct: 44  RLLLDSYVKI-GEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQH 101

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            ++V +   Y     G   L V+ME + GG L   + Q       E + A +   +  A+
Sbjct: 102 FNVVEMYKSY---LVGEE-LWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQAL 154

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            +LH Q + HRD+K +++L           LT  G VK                L+DFGF
Sbjct: 155 AYLHAQGVIHRDIKSDSIL-----------LTLDGRVK----------------LSDFGF 187

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI-LLCGFPPFFSNHG 247
             +I  +    ++   TPY++APEV+    Y    DIWSLG IM I ++ G PP+FS+  
Sbjct: 188 CAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLG-IMVIEMVDGEPPYFSDS- 245

Query: 248 QAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               P ++   RL     P       VS   +  ++ ML  DP ER T  +++++ ++ Q
Sbjct: 246 ----P-VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  140 bits (355), Expect = 7e-39
 Identities = 72/304 (23%), Positives = 132/304 (43%), Gaps = 45/304 (14%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL---HDTVKA-RREVELQLAVGSHK 69
              +++  E++G G  G+V +    KT ++ A+KV+    D  +  ++E+ +      H+
Sbjct: 23  AGIFEL-VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHR 81

Query: 70  HIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           +I      +  +N       L ++ME    G +   I+  +     E   A I  EI   
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  LH   + HRD+K +N+L           LT+  +V                KL DFG
Sbjct: 142 LSHLHQHKVIHRDIKGQNVL-----------LTENAEV----------------KLVDFG 174

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-----YDKSCDIWSLGVIMYILLCGFPPF 242
            + ++        T   TPY++APEV+  D+     YD   D+WSLG+    +  G PP 
Sbjct: 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
              H     P M+    + +   P  + +  S++ ++ I++ L  + S+R   +Q+M++ 
Sbjct: 235 CDMH-----P-MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288

Query: 303 WISQ 306
           +I  
Sbjct: 289 FIRD 292

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  136 bits (345), Expect = 7e-38
 Identities = 76/313 (24%), Positives = 130/313 (41%), Gaps = 54/313 (17%)

Query: 9   KTTPIQDDYDIST----EILGLGINGKVLQIVEKKTSEVYALKVL----HDTVKA-RREV 59
           ++  ++ DY+        +LG G  G V    +       A+K +        +    E+
Sbjct: 11  ESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEI 70

Query: 60  ELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
            L      HK+IV     Y   ++ +  + + ME + GG L   ++ K  G   + E  I
Sbjct: 71  AL-HKHLKHKNIVQ----YLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTI 124

Query: 120 --IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
                +I   +K+LHD  I HRD+K +N+L                 +   +        
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVL-----------------INTYS-------- 159

Query: 178 GGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL--GPDKYDKSCDIWSLGVIMYIL 235
            G+LK++DFG +K++       +T   T  Y+APE++  GP  Y K+ DIWSLG  +  +
Sbjct: 160 -GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218

Query: 236 LCGFPPF--FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             G PPF        A+        ++G F       E +S EAK  I      DP +R 
Sbjct: 219 ATGKPPFYELGEPQAAM-------FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA 271

Query: 294 TIDQVMENKWISQ 306
             + ++ ++++  
Sbjct: 272 CANDLLVDEFLKV 284

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  136 bits (344), Expect = 2e-37
 Identities = 72/298 (24%), Positives = 124/298 (41%), Gaps = 46/298 (15%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL---HDTVKARREVELQLAVGSHKH 70
           ++ +D+  ++ G G  G V + + K+T ++ A+K +    D  +  +E+ + +      H
Sbjct: 28  EEVFDVLEKL-GEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISI-MQQCDSPH 85

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +V     Y   +  +  L ++ME    G +   I +  +   TE E A I+      +++
Sbjct: 86  VVKYYGSY---FKNTD-LWIVMEYCGAGSV-SDIIRLRNKTLTEDEIATILQSTLKGLEY 140

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           LH     HRD+K  N+L           L   G  K                L DFG A 
Sbjct: 141 LHFMRKIHRDIKAGNIL-----------LNTEGHAK----------------LADFGVAG 173

Query: 191 KIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI-LLCGFPPFFSNHGQA 249
           ++    A   T   TP+++APEV+    Y+   DIWSLG I  I +  G PP+   H   
Sbjct: 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG-ITAIEMAEGKPPYADIH--- 229

Query: 250 ISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             P M+    +     P   + E  S      +K  L   P +R T  Q++++ ++  
Sbjct: 230 --P-MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  136 bits (344), Expect = 3e-37
 Identities = 64/330 (19%), Positives = 117/330 (35%), Gaps = 65/330 (19%)

Query: 4   TFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA------RR 57
              P +      +       +G G  G V ++V K + ++ A+K +  TV          
Sbjct: 10  KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM 69

Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGG--ELFQRIQQKEDGAFTER 115
           ++++ +      +IV     Y  ++       + ME M     + ++ +    D    E 
Sbjct: 70  DLDVVMRSSDCPYIV---QFYGALFREG-DCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125

Query: 116 EAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK 174
               I      A+  L +   I HRD+KP N+L           L   G++K        
Sbjct: 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNIL-----------LDRSGNIK-------- 166

Query: 175 PGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK----YDKSCDIWSLGV 230
                   L DFG + ++V + A  +       Y+APE + P      YD   D+WSLG+
Sbjct: 167 --------LCDFGISGQLVDSIAKTRDAG-CRPYMAPERIDPSASRQGYDVRSDVWSLGI 217

Query: 231 IMYILLCGFPPFFSNHG-----QAI----SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLI 281
            +Y L  G  P+   +        +     P +            N E    S      +
Sbjct: 218 TLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL-----------SNSEEREFSPSFINFV 266

Query: 282 KNMLCVDPSERLTIDQVMENKWISQFNQVP 311
              L  D S+R    +++++ +I  + +  
Sbjct: 267 NLCLTKDESKRPKYKELLKHPFILMYEERA 296

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  133 bits (336), Expect = 1e-36
 Identities = 63/299 (21%), Positives = 118/299 (39%), Gaps = 56/299 (18%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA-------RREVELQLAVGSHKHIVNI 74
             +G G    V + ++ +T+   A   L D           + E E+ L    H +IV  
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEM-LKGLQHPNIVRF 90

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            D +E+   G +C++++ E M  G L   +  K       +       +I   ++FLH +
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 135 N--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+K +N+  T                          G  G +K+ D G A   
Sbjct: 149 TPPIIHRDLKCDNIFIT--------------------------GPTGSVKIGDLGLATLK 182

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA--- 249
            ++ A  +    TP ++APE+   +KYD+S D+++ G+ M  +     P+      A   
Sbjct: 183 RASFA--KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239

Query: 250 --ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             ++ G+K          P    +    E K +I+  +  +  ER +I  ++ + +  +
Sbjct: 240 RRVTSGVK----------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  133 bits (337), Expect = 2e-36
 Identities = 76/299 (25%), Positives = 137/299 (45%), Gaps = 49/299 (16%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVL-----HDTVKA-RREVELQLAVGS 67
           ++ +    E +G G  G+V + ++ +T +V A+K++      D ++  ++E+ + L+   
Sbjct: 21  EELFTK-LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV-LSQCD 78

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
             ++      Y      ++ L +IME + GG     ++    G   E + A I+ EI   
Sbjct: 79  SPYVTKYYGSY---LKDTK-LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKG 131

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +LH +   HRD+K  N+L           L++ G+VK                L DFG
Sbjct: 132 LDYLHSEKKIHRDIKAANVL-----------LSEHGEVK----------------LADFG 164

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
            A ++   +    T   TP+++APEV+    YD   DIWSLG+    L  G PP    H 
Sbjct: 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH- 223

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
               P MK    + + + P  E  + S+  K  ++  L  +PS R T  +++++K+I +
Sbjct: 224 ----P-MKVLFLIPKNNPPTLE-GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  132 bits (334), Expect = 3e-36
 Identities = 79/305 (25%), Positives = 132/305 (43%), Gaps = 53/305 (17%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQ-----LAVGSH 68
            + ++I    LG G  GKV +   K+T  + A KV+ +T       +       LA   H
Sbjct: 18  NEVWEI-VGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDH 75

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            +IV +   Y   Y+  + L +++E   GG +   I  + D   TE +  ++  ++  A+
Sbjct: 76  PYIVKLLGAY---YHDGK-LWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            FLH + I HRD+K  N+L           +T  GD+                +L DFG 
Sbjct: 131 NFLHSKRIIHRDLKAGNVL-----------MTLEGDI----------------RLADFGV 163

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDK-----YDKSCDIWSLGVIMYI-LLCGFPPF 242
           + K +       +   TPY++APEV+  +      YD   DIWSLG I  I +    PP 
Sbjct: 164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEPPH 222

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
              +     P M+  +++ + D P        S E +  +K  L  +P  R +  Q++E+
Sbjct: 223 HELN-----P-MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276

Query: 302 KWISQ 306
            ++S 
Sbjct: 277 PFVSS 281

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  131 bits (331), Expect = 1e-35
 Identities = 64/313 (20%), Positives = 121/313 (38%), Gaps = 53/313 (16%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL------QLAVGS 67
           +DDY++  E++G G    V         E  A+K + +  K +  ++        ++   
Sbjct: 14  RDDYEL-QEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCH 71

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELF------QRIQQKEDGAFTEREAAIIM 121
           H +IV+    Y +       L ++M+ + GG +           + + G   E   A I+
Sbjct: 72  HPNIVS---YYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127

Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
            E+   +++LH     HRDVK  N+L           L + G V                
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNIL-----------LGEDGSV---------------- 160

Query: 182 KLTDFGFAKKIVSNKASLQTPCY-----TPYYVAPEVLGPDK-YDKSCDIWSLGVIMYIL 235
           ++ DFG +  + +     +         TP ++APEV+   + YD   DIWS G+    L
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220

Query: 236 LCGFPPFFSNHG-QAISPGMKNRI-RLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
             G  P+      + +   ++N    L          +   +  + +I   L  DP +R 
Sbjct: 221 ATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

Query: 294 TIDQVMENKWISQ 306
           T  +++ +K+  +
Sbjct: 281 TAAELLRHKFFQK 293

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  129 bits (326), Expect = 4e-35
 Identities = 62/311 (19%), Positives = 108/311 (34%), Gaps = 58/311 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA------RREVELQLAVGSH 68
           DD +     LG G  G V ++    + ++ A+K +  TV +        ++++ +     
Sbjct: 7   DDLEP-IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGG-ELFQRIQQKEDGAFTEREAAIIMNEICSA 127
              V     Y  ++      +  ME M    + F +    +     E     I   I  A
Sbjct: 66  PFTV---TFYGALFREGDVWIC-MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 128 IKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           ++ LH + ++ HRDVKP N+L           +   G VK                + DF
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVL-----------INALGQVK----------------MCDF 154

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK----YDKSCDIWSLGVIMYILLCGFPPF 242
           G +  +V + A          Y+APE + P+     Y    DIWSLG+ M  L     P+
Sbjct: 155 GISGYLVDDVAK-DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213

Query: 243 FSNHGQAISPGMKNRIRLGQ----FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
                           +  +       P    +  S E        L  +  ER T  ++
Sbjct: 214 ---------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264

Query: 299 MENKWISQFNQ 309
           M++ + +    
Sbjct: 265 MQHPFFTLHES 275

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  129 bits (327), Expect = 9e-35
 Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 58/305 (19%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVG------- 66
           +  +      +G G  G V    + + SEV A+K +      +   + Q  +        
Sbjct: 53  EKLFSD-LREIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQK 110

Query: 67  -SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
             H + +  +  Y           ++ME   G      + +       E E A + +   
Sbjct: 111 LRHPNTIQYRGCY---LREHT-AWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGAL 164

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             + +LH  N+ HRDVK  N+L           L++ G V                KL D
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNIL-----------LSEPGLV----------------KLGD 197

Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYI-LLCGFPP 241
           FG A  +    A   +   TPY++APEV+       YD   D+WSLG I  I L    PP
Sbjct: 198 FGSASIM--APA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPP 252

Query: 242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
            F+ +       M     + Q + P  +  H S+  +  + + L   P +R T + ++++
Sbjct: 253 LFNMN-----A-MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306

Query: 302 KWISQ 306
           +++ +
Sbjct: 307 RFVLR 311

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  128 bits (325), Expect = 1e-34
 Identities = 78/336 (23%), Positives = 127/336 (37%), Gaps = 83/336 (24%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----DTVK--ARREVEL--QLAV 65
           + Y+     +G G  G V +   + T ++ A+K          +K  A RE+ +  QL  
Sbjct: 3   EKYEK-IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-- 59

Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
             H ++VN+ +V        R  LV  E      +   + + + G   E     I  +  
Sbjct: 60  -KHPNLVNLLEV---FRRKRRLHLV-FEYCDH-TVLHELDRYQRG-VPEHLVKSITWQTL 112

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
            A+ F H  N  HRDVKPEN+L TK                             ++KL D
Sbjct: 113 QAVNFCHKHNCIHRDVKPENILITKH---------------------------SVIKLCD 145

Query: 186 FGFAKKIVSNKASLQTPCYTPY-----YVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGF 239
           FGFA+ +     +  +  Y        Y +PE+L G  +Y    D+W++G +   LL G 
Sbjct: 146 FGFARLL-----TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

Query: 240 PPF------------FSNHG---QAISPGMKNRIRLGQFDFPNPEWE--------HVSQE 276
           P +                G                     P+PE          ++S  
Sbjct: 201 PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYP 260

Query: 277 AKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQ 312
           A  L+K  L +DP+ERLT +Q++ + +   F  + +
Sbjct: 261 ALGLLKGCLHMDPTERLTCEQLLHHPY---FENIRE 293

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  128 bits (323), Expect = 2e-34
 Identities = 65/310 (20%), Positives = 128/310 (41%), Gaps = 53/310 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA------RREVELQLAVGSH 68
           +D +     +G G  G+V ++  +KT  V A+K +  +           ++++ L     
Sbjct: 25  NDLEN-LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            +IV     +      +  + + ME M       +++++  G   ER    +   I  A+
Sbjct: 84  PYIV---QCFGTFITNT-DVFIAMELMGTCAE--KLKKRMQGPIPERILGKMTVAIVKAL 137

Query: 129 KFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
            +L ++  + HRDVKP N+L           L + G +K                L DFG
Sbjct: 138 YYLKEKHGVIHRDVKPSNIL-----------LDERGQIK----------------LCDFG 170

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-----YDKSCDIWSLGVIMYILLCGFPPF 242
            + ++V +KA          Y+APE + P       YD   D+WSLG+ +  L  G  P+
Sbjct: 171 ISGRLVDDKAK-DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
            +          +   ++ Q + P  P     S + ++ +K+ L  D  +R   ++++E+
Sbjct: 230 KNCK-----TDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284

Query: 302 KWISQFNQVP 311
            +I ++  + 
Sbjct: 285 SFIKRYETLE 294

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  125 bits (316), Expect = 2e-33
 Identities = 72/327 (22%), Positives = 124/327 (37%), Gaps = 80/327 (24%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--DTVKARREVELQLAVGSHKH 70
            QDDY +  ++ G G   +V + +    +E   +K+L      K +RE+++   +    +
Sbjct: 34  NQDDYQLVRKL-GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPN 92

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           I+ + D+ ++    SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ +
Sbjct: 93  IITLADIVKD--PVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDY 145

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
            H   I HRDVKP N++                 +  E+           L+L D+G A+
Sbjct: 146 CHSMGIMHRDVKPHNVM-----------------IDHEH---------RKLRLIDWGLAE 179

Query: 191 KIVSNKASLQTPCYTPY-----YVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFF- 243
                +       Y        +  PE+L     YD S D+WSLG ++  ++    PFF 
Sbjct: 180 FYHPGQE------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233

Query: 244 --SNHGQAI----------------------------SPGMKNRIRLGQFDFPNPEWEHV 273
              N+ Q +                              G  +R R  +F   +     V
Sbjct: 234 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF-VHSENQHLV 292

Query: 274 SQEAKTLIKNMLCVDPSERLTIDQVME 300
           S EA   +  +L  D   RLT  + ME
Sbjct: 293 SPEALDFLDKLLRYDHQSRLTAREAME 319

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  124 bits (314), Expect = 8e-33
 Identities = 76/339 (22%), Positives = 130/339 (38%), Gaps = 78/339 (23%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREV--ELQ-LAVGSHK 69
           DD++     LG G  G V ++  K +  V A K++H  +K   R ++  ELQ L   +  
Sbjct: 33  DDFEK-ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91

Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           +IV     Y   Y+    + + ME M GG L Q +  K+ G   E+    +   +   + 
Sbjct: 92  YIV---GFYGAFYSDG-EISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 145

Query: 130 FLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           +L ++  I HRDVKP N+L    G+                           +KL DFG 
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFGV 178

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           + +++ + A   +   T  Y++PE L    Y    DIWS+G+ +  +  G  P      +
Sbjct: 179 SGQLIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236

Query: 249 AI---------------------------SPGMKNRIRLGQFDF---------PNPEWEH 272
            +                             GM +R  +  F+          P      
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296

Query: 273 VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVP 311
            S E +  +   L  +P+ER  + Q+M + +I + +   
Sbjct: 297 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  123 bits (310), Expect = 2e-32
 Identities = 76/335 (22%), Positives = 127/335 (37%), Gaps = 83/335 (24%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----DTVK--ARREVEL--QLAV 65
           + Y+    ++G G  G V++   K T  + A+K          VK  A RE++L  QL  
Sbjct: 25  EKYEN-LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-- 81

Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
             H+++VN+ +V        R  LV  E +    +   ++   +G    +     + +I 
Sbjct: 82  -RHENLVNLLEV---CKKKKRWYLV-FEFVDH-TILDDLELFPNG-LDYQVVQKYLFQII 134

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
           + I F H  NI HRD+KPEN+L ++                            G++KL D
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQS---------------------------GVVKLCD 167

Query: 186 FGFAKKIVSNKASLQTPCYTPY-----YVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGF 239
           FGFA+ +     +     Y        Y APE+L G  KY K+ D+W++G ++  +  G 
Sbjct: 168 FGFARTL-----AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

Query: 240 PPF------------FSNHG---QAISPGMK-----NRIRLGQFDFPNPEWEHV---SQE 276
           P F                G                  +RL +     P        S+ 
Sbjct: 223 PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEV 282

Query: 277 AKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVP 311
              L K  L +DP +R    +++ + +   F    
Sbjct: 283 VIDLAKKCLHIDPDKRPFCAELLHHDF---FQMDG 314

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  122 bits (307), Expect = 2e-31
 Identities = 74/318 (23%), Positives = 128/318 (40%), Gaps = 62/318 (19%)

Query: 12  PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKH 70
             +  Y    +++G G  G V Q    ++ EV A+K VL D     RE+++ + +  H +
Sbjct: 37  QREIAYTN-CKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNRELQI-MRIVKHPN 93

Query: 71  IVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICS 126
           +V++K  +           L +++E +    +++  +   K           + M ++  
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           ++ ++H   I HRD+KP+NLL                 + P +         G+LKL DF
Sbjct: 153 SLAYIHSIGICHRDIKPQNLL-----------------LDPPS---------GVLKLIDF 186

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF--F 243
           G AK +++ + ++   C + YY APE+  G   Y  + DIWS G +M  L+ G P F   
Sbjct: 187 GSAKILIAGEPNVSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245

Query: 244 SNHGQ-------------AISPGMKNRIRLGQFDFPNPE---WE-----HVSQEAKTLIK 282
           S   Q                  M       +  FP      +          +A  LI 
Sbjct: 246 SGIDQLVEIIKVLGTPSREQIKTMNPNYM--EHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303

Query: 283 NMLCVDPSERLTIDQVME 300
            +L   PS RLT  + + 
Sbjct: 304 RLLEYTPSARLTAIEALC 321

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  122 bits (307), Expect = 2e-31
 Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 61/318 (19%)

Query: 12  PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKH 70
           P +  Y   T+++G G  G V Q     + E+ A+K VL D     RE+++ +    H +
Sbjct: 51  PQEVSYTD-TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI-MRKLDHCN 108

Query: 71  IVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICS 126
           IV ++  +           L ++++ +    +++  +   +           + M ++  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           ++ ++H   I HRD+KP+NLL                 + P+           +LKL DF
Sbjct: 168 SLAYIHSFGICHRDIKPQNLL-----------------LDPDT---------AVLKLCDF 201

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN 245
           G AK++V  + ++   C + YY APE+  G   Y  S D+WS G ++  LL G P F  +
Sbjct: 202 GSAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260

Query: 246 HG---------------QAISPGMKNRIRLGQFDFPNPE---WE-----HVSQEAKTLIK 282
            G               +     M       +F FP  +   W          EA  L  
Sbjct: 261 SGVDQLVEIIKVLGTPTREQIREMNPNYT--EFKFPQIKAHPWTKVFRPRTPPEAIALCS 318

Query: 283 NMLCVDPSERLTIDQVME 300
            +L   P+ RLT  +   
Sbjct: 319 RLLEYTPTARLTPLEACA 336

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (313), Expect = 2e-31
 Identities = 54/256 (21%), Positives = 90/256 (35%), Gaps = 61/256 (23%)

Query: 45  ALKVLHDT----VKARREVELQLAVG-SHKHIVNIKDVYE-NIYNGSRCLLVIMECMHGG 98
            LK L  +     +A    E Q      H  IV I +  E    +G     ++ME + G 
Sbjct: 110 VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ 169

Query: 99  ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK 158
            L +             EA   + EI  A+ +LH   + + D+KPEN++ T   +  + K
Sbjct: 170 SLKRSKG----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---EEQL-K 221

Query: 159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL--GP 216
           L D G V                 +  FG+   +            TP + APE++  GP
Sbjct: 222 LIDLGAVSR---------------INSFGY---LYG----------TPGFQAPEIVRTGP 253

Query: 217 DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQE 276
                + DI+++G  +  L    P     +   +             D P  +       
Sbjct: 254 T--VAT-DIYTVGRTLAALTLDLPTRNGRYVDGLPE-----------DDPVLK---TYDS 296

Query: 277 AKTLIKNMLCVDPSER 292
              L++  +  DP +R
Sbjct: 297 YGRLLRRAIDPDPRQR 312

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  120 bits (303), Expect = 4e-31
 Identities = 57/361 (15%), Positives = 104/361 (28%), Gaps = 89/361 (24%)

Query: 11  TPIQDDYDISTEI-LGLGINGKVLQIVEKKTSEVYALKVL------HDTVKA-RREVELQ 62
            P    Y++ T I  G      V     K T E   ++ +      ++ V   + E+ + 
Sbjct: 21  LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV- 79

Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
             + +H +IV  +  +      +  L V+   M  G     I         E   A I+ 
Sbjct: 80  SKLFNHPNIVPYRATF---IADNE-LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
            +  A+ ++H     HR VK  ++L           ++  G V                 
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHIL-----------ISVDGKV----------------Y 168

Query: 183 LTDFGFAKKIVSNKASLQTPCY-------TPYYVAPEVL--GPDKYDKSCDIWSLGVIMY 233
           L+       ++S+    +              +++PEVL      YD   DI+S+G I  
Sbjct: 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG-ITA 227

Query: 234 I-LLCGFPPFFSNH--------------------------------------GQAISPGM 254
             L  G  PF                                          G + S   
Sbjct: 228 CELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT 287

Query: 255 KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
                       +P     S      ++  L  +P  R +   ++ + +  Q  +     
Sbjct: 288 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA 347

Query: 315 L 315
           L
Sbjct: 348 L 348

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  117 bits (295), Expect = 1e-30
 Identities = 69/339 (20%), Positives = 128/339 (37%), Gaps = 57/339 (16%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH---DTVKARREVELQLAVGSHKHIVNIKDVY 78
           E++G G  G V +   +   +V A+K +    +      E+   L+  +H +IV +    
Sbjct: 14  EVVGRGAFGVVCKAKWRAK-DV-AIKQIESESERKAFIVELRQ-LSRVNHPNIVKLYGAC 70

Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKE-DGAFTEREAAIIMNEICSAIKFLHDQN-- 135
            N      CL  +ME   GG L+  +   E    +T   A     +    + +LH     
Sbjct: 71  LNPV----CL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 136 -IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
            + HRD+KP NLL                              G +LK+ DFG A  I  
Sbjct: 125 ALIHRDLKPPNLLLVA--------------------------GGTVLKICDFGTACDI-- 156

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF--FSNHGQAISP 252
            +  +     +  ++APEV     Y + CD++S G+I++ ++    PF         I  
Sbjct: 157 -QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW 215

Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME--NKWISQFNQV 310
            + N  R           +++ +  ++L+      DPS+R +++++++     +  F   
Sbjct: 216 AVHNGTRP---PLI----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268

Query: 311 PQ-TPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQ 348
            +         L  GE+   E   +         VD+ +
Sbjct: 269 DEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDHGE 307

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  117 bits (295), Expect = 2e-30
 Identities = 70/340 (20%), Positives = 118/340 (34%), Gaps = 81/340 (23%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVK---------ARREVEL--Q 62
             Y+     +G+G  G V +  +  +    ALK +                 REV L  +
Sbjct: 9   SRYEP-VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 63  LAVGSHKHIVNIKDV-YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM 121
           L    H ++V + DV   +  +    + ++ E +   +L   + +             +M
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126

Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
            +    + FLH   I HRD+KPEN+L T                            GG +
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTS---------------------------GGTV 159

Query: 182 KLTDFGFAKKIVSNKASLQTPCYTP-----YYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
           KL DFG A+      A       TP     +Y APEVL    Y    D+WS+G I   + 
Sbjct: 160 KLADFGLARIYSYQMA------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

Query: 237 CGFPPF------------FSNHG---QAISPGMKNRIRLGQFDFPNPE-------WEHVS 274
              P F            F   G   +   P   +   L +  FP             + 
Sbjct: 214 RRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS---LPRGAFPPRGPRPVQSVVPEME 270

Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
           +    L+  ML  +P +R++  + +++ +    ++    P
Sbjct: 271 ESGAQLLLEMLTFNPHKRISAFRALQHSY---LHKDEGNP 307

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  117 bits (296), Expect = 2e-30
 Identities = 74/338 (21%), Positives = 129/338 (38%), Gaps = 80/338 (23%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVK------ARREVELQLAVGS 67
           D Y      LG G  G+V + ++  T+E  A+K +  +  +      A REV L L    
Sbjct: 34  DRYRR-ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSL-LKELQ 91

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H++I+ +K V     + +  L +I E     +L + + +      + R     + ++ + 
Sbjct: 92  HRNIIELKSVI----HHNHRLHLIFEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLING 144

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + F H +   HRD+KP+NLL +                       +   +  +LK+ DFG
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSV----------------------SDASETPVLKIGDFG 182

Query: 188 FAKKIVSNKASLQTPCYTP-----YYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPP 241
            A+        +    +T      +Y  PE+L G   Y  S DIWS+  I   +L   P 
Sbjct: 183 LARAF-----GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPL 237

Query: 242 F------------FSNHG---QAISPGMKNRIRLGQFDFPNPEWE----------HVSQE 276
           F            F   G       PG+     L  +    P++            +  E
Sbjct: 238 FPGDSEIDQLFKIFEVLGLPDDTTWPGVTA---LPDWKQSFPKFRGKTLKRVLGALLDDE 294

Query: 277 AKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
              L+  ML +DP +R++    +E+ +   F+     P
Sbjct: 295 GLDLLTAMLEMDPVKRISAKNALEHPY---FSHNDFDP 329

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (293), Expect = 4e-30
 Identities = 61/224 (27%), Positives = 91/224 (40%), Gaps = 52/224 (23%)

Query: 41  SEVY-----------ALKVLH------DTVKARREVELQLAVG-SHKHIVNIKDVYENIY 82
           SEV+           A+KVL        +   R   E Q A   +H  IV + D  E   
Sbjct: 26  SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85

Query: 83  NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK 142
                  ++ME + G  L   +  +  G  T + A  ++ + C A+ F H   I HRDVK
Sbjct: 86  PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 143

Query: 143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASL-QT 201
           P N++ +                               +K+ DFG A+ I  +  S+ QT
Sbjct: 144 PANIMIS---------------------------ATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 202 PCY--TPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
                T  Y++PE   G D  D   D++SLG ++Y +L G PPF
Sbjct: 177 AAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF 219

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  116 bits (292), Expect = 5e-30
 Identities = 74/342 (21%), Positives = 116/342 (33%), Gaps = 84/342 (24%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DT-----VKARREVELQLAVGSH 68
             +    E LG G    V + + K T    ALK +  D+       A RE+ L +    H
Sbjct: 5   SQFKQ-LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISL-MKELKH 62

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMH---GGELFQRIQQKEDGAFTEREAAIIMNEIC 125
           ++IV + DV     +    L ++ E M       +  R                   ++ 
Sbjct: 63  ENIVRLYDVI----HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             + F H+  I HRD+KP+NLL  K                            G LKL D
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINK---------------------------RGQLKLGD 151

Query: 186 FGFAKKIVSNKASLQTPCYTP-----YYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGF 239
           FG A+        +    ++      +Y AP+VL G   Y  S DIWS G I+  ++ G 
Sbjct: 152 FGLARAF-----GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

Query: 240 PPF------------FSNHG---QAISPGMKN------------RIRLGQFDFPNPEWEH 272
           P F            F   G   +++ P +                 L Q        E 
Sbjct: 207 PLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQV-LQPHTKEP 265

Query: 273 VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
           +       +  +L ++P  RL+  Q + + W   F +     
Sbjct: 266 LDGNLMDFLHGLLQLNPDMRLSAKQALHHPW---FAEYYHHA 304

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  114 bits (287), Expect = 2e-29
 Identities = 71/332 (21%), Positives = 121/332 (36%), Gaps = 78/332 (23%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVK------ARREVELQLAVGS 67
             Y+   E +G G  G V +   ++T E+ ALK +  D         A RE+ L L    
Sbjct: 2   QKYEK-LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL-LKELK 59

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           HK+IV + DV     +  + L ++ E     +L +                  + ++   
Sbjct: 60  HKNIVRLHDVL----HSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKG 113

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + F H +N+ HRD+KP+NLL  +                            G LKL +FG
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINR---------------------------NGELKLANFG 146

Query: 188 FAKKIVSNKASLQTPCYTP-----YYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPP 241
            A+        +   CY+      +Y  P+VL G   Y  S D+WS G I   L     P
Sbjct: 147 LARAF-----GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

Query: 242 FF---SNHGQ-------------AISPGMK---NRIRLGQFDFPNPEWEHV---SQEAKT 279
            F       Q                P M    +      +         V   +   + 
Sbjct: 202 LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRD 261

Query: 280 LIKNMLCVDPSERLTIDQVMENKWISQFNQVP 311
           L++N+L  +P +R++ ++ +++ +   F+   
Sbjct: 262 LLQNLLKCNPVQRISAEEALQHPY---FSDFC 290

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  115 bits (290), Expect = 2e-29
 Identities = 77/328 (23%), Positives = 129/328 (39%), Gaps = 66/328 (20%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVEL--QLAV 65
           ++    D + +   + G G  G V    EK T    A+K V+ D     RE+++   LAV
Sbjct: 17  RSRKEMDRFQV-ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAV 75

Query: 66  GSHKHIVNIKDVYENIYNGSR---CLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAII 120
             H +IV ++  +  +    R    L V+ME +    L +  +   +   A       + 
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 121 MNEICSAIKFLHDQ--NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           + ++  +I  LH    N+ HRD+KP N+L                 V   +         
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVL-----------------VNEAD--------- 168

Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLC 237
           G LKL DFG AKK+  ++ ++   C + YY APE+  G   Y  + DIWS+G I   ++ 
Sbjct: 169 GTLKLCDFGSAKKLSPSEPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227

Query: 238 GFPPF--FSNHGQ-----------------AISPGMKNRIRLGQFDFPNPE------WEH 272
           G P F   ++ GQ                  ++P     + L                  
Sbjct: 228 GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS-HTDVDLYNSKGIPWSNVFSDHSLK 286

Query: 273 VSQEAKTLIKNMLCVDPSERLTIDQVME 300
            ++EA  L+  +L   P ER+   + + 
Sbjct: 287 DAKEAYDLLSALLQYLPEERMKPYEALC 314

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  114 bits (287), Expect = 2e-29
 Identities = 56/222 (25%), Positives = 82/222 (36%), Gaps = 54/222 (24%)

Query: 41  SEVY-----------ALKVLH------DTVKARREVELQLAVG-SHKHIVNIKDVYENIY 82
            +VY           ALK++          + R + E + A      H+V I D  E   
Sbjct: 48  GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE--I 105

Query: 83  NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK 142
           +G   L V M  ++G +L   ++    G      A  I+ +I SA+   H     HRDVK
Sbjct: 106 DGQ--LYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVK 161

Query: 143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP 202
           PEN+L           ++                      L DFG A      K + Q  
Sbjct: 162 PENIL-----------VSADDFAY----------------LVDFGIASATTDEKLT-QLG 193

Query: 203 CY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
               T YY+APE           DI++L  ++Y  L G PP+
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPY 235

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  113 bits (285), Expect = 6e-29
 Identities = 70/334 (20%), Positives = 121/334 (36%), Gaps = 77/334 (23%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DT-----VKARREVELQLAVGSH 68
           + Y    + LG G    V +   K T  + ALK +  +        A REV L L    H
Sbjct: 2   ETYIK-LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSL-LKDLKH 59

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            +IV + D+   I+      LV  E +   +L Q +    +         + + ++   +
Sbjct: 60  ANIVTLHDI---IHTEKSLTLV-FEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLLRGL 113

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
            + H Q + HRD+KP+NLL  +                            G LKL DFG 
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINE---------------------------RGELKLADFGL 146

Query: 189 AKKIVSNKASLQTPCYTP-----YYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           A+       S+ T  Y       +Y  P++L G   Y    D+W +G I Y +  G P F
Sbjct: 147 ARAK-----SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

Query: 243 ------------FSNHG---QAISPGMKNRIRLGQFDFPNP-------EWEHVSQEAKTL 280
                       F   G   +   PG+ +      +++P             +  +   L
Sbjct: 202 PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADL 261

Query: 281 IKNMLCVDPSERLTIDQVMENKWISQFNQVPQTP 314
           +  +L  +   R++ +  M++ +   F  + +  
Sbjct: 262 LTKLLQFEGRNRISAEDAMKHPF---FLSLGERI 292

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  113 bits (284), Expect = 7e-29
 Identities = 78/308 (25%), Positives = 117/308 (37%), Gaps = 77/308 (25%)

Query: 39  KTSEVYALKVLH-DTVK------ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI 91
               + ALK +  D         A RE+ L L    H +IV++ DV     +  RCL ++
Sbjct: 43  SQGRIVALKRIRLDAEDEGIPSTAIREISL-LKELHHPNIVSLIDVI----HSERCLTLV 97

Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
            E M   +L + + + + G   + +  I + ++   +   H   I HRD+KP+NLL    
Sbjct: 98  FEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS- 154

Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP----- 206
                                      G LKL DFG A+        +    YT      
Sbjct: 155 --------------------------DGALKLADFGLARAF-----GIPVRSYTHEVVTL 183

Query: 207 YYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF------------FSNHG---QAI 250
           +Y AP+VL G  KY  S DIWS+G I   ++ G P F            FS  G      
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243

Query: 251 SPGMKNRIRLGQFDFPNP-------EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
            P ++      Q  F                QE   L+ NMLC DP++R++    M + +
Sbjct: 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

Query: 304 ISQFNQVP 311
              F  + 
Sbjct: 304 ---FKDLD 308

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  112 bits (282), Expect = 2e-28
 Identities = 65/311 (20%), Positives = 112/311 (36%), Gaps = 71/311 (22%)

Query: 38  KKTSEVYALK-VLHDTVK------ARREVEL--QLAVGSHKHIVNIKDV-YENIYNGSRC 87
           K      ALK V   T +        REV +   L    H ++V + DV   +  +    
Sbjct: 34  KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           L ++ E +   +L   + +  +          +M ++   + FLH   + HRD+KP+N+L
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 152

Query: 148 YTKPGDGGILKLTDFGDVKPENL--LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYT 205
            T     G +KL DFG      L  +Y+       + LT       +V           T
Sbjct: 153 VTS---SGQIKLADFG------LARIYSFQ-----MALT-----SVVV-----------T 182

Query: 206 PYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF------------FSNHG---QAI 250
            +Y APEVL    Y    D+WS+G I   +    P F                G   +  
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242

Query: 251 SPGMKNRIRLGQFDFPNPE-------WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW 303
            P       L +  F +            + +  K L+   L  +P++R++    + + +
Sbjct: 243 WPRDVA---LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

Query: 304 ISQFNQVPQTP 314
              F  + +  
Sbjct: 300 ---FQDLERCK 307

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  110 bits (278), Expect = 4e-28
 Identities = 71/307 (23%), Positives = 121/307 (39%), Gaps = 79/307 (25%)

Query: 39  KTSEVYALKVLH-DTVK------ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI 91
              E +ALK +  +           RE+ + L    H +IV + DV     +  + L+++
Sbjct: 24  NYGETFALKKIRLEKEDEGIPSTTIREISI-LKELKHSNIVKLYDVI----HTKKRLVLV 78

Query: 92  MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
            E +   +L + +   E G      A   + ++ + I + HD+ + HRD+KP+NLL  + 
Sbjct: 79  FEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR- 135

Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP----- 206
                                      G LK+ DFG A+        +    YT      
Sbjct: 136 --------------------------EGELKIADFGLARAF-----GIPVRKYTHEIVTL 164

Query: 207 YYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF------------FSNHG---QAI 250
           +Y AP+VL G  KY  + DIWS+G I   ++ G P F            F   G      
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224

Query: 251 SPGMKNRIRLGQFDFPNPEWE---------HVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
            P +     L ++D     +E          + +    L+  ML +DP++R+T  Q +E+
Sbjct: 225 WPNVTE---LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281

Query: 302 KWISQFN 308
            +  + N
Sbjct: 282 AYFKENN 288

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  111 bits (280), Expect = 9e-28
 Identities = 78/356 (21%), Positives = 134/356 (37%), Gaps = 89/356 (25%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEK--KTSEVYALKVLHDT---VKARREVELQLAVGS 67
           ++D ++     +G G  G V +   K  K  + YALK +  T   + A RE+ L L    
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIAL-LRELK 76

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECM------HGGELFQRIQQKEDGAFTEREAAIIM 121
           H ++++++ V+  + +  R + ++ +                   K+           ++
Sbjct: 77  HPNVISLQKVF--LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
            +I   I +LH   + HRD+KP N+L    G                        + G +
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGP-----------------------ERGRV 171

Query: 182 KLTDFGFAKKIVSNKASLQTPCY---TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLC 237
           K+ D GFA+   S    L        T +Y APE+L G   Y K+ DIW++G I   LL 
Sbjct: 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231

Query: 238 GFPPFFSNHGQAISPGMKNRIRLGQFD-------FPNPE-WEHVSQ-------------- 275
             P F   H +       N     Q D       FP  + WE + +              
Sbjct: 232 SEPIF---HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN 288

Query: 276 --------------------EAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVP 311
                               +A  L++ +L +DP +R+T +Q M++ +   F + P
Sbjct: 289 TYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY---FLEDP 341

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  109 bits (275), Expect = 9e-28
 Identities = 64/223 (28%), Positives = 92/223 (41%), Gaps = 56/223 (25%)

Query: 41  SEVY-----------ALKVLHD------TVKARREVELQLAVG-SHKHIVNIKDVYENIY 82
           S VY           A+K +            R E E+  +   SH++IV++ DV E   
Sbjct: 25  STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-- 82

Query: 83  NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK 142
                 LV ME + G  L + I+    G  +   A    N+I   IK  HD  I HRD+K
Sbjct: 83  -DDCYYLV-MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIK 138

Query: 143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTP 202
           P+N+L                                 LK+ DFG AK  +S  +  QT 
Sbjct: 139 PQNILID---------------------------SNKTLKIFDFGIAK-ALSETSLTQTN 170

Query: 203 CY--TPYYVAPE-VLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
               T  Y +PE   G +  D+  DI+S+G+++Y +L G PPF
Sbjct: 171 HVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPF 212

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  109 bits (275), Expect = 1e-27
 Identities = 64/322 (19%), Positives = 119/322 (36%), Gaps = 70/322 (21%)

Query: 6   KPFKTTPIQDDYDIS------TEILGLGINGKVLQIVEKKTSEVYALKVLH------DTV 53
           K  +T+    ++DI        E++G G  G+V         EV A++++       D +
Sbjct: 17  KASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EV-AIRLIDIERDNEDQL 73

Query: 54  KA-RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAF 112
           KA +REV        H+++V       +       L +I     G  L+  ++  +    
Sbjct: 74  KAFKREVMA-YRQTRHENVVLFMGACMS----PPHLAIITSLCKGRTLYSVVRDAKI-VL 127

Query: 113 TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY 172
              +   I  EI   + +LH + I H+D+K +N+ Y                        
Sbjct: 128 DVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY------------------------ 163

Query: 173 TKPGDGGILKLTDFGFAK-----KIVSNKASLQTPCYTPYYVAPEVL---------GPDK 218
               D G + +TDFG        +    +  L+       ++APE++             
Sbjct: 164 ----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219

Query: 219 YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAK 278
           + K  D+++LG I Y L     PF +   +AI   M   ++      PN     + +E  
Sbjct: 220 FSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK------PNLSQIGMGKEIS 273

Query: 279 TLIKNMLCVDPSERLTIDQVME 300
            ++      +  ER T  ++M+
Sbjct: 274 DILLFCWAFEQEERPTFTKLMD 295

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  107 bits (270), Expect = 2e-26
 Identities = 75/376 (19%), Positives = 137/376 (36%), Gaps = 93/376 (24%)

Query: 12  PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVKARREVELQLAVGSHKH 70
                Y +  + LG G  G V ++ + ++ + +ALK VL D     RE+++ + V  H +
Sbjct: 4   TSSKKYSL-GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDI-MKVLDHVN 61

Query: 71  IVNIKDVYENIYNGSRCLL----------------------------------VIMECMH 96
           I+ + D +    +                                        VIME + 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120

Query: 97  GGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDG 154
              L + ++   +   +      +I + ++  A+ F+H   I HRD+KP+NLL       
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL------- 173

Query: 155 GILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEV- 213
                     V  ++           LKL DFG AKK++ ++ S+   C + +Y APE+ 
Sbjct: 174 ----------VNSKD---------NTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELM 213

Query: 214 LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG---------------QAISPGMKNRI 258
           LG  +Y  S D+WS+G +   L+ G P F                    +     M    
Sbjct: 214 LGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP-- 271

Query: 259 RLGQFDFPNPE---WEHV-----SQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV 310
              +  FP  +   W  +        A  L++ +L  +P  R+   + M + +       
Sbjct: 272 HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNS 331

Query: 311 PQTPLCTGKMLKEGEE 326
            ++ +        G  
Sbjct: 332 YESEVKNNSNFPHGVN 347

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  105 bits (264), Expect = 4e-26
 Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 28/228 (12%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH----DTVKA-RREVEL--QLAVGSHKHIVNI 74
           E+LG G  G+ +++  ++T EV  +K L     +T +   +EV++   L    H +++  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL---EHPNVLK- 71

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              +  +    + L  I E + GG L   I+   D  +   +      +I S + +LH  
Sbjct: 72  ---FIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHSM 127

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS 194
           NI HRD+   N L     +   + + DFG  +      T+P     LK  D         
Sbjct: 128 NIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY---- 180

Query: 195 NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
                 T    PY++APE++    YD+  D++S G+++  ++      
Sbjct: 181 ------TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  106 bits (266), Expect = 5e-26
 Identities = 77/366 (21%), Positives = 134/366 (36%), Gaps = 81/366 (22%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALK-VLHDTVK------ARREVELQLAVGS 67
             Y+     +G G  G+V +   +KT +  ALK VL +  K      A RE+++ L +  
Sbjct: 17  SKYEK-LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLK 74

Query: 68  HKHIVNIKDV----YENIYNGSRCLLVIMECM-HGGELFQRIQQKEDGAFTEREAAIIMN 122
           H+++VN+ ++              + ++ +   H  +L   +       FT  E   +M 
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--DL-AGLLSNVLVKFTLSEIKRVMQ 131

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL--LYTKPGDGGI 180
            + + + ++H   I HRD+K  N+L T+    G+LKL DFG      L   ++   +   
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFG------LARAFSLAKNSQP 182

Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYIL---- 235
            + T      ++V           T +Y  PE+L G   Y    D+W  G IM  +    
Sbjct: 183 NRYT-----NRVV-----------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

Query: 236 -----------------LCGFP-----PFFSN--HGQAISPGMKNRIRLGQFDFPNPEWE 271
                            LCG       P   N    + +      + ++           
Sbjct: 227 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKD-RLKAYV-- 283

Query: 272 HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWPEV 331
                A  LI  +L +DP++R+  D  + + +   F   P  P     ML     +  E 
Sbjct: 284 -RDPYALDLIDKLLVLDPAQRIDSDDALNHDF---FWSDPM-PSDLKGMLSTHLTSMFEY 338

Query: 332 QDEMTR 337
                R
Sbjct: 339 LAPPRR 344

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  104 bits (261), Expect = 8e-26
 Identities = 60/314 (19%), Positives = 114/314 (36%), Gaps = 65/314 (20%)

Query: 12  PIQDDYDIS------TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA---------- 55
           P      ++       + +G G  G V +    K   V A+K L                
Sbjct: 9   PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68

Query: 56  --RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
             +REV + ++  +H +IV +  +  N         ++ME +  G+L+ R+   +     
Sbjct: 69  EFQREVFI-MSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLL-DKAHPIK 120

Query: 114 EREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
                 +M +I   I+++ +QN  I HRD++  N+                       L 
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF----------------------LQ 158

Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLG 229
                     K+ DFG +++ V + + L        ++APE +G   + Y +  D +S  
Sbjct: 159 SLDENAPVCAKVADFGLSQQSVHSVSGL---LGNFQWMAPETIGAEEESYTEKADTYSFA 215

Query: 230 VIMYILLCGFPPFFSNHGQAISPGM---KNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC 286
           +I+Y +L G  PF       I       +  +R      P    E      + +I+    
Sbjct: 216 MILYTILTGEGPFDEYSYGKIKFINMIREEGLRP---TIP----EDCPPRLRNVIELCWS 268

Query: 287 VDPSERLTIDQVME 300
            DP +R     +++
Sbjct: 269 GDPKKRPHFSYIVK 282

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  103 bits (259), Expect = 1e-25
 Identities = 40/221 (18%), Positives = 81/221 (36%), Gaps = 39/221 (17%)

Query: 87  CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENL 146
            L ++ +   G  L+  +   E   F  ++   I  +    + +LH ++I HRD+K  N+
Sbjct: 93  QLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNI 151

Query: 147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA--KKIVSNKASLQTPCY 204
                                         +   +K+ DFG A  K   S     +    
Sbjct: 152 FL---------------------------HEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184

Query: 205 TPYYVAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPPF--FSNHGQAISPGMKNRIR 259
           +  ++APEV+     + Y    D+++ G+++Y L+ G  P+   +N  Q I    +  + 
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244

Query: 260 LGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
                       +  +  K L+   L     ER +  +++ 
Sbjct: 245 PDLSKVR----SNCPKRMKRLMAECLKKKRDERPSFPRILA 281

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  103 bits (260), Expect = 1e-25
 Identities = 66/310 (21%), Positives = 124/310 (40%), Gaps = 58/310 (18%)

Query: 8   FKTTPIQDDYDIS------TEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKA 55
           F+     DD DI        E +G G  G V +     + +V A+K+L       + V  
Sbjct: 23  FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGS-DV-AVKILMEQDFHAERVNE 80

Query: 56  -RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDG-AFT 113
             REV + +    H +IV               L ++ E +  G L++ + +        
Sbjct: 81  FLREVAI-MKRLRHPNIVLFMGAV----TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135

Query: 114 EREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
           ER    +  ++   + +LH++N  I HR++K  NLL                        
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---------------------- 173

Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI 231
                    +K+ DFG ++   S   S ++   TP ++APEVL  +  ++  D++S GVI
Sbjct: 174 -----KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228

Query: 232 MYILLCGFPPFFS-NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPS 290
           ++ L     P+ + N  Q ++       RL   + P     +++ +   +I+     +P 
Sbjct: 229 LWELATLQQPWGNLNPAQVVAAVGFKCKRL---EIP----RNLNPQVAAIIEGCWTNEPW 281

Query: 291 ERLTIDQVME 300
           +R +   +M+
Sbjct: 282 KRPSFATIMD 291

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (260), Expect = 3e-25
 Identities = 80/336 (23%), Positives = 124/336 (36%), Gaps = 85/336 (25%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----DTVK------ARREVELQLA 64
             Y+   + LG G    V +  +K T+++ A+K +        K      A RE++L L 
Sbjct: 10  KRYEK-LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL-LQ 67

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
             SH +I+ + D      + S   LV  + M   +L + I +      T       M   
Sbjct: 68  ELSHPNIIGLLDA---FGHKSNISLV-FDFMET-DL-EVIIKDNSLVLTPSHIKAYMLMT 121

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              +++LH   I HRD+KP NLL  +                            G+LKL 
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDE---------------------------NGVLKLA 154

Query: 185 DFGFAKKIVSNKASLQTPCYTP-----YYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCG 238
           DFG AK             YT      +Y APE+L G   Y    D+W++G I+  LL  
Sbjct: 155 DFGLAKSF-----GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

Query: 239 FPPF------------FSNHG---QAISPGMKNRIRLGQF----DFPNPEWEHV----SQ 275
            P              F   G   +   P M +   L  +     FP     H+      
Sbjct: 210 VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS---LPDYVTFKSFPGIPLHHIFSAAGD 266

Query: 276 EAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVP 311
           +   LI+ +   +P  R+T  Q ++ K+   F+  P
Sbjct: 267 DLLDLIQGLFLFNPCARITATQALKMKY---FSNRP 299

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  101 bits (255), Expect = 3e-25
 Identities = 44/292 (15%), Positives = 96/292 (32%), Gaps = 57/292 (19%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA-------RREVELQLAVGSHKHIVNI 74
             L    +G++ +   +   ++  +KVL     +         E    L + SH +++ +
Sbjct: 16  TKLNENHSGELWKGRWQGN-DI-VVKVLKVRDWSTRKSRDFNEECPR-LRIFSHPNVLPV 72

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
               ++         +I   M  G L+  + +  +    + +A     ++   + FLH  
Sbjct: 73  LGACQSPPAPHPT--LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 135 N--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I    +   +++                             +    +++        
Sbjct: 131 EPLIPRHALNSRSVMID---------------------------EDMTARISMADVKFSF 163

Query: 193 VSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPPFFS-NHGQ 248
            S         Y P +VAPE L     D   +S D+WS  V+++ L+    PF   ++ +
Sbjct: 164 QSP-----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME 218

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
                    +R      P      +S     L+K  +  DP++R   D ++ 
Sbjct: 219 IGMKVALEGLRP---TIP----PGISPHVSKLMKICMNEDPAKRPKFDMIVP 263

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  103 bits (259), Expect = 1e-24
 Identities = 73/350 (20%), Positives = 141/350 (40%), Gaps = 83/350 (23%)

Query: 4   TFKPFKTT-PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK----VLHDTVKAR-- 56
           + +   +T  +   Y    + +G G  G V    +       A+K       +   A+  
Sbjct: 50  SVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 108

Query: 57  -REVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
            RE+ L +   +HK+I+++ +V+  +      + + ++ME M    L Q IQ +      
Sbjct: 109 YRELVL-MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME----LD 162

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
               + ++ ++   IK LH   I HRD+KP N++                          
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-------------------- 202

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVI 231
                  LK+ DFG A+   ++     TP Y  T YY APEV+    Y ++ DIWS+G I
Sbjct: 203 -------LKILDFGLARTAGTSFMM--TP-YVVTRYYRAPEVILGMGYKENVDIWSVGCI 252

Query: 232 MYILLCGFPPFFSNH------------G-------QAISPGMKNRIR-LGQFD------- 264
           M  ++     F                G       + + P ++N +    ++        
Sbjct: 253 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 312

Query: 265 FPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
           FP+          +  + +A+ L+  ML +DP++R+++D  +++ +I+ +
Sbjct: 313 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  102 bits (256), Expect = 1e-24
 Identities = 72/350 (20%), Positives = 139/350 (39%), Gaps = 83/350 (23%)

Query: 4   TFKPFKTT-PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK----VLHDTVKAR-- 56
           + +   +T  +   Y    + +G G  G V    +       A+K       +   A+  
Sbjct: 13  SVEIGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA 71

Query: 57  -REVELQLAVGSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
            RE+ L +   +HK+I+ + +V+  +      + + ++ME M    L Q IQ +      
Sbjct: 72  YRELVL-MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME----LD 125

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
               + ++ ++   IK LH   I HRD+KP N++                          
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-------------------- 165

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVI 231
                  LK+ DFG A+   ++     TP Y  T YY APEV+    Y ++ DIWS+G I
Sbjct: 166 -------LKILDFGLARTAGTSFMM--TP-YVVTRYYRAPEVILGMGYKENVDIWSVGCI 215

Query: 232 MYILLCGFPPFFSNHG-------------------QAISPGMKNRIR-LGQFD------- 264
           M  ++ G   F                        + + P ++  +    ++        
Sbjct: 216 MGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 275

Query: 265 FPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
           FP+          +  + +A+ L+  ML +D S+R+++D+ +++ +I+ +
Sbjct: 276 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  101 bits (253), Expect = 2e-24
 Identities = 71/343 (20%), Positives = 131/343 (38%), Gaps = 87/343 (25%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK--VLHDTVKAR---REVELQLAVGS 67
           +   Y    + LG G NG V   V+    +  A+K  VL D    +   RE+++ +    
Sbjct: 9   LGSRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKI-IRRLD 66

Query: 68  HKHIVNIKDVYENIYNGSRCLL----------VIMECMHGGELFQRIQQKEDGAFTEREA 117
           H +IV + ++     +     +          ++ E M   +L   ++Q   G   E  A
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ---GPLLEEHA 122

Query: 118 AIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
            + M ++   +K++H  N+ HRD+KP NL                  +  E+L+      
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLF-----------------INTEDLV------ 159

Query: 178 GGILKLTDFGFAKKIVSNKASLQTPCYTPY-----YVAPEV-LGPDKYDKSCDIWSLGVI 231
              LK+ DFG A+ +  + +       +       Y +P + L P+ Y K+ D+W+ G I
Sbjct: 160 ---LKIGDFGLARIMDPHYSH--KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 214

Query: 232 MYILLCGFPPFFSNH------------G-------QAISPGMKNRIR-LGQFD------- 264
              +L G   F   H                    Q +   +   IR             
Sbjct: 215 FAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQL 274

Query: 265 FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            P      +S+EA   ++ +L   P +RLT ++ + + ++S +
Sbjct: 275 LPG-----ISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  101 bits (253), Expect = 2e-24
 Identities = 77/354 (21%), Positives = 134/354 (37%), Gaps = 98/354 (27%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK----VLHDTVKAR---REVELQLAV 65
           +   Y      +G G  G V   ++K++ E  A+K         + A+   RE+ L L  
Sbjct: 22  LPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL-LKH 79

Query: 66  GSHKHIVNIKDV---------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTERE 116
             H++++ + DV         + + Y       ++M  M   +L + +  K    F+E +
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFY-------LVMPFM-QTDLQKIMGLK----FSEEK 127

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
              ++ ++   +K++H   + HRD+KP NL   +  +                       
Sbjct: 128 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE----------------------- 164

Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCY--TPYYVAPEV-LGPDKYDKSCDIWSLGVIMY 233
               LK+ DFG A+   +      T  Y  T +Y APEV L    Y+++ DIWS+G IM 
Sbjct: 165 ----LKILDFGLARHADAEM----TG-YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215

Query: 234 ILLCGFPPF----FSNHGQAI----------------SPGMKNRIR-LGQFD-------F 265
            +L G   F    + +    I                    K+ I+ L Q         F
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 275

Query: 266 PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGK 319
           P       S +A  L++ ML +D  +RLT  Q + + +   F    +       
Sbjct: 276 PR-----ASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP 324

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 99.4 bits (248), Expect = 5e-24
 Identities = 64/319 (20%), Positives = 105/319 (32%), Gaps = 84/319 (26%)

Query: 33  LQIVEKKTS----EVY---------ALKVL--HDTVKARREVEL-QLAVGSHKHIVNIKD 76
           + ++E        EV+         A+K+    D     RE EL    +  H++I+    
Sbjct: 10  ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-- 134
                 + S  L +I      G L+  +Q              I+  I S +  LH +  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 135 ------NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
                  IAHRD+K +N+L                 VK            G   + D G 
Sbjct: 127 GTQGKPAIAHRDLKSKNIL-----------------VK----------KNGQCCIADLGL 159

Query: 189 AKKIVSNKASLQTPCY----TPYYVAPEVL------GPDKYDKSCDIWSLGVIMYILLCG 238
           A     +   L         T  Y+APEVL            K  DIW+ G++++ +   
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

Query: 239 F----------PPFFSNHGQAISPGM------KNRIRLGQFDFPNPEWEHVSQEA-KTLI 281
                      PPF+       S          ++ R    + PN  +   +  +   L+
Sbjct: 220 MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP---NIPNRWFSDPTLTSLAKLM 276

Query: 282 KNMLCVDPSERLTIDQVME 300
           K     +PS RLT  ++ +
Sbjct: 277 KECWYQNPSARLTALRIKK 295

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 98.5 bits (246), Expect = 8e-24
 Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 51/292 (17%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA---------RREVELQLAVGSHKHIV 72
           EI+G+G  GKV +       EV A+K                 R+E +L  A+  H +I+
Sbjct: 13  EIIGIGGFGKVYRAFWIGD-EV-AVKAARHDPDEDISQTIENVRQEAKL-FAMLKHPNII 69

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            ++ V          L ++ME   GG L + +  K               +I   + +LH
Sbjct: 70  ALRGVCLK----EPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLH 122

Query: 133 DQN---IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           D+    I HRD+K  N+L  +  + G                        ILK+TDFG A
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENG-------------------DLSNKILKITDFGLA 163

Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
           +    ++ +  +      ++APEV+    + K  D+WS GV+++ LL G  PF    G A
Sbjct: 164 R--EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221

Query: 250 ISPGMKNR-IRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           ++ G+    + L     P P      +    L+++    DP  R +   +++
Sbjct: 222 VAYGVAMNKLAL-----PIPST--CPEPFAKLMEDCWNPDPHSRPSFTNILD 266

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 99.7 bits (249), Expect = 9e-24
 Identities = 70/341 (20%), Positives = 127/341 (37%), Gaps = 63/341 (18%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK----ARREVE----LQLA 64
           + + + +    +G G  G+VL        + YA+KV+ +  K    A+ E +    +Q  
Sbjct: 33  LNNAFLV-IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND 91

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
             ++ +IV     +   Y    CL  I E + G  L++ I +     F   +  +   EI
Sbjct: 92  DINNNNIVKYHGKFM--YYDHMCL--IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEI 146

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
             A+ +L   ++ H D+KPEN+L   P       +T       + +   +    GI KL 
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDP-YFEKSLITVRRVTDGKKIQIYRTKSTGI-KLI 204

Query: 185 DFG---FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP 241
           DFG   F      +  +      T  Y APEV+    +D S D+WS G ++  L  G   
Sbjct: 205 DFGCATFKSDYHGSIIN------TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258

Query: 242 F--FSNHGQ---------AISPGM--KNRIRLGQFDFPNPEWEHVSQEAKT--------- 279
           F    +             I   M  +     G       E +    E  +         
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318

Query: 280 ----------------LIKNMLCVDPSERLTIDQVMENKWI 304
                            + ++L +DP+ R +  +++++K++
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 78/363 (21%), Positives = 145/363 (39%), Gaps = 78/363 (21%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK----VLHDTVKAR---REVELQLAV 65
           +   Y++  + LG G  G V + ++++T EV A+K       ++  A+   RE+ +   +
Sbjct: 7   VLRKYEL-VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65

Query: 66  GSHKHIVNIKDV-----YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
             H++IVN+ +V       ++Y       ++ + M   +L   I+              +
Sbjct: 66  SGHENIVNLLNVLRADNDRDVY-------LVFDYM-ETDLHAVIRANI---LEPVHKQYV 114

Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL--LYTKPGDG 178
           + ++   IK+LH   + HRD+KP N+L         +K+ DFG      L   +      
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH---VKVADFG------LSRSFVNIRRV 165

Query: 179 GILKLTDFGFAKKIVSNKASLQTPCY--TPYYVAPEV-LGPDKYDKSCDIWSLGVIMYIL 235
                       +   +   + T  Y  T +Y APE+ LG  KY K  D+WSLG I+  +
Sbjct: 166 TNNIPLSINENTENFDDDQPILTD-YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

Query: 236 LCGFPPF---------------------------FSNHGQAI--SPGMKNRIRLGQFDFP 266
           LCG P F                            S   + +  S   K  IR       
Sbjct: 225 LCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDI 284

Query: 267 NPEWE----------HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
             +W+            ++EA  L+  +L  +P++R++ +  +++ ++S F+   + P C
Sbjct: 285 FTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNC 344

Query: 317 TGK 319
              
Sbjct: 345 DHI 347

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 71/335 (21%), Positives = 133/335 (39%), Gaps = 83/335 (24%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK----VLHDTVKAR---REVELQLAV 65
           ++  Y    + +G G  G V   V+ +T    A+K         + A+   RE+ L L  
Sbjct: 23  VRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL-LKH 80

Query: 66  GSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
             H++++ + DV+  +   +      ++M  M G +L + ++ ++     E     ++ +
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQ 136

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +   ++++H   I HRD+KP NL   +  +                           LK+
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCE---------------------------LKI 169

Query: 184 TDFGFAKKIVSNKASLQTPCY--TPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFP 240
            DFG A++  S      T  Y  T +Y APEV L   +Y ++ DIWS+G IM  ++ G  
Sbjct: 170 LDFGLARQADSEM----TG-YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

Query: 241 PF----FSNHGQAI----------------SPGMKNRIR-LGQFD-------FPNPEWEH 272
            F      +  + I                S   KN ++ L + +         N     
Sbjct: 225 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN----- 279

Query: 273 VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            S  A  L++ ML +D  +R+T  + + + +    
Sbjct: 280 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 97.3 bits (243), Expect = 7e-23
 Identities = 80/349 (22%), Positives = 133/349 (38%), Gaps = 99/349 (28%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK---VLHDTVKAR---REVELQLAVG 66
           I  D+ +   +LG G  G V     K T E+ A+K        + A    RE+++ L   
Sbjct: 9   ISSDFQL-KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI-LKHF 66

Query: 67  SHKHIVNIKDV--------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
            H++I+ I ++        +  +Y       +I E M   +L + I  +     ++    
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVY-------IIQELM-QTDLHRVISTQM---LSDDHIQ 115

Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             + +   A+K LH  N+ HRD+KP NLL     D                         
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD------------------------- 150

Query: 179 GILKLTDFGFAKKIVSNKASLQTPCY-----TPY-----YVAPEV-LGPDKYDKSCDIWS 227
             LK+ DFG A+ I  + A    P         +     Y APEV L   KY ++ D+WS
Sbjct: 151 --LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWS 208

Query: 228 LGVIMYILLCGFPPF----FSNHGQAI-----------------SPGMKNRIR-LGQFD- 264
            G I+  L    P F    + +    I                 SP  +  I+ L  +  
Sbjct: 209 CGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268

Query: 265 ------FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
                 FP      V+ +   L++ ML  DP++R+T  + +E+ ++  +
Sbjct: 269 APLEKMFPR-----VNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 97.4 bits (243), Expect = 8e-23
 Identities = 75/342 (21%), Positives = 132/342 (38%), Gaps = 97/342 (28%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK----VLHDTVKAR---REVELQLAV 65
           + + Y      +G G  G V    + KT    A+K         + A+   RE+ L L  
Sbjct: 27  VPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL-LKH 84

Query: 66  GSHKHIVNIKDV---------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTERE 116
             H++++ + DV         + ++Y       ++   M G +L   ++ ++    T+  
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLM-GADLNNIVKCQK---LTDDH 133

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
              ++ +I   +K++H  +I HRD+KP NL   +  +                       
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE----------------------- 170

Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCY--TPYYVAPEV-LGPDKYDKSCDIWSLGVIMY 233
               LK+ DFG A+          T  Y  T +Y APE+ L    Y+++ DIWS+G IM 
Sbjct: 171 ----LKILDFGLARHTADEM----TG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221

Query: 234 ILLCGFPPF----FSNHGQAI----------------SPGMKNRIR-LGQFD-------F 265
            LL G   F      +  + I                S   +N I+ L Q         F
Sbjct: 222 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 281

Query: 266 PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
                   +  A  L++ ML +D  +R+T  Q + + + +Q+
Sbjct: 282 IG-----ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 97.0 bits (242), Expect = 8e-23
 Identities = 64/346 (18%), Positives = 116/346 (33%), Gaps = 93/346 (26%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR---------------- 56
           +Q  Y +    +  G  G V   V+ +   V A+K + +TV                   
Sbjct: 20  MQSPYTV-QRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 57  REVELQLAVGSHKHIVNIKDV--------YENIYNGSRCLLVIMECMHGGELFQRIQQKE 108
           RE+ L L    H +I+ ++D+           +Y       ++ E M   +L  ++   +
Sbjct: 78  REIRL-LNHFHHPNILGLRDIFVHFEEPAMHKLY-------LVTELM-RTDL-AQVIHDQ 127

Query: 109 DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE 168
               + +     M  I   +  LH+  + HRD+ P N+L     D               
Sbjct: 128 RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--------------- 172

Query: 169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY--TPYYVAPEV-LGPDKYDKSCDI 225
                       + + DF  A++  ++        Y    +Y APE+ +    + K  D+
Sbjct: 173 ------------ITICDFNLAREDTADANKTH---YVTHRWYRAPELVMQFKGFTKLVDM 217

Query: 226 WSLGVIMYILLCGFPPF----FSNHGQAI----------------SPGMKNRIRLGQFDF 265
           WS G +M  +      F    F N    I                SP  ++ +R    + 
Sbjct: 218 WSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277

Query: 266 PNPEWE----HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
           P   W          A  LI  ML  +P  R++ +Q + + +    
Sbjct: 278 PARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 72/355 (20%), Positives = 128/355 (36%), Gaps = 95/355 (26%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK---VLHDTVKAR---REVELQLAVG 66
           +   Y      +G G  G V    +       A+K           +   RE+++ L   
Sbjct: 25  VGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI-LLRF 82

Query: 67  SHKHIVNIKDV--------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
            H++I+ I D+         +++Y       ++ + M   +L++ ++ +     +     
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVY-------IVQDLM-ETDLYKLLKTQH---LSNDHIC 131

Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
             + +I   +K++H  N+ HRD+KP NLL     D                         
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD------------------------- 166

Query: 179 GILKLTDFGFAKKIVSNKASLQTPCYTPY-----YVAPEV-LGPDKYDKSCDIWSLGVIM 232
             LK+ DFG A+    +     T   T Y     Y APE+ L    Y KS DIWS+G I+
Sbjct: 167 --LKICDFGLARVADPDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222

Query: 233 YILLCGFPPFFSNH--------------------GQAISPGMKNRIR-LGQFD------- 264
             +L   P F   H                       I+   +N +  L   +       
Sbjct: 223 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 282

Query: 265 FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGK 319
           FPN        +A  L+  ML  +P +R+ ++Q + + ++ Q+      P+    
Sbjct: 283 FPN-----ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP 332

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 69/344 (20%), Positives = 134/344 (38%), Gaps = 71/344 (20%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVE-KKTSEVYALKVLHDTVK----ARREVELQLAVGS 67
           +Q+ Y+I    LG G  GKV++ ++  +     ALK++ +  K    AR E+ +   +  
Sbjct: 17  LQERYEI-VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKE 75

Query: 68  H-----KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                    V + D +   ++G  C+    E + G   F+ +++     +       +  
Sbjct: 76  KDKENKFLCVLMSDWFN--FHGHMCI--AFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 130

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++C A++FLH+  + H D+KPEN+L+       +       + K          +  I +
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK-------SVKNTSI-R 182

Query: 183 LTDFG---FAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG 238
           + DFG   F  +  +   +      T +Y  PEV L    + + CD+WS+G I++    G
Sbjct: 183 VADFGSATFDHEHHTTIVA------TRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRG 235

Query: 239 FPPF--FSNHGQ---------AISPGM-KNRIRLGQFDFPNPEWEHVSQEAKT------- 279
           F  F    N             I   M     +   F      W+  S + +        
Sbjct: 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP 295

Query: 280 -----------------LIKNMLCVDPSERLTIDQVMENKWISQ 306
                            L++ ML  DP++R+T+ + + + + + 
Sbjct: 296 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 57/317 (17%), Positives = 109/317 (34%), Gaps = 73/317 (23%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVEL-QLAVGSHKHIVNIKDVY 78
           E +G G  G+V +  + +  EV A+K+     +    RE E+ Q  +  H++I+      
Sbjct: 48  ESIGKGRFGEVWR-GKWRGEEV-AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105

Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ---- 134
                    L ++ +    G LF  + +      T      +     S +  LH +    
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 135 ----NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
                IAHRD+K +N+L                 VK            G   + D G A 
Sbjct: 163 QGKPAIAHRDLKSKNIL-----------------VK----------KNGTCCIADLGLAV 195

Query: 191 KIVSNKASLQTPCY----TPYYVAPEVL------GPDKYDKSCDIWSLGVIMYILLCGF- 239
           +  S   ++         T  Y+APEVL         +  K  DI+++G++ + +     
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255

Query: 240 ---------PPFFSNHGQAISPGM------KNRIRLGQFDFPNPEWEH-VSQEAKTLIKN 283
                     P++       S         + ++R    + PN        +    +++ 
Sbjct: 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP---NIPNRWQSCEALRVMAKIMRE 312

Query: 284 MLCVDPSERLTIDQVME 300
               + + RLT  ++ +
Sbjct: 313 CWYANGAARLTALRIKK 329

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 62/324 (19%), Positives = 107/324 (33%), Gaps = 84/324 (25%)

Query: 28  INGKVLQIVEKKTS----EVY---------ALKVLHDTVKA--RREVE-LQLAVGSHKHI 71
              K +Q+V++       EV+         A+KV   T +A   RE E  Q  +  H++I
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENI 93

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           +               L +I +    G L+  ++         +    +     S +  L
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHL 150

Query: 132 HDQN--------IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           H +         IAHRD+K +N+L                 VK            G   +
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNIL-----------------VK----------KNGTCCI 183

Query: 184 TDFGFAKKIVSNKASLQTPCY----TPYYVAPEVLGPD------KYDKSCDIWSLGVIMY 233
            D G A K +S+   +  P      T  Y+ PEVL         +     D++S G+I++
Sbjct: 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

Query: 234 ILLCGF----------PPFFSNHGQAISPGM------KNRIRLGQFDFPNPEWEH-VSQE 276
            +               P+        S           ++R     FPN        ++
Sbjct: 244 EVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP---SFPNRWSSDECLRQ 300

Query: 277 AKTLIKNMLCVDPSERLTIDQVME 300
              L+      +P+ RLT  +V +
Sbjct: 301 MGKLMTECWAHNPASRLTALRVKK 324

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 70/347 (20%), Positives = 136/347 (39%), Gaps = 71/347 (20%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKT-SEVYALKVLHDTVK----ARREVELQLAVGS 67
           +   Y+I  + LG G  GKV++ ++ K      A+K++ +  +    AR E+++   + +
Sbjct: 12  LSARYEI-VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNT 70

Query: 68  H-----KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
                    V + + +E  ++G  C+  + E + G   +  I++     F       +  
Sbjct: 71  TDPNSTFRCVQMLEWFE--HHGHICI--VFELL-GLSTYDFIKENGFLPFRLDHIRKMAY 125

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           +IC ++ FLH   + H D+KPEN+L+ +             D +          +  I K
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER-------TLINPDI-K 177

Query: 183 LTDFG---FAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCG 238
           + DFG   +  +  S   S      T +Y APEV L    + + CD+WS+G I+     G
Sbjct: 178 VVDFGSATYDDEHHSTLVS------TRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLG 230

Query: 239 FPPF--FSNHGQ---------AISPGM-KNRIRLGQFDFPNPEWEHVSQEAKT------- 279
           F  F    +             +   M +   +   F     +W+  S   +        
Sbjct: 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP 290

Query: 280 -----------------LIKNMLCVDPSERLTIDQVMENKWISQFNQ 309
                            LI+ ML  DP++R+T+ + +++ +     +
Sbjct: 291 LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 94.8 bits (236), Expect = 9e-22
 Identities = 70/363 (19%), Positives = 138/363 (38%), Gaps = 98/363 (26%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK----ARREVELQLAVGSH 68
           +   Y++  +++G G  G+V++  + K  +  ALK++ +  +    A  E+ +   +   
Sbjct: 95  VAYRYEV-LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQ 153

Query: 69  -----KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
                 +++++ + +   +    C+    E +    L++ I++ +   F+        + 
Sbjct: 154 DKDNTMNVIHMLENF--TFRNHICM--TFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN-LLYTKPGDGGILK 182
           I   +  LH   I H D+KPEN+L  + G  GI K+ DFG    E+  +YT         
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGI-KVIDFGSSCYEHQRVYT--------- 258

Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP-- 240
                     +           + +Y APEV+   +Y    D+WSLG I+  LL G+P  
Sbjct: 259 ---------YIQ----------SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299

Query: 241 -------------------------------PFFSNHGQ-------------AISPGMKN 256
                                           F S+ G               +  G ++
Sbjct: 300 PGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRS 359

Query: 257 RIRLGQFDFPNPEWEHVSQEAKT-----LIKNMLCVDPSERLTIDQVMENKWISQFNQVP 311
           R    +    + EW +  +          +K  L  DP+ R+T  Q + + W+ +  ++P
Sbjct: 360 RRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR--RLP 417

Query: 312 QTP 314
           + P
Sbjct: 418 KPP 420

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 92.9 bits (231), Expect = 9e-22
 Identities = 35/257 (13%), Positives = 60/257 (23%), Gaps = 74/257 (28%)

Query: 45  ALKVLH------DTVKARREVELQLAVG-SHKHIVNIKDVYENIYNGSRCLLVIMECMHG 97
           AL  +       D V                  +  + DV       +  L+V  E + G
Sbjct: 60  ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT---RAGGLVV-AEWIRG 115

Query: 98  GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL 157
           G L +      D + +   A   M  + +A    H   +A     P  +           
Sbjct: 116 GSLQEVA----DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVR---------- 161

Query: 158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD 217
            ++  GDV                 L                         +        
Sbjct: 162 -VSIDGDVV----------------LAYPA--------------------TMPDA----- 179

Query: 218 KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEH--VSQ 275
             +   DI  +G  +Y LL    P        +  G+    R        P      +  
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPL---PEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 276 EAKTLIKNMLCVDPSER 292
           +   +    +  D   R
Sbjct: 235 QISAVAARSVQGDGGIR 251

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 78/399 (19%), Positives = 140/399 (35%), Gaps = 103/399 (25%)

Query: 2   TPTFKPFKTT-PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK----VLHDTVKAR 56
           T +     +   I D Y+I   ++G G  G V +  +K    V A+K    V  D +  +
Sbjct: 39  TASMPRPHSDWQIPDRYEI-RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK 97

Query: 57  ---REVELQLAVGSHKHIVNIKDV--------YENIYNGSRCLLVIMECMHGGELFQRIQ 105
              RE+ + L   +H H+V + D+        ++ +Y       V++E     +  +  +
Sbjct: 98  RILREIAI-LNRLNHDHVVKVLDIVIPKDVEKFDELY-------VVLEIA-DSDFKKLFR 148

Query: 106 QKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV 165
                  TE     ++  +   +K++H   I HRD+KP N L  +      +K+ DFG  
Sbjct: 149 TPVY--LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS---VKVCDFG-- 201

Query: 166 KPENLL-----YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY-----YVAPEV-L 214
                L     Y + G+  +           +            T +     Y APE+ L
Sbjct: 202 -----LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256

Query: 215 GPDKYDKSCDIWSLGVIMYILLCG--------------FP-----PFFSNHGQAISPGMK 255
             + Y ++ D+WS+G I   LL                FP     P   +          
Sbjct: 257 LQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFH 316

Query: 256 NRIRLGQFDF-------PNPE-WEHV-SQEAKT--------------------------L 280
            R    Q +        P+ E  E +  ++AK                           L
Sbjct: 317 TRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHL 376

Query: 281 IKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGK 319
           +K ML  +P++R+TI++ + + +  +          T K
Sbjct: 377 LKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEK 415

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 67/360 (18%), Positives = 116/360 (32%), Gaps = 86/360 (23%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREVELQLAVGS-------HKHIV 72
           LG G    V    + +  +  A+KV+    H T  A  E+ L  +V +        + +V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 73  NIKDVYE-NIYNGS-RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
            + D ++ +  NG+  C+  + E + G  L + I +             I+ ++   + +
Sbjct: 105 QLLDDFKISGVNGTHICM--VFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161

Query: 131 LHDQ-NIAHRDVKPENLL----------------------YTKPGDGGILKLTDFGDVKP 167
           LH +  I H D+KPEN+L                         P    +           
Sbjct: 162 LHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221

Query: 168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWS 227
            N L  K  +   +K+ D G A               T  Y + EVL    Y+   DIWS
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWS 278

Query: 228 LGVIMYILLCGFPPF---------------------------------------FSNHGQ 248
              + + L  G   F                                       F+  G 
Sbjct: 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAK---TLIKNMLCVDPSERLTIDQVMENKWIS 305
                      L  F+    ++E   +EA      +  ML + P +R T  + + + W++
Sbjct: 339 LKHITKLKPWGL--FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 92.1 bits (229), Expect = 6e-21
 Identities = 62/352 (17%), Positives = 113/352 (32%), Gaps = 95/352 (26%)

Query: 17  YDISTEILGLGINGKVLQIVEKKTSEVYALKVL----HDTVKARREVEL----------Q 62
           Y +    LG G    V    +   +   A+K++      T  A  E++L          +
Sbjct: 21  YIL-VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 63  LAVGSHKHIVNIKD--VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
                  HI+ + D   ++        +  + E + G  L   I++ E           I
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVM--VFEVL-GENLLALIKKYEHRGIPLIYVKQI 136

Query: 121 MNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
             ++   + ++H +  I H D+KPEN+L                           P +  
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV---------------------DSPENLI 175

Query: 180 ILKLTDFG---FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
            +K+ D G   +  +  +N         T  Y +PEVL    +    DIWS   +++ L+
Sbjct: 176 QIKIADLGNACWYDEHYTNSIQ------TREYRSPEVLLGAPWGCGADIWSTACLIFELI 229

Query: 237 CG---FPP------------------------------------FFSNHGQAISPGMKNR 257
            G   F P                                    FF++ G   +      
Sbjct: 230 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 289

Query: 258 IRLGQFDFPNPEWEHVSQEAKT---LIKNMLCVDPSERLTIDQVMENKWISQ 306
             L   D    +++    EAK     +  ML +DP +R     ++ + W+  
Sbjct: 290 WPLE--DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 71/379 (18%), Positives = 131/379 (34%), Gaps = 94/379 (24%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALK----VLHDTVKAR---REVELQLAV 65
           + D+Y I   ++G G  G V    +K T +  A+K    +  D +  +   RE+ + L  
Sbjct: 24  VPDNYII-KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITI-LNR 81

Query: 66  GSHKHIVNIKDV--------YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREA 117
               +I+ + D+        ++ +Y       +++E     +L +  +       TE   
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELY-------IVLEIA-DSDLKKLFKTPIF--LTEEHI 131

Query: 118 AIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
             I+  +     F+H+  I HRD+KP N L  +      +K+ DFG       L      
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS---VKVCDFG-------LARTINS 181

Query: 178 GGILKLTDFGFAKKIVSNKASLQTPCYTPY-----YVAPEV-LGPDKYDKSCDIWSLGVI 231
                + +     +             T +     Y APE+ L  + Y KS DIWS G I
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241

Query: 232 MYILLCGFP----------PFFSNHGQAISPGMKNRIRLGQFDF-------------PNP 268
              LL              P F           +N  ++ +                P  
Sbjct: 242 FAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE 301

Query: 269 E------------------------WE----HVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           +                         +     +S +   L+++ML  +P++R+TIDQ ++
Sbjct: 302 DDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361

Query: 301 NKWISQFNQVPQTPLCTGK 319
           + ++    +       T K
Sbjct: 362 HPYLKDVRKKKLENFSTKK 380

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 66/362 (18%), Positives = 119/362 (32%), Gaps = 103/362 (28%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK----ARREVEL-----QL 63
             D Y+I   ++G G  G+V++  ++   E  A+K++ +       A+ EV L     + 
Sbjct: 52  WMDRYEI-DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH 110

Query: 64  AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
                 +IV++K  +   +    CL  + E +    L+  ++       +         +
Sbjct: 111 DTEMKYYIVHLKRHFM--FRNHLCL--VFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 124 ICSAIKFLHDQ--NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
           +C+A+ FL     +I H D+KPEN+L   P    I                         
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAI------------------------- 200

Query: 182 KLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL----- 235
           K+ DFG + ++       +Q+     +Y +PEVL    YD + D+WSLG I+  +     
Sbjct: 201 KIVDFGSSCQLGQRIYQYIQSR----FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256

Query: 236 ----------------LCGFPP------------FFSNHGQAISPGM------------- 254
                           + G PP            FF                        
Sbjct: 257 LFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPG 316

Query: 255 ----KNRIRLGQFDFPNPEWEHVSQEAKT------LIKNMLCVDPSERLTIDQVMENKWI 304
                N + +                         LI  ML  DP  R+     +++ + 
Sbjct: 317 TRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376

Query: 305 SQ 306
            +
Sbjct: 377 KK 378

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 85.5 bits (212), Expect = 6e-19
 Identities = 59/314 (18%), Positives = 106/314 (33%), Gaps = 67/314 (21%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA--RREVELQLAVG-SHKHIVNIKDVY 78
           E+   G  G V +  +     V A+K+     K   + E E+    G  H++I+      
Sbjct: 30  EVKARGRFGCVWK-AQLLNEYV-AVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAE 87

Query: 79  ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ---- 134
           +   +    L +I      G L   ++       +  E   I   +   + +LH+     
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGL 144

Query: 135 ------NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
                  I+HRD+K +N+L                 +K          +     + DFG 
Sbjct: 145 KDGHKPAISHRDIKSKNVL-----------------LK----------NNLTACIADFGL 177

Query: 189 AKKIVSNKASLQT--PCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCGF-- 239
           A K  + K++  T     T  Y+APEVL              D++++G++++ L      
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 240 ---------PPFFSNHGQAISPG-MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML-CV- 287
                     PF    GQ  S   M+  +   +      ++         L + +  C  
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 288 -DPSERLTIDQVME 300
            D   RL+   V E
Sbjct: 298 HDAEARLSAGCVGE 311

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 59/336 (17%), Positives = 110/336 (32%), Gaps = 97/336 (28%)

Query: 28  INGKVLQIVEKKTS----EVY---------ALKVLHDTVKA--RREVEL-QLAVGSHKHI 71
           ++   L+++E         VY         A+KV     +     E  + ++ +  H +I
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI 69

Query: 72  VN-IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
              I        +G    L++ME    G L + +            +  + + +   + +
Sbjct: 70  ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAY 126

Query: 131 LHDQ---------NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
           LH +          I+HRD+   N+L                 VK          + G  
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVL-----------------VK----------NDGTC 159

Query: 182 KLTDFGFAKKIVSNKASLQTPCY--------TPYYVAPEVL-------GPDKYDKSCDIW 226
            ++DFG + ++  N+                T  Y+APEVL         +   K  D++
Sbjct: 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219

Query: 227 SLGVIMYILLCGF-------------PPFFSNHGQAISPG-MK-----NRIRLGQFDFPN 267
           +LG+I + +                   F +  G   +   M+      + R     FP 
Sbjct: 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP---KFPE 276

Query: 268 PEWEHVSQEAKTLIKNML-CV--DPSERLTIDQVME 300
             W+  S   ++L + +  C   D   RLT     E
Sbjct: 277 -AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 64/291 (21%), Positives = 97/291 (33%), Gaps = 74/291 (25%)

Query: 1   MTPTFKPFKTTPIQDDYDIS------TEILGLGINGKV----LQIVEKKTSEVYALKVL- 49
           +            +D            + LG G  G V       ++  T EV A+K L 
Sbjct: 20  LYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ 79

Query: 50  HDTVKAR----REVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQ 105
           H T +      RE+E+ L    H +IV  K V  +   G R L +IME +  G L   +Q
Sbjct: 80  HSTEEHLRDFEREIEI-LKSLQHDNIVKYKGVCYS--AGRRNLKLIMEYLPYGSLRDYLQ 136

Query: 106 QKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV 165
            K        +     ++IC  +++L  +   HRD+   N+L                 V
Sbjct: 137 -KHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL-----------------V 178

Query: 166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEV 213
                      +   +K+ DFG  K +  +K          YY             APE 
Sbjct: 179 ----------ENENRVKIGDFGLTKVLPQDKE---------YYKVKEPGESPIFWYAPES 219

Query: 214 LGPDKYDKSCDIWSLGVIMY-------ILLCGFPPFFSNHGQAISPGMKNR 257
           L   K+  + D+WS GV++Y               F    G      M   
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 70.7 bits (174), Expect = 5e-14
 Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 59/245 (24%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR---REVEL--QLAVGSHKHIVNIKD 76
           + +G G  G V+    +   +V A+K + +   A+    E  +  QL    H ++V +  
Sbjct: 27  QTIGKGEFGDVMLGDYRGN-KV-AVKCIKNDATAQAFLAEASVMTQL---RHSNLVQLLG 81

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V   I      L ++ E M  G L   ++ +               ++C A+++L   N 
Sbjct: 82  V---IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+   N+L                 V           +  + K++DFG  K+  S +
Sbjct: 139 VHRDLAARNVL-----------------V----------SEDNVAKVSDFGLTKEASSTQ 171

Query: 197 ASLQTPCYTPYYV---APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISP 252
            + + P      V   APE L   K+    D+WS G++++ I   G  P+         P
Sbjct: 172 DTGKLP------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY---------P 216

Query: 253 GMKNR 257
            +  +
Sbjct: 217 RIPLK 221

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 53/243 (21%), Positives = 91/243 (37%), Gaps = 51/243 (20%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE--VELQLAVG-SHKHIVNIKDV- 77
             LG G  G+V       T+ V A+K L     +      E Q+     H+ +V +  V 
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 78  -YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
             E IY       ++ E M  G L   ++ +        +   +  +I S + ++   N 
Sbjct: 249 SEEPIY-------IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD++  N+L                            G+  + K+ DFG A+ I  N+
Sbjct: 302 VHRDLRAANILV---------------------------GENLVCKVADFGLARLIEDNE 334

Query: 197 ASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGM 254
            + +     P  + APE     ++    D+WS G+++  +   G  P+         PGM
Sbjct: 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---------PGM 385

Query: 255 KNR 257
            NR
Sbjct: 386 VNR 388

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 70.4 bits (173), Expect = 7e-14
 Identities = 61/264 (23%), Positives = 94/264 (35%), Gaps = 68/264 (25%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVL-HDTVKAR----REVELQLAVGSHKHIV 72
           + LG G  G V       ++  T EV A+K L H T +      RE+E+ L    H +IV
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI-LKSLQHDNIV 74

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
             K V  +   G R L +IME +  G L   +Q K        +     ++IC  +++L 
Sbjct: 75  KYKGVCYS--AGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLG 131

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
            +   HRD+   N+L                 V           +   +K+ DFG  K +
Sbjct: 132 TKRYIHRDLATRNIL-----------------V----------ENENRVKIGDFGLTKVL 164

Query: 193 VSNKASLQTPCYTPYYV------------APEVLGPDKYDKSCDIWSLGVIMY------- 233
             +K          ++             APE L   K+  + D+WS GV++Y       
Sbjct: 165 PQDK---------EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215

Query: 234 ILLCGFPPFFSNHGQAISPGMKNR 257
                   F    G      M   
Sbjct: 216 KSKSPPAEFMRMIGNDKQGQMIVF 239

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 59/268 (22%), Positives = 100/268 (37%), Gaps = 57/268 (21%)

Query: 3   PTFKPFKTTPIQDDYDIS------TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR 56
           PT KP      +D ++I          LG G  G+V       T+ V A+K L     + 
Sbjct: 248 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP 306

Query: 57  RE--VELQLAVG-SHKHIVNIKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGA 111
                E Q+     H+ +V +  V   E IY       ++ E M  G L   ++ +    
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-------IVTEYMSKGSLLDFLKGETGKY 359

Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
               +   +  +I S + ++   N  HRD++  N+L                        
Sbjct: 360 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----------------------- 396

Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGV 230
               G+  + K+ DFG A+ I  N+ + +     P  + APE     ++    D+WS G+
Sbjct: 397 ----GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 452

Query: 231 IMY-ILLCGFPPFFSNHGQAISPGMKNR 257
           ++  +   G  P+         PGM NR
Sbjct: 453 LLTELTTKGRVPY---------PGMVNR 471

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 48/251 (19%), Positives = 95/251 (37%), Gaps = 63/251 (25%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVEL--------QLAVGSHKHIVN 73
           E +G G  G+V     +  + + A+K   +T+    + +         Q    SH +IV 
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY---SHPNIVR 176

Query: 74  IKDV---YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +  V    + IY       ++ME + GG+    ++  E      +    ++ +  + +++
Sbjct: 177 LIGVCTQKQPIY-------IVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEY 228

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG--DVKPENLLYTKPGDGGI-LKLTDFG 187
           L  +   HRD+   N L     +  +LK++DFG    + + +     G   + +K T   
Sbjct: 229 LESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT--- 282

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNH 246
                                 APE L   +Y    D+WS G++++     G  P+    
Sbjct: 283 ----------------------APEALNYGRYSSESDVWSFGILLWETFSLGASPY---- 316

Query: 247 GQAISPGMKNR 257
                P + N+
Sbjct: 317 -----PNLSNQ 322

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 52/253 (20%), Positives = 85/253 (33%), Gaps = 71/253 (28%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARRE--VELQLAVG-SHKHIVNIKDV- 77
           + LG G  G+V      K ++V A+K +     +      E  +     H  +V +  V 
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 78  -YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
             E IY       +I E M  G L   ++  E       +      +I   + F+  +N 
Sbjct: 253 TKEPIY-------IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD++  N+L                                + K+ DFG A+ I  N+
Sbjct: 306 IHRDLRAANILV---------------------------SASLVCKIADFGLARVIEDNE 338

Query: 197 ASLQTPCYTPYYV-----------APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFS 244
                     Y             APE +    +    D+WS G+++  I+  G  P+  
Sbjct: 339 ----------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-- 386

Query: 245 NHGQAISPGMKNR 257
                  PGM N 
Sbjct: 387 -------PGMSNP 392

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 51/249 (20%), Positives = 94/249 (37%), Gaps = 61/249 (24%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR----REVEL--QLAVGSHKHIVNIK 75
             LG G  G+V + V KK S   A+K L +         +E  +  ++    H ++V + 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI---KHPNLVQLL 282

Query: 76  DVYENIYNGSRC-----LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
            V         C       +I E M  G L   +++      +      +  +I SA+++
Sbjct: 283 GV---------CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           L  +N  HR++   N L                            G+  ++K+ DFG ++
Sbjct: 334 LEKKNFIHRNLAARNCLV---------------------------GENHLVKVADFGLSR 366

Query: 191 KIVSNKASLQTPCYTPY-YVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQ 248
            +  +  +       P  + APE L  +K+    D+W+ GV+++ I   G  P+      
Sbjct: 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------ 420

Query: 249 AISPGMKNR 257
              PG+   
Sbjct: 421 ---PGIDLS 426

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 55/264 (20%), Positives = 86/264 (32%), Gaps = 68/264 (25%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKHI 71
             LG G  GKV           T E  A+K L             +E+E+ L    H++I
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI-LRNLYHENI 85

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           V  K +     +G   + +IME +  G L + +  K       ++      +IC  + +L
Sbjct: 86  VKYKGICTE--DGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYL 142

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
             +   HRD+   N+L                 V               +K+ DFG  K 
Sbjct: 143 GSRQYVHRDLAARNVL-----------------V----------ESEHQVKIGDFGLTKA 175

Query: 192 IVSNKASLQTPCYTPYYV------------APEVLGPDKYDKSCDIWSLGVIMY-ILLCG 238
           I ++K          YY             APE L   K+  + D+WS GV ++ +L   
Sbjct: 176 IETDKE---------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226

Query: 239 FPPFFSNHGQAIS-----PGMKNR 257
                               M   
Sbjct: 227 DSDSSPMALFLKMIGPTHGQMTVT 250

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 67.7 bits (166), Expect = 5e-13
 Identities = 54/277 (19%), Positives = 98/277 (35%), Gaps = 89/277 (32%)

Query: 11  TPIQDDYDIS------TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR----REVE 60
           +P  D +++          LG G  G+V + V KK S   A+K L +         +E  
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA 61

Query: 61  L--QLAVGSHKHIVNIKDVYENIYNGSRC-----LLVIMECMHGGELFQRIQQKEDGAFT 113
           +  ++    H ++V +  V         C       +I E M  G L   +++      +
Sbjct: 62  VMKEI---KHPNLVQLLGV---------CTREPPFYIITEFMTYGNLLDYLRECNRQEVS 109

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                 +  +I SA+++L  +N  HRD+   N L                          
Sbjct: 110 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL-------------------------- 143

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPDKYDK 221
             G+  ++K+ DFG ++ +  +            Y             APE L  +K+  
Sbjct: 144 -VGENHLVKVADFGLSRLMTGD-----------TYTAHAGAKFPIKWTAPESLAYNKFSI 191

Query: 222 SCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
             D+W+ GV+++ I   G  P+         PG+   
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPY---------PGIDLS 219

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 59/245 (24%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR---REVEL--QLAVGSHKHIVNIKD 76
           + +G G  G V+    +   +V A+K + +   A+    E  +  QL    H ++V +  
Sbjct: 199 QTIGKGEFGDVMLGDYRGN-KV-AVKCIKNDATAQAFLAEASVMTQL---RHSNLVQLLG 253

Query: 77  VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           V   I      L ++ E M  G L   ++ +               ++C A+++L   N 
Sbjct: 254 V---IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK 196
            HRD+   N+L                 V           +  + K++DFG  K+  S +
Sbjct: 311 VHRDLAARNVL-----------------V----------SEDNVAKVSDFGLTKEASSTQ 343

Query: 197 ASLQTPCYTPYYV---APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISP 252
            + + P      V   APE L   K+    D+WS G++++ I   G  P+         P
Sbjct: 344 DTGKLP------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY---------P 388

Query: 253 GMKNR 257
            +  +
Sbjct: 389 RIPLK 393

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 58/273 (21%), Positives = 92/273 (33%), Gaps = 76/273 (27%)

Query: 10  TTPIQDDYDIS------TEILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKARREV 59
           T P   DY+I          +G G  G V        E     V A+K   +        
Sbjct: 378 TMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVRE 436

Query: 60  EL--------QLAVGSHKHIVNIKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKED 109
           +         Q     H HIV +  V     ++       +IME    GEL   +Q +  
Sbjct: 437 KFLQEALTMRQF---DHPHIVKLIGVITENPVW-------IIMELCTLGELRSFLQVR-K 485

Query: 110 GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVK 166
            +       +   ++ +A+ +L  +   HRD+   N+L         +KL DFG    ++
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYME 542

Query: 167 PENLLYTKPGDGGI-LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDI 225
                Y K   G + +K                           APE +   ++  + D+
Sbjct: 543 DST--YYKASKGKLPIKWM-------------------------APESINFRRFTSASDV 575

Query: 226 WSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
           W  GV M+ IL+ G  PF          G+KN 
Sbjct: 576 WMFGVCMWEILMHGVKPF---------QGVKNN 599

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 56/264 (21%), Positives = 91/264 (34%), Gaps = 70/264 (26%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVL--HDTVKAR----REVELQLAVGSHKHI 71
             LG G  GKV           T E+ A+K L      + R    +E+++ L    H+HI
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI-LRTLYHEHI 95

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           +  K   E+   G+  L ++ME +  G L   + +         +  +   +IC  + +L
Sbjct: 96  IKYKGCCED--AGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL 150

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H Q+  HRD+   N+L                 +           +  ++K+ DFG AK 
Sbjct: 151 HAQHYIHRDLAARNVL-----------------L----------DNDRLVKIGDFGLAKA 183

Query: 192 IVSNKASLQTPCYTPYYV------------APEVLGPDKYDKSCDIWSLGVIMY-ILLCG 238
           +              YY             APE L   K+  + D+WS GV +Y +L   
Sbjct: 184 VPEGHE---------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234

Query: 239 FPPFFSNHGQAIS-----PGMKNR 257
                               M   
Sbjct: 235 DSSQSPPTKFLELIGIAQGQMTVL 258

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 58/256 (22%), Positives = 90/256 (35%), Gaps = 77/256 (30%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR----REVEL--QLAVGSHKHIVNIK 75
           E LG G  G+V        ++V A+K L     +      E  L  QL    H+ +V + 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLAEANLMKQL---QHQRLVRLY 74

Query: 76  DV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
            V   E IY       +I E M  G L   ++       T  +   +  +I   + F+ +
Sbjct: 75  AVVTQEPIY-------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           +N  HRD++  N+L                 V           D    K+ DFG A+ I 
Sbjct: 128 RNYIHRDLRAANIL-----------------V----------SDTLSCKIADFGLARLIE 160

Query: 194 SNKASLQTPCYTPYYV-----------APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPP 241
            N+          Y             APE +    +    D+WS G+++  I+  G  P
Sbjct: 161 DNE----------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

Query: 242 FFSNHGQAISPGMKNR 257
           +         PGM N 
Sbjct: 211 Y---------PGMTNP 217

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 65.3 bits (160), Expect = 3e-12
 Identities = 47/257 (18%), Positives = 88/257 (34%), Gaps = 79/257 (30%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR----REVEL--QLAVGSHKHIVNIK 75
           + +G G  G V         +V A+K + +   +      E E+  +L   SH  +V + 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIEEAEVMMKL---SHPKLVQLY 69

Query: 76  DV---YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            V      I        ++ E M  G L   ++  + G F       +  ++C  + +L 
Sbjct: 70  GVCLEQAPIC-------LVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLE 121

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
           +  + HRD+   N L                            G+  ++K++DFG  + +
Sbjct: 122 EACVIHRDLAARNCL---------------------------VGENQVIKVSDFGMTRFV 154

Query: 193 VSNKASLQTPCYTPYYV-----------APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFP 240
           + ++          Y             +PEV    +Y    D+WS GV+M+ +   G  
Sbjct: 155 LDDQ----------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

Query: 241 PFFSNHGQAISPGMKNR 257
           P+             N 
Sbjct: 205 PY---------ENRSNS 212

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 64.9 bits (159), Expect = 4e-12
 Identities = 47/257 (18%), Positives = 83/257 (32%), Gaps = 79/257 (30%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR----REVEL--QLAVGSHKHIVNIK 75
           + LG G  G V     K   +V A+K++ +   +     +E +   +L   SH  +V   
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQEAQTMMKL---SHPKLVKFY 69

Query: 76  DV---YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            V      IY       ++ E +  G L   ++          +   +  ++C  + FL 
Sbjct: 70  GVCSKEYPIY-------IVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
                HRD+   N L                 V               +K++DFG  + +
Sbjct: 122 SHQFIHRDLAARNCL-----------------V----------DRDLCVKVSDFGMTRYV 154

Query: 193 VSNKASLQTPCYTPYYV-----------APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFP 240
           + +           Y             APEV    KY    D+W+ G++M+ +   G  
Sbjct: 155 LDD----------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204

Query: 241 PFFSNHGQAISPGMKNR 257
           P+             N 
Sbjct: 205 PY---------DLYTNS 212

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 48/255 (18%), Positives = 83/255 (32%), Gaps = 51/255 (20%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVL-HDTVKAR----REVELQLAVGSHKHIV 72
             LG G  G V       +   T  + A+K L H     +    RE+++ L       IV
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI-LKALHSDFIV 87

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
             + V      G + L ++ME +  G L   +Q +           +  ++IC  +++L 
Sbjct: 88  KYRGVSYG--PGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLG 144

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGGI-LKLTDFGF 188
            +   HRD+   N+L         +K+ DFG    +  +   Y     G   +       
Sbjct: 145 SRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY---- 197

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF----- 242
                                APE L  + + +  D+WS GV++Y +             
Sbjct: 198 ---------------------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

Query: 243 FSNHGQAISPGMKNR 257
           F              
Sbjct: 237 FLRMMGCERDVPALS 251

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 59/261 (22%), Positives = 100/261 (38%), Gaps = 63/261 (24%)

Query: 13  IQDDYDISTEILGLGINGKVLQ---IVEKKTSEVYALKVLHD--TVKARRE------VEL 61
            +D+  I+   LG G  G V Q    + KK  +V A+KVL          E      +  
Sbjct: 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQGTEKADTEEMMREAQIMH 391

Query: 62  QLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM 121
           QL    + +IV +  V +     +  L+++ME   GG L + +   +         A ++
Sbjct: 392 QL---DNPYIVRLIGVCQ-----AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELL 442

Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDG 178
           +++   +K+L ++N  HR++   N+L     +    K++DFG    +  ++  YT    G
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAG 499

Query: 179 GI-LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILL 236
              LK                           APE +   K+    D+WS GV M+  L 
Sbjct: 500 KWPLKWY-------------------------APECINFRKFSSRSDVWSYGVTMWEALS 534

Query: 237 CGFPPFFSNHGQAISPGMKNR 257
            G  P+           MK  
Sbjct: 535 YGQKPY---------KKMKGP 546

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 45/257 (17%), Positives = 88/257 (34%), Gaps = 69/257 (26%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKARREVELQ-----LAVGSHKHIV 72
           E++G G  G V    L   + K     A+K L+         +       +   SH +++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           ++  +           LV++  M  G+L   I + E    T ++      ++   +KFL 
Sbjct: 154 SLLGI---CLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
            +   HRD+   N +                 +           +   +K+ DFG A+ +
Sbjct: 210 SKKFVHRDLAARNCM-----------------L----------DEKFTVKVADFGLARDM 242

Query: 193 VSNKASLQTPCYTPYYV-----------APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFP 240
              +       +   +            A E L   K+    D+WS GV+++ ++  G P
Sbjct: 243 YDKE-------FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

Query: 241 PFFSNHGQAISPGMKNR 257
           P+         P +   
Sbjct: 296 PY---------PDVNTF 303

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 51/262 (19%), Positives = 92/262 (35%), Gaps = 71/262 (27%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVLHD--TVKAR----REVELQLAVGSHKH 70
             LG G  G+V +     +    +    A+K L +  + +       E  + ++  +H++
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI-ISKFNHQN 135

Query: 71  IVNIKDVYENIYNGSRC-----LLVIMECMHGGELFQ-----RIQQKEDGAFTEREAAII 120
           IV    V                 +++E M GG+L       R +  +  +    +   +
Sbjct: 136 IVRCIGV---------SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGD 177
             +I    ++L + +  HRD+   N L T PG G + K+ DFG   D+      Y K G 
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGC 245

Query: 178 GGI-LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
             + +K                            PE      +    D WS GV+++ I 
Sbjct: 246 AMLPVKWM-------------------------PPEAFMEGIFTSKTDTWSFGVLLWEIF 280

Query: 236 LCGFPPFFSNHGQAISPGMKNR 257
             G+ P+         P   N+
Sbjct: 281 SLGYMPY---------PSKSNQ 293

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 52/257 (20%), Positives = 95/257 (36%), Gaps = 79/257 (30%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR----REVEL--QLAVGSHKHIVNIK 75
           + LG G  G V     +   +V A+K++ +   +      E ++   L   SH+ +V + 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMNL---SHEKLVQLY 85

Query: 76  DV---YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            V      I+       +I E M  G L   ++ +    F  ++   +  ++C A+++L 
Sbjct: 86  GVCTKQRPIF-------IITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
            +   HRD+   N L                 V           D G++K++DFG ++ +
Sbjct: 138 SKQFLHRDLAARNCL-----------------V----------NDQGVVKVSDFGLSRYV 170

Query: 193 VSNKASLQTPCYTPYYV-----------APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFP 240
           + ++          Y              PEVL   K+    DIW+ GV+M+ I   G  
Sbjct: 171 LDDE----------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220

Query: 241 PFFSNHGQAISPGMKNR 257
           P+             N 
Sbjct: 221 PY---------ERFTNS 228

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 52/262 (19%), Positives = 91/262 (34%), Gaps = 71/262 (27%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
             LG G  G+V +     +    +    A+K L +    +       E  + ++  +H++
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI-ISKFNHQN 94

Query: 71  IVNIKDVYENIYNGSRC-----LLVIMECMHGGELFQ-----RIQQKEDGAFTEREAAII 120
           IV    V                 ++ME M GG+L       R +  +  +    +   +
Sbjct: 95  IVRCIGV---------SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145

Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGD 177
             +I    ++L + +  HRD+   N L T PG G + K+ DFG   D+      Y K G 
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGC 204

Query: 178 GGI-LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-IL 235
             + +K                            PE      +    D WS GV+++ I 
Sbjct: 205 AMLPVKWM-------------------------PPEAFMEGIFTSKTDTWSFGVLLWEIF 239

Query: 236 LCGFPPFFSNHGQAISPGMKNR 257
             G+ P+         P   N+
Sbjct: 240 SLGYMPY---------PSKSNQ 252

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 45/263 (17%), Positives = 84/263 (31%), Gaps = 84/263 (31%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVLHDTVKARREVEL--------QLAVGSH 68
           ++LG G  G V +       EK    V A+K L +    +   E+         +    +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANKEILDEAYVMASV---DN 76

Query: 69  KHIVNIKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
            H+  +  +     +        +I + M  G L   ++ +       +       +I  
Sbjct: 77  PHVCRLLGICLTSTVQ-------LITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAK 128

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            + +L D+ + HRD+   N+L                 V               +K+TDF
Sbjct: 129 GMNYLEDRRLVHRDLAARNVL-----------------V----------KTPQHVKITDF 161

Query: 187 GFAKKIVSNKASLQTPCYTPYYV-----------APEVLGPDKYDKSCDIWSLGVIMY-I 234
           G AK + + +           Y            A E +    Y    D+WS GV ++ +
Sbjct: 162 GLAKLLGAEEK---------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212

Query: 235 LLCGFPPFFSNHGQAISPGMKNR 257
           +  G  P+          G+   
Sbjct: 213 MTFGSKPY---------DGIPAS 226

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 47/261 (18%), Positives = 90/261 (34%), Gaps = 77/261 (29%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHD--TVKAR----REVELQLAVGSHKHI 71
           E++G G  G V    L   + K     A+K L+    +        E  + +   SH ++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIGEVSQFLTEGII-MKDFSHPNV 88

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           +++  +           LV++  M  G+L   I+  E    T ++      ++   +K+L
Sbjct: 89  LSLLGI---CLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYL 144

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
             +   HRD+   N +                 +           +   +K+ DFG A+ 
Sbjct: 145 ASKKFVHRDLAARNCM-----------------L----------DEKFTVKVADFGLARD 177

Query: 192 IVSNKASLQTPCYTPYYV--------------APEVLGPDKYDKSCDIWSLGVIMY-ILL 236
           +   +          YY               A E L   K+    D+WS GV+++ ++ 
Sbjct: 178 MYDKE----------YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

Query: 237 CGFPPFFSNHGQAISPGMKNR 257
            G PP+         P +   
Sbjct: 228 RGAPPY---------PDVNTF 239

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 50/265 (18%), Positives = 87/265 (32%), Gaps = 76/265 (28%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKARREV-----ELQLAVG-SHKHI 71
            +LG G  G V    L+  +    +V A+K+L   + A  ++     E        H H+
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKV-AVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 72  VNIKDV--YENIYNGSRCLLVIMECMHGGELF----QRIQQKEDGAFTEREAAIIMNEIC 125
             +  V             +VI+  M  G+L          +       +     M +I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +++L  +N  HRD+   N +                 +           +   + + D
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCM-----------------L----------AEDMTVCVAD 180

Query: 186 FGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPDKYDKSCDIWSLGVIMY 233
           FG ++KI S            YY             A E L  + Y    D+W+ GV M+
Sbjct: 181 FGLSRKIYSGD----------YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMW 230

Query: 234 -ILLCGFPPFFSNHGQAISPGMKNR 257
            I+  G  P+          G++N 
Sbjct: 231 EIMTRGQTPY---------AGIENA 246

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 36/204 (17%), Positives = 68/204 (33%), Gaps = 61/204 (29%)

Query: 67  SHKHIVNIKDVYENIYNGSRC-----LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIM 121
           SHKH+V    V         C      +++ E +  G L   ++ K            + 
Sbjct: 70  SHKHLVLNYGV---------CVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVA 119

Query: 122 NEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
            ++ +A+ FL +  + H +V  +N+L  +  D                    K G+   +
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREED-------------------RKTGNPPFI 160

Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYY------VAPEVLG-PDKYDKSCDIWSLGVIMY- 233
           KL+D G +  ++                     V PE +  P   + + D WS G  ++ 
Sbjct: 161 KLSDPGISITVLPKD----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210

Query: 234 ILLCGFPPFFSNHGQAISPGMKNR 257
           I   G  P            + ++
Sbjct: 211 ICSGGDKPL---------SALDSQ 225

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 56/264 (21%), Positives = 93/264 (35%), Gaps = 75/264 (28%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKARREV-----ELQLAVG-SHKHI 71
           +ILG G  G V    L+  +  + +V A+K +     ++RE+     E       SH ++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKV-AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 72  VNIKDV-YENIYNGSRCLLVIMECMHGGELF----QRIQQKEDGAFTEREAAIIMNEICS 126
           + +  V  E    G    +VI+  M  G+L         +        +     M +I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            +++L ++N  HRD+   N +                 +           D   + + DF
Sbjct: 159 GMEYLSNRNFLHRDLAARNCM-----------------L----------RDDMTVCVADF 191

Query: 187 GFAKKIVSNKASLQTPCYTPYYV------------APEVLGPDKYDKSCDIWSLGVIMY- 233
           G +KKI S            YY             A E L    Y    D+W+ GV M+ 
Sbjct: 192 GLSKKIYSGD----------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE 241

Query: 234 ILLCGFPPFFSNHGQAISPGMKNR 257
           I   G  P+         PG++N 
Sbjct: 242 IATRGMTPY---------PGVQNH 256

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 53/262 (20%), Positives = 85/262 (32%), Gaps = 84/262 (32%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKAR------REVEL--QLAVGSHK 69
             +G G  G V        E     V A+K   +           +E     Q     H 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQF---DHP 76

Query: 70  HIVNIKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           HIV +  V     ++       +IME    GEL   +Q     +       +   ++ +A
Sbjct: 77  HIVKLIGVITENPVW-------IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTA 128

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +L  +   HRD+   N+L                 V               +KL DFG
Sbjct: 129 LAYLESKRFVHRDIAARNVL-----------------V----------SSNDCVKLGDFG 161

Query: 188 FAKKIVSNKASLQTPCYTPYYV-----------APEVLGPDKYDKSCDIWSLGVIMY-IL 235
            ++ +  +           YY            APE +   ++  + D+W  GV M+ IL
Sbjct: 162 LSRYMEDST----------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

Query: 236 LCGFPPFFSNHGQAISPGMKNR 257
           + G  PF          G+KN 
Sbjct: 212 MHGVKPF---------QGVKNN 224

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 53/258 (20%), Positives = 98/258 (37%), Gaps = 73/258 (28%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKAR------REVEL--QLAVGSHK 69
           +I+G G +G+V    L++  ++   V A+K L      R       E  +  Q     H 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPV-AIKALKAGYTERQRRDFLSEASIMGQF---DHP 110

Query: 70  HIVNIKDVYENIYNGSRC-----LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
           +I+ ++ V                +++ E M  G L   ++   DG FT  +   ++  +
Sbjct: 111 NIIRLEGV---------VTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGV 160

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGGI- 180
            + +++L D    HRD+   N+L        + K++DFG    ++ +         G I 
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217

Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGF 239
           ++ T                         APE +    +  + D+WS GV+M+ +L  G 
Sbjct: 218 IRWT-------------------------APEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252

Query: 240 PPFFSNHGQAISPGMKNR 257
            P+           M NR
Sbjct: 253 RPY---------WNMTNR 261

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 44/261 (16%), Positives = 89/261 (34%), Gaps = 77/261 (29%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKHI 71
            ++G G  G V         +   +  A+K L    + +      RE  L +   +H ++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQQVEAFLREGLL-MRGLNHPNV 84

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           + +  +   +        V++  M  G+L Q I+       T ++      ++   +++L
Sbjct: 85  LALIGI---MLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYL 140

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
            +Q   HRD+   N +                 +           +   +K+ DFG A+ 
Sbjct: 141 AEQKFVHRDLAARNCM-----------------L----------DESFTVKVADFGLARD 173

Query: 192 IVSNKASLQTPCYTPYYV--------------APEVLGPDKYDKSCDIWSLGVIMY-ILL 236
           I+  +          YY               A E L   ++    D+WS GV+++ +L 
Sbjct: 174 ILDRE----------YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

Query: 237 CGFPPFFSNHGQAISPGMKNR 257
            G PP+           +   
Sbjct: 224 RGAPPY---------RHIDPF 235

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 51/298 (17%), Positives = 97/298 (32%), Gaps = 99/298 (33%)

Query: 2   TPTFKPFKTTPIQDDYDIS------TEILGLGINGKVLQ-----IVEKKTSEVYALKVLH 50
            P +       + D+++++      +  LG G  G V +     +V+ +     A+K ++
Sbjct: 5   NPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 64

Query: 51  D--TVKAR----REVELQLAVGSHKHIVNIKDVYENIYNGSRC-----LLVIMECMHGGE 99
           +  +++ R     E  + +   +  H+V +  V                LVIME M  G+
Sbjct: 65  EAASMRERIEFLNEASV-MKEFNCHHVVRLLGV---------VSQGQPTLVIMELMTRGD 114

Query: 100 L--FQR------IQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP 151
           L  + R               +  +   +  EI   + +L+     HRD+   N +    
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM---- 170

Query: 152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV-- 209
                        V           +   +K+ DFG  + I              YY   
Sbjct: 171 -------------V----------AEDFTVKIGDFGMTRDIYETD----------YYRKG 197

Query: 210 ----------APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKN 256
                     +PE L    +    D+WS GV+++ I      P+          G+ N
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---------QGLSN 246

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 63/250 (25%)

Query: 24  LGLGINGKVLQ---IVEKKTSEVYALKVLHDTVKAR------REVEL--QLAVGSHKHIV 72
           LG G  G V Q    + KK  +V A+KVL    +        RE ++  QL    + +IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQGTEKADTEEMMREAQIMHQL---DNPYIV 73

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
            +  V +     +  L+++ME   GG L + +   +         A +++++   +K+L 
Sbjct: 74  RLIGVCQ-----AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLE 127

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGGI-LKLTDFGF 188
           ++N  HRD+   N+L     +    K++DFG    +  ++  YT    G   LK      
Sbjct: 128 EKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY---- 180

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHG 247
                                APE +   K+    D+WS GV M+  L  G  P+     
Sbjct: 181 ---------------------APECINFRKFSSRSDVWSYGVTMWEALSYGQKPY----- 214

Query: 248 QAISPGMKNR 257
                 MK  
Sbjct: 215 ----KKMKGP 220

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 55/259 (21%), Positives = 101/259 (38%), Gaps = 75/259 (28%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHD--TVKARR----EVEL--QLAVGSHK 69
           +++G G  G+V    L++  KK   V A+K L    T K RR    E  +  Q     H 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEASIMGQF---DHP 106

Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           +I+ +    E +   S+ ++++ E M  G L   ++ K D  FT  +   ++  I S +K
Sbjct: 107 NIIRL----EGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMK 161

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           +L D    HRD+   N+L                 +              + K++DFG  
Sbjct: 162 YLSDMGYVHRDLAARNIL-----------------I----------NSNLVCKVSDFGLG 194

Query: 190 KKIVSNKASLQTPCYTPYYV----------APEVLGPDKYDKSCDIWSLGVIMY-ILLCG 238
           + +  +           Y            +PE +   K+  + D+WS G++++ ++  G
Sbjct: 195 RVLEDDP-------EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247

Query: 239 FPPFFSNHGQAISPGMKNR 257
             P+           M N+
Sbjct: 248 ERPY---------WEMSNQ 257

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 58.4 bits (142), Expect = 6e-10
 Identities = 55/276 (19%), Positives = 88/276 (31%), Gaps = 90/276 (32%)

Query: 14  QDDYDIS------TEILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKAR------R 57
              Y I+        ILG G  G+V        + +   V A+K                
Sbjct: 4   GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINV-AVKTCKKDCTLDNKEKFMS 62

Query: 58  EVEL--QLAVGSHKHIVNIKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
           E  +   L    H HIV +  +   E  +       +IME    GEL   ++ +   +  
Sbjct: 63  EAVIMKNL---DHPHIVKLIGIIEEEPTW-------IIMELYPYGELGHYLE-RNKNSLK 111

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
                +   +IC A+ +L   N  HRD+   N+L                 V        
Sbjct: 112 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL-----------------V-------- 146

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV-----------APEVLGPDKYDKS 222
                  +KL DFG ++ I              YY            +PE +   ++  +
Sbjct: 147 --ASPECVKLGDFGLSRYIEDED----------YYKASVTRLPIKWMSPESINFRRFTTA 194

Query: 223 CDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
            D+W   V M+ IL  G  PF           ++N+
Sbjct: 195 SDVWMFAVCMWEILSFGKQPF---------FWLENK 221

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 35/182 (19%), Positives = 71/182 (39%), Gaps = 57/182 (31%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLL 147
           +++I E M  G L + ++ ++DG F+  +   ++  I + +K+L + N  HRD+   N+L
Sbjct: 121 MMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 179

Query: 148 YTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPY 207
                            V              + K++DFG ++ +  +            
Sbjct: 180 -----------------V----------NSNLVCKVSDFGLSRVLEDD--------PEAT 204

Query: 208 YV-----------APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMK 255
           Y            APE +   K+  + D+WS G++M+ ++  G  P+           + 
Sbjct: 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY---------WELS 255

Query: 256 NR 257
           N 
Sbjct: 256 NH 257

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 58.0 bits (141), Expect = 8e-10
 Identities = 49/257 (19%), Positives = 82/257 (31%), Gaps = 70/257 (27%)

Query: 22  EILGLGINGKV----LQIVEKKTSEVYALKVLHDTVKAR--------REVEL--QLAVGS 67
           E LG G  G V          KT  V A+K L   V ++        REV     L    
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSL---D 79

Query: 68  HKHIVNIKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
           H++++ +  V     +        ++ E    G L  R++ K  G F     +    ++ 
Sbjct: 80  HRNLIRLYGVVLTPPMK-------MVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVA 131

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENLLYTKPGDGGI-L 181
             + +L  +   HRD+   NLL        ++K+ DFG    +   +  Y       +  
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188

Query: 182 KLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFP 240
                                       APE L    +  + D W  GV ++ +   G  
Sbjct: 189 AWC-------------------------APESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

Query: 241 PFFSNHGQAISPGMKNR 257
           P+          G+   
Sbjct: 224 PW---------IGLNGS 231

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 45/265 (16%), Positives = 84/265 (31%), Gaps = 88/265 (33%)

Query: 22  EILGLGINGKV-----LQIVEKKTSEVYALKVLHDTVKARREVEL--------QLAVGSH 68
           ++LG G  G V     +   EK    V A+K L +    +   E+         +    +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANKEILDEAYVMASV---DN 76

Query: 69  KHIVNIKDVYENIYNGSRC----LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
            H+  +  +         C    + +I + M  G L   ++ +       +       +I
Sbjct: 77  PHVCRLLGI---------CLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQI 126

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              + +L D+ + HRD+   N+L                                 +K+T
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLV---------------------------KTPQHVKIT 159

Query: 185 DFGFAKKIVSNKASLQTPCYTPYYV-----------APEVLGPDKYDKSCDIWSLGVIMY 233
           DFG AK + + +           Y            A E +    Y    D+WS GV ++
Sbjct: 160 DFGLAKLLGAEEK---------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210

Query: 234 -ILLCGFPPFFSNHGQAISPGMKNR 257
            ++  G  P+          G+   
Sbjct: 211 ELMTFGSKPY---------DGIPAS 226

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 50/252 (19%), Positives = 90/252 (35%), Gaps = 86/252 (34%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           + LG G  GKV++     + ++      A+K+L  T  A        E+++   +G H++
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 71  IVNIKDVYENIYNGSRC-----LLVIMECMHGGEL------------FQRIQQKEDGAFT 113
           IVN+            C     +LVI E    G+L                    +   +
Sbjct: 112 IVNLLGA---------CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
            R+     +++   + FL  +N  HRDV   N+L                 +        
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL-----------------L-------- 197

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPDKYDK 221
              +G + K+ DFG A+ I++             Y+            APE +    Y  
Sbjct: 198 --TNGHVAKIGDFGLARDIMN----------DSNYIVKGNARLPVKWMAPESIFDCVYTV 245

Query: 222 SCDIWSLGVIMY 233
             D+WS G++++
Sbjct: 246 QSDVWSYGILLW 257

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 52/269 (19%), Positives = 100/269 (37%), Gaps = 63/269 (23%)

Query: 5   FKPFKTTPIQDDYDISTEILGLGINGKVLQ---IVEKKTSEVYALKVLHD--TVKARREV 59
            +P +    +    +  + LG G  G V +    ++K    V A+K+L +     A ++ 
Sbjct: 6   IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTV-AVKILKNEANDPALKDE 64

Query: 60  ELQLAVG----SHKHIVNIKDV--YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFT 113
            L  A       + +IV +  +   E+         ++ME    G L + +Q  ++    
Sbjct: 65  LLAEANVMQQLDNPYIVRMIGICEAESWM-------LVMEMAELGPLNKYLQ--QNRHVK 115

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG---DVKPENL 170
           ++    +++++   +K+L + N  HRD+   N+L          K++DFG    ++ +  
Sbjct: 116 DKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADEN 172

Query: 171 LYTKPGDGGI-LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG 229
            Y     G   +K                           APE +   K+    D+WS G
Sbjct: 173 YYKAQTHGKWPVKWY-------------------------APECINYYKFSSKSDVWSFG 207

Query: 230 VIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
           V+M+     G  P+          GMK  
Sbjct: 208 VLMWEAFSYGQKPY---------RGMKGS 227

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 51/281 (18%), Positives = 92/281 (32%), Gaps = 96/281 (34%)

Query: 3   PTFKPFKTTPIQDDYDIS------TEILGLGINGKVLQ-----IVEKKTSEVYALKVLHD 51
             +      P    ++         + LG G  GKV++     +++   +   A+K+L  
Sbjct: 4   YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63

Query: 52  TVKAR------REVELQLAVGSHKHIVNIKDVYENIYNGSRC-----LLVIMECMHGGEL 100
           +           E+++   +G+H +IVN+            C      LVI E    G+L
Sbjct: 64  SAHLTEREALMSELKVLSYLGNHMNIVNLLGA---------CTIGGPTLVITEYCCYGDL 114

Query: 101 ----------------FQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
                              I + ++ A    +      ++   + FL  +N  HRD+   
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174

Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                 +            G I K+ DFG A+ I ++         
Sbjct: 175 NIL-----------------L----------THGRITKICDFGLARDIKNDS-------- 199

Query: 205 TPYYV------------APEVLGPDKYDKSCDIWSLGVIMY 233
              YV            APE +    Y    D+WS G+ ++
Sbjct: 200 --NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 44/265 (16%), Positives = 85/265 (32%), Gaps = 88/265 (33%)

Query: 22  EILGLGINGKV-----LQIVEKKTSEVYALKVLHDTVKARREVEL--------QLAVGSH 68
           ++LG G+ G V     +   E     V  +KV+ D    +    +         L    H
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPV-CIKVIEDKSGRQSFQAVTDHMLAIGSL---DH 74

Query: 69  KHIVNIKDVYENIYNGSRC----LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
            HIV +  +         C    L ++ + +  G L   ++Q   GA   +       +I
Sbjct: 75  AHIVRLLGL---------CPGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQI 124

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              + +L +  + HR++   N+L                 +               +++ 
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVL-----------------L----------KSPSQVQVA 157

Query: 185 DFGFAKKIVSNKASLQTPCYTPYYV-----------APEVLGPDKYDKSCDIWSLGVIMY 233
           DFG A  +  +             +           A E +   KY    D+WS GV ++
Sbjct: 158 DFGVADLLPPDDK---------QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVW 208

Query: 234 -ILLCGFPPFFSNHGQAISPGMKNR 257
            ++  G  P+          G++  
Sbjct: 209 ELMTFGAEPY---------AGLRLA 224

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 32/151 (21%), Positives = 69/151 (45%), Gaps = 17/151 (11%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKA---RREVELQLAVGSHKHIVNIKD-VYE 79
           +G G  G++      +T+E  A+K+ +   K      E ++   +     I N++    E
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74

Query: 80  NIYNGSRCLLVIMECMHG---GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
             YN     +++M+ + G    +LF    +K     + +   ++ +++ + ++F+H ++ 
Sbjct: 75  GDYN-----VLVMD-LLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVHSKSF 124

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVKP 167
            HRD+KP+N L         + + DFG  K 
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 58/277 (20%), Positives = 95/277 (34%), Gaps = 97/277 (35%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVLHD-TVKAR----REVELQLAVGSHKHI 71
             LG G  GKV       ++ ++   + A+K L + +  AR    RE EL L +  H+HI
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL-LTMLQHQHI 105

Query: 72  VNIKDVYENIYNGSRC-----LLVIMECMHGGEL-------------FQRIQQKEDGAFT 113
           V    V         C     LL++ E M  G+L                 +    G   
Sbjct: 106 VRFFGV---------CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 114 EREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYT 173
             +   + +++ + + +L   +  HRD+   N L                 V        
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL-----------------V-------- 191

Query: 174 KPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPDKYDK 221
             G G ++K+ DFG ++ I S            YY              PE +   K+  
Sbjct: 192 --GQGLVVKIGDFGMSRDIYSTD----------YYRVGGRTMLPIRWMPPESILYRKFTT 239

Query: 222 SCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
             D+WS GV+++ I   G  P+           + N 
Sbjct: 240 ESDVWSFGVVLWEIFTYGKQPW---------YQLSNT 267

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 47/255 (18%), Positives = 85/255 (33%), Gaps = 89/255 (34%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           + LG G  G+V++     I +  T    A+K+L +            E+++ + +G H +
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 71  IVNIKDVYENIYNGSRC------LLVIMECMHGGEL--------------FQRIQQKEDG 110
           +VN+            C      L+VI+E    G L                  +     
Sbjct: 93  VVNLLGA---------CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 111 AFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL 170
             T         ++   ++FL  +   HRD+   N+L                 +     
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL-----------------L----- 181

Query: 171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPDK 218
                 +  ++K+ DFG A+ I  +            YV            APE +    
Sbjct: 182 -----SEKNVVKICDFGLARDIYKDP----------DYVRKGDARLPLKWMAPETIFDRV 226

Query: 219 YDKSCDIWSLGVIMY 233
           Y    D+WS GV+++
Sbjct: 227 YTIQSDVWSFGVLLW 241

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 55.3 bits (134), Expect = 8e-09
 Identities = 63/278 (22%), Positives = 94/278 (33%), Gaps = 98/278 (35%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVLHD-TVKAR----REVELQLAVGSHKHI 71
             LG G  GKV       +   K   + A+K L D T+ AR    RE EL L    H+HI
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL-LTNLQHEHI 79

Query: 72  VNIKDVYENIYNGSRC-----LLVIMECMHGGEL--------------FQRIQQKEDGAF 112
           V    V         C     L+++ E M  G+L                   ++  G  
Sbjct: 80  VKFYGV---------CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 113 TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY 172
              +   I ++I S + +L  Q+  HRD+   N L                 V       
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL-----------------V------- 166

Query: 173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPDKYD 220
              G   ++K+ DFG ++ + S            YY              PE +   K+ 
Sbjct: 167 ---GANLLVKIGDFGMSRDVYST----------DYYRVGGHTMLPIRWMPPESIMYRKFT 213

Query: 221 KSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
              D+WS GVI++ I   G  P+           + N 
Sbjct: 214 TESDVWSFGVILWEIFTYGKQPW---------FQLSNT 242

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 59/281 (20%), Positives = 97/281 (34%), Gaps = 100/281 (35%)

Query: 22  EILGLGINGKV-------LQIVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSH 68
           + LG G  G+V       +   + K +   A+K+L D    +       E+E+   +G H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 69  KHIVNIKDVYENIYNGSRC-----LLVIMECMHGGEL--FQR------------IQQKED 109
           K+I+N+            C     L VI+E    G L  + R            I +  +
Sbjct: 147 KNIINLLGA---------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 110 GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN 169
              T ++      ++   +++L  Q   HRD+   N+L                 V    
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL-----------------V---- 236

Query: 170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPD 217
                  +  ++K+ DFG A+ I +            YY             APE L   
Sbjct: 237 ------TENNVMKIADFGLARDINNID----------YYKKTTNGRLPVKWMAPEALFDR 280

Query: 218 KYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
            Y    D+WS GV+M+ I   G  P+         PG+   
Sbjct: 281 VYTHQSDVWSFGVLMWEIFTLGGSPY---------PGIPVE 312

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.1 bits (133), Expect = 9e-09
 Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 61/237 (25%)

Query: 21  TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA---RREVELQLAVGSHKHIVNIKD- 76
            + +G G  G++       T+E  A+K+     +A     E      +GS   I  +   
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 77  VYENIYNGSRCLLVIMECMHG---GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
                YN      +++E + G    +LF    +     F+ +   +I  ++ S ++++H 
Sbjct: 74  GPCGKYN-----AMVLE-LLGPSLEDLFDLCDRT----FSLKTVLMIAIQLISRMEYVHS 123

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
           +N+ +RDVKPEN L  +PG+            K + +++          + DF  AK+ +
Sbjct: 124 KNLIYRDVKPENFLIGRPGN------------KTQQVIH----------IIDFALAKEYI 161

Query: 194 SNKASLQTPCYTPYYVAPEVLGPDKY--------------DKSCDIWSLG-VIMYIL 235
             +    T  + PY     + G  +Y              D   D+ +LG + MY L
Sbjct: 162 DPE----TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRD---DLEALGHMFMYFL 211

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 44/233 (18%), Positives = 76/233 (32%), Gaps = 87/233 (37%)

Query: 57  REVELQLAVGSHKHIVNIKDVYENIYNGSRC-----LLVIMECMHGGEL--FQR------ 103
            E+E+   +G HK+I+N+            C     L VI+E    G L  + +      
Sbjct: 123 SEMEMMKMIGKHKNIINLLGA---------CTQDGPLYVIVEYASKGNLREYLQARRPPG 173

Query: 104 ------IQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL 157
                      +   + ++      ++   +++L  +   HRD+   N+L          
Sbjct: 174 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---------- 223

Query: 158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV-------- 209
                  V           +  ++K+ DFG A+ I              YY         
Sbjct: 224 -------V----------TEDNVMKIADFGLARDIHHID----------YYKKTTNGRLP 256

Query: 210 ----APEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
               APE L    Y    D+WS GV+++ I   G  P+         PG+   
Sbjct: 257 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY---------PGVPVE 300

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 59/281 (20%), Positives = 97/281 (34%), Gaps = 100/281 (35%)

Query: 22  EILGLGINGKV-------LQIVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSH 68
           + LG G  G+V       +   + K +   A+K+L D    +       E+E+   +G H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 69  KHIVNIKDVYENIYNGSRC-----LLVIMECMHGGEL--FQR------------IQQKED 109
           K+I+N+            C     L VI+E    G L  + R            I +  +
Sbjct: 101 KNIINLLGA---------CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 110 GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN 169
              T ++      ++   +++L  Q   HRD+   N+L                 V    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL-----------------V---- 190

Query: 170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPD 217
                  +  ++K+ DFG A+ I +            YY             APE L   
Sbjct: 191 ------TENNVMKIADFGLARDINNID----------YYKKTTNGRLPVKWMAPEALFDR 234

Query: 218 KYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
            Y    D+WS GV+M+ I   G  P+         PG+   
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPY---------PGIPVE 266

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 49/279 (17%), Positives = 88/279 (31%), Gaps = 99/279 (35%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVLHD--TVKAR----REVELQLAVGSHKH 70
           E LG    GKV +         + ++  A+K L D      R     E  L  A   H +
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML-RARLQHPN 73

Query: 71  IVNIKDVYENIYNGSRC-----LLVIMECMHGGEL--------------FQRIQQKEDGA 111
           +V +  V               L +I      G+L                   +    A
Sbjct: 74  VVCLLGV---------VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 112 FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL 171
               +   ++ +I + +++L   ++ H+D+   N+L                 V      
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL-----------------V------ 161

Query: 172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPDKY 219
                D   +K++D G  +++ +            YY             APE +   K+
Sbjct: 162 ----YDKLNVKISDLGLFREVYAAD----------YYKLLGNSLLPIRWMAPEAIMYGKF 207

Query: 220 DKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
               DIWS GV+++ +   G  P+          G  N+
Sbjct: 208 SIDSDIWSYGVVLWEVFSYGLQPY---------CGYSNQ 237

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 48/271 (17%), Positives = 88/271 (32%), Gaps = 88/271 (32%)

Query: 22  EILGLGINGKVLQ--IVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKHIVN 73
           +++G G  G+VL+  I +       A+K + +            E+E+   +G H +I+N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGEL--------------FQRIQQKEDGAFTEREAAI 119
           +    E+       L + +E    G L                 I        + ++   
Sbjct: 91  LLGACEH----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
              ++   + +L  +   HRD+   N+L                 V          G+  
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNIL-----------------V----------GENY 179

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPDKYDKSCDIWS 227
           + K+ DFG ++                 YV            A E L    Y  + D+WS
Sbjct: 180 VAKIADFGLSRG-------------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 226

Query: 228 LGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
            GV+++ I+  G  P+          GM   
Sbjct: 227 YGVLLWEIVSLGGTPY---------CGMTCA 248

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 6e-08
 Identities = 59/425 (13%), Positives = 121/425 (28%), Gaps = 132/425 (31%)

Query: 16  DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA---RREVELQLAVGSHKHIV 72
           D++             +L + E    + +  K + D  K+   + E++         HI+
Sbjct: 8   DFETGEHQYQ---YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID---------HII 55

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQR----IQQKEDGAFTEREAAIIMNEICSAI 128
             KD            L         E+ Q+    + +                      
Sbjct: 56  MSKDAVSGTL-----RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR 110

Query: 129 KFLHDQNIAHRDV---KPENLLYTKPGDGGILKLTD-FGDVKPEN--LLYTKPGDGGILK 182
            ++  ++  + D       N+   +P     LKL     +++P    L+    G  G   
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQP----YLKLRQALLELRPAKNVLID---GVLG--- 160

Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCD---IW-SLG------VIM 232
               G        K  +          A +V    K     D    W +L        ++
Sbjct: 161 ---SG--------KTWV----------ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199

Query: 233 YIL--LCGF--PPFFSNHGQAISP-----GMKNRIR--LGQFDFPN----------PE-W 270
            +L  L     P + S    + +       ++  +R  L    + N           + W
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259

Query: 271 EHVSQEAKTLI----------------KNMLCVDPSERLTIDQVME--NKWISQ-FNQVP 311
              +   K L+                 ++     S  LT D+V     K++      +P
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP 319

Query: 312 Q-----TPLCT---GKMLKEGEETWPEVQDEMTRSLATMRVDYDQIH--IKSLINSKNPL 361
           +      P       + +++G  TW   +           V+ D++   I+S +N   P 
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWK----------HVNCDKLTTIIESSLNVLEPA 369

Query: 362 LNKRR 366
             ++ 
Sbjct: 370 EYRKM 374

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 52.3 bits (126), Expect = 8e-08
 Identities = 51/261 (19%), Positives = 94/261 (36%), Gaps = 95/261 (36%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVLHDTVKAR------REVELQLAVGSHKH 70
           ++LG G  GKV+      I +   S   A+K+L +   +        E+++   +GSH++
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 71  IVNIKDVYENIYNGSRC-----LLVIMECMHGGEL---------------------FQRI 104
           IVN+            C     + +I E    G+L                      +  
Sbjct: 111 IVNLLGA---------CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 105 QQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD 164
           ++++    T  +      ++   ++FL  ++  HRD+   N+L                 
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL----------------- 204

Query: 165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APE 212
           V            G ++K+ DFG A+ I+S+            YV            APE
Sbjct: 205 V----------THGKVVKICDFGLARDIMSD----------SNYVVRGNARLPVKWMAPE 244

Query: 213 VLGPDKYDKSCDIWSLGVIMY 233
            L    Y    D+WS G++++
Sbjct: 245 SLFEGIYTIKSDVWSYGILLW 265

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.0 bits (125), Expect = 9e-08
 Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 17/150 (11%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKA---RREVELQLAVGSHKHIVNIKD-VYE 79
           +G G  G +    +    E  A+K+     K      E ++   +     I  I+    E
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76

Query: 80  NIYNGSRCLLVIMECMHG---GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
             YN     +++ME + G    +LF    +K    F+ +   ++ +++ S I+++H +N 
Sbjct: 77  GDYN-----VMVME-LLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSKNF 126

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFGDVK 166
            HRDVKP+N L      G ++ + DFG  K
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 51/287 (17%), Positives = 96/287 (33%), Gaps = 107/287 (37%)

Query: 22  EILGLGINGKVLQ-----IVEKKTSEVYALKVLHD--TVKAR----REVELQLAVGSHKH 70
             +G G  G+V Q     ++  +   + A+K+L +  +   +    RE  L +A   + +
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL-MAEFDNPN 111

Query: 71  IVNIKDVYENIYNGSRC-----LLVIMECMHGGEL----------------------FQR 103
           IV +  V         C     + ++ E M  G+L                        R
Sbjct: 112 IVKLLGV---------CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 104 IQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
           +        +  E   I  ++ + + +L ++   HRD+   N L                
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL---------------- 206

Query: 164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------AP 211
            V          G+  ++K+ DFG ++ I S            YY              P
Sbjct: 207 -V----------GENMVVKIADFGLSRNIYSAD----------YYKADGNDAIPIRWMPP 245

Query: 212 EVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
           E +  ++Y    D+W+ GV+++ I   G  P+          GM + 
Sbjct: 246 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---------YGMAHE 283

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 23/149 (15%), Positives = 45/149 (30%), Gaps = 13/149 (8%)

Query: 26  LGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYEN----- 80
                  L        + ++LK+     +   E            +   K +Y       
Sbjct: 60  EAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119

Query: 81  ---IYNGSRCL---LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
              +  G        +++    G  L   +        +ER    +   +  A++FLH+ 
Sbjct: 120 PTCMGFGVHQDKYRFLVLP-SLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN 178

Query: 135 NIAHRDVKPENLLYTKPGDGGILKLTDFG 163
              H +V  EN+    P D   + L  +G
Sbjct: 179 EYVHGNVTAENIF-VDPEDQSQVTLAGYG 206

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 49.7 bits (119), Expect = 5e-07
 Identities = 30/152 (19%), Positives = 69/152 (45%), Gaps = 19/152 (12%)

Query: 24  LGLGINGKVLQIVEKKTSEVYALKVLHDTVKA---RREVELQLAVGSHKHIVNIKD-VYE 79
           +G G  G + +      ++  A+K       A   R E      +     I N+     E
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77

Query: 80  NIYNGSRCLLVIMECMHG---GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
            ++N     +++++ + G    +L     +K    F+ +  A+   ++ + ++ +H++++
Sbjct: 78  GLHN-----VLVID-LLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHEKSL 127

Query: 137 AHRDVKPENLLYTKPG--DGGILKLTDFGDVK 166
            +RD+KP+N L  +P   +  ++ + DFG VK
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 12/57 (21%), Positives = 26/57 (45%), Gaps = 1/57 (1%)

Query: 107 KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
            ++G F +     +   +   ++++H+    H D+K  NLL     +   + L D+G
Sbjct: 143 GQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL-LGYKNPDQVYLADYG 198

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.0 bits (113), Expect = 3e-06
 Identities = 26/142 (18%), Positives = 50/142 (35%), Gaps = 17/142 (11%)

Query: 88  LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENL 146
           L +++E   GG   ++++ K     +   A  I++++ +++          HRD+   N+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193

Query: 147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTP 206
           L  K       KL    + K      T P  G  + + D+  ++                
Sbjct: 194 LLKKTSL---KKLHYTLNGKS----STIPSCGLQVSIIDYTLSRLERDGI------VVFC 240

Query: 207 YYVAPEVLGPDKYDKSCDIWSL 228
                E L     D   DI+ L
Sbjct: 241 DVSMDEDLFTGDGDYQFDIYRL 262

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 46.8 bits (112), Expect = 4e-06
 Identities = 45/274 (16%), Positives = 83/274 (30%), Gaps = 102/274 (37%)

Query: 30  GKVLQIVEKKTSEVYALKVLHD--TVKAR----REVELQLAVGSHKHIVNIKDVYENIYN 83
                +  +      A+K+L +  +         E  +   V  H H++ +         
Sbjct: 42  ATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGA------ 94

Query: 84  GSRC-----LLVIMECMHGGEL----------------------FQRIQQKEDGAFTERE 116
              C     LL+I+E    G L                         +   ++ A T  +
Sbjct: 95  ---CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
                 +I   +++L +  + HRD+   N+L                 V           
Sbjct: 152 LISFAWQISQGMQYLAEMKLVHRDLAARNIL-----------------V----------A 184

Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYV------------APEVLGPDKYDKSCD 224
           +G  +K++DFG ++ +               YV            A E L    Y    D
Sbjct: 185 EGRKMKISDFGLSRDVYE----------EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSD 234

Query: 225 IWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNR 257
           +WS GV+++ I+  G  P+         PG+   
Sbjct: 235 VWSFGVLLWEIVTLGGNPY---------PGIPPE 259

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 28/161 (17%), Positives = 51/161 (31%), Gaps = 49/161 (30%)

Query: 85  SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE 144
           +    V  + +   E  +  +       T         ++   ++FL  +   HRD+   
Sbjct: 163 ASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 222

Query: 145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY 204
           N+L                             +  ++K+ DFG A+ I  +         
Sbjct: 223 NILL---------------------------SEKNVVKICDFGLARDIYKD--------- 246

Query: 205 TPYYV------------APEVLGPDKYDKSCDIWSLGVIMY 233
            P YV            APE +    Y    D+WS GV+++
Sbjct: 247 -PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 12/55 (21%), Positives = 24/55 (43%), Gaps = 1/55 (1%)

Query: 109 DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG 163
              F+ +    +   I   ++++H+    H D+K  NLL     +   + L D+G
Sbjct: 146 AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL-LNYKNPDQVYLVDYG 199

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 39/189 (20%), Positives = 64/189 (33%), Gaps = 55/189 (29%)

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           FLH+ +  HRD+K  N          IL    F                   K++DFG A
Sbjct: 148 FLHENHHIHRDIKSAN----------ILLDEAF-----------TA------KISDFGLA 180

Query: 190 KKIVSNKASLQTPCY--TPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-FSNH 246
           +       ++ T     T  Y+APE L  +   KS DI+S GV++  ++ G P       
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKS-DIYSFGVVLLEIITGLPAVDEHRE 239

Query: 247 GQAI---------SPGMKNRI---RLGQFDFPNPEWEHVSQEAKTLIK-NMLCV--DPSE 291
            Q +                    ++   D         S   + +      C+    ++
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDAD---------STSVEAMYSVASQCLHEKKNK 290

Query: 292 RLTIDQVME 300
           R  I +V +
Sbjct: 291 RPDIKKVQQ 299

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 36/137 (26%), Positives = 54/137 (39%), Gaps = 57/137 (41%)

Query: 123 EIC--SA--IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
           EIC  +A  + +LH + I HRDVK  N          IL   +F                
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSIN----------ILLDENF---------------- 176

Query: 179 GILKLTDFGFAKKIVSNKASLQTPCY-------TPYYVAPEVLGPDKY-------DKSCD 224
            + K+TDFG +KK      +     +       T  Y+ PE      Y       +KS D
Sbjct: 177 -VPKITDFGISKKGTELDQT-----HLSTVVKGTLGYIDPE------YFIKGRLTEKS-D 223

Query: 225 IWSLGVIMYILLCGFPP 241
           ++S GV+++ +LC    
Sbjct: 224 VYSFGVVLFEVLCARSA 240

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	372
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.03
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.68
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.54
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.31
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.03
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.0
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.96
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.96
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.76
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.54
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.35
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.35
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.03
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.01
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.86
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.75
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.67
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.45
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.29
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.18
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.15
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.87
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.17
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.81
2okr_C	26	MAP kinase-activated protein kinase 2; NLS, NES, h	90.94
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.9
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.57

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.3e-65  Score=471.48  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=220.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-----hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-----TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ....|+++ +.||+|+||+||+|.++.+|+.||||++..     .....+|+.+ ++.++||||++++++|++    ++.
T Consensus        72 p~~~y~~~-~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~i-l~~l~HpnIV~l~~~~~~----~~~  145 (346)
T 4fih_A           72 PRSYLDNF-IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVI-MRDYQHENVVEMYNSYLV----GDE  145 (346)
T ss_dssp             GGGTEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHH-HHHCCCTTBCCEEEEEEE----TTE
T ss_pred             hhHhcEEe-EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHH-HHhCCCCCCCcEEEEEEE----CCE
Confidence            34679996 569999999999999999999999999963     2346789988 677799999999999987    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+|||||+||+|.+++.+   +.+++.+++.++.||+.||+|||++||+||||||+|||++                  
T Consensus       146 ~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~------------------  204 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT------------------  204 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------------
T ss_pred             EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC------------------
Confidence            9999999999999999875   3499999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.+||+|||+|+..........+.|||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus       205 ---------~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~  275 (346)
T 4fih_A          205 ---------HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP  275 (346)
T ss_dssp             ---------TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             ---------CCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence                     67789999999999876655666788999999999999999999999999999999999999999976543


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                          ......+... .....+.+..+|+++++||.+||+.||++|||++|+|+||||++.
T Consensus       276 ----~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          276 ----LKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             ----HHHHHHHHHS-SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ----HHHHHHHHcC-CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence                2233444332 222334456899999999999999999999999999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.5e-65  Score=467.29  Aligned_cols=251  Identities=30%  Similarity=0.524  Sum_probs=220.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|++ .+.||+|+||+||+|+++.+|+.||||++...        ....+|+.+ ++.++||||++++++|++    +
T Consensus        31 ~~dy~i-~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~----~  104 (311)
T 4aw0_A           31 PEDFKF-GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV-MSRLDHPFFVKLYFTFQD----D  104 (311)
T ss_dssp             GGGEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HTTCCCTTBCCEEEEEEC----S
T ss_pred             ccccEE-EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEEe----C
Confidence            467999 48899999999999999999999999999632        245678888 677799999999999986    7


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +.+|+|||||+||+|.+++.+.  +.+++.+++.++.||+.||+|||++||+||||||+|||++                
T Consensus       105 ~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~----------------  166 (311)
T 4aw0_A          105 EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----------------  166 (311)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             CEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc----------------
Confidence            7899999999999999999876  4599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccC--CCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSN--KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                 .++.+||+|||+|+.....  .....+.|||+.|||||++.+..|+.++|||||||++|+|++|.+||.
T Consensus       167 -----------~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  235 (311)
T 4aw0_A          167 -----------EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR  235 (311)
T ss_dssp             -----------TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -----------CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                       6778999999999876532  234567899999999999999999999999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhH------HhcCCccccC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQ------VMENKWISQF  307 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~e------il~hp~~~~~  307 (372)
                      +.+.    ..+...+..+.+.+|.    .+|+++++||.+||++||++|||++|      +++||||+++
T Consensus       236 ~~~~----~~~~~~i~~~~~~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          236 AGNE----GLIFAKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             CSSH----HHHHHHHHHTCCCCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             CCCH----HHHHHHHHcCCCCCCc----ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            5442    4456677777776663    68999999999999999999999998      5899999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.6e-65  Score=474.61  Aligned_cols=253  Identities=29%  Similarity=0.535  Sum_probs=214.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|+++ +.||+|+||+||+|+++.+|+.||||++...       ....+|+.+ ++.++||||++++++|++    ++.
T Consensus        24 e~Y~~~-~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~i-l~~l~HpnIV~~~~~~~~----~~~   97 (350)
T 4b9d_A           24 EKYVRL-QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV-LANMKHPNIVQYRESFEE----NGS   97 (350)
T ss_dssp             CCEEEE-EEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHH-HHHCCCTTBCCEEEEEEE----TTE
T ss_pred             cceEEe-EEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHH-HHHCCCCCCCcEEEEEEE----CCE
Confidence            699996 6799999999999999999999999999632       245678888 677799999999999987    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+|||||+||+|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++                  
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~------------------  159 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT------------------  159 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC------------------
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC------------------
Confidence            99999999999999999876666789999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.+||+|||+|+..........+.+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+.
T Consensus       160 ---------~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~  230 (350)
T 4b9d_A          160 ---------KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM  230 (350)
T ss_dssp             ---------TTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ---------CCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence                     56789999999998775443445567899999999999999999999999999999999999999966542


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                          ..+...+..+.++   +.+..+|+++++||.+||+.||++|||++|+|+||||++-
T Consensus       231 ----~~~~~~i~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          231 ----KNLVLKIISGSFP---PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             ----HHHHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             ----HHHHHHHHcCCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence                3345555555543   2235789999999999999999999999999999999764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-63  Score=472.66  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=220.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-----hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-----TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ..+.|+++ +.||+|+||+||+|.++.+|+.||||++..     .....+|+.+ ++.++|||||+++++|++    ++.
T Consensus       149 p~~~y~~~-~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~i-l~~l~HpnIV~l~~~~~~----~~~  222 (423)
T 4fie_A          149 PRSYLDNF-IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVI-MRDYQHENVVEMYNSYLV----GDE  222 (423)
T ss_dssp             GGGTEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHH-HHHCCCTTBCCEEEEEEE----TTE
T ss_pred             hhHhcEee-eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHH-HHhCCCCCCCceEEEEEE----CCE
Confidence            45779996 669999999999999999999999999963     2346789988 677799999999999987    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+|||||+||+|.+++...   .+++.+++.++.||+.||+|||++|||||||||+||||+                  
T Consensus       223 ~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~------------------  281 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT------------------  281 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC------------------
T ss_pred             EEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc------------------
Confidence            99999999999999998753   499999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.+||+|||+|+..........+.|||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus       282 ---------~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~  352 (423)
T 4fie_A          282 ---------HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP  352 (423)
T ss_dssp             ---------TTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             ---------CCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence                     57789999999999876666667788999999999999999999999999999999999999999976543


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                          ......+.... ......+..+|+++++||.+||+.||++|||++|+|+||||++.
T Consensus       353 ----~~~~~~i~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          353 ----LKAMKMIRDNL-PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             ----HHHHHHHHHSC-CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ----HHHHHHHHcCC-CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence                22333443322 22233446799999999999999999999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-63  Score=450.15  Aligned_cols=247  Identities=35%  Similarity=0.635  Sum_probs=202.2

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++. +.||+|+||+||+|.++.+|+.||||++...        ....+|+.+ ++.++||||++++++|++    ++
T Consensus        13 g~Y~i~-~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~~~~~~~~----~~   86 (275)
T 3hyh_A           13 GNYQIV-KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY-LRLLRHPHIIKLYDVIKS----KD   86 (275)
T ss_dssp             -CCEEE-EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHH-HHHCCCTTBCCEEEEEEC----SS
T ss_pred             eCeEEE-EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHH-HHHCCCCCCCeEEEEEEE----CC
Confidence            789995 7799999999999999999999999998632        245688888 677799999999999986    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+||||| +|+|.+++.+.  +.+++.+++.++.||+.||+|||++||+||||||+|||++                 
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~-----------------  146 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD-----------------  146 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC-----------------
T ss_pred             EEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC-----------------
Confidence            899999999 68999999875  4699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                .++.+||+|||+|+.... .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.
T Consensus       147 ----------~~~~vkl~DFGla~~~~~-~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~  215 (275)
T 3hyh_A          147 ----------EHLNVKIADFGLSNIMTD-GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE  215 (275)
T ss_dssp             ----------TTCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ----------CCCCEEEeecCCCeecCC-CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence                      567899999999986543 334456799999999999988776 58999999999999999999999654


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      +    ...+...+..+.+.+|    ..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus       216 ~----~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          216 S----IPVLFKNISNGVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             S----HHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             C----HHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            3    2445666666666655    368999999999999999999999999999999974

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.1e-63  Score=449.18  Aligned_cols=257  Identities=23%  Similarity=0.358  Sum_probs=214.3

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ..++|..+++.||+|+||+||+|.+..+++.||||++...       ....+|+.+ ++.++|||||+++++|++...++
T Consensus        23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~i-l~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEM-LKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHH-HHTCCCTTBCCEEEEEEEEETTE
T ss_pred             CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHH-HHhCCCCCCCcEEEEEeeccCCC
Confidence            4567744467799999999999999999999999999632       235678887 67789999999999998766667


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~--ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ..+|+|||||+||+|.+++.+.  +.+++..++.++.||+.||+|||++|  |+||||||+|||++.             
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~-------------  166 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-------------  166 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS-------------
T ss_pred             cEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC-------------
Confidence            8899999999999999999876  45999999999999999999999998  999999999999972             


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   .++.+||+|||+|+...  .....+.+|||.|||||++.+ .|+.++|||||||++|+|+||..||.
T Consensus       167 -------------~~g~vKl~DFGla~~~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~  230 (290)
T 3fpq_A          167 -------------PTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             -------------TTSCEEECCTTGGGGCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -------------CCCCEEEEeCcCCEeCC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence                         46789999999997543  234556799999999999864 69999999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      +...   ...+...+..+..  |.......++++++||.+||+.||++|||++|+|+||||++
T Consensus       231 ~~~~---~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          231 ECQN---AAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             TCSS---HHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCc---HHHHHHHHHcCCC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            5432   2233444443322  22233567899999999999999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.8e-64  Score=457.80  Aligned_cols=250  Identities=30%  Similarity=0.574  Sum_probs=211.8

Q ss_pred             cceeeccccccccCCeEEEEEEEc---CCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ++|+++ +.||+|+||+||+|++.   .+++.||||++...       ....+|+.+ ++.++||||++++++|++    
T Consensus        24 ~~Y~i~-~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~----   97 (304)
T 3ubd_A           24 SQFELL-KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI-LVEVNHPFIVKLHYAFQT----   97 (304)
T ss_dssp             GGEEEE-EEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CC-CCCCCCTTEECEEEEEEE----
T ss_pred             cccEEE-EEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHH-HHHCCCCCCCeEEEEEEE----
Confidence            689995 77999999999999984   46899999998632       245567777 667799999999999987    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ++.+|+|||||+||+|.+++.+.  +.+++.+++.++.||+.||+|||++||+||||||+|||++               
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---------------  160 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---------------  160 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---------------
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---------------
Confidence            67899999999999999999876  4599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.+||+|||+|+..........+.+||+.|||||++.+..|+.++|||||||++|+|++|..||.+
T Consensus       161 ------------~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~  228 (304)
T 3ubd_A          161 ------------EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG  228 (304)
T ss_dssp             ------------TTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ------------CCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence                        67789999999998766555566778999999999999999999999999999999999999999976


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh-----hHHhcCCccccC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-----DQVMENKWISQF  307 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~-----~eil~hp~~~~~  307 (372)
                      .+.    ..+...+..+.+.+|.    .+|+++++||.+||+.||++|||+     +|+++||||+++
T Consensus       229 ~~~----~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          229 KDR----KETMTMILKAKLGMPQ----FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             SSH----HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cCH----HHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            543    3445666666665553    689999999999999999999995     799999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-62  Score=455.15  Aligned_cols=255  Identities=24%  Similarity=0.286  Sum_probs=214.2

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEec
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      +.|++ .+.||+|+||+||+|+++.+|+.||||+++......+|+.+ ++.++|||||+++++|++    ++.+|+||||
T Consensus        58 ~~~~~-~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~i-l~~l~HpnIV~l~~~~~~----~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTH-QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA-CAGLSSPRIVPLYGAVRE----GPWVNIFMEL  131 (336)
T ss_dssp             TEEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHT-TTTCCCTTBCCEEEEEEE----TTEEEEEECC
T ss_pred             hheEe-CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHH-HHhCCCCCCCcEEEEEEE----CCEEEEEEec
Confidence            45777 46799999999999999999999999999876666788887 677799999999999986    6789999999


Q ss_pred             cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCC
Q psy3151          95 MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTK  174 (372)
Q Consensus        95 ~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~  174 (372)
                      |+||+|.+++.+.  +.+++.+++.++.||+.||+|||++|||||||||+|||++                         
T Consensus       132 ~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~-------------------------  184 (336)
T 4g3f_A          132 LEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS-------------------------  184 (336)
T ss_dssp             CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC-------------------------
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe-------------------------
Confidence            9999999999876  4599999999999999999999999999999999999998                         


Q ss_pred             CCCCC-CeeeeccccccccccCCC-----cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         175 PGDGG-ILKLTDFGFAKKIVSNKA-----SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       175 ~~~~~-~~ki~Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                        .++ .+||+|||+|+.......     .....+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..
T Consensus       185 --~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~  262 (336)
T 4g3f_A          185 --SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG  262 (336)
T ss_dssp             --TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred             --CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence              344 699999999987644221     123468999999999999999999999999999999999999999876655


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH-------------hcCCccccCCC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV-------------MENKWISQFNQ  309 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei-------------l~hp~~~~~~~  309 (372)
                      ++    ...+.....+.. ..+..+++++.+||.+||+.||.+|||+.|+             |+|||+.++..
T Consensus       263 ~~----~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          263 PL----CLKIASEPPPIR-EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             CC----HHHHHHSCCGGG-GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             HH----HHHHHcCCCCch-hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence            54    333333332211 1234789999999999999999999999997             57999987643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.2e-61  Score=461.09  Aligned_cols=335  Identities=64%  Similarity=1.103  Sum_probs=246.6

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      ...+.++|.+..++||.|+||+||+|.+..+|+.||||++.......+|+.++.+..+||||++++++|+....+..++|
T Consensus        56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            34467889886678999999999999999999999999998888888999988888899999999999987666678899


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+.||+|.+++.......+++..++.++.||+.||.|||+.||+||||||+|||++.++                 
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-----------------  198 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-----------------  198 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-----------------
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC-----------------
Confidence            999999999999999876545699999999999999999999999999999999999998422                 


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA  249 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  249 (372)
                             .++.+||+|||++..... .....+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.....
T Consensus       199 -------~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  270 (400)
T 1nxk_A          199 -------PNAILKLTDFGFAKETTS-HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  270 (400)
T ss_dssp             -------TTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS
T ss_pred             -------CCccEEEEecccccccCC-CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc
Confidence                   267899999999986543 233456789999999999999999999999999999999999999998877666


Q ss_pred             CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCCCCccccccccCCCCch
Q psy3151         250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETWP  329 (372)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (372)
                      ....+...+..+.+.++.+.|..++.++.+||.+||+.||++|||++++++||||.+....+..+......+.+..+.|.
T Consensus       271 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (400)
T 1nxk_A          271 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE  350 (400)
T ss_dssp             SCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCCCBCSHHHHHHHC-----
T ss_pred             ccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCCCccccchhhhhhhHHHH
Confidence            65667778888888888888888999999999999999999999999999999999877777777666666667777888


Q ss_pred             hhHHHHHHHHHHhhccCCcceeecccCCCChHHHhhhccC
Q psy3151         330 EVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNKRRKNQ  369 (372)
Q Consensus       330 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (372)
                      ++.+++...+..++.++++..++.+..+.|+.+.++|++.
T Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~rr~~~  390 (400)
T 1nxk_A          351 DVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKA  390 (400)
T ss_dssp             ----------------------------------------
T ss_pred             HHHHHHHHHHHHhccCcccceeccccccccHHHHHHHHhh
Confidence            8889999999999999999999999999999999988865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-60  Score=452.52  Aligned_cols=271  Identities=23%  Similarity=0.415  Sum_probs=214.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeee--cC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENI--YN   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~--~~   83 (372)
                      +.++|+++ +.||+|+||+||+|.++.+|+.||||++...       ....+|+.+ ++.++||||+++++++...  +.
T Consensus        52 i~~~Y~~~-~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           52 VGDEYEII-ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI-LKHFKHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CCSSEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHH-HHHCCCTTBCCEEEECCCSSCTT
T ss_pred             CCCCeEEE-EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHH-HHhcCCCCcceEeeeeecccccc
Confidence            56899995 7799999999999999999999999999632       245679988 6777999999999998642  23


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ..+.+|+|||||. |+|.+++.+.  +.+++.+++.++.||+.||+|||++|||||||||+|||++              
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~--------------  192 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN--------------  192 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC--------------
T ss_pred             cCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC--------------
Confidence            4578999999995 6899999764  4699999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccC----CCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSN----KASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g  238 (372)
                                   .++.+||+|||+|+.+...    .....+.+||++|+|||++.+. .|+.++||||+||++|||++|
T Consensus       193 -------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G  259 (398)
T 4b99_A          193 -------------ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR  259 (398)
T ss_dssp             -------------TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             -------------CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHC
Confidence                         6778999999999876432    2235568999999999998764 579999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhC------------------Ccc-CCCCc----ccccCHHHHHHHHHhccCCCCCCCCh
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLG------------------QFD-FPNPE----WEHVSQEAKTLIKNMLCVDPSERLTI  295 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~------------------~~~-~~~~~----~~~~s~~~~~li~~ll~~dP~~R~s~  295 (372)
                      .+||.+.+..+....+.......                  .++ ..+..    +..++++++|||.+||++||++||||
T Consensus       260 ~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  339 (398)
T 4b99_A          260 RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA  339 (398)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH
Confidence            99997654332211111111000                  000 00000    13578999999999999999999999


Q ss_pred             hHHhcCCccccCCCCCCCCC
Q psy3151         296 DQVMENKWISQFNQVPQTPL  315 (372)
Q Consensus       296 ~eil~hp~~~~~~~~~~~~~  315 (372)
                      +|+|+||||+++......|.
T Consensus       340 ~e~L~Hp~f~~~~~p~~~p~  359 (398)
T 4b99_A          340 AAALRHPFLAKYHDPDDEPD  359 (398)
T ss_dssp             HHHTTSGGGTTTCCGGGSCC
T ss_pred             HHHhcCHhhCcCCCCccccC
Confidence            99999999998765444443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-60  Score=446.60  Aligned_cols=277  Identities=23%  Similarity=0.393  Sum_probs=200.4

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEc---CCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +.+.++|++. +.||+|+||+||+|.++   .+++.||||++...   .+..+|+.++..+.+||||++++++|++    
T Consensus        17 p~l~~~Y~i~-~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~----   91 (361)
T 4f9c_A           17 PQLSNVFKIE-DKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK----   91 (361)
T ss_dssp             GGGGGTCEEE-EEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE----
T ss_pred             CCccCcEEEE-EEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE----
Confidence            3578999994 77999999999999885   46899999998643   3567888886667789999999999987    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ++++|+|||||+||+|.+++.     .+++.+++.++.||+.||+|||++||+||||||+|||++.  +.+.++|+|||+
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGl  164 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGL  164 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTT
T ss_pred             CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCC
Confidence            678999999999999999983     3999999999999999999999999999999999999983  122344444444


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccc------------cCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHH
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIV------------SNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVI  231 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~i  231 (372)
                      ++..        ......+.+|+.+....            .......+.+||++|+|||++.+. .|+.++||||+||+
T Consensus       165 a~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~i  236 (361)
T 4f9c_A          165 AQGT--------HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI  236 (361)
T ss_dssp             CEEC--------TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred             Cccc--------CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHH
Confidence            3321        11112222222111100            011223456899999999998765 58999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCC-CH----------------------------------hHHHHHhhCCcc------------
Q psy3151         232 MYILLCGFPPFFSNHGQAI-SP----------------------------------GMKNRIRLGQFD------------  264 (372)
Q Consensus       232 l~~ll~g~~pf~~~~~~~~-~~----------------------------------~~~~~~~~~~~~------------  264 (372)
                      +|+|++|+.||...+.... ..                                  .....+......            
T Consensus       237 l~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  316 (361)
T 4f9c_A          237 FLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHA  316 (361)
T ss_dssp             HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----------------
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccc
Confidence            9999999999965432110 00                                  000000000000            


Q ss_pred             CCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         265 FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       265 ~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .....|..+|++++|||.+||++||++|+||+|+|+||||+++
T Consensus       317 ~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          317 TNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            1112345789999999999999999999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.4e-59  Score=427.14  Aligned_cols=256  Identities=25%  Similarity=0.386  Sum_probs=195.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC----
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN----   83 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~----   83 (372)
                      .++|+++ +.||+|+||+||+|+++.+|+.||||++...      ....+|+.+ ++.++||||++++++|.....    
T Consensus         4 l~dy~~~-~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~i-l~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPI-QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA-LAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEE-EEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHH-HTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEe-eEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEEecCccccc
Confidence            3568995 7799999999999999999999999998531      245678887 677799999999999874221    


Q ss_pred             ----CceEEEEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          84 ----GSRCLLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        84 ----~~~~~~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                          ...++|+|||||.||+|.+++..... ...++..++.++.||+.||+|||++||+||||||+|||++         
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~---------  152 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---------  152 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---------
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC---------
Confidence                23468999999999999999986432 2245677899999999999999999999999999999998         


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCC------------cccccccCCCcCCCcccCCCCCCCccchh
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA------------SLQTPCYTPYYVAPEVLGPDKYDKSCDIW  226 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  226 (372)
                                        .++.+||+|||+|+.......            ...+.+||+.|||||++.+..|+.++|||
T Consensus       153 ------------------~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Diw  214 (299)
T 4g31_A          153 ------------------MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIF  214 (299)
T ss_dssp             ------------------TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHH
T ss_pred             ------------------CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHH
Confidence                              567799999999987643221            23446899999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         227 SLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       227 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      ||||++|||++   ||.+...   .......+...  .+| +.+...++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       215 SlGvilyell~---Pf~~~~~---~~~~~~~~~~~--~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          215 SLGLILFELLY---PFSTQME---RVRTLTDVRNL--KFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHHHHHHHHS---CCSSHHH---HHHHHHHHHTT--CCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHHHHHHHHcc---CCCCccH---HHHHHHHHhcC--CCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            99999999996   7743210   01112222222  222 234456788999999999999999999999999999987


Q ss_pred             C
Q psy3151         307 F  307 (372)
Q Consensus       307 ~  307 (372)
                      +
T Consensus       286 ~  286 (299)
T 4g31_A          286 L  286 (299)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2e-58  Score=457.92  Aligned_cols=254  Identities=27%  Similarity=0.465  Sum_probs=215.1

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHH--HHHhcCCCCEeEEeEeeeeecC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVEL--QLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~--~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      .++|+++ ++||+|+||+||+|+++.+|+.||||++.+..        ...+|..+  +++.++||||++++++|++   
T Consensus       188 lddf~i~-k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~---  263 (689)
T 3v5w_A          188 MNDFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---  263 (689)
T ss_dssp             GGGEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC---
T ss_pred             hHHeEEE-EEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE---
Confidence            4789995 88999999999999999999999999996321        12233322  2445689999999999987   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ...+|+|||||+||+|.+++.+.  +.+++..++.|+.||+.||+|||++|||||||||+||||+              
T Consensus       264 -~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld--------------  326 (689)
T 3v5w_A          264 -PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD--------------  326 (689)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC--------------
T ss_pred             -CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe--------------
Confidence             78899999999999999999876  4599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-CCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-PDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .+|.+||+|||+|+....  ....+.||||.|||||++. +..|+.++|+|||||++|+|++|.+||
T Consensus       327 -------------~~G~vKL~DFGlA~~~~~--~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF  391 (689)
T 3v5w_A          327 -------------EHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF  391 (689)
T ss_dssp             -------------TTSCEEECCCTTCEECSS--CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             -------------CCCCEEecccceeeecCC--CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                         677899999999987643  2345679999999999996 467999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccCC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQFN  308 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~~  308 (372)
                      .+....+. ..+...+......+|    ..+|+++++||.+||+.||.+|++     ++|+++||||+++.
T Consensus       392 ~~~~~~~~-~~i~~~i~~~~~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          392 RQHKTKDK-HEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             CGGGCCCH-HHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             CCCChHHH-HHHHHhhcCCCCCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            76544332 334455555555554    378999999999999999999998     79999999999763

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-58  Score=459.97  Aligned_cols=262  Identities=31%  Similarity=0.599  Sum_probs=228.4

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ..+.++|+++ +.||+|+||+||+|.++.+|+.||||++...     ....+|+.+ ++.++||||++++++|++    +
T Consensus       153 ~~il~~Y~i~-~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~----~  226 (573)
T 3uto_A          153 DHVLDHYDIH-EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT-MSVLRHPTLVNLHDAFED----D  226 (573)
T ss_dssp             SCGGGTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHH-HHHTCCTTBCCEEEEEEC----S
T ss_pred             CcCccccEEE-EEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHH-HHhCCCCCCCeEEEEEEE----C
Confidence            3466899995 7799999999999999999999999998632     345678888 677799999999999986    7


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+|||||.||+|.+++.... +.+++.+++.++.||+.||+|||++||+||||||+|||++.+              
T Consensus       227 ~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~--------------  291 (573)
T 3uto_A          227 NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--------------  291 (573)
T ss_dssp             SEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--------------
T ss_pred             CEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC--------------
Confidence            88999999999999999997543 469999999999999999999999999999999999999731              


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 ..+.+||+|||+|+.+.. .....+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.
T Consensus       292 -----------~~~~vKl~DFG~a~~~~~-~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~  359 (573)
T 3uto_A          292 -----------RSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE  359 (573)
T ss_dssp             -----------SCCCEEECCCSSCEECCT-TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             -----------CCCCEEEeeccceeEccC-CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                       246899999999988754 33456679999999999999999999999999999999999999999765


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      +.    ......+....+.++...+..+|+++++||.+||+.||.+|||++|+|+||||+....
T Consensus       360 ~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          360 ND----DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             SH----HHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             CH----HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            43    3456667777777777778889999999999999999999999999999999987543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.5e-57  Score=423.46  Aligned_cols=315  Identities=64%  Similarity=1.098  Sum_probs=244.4

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      +...+.++|.+++++||+|+||+||+|.+..+|+.||||++.......+|+...++..+||||+++++++.....++..+
T Consensus        22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            34568999999777899999999999999999999999999887788888888888999999999999998766667789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++                
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~----------------  165 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE----------------  165 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS----------------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC----------------
Confidence            9999999999999999876656799999999999999999999999999999999999997433                


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              ..+.+||+|||++.....  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       166 --------~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (336)
T 3fhr_A          166 --------KDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ  235 (336)
T ss_dssp             --------TTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             --------CCceEEEeccccceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence                    356689999999876542  2334567899999999998888999999999999999999999999877665


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCCCCccccccccCCCCc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEETW  328 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (372)
                      .........+.......+.+.+..+++++.+||.+||+.||.+|||++++++||||++....+..+......+.+..+.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (336)
T 3fhr_A          236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW  315 (336)
T ss_dssp             ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBCSHHHHHHHTGGGH
T ss_pred             hhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCccccccccccccchh
Confidence            55444555566666677777778899999999999999999999999999999999987777777777777777888899


Q ss_pred             hhhHHHHHHHHHHhhccCCcc
Q psy3151         329 PEVQDEMTRSLATMRVDYDQI  349 (372)
Q Consensus       329 ~~~~~~~~~~l~~~~~~~~~~  349 (372)
                      .+..+++.+.+..++++.+++
T Consensus       316 ~~~~~~~~~~l~~~~~~~~~~  336 (336)
T 3fhr_A          316 DEVKEEMTSALATMRVDYDQV  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHCSSCCC
T ss_pred             hHHHHHHHHHHHHhcCCcccC
Confidence            999999999999999988763

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.7e-57  Score=413.26  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=205.6

Q ss_pred             cceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ++|.+ .+.||+|+||+||+|++.     .++..||||+++..     ....+|+.+ ++.++|||||++++++.+    
T Consensus        13 ~~~~l-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~i-l~~l~HpnIV~l~g~~~~----   86 (299)
T 4asz_A           13 HNIVL-KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL-LTNLQHEHIVKFYGVCVE----   86 (299)
T ss_dssp             GGEEE-EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHH-HTTCCCTTBCCEEEEECS----
T ss_pred             HHeEE-eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHH-HHhCCCCCCccEEEEEee----
Confidence            67887 577999999999999875     46889999999642     235678887 677799999999999975    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKE-----------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~-----------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                      ++.+|+|||||++|+|.+++....           ...+++.++..++.||+.||+|||+++|+||||||+|||++    
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~----  162 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----  162 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC----
Confidence            567999999999999999997642           24699999999999999999999999999999999999998    


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHH
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI  231 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  231 (372)
                                             .++.+||+|||+|+........  ....+||+.|||||++.+..|+.++|||||||+
T Consensus       163 -----------------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvv  219 (299)
T 4asz_A          163 -----------------------ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV  219 (299)
T ss_dssp             -----------------------GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             -----------------------CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHH
Confidence                                   5678999999999876443222  233568999999999999999999999999999


Q ss_pred             HHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         232 MYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       232 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +|||+| |+.||.+.+.    ..+...+..+.....   ...+++++.+||.+||+.||++|||++++  |+|++++
T Consensus       220 l~Ellt~G~~Pf~~~~~----~~~~~~i~~~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          220 LWEIFTYGKQPWYQLSN----NEVIECITQGRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HHHHHTTTCCTTTTSCH----HHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCH----HHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence            999998 8999976543    334555555543211   24789999999999999999999999999  4577654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-56  Score=409.43  Aligned_cols=246  Identities=21%  Similarity=0.344  Sum_probs=193.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +++.+ .+.||+|+||+||+|++.   ..||||+++..       ....+|+.+ ++.++|||||++++++..     ..
T Consensus        36 ~~l~l-~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~i-l~~l~HpNIV~l~g~~~~-----~~  105 (307)
T 3omv_A           36 SEVML-STRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAV-LRKTRHVNILLFMGYMTK-----DN  105 (307)
T ss_dssp             TSCCE-EEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHH-HTTCCCTTBCCEEEEECS-----SS
T ss_pred             HHeEE-eeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEEC-----Ce
Confidence            56677 577999999999999864   35999998621       234578877 677799999999998743     35


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+|||||+||+|.+++.... +.+++.++..|+.||+.||+|||+++||||||||+|||++                  
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~------------------  166 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH------------------  166 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE------------------
T ss_pred             EEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC------------------
Confidence            899999999999999997654 5699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccC--CCcccccccCCCcCCCcccC---CCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSN--KASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                               .++.+||+|||+|+.....  .....+.+||+.|||||++.   ..+|+.++|||||||++|||+||+.||
T Consensus       167 ---------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf  237 (307)
T 3omv_A          167 ---------EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY  237 (307)
T ss_dssp             ---------TTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ---------CCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence                     6778999999999865432  22345678999999999984   346999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCcc-CCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFD-FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .+.+..   ..+...+..+... .....+..+++++.+||.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          238 SHINNR---DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             TTCCCH---HHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             CCCChH---HHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            654432   1222333332211 1122345789999999999999999999999987653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5e-56  Score=412.34  Aligned_cols=246  Identities=24%  Similarity=0.418  Sum_probs=196.7

Q ss_pred             cceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ++|.+ .+.||+|+||+||+|++.     .+++.||||++...     ....+|+++ ++.++|||||++++++.+    
T Consensus        41 ~d~~l-~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~i-l~~l~HpnIV~l~g~~~~----  114 (329)
T 4aoj_A           41 RDIVL-KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL-LTMLQHQHIVRFFGVCTE----  114 (329)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHH-HTTCCCTTBCCEEEEECS----
T ss_pred             HHeEE-EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHH-HHhCCCCCCCcEEEEEEE----
Confidence            45666 577999999999999864     46899999999642     235678887 677799999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKE-------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKP  151 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~-------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~  151 (372)
                      +..+|+|||||++|+|.+++.+..             .+++++.++..++.||+.||+|||+++||||||||+|||++  
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~--  192 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG--  192 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE--
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC--
Confidence            667999999999999999997642             24699999999999999999999999999999999999998  


Q ss_pred             CCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHH
Q psy3151         152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG  229 (372)
Q Consensus       152 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  229 (372)
                                               .++.+||+|||+|+.......  .....+||+.|||||++.+..|+.++||||||
T Consensus       193 -------------------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~G  247 (329)
T 4aoj_A          193 -------------------------QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG  247 (329)
T ss_dssp             -------------------------TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHH
T ss_pred             -------------------------CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchH
Confidence                                     677899999999987643322  23456789999999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         230 VIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       230 ~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |++|||+| |+.||.+.+.    ..+...+..+. .+.|    ..+++++.+||.+||+.||++|||++|++++
T Consensus       248 vvl~Ellt~G~~Pf~~~~~----~~~~~~i~~g~~~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          248 VVLWEIFTYGKQPWYQLSN----TEAIDCITQGRELERP----RACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHHTTSCCTTCSSCH----HHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCCCCH----HHHHHHHHcCCCCCCc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            99999999 8999976543    23344444443 2222    4789999999999999999999999999773

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.4e-55  Score=413.29  Aligned_cols=275  Identities=37%  Similarity=0.735  Sum_probs=234.3

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ....+.++|++. +.||+|+||+||+|.++.+|+.||||++... ....+|++++.++.+||||+++++++++    +..
T Consensus        16 ~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~----~~~   90 (342)
T 2qr7_A           16 NSIQFTDGYEVK-EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDD----GKY   90 (342)
T ss_dssp             ---CHHHHEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEEC----SSE
T ss_pred             cccCccccEEEE-EEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEc----CCE
Confidence            345688999995 7799999999999999999999999999754 3456788887788899999999999976    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+.||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||+..++.              
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~--------------  154 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESG--------------  154 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSC--------------
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCC--------------
Confidence            99999999999999999765  45999999999999999999999999999999999999863221              


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               ..+.+||+|||++...........+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+...
T Consensus       155 ---------~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  225 (342)
T 2qr7_A          155 ---------NPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD  225 (342)
T ss_dssp             ---------SGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred             ---------CcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence                     23469999999998776555556677899999999999877899999999999999999999999975432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCCC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTP  314 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~~  314 (372)
                       .....+...+..+.+.++...|..+++++++||.+||+.||++|||++++++||||.++...+...
T Consensus       226 -~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~~~~  291 (342)
T 2qr7_A          226 -DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ  291 (342)
T ss_dssp             -SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSCCSC
T ss_pred             -CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccccccc
Confidence             233456777778888877777788999999999999999999999999999999998876555443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.1e-56  Score=408.10  Aligned_cols=247  Identities=21%  Similarity=0.324  Sum_probs=203.6

Q ss_pred             cceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      +.++++ +.||+|+||+||+|...     .+++.||||++...      ....+|+.+ ++.++|||||++++++..   
T Consensus        26 ~~~~~~-~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~i-l~~l~HpNIV~l~g~~~~---  100 (308)
T 4gt4_A           26 SAVRFM-EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML-RARLQHPNVVCLLGVVTK---  100 (308)
T ss_dssp             GGEEEE-EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHH-HHHCCCTTBCCEEEEECS---
T ss_pred             HHCeEe-eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHH-HHhCCCCCCCCcceEEEE---
Confidence            567775 66999999999999853     46789999999632      345678877 677799999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeee
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYT  149 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~  149 (372)
                       ++.+|+|||||++|+|.+++....              ...+++..+..++.||+.||+|||+++||||||||+|||++
T Consensus       101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence             567899999999999999997532              13599999999999999999999999999999999999998


Q ss_pred             cCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCCCCCccchhh
Q psy3151         150 KPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWS  227 (372)
Q Consensus       150 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  227 (372)
                                                 .++.+||+|||+|+......  ......+||+.|||||++.+..|+.++||||
T Consensus       180 ---------------------------~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwS  232 (308)
T 4gt4_A          180 ---------------------------DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS  232 (308)
T ss_dssp             ---------------------------GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             ---------------------------CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhh
Confidence                                       56789999999998764432  2344568999999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         228 LGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       228 lG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||++|||+| |..||.+.+.    ..+...+..+... +  ....+++++.+||.+||+.||++|||+.|++++
T Consensus       233 fGvvl~El~t~g~~Pf~~~~~----~~~~~~i~~~~~~-~--~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          233 YGVVLWEVFSYGLQPYCGYSN----QDVVEMIRNRQVL-P--CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHHHHTTTCCTTTTCCH----HHHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCC-C--CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999998 8999976543    2344555544322 2  224789999999999999999999999999874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-55  Score=412.32  Aligned_cols=250  Identities=22%  Similarity=0.391  Sum_probs=206.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCC-----CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKT-----SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .++|++ .+.||+|+||+||+|.+..+     ++.||||.+...      ....+|+.++.++.+|||||++++++..  
T Consensus        63 ~~~~~l-~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~--  139 (353)
T 4ase_A           63 RDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--  139 (353)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred             HHHeEE-eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe--
Confidence            478998 57899999999999998654     468999998632      2356788887777677999999998753  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceee
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLY  148 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli  148 (372)
                       .++.+|+|||||++|+|.++++...              ...+++.++..++.||+.||+|||+++||||||||+|||+
T Consensus       140 -~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          140 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             -TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             -cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence             2456899999999999999997642              2358999999999999999999999999999999999999


Q ss_pred             ecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchh
Q psy3151         149 TKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIW  226 (372)
Q Consensus       149 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  226 (372)
                      +                           .++.+||+|||+|+.......  ...+.+||+.|||||++.+..|+.++|||
T Consensus       219 ~---------------------------~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVw  271 (353)
T 4ase_A          219 S---------------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW  271 (353)
T ss_dssp             C---------------------------GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred             C---------------------------CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEe
Confidence            8                           567899999999987644332  23456789999999999999999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         227 SLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       227 slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ||||++|||+| |..||.+....   ..+...+..+. ...|    ..+++++.+||.+||+.||++|||+.|+++|
T Consensus       272 S~Gv~l~El~t~G~~Pf~~~~~~---~~~~~~i~~g~~~~~p----~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          272 SFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCS---HHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ehHHHHHHHHhCCCCCCCCCCHH---HHHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            99999999998 99999764432   33444444432 2222    3689999999999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.4e-54  Score=400.57  Aligned_cols=280  Identities=38%  Similarity=0.714  Sum_probs=214.1

Q ss_pred             ccCCcccceeec--cccccccCCeEEEEEEEcCCCcEEEEEEecch--hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151           9 KTTPIQDDYDIS--TEILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus         9 ~~~~~~~~Y~i~--~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +..+|.++|++.  ++.||+|+||+||+|.+..+|+.||||++...  ....+|+.++..+.+||||+++++++.+    
T Consensus         2 ~~~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~----   77 (325)
T 3kn6_A            2 KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD----   77 (325)
T ss_dssp             CCCHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred             CCCcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc----
Confidence            346678899983  36799999999999999999999999999753  3556788886666569999999999976    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...|+||||+++|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++.++            
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~------------  143 (325)
T 3kn6_A           78 QLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN------------  143 (325)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC--------------
T ss_pred             CCEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC------------
Confidence            67899999999999999999875  4599999999999999999999999999999999999998422            


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  ....+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus       144 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  211 (325)
T 3kn6_A          144 ------------DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS  211 (325)
T ss_dssp             --------------CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             ------------CcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                        23479999999998765555555677889999999999999999999999999999999999999976


Q ss_pred             CCCCC---CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCCCCccc
Q psy3151         245 NHGQA---ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTG  318 (372)
Q Consensus       245 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~  318 (372)
                      .....   ....+...+..+.+.++...+..+++++++||.+||+.||.+|||++++++||||++....+..+...+
T Consensus       212 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~~~  288 (325)
T 3kn6_A          212 HDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTP  288 (325)
T ss_dssp             ------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCSHH
T ss_pred             CccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCCCC
Confidence            54321   123456667777777777777789999999999999999999999999999999998766655554433

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.3e-54  Score=403.91  Aligned_cols=264  Identities=34%  Similarity=0.573  Sum_probs=226.2

Q ss_pred             CccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----------hhhHHHHHHHHHhcCCCCEeEEeE
Q psy3151           8 FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------VKARREVELQLAVGSHKHIVNIKD   76 (372)
Q Consensus         8 ~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~ni~~~~~   76 (372)
                      .+...+.++|++ .+.||+|+||+||+|.+..+|+.||||++...           ....+|+.+ ++.++||||+++++
T Consensus         5 ~~~~~~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~   82 (361)
T 2yab_A            5 FKQQKVEDFYDI-GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI-LRQVLHPNIITLHD   82 (361)
T ss_dssp             CBCSCGGGTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHH-HTTCCCTTBCCEEE
T ss_pred             ccCCChhhceEE-eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHH-HHhCCCcCCCcEEE
Confidence            456778999999 57899999999999999999999999999632           234678877 66778999999999


Q ss_pred             eeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCc
Q psy3151          77 VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        77 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                      +|++    ...+|+||||+.||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.   
T Consensus        83 ~~~~----~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~---  153 (361)
T 2yab_A           83 VYEN----RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI---  153 (361)
T ss_dssp             EEEC----SSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS---
T ss_pred             EEEe----CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCC---
Confidence            9976    67899999999999999999764  46999999999999999999999999999999999999973221   


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  236 (372)
                                          ....+||+|||++..... .......+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus       154 --------------------~~~~vkl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll  212 (361)
T 2yab_A          154 --------------------PIPHIKLIDFGLAHEIED-GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL  212 (361)
T ss_dssp             --------------------SSCCEEECCCSSCEECCT-TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             --------------------CccCEEEEecCCceEcCC-CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHH
Confidence                                223799999999987644 23345678999999999999889999999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +|..||.+.+.    ......+..+.+.++...+..+++++++||.+||..||.+|||++|+|+||||+..
T Consensus       213 ~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          213 SGASPFLGDTK----QETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HSCCSSCCSSH----HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             hCCCCCCCCCH----HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            99999976432    34456666677777666667899999999999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.6e-53  Score=392.99  Aligned_cols=255  Identities=33%  Similarity=0.600  Sum_probs=219.6

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ..+..++|+++ +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++..  
T Consensus        10 ~~~~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~--   85 (328)
T 3fe3_A           10 EQPHIGNYRLL-KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRI-MKILNHPNIVKLFEVIET--   85 (328)
T ss_dssp             -CCEETTEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHH-HHHCCCTTBCCEEEEEEC--
T ss_pred             cCCccCCEEEE-EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEEE--
Confidence            34567899995 7899999999999999999999999998632       234578887 677799999999999876  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        .+.+|+||||+.+|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++             
T Consensus        86 --~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~-------------  148 (328)
T 3fe3_A           86 --EKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD-------------  148 (328)
T ss_dssp             --SSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-------------
T ss_pred             --CCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc-------------
Confidence              67899999999999999999876  4599999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCC-CccchhhHHHHHHHHHhCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~p  241 (372)
                                    .++.+||+|||++..... .......+||++|+|||++.+..++ .++|||||||++|+|++|..|
T Consensus       149 --------------~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  213 (328)
T 3fe3_A          149 --------------ADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP  213 (328)
T ss_dssp             --------------TTSCEEECSTTCCGGGSS-SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             --------------CCCCEEEeeccCceecCC-CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence                          567899999999986643 2345667899999999999877765 799999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      |.+.+    ...+...+..+.+..|.    .+++++.+||.+||..||.+|||++|+++||||+...
T Consensus       214 f~~~~----~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          214 FDGQN----LKELRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             SCCSS----HHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             CCCCC----HHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            96543    23455666666666553    6899999999999999999999999999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.5e-53  Score=402.87  Aligned_cols=257  Identities=29%  Similarity=0.511  Sum_probs=220.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|+++ ++||+|+||+||+|+++.+++.||||++...        ....+|..++..+.+||||++++++|.+    .
T Consensus        51 ~~~y~~~-~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----~  125 (396)
T 4dc2_A           51 LQDFDLL-RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----E  125 (396)
T ss_dssp             GGGEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC----S
T ss_pred             hhHcEEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE----C
Confidence            4689995 7899999999999999999999999999643        2345777776677799999999999986    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+||||++||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----------------  187 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----------------  187 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----------------
T ss_pred             CEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC----------------
Confidence            7899999999999999999876  3599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||+|+..........+.+||+.|+|||++.+..|+.++|+|||||++|+|++|..||...
T Consensus       188 -----------~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          188 -----------SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             -----------TTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             -----------CCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence                       667899999999986544455567789999999999999999999999999999999999999999644


Q ss_pred             CCCC-----CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh------hHHhcCCccccCC
Q psy3151         246 HGQA-----ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI------DQVMENKWISQFN  308 (372)
Q Consensus       246 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~------~eil~hp~~~~~~  308 (372)
                      ...+     ....+...+......+|.    .++.++++||++||+.||.+||++      +|+++||||+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          257 GSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             TC------CCHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             ccccccchhhHHHHHHHHhccccCCCC----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            2211     123345566666666654    689999999999999999999996      7999999998763

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.7e-53  Score=410.69  Aligned_cols=262  Identities=34%  Similarity=0.643  Sum_probs=227.5

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ...+.++|++. +.||+|+||+||+|.+..+|+.||+|++...       ....+|+.+ ++.++||||+++++++.+  
T Consensus         6 ~~~~~~~Y~i~-~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~--   81 (444)
T 3soa_A            6 CTRFTEEYQLF-EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI-CRLLKHPNIVRLHDSISE--   81 (444)
T ss_dssp             -CHHHHHEEEE-EEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHH-HHHCCBTTBCCEEEEEEC--
T ss_pred             cccccCCeEEE-EEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHH-HHhCCCcCCCeEEEEEEE--
Confidence            34578999995 7799999999999999999999999998632       234678877 667799999999999976  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        ++..|+||||+.||+|.+.+...  +.+++..++.++.||+.||.|||++||+||||||+|||++.+.          
T Consensus        82 --~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~----------  147 (444)
T 3soa_A           82 --EGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL----------  147 (444)
T ss_dssp             --SSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS----------
T ss_pred             --CCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC----------
Confidence              77899999999999999999875  4599999999999999999999999999999999999998533          


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    .++.+||+|||+|.............+||+.|+|||++.+..|+.++|||||||++|+|++|.+||
T Consensus       148 --------------~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf  213 (444)
T 3soa_A          148 --------------KGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF  213 (444)
T ss_dssp             --------------TTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             --------------CCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence                          357799999999987765555556678999999999999989999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .+.+    ...+...+..+.+.++.+.|..+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       214 ~~~~----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          214 WDED----QHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             CCSS----HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             CCcc----HHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            6543    245567778888888888888999999999999999999999999999999999753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.9e-53  Score=400.36  Aligned_cols=252  Identities=30%  Similarity=0.552  Sum_probs=213.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|+++ +.||+|+||+||+|+++.+|+.||||++...        ....+|..++..+.+||||++++++|.+    .
T Consensus        22 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----~   96 (353)
T 3txo_A           22 IDNFEFI-RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----P   96 (353)
T ss_dssp             -CCEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----S
T ss_pred             hhheEEE-EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe----C
Confidence            4789995 7899999999999999999999999999642        2345677775556689999999999986    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+||||+.||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~----------------  158 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD----------------  158 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----------------
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC----------------
Confidence            78999999999999999998763  599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||+|...........+.+||+.|+|||++.+..|+.++|+|||||++|+|++|..||.+.
T Consensus       159 -----------~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  227 (353)
T 3txo_A          159 -----------HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE  227 (353)
T ss_dssp             -----------TTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -----------CCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence                       567899999999986554455566788999999999998888999999999999999999999999655


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh------hHHhcCCccccC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI------DQVMENKWISQF  307 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~------~eil~hp~~~~~  307 (372)
                      +.    ..+...+..+...+|.    .+++++.+||++||+.||.+||++      +++++||||+++
T Consensus       228 ~~----~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          228 NE----DDLFEAILNDEVVYPT----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             SH----HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             CH----HHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            42    3456666666666653    689999999999999999999998      899999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.7e-53  Score=389.87  Aligned_cols=254  Identities=20%  Similarity=0.231  Sum_probs=192.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--hhHHHHHHH-HHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--KARREVELQ-LAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~e~~~~-~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      ..+|.+ ++.||+|+||+||+|++  +|+.||||++....  ...+|.++. +..++||||+++++++.........+|+
T Consensus         2 ar~i~L-~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            2 ARTIVL-QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEE-EEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEE-EEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            467877 68899999999999987  58999999996432  233454443 3456899999999998764333457999


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCceeeecCCCCCceeeecc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ--------NIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~--------~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      |||||++|+|.+++...   .++++.+..++.|++.||+|||++        +|+||||||+|||++             
T Consensus        79 V~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-------------  142 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------------  142 (303)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-------------
T ss_pred             EecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-------------
Confidence            99999999999999764   499999999999999999999987        999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCCC------CCCCccchhhHHHHH
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGPD------KYDKSCDIWSLGVIM  232 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il  232 (372)
                                    .++.+||+|||+|+.......    .....+||+.|||||++.+.      .|+.++|||||||++
T Consensus       143 --------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl  208 (303)
T 3hmm_A          143 --------------KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF  208 (303)
T ss_dssp             --------------TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred             --------------CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHH
Confidence                          677899999999987654322    22346899999999998654      367799999999999


Q ss_pred             HHHHhCCCCCCCCCCCC----------CC-HhHHHHHhhCCccCCCCcc---cccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         233 YILLCGFPPFFSNHGQA----------IS-PGMKNRIRLGQFDFPNPEW---EHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       233 ~~ll~g~~pf~~~~~~~----------~~-~~~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |||+||.+||.......          .. ..+...+.......+.+..   ...+..+.+|+.+||+.||++|||+.|+
T Consensus       209 ~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei  288 (303)
T 3hmm_A          209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  288 (303)
T ss_dssp             HHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred             HHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence            99999988764432211          11 1223333333332222211   1234578899999999999999999999


Q ss_pred             hc
Q psy3151         299 ME  300 (372)
Q Consensus       299 l~  300 (372)
                      ++
T Consensus       289 ~~  290 (303)
T 3hmm_A          289 KK  290 (303)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-52  Score=390.60  Aligned_cols=252  Identities=36%  Similarity=0.657  Sum_probs=218.2

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|+++ +.||+|+||+||+|+++.+|+.||||++...        ....+|+.+ ++.++||||++++++|..    .
T Consensus         4 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~~----~   77 (337)
T 1o6l_A            4 MNDFDYL-KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV-LQNTRHPFLTALKYAFQT----H   77 (337)
T ss_dssp             GGGEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHSCCCTTBCCEEEEEEC----S
T ss_pred             hHHeEEE-EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHH-HHhCCCCcCcceEEEEEe----C
Confidence            3789995 7899999999999999999999999999642        234567766 667799999999999986    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+||||++||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----------------  139 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----------------  139 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----------------
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC----------------
Confidence            7899999999999999999875  3599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||++...........+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.
T Consensus       140 -----------~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  208 (337)
T 1o6l_A          140 -----------KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             -----------TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -----------CCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence                       567899999999986554445566788999999999999999999999999999999999999999654


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccCC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFN  308 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~~  308 (372)
                      +.    ..+...+......+|.    .+++++.+||.+||+.||++||     +++++++||||..+.
T Consensus       209 ~~----~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          209 DH----ERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             SH----HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CH----HHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            32    3345555556555553    6899999999999999999999     899999999998753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.4e-53  Score=396.43  Aligned_cols=262  Identities=30%  Similarity=0.583  Sum_probs=222.7

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc----------hhhhHHHHHHHHHhcCCCCEeEEeEeeee
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD----------TVKARREVELQLAVGSHKHIVNIKDVYEN   80 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~   80 (372)
                      ..+.++|++. +.||+|+||+||+|.+..+|+.||||++..          .....+|+.+ ++.++||||+++++++..
T Consensus        20 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~   97 (351)
T 3c0i_A           20 VLFEDVYELC-EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI-CHMLKHPHIVELLETYSS   97 (351)
T ss_dssp             CCHHHHEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHH-HHHCCCTTBCCEEEEEEE
T ss_pred             CccccceEEe-eEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHH-HHhCCCCCCCcEEEEEEe
Confidence            3477899994 789999999999999999999999999852          2335678877 667799999999999986


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKE--DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~--~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                          +..+|+||||+++++|.+.+....  ...+++..++.++.||+.||+|||++||+||||||+|||++.++      
T Consensus        98 ----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~------  167 (351)
T 3c0i_A           98 ----DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE------  167 (351)
T ss_dssp             ----TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS------
T ss_pred             ----CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC------
Confidence                678999999999999998886532  23589999999999999999999999999999999999998433      


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                        ..+.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       168 ------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  229 (351)
T 3c0i_A          168 ------------------NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG  229 (351)
T ss_dssp             ------------------TTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             ------------------CCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHC
Confidence                              34568999999998765544445567899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ..||.+..     ......+..+.+..+...+..+++++.+||.+||+.||++|||+.++|+||||+..
T Consensus       230 ~~pf~~~~-----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          230 CLPFYGTK-----ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             SCSSCSSH-----HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCCCCCcH-----HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            99996532     34455566666666655567889999999999999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.9e-53  Score=394.17  Aligned_cols=254  Identities=30%  Similarity=0.522  Sum_probs=219.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      -.++|.+ .+.||+|+||+||+|+++.+|+.||||++...        .....|..++....+||||++++++|.+    
T Consensus        15 ~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----   89 (345)
T 1xjd_A           15 KIEDFIL-HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----   89 (345)
T ss_dssp             -CTTEEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----
T ss_pred             ChHHeEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----
Confidence            4578999 58899999999999999999999999999643        2345677776666799999999999986    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+|+||||++||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---------------  152 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---------------  152 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---------------
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC---------------
Confidence            678999999999999999998753  599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.+||+|||+|...........+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+
T Consensus       153 ------------~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (345)
T 1xjd_A          153 ------------KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  220 (345)
T ss_dssp             ------------TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ------------CCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence                        56789999999998654444456678899999999999999999999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChh-HHhcCCccccCC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID-QVMENKWISQFN  308 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~-eil~hp~~~~~~  308 (372)
                      .+.    ..+...+......+|    ..+++++.+||.+||+.||++|||+. ++++||||+++.
T Consensus       221 ~~~----~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          221 QDE----EELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             SSH----HHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             CCH----HHHHHHHHhCCCCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            442    344555665555554    36899999999999999999999998 999999998764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.2e-52  Score=391.01  Aligned_cols=257  Identities=29%  Similarity=0.513  Sum_probs=217.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|+++ +.||+|+||+||+|+++.+|+.||||++...        ....+|..++..+.+||||++++++|.+    .
T Consensus         8 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----~   82 (345)
T 3a8x_A            8 LQDFDLL-RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----E   82 (345)
T ss_dssp             GGGEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----S
T ss_pred             hhheEEE-EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe----C
Confidence            4789995 7899999999999999999999999999642        1245677775566699999999999976    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+||||+++|+|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----------------  144 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----------------  144 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----------------
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----------------
Confidence            78999999999999999998753  599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||++...........+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||...
T Consensus       145 -----------~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  213 (345)
T 3a8x_A          145 -----------SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  213 (345)
T ss_dssp             -----------TTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred             -----------CCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence                       567899999999986544444556778999999999999999999999999999999999999999653


Q ss_pred             CCC-----CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh------hHHhcCCccccCC
Q psy3151         246 HGQ-----AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI------DQVMENKWISQFN  308 (372)
Q Consensus       246 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~------~eil~hp~~~~~~  308 (372)
                      ...     .....+...+......+|.    .++.++++||.+||+.||.+|||+      +++++||||+++.
T Consensus       214 ~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          214 GSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             TC-------CHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             ccccccccccHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            221     1112344555555555553    689999999999999999999996      7999999998753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-52  Score=396.10  Aligned_cols=262  Identities=36%  Similarity=0.677  Sum_probs=225.8

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ....+.++|++. +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++.+ 
T Consensus        23 ~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~~~~~~~~-   99 (362)
T 2bdw_A           23 ASTKFSDNYDVK-EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQE-   99 (362)
T ss_dssp             -CCHHHHHEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHH-HHHCCCTTBCCEEEEEEC-
T ss_pred             CCCCcccCeEEe-eEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEEe-
Confidence            344578899994 7799999999999999999999999999632       234578877 666799999999999976 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         +...|+||||+.+|+|.+.+...  +.+++..++.++.||+.||.|||++||+||||||+|||++.++         
T Consensus       100 ---~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~---------  165 (362)
T 2bdw_A          100 ---ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA---------  165 (362)
T ss_dssp             ---SSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS---------
T ss_pred             ---CCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC---------
Confidence               67899999999999999999765  4599999999999999999999999999999999999998433         


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                     ..+.+||+|||++..... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..|
T Consensus       166 ---------------~~~~~kl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P  229 (362)
T 2bdw_A          166 ---------------KGAAVKLADFGLAIEVND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP  229 (362)
T ss_dssp             ---------------TTCCEEECCCTTCBCCTT-CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ---------------CCCCEEEeecCcceEecC-CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence                           345689999999876643 2234456899999999999998999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |.+.+.    ..+...+..+.+.++.+.|..+++++.+||.+||+.||.+|||++++|+||||...
T Consensus       230 f~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          230 FWDEDQ----HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             SCCSSH----HHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             CCCCCH----HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            965432    34566777788888888888999999999999999999999999999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.5e-52  Score=382.20  Aligned_cols=256  Identities=26%  Similarity=0.446  Sum_probs=215.6

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ....++|+++ +.||+|+||+||+|.+..+|+.||||++...     ....+|+.+ ++.++||||+++++++..    +
T Consensus        16 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~----~   89 (297)
T 3fxz_A           16 GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV-MRENKNPNIVNYLDSYLV----G   89 (297)
T ss_dssp             SCGGGTBCCC-EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHH-HHHCCCTTBCCEEEEEEE----T
T ss_pred             CChhhceeee-eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHH-HhcCCCCCCCeEeEEEEE----C
Confidence            3467899995 7799999999999999999999999998532     334567776 677799999999999986    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+||||+.+|+|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----------------  150 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----------------  150 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----------------
T ss_pred             CEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC----------------
Confidence            6799999999999999999764   499999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus       151 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  219 (297)
T 3fxz_A          151 -----------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (297)
T ss_dssp             -----------TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             -----------CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                       567799999999987765555566678999999999998899999999999999999999999999654


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ....   .............  .....+++.+.+||.+||+.||++|||++|+++||||+..
T Consensus       220 ~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          220 NPLR---ALYLIATNGTPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             CHHH---HHHHHHHHCSCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CHHH---HHHHHHhCCCCCC--CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            3211   1122222222222  2234789999999999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-53  Score=392.16  Aligned_cols=259  Identities=28%  Similarity=0.587  Sum_probs=222.5

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .+.++|++. +.||+|+||+||+|.+..+|+.||+|++...    ....+|+.+ ++.++||||+++++++++    ...
T Consensus         2 ~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~----~~~   75 (321)
T 1tki_A            2 ELYEKYMIA-EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISI-LNIARHRNILHLHESFES----MEE   75 (321)
T ss_dssp             CCTTTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHH-HHHSCCTTBCCEEEEEEE----TTE
T ss_pred             chhhceEee-eEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHH-HHhCCCCCCCeEeEEEec----CCE
Confidence            478999994 7799999999999999999999999998632    234578877 677799999999999976    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+                
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~----------------  138 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR----------------  138 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS----------------
T ss_pred             EEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC----------------
Confidence            999999999999999997643 469999999999999999999999999999999999999731                


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus       139 ---------~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  208 (321)
T 1tki_A          139 ---------RSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN  208 (321)
T ss_dssp             ---------SCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             ---------CCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence                     2578999999999876432 234556789999999999988899999999999999999999999965432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                          ......+..+.+.++...+..++.++.+||.+||..||.+|||+.|+|+||||++.
T Consensus       209 ----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          209 ----QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ----HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ----HHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                34456666666666665667899999999999999999999999999999999864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-52  Score=385.72  Aligned_cols=290  Identities=62%  Similarity=1.079  Sum_probs=242.1

Q ss_pred             CccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151           8 FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus         8 ~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .+...+.++|.++.++||+|+||+||+|.+..+|+.||||++.......+|+..+.+..+||||+++++++.....++..
T Consensus        10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            34556889999976889999999999999999999999999988888899999988999999999999999866666788


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++               
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---------------  154 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR---------------  154 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS---------------
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC---------------
Confidence            99999999999999999887656799999999999999999999999999999999999998422               


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.+||+|||++....                      +..++.++|||||||++|+|++|..||.....
T Consensus       155 ---------~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  203 (299)
T 3m2w_A          155 ---------PNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  203 (299)
T ss_dssp             ---------TTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred             ---------CCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence                     26789999999886432                      24577899999999999999999999976554


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCCCCccccccccCCCC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEET  327 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  327 (372)
                      ..........+..+....+.+.+..+++++.+||.+||+.||.+|||++|+++||||++....+..+........+..+.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~  283 (299)
T 3m2w_A          204 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER  283 (299)
T ss_dssp             ----CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBCSHHHHHHHTGGG
T ss_pred             hhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCCcccccchhhcch
Confidence            33322222333334444454445678999999999999999999999999999999999888888777777777788888


Q ss_pred             chhhHHHHHHHHHHhh
Q psy3151         328 WPEVQDEMTRSLATMR  343 (372)
Q Consensus       328 ~~~~~~~~~~~l~~~~  343 (372)
                      |+++.++++..+.++|
T Consensus       284 ~~~~~~~~~~~l~~~~  299 (299)
T 3m2w_A          284 WEDVKEEMTSALATMR  299 (299)
T ss_dssp             HHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHhhC
Confidence            9999999988887654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-51  Score=391.42  Aligned_cols=266  Identities=27%  Similarity=0.497  Sum_probs=218.8

Q ss_pred             CCCccCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEe
Q psy3151           1 MTPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIV   72 (372)
Q Consensus         1 ~~~~~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~   72 (372)
                      |.|.+.+.... ..++|+++ +.||+|+||+||+|.+..+|+.||+|++...        ....+|+.+ ++.++||||+
T Consensus         2 ~pp~~~~~~~v-~~~~y~i~-~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv   78 (384)
T 4fr4_A            2 MPPVFDENEDV-NFDHFEIL-RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI-MQGLEHPFLV   78 (384)
T ss_dssp             ------CCCCC-CGGGEEEE-EEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHTCCCTTBC
T ss_pred             CCCccCCCCCC-ChHHeEEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHH-HHhCCCCCCC
Confidence            44555554433 45889995 7899999999999999999999999998632        234578877 6777999999


Q ss_pred             EEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCC
Q psy3151          73 NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~  152 (372)
                      +++++|.+    ...+|+||||+.||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++   
T Consensus        79 ~l~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---  149 (384)
T 4fr4_A           79 NLWYSFQD----EEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---  149 (384)
T ss_dssp             CEEEEEEC----SSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---
T ss_pred             cEEEEEEe----CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC---
Confidence            99999986    67899999999999999999764  4599999999999999999999999999999999999998   


Q ss_pred             CCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC---CCCCCccchhhHH
Q psy3151         153 DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP---DKYDKSCDIWSLG  229 (372)
Q Consensus       153 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG  229 (372)
                                              .++.+||+|||+|..... .....+.+||+.|+|||++..   ..|+.++|+||||
T Consensus       150 ------------------------~~g~vkL~DFG~a~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG  204 (384)
T 4fr4_A          150 ------------------------EHGHVHITDFNIAAMLPR-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG  204 (384)
T ss_dssp             ------------------------TTSCEEECCCTTCEECCT-TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHH
T ss_pred             ------------------------CCCCEEEeccceeeeccC-CCceeccCCCccccCCeeeccCCCCCCCccceeechH
Confidence                                    677899999999987643 334566789999999999863   4589999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-hhHHhcCCccccCC
Q psy3151         230 VIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-IDQVMENKWISQFN  308 (372)
Q Consensus       230 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-~~eil~hp~~~~~~  308 (372)
                      |++|+|++|..||........ ..+...+......+|.    .+++++.+||.+||+.||.+||+ ++++++||||+++.
T Consensus       205 ~il~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          205 VTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPS----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             HHHHHHHHSSCSSCCCTTSCH-HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             HHHHHHHhCCCCCCCCCCccH-HHHHHHHhhcccCCCC----cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            999999999999976544332 3344444555554443    68999999999999999999998 89999999998753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.6e-52  Score=384.93  Aligned_cols=268  Identities=35%  Similarity=0.720  Sum_probs=215.6

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-----hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-----TVKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ..+.++|++.++.||+|+||+||+|.+..+|+.||||++..     .....+|+.++.++.+||||+++++++..    +
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----~   83 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE----E   83 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----T
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee----C
Confidence            34789999977889999999999999999999999999963     24567888887777899999999999986    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +.+|+||||+.+++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++             
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-------------  148 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN-------------  148 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS-------------
T ss_pred             CEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC-------------
Confidence            78999999999999999998753  599999999999999999999999999999999999998433             


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccC-------CCcccccccCCCcCCCcccCC-----CCCCCccchhhHHHHHH
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSN-------KASLQTPCYTPYYVAPEVLGP-----DKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~  233 (372)
                                 ....+||+|||++......       .......+||+.|+|||++..     ..++.++|||||||++|
T Consensus       149 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~  217 (316)
T 2ac3_A          149 -----------QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY  217 (316)
T ss_dssp             -----------SSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHH
T ss_pred             -----------CcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHH
Confidence                       2234788888887654321       112334568999999999864     45889999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCC-----------HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         234 ILLCGFPPFFSNHGQAIS-----------PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      +|++|..||.+....+..           ..+...+..+.+.++...+..+++++++||.+||+.||.+|||++|+|+||
T Consensus       218 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             HHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             HHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence            999999999765443211           223455566666666555567899999999999999999999999999999


Q ss_pred             ccccCC
Q psy3151         303 WISQFN  308 (372)
Q Consensus       303 ~~~~~~  308 (372)
                      ||++..
T Consensus       298 ~~~~~~  303 (316)
T 2ac3_A          298 WVQGCA  303 (316)
T ss_dssp             TCC---
T ss_pred             hhcCCC
Confidence            998753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.5e-52  Score=389.82  Aligned_cols=253  Identities=29%  Similarity=0.504  Sum_probs=217.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      -.++|+++ +.||+|+||+||+|.+..+|+.||||++...        ....+|..++..+..||||++++++|.+    
T Consensus        18 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----   92 (353)
T 2i0e_A           18 KLTDFNFL-MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----   92 (353)
T ss_dssp             -CTTEEEE-EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC----
T ss_pred             chHHcEEE-EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc----
Confidence            34789995 7899999999999999999999999999643        2234566664444589999999999986    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+|+||||++||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---------------  155 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---------------  155 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---------------
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc---------------
Confidence            678999999999999999998753  599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.+||+|||+|...........+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+
T Consensus       156 ------------~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  223 (353)
T 2i0e_A          156 ------------SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  223 (353)
T ss_dssp             ------------TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ------------CCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence                        56789999999998654444455677899999999999999999999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      .+.    ..+...+......+|.    .+++++.+||.+||+.||.+||+     ++++++||||+.+
T Consensus       224 ~~~----~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          224 EDE----DELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             SSH----HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             CCH----HHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            432    3455666666666553    68999999999999999999995     6999999999865

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.4e-52  Score=385.05  Aligned_cols=263  Identities=32%  Similarity=0.555  Sum_probs=221.4

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----------hhhHHHHHHHHHhcCCCCEeEEeEe
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------VKARREVELQLAVGSHKHIVNIKDV   77 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~ni~~~~~~   77 (372)
                      ....+.++|++ .+.||+|+||+||+|.+..+|+.||||++...           ....+|+.+ ++.++||||++++++
T Consensus         5 ~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~   82 (326)
T 2y0a_A            5 RQENVDDYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI-LKEIQHPNVITLHEV   82 (326)
T ss_dssp             BCSCHHHHEEE-EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHH-HHHCCCTTBCCEEEE
T ss_pred             ccCCcccceEe-ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHH-HHhCCCCCCCcEEEE
Confidence            45678899999 57899999999999999999999999998632           235678877 666799999999999


Q ss_pred             eeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          78 YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        78 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      +..    ....|+||||+.+++|.+++...  +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.    
T Consensus        83 ~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~----  152 (326)
T 2y0a_A           83 YEN----KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV----  152 (326)
T ss_dssp             EEC----SSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSS----
T ss_pred             EEe----CCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCC----
Confidence            976    67899999999999999999764  45999999999999999999999999999999999999984321    


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  237 (372)
                                         ....+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       153 -------------------~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  212 (326)
T 2y0a_A          153 -------------------PKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS  212 (326)
T ss_dssp             -------------------SSCCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             -------------------CCCCEEEEECCCCeECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH
Confidence                               2347999999999876432 23445679999999999998999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |..||.+...    ......+......++...+..++.++.+||.+||+.||.+|||++++|+||||+..
T Consensus       213 g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          213 GASPFLGDTK----QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             SCCSSCCSSH----HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CcCCCCCCCH----HHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            9999965432    23344455555555554556789999999999999999999999999999999753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-51  Score=380.96  Aligned_cols=248  Identities=32%  Similarity=0.646  Sum_probs=214.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|+++ +.||+|+||+||+|++..+|+.||+|++...        ....+|..+ ++.++||||+++++++.+    .
T Consensus         5 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~Iv~~~~~~~~----~   78 (318)
T 1fot_A            5 LQDFQIL-RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM-LSIVTHPFIIRMWGTFQD----A   78 (318)
T ss_dssp             GGGEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHSCCBTTBCCEEEEEEC----S
T ss_pred             hHHcEEE-EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH-HhhCCCCCCceEeEEEEe----C
Confidence            3789995 7899999999999999999999999999642        123456665 677899999999999976    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+||||+.||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----------------  140 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----------------  140 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----------------
T ss_pred             CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc----------------
Confidence            7899999999999999999875  4599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||++.....   ...+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.
T Consensus       141 -----------~~g~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  206 (318)
T 1fot_A          141 -----------KNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS  206 (318)
T ss_dssp             -----------TTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             -----------CCCCEEEeecCcceecCC---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence                       567899999999986532   234568999999999999999999999999999999999999999654


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      +.    ......+..+...+|.    .+++++.+||.+||..||++||     +++++++||||+++
T Consensus       207 ~~----~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          207 NT----MKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             SH----HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CH----HHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            32    3344555555555553    6899999999999999999999     99999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-52  Score=396.33  Aligned_cols=271  Identities=26%  Similarity=0.495  Sum_probs=202.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+.++|+++ +.||+|+||+||+|.+..+|+.||||++..       .....+|+.++..+.+||||+++++++..  .+
T Consensus         6 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~   82 (388)
T 3oz6_A            6 HVLRKYELV-KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA--DN   82 (388)
T ss_dssp             HHHTTEEEE-EC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--TT
T ss_pred             cccCceEEE-EEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec--CC
Confidence            366899995 779999999999999999999999999842       23456788886666669999999999864  23


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+|+||||+. ++|.+++...   .+++..++.++.||+.||+|||+.||+||||||+|||++               
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---------------  143 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN---------------  143 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---------------
T ss_pred             CCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc---------------
Confidence            457999999996 6999998763   599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeecccccccccc---------------------CCCcccccccCCCcCCCcccCC-CCCCCc
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVS---------------------NKASLQTPCYTPYYVAPEVLGP-DKYDKS  222 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  222 (372)
                                  .++.+||+|||+|+....                     ........+||++|+|||++.+ ..|+.+
T Consensus       144 ------------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  211 (388)
T 3oz6_A          144 ------------AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG  211 (388)
T ss_dssp             ------------TTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTH
T ss_pred             ------------CCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCCh
Confidence                        566788888888875432                     1122345689999999999876 679999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCC---------------------------ccCCC--------
Q psy3151         223 CDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ---------------------------FDFPN--------  267 (372)
Q Consensus       223 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~--------  267 (372)
                      +|||||||++|+|++|.+||.+.+.......+...+....                           .....        
T Consensus       212 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (388)
T 3oz6_A          212 IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL  291 (388)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhh
Confidence            9999999999999999999976543222111111110000                           00000        


Q ss_pred             ----CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCCCCc
Q psy3151         268 ----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLC  316 (372)
Q Consensus       268 ----~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~  316 (372)
                          .....+++++.+||.+||+.||++|||++|+|+||||+.+......+.+
T Consensus       292 ~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~  344 (388)
T 3oz6_A          292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNC  344 (388)
T ss_dssp             HHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCC
T ss_pred             cccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCCCC
Confidence                0012578999999999999999999999999999999987655444433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.4e-51  Score=387.52  Aligned_cols=260  Identities=31%  Similarity=0.493  Sum_probs=206.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ...++|+++ +.||+|+||+||+|.+..+|+.||||++...    ....+|+.. ++.++||||+++++++..    ...
T Consensus        17 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~----~~~   90 (361)
T 3uc3_A           17 HDSDRYDFV-KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN-HRSLRHPNIVRFKEVILT----PTH   90 (361)
T ss_dssp             CCTTTEEEE-EEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHH-HHHCCCTTBCCEEEEEEC----SSE
T ss_pred             CCCCcEEEE-EEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHH-HHhCCCCCCCcEEEEEee----CCE
Confidence            356899995 7799999999999999999999999999642    345678877 677799999999999976    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+.+|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+                
T Consensus        91 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~----------------  152 (361)
T 3uc3_A           91 LAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS----------------  152 (361)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS----------------
T ss_pred             EEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC----------------
Confidence            999999999999999997753  59999999999999999999999999999999999999731                


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCc-cchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKS-CDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               ..+.+||+|||+|+.... .......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+..
T Consensus       153 ---------~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (361)
T 3uc3_A          153 ---------PAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE  222 (361)
T ss_dssp             ---------SSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred             ---------CCceEEEeecCccccccc-cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence                     234599999999875432 223345678999999999977777654 899999999999999999998766


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ...........+....+..+.  ...+++++.+||.+||+.||.+|||++|+++||||.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          223 EPRDYRKTIQRILSVKYSIPD--DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -CCCHHHHHHHHHTTCCCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             cHHHHHHHHHHHhcCCCCCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            554444445555554444433  23689999999999999999999999999999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.7e-52  Score=395.62  Aligned_cols=255  Identities=30%  Similarity=0.517  Sum_probs=213.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      -.++|+++ +.||+|+||+||+|+++.+++.||+|++....        ...+|+.+ +..++||||++++++|.+    
T Consensus        67 ~~~~y~~~-~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~----  140 (410)
T 3v8s_A           67 KAEDYEVV-KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI-MAFANSPWVVQLFYAFQD----  140 (410)
T ss_dssp             CGGGEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHH-HHHCCCTTBCCEEEEEEC----
T ss_pred             CccccEEE-EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHH-HHhCCCCCCCeEEEEEEE----
Confidence            35789995 78999999999999999999999999996421        24467766 677899999999999986    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +..+|+||||++||+|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---------------  202 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---------------  202 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---------------
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC---------------
Confidence            77899999999999999998753   499999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCC----CCCccchhhHHHHHHHHHhCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDK----YDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~  239 (372)
                                  .++.+||+|||+|........ ...+.+||+.|+|||++.+..    |+.++|+|||||++|+|++|.
T Consensus       203 ------------~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~  270 (410)
T 3v8s_A          203 ------------KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD  270 (410)
T ss_dssp             ------------TTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSS
T ss_pred             ------------CCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCC
Confidence                        667899999999987644322 344678999999999986654    889999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCC--CCChhHHhcCCccccC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE--RLTIDQVMENKWISQF  307 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~--R~s~~eil~hp~~~~~  307 (372)
                      .||.+.+.    ......+..+...+..+.+..++.++++||.+||+.+|.+  |++++|+++||||++.
T Consensus       271 ~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          271 TPFYADSL----VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             CTTCCSSH----HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             CCCCCCCh----hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            99976543    2333444333222233334578999999999999999988  9999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-51  Score=379.76  Aligned_cols=264  Identities=29%  Similarity=0.478  Sum_probs=211.2

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..+.+.++|+++ +.||+|+||+||+|.+. +|+.||||++...       ....+|+.+ ++.++||||+++++++.+ 
T Consensus        15 ~~q~l~~~y~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~-   90 (311)
T 3niz_A           15 YFQGLMEKYQKL-EKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISL-LKELHHPNIVSLIDVIHS-   90 (311)
T ss_dssp             CEECSSCEEEEE-EEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHH-HHHCCCTTBCCEEEEECC-
T ss_pred             eecchHhhhHhh-hhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHH-HHHcCCCCEeeeeeEEcc-
Confidence            345689999995 77999999999999995 5999999998632       235578877 666799999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         +..+|+||||+. ++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++            
T Consensus        91 ---~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~------------  153 (311)
T 3niz_A           91 ---ERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN------------  153 (311)
T ss_dssp             ---SSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC------------
T ss_pred             ---CCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC------------
Confidence               678999999996 58888887654 4699999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                     .++.+||+|||++.............+||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus       154 ---------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  218 (311)
T 3niz_A          154 ---------------SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP  218 (311)
T ss_dssp             ---------------TTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ---------------CCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCC
Confidence                           5678999999999876554445556788999999999865 568999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCc-----------------c-CCCC----cccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQF-----------------D-FPNP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~-----------------~-~~~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      ||.+....+....+.........                 . ....    ....+++++.+||.+||+.||++|||++|+
T Consensus       219 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  298 (311)
T 3niz_A          219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA  298 (311)
T ss_dssp             SCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            99766554432222222111100                 0 0000    012468899999999999999999999999


Q ss_pred             hcCCccccCC
Q psy3151         299 MENKWISQFN  308 (372)
Q Consensus       299 l~hp~~~~~~  308 (372)
                      |+||||+++.
T Consensus       299 l~hp~f~~~~  308 (311)
T 3niz_A          299 MNHPYFKDLD  308 (311)
T ss_dssp             HTSGGGTTSC
T ss_pred             hcCcccccCC
Confidence            9999998864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.4e-52  Score=386.86  Aligned_cols=251  Identities=33%  Similarity=0.586  Sum_probs=212.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ...++|.+ .+.||+|+||+||+|.+..+|+.||||++...        ....+|+.+ ++.++||||+++++++..   
T Consensus         6 ~~i~~Y~i-~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~---   80 (336)
T 3h4j_B            6 RHIGPYII-RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY-LKLLRHPHIIKLYDVITT---   80 (336)
T ss_dssp             SEETTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHH-HTTCCCTTBCCEEEEEEC---
T ss_pred             cccCCEEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHH-HHhCCCCCCCeEEEEEEe---
Confidence            35689999 58899999999999999999999999998632        245678877 677899999999999976   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ...+|+||||+ +|+|.+++...  +.+++.+++.++.||+.||.|||+.||+||||||+|||++              
T Consensus        81 -~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~--------------  142 (336)
T 3h4j_B           81 -PTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD--------------  142 (336)
T ss_dssp             -SSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC--------------
T ss_pred             -CCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc--------------
Confidence             67899999999 78999998776  3599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .++.+||+|||++..... .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus       143 -------------~~~~~kl~DFG~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf  208 (336)
T 3h4j_B          143 -------------DNLNVKIADFGLSNIMTD-GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF  208 (336)
T ss_dssp             -------------TTCCEEECCSSCTBTTTT-SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             -------------CCCCEEEEEeccceeccC-CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC
Confidence                         567899999999986543 334456789999999999988776 68999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .+.......    ..+..+.+..|    ..+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus       209 ~~~~~~~~~----~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          209 DDEFIPNLF----KKVNSCVYVMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             BCSSSTTCB----CCCCSSCCCCC----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             CCccHHHHH----HHHHcCCCCCc----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            765443321    22222233333    3689999999999999999999999999999999863

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.5e-51  Score=382.77  Aligned_cols=251  Identities=32%  Similarity=0.632  Sum_probs=217.5

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ....++|+++ +.||+|+||+||+|++..+|+.||||++...        ....+|+.+ ++.++||||+++++++.+  
T Consensus        37 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~--  112 (350)
T 1rdq_E           37 TAQLDQFDRI-KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-LQAVNFPFLVKLEFSFKD--  112 (350)
T ss_dssp             CCCGGGEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HTTCCCTTBCCEEEEEEC--
T ss_pred             CCCHHHCEEE-EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEEc--
Confidence            3456899995 7899999999999999999999999999632        234567776 567799999999999976  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        ...+|+||||++||+|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++             
T Consensus       113 --~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~-------------  175 (350)
T 1rdq_E          113 --NSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-------------  175 (350)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-------------
T ss_pred             --CCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC-------------
Confidence              678999999999999999998763  599999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    .++.+||+|||++.....   ...+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       176 --------------~~g~~kL~DFg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  238 (350)
T 1rdq_E          176 --------------QQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF  238 (350)
T ss_dssp             --------------TTSCEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             --------------CCCCEEEcccccceeccC---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCC
Confidence                          567899999999987643   234568999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      .+.+.    ..+...+..+...+|.    .+++++.+||.+||+.||.+||+     ++++++||||+..
T Consensus       239 ~~~~~----~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          239 FADQP----IQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CCSSH----HHHHHHHHHCCCCCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             CCCCH----HHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            65432    3445666666665553    68999999999999999999998     9999999999874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.9e-51  Score=401.93  Aligned_cols=262  Identities=37%  Similarity=0.714  Sum_probs=224.4

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      -.+.++|+++ +.||+|+||+||+|.+..+|+.||||++..       .....+|+.+ ++.++||||+++++++..   
T Consensus        18 g~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~---   92 (486)
T 3mwu_A           18 GTFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL-LKKLDHPNIMKLFEILED---   92 (486)
T ss_dssp             CHHHHHEEEE-EEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHH-HHHCCCTTBCCEEEEEEC---
T ss_pred             CChhcceEEe-EEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHH-HHhCCCCCcCeEEEEEEc---
Confidence            3488999995 789999999999999999999999999853       2345678887 566699999999999976   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ...+|+||||+.+++|.+.+....  .+++..++.++.||+.||.|||++||+||||||+|||++..+           
T Consensus        93 -~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-----------  158 (486)
T 3mwu_A           93 -SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-----------  158 (486)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS-----------
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-----------
Confidence             678999999999999999997763  599999999999999999999999999999999999997433           


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   ..+.+||+|||++..... .......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.
T Consensus       159 -------------~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  223 (486)
T 3mwu_A          159 -------------KDCDIKIIDFGLSTCFQQ-NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY  223 (486)
T ss_dssp             -------------TTCCEEECSCSCTTTBCC-C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------CCCCEEEEECCcCeECCC-CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                         456799999999876543 233455689999999999875 59999999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV  310 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~  310 (372)
                      +...    ..+...+..+.+.++.+.|..+|+++++||.+||+.||.+|||+.++|+||||++....
T Consensus       224 ~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          224 GKNE----YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             CSSH----HHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             CCCH----HHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence            6442    34566777778888888888999999999999999999999999999999999986543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-51  Score=389.72  Aligned_cols=254  Identities=32%  Similarity=0.578  Sum_probs=214.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      -.++|+++ +.||+|+||+||+|+++.+++.||||++....        ...+|..++++.++||||++++++|.+    
T Consensus        36 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----  110 (373)
T 2r5t_A           36 KPSDFHFL-KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----  110 (373)
T ss_dssp             CGGGEEEE-EEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC----
T ss_pred             ChhheEEE-EEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe----
Confidence            45789995 88999999999999999999999999996432        123344443456789999999999986    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+|+||||+.||+|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---------------  173 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---------------  173 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---------------
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---------------
Confidence            678999999999999999998753  599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.+||+|||+++..........+.+||+.|+|||++.+..|+.++|+|||||++|+|++|..||.+
T Consensus       174 ------------~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  241 (373)
T 2r5t_A          174 ------------SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  241 (373)
T ss_dssp             ------------TTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ------------CCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence                        56789999999998755444556678999999999999999999999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh----hHHhcCCccccCC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI----DQVMENKWISQFN  308 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~----~eil~hp~~~~~~  308 (372)
                      .+.    ..+...+......++.    .++.++++||.+||+.||.+||++    +++++||||+.+.
T Consensus       242 ~~~----~~~~~~i~~~~~~~~~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          242 RNT----AEMYDNILNKPLQLKP----NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             SBH----HHHHHHHHHSCCCCCS----SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             CCH----HHHHHHHHhcccCCCC----CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            432    3445556555555543    689999999999999999999997    6899999998753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-51  Score=378.43  Aligned_cols=267  Identities=25%  Similarity=0.405  Sum_probs=206.7

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------hhhHHHHHHHHHh--cCCCCEeEEeEeee
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAV--GSHKHIVNIKDVYE   79 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~--~~h~ni~~~~~~~~   79 (372)
                      .+.++|+++ +.||+|+||+||+|.+..+|+.||||++...          ....+|+.++..+  ++||||+++++++.
T Consensus         6 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            6 MATSRYEPV-AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             ----CCEEE-EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             ccccceEEE-EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            467899995 7799999999999999999999999998632          2455677664333  36999999999987


Q ss_pred             eecC-CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          80 NIYN-GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        80 ~~~~-~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      .... ....+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++         
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~---------  154 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---------  154 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC---------
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---------
Confidence            5322 2336899999996 5999999887655699999999999999999999999999999999999998         


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                        .++.+||+|||++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       155 ------------------~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g  215 (308)
T 3g33_A          155 ------------------SGGTVKLADFGLARIYSY-QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR  215 (308)
T ss_dssp             ------------------TTSCEEECSCSCTTTSTT-CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTS
T ss_pred             ------------------CCCCEEEeeCccccccCC-CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhC
Confidence                              567799999999986543 3334567889999999999888999999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCc-cC-----------CC-------CcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQF-DF-----------PN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~-~~-----------~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      ..||.+....+....+......... .+           +.       .....+++++.+||.+||+.||++|||++|+|
T Consensus       216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  295 (308)
T 3g33_A          216 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL  295 (308)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence            9999665433221112111110000 00           00       00135789999999999999999999999999


Q ss_pred             cCCccccCC
Q psy3151         300 ENKWISQFN  308 (372)
Q Consensus       300 ~hp~~~~~~  308 (372)
                      +||||++..
T Consensus       296 ~h~~~~~~~  304 (308)
T 3g33_A          296 QHSYLHKDE  304 (308)
T ss_dssp             TSTTC----
T ss_pred             cCccccCCC
Confidence            999998753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.9e-51  Score=374.69  Aligned_cols=255  Identities=28%  Similarity=0.463  Sum_probs=205.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|+++ +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++.+    +..
T Consensus         2 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~   75 (292)
T 3o0g_A            2 QKYEKL-EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL-LKELKHKNIVRLHDVLHS----DKK   75 (292)
T ss_dssp             CSEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHH-HTTCCCTTBCCEEEEEEE----TTE
T ss_pred             CCceee-eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHH-HhcCCCCCEeeEEeEEEe----CCE
Confidence            689995 7799999999999999999999999999632       334577777 677799999999999986    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+.+ +|.+.+.... +.+++..++.++.||+.||+|||++||+||||||+|||++                  
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~------------------  135 (292)
T 3o0g_A           76 LTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN------------------  135 (292)
T ss_dssp             EEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------------
T ss_pred             EEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc------------------
Confidence            9999999965 7777766543 5699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.+||+|||++.............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||....
T Consensus       136 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~  206 (292)
T 3o0g_A          136 ---------RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_dssp             ---------TTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS
T ss_pred             ---------CCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC
Confidence                     567799999999987755455556678899999999987655 8999999999999999999888864432


Q ss_pred             CCCCCHhHHHHHhh--CCc---------------cCC--------CCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         247 GQAISPGMKNRIRL--GQF---------------DFP--------NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       247 ~~~~~~~~~~~~~~--~~~---------------~~~--------~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ..   ......+..  +..               ..+        ......+++++++||.+||+.||++|||++|+|+|
T Consensus       207 ~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          207 DV---DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             SH---HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CH---HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            21   111111111  000               000        01113578999999999999999999999999999


Q ss_pred             CccccC
Q psy3151         302 KWISQF  307 (372)
Q Consensus       302 p~~~~~  307 (372)
                      |||+++
T Consensus       284 p~f~~~  289 (292)
T 3o0g_A          284 PYFSDF  289 (292)
T ss_dssp             GGGTTC
T ss_pred             cccccC
Confidence            999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-50  Score=369.06  Aligned_cols=262  Identities=36%  Similarity=0.678  Sum_probs=224.0

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ..|.++|++. +.||+|+||+||+|.+..+|+.||+|++...       ....+|+.+ ++.++||||+++++++..   
T Consensus         2 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~---   76 (284)
T 3kk8_A            2 TKFSDNYDVK-EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQE---   76 (284)
T ss_dssp             CTTTTTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHH-HHHCCCTTBCCEEEEEEC---
T ss_pred             chhhhhhhhh-hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHH-HHHcCCCCcCeEEEEEEc---
Confidence            4578999995 7799999999999999999999999998632       234467776 566699999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       +...|+||||+.+++|.+.+...  +.+++..++.++.||+.||.|||++||+||||||+||+++.++           
T Consensus        77 -~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-----------  142 (284)
T 3kk8_A           77 -ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-----------  142 (284)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-----------
T ss_pred             -CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC-----------
Confidence             67889999999999999988776  3599999999999999999999999999999999999998433           


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   ..+.+||+|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       143 -------------~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  208 (284)
T 3kk8_A          143 -------------KGAAVKLADFGLAIEVND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  208 (284)
T ss_dssp             -------------TTCCEEECCCTTCEECCS-SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------CCCcEEEeeceeeEEccc-CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence                         345689999999876543 223345678999999999999999999999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      +...    ......+..+....+.+.+..+++++.+||.+||+.||++|||++|+++||||++...
T Consensus       209 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          209 DEDQ----HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             CSSH----HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             CCch----hHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            5432    3455666777777777777889999999999999999999999999999999987543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5e-51  Score=383.64  Aligned_cols=263  Identities=38%  Similarity=0.711  Sum_probs=210.2

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ....+.++|++ .+.||+|+||+||+|.+..+++.||||++...   ....+|+.+ ++.++||||+++++++..    .
T Consensus        47 ~~~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~----~  120 (349)
T 2w4o_A           47 NRDALSDFFEV-ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGV-LLRLSHPNIIKLKEIFET----P  120 (349)
T ss_dssp             BCSCGGGTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHH-HHHCCCTTBCCEEEEEEC----S
T ss_pred             ccccccCcEEE-eeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHH-HHhCCCCCCcceeeeEec----C
Confidence            34557889999 57899999999999999999999999999743   234567777 666799999999999976    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...|+||||+.+++|.+++...  +.+++..++.++.||+.||.|||+.||+||||||+|||++..+             
T Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~-------------  185 (349)
T 2w4o_A          121 TEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA-------------  185 (349)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS-------------
T ss_pred             CeEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC-------------
Confidence            7899999999999999999764  4599999999999999999999999999999999999997422             


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       186 -----------~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  253 (349)
T 2w4o_A          186 -----------PDAPLKIADFGLSKIVEH-QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE  253 (349)
T ss_dssp             -----------TTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred             -----------CCCCEEEccCccccccCc-ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence                       367799999999876543 22334567899999999999889999999999999999999999999654


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ...   ..+...+.......+.+.+..++.++.+||.+||+.||++|||+.++|+||||.+.
T Consensus       254 ~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          254 RGD---QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             TCH---HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             ccc---HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            432   22455566666666666667899999999999999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.7e-51  Score=395.49  Aligned_cols=257  Identities=29%  Similarity=0.559  Sum_probs=212.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..++|+++ +.||+|+||+||+|+++.+++.||||++....        ...+|..+ +..++||||++++++|.+    
T Consensus        72 ~~~~y~~~-~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~i-l~~~~hp~Iv~l~~~~~~----  145 (437)
T 4aw2_A           72 HREDFEIL-KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV-LVNGDSKWITTLHYAFQD----  145 (437)
T ss_dssp             CGGGEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHH-HHHSCTTTBCCEEEEEEC----
T ss_pred             ChhheEEE-EEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHH-HHhCCCCCEEEEEEEEee----
Confidence            45789994 78999999999999999999999999996421        24566666 566799999999999986    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +..+|+||||+.||+|.+++.... +.+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~---------------  209 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---------------  209 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---------------
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc---------------
Confidence            678999999999999999998643 4699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                  .++.+||+|||+|+....... .....+||+.|+|||++.     ...|+.++|+|||||++|||++|
T Consensus       210 ------------~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG  277 (437)
T 4aw2_A          210 ------------MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG  277 (437)
T ss_dssp             ------------TTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHS
T ss_pred             ------------CCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhC
Confidence                        567899999999976644332 234468999999999985     56799999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhC--CccCCCCcccccCHHHHHHHHHhccCCCCC--CCChhHHhcCCccccCC
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLG--QFDFPNPEWEHVSQEAKTLIKNMLCVDPSE--RLTIDQVMENKWISQFN  308 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~ll~~dP~~--R~s~~eil~hp~~~~~~  308 (372)
                      ..||.+.+..+    ....+...  .+.+|. .+..+++++++||++||+.+|++  |++++|+++||||+++.
T Consensus       278 ~~Pf~~~~~~~----~~~~i~~~~~~~~~p~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          278 ETPFYAESLVE----TYGKIMNHKERFQFPT-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             SCTTCCSSHHH----HHHHHHTHHHHCCCCS-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             CCCCCCCChhH----HHHhhhhccccccCCc-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence            99997654322    23333221  122222 22468999999999999998888  99999999999998753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.6e-51  Score=400.62  Aligned_cols=265  Identities=38%  Similarity=0.722  Sum_probs=225.4

Q ss_pred             cCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEe
Q psy3151           5 FKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDV   77 (372)
Q Consensus         5 ~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~   77 (372)
                      |.+.....+.++|+++ +.||+|+||+||+|.+..++..||||++...       ....+|+.+ ++.++||||++++++
T Consensus        27 ~~~~~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~  104 (494)
T 3lij_A           27 FITSKKGHLSEMYQRV-KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAV-LKLLDHPNIMKLYDF  104 (494)
T ss_dssp             GCCCCBCCHHHHEEEE-EEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHH-HTTCCCTTBCCEEEE
T ss_pred             eeecCCCchhcCeEEe-eEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHH-HHhCCCCCCCeEEEE
Confidence            4555666788899995 7799999999999999999999999998632       345678877 677799999999999


Q ss_pred             eeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          78 YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        78 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      |..    ...+|+|||||.+|+|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++..+     
T Consensus       105 ~~~----~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-----  173 (494)
T 3lij_A          105 FED----KRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE-----  173 (494)
T ss_dssp             EEC----SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-----
T ss_pred             EEe----CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC-----
Confidence            976    67899999999999999998776  3599999999999999999999999999999999999997433     


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  237 (372)
                                         ..+.+||+|||+|..... .......+||+.|+|||++. ..|+.++||||+||++|+|++
T Consensus       174 -------------------~~~~~kl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~  232 (494)
T 3lij_A          174 -------------------KDALIKIVDFGLSAVFEN-QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA  232 (494)
T ss_dssp             -------------------TTCCEEECCCTTCEECBT-TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH
T ss_pred             -------------------CCCcEEEEECCCCeECCC-CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh
Confidence                               356699999999877643 23345678999999999986 569999999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |..||.+...    ..+...+..+.+.++.+.|..+++++++||.+||+.||.+|||+.++|+||||++.
T Consensus       233 g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          233 GYPPFGGQTD----QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             SSCSSCCSSH----HHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             CCCCCCCCCH----HHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            9999965443    44567777788888888888999999999999999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-51  Score=386.60  Aligned_cols=263  Identities=30%  Similarity=0.587  Sum_probs=223.4

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      +...+.++|+++ +.||+|+||+||+|.+..+|+.||+|++...     ....+|+.+ ++.++||||+++++++..   
T Consensus        45 ~~~~~~~~y~i~-~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~~~~~~~~---  119 (387)
T 1kob_A           45 KQGSVYDYYDIL-EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISI-MNQLHHPKLINLHDAFED---  119 (387)
T ss_dssp             BCSCGGGTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHH-HTTCCSTTBCCEEEEEEC---
T ss_pred             cCCccccceEEE-EEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHH-HHhCCCcCCCeEEEEEEe---
Confidence            444578899995 7799999999999999999999999998642     245577877 677799999999999976   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       +..+|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+            
T Consensus       120 -~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~------------  185 (387)
T 1kob_A          120 -KYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK------------  185 (387)
T ss_dssp             -SSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST------------
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC------------
Confidence             678999999999999999987543 469999999999999999999999999999999999999731            


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   ..+.+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       186 -------------~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  251 (387)
T 1kob_A          186 -------------KASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA  251 (387)
T ss_dssp             -------------TCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             -------------CCCceEEEecccceecCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence                         3467999999999876432 23345678999999999999999999999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      +.+.    ......+....+.++...+..+++++.+||.+||+.||.+|||++++|+||||++..
T Consensus       252 ~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          252 GEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             CSSH----HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCCH----HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            5432    234455556666666666678999999999999999999999999999999998743

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.4e-51  Score=387.59  Aligned_cols=270  Identities=19%  Similarity=0.231  Sum_probs=211.4

Q ss_pred             CCccCCcccceeecccccccc--CCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEe
Q psy3151           7 PFKTTPIQDDYDISTEILGLG--INGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDV   77 (372)
Q Consensus         7 ~~~~~~~~~~Y~i~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~   77 (372)
                      +....+-.++|+++ +.||+|  +||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||++++++
T Consensus        17 ~s~~~~~~~~y~~~-~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~   94 (389)
T 3gni_B           17 MSSFLPEGGCYELL-TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV-SKLFNHPNIVPYRAT   94 (389)
T ss_dssp             -CCCCCCGGGEEEE-EEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHH-HHHCCCTTBCCEEEE
T ss_pred             hhcccCCCCcEEEE-ecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHH-HHhCCCCCCCcEeEE
Confidence            34455678999995 789999  9999999999999999999999633       234457776 677799999999999


Q ss_pred             eeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          78 YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        78 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      +..    ++.+|+||||+.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++        
T Consensus        95 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~--------  162 (389)
T 3gni_B           95 FIA----DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS--------  162 (389)
T ss_dssp             EEE----TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--------
T ss_pred             EEE----CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--------
Confidence            986    67899999999999999999876556799999999999999999999999999999999999998        


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCC-------CcccccccCCCcCCCcccCC--CCCCCccchhhH
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-------ASLQTPCYTPYYVAPEVLGP--DKYDKSCDIWSL  228 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Diwsl  228 (372)
                                         .++.+||+|||.+.......       ......+||+.|+|||++.+  ..|+.++|||||
T Consensus       163 -------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  223 (389)
T 3gni_B          163 -------------------VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV  223 (389)
T ss_dssp             -------------------TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred             -------------------CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence                               56679999998876543221       12233578999999999977  679999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhC--------------------------------------CccCCCCcc
Q psy3151         229 GVIMYILLCGFPPFFSNHGQAISPGMKNRIRLG--------------------------------------QFDFPNPEW  270 (372)
Q Consensus       229 G~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~  270 (372)
                      ||++|+|++|..||.+.................                                      ......+.+
T Consensus       224 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (389)
T 3gni_B          224 GITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH  303 (389)
T ss_dssp             HHHHHHHHHSSCTTTTCCSTTHHHHC------------------------------------------------------
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccc
Confidence            999999999999997654432211100000000                                      000011123


Q ss_pred             cccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         271 EHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       271 ~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      ..+++++.+||.+||+.||++|||++|+|+||||+++..
T Consensus       304 ~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          304 RTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             --CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             cccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence            467899999999999999999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.8e-51  Score=381.03  Aligned_cols=265  Identities=28%  Similarity=0.503  Sum_probs=220.9

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ..|.++|.+..+.||+|+||+||+|.+..+|+.||||++..       .....+|+.++..+..||||+++++++..   
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~---  100 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN---  100 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe---
Confidence            45889999976889999999999999999999999999863       23456788887777788999999999976   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ...+|+||||+.+|+|.+++.....+.+++..++.++.||+.||+|||++||+||||||+|||++...           
T Consensus       101 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~-----------  168 (327)
T 3lm5_A          101 -TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY-----------  168 (327)
T ss_dssp             -SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT-----------
T ss_pred             -CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC-----------
Confidence             67899999999999999998765456799999999999999999999999999999999999997321           


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   ..+.+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       169 -------------~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  234 (327)
T 3lm5_A          169 -------------PLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV  234 (327)
T ss_dssp             -------------TBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------CCCcEEEeeCccccccCCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                         2578999999999876432 23345678999999999999999999999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      ....    ......+.......+...+..+++++.+||.+||+.||.+|||++++|+||||+++.
T Consensus       235 ~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          235 GEDN----QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             CSSH----HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             CCCc----hHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            5432    233444555555666666678999999999999999999999999999999998764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.3e-51  Score=396.21  Aligned_cols=268  Identities=26%  Similarity=0.423  Sum_probs=190.1

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec-
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY-   82 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~-   82 (372)
                      ..+.++|+++ +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++.... 
T Consensus        49 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           49 WQIPDRYEIR-HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI-LNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             CCSCTTEEEC-CC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHH-HHHCCCTTBCCEEEECCCSCT
T ss_pred             CccCCCeEEe-eEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHH-HHhCCCCCCCceEEEEecCCc
Confidence            3467999995 7899999999999999999999999998532       345678888 56669999999999985322 


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      .....+|+||||+ +++|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+|||++             
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~-------------  190 (458)
T 3rp9_A          127 EKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN-------------  190 (458)
T ss_dssp             TTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-------------
T ss_pred             ccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC-------------
Confidence            2346799999998 57999998764  4599999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCC---------------------------CcccccccCCCcCCCccc-
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK---------------------------ASLQTPCYTPYYVAPEVL-  214 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~-  214 (372)
                                    .++.+||+|||+|+......                           ......+||++|+|||++ 
T Consensus       191 --------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  256 (458)
T 3rp9_A          191 --------------QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL  256 (458)
T ss_dssp             --------------TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred             --------------CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence                          44556677777665543211                           124556889999999976 


Q ss_pred             CCCCCCCccchhhHHHHHHHHHh-----------CCCCCCCCCCCCCCH----------------hHHHHHh--------
Q psy3151         215 GPDKYDKSCDIWSLGVIMYILLC-----------GFPPFFSNHGQAISP----------------GMKNRIR--------  259 (372)
Q Consensus       215 ~~~~~~~~~DiwslG~il~~ll~-----------g~~pf~~~~~~~~~~----------------~~~~~~~--------  259 (372)
                      ....|+.++|||||||++|||++           |.++|.+.+......                .....+.        
T Consensus       257 ~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~  336 (458)
T 3rp9_A          257 LQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE  336 (458)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCH
T ss_pred             CCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCH
Confidence            56679999999999999999998           666665433111000                0000000        


Q ss_pred             --------------hCCccC-----CCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCC
Q psy3151         260 --------------LGQFDF-----PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV  310 (372)
Q Consensus       260 --------------~~~~~~-----~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~  310 (372)
                                    ...+..     ....+...++++.+||.+||.+||++|||++|+|+||||+++...
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~  406 (458)
T 3rp9_A          337 EDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA  406 (458)
T ss_dssp             HHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred             HHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence                          000000     001123568999999999999999999999999999999987643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.7e-51  Score=377.56  Aligned_cols=267  Identities=34%  Similarity=0.586  Sum_probs=223.7

Q ss_pred             cCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----------hhhHHHHHHHHHhcCCCCEeE
Q psy3151           5 FKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------VKARREVELQLAVGSHKHIVN   73 (372)
Q Consensus         5 ~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~ni~~   73 (372)
                      +.|.....+.++|++ .+.||+|+||.||+|.+..+|+.||||++...           ....+|+.+ ++.++||||++
T Consensus         2 ~~~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~   79 (321)
T 2a2a_A            2 MEPFKQQKVEDFYDI-GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI-LRQVLHHNVIT   79 (321)
T ss_dssp             CCCCBCSCHHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHH-HHHCCCTTBCC
T ss_pred             CCcccchhhhccEEE-eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHH-HHhCCCCCcce
Confidence            567777889999999 57899999999999999999999999998632           235578877 66678999999


Q ss_pred             EeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          74 IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        74 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                      +++++..    +...|+||||+.+++|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+||+++.++.
T Consensus        80 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~  153 (321)
T 2a2a_A           80 LHDVYEN----RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI  153 (321)
T ss_dssp             EEEEEEC----SSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS
T ss_pred             EEEEEec----CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCC
Confidence            9999876    67899999999999999999764  45999999999999999999999999999999999999983221


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHH
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  233 (372)
                                             ....+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|
T Consensus       154 -----------------------~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  209 (321)
T 2a2a_A          154 -----------------------PIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY  209 (321)
T ss_dssp             -----------------------SSCCEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred             -----------------------CcCCEEEccCccceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHH
Confidence                                   1237999999999876442 2334567899999999999899999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +|++|..||.+...    ......+......++...+..++.++.+||.+||..||++|||++++++||||+..
T Consensus       210 ~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          210 ILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HHHHSCCSSCCSSH----HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HHHHCCCCCCCCCH----HHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            99999999965432    23344455555554444445789999999999999999999999999999999764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.1e-51  Score=380.24  Aligned_cols=258  Identities=27%  Similarity=0.499  Sum_probs=213.2

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .++.++|+++ +.||+|+||+||+|.+..+++.||||++...      ....+|+.+ ++.++||||+++++++..    
T Consensus         3 ~~~~~~y~i~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~----   76 (323)
T 3tki_A            3 VPFVEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYGHRRE----   76 (323)
T ss_dssp             CTTTTCEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHH-HHHCCCTTBCCEEEEEEC----
T ss_pred             CcHhhhceee-eEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHH-HHhCCCCCCCeEEEEEec----
Confidence            4678999995 7799999999999999999999999998532      234577777 677799999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...|+||||+.+++|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+|||++               
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---------------  139 (323)
T 3tki_A           77 GNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---------------  139 (323)
T ss_dssp             SSEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             CCeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe---------------
Confidence            67899999999999999998654  4599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.+||+|||++.......  ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus       140 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  207 (323)
T 3tki_A          140 ------------ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP  207 (323)
T ss_dssp             ------------TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ------------CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence                        56779999999997654322  22345689999999999977665 7799999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      |........   ..........  ....+..+++++.+||.+||+.||++|||++|+++||||++..
T Consensus       208 f~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          208 WDQPSDSCQ---EYSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             CSSSCTTSH---HHHHHHTTCT--TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CCCCchHHH---HHHHHhcccc--cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            976543321   1222222221  1223467899999999999999999999999999999998753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.3e-51  Score=402.68  Aligned_cols=257  Identities=28%  Similarity=0.504  Sum_probs=219.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      -.++|+++ ++||+|+||+||+|.+..+|+.||||++...        ....+|+.+ +..++||||++++++|.+    
T Consensus       182 ~~~~f~~~-~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~~~~----  255 (576)
T 2acx_A          182 TKNTFRQY-RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI-LEKVNSRFVVSLAYAYET----  255 (576)
T ss_dssp             CGGGEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHHCCCTTBCCEEEEEEC----
T ss_pred             cccceEEE-EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHH-HHHcCCCCEeeEEEEEee----
Confidence            34779984 8899999999999999999999999999632        234567777 666799999999999976    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+|+||||++||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld---------------  320 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---------------  320 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---------------
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe---------------
Confidence            67899999999999999999876555699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.+||+|||+|...... ......+||+.|+|||++.+..|+.++|+|||||++|+|++|..||.+
T Consensus       321 ------------~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~  387 (576)
T 2acx_A          321 ------------DHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ  387 (576)
T ss_dssp             ------------TTSCEEECCCTTCEECCTT-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred             ------------CCCCeEEEecccceecccC-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence                        5678999999999876432 234456899999999999988999999999999999999999999977


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      .........+...+......++    ..+++++++||.+||+.||.+||     |++|+++||||+++
T Consensus       388 ~~~~~~~~~i~~~i~~~~~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          388 RKKKIKREEVERLVKEVPEEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             SSSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             cccchhHHHHHHHhhcccccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            6544433445555555444444    46899999999999999999999     79999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.2e-51  Score=374.94  Aligned_cols=254  Identities=26%  Similarity=0.535  Sum_probs=209.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------------------------------hhhHHHHHH
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------------------------------VKARREVEL   61 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------------------------~~~~~e~~~   61 (372)
                      ..++|++. +.||+|+||+||+|.+..+|+.||||++...                               ....+|+.+
T Consensus        11 ~~~~y~~~-~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           11 QLNQYTLK-DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             EETTEEEE-EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eecceEEE-eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            46899994 7799999999999999999999999998532                               234578877


Q ss_pred             HHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q psy3151          62 QLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDV  141 (372)
Q Consensus        62 ~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDl  141 (372)
                       ++.++||||+++++++..  ..+..+|+||||+++++|.+++..   +.+++..++.++.||+.||+|||++||+||||
T Consensus        90 -l~~l~h~~iv~~~~~~~~--~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  163 (298)
T 2zv2_A           90 -LKKLDHPNVVKLVEVLDD--PNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI  163 (298)
T ss_dssp             -HHTCCCTTBCCEEEEEEC--SSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             -HHhCCCCCCCeEEEEEEc--CCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence             677799999999999864  235689999999999999886532   46999999999999999999999999999999


Q ss_pred             CCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC---
Q psy3151         142 KPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK---  218 (372)
Q Consensus       142 kp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---  218 (372)
                      ||+|||++                           .++.+||+|||++.............+||+.|+|||++.+..   
T Consensus       164 kp~Nil~~---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  216 (298)
T 2zv2_A          164 KPSNLLVG---------------------------EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIF  216 (298)
T ss_dssp             CGGGEEEC---------------------------TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCE
T ss_pred             CHHHEEEC---------------------------CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCC
Confidence            99999998                           567899999999987655444455678999999999997655   


Q ss_pred             CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         219 YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       219 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      ++.++|||||||++|+|++|..||.+...    ......+......++.  ...+++++.+||.+||+.||++|||+.|+
T Consensus       217 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~  290 (298)
T 2zv2_A          217 SGKALDVWAMGVTLYCFVFGQCPFMDERI----MCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEI  290 (298)
T ss_dssp             ESHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCchhhhHhHHHHHHHHHHCCCCCCCccH----HHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHH
Confidence            37789999999999999999999965432    2333444444444332  34689999999999999999999999999


Q ss_pred             hcCCcccc
Q psy3151         299 MENKWISQ  306 (372)
Q Consensus       299 l~hp~~~~  306 (372)
                      ++||||++
T Consensus       291 l~hp~~~~  298 (298)
T 2zv2_A          291 KLHPWVTR  298 (298)
T ss_dssp             TTCHHHHC
T ss_pred             hcCccccC
Confidence            99999963

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-50  Score=399.33  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=220.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|.++ ++||+|+||+||+|+++.+|+.||||++...        ....+|+.+ ++.++||||++++++|..    .
T Consensus       184 ~~~f~~~-~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~~~~----~  257 (543)
T 3c4z_A          184 EDWFLDF-RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI-LAKVHSRFIVSLAYAFET----K  257 (543)
T ss_dssp             GGGEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHHCCCTTBCCEEEEEEC----S
T ss_pred             hhheEEE-EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHH-HHhcCCCCEeeEEEEEee----C
Confidence            4788884 8899999999999999999999999999632        234567777 566799999999999976    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKE--DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~--~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ..+|+||||++||+|.+++....  ...+++..++.++.||+.||+|||++||+||||||+|||++              
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~--------------  323 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD--------------  323 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--------------
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe--------------
Confidence            78999999999999999997643  34699999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   .++.+||+|||++.............+||+.|+|||++.+..|+.++|+|||||++|+|++|..||.
T Consensus       324 -------------~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~  390 (543)
T 3c4z_A          324 -------------DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR  390 (543)
T ss_dssp             -------------TTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------CCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCC
Confidence                         6778999999999876554444455689999999999999999999999999999999999999997


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      +.........+...+......+|    ..+++++.+||.+||+.||.+||+     ++++++||||+++
T Consensus       391 ~~~~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          391 ARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             CTTCCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             CCccchhHHHHHHHHhhcccCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            76544343455666666555555    368999999999999999999996     5899999999975

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-51  Score=399.74  Aligned_cols=262  Identities=25%  Similarity=0.396  Sum_probs=201.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--C
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--N   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--~   83 (372)
                      +.++|+++ +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||++++++|....  .
T Consensus        60 ~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           60 VLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL-MKCVNHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EETTEEEE-EEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHH-HHHCCCTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEE-EEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHH-HHhCCCCCCCcEEEEEccCCccc
Confidence            56899995 7799999999999999999999999999632       345578877 67779999999999986421  2


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ....+|+||||+.+ +|.+.+..    .+++..++.++.||+.||+|||++||+||||||+|||++              
T Consensus       138 ~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~--------------  198 (464)
T 3ttj_A          138 EFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK--------------  198 (464)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--------------
T ss_pred             cCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe--------------
Confidence            34678999999965 67777643    399999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   .++.+||+|||+|+.... .......+||++|+|||++.+..|+.++|||||||++|+|++|+.||.
T Consensus       199 -------------~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~  264 (464)
T 3ttj_A          199 -------------SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP  264 (464)
T ss_dssp             -------------TTSCEEECCCCCC------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------CCCCEEEEEEEeeeecCC-CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence                         567899999999986643 333456789999999999999999999999999999999999999997


Q ss_pred             CCCCCCCCHhHHHHHh------------------hCCccCCCCc----------------ccccCHHHHHHHHHhccCCC
Q psy3151         244 SNHGQAISPGMKNRIR------------------LGQFDFPNPE----------------WEHVSQEAKTLIKNMLCVDP  289 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~----------------~~~~s~~~~~li~~ll~~dP  289 (372)
                      +.+..+....+...+.                  ..........                ....++++++||.+||++||
T Consensus       265 g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP  344 (464)
T 3ttj_A          265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP  344 (464)
T ss_dssp             CSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSST
T ss_pred             CCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCCh
Confidence            6543221111111100                  0000000000                01126789999999999999


Q ss_pred             CCCCChhHHhcCCccccCCC
Q psy3151         290 SERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       290 ~~R~s~~eil~hp~~~~~~~  309 (372)
                      ++|||++|+|+||||+.+..
T Consensus       345 ~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          345 AKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             TTSCCHHHHHTSTTTGGGCC
T ss_pred             hhCCCHHHHhcChhhhhccC
Confidence            99999999999999987643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.6e-51  Score=391.55  Aligned_cols=258  Identities=33%  Similarity=0.684  Sum_probs=209.4

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-------------hhHHHHHHHHHhcCCCCEeEEeEee
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------------KARREVELQLAVGSHKHIVNIKDVY   78 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~e~~~~~~~~~h~ni~~~~~~~   78 (372)
                      .+.++|.+ .+.||+|+||+||+|.+..+++.||||++....             ...+|+.+ ++.++||||+++++++
T Consensus       132 ~~~~~y~~-~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~  209 (419)
T 3i6u_A          132 ALRDEYIM-SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI-LKKLNHPCIIKIKNFF  209 (419)
T ss_dssp             HHHTTEEE-EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHH-HHHCCCTTBCCCCEEE
T ss_pred             hhhccEEE-EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHH-HHhCCCCCEeeEEEEE
Confidence            36789999 478999999999999999999999999986421             24578877 5666999999999998


Q ss_pred             eeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          79 ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      ..     ...|+||||+.+|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++.++      
T Consensus       210 ~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~------  276 (419)
T 3i6u_A          210 DA-----EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------  276 (419)
T ss_dssp             ES-----SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS------
T ss_pred             ec-----CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC------
Confidence            53     4579999999999999988654  4699999999999999999999999999999999999997433      


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC---CCCCCccchhhHHHHHHHH
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP---DKYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l  235 (372)
                                        ....+||+|||+|..... .....+.+||+.|+|||++.+   ..|+.++|||||||++|+|
T Consensus       277 ------------------~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~l  337 (419)
T 3i6u_A          277 ------------------EDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC  337 (419)
T ss_dssp             ------------------SSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHH
T ss_pred             ------------------CcceEEEeecccceecCC-CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHH
Confidence                              345699999999986543 233456789999999999853   6688899999999999999


Q ss_pred             HhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       236 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      ++|..||.......   .+...+..+.+.+.+..+..+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus       338 ltg~~pf~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          338 LSGYPPFSEHRTQV---SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HHSSCSSCCCSSSC---CHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHCCCCCCCCcchH---HHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            99999997544332   245556666666655556678999999999999999999999999999999975

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.4e-50  Score=375.75  Aligned_cols=252  Identities=32%  Similarity=0.576  Sum_probs=207.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEc---CCCcEEEEEEecch---------hhhHHHHHHHHHhcCCCCEeEEeEeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHDT---------VKARREVELQLAVGSHKHIVNIKDVYEN   80 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~ni~~~~~~~~~   80 (372)
                      ..++|+++ +.||+|+||+||+|++.   .+|+.||||++...         ....+|+.+ ++.++||||+++++++..
T Consensus        15 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           15 RPECFELL-RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI-LEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CGGGEEEE-EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHH-HHHCCCTTBCCEEEEEEC
T ss_pred             CHHHeEEE-EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHH-HHhCCCCCccceeEEEEc
Confidence            45899995 78999999999999985   68999999998642         123467777 667799999999999976


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                          ++.+|+||||+.+++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++           
T Consensus        93 ----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~-----------  155 (327)
T 3a62_A           93 ----GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN-----------  155 (327)
T ss_dssp             ----SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC-----------
T ss_pred             ----CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC-----------
Confidence                67899999999999999999875  3599999999999999999999999999999999999998           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                      .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       156 ----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  219 (327)
T 3a62_A          156 ----------------HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP  219 (327)
T ss_dssp             ----------------TTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ----------------CCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCC
Confidence                            5678999999998765444444556789999999999998899999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      ||.+.+.    ......+......+|.    .+++++.+||.+||..||.+||     +++++++||||+++
T Consensus       220 pf~~~~~----~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          220 PFTGENR----KKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             SCCCSSH----HHHHHHHHHTCCCCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             CCCCCCH----HHHHHHHHhCCCCCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            9965432    2334455555555543    6899999999999999999999     88999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-50  Score=398.11  Aligned_cols=267  Identities=37%  Similarity=0.664  Sum_probs=224.9

Q ss_pred             cCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------------------hhhHHHHHHHHHhc
Q psy3151           5 FKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------------------VKARREVELQLAVG   66 (372)
Q Consensus         5 ~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------~~~~~e~~~~~~~~   66 (372)
                      |.+.....+.++|+++ +.||+|+||+||+|.+..+++.||||++...                  ....+|+.+ ++.+
T Consensus        26 ~~~~~~~~i~~~Y~~~-~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l  103 (504)
T 3q5i_A           26 YVRKKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL-LKSL  103 (504)
T ss_dssp             GCCEECSCGGGTEEEE-EEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHH-HHTC
T ss_pred             eeeccCCCcccceEEE-eEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHH-HHhC
Confidence            3444555689999995 7799999999999999999999999998632                  234567777 6777


Q ss_pred             CCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q psy3151          67 SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENL  146 (372)
Q Consensus        67 ~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NI  146 (372)
                      +||||+++++++..    +..+|+|||||.+|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus       104 ~hpniv~~~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni  177 (504)
T 3q5i_A          104 DHPNIIKLFDVFED----KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI  177 (504)
T ss_dssp             CCTTBCCEEEEEEC----SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCeEEEEEEc----CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHE
Confidence            99999999999976    67899999999999999999776  3599999999999999999999999999999999999


Q ss_pred             eeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchh
Q psy3151         147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIW  226 (372)
Q Consensus       147 li~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  226 (372)
                      |++.++                        ....+||+|||+|..... .......+||+.|+|||++. ..|+.++|||
T Consensus       178 l~~~~~------------------------~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~Diw  231 (504)
T 3q5i_A          178 LLENKN------------------------SLLNIKIVDFGLSSFFSK-DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVW  231 (504)
T ss_dssp             EESSTT------------------------CCSSEEECCCTTCEECCT-TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHH
T ss_pred             EEecCC------------------------CCccEEEEECCCCEEcCC-CCccccccCCcCCCCHHHhc-cCCCchHHHH
Confidence            998432                        234689999999986643 23345678999999999987 4699999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         227 SLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       227 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      |+||++|+|++|..||.+...    ..+...+..+.+.++.+.|..+++++++||.+||+.||.+|||++|+|+||||++
T Consensus       232 slG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          232 SCGVIMYILLCGYPPFGGQND----QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence            999999999999999966443    3456667777777776777789999999999999999999999999999999987


Q ss_pred             CCC
Q psy3151         307 FNQ  309 (372)
Q Consensus       307 ~~~  309 (372)
                      ...
T Consensus       308 ~~~  310 (504)
T 3q5i_A          308 YAN  310 (504)
T ss_dssp             TCC
T ss_pred             chh
Confidence            643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.8e-51  Score=400.17  Aligned_cols=266  Identities=34%  Similarity=0.654  Sum_probs=227.6

Q ss_pred             CCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEe
Q psy3151           6 KPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDV   77 (372)
Q Consensus         6 ~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~   77 (372)
                      .......+.++|++ .+.||+|+||+||+|.+..+|+.||||++...        ....+|+.+ ++.++||||++++++
T Consensus        17 ~~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~   94 (484)
T 3nyv_A           17 VQHSTAIFSDRYKG-QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL-LKQLDHPNIMKLYEF   94 (484)
T ss_dssp             --CCCCCHHHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHH-HTTCCCTTBCCEEEE
T ss_pred             eccCCCcccCceEE-eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHH-HHhCCCCCCCcEEEE
Confidence            34455668899999 58899999999999999999999999998532        345678887 667799999999999


Q ss_pred             eeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          78 YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        78 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      +..    ....|+||||+.+|+|.+.+...  +.+++..++.++.||+.||.|||++||+||||||+|||++..+     
T Consensus        95 ~~~----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-----  163 (484)
T 3nyv_A           95 FED----KGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS-----  163 (484)
T ss_dssp             EEC----SSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-----
T ss_pred             EEe----CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-----
Confidence            976    67899999999999999999765  4599999999999999999999999999999999999996322     


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  237 (372)
                                         ..+.+||+|||+|...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++
T Consensus       164 -------------------~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~  222 (484)
T 3nyv_A          164 -------------------KDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS  222 (484)
T ss_dssp             -------------------TTCCEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHH
T ss_pred             -------------------CCCcEEEEeeeeeEEcccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHH
Confidence                               4678999999999876432 33455679999999999865 69999999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      |.+||.+.+.    ..+...+..+.+.++.+.|..+++++++||.+||+.||.+|||++++|+||||+....
T Consensus       223 g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          223 GCPPFNGANE----YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             SSCSSCCSSH----HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             CCCCCCCCCH----HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            9999965442    3456677777777777888899999999999999999999999999999999987643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=373.25  Aligned_cols=249  Identities=25%  Similarity=0.372  Sum_probs=203.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      +.++|+++ +.||+|+||+||+|.+..+|+.||||++...       .....|+..+.....||||+++++++..    +
T Consensus        55 ~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~----~  129 (311)
T 3p1a_A           55 FQQSFQRL-SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE----G  129 (311)
T ss_dssp             HHHHEEEE-EEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----T
T ss_pred             hhhheeee-heeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe----C
Confidence            45889995 7799999999999999999999999998531       2334556565677799999999999976    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~----------------  191 (311)
T 3p1a_A          130 GILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG----------------  191 (311)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----------------
T ss_pred             CEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----------------
Confidence            7899999999 679999887754 4699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||++..... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus       192 -----------~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~  258 (311)
T 3p1a_A          192 -----------PRGRCKLGDFGLLVELGT-AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG  258 (311)
T ss_dssp             -----------GGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred             -----------CCCCEEEccceeeeeccc-CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                       566799999999876643 223345678999999999875 7999999999999999999997766432


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                             .....+..+.  .+......+++++.+||.+||+.||++|||++++|+||||++
T Consensus       259 -------~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          259 -------EGWQQLRQGY--LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             -------HHHHHHTTTC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             -------cHHHHHhccC--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                   1122222222  122223468999999999999999999999999999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9e-51  Score=376.91  Aligned_cols=262  Identities=25%  Similarity=0.412  Sum_probs=197.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .++|+++ +.||+|+||+||+|.+..+|+.||||++...      ....+|+.+ ++.++||||+++++++..    ++.
T Consensus         4 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~----~~~   77 (317)
T 2pmi_A            4 SSQFKQL-EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISL-MKELKHENIVRLYDVIHT----ENK   77 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHH-HTTCCBTTBCCEEEEECC----TTE
T ss_pred             ccceeEe-eEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHH-HHhcCCCCcceEEEEEEE----CCe
Confidence            4789985 7799999999999999999999999998632      345678877 677799999999999876    678


Q ss_pred             EEEEEeccCCCchhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          88 LLVIMECMHGGELFQRIQQKE----DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~----~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      +|+||||+. ++|.+++....    ...+++..++.++.||+.||.|||++||+||||||+|||++              
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~--------------  142 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN--------------  142 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--------------
T ss_pred             EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc--------------
Confidence            999999997 59999887642    13599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .++.+||+|||++.............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus       143 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  209 (317)
T 2pmi_A          143 -------------KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF  209 (317)
T ss_dssp             -------------TTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             -------------CCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                         5678999999999876544444556788999999999865 46899999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhC------------Ccc--C------------CCCcccccCHHHHHHHHHhccCCCCCCCChh
Q psy3151         243 FSNHGQAISPGMKNRIRLG------------QFD--F------------PNPEWEHVSQEAKTLIKNMLCVDPSERLTID  296 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~------------~~~--~------------~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~  296 (372)
                      .+....+....+.......            .+.  .            .......++.++.+||.+||+.||++|||++
T Consensus       210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  289 (317)
T 2pmi_A          210 PGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK  289 (317)
T ss_dssp             CCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHH
Confidence            6654322111111111000            000  0            0001125789999999999999999999999


Q ss_pred             HHhcCCccccCCC
Q psy3151         297 QVMENKWISQFNQ  309 (372)
Q Consensus       297 eil~hp~~~~~~~  309 (372)
                      |+|+||||+++..
T Consensus       290 e~l~hp~f~~~~~  302 (317)
T 2pmi_A          290 QALHHPWFAEYYH  302 (317)
T ss_dssp             HHTTSGGGGGGCC
T ss_pred             HHhCChhhhcccc
Confidence            9999999998644

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.3e-51  Score=394.88  Aligned_cols=252  Identities=34%  Similarity=0.643  Sum_probs=211.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..++|+++ +.||+|+||+||+|.+..+|+.||||++....        ...+|+.+ ++.++||||+++++++..    
T Consensus       146 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~----  219 (446)
T 4ejn_A          146 TMNEFEYL-KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV-LQNSRHPFLTALKYSFQT----  219 (446)
T ss_dssp             CGGGEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------C-CCCCSCTTSCCEEEEEEE----
T ss_pred             ChHHcEEe-EEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHH-HHhCCCCeEeeEEEEEee----
Confidence            45789995 78999999999999999999999999996431        23345555 566789999999999986    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      .+.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||+ .||+||||||+|||++              
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~--------------  283 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD--------------  283 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC--------------
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC--------------
Confidence            678999999999999999997753  59999999999999999999998 9999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   .++.+||+|||+|.............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.
T Consensus       284 -------------~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  350 (446)
T 4ejn_A          284 -------------KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  350 (446)
T ss_dssp             -------------SSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------CCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence                         5678999999999865554555667889999999999988999999999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      +.+.    ..+...+......+|.    .+++++.+||.+||+.||.+||     |++|+++||||+++
T Consensus       351 ~~~~----~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          351 NQDH----EKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             CSSH----HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CCCH----HHHHHHHHhCCCCCCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            5432    3445555555555553    6899999999999999999999     99999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-51  Score=390.13  Aligned_cols=255  Identities=27%  Similarity=0.508  Sum_probs=209.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      -.++|+++ +.||+|+||+||+|+++.+|+.||||++....        ...+|..+ +..++||||++++++|.+    
T Consensus        59 ~~~~f~~~-~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~i-l~~~~hp~Iv~l~~~~~~----  132 (412)
T 2vd5_A           59 QRDDFEIL-KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV-LVNGDRRWITQLHFAFQD----  132 (412)
T ss_dssp             CGGGEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHH-HHHSCTTTBCCEEEEEEC----
T ss_pred             ChhhEEEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHH-HHhcCCCCeeeEEEEEee----
Confidence            35789995 78999999999999999999999999996421        23456666 566799999999999986    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      .+.+|+||||++||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld---------------  196 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---------------  196 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---------------
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec---------------
Confidence            678999999999999999998753 3599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccC-------CCCCCCccchhhHHHHHHHHH
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLG-------PDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll  236 (372)
                                  .++.+||+|||+|........ .....+||+.|+|||++.       ...|+.++|+|||||++|||+
T Consensus       197 ------------~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell  264 (412)
T 2vd5_A          197 ------------RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF  264 (412)
T ss_dssp             ------------TTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred             ------------CCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence                        567899999999987644332 234568999999999986       457899999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCC--ccCCCCcccccCHHHHHHHHHhccCCCCCC---CChhHHhcCCccccC
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQ--FDFPNPEWEHVSQEAKTLIKNMLCVDPSER---LTIDQVMENKWISQF  307 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~ll~~dP~~R---~s~~eil~hp~~~~~  307 (372)
                      +|..||.+.+..    .....+....  +.+|. ....+++++++||++||+ +|.+|   ++++++++||||+++
T Consensus       265 tG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          265 YGQTPFYADSTA----ETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             HSSCTTCCSSHH----HHHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             hCCCCCCCCCHH----HHHHHHHhcccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            999999765432    2233332211  22221 124689999999999999 99998   599999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.4e-50  Score=389.64  Aligned_cols=274  Identities=26%  Similarity=0.404  Sum_probs=205.9

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .-.+.++|.+ .+.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++....
T Consensus        21 ~~~i~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           21 NVHVPDNYII-KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITI-LNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             GCCCCTTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHH-HHHCCCTTBCCEEEECCCSC
T ss_pred             cceecCCEEE-EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHH-HHHcCCCCcceEEEEEecCC
Confidence            3447899999 48899999999999999999999999999632       345678887 66678999999999986421


Q ss_pred             -CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          83 -NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        83 -~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                       .....+|+||||+. ++|.+++...  ..+++..++.++.||+.||+|||+.||+||||||+|||++            
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~------------  163 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN------------  163 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC------------
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC------------
Confidence             12267999999995 6999999764  4599999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCC----------------------CcccccccCCCcCCCccc-CCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK----------------------ASLQTPCYTPYYVAPEVL-GPDK  218 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~----------------------~~~~~~~gt~~y~aPE~~-~~~~  218 (372)
                                     .++.+||+|||+|+......                      ......+||++|+|||++ ....
T Consensus       164 ---------------~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~  228 (432)
T 3n9x_A          164 ---------------QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN  228 (432)
T ss_dssp             ---------------TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSC
T ss_pred             ---------------CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCC
Confidence                           56678999999887654322                      124567899999999985 5667


Q ss_pred             CCCccchhhHHHHHHHHHhCCCCC-----------CCCCCCCC-------------------------------------
Q psy3151         219 YDKSCDIWSLGVIMYILLCGFPPF-----------FSNHGQAI-------------------------------------  250 (372)
Q Consensus       219 ~~~~~DiwslG~il~~ll~g~~pf-----------~~~~~~~~-------------------------------------  250 (372)
                      |+.++|||||||++|+|++|..||           .+.+....                                     
T Consensus       229 ~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~  308 (432)
T 3n9x_A          229 YTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN  308 (432)
T ss_dssp             CCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhcc
Confidence            999999999999999999854444           22221000                                     


Q ss_pred             CHhHHHHHhhCCccCCCC---cccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCCCC
Q psy3151         251 SPGMKNRIRLGQFDFPNP---EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPL  315 (372)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~~~  315 (372)
                      .......+.......+..   .+..+++++.+||.+||+.||++|||++|+|+||||+++......+.
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~  376 (432)
T 3n9x_A          309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENF  376 (432)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC--
T ss_pred             CHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcC
Confidence            000011111100000000   12357999999999999999999999999999999999866544443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-50  Score=370.69  Aligned_cols=257  Identities=27%  Similarity=0.445  Sum_probs=200.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|+++ +.||+|+||+||+|.+ .+|+.||||++...       ....+|+.+ ++.++||||+++++++..    ++.
T Consensus         2 ~~y~~~-~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~   74 (288)
T 1ob3_A            2 EKYHGL-EKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISI-LKELKHSNIVKLYDVIHT----KKR   74 (288)
T ss_dssp             CSEEEE-EEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHG-GGGCCCTTBCCEEEEEEC----SSC
T ss_pred             ccchhh-hhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHH-HHhcCCCCEeeeeeEEcc----CCe
Confidence            689995 7799999999999999 68999999998532       234577777 667799999999999976    568


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+.+ +|.+++.... +.+++..++.++.||+.||+|||++||+||||||+||+++                  
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~------------------  134 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN------------------  134 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC------------------
T ss_pred             EEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc------------------
Confidence            9999999965 9999987653 5699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.+||+|||++.............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus       135 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (288)
T 1ob3_A          135 ---------REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (288)
T ss_dssp             ---------TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ---------CCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                     5678999999999876544444455678999999999865 458999999999999999999999996543


Q ss_pred             CCCCCHhHHHHHhhC------------Ccc--C---CC----CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         247 GQAISPGMKNRIRLG------------QFD--F---PN----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~------------~~~--~---~~----~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      ..+....+.......            .+.  +   .+    .....+++++.+||.+||+.||++|||++|+|+||||+
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  285 (288)
T 1ob3_A          206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (288)
T ss_dssp             HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             HHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence            222111111111000            000  0   00    01135789999999999999999999999999999997


Q ss_pred             cC
Q psy3151         306 QF  307 (372)
Q Consensus       306 ~~  307 (372)
                      +.
T Consensus       286 ~~  287 (288)
T 1ob3_A          286 EN  287 (288)
T ss_dssp             C-
T ss_pred             hc
Confidence            63

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.1e-50  Score=407.16  Aligned_cols=253  Identities=29%  Similarity=0.512  Sum_probs=220.1

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|+++ +.||+|+||+||+|.+..+++.||||++...        .....|..++..+.+||||+.++++|++    .
T Consensus       340 ~~~f~~~-~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----~  414 (674)
T 3pfq_A          340 LTDFNFL-MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----M  414 (674)
T ss_dssp             CTTEEEE-EESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC----S
T ss_pred             ccceEEE-EEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe----C
Confidence            4679985 7899999999999999999999999999642        2345666665555689999999999976    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+||||++||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~----------------  476 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----------------  476 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC----------------
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc----------------
Confidence            78999999999999999998763  599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||+|+..........+.+||+.|+|||++.+..|+.++|+|||||++|||++|..||.+.
T Consensus       477 -----------~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  545 (674)
T 3pfq_A          477 -----------SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  545 (674)
T ss_dssp             -----------SSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -----------CCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence                       567899999999987555455566789999999999999999999999999999999999999999764


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh-----hHHhcCCccccCC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-----DQVMENKWISQFN  308 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~-----~eil~hp~~~~~~  308 (372)
                      +.    ..+...+......+|.    .+++++.+||++||+.||++||++     +++++||||+.+.
T Consensus       546 ~~----~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          546 DE----DELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             SH----HHHHHHHHSSCCCCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             CH----HHHHHHHHhCCCCCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            42    3456667766666664    689999999999999999999998     9999999998753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=377.00  Aligned_cols=261  Identities=23%  Similarity=0.409  Sum_probs=202.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ++|.++ +.||+|+||+||+|.+..+|+.||||++....      ...+|+.+ ++.++||||+++++++..    +...
T Consensus         2 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~~~~   75 (324)
T 3mtl_A            2 ETYIKL-DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSL-LKDLKHANIVTLHDIIHT----EKSL   75 (324)
T ss_dssp             CSEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHH-HSCCCCTTBCCEEEEEEC----SSCE
T ss_pred             CceEEE-EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHH-HHhcCCCCCCeeeeEEee----CCEE
Confidence            689995 77999999999999999999999999986322      33468877 677799999999999875    6779


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+. |+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++                   
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~-------------------  134 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN-------------------  134 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC-------------------
T ss_pred             EEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC-------------------
Confidence            99999996 59999988754 4699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                              .++.+||+|||++.............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.
T Consensus       135 --------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  206 (324)
T 3mtl_A          135 --------ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV  206 (324)
T ss_dssp             --------TTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             --------CCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence                    5678999999999876554445556688999999999865 6689999999999999999999999966543


Q ss_pred             CCCCHhHHHHHhhCC---------------ccCCC-------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         248 QAISPGMKNRIRLGQ---------------FDFPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~---------------~~~~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      .+....+........               +.++.       .....+++++.+||.+||+.||.+|||++|+|+||||.
T Consensus       207 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  286 (324)
T 3mtl_A          207 EEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL  286 (324)
T ss_dssp             HHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             HHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence            221111111110000               00000       01135789999999999999999999999999999999


Q ss_pred             cCCCC
Q psy3151         306 QFNQV  310 (372)
Q Consensus       306 ~~~~~  310 (372)
                      +....
T Consensus       287 ~~~~~  291 (324)
T 3mtl_A          287 SLGER  291 (324)
T ss_dssp             GGCST
T ss_pred             hcccc
Confidence            87654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5e-50  Score=364.34  Aligned_cols=259  Identities=37%  Similarity=0.677  Sum_probs=219.3

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ..+.++|++ .+.||+|+||+||+|.+..++..+|+|++...     ....+|+.+ ++.++||||+++++++..    +
T Consensus         5 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~   78 (277)
T 3f3z_A            5 GDINQYYTL-ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEI-MKSLDHPNIIRLYETFED----N   78 (277)
T ss_dssp             -CHHHHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHH-HHTCCCTTBCCEEEEEEC----S
T ss_pred             hhhhhhEEe-eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHH-HHhCCCCCEeeEEEEEec----C
Confidence            357899999 57899999999999999999999999998632     345678877 677799999999999975    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...|+||||+.+++|.+++...  +.+++..++.++.||+.||+|||++||+||||||+||++..++             
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------------  143 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-------------  143 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-------------
T ss_pred             CeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC-------------
Confidence            7899999999999999998775  3599999999999999999999999999999999999994322             


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.++|+|||++..... .......+||+.|+|||++.+. ++.++|||||||++|+|++|..||...
T Consensus       144 -----------~~~~~~l~Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (277)
T 3f3z_A          144 -----------PDSPLKLIDFGLAARFKP-GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP  210 (277)
T ss_dssp             -----------TTCCEEECCCTTCEECCT-TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -----------CCCcEEEEecccceeccC-ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence                       567799999999876643 2334556789999999998654 899999999999999999999999654


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ..    ......+..+....+...+..+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus       211 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          211 TD----SEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             SH----HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             CH----HHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            32    34455566666666655556789999999999999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.8e-50  Score=391.26  Aligned_cols=252  Identities=35%  Similarity=0.597  Sum_probs=217.0

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ...++|.+ .+.||+|+||+||+|.+..+|+.||||++...        ....+|+.+ ++.++||||+++++++..   
T Consensus        13 ~~~~~Y~l-~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~-l~~l~HpnIv~l~~~~~~---   87 (476)
T 2y94_A           13 VKIGHYIL-GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN-LKLFRHPHIIKLYQVIST---   87 (476)
T ss_dssp             CEETTEEE-EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHH-HTTCCCTTBCCEEEEEEC---
T ss_pred             ceecCEEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHH-HHhCCCCCCCcEEEEEEE---
Confidence            35689998 58899999999999999999999999999632        235578877 677899999999999976   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ...+|+||||+.+|+|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+|||++              
T Consensus        88 -~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~--------------  150 (476)
T 2y94_A           88 -PSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD--------------  150 (476)
T ss_dssp             -SSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC--------------
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe--------------
Confidence             67899999999999999999754  4699999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .++.+||+|||++..... .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus       151 -------------~~~~vkL~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf  216 (476)
T 2y94_A          151 -------------AHMNAKIADFGLSNMMSD-GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF  216 (476)
T ss_dssp             -------------TTCCEEECCCSSCEECCT-TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             -------------cCCCeEEEeccchhhccc-cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC
Confidence                         567799999999987643 334556789999999999988765 68999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .+..    ...+...+..+.+..|    ..+++++.+||.+||+.||.+|||++++++||||++.
T Consensus       217 ~~~~----~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          217 DDDH----VPTLFKKICDGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             CCSS----SHHHHHHHHTTCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             CCCC----HHHHHHHHhcCCcCCC----ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            6543    2445566666655544    3689999999999999999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.5e-50  Score=378.44  Aligned_cols=283  Identities=22%  Similarity=0.292  Sum_probs=211.3

Q ss_pred             CCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhc----CCCCEeEEeEee
Q psy3151           7 PFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVG----SHKHIVNIKDVY   78 (372)
Q Consensus         7 ~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~----~h~ni~~~~~~~   78 (372)
                      .....-+.++|+++ +.||+|+||+||+|.+..+++.||||++...    ....+|+.++..+.    .||||+++++++
T Consensus        27 ~~~g~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           27 WKKGMLLNNAFLVI-RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             CCTTCEETTTEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             eecceEecCEEEEE-EEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            34445588999995 7799999999999999999999999999642    23455777644443    499999999999


Q ss_pred             eeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce-
Q psy3151          79 ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL-  157 (372)
Q Consensus        79 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~-  157 (372)
                      ..    ...+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+...... 
T Consensus       106 ~~----~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          106 MY----YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EE----TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred             eE----CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence            76    57899999999 8999999988765679999999999999999999999999999999999999742211100 


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  237 (372)
                      .+.+....+.   ........+.+||+|||+|.....   .....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       181 ~~~~~~~~~~---~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          181 TVRRVTDGKK---IQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEECTTTCCE---EEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             chhccccccc---ccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence            0000000000   000001367899999999986533   2345678999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccC--------------------------CCC----------------cccccCH
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDF--------------------------PNP----------------EWEHVSQ  275 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~----------------~~~~~s~  275 (372)
                      |..||......+.    ...+.......                          |..                .....++
T Consensus       255 g~~pf~~~~~~~~----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          255 GSLLFRTHEHMEH----LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             SSCSCCCSSHHHH----HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             CCCCCCCCcHHHH----HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            9999965442211    11111100000                          000                0011347


Q ss_pred             HHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         276 EAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       276 ~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      ++.+||.+||+.||++|||++|+|+||||+
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            788999999999999999999999999995

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.7e-50  Score=363.28  Aligned_cols=253  Identities=29%  Similarity=0.540  Sum_probs=188.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..++|++ .+.||+|+||.||+|.+..+|+.||||++...        ....+|+.+ ++.++||||+++++++..    
T Consensus         9 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   82 (278)
T 3cok_A            9 KIEDFKV-GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI-HCQLKHPSILELYNYFED----   82 (278)
T ss_dssp             SGGGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HTTBCCTTBCCEEEEEEC----
T ss_pred             cccccee-eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHH-HHhCCCCCeEeEEEEEcc----
Confidence            3478999 57899999999999999999999999999632        234567766 667799999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      .+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++               
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~---------------  146 (278)
T 3cok_A           83 SNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT---------------  146 (278)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC---------------
T ss_pred             CCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---------------
Confidence            678999999999999999998643 4699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus       147 ------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  214 (278)
T 3cok_A          147 ------------RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT  214 (278)
T ss_dssp             ------------TTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ------------CCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                        56779999999998765444444456789999999999888899999999999999999999999976


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ......    ...+....+..+    ..++.++.+||.+||+.||++|||++++++||||.+.
T Consensus       215 ~~~~~~----~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          215 DTVKNT----LNKVVLADYEMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             CSCC---------CCSSCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             hhHHHH----HHHHhhcccCCc----cccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            543322    222222223222    3579999999999999999999999999999999764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.6e-50  Score=370.65  Aligned_cols=262  Identities=27%  Similarity=0.471  Sum_probs=202.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      +.++|+++ +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++..    +
T Consensus         1 l~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~   74 (311)
T 4agu_A            1 MMEKYEKI-GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRM-LKQLKHPNLVNLLEVFRR----K   74 (311)
T ss_dssp             --CCEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHH-HHHCCCTTBCCEEEEEEE----T
T ss_pred             CcccceEe-eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHH-HHhCCCCCccchhheeec----C
Confidence            35789995 7799999999999999999999999998532       234567777 667799999999999976    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...++||||+.+++|.+++...  +.+++..++.++.|++.||+|||++||+||||||+||+++                
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~----------------  136 (311)
T 4agu_A           75 RRLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT----------------  136 (311)
T ss_dssp             TEEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----------------
T ss_pred             CeEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc----------------
Confidence            7899999999999998887654  4599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                 .++.+||+|||++.............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus       137 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  205 (311)
T 4agu_A          137 -----------KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG  205 (311)
T ss_dssp             -----------TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -----------CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                       5678999999999876654444556788999999999865 6789999999999999999999999966


Q ss_pred             CCCCCCCHhHHHHHh-----------h----CCccCCCC--------cccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         245 NHGQAISPGMKNRIR-----------L----GQFDFPNP--------EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~-----------~----~~~~~~~~--------~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ....+....+.....           .    .....+.+        .+..++.++.+||.+||+.||.+|||++|+|+|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          206 KSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             SSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            543221111111100           0    01111111        113578999999999999999999999999999


Q ss_pred             CccccCCC
Q psy3151         302 KWISQFNQ  309 (372)
Q Consensus       302 p~~~~~~~  309 (372)
                      |||++...
T Consensus       286 p~f~~~~~  293 (311)
T 4agu_A          286 PYFENIRE  293 (311)
T ss_dssp             GGGTTCC-
T ss_pred             hHHHhccC
Confidence            99998644

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=382.87  Aligned_cols=259  Identities=32%  Similarity=0.591  Sum_probs=212.8

Q ss_pred             cccceeec-cccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          13 IQDDYDIS-TEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        13 ~~~~Y~i~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      +.+.|.+. .+.||+|+||.||+|.+..+|+.||+|++...     ....+|+.+ ++.++||||+++++++..    .+
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~----~~  159 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISV-MNQLDHANLIQLYDAFES----KN  159 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHH-HTTCCCTTBCCEEEEEEC----SS
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHH-HHhCCCCCCCeEEEEEEE----CC
Confidence            44556652 35799999999999999999999999999642     245577777 667799999999999976    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||+..+               
T Consensus       160 ~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---------------  223 (373)
T 2x4f_A          160 DIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR---------------  223 (373)
T ss_dssp             EEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET---------------
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC---------------
Confidence            8999999999999999887643 459999999999999999999999999999999999999521               


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                ..+.+||+|||++...... ......+||+.|+|||++....++.++|||||||++|+|++|..||.+..
T Consensus       224 ----------~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  292 (373)
T 2x4f_A          224 ----------DAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN  292 (373)
T ss_dssp             ----------TTTEEEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ----------CCCcEEEEeCCCceecCCc-cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence                      4567999999999876432 23445679999999999998899999999999999999999999996554


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .    ......+....+.++...+..+++++++||.+||+.||.+|||++|+|+||||++.
T Consensus       293 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          293 D----AETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             H----HHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             H----HHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            2    23445555566666666667899999999999999999999999999999999763

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-50  Score=375.84  Aligned_cols=267  Identities=26%  Similarity=0.398  Sum_probs=202.5

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ....++|+++ +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++..   
T Consensus        30 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~---  104 (329)
T 3gbz_A           30 ATSIDRYRRI-TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSL-LKELQHRNIIELKSVIHH---  104 (329)
T ss_dssp             --CGGGEEEE-EEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHH-GGGCCCTTBCCEEEEEEE---
T ss_pred             ccchhhEEEE-EEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHH-HHHcCCCCcceEEEEEec---
Confidence            4467899995 7799999999999999999999999998632       234578877 667799999999999986   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       +..+|+||||+. |+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+++          
T Consensus       105 -~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~----------  170 (329)
T 3gbz_A          105 -NHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA----------  170 (329)
T ss_dssp             -TTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-------------
T ss_pred             -CCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC----------
Confidence             678999999996 59999998753  5999999999999999999999999999999999999974331          


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                  ...+.+||+|||++.............+||+.|+|||++.+. .++.++|||||||++|+|++|..||
T Consensus       171 ------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  238 (329)
T 3gbz_A          171 ------------SETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF  238 (329)
T ss_dssp             --------------CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ------------CccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence                        145679999999998765544455667889999999998764 5899999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCc-cCC-----------CC----------cccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQF-DFP-----------NP----------EWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~-~~~-----------~~----------~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .+....+....+......... .++           .+          ....+++++.+||.+||+.||.+|||++|+|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          239 PGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            665432211111111100000 000           00          00127899999999999999999999999999


Q ss_pred             CCccccCC
Q psy3151         301 NKWISQFN  308 (372)
Q Consensus       301 hp~~~~~~  308 (372)
                      ||||++..
T Consensus       319 hp~f~~~~  326 (329)
T 3gbz_A          319 HPYFSHND  326 (329)
T ss_dssp             SGGGSSSC
T ss_pred             CcccCCCC
Confidence            99998753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.9e-50  Score=377.74  Aligned_cols=255  Identities=37%  Similarity=0.689  Sum_probs=216.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      +.++|++ .+.||.|+||.||+|.+..+|+.||||++...             ....+|+.++..+.+||||+++++++.
T Consensus        92 ~~~~y~~-~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           92 FYQKYDP-KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhccc-ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            5578998 58899999999999999999999999998532             234567777666668999999999987


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      .    ....|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+|||++          
T Consensus       171 ~----~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~----------  234 (365)
T 2y7j_A          171 S----SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD----------  234 (365)
T ss_dssp             B----SSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------
T ss_pred             e----CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----------
Confidence            6    67899999999999999999865  3599999999999999999999999999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC------CCCCCCccchhhHHHHHH
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG------PDKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~  233 (372)
                                       .++.++|+|||++...... ......+||+.|+|||++.      ...++.++|||||||++|
T Consensus       235 -----------------~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~  296 (365)
T 2y7j_A          235 -----------------DNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF  296 (365)
T ss_dssp             -----------------TTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHH
T ss_pred             -----------------CCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHH
Confidence                             5678999999998876442 3345578999999999874      346889999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      +|++|..||.....    ......+..+.+.++.+.+..++.++.+||.+||+.||++|||++++|+||||++
T Consensus       297 ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          297 TLLAGSPPFWHRRQ----ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHSSCSSCCSSH----HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHCCCCCCCCCH----HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            99999999965432    2344555566666666666788999999999999999999999999999999963

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-49  Score=366.61  Aligned_cols=260  Identities=38%  Similarity=0.760  Sum_probs=220.1

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ...+.++|.+ .+.||+|+||+||+|.+..+|+.||||++...     ....+|+.+ ++.++||||+++++++..    
T Consensus         4 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   77 (304)
T 2jam_A            4 TTNIRKTFIF-MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV-LKKIKHENIVTLEDIYES----   77 (304)
T ss_dssp             --CHHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHH-HHHCCCTTBCCEEEEEEC----
T ss_pred             ccchhcccee-eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHH-HHhCCCCCeeehhhhccc----
Confidence            4567899999 58899999999999999999999999998643     234577777 666799999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...|+||||+.+++|.+++....  .+++..++.++.||+.||.|||+.||+||||||+||++..++            
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~------------  143 (304)
T 2jam_A           78 TTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE------------  143 (304)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS------------
T ss_pred             CCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC------------
Confidence            678999999999999999997653  599999999999999999999999999999999999994322            


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  ..+.++|+|||++.....  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       144 ------------~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  209 (304)
T 2jam_A          144 ------------ENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE  209 (304)
T ss_dssp             ------------TTCCEEBCSCSTTCCCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ------------CCCCEEEccCCcceecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                        567799999998875432  223456789999999999989999999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ...    ......+..+.+.++.+.+..+++++.+||.+||..||++|||++++++||||++.
T Consensus       210 ~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          210 ETE----SKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             SCH----HHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             CCH----HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            432    34455666666666666667899999999999999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-50  Score=376.58  Aligned_cols=264  Identities=33%  Similarity=0.591  Sum_probs=214.8

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------hhhHHHHHHHHHhcCCCCEeEEeEeeee
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKDVYEN   80 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~   80 (372)
                      ..+.++|++. +.||+|+||+||+|.+..+++.||+|++...          ....+|+.+ ++.++||||+++++++..
T Consensus        22 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           22 LELQKKYHLK-GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL-MKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             HHHHHHEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHH-HHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhheeec-ceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHH-HHhCCCCCcceeehhhcc
Confidence            3478999994 7899999999999999999999999998532          234567877 566699999999999976


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhcc--------------------------------------CCCCCHHHHHHHHH
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKE--------------------------------------DGAFTEREAAIIMN  122 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~--------------------------------------~~~l~~~~~~~i~~  122 (372)
                          +...++||||+++|+|.+++....                                      ...+++..++.++.
T Consensus       100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A          100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence                678999999999999999885210                                      11246888999999


Q ss_pred             HHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC----c
Q psy3151         123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----S  198 (372)
Q Consensus       123 qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~  198 (372)
                      ||+.||+|||++||+||||||+|||++.+                         ..+.+||+|||++........    .
T Consensus       176 qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~  230 (345)
T 3hko_A          176 QIFSALHYLHNQGICHRDIKPENFLFSTN-------------------------KSFEIKLVDFGLSKEFYKLNNGEYYG  230 (345)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEESCS-------------------------SSCCEEECCCTTCEEGGGTTCC----
T ss_pred             HHHHHHHHHHHCCccccCCChhhEEEecC-------------------------CCceEEEeeccccccccccCcccccc
Confidence            99999999999999999999999999731                         223799999999986543211    2


Q ss_pred             ccccccCCCcCCCcccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHH
Q psy3151         199 LQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQE  276 (372)
Q Consensus       199 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  276 (372)
                      ....+||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+...    ......+......++.+.+..++++
T Consensus       231 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  306 (345)
T 3hko_A          231 MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND----ADTISQVLNKKLCFENPNYNVLSPL  306 (345)
T ss_dssp             ----CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCTTSGGGGGSCHH
T ss_pred             ccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh----HHHHHHHHhcccccCCcccccCCHH
Confidence            345678999999999865  6789999999999999999999999965442    2334555556666666666779999


Q ss_pred             HHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         277 AKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       277 ~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      +.+||.+||+.||.+|||+.++|+||||+++..
T Consensus       307 ~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          307 ARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            999999999999999999999999999988643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.8e-49  Score=367.50  Aligned_cols=251  Identities=29%  Similarity=0.461  Sum_probs=210.1

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .|+.. +.||+|+||.||+|.+..+|+.||||++...     ....+|+.+ ++.++||||+++++++..    +...|+
T Consensus        46 ~~~~~-~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~----~~~~~l  119 (321)
T 2c30_A           46 LLDSY-VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVI-MRDYQHFNVVEMYKSYLV----GEELWV  119 (321)
T ss_dssp             HEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHH-HTTCCCTTBCCEEEEEEE----TTEEEE
T ss_pred             hhhcc-EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEE----CCEEEE
Confidence            47763 6799999999999999999999999998632     235577776 677799999999999876    567999


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+.+++|.+++..   ..+++..++.++.||+.||+|||+.||+||||||+|||++                     
T Consensus       120 v~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---------------------  175 (321)
T 2c30_A          120 LMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---------------------  175 (321)
T ss_dssp             EECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---------------------
T ss_pred             EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---------------------
Confidence            9999999999998864   3599999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI  250 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  250 (372)
                            .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.....   
T Consensus       176 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---  246 (321)
T 2c30_A          176 ------LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---  246 (321)
T ss_dssp             ------TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---
T ss_pred             ------CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence                  56789999999998765544445567899999999999999999999999999999999999999965432   


Q ss_pred             CHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                       ......+.....+ .......+++++.+||.+||+.||++|||++++++||||.+.
T Consensus       247 -~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          247 -VQAMKRLRDSPPP-KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             -HHHHHHHHHSSCC-CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             -HHHHHHHhcCCCC-CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence             1223333332211 112234689999999999999999999999999999999763

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-50  Score=378.06  Aligned_cols=268  Identities=24%  Similarity=0.400  Sum_probs=203.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--   82 (372)
                      .+.++|+++ +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++....  
T Consensus        22 ~~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           22 EVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL-LKHMRHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             CCBSSEEEE-EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHH-HHHCCBTTBCCCSEEECSCSST
T ss_pred             eecceEEEe-EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHH-HHhCCCcCCCCceeeEecCCcc
Confidence            367899995 7799999999999999999999999998531       245678887 66678999999999987421  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      .....+|+||||+ +++|.+++..   +.+++..++.++.||+.||+|||++||+||||||+|||++             
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~-------------  162 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN-------------  162 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-------------
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc-------------
Confidence            1224579999999 8899999876   3499999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                    .++.+||+|||+++....   .....+||++|+|||++.+ ..++.++||||+||++|+|++|..|
T Consensus       163 --------------~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  225 (367)
T 1cm8_A          163 --------------EDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL  225 (367)
T ss_dssp             --------------TTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             --------------CCCCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence                          567899999999987533   2445678999999999866 6799999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHh-------------------hCCccCCC----CcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         242 FFSNHGQAISPGMKNRIR-------------------LGQFDFPN----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~-------------------~~~~~~~~----~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |.+.+..+....+.....                   ......+.    ..+..+++++.+||.+||+.||.+|||++++
T Consensus       226 f~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~  305 (367)
T 1cm8_A          226 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA  305 (367)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH
Confidence            976543221111111000                   00000001    1123578999999999999999999999999


Q ss_pred             hcCCccccCCCCCCCCC
Q psy3151         299 MENKWISQFNQVPQTPL  315 (372)
Q Consensus       299 l~hp~~~~~~~~~~~~~  315 (372)
                      |+||||+.+......+.
T Consensus       306 l~hp~f~~~~~~~~~~~  322 (367)
T 1cm8_A          306 LAHPYFESLHDTEDEPQ  322 (367)
T ss_dssp             HHSGGGTTTC------C
T ss_pred             hcChHHHhhcCCccCCC
Confidence            99999998765444433

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-49  Score=361.32  Aligned_cols=258  Identities=30%  Similarity=0.544  Sum_probs=207.2

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .+.++|.+ .+.||+|+||+||+|.+..+|+.+|+|++...      ....+|+.+ ++.++||||+++++++..    .
T Consensus        19 ~i~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~----~   92 (285)
T 3is5_A           19 TIDDLFIF-KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEV-LKSLDHPNIIKIFEVFED----Y   92 (285)
T ss_dssp             CHHHHEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHH-HHTCCCTTBCCEEEEEEC----S
T ss_pred             Chhhheee-cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHH-HHhCCCchHHhHHHheec----C
Confidence            48899999 57899999999999999999999999998643      344677877 677799999999999875    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ...|+||||+++++|.+.+...  ....+++..++.++.||+.||+|||++||+||||||+||+++.++           
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~-----------  161 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-----------  161 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS-----------
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC-----------
Confidence            7899999999999999988653  235699999999999999999999999999999999999996322           


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   ..+.+||+|||++...... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.
T Consensus       162 -------------~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~  226 (285)
T 3is5_A          162 -------------PHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT  226 (285)
T ss_dssp             -------------TTCCEEECCCCCCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------CCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence                         4567999999998765432 2334567899999999986 568899999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      +...    ..............+. ....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       227 ~~~~----~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          227 GTSL----EEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CSSH----HHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CCCH----HHHHhhhccCCccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            5432    2233333333322221 22347899999999999999999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.7e-49  Score=361.57  Aligned_cols=259  Identities=36%  Similarity=0.663  Sum_probs=219.2

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------------hhhHHHHHHHHHhcCCCCEeEEe
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------------VKARREVELQLAVGSHKHIVNIK   75 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~ni~~~~   75 (372)
                      ...+.++|++ .+.||+|+||.||+|.+..+|+.||||++...              ....+|+.++.++.+||||++++
T Consensus        12 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           12 THGFYENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             ---CTTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             Ccchhhccce-eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            4458899999 48899999999999999999999999998532              23456777766665799999999


Q ss_pred             EeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCC
Q psy3151          76 DVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGG  155 (372)
Q Consensus        76 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~  155 (372)
                      +++..    +...|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+||+++      
T Consensus        91 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~------  158 (298)
T 1phk_A           91 DTYET----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD------  158 (298)
T ss_dssp             EEEEC----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------
T ss_pred             eeecc----CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc------
Confidence            99875    67899999999999999999875  3599999999999999999999999999999999999998      


Q ss_pred             ceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC------CCCCCCccchhhHH
Q psy3151         156 ILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG------PDKYDKSCDIWSLG  229 (372)
Q Consensus       156 ~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG  229 (372)
                                           .++.+||+|||++..... .......+||+.|+|||++.      ...++.++||||||
T Consensus       159 ---------------------~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG  216 (298)
T 1phk_A          159 ---------------------DDMNIKLTDFGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG  216 (298)
T ss_dssp             ---------------------TTCCEEECCCTTCEECCT-TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred             ---------------------CCCcEEEecccchhhcCC-CcccccccCCccccCHHHhccccccccccCCcccccHhHH
Confidence                                 567799999999987643 22344567899999999873      45688999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         230 VIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       230 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |++|+|++|..||.....    ......+..+....+.+.+..++.++.+||.+||+.||.+|||++++++||||++.
T Consensus       217 ~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          217 VIMYTLLAGSPPFWHRKQ----MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             HHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             HHHHHHHHCCCCCcCccH----HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            999999999999965432    23445556666666667777899999999999999999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=381.54  Aligned_cols=272  Identities=26%  Similarity=0.432  Sum_probs=197.1

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEc--CCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEK--KTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ...+.+.|++.++.||+|+||+||+|.+.  .+++.||||++...   ....+|+.+ ++.++||||++++++|..  ..
T Consensus        15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~--~~   91 (405)
T 3rgf_A           15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIAL-LRELKHPNVISLQKVFLS--HA   91 (405)
T ss_dssp             CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHH-HHHCCCTTBCCCCEEEEE--TT
T ss_pred             hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHH-HHhcCCCCeeeEeeEEec--CC
Confidence            45678899997778999999999999965  57899999999743   356788887 666789999999999853  23


Q ss_pred             ceEEEEEEeccCCCchhHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKE-------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~-------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      +..+|+||||+. ++|.+++....       ...+++..++.++.||+.||+|||++||+||||||+|||+..+++    
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~----  166 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP----  166 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSST----
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCC----
Confidence            668999999995 58888886421       124999999999999999999999999999999999999964322    


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCC---CcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHH
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK---ASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~  233 (372)
                                         ..+.+||+|||+|.......   ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus       167 -------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~  227 (405)
T 3rgf_A          167 -------------------ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA  227 (405)
T ss_dssp             -------------------TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred             -------------------CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence                               56789999999998764321   23445788999999999876 45899999999999999


Q ss_pred             HHHhCCCCCCCCCCCC-----CCHhHHHHHhhCCccCCCCcc----------------------------------cccC
Q psy3151         234 ILLCGFPPFFSNHGQA-----ISPGMKNRIRLGQFDFPNPEW----------------------------------EHVS  274 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~s  274 (372)
                      +|++|..||.+.....     ........+.......+...|                                  ...+
T Consensus       228 ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (405)
T 3rgf_A          228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD  307 (405)
T ss_dssp             HHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTT
T ss_pred             HHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCC
Confidence            9999999997654321     011111111100000000111                                  1127


Q ss_pred             HHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         275 QEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       275 ~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      +++.+||.+||++||.+|||++|+|+||||.+..
T Consensus       308 ~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~  341 (405)
T 3rgf_A          308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP  341 (405)
T ss_dssp             SHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence            7899999999999999999999999999998753

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.6e-49  Score=383.39  Aligned_cols=266  Identities=22%  Similarity=0.364  Sum_probs=207.2

Q ss_pred             CccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHh-----cCCCCEeEEeEee
Q psy3151           8 FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAV-----GSHKHIVNIKDVY   78 (372)
Q Consensus         8 ~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~-----~~h~ni~~~~~~~   78 (372)
                      .....+.++|+++ +.||+|+||+||+|.+..+++.||||++....    ...+|+.++..+     .+|+||+.+++++
T Consensus        90 ~~~~~~~~ry~~~-~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           90 VPHDHVAYRYEVL-KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             CTTCEETTTEEEE-EEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             cCCCcccCcEEEE-EEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            3344577899995 78999999999999999999999999997532    345566664333     2678999999998


Q ss_pred             eeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          79 ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      ..    ...+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++         
T Consensus       169 ~~----~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---------  234 (429)
T 3kvw_A          169 TF----RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---------  234 (429)
T ss_dssp             EE----TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---------
T ss_pred             cc----CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---------
Confidence            76    678999999995 6999999887656699999999999999999999999999999999999998         


Q ss_pred             eeccCCCCccccccCCCCCCCC--eeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHH
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGI--LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~--~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  236 (372)
                                        .++.  +||+|||+|....   ....+.+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus       235 ------------------~~~~~~vkL~DFG~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  293 (429)
T 3kvw_A          235 ------------------QQGRSGIKVIDFGSSCYEH---QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL  293 (429)
T ss_dssp             ------------------STTSCCEEECCCTTCEETT---CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHH
T ss_pred             ------------------cCCCcceEEeecccceecC---CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHH
Confidence                              3333  9999999997543   2344568899999999998889999999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhh------------------CCc--------------------------cCCC--Cc-
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRL------------------GQF--------------------------DFPN--PE-  269 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~--------------------------~~~~--~~-  269 (372)
                      +|.+||.+.+..+....+......                  ..+                          ..++  .. 
T Consensus       294 tG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (429)
T 3kvw_A          294 TGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREW  373 (429)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCH
T ss_pred             hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhh
Confidence            999999765432211111111000                  000                          0000  00 


Q ss_pred             ----ccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         270 ----WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       270 ----~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                          ....++++.+||.+||++||++|||++|+|+||||++...
T Consensus       374 ~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          374 GNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP  417 (429)
T ss_dssp             HHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC----
T ss_pred             HhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCC
Confidence                0124788999999999999999999999999999987543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4e-49  Score=358.86  Aligned_cols=253  Identities=33%  Similarity=0.574  Sum_probs=211.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      -.++|++ .+.||+|+||+||+|.+..+++.||||++...        ....+|+.+ ++.++||||+++++++..    
T Consensus         7 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   80 (279)
T 3fdn_A            7 ALEDFEI-GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHPNILRLYGYFHD----   80 (279)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHH-HTTCCCTTBCCEEEEEEC----
T ss_pred             ecccEEE-eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHH-HHcCCCCCCcchhheEec----
Confidence            4588999 47899999999999999999999999998532        234566666 677789999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ....++||||+++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||+++               
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~---------------  143 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---------------  143 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC---------------
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc---------------
Confidence            678999999999999999998763  599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.++|+|||++.....  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       144 ------------~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  209 (279)
T 3fdn_A          144 ------------SAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA  209 (279)
T ss_dssp             ------------TTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ------------CCCCEEEEeccccccCCc--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence                        567799999998865432  223456789999999999999999999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV  310 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~  310 (372)
                      ...    ......+......++    ..+++++.+||.+||+.||.+|||++|+++||||+.....
T Consensus       210 ~~~----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          210 NTY----QETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             SSH----HHHHHHHHHTCCCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             CcH----HHHHHHHHhCCCCCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence            432    233444555554444    3689999999999999999999999999999999875443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.1e-50  Score=371.39  Aligned_cols=257  Identities=25%  Similarity=0.394  Sum_probs=203.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecC---
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD------TVKARREVELQLAVGSHKHIVNIKDVYENIYN---   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~---   83 (372)
                      +.++|+++ +.||+|+||+||+|++..+|+.||||++..      .....+|+.+ ++.++||||++++++|.....   
T Consensus         4 ~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            4 YLTDFEPI-QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA-LAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHEEEE-EEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHH-HTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhcCcee-eEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHH-HHhCCCCCEeeEEEEEEEeccchh
Confidence            56889995 789999999999999999999999999862      1345678877 666799999999999854211   


Q ss_pred             --------------------------------------------------CceEEEEEEeccCCCchhHHHHhccC-CCC
Q psy3151          84 --------------------------------------------------GSRCLLVIMECMHGGELFQRIQQKED-GAF  112 (372)
Q Consensus        84 --------------------------------------------------~~~~~~lv~e~~~~g~L~~~i~~~~~-~~l  112 (372)
                                                                        ...++|+||||+.+++|.+++..... ...
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                              12358999999999999999987432 235


Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeecccccccc
Q psy3151         113 TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI  192 (372)
Q Consensus       113 ~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~  192 (372)
                      ++..++.++.||+.||+|||++||+||||||+|||++                           .++.+||+|||++...
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---------------------------~~~~~kL~DfG~a~~~  214 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---------------------------MDDVVKVGDFGLVTAM  214 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---------------------------TTCCEEECCCTTCEEC
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---------------------------CCCCEEEeecCccccc
Confidence            6678999999999999999999999999999999998                           5677999999998876


Q ss_pred             ccCC------------CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhh
Q psy3151         193 VSNK------------ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL  260 (372)
Q Consensus       193 ~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  260 (372)
                      ....            ......+||+.|+|||++.+..++.++|||||||++|+|++|..|+...      .........
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------~~~~~~~~~  288 (332)
T 3qd2_B          215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------VRIITDVRN  288 (332)
T ss_dssp             SCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------HHHHHHHHT
T ss_pred             ccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------HHHHHHhhc
Confidence            5432            1234457899999999998889999999999999999999987775211      111222222


Q ss_pred             CCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         261 GQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       261 ~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ..+  + ..+...++++.+||.+||+.||.+|||++|+++||||+++
T Consensus       289 ~~~--~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          289 LKF--P-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             TCC--C-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             cCC--C-cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            221  1 2234568889999999999999999999999999999863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-49  Score=370.62  Aligned_cols=255  Identities=33%  Similarity=0.583  Sum_probs=211.9

Q ss_pred             cceeeccccccccCCeEEEEEEEc---CCCcEEEEEEecch---------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHDT---------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ++|++. +.||+|+||+||+|.+.   .+|+.||||++...         ....+|+.++..+.+||||+++++++..  
T Consensus        54 ~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  130 (355)
T 1vzo_A           54 ENFELL-KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  130 (355)
T ss_dssp             GGEEEE-EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             cceEEE-EEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence            799994 78999999999999984   58999999998532         3355788886666689999999999876  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        +..+|+||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++             
T Consensus       131 --~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-------------  193 (355)
T 1vzo_A          131 --ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD-------------  193 (355)
T ss_dssp             --TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-------------
T ss_pred             --CceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-------------
Confidence              678999999999999999998753  599999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCC--CCCCCccchhhHHHHHHHHHhCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                    .++.+||+|||++....... ......+||+.|+|||++.+  ..++.++|||||||++|+|++|.
T Consensus       194 --------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~  259 (355)
T 1vzo_A          194 --------------SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  259 (355)
T ss_dssp             --------------TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             --------------CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence                          56789999999998654322 22345679999999999975  44789999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      .||...........+...+......++    ..++..+.+||.+||..||.+||     |++++++||||++.
T Consensus       260 ~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          260 SPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             CTTSCTTSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCCccCCccchHHHHHHHHhccCCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            999765544443444444444443333    36899999999999999999999     99999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.8e-49  Score=367.52  Aligned_cols=259  Identities=34%  Similarity=0.692  Sum_probs=212.4

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-------------hhHHHHHHHHHhcCCCCEeEEeEe
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------------KARREVELQLAVGSHKHIVNIKDV   77 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~e~~~~~~~~~h~ni~~~~~~   77 (372)
                      ..+.++|.+. +.||+|+||.||+|.+..+++.||||++....             ...+|+.+ ++.++||||++++++
T Consensus         6 ~~l~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~   83 (322)
T 2ycf_A            6 KALRDEYIMS-KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI-LKKLNHPCIIKIKNF   83 (322)
T ss_dssp             HHHHHHEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHH-HHHCCCTTBCCEEEE
T ss_pred             hhhhhceeEe-eEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHH-HHhCCCCCCceEeeE
Confidence            3477899995 78999999999999999999999999985321             24577877 566799999999999


Q ss_pred             eeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          78 YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        78 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      +..    + ..|+||||+.+++|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++.++     
T Consensus        84 ~~~----~-~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-----  151 (322)
T 2ycf_A           84 FDA----E-DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-----  151 (322)
T ss_dssp             EES----S-SEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-----
T ss_pred             EcC----C-ceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC-----
Confidence            864    2 389999999999999998754  4699999999999999999999999999999999999998433     


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc---CCCCCCCccchhhHHHHHHH
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYI  234 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~  234 (372)
                                         ..+.+||+|||++..... .......+||+.|+|||++   ....++.++|||||||++|+
T Consensus       152 -------------------~~~~~kl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~  211 (322)
T 2ycf_A          152 -------------------EDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFI  211 (322)
T ss_dssp             -------------------SSCCEEECCCTTCEECCC-CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHH
T ss_pred             -------------------CCCeEEEccCccceeccc-ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHH
Confidence                               244689999999876533 2223446789999999996   35678999999999999999


Q ss_pred             HHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       235 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      |++|..||........   +...+..+.....+..+..++.++.+||.+||+.||++|||++++|+||||++
T Consensus       212 l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          212 CLSGYPPFSEHRTQVS---LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HHHSSCSSCSTTCSSC---HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             HHhCCCCCcccchHHH---HHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            9999999976544322   34445555554444444578999999999999999999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=371.76  Aligned_cols=245  Identities=29%  Similarity=0.472  Sum_probs=207.3

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-------------hhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------------KARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      +.++|+++ +.||+|+||+||+|.+..+|+.||||++....             ...+|+.+ ++.++||||+++++++.
T Consensus        22 ~~~~y~~~-~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           22 YSQKYSTM-SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI-LSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             HHHHEEEE-EECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHH-HTTCCCTTBCCEEEEEE
T ss_pred             cccceEEE-eEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHH-HHhCCCCCEeeEEEEEe
Confidence            67899995 77999999999999999999999999986432             34568887 66679999999999997


Q ss_pred             eecCCceEEEEEEeccCCC-chhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          80 NIYNGSRCLLVIMECMHGG-ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g-~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      .    ...+++||||+.+| +|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++         
T Consensus       100 ~----~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---------  164 (335)
T 3dls_A          100 N----QGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---------  164 (335)
T ss_dssp             C----SSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred             e----CCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---------
Confidence            6    67899999999766 999999765  4599999999999999999999999999999999999998         


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHHHHHh
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~  237 (372)
                                        .++.+||+|||++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus       165 ------------------~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  225 (335)
T 3dls_A          165 ------------------EDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF  225 (335)
T ss_dssp             ------------------TTSCEEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred             ------------------CCCcEEEeecccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh
Confidence                              5678999999999876442 33455678999999999988776 789999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |..||.....          ........+    ..+++++.+||.+||+.||.+|||++++++||||++.
T Consensus       226 g~~pf~~~~~----------~~~~~~~~~----~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          226 EENPFCELEE----------TVEAAIHPP----YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             SSCSCSSGGG----------GTTTCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             CCCchhhHHH----------HHhhccCCC----cccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            9999954211          111111111    3579999999999999999999999999999999763

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-49  Score=361.04  Aligned_cols=261  Identities=34%  Similarity=0.595  Sum_probs=213.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      +.++|++. +.||+|+||+||+|.+..+|+.||+|++...           ....+|+.+ ++.++||||+++++++.. 
T Consensus         3 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~-   79 (283)
T 3bhy_A            3 VEDHYEMG-EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI-LREIRHPNIITLHDIFEN-   79 (283)
T ss_dssp             HHHHEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHH-HHHCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhH-HhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHH-HHhCCCCCeeehhheecC-
Confidence            56889995 7799999999999999999999999998632           234577777 666789999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         ....|+||||+.+++|.+++...  +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.        
T Consensus        80 ---~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--------  146 (283)
T 3bhy_A           80 ---KTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNV--------  146 (283)
T ss_dssp             ---SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSS--------
T ss_pred             ---CCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCC--------
Confidence               67899999999999999999765  35999999999999999999999999999999999999984332        


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                     ....+||+|||++...... .......||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus       147 ---------------~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  210 (283)
T 3bhy_A          147 ---------------PNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  210 (283)
T ss_dssp             ---------------SSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ---------------CCCceEEEecccceeccCC-CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCC
Confidence                           3347999999999866432 223445789999999999988999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      |.+...    ......+.......+...+..++.++.+||.+||..||.+|||++++++||||+....
T Consensus       211 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          211 FLGETK----QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             TCCSSH----HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             CCCcch----HHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            965432    2233444444444444344578999999999999999999999999999999987643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.6e-48  Score=357.65  Aligned_cols=254  Identities=30%  Similarity=0.515  Sum_probs=215.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ...++|.+ .+.||+|+||+||+|.+..+++.||+|++...        ....+|+.+ ++.++||||+++++++..   
T Consensus        12 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~---   86 (294)
T 2rku_A           12 RSRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI-HRSLAHQHVVGFHGFFED---   86 (294)
T ss_dssp             TTTEEEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHH-HHTCCCTTBCCEEEEEEC---
T ss_pred             CcccceEE-EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHH-HHhCCCCCEeeeeeeecc---
Confidence            46789998 58899999999999999999999999998532        234467766 677799999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ++..|+||||+.+++|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+||+++              
T Consensus        87 -~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--------------  149 (294)
T 2rku_A           87 -NDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN--------------  149 (294)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--------------
T ss_pred             -CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc--------------
Confidence             67899999999999999998765  3599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   .++.+||+|||++.............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus       150 -------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  216 (294)
T 2rku_A          150 -------------EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE  216 (294)
T ss_dssp             -------------TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             -------------CCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                         5677999999999876544444555678999999999998889999999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      ....    ......+.......+    ..+++++.+||.+||+.||++|||++++++||||....
T Consensus       217 ~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          217 TSCL----KETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             CSSH----HHHHHHHHTTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             CCCH----HHHHHHHhhccCCCc----cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence            5432    223344444444444    36789999999999999999999999999999998653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.6e-49  Score=377.49  Aligned_cols=288  Identities=21%  Similarity=0.290  Sum_probs=211.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhc-------CCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVG-------SHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~-------~h~ni~~~~~~~~~~   81 (372)
                      +.++|++. +.||+|+||+||+|.+..+|+.||||++...    ....+|+.++..+.       +|+||++++++|...
T Consensus        35 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           35 FNGRYHVI-RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             ETTTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             cCCeEEEE-EEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            66899995 7799999999999999999999999999743    34557887754443       288899999999854


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCC------
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDG------  154 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~------  154 (372)
                      ...+..+|+||||+ +++|.+.+.....+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++..      
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            44578899999999 66887777765546799999999999999999999999 99999999999999854310      


Q ss_pred             -----------------CceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC
Q psy3151         155 -----------------GILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD  217 (372)
Q Consensus       155 -----------------~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  217 (372)
                                       ........+.... ............+||+|||++.....   .....+||+.|+|||++.+.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLV-NPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HHC---------------------CCTTSC-CTTSGGGGGGCCEEECCGGGCEETTB---CSCSCCSCGGGCCHHHHHTS
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccc-cccccccccccceEeccccccccccc---cCccCCCCCcccCChhhcCC
Confidence                             0000000000000 00000001234799999999987643   23456789999999999888


Q ss_pred             CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHH--HHHh--hCCc----------c------------CC-----
Q psy3151         218 KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMK--NRIR--LGQF----------D------------FP-----  266 (372)
Q Consensus       218 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~--~~~~----------~------------~~-----  266 (372)
                      .++.++|||||||++|+|++|..||...+.........  ..+.  .+..          .            ..     
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            89999999999999999999999998766554332111  0000  0000          0            00     


Q ss_pred             ---------CCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         267 ---------NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       267 ---------~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                               .......+.++.+||.+||+.||++|||++|+|+||||++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                     0001234577899999999999999999999999999963

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-48  Score=364.74  Aligned_cols=253  Identities=30%  Similarity=0.518  Sum_probs=215.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..++|.+ .+.||+|+||.||+|.+..+++.||+|++...        ....+|+.+ ++.++||||+++++++..    
T Consensus        39 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----  112 (335)
T 2owb_A           39 SRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI-HRSLAHQHVVGFHGFFED----  112 (335)
T ss_dssp             TTEEEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHH-HHTCCCTTBCCEEEEEEC----
T ss_pred             cCCceEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEec----
Confidence            5678998 58899999999999999999999999998632        234567766 677799999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      .+..|+||||+.+++|.+++...  +.+++.+++.++.||+.||.|||++||+||||||+|||++               
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---------------  175 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---------------  175 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---------------
T ss_pred             CCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc---------------
Confidence            67899999999999999998765  3599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       176 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  243 (335)
T 2owb_A          176 ------------EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET  243 (335)
T ss_dssp             ------------TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ------------CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence                        56779999999998765444445567789999999999888899999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      ...    ......+....+..+    ..++.++.+||.+||+.||++|||++++++||||....
T Consensus       244 ~~~----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          244 SCL----KETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             SSH----HHHHHHHHHTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             CCH----HHHHHHHhcCCCCCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            432    233344444444444    36799999999999999999999999999999998753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-48  Score=367.97  Aligned_cols=260  Identities=24%  Similarity=0.375  Sum_probs=204.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC--
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN--   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~--   83 (372)
                      ..++|+++ +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++.....  
T Consensus        15 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           15 EVSKYEKL-AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             BGGGEEEE-EECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHH-HHHCCCTTBCCEEEEEEEC----
T ss_pred             cccceeEE-EEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHH-HHhccCCCcccHhheeecccccc
Confidence            46899995 7799999999999999999999999998532       245678887 667789999999999875211  


Q ss_pred             --CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          84 --GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        84 --~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                        .++.+|+||||+.+ +|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++            
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~------------  158 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT------------  158 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc------------
Confidence              14578999999964 8888877643 4699999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccC----CCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHH
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN----KASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll  236 (372)
                                     .++.+||+|||++......    .......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus       159 ---------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  223 (351)
T 3mi9_A          159 ---------------RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW  223 (351)
T ss_dssp             ---------------TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHH
Confidence                           5677999999999765421    223345678999999998865 56899999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCccc----------------------------ccCHHHHHHHHHhccCC
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWE----------------------------HVSQEAKTLIKNMLCVD  288 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~s~~~~~li~~ll~~d  288 (372)
                      +|..||.+......    ...+.......+...+.                            ..++++.+||.+||+.|
T Consensus       224 ~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  299 (351)
T 3mi9_A          224 TRSPIMQGNTEQHQ----LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD  299 (351)
T ss_dssp             HSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSS
T ss_pred             hCCCCCCCCChHHH----HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCC
Confidence            99999976543221    11111111111111111                            12788999999999999


Q ss_pred             CCCCCChhHHhcCCccccC
Q psy3151         289 PSERLTIDQVMENKWISQF  307 (372)
Q Consensus       289 P~~R~s~~eil~hp~~~~~  307 (372)
                      |++|||++|+|+||||...
T Consensus       300 P~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          300 PAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             GGGSCCHHHHHTSGGGGSS
T ss_pred             hhhCCCHHHHhCCCCcCCC
Confidence            9999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-49  Score=365.04  Aligned_cols=265  Identities=25%  Similarity=0.413  Sum_probs=211.7

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..+.++|.+ .+.||+|+||+||+|.+..+|+.||||++...      ....+|+.+ ++.++||||+++++++..  ..
T Consensus         5 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~--~~   80 (319)
T 4euu_A            5 STSNHLWLL-SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV-LKKLNHKNIVKLFAIEEE--TT   80 (319)
T ss_dssp             ECSSEEEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHH-HHHCCCTTBCCEEEEEEC--TT
T ss_pred             cCCCCCEEE-EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHH-HHhcCCCCcceEEEEeec--CC
Confidence            457789999 58899999999999999999999999998632      234578777 666789999999999864  23


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ....|+||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+....+          
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~----------  150 (319)
T 4euu_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED----------  150 (319)
T ss_dssp             TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTT----------
T ss_pred             CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCC----------
Confidence            4578999999999999999987432 23999999999999999999999999999999999999843222          


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC--------CCCCCCccchhhHHHHHHHH
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG--------PDKYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~l  235 (372)
                                   ..+.+||+|||++...... ......+||+.|+|||++.        +..++.++|||||||++|+|
T Consensus       151 -------------~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el  216 (319)
T 4euu_A          151 -------------GQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA  216 (319)
T ss_dssp             -------------SCEEEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred             -------------CCceEEEccCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence                         5567999999999876443 2334567899999999875        57789999999999999999


Q ss_pred             HhCCCCCCCCCCCCCCHhHHHHHhhCCc---------------------cCCCCcccccCHHHHHHHHHhccCCCCCCCC
Q psy3151         236 LCGFPPFFSNHGQAISPGMKNRIRLGQF---------------------DFPNPEWEHVSQEAKTLIKNMLCVDPSERLT  294 (372)
Q Consensus       236 l~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s  294 (372)
                      ++|..||...............+..+..                     +.+......++..+.+||.+||+.||++|||
T Consensus       217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s  296 (319)
T 4euu_A          217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG  296 (319)
T ss_dssp             HHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred             HhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc
Confidence            9999999765554444444444433221                     1111112345678999999999999999999


Q ss_pred             hhHHhcCCc
Q psy3151         295 IDQVMENKW  303 (372)
Q Consensus       295 ~~eil~hp~  303 (372)
                      ++|+|+||-
T Consensus       297 ~~ell~h~~  305 (319)
T 4euu_A          297 FDQFFAETS  305 (319)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHhhhccH
Confidence            999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-49  Score=364.29  Aligned_cols=268  Identities=25%  Similarity=0.378  Sum_probs=209.2

Q ss_pred             CCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc----hhhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151           6 KPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD----TVKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus         6 ~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      .........++|++. +.||+|+||.||+|.+..+|+.||||++..    .....+|+.++.++.+||||+++++++...
T Consensus        15 ~~~~l~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELV-ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEE-EEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            344555678999994 789999999999999999999999999863    245667888866666899999999998752


Q ss_pred             cC--CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          82 YN--GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        82 ~~--~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      ..  ....+|+||||+.+++|.+++.......+++..++.++.||+.||.|||+.||+||||||+||+++          
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~----------  163 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----------  163 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----------
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc----------
Confidence            21  146799999999999999999876545699999999999999999999999999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHH
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYI  234 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~  234 (372)
                                       .++.+||+|||++.............+||+.|+|||++.     ...++.++|||||||++|+
T Consensus       164 -----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~  226 (326)
T 2x7f_A          164 -----------------ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE  226 (326)
T ss_dssp             -----------------TTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred             -----------------CCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence                             567799999999887654333445567899999999986     5678999999999999999


Q ss_pred             HHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       235 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |++|..||......    .....+....  .+......++.++.+||.+||..||.+|||++++++||||++.
T Consensus       227 l~~g~~p~~~~~~~----~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          227 MAEGAPPLCDMHPM----RALFLIPRNP--APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             HHHSSCTTTTSCHH----HHHHHHHHSC--CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             HHhCCCCCCCCcHH----HHHHHhhcCc--cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            99999999654321    1122222221  1222234689999999999999999999999999999999763

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.8e-49  Score=378.53  Aligned_cols=269  Identities=25%  Similarity=0.401  Sum_probs=209.4

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-hhHHHHHHHHHhcCCCCEeEEeEeeeeecC--CceE
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-KARREVELQLAVGSHKHIVNIKDVYENIYN--GSRC   87 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~--~~~~   87 (372)
                      .+...+|++ .+.||+|+||+||+|.+..+|+.||||++.... ...+|+.+ ++.++||||++++++|.....  +..+
T Consensus        50 ~~~~~~y~~-~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           50 RPQEVSYTD-TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI-MRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             CCEEEEEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHH-HHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             CcccceEEe-eeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHH-HHHcCCCCccceeeEEeccCCCCccee
Confidence            345668999 588999999999999999999999999986443 34578887 677899999999999864322  3456


Q ss_pred             EEEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          88 LLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +++||||+.+ +|.+.+..  .....+++..++.++.||+.||+|||++||+||||||+|||++.               
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---------------  191 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---------------  191 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET---------------
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC---------------
Confidence            8899999965 77766653  22356999999999999999999999999999999999999983               


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                 +.+.+||+|||+++..... ......+||++|+|||++.+. .|+.++|||||||++|+|++|+.||.+
T Consensus       192 -----------~~~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~  259 (420)
T 1j1b_A          192 -----------DTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  259 (420)
T ss_dssp             -----------TTTEEEECCCTTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -----------CCCeEEeccchhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence                       3456899999999876432 233456789999999998654 799999999999999999999999976


Q ss_pred             CCCCCCCHhHHHHHh----------h---CCccCCCC---c-----ccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         245 NHGQAISPGMKNRIR----------L---GQFDFPNP---E-----WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~----------~---~~~~~~~~---~-----~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      .+..+....+...+.          .   ..+.++..   .     ...+++++.+||.+||+.||.+|||+.|+++|||
T Consensus       260 ~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~  339 (420)
T 1j1b_A          260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  339 (420)
T ss_dssp             SSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence            543222111111100          0   11111110   0     1246899999999999999999999999999999


Q ss_pred             cccCCC
Q psy3151         304 ISQFNQ  309 (372)
Q Consensus       304 ~~~~~~  309 (372)
                      |+.+..
T Consensus       340 f~~~~~  345 (420)
T 1j1b_A          340 FDELRD  345 (420)
T ss_dssp             GGGGGC
T ss_pred             hccccc
Confidence            988654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.4e-48  Score=356.17  Aligned_cols=252  Identities=33%  Similarity=0.593  Sum_probs=213.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..++|++ .+.||+|+||.||+|.+..+++.||||++...        ....+|+.+ ++.++||||+++++++..    
T Consensus        12 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   85 (284)
T 2vgo_A           12 TIDDFDI-GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI-QSHLRHPNILRMYNYFHD----   85 (284)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHTCCCTTBCCEEEEEEC----
T ss_pred             hhhhcee-eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHH-HhcCCCCCEeeEEEEEEc----
Confidence            3478999 57899999999999999999999999998532        234567776 677799999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ++..|+||||+.+++|.+++....  .+++..++.++.||+.||.|||+.||+||||||+||+++               
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---------------  148 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---------------  148 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---------------
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc---------------
Confidence            678999999999999999998763  599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.++|+|||++.....  ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus       149 ------------~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  214 (284)
T 2vgo_A          149 ------------YKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS  214 (284)
T ss_dssp             ------------TTCCEEECCCTTCEECSS--SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ------------CCCCEEEecccccccCcc--cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence                        567799999999876533  223456789999999999998999999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      ...    ......+......++    ..++.++.+||.+||+.||.+|||++++++||||+....
T Consensus       215 ~~~----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          215 PSH----TETHRRIVNVDLKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             SSH----HHHHHHHHTTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             CCH----hHHHHHHhccccCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            432    223344444444444    368999999999999999999999999999999987544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-49  Score=368.49  Aligned_cols=266  Identities=27%  Similarity=0.423  Sum_probs=209.4

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ..+.++|++ .+.||+|+||+||+|.+..+++.||||++....        ...+|+.. ++.++||||+++++++....
T Consensus         8 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            8 SHLSDRYEL-GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQN-AAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             SEETTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTT-CCCCCCTTBCCEEEEEEEEE
T ss_pred             ceecCcEEE-EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHH-HHcCCCCCcceEEEeeeccC
Confidence            457899999 578999999999999999999999999996421        23456655 56668999999999998655


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ..+...|+||||+++++|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++             
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~-------------  150 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS-------------  150 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-------------
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc-------------
Confidence            5556779999999999999999865  3599999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                    .++.+||+|||++........   .....+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       151 --------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~  216 (311)
T 3ork_A          151 --------------ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE  216 (311)
T ss_dssp             --------------TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             --------------CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence                          567799999999976543222   233457899999999998889999999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVP  311 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~  311 (372)
                      .||.+....    .............+......++.++.+||.+||+.||.+||++.+++.|+|++.....+
T Consensus       217 ~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  284 (311)
T 3ork_A          217 PPFTGDSPV----SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP  284 (311)
T ss_dssp             CSCCCSSHH----HHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred             CCCCCCChH----HHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence            999654321    22222222222222222346899999999999999999999999999999998655433

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-49  Score=376.17  Aligned_cols=267  Identities=25%  Similarity=0.418  Sum_probs=206.8

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--------
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARREVELQLAVGSHKHIVNIKDVYENIY--------   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--------   82 (372)
                      ...++|++ .+.||+|+||+||+|.+..+|+.||||++... ....+|+.+ ++.++||||++++++|....        
T Consensus         4 ~~~~~y~~-~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            4 TSSKKYSL-GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDI-MKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             --CTTEEE-EEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHH-HTTCCCTTBCCEEEEEEEC---------
T ss_pred             cccceEEE-EEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHH-HHHcCCCCccchhheeeecCcccccccc
Confidence            45689999 58899999999999999999999999998643 334578887 67779999999999985422        


Q ss_pred             --------------------------CCceEEEEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC
Q psy3151          83 --------------------------NGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQ  134 (372)
Q Consensus        83 --------------------------~~~~~~~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~~  134 (372)
                                                ..+.++++||||+. ++|.+.+..  ...+.+++..++.++.||+.||+|||+.
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  160 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL  160 (383)
T ss_dssp             ----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence                                      23456899999997 588777764  2335699999999999999999999999


Q ss_pred             CceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc
Q psy3151         135 NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL  214 (372)
Q Consensus       135 ~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~  214 (372)
                      ||+||||||+|||++.                          .++.+||+|||+|...... ......+||+.|+|||++
T Consensus       161 gi~H~Dikp~Nil~~~--------------------------~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~  213 (383)
T 3eb0_A          161 GICHRDIKPQNLLVNS--------------------------KDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELM  213 (383)
T ss_dssp             TEECSCCCGGGEEEET--------------------------TTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHH
T ss_pred             cCccCccCHHHEEEcC--------------------------CCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHh
Confidence            9999999999999973                          4678999999999876442 334456789999999988


Q ss_pred             CCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhh-------------CCccCCC---C-----cccc
Q psy3151         215 GPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRL-------------GQFDFPN---P-----EWEH  272 (372)
Q Consensus       215 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------------~~~~~~~---~-----~~~~  272 (372)
                      .+. .++.++||||+||++|+|++|..||.+.+..+....+......             ....++.   .     ....
T Consensus       214 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (383)
T 3eb0_A          214 LGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEG  293 (383)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTT
T ss_pred             cCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCC
Confidence            664 5999999999999999999999999765432221111111000             0011111   0     1134


Q ss_pred             cCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         273 VSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       273 ~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      +++++.+||.+||+.||.+|||+.|+|+||||+.+.
T Consensus       294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence            789999999999999999999999999999998754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-48  Score=370.42  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=196.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--   82 (372)
                      .+.++|+++ +.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++....  
T Consensus        22 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           22 TVLKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL-MKCVNHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EEETTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHH-HHHCCCTTBCCEEEEECSCCST
T ss_pred             chhhheeEe-eeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHH-HHhcCCCCccceEEeecccccc
Confidence            367899995 7799999999999999999999999998632       234577777 67779999999999986421  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ......|+||||+. ++|.+.+..    .+++..++.++.||+.||+|||++||+||||||+|||++             
T Consensus       100 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~-------------  161 (371)
T 2xrw_A          100 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-------------  161 (371)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-------------
T ss_pred             ccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc-------------
Confidence            22347899999996 588888853    399999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    .++.+||+|||++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       162 --------------~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  226 (371)
T 2xrw_A          162 --------------SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF  226 (371)
T ss_dssp             --------------TTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             --------------CCCCEEEEEeeccccccc-ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence                          567899999999986543 22334568899999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhC----------------------CccC--------------CC--CcccccCHHHHHHHHHh
Q psy3151         243 FSNHGQAISPGMKNRIRLG----------------------QFDF--------------PN--PEWEHVSQEAKTLIKNM  284 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~----------------------~~~~--------------~~--~~~~~~s~~~~~li~~l  284 (372)
                      .+.+...    ....+...                      ...+              +.  ......+.++++||.+|
T Consensus       227 ~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m  302 (371)
T 2xrw_A          227 PGTDHID----QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM  302 (371)
T ss_dssp             CCSSHHH----HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHH----HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHH
Confidence            7654211    11111100                      0000              00  00012367899999999


Q ss_pred             ccCCCCCCCChhHHhcCCccccCC
Q psy3151         285 LCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       285 l~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      |+.||++|||++|+|+||||+.+.
T Consensus       303 L~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          303 LVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             SCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             CcCChhhCCCHHHHhCCcchhhhc
Confidence            999999999999999999998754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-49  Score=368.51  Aligned_cols=262  Identities=26%  Similarity=0.405  Sum_probs=204.7

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ...++|++. +.||+|+||+||+|.+..+|+.||||++...          ....+|+.+ ++.++||||+++++++.. 
T Consensus         7 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~-   83 (346)
T 1ua2_A            7 SRAKRYEKL-DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL-LQELSHPNIIGLLDAFGH-   83 (346)
T ss_dssp             ------CEE-EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHH-HHHCCCTTBCCEEEEECC-
T ss_pred             HHhcccEEE-eEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHH-HhhCCCCCCCeEEEEEee-
Confidence            356899994 7899999999999999999999999998631          234578887 566799999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         ....++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++            
T Consensus        84 ---~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~------------  146 (346)
T 1ua2_A           84 ---KSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD------------  146 (346)
T ss_dssp             ---TTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC------------
T ss_pred             ---CCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc------------
Confidence               5678999999975 8988887643 4699999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                     .++.+||+|||++.............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus       147 ---------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  211 (346)
T 1ua2_A          147 ---------------ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP  211 (346)
T ss_dssp             ---------------TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ---------------CCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence                           5678999999999877554555566788999999999865 458999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCc-cCC---------------C----CcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQF-DFP---------------N----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~-~~~---------------~----~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||.+....+....+......... .++               .    ..+..+++++.+||.+||+.||++|||++|+|+
T Consensus       212 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          212 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            99665432211111111110000 000               0    001456799999999999999999999999999


Q ss_pred             CCccccCC
Q psy3151         301 NKWISQFN  308 (372)
Q Consensus       301 hp~~~~~~  308 (372)
                      ||||++..
T Consensus       292 h~~f~~~~  299 (346)
T 1ua2_A          292 MKYFSNRP  299 (346)
T ss_dssp             SGGGTSSS
T ss_pred             ChhhhcCC
Confidence            99998753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.4e-49  Score=370.54  Aligned_cols=268  Identities=23%  Similarity=0.413  Sum_probs=210.6

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec-
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY-   82 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~-   82 (372)
                      ...+.++|+++ +.||+|+||+||+|.+..+++.||||++...      ....+|+.+ +..++||||+++++++.... 
T Consensus        22 ~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           22 VFDVGPRYTNL-SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI-LLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             BCCCTTTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHH-HHHCCCTTBCCCCEEECCSST
T ss_pred             eccccccEEEE-EEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHH-HHhcCCCCCccceeEEecCCc
Confidence            34566899995 7899999999999999999999999999632      344578877 56679999999999986422 


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ......|+||||+. ++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++             
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~-------------  162 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-------------  162 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-------------
T ss_pred             cccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC-------------
Confidence            22357899999996 5999998763   499999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccC-CCCCCCccchhhHHHHHHHHHhC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLG-PDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                    .++.+||+|||++........   .....+||+.|+|||++. ...++.++|||||||++|+|++|
T Consensus       163 --------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  228 (364)
T 3qyz_A          163 --------------TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN  228 (364)
T ss_dssp             --------------TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred             --------------CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHC
Confidence                          567799999999986643222   234568899999999864 45689999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCC----------------ccCCC-------CcccccCHHHHHHHHHhccCCCCCCCCh
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQ----------------FDFPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTI  295 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~----------------~~~~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~  295 (372)
                      ..||.+.+..+....+........                ...+.       .....+++++.+||.+||+.||.+|||+
T Consensus       229 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  308 (364)
T 3qyz_A          229 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV  308 (364)
T ss_dssp             SCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence            999976554332211111100000                00000       0013578999999999999999999999


Q ss_pred             hHHhcCCccccCCCC
Q psy3151         296 DQVMENKWISQFNQV  310 (372)
Q Consensus       296 ~eil~hp~~~~~~~~  310 (372)
                      +|+|+||||+++...
T Consensus       309 ~e~l~hp~~~~~~~~  323 (364)
T 3qyz_A          309 EQALAHPYLEQYYDP  323 (364)
T ss_dssp             HHHHTSGGGTTTCCG
T ss_pred             HHHhcCcchhhccCc
Confidence            999999999987543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.4e-49  Score=355.46  Aligned_cols=256  Identities=27%  Similarity=0.507  Sum_probs=210.8

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ++.++|++. +.||+|+||.||+|.+..+|+.||||++...      ....+|+.+ ++.++||||+++++++..    +
T Consensus         4 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~   77 (276)
T 2yex_A            4 PFVEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYGHRRE----G   77 (276)
T ss_dssp             HHHHHEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHH-HHTCCCTTBCCEEEEEEE----T
T ss_pred             ceecceEEE-EEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHH-HHhcCCCCceeeeeEEEc----C
Confidence            467899995 7899999999999999999999999998632      234567766 677799999999999876    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +..|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+||+++                
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----------------  139 (276)
T 2yex_A           78 NIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----------------  139 (276)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             CEEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc----------------
Confidence            7899999999999999988654  4599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHHHHHhCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                 .++.+||+|||++.......  ......+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||
T Consensus       140 -----------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  208 (276)
T 2yex_A          140 -----------ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW  208 (276)
T ss_dssp             -----------TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             -----------cCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence                       56779999999987654322  22345678999999999987665 67999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ........   ...........  ...+..+++++.+||.+||+.||.+|||++++++||||++.
T Consensus       209 ~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          209 DQPSDSCQ---EYSDWKEKKTY--LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             SCSCTTSH---HHHHHHTTCTT--STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CCCchHHH---HHHHhhhcccc--cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            76543221   12222222211  12245789999999999999999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-49  Score=369.68  Aligned_cols=267  Identities=25%  Similarity=0.407  Sum_probs=204.5

Q ss_pred             cCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEe
Q psy3151           5 FKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDV   77 (372)
Q Consensus         5 ~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~   77 (372)
                      +.|.......++|+++ +.||+|+||.||+|.+..+|+.||||++...       ....+|+.+ ++.++||||++++++
T Consensus        15 ~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~   92 (331)
T 4aaa_A           15 GTENLYFQSMEKYENL-GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKL-LKQLRHENLVNLLEV   92 (331)
T ss_dssp             ----CCCBCGGGEEEE-EEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHH-HHHCCCTTBCCEEEE
T ss_pred             ccchhhhhhhhhheee-eEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHH-HhhCCCCCEeeEEEE
Confidence            4455556678999995 7899999999999999999999999998532       224467777 666789999999999


Q ss_pred             eeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          78 YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        78 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      +..    +...|+||||+.+++|.+++...  +.+++..++.++.||+.||.|||+.||+||||||+||+++        
T Consensus        93 ~~~----~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~--------  158 (331)
T 4aaa_A           93 CKK----KKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS--------  158 (331)
T ss_dssp             EEE----TTEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--------
T ss_pred             eec----CCEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc--------
Confidence            976    67899999999998888876544  4599999999999999999999999999999999999998        


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHH
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll  236 (372)
                                         .++.+||+|||++.............+||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus       159 -------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  219 (331)
T 4aaa_A          159 -------------------QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF  219 (331)
T ss_dssp             -------------------TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred             -------------------CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHH
Confidence                               56789999999998765544445567889999999998765 7899999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHH-----------h----hCCccCCC--------CcccccCHHHHHHHHHhccCCCCCCC
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRI-----------R----LGQFDFPN--------PEWEHVSQEAKTLIKNMLCVDPSERL  293 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~-----------~----~~~~~~~~--------~~~~~~s~~~~~li~~ll~~dP~~R~  293 (372)
                      +|..||.+....+....+....           .    ......+.        ..+..+++++.+||.+||+.||.+||
T Consensus       220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  299 (331)
T 4aaa_A          220 MGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP  299 (331)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC
Confidence            9999996654322111111000           0    00011110        01135789999999999999999999


Q ss_pred             ChhHHhcCCcccc
Q psy3151         294 TIDQVMENKWISQ  306 (372)
Q Consensus       294 s~~eil~hp~~~~  306 (372)
                      |++|+|+||||+.
T Consensus       300 t~~ell~hp~f~~  312 (331)
T 4aaa_A          300 FCAELLHHDFFQM  312 (331)
T ss_dssp             CGGGGGGSHHHHG
T ss_pred             CHHHHhcCchhcc
Confidence            9999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1e-48  Score=364.62  Aligned_cols=261  Identities=26%  Similarity=0.426  Sum_probs=208.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc--hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD--TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      ..++|++. +.||+|+||+||+|.+..+++.||||++..  .....+|+.++..+..||||+++++++..  ......++
T Consensus        34 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~--~~~~~~~l  110 (330)
T 3nsz_A           34 NQDDYQLV-RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD--PVSRTPAL  110 (330)
T ss_dssp             EGGGEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--TTTCCEEE
T ss_pred             CCCceEEE-EEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc--CCCCceEE
Confidence            45889995 789999999999999999999999999963  34567888886666669999999999864  23567899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+.+++|.+++..     +++..++.++.||+.||+|||++||+||||||+|||++.                    
T Consensus       111 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--------------------  165 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--------------------  165 (330)
T ss_dssp             EEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--------------------
T ss_pred             EEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--------------------
Confidence            9999999999988742     899999999999999999999999999999999999983                    


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA  249 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  249 (372)
                            +...+||+|||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus       166 ------~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~  238 (330)
T 3nsz_A          166 ------EHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY  238 (330)
T ss_dssp             ------TTTEEEECCCTTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred             ------CCCEEEEEeCCCceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH
Confidence                  2337999999999865432 23455678999999999876 679999999999999999999999995432211


Q ss_pred             C-C---------HhHHHHHhhCCccC--------------------CCCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         250 I-S---------PGMKNRIRLGQFDF--------------------PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       250 ~-~---------~~~~~~~~~~~~~~--------------------~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      . .         ......+.......                    .......+++++.+||.+||+.||.+|||++|+|
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l  318 (330)
T 3nsz_A          239 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM  318 (330)
T ss_dssp             HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence            0 0         00011111111111                    1111234799999999999999999999999999


Q ss_pred             cCCccccCC
Q psy3151         300 ENKWISQFN  308 (372)
Q Consensus       300 ~hp~~~~~~  308 (372)
                      +||||+++.
T Consensus       319 ~hp~f~~~~  327 (330)
T 3nsz_A          319 EHPYFYTVV  327 (330)
T ss_dssp             TSGGGTTCC
T ss_pred             cCccHhhhc
Confidence            999998764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-49  Score=374.95  Aligned_cols=266  Identities=25%  Similarity=0.423  Sum_probs=193.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeee--cC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENI--YN   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~--~~   83 (372)
                      +.++|+++ +.||+|+||.||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++...  ..
T Consensus        27 ~~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           27 VPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL-LKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             EETTEEEE-EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHH-HHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CCCceEEe-eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHH-HHhCCCCCCCcEEEEEecCCccc
Confidence            67899995 7799999999999999999999999998532       245578877 6667899999999998642  11


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      .....|+|+|++ +++|.+++..   +.+++..++.++.||+.||+|||+.||+||||||+|||++              
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~--------------  166 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN--------------  166 (367)
T ss_dssp             GCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--------------
T ss_pred             cCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC--------------
Confidence            235689999999 7899998865   3599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .++.+||+|||+++....   .....+||++|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus       167 -------------~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  230 (367)
T 2fst_X          167 -------------EDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  230 (367)
T ss_dssp             -------------TTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             -------------CCCCEEEeeccccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                         567899999999986532   2345688999999999876 67999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHh-------------------hCCccCCCCc----ccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         243 FSNHGQAISPGMKNRIR-------------------LGQFDFPNPE----WEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~----~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .+.+..+....+...+.                   ......+...    +...++++.+||.+||+.||.+|||++++|
T Consensus       231 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L  310 (367)
T 2fst_X          231 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL  310 (367)
T ss_dssp             CCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence            76543221111111100                   0000011111    135689999999999999999999999999


Q ss_pred             cCCccccCCCCCCCC
Q psy3151         300 ENKWISQFNQVPQTP  314 (372)
Q Consensus       300 ~hp~~~~~~~~~~~~  314 (372)
                      +||||+.+......+
T Consensus       311 ~hp~~~~~~~~~~~~  325 (367)
T 2fst_X          311 AHAYFAQYHDPDDEP  325 (367)
T ss_dssp             TSGGGTTTCCGGGCC
T ss_pred             cChhhhhccCCCCCC
Confidence            999999876544333

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-48  Score=356.38  Aligned_cols=269  Identities=22%  Similarity=0.315  Sum_probs=205.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+.++|++. +.||+|+||+||+|.+..+++.||||++..       .....+|+..+..+.+||||+++++++..    
T Consensus         8 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~----   82 (289)
T 1x8b_A            8 RYTTEFHEL-EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE----   82 (289)
T ss_dssp             HHHHHEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE----
T ss_pred             cccchhhhh-hhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec----
Confidence            367899995 779999999999999999999999999863       23455677775666699999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKE--DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~--~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      +...++||||+++++|.+++....  .+.+++..++.++.||+.||+|||++||+||||||+||+++.++......  ++
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~--~~  160 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS--EE  160 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccc--cc
Confidence            678999999999999999998642  14599999999999999999999999999999999999998543211100  00


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                      +..      .........+||+|||.+......    ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus       161 ~~~------~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~  230 (289)
T 1x8b_A          161 GDE------DDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL  230 (289)
T ss_dssp             ---------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccc------ccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence            000      000014567999999999876432    234589999999998765 566899999999999999999887


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +...       .....+..+.....   ...+++++.+||.+||+.||++|||+.++++||||.+.
T Consensus       231 ~~~~-------~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          231 PRNG-------DQWHEIRQGRLPRI---PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             CSSS-------HHHHHHHTTCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             Ccch-------hHHHHHHcCCCCCC---CcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            6432       12233333333211   24689999999999999999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.5e-48  Score=352.83  Aligned_cols=254  Identities=23%  Similarity=0.372  Sum_probs=207.4

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ..|.+ .+.||+|+||+||+|.+..++..||+|++...       ....+|+.+ ++.++||||+++++++.....++..
T Consensus        26 ~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           26 RFLKF-DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEM-LKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             CEEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHH-HTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             eeEEe-eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHH-HHhCCCCCeeeeeeeeccccCCCce
Confidence            44666 67899999999999999999999999998632       234567766 6677999999999999876666788


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~--ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +|+||||+++++|.+++...  +.+++..++.++.||+.||.|||+.|  |+||||||+||+++.               
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~---------------  166 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---------------  166 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---------------
T ss_pred             EEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC---------------
Confidence            99999999999999999875  35999999999999999999999999  999999999999962               


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||++.....  ......+||+.|+|||++. ..++.++|||||||++|+|++|..||...
T Consensus       167 -----------~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~  232 (290)
T 1t4h_A          167 -----------PTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             -----------TTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             -----------CCCCEEEeeCCCcccccc--cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence                       466799999999975432  2334567899999999886 45999999999999999999999999653


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      ..   .......+..+..  +.......++++.+||.+||+.||.+|||++++++||||++
T Consensus       233 ~~---~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          233 QN---AAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             SS---HHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             Cc---HHHHHHHHhccCC--ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            32   1222333332221  22223457899999999999999999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7e-49  Score=371.70  Aligned_cols=271  Identities=21%  Similarity=0.335  Sum_probs=207.6

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhc----------CCCCEeEEeEeee
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVG----------SHKHIVNIKDVYE   79 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~----------~h~ni~~~~~~~~   79 (372)
                      .++|++. +.||+|+||+||+|.+..+|+.||||++...    ....+|+.++.++.          .||||+++++++.
T Consensus        18 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILV-RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEE-EeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            5799995 7799999999999999999999999999743    23456776644332          3899999999998


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCcee
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      ....++..+++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++.     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~-----  170 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS-----  170 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET-----
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC-----
Confidence            6544556899999999 88999999886656799999999999999999999998 9999999999999974321     


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                      +...+.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       171 ----------------~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  231 (373)
T 1q8y_A          171 ----------------PENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG  231 (373)
T ss_dssp             ----------------TTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ----------------CcCcceEEEcccccccccCC---CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhC
Confidence                            01345799999999976543   23445789999999999888999999999999999999999


Q ss_pred             CCCCCCCCCCCCCHh--HHHHHhh--CCcc---------------------------C---------CCCcccccCHHHH
Q psy3151         239 FPPFFSNHGQAISPG--MKNRIRL--GQFD---------------------------F---------PNPEWEHVSQEAK  278 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~--~~~~~~~--~~~~---------------------------~---------~~~~~~~~s~~~~  278 (372)
                      ..||...........  ....+..  +..+                           .         .......++.++.
T Consensus       232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (373)
T 1q8y_A          232 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS  311 (373)
T ss_dssp             SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHH
T ss_pred             CCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHH
Confidence            999976543321100  0000000  0000                           0         0000124568899


Q ss_pred             HHHHHhccCCCCCCCChhHHhcCCccccCCCC
Q psy3151         279 TLIKNMLCVDPSERLTIDQVMENKWISQFNQV  310 (372)
Q Consensus       279 ~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~  310 (372)
                      +||.+||+.||++|||++|+|+||||++....
T Consensus       312 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  343 (373)
T 1q8y_A          312 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM  343 (373)
T ss_dssp             HHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred             HHHHHHhccCccccCCHHHHhhChhhhcccCc
Confidence            99999999999999999999999999986543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.9e-48  Score=355.90  Aligned_cols=258  Identities=38%  Similarity=0.729  Sum_probs=218.0

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .+.++|+++ +.||+|+||+||+|.+..+++.||||++...       ....+|+.+ ++.++||||+++++++..    
T Consensus        19 ~~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   92 (287)
T 2wei_A           19 TFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL-LKKLDHPNIMKLFEILED----   92 (287)
T ss_dssp             HHHHHEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHH-HHTCCCTTBCCEEEEEEC----
T ss_pred             HHhhcceee-EEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHH-HHhccCCCccEEEEEEeC----
Confidence            367899995 7899999999999999999999999998532       244577777 666799999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ....|+||||+.+++|.+.+....  .+++..++.++.||+.||.|||++||+||||||+||+++.++            
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~------------  158 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE------------  158 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS------------
T ss_pred             CCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC------------
Confidence            678999999999999999987653  599999999999999999999999999999999999997433            


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  ..+.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus       159 ------------~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          159 ------------KDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             ------------TTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ------------CcccEEEeccCcceeecCC-CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence                        3457999999998765432 22344568899999999875 489999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ...    ......+..+.+..+.+.+..+++++.+||.+||..||.+|||++++++||||++.
T Consensus       225 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          225 KNE----YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             SSH----HHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             CCH----HHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            432    33455666666666666667899999999999999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.7e-48  Score=351.68  Aligned_cols=252  Identities=36%  Similarity=0.596  Sum_probs=204.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ...++|.+ .+.||+|+||.||+|.+..+|+.||||++...        ....+|+.. ++.++||||+++++++..   
T Consensus         8 ~~~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~---   82 (276)
T 2h6d_A            8 VKIGHYVL-GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN-LKLFRHPHIIKLYQVIST---   82 (276)
T ss_dssp             CEETTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHTCCCTTBCCEEEEEEC---
T ss_pred             ceeccEEE-EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHH-HhcCCCCCEeEEEEEEec---
Confidence            35689999 58899999999999999999999999998632        134567776 677799999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ....|+||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++              
T Consensus        83 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--------------  145 (276)
T 2h6d_A           83 -PTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD--------------  145 (276)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC--------------
T ss_pred             -CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC--------------
Confidence             678999999999999999998753  599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .++.++|+|||++...... ......+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||
T Consensus       146 -------------~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  211 (276)
T 2h6d_A          146 -------------AHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF  211 (276)
T ss_dssp             -------------TTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             -------------CCCCEEEeecccccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence                         5677999999999876432 22345678999999999987765 58999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ....    .......+..+....+    ..++.++.+||.+||+.||.+|||++++++||||++.
T Consensus       212 ~~~~----~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          212 DDEH----VPTLFKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             CCSS----HHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CCCc----HHHHHHHhhcCcccCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            6533    2334445555544443    3578999999999999999999999999999999764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.8e-48  Score=372.17  Aligned_cols=269  Identities=24%  Similarity=0.387  Sum_probs=205.7

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-hhhhHHHHHHHHHhcCCCCEeEEeEeeeeec--CCceE
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-TVKARREVELQLAVGSHKHIVNIKDVYENIY--NGSRC   87 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--~~~~~   87 (372)
                      .....+|++ .+.||+|+||+||+|.+..+++ +|+|.+.. .....+|+.+ ++.++||||++++++|....  .+..+
T Consensus        36 ~~~~~~Y~~-~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           36 EQREIAYTN-CKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQI-MRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             CEEEEEEEE-EEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHH-HHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             CcccceEEE-eEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHH-HHhCCCCCcceEEEEEEecCCCCCceE
Confidence            346788999 4889999999999999987776 77777653 3344578887 67789999999999986432  23456


Q ss_pred             EEEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          88 LLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +|+||||+.+ ++.+.+..  .....+++..++.++.||+.||+|||++||+||||||+|||++.               
T Consensus       113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~---------------  176 (394)
T 4e7w_A          113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP---------------  176 (394)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---------------
T ss_pred             EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC---------------
Confidence            8899999976 55444432  12356999999999999999999999999999999999999972               


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                 .++.+||+|||+|+..... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+
T Consensus       177 -----------~~~~~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  244 (394)
T 4e7w_A          177 -----------PSGVLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG  244 (394)
T ss_dssp             -----------TTTEEEECCCTTCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -----------CCCcEEEeeCCCcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                       4677999999999876432 233456789999999998654 599999999999999999999999976


Q ss_pred             CCCCCCCHhHHHHHh-------------hCCccCCC--------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         245 NHGQAISPGMKNRIR-------------LGQFDFPN--------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~-------------~~~~~~~~--------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      .+..+....+.....             .....++.        .....+++++.+||.+||+.||.+|||+.|+++|||
T Consensus       245 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (394)
T 4e7w_A          245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF  324 (394)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence            543222111111100             00001110        011247899999999999999999999999999999


Q ss_pred             cccCCCC
Q psy3151         304 ISQFNQV  310 (372)
Q Consensus       304 ~~~~~~~  310 (372)
                      |+++...
T Consensus       325 f~~~~~~  331 (394)
T 4e7w_A          325 FDELRTG  331 (394)
T ss_dssp             GSTTTSS
T ss_pred             hhhhccc
Confidence            9987653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9e-48  Score=355.75  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=206.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ...++|+++ +.||+|+||.||+|.+..+|+.||||++...   ....+|+.+ +..++||||+++++++..    +..+
T Consensus        26 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~   99 (314)
T 3com_A           26 QPEEVFDVL-EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISI-MQQCDSPHVVKYYGSYFK----NTDL   99 (314)
T ss_dssp             ----CEEEE-EECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHH-HHTCCCTTBCCEEEEEEE----TTEE
T ss_pred             cchhhhhhh-eeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHH-HHhCCCCCCccEEEEEEe----CCEE
Confidence            367889995 7799999999999999999999999999643   345678877 667799999999999876    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++                   
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~-------------------  159 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN-------------------  159 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-------------------
T ss_pred             EEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC-------------------
Confidence            99999999999999987543 5699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                              .++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       160 --------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  231 (314)
T 3com_A          160 --------TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM  231 (314)
T ss_dssp             --------TTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             --------CCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Confidence                    567799999999987655444455667899999999999889999999999999999999999999654321


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                          .....+.... .........++.++.+||.+||..||.+|||+.++++||||+..
T Consensus       232 ----~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          232 ----RAIFMIPTNP-PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             ----HHHHHHHHSC-CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             ----HHHHHHhcCC-CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence                1111111111 11111224679999999999999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.1e-48  Score=355.31  Aligned_cols=258  Identities=26%  Similarity=0.480  Sum_probs=209.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .+.++|++ .+.||+|+||.||+|.+..+++.||+|++...         ....+|+.. ++.++||||+++++++..  
T Consensus         2 ~l~~~y~i-~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~--   77 (305)
T 2wtk_C            2 KLIGKYLM-GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL-LRRLRHKNVIQLVDVLYN--   77 (305)
T ss_dssp             ---CCBCC-CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHH-HTTCCCTTBCCEEEEEEC--
T ss_pred             ccccceeE-eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHH-HHhcCCCCeeEEEEEEEc--
Confidence            36789999 58899999999999999999999999999632         234567776 667799999999999843  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ......|+||||+.++ |.+++.....+.+++..++.++.||+.||.|||++||+||||||+||+++             
T Consensus        78 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~-------------  143 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT-------------  143 (305)
T ss_dssp             C---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred             CCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc-------------
Confidence            2356789999999765 88888776556799999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccC--CCcccccccCCCcCCCcccCCCC--CCCccchhhHHHHHHHHHhC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN--KASLQTPCYTPYYVAPEVLGPDK--YDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g  238 (372)
                                    .++.+||+|||++......  ........||+.|+|||++.+..  ++.++|||||||++|+|++|
T Consensus       144 --------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  209 (305)
T 2wtk_C          144 --------------TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG  209 (305)
T ss_dssp             --------------TTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHS
T ss_pred             --------------CCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhC
Confidence                          5677999999998865432  22234566899999999987644  37799999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      ..||.+..    .......+..+....+    ..+++++.+||.+||+.||.+|||++++++||||++...
T Consensus       210 ~~p~~~~~----~~~~~~~i~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          210 LYPFEGDN----IYKLFENIGKGSYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SCSCCCSS----HHHHHHHHHHCCCCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CCCCCCch----HHHHHHHHhcCCCCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            99996543    2334455555555444    368999999999999999999999999999999987644

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.4e-48  Score=355.13  Aligned_cols=260  Identities=27%  Similarity=0.394  Sum_probs=209.0

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ....+.++|+++ +.||+|+||+||+|.+..+|+.||+|++...     ....+|+.+ +..++||||+++++++..   
T Consensus        13 ~~~~~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~---   87 (302)
T 2j7t_A           13 RDLDPNEVWEIV-GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI-LATCDHPYIVKLLGAYYH---   87 (302)
T ss_dssp             SSSCGGGTEEEE-EEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHH-HHHCCCTTBCCEEEEEEC---
T ss_pred             cccCCccceeec-ceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHH-HhcCCCCCEeeeeeeeee---
Confidence            345688999995 7799999999999999999999999998632     345577777 566799999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ++..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++              
T Consensus        88 -~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~--------------  151 (302)
T 2j7t_A           88 -DGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT--------------  151 (302)
T ss_dssp             -C-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC--------------
T ss_pred             -CCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC--------------
Confidence             567999999999999999887643 4599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc-----CCCCCCCccchhhHHHHHHHHHhC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-----GPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                   .++.+||+|||++.............+||+.|+|||++     ....++.++|||||||++|+|++|
T Consensus       152 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  218 (302)
T 2j7t_A          152 -------------LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI  218 (302)
T ss_dssp             -------------TTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS
T ss_pred             -------------CCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC
Confidence                         56779999999876543322233456789999999988     467789999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ..||...+..    .....+...... .......++.++.+||.+||+.||.+|||++++++||||+..
T Consensus       219 ~~p~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          219 EPPHHELNPM----RVLLKIAKSDPP-TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             SCTTTTSCHH----HHHHHHHHSCCC-CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             CCCCccCCHH----HHHHHHhccCCc-ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            9999654321    122222222221 112234689999999999999999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.3e-48  Score=355.37  Aligned_cols=256  Identities=24%  Similarity=0.317  Sum_probs=195.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ..++|+++ +.||+|+||+||+|.+..+|+.||||++....      ....|....++..+||||+++++++..    +.
T Consensus         5 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----~~   79 (290)
T 3fme_A            5 KADDLEPI-MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR----EG   79 (290)
T ss_dssp             CGGGEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SS
T ss_pred             cHHhhhhH-HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec----cC
Confidence            45899995 77999999999999999999999999996421      223444455777899999999999875    66


Q ss_pred             EEEEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          87 CLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ..|+||||++ |+|.+++..  .....+++..++.++.||+.||+|||++ ||+||||||+||+++              
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~--------------  144 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN--------------  144 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC--------------
T ss_pred             CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC--------------
Confidence            7999999996 588887764  2335699999999999999999999998 999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc----CCCCCCCccchhhHHHHHHHHHhCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL----GPDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                   .++.+||+|||++...... .......||+.|+|||++    ....++.++|||||||++|+|++|.
T Consensus       145 -------------~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~  210 (290)
T 3fme_A          145 -------------ALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR  210 (290)
T ss_dssp             -------------TTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTS
T ss_pred             -------------CCCCEEEeecCCccccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCC
Confidence                         5678999999999766432 223445789999999996    5567899999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .||......  ...............+   ...+++++.+||.+||+.||++|||++++++||||+..
T Consensus       211 ~p~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          211 FPYDSWGTP--FQQLKQVVEEPSPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CSSCCCSCH--HHHHHHHHHSCCCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCccccCch--HHHHHHHhccCCCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            999643221  1122222222222222   24689999999999999999999999999999999763

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.5e-48  Score=368.30  Aligned_cols=260  Identities=26%  Similarity=0.419  Sum_probs=200.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC--
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN--   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~--   83 (372)
                      +.++|.+ .+.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++.....  
T Consensus        40 l~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           40 LPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL-LKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             EETTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHH-HHHCCCTTBCCCSEEECSCSSST
T ss_pred             ccccEEE-EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHH-HHhcCCCCchhhhhheeccCCcc
Confidence            7789999 47899999999999999999999999999642       344577776 677799999999999875211  


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      .....|+||||+. ++|.+.+.    ..+++..++.++.||+.||+|||++||+||||||+|||++              
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~--------------  178 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN--------------  178 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--------------
T ss_pred             cceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC--------------
Confidence            1113499999996 68887763    3499999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .++.+||+|||++.....   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus       179 -------------~~~~~kL~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  242 (371)
T 4exu_A          179 -------------EDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF  242 (371)
T ss_dssp             -------------TTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             -------------CCCCEEEEecCccccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence                         567799999999986532   2345678999999999876 77999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHh-------------------hCCccCCCC----cccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         243 FSNHGQAISPGMKNRIR-------------------LGQFDFPNP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .+.+..+....+.....                   ......+..    .+..+++++.+||.+||+.||.+|||++|+|
T Consensus       243 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  322 (371)
T 4exu_A          243 KGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL  322 (371)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             CCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence            76542221111111000                   000000000    1135689999999999999999999999999


Q ss_pred             cCCccccCCC
Q psy3151         300 ENKWISQFNQ  309 (372)
Q Consensus       300 ~hp~~~~~~~  309 (372)
                      +||||+.+..
T Consensus       323 ~hp~f~~~~~  332 (371)
T 4exu_A          323 THPFFEPFRD  332 (371)
T ss_dssp             TSGGGTTTCC
T ss_pred             cCcccccCCC
Confidence            9999997654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.5e-48  Score=361.55  Aligned_cols=280  Identities=24%  Similarity=0.392  Sum_probs=208.1

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEE-cCCCcEEEEEEecch----hhhHHHHHHHHHhcC------CCCEeEEeEe
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVE-KKTSEVYALKVLHDT----VKARREVELQLAVGS------HKHIVNIKDV   77 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~------h~ni~~~~~~   77 (372)
                      ....+.++|+++ +.||+|+||+||+|.+ ..+|+.||||++...    ....+|+.++ +.++      |++|++++++
T Consensus         8 ~g~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A            8 SGDVLSARYEIV-DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVL-EHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             TTCEETTTEEEE-EEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHH-HHHHHHCTTCTTCBCCEEEE
T ss_pred             cCCCccCceEEE-EEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHH-HHhhhcCCCCceeeEeeecc
Confidence            344578999995 7799999999999999 568999999999743    2345676663 3333      4469999999


Q ss_pred             eeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          78 YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        78 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      +..    ....|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+.   .
T Consensus        86 ~~~----~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~---~  157 (339)
T 1z57_A           86 FEH----HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDY---T  157 (339)
T ss_dssp             EEE----TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCE---E
T ss_pred             ccc----CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccc---c
Confidence            876    67899999999 889999998766557999999999999999999999999999999999999974221   0


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  237 (372)
                      ...+.+....     .....++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       158 ~~~~~~~~~~-----~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  229 (339)
T 1z57_A          158 EAYNPKIKRD-----ERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL  229 (339)
T ss_dssp             EEEC----CE-----EEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred             cccCCccccc-----cccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence            0000000000     0000256799999999986432   2345678999999999999899999999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCc-------------------cCC-------------------CCcccccCHHHHH
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQF-------------------DFP-------------------NPEWEHVSQEAKT  279 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~~~-------------------~~~~~~~s~~~~~  279 (372)
                      |..||...+..+....+. .+. +..                   .++                   .......++++.+
T Consensus       230 g~~pf~~~~~~~~~~~~~-~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  307 (339)
T 1z57_A          230 GFTVFPTHDSKEHLAMME-RIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD  307 (339)
T ss_dssp             SSCSCCCSCHHHHHHHHH-HHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred             CCCCCCCCChHHHHHHHH-HHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence            999996544322111111 100 000                   000                   0001124578999


Q ss_pred             HHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         280 LIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       280 li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      ||.+||+.||.+|||++|+++||||+.++
T Consensus       308 li~~~L~~dP~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          308 LIQKMLEYDPAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred             HHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence            99999999999999999999999998764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.2e-47  Score=354.81  Aligned_cols=269  Identities=23%  Similarity=0.390  Sum_probs=211.3

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEc-CCCcEEEEEEecch-------hhhHHHHHHHHHh--cCCCCEeEEeEeeee
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEK-KTSEVYALKVLHDT-------VKARREVELQLAV--GSHKHIVNIKDVYEN   80 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~-------~~~~~e~~~~~~~--~~h~ni~~~~~~~~~   80 (372)
                      ....++|++. +.||+|+||+||+|.+. .+|+.||||++...       ....+|+.++..+  +.||||+++++++..
T Consensus         7 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            7 CRADQQYECV-AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CCGGGTEEEE-EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             cCchhceeee-eeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            3466899995 77999999999999995 67899999998532       2345677664333  389999999999862


Q ss_pred             e-cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          81 I-YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        81 ~-~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      . .......++||||+. |+|.+++.......+++..++.++.||+.||.|||+.||+||||||+||+++          
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~----------  154 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----------  154 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----------
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc----------
Confidence            2 123678999999996 6999999876656699999999999999999999999999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                       .++.+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       155 -----------------~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  216 (326)
T 1blx_A          155 -----------------SSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK  216 (326)
T ss_dssp             -----------------TTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             -----------------CCCCEEEecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCC
Confidence                             5677999999998765432 2334567899999999999889999999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhC-CccCC------------------CCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLG-QFDFP------------------NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~-~~~~~------------------~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .||.+.........+....... ...++                  ......++.++.+||.+||+.||.+|||+.++++
T Consensus       217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          217 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            9997654322111111111000 00000                  0112457899999999999999999999999999


Q ss_pred             CCccccCCC
Q psy3151         301 NKWISQFNQ  309 (372)
Q Consensus       301 hp~~~~~~~  309 (372)
                      ||||++...
T Consensus       297 hp~~~~~~~  305 (326)
T 1blx_A          297 HPYFQDLER  305 (326)
T ss_dssp             SGGGTTCCC
T ss_pred             Cccccccch
Confidence            999987643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.9e-48  Score=365.29  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=207.5

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      -..++|+++ +.||+|+||+||+|.+..+|+.||+|++...      ....+|+.+ ++.++||||+++++++..    +
T Consensus        30 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~----~  103 (360)
T 3eqc_A           30 LKDDDFEKI-SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV-LHECNSPYIVGFYGAFYS----D  103 (360)
T ss_dssp             CCGGGEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGG-GGGCCCTTBCCEEEEEEE----T
T ss_pred             cccccceee-eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHH-HHHCCCCCEEEEeEEEEE----C
Confidence            356899995 7799999999999999999999999998642      234567766 566799999999999976    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...|+||||+++++|.+++....  .+++..++.++.||+.||.|||+. ||+||||||+|||++               
T Consensus       104 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---------------  166 (360)
T 3eqc_A          104 GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---------------  166 (360)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---------------
T ss_pred             CEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC---------------
Confidence            78999999999999999998763  599999999999999999999996 999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.+||+|||++......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       167 ------------~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          167 ------------SRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             ------------TTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             ------------CCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                        5677999999998765332  23446789999999999999999999999999999999999999965


Q ss_pred             CCCCCCC--------------------------------------HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhcc
Q psy3151         245 NHGQAIS--------------------------------------PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLC  286 (372)
Q Consensus       245 ~~~~~~~--------------------------------------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~  286 (372)
                      .+.....                                      ......+.....  +......++.++.+||.+||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~  310 (360)
T 3eqc_A          233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLI  310 (360)
T ss_dssp             CCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHC
T ss_pred             CCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhh
Confidence            4321100                                      001111111111  111123578999999999999


Q ss_pred             CCCCCCCChhHHhcCCccccC
Q psy3151         287 VDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       287 ~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .||++|||++++|+||||++.
T Consensus       311 ~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          311 KNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             SSTTTSCCHHHHHTSHHHHHH
T ss_pred             cChhhCCCHHHHhhChHhhcc
Confidence            999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.2e-48  Score=365.79  Aligned_cols=265  Identities=24%  Similarity=0.410  Sum_probs=205.2

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCC-----CEeEEeEeee
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHK-----HIVNIKDVYE   79 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~-----ni~~~~~~~~   79 (372)
                      ....+.++|++ .+.||+|+||+||+|.+..+|+.||||++....    ...+|+.++..+..|+     +|+.+++++.
T Consensus        48 ~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           48 NGEKWMDRYEI-DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             TTCEETTTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             cCCEeeeeEEE-EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            34457899999 478999999999999999999999999997443    3345666644444465     4899999887


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCceeeecCCCCCce
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH--DQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH--~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      .    ...+|+||||+. ++|.+++.....+.+++..++.++.||+.||.|||  +.||+||||||+|||++.+      
T Consensus       127 ~----~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~------  195 (382)
T 2vx3_A          127 F----RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP------  195 (382)
T ss_dssp             E----TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST------
T ss_pred             c----CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC------
Confidence            6    678999999995 59999998765566999999999999999999999  5799999999999999621      


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  237 (372)
                                         ..+.+||+|||+|.....   .....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       196 -------------------~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  253 (382)
T 2vx3_A          196 -------------------KRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT  253 (382)
T ss_dssp             -------------------TSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             -------------------CCCcEEEEeccCceeccc---ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence                               356799999999987632   2345688999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhh---------------------CCc----------cCCCCccc---------------
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRL---------------------GQF----------DFPNPEWE---------------  271 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~---------------------~~~----------~~~~~~~~---------------  271 (372)
                      |..||.+.+..+....+......                     +.+          .+..+...               
T Consensus       254 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  333 (382)
T 2vx3_A          254 GEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG  333 (382)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGG
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCc
Confidence            99999765432221111111000                     000          00000000               


Q ss_pred             ----------ccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         272 ----------HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       272 ----------~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                                ..++++++||.+||++||++|||++|+|+||||++.
T Consensus       334 ~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             cccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence                      011478999999999999999999999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.8e-48  Score=366.79  Aligned_cols=252  Identities=24%  Similarity=0.433  Sum_probs=198.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcC-CCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGS-HKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~-h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|++. +.||+|+||+||+|.+.. ++.||||++...       ....+|+.++..+.. ||||+++++++..    +
T Consensus        55 ~~~y~~~-~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~----~  128 (390)
T 2zmd_A           55 GRIYSIL-KQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----D  128 (390)
T ss_dssp             TEEEEEE-EEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----S
T ss_pred             CCceEEE-EEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec----C
Confidence            3569984 789999999999999865 999999998532       245678888656653 7999999998875    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+|||+ .+++|.+++....  .+++.+++.++.||+.||.|||+.||+||||||+|||++                
T Consensus       129 ~~~~lv~E~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----------------  189 (390)
T 2zmd_A          129 QYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----------------  189 (390)
T ss_dssp             SEEEEEEEC-CSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----------------
T ss_pred             CEEEEEEec-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----------------
Confidence            679999995 5889999998753  599999999999999999999999999999999999995                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCC-----------CCCCCccchhhHHHHH
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGP-----------DKYDKSCDIWSLGVIM  232 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il  232 (372)
                                  ++.+||+|||++........  .....+||+.|+|||++.+           ..++.++|||||||++
T Consensus       190 ------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil  257 (390)
T 2zmd_A          190 ------------DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL  257 (390)
T ss_dssp             ------------SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHH
T ss_pred             ------------CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHH
Confidence                        35699999999987643222  2345689999999999854           4688999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       233 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |+|++|..||......   ......+.......+.+  ...+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       258 ~ell~G~~Pf~~~~~~---~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          258 YYMTYGKTPFQQIINQ---ISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HHHHHSSCTTTTCCCH---HHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHHCCCcchhhhHH---HHHHHHHhCccccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            9999999999653221   11222333322222222  2458899999999999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-48  Score=370.14  Aligned_cols=259  Identities=19%  Similarity=0.192  Sum_probs=187.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHHH--HHhcCCCCEeEEeE-------e
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQ--LAVGSHKHIVNIKD-------V   77 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~--~~~~~h~ni~~~~~-------~   77 (372)
                      ..|++ .+.||+|+||+||+|.+..+|+.||||++....        ...+|+.++  ++. +||||++++.       +
T Consensus        62 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           62 RKLKL-VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             eeeee-eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            45888 578999999999999999999999999997421        223554432  233 6999888553       3


Q ss_pred             eeeecC-------------CceEEEEEEeccCCCchhHHHHhccCCCCCHHHH------HHHHHHHHHHHHHHHHCCcee
Q psy3151          78 YENIYN-------------GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREA------AIIMNEICSAIKFLHDQNIAH  138 (372)
Q Consensus        78 ~~~~~~-------------~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~------~~i~~qil~~l~~LH~~~ivH  138 (372)
                      +.....             ....+|+||||+. |+|.+++.... ..+++..+      ..++.||+.||+|||++||+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            322110             0156899999997 89999998753 23555555      677799999999999999999


Q ss_pred             cCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC--
Q psy3151         139 RDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP--  216 (372)
Q Consensus       139 rDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--  216 (372)
                      |||||+|||++                           .++.+||+|||+|.....   ......+|+.|+|||++.+  
T Consensus       218 rDikp~NIll~---------------------------~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~  267 (371)
T 3q60_A          218 GHFTPDNLFIM---------------------------PDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNAST  267 (371)
T ss_dssp             TTCSGGGEEEC---------------------------TTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSE
T ss_pred             CcCCHHHEEEC---------------------------CCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCC
Confidence            99999999998                           567899999999986532   2224566799999999987  


Q ss_pred             CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHh-HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCCh
Q psy3151         217 DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG-MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI  295 (372)
Q Consensus       217 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~  295 (372)
                      ..++.++|||||||++|+|++|..||.+......... ..............+.+..+++++.+||.+||+.||++|||+
T Consensus       268 ~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  347 (371)
T 3q60_A          268 ATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP  347 (371)
T ss_dssp             EECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH
T ss_pred             CCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence            6799999999999999999999999976643221000 000011111122223345789999999999999999999999


Q ss_pred             hHHhcCCccccC
Q psy3151         296 DQVMENKWISQF  307 (372)
Q Consensus       296 ~eil~hp~~~~~  307 (372)
                      +++|+||||++.
T Consensus       348 ~e~l~hp~f~~~  359 (371)
T 3q60_A          348 LEAMETPEFLQL  359 (371)
T ss_dssp             HHHTTSHHHHHH
T ss_pred             HHHhcCHHHHHH
Confidence            999999999764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-47  Score=360.39  Aligned_cols=250  Identities=25%  Similarity=0.406  Sum_probs=205.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..++|+++ +.||+|+||+||+|.+..+|+.||||++...        ....+|+.+ ++.++||||+++++++..    
T Consensus        52 ~~~~y~~~-~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~----  125 (348)
T 1u5q_A           52 PEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF-LQKLRHPNTIQYRGCYLR----  125 (348)
T ss_dssp             HHHHEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHH-HHHCCCTTBCCEEEEEEE----
T ss_pred             hhhheeee-eEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHH-HHhCCCCCEeeEEEEEEE----
Confidence            45679985 7799999999999999999999999998532        234577777 566799999999999976    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...|+||||+. |+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus       126 ~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---------------  188 (348)
T 1u5q_A          126 EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---------------  188 (348)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---------------
T ss_pred             CCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---------------
Confidence            678999999996 68888886543 5699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc---CCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.+||+|||++.....    ....+||+.|+|||++   ....++.++|||||||++|+|++|..|
T Consensus       189 ------------~~~~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  252 (348)
T 1u5q_A          189 ------------EPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  252 (348)
T ss_dssp             ------------TTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ------------CCCCEEEeeccCceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence                        567899999999876532    2346789999999998   356789999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |.+....    .....+.....  +......+++++.+||.+||+.||++|||++++++||||...
T Consensus       253 ~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          253 LFNMNAM----SALYHIAQNES--PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             TTTSCHH----HHHHHHHHSCC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCCChH----HHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            9654321    11222222222  112224679999999999999999999999999999999763

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.9e-47  Score=352.00  Aligned_cols=254  Identities=27%  Similarity=0.438  Sum_probs=212.7

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ....++|+++ +.||+|+||.||+|.+..+++.||||++...      ....+|+.+ ++.++||||+++++++..    
T Consensus        18 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   91 (303)
T 3a7i_A           18 ADPEELFTKL-EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV-LSQCDSPYVTKYYGSYLK----   91 (303)
T ss_dssp             ECGGGTEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHH-HHHCCCTTBCCEEEEEEE----
T ss_pred             CChHHHHHHh-hhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHH-HHhCCCCCEeEEEEEEec----
Confidence            3466889995 7799999999999999999999999998632      345567776 566799999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...|+||||+.+++|.+++..   +.+++..++.++.||+.||.|||+.||+||||||+||+++               
T Consensus        92 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---------------  153 (303)
T 3a7i_A           92 DTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---------------  153 (303)
T ss_dssp             TTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---------------
T ss_pred             CCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC---------------
Confidence            6689999999999999999864   4599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                  .++.+||+|||++..............||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus       154 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  221 (303)
T 3a7i_A          154 ------------EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE  221 (303)
T ss_dssp             ------------TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ------------CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence                        56779999999998765544445566789999999999989999999999999999999999999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ....    .....+.....   ......++.++.+||.+||+.||.+|||++++++||||...
T Consensus       222 ~~~~----~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          222 LHPM----KVLFLIPKNNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             SCHH----HHHHHHHHSCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             cCHH----HHHHHhhcCCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            4321    22222222221   11224689999999999999999999999999999999763

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=360.12  Aligned_cols=253  Identities=24%  Similarity=0.415  Sum_probs=196.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCC-CCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSH-KHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h-~ni~~~~~~~~~~~~~   84 (372)
                      ..++|+++ +.||+|+||+||+|.+ .+++.||||++...       ....+|+.++..+..| |||+++++++..    
T Consensus         7 ~~~~y~i~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----   80 (343)
T 3dbq_A            7 KGRIYSIL-KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----   80 (343)
T ss_dssp             SSCEEEEE-EEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred             ecCEEEEE-EEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee----
Confidence            45689995 7799999999999998 46999999998632       2345788875555433 999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +..+|+|||+ .+++|.+++...  +.+++.+++.++.||+.||+|||++||+||||||+|||++               
T Consensus        81 ~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~---------------  142 (343)
T 3dbq_A           81 DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---------------  142 (343)
T ss_dssp             SSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---------------
T ss_pred             CCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE---------------
Confidence            6789999995 478999999875  4599999999999999999999999999999999999996               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCC-----------CCCCCccchhhHHHH
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGP-----------DKYDKSCDIWSLGVI  231 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~i  231 (372)
                                   ++.+||+|||++........  .....+||+.|+|||++.+           ..++.++|||||||+
T Consensus       143 -------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~i  209 (343)
T 3dbq_A          143 -------------DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  209 (343)
T ss_dssp             -------------TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHH
T ss_pred             -------------CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHH
Confidence                         35699999999987643322  2345679999999999843           678899999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       232 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +|+|++|..||......   ......+........  .....+.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       210 l~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          210 LYYMTYGKTPFQQIINQ---ISKLHAIIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             HHHHHHSSCTTTTCCSH---HHHHHHHHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHHhCCCcchhhhhH---HHHHHHHhcCCcccC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            99999999999643221   111222222221111  113567899999999999999999999999999999854

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.4e-48  Score=363.17  Aligned_cols=265  Identities=22%  Similarity=0.357  Sum_probs=200.3

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------------hhhHHHHHHHHHhcCCCCEeEEe
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------------VKARREVELQLAVGSHKHIVNIK   75 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------~~~~~e~~~~~~~~~h~ni~~~~   75 (372)
                      .+.++|++ .+.||+|+||.||+|.+.. |+.||||++...                ....+|+.+ ++.++||||++++
T Consensus        19 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~   95 (362)
T 3pg1_A           19 AMQSPYTV-QRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL-LNHFHHPNILGLR   95 (362)
T ss_dssp             HTTCSCEE-EEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH-HHHCCCTTBCCCS
T ss_pred             HhccceEE-eEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH-HHhCCCcCcccee
Confidence            47899999 5889999999999999865 999999998521                345678887 5667999999999


Q ss_pred             Eeeeeec-CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCC
Q psy3151          76 DVYENIY-NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDG  154 (372)
Q Consensus        76 ~~~~~~~-~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~  154 (372)
                      +++.... .....+|+||||+. |+|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++     
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~-----  168 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-----  168 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-----
T ss_pred             eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc-----
Confidence            9985432 23557999999996 68988887543 4699999999999999999999999999999999999998     


Q ss_pred             CceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHH
Q psy3151         155 GILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       155 ~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~  233 (372)
                                            .++.+||+|||++..... .......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus       169 ----------------------~~~~~kl~Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  225 (362)
T 3pg1_A          169 ----------------------DNNDITICDFNLAREDTA-DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA  225 (362)
T ss_dssp             ----------------------TTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHH
T ss_pred             ----------------------CCCCEEEEecCccccccc-ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHH
Confidence                                  567799999999975433 223345678999999999876 67999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCHhHHHHH--------------------hhCCccCCCCc----ccccCHHHHHHHHHhccCCC
Q psy3151         234 ILLCGFPPFFSNHGQAISPGMKNRI--------------------RLGQFDFPNPE----WEHVSQEAKTLIKNMLCVDP  289 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~----~~~~s~~~~~li~~ll~~dP  289 (372)
                      +|++|..||.+.........+....                    .......+...    ...+++++.+||.+||+.||
T Consensus       226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  305 (362)
T 3pg1_A          226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP  305 (362)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCCh
Confidence            9999999996644221111111100                    00000111111    13468899999999999999


Q ss_pred             CCCCChhHHhcCCccccCCC
Q psy3151         290 SERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       290 ~~R~s~~eil~hp~~~~~~~  309 (372)
                      .+|||++|+|+||||+.+..
T Consensus       306 ~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          306 QRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             GGSCCHHHHHTSGGGTTTCC
T ss_pred             hhCCCHHHHHcCchhhhccC
Confidence            99999999999999998743

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.8e-48  Score=360.90  Aligned_cols=256  Identities=23%  Similarity=0.455  Sum_probs=212.8

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----------------------hhhHHHHHHHHHhcCCC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----------------------VKARREVELQLAVGSHK   69 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~e~~~~~~~~~h~   69 (372)
                      .+.++|++. +.||+|+||+||+|.+  +|+.||||++...                      ....+|+.+ ++.++||
T Consensus        28 ~~~~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~  103 (348)
T 2pml_X           28 KYINDYRII-RTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI-ITDIKNE  103 (348)
T ss_dssp             EEETTEEEE-EEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHH-HTTCCCT
T ss_pred             cccCceEEE-EEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHH-HHhCCCC
Confidence            356899995 7899999999999999  8999999998632                      445678877 6667899


Q ss_pred             CEeEEeEeeeeecCCceEEEEEEeccCCCchhHH------HHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCC
Q psy3151          70 HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQR------IQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVK  142 (372)
Q Consensus        70 ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~------i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlk  142 (372)
                      ||+++++++..    .+..|+||||+++++|.++      +.......+++..++.++.||+.||.|||+ .||+|||||
T Consensus       104 ~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~  179 (348)
T 2pml_X          104 YCLTCEGIITN----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK  179 (348)
T ss_dssp             TBCCCSEEEES----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred             CcceEEEEEee----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence            99999999876    6789999999999999998      655434679999999999999999999999 999999999


Q ss_pred             CCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCC
Q psy3151         143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDK  221 (372)
Q Consensus       143 p~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~  221 (372)
                      |+||+++                           .++.+||+|||++......  ......||+.|+|||++.+. .++.
T Consensus       180 p~Nil~~---------------------------~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~  230 (348)
T 2pml_X          180 PSNILMD---------------------------KNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNG  230 (348)
T ss_dssp             GGGEEEC---------------------------TTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEH
T ss_pred             hHhEEEc---------------------------CCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCc
Confidence            9999998                           5677999999999875432  34456789999999999876 6666


Q ss_pred             -ccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCc---------------ccccCHHHHHHHHHhc
Q psy3151         222 -SCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPE---------------WEHVSQEAKTLIKNML  285 (372)
Q Consensus       222 -~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~s~~~~~li~~ll  285 (372)
                       ++|||||||++|+|++|..||.....   .......+..+...++...               ...++.++.+||.+||
T Consensus       231 ~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  307 (348)
T 2pml_X          231 AKVDIWSLGICLYVMFYNVVPFSLKIS---LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL  307 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSC---SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHC
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHc
Confidence             99999999999999999999965443   1344555555554444211               1468999999999999


Q ss_pred             cCCCCCCCChhHHhcCCccccC
Q psy3151         286 CVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       286 ~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +.||.+|||++++++||||++.
T Consensus       308 ~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          308 RKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             CSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cCChhhCCCHHHHhcCccccCC
Confidence            9999999999999999999763

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-47  Score=361.25  Aligned_cols=268  Identities=25%  Similarity=0.357  Sum_probs=193.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeec---CCc
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIY---NGS   85 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~---~~~   85 (372)
                      ..++|++ .+.||+|+||+||+|.+..+|+.||||++....    ...+++.. +..++||||++++++|....   ...
T Consensus        21 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~-l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           21 EMDRFQV-ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD-LAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HHTTEEE-C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHH-HHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             hccceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHH-HHhcCCCCcccHHHhhhccccccccc
Confidence            4578999 478999999999999999999999999885432    23334443 45569999999999986432   224


Q ss_pred             eEEEEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          86 RCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLH--DQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH--~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                      .++++||||+.+ +|.+.+..  .....+++..++.++.||+.||.|||  +.||+||||||+|||++.           
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-----------  166 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE-----------  166 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-----------
T ss_pred             eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-----------
Confidence            458999999975 66555443  23356999999999999999999999  999999999999999982           


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                     .++.+||+|||++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus       167 ---------------~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~  230 (360)
T 3e3p_A          167 ---------------ADGTLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP  230 (360)
T ss_dssp             ---------------TTTEEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ---------------CCCcEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence                           3678999999999876442 233456789999999998654 48999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHh-----------hCCc--cC---CC--------CcccccCHHHHHHHHHhccCCCCCCCChh
Q psy3151         241 PFFSNHGQAISPGMKNRIR-----------LGQF--DF---PN--------PEWEHVSQEAKTLIKNMLCVDPSERLTID  296 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~-----------~~~~--~~---~~--------~~~~~~s~~~~~li~~ll~~dP~~R~s~~  296 (372)
                      ||.+.+.......+.....           ....  ..   ..        ......++++.+||.+||+.||.+|||+.
T Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  310 (360)
T 3e3p_A          231 IFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY  310 (360)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHH
Confidence            9976543221111111100           0000  00   00        00112578999999999999999999999


Q ss_pred             HHhcCCccccCCCC
Q psy3151         297 QVMENKWISQFNQV  310 (372)
Q Consensus       297 eil~hp~~~~~~~~  310 (372)
                      |+|+||||++....
T Consensus       311 e~l~hp~f~~~~~~  324 (360)
T 3e3p_A          311 EALCHPYFDELHDP  324 (360)
T ss_dssp             HHTTSGGGGGGGCT
T ss_pred             HHhcCccccccCCc
Confidence            99999999987553

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8e-48  Score=353.32  Aligned_cols=258  Identities=28%  Similarity=0.381  Sum_probs=202.6

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ..+.++|+++ +.||+|+||+||+|.+..+++.||+|++...        ....+|+.. +..++||||+++++++..  
T Consensus         7 ~~~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~hp~iv~~~~~~~~--   82 (294)
T 4eqm_A            7 KIINERYKIV-DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN-SSQLSHQNIVSMIDVDEE--   82 (294)
T ss_dssp             SCEETTEEEE-EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHH-HTTCCBTTBCCEEEEEEC--
T ss_pred             hHhhccEEEE-EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHH-HhcCCCCCCceEEEeeee--
Confidence            4478999995 7799999999999999999999999998421        234567766 667799999999999875  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        ++..|+||||+++++|.+++...  +.+++..++.++.||+.||+|||++||+||||||+||+++             
T Consensus        83 --~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~-------------  145 (294)
T 4eqm_A           83 --DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID-------------  145 (294)
T ss_dssp             --SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-------------
T ss_pred             --CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-------------
Confidence              67899999999999999999876  3599999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                    .++.+||+|||++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       146 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p  211 (294)
T 4eqm_A          146 --------------SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP  211 (294)
T ss_dssp             --------------TTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             --------------CCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence                          56779999999998664332 223446789999999999888999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      |.+.....   .....+.......+......+++.+.++|.+||+.||.+||+..+.+.+.|..-
T Consensus       212 f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          212 FNGETAVS---IAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             SCSSCHHH---HHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             CCCCChHH---HHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            96543211   111112111111111122468999999999999999999997677777766543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.9e-47  Score=350.66  Aligned_cols=261  Identities=15%  Similarity=0.193  Sum_probs=209.5

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ...+.++|++ .+.||+|+||+||+|.+..+|+.||||++...   ....+|+..+..+.+|+||+++++++..    +.
T Consensus         5 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~   79 (298)
T 1csn_A            5 NNVVGVHYKV-GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE----GL   79 (298)
T ss_dssp             -CEETTTEEE-EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE----TT
T ss_pred             CcccccceEE-EEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC----Cc
Confidence            3447789999 57899999999999999999999999998632   3456788886666699999999999875    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ..|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.             
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-------------  144 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS-------------  144 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS-------------
T ss_pred             eeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC-------------
Confidence            899999999 999999998653 45999999999999999999999999999999999999985431             


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                               ...+.+||+|||++........       .....+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       145 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  215 (298)
T 1csn_A          145 ---------KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS  215 (298)
T ss_dssp             ---------TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ---------CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCC
Confidence                     0345599999999987654322       234567899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .||.+...... ......+.......+. .....+++++.+||.+||+.||++|||++++++
T Consensus       216 ~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          216 LPWQGLKAATN-KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             CTTSSCCSCCH-HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCcchhhcccc-HHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            99977543332 1222222221111111 112367999999999999999999999999976

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.3e-47  Score=358.74  Aligned_cols=268  Identities=26%  Similarity=0.433  Sum_probs=206.9

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee-c
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI-Y   82 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~-~   82 (372)
                      ...+.++|++ .+.||+|+||+||+|.+..+|+.||||++...      ....+|+.+ ++.++||||+++++++... .
T Consensus         6 ~~~i~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            6 VYNISSDFQL-KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI-LKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CCCSCTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHH-HHHCCCTTBCCEEEECCCSCS
T ss_pred             ccccccceEE-eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHH-HHhCcCCCcCCeeeeeccccc
Confidence            3457899999 58899999999999999999999999998632      234578877 5667999999999987642 2


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ......|+||||+. ++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++             
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~-------------  146 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN-------------  146 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-------------
T ss_pred             CccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc-------------
Confidence            23467999999996 6999988763   599999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC----------cccccccCCCcCCCcccC-CCCCCCccchhhHHHH
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----------SLQTPCYTPYYVAPEVLG-PDKYDKSCDIWSLGVI  231 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~i  231 (372)
                                    .++.+||+|||++........          .....+||+.|+|||++. +..++.++|||||||+
T Consensus       147 --------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i  212 (353)
T 2b9h_A          147 --------------SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI  212 (353)
T ss_dssp             --------------TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHH
T ss_pred             --------------CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHH
Confidence                          566799999999876543211          123357899999999874 4778999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCHhHHHHH--------------------hhCCccCCC----CcccccCHHHHHHHHHhccC
Q psy3151         232 MYILLCGFPPFFSNHGQAISPGMKNRI--------------------RLGQFDFPN----PEWEHVSQEAKTLIKNMLCV  287 (372)
Q Consensus       232 l~~ll~g~~pf~~~~~~~~~~~~~~~~--------------------~~~~~~~~~----~~~~~~s~~~~~li~~ll~~  287 (372)
                      +|+|++|..||.+.+.......+....                    .......+.    ..+..+++++.+||.+||+.
T Consensus       213 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  292 (353)
T 2b9h_A          213 LAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF  292 (353)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCc
Confidence            999999999996654211100000000                    000000010    01236789999999999999


Q ss_pred             CCCCCCChhHHhcCCccccCCCC
Q psy3151         288 DPSERLTIDQVMENKWISQFNQV  310 (372)
Q Consensus       288 dP~~R~s~~eil~hp~~~~~~~~  310 (372)
                      ||++|||++++++||||+.....
T Consensus       293 dP~~Rpt~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          293 DPAKRITAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             SGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             CcccCCCHHHHhcCccccccCCc
Confidence            99999999999999999987543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=352.51  Aligned_cols=251  Identities=22%  Similarity=0.387  Sum_probs=203.8

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .++|.+ .+.||+|+||+||+|.+..+++.||+|++...     ....+|+.+ ++.++||||+++++++..    +...
T Consensus         9 ~~~~~~-~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~----~~~~   82 (310)
T 3s95_A            9 PSDLIH-GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV-MRCLEHPNVLKFIGVLYK----DKRL   82 (310)
T ss_dssp             GGGEEE-EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHH-HTTCCCTTBCCEEEEEEE----TTEE
T ss_pred             hhHeec-cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHH-HHhCCCcCcccEEEEEec----CCee
Confidence            478998 58899999999999999999999999988532     244577777 677799999999999986    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+.+++|.+++.... +.+++..++.++.||+.||+|||++||+||||||+|||++                   
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~-------------------  142 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR-------------------  142 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC-------------------
T ss_pred             EEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC-------------------
Confidence            99999999999999998743 5699999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCc--------------ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHH
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKAS--------------LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI  234 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  234 (372)
                              .++.+||+|||++.........              ....+||+.|+|||++.+..++.++|||||||++|+
T Consensus       143 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~e  214 (310)
T 3s95_A          143 --------ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE  214 (310)
T ss_dssp             --------TTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred             --------CCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHH
Confidence                    5667999999988765432211              125678999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCCCC--HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         235 LLCGFPPFFSNHGQAIS--PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       235 ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |++|..||.........  .........   ..+    ..+++++.+||.+||+.||++|||++++++  |++.+
T Consensus       215 l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          215 IIGRVNADPDYLPRTMDFGLNVRGFLDR---YCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             HHHTCCSSTTTSCBCTTSSBCHHHHHHH---TCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             HhcCCCCCcchhhhHHHHhhhhhccccc---cCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            99999998654332221  111111111   111    367889999999999999999999999987  55543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-47  Score=357.21  Aligned_cols=259  Identities=19%  Similarity=0.242  Sum_probs=206.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      -+.++|++ .+.||+|+||+||+|.+..+|+.||||++...   ....+|+.++..+.+||||+++++++..    +...
T Consensus         6 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----~~~~   80 (330)
T 2izr_A            6 MVGPNFRV-GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC----GKYN   80 (330)
T ss_dssp             EETTTEEE-EEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE----TTEE
T ss_pred             EEcCCeEE-EEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec----CCcc
Confidence            36689999 57899999999999999999999999998632   3467888886666699999999999876    6789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+ +++|.+++.... +.+++..++.++.||+.||+|||+.||+||||||+|||++.++..              
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~--------------  144 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNK--------------  144 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT--------------
T ss_pred             EEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCC--------------
Confidence            9999999 899999998653 569999999999999999999999999999999999999843210              


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                              ....+||+|||++........       .....+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       145 --------~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~P  216 (330)
T 2izr_A          145 --------TQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP  216 (330)
T ss_dssp             --------CTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             --------CCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence                    223499999999986543222       12456899999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |.+...... ......+.......+........+++.++|..||+.||.+||+++++++
T Consensus       217 f~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          217 WQGLKADTL-KERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             TTTCCCSSH-HHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccccccccH-HHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            987654433 2222333222222222111122349999999999999999999999876

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.6e-47  Score=350.07  Aligned_cols=258  Identities=26%  Similarity=0.444  Sum_probs=201.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeee-------
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENI-------   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~-------   81 (372)
                      +.++|+++ +.||+|+||+||+|.+..+|+.||||++....    ...+|+.+ ++.++||||+++++++...       
T Consensus         4 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            4 YASDFEEI-AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVML-LASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHHEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHH-HTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccccchhh-heeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHH-HHhcCchHHHHHHHHHHhhcchhhhh
Confidence            57899995 78999999999999999999999999996432    34567776 6677999999999987532       


Q ss_pred             --cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          82 --YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        82 --~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                        .......|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++          
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~----------  150 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID----------  150 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----------
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc----------
Confidence              123678999999999999999998643 4589999999999999999999999999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccC--------------CCcccccccCCCcCCCcccCCC-CCCCccc
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN--------------KASLQTPCYTPYYVAPEVLGPD-KYDKSCD  224 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D  224 (372)
                                       .++.+||+|||++......              .......+||+.|+|||++.+. .++.++|
T Consensus       151 -----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  213 (303)
T 1zy4_A          151 -----------------ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKID  213 (303)
T ss_dssp             -----------------TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHH
T ss_pred             -----------------CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhh
Confidence                             5567888888888754321              1223456789999999998754 6899999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         225 IWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       225 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ||||||++|+|++   ||....   ........+......++.......+..+.+||.+||+.||.+|||++++++||||
T Consensus       214 i~slG~il~~l~~---p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (303)
T 1zy4_A          214 MYSLGIIFFEMIY---PFSTGM---ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL  287 (303)
T ss_dssp             HHHHHHHHHHHHS---CCSSHH---HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred             HHHHHHHHHHHHh---ccCCch---hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence            9999999999998   553211   0122334444444555554445678899999999999999999999999999999


Q ss_pred             cc
Q psy3151         305 SQ  306 (372)
Q Consensus       305 ~~  306 (372)
                      +.
T Consensus       288 ~~  289 (303)
T 1zy4_A          288 PV  289 (303)
T ss_dssp             CC
T ss_pred             CC
Confidence            65

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=358.40  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=201.7

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC-
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN-   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~-   83 (372)
                      .+.++|.+ .+.||+|+||+||+|.+..+|+.||||++...       ....+|+.+ ++.++||||+++++++..... 
T Consensus        21 ~l~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           21 ELPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL-LKHMQHENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EEETTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHH-HHHCCCTTBCCCSEEECSCSSG
T ss_pred             ccCceEEE-eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHH-HHhcCCCCcccHhheEeccccc
Confidence            36789999 57899999999999999999999999998532       234567777 667799999999999875211 


Q ss_pred             -CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          84 -GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        84 -~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                       .....|+||||+. ++|.+++.    ..+++..++.++.||+.||+|||++||+||||||+||+++             
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~-------------  160 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-------------  160 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC-------------
T ss_pred             ccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC-------------
Confidence             1124699999996 58888763    2499999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                    .++.+||+|||++.....   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus       161 --------------~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p  223 (353)
T 3coi_A          161 --------------EDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL  223 (353)
T ss_dssp             --------------TTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             --------------CCCcEEEeecccccCCCC---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence                          567799999999876532   2345678999999999876 6789999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHH-------------------hhCCccCC----CCcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         242 FFSNHGQAISPGMKNRI-------------------RLGQFDFP----NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~-------------------~~~~~~~~----~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |.+.+..+....+....                   .......+    ...+..+++++.+||.+||+.||++|||++++
T Consensus       224 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  303 (353)
T 3coi_A          224 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  303 (353)
T ss_dssp             SBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            97654321111111100                   00000000    11124679999999999999999999999999


Q ss_pred             hcCCccccCCC
Q psy3151         299 MENKWISQFNQ  309 (372)
Q Consensus       299 l~hp~~~~~~~  309 (372)
                      |+||||+.+..
T Consensus       304 l~hp~f~~~~~  314 (353)
T 3coi_A          304 LTHPFFEPFRD  314 (353)
T ss_dssp             HTSGGGTTTCC
T ss_pred             hcCcchhhccC
Confidence            99999988654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.8e-47  Score=359.18  Aligned_cols=277  Identities=23%  Similarity=0.384  Sum_probs=205.0

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCC-cEEEEEEecch----hhhHHHHHHHHHhcCCCC------EeEEeEeee
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTS-EVYALKVLHDT----VKARREVELQLAVGSHKH------IVNIKDVYE   79 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~----~~~~~e~~~~~~~~~h~n------i~~~~~~~~   79 (372)
                      ..+.++|++. +.||+|+||+||+|.+..++ +.||||++...    ....+|+.++ +.+.|++      ++.+.+++.
T Consensus        15 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           15 DWLQERYEIV-GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVL-KKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             CEETTTEEEE-EEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHH-HHHHHHCTTSCSCBCCEEEEEE
T ss_pred             ceecccEEEE-EEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHH-HHHhhcCCCCceeEEEeeeeee
Confidence            3478999995 77999999999999998877 79999999643    2345677664 3334433      888888887


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      .    ....|+||||+ +++|.+.+.......+++..++.++.||+.||+|||++||+||||||+|||++..+.   ..+
T Consensus        93 ~----~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~---~~~  164 (355)
T 2eu9_A           93 F----HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF---ETL  164 (355)
T ss_dssp             E----TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE---EEE
T ss_pred             e----CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc---ccc
Confidence            6    67899999999 678888887765557999999999999999999999999999999999999963221   111


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                      .+.....     .......+.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       165 ~~~~~~~-----~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  236 (355)
T 2eu9_A          165 YNEHKSC-----EEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF  236 (355)
T ss_dssp             ECCC-CC-----CEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccccc-----cccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence            1100000     00011567899999999986432   234567899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCcc-------------------CC-------------------CCcccccCHHHHHHH
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFD-------------------FP-------------------NPEWEHVSQEAKTLI  281 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~-------------------~~-------------------~~~~~~~s~~~~~li  281 (372)
                      .||......+....+.. +. +..+                   ++                   .......+.++.+||
T Consensus       237 ~pf~~~~~~~~~~~~~~-~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  314 (355)
T 2eu9_A          237 TLFQTHENREHLVMMEK-IL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM  314 (355)
T ss_dssp             CSCCCSSHHHHHHHHHH-HH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHH-Hc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence            99965443221111111 00 0000                   00                   000012356899999


Q ss_pred             HHhccCCCCCCCChhHHhcCCccccC
Q psy3151         282 KNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       282 ~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .+||+.||++|||++|+|+||||++.
T Consensus       315 ~~~L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          315 RRMLEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             HHHhcCChhhCcCHHHHhcChhhcCC
Confidence            99999999999999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.3e-47  Score=354.44  Aligned_cols=251  Identities=28%  Similarity=0.485  Sum_probs=207.0

Q ss_pred             CccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----------hhhHHHHHHHHHhc-CCCCEeEEe
Q psy3151           8 FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------VKARREVELQLAVG-SHKHIVNIK   75 (372)
Q Consensus         8 ~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~-~h~ni~~~~   75 (372)
                      ....++.++|++ .+.||+|+||+||+|.+..+|+.||||++...           ....+|+.++..+. .||||++++
T Consensus        36 ~~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           36 KEKEPLESQYQV-GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             ----CCTTTEEE-EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             cccCCccCceEE-EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            445668999999 58899999999999999999999999998643           23456888855554 479999999


Q ss_pred             EeeeeecCCceEEEEEEeccCC-CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCC
Q psy3151          76 DVYENIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDG  154 (372)
Q Consensus        76 ~~~~~~~~~~~~~~lv~e~~~~-g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~  154 (372)
                      +++..    ++..++|||++.+ ++|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+|||++.    
T Consensus       115 ~~~~~----~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~----  184 (320)
T 3a99_A          115 DWFER----PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL----  184 (320)
T ss_dssp             EEEEC----SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET----
T ss_pred             EEEec----CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC----
Confidence            99976    6789999999976 8999999875  45999999999999999999999999999999999999973    


Q ss_pred             CceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHH
Q psy3151         155 GILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMY  233 (372)
Q Consensus       155 ~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~  233 (372)
                                            .++.+||+|||++.....  .......||+.|+|||++.+..+ +.++|||||||++|
T Consensus       185 ----------------------~~~~~kL~Dfg~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~  240 (320)
T 3a99_A          185 ----------------------NRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLY  240 (320)
T ss_dssp             ----------------------TTTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHH
T ss_pred             ----------------------CCCCEEEeeCcccccccc--ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHH
Confidence                                  456799999999887643  22344678999999999876665 68899999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +|++|..||...          ..+......++    ..+++++.+||.+||+.||.+|||++++++||||++.
T Consensus       241 el~~g~~pf~~~----------~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          241 DMVCGDIPFEHD----------EEIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             HHHHSSCSCCSH----------HHHHHCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHCCCCCCCh----------hhhhccccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence            999999999532          12222233222    3689999999999999999999999999999999874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-47  Score=347.46  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=209.8

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ...++|+++ +.||+|+||+||+|.+..+|+.||+|++...       ....+|+.. ++.++||||+++++++..  ..
T Consensus         3 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~--~~   78 (279)
T 2w5a_A            3 SRAEDYEVL-YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL-LRELKHPNIVRYYDRIID--RT   78 (279)
T ss_dssp             CCGGGEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHH-HHHCCCTTBCCEEEEEEE--GG
T ss_pred             Cchhheeee-hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHH-HHhcCCCCCCeEEEEEec--CC
Confidence            346899995 7899999999999999999999999999632       234567776 566699999999998753  23


Q ss_pred             ceEEEEEEeccCCCchhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCceeeecCCCCCce
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKE--DGAFTEREAAIIMNEICSAIKFLHDQN-----IAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~--~~~l~~~~~~~i~~qil~~l~~LH~~~-----ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      +..+|+||||+++++|.+++....  ...+++..++.++.||+.||.|||+.|     |+||||||+||+++        
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~--------  150 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD--------  150 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC--------
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc--------
Confidence            567999999999999999997632  235999999999999999999999999     99999999999998        


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  237 (372)
                                         .++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       151 -------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  211 (279)
T 2w5a_A          151 -------------------GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA  211 (279)
T ss_dssp             -------------------SSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH
T ss_pred             -------------------CCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHH
Confidence                               5677999999999876543333345678999999999988889999999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      |..||.....    ..+...+..+.....   ...++.++.++|.+||+.||.+|||++++++|+|+..
T Consensus       212 g~~p~~~~~~----~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          212 LMPPFTAFSQ----KELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             SSCSSCCSSH----HHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             CCCCCcccCH----HHHHHHHhhcccccC---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            9999965432    233444544444211   1368999999999999999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.2e-48  Score=357.70  Aligned_cols=264  Identities=26%  Similarity=0.436  Sum_probs=201.6

Q ss_pred             cCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeee---
Q psy3151          10 TTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENI---   81 (372)
Q Consensus        10 ~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~---   81 (372)
                      ...+.++|+++ +.||+|+||.||+|.+..+|+.||||++...     ....+|+.+ ++.++||||+++++++...   
T Consensus         6 ~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            6 GFDLGSRYMDL-KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKI-IRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             CEEETTTEEEE-EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHH-HHTCCCTTBCCEEEEECTTSCB
T ss_pred             cCccCCceeEE-EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHH-HHhcCCCCeeEEEEeccccccc
Confidence            34578999995 7799999999999999999999999998632     244577777 6777999999999987431   


Q ss_pred             -------cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCC
Q psy3151          82 -------YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDG  154 (372)
Q Consensus        82 -------~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~  154 (372)
                             .......|+||||+. |+|.+++..   +.+++..++.++.||+.||+|||++||+||||||+||+++.    
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~----  155 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT----  155 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET----
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC----
Confidence                   123568999999996 699998864   45999999999999999999999999999999999999973    


Q ss_pred             CceeeeccCCCCccccccCCCCCCCCeeeeccccccccccC---CCcccccccCCCcCCCcccCC-CCCCCccchhhHHH
Q psy3151         155 GILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN---KASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGV  230 (372)
Q Consensus       155 ~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~  230 (372)
                                            .++.+||+|||++......   ........+|+.|+|||++.+ ..++.++|||||||
T Consensus       156 ----------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~  213 (320)
T 2i6l_A          156 ----------------------EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC  213 (320)
T ss_dssp             ----------------------TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHH
T ss_pred             ----------------------CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHH
Confidence                                  3567999999998865432   122344567999999998754 67899999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCC----------------------ccCCC----CcccccCHHHHHHHHHh
Q psy3151         231 IMYILLCGFPPFFSNHGQAISPGMKNRIRLGQ----------------------FDFPN----PEWEHVSQEAKTLIKNM  284 (372)
Q Consensus       231 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------~~~~~----~~~~~~s~~~~~li~~l  284 (372)
                      ++|+|++|..||.+....+.    ...+....                      ...+.    .....++.++.+||.+|
T Consensus       214 il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  289 (320)
T 2i6l_A          214 IFAEMLTGKTLFAGAHELEQ----MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQI  289 (320)
T ss_dssp             HHHHHHHSSCSSCCSSHHHH----HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTT
T ss_pred             HHHHHHhCCCCCCCCCHHHH----HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHH
Confidence            99999999999976542211    11111000                      00000    01135799999999999


Q ss_pred             ccCCCCCCCChhHHhcCCccccCCC
Q psy3151         285 LCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       285 l~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      |+.||.+|||++++|+||||+.+.-
T Consensus       290 L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          290 LTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             SCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             cCCCccccCCHHHHhCCcccccccC
Confidence            9999999999999999999987643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.6e-49  Score=373.02  Aligned_cols=248  Identities=17%  Similarity=0.202  Sum_probs=193.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHH--HHhcCCCCEeEEe-------
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQ--LAVGSHKHIVNIK-------   75 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~--~~~~~h~ni~~~~-------   75 (372)
                      ..++|++ .+.||+|+||+||+|.+..+|+.||||++...        ....+|+.++  ++.++||||++++       
T Consensus        71 ~~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           71 RPRTLVR-GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCEEEEE-EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCceEEE-cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3588998 57899999999999999999999999998521        2345677442  3344899999988       


Q ss_pred             EeeeeecC--------Cce-----EEEEEEeccCCCchhHHHHhccCCCCCH-------HHHHHHHHHHHHHHHHHHHCC
Q psy3151          76 DVYENIYN--------GSR-----CLLVIMECMHGGELFQRIQQKEDGAFTE-------REAAIIMNEICSAIKFLHDQN  135 (372)
Q Consensus        76 ~~~~~~~~--------~~~-----~~~lv~e~~~~g~L~~~i~~~~~~~l~~-------~~~~~i~~qil~~l~~LH~~~  135 (372)
                      ++++....        +++     ..|+||||+ +|+|.+++....  .+++       ..++.++.||+.||+|||++|
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            55543100        011     378999999 679999998653  2444       888899999999999999999


Q ss_pred             ceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC
Q psy3151         136 IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG  215 (372)
Q Consensus       136 ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~  215 (372)
                      |+||||||+|||++                           .++.+||+|||+|....   ......+| +.|+|||++.
T Consensus       227 ivHrDikp~NIll~---------------------------~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~  275 (377)
T 3byv_A          227 LVHTYLRPVDIVLD---------------------------QRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEA  275 (377)
T ss_dssp             EECSCCCGGGEEEC---------------------------TTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHH
T ss_pred             eecCCCCHHHEEEc---------------------------CCCCEEEEechhheecC---CcccCCCC-cCccChhhhc
Confidence            99999999999998                           56789999999998642   23445677 9999999997


Q ss_pred             CC-----------CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHh
Q psy3151         216 PD-----------KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNM  284 (372)
Q Consensus       216 ~~-----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~l  284 (372)
                      +.           .++.++|||||||++|+|++|..||.+.........+    .        ..+..+++++.+||.+|
T Consensus       276 ~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----~--------~~~~~~~~~~~~li~~~  343 (377)
T 3byv_A          276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI----F--------RSCKNIPQPVRALLEGF  343 (377)
T ss_dssp             HHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG----G--------SSCCCCCHHHHHHHHHH
T ss_pred             ccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh----h--------hhccCCCHHHHHHHHHH
Confidence            76           7999999999999999999999999765543332111    1        11246899999999999


Q ss_pred             ccCCCCCCCChhHHhcCCccccC
Q psy3151         285 LCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       285 l~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |+.||++|||+.++++||||++.
T Consensus       344 L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          344 LRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             TCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             cCCCchhCCCHHHHhhChHHHHH
Confidence            99999999999999999999764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.8e-47  Score=348.17  Aligned_cols=251  Identities=27%  Similarity=0.406  Sum_probs=200.2

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      .+||+|+||+||+|.+..+++.||||++...     ....+|+.. ++.++||||+++++++..    ....++||||++
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~  102 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL-HKHLKHKNIVQYLGSFSE----NGFIKIFMEQVP  102 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHH-HHTCCCTTBCCEEEEEEE----TTEEEEEEECCS
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHH-HHhCCCCCEeeEeeEEEe----CCcEEEEEEeCC
Confidence            3799999999999999999999999998642     234567766 677799999999999976    668999999999


Q ss_pred             CCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151          97 GGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus        97 ~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                      +++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+||+++.                         
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-------------------------  157 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT-------------------------  157 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-------------------------
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC-------------------------
Confidence            9999999986532 34679999999999999999999999999999999999982                         


Q ss_pred             CCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHh
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK--YDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPG  253 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  253 (372)
                       .++.+||+|||++..............||+.|+|||++.+..  ++.++|||||||++|+|++|..||.......  ..
T Consensus       158 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~  234 (295)
T 2clq_A          158 -YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AA  234 (295)
T ss_dssp             -TTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HH
T ss_pred             -CCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HH
Confidence             367899999999987654333345567899999999986543  8899999999999999999999996533211  11


Q ss_pred             HHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         254 MKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      .......   .........+++++.+||.+||+.||++|||++++++||||+...
T Consensus       235 ~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          235 MFKVGMF---KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHH---CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHhhccc---cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            1111111   111122246899999999999999999999999999999998653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.9e-47  Score=348.43  Aligned_cols=257  Identities=25%  Similarity=0.301  Sum_probs=202.0

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--hhHHHHHHHHHh-cCCCCEeEEeEeeeeecCCceE
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--KARREVELQLAV-GSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~e~~~~~~~-~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ..+.++|++. +.||+|+||+||+|.+  +|+.||||++....  ...+|.+++... ++||||+++++++.........
T Consensus         4 ~~~~~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            4 RTVARDITLL-ECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CCCGGGCEEE-EEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccccCcEEEE-EeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            4578999995 7799999999999988  59999999996432  344566654333 6999999999998765556778


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCceeeecCCCCCceee
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH--------DQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH--------~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      +|+||||+.+|+|.+++..   ..+++..++.++.||+.||+|||        +.||+||||||+|||++          
T Consensus        81 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~----------  147 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK----------  147 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC----------
T ss_pred             eEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc----------
Confidence            9999999999999999954   35999999999999999999999        99999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCCc----ccccccCCCcCCCcccCCC------CCCCccchhhHH
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS----LQTPCYTPYYVAPEVLGPD------KYDKSCDIWSLG  229 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG  229 (372)
                                       .++.+||+|||+|.........    ....+||+.|+|||++.+.      .++.++||||||
T Consensus       148 -----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG  210 (301)
T 3q4u_A          148 -----------------KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG  210 (301)
T ss_dssp             -----------------TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHH
T ss_pred             -----------------CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHH
Confidence                             5677999999999765433222    2335789999999999766      455799999999


Q ss_pred             HHHHHHHhC----------CCCCCCCCCCCCCHhHHHHHhhCCc-cCCCCc---ccccCHHHHHHHHHhccCCCCCCCCh
Q psy3151         230 VIMYILLCG----------FPPFFSNHGQAISPGMKNRIRLGQF-DFPNPE---WEHVSQEAKTLIKNMLCVDPSERLTI  295 (372)
Q Consensus       230 ~il~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~s~~~~~li~~ll~~dP~~R~s~  295 (372)
                      |++|+|++|          ..||..................... ....+.   ....++++.+||.+||+.||++|||+
T Consensus       211 ~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  290 (301)
T 3q4u_A          211 LVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA  290 (301)
T ss_dssp             HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH
Confidence            999999999          8888665444433333332222211 111111   12356889999999999999999999


Q ss_pred             hHHhc
Q psy3151         296 DQVME  300 (372)
Q Consensus       296 ~eil~  300 (372)
                      +++++
T Consensus       291 ~~i~~  295 (301)
T 3q4u_A          291 LRIKK  295 (301)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-46  Score=347.81  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=194.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ..++|++ .+.||+|+||+||+|.+  +|+.||||++...       ....+|+.+ ++.++||||+++++++..    .
T Consensus        35 ~~~~y~i-~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~----~  106 (309)
T 3p86_A           35 PWCDLNI-KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAI-MKRLRHPNIVLFMGAVTQ----P  106 (309)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHH-HHHCCCTTBCCEEEEECS----T
T ss_pred             ChhHcee-eeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEEE----C
Confidence            5689999 47899999999999987  5889999998632       234578877 566689999999999875    5


Q ss_pred             eEEEEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceeeecCCCCCceeeecc
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~--ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ..+++||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++|  |+||||||+|||++             
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-------------  173 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-------------  173 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-------------
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-------------
Confidence            678999999999999999976421 23999999999999999999999999  99999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    .++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       174 --------------~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf  239 (309)
T 3p86_A          174 --------------KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW  239 (309)
T ss_dssp             --------------TTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTT
T ss_pred             --------------CCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                          567899999999986554444455678899999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc--CCcccc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME--NKWISQ  306 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~--hp~~~~  306 (372)
                      ......    .....+.......+  ....+++++.+||.+||+.||.+|||++++++  .++++.
T Consensus       240 ~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          240 GNLNPA----QVVAAVGFKCKRLE--IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             TTSCHH----HHHHHHHHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCCCHH----HHHHHHHhcCCCCC--CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            654322    22222322221111  12368999999999999999999999999988  445443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-47  Score=359.55  Aligned_cols=254  Identities=22%  Similarity=0.365  Sum_probs=206.0

Q ss_pred             CCcccceeeccccccccCCeEEEEEE-----EcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIV-----EKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      .-..++|++ .+.||+|+||.||+|.     +..+++.||||++...      ....+|+.++.++.+||||+++++++.
T Consensus        18 ~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           18 EFPRDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             BCCGGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccceee-ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            345689999 5789999999999999     5667899999999642      245678888777779999999999986


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccC--------------------------------------------------
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKED--------------------------------------------------  109 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~--------------------------------------------------  109 (372)
                      .   .+..+++||||+.+|+|.+++.....                                                  
T Consensus        97 ~---~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           97 K---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             S---TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             c---CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            5   24568999999999999999986532                                                  


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCC
Q psy3151         110 --------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP  175 (372)
Q Consensus       110 --------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~  175 (372)
                                    ..+++..++.++.||+.||+|||++||+||||||+|||++                          
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~--------------------------  227 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS--------------------------  227 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--------------------------
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc--------------------------
Confidence                          1289999999999999999999999999999999999998                          


Q ss_pred             CCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCH
Q psy3151         176 GDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISP  252 (372)
Q Consensus       176 ~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  252 (372)
                       .++.+||+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....   .
T Consensus       228 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~  303 (359)
T 3vhe_A          228 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---E  303 (359)
T ss_dssp             -GGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---H
T ss_pred             -CCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---H
Confidence             566799999999986643222  2344567899999999988889999999999999999998 99999655432   2


Q ss_pred             hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .....+..+... +  ....+++++.++|.+||+.||.+|||++++++|
T Consensus       304 ~~~~~~~~~~~~-~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          304 EFCRRLKEGTRM-R--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHHHHTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            333333333221 1  113689999999999999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.9e-47  Score=358.20  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=203.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEc-------CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEK-------KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      ..++|++ .+.||+|+||+||+|.+.       .++..||||++...      ....+|+.++..+.+||||+++++++.
T Consensus        79 ~~~~~~~-~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           79 PRDKLTL-GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CGGGEEE-EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             cHHHCEe-eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            3578998 588999999999999975       35678999999632      235678888555558999999999987


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKED--------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN  145 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~--------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~N  145 (372)
                      .    ...+|+||||+.+|+|.+++.....              ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus       158 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          158 Q----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             S----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             c----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            5    5679999999999999999986531              348999999999999999999999999999999999


Q ss_pred             eeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCcc
Q psy3151         146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSC  223 (372)
Q Consensus       146 Ili~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~  223 (372)
                      ||++                           .++.+||+|||++........  ......+|+.|+|||++.+..++.++
T Consensus       234 Ill~---------------------------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  286 (370)
T 2psq_A          234 VLVT---------------------------ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS  286 (370)
T ss_dssp             EEEC---------------------------TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHH
T ss_pred             EEEC---------------------------CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHH
Confidence            9998                           567899999999986644322  22334567899999999888999999


Q ss_pred             chhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         224 DIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       224 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||||||++|+|++ |..||.+....    .+...+..+...   .....++.++.+||.+||+.||.+|||+.|++++
T Consensus       287 DvwslG~il~ellt~g~~p~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          287 DVWSFGVLMWEIFTLGGSPYPGIPVE----ELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999 99999765432    233334333221   1123689999999999999999999999999873

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.8e-47  Score=351.50  Aligned_cols=261  Identities=23%  Similarity=0.409  Sum_probs=190.0

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ...++|++ .+.||+|+||+||+|.+..+++.||||++...      ....+|+.. +..++||||+++++++..    .
T Consensus        12 i~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~   85 (303)
T 2vwi_A           12 INRDDYEL-QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQA-MSQCHHPNIVSYYTSFVV----K   85 (303)
T ss_dssp             -CCCCCEE-EEECC---CCCEEEEEC----CEEEEECCC----------------C-CCCCCCTTBCCEEEEEES----S
T ss_pred             cchhhhhh-hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHH-HhhcCCCCEeeEEEEEee----c
Confidence            35689999 47899999999999999999999999988532      223456655 555689999999999875    5


Q ss_pred             eEEEEEEeccCCCchhHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          86 RCLLVIMECMHGGELFQRIQQK------EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~------~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      +..++||||+.+++|.+++...      ..+.+++..++.++.||+.||.|||+.||+||||||+||+++          
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----------  155 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG----------  155 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----------
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc----------
Confidence            6789999999999999998741      235699999999999999999999999999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCC-----CcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHH
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-----ASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~  233 (372)
                                       .++.+||+|||++.......     ......+||+.|+|||++.. ..++.++|||||||++|
T Consensus       156 -----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~  218 (303)
T 2vwi_A          156 -----------------EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI  218 (303)
T ss_dssp             -----------------TTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHH
T ss_pred             -----------------CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHH
Confidence                             56779999999987654321     12234578999999999865 56899999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCHhHHHHHhhCCccC-----CCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDF-----PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       234 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      +|++|..||........   ............     .......++.++.+||.+||+.||.+|||++++++||||++..
T Consensus       219 ~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          219 ELATGAAPYHKYPPMKV---LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             HHHHSSCTTTTSCGGGH---HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             HHHhCCCCCccCchhhH---HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            99999999966543221   111111111110     0112246789999999999999999999999999999998753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.1e-47  Score=365.92  Aligned_cols=273  Identities=25%  Similarity=0.333  Sum_probs=199.6

Q ss_pred             CCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151           7 PFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus         7 ~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      |.-...+.+.|.+ +++||+|+||+||.+ ...+|+.||||++...  ....+|+.++..+.+||||+++++++..    
T Consensus         7 p~~~~~l~~~~~~-~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----   80 (434)
T 2rio_A            7 PNFEQSLKNLVVS-EKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT----   80 (434)
T ss_dssp             -CCSCSCSSCEEE-EEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC----
T ss_pred             cchhhhhhheeec-cCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec----
Confidence            4555667777776 788999999999875 4568999999998643  3457888886667799999999998875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceee
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGA-----FTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~-----l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      +..+|+||||+. |+|.+++.......     .++..++.++.||+.||+|||++||+||||||+|||++.++....   
T Consensus        81 ~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~---  156 (434)
T 2rio_A           81 DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTA---  156 (434)
T ss_dssp             SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHS---
T ss_pred             CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccc---
Confidence            678999999995 69999998643211     133356789999999999999999999999999999984320000   


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCC-------CCCCCccchhhH
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGP-------DKYDKSCDIWSL  228 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~~~~~~~Diwsl  228 (372)
                                 ........+.+||+|||++........    .....+||+.|+|||++.+       ..++.++|||||
T Consensus       157 -----------~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSl  225 (434)
T 2rio_A          157 -----------DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSM  225 (434)
T ss_dssp             -----------CCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHH
T ss_pred             -----------ccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhH
Confidence                       000001456899999999987654322    1234679999999999865       668999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCC---CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         229 GVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPN---PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       229 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ||++|+|++ |..||......      ...+..+....+.   .....+++++.+||.+||+.||.+|||+.++++||||
T Consensus       226 G~il~ellt~g~~Pf~~~~~~------~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          226 GCVFYYILSKGKHPFGDKYSR------ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             HHHHHHHHTTSCCTTCSTTTH------HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHhCCCCCCCCchhh------HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence            999999999 99999543321      1223333333222   1123467899999999999999999999999999999


Q ss_pred             cc
Q psy3151         305 SQ  306 (372)
Q Consensus       305 ~~  306 (372)
                      ..
T Consensus       300 ~~  301 (434)
T 2rio_A          300 WP  301 (434)
T ss_dssp             SC
T ss_pred             CC
Confidence            64

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2e-46  Score=343.42  Aligned_cols=257  Identities=18%  Similarity=0.220  Sum_probs=196.4

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .+.++|++ .+.||+|+||+||+|.+..+++.||||++...   ....+|+.++..+ .|++++..+..+..   .+...
T Consensus         6 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~---~~~~~   80 (296)
T 4hgt_A            6 RVGNRYRL-GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA---EGDYN   80 (296)
T ss_dssp             -----CEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEE---ETTEE
T ss_pred             ccCCceEE-eeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecC---CCCce
Confidence            47799999 58899999999999999999999999987532   3456788875444 55555544444432   26788


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+ +++|.+++.... +.+++..++.++.||+.||.|||++||+||||||+|||++.+.                
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~----------------  142 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK----------------  142 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG----------------
T ss_pred             EEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC----------------
Confidence            9999999 899999997543 4699999999999999999999999999999999999994211                


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                              ..+.+||+|||++........       ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       143 --------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  214 (296)
T 4hgt_A          143 --------KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP  214 (296)
T ss_dssp             --------GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             --------CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence                    466799999999876644322       22356789999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCC-cccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNP-EWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |.+.......... ..+.......+.+ ....+++++.+||.+||+.||++|||++++++
T Consensus       215 f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          215 WQGLKAATKRQKY-ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TSSCCCSSSSSHH-HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             Ccccchhhhhhhh-hhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            9876554433222 2222222222211 11357899999999999999999999999987

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=359.76  Aligned_cols=256  Identities=20%  Similarity=0.328  Sum_probs=205.8

Q ss_pred             cccceeeccccccccCCeEEEEEE-----EcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIV-----EKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..++|++. +.||+|+||+||+|.     +..+++.||||++...      ....+|+.+ +..++||||+++++++.. 
T Consensus        69 ~~~~~~~~-~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~-  145 (367)
T 3l9p_A           69 PRKNITLI-RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI-ISKFNHQNIVRCIGVSLQ-  145 (367)
T ss_dssp             CGGGEEEE-EECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHH-HHHCCCTTBCCEEEEECS-
T ss_pred             CHhHeEEe-eEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHH-HHhCCCCCCCeEEEEEec-
Confidence            45789984 779999999999999     5567889999998532      234567776 566699999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCc
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKED-----GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                         +...|+||||+.+|+|.+++.....     ..+++..++.++.||+.||+|||++||+||||||+|||++.++    
T Consensus       146 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----  218 (367)
T 3l9p_A          146 ---SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG----  218 (367)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS----
T ss_pred             ---CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC----
Confidence               5667999999999999999987532     3599999999999999999999999999999999999998433    


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI  234 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  234 (372)
                                          ....+||+|||+|+......  .......||+.|+|||++.+..++.++|||||||++|+
T Consensus       219 --------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~e  278 (367)
T 3l9p_A          219 --------------------PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE  278 (367)
T ss_dssp             --------------------TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             --------------------CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHH
Confidence                                34569999999997653322  22344567899999999988889999999999999999


Q ss_pred             HHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         235 LLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       235 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      |++ |..||.....    ..+...+..+....+   ...++.++.+||.+||+.||.+|||+++++++.++.
T Consensus       279 llt~g~~pf~~~~~----~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          279 IFSLGYMPYPSKSN----QEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHTTSCCSSTTCCH----HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhCCCCCCCCCCH----HHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            998 9999965442    233444443332211   236899999999999999999999999999988764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.3e-47  Score=351.83  Aligned_cols=257  Identities=23%  Similarity=0.335  Sum_probs=186.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .++|+++ +.||+|+||.||+|.+..+|+.||||++...      ....+|+..+++.++||||+++++++..    ++.
T Consensus        21 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~----~~~   95 (327)
T 3aln_A           21 AEDLKDL-GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR----EGD   95 (327)
T ss_dssp             SCSEEC--CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC----SSE
T ss_pred             HHHhheh-heeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe----CCc
Confidence            4789985 7799999999999999999999999999642      2334566555777899999999999875    678


Q ss_pred             EEEEEeccCCCchhHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          88 LLVIMECMHGGELFQRIQQ---KEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~---~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      .|+||||+.+ +|.+++..   .....+++..++.++.|++.||.|||+. ||+||||||+||+++              
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~--------------  160 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD--------------  160 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE--------------
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc--------------
Confidence            9999999975 88877763   2235699999999999999999999999 999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc----CCCCCCCccchhhHHHHHHHHHhCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL----GPDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                   .++.+||+|||++...... .......||+.|+|||++    .+..++.++|||||||++|+|++|.
T Consensus       161 -------------~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~  226 (327)
T 3aln_A          161 -------------RSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR  226 (327)
T ss_dssp             -------------TTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSC
T ss_pred             -------------CCCCEEEccCCCceecccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCC
Confidence                         5678999999999766432 223344789999999998    4567899999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhC-CccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLG-QFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      .||........   ....+..+ ...++......+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       227 ~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          227 FPYPKWNSVFD---QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCSSCC----------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCCcchHHH---HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            99965432110   01111111 1122223334689999999999999999999999999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.3e-46  Score=340.76  Aligned_cols=257  Identities=18%  Similarity=0.213  Sum_probs=200.5

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc---hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .+.++|++ .+.||+|+||+||+|.+..+|+.||||++..   .....+|+.++ +.+.|++++..+..+..   .+...
T Consensus         6 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l-~~l~~~~~i~~~~~~~~---~~~~~   80 (296)
T 3uzp_A            6 RVGNRYRL-GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIY-KMMQGGVGIPTIRWCGA---EGDYN   80 (296)
T ss_dssp             EETTTEEE-EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHH-HHHTTSTTCCCEEEEEE---ETTEE
T ss_pred             eeccEEEE-EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHH-HHhhcCCCCCccccccC---CCCce
Confidence            46789999 5889999999999999999999999999863   23566788874 44456555444444432   26678


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+ +++|.+++.... +.+++..++.++.||+.||+|||++||+||||||+|||++.+.                
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~----------------  142 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK----------------  142 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG----------------
T ss_pred             EEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCC----------------
Confidence            9999999 899999997543 4699999999999999999999999999999999999995221                


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                              .++.+||+|||++........       .....+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       143 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  214 (296)
T 3uzp_A          143 --------KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP  214 (296)
T ss_dssp             --------GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             --------CCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                    456789999998876644322       12456789999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |.+......... ...+.......+. .....+++++.+||.+||+.||.+|||++++++
T Consensus       215 f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          215 WQGLKAATKRQK-YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TSSCCCSSSSSH-HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CCCcCchhhhhh-hhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            977544333222 2222222222221 111367899999999999999999999999977

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-46  Score=349.92  Aligned_cols=262  Identities=21%  Similarity=0.325  Sum_probs=186.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCc---EEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSE---VYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ..++|++ .+.||+|+||+||+|.+..++.   .||||++...       ....+|+.+ ++.++||||+++++++....
T Consensus        21 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           21 PEQQFTL-GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC-MKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             C---CEE-EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHH-HTTCCCTTBCCCCEEEECC-
T ss_pred             ChhHeEE-eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHH-HHHCCCCceehhhceeeccc
Confidence            5678998 5889999999999999987775   8999998632       245577777 56669999999999987521


Q ss_pred             CC--ceEEEEEEeccCCCchhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCc
Q psy3151          83 NG--SRCLLVIMECMHGGELFQRIQQKED----GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        83 ~~--~~~~~lv~e~~~~g~L~~~i~~~~~----~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                      ..  ....++||||+.+|+|.+++.....    ..+++..++.++.||+.||+|||++||+||||||+|||++       
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~-------  171 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA-------  171 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-------
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc-------
Confidence            11  1124899999999999999975431    1499999999999999999999999999999999999998       


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI  234 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  234 (372)
                                          .++.+||+|||++........  ......+|+.|+|||++.+..++.++|||||||++|+
T Consensus       172 --------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  231 (323)
T 3qup_A          172 --------------------EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWE  231 (323)
T ss_dssp             --------------------TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             --------------------CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHH
Confidence                                567899999999976543222  1223445778999999988889999999999999999


Q ss_pred             HHh-CCCCCCCCCCCCCCHhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCC-------hhHHhcCCccc
Q psy3151         235 LLC-GFPPFFSNHGQAISPGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-------IDQVMENKWIS  305 (372)
Q Consensus       235 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-------~~eil~hp~~~  305 (372)
                      |++ |..||.+....+    ....+..+. ...+    ..+++++.+||.+||+.||.+|||       +++++.|||+.
T Consensus       232 ll~~g~~p~~~~~~~~----~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~  303 (323)
T 3qup_A          232 IMTRGQTPYAGIENAE----IYNYLIGGNRLKQP----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL  303 (323)
T ss_dssp             HHTTSCCTTTTCCGGG----HHHHHHTTCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred             HHhCCCCCccccChHH----HHHHHhcCCCCCCC----CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence            999 999997654332    233333322 2222    368999999999999999999999       77788999998


Q ss_pred             cCCCCC
Q psy3151         306 QFNQVP  311 (372)
Q Consensus       306 ~~~~~~  311 (372)
                      ...+.|
T Consensus       304 ~~~~~p  309 (323)
T 3qup_A          304 STSQDP  309 (323)
T ss_dssp             ------
T ss_pred             CCCCCC
Confidence            765544

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=346.47  Aligned_cols=249  Identities=27%  Similarity=0.508  Sum_probs=198.3

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----------hhhHHHHHHHHHhc---CCCCEeEEeE
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------VKARREVELQLAVG---SHKHIVNIKD   76 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~---~h~ni~~~~~   76 (372)
                      ..+.++|++ .+.||+|+||.||+|.+..+|+.||||++...           ....+|+..+.++.   +||||+++++
T Consensus        27 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           27 EAFEAEYRL-GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             ------CEE-EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhceEE-eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            447899999 58899999999999999999999999998532           22346777754443   8999999999


Q ss_pred             eeeeecCCceEEEEEEec-cCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCC
Q psy3151          77 VYENIYNGSRCLLVIMEC-MHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGG  155 (372)
Q Consensus        77 ~~~~~~~~~~~~~lv~e~-~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~  155 (372)
                      ++..    .+..++|||+ +.+++|.+++...  +.+++..++.++.||+.||+|||+.||+||||||+||+++.     
T Consensus       106 ~~~~----~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-----  174 (312)
T 2iwi_A          106 WFET----QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-----  174 (312)
T ss_dssp             EC---------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET-----
T ss_pred             EEec----CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC-----
Confidence            9875    5678999999 7899999999875  35999999999999999999999999999999999999972     


Q ss_pred             ceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCC-CccchhhHHHHHHH
Q psy3151         156 ILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYD-KSCDIWSLGVIMYI  234 (372)
Q Consensus       156 ~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~  234 (372)
                                           .++.+||+|||++......  ......||+.|+|||++.+..+. .++|||||||++|+
T Consensus       175 ---------------------~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~  231 (312)
T 2iwi_A          175 ---------------------RRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYD  231 (312)
T ss_dssp             ---------------------TTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred             ---------------------CCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHH
Confidence                                 4567999999998876432  23456789999999998766654 58999999999999


Q ss_pred             HHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       235 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      |++|..||...          ..+......++    ..++.++.+||.+||+.||++|||++++++||||+...
T Consensus       232 l~~g~~pf~~~----------~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          232 MVCGDIPFERD----------QEILEAELHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHSSCSCCSH----------HHHHHTCCCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             HHHCCCCCCCh----------HHHhhhccCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            99999999532          12222333333    36899999999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=350.27  Aligned_cols=247  Identities=20%  Similarity=0.371  Sum_probs=199.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCc---EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSE---VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ..++|++ .+.||+|+||+||+|.+..+|+   .||||++...      ....+|+.+ ++.++||||+++++++..   
T Consensus        47 ~~~~y~i-~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~---  121 (325)
T 3kul_A           47 EASRIHI-EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI-MGQFDHPNIIRLEGVVTR---  121 (325)
T ss_dssp             CGGGEEE-EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHH-HTTCCCTTBCCEEEEECG---
T ss_pred             ChhHeEE-eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHH-HHhCCCCCCCcEEEEEEe---
Confidence            5678998 5889999999999999986665   4999999642      234567777 666799999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       +...|+||||+++++|.+++.... +.+++..++.++.||+.||+|||+.||+||||||+|||++              
T Consensus       122 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--------------  185 (325)
T 3kul_A          122 -GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD--------------  185 (325)
T ss_dssp             -GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred             -CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC--------------
Confidence             677899999999999999997653 4699999999999999999999999999999999999997              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF  239 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  239 (372)
                                   .++.+||+|||++.........   .....+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       186 -------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~  252 (325)
T 3kul_A          186 -------------SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE  252 (325)
T ss_dssp             -------------TTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             -------------CCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence                         5678999999999876443222   222345778999999988889999999999999999999 99


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .||.+....    .....+..+. ..+  ....+++++.+||.+||..||.+|||+.++++
T Consensus       253 ~p~~~~~~~----~~~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          253 RPYWNMTNR----DVISSVEEGY-RLP--APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CTTTTSCHH----HHHHHHHTTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccCCHH----HHHHHHHcCC-CCC--CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999654432    2333333321 111  22478999999999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=344.45  Aligned_cols=256  Identities=23%  Similarity=0.391  Sum_probs=189.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      -.++|+++ +.||+|+||.||+|.+..+|+.||||++...      .....|...+++..+||||+++++++..    +.
T Consensus        23 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~   97 (318)
T 2dyl_A           23 EINDLENL-GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT----NT   97 (318)
T ss_dssp             CGGGEEEE-EEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SS
T ss_pred             hhcccccc-ceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CC
Confidence            45789985 7799999999999999999999999999642      1233455555778899999999999876    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..|+||||+ ++.+..+.... .+.+++..++.++.||+.||.|||++ ||+||||||+||+++                
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~----------------  159 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----------------  159 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC----------------
T ss_pred             cEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC----------------
Confidence            899999999 55555555433 35699999999999999999999996 999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                 .++.+||+|||++...... .......||+.|+|||++.     ...++.++|||||||++|+|++|..
T Consensus       160 -----------~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  227 (318)
T 2dyl_A          160 -----------ERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF  227 (318)
T ss_dssp             -----------TTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred             -----------CCCCEEEEECCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence                       5677999999998765432 2234457899999999984     5668899999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ||.....   .......+....... .+....+++++.+||.+||+.||.+|||++++++||||++.
T Consensus       228 pf~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          228 PYKNCKT---DFEVLTKVLQEEPPL-LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             TTTTCCS---HHHHHHHHHHSCCCC-CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCCCCCc---cHHHHHHHhccCCCC-CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            9965322   122233333332221 12234689999999999999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=359.55  Aligned_cols=262  Identities=25%  Similarity=0.421  Sum_probs=208.1

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..+.++|.+ .+.||+|+||+||+|.+..+|+.||||++...      ....+|+.+ ++.++||||+++++++..  .+
T Consensus         5 ~~~~~~y~i-~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~--~~   80 (396)
T 4eut_A            5 STSNHLWLL-SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV-LKKLNHKNIVKLFAIEEE--TT   80 (396)
T ss_dssp             ECSSEEEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHH-HHHCCCTTBCCEEEEEEC--TT
T ss_pred             CCCCCceEE-EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHH-HHhcCCCCCCeEEEeecc--CC
Confidence            346789999 58899999999999999999999999998632      234578877 666799999999999864  23


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ....|+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+....+          
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~----------  150 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED----------  150 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTT----------
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCC----------
Confidence            4578999999999999999976432 23999999999999999999999999999999999999843222          


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC--------CCCCCccchhhHHHHHHHH
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP--------DKYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l  235 (372)
                                   ..+.+||+|||++...... ......+||+.|+|||++.+        ..++.++|||||||++|+|
T Consensus       151 -------------~~~~~kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el  216 (396)
T 4eut_A          151 -------------GQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA  216 (396)
T ss_dssp             -------------SCEEEEECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred             -------------CceeEEEecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence                         5567999999999876442 23345678999999998754        4577899999999999999


Q ss_pred             HhCCCCCCCCCCCCCCHhHHHHHhhCCcc---------------------CCCCcccccCHHHHHHHHHhccCCCCCCCC
Q psy3151         236 LCGFPPFFSNHGQAISPGMKNRIRLGQFD---------------------FPNPEWEHVSQEAKTLIKNMLCVDPSERLT  294 (372)
Q Consensus       236 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~s~~~~~li~~ll~~dP~~R~s  294 (372)
                      ++|..||...............+..+...                     .+......++..+.+||.+||+.||++|||
T Consensus       217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s  296 (396)
T 4eut_A          217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG  296 (396)
T ss_dssp             HHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred             HHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc
Confidence            99999997665544444554444443321                     111111345678899999999999999999


Q ss_pred             hhHHhc
Q psy3151         295 IDQVME  300 (372)
Q Consensus       295 ~~eil~  300 (372)
                      ++++++
T Consensus       297 ~~e~l~  302 (396)
T 4eut_A          297 FDQFFA  302 (396)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999865

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-46  Score=349.73  Aligned_cols=253  Identities=21%  Similarity=0.227  Sum_probs=196.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|++ .+.||+|+||+||+|.+.  ++.||||++....    ...+|+.. +..++||||+++++++.........+|
T Consensus        23 ~~~y~~-~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           23 SMPLQL-LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYS-LPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TEEEEE-EEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHT-STTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             hhhchh-hheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHH-HhcCCCCCchhhcceeccCCCCCceEE
Confidence            478998 478999999999999875  8999999996432    22345544 556789999999999986444456789


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCceeeecCCCCCceee
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ----------NIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~----------~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      +||||+++|+|.+++...   .+++..++.++.||+.||+|||+.          ||+||||||+|||++          
T Consensus        99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~----------  165 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK----------  165 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC----------
T ss_pred             EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC----------
Confidence            999999999999999764   499999999999999999999999          999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCC-----CCCCccchhhHHHHH
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPD-----KYDKSCDIWSLGVIM  232 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il  232 (372)
                                       .++.+||+|||++........  .....+||+.|+|||++.+.     .++.++|||||||++
T Consensus       166 -----------------~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il  228 (322)
T 3soc_A          166 -----------------NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL  228 (322)
T ss_dssp             -----------------TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred             -----------------CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHH
Confidence                             567899999999977644322  23346789999999998763     455688999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCH------------hHHHHHhhCCccCCCCc-c--cccCHHHHHHHHHhccCCCCCCCChhH
Q psy3151         233 YILLCGFPPFFSNHGQAISP------------GMKNRIRLGQFDFPNPE-W--EHVSQEAKTLIKNMLCVDPSERLTIDQ  297 (372)
Q Consensus       233 ~~ll~g~~pf~~~~~~~~~~------------~~~~~~~~~~~~~~~~~-~--~~~s~~~~~li~~ll~~dP~~R~s~~e  297 (372)
                      |+|++|..||.+........            .+.............+. +  ...++++.+||.+||+.||++|||+++
T Consensus       229 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (322)
T 3soc_A          229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC  308 (322)
T ss_dssp             HHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHH
Confidence            99999999997754432211            11111211111111111 1  123466999999999999999999999


Q ss_pred             Hhc
Q psy3151         298 VME  300 (372)
Q Consensus       298 il~  300 (372)
                      +++
T Consensus       309 ll~  311 (322)
T 3soc_A          309 VGE  311 (322)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=360.88  Aligned_cols=257  Identities=24%  Similarity=0.355  Sum_probs=194.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      .+|.+ .++||+|+||+|+. ....+|+.||||++...  ....+|+.++..+.+||||+++++++.+    ....|+||
T Consensus        24 ~~y~~-~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~----~~~~~lv~   97 (432)
T 3p23_A           24 ISFCP-KDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD----RQFQYIAI   97 (432)
T ss_dssp             EEEEE-EEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE----TTEEEEEE
T ss_pred             EEEec-CCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec----CCEEEEEE
Confidence            46887 58899999999763 44568999999998643  3467888886666689999999999876    67899999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      ||+. |+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++..                  
T Consensus        98 E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~------------------  157 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAH------------------  157 (432)
T ss_dssp             ECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTT------------------
T ss_pred             ECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCC------------------
Confidence            9995 69999998654 346667788999999999999999999999999999999743211                  


Q ss_pred             CCCCCCCCeeeeccccccccccCC---CcccccccCCCcCCCcccC---CCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNK---ASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILLC-GFPPFFSN  245 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  245 (372)
                          ....+||+|||+|.......   ......+||+.|+|||++.   ...++.++|||||||++|+|++ |..||...
T Consensus       158 ----~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~  233 (432)
T 3p23_A          158 ----GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS  233 (432)
T ss_dssp             ----TBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred             ----CceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence                23457899999998764332   2234567999999999987   4567889999999999999999 99998543


Q ss_pred             CCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ..    ....  ........+. ......+..+.+||.+||+.||.+|||++++++||||...
T Consensus       234 ~~----~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          234 LQ----RQAN--ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             TT----HHHH--HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             hH----HHHH--HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            21    1111  1122211111 1112456778999999999999999999999999999753

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.2e-46  Score=352.91  Aligned_cols=260  Identities=15%  Similarity=0.150  Sum_probs=197.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCC-----CcEEEEEEecchh-hhHHHHHHH--------------HHhcCCCCEe
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKT-----SEVYALKVLHDTV-KARREVELQ--------------LAVGSHKHIV   72 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-~~~~e~~~~--------------~~~~~h~ni~   72 (372)
                      ..++|++ .+.||+|+||+||+|.+..+     ++.||||++.... ...+|+..+              +..++||||+
T Consensus        33 ~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           33 AAAAWKV-GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TCCEEEE-EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCCeEEE-EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3459999 57899999999999999765     5889999986432 233333332              3445699999


Q ss_pred             EEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCC
Q psy3151          73 NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~  152 (372)
                      ++++++.....+..+.|+||||+ +++|.+++.... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-  188 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-  188 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-
Confidence            99999986555567899999999 999999998753 569999999999999999999999999999999999999831 


Q ss_pred             CCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCCccch
Q psy3151         153 DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDKSCDI  225 (372)
Q Consensus       153 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di  225 (372)
                                              ..+.+||+|||+|+.......       .....+||+.|+|||++.+..++.++||
T Consensus       189 ------------------------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  244 (364)
T 3op5_A          189 ------------------------NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDL  244 (364)
T ss_dssp             ------------------------CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHH
T ss_pred             ------------------------CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhH
Confidence                                    356799999999976543221       1234568999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCCCCCCHh-HHHHHhhCCccC--CCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         226 WSLGVIMYILLCGFPPFFSNHGQAISPG-MKNRIRLGQFDF--PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       226 wslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |||||++|+|++|..||.+......... ...........+  +......++.++.+||..||..||.+|||++++++
T Consensus       245 ~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          245 EILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            9999999999999999975432211110 000000000000  00001357899999999999999999999999876

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.4e-46  Score=337.00  Aligned_cols=246  Identities=19%  Similarity=0.365  Sum_probs=202.0

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|+++ +.||+|+||+||+|.+. +++.||+|++...    ....+|+.+ ++.++||||+++++++..    +...|
T Consensus         9 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~~~~~   81 (269)
T 4hcu_A            9 PSELTFV-QEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEV-MMKLSHPKLVQLYGVCLE----QAPIC   81 (269)
T ss_dssp             GGGEEEE-EEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHH-HHTCCCTTBCCEEEEECS----SSSEE
T ss_pred             hhhceee-heecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHH-HHhCCCCCEeeEEEEEec----CCceE
Confidence            4789995 77999999999999986 5778999999642    345678877 677799999999999875    56789


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+++++|.+++.... +.+++..++.++.|++.||+|||+.||+||||||+||+++                    
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~--------------------  140 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG--------------------  140 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--------------------
T ss_pred             EEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc--------------------
Confidence            9999999999999997654 5699999999999999999999999999999999999997                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                             .++.+||+|||++....... .......+|+.|+|||++.+..++.++|+|||||++|+|++ |..||.....
T Consensus       141 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~  213 (269)
T 4hcu_A          141 -------ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN  213 (269)
T ss_dssp             -------GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             -------CCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence                   55679999999998654321 12233456778999999988889999999999999999999 9999965432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                          ......+..+....   ....+++++.+++.+||+.||++|||++++++|
T Consensus       214 ----~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          214 ----SEVVEDISTGFRLY---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ----HHHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----HHHHHHHhcCccCC---CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                22333343332211   123679999999999999999999999999885

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.8e-46  Score=338.84  Aligned_cols=253  Identities=24%  Similarity=0.433  Sum_probs=210.0

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--------
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-VKARREVELQLAVGSHKHIVNIKDVYENIY--------   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--------   82 (372)
                      .+.++|+++ +.||+|+||.||+|.+..+|+.||+|++... ....+|+.+ ++.++||||+++++++....        
T Consensus         8 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B            8 RFGMDFKEI-ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKA-LAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHHHEEEE-EEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHH-HHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             hhcccccee-eeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHH-HHhCCCCCEEEEeeeEeccccCcccccc
Confidence            367889995 7899999999999999999999999999743 456778877 66679999999999886411        


Q ss_pred             ----CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          83 ----NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        83 ----~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                          .....+|+||||+.+++|.+++.......+++..++.++.||+.||.|||+.||+||||||+||+++         
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---------  156 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---------  156 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---------
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---------
Confidence                1256689999999999999999876556799999999999999999999999999999999999998         


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                        .++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       157 ------------------~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~  217 (284)
T 2a19_B          157 ------------------DTKQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV  217 (284)
T ss_dssp             ------------------ETTEEEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred             ------------------CCCCEEECcchhheecccc-ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhc
Confidence                              5667999999998876442 233455789999999999888899999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      ..||...      ......+..+.+  +    ..++.++.+||.+||..||.+|||+.++++|.+.-.
T Consensus       218 ~~~~~~~------~~~~~~~~~~~~--~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          218 CDTAFET------SKFFTDLRDGII--S----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             CSSHHHH------HHHHHHHHTTCC--C----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             CCcchhH------HHHHHHhhcccc--c----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            9887421      112222222222  1    357899999999999999999999999999987643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-45  Score=337.33  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=199.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------------hhhHHHHHHHHHhcCCCCEeEEeEeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------------VKARREVELQLAVGSHKHIVNIKDVYEN   80 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~e~~~~~~~~~h~ni~~~~~~~~~   80 (372)
                      ..++|++ .+.||+|+||+||+|.+..+++.||||++...            ....+|+.+ ++.++||||+++++++..
T Consensus        17 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           17 ADNEIEY-EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI-MSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             CSTTEEE-EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHH-HTTCCCTTBCCEEEEETT
T ss_pred             hhcccee-hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHH-HHhCCCCCchhhheeecC
Confidence            5689999 57899999999999999999999999998421            334567777 566799999999999864


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceeeecCCCCCcee
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~--ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                          ..  ++||||+.+++|.+.+.... ..+++..++.++.|++.||+|||+.|  |+||||||+||+++.+++.    
T Consensus        95 ----~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~----  163 (287)
T 4f0f_A           95 ----PP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDEN----  163 (287)
T ss_dssp             ----TT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTT----
T ss_pred             ----CC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCC----
Confidence                22  68999999999999887654 46999999999999999999999999  9999999999999843320    


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc--CCCCCCCccchhhHHHHHHHHH
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL--GPDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll  236 (372)
                                        ....+||+|||++.....   ......||+.|+|||++  ....++.++|||||||++|+|+
T Consensus       164 ------------------~~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~  222 (287)
T 4f0f_A          164 ------------------APVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL  222 (287)
T ss_dssp             ------------------CSCCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred             ------------------CceeEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence                              233489999999875432   34456789999999998  4456789999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +|..||........  .....+......  ......+++++.+||.+||+.||.+|||++++++
T Consensus       223 ~g~~pf~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          223 TGEGPFDEYSYGKI--KFINMIREEGLR--PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HSSCTTTTCCCCHH--HHHHHHHHSCCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCccccccHH--HHHHHHhccCCC--CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999965543321  112222222222  2223478999999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=350.91  Aligned_cols=250  Identities=22%  Similarity=0.373  Sum_probs=204.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCC-------CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKT-------SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      ..++|.+ .+.||+|+||+||+|.+..+       +..||||++...      ....+|++++.++.+||||+++++++.
T Consensus        67 ~~~~y~i-~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           67 PRDRLVL-GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             chhheEe-eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            4689998 57899999999999997643       367999999642      345678888666669999999999987


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN  145 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~N  145 (372)
                      .    ++..|+||||+.+|+|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus       146 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          146 Q----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             S----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             c----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            5    567899999999999999998753              1359999999999999999999999999999999999


Q ss_pred             eeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCCCCCcc
Q psy3151         146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDKYDKSC  223 (372)
Q Consensus       146 Ili~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  223 (372)
                      ||++                           .++.+||+|||+|.......  .......+|+.|+|||++.+..++.++
T Consensus       222 Ill~---------------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  274 (382)
T 3tt0_A          222 VLVT---------------------------EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS  274 (382)
T ss_dssp             EEEC---------------------------TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHH
T ss_pred             EEEc---------------------------CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchh
Confidence            9998                           56779999999998664322  223344568889999999888999999


Q ss_pred             chhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         224 DIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       224 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||||||++|+|++ |..||.+...    ..+...+..+....   ....+++++.+||.+||+.||++|||+++++++
T Consensus       275 DiwslG~il~ellt~g~~p~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          275 DVWSFGVLLWEIFTLGGSPYPGVPV----EELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999 9999965432    23333443332211   124689999999999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.7e-45  Score=339.92  Aligned_cols=253  Identities=24%  Similarity=0.438  Sum_probs=194.3

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ....++|++ .+.||+|+||.||+|.+..+|+.||||++...        ....+|+.. ++.++||||+++++++..  
T Consensus        28 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~--  103 (310)
T 2wqm_A           28 YNTLANFRI-EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDL-LKQLNHPNVIKYYASFIE--  103 (310)
T ss_dssp             TSSGGGEEE-EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHH-HHTCCCTTBCCEEEEEEE--
T ss_pred             cccccceEE-EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEEc--
Confidence            346689999 47899999999999999999999999998631        234567776 677799999999999876  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                        ++..++||||+.+++|.+++...  ....+++..++.++.||+.||.|||+.||+||||||+||+++           
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~-----------  170 (310)
T 2wqm_A          104 --DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-----------  170 (310)
T ss_dssp             --TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-----------
T ss_pred             --CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc-----------
Confidence              66899999999999999998752  235699999999999999999999999999999999999998           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                      .++.+||+|||++..............||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus       171 ----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~  234 (310)
T 2wqm_A          171 ----------------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS  234 (310)
T ss_dssp             ----------------TTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ----------------CCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence                            5677999999998876544444455678999999999998899999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||.+....  .......+....+  +......++.++.+||.+||..||.+|||+.++++
T Consensus       235 p~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          235 PFYGDKMN--LYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             TTC---CC--HHHHHHHHHTTCS--CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccchh--HHHHHHHhhcccC--CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99654322  1223333333332  22223468999999999999999999999999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.9e-46  Score=334.37  Aligned_cols=247  Identities=19%  Similarity=0.316  Sum_probs=201.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      -.++|+++ +.||+|+||+||+|.+. ++..||+|++...    ....+|+.. ++.++||||+++++++..    +...
T Consensus         6 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~~~~   78 (268)
T 3sxs_A            6 KREEITLL-KELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQT-MMKLSHPKLVKFYGVCSK----EYPI   78 (268)
T ss_dssp             CGGGEEEE-EEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHH-HHHCCCTTBCCEEEEECS----SSSE
T ss_pred             chhheeee-eeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHH-HHhCCCCCEeeEEEEEcc----CCce
Confidence            45889995 77999999999999876 6778999999643    345678877 566689999999999865    6679


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+||+++                   
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~-------------------  138 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD-------------------  138 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC-------------------
T ss_pred             EEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC-------------------
Confidence            99999999999999998753 3599999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  246 (372)
                              .++.++|+|||++........ ......+|+.|+|||++.+..++.++|+|||||++|+|++ |..||....
T Consensus       139 --------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (268)
T 3sxs_A          139 --------RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT  210 (268)
T ss_dssp             --------TTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             --------CCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence                    567899999999986543322 2223445678999999988889999999999999999999 999996543


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ..    .....+..+.....+   ..+++++.++|.+||+.||.+|||+++++++
T Consensus       211 ~~----~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          211 NS----EVVLKVSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HH----HHHHHHHTTCCCCCC---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hH----HHHHHHHcCCCCCCC---CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22    223333333222221   3578999999999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-46  Score=347.21  Aligned_cols=252  Identities=23%  Similarity=0.393  Sum_probs=203.3

Q ss_pred             cccceeeccccccccCCeEEEEEEE-----cCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVE-----KKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..++|++ .+.||+|+||+||+|.+     ..++..||||++...      ....+|+.++.++.+||||+++++++.. 
T Consensus        43 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  120 (344)
T 1rjb_A           43 PRENLEF-GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-  120 (344)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CHHHcee-eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence            3578998 58899999999999997     346778999998632      3456788886556599999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKED---------------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRD  140 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~---------------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrD  140 (372)
                         +...|+||||+++|+|.+++.....                     ..+++..++.++.||+.||+|||+.||+|||
T Consensus       121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  197 (344)
T 1rjb_A          121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  197 (344)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence               5678999999999999999986532                     2379999999999999999999999999999


Q ss_pred             CCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCC
Q psy3151         141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDK  218 (372)
Q Consensus       141 lkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~  218 (372)
                      |||+|||++                           .++.+||+|||++........  ......||+.|+|||++.+..
T Consensus       198 ikp~NIll~---------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  250 (344)
T 1rjb_A          198 LAARNVLVT---------------------------HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI  250 (344)
T ss_dssp             CSGGGEEEE---------------------------TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred             CChhhEEEc---------------------------CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC
Confidence            999999998                           567899999999986644322  223455688999999998888


Q ss_pred             CCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhH
Q psy3151         219 YDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQ  297 (372)
Q Consensus       219 ~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~e  297 (372)
                      ++.++|||||||++|+|++ |..||.+....   ......+..+ ...+.  ...+++++.+||.+||..||.+|||+.+
T Consensus       251 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~  324 (344)
T 1rjb_A          251 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVD---ANFYKLIQNG-FKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPN  324 (344)
T ss_dssp             CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---HHHHHHHHTT-CCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CChhHhHHHHHHHHHHHHcCCCCCcccCCcH---HHHHHHHhcC-CCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            9999999999999999998 99999665432   2222333222 22221  2367999999999999999999999999


Q ss_pred             HhcCC
Q psy3151         298 VMENK  302 (372)
Q Consensus       298 il~hp  302 (372)
                      +++|.
T Consensus       325 l~~~l  329 (344)
T 1rjb_A          325 LTSFL  329 (344)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99854

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.3e-46  Score=339.06  Aligned_cols=249  Identities=21%  Similarity=0.361  Sum_probs=207.0

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      -..++|++ .+.||+|+||+||+|.+..+++.||+|++...    ....+|+.+ ++.++||||+++++++..    +..
T Consensus        10 ~~~~~~~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~~~   83 (288)
T 3kfa_A           10 MERTDITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV-MKEIKHPNLVQLLGVCTR----EPP   83 (288)
T ss_dssp             CCGGGEEE-EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHH-HHHCCCTTBCCEEEEECS----SSS
T ss_pred             ccccceeE-EeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEcc----CCC
Confidence            35789999 47899999999999999999999999999643    345577777 677799999999999875    667


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|+||||+.+++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++                  
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~------------------  145 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG------------------  145 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC------------------
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc------------------
Confidence            89999999999999999886666799999999999999999999999999999999999997                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSN  245 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  245 (372)
                               .++.++|+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       146 ---------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~  216 (288)
T 3kfa_A          146 ---------ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  216 (288)
T ss_dssp             ---------GGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ---------CCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                     566799999999987654332 2233456788999999988889999999999999999999 99999665


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +...    ....+... ...  .....+++++.+||.+||..||.+|||++++++
T Consensus       217 ~~~~----~~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          217 DLSQ----VYELLEKD-YRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CGGG----HHHHHHTT-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHH----HHHHHhcc-CCC--CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            4322    23333322 111  122468999999999999999999999999977

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=350.20  Aligned_cols=254  Identities=16%  Similarity=0.224  Sum_probs=200.8

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCC--------CcEEEEEEecchhhhHHHHHHHHHhcCCCCEeE------------
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKT--------SEVYALKVLHDTVKARREVELQLAVGSHKHIVN------------   73 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~------------   73 (372)
                      .++|++ .+.||+|+||+||+|.+..+        ++.||||++.......+|+.+ ++.++||||++            
T Consensus        41 ~~~y~~-~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           41 GRQWKL-KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF-FQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             SCEEEE-EEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHH-HHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             CCeEEE-EEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHH-HHHhcccchhhhhhhhccCCccC
Confidence            479999 57899999999999999874        899999999877788899988 55558999887            


Q ss_pred             ---EeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeec
Q psy3151          74 ---IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTK  150 (372)
Q Consensus        74 ---~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~  150 (372)
                         +++++..   .+...|+||||+ +++|.+++.....+.+++..++.++.||+.||.|||++||+||||||+|||++ 
T Consensus       119 i~~~~~~~~~---~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~-  193 (352)
T 2jii_A          119 IPTCMGFGVH---QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD-  193 (352)
T ss_dssp             CCCCCEEEEE---TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE-
T ss_pred             ccchhhcccc---CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc-
Confidence               4444432   357899999999 99999999876445699999999999999999999999999999999999998 


Q ss_pred             CCCCCceeeeccCCCCccccccCCCCCCC--CeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCC
Q psy3151         151 PGDGGILKLTDFGDVKPENLLYTKPGDGG--ILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDK  221 (372)
Q Consensus       151 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~--~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~  221 (372)
                                                .++  .+||+|||++........       ......||+.|+|||++.+..++.
T Consensus       194 --------------------------~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  247 (352)
T 2jii_A          194 --------------------------PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR  247 (352)
T ss_dssp             --------------------------TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH
T ss_pred             --------------------------CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc
Confidence                                      344  799999999976543221       123457899999999999989999


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCCCCCC-CCHhHHHHHhhCC--ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         222 SCDIWSLGVIMYILLCGFPPFFSNHGQA-ISPGMKNRIRLGQ--FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       222 ~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      ++|||||||++|+|++|..||....... .............  +......+..+++++.+||.+||+.||++|||++++
T Consensus       248 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  327 (352)
T 2jii_A          248 RSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAML  327 (352)
T ss_dssp             HHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             hhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence            9999999999999999999997653211 1111111111111  111222345679999999999999999999999999


Q ss_pred             hc
Q psy3151         299 ME  300 (372)
Q Consensus       299 l~  300 (372)
                      ++
T Consensus       328 ~~  329 (352)
T 2jii_A          328 RN  329 (352)
T ss_dssp             HH
T ss_pred             HH
Confidence            77

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7e-46  Score=344.41  Aligned_cols=261  Identities=20%  Similarity=0.305  Sum_probs=205.3

Q ss_pred             CccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151           8 FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus         8 ~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .......++|++ .+.||+|+||+||+|.+. +|+.||||++...     ....+|+.+ ++.++||||+++++++..  
T Consensus        32 ~~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~--  106 (321)
T 2qkw_B           32 VDLEEATNNFDH-KFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIET-LSFCRHPHLVSLIGFCDE--  106 (321)
T ss_dssp             SCCCCCCCCCSC-CCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHG-GGSCCCTTBCCEEEECCC--
T ss_pred             HHHHHHHhccCc-cceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHH-HHhCCCCCEeeEEEEEcC--
Confidence            334457799998 588999999999999974 7999999988632     234567776 667799999999999875  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKED--GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~--~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                        ++..|+||||+.+|+|.+++.....  ..+++..++.++.||+.||+|||++||+||||||+||+++           
T Consensus       107 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~-----------  173 (321)
T 2qkw_B          107 --RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD-----------  173 (321)
T ss_dssp             --TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC-----------
T ss_pred             --CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC-----------
Confidence              5678999999999999999865432  3599999999999999999999999999999999999998           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                      .++.+||+|||++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       174 ----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g  237 (321)
T 2qkw_B          174 ----------------ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA  237 (321)
T ss_dssp             ----------------TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHC
T ss_pred             ----------------CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhC
Confidence                            56789999999987653322  123345689999999999888899999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHH---HHHhhCCcc------CCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         239 FPPFFSNHGQAISPGMK---NRIRLGQFD------FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~---~~~~~~~~~------~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      ..||......+......   .....+.+.      .........+.++.+++.+||+.||++|||+.+++++.
T Consensus       238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            99997665444322111   111111111      11111234567899999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.2e-45  Score=338.31  Aligned_cols=249  Identities=26%  Similarity=0.396  Sum_probs=191.4

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ...++|++ .+.||+|+||.||+|.+..+++.||||++...        ....+|+.. +..++||||+++++++..   
T Consensus        31 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~hp~iv~~~~~~~~---  105 (309)
T 2h34_A           31 TQFGPYRL-RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREART-AGRLQEPHVVPIHDFGEI---  105 (309)
T ss_dssp             ---CCEEE-EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHH-HTTCCCTTBCCEEEEEEE---
T ss_pred             cEeccEEE-EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHH-HhhcCCCCeeEEEEEEee---
Confidence            35689999 47899999999999999999999999998643        234467766 667799999999999876   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ++..|+||||+++++|.+++...  +.+++..++.++.||+.||.|||+.||+||||||+||+++              
T Consensus       106 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~--------------  168 (309)
T 2h34_A          106 -DGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS--------------  168 (309)
T ss_dssp             -TTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--------------
T ss_pred             -CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc--------------
Confidence             67899999999999999999875  3599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       169 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  235 (309)
T 2h34_A          169 -------------ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPY  235 (309)
T ss_dssp             -------------TTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSS
T ss_pred             -------------CCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCC
Confidence                         56779999999987654322 2233557899999999999899999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-ChhHHhc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-TIDQVME  300 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-s~~eil~  300 (372)
                      .....    ..+...+ ......+......+++++.++|.+||+.||++|| |++++++
T Consensus       236 ~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          236 QGDQL----SVMGAHI-NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CSCHH----HHHHHHH-HSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCchH----HHHHHHh-ccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            65432    1122222 2222222223356899999999999999999999 7777765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.4e-46  Score=345.90  Aligned_cols=247  Identities=19%  Similarity=0.299  Sum_probs=198.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcE----EEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEV----YALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      -.++|+++ +.||+|+||+||+|.+..+++.    ||+|.+...      ....+|+.+ +..++||||+++++++.   
T Consensus        11 ~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~---   85 (325)
T 3kex_A           11 KETELRKL-KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA-IGSLDHAHIVRLLGLCP---   85 (325)
T ss_dssp             CTTTEEEE-EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHH-HHTCCCTTBCCEEEEEC---
T ss_pred             CHhHceee-eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHH-HhcCCCCCcCeEEEEEc---
Confidence            35789995 7899999999999999888876    777776422      234567766 67779999999999885   


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        +...++||||+.+|+|.+++.... +.+++..++.++.||+.||+|||+.||+||||||+|||++             
T Consensus        86 --~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~-------------  149 (325)
T 3kex_A           86 --GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK-------------  149 (325)
T ss_dssp             --BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES-------------
T ss_pred             --CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC-------------
Confidence              345899999999999999997653 4699999999999999999999999999999999999997             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF  239 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  239 (372)
                                    .++.+||+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       150 --------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~  215 (325)
T 3kex_A          150 --------------SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA  215 (325)
T ss_dssp             --------------SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             --------------CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCC
Confidence                          567799999999987644322  2334566789999999988889999999999999999999 99


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .||.+....    .+...+..+.....   ...++.++.+||.+||..||.+|||+.+++++
T Consensus       216 ~p~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          216 EPYAGLRLA----EVPDLLEKGERLAQ---PQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTSCTT----HHHHHHHTTCBCCC---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCccccCHH----HHHHHHHcCCCCCC---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999765432    23333333322111   13578899999999999999999999999886

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-45  Score=340.31  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=203.8

Q ss_pred             cccceeeccccccccCCeEEEEEEE-----cCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVE-----KKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..++|++ .+.||+|+||+||+|.+     ..+++.||||++...      ....+|+.++.++.+||||+++++++.. 
T Consensus        21 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   98 (313)
T 1t46_A           21 PRNRLSF-GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-   98 (313)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ChhhhhH-HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-
Confidence            4578998 58899999999999985     457899999999632      3455788875555599999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKED----------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN  145 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~N  145 (372)
                         ++..++||||+.+|+|.+++.....                ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus        99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             ---CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence               5678999999999999999987542                248999999999999999999999999999999999


Q ss_pred             eeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCcc
Q psy3151         146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSC  223 (372)
Q Consensus       146 Ili~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~  223 (372)
                      |+++                           .++.+||+|||++........  ......+|+.|+|||++.+..++.++
T Consensus       176 il~~---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  228 (313)
T 1t46_A          176 ILLT---------------------------HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES  228 (313)
T ss_dssp             EEEE---------------------------TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred             EEEc---------------------------CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHH
Confidence            9998                           567899999999987654322  12334568889999999888899999


Q ss_pred             chhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         224 DIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       224 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||||||++|+|++ |..||.+....   ......+.... ..  .....++.++.+||.+||+.||.+|||+++++++
T Consensus       229 Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          229 DVWSYGIFLWELFSLGSSPYPGMPVD---SKFYKMIKEGF-RM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHHHHHHTTTCCSSTTCCSS---HHHHHHHHHTC-CC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcccch---hHHHHHhccCC-CC--CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            99999999999998 99999655432   22233332221 11  1124689999999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-45  Score=341.26  Aligned_cols=257  Identities=22%  Similarity=0.310  Sum_probs=198.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--hhHHHHHHHHH-hcCCCCEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--KARREVELQLA-VGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~e~~~~~~-~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .+.++|++. +.||+|+||+||+|.+.  |+.||||++....  ...+|.+++.. .++||||+++++++.........+
T Consensus        34 ~~~~~y~~~-~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           34 TIAKQIQMV-KQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             THHHHCEEE-EEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccccceEEE-eEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            467899995 78999999999999985  8999999986433  33445554322 348999999999987633333789


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCceeeecCCCCCceeee
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ--------NIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~--------~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                      |+||||+.+|+|.+++...   .+++..++.++.|++.||.|||+.        ||+||||||+|||++           
T Consensus       111 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~-----------  176 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-----------  176 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC-----------
T ss_pred             EEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC-----------
Confidence            9999999999999999764   499999999999999999999999        999999999999998           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCCCc----ccccccCCCcCCCcccCCCCCCCc------cchhhHHH
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS----LQTPCYTPYYVAPEVLGPDKYDKS------CDIWSLGV  230 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~  230 (372)
                                      .++.+||+|||++.........    ....+||+.|+|||++.+..++..      +|||||||
T Consensus       177 ----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~  240 (337)
T 3mdy_A          177 ----------------KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL  240 (337)
T ss_dssp             ----------------TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHH
T ss_pred             ----------------CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHH
Confidence                            5678999999999765433222    235678999999999987777665      99999999


Q ss_pred             HHHHHHhC----------CCCCCCCCCCCCCHh-HHHHHhhCCccCCCCc---ccccCHHHHHHHHHhccCCCCCCCChh
Q psy3151         231 IMYILLCG----------FPPFFSNHGQAISPG-MKNRIRLGQFDFPNPE---WEHVSQEAKTLIKNMLCVDPSERLTID  296 (372)
Q Consensus       231 il~~ll~g----------~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~ll~~dP~~R~s~~  296 (372)
                      ++|+|++|          ..||........... ....+.........+.   ...+++++.+||.+||+.||.+|||+.
T Consensus       241 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  320 (337)
T 3mdy_A          241 ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL  320 (337)
T ss_dssp             HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence            99999999          667755443333222 2222222222221111   124678899999999999999999999


Q ss_pred             HHhcC
Q psy3151         297 QVMEN  301 (372)
Q Consensus       297 eil~h  301 (372)
                      ++++|
T Consensus       321 ell~~  325 (337)
T 3mdy_A          321 RVKKT  325 (337)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99885

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.6e-46  Score=340.33  Aligned_cols=254  Identities=23%  Similarity=0.344  Sum_probs=197.0

Q ss_pred             CcccceeeccccccccCCeEEEEEE----EcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIV----EKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      -..++|+++ +.||+|+||+||+|.    +..+++.||||++...     ....+|+.+ ++.++||||+++++++..  
T Consensus         7 ~~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~--   82 (295)
T 3ugc_A            7 FEERHLKFL-QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI-LKSLQHDNIVKYKGVCYS--   82 (295)
T ss_dssp             CCGGGEEEE-EEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHH-HHTCCCTTBCCEEEEECH--
T ss_pred             CCHHHhhhh-heeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEec--
Confidence            356899995 779999999999998    6678999999998643     234577777 677799999999998853  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      .+...+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++             
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~-------------  148 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-------------  148 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-------------
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc-------------
Confidence            12356899999999999999998754 3599999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                    .++.+||+|||++........   ......+|+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       149 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  214 (295)
T 3ugc_A          149 --------------NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI  214 (295)
T ss_dssp             --------------ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred             --------------CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcc
Confidence                          567799999999987643322   122344677899999998888999999999999999999999


Q ss_pred             CCCCCCCC--------CCCCH----hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         240 PPFFSNHG--------QAISP----GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       240 ~pf~~~~~--------~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .||.....        .....    .....+... ...+  ....+++++.+||.+||+.||++|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          215 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-GRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             CTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT-CCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccCCChHHHHhhhcCccccchhHHHHHHHHhcc-CcCC--CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99853211        00000    111111111 1111  22478999999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.7e-46  Score=342.50  Aligned_cols=249  Identities=20%  Similarity=0.346  Sum_probs=202.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..++|.+ .+.||+|+||.||+|.+.     .+++.||||++...      ....+|+.+ ++.++||||+++++++.. 
T Consensus        21 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~-   97 (314)
T 2ivs_A           21 PRKNLVL-GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV-LKQVNHPHVIKLYGACSQ-   97 (314)
T ss_dssp             CGGGEEE-EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHH-HTTCCCTTBCCEEEEECS-
T ss_pred             chhheee-eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHH-HhhCCCCceeeEEEEEec-
Confidence            4688998 588999999999999983     45689999999642      234567776 566799999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKED----------------------GAFTEREAAIIMNEICSAIKFLHDQNIAHR  139 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~----------------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHr  139 (372)
                         +...|+||||+.+++|.+++.....                      ..+++..++.++.||+.||.|||++||+||
T Consensus        98 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           98 ---DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             ---CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence               5678999999999999999986432                      248999999999999999999999999999


Q ss_pred             CCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCC
Q psy3151         140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPD  217 (372)
Q Consensus       140 Dlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~  217 (372)
                      ||||+||+++                           .++.+||+|||++........  ......+|+.|+|||++.+.
T Consensus       175 dikp~NIli~---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  227 (314)
T 2ivs_A          175 DLAARNILVA---------------------------EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH  227 (314)
T ss_dssp             CCSGGGEEEE---------------------------TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC
T ss_pred             ccchheEEEc---------------------------CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC
Confidence            9999999998                           567799999999986643322  22334567889999999888


Q ss_pred             CCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChh
Q psy3151         218 KYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID  296 (372)
Q Consensus       218 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~  296 (372)
                      .++.++|||||||++|+|++ |..||.+....    .+...+..+...   .....+++++.+||.+||+.||.+|||++
T Consensus       228 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~  300 (314)
T 2ivs_A          228 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE----RLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFA  300 (314)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence            89999999999999999999 99999765432    233333333221   12246899999999999999999999999


Q ss_pred             HHhcC
Q psy3151         297 QVMEN  301 (372)
Q Consensus       297 eil~h  301 (372)
                      +++++
T Consensus       301 ~l~~~  305 (314)
T 2ivs_A          301 DISKD  305 (314)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.6e-45  Score=338.33  Aligned_cols=253  Identities=24%  Similarity=0.407  Sum_probs=195.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcC-CCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGS-HKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~-h~ni~~~~~~~~~~~~~   84 (372)
                      ..++|+++ +.||+|+||.||+|.+. +++.||||++...       ....+|+.++..+.. ||||+++++++..    
T Consensus        26 ~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----   99 (313)
T 3cek_A           26 KGRIYSIL-KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----   99 (313)
T ss_dssp             TTEEEEEE-EEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC----
T ss_pred             ccceEEEE-EEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec----
Confidence            45779995 77999999999999985 5999999998532       234577877555543 6999999999876    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...|+|||+ .+++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++               
T Consensus       100 ~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---------------  161 (313)
T 3cek_A          100 DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---------------  161 (313)
T ss_dssp             SSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---------------
T ss_pred             CCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE---------------
Confidence            6789999995 578999999875  4599999999999999999999999999999999999996               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCC-----------CCCCCccchhhHHHH
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGP-----------DKYDKSCDIWSLGVI  231 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~i  231 (372)
                                   ++.+||+|||++........  .....+||+.|+|||++.+           ..++.++|||||||+
T Consensus       162 -------------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~i  228 (313)
T 3cek_A          162 -------------DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  228 (313)
T ss_dssp             -------------TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHH
T ss_pred             -------------CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHH
Confidence                         35689999999876543222  2234578999999999865           468889999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       232 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +|+|++|..||......   ...............  .....+.++.+||.+||+.||.+|||++++++||||+..
T Consensus       229 l~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          229 LYYMTYGKTPFQQIINQ---ISKLHAIIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             HHHHHHSSCTTTTCCSH---HHHHHHHHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             HHHHHhCCCchhhHHHH---HHHHHHHHhcccccC--CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            99999999999643321   111222222222111  113568999999999999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.4e-46  Score=352.47  Aligned_cols=246  Identities=21%  Similarity=0.395  Sum_probs=200.4

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .++|.+ .+.||+|+||+||+|.+..+++.||||++...      ....+|+.+ ++.++||||+++++++..    +..
T Consensus       113 ~~~~~~-~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~----~~~  186 (377)
T 3cbl_A          113 HEDLVL-GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI-LKQYSHPNIVRLIGVCTQ----KQP  186 (377)
T ss_dssp             GGGEEE-EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHH-HTTCCCTTBCCEEEEECS----SSS
T ss_pred             hHHeEE-eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHH-HHhCCCCCEEEEEEEEec----CCC
Confidence            468888 57899999999999999999999999998642      234578877 677799999999999865    567


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++                  
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~------------------  247 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT------------------  247 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc------------------
Confidence            899999999999999998653 3599999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFS  244 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~  244 (372)
                               .++.+||+|||+++........  .....+++.|+|||++....++.++|||||||++|||++ |..||.+
T Consensus       248 ---------~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~  318 (377)
T 3cbl_A          248 ---------EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN  318 (377)
T ss_dssp             ---------TTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ---------CCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                     5678999999999764332111  112234667999999988889999999999999999998 9999965


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ....    .....+..+. ..+.  ...+++++.+||.+||+.||++|||++++++
T Consensus       319 ~~~~----~~~~~~~~~~-~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          319 LSNQ----QTREFVEKGG-RLPC--PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             SCHH----HHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHH----HHHHHHHcCC-CCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            4322    2233333222 2222  2368999999999999999999999999976

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.1e-45  Score=334.88  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=199.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      -.++|+++ +.||+|+||+||+|.+. ++..||||++...    ....+|+.+ ++.++||||+++++++..    ++..
T Consensus        22 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~~~~   94 (283)
T 3gen_A           22 DPKDLTFL-KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKV-MMNLSHEKLVQLYGVCTK----QRPI   94 (283)
T ss_dssp             CGGGEEEE-EECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHH-HHTCCCTTBCCEEEEECS----SSSE
T ss_pred             CHHHHHhH-hhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHH-HhcCCCCCEeeEEEEEec----CCCe
Confidence            45789995 77999999999999886 6788999999742    345677777 677789999999999875    6679


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++                   
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~-------------------  154 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-------------------  154 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC-------------------
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc-------------------
Confidence            99999999999999998643 4599999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  246 (372)
                              .++.+||+|||++....... .......+|+.|+|||++.+..++.++|+|||||++|+|++ |..||....
T Consensus       155 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~  226 (283)
T 3gen_A          155 --------DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT  226 (283)
T ss_dssp             --------TTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             --------CCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence                    56789999999998654321 12233445778999999988889999999999999999998 999996544


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .    ......+..+.....   ...+++++.+||.+||+.||.+|||++++++|
T Consensus       227 ~----~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          227 N----SETAEHIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             H----HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             h----hHHHHHHhcccCCCC---CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            2    223333333322211   23678999999999999999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.4e-46  Score=348.76  Aligned_cols=255  Identities=15%  Similarity=0.166  Sum_probs=193.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcC---CCcEEEEEEecchh-h---------------hHHHHHHHHHhcCCCCEeE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKK---TSEVYALKVLHDTV-K---------------ARREVELQLAVGSHKHIVN   73 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~---------------~~~e~~~~~~~~~h~ni~~   73 (372)
                      ..++|++ .+.||+|+||+||+|.+..   ++..+|||++.... .               ..+|+.. +..++||||++
T Consensus        35 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~-~~~l~h~ni~~  112 (345)
T 2v62_A           35 EGNQWVL-GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE-RKQLDYLGIPL  112 (345)
T ss_dssp             TSCEEEE-EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHH-HHTCSCCCCCC
T ss_pred             cCceEEE-EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHh-hccccccCcce
Confidence            4578999 5789999999999999987   88999999986432 1               1233333 56679999999


Q ss_pred             EeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCC
Q psy3151          74 IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGD  153 (372)
Q Consensus        74 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~  153 (372)
                      +++++.....+....|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-  188 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-  188 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-
Confidence            9999987555678999999999 999999987654  599999999999999999999999999999999999998321 


Q ss_pred             CCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCCccchh
Q psy3151         154 GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDKSCDIW  226 (372)
Q Consensus       154 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  226 (372)
                                              .+.+||+|||+++.......       .....+||+.|+|||++.+..++.++|||
T Consensus       189 ------------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~  244 (345)
T 2v62_A          189 ------------------------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVE  244 (345)
T ss_dssp             ------------------------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHH
T ss_pred             ------------------------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHH
Confidence                                    23799999999976543211       12445789999999999888899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCCC-HhHHHHHhhCCccCCCC-----cccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         227 SLGVIMYILLCGFPPFFSNHGQAIS-PGMKNRIRLGQFDFPNP-----EWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       227 slG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||||++|+|++|..||......... .........   ..+..     ....+++++.+||.+||..||++|||++++++
T Consensus       245 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          245 ILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLD---ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHH---TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCccccccccHHHHHHHHhhcc---cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            9999999999999999643222110 011111111   11110     01268899999999999999999999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-45  Score=336.39  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=191.4

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCC---CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKT---SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ....++|++ .+.||+|+||+||+|.+..+   +..||+|++...      ....+|+.. ++.++||||+++++++.  
T Consensus        11 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~--   86 (281)
T 1mp8_A           11 EIQRERIEL-GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT-MRQFDHPHIVKLIGVIT--   86 (281)
T ss_dssp             BCCGGGEEE-EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHH-HHTCCCTTBCCEEEEEC--
T ss_pred             EEehHHeEE-EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHH-HHhCCCCccceEEEEEc--
Confidence            446789999 58899999999999998654   567999998632      234567766 67779999999999874  


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         ++..|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++            
T Consensus        87 ---~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~------------  150 (281)
T 1mp8_A           87 ---ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS------------  150 (281)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE------------
T ss_pred             ---cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC------------
Confidence               345789999999999999998653 4699999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF  239 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  239 (372)
                                     .++.+||+|||++........ ......+|+.|+|||++....++.++|||||||++|+|++ |.
T Consensus       151 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~  215 (281)
T 1mp8_A          151 ---------------SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV  215 (281)
T ss_dssp             ---------------ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred             ---------------CCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCC
Confidence                           566799999999886643222 1233455778999999988889999999999999999996 99


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .||.+....+    ....+..+...   +....+++++.++|.+||+.||++|||+.+++++
T Consensus       216 ~pf~~~~~~~----~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          216 KPFQGVKNND----VIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CTTTTCCGGG----HHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcCCHHH----HHHHHHcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9997654332    23333333211   1224789999999999999999999999999873

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=345.71  Aligned_cols=248  Identities=20%  Similarity=0.359  Sum_probs=202.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..++|++. +.||+|+||.||+|.+.     .+++.||||++...      ....+|+.+ ++.++||||+++++++.. 
T Consensus        45 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~-  121 (343)
T 1luf_A           45 PRNNIEYV-RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL-MAEFDNPNIVKLLGVCAV-  121 (343)
T ss_dssp             CGGGCEEE-EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHH-HHTCCCTTBCCEEEEECS-
T ss_pred             cHHHCeee-eeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHH-HHhCCCCCEEEEEEEEcc-
Confidence            45889985 77999999999999997     45689999998642      234567777 666799999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKE----------------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHR  139 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~----------------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHr  139 (372)
                         +...|+||||+.+|+|.+++....                      ...+++.+++.++.||+.||.|||++||+||
T Consensus       122 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          122 ---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             ---CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence               567899999999999999998742                      1469999999999999999999999999999


Q ss_pred             CCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCC
Q psy3151         140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPD  217 (372)
Q Consensus       140 Dlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~  217 (372)
                      ||||+|||++                           .++.+||+|||++.......  .......+|+.|+|||++.+.
T Consensus       199 Dlkp~NIl~~---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  251 (343)
T 1luf_A          199 DLATRNCLVG---------------------------ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN  251 (343)
T ss_dssp             CCSGGGEEEC---------------------------GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred             CCCcceEEEC---------------------------CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence            9999999998                           56679999999997654322  223345678899999999888


Q ss_pred             CCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChh
Q psy3151         218 KYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID  296 (372)
Q Consensus       218 ~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~  296 (372)
                      .++.++|||||||++|+|++ |..||.+...    ......+..+.....   ...++.++.+||.+||+.||.+|||+.
T Consensus       252 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~  324 (343)
T 1luf_A          252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----EEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFC  324 (343)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CcCcccccHHHHHHHHHHHhcCCCcCCCCCh----HHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            89999999999999999999 9999965432    233344444433211   246899999999999999999999999


Q ss_pred             HHhc
Q psy3151         297 QVME  300 (372)
Q Consensus       297 eil~  300 (372)
                      ++++
T Consensus       325 ~~~~  328 (343)
T 1luf_A          325 SIHR  328 (343)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-45  Score=342.05  Aligned_cols=253  Identities=22%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             CCcccceeeccccccccCCeEEEEEEE-----cCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVE-----KKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      .-..++|++ .+.||+|+||+||+|.+     ..+++.||||++...      ....+|+.++..+.+||||+++++++.
T Consensus        23 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           23 EFPRDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             BCCGGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecchhheee-eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            335689999 58899999999999985     457899999999642      235578888666668999999999986


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKED--------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN  145 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~--------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~N  145 (372)
                      .   .+..+|+||||+.+++|.+++.....              ..+++..++.++.||+.||.|||+.||+||||||+|
T Consensus       102 ~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A          102 K---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             C---TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             c---CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            4   24568999999999999999987542              128999999999999999999999999999999999


Q ss_pred             eeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCcc
Q psy3151         146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSC  223 (372)
Q Consensus       146 Ili~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~  223 (372)
                      |+++                           .++.+||+|||++........  ......||+.|+|||++.+..++.++
T Consensus       179 il~~---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  231 (316)
T 2xir_A          179 ILLS---------------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS  231 (316)
T ss_dssp             EEEC---------------------------GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred             EEEC---------------------------CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchh
Confidence            9998                           566799999999986643322  22345678899999999888899999


Q ss_pred             chhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         224 DIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       224 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||||||++|+|++ |..||.+....   ......+..+. ...+    ..+++++.++|.+||+.||.+|||+.++++|
T Consensus       232 Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          232 DVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCCS---HHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCcccchh---HHHHHHhccCccCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999998 99999654432   23333333332 2222    3579999999999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=339.72  Aligned_cols=254  Identities=24%  Similarity=0.374  Sum_probs=199.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .++|++. +.||+|+||.||+|.+..+|+.||||++...     ....+|+.+ ++.++||||+++++++..........
T Consensus        28 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           28 NKHYLFI-QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADM-HRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TEEEEEE-EEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHH-HHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CeEEEEE-EEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHH-HhhcCCCCeeeEEEEEEeccCCCcee
Confidence            4789995 7799999999999999999999999988532     344567776 67779999999999987544446789


Q ss_pred             EEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          89 LVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      |+||||+.+++|.+++...  ....+++..++.++.||+.||.|||+.||+||||||+||+++                 
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~-----------------  168 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-----------------  168 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-----------------
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc-----------------
Confidence            9999999999999998763  235699999999999999999999999999999999999997                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCC---------cccccccCCCcCCCcccCCCC---CCCccchhhHHHHHHH
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKA---------SLQTPCYTPYYVAPEVLGPDK---YDKSCDIWSLGVIMYI  234 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~  234 (372)
                                .++.+||+|||++........         ......||+.|+|||++....   ++.++|||||||++|+
T Consensus       169 ----------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e  238 (317)
T 2buj_A          169 ----------DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA  238 (317)
T ss_dssp             ----------TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHH
T ss_pred             ----------CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHH
Confidence                      566799999998875432111         112345799999999987554   6899999999999999


Q ss_pred             HHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       235 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |++|..||.........  ....+. .....+  ....++.++.+||.+||+.||.+|||+++++++
T Consensus       239 l~~g~~p~~~~~~~~~~--~~~~~~-~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          239 MMFGEGPYDMVFQKGDS--VALAVQ-NQLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHSSCTTHHHHHTTSC--HHHHHH-CC--CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCChhhhhcccch--hhHHhh-ccCCCC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            99999999542111111  111111 122222  224689999999999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-45  Score=341.85  Aligned_cols=258  Identities=18%  Similarity=0.285  Sum_probs=207.9

Q ss_pred             ccCCCccCCcccceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEe
Q psy3151           4 TFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDTV------KARREVELQLAVGSHKHIV   72 (372)
Q Consensus         4 ~~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~   72 (372)
                      .+.|.......++|++ .+.||+|+||+||+|.+.     .+++.||||++....      ...+|+.+ ++.++||||+
T Consensus        14 ~~~~~~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~   91 (322)
T 1p4o_A           14 VYVPDEWEVAREKITM-SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV-MKEFNCHHVV   91 (322)
T ss_dssp             CCCCCTTBCCGGGEEE-EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHH-GGGCCCTTBC
T ss_pred             ccChhhhcchhhheee-eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHH-HHhcCCCCEe
Confidence            3455556667889999 578999999999999887     468899999996422      34467766 6677999999


Q ss_pred             EEeEeeeeecCCceEEEEEEeccCCCchhHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy3151          73 NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE  144 (372)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~--------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~  144 (372)
                      ++++++..    +...|+||||+.+|+|.+++....        ...+++..++.++.||+.||.|||++||+||||||+
T Consensus        92 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~  167 (322)
T 1p4o_A           92 RLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR  167 (322)
T ss_dssp             CEEEEECS----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred             eeEEEEcc----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccc
Confidence            99999875    567899999999999999997632        135799999999999999999999999999999999


Q ss_pred             ceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCc
Q psy3151         145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKS  222 (372)
Q Consensus       145 NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~  222 (372)
                      ||+++                           .++.+||+|||++........  ......+|+.|+|||++.+..++.+
T Consensus       168 NIli~---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  220 (322)
T 1p4o_A          168 NCMVA---------------------------EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY  220 (322)
T ss_dssp             GEEEC---------------------------TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH
T ss_pred             eEEEc---------------------------CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCch
Confidence            99998                           567799999999876543221  2233456889999999988889999


Q ss_pred             cchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         223 CDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       223 ~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      +|||||||++|+|++ |..||.+...    ......+..+....   ....++.++.+||.+||+.||.+|||+.++++|
T Consensus       221 ~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          221 SDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHHHHHHHHHHHHTSCCTTTTSCH----HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhcCCCccccCCH----HHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999 8999965432    22333343333221   124689999999999999999999999999985

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.5e-45  Score=332.20  Aligned_cols=250  Identities=25%  Similarity=0.424  Sum_probs=192.2

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .++|++ .+.||+|+||+||+|.+.  |+.||||++...         ....+|+.+ ++.++||||+++++++..    
T Consensus         6 ~~~~~~-~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----   77 (271)
T 3dtc_A            6 FAELTL-EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKL-FAMLKHPNIIALRGVCLK----   77 (271)
T ss_dssp             TTSEEE-EEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHH-HHHCCCTTBCCEEEEECC----
T ss_pred             hhheee-eeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHH-HHhcCCCCEeeEEEEEec----
Confidence            478998 588999999999999985  899999998532         234567766 677799999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCceeeecCCCCCceeeec
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN---IAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~---ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                      +...|+||||+.+++|.+++..   +.+++..++.++.||+.||.|||++|   |+||||||+||+++.+.+.+.     
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~-----  149 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD-----  149 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC-----
T ss_pred             CCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc-----
Confidence            6678999999999999998853   45999999999999999999999999   899999999999984322100     


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                    ...+.+||+|||++.......  .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       150 --------------~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  213 (271)
T 3dtc_A          150 --------------LSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP  213 (271)
T ss_dssp             --------------CSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCT
T ss_pred             --------------ccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence                          036779999999997654322  2345789999999999888899999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |.+.+..    .............+.  ...+++++.++|.+||+.||.+|||+.+++++
T Consensus       214 ~~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          214 FRGIDGL----AVAYGVAMNKLALPI--PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TTTSCHH----HHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHH----HHHHhhhcCCCCCCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            9654321    222333333332222  24689999999999999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.6e-45  Score=343.15  Aligned_cols=247  Identities=19%  Similarity=0.305  Sum_probs=195.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEE----EEEEecc------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVY----ALKVLHD------TVKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ..++|+++ +.||+|+||+||+|.+..+|+.+    |+|.+..      .....+|+.+ ++.++||||+++++++..  
T Consensus        13 ~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~--   88 (327)
T 3poz_A           13 KETEFKKI-KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV-MASVDNPHVCRLLGICLT--   88 (327)
T ss_dssp             CGGGEEEE-EEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHH-HHHCCBTTBCCEEEEEES--
T ss_pred             CHHHcccc-eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHH-HHhCCCCCEeEEEEEEec--
Confidence            45789995 78999999999999998887765    7777642      2345567777 667799999999999874  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                         ...++|+||+.+|+|.+++.... +.+++..++.++.||+.||.|||++||+||||||+|||++             
T Consensus        89 ---~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~-------------  151 (327)
T 3poz_A           89 ---STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-------------  151 (327)
T ss_dssp             ---SSEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-------------
T ss_pred             ---CCeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC-------------
Confidence               23788999999999999998754 5699999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF  239 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  239 (372)
                                    .++.+||+|||+|+........  .....+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       152 --------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  217 (327)
T 3poz_A          152 --------------TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS  217 (327)
T ss_dssp             --------------ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             --------------CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCC
Confidence                          5677999999999876443222  223455778999999988899999999999999999999 99


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .||.+.....    +...+..+.. .+  ....++.++.+++.+||+.||.+|||+.+++++
T Consensus       218 ~p~~~~~~~~----~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          218 KPYDGIPASE----ISSILEKGER-LP--QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CTTTTCCGGG----HHHHHHTTCC-CC--CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCccCCCHHH----HHHHHHcCCC-CC--CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9997654332    2333333221 11  123689999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3e-45  Score=336.81  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=199.1

Q ss_pred             ccceeeccccccccCCeEEEEEE----EcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIV----EKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ..+|++. +.||+|+||.||+|.    +..+++.||||++...      ....+|+.+ ++.++||||+++++++..  .
T Consensus        20 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~--~   95 (302)
T 4e5w_A           20 KRFLKRI-RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI-LRNLYHENIVKYKGICTE--D   95 (302)
T ss_dssp             GGGEEEE-EEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHH-HHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhh-hccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHH-HHhCCCCCeeeeeeEEec--C
Confidence            4668884 779999999999999    6778999999998632      345678877 677799999999999875  2


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      +...+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++              
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~--------------  160 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE--------------  160 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--------------
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc--------------
Confidence            2366899999999999999997654 4699999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                   .++.++|+|||++........   ......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       161 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  227 (302)
T 4e5w_A          161 -------------SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD  227 (302)
T ss_dssp             -------------ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred             -------------CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccC
Confidence                         566799999999987654332   2334567888999999988889999999999999999999999


Q ss_pred             CCCCCC-----------CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         241 PFFSNH-----------GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       241 pf~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |+....           ...........+..+. ..  +....+++++.+||.+||+.||.+|||++++++
T Consensus       228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          228 SDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK-RL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC-CC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCcchhhHHhhccCCcccccCHHHHHHHHhccC-CC--CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            863221           0000111122222211 11  122468999999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.3e-45  Score=355.64  Aligned_cols=257  Identities=15%  Similarity=0.196  Sum_probs=201.6

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc---hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD---TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .+.++|++. +.||+|+||.||+|.+..+++.||||++..   .....+|+.++..+..|++|..+..++..    +...
T Consensus         4 ~i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~----~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE----GDYN   78 (483)
T ss_dssp             EETTTEECC-CCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE----TTEE
T ss_pred             CcCCcEEEE-EEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee----CCEE
Confidence            467899994 789999999999999999999999998863   23567788885555555666666555543    6788


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+ +++|.+++.... +.+++..++.++.||+.||+|||++||+||||||+||||+...                
T Consensus        79 ~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~----------------  140 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----------------  140 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG----------------
T ss_pred             EEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCC----------------
Confidence            9999999 899999998643 4699999999999999999999999999999999999995211                


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                              ..+.+||+|||++........       .....+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       141 --------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~P  212 (483)
T 3sv0_A          141 --------RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP  212 (483)
T ss_dssp             --------GTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             --------CCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence                    467799999999887644322       12256789999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |.+........ ....+......... .....++.++.+||..||+.||.+||+++++++
T Consensus       213 f~~~~~~~~~~-~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          213 WQGLKAGTKKQ-KYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             TSSCCCSSHHH-HHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CccccchhHHH-HHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            97755433221 11222111111110 111367899999999999999999999998765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-45  Score=335.91  Aligned_cols=251  Identities=20%  Similarity=0.296  Sum_probs=197.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCC-------cEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTS-------EVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYEN   80 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~   80 (372)
                      ..++|.+ .+.||+|+||+||+|.+..++       ..||+|++...     ....+|+.+ ++.++||||+++++++..
T Consensus         6 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            6 RNEDLIF-NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM-MSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             CGGGEEE-EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHH-HHTSCCTTBCCEEEEECC
T ss_pred             chhHeee-eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHH-HHhCCCCCEeEEEEEEEe
Confidence            4579998 578999999999999998877       47999998532     234567766 677799999999999875


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                          ++..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..   ++ 
T Consensus        84 ----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~---~~-  154 (289)
T 4fvq_A           84 ----GDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR---KT-  154 (289)
T ss_dssp             ----TTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBG---GG-
T ss_pred             ----CCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcc---cc-
Confidence                566899999999999999998753 349999999999999999999999999999999999999854321   00 


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCC
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                     ++.+.+||+|||++.....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus       155 ---------------~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  215 (289)
T 4fvq_A          155 ---------------GNPPFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGG  215 (289)
T ss_dssp             ---------------TBCCEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTT
T ss_pred             ---------------cccceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCC
Confidence                           1233499999999875432    233567899999999876 67999999999999999999965


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .|+.....    ..............+    ...++++.+||.+||+.||.+|||++++++|
T Consensus       216 ~~~~~~~~----~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          216 DKPLSALD----SQRKLQFYEDRHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCTTTTSC----HHHHHHHHHTTCCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCccccc----hHHHHHHhhccCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55433221    111222222222333    2458889999999999999999999999984

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.9e-45  Score=342.42  Aligned_cols=257  Identities=20%  Similarity=0.328  Sum_probs=201.9

Q ss_pred             CcccceeeccccccccCCeEEEEEE-----EcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeee
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIV-----EKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYEN   80 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~   80 (372)
                      -..++|++. +.||+|+||+||+|.     +..+++.||||++...      ....+|+.+ ++.++||||+++++++..
T Consensus        27 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           27 VPRKNITLI-RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI-ISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CCGGGCEEE-EECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHH-HHHCCCTTBCCEEEEECS
T ss_pred             CChhheEEE-EEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHH-HhhCCCCCCCeEEEEEcC
Confidence            366899995 779999999999999     5678899999998532      234567776 566699999999999875


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCC
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKED-----GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGG  155 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~  155 (372)
                          ....|+||||+++++|.+++.....     ..+++..++.++.||+.||.|||+.||+||||||+|||++.++   
T Consensus       105 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~---  177 (327)
T 2yfx_A          105 ----SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG---  177 (327)
T ss_dssp             ----SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS---
T ss_pred             ----CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC---
Confidence                5668999999999999999987532     3489999999999999999999999999999999999998433   


Q ss_pred             ceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHH
Q psy3151         156 ILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       156 ~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  233 (372)
                                           ....+||+|||++.......  .......||+.|+|||++.+..++.++|||||||++|
T Consensus       178 ---------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  236 (327)
T 2yfx_A          178 ---------------------PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW  236 (327)
T ss_dssp             ---------------------TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             ---------------------CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHH
Confidence                                 34569999999987553322  1223456788999999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         234 ILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       234 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      +|++ |..||.....    ......+..+....+   ...++.++.+||.+||+.||.+|||+.++++|.|+.
T Consensus       237 ellt~g~~p~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          237 EIFSLGYMPYPSKSN----QEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHHTTSCCSSTTCCH----HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCcCH----HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            9998 9999965432    223333433322211   246899999999999999999999999999998864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.1e-45  Score=339.60  Aligned_cols=250  Identities=22%  Similarity=0.419  Sum_probs=201.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCc-----EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSE-----VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..++|++ .+.||+|+||+||+|.+..+++     .||+|++...      ....+|+.++..+.+||||+++++++.. 
T Consensus        44 ~~~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  121 (333)
T 2i1m_A           44 PRNNLQF-GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-  121 (333)
T ss_dssp             CTTSEEE-EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CHHHcee-eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence            4578988 5889999999999999987664     7999999643      2456788885555589999999999875 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeee
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKE------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYT  149 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~  149 (372)
                         +...|+||||+++|+|.+++....            ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       122 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 ---GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             ---CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence               567899999999999999997642            24589999999999999999999999999999999999998


Q ss_pred             cCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhh
Q psy3151         150 KPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWS  227 (372)
Q Consensus       150 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  227 (372)
                                                 .++.+||+|||++........  ......||+.|+|||++.+..++.++||||
T Consensus       199 ---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  251 (333)
T 2i1m_A          199 ---------------------------NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS  251 (333)
T ss_dssp             ---------------------------GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHH
T ss_pred             ---------------------------CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHH
Confidence                                       566799999999986643322  123345678899999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         228 LGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       228 lG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |||++|+|++ |..||.+....   ......+..+ ...+  ....+++++.+||.+||+.||.+|||+.++++
T Consensus       252 lG~il~el~t~g~~p~~~~~~~---~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          252 YGILLWEIFSLGLNPYPGILVN---SKFYKLVKDG-YQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHHTTTSCCSSTTCCSS---HHHHHHHHHT-CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCcccchh---HHHHHHHhcC-CCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            9999999998 99999654432   2222222222 2211  12357899999999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-44  Score=350.34  Aligned_cols=243  Identities=21%  Similarity=0.364  Sum_probs=199.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .++|++. +.||+|+||+||+|.+.  |+.||||++...   ....+|+.+ ++.++||||+++++++..   .+..+|+
T Consensus       192 ~~~~~~~-~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~---~~~~~~i  264 (450)
T 1k9a_A          192 MKELKLL-QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASV-MTQLRHSNLVQLLGVIVE---EKGGLYI  264 (450)
T ss_dssp             GGGEEEE-EEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHH-HHTCCCTTBCCEEEEEEC---TTSCEEE
T ss_pred             hHHeEEE-eeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHH-HHhccCCCEEEEEEEEEc---CCCceEE
Confidence            4688884 78999999999999985  789999999743   345678877 677799999999998754   2447899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++                     
T Consensus       265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---------------------  323 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---------------------  323 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---------------------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC---------------------
Confidence            99999999999999887555589999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQA  249 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  249 (372)
                            .++.+||+|||+++.....   .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus       324 ------~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~  394 (450)
T 1k9a_A          324 ------EDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD  394 (450)
T ss_dssp             ------TTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT
T ss_pred             ------CCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence                  5678999999999854322   223356889999999988899999999999999999998 999997655433


Q ss_pred             CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                          +...+..+. ..+.  ...+++++.+||.+||+.||.+|||+.++++
T Consensus       395 ----~~~~i~~~~-~~~~--p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          395 ----VVPRVEKGY-KMDA--PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----HHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----HHHHHHcCC-CCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                233333332 1221  2478999999999999999999999999876

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=340.92  Aligned_cols=262  Identities=22%  Similarity=0.313  Sum_probs=193.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--hhHHHHHHH-HHhcCCCCEeEEeEeeeee-cCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--KARREVELQ-LAVGSHKHIVNIKDVYENI-YNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~e~~~~-~~~~~h~ni~~~~~~~~~~-~~~~~~~   88 (372)
                      -.++|++. +.||+|+||+||+|.+  +++.||||++....  ....|.++. +..++||||+++++.+... ..+...+
T Consensus        11 ~~~~y~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           11 DLDNLKLL-ELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CTTSEEEE-EEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             ChHHhhee-eecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            35889994 7899999999999976  68999999996432  223333332 3347999999999876532 3345678


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCceeeecCCCCCceee
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ---------NIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~---------~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      |+||||+++|+|.+++....   .++..++.++.||+.||.|||+.         ||+||||||+|||++          
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~----------  154 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK----------  154 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC----------
T ss_pred             EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc----------
Confidence            99999999999999997643   69999999999999999999999         999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCC--------CcccccccCCCcCCCcccCC-------CCCCCccc
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK--------ASLQTPCYTPYYVAPEVLGP-------DKYDKSCD  224 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~D  224 (372)
                                       .++.+||+|||++.......        ......+||+.|+|||++.+       ..++.++|
T Consensus       155 -----------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D  217 (336)
T 3g2f_A          155 -----------------NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVD  217 (336)
T ss_dssp             -----------------TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHH
T ss_pred             -----------------CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccc
Confidence                             56779999999997654321        12234578999999999976       35667899


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCCCCCC-H-------------hHHHHHhhCCc--cCC--CCcccccCHHHHHHHHHhcc
Q psy3151         225 IWSLGVIMYILLCGFPPFFSNHGQAIS-P-------------GMKNRIRLGQF--DFP--NPEWEHVSQEAKTLIKNMLC  286 (372)
Q Consensus       225 iwslG~il~~ll~g~~pf~~~~~~~~~-~-------------~~~~~~~~~~~--~~~--~~~~~~~s~~~~~li~~ll~  286 (372)
                      ||||||++|+|++|..||......... .             .+.........  .++  ......+++++.+||.+||+
T Consensus       218 iwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  297 (336)
T 3g2f_A          218 MYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD  297 (336)
T ss_dssp             HHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSC
T ss_pred             hHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhc
Confidence            999999999999997776543322111 0             01111111111  111  11122356789999999999


Q ss_pred             CCCCCCCChhHHhc------CCccccC
Q psy3151         287 VDPSERLTIDQVME------NKWISQF  307 (372)
Q Consensus       287 ~dP~~R~s~~eil~------hp~~~~~  307 (372)
                      .||++|||++|+++      ++|-++-
T Consensus       298 ~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          298 QDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             CChhhCcchHHHHHHHHHHHHHHHhcc
Confidence            99999999999954      6776654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.4e-45  Score=338.76  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=201.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEc-------CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEK-------KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYE   79 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~   79 (372)
                      ..++|++ .+.||+|+||+||+|.+.       .+++.||||++...      ....+|+.++..+.+||||+++++++.
T Consensus        33 ~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           33 PRDKLTL-GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CGGGEEE-EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHhHeEE-eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            4589998 588999999999999986       46789999999632      235578888666669999999999987


Q ss_pred             eecCCceEEEEEEeccCCCchhHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q psy3151          80 NIYNGSRCLLVIMECMHGGELFQRIQQKED--------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPEN  145 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~--------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~N  145 (372)
                      .    ++.+|+||||+.+|+|.+++.....              ..+++..++.++.||+.||.|||+.||+||||||+|
T Consensus       112 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          112 Q----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             S----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             c----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            5    5678999999999999999986531              248999999999999999999999999999999999


Q ss_pred             eeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCcc
Q psy3151         146 LLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSC  223 (372)
Q Consensus       146 Ili~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~  223 (372)
                      |+++                           .++.+||+|||++........  ......+|+.|+|||++.+..++.++
T Consensus       188 Ill~---------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  240 (334)
T 2pvf_A          188 VLVT---------------------------ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS  240 (334)
T ss_dssp             EEEC---------------------------TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHH
T ss_pred             EEEc---------------------------CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHH
Confidence            9998                           567799999999986644322  12334567889999999888899999


Q ss_pred             chhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         224 DIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       224 DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||||||++|+|++ |..||.+...    ..+...+..+...   .....++.++.++|.+||..||.+|||+.+++++
T Consensus       241 Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          241 DVWSFGVLMWEIFTLGGSPYPGIPV----EELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCcCcCCH----HHHHHHHhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999 9999965432    2233333333221   1124689999999999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4e-45  Score=346.41  Aligned_cols=247  Identities=21%  Similarity=0.376  Sum_probs=189.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEc---CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      -.++|++ .+.||+|+||+||+|.+.   .++..||||++...      ....+|+.+ +..++||||+++++++..   
T Consensus        43 ~~~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~---  117 (373)
T 2qol_A           43 DATNISI-DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI-MGQFDHPNIIRLEGVVTK---  117 (373)
T ss_dssp             CGGGCCC-CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHH-HTTCCCTTBCCEEEEECS---
T ss_pred             CHhhcee-eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEee---
Confidence            3468988 588999999999999987   56788999998632      234567776 667799999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       +...|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++              
T Consensus       118 -~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--------------  181 (373)
T 2qol_A          118 -SKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN--------------  181 (373)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--------------
T ss_pred             -CCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc--------------
Confidence             567899999999999999997653 4699999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF  239 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  239 (372)
                                   .++.+||+|||++.........   .....+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       182 -------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~  248 (373)
T 2qol_A          182 -------------SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE  248 (373)
T ss_dssp             -------------TTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-
T ss_pred             -------------CCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCC
Confidence                         5678999999999876443221   122334678999999988889999999999999999998 99


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .||......    .+...+..+ ...+.  ...++.++.+||.+||+.||.+|||++++++
T Consensus       249 ~P~~~~~~~----~~~~~i~~~-~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          249 RPYWEMSNQ----DVIKAVDEG-YRLPP--PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CTTTTCCHH----HHHHHHHTT-EECCC--CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHH----HHHHHHHcC-CCCCC--CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            999655422    233333332 22222  2368899999999999999999999999876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-45  Score=331.73  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=201.5

Q ss_pred             ccceeeccccccccCCeEEEEEEEc--CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEK--KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|.++++.||+|+||.||+|.+.  .+++.||||++...      ....+|+.+ ++.++||||+++++++.     .
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~-----~   81 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI-MHQLDNPYIVRLIGVCQ-----A   81 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHH-HHHCCCTTBCCEEEEEE-----S
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHH-HHhCCCCCEeEEEEEec-----C
Confidence            5788887658999999999999864  56889999999642      234577777 56669999999999984     3


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++                
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----------------  144 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----------------  144 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----------------
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc----------------
Confidence            45899999999999999997543 4699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                 .++.++|+|||++........   ......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       145 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  213 (287)
T 1u59_A          145 -----------NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP  213 (287)
T ss_dssp             -----------ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             -----------CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence                       566799999999987643322   1223456888999999988889999999999999999998 9999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      |.....    ......+..+...   .....+++++.+||.+||..||.+|||+.+++++.+
T Consensus       214 ~~~~~~----~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          214 YKKMKG----PEVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TTTCCT----HHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cccCCH----HHHHHHHhcCCcC---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            965543    2333444433221   112468999999999999999999999999998643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-45  Score=343.59  Aligned_cols=258  Identities=20%  Similarity=0.273  Sum_probs=201.6

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh------hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV------KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ....++|++ .+.||+|+||+||+|.+ .+|+.||||++....      ...+|+.+ ++.++||||+++++++..    
T Consensus        26 ~~~~~~y~~-~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~----   98 (326)
T 3uim_A           26 QVASDNFSN-KNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEM-ISMAVHRNLLRLRGFCMT----   98 (326)
T ss_dssp             HTTTTSSCS-TTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHG-GGTCCCTTBCCCCEEECC----
T ss_pred             HHHhhcccc-ceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHH-HHhccCCCccceEEEEec----
Confidence            346789998 58899999999999986 469999999986432      34677776 677789999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCceeeecCCCCCceee
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKED--GAFTEREAAIIMNEICSAIKFLHDQ---NIAHRDVKPENLLYTKPGDGGILKL  159 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~--~~l~~~~~~~i~~qil~~l~~LH~~---~ivHrDlkp~NIli~~~~~~~~~~~  159 (372)
                      ....++||||+.+|+|.+++.....  ..+++..++.++.||+.||+|||+.   ||+||||||+|||++          
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~----------  168 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD----------  168 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC----------
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC----------
Confidence            5678999999999999999986432  3499999999999999999999999   999999999999998          


Q ss_pred             eccCCCCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         160 TDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       160 ~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                       .++.+||+|||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       169 -----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  231 (326)
T 3uim_A          169 -----------------EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG  231 (326)
T ss_dssp             -----------------TTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred             -----------------CCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence                             567899999999987643332 23345689999999999888899999999999999999999


Q ss_pred             CCCCCCCC---CCCCCHhHHHHHhh----CC------ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         239 FPPFFSNH---GQAISPGMKNRIRL----GQ------FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       239 ~~pf~~~~---~~~~~~~~~~~~~~----~~------~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ..||....   .....  ....+..    ..      ...........+.++.+|+.+||+.||.+|||+.++++|-.-
T Consensus       232 ~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          232 QRAFDLARLANDDDVM--LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             CCSBCHHHHTTTSCSB--HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             CCcccccccccccchh--HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            99995211   01100  0111100    00      001111123345789999999999999999999999997653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=337.34  Aligned_cols=251  Identities=28%  Similarity=0.423  Sum_probs=183.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeee----ecCC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYEN----IYNG   84 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~----~~~~   84 (372)
                      ..+|++ .+.||+|+||+||+|.+..+|+.||||++...     ....+|+.++.++.+||||+++++++..    ....
T Consensus        27 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           27 ELRLRV-RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TEEEEE-EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             CceEEE-EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            458998 58899999999999999999999999988432     3456788876666679999999999842    1234


Q ss_pred             ceEEEEEEeccCCCchhHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceeeecCCCCCceeeec
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQ-KEDGAFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~-~~~~~l~~~~~~~i~~qil~~l~~LH~~~--ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                      ...+++||||+. |+|.+++.. ...+.+++..++.++.||+.||.|||+.|  |+||||||+|||++            
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~------------  172 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS------------  172 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC------------
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC------------
Confidence            677999999995 699998875 23356999999999999999999999999  99999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCC------------cccccccCCCcCCCccc---CCCCCCCccchh
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA------------SLQTPCYTPYYVAPEVL---GPDKYDKSCDIW  226 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~------------~~~~~~gt~~y~aPE~~---~~~~~~~~~Diw  226 (372)
                                     .++.+||+|||++........            .....+||+.|+|||++   .+..++.++|||
T Consensus       173 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~  237 (337)
T 3ll6_A          173 ---------------NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW  237 (337)
T ss_dssp             ---------------TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHH
T ss_pred             ---------------CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHH
Confidence                           566799999999876543221            11245689999999998   566788999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         227 SLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       227 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      ||||++|+|++|..||........        .......+.  ....+..+.+||.+||+.||.+|||++++++|-+
T Consensus       238 slG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          238 ALGCILYLLCFRQHPFEDGAKLRI--------VNGKYSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             HHHHHHHHHHHSSCCC--------------------CCCCT--TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCcchhHHHh--------hcCcccCCc--ccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            999999999999999965432211        111222222  2456788999999999999999999999999743

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-45  Score=359.17  Aligned_cols=247  Identities=21%  Similarity=0.367  Sum_probs=204.1

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|++ .+.||+|+||+||+|.+..++..||||++...    ....+|+.+ ++.++||||+++++++..    ...+|
T Consensus       219 ~~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~----~~~~~  292 (495)
T 1opk_A          219 RTDITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV-MKEIKHPNLVQLLGVCTR----EPPFY  292 (495)
T ss_dssp             GGGEEE-EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHH-HHHCCCTTBCCEEEEECS----SSSCE
T ss_pred             HHHcee-eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHH-HHhcCCCCEeeEEEEEec----CCcEE
Confidence            467888 57899999999999999999999999999632    345678877 666799999999999875    56789


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++                    
T Consensus       293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~--------------------  352 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG--------------------  352 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC--------------------
Confidence            999999999999999876556799999999999999999999999999999999999997                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                             .++.+||+|||+++....... ......+++.|+|||++....++.++|||||||++|+|++ |..||.+.+.
T Consensus       353 -------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~  425 (495)
T 1opk_A          353 -------ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  425 (495)
T ss_dssp             -------GGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             -------CCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence                   566799999999987643221 1223345678999999988889999999999999999999 9999976543


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ..    +...+..+ ...+  ....+++++.+||.+||+.||.+|||+.++++
T Consensus       426 ~~----~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          426 SQ----VYELLEKD-YRME--RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             GG----HHHHHHTT-CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH----HHHHHHcC-CCCC--CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            32    23333322 2222  22478999999999999999999999999977

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.2e-45  Score=339.41  Aligned_cols=247  Identities=20%  Similarity=0.365  Sum_probs=199.1

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEE--EEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVY--ALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~v--aiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++ .+.||+|+||.||+|.+..+|..+  |+|.+...      ....+|+.++.++.+||||+++++++..    .+
T Consensus        25 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~   99 (327)
T 1fvr_A           25 NDIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RG   99 (327)
T ss_dssp             GGCEE-EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----TT
T ss_pred             HHccc-eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee----CC
Confidence            78998 588999999999999999999866  99988632      2355788774444499999999999976    67


Q ss_pred             EEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~  152 (372)
                      ..|+||||+++++|.+++....              ...+++..++.++.||+.||.|||++||+||||||+||+++   
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc---
Confidence            8999999999999999997642              23699999999999999999999999999999999999997   


Q ss_pred             CCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHH
Q psy3151         153 DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM  232 (372)
Q Consensus       153 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  232 (372)
                                              .++.+||+|||++...... .......+|+.|+|||++.+..++.++|||||||++
T Consensus       177 ------------------------~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  231 (327)
T 1fvr_A          177 ------------------------ENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL  231 (327)
T ss_dssp             ------------------------GGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred             ------------------------CCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHH
Confidence                                    5567999999998754321 122334568899999999888899999999999999


Q ss_pred             HHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         233 YILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       233 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |+|++ |..||.+...    ......+..+.. .  .....+++++.+||.+||+.||.+|||+++++++
T Consensus       232 ~ellt~g~~pf~~~~~----~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          232 WEIVSLGGTPYCGMTC----AELYEKLPQGYR-L--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHHHTTSCCTTTTCCH----HHHHHHGGGTCC-C--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCCCcH----HHHHHHhhcCCC-C--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99998 9999965432    223333333211 1  1124689999999999999999999999999885

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.7e-45  Score=341.30  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=202.1

Q ss_pred             ccceeeccccccccCCeEEEEEE----EcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIV----EKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .++|+++ +.||+|+||+||+|.    +..+++.||||++...     ....+|+.+ ++.++||||+++++++..  .+
T Consensus        22 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~--~~   97 (327)
T 3lxl_A           22 ERHLKYI-SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI-LKALHSDFIVKYRGVSYG--PG   97 (327)
T ss_dssp             GGGEEEE-EEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHH-HHTCCCTTBCCEEEEEEC--SS
T ss_pred             hhhhhhh-hhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHH-HHhcCCCceeEEEEEEec--CC
Confidence            4789995 779999999999999    5778999999999643     235678877 667799999999998753  23


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++               
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---------------  161 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---------------  161 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---------------
T ss_pred             CceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---------------
Confidence            677999999999999999998743 3599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.+||+|||++........   ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       162 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p  229 (327)
T 3lxl_A          162 ------------SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK  229 (327)
T ss_dssp             ------------ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             ------------CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence                        567799999999987643322   22335578889999999888899999999999999999999999


Q ss_pred             CCCCCCC---------C--CCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         242 FFSNHGQ---------A--ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       242 f~~~~~~---------~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |......         .  ........+..+. .  .+....+++++.+||.+||+.||.+|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQ-R--LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             GGSHHHHHHHHCC----CCHHHHHHHHHHTTC-C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccccchhhhhcccccccccHHHHHHHhhccc-C--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8543211         0  0011122222221 1  12224789999999999999999999999999764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-44  Score=327.23  Aligned_cols=246  Identities=19%  Similarity=0.359  Sum_probs=201.2

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|++. +.||+|+||.||+|.+. +++.||+|++...    ....+|+.. ++.++||||+++++++..    +...|
T Consensus         7 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~----~~~~~   79 (267)
T 3t9t_A            7 PSELTFV-QEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEV-MMKLSHPKLVQLYGVCLE----QAPIC   79 (267)
T ss_dssp             GGGEEEE-EEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHH-HHTCCCTTBCCEEEEECS----SSSCE
T ss_pred             hhheeee-eEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHH-HHhCCCCCEeeEEEEEcc----CCCeE
Confidence            4789984 77999999999999986 6789999999743    345677777 667799999999999875    56789


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+++++|.+++.... +.+++..++.++.|++.||.|||+.||+||||||+||+++                    
T Consensus        80 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~--------------------  138 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG--------------------  138 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC--------------------
T ss_pred             EEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC--------------------
Confidence            9999999999999998653 4699999999999999999999999999999999999997                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                             .++.+||+|||++....... .......+|+.|+|||++.+..++.++|+|||||++|+|++ |..||.....
T Consensus       139 -------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  211 (267)
T 3t9t_A          139 -------ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN  211 (267)
T ss_dssp             -------GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             -------CCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH
Confidence                   56679999999987653321 12233456778999999988889999999999999999999 8999965432


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                          ......+..+.....   ...++.++.++|.+||+.||.+|||+++++++
T Consensus       212 ----~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          212 ----SEVVEDISTGFRLYK---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ----HHHHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----HHHHHHHhcCCcCCC---CccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                223333433322111   23579999999999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.6e-46  Score=370.21  Aligned_cols=278  Identities=25%  Similarity=0.379  Sum_probs=203.0

Q ss_pred             ccCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEe
Q psy3151           4 TFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDV   77 (372)
Q Consensus         4 ~~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~   77 (372)
                      +|.|.......++|++. +.||.|+||+||+|.+..+|+.||||++...      ....+|+.+ ++.++||||++++++
T Consensus         3 G~~p~~pg~~~grY~i~-~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~i-L~~L~HpnIV~l~~v   80 (676)
T 3qa8_A            3 GRSPSLPTQTCGPWEMK-ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQI-MKKLNHPNVVSAREV   80 (676)
T ss_dssp             --------------CCC-CCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHH-HHHCCBTTBCCEEEC
T ss_pred             CCCCCCCCCCCCCeEEE-EEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHH-HHhCCCCCCCceeee
Confidence            34555556677999995 7799999999999999999999999998532      235568877 566699999999998


Q ss_pred             eeee--cCCceEEEEEEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCC
Q psy3151          78 YENI--YNGSRCLLVIMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDG  154 (372)
Q Consensus        78 ~~~~--~~~~~~~~lv~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~  154 (372)
                      +...  ...+...|+||||+.||+|.+++..... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++  
T Consensus        81 ~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g--  158 (676)
T 3qa8_A           81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP--  158 (676)
T ss_dssp             CTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS--
T ss_pred             ecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC--
Confidence            7531  1235678999999999999999987432 3599999999999999999999999999999999999998433  


Q ss_pred             CceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHH
Q psy3151         155 GILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI  234 (372)
Q Consensus       155 ~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  234 (372)
                                            ....+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus       159 ----------------------~~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLye  215 (676)
T 3qa8_A          159 ----------------------QRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFE  215 (676)
T ss_dssp             ----------------------SSCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHH
T ss_pred             ----------------------CceeEEEcccccccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHH
Confidence                                  2345889999998866432 23345678999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCC-----CCHhHHH-----HHhhCC------ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         235 LLCGFPPFFSNHGQA-----ISPGMKN-----RIRLGQ------FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       235 ll~g~~pf~~~~~~~-----~~~~~~~-----~~~~~~------~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |++|..||.......     .......     ....+.      .+.+......+++++.+||.+||.+||++|||++++
T Consensus       216 LltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          216 CITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             HHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             HHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            999999996531100     0000000     000011      111222234578999999999999999999999999


Q ss_pred             hcCCccccCC
Q psy3151         299 MENKWISQFN  308 (372)
Q Consensus       299 l~hp~~~~~~  308 (372)
                      ++||||+.+.
T Consensus       296 L~hp~F~~l~  305 (676)
T 3qa8_A          296 PNVGCFQALD  305 (676)
T ss_dssp             CCCTTHHHHH
T ss_pred             hcCHHHHHHH
Confidence            9999998754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=343.76  Aligned_cols=256  Identities=16%  Similarity=0.178  Sum_probs=193.4

Q ss_pred             ccceeeccccccccCCeEEEEE-----EEcCCCcEEEEEEecch--hhhHHHHHHHHHhcC---CCCEeEEeEeeeeecC
Q psy3151          14 QDDYDISTEILGLGINGKVLQI-----VEKKTSEVYALKVLHDT--VKARREVELQLAVGS---HKHIVNIKDVYENIYN   83 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~-----~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~---h~ni~~~~~~~~~~~~   83 (372)
                      .++|.+ .+.||+|+||+||+|     .+..+++.||||++...  ....+|+.++ ..+.   |+||+.+++++..   
T Consensus        64 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~-~~l~~~~~~~iv~~~~~~~~---  138 (365)
T 3e7e_A           64 SKLVYV-HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM-ERLKPSMQHMFMKFYSAHLF---  138 (365)
T ss_dssp             SSEEEE-EEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHH-HHSCGGGGGGBCCEEEEEEC---
T ss_pred             CEEEEE-EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHH-HHhhhhhhhhhhhhheeeec---
Confidence            467888 578999999999999     47788999999999743  3445566653 3444   8999999999875   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeee
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQK---EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~---~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                       ++..|+||||+++|+|.+++...   ....+++..++.++.||+.||+|||+.||+||||||+|||++.+....     
T Consensus       139 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~-----  212 (365)
T 3e7e_A          139 -QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ-----  212 (365)
T ss_dssp             -SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             -CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc-----
Confidence             56789999999999999999753   235699999999999999999999999999999999999997411000     


Q ss_pred             ccCCCCccccccCCCCCCCCeeeecccccccccc--CCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVS--NKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                 .......+.+||+|||+|.....  ........+||+.|+|||++.+..|+.++|||||||++|+|++|
T Consensus       213 -----------~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  281 (365)
T 3e7e_A          213 -----------DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG  281 (365)
T ss_dssp             -----------------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred             -----------cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence                       00001368899999999976532  22334567899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCc
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKW  303 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~  303 (372)
                      ..||.........       ....+  ..   ...++.+.+++..||..+|.+|++..+.+.+.+
T Consensus       282 ~~pf~~~~~~~~~-------~~~~~--~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          282 TYMKVKNEGGECK-------PEGLF--RR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             SCCCEEEETTEEE-------ECSCC--TT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             CCccccCCCCcee-------echhc--cc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence            9999654332110       00000  10   124678899999999999999977666555443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-45  Score=338.57  Aligned_cols=246  Identities=19%  Similarity=0.311  Sum_probs=193.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEE----EEEEecc------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVY----ALKVLHD------TVKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ..++|+++ +.||+|+||+||+|.+..+++.+    |+|.+..      .....+|+.+ ++.++||||+++++++..  
T Consensus        13 ~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~--   88 (327)
T 3lzb_A           13 KETEFKKI-KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV-MASVDNPHVCRLLGICLT--   88 (327)
T ss_dssp             CTTTEEEE-EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHH-HTTCCBTTBCCCCEEEES--
T ss_pred             CHhHceEE-EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHH-HHhCCCCCeeEEEEEEec--
Confidence            46899995 78999999999999999888765    6666532      2345667777 677799999999999874  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                         ...++|++|+.+|+|.+++.... +.+++..++.++.||+.||.|||++||+||||||+|||++             
T Consensus        89 ---~~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~-------------  151 (327)
T 3lzb_A           89 ---STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK-------------  151 (327)
T ss_dssp             ---SSEEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-------------
T ss_pred             ---CCceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc-------------
Confidence               23788999999999999998754 4699999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF  239 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  239 (372)
                                    .++.+||+|||++........  ......+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       152 --------------~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~  217 (327)
T 3lzb_A          152 --------------TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS  217 (327)
T ss_dssp             --------------ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             --------------CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCC
Confidence                          566799999999987643222  2223445778999999988899999999999999999999 99


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .||.+.....    +...+..+.. .+  ....++.++.+||.+||..||.+|||+.++++
T Consensus       218 ~p~~~~~~~~----~~~~~~~~~~-~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          218 KPYDGIPASE----ISSILEKGER-LP--QPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CTTTTCCGGG----HHHHHHTTCC-CC--CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHH----HHHHHHcCCC-CC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9997654332    2333333221 11  12368999999999999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.7e-45  Score=330.58  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=196.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcC---CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKK---TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ..++|.+ .+.||+|+||+||+|.+..   ++..||+|++...      ....+|+.+ ++.++||||+++++++..   
T Consensus        10 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~---   84 (281)
T 3cc6_A           10 AREDVVL-NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI-MKNLDHPHIVKLIGIIEE---   84 (281)
T ss_dssp             CGGGEEE-EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHH-HHHHCCTTBCCEEEEECS---
T ss_pred             cccceEE-EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHH-HHhCCCCCcceEEEEEcC---
Confidence            4588998 5889999999999998754   3456999998642      234567777 555699999999999863   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                        ...|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++              
T Consensus        85 --~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~--------------  147 (281)
T 3cc6_A           85 --EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA--------------  147 (281)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE--------------
T ss_pred             --CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC--------------
Confidence              34689999999999999998754 4599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                   .++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       148 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p  214 (281)
T 3cc6_A          148 -------------SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP  214 (281)
T ss_dssp             -------------ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             -------------CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCC
Confidence                         566799999999886643222 2233456788999999988889999999999999999998 9999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |.......    ....+..+...   +....+++++.+||.+||..||.+|||+.+++++
T Consensus       215 ~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          215 FFWLENKD----VIGVLEKGDRL---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TTTSCGGG----HHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCChHH----HHHHHhcCCCC---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            96544332    22333332211   1123689999999999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5e-45  Score=338.35  Aligned_cols=260  Identities=26%  Similarity=0.398  Sum_probs=200.9

Q ss_pred             ccCCCccCCcccce-eeccccccccCCeEEEEEE----EcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEe
Q psy3151           4 TFKPFKTTPIQDDY-DISTEILGLGINGKVLQIV----EKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIV   72 (372)
Q Consensus         4 ~~~~~~~~~~~~~Y-~i~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~   72 (372)
                      ...|.....|.++| ++ .+.||+|+||+||+|.    +..+|+.||||++...      ....+|+.+ ++.++||||+
T Consensus        19 ~~~pg~~~~~~~r~~~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv   96 (318)
T 3lxp_A           19 FQGPGDPTVFHKRYLKK-IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI-LRTLYHEHII   96 (318)
T ss_dssp             -----CCCBCCGGGEEE-EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHH-HHHCCCTTBC
T ss_pred             ecCCCCCceecHHHHhh-hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHH-HHhCCCcchh
Confidence            45666677799999 77 5779999999997765    4458999999999643      234678877 6667899999


Q ss_pred             EEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCC
Q psy3151          73 NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~  152 (372)
                      ++++++..  .+...+++||||+++++|.+++...   .+++..++.++.||+.||.|||+.||+||||||+||+++   
T Consensus        97 ~~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~---  168 (318)
T 3lxp_A           97 KYKGCCED--AGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD---  168 (318)
T ss_dssp             CEEEEEEE--TTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred             hEEEEEec--CCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc---
Confidence            99999875  2346799999999999999999764   399999999999999999999999999999999999998   


Q ss_pred             CCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCCCCCCCccchhhHH
Q psy3151         153 DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLG  229 (372)
Q Consensus       153 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  229 (372)
                                              .++.+||+|||++........   ......+|+.|+|||++.+..++.++||||||
T Consensus       169 ------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  224 (318)
T 3lxp_A          169 ------------------------NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFG  224 (318)
T ss_dssp             ------------------------TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHH
T ss_pred             ------------------------CCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHH
Confidence                                    567899999999987654322   22345578889999999888899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCC-----CCC------HhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         230 VIMYILLCGFPPFFSNHGQ-----AIS------PGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       230 ~il~~ll~g~~pf~~~~~~-----~~~------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |++|+|++|..||......     ...      ..+...+..+. .  .+....+++++.+||.+||+.||.+|||++++
T Consensus       225 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  301 (318)
T 3lxp_A          225 VTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE-R--LPRPDKCPAEVYHLMKNCWETEASFRPTFENL  301 (318)
T ss_dssp             HHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC-C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc-C--CCCCccccHHHHHHHHHHcCCCcccCcCHHHH
Confidence            9999999999998543210     000      01111122111 1  12224789999999999999999999999999


Q ss_pred             hc
Q psy3151         299 ME  300 (372)
Q Consensus       299 l~  300 (372)
                      ++
T Consensus       302 l~  303 (318)
T 3lxp_A          302 IP  303 (318)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-44  Score=326.93  Aligned_cols=244  Identities=17%  Similarity=0.244  Sum_probs=195.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      -.++|++. +.||+|+||+||+|.+.  |+.||||++...       ....+|+.+ ++.++||||+++++++..  ...
T Consensus         8 ~~~~y~~~-~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~--~~~   81 (271)
T 3kmu_A            8 DFKQLNFL-TKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPR-LRIFSHPNVLPVLGACQS--PPA   81 (271)
T ss_dssp             CGGGCEEE-EEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGG-GCCCSCTTEECEEEEECT--TTS
T ss_pred             CHHHhHHH-HHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHH-HHhcCCCchhheEEEEcc--CCC
Confidence            45789994 78999999999999985  889999999632       234456665 566689999999999865  223


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~--ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ...++||||+++|+|.+++.......+++..++.++.||+.||+|||+.|  |+||||||+||+++              
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--------------  147 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID--------------  147 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC--------------
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc--------------
Confidence            67899999999999999998765456999999999999999999999999  99999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCC---ccchhhHHHHHHHHHhCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDK---SCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~~ll~g~~  240 (372)
                                   .++.++++|||++....     .....||+.|+|||++.+..++.   ++|||||||++|+|++|..
T Consensus       148 -------------~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  209 (271)
T 3kmu_A          148 -------------EDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV  209 (271)
T ss_dssp             -------------TTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred             -------------CCcceeEEeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence                         56678888887765432     23457799999999997665554   7999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||.+....    .....+.......  .....+++++.+||.+||+.||++|||++++++
T Consensus       210 p~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          210 PFADLSNM----EIGMKVALEGLRP--TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TTTTSCHH----HHHHHHHHSCCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccccChH----HHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99654322    2222232222221  222468999999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.2e-44  Score=329.71  Aligned_cols=253  Identities=21%  Similarity=0.320  Sum_probs=199.2

Q ss_pred             CCCccCCcccceeeccccccccCCeEEEEEE--EcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeE
Q psy3151           6 KPFKTTPIQDDYDISTEILGLGINGKVLQIV--EKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKD   76 (372)
Q Consensus         6 ~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~--~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~   76 (372)
                      .|.....-.++|++.++.||+|+||+||+|.  +..+++.||||++...       ....+|+.+ ++.++||||+++++
T Consensus         7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~   85 (291)
T 1xbb_A            7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV-MQQLDNPYIVRMIG   85 (291)
T ss_dssp             ----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHH-HHTCCCTTBCCEEE
T ss_pred             CcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHH-HHhCCCCCEEEEEE
Confidence            3444444567899964489999999999994  4667899999998632       234567776 66779999999999


Q ss_pred             eeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCc
Q psy3151          77 VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        77 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                      ++.     ....|+||||+.+++|.+++...  +.+++..++.++.||+.||.|||+.||+||||||+||+++       
T Consensus        86 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~-------  151 (291)
T 1xbb_A           86 ICE-----AESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-------  151 (291)
T ss_dssp             EEE-----SSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-------
T ss_pred             EEC-----CCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe-------
Confidence            984     35689999999999999999875  4599999999999999999999999999999999999998       


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY  233 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  233 (372)
                                          .++.+||+|||++.........   .....+|+.|+|||++.+..++.++|||||||++|
T Consensus       152 --------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  211 (291)
T 1xbb_A          152 --------------------TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW  211 (291)
T ss_dssp             --------------------ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred             --------------------CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHH
Confidence                                4667999999998866433221   22234578899999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         234 ILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       234 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +|++ |..||.+...    ..+...+..+...   .....+++++.++|.+||+.||.+|||+.++++
T Consensus       212 ~l~~~g~~p~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          212 EAFSYGQKPYRGMKG----SEVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHTTTCCSSTTCCH----HHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCCCCCCCH----HHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999 9999965443    2233333333211   112468999999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.7e-44  Score=330.24  Aligned_cols=248  Identities=20%  Similarity=0.341  Sum_probs=188.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      -..++|++ .+.||+|+||+||+|.+.   ..+|||++...       ....+|+.+ ++.++||||++++++..     
T Consensus        21 i~~~~y~~-~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~-----   90 (289)
T 3og7_A           21 IPDGQITV-GQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGV-LRKTRHVNILLFMGYST-----   90 (289)
T ss_dssp             CCTTSCEE-EEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHH-HTTCCCTTBCCEEEEEC-----
T ss_pred             cCccceee-eeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHH-HHhCCCCcEEEEEeecc-----
Confidence            36789999 578999999999999864   35999998632       234567776 67779999999999653     


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++               
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---------------  154 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---------------  154 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---------------
T ss_pred             CCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---------------
Confidence            345899999999999999996543 5699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccC--CCcccccccCCCcCCCcccC---CCCCCCccchhhHHHHHHHHHhCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSN--KASLQTPCYTPYYVAPEVLG---PDKYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~  239 (372)
                                  .++.+||+|||++......  ........||+.|+|||++.   ...++.++|||||||++|+|++|.
T Consensus       155 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  222 (289)
T 3og7_A          155 ------------EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ  222 (289)
T ss_dssp             ------------TTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSS
T ss_pred             ------------CCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCC
Confidence                        5677999999998765321  22234467899999999986   567888999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .||......   ..+...+..+....+. .....+++++.+||.+||+.||.+|||++++++
T Consensus       223 ~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          223 LPYSNINNR---DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CTTSSCCCH---HHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccccchH---HHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999654432   2233344443332221 223468899999999999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.9e-44  Score=329.73  Aligned_cols=250  Identities=18%  Similarity=0.274  Sum_probs=196.0

Q ss_pred             CCcccceeeccccccccCCeEEEEEEEcCC---CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          11 TPIQDDYDISTEILGLGINGKVLQIVEKKT---SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        11 ~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      .+-..+|++ .+.||+|+||+||+|.+..+   +..+|+|.+...      ....+|+.+ ++.++||||+++++++.. 
T Consensus        21 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~-   97 (298)
T 3f66_A           21 GPSSLIVHF-NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-MKDFSHPNVLSLLGICLR-   97 (298)
T ss_dssp             CGGGEEEEE-EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHH-HHTCCCTTBCCCCEEECC-
T ss_pred             Cccceehhh-cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHH-HHhCCCCCEeeeeeEEEc-
Confidence            345678998 58899999999999997543   346899998632      234567776 677799999999998543 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                        .++..|+||||+.+++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++            
T Consensus        98 --~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~------------  162 (298)
T 3f66_A           98 --SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD------------  162 (298)
T ss_dssp             --SSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC------------
T ss_pred             --CCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC------------
Confidence              2567899999999999999997643 5689999999999999999999999999999999999997            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCC----CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK----ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  237 (372)
                                     .++.+||+|||++.......    .......+|+.|+|||++.+..++.++|+|||||++|+|++
T Consensus       163 ---------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  227 (298)
T 3f66_A          163 ---------------EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT  227 (298)
T ss_dssp             ---------------TTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ---------------CCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence                           56789999999998654322    12334556788999999988889999999999999999999


Q ss_pred             -CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         238 -GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       238 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                       |.+||......+    ....+..+.....+   ..+++++.++|.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          228 RGAPPYPDVNTFD----ITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TSCCSSTTSCTTT----HHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCccCCHHH----HHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             566665443332    22333333322221   367899999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.5e-44  Score=327.11  Aligned_cols=250  Identities=21%  Similarity=0.319  Sum_probs=201.6

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ......++|++. +.||+|+||+||+|.+. +++.||||++...    ....+|+.+ ++.++||||+++++++..    
T Consensus         7 ~~~v~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----   79 (279)
T 1qpc_A            7 EWEVPRETLKLV-ERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANL-MKQLQHQRLVRLYAVVTQ----   79 (279)
T ss_dssp             TTBCCGGGEEEE-EEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHH-HHHCCCTTBCCEEEEECS----
T ss_pred             hcccCHHhhhhe-eeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHH-HHhCCCcCcceEEEEEcC----
Confidence            344467899995 77999999999999975 5778999999642    345678877 566699999999998753    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                       +..|+||||+.+++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++               
T Consensus        80 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---------------  143 (279)
T 1qpc_A           80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---------------  143 (279)
T ss_dssp             -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             -CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc---------------
Confidence             3479999999999999999764333599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPF  242 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  242 (372)
                                  .++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       144 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  211 (279)
T 1qpc_A          144 ------------DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY  211 (279)
T ss_dssp             ------------TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             ------------CCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence                        567799999999987644322 2233456788999999988889999999999999999999 99999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .+...    ......+..+...   .....++.++.+||.+||..||++|||++++++
T Consensus       212 ~~~~~----~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          212 PGMTN----PEVIQNLERGYRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             TTCCH----HHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCH----HHHHHHHhcccCC---CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            65432    2233333332211   112468999999999999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-44  Score=327.30  Aligned_cols=247  Identities=19%  Similarity=0.272  Sum_probs=194.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCc---EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSE---VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      -+|.+ ++.||+|+||+||+|.+..+++   .+|+|++...      ....+|+.+ ++.++||||+++++++..   .+
T Consensus        21 ~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~---~~   95 (298)
T 3pls_A           21 VVTHS-DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL-MRGLNHPNVLALIGIMLP---PE   95 (298)
T ss_dssp             EEEEE-EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHH-HHTCCCTTBCCCCEEECC---SS
T ss_pred             eEEcc-CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEec---CC
Confidence            35655 5889999999999999766554   7999998632      234567776 677799999999999864   23


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++                
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~----------------  158 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD----------------  158 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----------------
T ss_pred             CCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----------------
Confidence            44589999999999999997643 5699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccC----CCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSN----KASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                 .++.+||+|||++......    ........+|+.|+|||.+.+..++.++|||||||++|+|++|..|
T Consensus       159 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~  227 (298)
T 3pls_A          159 -----------ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP  227 (298)
T ss_dssp             -----------TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred             -----------CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCC
Confidence                       5677999999998765332    1223345668899999999999999999999999999999996555


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |......   ......+..+...   +....+++++.+||.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          228 PYRHIDP---FDLTHFLAQGRRL---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             TTTTSCG---GGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccCCH---HHHHHHhhcCCCC---CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            4333221   1223333332211   112468999999999999999999999999987

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2e-44  Score=337.08  Aligned_cols=256  Identities=21%  Similarity=0.283  Sum_probs=199.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--hhhHHHHHHHHHh-cCCCCEeEEeEeeeeecCCceEEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAV-GSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~-~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +.++|++ .+.||+|+||+||+|.+  +|+.||||++...  ....+|.+++... ++||||+++++++.........+|
T Consensus        40 ~~~~y~~-~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           40 IARTIVL-QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHHHCEE-EEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             ccccEEE-EeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            5689999 57899999999999998  4999999999643  3445677774443 799999999999876322224799


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH--------DQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH--------~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                      +||||+.+|+|.+++...   .+++..++.++.||+.||.|||        +.||+||||||+|||++            
T Consensus       117 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~------------  181 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK------------  181 (342)
T ss_dssp             EEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC------------
T ss_pred             EEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC------------
Confidence            999999999999999764   4999999999999999999999        89999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCCCC------CCCccchhhHHHH
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGPDK------YDKSCDIWSLGVI  231 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~i  231 (372)
                                     .++.+||+|||++........    .....+||+.|+|||++.+..      ++.++|||||||+
T Consensus       182 ---------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i  246 (342)
T 1b6c_B          182 ---------------KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV  246 (342)
T ss_dssp             ---------------TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHH
Confidence                           567799999999977654332    234457899999999987652      3368999999999


Q ss_pred             HHHHHhC----------CCCCCCCCCCCCCH-hHHHHHhhCCccCCCCc-c--cccCHHHHHHHHHhccCCCCCCCChhH
Q psy3151         232 MYILLCG----------FPPFFSNHGQAISP-GMKNRIRLGQFDFPNPE-W--EHVSQEAKTLIKNMLCVDPSERLTIDQ  297 (372)
Q Consensus       232 l~~ll~g----------~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~--~~~s~~~~~li~~ll~~dP~~R~s~~e  297 (372)
                      +|+|++|          ..||.......... .+...+.........+. +  ...+..+.+||.+||+.||++|||+++
T Consensus       247 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          247 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             HHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence            9999999          78886654433322 23333333322222111 1  234568999999999999999999999


Q ss_pred             HhcC
Q psy3151         298 VMEN  301 (372)
Q Consensus       298 il~h  301 (372)
                      +++|
T Consensus       327 i~~~  330 (342)
T 1b6c_B          327 IKKT  330 (342)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9885

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.6e-44  Score=349.54  Aligned_cols=246  Identities=20%  Similarity=0.367  Sum_probs=200.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ..++|++ .+.||+|+||+||+|.+. ++..||||++...    ....+|+.+ ++.++||||+++++++.     ...+
T Consensus       186 ~~~~~~~-~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~-----~~~~  257 (454)
T 1qcf_A          186 PRESLKL-EKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANV-MKTLQHDKLVKLHAVVT-----KEPI  257 (454)
T ss_dssp             CGGGEEE-EEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHH-HTTCCCTTBCCEEEEEC-----SSSC
T ss_pred             chHHeEE-EEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHH-HhhCCCCCEeeEEEEEe-----CCcc
Confidence            4578988 578999999999999986 4778999999642    345678877 67779999999999875     3458


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++                   
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~-------------------  318 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS-------------------  318 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC-------------------
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC-------------------
Confidence            9999999999999999865434589999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  246 (372)
                              .++.+||+|||+++....... ......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+
T Consensus       319 --------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~  390 (454)
T 1qcf_A          319 --------ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS  390 (454)
T ss_dssp             --------TTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             --------CCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence                    567899999999987643211 1223345678999999988889999999999999999999 999996544


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .    ..+...+..+ ...+.  ...+++++.+||.+||+.||++|||+++++.
T Consensus       391 ~----~~~~~~i~~~-~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          391 N----PEVIRALERG-YRMPR--PENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             H----HHHHHHHHHT-CCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H----HHHHHHHHcC-CCCCC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            3    2233333333 22222  2478999999999999999999999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-44  Score=328.56  Aligned_cols=245  Identities=20%  Similarity=0.341  Sum_probs=193.5

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      --.++|++. +.||+|+||+||+|.+.  |+.||||++...   ....+|+.+ ++.++||||+++++++..   .+...
T Consensus        18 ~~~~~y~~~-~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~---~~~~~   90 (278)
T 1byg_A           18 LNMKELKLL-QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASV-MTQLRHSNLVQLLGVIVE---EKGGL   90 (278)
T ss_dssp             CCGGGEEEE-EEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHH-HTTCCCTTBCCEEEEECC---C--CC
T ss_pred             CChhhceEE-eEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHH-HHhCCCCCEeeEEEEEEc---CCCce
Confidence            346899995 77999999999999874  889999999743   345567777 667799999999998653   24568


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++                   
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~-------------------  151 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-------------------  151 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-------------------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe-------------------
Confidence            9999999999999999875433489999999999999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                              .++.++|+|||++......   .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       152 --------~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  220 (278)
T 1byg_A          152 --------EDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL  220 (278)
T ss_dssp             --------TTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred             --------CCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence                    5677999999998765332   233456889999999988889999999999999999998 9999965443


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .    .....+..+..   ......+++++.++|.+||+.||.+|||+.++++
T Consensus       221 ~----~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          221 K----DVVPRVEKGYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             G----GHHHHHTTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H----HHHHHHhcCCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            2    22333333211   1122468999999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.1e-44  Score=331.95  Aligned_cols=253  Identities=22%  Similarity=0.289  Sum_probs=191.3

Q ss_pred             cccceeeccccccccCCeEEEEEEEcC---CCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKK---TSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      -.++|.+ .+.||+|+||+||+|.+..   +++.||||++...       ....+|+.. ++.++||||+++++++....
T Consensus        32 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           32 DRNLLIL-GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC-MKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CGGGEEE-EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHH-HHTCCCTTBCCCCEEEEC--
T ss_pred             CHHHeee-ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHH-HhcCCCCCeeeeeEEEeecc
Confidence            3478988 5889999999999998865   5668999998632       234567776 67779999999999987522


Q ss_pred             C-CceEEEEEEeccCCCchhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          83 N-GSRCLLVIMECMHGGELFQRIQQK----EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        83 ~-~~~~~~lv~e~~~~g~L~~~i~~~----~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      . +....|+||||+.+++|.+++...    ....+++..++.++.||+.||.|||++||+||||||+||+++        
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~--------  181 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR--------  181 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC--------
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc--------
Confidence            1 122569999999999999998542    235699999999999999999999999999999999999998        


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHH
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL  235 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  235 (372)
                                         .++.+||+|||++........  ......+++.|+|||++.+..++.++|||||||++|+|
T Consensus       182 -------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  242 (313)
T 3brb_A          182 -------------------DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI  242 (313)
T ss_dssp             -------------------TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHH
T ss_pred             -------------------CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHH
Confidence                               567799999999876543221  12334567889999999888999999999999999999


Q ss_pred             Hh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         236 LC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       236 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ++ |..||.+.....    ....+..+...   .....+++++.+||.+||..||.+|||+.+++++
T Consensus       243 ~~~g~~p~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          243 ATRGMTPYPGVQNHE----MYDYLLHGHRL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HTTSCCSSTTCCGGG----HHHHHHTTCCC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCccCCHHH----HHHHHHcCCCC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99 889996654332    23333332211   1224689999999999999999999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-43  Score=327.49  Aligned_cols=246  Identities=21%  Similarity=0.296  Sum_probs=196.1

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecch---------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDT---------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      ++.||+|+||+||+|.+  +++.||||++...         ....+|+.+ ++.++||||+++++++..    +...++|
T Consensus        36 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~----~~~~~lv  108 (307)
T 2nru_A           36 GNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKV-MAKCQHENLVELLGFSSD----GDDLCLV  108 (307)
T ss_dssp             CCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHH-HHHCCCTTBCCEEEEECS----SSSCEEE
T ss_pred             CCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHH-HHhcCCCCeEEEEEEEec----CCceEEE
Confidence            57899999999999986  5889999998531         234567777 666799999999999875    5678999


Q ss_pred             EeccCCCchhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          92 MECMHGGELFQRIQQKE-DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~-~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      |||+++++|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+||+++                     
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~---------------------  167 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD---------------------  167 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---------------------
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc---------------------
Confidence            99999999999997532 34699999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                            .++.+||+|||++........  .....+||+.|+|||++.+ .++.++|+|||||++|+|++|..||......
T Consensus       168 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  240 (307)
T 2nru_A          168 ------EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP  240 (307)
T ss_dssp             ------TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred             ------CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence                  567899999999876543222  1234578999999999865 5889999999999999999999999876655


Q ss_pred             CCCHhHHHHHhhCCccC-------CCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         249 AISPGMKNRIRLGQFDF-------PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~-------~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .....+...+......+       ........+..+.+++.+||+.||.+|||+++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            54444433332221100       011113456789999999999999999999999873

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-44  Score=333.20  Aligned_cols=248  Identities=21%  Similarity=0.369  Sum_probs=193.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCC----cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTS----EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ...+|++ .+.||+|+||+||+|.+..++    ..||||++...      ....+|+.+ ++.++||||+++++++..  
T Consensus        42 ~~~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~--  117 (333)
T 1mqb_A           42 HPSCVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI-MGQFSHHNIIRLEGVISK--  117 (333)
T ss_dssp             CTTTEEE-EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHH-HHTCCCTTBCCEEEEECS--
T ss_pred             ChHHhhc-ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHH-HHhCCCCCCCcEEEEEec--
Confidence            4578888 588999999999999987654    45999998632      234567776 677799999999999875  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        .+..++||||+.+++|.+++.... +.+++..++.++.||+.||.|||+.||+||||||+||+++             
T Consensus       118 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~-------------  181 (333)
T 1mqb_A          118 --YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN-------------  181 (333)
T ss_dssp             --SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-------------
T ss_pred             --CCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC-------------
Confidence              667999999999999999997643 5699999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-G  238 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g  238 (372)
                                    .++.+||+|||++.........   .....+|+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus       182 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g  247 (333)
T 1mqb_A          182 --------------SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG  247 (333)
T ss_dssp             --------------TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             --------------CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCC
Confidence                          5677999999998876433221   122345778999999988889999999999999999998 9


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ..||.....    ..+...+..+. ..+  ....++.++.+||.+||+.||.+|||+.+++++
T Consensus       248 ~~pf~~~~~----~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          248 ERPYWELSN----HEVMKAINDGF-RLP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CCTTTTCCH----HHHHHHHHTTC-CCC--CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCcccCCH----HHHHHHHHCCC-cCC--CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999965432    22333333331 111  124689999999999999999999999999873

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=329.73  Aligned_cols=242  Identities=25%  Similarity=0.440  Sum_probs=189.4

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      .++|++ .+.||+|+||+||+|.+.  ++.||||++...   ....+|+.. ++.++||||+++++++.+      ..|+
T Consensus         7 ~~~~~~-~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~------~~~l   76 (307)
T 2eva_A            7 YKEIEV-EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQ-LSRVNHPNIVKLYGACLN------PVCL   76 (307)
T ss_dssp             GGGEEE-EEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHH-HHHCCCTTBCCEEEBCTT------TTEE
T ss_pred             HhHeee-eeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHH-HhcCCCCCcCeEEEEEcC------CcEE
Confidence            368998 588999999999999985  789999999643   234577777 566799999999998753      2689


Q ss_pred             EEeccCCCchhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          91 IMECMHGGELFQRIQQKED-GAFTEREAAIIMNEICSAIKFLHD---QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~-~~l~~~~~~~i~~qil~~l~~LH~---~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ||||+++++|.+++..... ..+++..++.++.||+.||+|||+   +||+||||||+||+++                 
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~-----------------  139 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV-----------------  139 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE-----------------
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe-----------------
Confidence            9999999999999976432 247899999999999999999999   8999999999999998                 


Q ss_pred             ccccccCCCCCCC-CeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         167 PENLLYTKPGDGG-ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       167 ~~~~~~~~~~~~~-~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                .++ .+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       140 ----------~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          140 ----------AGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             ----------TTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             ----------CCCCEEEEccccccccccc---ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence                      334 379999999876532   223456899999999999999999999999999999999999999654


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ....  .........+.   ..+....++.++.+||.+||+.||.+|||++++++
T Consensus       207 ~~~~--~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          207 GGPA--FRIMWAVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             CSSH--HHHHHHHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccH--HHHHHHHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3221  11222222222   12223478999999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=341.16  Aligned_cols=247  Identities=19%  Similarity=0.269  Sum_probs=187.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCC---cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTS---EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ..|++ .+.||+|+||+||+|.+..++   ..||+|.+...      ....+|+.+ ++.++||||+++++++..   .+
T Consensus        89 ~~~~~-~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~~~~~~~~---~~  163 (373)
T 3c1x_A           89 LIVHF-NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-MKDFSHPNVLSLLGICLR---SE  163 (373)
T ss_dssp             EEEEE-EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTT-STTCCCTTBCCCCEEECC---CS
T ss_pred             ceeec-CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHH-HHhCCCCCcceEEEEEEc---CC
Confidence            45777 578999999999999886433   46899998532      234566666 566799999999998643   24


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +..|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----------------  226 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----------------  226 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----------------
T ss_pred             CCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC----------------
Confidence            56889999999999999997643 4689999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFP  240 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~  240 (372)
                                 .++.+||+|||+++.......    ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+
T Consensus       227 -----------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~  295 (373)
T 3c1x_A          227 -----------EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP  295 (373)
T ss_dssp             -----------TTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             -----------CCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCC
Confidence                       567899999999986543221    1223456788999999988899999999999999999999 677


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ||......+.    ...+..+.....   ...++.++.++|.+||+.||++|||+.+++++
T Consensus       296 p~~~~~~~~~----~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          296 PYPDVNTFDI----TVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             SCTTSCSSCH----HHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHH----HHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8865544332    233333322211   13689999999999999999999999999873

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.1e-44  Score=347.23  Aligned_cols=246  Identities=20%  Similarity=0.327  Sum_probs=195.0

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ..++|++ .+.||+|+||+||+|.+.. +..||||++...    ....+|+.+ ++.++||||+++++++..     ...
T Consensus       182 ~~~~~~~-~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~-----~~~  253 (452)
T 1fmk_A          182 PRESLRL-EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQV-MKKLRHEKLVQLYAVVSE-----EPI  253 (452)
T ss_dssp             CGGGEEE-EEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHH-HHHCCCTTBCCEEEEECS-----SSC
T ss_pred             ChhHcee-eeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHH-HHhCCCCCEeeEEEEEcC-----Cce
Confidence            4578888 5779999999999999974 567999999642    345678877 667799999999998753     458


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++                   
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~-------------------  314 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-------------------  314 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-------------------
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC-------------------
Confidence            9999999999999999765445699999999999999999999999999999999999997                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  246 (372)
                              .++.+||+|||+++....... ......+|+.|+|||++....++.++|||||||++|+|++ |..||.+..
T Consensus       315 --------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  386 (452)
T 1fmk_A          315 --------ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  386 (452)
T ss_dssp             --------GGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             --------CCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence                    566799999999986643221 1223345778999999988889999999999999999999 999996543


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .    ..+...+..+ ...+.  ...+++++.+||.+||+.||++|||++++++
T Consensus       387 ~----~~~~~~i~~~-~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          387 N----REVLDQVERG-YRMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             H----HHHHHHHHTT-CCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H----HHHHHHHHcC-CCCCC--CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2    2233333333 22222  2368999999999999999999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.2e-45  Score=339.83  Aligned_cols=266  Identities=14%  Similarity=0.211  Sum_probs=191.6

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------------hhhHHHHHHHHHhc--------CCCCE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------------VKARREVELQLAVG--------SHKHI   71 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~--------~h~ni   71 (372)
                      ..++|++. +.||+|+||+||+|++  +|+.||||++...             ....+|+.++..+.        .||||
T Consensus        18 ~~~~y~~~-~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           18 PTEKLQRC-EKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             CHHHHHTC-EEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             ccccchhe-eeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            34889985 7799999999999998  6899999999643             45678888755543        47777


Q ss_pred             eEEeEeeeee--------------------------cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHH
Q psy3151          72 VNIKDVYENI--------------------------YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC  125 (372)
Q Consensus        72 ~~~~~~~~~~--------------------------~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil  125 (372)
                      +++.+++...                          ..++..+|+||||+.+|++.+.+.+   +.+++..++.++.||+
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT  171 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence            7777764311                          0125689999999999987777644   4589999999999999


Q ss_pred             HHHHHHH-HCCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCccccccc
Q psy3151         126 SAIKFLH-DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY  204 (372)
Q Consensus       126 ~~l~~LH-~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~g  204 (372)
                      .||+||| +.||+||||||+|||++.++...    .+++......   ..+.....+||+|||+|+....     ...+|
T Consensus       172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~----~~~~~~~~~~---~~~~~~~~vkL~DFG~a~~~~~-----~~~~g  239 (336)
T 2vuw_A          172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKK----LHYTLNGKSS---TIPSCGLQVSIIDYTLSRLERD-----GIVVF  239 (336)
T ss_dssp             HHHHHHHHHHCCBCSCCCGGGEEEEECSCSE----EEEEETTEEE---EEECTTEEEEECCCTTCBEEET-----TEEEC
T ss_pred             HHHHHHHHhCCEeECCCCHHHEEEeccCCcc----eeeeccCccc---cccCCCceEEEeeccccEecCC-----CcEEE
Confidence            9999999 99999999999999998644211    0111000000   0001233799999999987643     24589


Q ss_pred             CCCcCCCcccCCCCCCCccchhhHHHH-HHHHHhCCCCCCCCCCCCCCHhHHHHHh-hCCcc--CCCCcccccCHHHHHH
Q psy3151         205 TPYYVAPEVLGPDKYDKSCDIWSLGVI-MYILLCGFPPFFSNHGQAISPGMKNRIR-LGQFD--FPNPEWEHVSQEAKTL  280 (372)
Q Consensus       205 t~~y~aPE~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~s~~~~~l  280 (372)
                      |+.|+|||++.+.. +.++||||+|++ .+++++|..||....   ........+. .....  .+.+.+..+++++++|
T Consensus       240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHH
T ss_pred             eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHH
Confidence            99999999998766 889999998777 778889999983210   0001111221 11111  1222345688999999


Q ss_pred             HHHhccCCCCCCCChhHHh-cCCccc
Q psy3151         281 IKNMLCVDPSERLTIDQVM-ENKWIS  305 (372)
Q Consensus       281 i~~ll~~dP~~R~s~~eil-~hp~~~  305 (372)
                      |++||+.|     ||+|+| +||||+
T Consensus       316 i~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             HHHHhccC-----CHHHHHhcCCCcC
Confidence            99999977     999999 999995

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.4e-43  Score=355.21  Aligned_cols=238  Identities=22%  Similarity=0.340  Sum_probs=191.2

Q ss_pred             cccccccCCeEEEEEEE--cCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          21 TEILGLGINGKVLQIVE--KKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      ++.||+|+||+||+|.+  ..+++.||||++...       ....+|+.+ +..++||||++++++++.     ...++|
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~-----~~~~lv  447 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV-MQQLDNPYIVRMIGICEA-----ESWMLV  447 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHH-HHHCCCTTBCCEEEEEES-----SSEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEec-----CCEEEE
Confidence            34699999999999954  567799999999642       245678877 566699999999998863     347899


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      |||+.+|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                      
T Consensus       448 ~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~----------------------  503 (635)
T 4fl3_A          448 MEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----------------------  503 (635)
T ss_dssp             EECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----------------------
T ss_pred             EEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe----------------------
Confidence            9999999999999765  4599999999999999999999999999999999999998                      


Q ss_pred             cCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q psy3151         172 YTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG  247 (372)
Q Consensus       172 ~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  247 (372)
                           .++.+||+|||+|+.......   ......+|+.|+|||++....++.++|||||||++|+|++ |..||.+...
T Consensus       504 -----~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~  578 (635)
T 4fl3_A          504 -----TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG  578 (635)
T ss_dssp             -----ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             -----CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence                 566799999999987643322   1223445788999999988899999999999999999998 9999976543


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .    .+...+..+... +  ....+++++.+||.+||+.||++|||++++++
T Consensus       579 ~----~~~~~i~~~~~~-~--~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          579 S----EVTAMLEKGERM-G--CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             H----HHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             H----HHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            2    234444433221 1  12368999999999999999999999999976

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=329.40  Aligned_cols=253  Identities=23%  Similarity=0.354  Sum_probs=197.7

Q ss_pred             cccceeeccccccccCCeEEEEEE----EcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIV----EKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ..++|+++ +.||+|+||.||+|.    +..+|+.||||++...     ....+|+.+ ++.++||||+++++++..  .
T Consensus        39 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~--~  114 (326)
T 2w1i_A           39 EERHLKFL-QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI-LKSLQHDNIVKYKGVCYS--A  114 (326)
T ss_dssp             CGGGEEEE-EEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHH-HHTCCCTTBCCEEEEECC---
T ss_pred             CHHHceee-eeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEEe--c
Confidence            45678884 779999999999998    5678999999998642     245577777 667799999999998764  1


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      +...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++              
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~--------------  179 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE--------------  179 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE--------------
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc--------------
Confidence            2346899999999999999998754 4599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                   .++.+||+|||++.........   .....+|+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       180 -------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~  246 (326)
T 2w1i_A          180 -------------NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE  246 (326)
T ss_dssp             -------------ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTC
T ss_pred             -------------CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCC
Confidence                         5667999999999876443221   223456778999999988889999999999999999999999


Q ss_pred             CCCCCC--------CCCCCH----hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         241 PFFSNH--------GQAISP----GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       241 pf~~~~--------~~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||....        ......    .+...+..+. ..+  ....+++++.+||.+||..||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          247 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG-RLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             GGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC-CCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHhhccccchhhhHHHHHHHhhcCC-CCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            985321        000000    1111222111 111  22468999999999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=352.21  Aligned_cols=244  Identities=25%  Similarity=0.391  Sum_probs=193.9

Q ss_pred             cceeeccccccccCCeEEEEEEEc--CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK--KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|.+.+..||+|+||+||+|.+.  .++..||||++...      ....+|+.+ ++.++||||+++++++..     .
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~-----~  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI-MHQLDNPYIVRLIGVCQA-----E  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHH-HTTCCCTTBCCEEEEEES-----S
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHH-HHhCCCCCEeeEEEEecc-----C
Confidence            345554436999999999999876  35678999999632      345678877 667799999999999863     3


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++                 
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-----------------  470 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-----------------  470 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-----------------
T ss_pred             CeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc-----------------
Confidence            4899999999999999997543 5699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPF  242 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  242 (372)
                                .++.+||+|||+++........   .....+|+.|+|||++....++.++|||||||++|||++ |..||
T Consensus       471 ----------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf  540 (613)
T 2ozo_A          471 ----------NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY  540 (613)
T ss_dssp             ----------ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ----------CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence                      5667999999999876432221   222345688999999988899999999999999999998 99999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCc-cCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQF-DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .+...    ..+...+..+.. ..|    ..+++++.+||.+||+.||++|||++++++
T Consensus       541 ~~~~~----~~~~~~i~~~~~~~~p----~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          541 KKMKG----PEVMAFIEQGKRMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TTCCS----HHHHHHHHTTCCCCCC----TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCCCH----HHHHHHHHcCCCCCCC----CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            76543    234444444332 222    368999999999999999999999999854

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-44  Score=344.61  Aligned_cols=246  Identities=18%  Similarity=0.199  Sum_probs=185.1

Q ss_pred             ceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCC-CCE---------------
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSH-KHI---------------   71 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h-~ni---------------   71 (372)
                      .|.+ +++||+|+||+||+|.+..+|+.||||++...        ....+|+.+ +..+.| +|+               
T Consensus        79 ~~~~-~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~-~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           79 TLVR-GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR-LRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHG-GGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             eEEE-ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHH-HHhhccCCCHHHHHHhcccccchhh
Confidence            4666 68899999999999999999999999998621        233466655 445555 221               


Q ss_pred             ------eEEeEeeeeec-CCceEEEEEEeccCCCchhHHHHh-----ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy3151          72 ------VNIKDVYENIY-NGSRCLLVIMECMHGGELFQRIQQ-----KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHR  139 (372)
Q Consensus        72 ------~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~i~~-----~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHr  139 (372)
                            ..+..++.... .....++++|+++ +++|.+++..     ...+.+++..+..++.||+.||+|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                  11111111100 0012367778877 6799998852     223458888999999999999999999999999


Q ss_pred             CCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCccc-----
Q psy3151         140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL-----  214 (372)
Q Consensus       140 Dlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~-----  214 (372)
                      ||||+|||++                           .++.+||+|||+++.....   ....+| +.|+|||++     
T Consensus       236 DiKp~NILl~---------------------------~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~  284 (413)
T 3dzo_A          236 YLRPVDIVLD---------------------------QRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERML  284 (413)
T ss_dssp             CCCGGGEEEC---------------------------TTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTS
T ss_pred             CcccceEEEe---------------------------cCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhcccc
Confidence            9999999998                           5677999999998865432   455677 999999998     


Q ss_pred             -----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCC
Q psy3151         215 -----GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDP  289 (372)
Q Consensus       215 -----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP  289 (372)
                           ....|+.++|||||||++|+|++|+.||...........+        +    ..+..+++++.+||.+||+.||
T Consensus       285 ~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~--------~----~~~~~~~~~~~~li~~~l~~dP  352 (413)
T 3dzo_A          285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI--------F----RSCKNIPQPVRALLEGFLRYPK  352 (413)
T ss_dssp             TTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG--------G----SSCCCCCHHHHHHHHHHTCSSG
T ss_pred             ccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH--------H----hhcccCCHHHHHHHHHHccCCh
Confidence                 6667889999999999999999999999765433322111        1    1123678999999999999999


Q ss_pred             CCCCChhHHhcCCccccC
Q psy3151         290 SERLTIDQVMENKWISQF  307 (372)
Q Consensus       290 ~~R~s~~eil~hp~~~~~  307 (372)
                      ++|||+.++++||||+.+
T Consensus       353 ~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          353 EDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             GGSCCHHHHTTSHHHHHH
T ss_pred             hhCcCHHHHHhCHHHHHH
Confidence            999999999999999764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.7e-43  Score=323.29  Aligned_cols=247  Identities=21%  Similarity=0.341  Sum_probs=190.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcC-CCc--EEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKK-TSE--VYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~-~~~--~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      ..++|++. +.||+|+||+||+|.+.. +++  .||||++...        ....+|+.. ++.++||||+++++++.. 
T Consensus        16 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~-   92 (291)
T 1u46_A           16 GEKDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA-MHSLDHRNLIRLYGVVLT-   92 (291)
T ss_dssp             CGGGEEEE-EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHH-HHHCCCTTBCCEEEEECS-
T ss_pred             chhHeeee-eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHH-HHhCCCCCcccEEEEEcc-
Confidence            45789995 779999999999998653 333  6899988532        234567777 566699999999999874 


Q ss_pred             cCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          82 YNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        82 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                         + ..++||||+.+++|.+++.... +.+++..++.++.||+.||.|||+.||+||||||+||+++            
T Consensus        93 ---~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~------------  155 (291)
T 1u46_A           93 ---P-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA------------  155 (291)
T ss_dssp             ---S-SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE------------
T ss_pred             ---C-CceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc------------
Confidence               2 3789999999999999998753 4599999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-  237 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-  237 (372)
                                     .++.+||+|||++........   ......+|+.|+|||++.+..++.++|||||||++|+|++ 
T Consensus       156 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~  220 (291)
T 1u46_A          156 ---------------TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY  220 (291)
T ss_dssp             ---------------ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred             ---------------CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence                           566799999999887644322   1223456778999999988889999999999999999999 


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |..||.+...    ......+.......+  ....++.++.++|.+||..||.+|||+.++++
T Consensus       221 g~~p~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          221 GQEPWIGLNG----SQILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             SCCTTTTCCH----HHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccCCH----HHHHHHHHccCCCCC--CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999965542    223334433332222  22478999999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=351.02  Aligned_cols=246  Identities=20%  Similarity=0.327  Sum_probs=199.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ..++|++ .+.||+|+||+||+|.+.. +..||||++...    ....+|+.+ ++.++||||+++++++..     ..+
T Consensus       265 ~~~~~~~-~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~-----~~~  336 (535)
T 2h8h_A          265 PRESLRL-EVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQV-MKKLRHEKLVQLYAVVSE-----EPI  336 (535)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHH-HHHCCCTTBCCEEEEECS-----SSC
T ss_pred             chhhhhh-heecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHH-HHhCCCCCEeeEEEEEee-----ccc
Confidence            4578888 5779999999999999964 567999999642    345678887 667799999999998753     458


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      |+||||+.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++                   
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~-------------------  397 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-------------------  397 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-------------------
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc-------------------
Confidence            9999999999999999764445699999999999999999999999999999999999997                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNH  246 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  246 (372)
                              .++.+||+|||+++....... ......++..|+|||++....++.++|||||||++|+|++ |..||.+..
T Consensus       398 --------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~  469 (535)
T 2h8h_A          398 --------ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  469 (535)
T ss_dssp             --------GGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred             --------CCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence                    566799999999986543211 1223345678999999988889999999999999999999 999996543


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .    ..+...+..+ ...+.  ...++.++.+||.+||+.||++|||++++++
T Consensus       470 ~----~~~~~~i~~~-~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          470 N----REVLDQVERG-YRMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             H----HHHHHHHHTT-CCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H----HHHHHHHHcC-CCCCC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            2    2233333333 22221  2368999999999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=320.68  Aligned_cols=244  Identities=21%  Similarity=0.308  Sum_probs=191.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ..++|++ .+.||+|+||.||+|.+..   .+|+|++...       ....+|+.. ++.++||||+++++++..    .
T Consensus        31 ~~~~~~~-~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~----~  101 (319)
T 2y4i_B           31 PFEQLEI-GELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMA-YRQTRHENVVLFMGACMS----P  101 (319)
T ss_dssp             CCSCEEC-CCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGG-GTTCCCTTBCCCCEEEEC----S
T ss_pred             CHHHeEE-eeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHH-HhcCCCCCEeEEEEEEec----C
Confidence            4588998 5889999999999999853   4999998632       234567776 667799999999999875    5


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+||+++                
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----------------  164 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----------------  164 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----------------
T ss_pred             CceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----------------
Confidence            67999999999999999997643 4699999999999999999999999999999999999995                


Q ss_pred             CccccccCCCCCCCCeeeecccccccccc-----CCCcccccccCCCcCCCcccCC---------CCCCCccchhhHHHH
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVS-----NKASLQTPCYTPYYVAPEVLGP---------DKYDKSCDIWSLGVI  231 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~i  231 (372)
                                  ++.++|+|||++.....     .........||+.|+|||++..         ..++.++|||||||+
T Consensus       165 ------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i  232 (319)
T 2y4i_B          165 ------------NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI  232 (319)
T ss_dssp             --------------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred             ------------CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence                        34688888888765422     1122334568999999999864         457889999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         232 MYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       232 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +|+|++|..||.....    ......+..+...  ......++.++.++|.+||..||.+|||+.++++
T Consensus       233 l~el~~g~~p~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          233 WYELHAREWPFKTQPA----EAIIWQMGTGMKP--NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHHHHHSSCSSSSCCH----HHHHHHHHTTCCC--CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             HHHHHhCCCCCCCCCH----HHHHHHhccCCCC--CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999965432    2223333333222  1222357899999999999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-42  Score=349.41  Aligned_cols=245  Identities=22%  Similarity=0.366  Sum_probs=195.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCC---CcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKT---SEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ..++|++ .+.||+|+||+||+|.+..+   +..||||.+...      ....+|+.+ ++.++||||+++++++.    
T Consensus       388 ~~~~y~i-~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~----  461 (656)
T 2j0j_A          388 QRERIEL-GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT-MRQFDHPHIVKLIGVIT----  461 (656)
T ss_dssp             CGGGEEE-EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHH-HHHCCCTTBCCEEEEEC----
T ss_pred             ccccEEE-eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEe----
Confidence            4578988 57899999999999998654   567999998632      234567776 66779999999999874    


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ++..|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++              
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~--------------  525 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS--------------  525 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--------------
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe--------------
Confidence             345899999999999999998653 4599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                   .++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       526 -------------~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~P  592 (656)
T 2j0j_A          526 -------------SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP  592 (656)
T ss_dssp             -------------ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             -------------CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCC
Confidence                         566799999999987643222 1223456788999999988889999999999999999997 9999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |.+....    .....+..+. ...+    ..+++++.+||.+||..||.+|||+.++++
T Consensus       593 f~~~~~~----~~~~~i~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          593 FQGVKNN----DVIGRIENGERLPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             TTTCCHH----HHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHH----HHHHHHHcCCCCCCC----ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9654432    2333333332 2222    368999999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.8e-42  Score=314.28  Aligned_cols=223  Identities=15%  Similarity=0.090  Sum_probs=177.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      -+.++|++. +.||+|+||.||+|.+..+|+.||||++...        ....+|+.. +..++||||+++++++..   
T Consensus        28 ~~~~~y~i~-~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~hp~iv~~~~~~~~---  102 (286)
T 3uqc_A           28 IANGRYRLL-IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLR-LSRIDKPGVARVLDVVHT---  102 (286)
T ss_dssp             ETTTTEEEE-EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHH-HHTCCCTTBCCEEEEEEE---
T ss_pred             EecCcEEEE-EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHH-HhcCCCCCcceeeEEEEE---
Confidence            467899995 7899999999999999999999999999632        334567766 677799999999999976   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                       ++..|+||||++|++|.+++..   + ....++..++.||+.||+|||++||+||||||+|||++              
T Consensus       103 -~~~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~--------------  163 (286)
T 3uqc_A          103 -RAGGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS--------------  163 (286)
T ss_dssp             -TTEEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE--------------
T ss_pred             -CCcEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc--------------
Confidence             6779999999999999999853   2 46677899999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   .++.+||+++                    .|++|       ++.++|||||||++|+|++|..||.
T Consensus       164 -------------~~g~~kl~~~--------------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~  203 (286)
T 3uqc_A          164 -------------IDGDVVLAYP--------------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLP  203 (286)
T ss_dssp             -------------TTSCEEECSC--------------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSC
T ss_pred             -------------CCCCEEEEec--------------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCC
Confidence                         5667888743                    24443       7899999999999999999999997


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +.+.......... ...+....+......+++++.+||.+||+.||.+| |++++++
T Consensus       204 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          204 EAGVRSGLAPAER-DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             CCSBCCCSEECCB-CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             cCCcchhhHHHHH-HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            7654331100000 00111111111224689999999999999999999 9999987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-42  Score=350.59  Aligned_cols=242  Identities=24%  Similarity=0.312  Sum_probs=193.4

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcC-CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC-
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKK-TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN-   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~-   83 (372)
                      .+.++|++. +.||+|+||+||+|.+.. +|+.||||++...      ....+|+.+ +..++||||+++++++..... 
T Consensus        77 ~~~~~y~i~-~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           77 IVAGQYEVK-GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF-LAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             EETTTEEEE-EEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGG-GGGCCCTTBCCEEEEEEEECTT
T ss_pred             EeCCceEEE-EEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHH-HHhcCCCCcCeEeeeEeecCCC
Confidence            356899994 789999999999999976 7999999998532      233567766 567799999999999976332 


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      +....|+||||+.|++|.+++..    .+++..++.++.||+.||.|||++||+||||||+|||++              
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~--------------  216 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT--------------  216 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--------------
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe--------------
Confidence            22337999999999999987754    499999999999999999999999999999999999997              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   . +.+||+|||++......    ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.
T Consensus       217 -------------~-~~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~  277 (681)
T 2pzi_A          217 -------------E-EQLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRN  277 (681)
T ss_dssp             -------------S-SCEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEET
T ss_pred             -------------C-CcEEEEecccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCc
Confidence                         2 36899999999866432    456789999999998654 4889999999999999999999886


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      +.......              ........++.+.+||.+||+.||.+||++.+++.|+|+.-
T Consensus       278 ~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          278 GRYVDGLP--------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             TEECSSCC--------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cccccccc--------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            43222110              00111235788999999999999999999999999998753

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3e-36  Score=299.58  Aligned_cols=182  Identities=15%  Similarity=0.084  Sum_probs=131.2

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecch---------------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHDT---------------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .+.|+.|.+..++....|+.||||++...               ....+|++++.++..|+||+++++++++    +..+
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed----~~~~  317 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN----AQSG  317 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC----SSEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE----CCEE
Confidence            67788888888888888999999999532               2356788886667789999999999987    7889


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ||||||++|++|.++|...  +++++.   .|+.||+.||+|||++|||||||||+|||++                   
T Consensus       318 yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~-------------------  373 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD-------------------  373 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC-------------------
T ss_pred             EEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC-------------------
Confidence            9999999999999999865  457765   4789999999999999999999999999998                   


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                              .++.+||+|||+|+..........+.+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus       374 --------~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          374 --------ARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --------TTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             --------CCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence                    6778999999999887665566677899999999999975 4678899999999998876664443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=3.6e-29  Score=247.32  Aligned_cols=178  Identities=16%  Similarity=0.169  Sum_probs=134.5

Q ss_pred             eccccccccCCeEEEEEEEcCCCcEEEEEEecch-------------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          19 ISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        19 i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      +.++.||+|+||+||+|.  ..++.+|+|.....             .+..+|+.+ ++.++||||+.+..++..    .
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~h~nIv~~~~~~~~----~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARY-LALVKDFGIPAPYIFDVD----L  411 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHH-HHHGGGGTCCCCCEEEEE----T
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHH-HHhcCCCCcCceEEEEEe----C
Confidence            446789999999999994  45888999986321             124678887 566699999944333322    3


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ...|+||||+++++|.+++..          +..++.||+.||+|||++||+||||||+|||++                
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~----------------  465 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD----------------  465 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES----------------
T ss_pred             CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC----------------
Confidence            346999999999999998854          568999999999999999999999999999997                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCc-------ccccccCCCcCCCcccCC--CCCCCccchhhHHHHHHHHH
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS-------LQTPCYTPYYVAPEVLGP--DKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll  236 (372)
                                 .  .+||+|||+|+........       ..+.+||+.|+|||++..  ..|+..+|+||..+-..+..
T Consensus       466 -----------~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v  532 (540)
T 3en9_A          466 -----------K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV  532 (540)
T ss_dssp             -----------S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred             -----------C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence                       3  7999999999876542221       245689999999999976  56888899999988888887


Q ss_pred             hCCCCC
Q psy3151         237 CGFPPF  242 (372)
Q Consensus       237 ~g~~pf  242 (372)
                      .++.+|
T Consensus       533 ~~r~rY  538 (540)
T 3en9_A          533 ERRARY  538 (540)
T ss_dssp             HTCSCC
T ss_pred             Hhcccc
Confidence            776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.2e-25  Score=204.43  Aligned_cols=147  Identities=19%  Similarity=0.231  Sum_probs=113.6

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecch-----------------------hhhHHHHHHHHHhcCCCCEeEEeEe
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------------------VKARREVELQLAVGSHKHIVNIKDV   77 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------------~~~~~e~~~~~~~~~h~ni~~~~~~   77 (372)
                      .+.||+|+||.||+|.+ .+|+.||||++...                       ....+|+.++.++ +  | +++.++
T Consensus        95 ~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~v~~~  169 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LAVPKV  169 (282)
T ss_dssp             EEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SSSCCE
T ss_pred             cCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CCcCeE
Confidence            37799999999999999 88999999998521                       2346788885444 4  4 566665


Q ss_pred             eeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          78 YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        78 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      +..     +..|+||||++|++|.+ +.      .  .....++.||+.||.|||+.||+||||||+|||++        
T Consensus       170 ~~~-----~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~--------  227 (282)
T 1zar_A          170 YAW-----EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--------  227 (282)
T ss_dssp             EEE-----ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE--------
T ss_pred             Eec-----cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE--------
Confidence            542     45699999999999988 31      1  23457999999999999999999999999999996        


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC----------CCCCCccchhh
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP----------DKYDKSCDIWS  227 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diws  227 (372)
                                          ++.+||+|||+|..             +..+.|||.+..          ..|+..+|+|.
T Consensus       228 --------------------~~~vkl~DFG~a~~-------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          228 --------------------EEGIWIIDFPQSVE-------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             --------------------TTEEEECCCTTCEE-------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             --------------------CCcEEEEECCCCeE-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence                                34599999999864             445789998743          34555666664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.6e-21  Score=174.95  Aligned_cols=132  Identities=16%  Similarity=0.219  Sum_probs=99.7

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcE--EEEEEecch-----------------------------hhhHHHHHHHHHh
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEV--YALKVLHDT-----------------------------VKARREVELQLAV   65 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~-----------------------------~~~~~e~~~~~~~   65 (372)
                      |.+ .+.||+|+||.||+|.+..+|+.  ||||++...                             ....+|+..+ ..
T Consensus        49 ~~i-~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~  126 (258)
T 1zth_A           49 TAM-GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL-ER  126 (258)
T ss_dssp             EEE-EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH-HH
T ss_pred             hhh-CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH-HH
Confidence            566 57899999999999999778999  999986421                             1345677774 44


Q ss_pred             cCCCCE--eEEeEeeeeecCCceEEEEEEeccCC-C----chhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCce
Q psy3151          66 GSHKHI--VNIKDVYENIYNGSRCLLVIMECMHG-G----ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH-DQNIA  137 (372)
Q Consensus        66 ~~h~ni--~~~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH-~~~iv  137 (372)
                      +.|+|+  +.++..        ...++||||+.+ |    +|.+....     .++..+..++.||+.||.||| +.||+
T Consensus       127 l~~~~i~~p~~~~~--------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~giv  193 (258)
T 1zth_A          127 AKEAGVSVPQPYTY--------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELV  193 (258)
T ss_dssp             HHHTTCCCCCEEEE--------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEE
T ss_pred             HHhCCCCCCeEEEc--------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            456653  333332        235899999932 3    56655422     346678899999999999999 99999


Q ss_pred             ecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeecccccccc
Q psy3151         138 HRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI  192 (372)
Q Consensus       138 HrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~  192 (372)
                      ||||||+|||++                           .  .++|+|||+|...
T Consensus       194 HrDlkp~NILl~---------------------------~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYI---------------------------D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEES---------------------------S--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEc---------------------------C--cEEEEECcccccC
Confidence            999999999996                           3  6999999998754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=5.2e-19  Score=165.44  Aligned_cols=142  Identities=13%  Similarity=0.148  Sum_probs=93.8

Q ss_pred             eeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh---------------------------hhHHHHHHHHHhcCCC
Q psy3151          17 YDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV---------------------------KARREVELQLAVGSHK   69 (372)
Q Consensus        17 Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------------~~~~e~~~~~~~~~h~   69 (372)
                      |.| ...||.|++|.||+|.+. +|+.||||+++...                           .+.+|...+.++ .+.
T Consensus        97 Y~I-~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~  173 (397)
T 4gyi_A           97 YSV-GSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEE  173 (397)
T ss_dssp             SEE-EEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHT
T ss_pred             EEe-cCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hhc
Confidence            777 577999999999999985 69999999874210                           012334332222 222


Q ss_pred             CEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeee
Q psy3151          70 HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYT  149 (372)
Q Consensus        70 ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~  149 (372)
                      ++.. ...+..     ...++||||+.|++|..+.        ....+..++.||+.+|.+||+.|||||||||.|||++
T Consensus       174 gv~v-p~p~~~-----~~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          174 GFPV-PEPIAQ-----SRHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR  239 (397)
T ss_dssp             TCSC-CCEEEE-----ETTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred             CCCC-Ceeeec-----cCceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence            2211 111111     1137999999998886532        2234567889999999999999999999999999998


Q ss_pred             cCCCCCceeeeccCCCCccccccCCCCCCCCeeeecccccccc
Q psy3151         150 KPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI  192 (372)
Q Consensus       150 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~  192 (372)
                      .+++....                 .+....+.|+||+.+...
T Consensus       240 ~dgd~~d~-----------------~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          240 EEKDAEDP-----------------SSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEECSSCT-----------------TSEEEEEEECCCTTCEET
T ss_pred             CCCCcccc-----------------cccccceEEEEeCCcccC
Confidence            65431000                 001123789999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=1.1e-12  Score=117.32  Aligned_cols=106  Identities=16%  Similarity=0.159  Sum_probs=80.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-----hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-----TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .+.|++ ...+|.|+.+.||++...  +..+++|+...     .....+|.+.+..+..+..++++++++..    ....
T Consensus        13 l~~~~~-~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----~~~~   85 (263)
T 3tm0_A           13 IEKYRC-VKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH----DGWS   85 (263)
T ss_dssp             HTTSEE-EECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE----TTEE
T ss_pred             hcccee-EeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec----CCce
Confidence            356887 466888899999998753  68899999853     23467888886666567778888888764    5678


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD  133 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~  133 (372)
                      |+|||+++|.+|.+.+       .+......++.++..+|..||+
T Consensus        86 ~lv~e~i~G~~l~~~~-------~~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEY-------EDEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             EEEEECCSSEEHHHHC-------CTTTCHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEecCCeehhhcc-------CCcccHHHHHHHHHHHHHHHhC
Confidence            9999999999987653       1223345788899999999998

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=3.5e-11  Score=106.91  Aligned_cols=108  Identities=13%  Similarity=0.088  Sum_probs=70.7

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--hhhHHHHHHHHHhcCCC-CEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSHK-HIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h~-ni~~~~~~~~~~~~~~~~~   88 (372)
                      .....|.+ ..+.+.|..+.||++.. .+|..+++|+....  ....+|.+.+..+..+. .+++++.+...    ++..
T Consensus        17 ~~~~~~~~-~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~----~~~~   90 (264)
T 1nd4_A           17 ERLFGYDW-AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE----AGRD   90 (264)
T ss_dssp             TTTTTCEE-EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC----SSCE
T ss_pred             HhcCCCce-EecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC----CCCC
Confidence            34456776 45344666799999864 56788999998653  34567888755554441 25567776653    4558


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN  135 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~  135 (372)
                      ++||||++|.+|.  . .    ..+.   ..++.+++..|..||+..
T Consensus        91 ~~v~e~i~G~~l~--~-~----~~~~---~~~~~~l~~~l~~lh~~~  127 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--S-S----HLAP---AEKVSIMADAMRRLHTLD  127 (264)
T ss_dssp             EEEEECCSSEETT--T-S----CCCH---HHHHHHHHHHHHHHTTSC
T ss_pred             EEEEEecCCcccC--c-C----cCCH---hHHHHHHHHHHHHHhCCC
Confidence            9999999998884  1 1    1222   256677777888888643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.03  E-value=6.5e-10  Score=103.87  Aligned_cols=105  Identities=17%  Similarity=0.233  Sum_probs=73.5

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEec--c------hhhhHHHHHHHHHhcC-CCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLH--D------TVKARREVELQLAVGS-HKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~------~~~~~~e~~~~~~~~~-h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      +.|+.|.++.||++...  +..+++|+..  .      .....+|...+..+.. +..+++++.++.+.. .....|+||
T Consensus        44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~-~~g~~~~vm  120 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES-VIGRAFYIM  120 (359)
T ss_dssp             EECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT-TTSSCEEEE
T ss_pred             EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC-ccCCeEEEE
Confidence            45899999999998764  4678899875  2      1245678887544433 345777777765421 113478999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD  133 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~  133 (372)
                      ||++|..+.+..    ...++......++.+++.+|..||+
T Consensus       121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A          121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhC
Confidence            999988775421    1237889999999999999999997

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=4.1e-10  Score=102.75  Aligned_cols=102  Identities=12%  Similarity=0.099  Sum_probs=69.7

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCE--eEEeEeeeeecCCceEEEEEEeccC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHI--VNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni--~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      +.++.|..+.||++.     ..+++|+....   ....+|.+.+..+..+..+  ..++..... .......|+||++++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~-~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP-SETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC-CSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCC-CCCCCcceEEEcccC
Confidence            448999999999864     45899987643   3456788775555454433  334333221 111123478999999


Q ss_pred             CCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy3151          97 GGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD  133 (372)
Q Consensus        97 ~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~  133 (372)
                      |.+|.+....    .++.++...++.|++..|..||+
T Consensus       100 G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~  132 (304)
T 3sg8_A          100 GVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHS  132 (304)
T ss_dssp             CEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CeECCccccc----cCCHHHHHHHHHHHHHHHHHHHc
Confidence            9888764432    37888899999999999999996

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=1.1e-06  Score=80.01  Aligned_cols=100  Identities=11%  Similarity=0.098  Sum_probs=66.1

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCC--CEeEEeEeeeeecCCceEEEEEEeccC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHK--HIVNIKDVYENIYNGSRCLLVIMECMH   96 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~--ni~~~~~~~~~~~~~~~~~~lv~e~~~   96 (372)
                      +.++.|....||+.     |..+++|+-...   ....+|.+.+..+..+-  .+..++.+...   .....++|||+++
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~---~~g~~~~v~e~i~   96 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR---SDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC---TTSCEEEEEECCC
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc---CCCceEEEEeccC
Confidence            34788999999987     567889986532   34567888755554432  24455554431   2345679999999


Q ss_pred             CCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy3151          97 GGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD  133 (372)
Q Consensus        97 ~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~  133 (372)
                      |.++.+....    .++......++.|+...|..||+
T Consensus        97 G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~  129 (306)
T 3tdw_A           97 GQILGEDGMA----VLPDDAKDRLALQLAEFMNELSA  129 (306)
T ss_dssp             SEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhc
Confidence            9888764321    25666777777777777777774

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.54  E-value=6.6e-07  Score=79.72  Aligned_cols=100  Identities=14%  Similarity=0.177  Sum_probs=68.2

Q ss_pred             ccccCCe-EEEEEEEcCCCcEEEEEEecch--hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCch
Q psy3151          24 LGLGING-KVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGEL  100 (372)
Q Consensus        24 lG~G~~g-~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L  100 (372)
                      +..|..+ .||+.....++..+++|+-...  ....+|...+..+..+--+.+++.+..+    +...|+|||+++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~----~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT----PDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE----TTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE----CCeEEEEEEeeCCccc
Confidence            4445544 6999888777888999987543  2445777776555555446677777654    4567999999999888


Q ss_pred             hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy3151         101 FQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD  133 (372)
Q Consensus       101 ~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~  133 (372)
                      .+.....      ......+..++...|..||+
T Consensus       108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~  134 (272)
T 4gkh_A          108 FQVLEEY------PDSGENIVDALAVFLRRLHS  134 (272)
T ss_dssp             HHHHHHC------GGGHHHHHHHHHHHHHHHHT
T ss_pred             cccccCC------HHHHHHHHHHHHHHHHHhcC
Confidence            7765431      22334566777777777874

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.03  E-value=2.3e-05  Score=73.79  Aligned_cols=71  Identities=17%  Similarity=0.185  Sum_probs=43.5

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch------------hhhHHHHHHHHHhcCC-C-CEeEEeEeeeeecCCceE
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT------------VKARREVELQLAVGSH-K-HIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~e~~~~~~~~~h-~-ni~~~~~~~~~~~~~~~~   87 (372)
                      +.||.|..+.||++....+++.++||.....            .+...|.+.+..+..+ + .++.++.+ .     ...
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d-----~~~  109 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D-----TEM  109 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E-----TTT
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c-----CCc
Confidence            4599999999999987667889999975321            2335677775444332 2 34455433 2     122


Q ss_pred             EEEEEeccCCC
Q psy3151          88 LLVIMECMHGG   98 (372)
Q Consensus        88 ~~lv~e~~~~g   98 (372)
                      .++|||++.+.
T Consensus       110 ~~lvmE~l~g~  120 (397)
T 2olc_A          110 AVTVMEDLSHL  120 (397)
T ss_dssp             TEEEECCCTTS
T ss_pred             cEEEEEeCCCc
Confidence            47999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.00  E-value=1.1e-05  Score=74.94  Aligned_cols=79  Identities=9%  Similarity=0.100  Sum_probs=49.4

Q ss_pred             ccc-cccCCeEEEEEEEc--C----CCcEEEEEEecch--------hhhHHHHHHHHHhcCC--CCEeEEeEeeeeecCC
Q psy3151          22 EIL-GLGINGKVLQIVEK--K----TSEVYALKVLHDT--------VKARREVELQLAVGSH--KHIVNIKDVYENIYNG   84 (372)
Q Consensus        22 ~~l-G~G~~g~V~~~~~~--~----~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h--~ni~~~~~~~~~~~~~   84 (372)
                      +.| +.|..+.+|++...  .    ++..+++|+....        ....+|...+..+..+  -.+.+++.+..+... 
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~-  104 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV-  104 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT-
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc-
Confidence            457 88888999988653  1    2678999987532        2346777775544443  345666665543110 


Q ss_pred             ceEEEEEEeccCCCchh
Q psy3151          85 SRCLLVIMECMHGGELF  101 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~  101 (372)
                      ....|+|||+++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence            12457899999886653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.96  E-value=0.00011  Score=62.30  Aligned_cols=123  Identities=19%  Similarity=0.137  Sum_probs=76.8

Q ss_pred             CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCC
Q psy3151          98 GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG  176 (372)
Q Consensus        98 g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~  176 (372)
                      -+|.++++..+ .+++|+++|.++.|.+.+|.-+-. ..-..+=+-|..|++.                           
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---------------------------   84 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---------------------------   84 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---------------------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---------------------------
Confidence            48899998775 689999999999999999877622 1111222345777777                           


Q ss_pred             CCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCHhHHH
Q psy3151         177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISPGMKN  256 (372)
Q Consensus       177 ~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~  256 (372)
                      .+|.|...+ +.+.            .....+.|||... ...+.+.=|||||+++|.-+--..|               
T Consensus        85 ~dG~V~f~~-~~s~------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------  135 (229)
T 2yle_A           85 RDGAVTLAP-AADD------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------  135 (229)
T ss_dssp             TTSCEEECC-C------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC---------------
T ss_pred             cCCceeccc-cccc------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC---------------
Confidence            344454442 1110            0122367888763 3455778899999999998852221               


Q ss_pred             HHhhCCccCCCCcccccCHHHHHHHHHhccC
Q psy3151         257 RIRLGQFDFPNPEWEHVSQEAKTLIKNMLCV  287 (372)
Q Consensus       257 ~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~  287 (372)
                                ...-..+|+++..||..|..-
T Consensus       136 ----------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          136 ----------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ----------TTEEECCCHHHHHHHHHHTTC
T ss_pred             ----------cccchhhCHHHHHHHHHHHhc
Confidence                      111136899999999999865

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.76  E-value=0.00025  Score=64.94  Aligned_cols=76  Identities=16%  Similarity=0.141  Sum_probs=38.0

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecchh-hhHHHHHHHHHhcCC-CCEeEEeEeeee--ecCCceEEEEEEeccCCC
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDTV-KARREVELQLAVGSH-KHIVNIKDVYEN--IYNGSRCLLVIMECMHGG   98 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~e~~~~~~~~~h-~ni~~~~~~~~~--~~~~~~~~~lv~e~~~~g   98 (372)
                      .|+.|..+.||++...  +..+++|+..... ....|...+..+..+ -.++.++.....  ....+...+++|+|++|.
T Consensus        39 ~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~  116 (346)
T 2q83_A           39 VIQGNQMALVWKVHTD--SGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGR  116 (346)
T ss_dssp             ECC----CEEEEEEET--TEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCB
T ss_pred             eccccccCcEEEEEeC--CCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCc
Confidence            3666788999998763  3458999987532 223344443222111 133443331100  000134578999999886


Q ss_pred             ch
Q psy3151          99 EL  100 (372)
Q Consensus        99 ~L  100 (372)
                      ++
T Consensus       117 ~~  118 (346)
T 2q83_A          117 PF  118 (346)
T ss_dssp             CC
T ss_pred             cC
Confidence            54

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.54  E-value=0.00024  Score=67.36  Aligned_cols=68  Identities=18%  Similarity=0.101  Sum_probs=40.9

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEe--------cc-h---hhhHHHHHHH--HHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVL--------HD-T---VKARREVELQ--LAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~--------~~-~---~~~~~e~~~~--~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      +.||.|..+.||++..  +++.++||..        .. .   .+...|.+.+  ........+++++.+.      ...
T Consensus        40 ~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~------~~~  111 (420)
T 2pyw_A           40 KEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD------RTM  111 (420)
T ss_dssp             EECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE------TTT
T ss_pred             EEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC------CCc
Confidence            4589999999999964  5778999932        11 1   2223344332  2222233556665543      123


Q ss_pred             EEEEEecc-CC
Q psy3151          88 LLVIMECM-HG   97 (372)
Q Consensus        88 ~~lv~e~~-~~   97 (372)
                      .++|||++ +|
T Consensus       112 ~~lv~e~l~~g  122 (420)
T 2pyw_A          112 ALIGMRYLEPP  122 (420)
T ss_dssp             TEEEECCCCTT
T ss_pred             cEEEEeecCCc
Confidence            58999999 76

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.35  E-value=0.0008  Score=60.63  Aligned_cols=67  Identities=7%  Similarity=-0.010  Sum_probs=39.4

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEecc-C
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECM-H   96 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~   96 (372)
                      +.|+.|....+|++      ..+++|+.....    ...+|...+..+..+.-..+++....      ..-++++||+ +
T Consensus        24 ~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~------~~~~~v~e~i~~   91 (301)
T 3dxq_A           24 LERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDP------ATGVMVTRYIAG   91 (301)
T ss_dssp             EEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECT------TTCCEEEECCTT
T ss_pred             eEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEEC------CCCEEEEeecCC
Confidence            45889999999998      458899875321    22456665433322211144444332      1236789999 6


Q ss_pred             CCch
Q psy3151          97 GGEL  100 (372)
Q Consensus        97 ~g~L  100 (372)
                      |.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.35  E-value=0.0016  Score=59.06  Aligned_cols=73  Identities=11%  Similarity=0.114  Sum_probs=51.2

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch--hhhHHHHHHHHHhcCC--CCEeEEeEeeeeecCCceEEEEEEeccCC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSH--KHIVNIKDVYENIYNGSRCLLVIMECMHG   97 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h--~ni~~~~~~~~~~~~~~~~~~lv~e~~~~   97 (372)
                      +.|+.|....+|+...  ++..+++|+....  ....+|.+.+..+..+  ..+++++.+...    ....++|||+++|
T Consensus        42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~----~g~~~lvme~l~G  115 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS----QGHSFLLLEALNK  115 (312)
T ss_dssp             EEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC----SSEEEEEEECCCC
T ss_pred             EEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec----CCceEEEEEeccC
Confidence            3489999999999875  4778899987643  2345677765444332  456677766543    3568999999998


Q ss_pred             Cch
Q psy3151          98 GEL  100 (372)
Q Consensus        98 g~L  100 (372)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.03  E-value=0.0028  Score=57.86  Aligned_cols=75  Identities=12%  Similarity=0.022  Sum_probs=36.2

Q ss_pred             cccccCCeE-EEEEEEcCCCcEEEEEEecch--hhhHHHHHHHHHhcCC-CCEeEEeEeeeeecCCceEEEEEEeccCCC
Q psy3151          23 ILGLGINGK-VLQIVEKKTSEVYALKVLHDT--VKARREVELQLAVGSH-KHIVNIKDVYENIYNGSRCLLVIMECMHGG   98 (372)
Q Consensus        23 ~lG~G~~g~-V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h-~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g   98 (372)
                      .|+.|+... +|+... .+|..+++|.....  .....|...+..+..+ -.+++++.+-.    ...  +++||++.+.
T Consensus        25 ~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~----~~g--~ll~e~l~~~   97 (333)
T 3csv_A           25 PLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEH----ARG--LLLIEDLGDA   97 (333)
T ss_dssp             C--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEET----TTT--EEEECCCCSC
T ss_pred             ECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecC----CCC--EEEEeeCCCc
Confidence            366665554 666653 23677888876432  3445666664444333 23445554321    122  6789999776


Q ss_pred             chhHHH
Q psy3151          99 ELFQRI  104 (372)
Q Consensus        99 ~L~~~i  104 (372)
                      .+.+.+
T Consensus        98 ~l~~~l  103 (333)
T 3csv_A           98 LFTEVI  103 (333)
T ss_dssp             BHHHHH
T ss_pred             chHHHh
Confidence            665433

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.01  E-value=0.0028  Score=60.19  Aligned_cols=71  Identities=10%  Similarity=0.075  Sum_probs=46.2

Q ss_pred             ccccccCCeEEEEEEEcC-------CCcEEEEEEecc--h-hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          22 EILGLGINGKVLQIVEKK-------TSEVYALKVLHD--T-VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~--~-~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      +.|+.|....||++....       +++.+++|+...  . ....+|...+..+..+.-.+++++.+.+        .+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~--------g~v  150 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG--------GRL  150 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------EEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC--------CEE
Confidence            448889999999998653       357899999843  2 3455677775444333223566665432        278


Q ss_pred             EeccCCCch
Q psy3151          92 MECMHGGEL  100 (372)
Q Consensus        92 ~e~~~~g~L  100 (372)
                      +||++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.86  E-value=0.0035  Score=58.46  Aligned_cols=71  Identities=7%  Similarity=0.028  Sum_probs=41.5

Q ss_pred             ccccccCCeEEEEEEEcC-------CCcEEEEEEecc----hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          22 EILGLGINGKVLQIVEKK-------TSEVYALKVLHD----TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      +.|..|....+|++....       +++.+++|+.-.    .....+|..++..+..+.-..+++..+.+    +    +
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g----~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G----R  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c----c
Confidence            447888889999988742       457899998632    23345777775444443333566665532    2    8


Q ss_pred             EEeccCCCch
Q psy3151          91 IMECMHGGEL  100 (372)
Q Consensus        91 v~e~~~~g~L  100 (372)
                      ||||++|.+|
T Consensus       128 v~e~i~G~~l  137 (379)
T 3feg_A          128 LEQYIPSRPL  137 (379)
T ss_dssp             EEECCSEEEC
T ss_pred             EEEEecCccC
Confidence            8999987554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.75  E-value=0.0058  Score=55.28  Aligned_cols=76  Identities=8%  Similarity=-0.031  Sum_probs=39.5

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCC-CCEeEEeEeeee--ecCCceEEEEEEeccC
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSH-KHIVNIKDVYEN--IYNGSRCLLVIMECMH   96 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h-~ni~~~~~~~~~--~~~~~~~~~lv~e~~~   96 (372)
                      .|+.|....+|++... +| .+++|+....   .....|...+..+..+ -.+..++..-..  ....+...+++|++++
T Consensus        29 ~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             ccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            4777888999998764 34 6889998652   2344566654333322 113333321100  0000234688999998


Q ss_pred             CCch
Q psy3151          97 GGEL  100 (372)
Q Consensus        97 ~g~L  100 (372)
                      |..+
T Consensus       107 G~~~  110 (322)
T 2ppq_A          107 GMWL  110 (322)
T ss_dssp             CBCC
T ss_pred             CcCC
Confidence            7543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.67  E-value=0.0066  Score=56.24  Aligned_cols=71  Identities=14%  Similarity=0.193  Sum_probs=39.8

Q ss_pred             ccccccCCeEEEEEEEcC--------CCcEEEEEEecchhh----hHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          22 EILGLGINGKVLQIVEKK--------TSEVYALKVLHDTVK----ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~----~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +.|+.|....+|++....        .++.+++|+......    ...|.+.+..+..+.-+++++..+.     +   +
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~-----~---~  110 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTFN-----G---G  110 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEET-----T---E
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEecC-----C---c
Confidence            448889999999988653        136899998753221    2456666444333322345554431     1   5


Q ss_pred             EEEeccCCCch
Q psy3151          90 VIMECMHGGEL  100 (372)
Q Consensus        90 lv~e~~~~g~L  100 (372)
                      +||||++|.++
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            78999987543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.45  E-value=0.026  Score=50.13  Aligned_cols=70  Identities=13%  Similarity=-0.027  Sum_probs=45.7

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCC--EeEEeEeeeeecCCceEEEEEEec
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKH--IVNIKDVYENIYNGSRCLLVIMEC   94 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~n--i~~~~~~~~~~~~~~~~~~lv~e~   94 (372)
                      +.+|.|..+.||++.. .+|+.|.+|+-...     ....+|.+.+..+...-.  +++++..-      .  -++|||+
T Consensus        21 ~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~--~~lv~e~   91 (288)
T 3f7w_A           21 AERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------D--RTLAMEW   91 (288)
T ss_dssp             EEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------T--TEEEEEC
T ss_pred             EecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc------C--ceEEEEe
Confidence            3489999999999886 47899999986432     234578887555544322  33444321      1  2688999


Q ss_pred             cCCCch
Q psy3151          95 MHGGEL  100 (372)
Q Consensus        95 ~~~g~L  100 (372)
                      +.++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            976543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.29  E-value=0.028  Score=50.80  Aligned_cols=75  Identities=11%  Similarity=0.181  Sum_probs=42.3

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecc----hhhhHHHHHHHHHhcCC-CCEeEEeEeeeee--cCCceEEEEEEecc
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHD----TVKARREVELQLAVGSH-KHIVNIKDVYENI--YNGSRCLLVIMECM   95 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h-~ni~~~~~~~~~~--~~~~~~~~lv~e~~   95 (372)
                      .++ |....||++.. .+|+.+++|+...    ......|...+..+..+ -.++.++.. ...  ...++..+++|+++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEECC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEec
Confidence            366 88889998765 3567899999862    23344566654333322 123444332 100  00133567899999


Q ss_pred             CCCch
Q psy3151          96 HGGEL  100 (372)
Q Consensus        96 ~~g~L  100 (372)
                      +|..+
T Consensus       110 ~G~~~  114 (328)
T 1zyl_A          110 GGRQF  114 (328)
T ss_dssp             CCEEC
T ss_pred             CCCCC
Confidence            87543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.18  E-value=0.05  Score=49.71  Aligned_cols=73  Identities=12%  Similarity=0.078  Sum_probs=42.1

Q ss_pred             cccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcC--CCCEeEEeEeeee--ecCCceEEEEEEeccCCCch
Q psy3151          25 GLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS--HKHIVNIKDVYEN--IYNGSRCLLVIMECMHGGEL  100 (372)
Q Consensus        25 G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~--h~ni~~~~~~~~~--~~~~~~~~~lv~e~~~~g~L  100 (372)
                      |.|....||++... +| .+++|+..... ..+|...+..+..  -|+++..+.....  ....+...+++|+|++|..+
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~-~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYH-DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSS-CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCcc-chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            44457899998754 45 89999876433 3456555433322  2334454432110  00114567899999988655

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.15  E-value=0.03  Score=53.53  Aligned_cols=71  Identities=18%  Similarity=0.288  Sum_probs=44.3

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCC
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHG   97 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~   97 (372)
                      +.|+.|....+|++....++..+++|+.....    ...+|...+..+..+.-.++++.++..    +    +||||++|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G----~v~e~I~G  185 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----G----RIEEFMDG  185 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----E----EEEECCCS
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----e----EEEEeeCC
Confidence            45888999999999876545889999874321    224777775445443323566666531    2    48999987


Q ss_pred             Cch
Q psy3151          98 GEL  100 (372)
Q Consensus        98 g~L  100 (372)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.17  E-value=0.062  Score=50.73  Aligned_cols=75  Identities=12%  Similarity=0.158  Sum_probs=46.5

Q ss_pred             ceeeccccccccCCeEEEEEEEcCC-------CcEEEEEEecchh----hhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKKT-------SEVYALKVLHDTV----KARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ..++  +.|..|....+|++.....       ++.+++|+.....    ...+|...+..+..+.-..++++.+.     
T Consensus        72 ~~~v--~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~-----  144 (424)
T 3mes_A           72 YIEV--KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP-----  144 (424)
T ss_dssp             GEEE--EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET-----
T ss_pred             ceEE--EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC-----
Confidence            3444  4478888999999987521       6789999874321    23467776544433322345554332     


Q ss_pred             ceEEEEEEeccCCCch
Q psy3151          85 SRCLLVIMECMHGGEL  100 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L  100 (372)
                      +   ++||||++|.+|
T Consensus       145 ~---~~I~efI~G~~l  157 (424)
T 3mes_A          145 E---GRIEEFIDGEPL  157 (424)
T ss_dssp             T---EEEEECCCSEEC
T ss_pred             C---CEEEEEeCCccC
Confidence            1   678999988654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.81  E-value=0.44  Score=44.45  Aligned_cols=33  Identities=15%  Similarity=0.341  Sum_probs=22.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcC-------CCcEEEEEEe
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKK-------TSEVYALKVL   49 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~   49 (372)
                      +..+|  +.|+.|..-.+|++....       ..+.|.+++.
T Consensus        53 ~~l~v--~~lsGG~SN~~y~v~~~~~~~~~~~~~~~~llRi~   92 (401)
T 3g15_A           53 DEFHI--SVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLY   92 (401)
T ss_dssp             GGCEE--EEEECSSEEEEEEEECCTTCCCSSSCCSEEEEEEE
T ss_pred             CCEEE--EEeCCccccceEEEEECCCCcccccCCCeEEEEeC
Confidence            34455  448888888899988643       2367888875

>2okr_C MAP kinase-activated protein kinase 2; NLS, NES, heterodimer, docking groove, transferase; 2.00A {Homo sapiens}

Probab=90.94  E-value=0.12  Score=27.50  Aligned_cols=22  Identities=45%  Similarity=0.671  Sum_probs=18.7

Q ss_pred             eeecccCCCChHHHhhhccCCC
Q psy3151         350 HIKSLINSKNPLLNKRRKNQSP  371 (372)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~  371 (372)
                      +++.+..++||++.|+|+++..
T Consensus         2 ~iK~L~~snNpLL~kRrkk~~~   23 (26)
T 2okr_C            2 KIKKIEDASNPLLLKRRKKARA   23 (26)
T ss_dssp             CCCCTTTCCCHHHHHHHHHTTC
T ss_pred             CccccccccCHHHHHHHHHHHc
Confidence            5788899999999999998643

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.90  E-value=1.1  Score=37.70  Aligned_cols=119  Identities=13%  Similarity=0.159  Sum_probs=74.7

Q ss_pred             HHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy3151          63 LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK  142 (372)
Q Consensus        63 ~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlk  142 (372)
                      +-...||+.+.. .+-+.    +..+.+.++.-..+.-+..++     .++....++++.+|+....++++.  +|--|.
T Consensus        39 LL~~~~~~Fl~~-~I~e~----eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~r--~tf~L~  106 (215)
T 4ann_A           39 LLEQHSPYFIDA-ELTEL----RDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRTR--YTFVLA  106 (215)
T ss_dssp             GGGSCCTTBCCE-EEEEC----SSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGSS--EECCCS
T ss_pred             HHhccCCcccce-EEEEc----ccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcCc--eEEEEe
Confidence            344467887754 33322    334555554433222222232     288999999999999888555444  788999


Q ss_pred             CCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCc
Q psy3151         143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKS  222 (372)
Q Consensus       143 p~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  222 (372)
                      |+||+++                           .++.+++.--|+...+                 +|.     .++..
T Consensus       107 P~NL~f~---------------------------~~~~p~i~~RGik~~l-----------------~P~-----~~~ee  137 (215)
T 4ann_A          107 PDELFFT---------------------------RDGLPIAKTRGLQNVV-----------------DPL-----PVSEA  137 (215)
T ss_dssp             GGGEEEC---------------------------TTSCEEESCCEETTTB-----------------SCC-----CCCHH
T ss_pred             cceEEEc---------------------------CCCCEEEEEccCccCC-----------------CCC-----CCCHH
Confidence            9999998                           6777898887765432                 221     11111


Q ss_pred             cchhhHHHHHHHHHhCCCCC
Q psy3151         223 CDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       223 ~DiwslG~il~~ll~g~~pf  242 (372)
                      .=.-..=|++..+++++..|
T Consensus       138 ~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          138 EFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             HHHHHHHHHHHHHHCTTCCH
T ss_pred             HHHHHHHHHHHHHHcCCCCH
Confidence            11224678899999998888

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.57  E-value=1  Score=38.09  Aligned_cols=125  Identities=17%  Similarity=0.110  Sum_probs=76.1

Q ss_pred             hHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHH-HHHH
Q psy3151          55 ARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK-FLHD  133 (372)
Q Consensus        55 ~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~-~LH~  133 (372)
                      ..++.+..+-...||+...-+.  .+    +..+.+.++.-.++.-...++     .++..+.++++.+|+.... +++ 
T Consensus        36 ~~~~~e~~lL~~~~~~f~~~I~--~~----eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~-  103 (219)
T 4ano_A           36 MQDPLELEVLKEVDPCIVRDID--VS----EDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA-  103 (219)
T ss_dssp             CCSGGGGGGGGGSCSSSEEEEE--EC----SSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS-
T ss_pred             cCCHHHHHHHhccCCCCCeEEE--Ee----CCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh-
Confidence            3333333334446788722222  22    344555555543333334443     2899999999998888666 544 


Q ss_pred             CCceecCCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcc
Q psy3151         134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEV  213 (372)
Q Consensus       134 ~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~  213 (372)
                       .-+|--|.|+||+++                           .++.++|.-.|+-..+                 +|.-
T Consensus       104 -~r~tf~l~P~NL~f~---------------------------~~~~p~i~hRGi~~~l-----------------pP~e  138 (219)
T 4ano_A          104 -RRLIFIVCPENLMFN---------------------------RALEPFFLHVGVKESL-----------------PPDE  138 (219)
T ss_dssp             -SSEECCCCGGGEEEC---------------------------TTCCEEESCCEETTTB-----------------SSCS
T ss_pred             -CceeEEEeCceEEEe---------------------------CCCcEEEEEcCCcccC-----------------CCCC
Confidence             347888999999998                           6778999888865432                 2211


Q ss_pred             cCCCCCCCccchh-hHHHHHHHHHhCCCCC
Q psy3151         214 LGPDKYDKSCDIW-SLGVIMYILLCGFPPF  242 (372)
Q Consensus       214 ~~~~~~~~~~Diw-slG~il~~ll~g~~pf  242 (372)
                      +      ...|.| +.=|++..++.++..|
T Consensus       139 ~------~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          139 W------DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             C------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             C------CHHHHHHHHHHHHHHHHcCCCCH
Confidence            1      112222 4678888888888777

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	372
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-112
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-68
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-68
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-68
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-66
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-64
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-63
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-62
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-60
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-59
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-59
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-57
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-56
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-55
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-52
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-51
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-51
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-50
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-50
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-49
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-49
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-48
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-46
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-44
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-43
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-43
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-42
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-42
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-42
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-41
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-41
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-41
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-39
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-39
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-38
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-35
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-32
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-10

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  328 bits (841), Expect = e-112
 Identities = 209/357 (58%), Positives = 256/357 (71%), Gaps = 25/357 (7%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGS 67
            K   I DDY +++++LGLGINGKVLQI  K+T E +ALK+L D  KARREVEL      
Sbjct: 4   IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ 63

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
             HIV I DVYEN+Y G +CLL++MEC+ GGELF RIQ + D AFTEREA+ IM  I  A
Sbjct: 64  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I++LH  NIAHRDVKPENLLYT      ILKLTDFG  K                     
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------------------- 162

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
                 ++  SL TPCYTPYYVAPEVLGP+KYDKSCD+WSLGVIMYILLCG+PPF+SNHG
Sbjct: 163 ----ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
            AISPGMK RIR+GQ++FPNPEW  VS+E K LI+N+L  +P++R+TI + M + WI Q 
Sbjct: 219 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278

Query: 308 NQVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNK 364
            +VPQTPL T ++LKE +E W +V++EMT +LATMRVDY+QI IK + ++ NPLL K
Sbjct: 279 TKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLK 335

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  216 bits (552), Expect = 2e-68
 Identities = 90/347 (25%), Positives = 153/347 (44%), Gaps = 48/347 (13%)

Query: 2   TPTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----DTVKAR 56
            P     K   + D YDI  E LG G  G V + VEK T  V+  K ++     D    +
Sbjct: 16  VPQPVEVKQGSVYDYYDI-LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK 74

Query: 57  REVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTERE 116
            E+ + +    H  ++N+ D +E+       +++I+E + GGELF RI   ED   +E E
Sbjct: 75  NEISI-MNQLHHPKLINLHDAFED----KYEMVLILEFLSGGELFDRIA-AEDYKMSEAE 128

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
               M + C  +K +H+ +I H D+KPEN++                             
Sbjct: 129 VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS---------------------- 166

Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
               +K+ DFG A K+  ++  ++    T  + APE++  +      D+W++GV+ Y+LL
Sbjct: 167 ---SVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 222

Query: 237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID 296
            G  PF               ++   ++F    +  VS EAK  IKN+L  +P +RLT+ 
Sbjct: 223 SGLSPFAGEDDLET----LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVH 278

Query: 297 QVMENKWISQFNQVPQTPLCTGKM------LKEGEETWPEVQDEMTR 337
             +E+ W+   +    + + + +       +KE    WP  Q  + R
Sbjct: 279 DALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGR 325

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 5e-68
 Identities = 80/337 (23%), Positives = 153/337 (45%), Gaps = 43/337 (12%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH----DTVKARREVELQLAVGSH 68
           + + Y I  E LG G  G V + VE  + + Y  K +     D V  ++E+ + L +  H
Sbjct: 3   LYEKYMI-AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISI-LNIARH 60

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
           ++I+++ + +E+       L++I E + G ++F+RI         ERE    ++++C A+
Sbjct: 61  RNILHLHESFES----MEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEAL 115

Query: 129 KFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGF 188
           +FLH  NI H D++PEN++Y                                +K+ +FG 
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSS-------------------------TIKIIEFGQ 150

Query: 189 AKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ 248
           A+++     + +     P Y APEV   D    + D+WSLG ++Y+LL G  PF +   Q
Sbjct: 151 ARQL-KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
            I       I   ++ F    ++ +S EA   +  +L  +   R+T  + +++ W+ Q  
Sbjct: 210 QI----IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265

Query: 309 QVPQTPLCTGKMLKEGEETWPEVQDEMTRSLATMRVD 345
           +   T +   + LK        ++ ++   ++  R+ 
Sbjct: 266 ERVSTKVI--RTLKHRRYYHTLIKKDLNMVVSAARIS 300

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  216 bits (550), Expect = 5e-68
 Identities = 86/332 (25%), Positives = 146/332 (43%), Gaps = 42/332 (12%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----DTVKARREVELQLAVGS 67
           + D YDI  E LG G  G V ++ E+ T   +A K +      D    R+E++  ++V  
Sbjct: 24  VLDHYDI-HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT-MSVLR 81

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H  +VN+ D +E+       +++I E M GGELF+++   E    +E EA   M ++C  
Sbjct: 82  HPTLVNLHDAFED----DNEMVMIYEFMSGGELFEKVA-DEHNKMSEDEAVEYMRQVCKG 136

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           +  +H+ N  H D+KPEN+++T                               LKL DFG
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSN-------------------------ELKLIDFG 171

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
               +   K S++    T  + APEV          D+WS+GV+ YILL G  PF   + 
Sbjct: 172 LTAHL-DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
                     ++   ++  +  +  +S++ K  I+ +L  DP+ R+TI Q +E+ W++  
Sbjct: 231 DE----TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286

Query: 308 NQVPQTPLCTGKMLKEGEETWPEVQDEMTRSL 339
           N   +          +  ++     D     L
Sbjct: 287 NAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPL 318

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-66
 Identities = 85/299 (28%), Positives = 144/299 (48%), Gaps = 53/299 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVELQLAVG 66
           +D++I    LG G  G V    EK++  + ALKVL            + RREVE+  +  
Sbjct: 6   EDFEI-GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHL 63

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
            H +I+ +   + +    +  + +I+E    G +++ +Q+     F E+  A  + E+ +
Sbjct: 64  RHPNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELAN 117

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+ + H + + HRD+KPENLL    G+                           LK+ DF
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGE---------------------------LKIADF 150

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G++    S++    T C T  Y+ PE++    +D+  D+WSLGV+ Y  L G PPF +N 
Sbjct: 151 GWSVHAPSSR--RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208

Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS 305
            Q        RI   +F FP    + V++ A+ LI  +L  +PS+R  + +V+E+ WI+
Sbjct: 209 YQET----YKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  205 bits (523), Expect = 2e-64
 Identities = 100/311 (32%), Positives = 163/311 (52%), Gaps = 43/311 (13%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQ 62
           +   I+D YD   ++LG G   +V+   +K+T ++ A+K +              E+ + 
Sbjct: 3   QAEDIRDIYDF-RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV- 60

Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
           L    H +IV + D+YE+       L +IM+ + GGELF RI +K  G +TER+A+ ++ 
Sbjct: 61  LHKIKHPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIF 114

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           ++  A+K+LHD  I HRD+KPENLLY    +   + ++DFG  K                
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---------------- 158

Query: 183 LTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
                    +    + L T C TP YVAPEVL    Y K+ D WS+GVI YILLCG+PPF
Sbjct: 159 ---------MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 209

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
           +  +   +      +I   +++F +P W+ +S  AK  I++++  DP +R T +Q +++ 
Sbjct: 210 YDENDAKL----FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265

Query: 303 WISQFNQVPQT 313
           WI+    + + 
Sbjct: 266 WIAGDTALDKN 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  202 bits (514), Expect = 2e-63
 Identities = 91/314 (28%), Positives = 143/314 (45%), Gaps = 59/314 (18%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK--------------ARREV 59
            ++Y+   EILG G++  V + + K T + YA+K++  T                  +EV
Sbjct: 2   YENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 60  ELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
           ++   V  H +I+ +KD YE     +    ++ + M  GELF  + +K     +E+E   
Sbjct: 61  DILRKVSGHPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRK 114

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           IM  +   I  LH  NI HRD+KPEN+L     +                          
Sbjct: 115 IMRALLEVICALHKLNIVHRDLKPENILLDDDMN-------------------------- 148

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVL------GPDKYDKSCDIWSLGVIMY 233
            +KLTDFGF+ ++   +  L+  C TP Y+APE++          Y K  D+WS GVIMY
Sbjct: 149 -IKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206

Query: 234 ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL 293
            LL G PPF+      +       I  G + F +PEW+  S   K L+   L V P +R 
Sbjct: 207 TLLAGSPPFWHRKQMLM----LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 262

Query: 294 TIDQVMENKWISQF 307
           T ++ + + +  Q+
Sbjct: 263 TAEEALAHPFFQQY 276

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-62
 Identities = 74/317 (23%), Positives = 130/317 (41%), Gaps = 49/317 (15%)

Query: 9   KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----DTVKARREVELQL 63
           +    +D ++I    LG G  GKV +   K+TS + A KV+      +      E+++ L
Sbjct: 6   RDLNPEDFWEI-IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDI-L 63

Query: 64  AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
           A   H +IV + D +         L +++E   GG +   + + E    TE +  ++  +
Sbjct: 64  ASCDHPNIVKLLDAFYY----ENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQ 118

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
              A+ +LHD  I HRD+K  N+L+T  GD                           +KL
Sbjct: 119 TLDALNYLHDNKIIHRDLKAGNILFTLDGD---------------------------IKL 151

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-----KYDKSCDIWSLGVIMYILLCG 238
            DFG + K         +   TPY++APEV+  +      YD   D+WSLG+ +  +   
Sbjct: 152 ADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 211

Query: 239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
            PP    +   +      +I   +      +    S   K  +K  L  +   R T  Q+
Sbjct: 212 EPPHHELNPMRV----LLKIAKSEPPTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

Query: 299 MENKWISQFNQVPQTPL 315
           +++ +++  +  P   L
Sbjct: 267 LQHPFVTVDSNKPIREL 283

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-61
 Identities = 74/304 (24%), Positives = 126/304 (41%), Gaps = 52/304 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGS 67
           +DY++    +G G  G+  +I  K   ++   K L        +      EV L L    
Sbjct: 4   EDYEV-LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL-LRELK 61

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEIC 125
           H +IV   D   +  N +  +  +ME   GG+L   I +  KE     E     +M ++ 
Sbjct: 62  HPNIVRYYDRIIDRTNTTLYI--VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119

Query: 126 SAIKFLHDQN-----IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
            A+K  H ++     + HRD+KP N+      +                           
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--------------------------- 152

Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
           +KL DFG A+ +  + +  +    TPYY++PE +    Y++  DIWSLG ++Y L    P
Sbjct: 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212

Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF +   + +      +IR G+F          S E   +I  ML +    R ++++++E
Sbjct: 213 PFTAFSQKEL----AGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

Query: 301 NKWI 304
           N  I
Sbjct: 266 NPLI 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 6e-61
 Identities = 71/304 (23%), Positives = 128/304 (42%), Gaps = 49/304 (16%)

Query: 12  PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAV 65
           P  +D+D+  + LG G  G+V   V + T E  A+K++            ++E+ +   +
Sbjct: 2   PFVEDWDL-VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKM 59

Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
            +H+++V                 + +E   GGELF RI+        E +A    +++ 
Sbjct: 60  LNHENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLM 113

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
           + + +LH   I HRD+KPENLL                             +   LK++D
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLD---------------------------ERDNLKISD 146

Query: 186 FGFAKKIVSN--KASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           FG A     N  +  L   C T  YVAPE+L   + + +  D+WS G+++  +L G  P+
Sbjct: 147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK 302
                   S   +      +       W+ +      L+  +L  +PS R+TI  + +++
Sbjct: 207 DQP-----SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 261

Query: 303 WISQ 306
           W ++
Sbjct: 262 WYNK 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 1e-60
 Identities = 72/309 (23%), Positives = 130/309 (42%), Gaps = 47/309 (15%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----DTVKARREVELQLAVGS 67
            +  Y    E +G G +G V   ++  T +  A++ ++            E+ + +    
Sbjct: 18  PKKKYTR-FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV-MRENK 75

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           + +IVN  D Y         L V+ME + GG L   + +       E + A +  E   A
Sbjct: 76  NPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 128

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           ++FLH   + HRD+K +N+L    G                            +KLTDFG
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGS---------------------------VKLTDFG 161

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
           F  +I   ++   T   TPY++APEV+    Y    DIWSLG++   ++ G PP+ + + 
Sbjct: 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF 307
                 +      G  +  NPE   +S   +  +   L +D  +R +  ++++++++   
Sbjct: 222 LRA---LYLIATNGTPELQNPEK--LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

Query: 308 NQVPQ-TPL 315
             +   TPL
Sbjct: 277 KPLSSLTPL 285

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 3e-59
 Identities = 81/309 (26%), Positives = 138/309 (44%), Gaps = 55/309 (17%)

Query: 6   KPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARR 57
           +P K  P  +D+    +ILG G    V+   E  TS  YA+K+L               R
Sbjct: 1   QPRKKRP--EDFKFG-KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR 57

Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREA 117
           E ++ ++   H   V +   +++       L   +     GEL + I++   G+F E   
Sbjct: 58  ERDV-MSRLDHPFFVKLYFTFQD----DEKLYFGLSYAKNGELLKYIRK--IGSFDETCT 110

Query: 118 AIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
                EI SA+++LH + I HRD+KPEN+L                             +
Sbjct: 111 RFYTAEIVSALEYLHGKGIIHRDLKPENILLN---------------------------E 143

Query: 178 GGILKLTDFGFAKKIV--SNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYIL 235
              +++TDFG AK +   S +A   +   T  YV+PE+L      KS D+W+LG I+Y L
Sbjct: 144 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 203

Query: 236 LCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
           + G PPF + +       +  +I   ++DFP    E    +A+ L++ +L +D ++RL  
Sbjct: 204 VAGLPPFRAGNEYL----IFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGC 255

Query: 296 DQVMENKWI 304
           +++     +
Sbjct: 256 EEMEGYGPL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 4e-59
 Identities = 61/292 (20%), Positives = 117/292 (40%), Gaps = 46/292 (15%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAVGSHKHIVNI 74
             +G G    V + ++ +T+   A   L D         + + E E+ L    H +IV  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEM-LKGLQHPNIVRF 73

Query: 75  KDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ 134
            D +E+   G +C++++ E M  G L   +++        +       +I   ++FLH +
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 135 N--IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
              I HRD+K +N+  T                          G  G +K+ D G A   
Sbjct: 132 TPPIIHRDLKCDNIFIT--------------------------GPTGSVKIGDLGLAT-- 163

Query: 193 VSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAISP 252
           +   +  +    TP ++APE+   +KYD+S D+++ G+ M  +     P+      A   
Sbjct: 164 LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-- 220

Query: 253 GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI 304
            +  R+  G    P    +    E K +I+  +  +  ER +I  ++ + + 
Sbjct: 221 -IYRRVTSGV--KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 8e-59
 Identities = 78/303 (25%), Positives = 129/303 (42%), Gaps = 51/303 (16%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVG 66
           +D+ +  ++LG G  GKV     KKT++ +A+K L         D      E  +     
Sbjct: 2   EDFIL-HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
            H  + ++   ++        L  +ME ++GG+L   IQ      F    A     EI  
Sbjct: 61  EHPFLTHMFCTFQT----KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIIL 114

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            ++FLH + I +RD+K +N+L  K G                             K+ DF
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGHI---------------------------KIADF 147

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G  K+ +   A   T C TP Y+APE+L   KY+ S D WS GV++Y +L G  PF    
Sbjct: 148 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207

Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI-DQVMENKWIS 305
            + +     + IR+    +P      + +EAK L+  +   +P +RL +   + ++    
Sbjct: 208 EEEL----FHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259

Query: 306 QFN 308
           + N
Sbjct: 260 EIN 262

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 2e-57
 Identities = 67/337 (19%), Positives = 125/337 (37%), Gaps = 80/337 (23%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK------ARREVELQLAVGSH 68
           DD++     LG G  G V ++  K +  V A K++H  +K        RE+++ L   + 
Sbjct: 6   DDFEKI-SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV-LHECNS 63

Query: 69  KHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAI 128
            +IV     + +       + + ME M GG L Q +++   G   E+    +   +   +
Sbjct: 64  PYIVGFYGAFYS----DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117

Query: 129 KFLHDQN-IAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
            +L +++ I HRDVKP N+L                               G +KL DFG
Sbjct: 118 TYLREKHKIMHRDVKPSNILVN---------------------------SRGEIKLCDFG 150

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
            + +++ + A+  +   T  Y++PE L    Y    DIWS+G+ +  +  G  P      
Sbjct: 151 VSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

Query: 248 QAISPGMKNRIR------------------------------------LGQFDFPNPEWE 271
           + +      ++                                     +     P     
Sbjct: 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG 268

Query: 272 HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN 308
             S E +  +   L  +P+ER  + Q+M + +I + +
Sbjct: 269 VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 5e-57
 Identities = 87/312 (27%), Positives = 137/312 (43%), Gaps = 47/312 (15%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----------DTVKAR 56
           F+   + D YD   E LG G    V +  EK T   YA K +                  
Sbjct: 3   FRQENVDDYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61

Query: 57  REVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTERE 116
           REV + L    H +++ + +VYEN       +++I+E + GGELF  + +K   + TE E
Sbjct: 62  REVSI-LKEIQHPNVITLHEVYEN----KTDVILILELVAGGELFDFLAEK--ESLTEEE 114

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
           A   + +I + + +LH   IAH D+KPEN++                             
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV----------------------- 151

Query: 177 DGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
               +K+ DFG A KI       +    TP +VAPE++  +      D+WS+GVI YILL
Sbjct: 152 PKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210

Query: 237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID 296
            G  PF  +  Q         +    ++F +  + + S  AK  I+ +L  DP +R+TI 
Sbjct: 211 SGASPFLGDTKQET----LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266

Query: 297 QVMENKWISQFN 308
             +++ WI   +
Sbjct: 267 DSLQHPWIKPKD 278

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (465), Expect = 7e-56
 Identities = 69/332 (20%), Positives = 130/332 (39%), Gaps = 59/332 (17%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVK--------ARREVELQLAVGSHKHIVN 73
             +G G  G V    + + SEV A+K +  + K          +EV   L    H + + 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF-LQKLRHPNTIQ 79

Query: 74  IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD 133
            +  Y           ++ME   G         K      E E A + +     + +LH 
Sbjct: 80  YRGCYLR----EHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS 133

Query: 134 QNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIV 193
            N+ HRDVK  N+L ++P                           G++KL DFG A  + 
Sbjct: 134 HNMIHRDVKAGNILLSEP---------------------------GLVKLGDFGSASIMA 166

Query: 194 SNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
                  +   TPY++APEV+      +YD   D+WSLG+    L    PP F+ +  + 
Sbjct: 167 PA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222

Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQV 310
                    + Q + P  +  H S+  +  + + L   P +R T + +++++++ +  + 
Sbjct: 223 ------LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR-ERP 275

Query: 311 PQTPLCTGKMLKEGEETWPEVQDEMTRSLATM 342
           P   +    +++  ++   E+ +   R +  +
Sbjct: 276 PTVIM---DLIQRTKDAVRELDNLQYRKMKKI 304

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  179 bits (456), Expect = 7e-55
 Identities = 67/308 (21%), Positives = 114/308 (37%), Gaps = 42/308 (13%)

Query: 11  TP--IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVE 60
           TP  + D Y++  EILG G   +V    + +     A+KVL           ++ RRE +
Sbjct: 1   TPSHLSDRYEL-GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59

Query: 61  LQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAII 120
              A  +H  IV + D  E          ++ME + G  L   +    +G  T + A  +
Sbjct: 60  N-AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEV 116

Query: 121 MNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGI 180
           + + C A+ F H   I HRDVKP N++ +      ++       +       T+      
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA---- 172

Query: 181 LKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP 240
                                   T  Y++PE    D  D   D++SLG ++Y +L G P
Sbjct: 173 --------------------AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212

Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           PF  +   ++      +        P+   E +S +   ++   L  +P  R      M 
Sbjct: 213 PFTGDSPVSV----AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268

Query: 301 NKWISQFN 308
              +   N
Sbjct: 269 ADLVRVHN 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-52
 Identities = 67/308 (21%), Positives = 118/308 (38%), Gaps = 61/308 (19%)

Query: 12  PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-----------DTVKARREVE 60
           P++  Y +   +LG G  G V   +    +   A+K +            +  +   EV 
Sbjct: 1   PLESQYQV-GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 59

Query: 61  -LQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
            L+        ++ + D +         +L++       +LF  I ++  GA  E  A  
Sbjct: 60  LLKKVSSGFSGVIRLLDWF---ERPDSFVLILERPEPVQDLFDFITER--GALQEELARS 114

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
              ++  A++  H+  + HRD+K EN+L                             + G
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDL--------------------------NRG 148

Query: 180 ILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCG 238
            LKL DFG     +           T  Y  PE +   +Y  +S  +WSLG+++Y ++CG
Sbjct: 149 ELKLIDFGSGA--LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

Query: 239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV 298
             PF  +            I  GQ  F     + VS E + LI+  L + PS+R T +++
Sbjct: 207 DIPFEHD----------EEIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEI 252

Query: 299 MENKWISQ 306
             + W+  
Sbjct: 253 QNHPWMQD 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  172 bits (438), Expect = 3e-51
 Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 57/310 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVEL--QLA 64
           +D+ +   I+G G  G+V    +  T ++YA+K L             A  E  +   ++
Sbjct: 4   NDFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
            G    IV +   +         L  I++ M+GG+L   + Q   G F+E +      EI
Sbjct: 63  TGDCPFIVCMSYAFHT----PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEI 116

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              ++ +H++ + +RD+KP N+L  +                            G ++++
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEH---------------------------GHVRIS 149

Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
           D G A      K        T  Y+APEVL     YD S D +SLG +++ LL G  PF 
Sbjct: 150 DLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQV 298
            +         K+ I            +  S E ++L++ +L  D + RL        +V
Sbjct: 208 QH-----KTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262

Query: 299 MENKWISQFN 308
            E+ +    +
Sbjct: 263 KESPFFRSLD 272

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 5e-51
 Identities = 68/337 (20%), Positives = 121/337 (35%), Gaps = 54/337 (16%)

Query: 12  PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-DTVKARREVELQLAVGSHKH 70
           P +  Y  + +++G G  G V Q     + E+ A+K +  D     RE+++ +    H +
Sbjct: 17  PQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI-MRKLDHCN 74

Query: 71  IVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQ-RIQQKEDGAFTEREAAIIMNEICSA 127
           IV ++  +           L ++++ +        R   +           + M ++  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + ++H   I HRD+KP+NLL                             D  +LKL DFG
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDP--------------------------DTAVLKLCDFG 168

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
            AK++V  + ++   C   Y     + G   Y  S D+WS G ++  LL G P F  + G
Sbjct: 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

Query: 248 QAI-------------SPGMKNRIRLGQFDFPNPE--------WEHVSQEAKTLIKNMLC 286
                               +      +F FP  +              EA  L   +L 
Sbjct: 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288

Query: 287 VDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKE 323
             P+ RLT  +   + +  +    P   L  G+    
Sbjct: 289 YTPTARLTPLEACAHSFFDELRD-PNVKLPNGRDTPA 324

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 1e-50
 Identities = 92/307 (29%), Positives = 150/307 (48%), Gaps = 56/307 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVG 66
           +D+D   ++LG G  GKV+ + EK T   YA+K+L         +      E  + L   
Sbjct: 5   NDFDY-LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV-LQNT 62

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
            H  +  +K  ++        L  +ME  +GGELF  + ++    FTE  A     EI S
Sbjct: 63  RHPFLTALKYAFQT----HDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVS 116

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+++LH +++ +RD+K ENL+  K G                            +K+TDF
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGH---------------------------IKITDF 149

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G  K+ +S+ A+++T C TP Y+APEVL  + Y ++ D W LGV+MY ++CG  PF++  
Sbjct: 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMEN 301
            + +       I + +  FP      +S EAK+L+  +L  DP +RL        +VME+
Sbjct: 210 HERL----FELILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261

Query: 302 KWISQFN 308
           ++    N
Sbjct: 262 RFFLSIN 268

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 3e-50
 Identities = 51/299 (17%), Positives = 103/299 (34%), Gaps = 54/299 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA-------RREVELQLAVGS 67
               +  + +G G  G V +          A+K+L+ T          + EV + L    
Sbjct: 8   GQITV-GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGV-LRKTR 62

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +I+               L ++ +   G  L+  +   E   F   +   I  +    
Sbjct: 63  HVNILLFMGYSTA-----PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQG 116

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + +LH ++I HRD+K  N+                              +   +K+ DFG
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLH---------------------------EDLTVKIGDFG 149

Query: 188 FAKKI--VSNKASLQTPCYTPYYVAPEVL---GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
            A      S     +    +  ++APEV+     + Y    D+++ G+++Y L+ G  P+
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPE-WEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
            + + +     +   +  G       +   +  +  K L+   L     ER    Q++ 
Sbjct: 210 SNINNRDQ---IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  167 bits (423), Expect = 1e-49
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 59/307 (19%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARREVELQLAVG 66
            D+ I    LG G  G+V  I  +     YA+KVL                E  + L++ 
Sbjct: 4   QDFQI-LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM-LSIV 61

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
           +H  I+ +   +++    ++ + +IM+ + GGELF  +++ +   F    A     E+C 
Sbjct: 62  THPFIIRMWGTFQD----AQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCL 115

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           A+++LH ++I +RD+KPEN+L                               G +K+TDF
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLD---------------------------KNGHIKITDF 148

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           GFAK +        T C TP Y+APEV+    Y+KS D WS G+++Y +L G+ PF+ ++
Sbjct: 149 GFAKYVPDVT---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205

Query: 247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMEN 301
                     +I   +  FP       +++ K L+  ++  D S+RL       + V  +
Sbjct: 206 TMK----TYEKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257

Query: 302 KWISQFN 308
            W  +  
Sbjct: 258 PWFKEVV 264

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  167 bits (424), Expect = 1e-49
 Identities = 67/323 (20%), Positives = 120/323 (37%), Gaps = 68/323 (21%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR--REVELQLAVGSHKHI 71
           QDDY +    LG G   +V + +    +E   +K+L    K +  RE+++   +    +I
Sbjct: 34  QDDYQL-VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNI 92

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           + + D+ ++    SR   ++ E ++  +  Q  Q       T+ +    M EI  A+ + 
Sbjct: 93  ITLADIVKD--PVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYC 145

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I HRDVKP N++                             +   L+L D+G A+ 
Sbjct: 146 HSMGIMHRDVKPHNVMIDH--------------------------EHRKLRLIDWGLAEF 179

Query: 192 IVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI 250
               +        + Y+  PE+ +    YD S D+WSLG ++  ++    PFF  H    
Sbjct: 180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238

Query: 251 ----------SPGMKNRIRLGQFD--------------------FPNPEWEHVSQEAKTL 280
                     +  + + I     +                      +     VS EA   
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298

Query: 281 IKNMLCVDPSERLTIDQVMENKW 303
           +  +L  D   RLT  + ME+ +
Sbjct: 299 LDKLLRYDHQSRLTAREAMEHPY 321

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 3e-49
 Identities = 51/290 (17%), Positives = 107/290 (36%), Gaps = 48/290 (16%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKAR---REVELQLAVGSHKHI 71
            +  +  + +G G  G V+    +      A+K + +   A+    E  + +    H ++
Sbjct: 7   KELKL-LQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASV-MTQLRHSNL 62

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           V +  V   I      L ++ E M  G L   ++ +               ++C A+++L
Sbjct: 63  VQLLGV---IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
              N  HRD+   N+L +                           +  + K++DFG  K+
Sbjct: 120 EGNNFVHRDLAARNVLVS---------------------------EDNVAKVSDFGLTKE 152

Query: 192 IVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL-CGFPPFFSNHGQAI 250
             S +    T      + APE L   K+    D+WS G++++ +   G  P+     + +
Sbjct: 153 ASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209

Query: 251 SPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
            P ++   ++          +        ++KN   +D + R +  Q+ E
Sbjct: 210 VPRVEKGYKM-------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-48
 Identities = 63/337 (18%), Positives = 120/337 (35%), Gaps = 65/337 (19%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH------DTVKARREVELQLAVG 66
           +   Y      +G G  G V    +       A+K +          +  RE+++ L   
Sbjct: 6   VGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKI-LLRF 63

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
            H++I+ I D+           + ++  + G +L++ ++ +     +       + +I  
Sbjct: 64  RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILR 120

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            +K++H  N+ HRD+KP NLL     D                           LK+ DF
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLNTTCD---------------------------LKICDF 153

Query: 187 GFAKKIVSNKASLQ---TPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF 242
           G A+    +            T +Y APE++     Y KS DIWS+G I+  +L   P F
Sbjct: 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213

Query: 243 FSNHGQAI--------------SPGMKNRIRLGQFDFPNPEWE---------HVSQEAKT 279
              H                         ++   +    P            +   +A  
Sbjct: 214 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 273

Query: 280 LIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
           L+  ML  +P +R+ ++Q + + ++ Q+      P+ 
Sbjct: 274 LLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA 310

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 7e-47
 Identities = 70/316 (22%), Positives = 113/316 (35%), Gaps = 65/316 (20%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVK----------ARREVELQLAVGSHKHI 71
           + LG G    V +  +K T+++ A+K +    +          A RE++L L   SH +I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL-LQELSHPNI 62

Query: 72  VNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFL 131
           + + D + +       + ++ + M                 T       M      +++L
Sbjct: 63  IGLLDAFGH----KSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYL 116

Query: 132 HDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKK 191
           H   I HRD+KP NLL                             + G+LKL DFG AK 
Sbjct: 117 HQHWILHRDLKPNNLLLD---------------------------ENGVLKLADFGLAKS 149

Query: 192 IVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF-------- 242
             S   +      T +Y APE+L G   Y    D+W++G I+  LL   P          
Sbjct: 150 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209

Query: 243 ----FSNHGQAISPGMKNRIRLGQF----DFPNPEWEH----VSQEAKTLIKNMLCVDPS 290
               F   G        +   L  +     FP     H       +   LI+ +   +P 
Sbjct: 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC 269

Query: 291 ERLTIDQVMENKWISQ 306
            R+T  Q ++ K+ S 
Sbjct: 270 ARITATQALKMKYFSN 285

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-46
 Identities = 65/327 (19%), Positives = 113/327 (34%), Gaps = 58/327 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTS-EVYALKVLH-------DTVKARREVEL--QLA 64
             Y+     +G G  GKV +  + K      ALK +          +   REV +   L 
Sbjct: 7   QQYEC-VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEI 124
              H ++V + DV           L ++      +L   + +  +          +M ++
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 125 CSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLT 184
              + FLH   + HRD+KP+N+L T  G                             KL 
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQI---------------------------KLA 158

Query: 185 DFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF-- 242
           DFG A +I S + +L +   T +Y APEVL    Y    D+WS+G I   +    P F  
Sbjct: 159 DFGLA-RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217

Query: 243 ----------FSNHGQAISPGMKNRIRLGQFDFPNPE-------WEHVSQEAKTLIKNML 285
                         G          + L +  F +            + +  K L+   L
Sbjct: 218 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 277

Query: 286 CVDPSERLTIDQVMENKWISQFNQVPQ 312
             +P++R++    + + +     +  +
Sbjct: 278 TFNPAKRISAYSALSHPYFQDLERCKE 304

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (402), Expect = 4e-46
 Identities = 83/316 (26%), Positives = 147/316 (46%), Gaps = 59/316 (18%)

Query: 6   KPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--------DTVKARR 57
            P + T   D +D   + LG G  G+V+ +  K++   YA+K+L                
Sbjct: 32  TPSQNTAQLDQFDR-IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN 90

Query: 58  EVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREA 117
           E  + L   +   +V ++  +++       L ++ME + GGE+F  +++   G F+E  A
Sbjct: 91  EKRI-LQAVNFPFLVKLEFSFKDNS----NLYMVMEYVAGGEMFSHLRRI--GRFSEPHA 143

Query: 118 AIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGD 177
                +I    ++LH  ++ +RD+KPENLL                              
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---------------------------Q 176

Query: 178 GGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC 237
            G +++TDFGFAK++        T C TP  +APE++    Y+K+ D W+LGV++Y +  
Sbjct: 177 QGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233

Query: 238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL---- 293
           G+PPFF++    I      +I  G+  FP     H S + K L++N+L VD ++R     
Sbjct: 234 GYPPFFADQPIQI----YEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLK 285

Query: 294 -TIDQVMENKWISQFN 308
             ++ +  +KW +  +
Sbjct: 286 NGVNDIKNHKWFATTD 301

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 8e-46
 Identities = 44/291 (15%), Positives = 92/291 (31%), Gaps = 27/291 (9%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK---ARREVELQLAVGSHK 69
           + + Y +    +G G  G +    +    E  A+K+     K      E ++   +    
Sbjct: 5   VGNRYRL-GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 63

Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
            I  I+             +++ME +                F+ +   ++ +++ S I+
Sbjct: 64  GIPTIRWCGAE----GDYNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRIE 117

Query: 130 FLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFA 189
           ++H +N  HRDVKP+N L      G ++ + DFG  K               K  D    
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------------KYRDARTH 162

Query: 190 KKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
           + I   +        T  Y +       +  +  D+ SLG ++     G  P+       
Sbjct: 163 QHIPYRENK--NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220

Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
                +               +    E  T +     +   ++     + +
Sbjct: 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  152 bits (385), Expect = 2e-44
 Identities = 74/321 (23%), Positives = 122/321 (38%), Gaps = 65/321 (20%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGS 67
           + Y    E +G G  G V +  +    E +ALK +              RE+ + L    
Sbjct: 2   EKYHG-LEKIGEGTYGVVYK-AQNNYGETFALKKIRLEKEDEGIPSTTIREISI-LKELK 58

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +IV + DV          L+++ E +           +  G      A   + ++ + 
Sbjct: 59  HSNIVKLYDVIHTKKR----LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNG 112

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           I + HD+ + HRD+KP+NLL  + G+                           LK+ DFG
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGE---------------------------LKIADFG 145

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPF---- 242
            A+              T +Y AP+VL G  KY  + DIWS+G I   ++ G P F    
Sbjct: 146 LARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205

Query: 243 --------FSNHGQAISPGMKNRIRLGQFDFPNPEWE---------HVSQEAKTLIKNML 285
                   F   G   S    N   L ++D     +E          + +    L+  ML
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265

Query: 286 CVDPSERLTIDQVMENKWISQ 306
            +DP++R+T  Q +E+ +  +
Sbjct: 266 KLDPNQRITAKQALEHAYFKE 286

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-44
 Identities = 63/311 (20%), Positives = 117/311 (37%), Gaps = 56/311 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSE--VYALKVLH------DTVKARREVELQLAVG 66
           D+  I+   LG G  G V Q V +   +    A+KVL       DT +  RE ++ +   
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI-MHQL 66

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICS 126
            + +IV +  V +        L+++ME   GG L + +  K          A +++++  
Sbjct: 67  DNPYIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSM 120

Query: 127 AIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
            +K+L ++N  HRD+   N+L                             +    K++DF
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLV---------------------------NRHYAKISDF 153

Query: 187 GFAKKIVSNKASLQ---TPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPF 242
           G +K + ++ +         +   + APE +   K+    D+WS GV M+  L  G  P+
Sbjct: 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 213

Query: 243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV---M 299
               G  +   ++   R+               E   L+ +       +R     V   M
Sbjct: 214 KKMKGPEVMAFIEQGKRM-------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

Query: 300 ENKWISQFNQV 310
              + S  ++V
Sbjct: 267 RACYYSLASKV 277

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-44
 Identities = 50/291 (17%), Positives = 100/291 (34%), Gaps = 46/291 (15%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA----RREVELQLAVGSHKH 70
           +   +  E LG G  G+V            A+K L     +      E  L +    H+ 
Sbjct: 13  ETLKL-VERLGAGQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANL-MKQLQHQR 69

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +V +  V          + +I E M  G L   ++       T  +   +  +I   + F
Sbjct: 70  LVRLYAVVTQ-----EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           + ++N  HRD++  N+L +                           D    K+ DFG A+
Sbjct: 125 IEERNYIHRDLRAANILVS---------------------------DTLSCKIADFGLAR 157

Query: 191 KIVSNKASLQT-PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
            I  N+ + +    +   + APE +    +    D+WS G+++  ++      +      
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--- 214

Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
                   I+  +  +     ++  +E   L++      P +R T D +  
Sbjct: 215 ---TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 3e-44
 Identities = 60/321 (18%), Positives = 120/321 (37%), Gaps = 73/321 (22%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSE-----VYALKVLHDTVKA------RREVELQL 63
           ++ +   ++LG G  GKV+       S+       A+K+L +   +        E+++  
Sbjct: 37  ENLEFG-KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95

Query: 64  AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK---------------- 107
            +GSH++IVN+          S  + +I E    G+L   ++ K                
Sbjct: 96  QLGSHENIVNLLGACTL----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 108 -----EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF 162
                +    T  +      ++   ++FL  ++  HRD+   N+L T             
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT------------- 198

Query: 163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ--TPCYTPYYVAPEVLGPDKYD 220
                          G ++K+ DFG A+ I+S+   +          ++APE L    Y 
Sbjct: 199 --------------HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244

Query: 221 KSCDIWSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKT 279
              D+WS G++++ I   G  P+         P   N  +L Q  F   +  + ++E   
Sbjct: 245 IKSDVWSYGILLWEIFSLGVNPYPG------IPVDANFYKLIQNGFKMDQPFYATEEIYI 298

Query: 280 LIKNMLCVDPSERLTIDQVME 300
           ++++    D  +R +   +  
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTS 319

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 6e-44
 Identities = 71/328 (21%), Positives = 119/328 (36%), Gaps = 64/328 (19%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVK-------ARREVELQLAVGS 67
           +++    E +G G  G V +   K T EV ALK +    +       A RE+ L L   +
Sbjct: 2   ENFQK-VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELN 59

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           H +IV + DV          L ++ E +H   L + +                + ++   
Sbjct: 60  HPNIVKLLDVIHT----ENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQG 114

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + F H   + HRD+KP+NLL                               G +KL DFG
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLIN---------------------------TEGAIKLADFG 147

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPF---- 242
            A+       +      T +Y APE+L   KY   + DIWSLG I   ++     F    
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

Query: 243 --------FSNHGQAISPGMKNRIRLGQFDFPNPEWE---------HVSQEAKTLIKNML 285
                   F   G            +  +    P+W           + ++ ++L+  ML
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267

Query: 286 CVDPSERLTIDQVMENKWISQFNQ-VPQ 312
             DP++R++    + + +     + VP 
Sbjct: 268 HYDPNKRISAKAALAHPFFQDVTKPVPH 295

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (382), Expect = 7e-44
 Identities = 52/291 (17%), Positives = 108/291 (37%), Gaps = 44/291 (15%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA----RREVELQLAVGSHKH 70
            D  +    LG G  G+V + V KK S   A+K L +         +E  + +    H +
Sbjct: 17  TDITMK-HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV-MKEIKHPN 74

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +V +  V            +I E M  G L   +++      +      +  +I SA+++
Sbjct: 75  LVQLLGVCTR----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           L  +N  HRD+   N L                             +  ++K+ DFG ++
Sbjct: 131 LEKKNFIHRDLAARNCLVG---------------------------ENHLVKVADFGLSR 163

Query: 191 KIVSNKASLQTPC-YTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA 249
            +  +  +      +   + APE L  +K+    D+W+ GV+++ +       +      
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--- 220

Query: 250 ISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
               +     L + D+     E   ++   L++     +PS+R +  ++ +
Sbjct: 221 ---DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 1e-43
 Identities = 52/306 (16%), Positives = 107/306 (34%), Gaps = 51/306 (16%)

Query: 6   KPFKTTPIQDDYDIS------TEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA---- 55
           KP      +D ++I          LG G  G+V       T+ V A+K L     +    
Sbjct: 1   KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAF 59

Query: 56  RREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTER 115
            +E ++ +    H+ +V +  V          + ++ E M  G L   ++ +        
Sbjct: 60  LQEAQV-MKKLRHEKLVQLYAVVSE-----EPIYIVTEYMSKGSLLDFLKGETGKYLRLP 113

Query: 116 EAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKP 175
           +   +  +I S + ++   N  HRD++  N+L                            
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-------------------------- 147

Query: 176 GDGGILKLTDFGFAKKIVSNKASLQT-PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI 234
            +  + K+ DFG A+ I  N+ + +    +   + APE     ++    D+WS G+++  
Sbjct: 148 -ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 206

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
           L       +          + +++  G   +  P      +    L+      +P ER T
Sbjct: 207 LTTKGRVPYPGMVNRE---VLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERPT 260

Query: 295 IDQVME 300
            + +  
Sbjct: 261 FEYLQA 266

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-43
 Identities = 87/314 (27%), Positives = 144/314 (45%), Gaps = 58/314 (18%)

Query: 15  DDYDISTEILGLGINGKV---LQIVEKKTSEVYALKVLH---------DTVKARREVELQ 62
           +++++  ++LG G  GKV    +I    T ++YA+KVL           T   R E ++ 
Sbjct: 24  ENFEL-LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMN 122
             +     +V +   ++        L +I++ ++GGELF  + Q+E   FTE E  I + 
Sbjct: 83  EHIRQSPFLVTLHYAFQT----ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVG 136

Query: 123 EICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILK 182
           EI  A++ LH   I +RD+K EN+L                               G + 
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLD---------------------------SNGHVV 169

Query: 183 LTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVL--GPDKYDKSCDIWSLGVIMYILLCGF 239
           LTDFG +K+ V+++       C T  Y+AP+++  G   +DK+ D WSLGV+MY LL G 
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----T 294
            PF  +  +      +  I         P  + +S  AK LI+ +L  DP +RL      
Sbjct: 230 SPFTVDGEKNS----QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRD 285

Query: 295 IDQVMENKWISQFN 308
            D++ E+ +  + N
Sbjct: 286 ADEIKEHLFFQKIN 299

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 5e-43
 Identities = 56/293 (19%), Positives = 113/293 (38%), Gaps = 48/293 (16%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV----KARREVELQLAVGSHKH 70
            D     + LG G  G V    + +     A+K++ +      +   E ++ +   SH+ 
Sbjct: 4   KDLTFL-KELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIEEAKV-MMNLSHEK 60

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +V +  V        R + +I E M  G L   +++     F  ++   +  ++C A+++
Sbjct: 61  LVQLYGVCTK----QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEY 115

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           L  +   HRD+   N L                             D G++K++DFG ++
Sbjct: 116 LESKQFLHRDLAARNCLVN---------------------------DQGVVKVSDFGLSR 148

Query: 191 KIVSNKASLQT-PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFFSNHGQ 248
            ++ ++ +      +   +  PEVL   K+    DIW+ GV+M+ I   G  P+      
Sbjct: 149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN 301
             +  +   +RL             S++  T++ +       ER T   ++ N
Sbjct: 209 ETAEHIAQGLRL-------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 5e-43
 Identities = 56/313 (17%), Positives = 111/313 (35%), Gaps = 60/313 (19%)

Query: 15  DDYDISTE--ILGLGINGKVL--QIVEKKTSEVYALKVLHDTVK-------ARREVELQL 63
           D   ++ E   LG G  G V       KK  +  A+K+L +             E  + +
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV-M 62

Query: 64  AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
               + +IV +  + E         +++ME    G L + +QQ       ++    ++++
Sbjct: 63  QQLDNPYIVRMIGICEA-----ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQ 115

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +   +K+L + N  HRD+   N+L                                  K+
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLV---------------------------TQHYAKI 148

Query: 184 TDFGFAKKIVSNKASLQT---PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF 239
           +DFG +K + +++   +      +   + APE +   K+    D+WS GV+M+     G 
Sbjct: 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208

Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV- 298
            P+    G  ++  ++   R+              +E   L+      D   R     V 
Sbjct: 209 KPYRGMKGSEVTAMLEKGERM-------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVE 261

Query: 299 --MENKWISQFNQ 309
             + N +    N+
Sbjct: 262 LRLRNYYYDVVNE 274

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 8e-43
 Identities = 66/332 (19%), Positives = 115/332 (34%), Gaps = 71/332 (21%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGS 67
             Y+     +G G  G+V +   +KT +  ALK +          + A RE+++ L +  
Sbjct: 10  SKYEK-LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLK 67

Query: 68  HKHIVNIKDVYEN----IYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
           H+++VN+ ++              + ++ +                  FT  E   +M  
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQM 125

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           + + + ++H   I HRD+K  N+L T+                            G+LKL
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITR---------------------------DGVLKL 158

Query: 184 TDFGFAKKIVSNKASLQTPCY----TPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCG 238
            DFG A+     K S          T +Y  PE+L G   Y    D+W  G IM  +   
Sbjct: 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218

Query: 239 FPPFFSNHGQAI---------------SPGMKNRIRLGQFDFPNPEWEHV---------S 274
            P    N  Q                  P + N     + +    +   V          
Sbjct: 219 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD 278

Query: 275 QEAKTLIKNMLCVDPSERLTIDQVMENKWISQ 306
             A  LI  +L +DP++R+  D  + + +   
Sbjct: 279 PYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  146 bits (370), Expect = 4e-42
 Identities = 38/293 (12%), Positives = 97/293 (33%), Gaps = 29/293 (9%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH---DTVKARREVELQLAVGSHK 69
           +   Y +    +G G  G + +      ++  A+K      D  + R E      +    
Sbjct: 3   VGVHYKV-GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 61

Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
            I N+    +         +++++ +  G   + +       F+ +  A+   ++ + ++
Sbjct: 62  GIPNVYYFGQE----GLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115

Query: 130 FLHDQNIAHRDVKPENLLYTKPGD--GGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
            +H++++ +RD+KP+N L  +P      ++ + DFG                ++K     
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG----------------MVKFYRDP 159

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG 247
             K+ +  +   +    T  Y++       +  +  D+ +LG +    L G  P+     
Sbjct: 160 VTKQHIPYR-EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
                  +      Q            +E    +     +        D +  
Sbjct: 219 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 4e-42
 Identities = 66/337 (19%), Positives = 126/337 (37%), Gaps = 69/337 (20%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-------KARREVELQLAV 65
           ++  Y    + +G G  G V   V+ +T    A+K L+          +A RE+ L L  
Sbjct: 16  VRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL-LKH 73

Query: 66  GSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
             H++++ + DV+  +   +      ++M  M  G    ++ +       E     ++ +
Sbjct: 74  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH--EKLGEDRIQFLVYQ 129

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +   ++++H   I HRD+KP NL                              +   LK+
Sbjct: 130 MLKGLRYIHAAGIIHRDLKPGNLAVN---------------------------EDCELKI 162

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPF 242
            DFG A++  S    +     T +Y APEV L   +Y ++ DIWS+G IM  ++ G   F
Sbjct: 163 LDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 219

Query: 243 FSNHG-------------------QAISPGMKNRIRLGQFDFPNPEWE----HVSQEAKT 279
             +                     Q +          G  +    ++     + S  A  
Sbjct: 220 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVN 279

Query: 280 LIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLC 316
           L++ ML +D  +R+T  + + + +    +     P  
Sbjct: 280 LLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 9e-42
 Identities = 69/336 (20%), Positives = 121/336 (36%), Gaps = 65/336 (19%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAV 65
           + + Y      +G G  G V    + KT    A+K L           +  RE+ L L  
Sbjct: 16  VPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL-LKH 73

Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
             H++++ + DV+    +      V +     G     I +      T+     ++ +I 
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 131

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
             +K++H  +I HRD+KP NL   +  +                            K+ D
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCEL---------------------------KILD 164

Query: 186 FGFAKKIVSNKASLQTPCYTPYYVAPEV-LGPDKYDKSCDIWSLGVIMYILLCGFPPFFS 244
           FG A+        +     T +Y APE+ L    Y+++ DIWS+G IM  LL G   F  
Sbjct: 165 FGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221

Query: 245 NH-------------------GQAISPGMKNRIRLGQFDFPNPEWEHV----SQEAKTLI 281
                                 + IS              P   + +V    +  A  L+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281

Query: 282 KNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCT 317
           + ML +D  +R+T  Q + + + +Q++     P+  
Sbjct: 282 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 317

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-41
 Identities = 56/301 (18%), Positives = 99/301 (32%), Gaps = 56/301 (18%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTS---EVYALKVLHDTVKA--------RREVELQL 63
            D  +  E LG G  G V +      S      A+K L   V +         REV   +
Sbjct: 8   KDLRL-LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA-M 65

Query: 64  AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
               H++++ +  V          + ++ E    G L  R  +K  G F     +    +
Sbjct: 66  HSLDHRNLIRLYGVVLT-----PPMKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQ 119

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +   + +L  +   HRD+   NLL                                ++K+
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---------------------------LVKI 152

Query: 184 TDFGFAKKIVSNKASL---QTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF 239
            DFG  + +  N       +       + APE L    +  + D W  GV ++ +   G 
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212

Query: 240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM 299
            P+   +G  I     ++I       P P  E   Q+   ++       P +R T   + 
Sbjct: 213 EPWIGLNGSQI----LHKIDKEGERLPRP--EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

Query: 300 E 300
           +
Sbjct: 267 D 267

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-41
 Identities = 55/297 (18%), Positives = 101/297 (34%), Gaps = 53/297 (17%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSE---VYALKVLHDTV------KARREVELQLAV 65
           +  ++    +G G  G V Q +           A+K   +        K  +E    +  
Sbjct: 7   ERIEL-GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT-MRQ 64

Query: 66  GSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEIC 125
             H HIV +  V          + +IME    GEL     Q    +       +   ++ 
Sbjct: 65  FDHPHIVKLIGVITE-----NPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLS 118

Query: 126 SAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTD 185
           +A+ +L  +   HRD+   N+L +                               +KL D
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSN---------------------------DCVKLGD 151

Query: 186 FGFAKKIVSNKASLQTPCY-TPYYVAPEVLGPDKYDKSCDIWSLGVIMY-ILLCGFPPFF 243
           FG ++ +  +     +       ++APE +   ++  + D+W  GV M+ IL+ G  PF 
Sbjct: 152 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211

Query: 244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
                 +   ++N  RL       P   +      +L+      DPS R    ++  
Sbjct: 212 GVKNNDVIGRIENGERL-------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-41
 Identities = 46/292 (15%), Positives = 102/292 (34%), Gaps = 48/292 (16%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA----RREVELQLAVGSHKH 70
            +     + +G G  G V         +  A+K + +   +      E E+ +   SH  
Sbjct: 5   SELTFV-QEIGSGQFGLVHL-GYWLNKDKVAIKTIREGAMSEEDFIEEAEV-MMKLSHPK 61

Query: 71  IVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKF 130
           +V +  V          + ++ E M  G L     + + G F       +  ++C  + +
Sbjct: 62  LVQLYGVCLE----QAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAY 116

Query: 131 LHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAK 190
           L +  + HRD+   N L                             +  ++K++DFG  +
Sbjct: 117 LEEACVIHRDLAARNCLVG---------------------------ENQVIKVSDFGMTR 149

Query: 191 KIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ 248
            ++ ++ +      +   + +PEV    +Y    D+WS GV+M+ +   G  P+ +    
Sbjct: 150 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209

Query: 249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
            +   +    RL        +    S     ++ +     P +R    +++ 
Sbjct: 210 EVVEDISTGFRL-------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (365), Expect = 2e-41
 Identities = 68/326 (20%), Positives = 115/326 (35%), Gaps = 71/326 (21%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAVGS 67
             Y+   E +G G  G V +   ++T E+ ALK +            A RE+ L L    
Sbjct: 2   QKYEK-LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL-LKELK 59

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
           HK+IV + DV  +     + L ++ E                G          + ++   
Sbjct: 60  HKNIVRLHDVLHS----DKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKG 113

Query: 128 IKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFG 187
           + F H +N+ HRD+KP+NLL  + G+                            KL +FG
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGEL---------------------------KLANFG 146

Query: 188 FAKKIVSNKASLQTPCYTPYYVAPEVL-GPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
            A+              T +Y  P+VL G   Y  S D+WS G I   L     P F  +
Sbjct: 147 LARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206

Query: 247 GQAISPGMKNRIRLGQFDFPNPEWE-------------------------HVSQEAKTLI 281
                     RI          +W                           ++   + L+
Sbjct: 207 DVD---DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263

Query: 282 KNMLCVDPSERLTIDQVMENKWISQF 307
           +N+L  +P +R++ ++ +++ + S F
Sbjct: 264 QNLLKCNPVQRISAEEALQHPYFSDF 289

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 5e-41
 Identities = 62/323 (19%), Positives = 114/323 (35%), Gaps = 68/323 (21%)

Query: 15  DDYDISTEILGLGINGKV-----LQIVEKKTSEVYALKVLHDTVKA------RREVELQL 63
           +      + LG G  GKV       +++   +   A+K+L  +           E+++  
Sbjct: 23  NRLSFG-KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 81

Query: 64  AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK---------------- 107
            +G+H +IVN+              LVI E    G+L   +++K                
Sbjct: 82  YLGNHMNIVNLLGACTI----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 108 EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP 167
           ++ A    +      ++   + FL  +N  HRD+   N+L                    
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL-------------------- 177

Query: 168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQT--PCYTPYYVAPEVLGPDKYDKSCDI 225
                     G I K+ DFG A+ I ++   +          ++APE +    Y    D+
Sbjct: 178 -------LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230

Query: 226 WSLGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNML 285
           WS G+ ++ L       +        P      ++ +  F     EH   E   ++K   
Sbjct: 231 WSYGIFLWELFSLGSSPYPGM-----PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCW 285

Query: 286 CVDPSERLTIDQVME--NKWISQ 306
             DP +R T  Q+++   K IS+
Sbjct: 286 DADPLKRPTFKQIVQLIEKQISE 308

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (358), Expect = 3e-40
 Identities = 57/308 (18%), Positives = 112/308 (36%), Gaps = 56/308 (18%)

Query: 8   FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSE---VYALKVLHDTVKA------RRE 58
           F          I  +++G G  G+V     K   +     A+K L              E
Sbjct: 19  FAKEIDISCVKIE-QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 77

Query: 59  VELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAA 118
             + +    H ++++++ V       S  +++I E M  G L     ++ DG FT  +  
Sbjct: 78  ASI-MGQFDHPNVIHLEGVVTK----STPVMIITEFMENGSLDS-FLRQNDGQFTVIQLV 131

Query: 119 IIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDG 178
            ++  I + +K+L D N  HRD+   N+L                               
Sbjct: 132 GMLRGIAAGMKYLADMNYVHRDLAARNILVN---------------------------SN 164

Query: 179 GILKLTDFGFAKKIVSNKA-----SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMY 233
            + K++DFG ++ +  + +     S         + APE +   K+  + D+WS G++M+
Sbjct: 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 224

Query: 234 -ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSER 292
            ++  G  P++    Q +       I   + D+  P           L+ +    D + R
Sbjct: 225 EVMSYGERPYWDMTNQDV-------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277

Query: 293 LTIDQVME 300
               Q++ 
Sbjct: 278 PKFGQIVN 285

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-39
 Identities = 52/315 (16%), Positives = 109/315 (34%), Gaps = 57/315 (18%)

Query: 14  QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKA----------RREVELQL 63
           + ++    ++LG G  G V + +     E   + V    ++             E  + +
Sbjct: 8   ETEFKKI-KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV-M 65

Query: 64  AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
           A   + H+  +  +          + +I + M  G L   +++ +D     +       +
Sbjct: 66  ASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQ 119

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           I   + +L D+ + HRD+   N+L                                 +K+
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVK---------------------------TPQHVKI 152

Query: 184 TDFGFAKKIVSNKASLQT--PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFP 240
           TDFG AK + + +             ++A E +    Y    D+WS GV ++ L+  G  
Sbjct: 153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212

Query: 241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
           P+       IS  ++   RL       P+    + +   ++     +D   R    +++ 
Sbjct: 213 PYDGIPASEISSILEKGERL-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELII 265

Query: 301 NKWISQFNQVPQTPL 315
               S+  + PQ  L
Sbjct: 266 E--FSKMARDPQRYL 278

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 4e-39
 Identities = 60/316 (18%), Positives = 116/316 (36%), Gaps = 69/316 (21%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSE-------VYALKVLH------DTVKARREVEL 61
           D   +  + LG G  G+V+        +         A+K+L       D      E+E+
Sbjct: 13  DRLVL-GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71

Query: 62  QLAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK-------------- 107
              +G HK+I+N+             L VI+E    G L + +Q +              
Sbjct: 72  MKMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 108 EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP 167
            +   + ++      ++   +++L  +   HRD+   N+L T                  
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT------------------ 169

Query: 168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCY--TPYYVAPEVLGPDKYDKSCDI 225
                    +  ++K+ DFG A+ I       +T        ++APE L    Y    D+
Sbjct: 170 ---------EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220

Query: 226 WSLGVIMY-ILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNM 284
           WS GV+++ I   G  P+     + +   +K   R+        +  + + E   ++++ 
Sbjct: 221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM-------DKPSNCTNELYMMMRDC 273

Query: 285 LCVDPSERLTIDQVME 300
               PS+R T  Q++E
Sbjct: 274 WHAVPSQRPTFKQLVE 289

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 4e-39
 Identities = 53/326 (16%), Positives = 111/326 (34%), Gaps = 65/326 (19%)

Query: 15  DDYDISTEILGLGINGKVLQIVEKKTSEVY--ALKVLHDTVKA------RREVELQLAVG 66
           +D     +++G G  G+VL+   KK       A+K + +            E+E+   +G
Sbjct: 10  NDIKFQ-DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 67  SHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK--------------EDGAF 112
            H +I+N+    E+       L + +E    G L   +++                    
Sbjct: 69  HHPNIINLLGACEH----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 113 TEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY 172
           + ++      ++   + +L  +   HRD+   N+L                         
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----------------------- 161

Query: 173 TKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM 232
               +  + K+ DFG ++                 ++A E L    Y  + D+WS GV++
Sbjct: 162 ----ENYVAKIADFGLSRGQEVYVKK-TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216

Query: 233 YILL-CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSE 291
           + ++  G  P+       +   +    RL        +  +   E   L++      P E
Sbjct: 217 WEIVSLGGTPYCGMTCAELYEKLPQGYRL-------EKPLNCDDEVYDLMRQCWREKPYE 269

Query: 292 RLTIDQVME--NKWISQFNQVPQTPL 315
           R +  Q++   N+ + +      T L
Sbjct: 270 RPSFAQILVSLNRMLEERKTYVNTTL 295

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-38
 Identities = 54/305 (17%), Positives = 116/305 (38%), Gaps = 54/305 (17%)

Query: 10  TTPIQ-DDYDISTEILGLGINGKVLQIVEKKTSE----VYALKVLHDTVKARREVELQ-- 62
           TT I         +++G G  G+V + + K +S       A+K L      ++ V+    
Sbjct: 1   TTEIHPSCVTRQ-KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59

Query: 63  ---LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAI 119
              +   SH +I+ ++ V        + +++I E M  G    +  +++DG F+  +   
Sbjct: 60  AGIMGQFSHHNIIRLEGVISK----YKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVG 114

Query: 120 IMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGG 179
           ++  I + +K+L + N  HRD+   N+L                                
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVN---------------------------SNL 147

Query: 180 ILKLTDFGFAKKIVSNKASLQTPC---YTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL 236
           + K++DFG ++ +  +  +  T         + APE +   K+  + D+WS G++M+ ++
Sbjct: 148 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 207

Query: 237 C-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTI 295
             G  P++      +   + +  RL       P           L+      + + R   
Sbjct: 208 TYGERPYWELSNHEVMKAINDGFRL-------PTPMDCPSAIYQLMMQCWQQERARRPKF 260

Query: 296 DQVME 300
             ++ 
Sbjct: 261 ADIVS 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (342), Expect = 6e-38
 Identities = 48/323 (14%), Positives = 114/323 (35%), Gaps = 76/323 (23%)

Query: 14  QDDYDISTEILGLGINGKV-----LQIVEKKTSEVYALKVLHDTVKA------RREVELQ 62
           +++ +     +G G  G+V       ++  +   + A+K+L +   A      +RE  L 
Sbjct: 12  RNNIEYV-RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL- 69

Query: 63  LAVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQK--------------- 107
           +A   + +IV +  V        + + ++ E M  G+L + ++                 
Sbjct: 70  MAEFDNPNIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 108 -------EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLT 160
                       +  E   I  ++ + + +L ++   HRD+   N L             
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----------- 174

Query: 161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQ--TPCYTPYYVAPEVLGPDK 218
                           +  ++K+ DFG ++ I S               ++ PE +  ++
Sbjct: 175 ----------------ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218

Query: 219 YDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEA 277
           Y    D+W+ GV+++ +   G  P++    + +   +++   L          E+   E 
Sbjct: 219 YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL-------ACPENCPLEL 271

Query: 278 KTLIKNMLCVDPSERLTIDQVME 300
             L++      P++R +   +  
Sbjct: 272 YNLMRLCWSKLPADRPSFCSIHR 294

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 4e-37
 Identities = 72/370 (19%), Positives = 136/370 (36%), Gaps = 82/370 (22%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH-------DTVKARREVELQLAV 65
           +   Y    + +G G  G V    +       A+K L           +A RE+ L +  
Sbjct: 15  VLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL-MKC 72

Query: 66  GSHKHIVNIKDVY--ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNE 123
            +HK+I+++ +V+  +      + + ++ME M          +           + ++ +
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQ 127

Query: 124 ICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKL 183
           +   IK LH   I HRD+KP N++                                 LK+
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVK---------------------------SDCTLKI 160

Query: 184 TDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF 243
            DFG A+   ++   +     T YY APEV+    Y ++ DIWS+G IM  ++     F 
Sbjct: 161 LDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219

Query: 244 SNHGQA-----------------------ISPGMKNRIRLGQFDFPN-----------PE 269
                                        +   ++NR +     FP              
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279

Query: 270 WEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF----NQVPQTPLCTGKMLKEGE 325
            +  + +A+ L+  ML +DP++R+++D  +++ +I+ +          P    K L E E
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDERE 339

Query: 326 ETWPEVQDEM 335
            T  E ++ +
Sbjct: 340 HTIEEWKELI 349

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 6e-37
 Identities = 53/323 (16%), Positives = 100/323 (30%), Gaps = 68/323 (21%)

Query: 13  IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLH--DTVKARREVE-LQLAVGSHK 69
           I     +  E +G G  G+V +   K   E  A+K+    +     RE E  Q  +  H+
Sbjct: 1   IARTIVLQ-ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHE 57

Query: 70  HIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIK 129
           +I+               L ++ +    G LF  + +      T      +     S + 
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 114

Query: 130 FLH--------DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGIL 181
            LH           IAHRD+K +N+L                               G  
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVK---------------------------KNGTC 147

Query: 182 KLTDFGFAKKIVSNKASLQ----TPCYTPYYVAPEVL------GPDKYDKSCDIWSLGVI 231
            + D G A +  S   ++         T  Y+APEVL         +  K  DI+++G++
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207

Query: 232 MYILLCGFPPFFSNH-----------GQAISPGMKNRIRLGQFDFPNPEWEH---VSQEA 277
            + +         +                   M+  +   +     P         +  
Sbjct: 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 267

Query: 278 KTLIKNMLCVDPSERLTIDQVME 300
             +++     + + RLT  ++ +
Sbjct: 268 AKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 1e-35
 Identities = 56/313 (17%), Positives = 113/313 (36%), Gaps = 63/313 (20%)

Query: 15  DDYDISTEILGLGINGKV-----LQIVEKKTSEVYALKVLHDTV------KARREVELQL 63
           D   +  + LG G  G+V       I +  T    A+K+L +            E+++ +
Sbjct: 13  DRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 71

Query: 64  AVGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED-------------- 109
            +G H ++VN+             L+VI+E    G L   ++ K +              
Sbjct: 72  HIGHHLNVVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128

Query: 110 GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN 169
              T         ++   ++FL  +   HRD+   N+L +                    
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-------------------- 168

Query: 170 LLYTKPGDGGILKLTDFGFAKKIVSNKASLQT--PCYTPYYVAPEVLGPDKYDKSCDIWS 227
                  +  ++K+ DFG A+ I  +   ++         ++APE +    Y    D+WS
Sbjct: 169 -------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221

Query: 228 LGVIMYILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCV 287
            GV+++ +       +   G  I      R++ G         ++ + E    + +    
Sbjct: 222 FGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHG 276

Query: 288 DPSERLTIDQVME 300
           +PS+R T  +++E
Sbjct: 277 EPSQRPTFSELVE 289

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 8e-35
 Identities = 48/293 (16%), Positives = 99/293 (33%), Gaps = 53/293 (18%)

Query: 22  EILGLGINGKVLQ---IVEKKTSEVYALKVLHDTVKA------RREVELQLAVGSHKHIV 72
           E++G G  G V     +         A+K L+             E  + +   SH +++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-MKDFSHPNVL 91

Query: 73  NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH 132
           ++  +           LV++  M  G+L     + E    T ++      ++   +KFL 
Sbjct: 92  SLLGIC---LRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 133 DQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKI 192
            +   HRD+   N +                             +   +K+ DFG A+ +
Sbjct: 148 SKKFVHRDLAARNCMLD---------------------------EKFTVKVADFGLARDM 180

Query: 193 VSNKASLQTP----CYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHG 247
              +               ++A E L   K+    D+WS GV+++ L+  G PP+   + 
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240

Query: 248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME 300
             I+  +    RL        + E+       ++          R +  +++ 
Sbjct: 241 FDITVYLLQGRRL-------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  125 bits (314), Expect = 2e-33
 Identities = 56/367 (15%), Positives = 118/367 (32%), Gaps = 80/367 (21%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLH----DTVKARREVEL----------QLAVGS 67
             LG G    V    +   +   A+K++      T  A  E++L          +     
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 68  HKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSA 127
             HI+ + D + +       + V++  + G  L   I++ E           I  ++   
Sbjct: 79  ANHILKLLDHFNHKGPNGVHV-VMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 128 IKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDF 186
           + ++H +  I H D+KPEN+L                           P +   +K+ D 
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDS---------------------PENLIQIKIADL 176

Query: 187 GFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH 246
           G A     +         T  Y +PEVL    +    DIWS   +++ L+ G   F  + 
Sbjct: 177 GNACWYDEHY---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233

Query: 247 GQAISPGMKNRIRLGQFDFPNPEW------------------------------------ 270
           G + +    +  ++ +     P +                                    
Sbjct: 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 293

Query: 271 ----EHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEE 326
               +  ++E    +  ML +DP +R     ++ + W+     + +  +   ++   G +
Sbjct: 294 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSD 353

Query: 327 TWPEVQD 333
                ++
Sbjct: 354 IPGWFEE 360

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 4e-32
 Identities = 49/306 (16%), Positives = 104/306 (33%), Gaps = 58/306 (18%)

Query: 15  DDYDISTEILGLGINGKVLQ-----IVEKKTSEVYALKVLHDTVKARREVELQ-----LA 64
           +   +S   LG G  G V +     +V+ +     A+K +++    R  +E       + 
Sbjct: 20  EKITMS-RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 78

Query: 65  VGSHKHIVNIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKED--------GAFTERE 116
             +  H+V +  V        +  LVIME M  G+L   ++               +  +
Sbjct: 79  EFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 117 AAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPG 176
              +  EI   + +L+     HRD+   N +                             
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVA--------------------------- 167

Query: 177 DGGILKLTDFGFAKKIVSNKASLQT--PCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYI 234
           +   +K+ DFG  + I       +         +++PE L    +    D+WS GV+++ 
Sbjct: 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227

Query: 235 LLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT 294
           +       +   G +    ++  +  G  D P    ++       L++     +P  R +
Sbjct: 228 IATLAEQPY--QGLSNEQVLRFVMEGGLLDKP----DNCPDMLFELMRMCWQYNPKMRPS 281

Query: 295 IDQVME 300
             +++ 
Sbjct: 282 FLEIIS 287

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 55.9 bits (134), Expect = 6e-10
 Identities = 22/147 (14%), Positives = 48/147 (32%), Gaps = 10/147 (6%)

Query: 22  EILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENI 81
           +++G G    V      +      +K       + ++V+ +   G     V       N 
Sbjct: 6   KLMGEGKESAVFN-CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 82  YNGSRCLLVI-----MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNI 136
           +   + L  +             L + I  KE           +++ I   +   + + I
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGI 124

Query: 137 AHRDVKPENLLYTKPGDGGILKLTDFG 163
            H D+   N+L ++ G    + + DF 
Sbjct: 125 VHGDLSQYNVLVSEEG----IWIIDFP 147

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	372
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.41
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.9
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.66
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.34
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.99
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	92.67

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-69  Score=502.62  Aligned_cols=333  Identities=64%  Similarity=1.100  Sum_probs=285.4

Q ss_pred             CCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151           7 PFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTVKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus         7 ~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ..+...+.++|+|++++||+|+||+||+|++..+|+.||||++.......+|+.++++..+||||++++++|++....+.
T Consensus         3 ~~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1           3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             CCBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cCCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            34566688999998788999999999999999999999999999888899999988888899999999999987666778


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      ++|+|||||+||+|.+++.+.....+++.+++.++.||+.||+|||++||+||||||+|||++.++              
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~--------------  148 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR--------------  148 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS--------------
T ss_pred             EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc--------------
Confidence            999999999999999999876556799999999999999999999999999999999999998433              


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                ..+.+||+|||+|+.... .......+||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+
T Consensus       149 ----------~~~~~Kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~  217 (335)
T d2ozaa1         149 ----------PNAILKLTDFGFAKETTS-HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  217 (335)
T ss_dssp             ----------TTCCEEECCCTTCEECCC-CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred             ----------ccccccccccceeeeccC-CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence                      456799999999987654 334566789999999999999999999999999999999999999998877


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCCCCCCCCccccccccCCC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQVPQTPLCTGKMLKEGEE  326 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  326 (372)
                      .......+...+..+.+.+|.+.+..+|+++++||.+||+.||++|||++|+|+||||.+....+..+......+.+...
T Consensus       218 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  297 (335)
T d2ozaa1         218 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE  297 (335)
T ss_dssp             CC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEESHHHHHHHCHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCcChhhhhhhhHH
Confidence            66665566667777777888777788999999999999999999999999999999998877666666555555555555


Q ss_pred             CchhhHHHHHHHHHHhhccCCcceeecccCCCChHHHh
Q psy3151         327 TWPEVQDEMTRSLATMRVDYDQIHIKSLINSKNPLLNK  364 (372)
Q Consensus       327 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  364 (372)
                      .+.+..+++...+...+.+.++..++...+.+||++.|
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~e~~~~k~~~~~~~p~l~k  335 (335)
T d2ozaa1         298 RWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLK  335 (335)
T ss_dssp             HHHHHHHHHHHHHHHHSCCTTSCCCCCGGGCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCHHHHhhhhhccccChhhcC
Confidence            56677777888888899999999999999999999876

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-63  Score=445.96  Aligned_cols=255  Identities=27%  Similarity=0.514  Sum_probs=214.4

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ||.++|+++ +.||+|+||+||+|+++.+|+.||||++...      ....+|+.+ ++.++||||+++++++.+    +
T Consensus         2 Pf~~dy~~~-~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~-l~~l~HpnIv~~~~~~~~----~   75 (271)
T d1nvra_           2 PFVEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKMLNHENVVKFYGHRRE----G   75 (271)
T ss_dssp             TTTTEEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHH-HHTCCCTTBCCEEEEEEE----T
T ss_pred             CCCcceEEE-EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHH-HHhCCCCCEeeEeeeecc----C
Confidence            678999995 7799999999999999999999999998632      245678887 677899999999999987    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +.+|+|||||++|+|.+++...  +.+++.+++.++.||+.||+|||++||+||||||+|||++                
T Consensus        76 ~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~----------------  137 (271)
T d1nvra_          76 NIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----------------  137 (271)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----------------
T ss_pred             ceeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC----------------
Confidence            7899999999999999998654  4699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHHHHHhCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                 .++.+||+|||+|+......  ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus       138 -----------~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf  206 (271)
T d1nvra_         138 -----------ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW  206 (271)
T ss_dssp             -----------TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             -----------CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCC
Confidence                       56779999999998764332  23456789999999999977776 57899999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      ........   ..........  ....+..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       207 ~~~~~~~~---~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         207 DQPSDSCQ---EYSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             SSSSTTSH---HHHHHHTTCT--TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             CCCChHHH---HHHHHhcCCC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            76543221   1222222221  22334678999999999999999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-62  Score=444.24  Aligned_cols=253  Identities=26%  Similarity=0.456  Sum_probs=217.3

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ..++|+++ +.||+|+||+||+|.+..+|+.||||++...     ....+|+.+ ++.++||||++++++|.+    ++.
T Consensus        18 p~~~Y~~~-~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~~~~~~~~----~~~   91 (293)
T d1yhwa1          18 PKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV-MRENKNPNIVNYLDSYLV----GDE   91 (293)
T ss_dssp             TTTTBCSC-EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHH-HHHCCCTTBCCEEEEEEE----TTE
T ss_pred             cccccEEE-EEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHH-HHhCCCCCEeeEeEEEEE----CCE
Confidence            45789996 6699999999999999999999999998632     345688887 677899999999999986    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+|||||+||+|.+++.+.   .+++.+++.++.||+.||+|||++||+||||||+|||++                  
T Consensus        92 ~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~------------------  150 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG------------------  150 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------------
T ss_pred             EEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC------------------
Confidence            99999999999999988653   499999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               .++.+||+|||+|+............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.
T Consensus       151 ---------~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~  221 (293)
T d1yhwa1         151 ---------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP  221 (293)
T ss_dssp             ---------TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             ---------CCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence                     56789999999999876655566778899999999999999999999999999999999999999965442


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      .   ..+..........+  ..+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       222 ~---~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         222 L---RALYLIATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             H---HHHHHHHHHCSCCC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             H---HHHHHHHhCCCCCC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            2   22233333333222  233578999999999999999999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-62  Score=448.83  Aligned_cols=261  Identities=38%  Similarity=0.743  Sum_probs=213.8

Q ss_pred             ccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151           9 KTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus         9 ~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      +.+.+.++|++ .+.||+|+||+||+|+++.+|+.||||++...      ....+|+.+ ++.++||||++++++|++  
T Consensus         3 ~~edi~d~Y~~-~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~--   78 (307)
T d1a06a_           3 QAEDIRDIYDF-RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV-LHKIKHPNIVALDDIYES--   78 (307)
T ss_dssp             ECSCGGGTEEE-EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHH-HHTCCCTTBCCEEEEEEC--
T ss_pred             CCCCCccceEE-EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHH-HHhCCCCCCCcEEEEEEE--
Confidence            45678899999 47899999999999999999999999998632      234578887 677799999999999986  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        ++.+|+|||||+||+|.+++...  +.+++.+++.++.||+.||+|||++||+||||||+|||+....          
T Consensus        79 --~~~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~----------  144 (307)
T d1a06a_          79 --GGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD----------  144 (307)
T ss_dssp             --SSEEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS----------
T ss_pred             --CCEEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccC----------
Confidence              67899999999999999999765  4699999999999999999999999999999999999997422          


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    .++.+||+|||+|+.... .....+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||
T Consensus       145 --------------~~~~vkl~DFG~a~~~~~-~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf  209 (307)
T d1a06a_         145 --------------EDSKIMISDFGLSKMEDP-GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF  209 (307)
T ss_dssp             --------------TTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             --------------CCceEEEeccceeEEccC-CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCC
Confidence                          467899999999986543 23345678999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      .+...    ......+..+...++.+.+..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       210 ~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         210 YDEND----AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             CCSSH----HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCCCH----HHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            65432    3455667777777777777789999999999999999999999999999999976

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-62  Score=436.55  Aligned_cols=247  Identities=34%  Similarity=0.600  Sum_probs=215.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++. +.||+|+||+||+|+++.+|+.||||++...        ....+|+.+ ++.++||||+++++++.+    ++
T Consensus         6 ~dy~i~-~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~~~~~~~~----~~   79 (263)
T d2j4za1           6 EDFEIG-RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHPNILRLYGYFHD----AT   79 (263)
T ss_dssp             GGEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHTCCCTTBCCEEEEEEC----SS
T ss_pred             hHeEEE-EEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHH-HHhcCCCCCCeEEEEEEE----CC
Confidence            689994 7799999999999999999999999998532        234578877 677899999999999986    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+|||||++|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++                 
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~-----------------  140 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-----------------  140 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-----------------
T ss_pred             EEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec-----------------
Confidence            8999999999999999998763  599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.+||+|||+|.....  ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+
T Consensus       141 ----------~~~~~kl~DFG~a~~~~~--~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  208 (263)
T d2j4za1         141 ----------SAGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT  208 (263)
T ss_dssp             ----------TTSCEEECCCCSCSCCCC--CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ----------CCCCEeecccceeeecCC--CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence                      567799999999986543  23456789999999999999999999999999999999999999996543


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      .    ..+...+....+.+|.    .+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       209 ~----~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         209 Y----QETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             H----HHHHHHHHTTCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             H----HHHHHHHHcCCCCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            2    3445666666665553    68999999999999999999999999999999964

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-61  Score=439.70  Aligned_cols=264  Identities=33%  Similarity=0.569  Sum_probs=225.9

Q ss_pred             CccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----------hhhHHHHHHHHHhcCCCCEeEEeE
Q psy3151           8 FKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------VKARREVELQLAVGSHKHIVNIKD   76 (372)
Q Consensus         8 ~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~ni~~~~~   76 (372)
                      ....++.++|++. +.||+|+||+||+|+++.+|+.||||++...           ....+|+.+ ++.++||||+++++
T Consensus         3 ~~~~~i~d~Y~~~-~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~~~~   80 (293)
T d1jksa_           3 FRQENVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI-LKEIQHPNVITLHE   80 (293)
T ss_dssp             CBCSCGGGTEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHH-HHHCCCTTBCCEEE
T ss_pred             ccCCCcccCEEEe-EEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHH-HHhCCCCCCCcEEE
Confidence            3567789999994 7799999999999999999999999998521           235678887 66779999999999


Q ss_pred             eeeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCc
Q psy3151          77 VYENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGI  156 (372)
Q Consensus        77 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~  156 (372)
                      +|++    ++.+|+|||||+||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.   
T Consensus        81 ~~~~----~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~---  151 (293)
T d1jksa_          81 VYEN----KTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV---  151 (293)
T ss_dssp             EEEC----SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSS---
T ss_pred             EEEE----CCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCC---
Confidence            9986    778999999999999999998763  5999999999999999999999999999999999999985432   


Q ss_pred             eeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHH
Q psy3151         157 LKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       157 ~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  236 (372)
                                          ....+|++|||+|...... ....+.+||+.|+|||++.+..|+.++||||+||++|+|+
T Consensus       152 --------------------~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell  210 (293)
T d1jksa_         152 --------------------PKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL  210 (293)
T ss_dssp             --------------------SSCCEEECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             --------------------cccceEecchhhhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHH
Confidence                                3456999999999876442 3345668899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         237 CGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      +|..||.+.+.    ......+......++...+..+|+++++||++||+.||++|||++|+|+||||+..
T Consensus       211 ~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         211 SGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HSSCSSCCSSH----HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             cCCCCCCCCCH----HHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999975442    33455566666666655556789999999999999999999999999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-61  Score=436.45  Aligned_cols=255  Identities=28%  Similarity=0.405  Sum_probs=215.3

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ..+.|+++ +.||+|+||+||+|++..+|+.||||++...     ....+|+.+ ++.++||||+++++++.+    ++.
T Consensus        10 p~d~Y~i~-~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~----~~~   83 (288)
T d2jfla1          10 PEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDI-LASCDHPNIVKLLDAFYY----ENN   83 (288)
T ss_dssp             GGGTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHH-HHHCCCTTBCCEEEEEEE----TTE
T ss_pred             cccCeEEe-EEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHH-HHhCCCCCCCeEEEEEee----CCe
Confidence            45789996 6699999999999999999999999998632     345678888 677799999999999986    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+|||||++|+|.+++.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++                  
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~------------------  144 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT------------------  144 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------------
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC------------------
Confidence            999999999999999987653 4699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-----CCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-----PDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                               .++.+||+|||+|...........+.+||+.|+|||++.     ...|+.++|||||||++|+|++|..||
T Consensus       145 ---------~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf  215 (288)
T d2jfla1         145 ---------LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH  215 (288)
T ss_dssp             ---------TTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ---------CCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCC
Confidence                     567799999999987654434455678999999999983     456899999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      .+.+..+    ....+..+..+. ......+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       216 ~~~~~~~----~~~~i~~~~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         216 HELNPMR----VLLKIAKSEPPT-LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             TTSCGGG----HHHHHHHSCCCC-CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CCCCHHH----HHHHHHcCCCCC-CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            7654332    334444433221 1223578999999999999999999999999999999964

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-60  Score=441.21  Aligned_cols=250  Identities=36%  Similarity=0.659  Sum_probs=221.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||+|+||+||+|+++.+|+.||||++.+.        ....+|+.+ ++.++||||++++++|++    +.
T Consensus         5 ~dy~~~-~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~----~~   78 (337)
T d1o6la_           5 NDFDYL-KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV-LQNTRHPFLTALKYAFQT----HD   78 (337)
T ss_dssp             GGEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHSCCCTTBCCEEEEEEC----SS
T ss_pred             HhcEEE-EEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHH-HHhCCCCCEEEEEeeecc----cc
Confidence            679995 7899999999999999999999999999632        235678777 677899999999999986    77


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+|||||+||+|.+++.+..  .+++..++.++.||+.||+|||++||+||||||+|||++                 
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~-----------------  139 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD-----------------  139 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-----------------
T ss_pred             ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec-----------------
Confidence            8999999999999999998764  599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .+|.+||+|||+|+..........+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+
T Consensus       140 ----------~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         140 ----------KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             ----------TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ----------CCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence                      5678999999999977665556677899999999999999999999999999999999999999997654


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQF  307 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~  307 (372)
                      .    ..+...+..+.+.+|.    .+|+++++||.+||++||.+|++     ++|+++||||+++
T Consensus       210 ~----~~~~~~i~~~~~~~p~----~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         210 H----ERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             H----HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             H----HHHHHHHhcCCCCCCc----cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence            3    3456667767666653    78999999999999999999994     8999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-61  Score=435.54  Aligned_cols=250  Identities=30%  Similarity=0.524  Sum_probs=213.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++ .+.||+|+||+||+|+++.+|+.||||++...        ....+|+.+ ++.++||||++++++|++    ++
T Consensus         8 ~dy~i-~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~----~~   81 (288)
T d1uu3a_           8 EDFKF-GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV-MSRLDHPFFVKLYFTFQD----DE   81 (288)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHHCCSTTBCCEEEEEEC----SS
T ss_pred             CCCEE-EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHH-HHHcCCCCeeEEEEEEEE----CC
Confidence            78999 58899999999999999999999999998632        235678887 677799999999999986    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+|||||+||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++                 
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~-----------------  142 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN-----------------  142 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC-----------------
Confidence            899999999999999998876  4599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFS  244 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  244 (372)
                                .++.+||+|||+|+......  ....+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+
T Consensus       143 ----------~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (288)
T d1uu3a_         143 ----------EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  212 (288)
T ss_dssp             ----------TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ----------CCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence                      56789999999998765322  234557899999999999999999999999999999999999999975


Q ss_pred             CCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhH------HhcCCccccC
Q psy3151         245 NHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQ------VMENKWISQF  307 (372)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~e------il~hp~~~~~  307 (372)
                      .+.    ..+...+..+.+.+|.    .+++++++||.+||+.||++|||++|      +++||||+++
T Consensus       213 ~~~----~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         213 GNE----YLIFQKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             SSH----HHHHHHHHTTCCCCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             cCH----HHHHHHHHcCCCCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            432    3445666666666553    68999999999999999999999998      5789999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-60  Score=443.76  Aligned_cols=268  Identities=30%  Similarity=0.567  Sum_probs=229.4

Q ss_pred             ccCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEee
Q psy3151           4 TFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVY   78 (372)
Q Consensus         4 ~~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~   78 (372)
                      .-...+...+.++|+++ +.||+|+||+||+|.+..+|+.||||++...     ....+|+.+ ++.++||||++++++|
T Consensus        18 ~p~~~~~~~~~d~Y~i~-~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~~~~~~   95 (352)
T d1koba_          18 QPVEVKQGSVYDYYDIL-EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISI-MNQLHHPKLINLHDAF   95 (352)
T ss_dssp             CCCCCBCSCGGGTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHH-HTTCCSTTBCCEEEEE
T ss_pred             CCccCCCCCcccceEEE-EEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHH-HHhCCCCCCCcEEEEE
Confidence            33344455678899995 7799999999999999999999999998632     244578887 6777999999999999


Q ss_pred             eeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          79 ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      ++    +..+|+|||||+||+|.+++.... .++++.+++.++.||+.||+|||++||+||||||+|||++..       
T Consensus        96 ~~----~~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-------  163 (352)
T d1koba_          96 ED----KYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-------  163 (352)
T ss_dssp             EC----SSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-------
T ss_pred             EE----CCEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-------
Confidence            86    778999999999999999876543 469999999999999999999999999999999999999731       


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG  238 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  238 (372)
                                        ..+.+||+|||+|..... .....+.+||+.|+|||++.+..|+.++|||||||++|+|++|
T Consensus       164 ------------------~~~~vkL~DFGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG  224 (352)
T d1koba_         164 ------------------KASSVKIIDFGLATKLNP-DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG  224 (352)
T ss_dssp             ------------------TCCCEEECCCTTCEECCT-TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred             ------------------CCCeEEEeecccceecCC-CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhC
Confidence                              357899999999987754 3334567889999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      ..||.+.+.    ......+..+.+.++...+..+|+++.+||.+||+.||.+|||++|+|+||||++..
T Consensus       225 ~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         225 LSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             CCSSCCSSH----HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCCCCCCCH----HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            999965442    334566777777777777778999999999999999999999999999999998753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-60  Score=445.48  Aligned_cols=261  Identities=31%  Similarity=0.601  Sum_probs=225.4

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      .+.++|+++ +.||+|+||+||+|+++.+|+.||||++...     ....+|+.+ ++.++||||++++++|++    ++
T Consensus        23 ~il~~Y~i~-~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~i-l~~l~HpnIv~~~~~~~~----~~   96 (350)
T d1koaa2          23 HVLDHYDIH-EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT-MSVLRHPTLVNLHDAFED----DN   96 (350)
T ss_dssp             CGGGTEEEE-EEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHH-HHHTCCTTBCCEEEEEEE----TT
T ss_pred             CCccCeEEE-EEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHH-HHhCCCCCCCcEEEEEEE----CC
Confidence            366899995 7799999999999999999999999999642     234678887 566799999999999986    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+|||||+||+|.+++.+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+               
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~---------------  160 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK---------------  160 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST---------------
T ss_pred             EEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC---------------
Confidence            8999999999999999986543 469999999999999999999999999999999999999631               


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.+||+|||+|+.... .....+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+
T Consensus       161 ----------~~~~vkL~DFG~a~~~~~-~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  229 (350)
T d1koaa2         161 ----------RSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN  229 (350)
T ss_dssp             ----------TSCCEEECCCTTCEECCT-TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ----------CCCeEEEeecchheeccc-ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence                      356899999999987644 334456789999999999999999999999999999999999999996543


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCCC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFNQ  309 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~~  309 (372)
                      .    ......+....+.++...+..+|+++++||.+||+.||++|||++|+|+||||+....
T Consensus       230 ~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         230 D----DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             H----HHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             H----HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            2    3455667777777777677789999999999999999999999999999999987643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-60  Score=426.61  Aligned_cols=257  Identities=23%  Similarity=0.359  Sum_probs=213.6

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ...+||..+++.||+|+||+||+|.+..+++.||+|++...       ....+|+++ ++.++||||++++++|+....+
T Consensus         5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~~~~~~~~~~~~   83 (270)
T d1t4ha_           5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEM-LKGLQHPNIVRFYDSWESTVKG   83 (270)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHH-HTTCCCTTBCCEEEEEEEESSS
T ss_pred             CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEeecccc
Confidence            45678854467799999999999999999999999998632       234578887 6777999999999999876666


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceeeecCCCCCceeeecc
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQN--IAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~--ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      +..+|+||||+++|+|.+++.+.  +.+++..++.++.||+.||+|||++|  |+||||||+|||++.            
T Consensus        84 ~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~------------  149 (270)
T d1t4ha_          84 KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG------------  149 (270)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS------------
T ss_pred             CCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC------------
Confidence            78899999999999999999876  35999999999999999999999999  999999999999962            


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                    +++.+||+|||+|+....  ....+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||
T Consensus       150 --------------~~~~~Kl~DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf  212 (270)
T d1t4ha_         150 --------------PTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY  212 (270)
T ss_dssp             --------------TTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             --------------CCCCEEEeecCcceeccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCC
Confidence                          467899999999975432  23456789999999999865 6999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      .+...   ...+...+..+..  +.......++++.+||.+||+.||++|||++|+|+||||+
T Consensus       213 ~~~~~---~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         213 SECQN---AAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             TTCSS---HHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCccc---HHHHHHHHHcCCC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            64332   2233444443322  2223356899999999999999999999999999999995

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-61  Score=431.54  Aligned_cols=252  Identities=29%  Similarity=0.462  Sum_probs=201.2

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|+++ +.||+|+||+||+|+++.+|+.||||++...       ....+|+.+ ++.++||||+++++++.+  ..++.
T Consensus         4 edy~~~-~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~~~~~~~~--~~~~~   79 (269)
T d2java1           4 EDYEVL-YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL-LRELKHPNIVRYYDRIID--RTNTT   79 (269)
T ss_dssp             GGEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHH-TTSCCCTTBCCEEEEEEC------C
T ss_pred             hhCEEe-EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHH-HHHCCCCCEeeEEEEEEe--CCCCE
Confidence            789996 7799999999999999999999999998632       234567776 677799999999998853  22456


Q ss_pred             EEEEEeccCCCchhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCceeeecCCCCCceeee
Q psy3151          88 LLVIMECMHGGELFQRIQQK--EDGAFTEREAAIIMNEICSAIKFLHDQN-----IAHRDVKPENLLYTKPGDGGILKLT  160 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~--~~~~l~~~~~~~i~~qil~~l~~LH~~~-----ivHrDlkp~NIli~~~~~~~~~~~~  160 (372)
                      +|+|||||++|+|.+++.+.  ..+.+++..++.++.||+.||+|||++|     |+||||||+|||++           
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-----------  148 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-----------  148 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-----------
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-----------
Confidence            89999999999999998752  3356999999999999999999999976     99999999999998           


Q ss_pred             ccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         161 DFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       161 d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                      .++.+||+|||+|+..........+.+||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus       149 ----------------~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~  212 (269)
T d2java1         149 ----------------GKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP  212 (269)
T ss_dssp             ----------------TTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ----------------CCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCC
Confidence                            5678999999999987655555567889999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcc
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWI  304 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~  304 (372)
                      ||.+.+.    ..+...+..+.+...   ...+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus       213 Pf~~~~~----~~~~~~i~~~~~~~~---~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         213 PFTAFSQ----KELAGKIREGKFRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             SCCCSSH----HHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCCCCH----HHHHHHHHcCCCCCC---CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9965432    334555555554322   24689999999999999999999999999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=441.64  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=209.2

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ..++|+++ +.||+|+||+||+|.+..+|+.||+|+++..      ....+|+.+ ++.++||||++++++|.+    +.
T Consensus         4 ~~d~y~~~-~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~----~~   77 (322)
T d1s9ja_           4 KDDDFEKI-SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV-LHECNSPYIVGFYGAFYS----DG   77 (322)
T ss_dssp             CGGGEEEE-EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGG-GGGCCCTTBCCEEEEEEC----SS
T ss_pred             CccCCEEE-EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHH-HHhCCCCCCCcEEEEEEE----CC
Confidence            46899996 6799999999999999999999999998632      245678887 677899999999999986    67


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQ-NIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~-~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      .+|+||||++||+|.+++.+..  .+++..++.++.||+.||.|||++ ||+||||||+|||++                
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~----------------  139 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----------------  139 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----------------
T ss_pred             EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC----------------
Confidence            8999999999999999998763  599999999999999999999975 999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||+|+.....  ...+.+||++|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       140 -----------~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         140 -----------SRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             -----------TTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             -----------CCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                       6678999999999876432  234678999999999999999999999999999999999999999765


Q ss_pred             CCCCCCH--------------------------------------hHHHHHhhCCccCCCCcccccCHHHHHHHHHhccC
Q psy3151         246 HGQAISP--------------------------------------GMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCV  287 (372)
Q Consensus       246 ~~~~~~~--------------------------------------~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~  287 (372)
                      +......                                      .....+...  ..+......+|.+++|||.+||+.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~  284 (322)
T d1s9ja_         207 DAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIK  284 (322)
T ss_dssp             CTTHHHHHC------------------------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCS
T ss_pred             CHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCC
Confidence            4321100                                      000000000  001111134789999999999999


Q ss_pred             CCCCCCChhHHhcCCccccC
Q psy3151         288 DPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       288 dP~~R~s~~eil~hp~~~~~  307 (372)
                      ||++||||+|+|+||||++.
T Consensus       285 dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         285 NPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             STTTSCCHHHHHTSHHHHHH
T ss_pred             ChhHCcCHHHHhhCHhhCcC
Confidence            99999999999999999763

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.9e-59  Score=423.79  Aligned_cols=256  Identities=36%  Similarity=0.672  Sum_probs=222.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------------hhhHHHHHHHHHhcCCCCEeEEeEee
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------------VKARREVELQLAVGSHKHIVNIKDVY   78 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~ni~~~~~~~   78 (372)
                      |.++|++ .+.||+|+||+||+|++..+|+.||||++...              ....+|+.++.++..||||++++++|
T Consensus         1 f~~~y~~-~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~   79 (277)
T d1phka_           1 FYENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   79 (277)
T ss_dssp             CTTTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CcccCEE-ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence            5689999 58899999999999999999999999998532              13567888866666799999999999


Q ss_pred             eeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          79 ENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        79 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      .+    +..+|+|||||++|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++         
T Consensus        80 ~~----~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---------  144 (277)
T d1phka_          80 ET----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---------  144 (277)
T ss_dssp             EC----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred             cc----CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---------
Confidence            86    77899999999999999999875  4599999999999999999999999999999999999998         


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC------CCCCCCccchhhHHHHH
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG------PDKYDKSCDIWSLGVIM  232 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il  232 (372)
                                        .++.+||+|||+|...... ......+||+.|+|||.+.      ...++.++||||+||++
T Consensus       145 ------------------~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvil  205 (277)
T d1phka_         145 ------------------DDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM  205 (277)
T ss_dssp             ------------------TTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred             ------------------CCCCeEEccchheeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhh
Confidence                              6778999999999876543 3345578999999999873      34578899999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         233 YILLCGFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       233 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |+|++|..||.+.+.    ......+..+...++.+.+..+|+++++||.+||+.||++|||++|+|+||||+++
T Consensus       206 yeml~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         206 YTLLAGSPPFWHRKQ----MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             HHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             hhhccCCCCCCCCCH----HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            999999999975442    33456666677777777777899999999999999999999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-60  Score=435.07  Aligned_cols=251  Identities=30%  Similarity=0.529  Sum_probs=220.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++ .+.||+|+||+||+|+++.+|+.||||++...        ....+|+.++.+.++||||+++++++++    ++
T Consensus         2 ddy~i-~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~----~~   76 (320)
T d1xjda_           2 EDFIL-HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----KE   76 (320)
T ss_dssp             TTEEE-EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----SS
T ss_pred             CCeEE-eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc----CC
Confidence            67998 48899999999999999999999999999632        2345677776678899999999999986    77


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+|||||++|+|.+++....  .+++.+++.++.||+.||+|||++||+||||||+|||++                 
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~-----------------  137 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD-----------------  137 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-----------------
T ss_pred             ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec-----------------
Confidence            8999999999999999998764  599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                ..+.+||+|||+|+............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+
T Consensus       138 ----------~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~  207 (320)
T d1xjda_         138 ----------KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  207 (320)
T ss_dssp             ----------TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ----------CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence                      5678999999999877665566667889999999999999999999999999999999999999997654


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChh-HHhcCCccccC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID-QVMENKWISQF  307 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~-eil~hp~~~~~  307 (372)
                      .    ..+...+..+.+.+|    ..+|+++.+||.+||+.||++|||+. ++++||||+++
T Consensus       208 ~----~~~~~~i~~~~~~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         208 E----EELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             H----HHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             H----HHHHHHHHcCCCCCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            3    345566666666555    36899999999999999999999996 89999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.8e-59  Score=427.61  Aligned_cols=247  Identities=32%  Similarity=0.654  Sum_probs=216.1

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|+++ +.||+|+||+||+|+++.+|+.||||++...        ....+|+.+ ++.++||||+++++++.+    +.
T Consensus         4 ~dy~i~-~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~~~~~~~~----~~   77 (316)
T d1fota_           4 QDFQIL-RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM-LSIVTHPFIIRMWGTFQD----AQ   77 (316)
T ss_dssp             GGEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHSCCBTTBCCEEEEEEC----SS
T ss_pred             hHeEEE-EEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHH-HHhccCcChhheeeeEee----CC
Confidence            579995 7799999999999999999999999999632        234567776 778899999999999986    77


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+|||||.||+|..++....  .+++..++.++.||+.||+|||++||+||||||+|||++                 
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~-----------------  138 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD-----------------  138 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC-----------------
T ss_pred             eeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc-----------------
Confidence            8999999999999999988754  599999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                                .++.+||+|||+|+....   ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+
T Consensus       139 ----------~~g~vkL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  205 (316)
T d1fota_         139 ----------KNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  205 (316)
T ss_dssp             ----------TTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ----------CCCCEEEecCccceEecc---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence                      567899999999987643   3456789999999999999999999999999999999999999996543


Q ss_pred             CCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         247 GQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      .    ..+...+..+...+|.    .++++++++|.+||..||.+|+     |++++++||||+++
T Consensus       206 ~----~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         206 T----MKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             H----HHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             H----HHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            2    3445666666665553    6899999999999999999996     99999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=433.44  Aligned_cols=259  Identities=28%  Similarity=0.585  Sum_probs=224.7

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      .|.++|++. +.||+|+||+||+|.++.+|+.||||++...    ....+|+.+ ++.++||||++++++|++    ++.
T Consensus         2 ~~~~rY~i~-~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~i-l~~l~HpnIv~~~~~~~~----~~~   75 (321)
T d1tkia_           2 ELYEKYMIA-EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISI-LNIARHRNILHLHESFES----MEE   75 (321)
T ss_dssp             CCTTTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHH-HHHSCCTTBCCEEEEEEE----TTE
T ss_pred             CCccceEEE-EEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHH-HHhCCCCCCCeEEEEEEE----CCE
Confidence            478999995 7799999999999999999999999999743    245688887 677899999999999987    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+|||||+||+|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+                
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~----------------  138 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR----------------  138 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS----------------
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC----------------
Confidence            999999999999999997653 469999999999999999999999999999999999999732                


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                               ....+||+|||++..... .....+.+||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+.
T Consensus       139 ---------~~~~ikl~DFG~~~~~~~-~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~  208 (321)
T d1tkia_         139 ---------RSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN  208 (321)
T ss_dssp             ---------SCCCEEECCCTTCEECCT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             ---------CceEEEEcccchhhcccc-CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence                     345799999999987643 2334556889999999999999999999999999999999999999965542


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                          ......+..+.+.++...+..+|+++++||.+||+.||++|||++|+|+||||++-
T Consensus       209 ----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         209 ----QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ----HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ----HHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                34566677777777766667899999999999999999999999999999999753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-58  Score=430.40  Aligned_cols=248  Identities=32%  Similarity=0.638  Sum_probs=217.0

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      .++|+++ +.||+|+||+||+|+++.+|+.||||++...        ....+|+.+ ++.++||||++++++|..    .
T Consensus        40 ld~y~i~-~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~~~~~~~~----~  113 (350)
T d1rdqe_          40 LDQFDRI-KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-LQAVNFPFLVKLEFSFKD----N  113 (350)
T ss_dssp             GGGEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHH-HTTCCCTTBCCEEEEEEC----S
T ss_pred             ccCeEEE-EEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHH-HHHcCCCcEeeccccccc----c
Confidence            4899996 6799999999999999999999999998632        234678877 677799999999999986    6


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      ..+|+||||+.+|+|.+++.+..  .+++..++.++.||+.||.|||++|||||||||+|||++                
T Consensus       114 ~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~----------------  175 (350)
T d1rdqe_         114 SNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----------------  175 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----------------
T ss_pred             cccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC----------------
Confidence            78999999999999999998764  599999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSN  245 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  245 (372)
                                 .++.+||+|||+|+....   ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.
T Consensus       176 -----------~~g~ikL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  241 (350)
T d1rdqe_         176 -----------QQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             -----------TTSCEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -----------CCCCEEeeeceeeeeccc---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence                       567899999999987643   334678999999999999999999999999999999999999999654


Q ss_pred             CCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccC
Q psy3151         246 HGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQF  307 (372)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~  307 (372)
                      +.    ..+...+..+.+..|    ..+++++.+||++||+.||.+|+     |++++++||||++.
T Consensus       242 ~~----~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         242 QP----IQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             SH----HHHHHHHHHCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             CH----HHHHHHHhcCCCCCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            32    345566666665554    36899999999999999999995     99999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-59  Score=428.12  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=208.4

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +..+|+++ +.||+|+||+||+|++..+|+.||||++...        ....+|+.+ ++.++||||++++++|.+    
T Consensus        13 p~~~y~~l-~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~~~~~~~~----   86 (309)
T d1u5ra_          13 PEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF-LQKLRHPNTIQYRGCYLR----   86 (309)
T ss_dssp             HHHHEEEE-EEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHH-HTTCCCTTBCCEEEEEEE----
T ss_pred             cHHhcEee-EEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHH-HHHCCCCCEeeEEEEEEE----
Confidence            45579996 6699999999999999999999999998632        235678887 677799999999999986    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ++.+|+|||||.+|+|..++...  +.+++..++.++.||+.||.|||++||+||||||+|||++               
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---------------  149 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---------------  149 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---------------
T ss_pred             CCEEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---------------
Confidence            67899999999999887766554  4699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC---CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP---DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.+||+|||+|.....    ....+||+.|+|||++.+   ..|+.++|||||||++|+|++|..|
T Consensus       150 ------------~~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~P  213 (309)
T d1u5ra_         150 ------------EPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  213 (309)
T ss_dssp             ------------TTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ------------CCCCEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCC
Confidence                        677899999999986533    345689999999999853   4689999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCcccc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQ  306 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~  306 (372)
                      |.+...    ......+..+..+.  .....+|+++++||.+||+.||.+|||++|+|+||||.+
T Consensus       214 f~~~~~----~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         214 LFNMNA----MSALYHIAQNESPA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             TTTSCH----HHHHHHHHHSCCCC--CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCCCCH----HHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            965432    22233333333222  223468999999999999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-58  Score=432.24  Aligned_cols=253  Identities=26%  Similarity=0.441  Sum_probs=209.0

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--------hhHHHHHH--HHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--------KARREVEL--QLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~--~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ++|++. +.||+|+||+||+|++..+|+.||||++....        ...+|...  .++.++||||++++++|++    
T Consensus         4 ddy~i~-~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----   78 (364)
T d1omwa3           4 NDFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----   78 (364)
T ss_dssp             TTEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred             HhCeee-eEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----
Confidence            679994 88999999999999999999999999985321        12333322  2445579999999999986    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ++.+|+|||||.||+|.+++.+.  +.+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~---------------  141 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---------------  141 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---------------
T ss_pred             CCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc---------------
Confidence            67899999999999999999876  4599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccC-CCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLG-PDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                  ..+.+||+|||+|+.....  .....+||+.|+|||++. +..|+.++|||||||++|+|++|..||.
T Consensus       142 ------------~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  207 (364)
T d1omwa3         142 ------------EHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR  207 (364)
T ss_dssp             ------------SSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ------------CCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence                        5678999999999876432  345678999999999986 4568999999999999999999999997


Q ss_pred             CCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCC-----hhHHhcCCccccCC
Q psy3151         244 SNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLT-----IDQVMENKWISQFN  308 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s-----~~eil~hp~~~~~~  308 (372)
                      +...... ..+.......    +...+..+|+++++||.+||+.||++|||     |+|+++||||+++.
T Consensus       208 ~~~~~~~-~~~~~~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         208 QHKTKDK-HEIDRMTLTM----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             SSCSSCH-HHHHHHSSSC----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             CCCHHHH-HHHHHhcccC----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence            6544332 1222222222    22233478999999999999999999999     79999999998763

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-58  Score=416.36  Aligned_cols=247  Identities=28%  Similarity=0.495  Sum_probs=208.8

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----------hhhHHHHHHHHHhc-CCCCEeEEeEeee
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------VKARREVELQLAVG-SHKHIVNIKDVYE   79 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~-~h~ni~~~~~~~~   79 (372)
                      ||.++|++ .+.||+|+||+||+|++..+|+.||||++...           .+..+|+.++.++. .||||++++++|+
T Consensus         1 pl~~~Y~i-~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~   79 (273)
T d1xwsa_           1 PLESQYQV-GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE   79 (273)
T ss_dssp             CCTTTEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCCCeEEE-eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence            68899999 68899999999999999999999999998632           22457888855553 4999999999998


Q ss_pred             eecCCceEEEEEEeccCC-CchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCcee
Q psy3151          80 NIYNGSRCLLVIMECMHG-GELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILK  158 (372)
Q Consensus        80 ~~~~~~~~~~lv~e~~~~-g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~  158 (372)
                      +    ++..|+||||+.+ +++.+++...  +.+++.+++.++.||+.||+|||++||+||||||+|||++.        
T Consensus        80 ~----~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--------  145 (273)
T d1xwsa_          80 R----PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--------  145 (273)
T ss_dssp             C----SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--------
T ss_pred             e----CCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--------
Confidence            6    6789999999976 5788888765  45999999999999999999999999999999999999983        


Q ss_pred             eeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCC-CCccchhhHHHHHHHHHh
Q psy3151         159 LTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKY-DKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       159 ~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~  237 (372)
                                        +.+.+||+|||+|.....  ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus       146 ------------------~~~~vkl~DFG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~  205 (273)
T d1xwsa_         146 ------------------NRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC  205 (273)
T ss_dssp             ------------------TTTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             ------------------CCCeEEECccccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh
Confidence                              346799999999976533  33456789999999999876655 578999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      |..||...          ..+..+...++    ..+|+++++||.+||+.||++|||++|+|+||||++.
T Consensus       206 g~~Pf~~~----------~~i~~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         206 GDIPFEHD----------EEIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             SSCSCCSH----------HHHHHCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCCCCCCc----------hHHhhcccCCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999542          23344444444    3689999999999999999999999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-57  Score=414.07  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=210.6

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc-------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD-------TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|+++ +.||+|+||+||+|.+..+|+.||||++..       .....+|+.+ ++.++||||++++++|.+    +..
T Consensus         2 d~Y~~~-~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~i-l~~l~Hp~Iv~~~~~~~~----~~~   75 (298)
T d1gz8a_           2 ENFQKV-EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-LKELNHPNIVKLLDVIHT----ENK   75 (298)
T ss_dssp             TTEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHH-HTTCCCTTBCCEEEEEEE----TTE
T ss_pred             CCCEec-cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHH-HHhCCCCcEEEecccccc----ccc
Confidence            689996 779999999999999999999999999852       2345678888 677899999999999987    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      +|+||||+.+ ++.+++.....+.+++..++.++.||+.||+|||++|||||||||+|||++                  
T Consensus        76 ~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~------------------  136 (298)
T d1gz8a_          76 LYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN------------------  136 (298)
T ss_dssp             EEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC------------------
T ss_pred             eeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec------------------
Confidence            9999999964 666666555556799999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.+||+|||.|+............+||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+
T Consensus       137 ---------~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~  207 (298)
T d1gz8a_         137 ---------TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  207 (298)
T ss_dssp             ---------TTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ---------ccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence                     567899999999988766556666778999999999876655 5789999999999999999999996543


Q ss_pred             CCCCCHhHHHHHhhC------------Cc--cCCC-------CcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         247 GQAISPGMKNRIRLG------------QF--DFPN-------PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       247 ~~~~~~~~~~~~~~~------------~~--~~~~-------~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      ..+....+.......            ..  ..+.       .....+|+++++||++||..||++|||++|+|+||||+
T Consensus       208 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~  287 (298)
T d1gz8a_         208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287 (298)
T ss_dssp             HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhc
Confidence            222111111110000            00  0000       00135689999999999999999999999999999999


Q ss_pred             cCCCC
Q psy3151         306 QFNQV  310 (372)
Q Consensus       306 ~~~~~  310 (372)
                      ++..+
T Consensus       288 ~~~~p  292 (298)
T d1gz8a_         288 DVTKP  292 (298)
T ss_dssp             TCCCC
T ss_pred             cCCCC
Confidence            87553

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=417.42  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=202.3

Q ss_pred             ccccccCCeEEEEEEEcCCCcEEEEEEecch----------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          22 EILGLGINGKVLQIVEKKTSEVYALKVLHDT----------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      ++||+|+||+||+|.++.+|+.||||++...          ....+|+.+ ++.++||||++++++|..    ++++|+|
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~~~~~~~~----~~~~~iv   78 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL-LQELSHPNIIGLLDAFGH----KSNISLV   78 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHH-HHHCCCTTBCCEEEEECC----TTCCEEE
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHH-HHhCCCCCEeEEEeeecc----CCceeeh
Confidence            6799999999999999999999999998522          235678887 677799999999999976    6779999


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      |||+.++++..+...  ...+++..++.++.||+.||+|||++||+||||||+|||++                      
T Consensus        79 mE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~----------------------  134 (299)
T d1ua2a_          79 FDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----------------------  134 (299)
T ss_dssp             EECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----------------------
T ss_pred             hhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec----------------------
Confidence            999988766655433  35699999999999999999999999999999999999998                      


Q ss_pred             cCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q psy3151         172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQAI  250 (372)
Q Consensus       172 ~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  250 (372)
                           ..+.+||+|||+|+..........+.+||+.|+|||++.. ..|+.++||||+||++|+|++|.+||.+.+..+.
T Consensus       135 -----~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~  209 (299)
T d1ua2a_         135 -----ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ  209 (299)
T ss_dssp             -----TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             -----CCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH
Confidence                 6778999999999877665555667789999999998854 5689999999999999999999999976543322


Q ss_pred             CHhHHHHHhhCC---c-------------cCCCC----cccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         251 SPGMKNRIRLGQ---F-------------DFPNP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       251 ~~~~~~~~~~~~---~-------------~~~~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                      ...+........   +             ..+..    ....+++++++||.+||+.||++||||+|+|+||||++.
T Consensus       210 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             HHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence            111111110000   0             00000    013568999999999999999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=409.77  Aligned_cols=267  Identities=24%  Similarity=0.373  Sum_probs=208.1

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCC-CcEEEEEEecc-------hhhhHHHHHHHHH--hcCCCCEeEEeEeeeeec
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKT-SEVYALKVLHD-------TVKARREVELQLA--VGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~-------~~~~~~e~~~~~~--~~~h~ni~~~~~~~~~~~   82 (372)
                      ..++|+++ +.||+|+||+||+|++..+ ++.||||++..       .....+|+.++..  ..+||||++++++|....
T Consensus         5 ~~~~Y~i~-~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           5 ADQQYECV-AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGGTEEEE-EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CcCCEEEE-EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            45899996 6699999999999999765 67899999852       1245578776433  348999999999986432


Q ss_pred             -CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeec
Q psy3151          83 -NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTD  161 (372)
Q Consensus        83 -~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d  161 (372)
                       ..+.++|++|||+.++++..... .....+++..++.++.||+.||+|||++||+||||||+|||++            
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~------------  150 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT------------  150 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC------------
T ss_pred             cccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc------------
Confidence             34678999999998766554433 3446799999999999999999999999999999999999998            


Q ss_pred             cCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         162 FGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                     ..+.+||+|||++..... .......+||+.|+|||++.+..|+.++||||+||++|+|++|.+|
T Consensus       151 ---------------~~~~~kl~dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~p  214 (305)
T d1blxa_         151 ---------------SSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL  214 (305)
T ss_dssp             ---------------TTCCEEECSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ---------------CCCCeeecchhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCC
Confidence                           567899999999876533 3345567899999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhC-CccC-----------------C-CCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         242 FFSNHGQAISPGMKNRIRLG-QFDF-----------------P-NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~-~~~~-----------------~-~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      |.+.+..+....+....... ...+                 + ......+++++++||.+||++||++||||+|+|+||
T Consensus       215 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp  294 (305)
T d1blxa_         215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  294 (305)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence            97654322211111111000 0000                 0 011245789999999999999999999999999999


Q ss_pred             ccccCCC
Q psy3151         303 WISQFNQ  309 (372)
Q Consensus       303 ~~~~~~~  309 (372)
                      ||+++.+
T Consensus       295 ff~~i~~  301 (305)
T d1blxa_         295 YFQDLER  301 (305)
T ss_dssp             GGTTCCC
T ss_pred             hhcCchh
Confidence            9988643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.9e-56  Score=401.81  Aligned_cols=259  Identities=27%  Similarity=0.424  Sum_probs=206.1

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      .|.++|++. +.||+|+||+||+|.+..+|+.||||++...        ....+|+.+ ++.++||||+++++++.....
T Consensus         4 ~l~drY~i~-~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~-l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           4 HLSDRYELG-EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN-AAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             EETTTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHH-HHTCCCTTBCCEEEEEEEECS
T ss_pred             CccceeEEe-EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHH-HHhcCCCCCCcccceeeeccC
Confidence            478999994 7899999999999999999999999998532        234578887 677899999999999986555


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ....+|+||||++|++|.+++...  +.+++.+++.++.||+.||+|||++||+||||||+|||++              
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~--------------  145 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS--------------  145 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--------------
T ss_pred             CCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC--------------
Confidence            566799999999999999998776  4599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCC---CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK---ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                   .++.++++|||.+.......   ......+||+.|+|||++.+..|+.++|||||||++|+|+||.+
T Consensus       146 -------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~  212 (277)
T d1o6ya_         146 -------------ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP  212 (277)
T ss_dssp             -------------TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             -------------ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCC
Confidence                         56778999999887553322   23455789999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         241 PFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      ||.+.+.    ..............+...+..+|+++.+||.+||+.||.+||+..+.+.|+|.+
T Consensus       213 Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         213 PFTGDSP----VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SCCCSSH----HHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCCcCH----HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9965432    223333333443334444567999999999999999999999555555666653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=409.61  Aligned_cols=266  Identities=24%  Similarity=0.408  Sum_probs=201.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--C
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--N   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--~   83 (372)
                      +.++|+++ +.||+|+||+||+|.++.+|+.||||++...       ....+|+.+ ++.++||||++++++|....  .
T Consensus        16 ~~~~Y~~i-~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~i-l~~l~hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          16 VRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL-LKHMRHENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CBSSEEEE-EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHH-HHHCCBTTBCCCSEEECSCSSTT
T ss_pred             cCCcEEEE-EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHH-HHhcCCCCeeEEEEEeccCcccc
Confidence            88999996 6799999999999999999999999999632       245678888 56779999999999997422  1


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ...++|+||||+ +.+|..++..   +.+++..++.++.||+.||+|||++||+||||||+|||++              
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~--------------  155 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN--------------  155 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--------------
T ss_pred             ccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc--------------
Confidence            234689999999 6678777654   3599999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                                   .++.+|++|||+|+....   .....+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||
T Consensus       156 -------------~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf  219 (346)
T d1cm8a_         156 -------------EDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF  219 (346)
T ss_dssp             -------------TTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             -------------cccccccccccceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC
Confidence                         677899999999987643   3456788999999998755 56789999999999999999999999


Q ss_pred             CCCCCCCCCHhHHH-------------------HHhhCCccCCC----CcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         243 FSNHGQAISPGMKN-------------------RIRLGQFDFPN----PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       243 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~~----~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .+.+..........                   ...........    .....+++++.+||.+||+.||.+||||+|+|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL  299 (346)
T d1cm8a_         220 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL  299 (346)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence            66542211100000                   00000001111    11245789999999999999999999999999


Q ss_pred             cCCccccCCCCCCCC
Q psy3151         300 ENKWISQFNQVPQTP  314 (372)
Q Consensus       300 ~hp~~~~~~~~~~~~  314 (372)
                      +||||+.+......|
T Consensus       300 ~Hp~f~~~~~~~~~~  314 (346)
T d1cm8a_         300 AHPYFESLHDTEDEP  314 (346)
T ss_dssp             HSGGGTTTC------
T ss_pred             cChhhCcCCCccccc
Confidence            999999876554443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-55  Score=408.25  Aligned_cols=275  Identities=24%  Similarity=0.393  Sum_probs=209.7

Q ss_pred             CccCCCccCCcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh-hhHHHHHHHHHhcCCCCEeEEeEeeeee
Q psy3151           3 PTFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV-KARREVELQLAVGSHKHIVNIKDVYENI   81 (372)
Q Consensus         3 ~~~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~e~~~~~~~~~h~ni~~~~~~~~~~   81 (372)
                      |+..|....  .-+|+.+ ++||+|+||+||+|++..+|+.||||++.... ...+|+.+ ++.++||||++++++|...
T Consensus        10 ~~~~p~~~~--~~~Y~~~-k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~i-l~~l~h~niv~~~~~~~~~   85 (350)
T d1q5ka_          10 PGQGPDRPQ--EVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI-MRKLDHCNIVRLRYFFYSS   85 (350)
T ss_dssp             ESSSSCCCE--EEEEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHH-HHHCCCTTBCCEEEEEEEC
T ss_pred             CCCCCCCcc--cCCcEee-eEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHH-HHhcCCCCCCcEEEEEEec
Confidence            344444333  3479985 88999999999999999999999999996533 44578888 5667999999999998643


Q ss_pred             c--CCceEEEEEEeccCCCchhHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          82 Y--NGSRCLLVIMECMHGGELFQRIQQ--KEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        82 ~--~~~~~~~lv~e~~~~g~L~~~i~~--~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      .  .+..++|+|||||.++ +.+.+..  .....+++..++.++.||+.||+|||++||+||||||+|||++.       
T Consensus        86 ~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~-------  157 (350)
T d1q5ka_          86 GEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-------  157 (350)
T ss_dssp             --CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-------
T ss_pred             CccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec-------
Confidence            2  2356789999999765 4443332  23356999999999999999999999999999999999999983       


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHH
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILL  236 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll  236 (372)
                                         +...+||+|||+|...... ....+.+||+.|+|||.+.+ ..|+.++||||+||++|||+
T Consensus       158 -------------------~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~  217 (350)
T d1q5ka_         158 -------------------DTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL  217 (350)
T ss_dssp             -------------------TTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             -------------------CCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehh
Confidence                               3347999999999876443 33456789999999998754 57899999999999999999


Q ss_pred             hCCCCCCCCCCCCCCHhHHHH-----------Hhh--CCccCCC--------CcccccCHHHHHHHHHhccCCCCCCCCh
Q psy3151         237 CGFPPFFSNHGQAISPGMKNR-----------IRL--GQFDFPN--------PEWEHVSQEAKTLIKNMLCVDPSERLTI  295 (372)
Q Consensus       237 ~g~~pf~~~~~~~~~~~~~~~-----------~~~--~~~~~~~--------~~~~~~s~~~~~li~~ll~~dP~~R~s~  295 (372)
                      +|..||...+..+....+...           ...  ....++.        ......++++.+||.+||++||++||||
T Consensus       218 ~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  297 (350)
T d1q5ka_         218 LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP  297 (350)
T ss_dssp             HTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH
Confidence            999999655432211111110           000  0011111        1123578999999999999999999999


Q ss_pred             hHHhcCCccccCCC
Q psy3151         296 DQVMENKWISQFNQ  309 (372)
Q Consensus       296 ~eil~hp~~~~~~~  309 (372)
                      .|+|+||||+++..
T Consensus       298 ~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         298 LEACAHSFFDELRD  311 (350)
T ss_dssp             HHHHTSGGGGGGGC
T ss_pred             HHHhcCHhhccccC
Confidence            99999999988644

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.6e-55  Score=404.90  Aligned_cols=260  Identities=26%  Similarity=0.410  Sum_probs=207.9

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecc--hhhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHD--TVKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      ..++|+++ +.||+|+||+||+|++..+|+.||||++..  .....+|+.++..+..||||++++++|..  .....+|+
T Consensus        33 ~~d~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~--~~~~~~~~  109 (328)
T d3bqca1          33 NQDDYQLV-RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD--PVSRTPAL  109 (328)
T ss_dssp             CGGGEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--TTTCSEEE
T ss_pred             CCcCeEEE-EEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe--cCCCceeE
Confidence            45889996 779999999999999999999999999874  34567899886666679999999999874  23567999


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      |||||.+++|..+.     +.+++..++.++.||+.||+|||++||+||||||+|||++.                    
T Consensus       110 v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--------------------  164 (328)
T d3bqca1         110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--------------------  164 (328)
T ss_dssp             EEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--------------------
T ss_pred             EEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--------------------
Confidence            99999999997653     34999999999999999999999999999999999999983                    


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFFSNHGQA  249 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  249 (372)
                            +++.+||+|||+|+..... ......+||+.|+|||.+.+. .++.++||||+||++|+|++|..||.......
T Consensus       165 ------~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~  237 (328)
T d3bqca1         165 ------EHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY  237 (328)
T ss_dssp             ------TTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred             ------CCCeeeecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH
Confidence                  3456899999999876543 334567889999999997654 58999999999999999999999996543211


Q ss_pred             CC-HhHHH---------HHhhCCc--------------------cCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         250 IS-PGMKN---------RIRLGQF--------------------DFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       250 ~~-~~~~~---------~~~~~~~--------------------~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .. ..+..         .......                    ..+......++++++|||++||++||++||||+|+|
T Consensus       238 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L  317 (328)
T d3bqca1         238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM  317 (328)
T ss_dssp             HHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            00 00000         0000000                    011122345789999999999999999999999999


Q ss_pred             cCCccccC
Q psy3151         300 ENKWISQF  307 (372)
Q Consensus       300 ~hp~~~~~  307 (372)
                      +||||+.+
T Consensus       318 ~Hp~F~~v  325 (328)
T d3bqca1         318 EHPYFYTV  325 (328)
T ss_dssp             TSGGGTTS
T ss_pred             cCcccCCC
Confidence            99999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.4e-55  Score=399.63  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=198.9

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|+++ +.||+|+||+||+|+++ +|+.||||++...       ....+|+.+ ++.++||||++++++|..    ++.
T Consensus         2 ~~Y~~~-~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~~~~~~~~----~~~   74 (286)
T d1ob3a_           2 EKYHGL-EKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISI-LKELKHSNIVKLYDVIHT----KKR   74 (286)
T ss_dssp             CSEEEE-EEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHG-GGGCCCTTBCCEEEEEEC----SSC
T ss_pred             CCceec-cEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHH-HHhCCCCcEEeeeeeccc----CCc
Confidence            699997 66999999999999995 7899999998532       345678887 677799999999999986    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .|++|||+.++.+..+....  +.+++..++.++.||+.||+|||+.||+||||||+|||++                  
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~------------------  134 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN------------------  134 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC------------------
T ss_pred             eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc------------------
Confidence            99999999776665555433  5699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGP-DKYDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               .++.+|++|||.|.............+||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus       135 ---------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~  205 (286)
T d1ob3a_         135 ---------REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (286)
T ss_dssp             ---------TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ---------CCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence                     5677999999999877655545556678999999999865 457899999999999999999999996543


Q ss_pred             CCCCCHhHHHHHhh------------CCcc--C------C-CCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccc
Q psy3151         247 GQAISPGMKNRIRL------------GQFD--F------P-NPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWIS  305 (372)
Q Consensus       247 ~~~~~~~~~~~~~~------------~~~~--~------~-~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~  305 (372)
                      ..+....+......            ....  .      + ......++++++|||++||++||++||||+|+|+||||+
T Consensus       206 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             HHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            22111111110000            0000  0      0 001235789999999999999999999999999999997


Q ss_pred             c
Q psy3151         306 Q  306 (372)
Q Consensus       306 ~  306 (372)
                      +
T Consensus       286 ~  286 (286)
T d1ob3a_         286 E  286 (286)
T ss_dssp             C
T ss_pred             c
Confidence            4

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.7e-55  Score=397.25  Aligned_cols=253  Identities=20%  Similarity=0.328  Sum_probs=208.4

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|++ .+.||+|+||+||+|.+..+|+.||||++...    ....+|+.+ ++.++||||+++++++.+    +..+|
T Consensus        16 ~~~~~~-~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~i-l~~l~HpnIv~~~~~~~~----~~~~~   89 (287)
T d1opja_          16 RTDITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV-MKEIKHPNLVQLLGVCTR----EPPFY   89 (287)
T ss_dssp             GGGEEE-EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHH-HHHCCCTTBCCEEEEECS----SSSCE
T ss_pred             HHHeEE-eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHH-HHhCCCCCEecCCccEee----CCeeE
Confidence            478998 47799999999999999999999999998632    345688887 677799999999999875    66789


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++                    
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~--------------------  149 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG--------------------  149 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--------------------
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC--------------------
Confidence            999999999999999876667799999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCCc-ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKAS-LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                             .++.+||+|||+|+........ .....||+.|+|||++.+..|+.++|||||||++|||++|..||..... 
T Consensus       150 -------~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-  221 (287)
T d1opja_         150 -------ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-  221 (287)
T ss_dssp             -------GGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred             -------CCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-
Confidence                   5677999999999876543322 3334578999999999889999999999999999999997776643322 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQF  307 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~  307 (372)
                        ...+...+..+ ...  +....+++++.+||.+||+.||++|||++++++  +|+.+
T Consensus       222 --~~~~~~~i~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         222 --LSQVYELLEKD-YRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             --HHHHHHHHHTT-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             --HHHHHHHHhcC-CCC--CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence              12233333332 222  223478999999999999999999999999976  45443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-55  Score=405.32  Aligned_cols=249  Identities=23%  Similarity=0.401  Sum_probs=204.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCc-----EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSE-----VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ++|++ .+.||+|+||+||+|.+..+++     .||+|.+...      ....+|+.++.++.+||||+++++++.+   
T Consensus        37 ~~~~l-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~---  112 (325)
T d1rjba_          37 ENLEF-GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---  112 (325)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHeEE-eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee---
Confidence            78998 5889999999999999876654     6999998532      2456788887777799999999999976   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKED---------------------GAFTEREAAIIMNEICSAIKFLHDQNIAHRDVK  142 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~---------------------~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlk  142 (372)
                       .+.+|+|||||++|+|.+++.....                     +.+++..++.++.||+.||+|||++||+|||||
T Consensus       113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             -CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence             6679999999999999999976431                     358999999999999999999999999999999


Q ss_pred             CCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCC
Q psy3151         143 PENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYD  220 (372)
Q Consensus       143 p~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~  220 (372)
                      |+|||++                           .++.+||+|||+|+.......  ...+.+||+.|+|||++.+..|+
T Consensus       192 p~Nill~---------------------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  244 (325)
T d1rjba_         192 ARNVLVT---------------------------HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT  244 (325)
T ss_dssp             GGGEEEE---------------------------TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             hhccccc---------------------------cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence            9999998                           677899999999987654332  23456789999999999889999


Q ss_pred             CccchhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHh
Q psy3151         221 KSCDIWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVM  299 (372)
Q Consensus       221 ~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil  299 (372)
                      .++|||||||++|||+| |..||.+.+...   .+...+. ....++.  ...+++++++||.+||+.||++|||++|++
T Consensus       245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~---~~~~~~~-~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~  318 (325)
T d1rjba_         245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDA---NFYKLIQ-NGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLT  318 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHH-TTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cceeccchhHHHHHHHhCCCCCCCCCCHHH---HHHHHHh-cCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            99999999999999997 899997654322   2233332 2233222  247899999999999999999999999998


Q ss_pred             cC
Q psy3151         300 EN  301 (372)
Q Consensus       300 ~h  301 (372)
                      +|
T Consensus       319 ~~  320 (325)
T d1rjba_         319 SF  320 (325)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-54  Score=396.96  Aligned_cols=256  Identities=34%  Similarity=0.586  Sum_probs=215.2

Q ss_pred             cceeeccccccccCCeEEEEEEEc---CCCcEEEEEEecc---------hhhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEK---KTSEVYALKVLHD---------TVKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~---------~~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      ++|+++ +.||+|+||+||+|.+.   .+|+.||||++..         .....+|+.++.++..||||+++++++++  
T Consensus        24 ~~y~~~-~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--  100 (322)
T d1vzoa_          24 ENFELL-KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  100 (322)
T ss_dssp             GGEEEE-EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             hceEEE-EEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence            779995 77999999999999874   4789999999852         13456899986666666999999999987  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                        ...+|++|||+.+|+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++             
T Consensus       101 --~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~-------------  163 (322)
T d1vzoa_         101 --ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD-------------  163 (322)
T ss_dssp             --TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-------------
T ss_pred             --CCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec-------------
Confidence              678999999999999999998764  489999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccC-CCcccccccCCCcCCCcccCCC--CCCCccchhhHHHHHHHHHhCC
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSN-KASLQTPCYTPYYVAPEVLGPD--KYDKSCDIWSLGVIMYILLCGF  239 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~  239 (372)
                                    .++.+||+|||+|+..... .....+..||+.|+|||.+.+.  .++.++|||||||+||+|++|.
T Consensus       164 --------------~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~  229 (322)
T d1vzoa_         164 --------------SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  229 (322)
T ss_dssp             --------------TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             --------------CCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCC
Confidence                          5678999999999876433 3335567899999999998654  4678999999999999999999


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCC-----ChhHHhcCCccccCC
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERL-----TIDQVMENKWISQFN  308 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~-----s~~eil~hp~~~~~~  308 (372)
                      .||.+....+....+...........|    ..+|+++++||.+||++||.+||     ||+|+++||||++++
T Consensus       230 ~PF~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         230 SPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             CTTSCTTSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CCCCCCCHHHHHHHHHHhcccCCCCCc----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            999877666655555555544444443    36899999999999999999999     589999999998754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-55  Score=406.18  Aligned_cols=268  Identities=23%  Similarity=0.388  Sum_probs=203.9

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC-C
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYN-G   84 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~-~   84 (372)
                      .+.+||+++ +.||+|+||+||+|.+..+|+.||||++...      ....+|+.+ ++.++||||+++++++..... .
T Consensus         5 ~i~~rY~~~-~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~i-l~~l~hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           5 DVGPRYTNL-SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKI-LLRFRHENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CCCTTEEEE-EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHH-HHHCCCTTBCCCCEEECCSSTTT
T ss_pred             CcCCCeEEE-EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHH-HHHcCCCCCCcEEEEEeeccccc
Confidence            466899996 6799999999999999999999999999632      245678888 566799999999999864322 2


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ..++|++ +|+.+|+|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus        83 ~~~~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~---------------  143 (345)
T d1pmea_          83 MKDVYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---------------  143 (345)
T ss_dssp             CCCEEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---------------
T ss_pred             cceEEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC---------------
Confidence            2345555 455689999999764   499999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccC-CCCCCCccchhhHHHHHHHHHhCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLG-PDKYDKSCDIWSLGVIMYILLCGFP  240 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~  240 (372)
                                  .++.+||+|||+|........   .....+||+.|+|||++. ...++.++||||+||++|+|++|..
T Consensus       144 ------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~  211 (345)
T d1pmea_         144 ------------TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP  211 (345)
T ss_dssp             ------------TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred             ------------CCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCC
Confidence                        567899999999976543222   245577899999999984 4567899999999999999999999


Q ss_pred             CCCCCCCCCCCHhHHH--------------------HHhhCCccCCC---CcccccCHHHHHHHHHhccCCCCCCCChhH
Q psy3151         241 PFFSNHGQAISPGMKN--------------------RIRLGQFDFPN---PEWEHVSQEAKTLIKNMLCVDPSERLTIDQ  297 (372)
Q Consensus       241 pf~~~~~~~~~~~~~~--------------------~~~~~~~~~~~---~~~~~~s~~~~~li~~ll~~dP~~R~s~~e  297 (372)
                      ||.+.+..+.......                    ...........   ..+..+++++++||.+||+.||.+||||+|
T Consensus       212 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e  291 (345)
T d1pmea_         212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ  291 (345)
T ss_dssp             SCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            9965442111100000                    00000000000   012357889999999999999999999999


Q ss_pred             HhcCCccccCCCCCC
Q psy3151         298 VMENKWISQFNQVPQ  312 (372)
Q Consensus       298 il~hp~~~~~~~~~~  312 (372)
                      +|+||||+.......
T Consensus       292 ~L~hpf~~~~~~~~~  306 (345)
T d1pmea_         292 ALAHPYLEQYYDPSD  306 (345)
T ss_dssp             HHTSGGGTTTCCGGG
T ss_pred             HhcCHhhccCCCCcc
Confidence            999999997655433

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=392.01  Aligned_cols=247  Identities=20%  Similarity=0.318  Sum_probs=194.6

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      .++|++ .+.||+|+||+||+|+..   ..||||+++..       ....+|+.+ ++.++||||++++++..     +.
T Consensus         7 ~~~~~~-~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~~~~~~~-----~~   76 (276)
T d1uwha_           7 DGQITV-GQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGV-LRKTRHVNILLFMGYST-----AP   76 (276)
T ss_dssp             TTCCCC-CSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHH-HTTCCCTTBCCEEEEEC-----SS
T ss_pred             cccEEE-EEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHH-HHhCCCCCEeeeeEEEe-----cc
Confidence            478988 578999999999999754   35999998522       234568877 66779999999999764     34


Q ss_pred             EEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVK  166 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~  166 (372)
                      .+|+|||||++|+|.+++...+ +.+++..+..++.||+.||+|||++|||||||||+|||++                 
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~-----------------  138 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH-----------------  138 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-----------------
T ss_pred             EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc-----------------
Confidence            5899999999999999997654 4699999999999999999999999999999999999998                 


Q ss_pred             ccccccCCCCCCCCeeeeccccccccccCC--CcccccccCCCcCCCcccCC---CCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         167 PENLLYTKPGDGGILKLTDFGFAKKIVSNK--ASLQTPCYTPYYVAPEVLGP---DKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       167 ~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                .++.+||+|||+|+......  ....+.+||+.|+|||++..   ..|+.++|||||||++|||+||..|
T Consensus       139 ----------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~P  208 (276)
T d1uwha_         139 ----------EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP  208 (276)
T ss_dssp             ----------TTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ----------CCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCC
Confidence                      67789999999997764322  23445688999999999854   4589999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccC-CCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDF-PNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |.+.+...   .+...+..+.... .......+++++.+||.+||+.||++|||++|++++
T Consensus       209 f~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         209 YSNINNRD---QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TTTCCCHH---HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCChHH---HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            97644322   2333333332211 112234689999999999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-54  Score=390.48  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=207.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRC   87 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~   87 (372)
                      ++|+++ +.||+|+||+||+|++..+|+.||||++...       ....+|+.+ ++.++||||++++++|..    ...
T Consensus         2 ~ry~~i-~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~i-l~~l~h~niv~~~~~~~~----~~~   75 (292)
T d1unla_           2 QKYEKL-EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL-LKELKHKNIVRLHDVLHS----DKK   75 (292)
T ss_dssp             CSEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHH-HTTCCCTTBCCEEEEEEC----SSE
T ss_pred             CCCEee-eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHH-HHhcCcCCEEeecccccc----ccc
Confidence            689997 6699999999999999999999999998522       345688887 677899999999999986    678


Q ss_pred             EEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCc
Q psy3151          88 LLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKP  167 (372)
Q Consensus        88 ~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~  167 (372)
                      .++|++++.+++|..++...  +.+++..++.++.|++.||+|||++||+||||||+|||++                  
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~------------------  135 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN------------------  135 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------------
T ss_pred             eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc------------------
Confidence            89999999998888877654  5699999999999999999999999999999999999998                  


Q ss_pred             cccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy3151         168 ENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDK-YDKSCDIWSLGVIMYILLCGFPPFFSNH  246 (372)
Q Consensus       168 ~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~  246 (372)
                               ..+.+||+|||.|..............+++.|+|||++.... ++.++||||+||++|+|++|..||....
T Consensus       136 ---------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~  206 (292)
T d1unla_         136 ---------RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_dssp             ---------TTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS
T ss_pred             ---------cCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC
Confidence                     566799999999987765555555566788999999986654 6899999999999999999999975433


Q ss_pred             CCCCCHhHHHHHhh--CC-----------------cc------CCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         247 GQAISPGMKNRIRL--GQ-----------------FD------FPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       247 ~~~~~~~~~~~~~~--~~-----------------~~------~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ...   .....+..  +.                 ..      ........+++++.+||++||+.||.+||||+|+|+|
T Consensus       207 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         207 DVD---DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             SHH---HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CHH---HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            211   11111110  00                 00      0001124578999999999999999999999999999


Q ss_pred             CccccC
Q psy3151         302 KWISQF  307 (372)
Q Consensus       302 p~~~~~  307 (372)
                      |||+++
T Consensus       284 p~f~~~  289 (292)
T d1unla_         284 PYFSDF  289 (292)
T ss_dssp             GGGSSC
T ss_pred             hhhcCC
Confidence            999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=391.17  Aligned_cols=251  Identities=20%  Similarity=0.314  Sum_probs=204.3

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|++. +.||+|+||+||+|.++ ++..||||++...    ....+|+.+ ++.++||||+++++++..     +.+|
T Consensus        12 ~~~~~~~-~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~~~g~~~~-----~~~~   83 (272)
T d1qpca_          12 RETLKLV-ERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANL-MKQLQHQRLVRLYAVVTQ-----EPIY   83 (272)
T ss_dssp             GGGEEEE-EEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHH-HHHCCCTTBCCEEEEECS-----SSCE
T ss_pred             HHHeEEe-EEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHH-HHhCCCCCEeEEEeeecc-----CCeE
Confidence            4789984 77999999999999985 6788999999642    345688887 566699999999998753     3578


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++                    
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~--------------------  143 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--------------------  143 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee--------------------
Confidence            999999999999988765444699999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                             .++.+||+|||+|+....... ......||+.|+|||++....|+.++|||||||++|||+||..|+..... 
T Consensus       144 -------~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-  215 (272)
T d1qpca_         144 -------DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-  215 (272)
T ss_dssp             -------TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-
T ss_pred             -------cccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-
Confidence                   677899999999987654332 23446789999999999888899999999999999999996555433221 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc--CCccc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME--NKWIS  305 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~--hp~~~  305 (372)
                        ...+...+..+... +  ....+++++.+||.+||+.||++|||++++++  |+||.
T Consensus       216 --~~~~~~~i~~~~~~-~--~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         216 --NPEVIQNLERGYRM-V--RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             --HHHHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHHhcCCC-C--CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence              12334444433221 1  22478999999999999999999999999988  78875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-54  Score=396.49  Aligned_cols=260  Identities=24%  Similarity=0.356  Sum_probs=198.2

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec----
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY----   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~----   82 (372)
                      -++|+++ +.||+|+||+||+|++..+|+.||||++...       ....+|+.+ ++.++||||+++++++....    
T Consensus         9 ~~rY~i~-~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~i-l~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKL-AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHH-HHHCCCTTBCCEEEEEEC------
T ss_pred             cCCEEEE-EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHH-HHHhcCCCccceEeeeeccccccc
Confidence            4899996 6699999999999999999999999998522       345688887 67779999999999985421    


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      ..+..+|+||||+.++.+......  ...+++..++.++.||+.||.|||++||+||||||+|||++             
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~-------------  151 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT-------------  151 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-------------
T ss_pred             ccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec-------------
Confidence            224568999999977655443322  35699999999999999999999999999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCC----CcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHh
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNK----ASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLC  237 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~  237 (372)
                                    .++.+|++|||+|.......    ....+.+||++|+|||++.+. .|+.++||||+||++|+|++
T Consensus       152 --------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~  217 (318)
T d3blha1         152 --------------RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT  217 (318)
T ss_dssp             --------------TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             --------------CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh
Confidence                          56779999999997654321    223446799999999998654 68999999999999999999


Q ss_pred             CCCCCCCCCCCCCCHhHHHHHhhCCccCC-----------------C----Cc-----ccccCHHHHHHHHHhccCCCCC
Q psy3151         238 GFPPFFSNHGQAISPGMKNRIRLGQFDFP-----------------N----PE-----WEHVSQEAKTLIKNMLCVDPSE  291 (372)
Q Consensus       238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------~----~~-----~~~~s~~~~~li~~ll~~dP~~  291 (372)
                      |+.||.+.+.......+....  +.+...                 .    ..     ....+++++|||.+||++||++
T Consensus       218 g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~  295 (318)
T d3blha1         218 RSPIMQGNTEQHQLALISQLC--GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ  295 (318)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHH--CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTT
T ss_pred             CCCCCCCCCHHHHHHHHHHhc--CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhH
Confidence            999996543222111111111  110000                 0    00     0124778999999999999999


Q ss_pred             CCChhHHhcCCcccc
Q psy3151         292 RLTIDQVMENKWISQ  306 (372)
Q Consensus       292 R~s~~eil~hp~~~~  306 (372)
                      ||||+|+|+||||+.
T Consensus       296 R~sa~elL~Hpff~~  310 (318)
T d3blha1         296 RIDSDDALNHDFFWS  310 (318)
T ss_dssp             SCCHHHHHHSGGGSS
T ss_pred             CcCHHHHHcChhhcc
Confidence            999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-54  Score=384.81  Aligned_cols=245  Identities=19%  Similarity=0.349  Sum_probs=192.3

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      ++|+++ +.||+|+||+||+|.+. +++.||||++...    ....+|+.. ++.++||||+++++++..    ++.+|+
T Consensus         5 ~~~~~~-~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~-l~~l~HpnIv~~~g~~~~----~~~~~l   77 (263)
T d1sm2a_           5 SELTFV-QEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEV-MMKLSHPKLVQLYGVCLE----QAPICL   77 (263)
T ss_dssp             SCEEEE-EEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHH-HHHCCCTTBCCEEEEECS----SSSCEE
T ss_pred             HHcEEE-EEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHH-HHhcCCCCcccccceecc----CCceEE
Confidence            679985 77999999999999986 6788999999632    345678877 667799999999999875    567899


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++                     
T Consensus        78 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---------------------  135 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---------------------  135 (263)
T ss_dssp             EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---------------------
T ss_pred             EEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---------------------
Confidence            999999999999987653 5689999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCG-FPPFFSNHGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~  248 (372)
                            .++.+||+|||+|+....... ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||...+. 
T Consensus       136 ------~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-  208 (263)
T d1sm2a_         136 ------ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-  208 (263)
T ss_dssp             ------GGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-
T ss_pred             ------CCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-
Confidence                  567799999999987654332 23346789999999999999999999999999999999995 555543221 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                         ..+...+..+.....   ...+++++.+||.+||+.||++|||++|+++|
T Consensus       209 ---~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         209 ---SEVVEDISTGFRLYK---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ---HHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---HHHHHHHHhcCCCCC---ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence               234444444322211   24679999999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=390.04  Aligned_cols=249  Identities=25%  Similarity=0.378  Sum_probs=202.4

Q ss_pred             cceeecccc-ccccCCeEEEEEEEcC--CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          15 DDYDISTEI-LGLGINGKVLQIVEKK--TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        15 ~~Y~i~~~~-lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ++|.+ .++ ||+|+||+||+|.++.  ++..||||++...      ....+|+.+ ++.++||||+++++++..     
T Consensus         8 ~~~~~-~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~~-----   80 (285)
T d1u59a_           8 DNLLI-ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI-MHQLDNPYIVRLIGVCQA-----   80 (285)
T ss_dssp             GGEEE-EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHH-HHHCCCTTBCCEEEEEES-----
T ss_pred             cCeEE-CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHH-HHhCCCCCEeeEeeeecc-----
Confidence            56777 454 9999999999998754  4558999998532      245678887 566799999999998863     


Q ss_pred             eEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCC
Q psy3151          86 RCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDV  165 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~  165 (372)
                      +.+|+|||||++|+|.+++.... +.+++..+..++.||+.||+|||++||+||||||+|||++                
T Consensus        81 ~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~----------------  143 (285)
T d1u59a_          81 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----------------  143 (285)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----------------
T ss_pred             CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec----------------
Confidence            34799999999999999886543 4699999999999999999999999999999999999998                


Q ss_pred             CccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         166 KPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       166 ~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                 .++.+||+|||+|+.......   .....+||+.|+|||++....++.++|||||||++|||+| |..|
T Consensus       144 -----------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~P  212 (285)
T d1u59a_         144 -----------NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP  212 (285)
T ss_dssp             -----------ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             -----------cCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCC
Confidence                       567799999999987654322   2334568899999999988899999999999999999998 9999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH---hcCCccc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV---MENKWIS  305 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei---l~hp~~~  305 (372)
                      |.+.+.    ..+...+..+....   ....+++++.+||.+||+.||++|||+.++   |+|+|+.
T Consensus       213 f~~~~~----~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         213 YKKMKG----PEVMAFIEQGKRME---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TTTCCT----HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCH----HHHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            976543    33445555443221   124789999999999999999999999888   5677764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=403.21  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=194.7

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec--C
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIY--N   83 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~--~   83 (372)
                      +.++|+++ +.||+|+||+||+|.++.+|+.||||++...       .+..+|+.+ ++.++||||++++++|....  .
T Consensus        15 i~~~Y~i~-~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          15 VLKRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL-MKCVNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             EETTEEEE-EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHH-HHHCCCTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEE-EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHH-HHhcCCCCeeEEEEEEecccccc
Confidence            45899996 7799999999999999999999999999632       245678887 56679999999999996432  2


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                      ...++|+|||||.+ ++.+.+.    ..+++..++.++.||+.||+|||++||+||||||+|||++              
T Consensus        93 ~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~--------------  153 (355)
T d2b1pa1          93 EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK--------------  153 (355)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--------------
T ss_pred             cCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc--------------
Confidence            35789999999965 5555553    3499999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                   .++.++++|||+++.... .......+||+.|+|||++.+..++.++||||+||++|+|++|++||.
T Consensus       154 -------------~~~~~kl~df~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~  219 (355)
T d2b1pa1         154 -------------SDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP  219 (355)
T ss_dssp             -------------TTCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------cccceeeechhhhhcccc-ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence                         566789999998876543 334456688999999999999999999999999999999999999996


Q ss_pred             CCCCCCCCHhHHH------------------HHhhCCccCC----------------CCcccccCHHHHHHHHHhccCCC
Q psy3151         244 SNHGQAISPGMKN------------------RIRLGQFDFP----------------NPEWEHVSQEAKTLIKNMLCVDP  289 (372)
Q Consensus       244 ~~~~~~~~~~~~~------------------~~~~~~~~~~----------------~~~~~~~s~~~~~li~~ll~~dP  289 (372)
                      +.+.......+..                  ..........                .......++++.+||++||++||
T Consensus       220 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP  299 (355)
T d2b1pa1         220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP  299 (355)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSST
T ss_pred             CCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCCh
Confidence            5432211111110                  0001110000                00112357889999999999999


Q ss_pred             CCCCChhHHhcCCccccCC
Q psy3151         290 SERLTIDQVMENKWISQFN  308 (372)
Q Consensus       290 ~~R~s~~eil~hp~~~~~~  308 (372)
                      ++||||+|+|+||||+...
T Consensus       300 ~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         300 AKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             TTSCCHHHHHTSTTTGGGC
T ss_pred             hHCcCHHHHhcCcccCCCC
Confidence            9999999999999998753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.8e-54  Score=392.81  Aligned_cols=247  Identities=22%  Similarity=0.377  Sum_probs=191.8

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCc---EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSE---VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .++|++ .+.||+|+||+||+|.++.+|+   .||||.+...      ....+|+.+ ++.++||||+++++++..    
T Consensus        25 ~~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~g~~~~----   98 (299)
T d1jpaa_          25 ISCVKI-EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI-MGQFDHPNVIHLEGVVTK----   98 (299)
T ss_dssp             GGGEEE-EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHH-HTTCCCTTBCCEEEEECS----
T ss_pred             hhhcEE-eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHH-HHhCCCCCCccEEEEEee----
Confidence            467888 6889999999999999987765   5889987532      235678887 667799999999999865    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +..+|+|||||++|+|.+++.... +.+++.++..++.||+.||+|||++||+||||||+|||++               
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~---------------  162 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN---------------  162 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---------------
T ss_pred             CCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC---------------
Confidence            567899999999999999887643 5699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCc-----ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS-----LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-G  238 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g  238 (372)
                                  .++.+||+|||+|+........     .....||+.|+|||++.+..|+.++|||||||++|||+| |
T Consensus       163 ------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g  230 (299)
T d1jpaa_         163 ------------SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG  230 (299)
T ss_dssp             ------------TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             ------------CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCC
Confidence                        6778999999999876442221     122456889999999988999999999999999999998 8


Q ss_pred             CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         239 FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       239 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ..||.+....    .+...+..+. ..+.  ...+++++.+||.+||+.||++|||++|++++
T Consensus       231 ~~Pf~~~~~~----~~~~~i~~~~-~~~~--~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         231 ERPYWDMTNQ----DVINAIEQDY-RLPP--PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCTTTTCCHH----HHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCCCHH----HHHHHHHcCC-CCCC--CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999765432    3344444332 1222  24689999999999999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-54  Score=402.26  Aligned_cols=269  Identities=24%  Similarity=0.397  Sum_probs=205.5

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC-C
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYN-G   84 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~-~   84 (372)
                      +.+||+++ +.||+|+||+||+|++..+|+.||||++...       ....+|+.+ ++.++||||++++++|..... .
T Consensus        16 ~~~rY~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~i-l~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          16 VPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL-LKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             EETTEEEE-EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHH-HHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCCeEEE-EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHH-HHhcCCCCeeeEEEEEeeccccc
Confidence            46899996 6799999999999999999999999998632       245688888 667799999999999864221 1


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      +...+++|+|+.+|+|.+++..   +++++.+++.++.||+.||+|||++||+||||||+|||++               
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~---------------  155 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---------------  155 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---------------
T ss_pred             cCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc---------------
Confidence            2334555667779999999854   3599999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPD-KYDKSCDIWSLGVIMYILLCGFPPFF  243 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  243 (372)
                                  .++.+|++|||+|....   ....+.+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.
T Consensus       156 ------------~~~~~kl~dfg~a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~  220 (348)
T d2gfsa1         156 ------------EDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  220 (348)
T ss_dssp             ------------TTCCEEECCC----CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ------------ccccccccccchhcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence                        56789999999987653   234556789999999987654 46899999999999999999999996


Q ss_pred             CCCCCCCCHhHHHHH-------------------hhCCccCCCC----cccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         244 SNHGQAISPGMKNRI-------------------RLGQFDFPNP----EWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       244 ~~~~~~~~~~~~~~~-------------------~~~~~~~~~~----~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      +.+.......+....                   .......+..    .+..++++++|||.+||+.||++||||+|+|+
T Consensus       221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         221 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            654322111111110                   0000011111    12357899999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCc
Q psy3151         301 NKWISQFNQVPQTPLC  316 (372)
Q Consensus       301 hp~~~~~~~~~~~~~~  316 (372)
                      ||||+++......|..
T Consensus       301 Hp~f~~~~~~~~~~~~  316 (348)
T d2gfsa1         301 HAYFAQYHDPDDEPVA  316 (348)
T ss_dssp             SGGGTTTCCTTSCCCC
T ss_pred             CHhhCCCCCCccCCCC
Confidence            9999988765555443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-54  Score=387.24  Aligned_cols=242  Identities=21%  Similarity=0.347  Sum_probs=195.7

Q ss_pred             ccccccCCeEEEEEEEc--CCCcEEEEEEecch-------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEEE
Q psy3151          22 EILGLGINGKVLQIVEK--KTSEVYALKVLHDT-------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVIM   92 (372)
Q Consensus        22 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv~   92 (372)
                      +.||+|+||+||+|.+.  .+++.||||++...       ....+|+.+ ++.++||||++++++++.     +..|+||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~~~g~~~~-----~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV-MQQLDNPYIVRMIGICEA-----ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHH-HHTCCCTTBCCEEEEEES-----SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHH-HHhCCCCCCceEEEEecc-----CCEEEEE
Confidence            35999999999999864  45689999998532       245678887 577799999999999863     3468999


Q ss_pred             eccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccccc
Q psy3151          93 ECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLLY  172 (372)
Q Consensus        93 e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~  172 (372)
                      ||+++|+|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++                       
T Consensus        87 E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~-----------------------  141 (277)
T d1xbba_          87 EMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV-----------------------  141 (277)
T ss_dssp             ECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-----------------------
T ss_pred             EcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc-----------------------
Confidence            999999999999865  4599999999999999999999999999999999999998                       


Q ss_pred             CCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q psy3151         173 TKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ  248 (372)
Q Consensus       173 ~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  248 (372)
                          .++.+||+|||+|+........   .....||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+. 
T Consensus       142 ----~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-  216 (277)
T d1xbba_         142 ----TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-  216 (277)
T ss_dssp             ----ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-
T ss_pred             ----ccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-
Confidence                5678999999999876443222   233568999999999988889999999999999999998 8999976543 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHH---hcCCccc
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQV---MENKWIS  305 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~ei---l~hp~~~  305 (372)
                         ..+...+..+...   +....+++++.+||.+||+.||++|||++++   |+|+|+.
T Consensus       217 ---~~~~~~i~~~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         217 ---SEVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ---HHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHcCCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence               2334444443321   1124789999999999999999999999998   4566653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-53  Score=377.48  Aligned_cols=245  Identities=23%  Similarity=0.380  Sum_probs=205.2

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      ++|++. +.||+|+||+||+|+++ +++.||||++...    ....+|+.. ++.++||||+++++++.+    ++.+++
T Consensus         4 ~~~~~~-~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~-~~~l~HpnIv~~~g~~~~----~~~~~i   76 (258)
T d1k2pa_           4 KDLTFL-KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKV-MMNLSHEKLVQLYGVCTK----QRPIFI   76 (258)
T ss_dssp             CCCCCC-CCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHH-HHTCCCTTBCCEEEEECC----SSSEEE
T ss_pred             HHCEEe-EEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHH-HHhcCCCceeeEEEEEee----CCceEE
Confidence            678885 77999999999999984 7889999999642    345678877 677799999999999875    567999


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcccc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENL  170 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~  170 (372)
                      ||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++                     
T Consensus        77 v~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~---------------------  134 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---------------------  134 (258)
T ss_dssp             EEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC---------------------
T ss_pred             EEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc---------------------
Confidence            999999999999977654 4699999999999999999999999999999999999998                     


Q ss_pred             ccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q psy3151         171 LYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQ  248 (372)
Q Consensus       171 ~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  248 (372)
                            .++.+||+|||+|+....... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+. 
T Consensus       135 ------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-  207 (258)
T d1k2pa_         135 ------DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-  207 (258)
T ss_dssp             ------TTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-
T ss_pred             ------CCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-
Confidence                  567899999999986644332 2334668999999999998899999999999999999998 8999966543 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                         ..+...+..+.. .+.  ....++++.+||.+||+.||++|||++++++|
T Consensus       208 ---~~~~~~i~~~~~-~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         208 ---SETAEHIAQGLR-LYR--PHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ---HHHHHHHHTTCC-CCC--CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---HHHHHHHHhCCC-CCC--cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence               334445544332 222  24789999999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=387.02  Aligned_cols=260  Identities=21%  Similarity=0.337  Sum_probs=199.1

Q ss_pred             cCCCccCCcccceeeccccccccCCeEEEEEEEcC-----CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeE
Q psy3151           5 FKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKK-----TSEVYALKVLHDT------VKARREVELQLAVGSHKHIVN   73 (372)
Q Consensus         5 ~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~   73 (372)
                      |.+.+.+--.++|++ .+.||+|+||+||+|.+..     +++.||||++...      ....+|...+.++.+|+||+.
T Consensus         3 ~~~~~wei~~~~y~~-~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~   81 (299)
T d1ywna1           3 YDASKWEFPRDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   81 (299)
T ss_dssp             CCHHHHBCCGGGEEE-EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCccccccHHHEEE-eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence            333333334588999 5789999999999999754     4578999998632      234566677778889999999


Q ss_pred             EeEeeeeecCCceEEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy3151          74 IKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHR  139 (372)
Q Consensus        74 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHr  139 (372)
                      +++++..   .+..+++|||||++|+|.+++....              ...+++..+..++.||+.||+|||++||+||
T Consensus        82 ~~~~~~~---~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr  158 (299)
T d1ywna1          82 LLGACTK---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR  158 (299)
T ss_dssp             EEEEECS---TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eeeeecc---CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence            9988753   3557899999999999999997542              1358999999999999999999999999999


Q ss_pred             CCCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCC
Q psy3151         140 DVKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPD  217 (372)
Q Consensus       140 Dlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~  217 (372)
                      ||||+|||++                           .++.+||+|||+|+.......  .....+||+.|+|||++.+.
T Consensus       159 DlKp~NILl~---------------------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~  211 (299)
T d1ywna1         159 DLAARNILLS---------------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR  211 (299)
T ss_dssp             CCCGGGEEEC---------------------------GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC
T ss_pred             cCCccceeEC---------------------------CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC
Confidence            9999999998                           567899999999986644322  33456789999999999999


Q ss_pred             CCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChh
Q psy3151         218 KYDKSCDIWSLGVIMYILLCG-FPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTID  296 (372)
Q Consensus       218 ~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~  296 (372)
                      .++.++|||||||++|||++| .+||.+....   ..+...+..+...   +....+++++.+||.+||+.||++|||++
T Consensus       212 ~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  285 (299)
T d1ywna1         212 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFS  285 (299)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---HHHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCcccceeehHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            999999999999999999986 5677544322   2333444433221   12246899999999999999999999999


Q ss_pred             HHhcC
Q psy3151         297 QVMEN  301 (372)
Q Consensus       297 eil~h  301 (372)
                      |+++|
T Consensus       286 eil~~  290 (299)
T d1ywna1         286 ELVEH  290 (299)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=381.53  Aligned_cols=246  Identities=22%  Similarity=0.343  Sum_probs=192.0

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCC---cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTS---EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      .++|++ .+.||+|+||+||+|.+..++   ..||||.+...      ....+|+.+ ++.++||||+++++++.     
T Consensus         6 ~~~~~l-~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~-----   78 (273)
T d1mp8a_           6 RERIEL-GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT-MRQFDHPHIVKLIGVIT-----   78 (273)
T ss_dssp             GGGEEE-EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHH-HHTCCCTTBCCEEEEEC-----
T ss_pred             HHHeEE-EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEe-----
Confidence            478999 588999999999999987553   56899988532      234577777 67779999999999885     


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ++.+|+||||+.+|+|.+++.... +.+++..++.++.||+.||.|||++||+||||||+||+++               
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---------------  142 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---------------  142 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---------------
T ss_pred             cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---------------
Confidence            346899999999999999877654 5699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCC-cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA-SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPF  242 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  242 (372)
                                  .++.+||+|||+|+....... .....+||+.|+|||++.+..|+.++|||||||++|||++ |.+||
T Consensus       143 ------------~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~  210 (273)
T d1mp8a_         143 ------------SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF  210 (273)
T ss_dssp             ------------ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ------------CCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCC
Confidence                        567799999999987654322 2344567899999999998999999999999999999998 89999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      .+.+..+    +...+..+...   +.+..+|+++.+||.+||+.||++|||++|+++|
T Consensus       211 ~~~~~~~----~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         211 QGVKNND----VIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             TTCCGGG----HHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHH----HHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            7655433    34444444321   2234789999999999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=380.42  Aligned_cols=253  Identities=19%  Similarity=0.301  Sum_probs=199.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      .++|++ ++.||+|+||+||+|.+..+ +.||||++...    ....+|+.+ ++.++||||+++++++..     +.+|
T Consensus        16 ~~~~~i-~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~-l~~l~h~nIv~~~g~~~~-----~~~~   87 (285)
T d1fmka3          16 RESLRL-EVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQV-MKKLRHEKLVQLYAVVSE-----EPIY   87 (285)
T ss_dssp             GGGEEE-EEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHH-HHHCCCTTBCCEEEEECS-----SSCE
T ss_pred             HHHEEE-eeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHH-HHhcccCCEeEEEEEEec-----CCeE
Confidence            478998 57799999999999999754 57999999632    345678877 677899999999998753     3478


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+.+|+|..++.....+.+++.++..++.||+.||+|||++||+||||||+||||+                    
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~--------------------  147 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG--------------------  147 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--------------------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC--------------------
Confidence            999999999999988765545699999999999999999999999999999999999998                    


Q ss_pred             cccCCCCCCCCeeeeccccccccccCC-CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNK-ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHGQ  248 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  248 (372)
                             .++.+||+|||+|+...... .......||+.|+|||++....++.++|||||||++|||++|..||..... 
T Consensus       148 -------~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-  219 (285)
T d1fmka3         148 -------ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-  219 (285)
T ss_dssp             -------GGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-
T ss_pred             -------CCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-
Confidence                   56779999999998764332 233446789999999999999999999999999999999996666543322 


Q ss_pred             CCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc--CCccccC
Q psy3151         249 AISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME--NKWISQF  307 (372)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~--hp~~~~~  307 (372)
                        ...+...+..+. ..  +....+++++++||.+||+.||++|||++++++  ++||...
T Consensus       220 --~~~~~~~i~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         220 --NREVLDQVERGY-RM--PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             --HHHHHHHHHTTC-CC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             --HHHHHHHHHhcC-CC--CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence              122334443332 11  223478999999999999999999999999988  8888764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-52  Score=383.23  Aligned_cols=245  Identities=19%  Similarity=0.308  Sum_probs=197.7

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCc----EEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSE----VYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      ++|+++ ++||+|+||+||+|.+..+|+    +||+|.+...      ....+|+.+ ++.++||||+++++++.+    
T Consensus         9 ~dy~~~-~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~g~~~~----   82 (317)
T d1xkka_           9 TEFKKI-KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV-MASVDNPHVCRLLGICLT----   82 (317)
T ss_dssp             TTEEEE-EEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHH-HHHCCCTTBCCEEEEEES----
T ss_pred             HHCEEe-eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEec----
Confidence            469995 789999999999999988876    5888887532      245678887 566799999999999864    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                       +..++++||+.+|+|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus        83 -~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---------------  145 (317)
T d1xkka_          83 -STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---------------  145 (317)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---------------
T ss_pred             -CCeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---------------
Confidence             34678899999999999887654 5699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p  241 (372)
                                  .++.+||+|||+|+........  .....||+.|+|||++.++.|+.++|||||||++|||+| |.+|
T Consensus       146 ------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p  213 (317)
T d1xkka_         146 ------------TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  213 (317)
T ss_dssp             ------------ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ------------CCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCC
Confidence                        5678999999999876543332  233568999999999988899999999999999999998 7889


Q ss_pred             CCCCCCCCCCHhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcCC
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMENK  302 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~hp  302 (372)
                      |.+.+..+    +...+..+. .+.|    ..+++++.+||.+||..||++|||+.|+++|.
T Consensus       214 ~~~~~~~~----~~~~i~~~~~~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         214 YDGIPASE----ISSILEKGERLPQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             TTTSCGGG----HHHHHHHTCCCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCHHH----HHHHHHcCCCCCCC----cccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            86654333    344444433 2222    47899999999999999999999999999873

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=374.45  Aligned_cols=246  Identities=20%  Similarity=0.341  Sum_probs=192.2

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCC----cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTS----EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNG   84 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~   84 (372)
                      +.|++ +++||+|+||+||+|.+..++    ..||||++...      ....+|+.+ ++.++||||+++++++..    
T Consensus         7 ~~~~~-~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~i-l~~l~H~nIv~~~g~~~~----   80 (283)
T d1mqba_           7 SCVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI-MGQFSHHNIIRLEGVISK----   80 (283)
T ss_dssp             TTEEE-EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHH-HHTCCCTTBCCEEEEECS----
T ss_pred             HHeEe-eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHH-HHhcCCCCEeeeeEEEec----
Confidence            57888 689999999999999987655    47999998532      234578877 677799999999999875    


Q ss_pred             ceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCC
Q psy3151          85 SRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGD  164 (372)
Q Consensus        85 ~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~  164 (372)
                      ...+++||||+.++++.+.+.... +.+++.++..++.||+.||+|||++||+||||||+|||++               
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~---------------  144 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---------------  144 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---------------
T ss_pred             CCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC---------------
Confidence            567899999999999998887653 5699999999999999999999999999999999999998               


Q ss_pred             CCccccccCCCCCCCCeeeeccccccccccCCCc---ccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         165 VKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS---LQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       165 ~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                                  .++.+||+|||+|+........   .....||+.|+|||++.+..++.++|||||||++|||+++..|
T Consensus       145 ------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~  212 (283)
T d1mqba_         145 ------------SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER  212 (283)
T ss_dssp             ------------TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ------------CCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCC
Confidence                        6778999999999876443221   2234678999999999999999999999999999999996655


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      |.....   ...+...+..+. ..+  ....++.++.+||.+||+.||++|||+.|+++
T Consensus       213 ~~~~~~---~~~~~~~i~~~~-~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         213 PYWELS---NHEVMKAINDGF-RLP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TTTTCC---HHHHHHHHHTTC-CCC--CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ccccCC---HHHHHHHHhccC-CCC--CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            533221   123344444332 222  22468999999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-51  Score=373.51  Aligned_cols=263  Identities=18%  Similarity=0.225  Sum_probs=199.0

Q ss_pred             CcccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          12 PIQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        12 ~~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      .+.++|++. +.||+|+||+||+|.+..+|+.||||++...   ....+|++++..+..|++|+.+..++..    +...
T Consensus         4 ~vg~rY~l~-~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~   78 (299)
T d1ckia_           4 RVGNRYRLG-RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYN   78 (299)
T ss_dssp             EETTTEEEE-EEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEE
T ss_pred             eECCEEEEe-EEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEE
Confidence            356899995 7799999999999999999999999998632   3556788884444444456666665554    6778


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCcc
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPE  168 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~  168 (372)
                      ++||||+ +++|.+.+.... +.+++..+..++.|++.||+|||++||+||||||+|||++..+                
T Consensus        79 ~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~----------------  140 (299)
T d1ckia_          79 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK----------------  140 (299)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG----------------
T ss_pred             EEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC----------------
Confidence            9999999 567777666543 5699999999999999999999999999999999999997433                


Q ss_pred             ccccCCCCCCCCeeeeccccccccccCCC-------cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3151         169 NLLYTKPGDGGILKLTDFGFAKKIVSNKA-------SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPP  241 (372)
Q Consensus       169 ~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  241 (372)
                              .+..++++|||+|+.......       ...+.+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       141 --------~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P  212 (299)
T d1ckia_         141 --------KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP  212 (299)
T ss_dssp             --------GTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             --------CCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCc
Confidence                    355688899998887643221       23456799999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhH---HhcCCcccc
Q psy3151         242 FFSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQ---VMENKWISQ  306 (372)
Q Consensus       242 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~e---il~hp~~~~  306 (372)
                      |............... .......+. .....+|+++.+||.+||+.||++||++++   +|+|+|.+.
T Consensus       213 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         213 WQGLKAATKRQKYERI-SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             TCCCC-------HHHH-HHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHHh-hcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            9765544332222111 111111111 112468999999999999999999999875   467776543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=369.34  Aligned_cols=242  Identities=21%  Similarity=0.388  Sum_probs=193.5

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      ++|++ .+.||+|+||.||+|.++  |..||||+++..   ....+|+++ ++.++||||+++++++..   +.+.+|+|
T Consensus         7 ~~~~~-~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~-l~~l~HpnIv~~~g~~~~---~~~~~~lv   79 (262)
T d1byga_           7 KELKL-LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASV-MTQLRHSNLVQLLGVIVE---EKGGLYIV   79 (262)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHH-HTTCCCTTBCCEEEEECC---C--CCEEE
T ss_pred             HHeEE-eEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHH-HHhCCCCCEeeEEEEEEe---cCCcEEEE
Confidence            57888 477999999999999984  788999999743   346678887 677799999999998743   24558999


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      |||+++|+|.+++.......+++..+..++.||+.||.|||+.+|+||||||+|||++                      
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~----------------------  137 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----------------------  137 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----------------------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec----------------------
Confidence            9999999999999765434589999999999999999999999999999999999998                      


Q ss_pred             cCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCC
Q psy3151         172 YTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GFPPFFSNHGQAI  250 (372)
Q Consensus       172 ~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  250 (372)
                           .++.+|++|||+++....   ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+..  
T Consensus       138 -----~~~~~kl~dfg~s~~~~~---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--  207 (262)
T d1byga_         138 -----EDNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--  207 (262)
T ss_dssp             -----TTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--
T ss_pred             -----CCCCEeecccccceecCC---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--
Confidence                 677899999999986533   2344567899999999988899999999999999999998 78888654433  


Q ss_pred             CHhHHHHHhhCC-ccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         251 SPGMKNRIRLGQ-FDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       251 ~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                        .+...+..+. .+.+    ..+++++.+||++||+.||.+|||+.+++++
T Consensus       208 --~~~~~i~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         208 --DVVPRVEKGYKMDAP----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             --GHHHHHTTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --HHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              2344444332 2222    3689999999999999999999999999873

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-51  Score=371.25  Aligned_cols=248  Identities=23%  Similarity=0.388  Sum_probs=198.4

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCC-------cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeee
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTS-------EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYEN   80 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~   80 (372)
                      .++|.+ .+.||+|+||.||+|++..++       ..||||+++..      ....+|...+.++.+||||+++++++.+
T Consensus        12 ~~~~~l-~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          12 RDRLVL-GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGGEEE-EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEE-eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            589998 578999999999999987655       47999998532      2345677776677799999999999975


Q ss_pred             ecCCceEEEEEEeccCCCchhHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q psy3151          81 IYNGSRCLLVIMECMHGGELFQRIQQKE--------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENL  146 (372)
Q Consensus        81 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~--------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NI  146 (372)
                          +..+|+||||+.+|+|.+++....              ...+++..++.++.||+.||+|||+.|||||||||+||
T Consensus        91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  166 (299)
T ss_dssp             ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence                567999999999999999997643              23589999999999999999999999999999999999


Q ss_pred             eeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccc
Q psy3151         147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCD  224 (372)
Q Consensus       147 li~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~D  224 (372)
                      |++                           .++.+||+|||+++.......  .....+||+.|+|||.+.++.|+.++|
T Consensus       167 Ll~---------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D  219 (299)
T d1fgka_         167 LVT---------------------------EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD  219 (299)
T ss_dssp             EEC---------------------------TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHH
T ss_pred             eec---------------------------CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhh
Confidence            998                           567899999999987654322  234467889999999998899999999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         225 IWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       225 iwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||||||++|||++ |.+||.+.+.    ..+...+..+.. .  +....+++++.+||.+||+.||++|||+.|+++
T Consensus       220 iwS~Gvvl~ell~~g~~p~~~~~~----~~~~~~i~~~~~-~--~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         220 VWSFGVLLWEIFTLGGSPYPGVPV----EELFKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHTTCC-C--CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHhHHHHHHhccCCCCCCCCCCH----HHHHHHHHcCCC-C--CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            9999999999998 7888865442    234444444321 1  222478999999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-51  Score=374.48  Aligned_cols=247  Identities=19%  Similarity=0.338  Sum_probs=199.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCCCcE--EEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCce
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKTSEV--YALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSR   86 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~   86 (372)
                      ++|++ ++.||+|+||+||+|.++.+|..  ||||.+...      ....+|++++.++.+||||+++++++..    ++
T Consensus        10 ~~~~~-~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----~~   84 (309)
T d1fvra_          10 NDIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RG   84 (309)
T ss_dssp             GGCEE-EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----TT
T ss_pred             HHcEE-EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec----CC
Confidence            68998 68899999999999999988875  677776421      2456888885555589999999999986    67


Q ss_pred             EEEEEEeccCCCchhHHHHhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCC
Q psy3151          87 CLLVIMECMHGGELFQRIQQK--------------EDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPG  152 (372)
Q Consensus        87 ~~~lv~e~~~~g~L~~~i~~~--------------~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~  152 (372)
                      .+|+||||+++|+|.++++..              ....+++..+..++.||+.||.|||++||+||||||+|||++   
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~---  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc---
Confidence            899999999999999999753              235699999999999999999999999999999999999998   


Q ss_pred             CCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHHH
Q psy3151         153 DGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIM  232 (372)
Q Consensus       153 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  232 (372)
                                              .++.+||+|||+|+...... .....+||+.|+|||.+....|+.++|||||||++
T Consensus       162 ------------------------~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil  216 (309)
T d1fvra_         162 ------------------------ENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL  216 (309)
T ss_dssp             ------------------------GGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred             ------------------------CCCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHH
Confidence                                    56679999999997654322 23345689999999999989999999999999999


Q ss_pred             HHHHhCC-CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         233 YILLCGF-PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       233 ~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      |||++|. +||.+.+.    ..+...+..+..   .+.+..+++++.+||.+||+.||++|||++++++|
T Consensus       217 ~ell~~~~~p~~~~~~----~~~~~~i~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         217 WEIVSLGGTPYCGMTC----AELYEKLPQGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHHHTTSCCTTTTCCH----HHHHHHGGGTCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCH----HHHHHHHHhcCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999975 56644332    233444444321   12224789999999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4e-50  Score=366.00  Aligned_cols=258  Identities=15%  Similarity=0.196  Sum_probs=204.8

Q ss_pred             cccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEE
Q psy3151          13 IQDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLL   89 (372)
Q Consensus        13 ~~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~   89 (372)
                      +.++|+| .+.||+|+||+||+|++..+|+.||||++...   ....+|++.+..+.+|+||+.+++++..    +...|
T Consensus         3 ig~~Y~i-~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~~~   77 (293)
T d1csna_           3 VGVHYKV-GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE----GLHNV   77 (293)
T ss_dssp             ETTTEEE-EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE----TTEEE
T ss_pred             CCCceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec----CCccE
Confidence            4679999 57899999999999999999999999998532   3457788886666667999999998876    67889


Q ss_pred             EEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccc
Q psy3151          90 VIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPEN  169 (372)
Q Consensus        90 lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~  169 (372)
                      +||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.+..                
T Consensus        78 ~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~----------------  139 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS----------------  139 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS----------------
T ss_pred             EEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc----------------
Confidence            999999 789999887654 46999999999999999999999999999999999999974321                


Q ss_pred             cccCCCCCCCCeeeeccccccccccCC-------CcccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3151         170 LLYTKPGDGGILKLTDFGFAKKIVSNK-------ASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPF  242 (372)
Q Consensus       170 ~~~~~~~~~~~~ki~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  242 (372)
                            ...+.+||+|||+|+......       ....+.+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       140 ------~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf  213 (293)
T d1csna_         140 ------KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW  213 (293)
T ss_dssp             ------TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ------ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcC
Confidence                  135679999999998754321       1234568999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHhHHHHHhhCCccCCC-CcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         243 FSNHGQAISPGMKNRIRLGQFDFPN-PEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .+........ ....+.......+. .....+++++.+++..|+..+|++||+++.+.+
T Consensus       214 ~~~~~~~~~~-~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         214 QGLKAATNKQ-KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SSCCSCCHHH-HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCccchhHHH-HHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            7655443221 11222111111111 112368899999999999999999999877654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-51  Score=366.71  Aligned_cols=245  Identities=21%  Similarity=0.340  Sum_probs=190.8

Q ss_pred             cceeeccccccccCCeEEEEEEEcCC-C--cEEEEEEecch--------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecC
Q psy3151          15 DDYDISTEILGLGINGKVLQIVEKKT-S--EVYALKVLHDT--------VKARREVELQLAVGSHKHIVNIKDVYENIYN   83 (372)
Q Consensus        15 ~~Y~i~~~~lG~G~~g~V~~~~~~~~-~--~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~   83 (372)
                      ++|+++ +.||+|+||+||+|++..+ +  ..||||++...        ....+|+.+ ++.++||||+++++++.+   
T Consensus         8 ~d~~~~-~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~-l~~l~H~nIv~~~g~~~~---   82 (273)
T d1u46a_           8 KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA-MHSLDHRNLIRLYGVVLT---   82 (273)
T ss_dssp             GGEEEE-EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHH-HHHCCCTTBCCEEEEECS---
T ss_pred             HHeEEE-EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHH-HHhCCCCCEEEEEEEEee---
Confidence            679996 6699999999999987533 3  46899988521        234678877 666799999999999864   


Q ss_pred             CceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccC
Q psy3151          84 GSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFG  163 (372)
Q Consensus        84 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~  163 (372)
                        ..+++||||+++|++.+.+.... +.+++..+..++.||+.||.|||++||+||||||+|||++              
T Consensus        83 --~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~--------------  145 (273)
T d1u46a_          83 --PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA--------------  145 (273)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE--------------
T ss_pred             --cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc--------------
Confidence              35789999999999999887654 4699999999999999999999999999999999999998              


Q ss_pred             CCCccccccCCCCCCCCeeeeccccccccccCCC---cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3151         164 DVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA---SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLC-GF  239 (372)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~  239 (372)
                                   .++.+||+|||+++.......   ......||..|+|||++.+..++.++|||||||++|||+| |.
T Consensus       146 -------------~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~  212 (273)
T d1u46a_         146 -------------TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ  212 (273)
T ss_dssp             -------------ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred             -------------cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCC
Confidence                         466799999999987644322   1233456778999999988899999999999999999998 89


Q ss_pred             CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         240 PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       240 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      .||.+.+..    .....+.......+  ....+++++.+||.+||..||++|||++++++
T Consensus       213 ~Pf~~~~~~----~~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         213 EPWIGLNGS----QILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CTTTTCCHH----HHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcCHH----HHHHHHHhCCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999654432    23444444433332  23578999999999999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=368.72  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=202.2

Q ss_pred             ccceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .++|++ .+.||+|+||.||+|.+.     .+++.||||++...      ....+|+.++.++.+||||+++++++..  
T Consensus        22 ~~~~~l-~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--   98 (311)
T d1t46a_          22 RNRLSF-GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (311)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             HHHeEE-eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence            489998 588999999999999863     56789999999632      2345788886666689999999999875  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhcc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKE----------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENL  146 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~----------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NI  146 (372)
                        +..+|+|||||++|+|.+++....                ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus        99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI  176 (311)
T d1t46a_          99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (311)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence              567899999999999999997643                13589999999999999999999999999999999999


Q ss_pred             eeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCCCCCccc
Q psy3151         147 LYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDKYDKSCD  224 (372)
Q Consensus       147 li~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~D  224 (372)
                      +++                           ..+.+|++|||+++.......  .....+||+.|+|||++....++.++|
T Consensus       177 l~~---------------------------~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  229 (311)
T d1t46a_         177 LLT---------------------------HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD  229 (311)
T ss_dssp             EEE---------------------------TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred             ccc---------------------------ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCccc
Confidence            998                           567899999999987654332  233467899999999998899999999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc
Q psy3151         225 IWSLGVIMYILLC-GFPPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME  300 (372)
Q Consensus       225 iwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~  300 (372)
                      ||||||++|||+| |.+||......   ..+...+..+...   .....+++++.+||.+||+.||++|||++++++
T Consensus       230 IwS~G~~l~ellt~g~p~~~~~~~~---~~~~~~i~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         230 VWSYGIFLWELFSLGSSPYPGMPVD---SKFYKMIKEGFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHHHHHTTTCCSSTTCCSS---HHHHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999998 55555443322   2233333333222   222468999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-50  Score=367.34  Aligned_cols=247  Identities=19%  Similarity=0.341  Sum_probs=201.7

Q ss_pred             ccceeeccccccccCCeEEEEEEEc-----CCCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeec
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEK-----KTSEVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIY   82 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~   82 (372)
                      .++|+++ +.||+|+||+||+|++.     .+++.||||++...      ....+|+.+ ++.++||||+++++++..  
T Consensus        12 ~~~~~~~-~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~i-l~~l~h~niv~~~~~~~~--   87 (301)
T d1lufa_          12 RNNIEYV-RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL-MAEFDNPNIVKLLGVCAV--   87 (301)
T ss_dssp             GGGCEEE-EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHH-HHTCCCTTBCCEEEEECS--
T ss_pred             HHHcEEe-EEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHH-HHhcCCCCcccceeeecc--
Confidence            5789995 67999999999999975     35689999998632      245678887 677899999999999875  


Q ss_pred             CCceEEEEEEeccCCCchhHHHHhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q psy3151          83 NGSRCLLVIMECMHGGELFQRIQQKE----------------------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRD  140 (372)
Q Consensus        83 ~~~~~~~lv~e~~~~g~L~~~i~~~~----------------------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrD  140 (372)
                        ....+++|||+.+|+|.+++....                      ...+++..+..++.||+.||+|||++||||||
T Consensus        88 --~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          88 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             --CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence              567899999999999999997532                      12489999999999999999999999999999


Q ss_pred             CCCCceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCC--cccccccCCCcCCCcccCCCC
Q psy3151         141 VKPENLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA--SLQTPCYTPYYVAPEVLGPDK  218 (372)
Q Consensus       141 lkp~NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~  218 (372)
                      |||+|||++                           .++.+||+|||+|+.......  ...+.+||+.|+|||.+.+..
T Consensus       166 lKp~NILld---------------------------~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  218 (301)
T d1lufa_         166 LATRNCLVG---------------------------ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR  218 (301)
T ss_dssp             CSGGGEEEC---------------------------GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred             EcccceEEC---------------------------CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC
Confidence            999999998                           567799999999986644322  234567899999999999999


Q ss_pred             CCCccchhhHHHHHHHHHhCC-CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhH
Q psy3151         219 YDKSCDIWSLGVIMYILLCGF-PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQ  297 (372)
Q Consensus       219 ~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~e  297 (372)
                      |+.++|||||||++|||++|. +||.+.+.    ..+...+..+...   +....+++++.+||.+||+.||++|||+.|
T Consensus       219 ~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~----~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~e  291 (301)
T d1lufa_         219 YTTESDVWAYGVVLWEIFSYGLQPYYGMAH----EEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCS  291 (301)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CChhhhhccchhhHHHHHccCCCCCCCCCH----HHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            999999999999999999985 67755432    3344555555432   122478999999999999999999999999


Q ss_pred             Hhc
Q psy3151         298 VME  300 (372)
Q Consensus       298 il~  300 (372)
                      +++
T Consensus       292 v~~  294 (301)
T d1lufa_         292 IHR  294 (301)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            965

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-50  Score=366.56  Aligned_cols=263  Identities=18%  Similarity=0.269  Sum_probs=210.9

Q ss_pred             ccCCCccCCcccceeeccccccccCCeEEEEEEEcC-----CCcEEEEEEecch------hhhHHHHHHHHHhcCCCCEe
Q psy3151           4 TFKPFKTTPIQDDYDISTEILGLGINGKVLQIVEKK-----TSEVYALKVLHDT------VKARREVELQLAVGSHKHIV   72 (372)
Q Consensus         4 ~~~~~~~~~~~~~Y~i~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~   72 (372)
                      -|.|.+-+-..++|++ .+.||+|+||+||+|.+..     ++..||||+++..      ....+|+.+ ++.++||||+
T Consensus         9 ~~~~~~~ei~~~~~~l-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~i-l~~l~h~nIv   86 (308)
T d1p4oa_           9 VYVPDEWEVAREKITM-SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV-MKEFNCHHVV   86 (308)
T ss_dssp             CCCCCTTBCCGGGEEE-EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHH-GGGCCCTTBC
T ss_pred             CcCccceeecHHHeEE-eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHH-HHHcCCCCEe
Confidence            4566655555689998 5779999999999998853     4678999999632      134578877 6777999999


Q ss_pred             EEeEeeeeecCCceEEEEEEeccCCCchhHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q psy3151          73 NIKDVYENIYNGSRCLLVIMECMHGGELFQRIQQKE--------DGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPE  144 (372)
Q Consensus        73 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~--------~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~  144 (372)
                      ++++++..    +...++||||+.+|+|.+++....        ...+++..+..++.|++.||.|||+++|+||||||+
T Consensus        87 ~~~~~~~~----~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~  162 (308)
T d1p4oa_          87 RLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR  162 (308)
T ss_dssp             CEEEEECS----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred             eeeeEEec----CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCC
Confidence            99999865    567899999999999999887532        134789999999999999999999999999999999


Q ss_pred             ceeeecCCCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCc--ccccccCCCcCCCcccCCCCCCCc
Q psy3151         145 NLLYTKPGDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKAS--LQTPCYTPYYVAPEVLGPDKYDKS  222 (372)
Q Consensus       145 NIli~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~  222 (372)
                      |||++                           .++.+||+|||+|+........  ....+||+.|+|||.+.+..++.+
T Consensus       163 NiLld---------------------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~  215 (308)
T d1p4oa_         163 NCMVA---------------------------EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY  215 (308)
T ss_dssp             GEEEC---------------------------TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH
T ss_pred             ceeec---------------------------CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc
Confidence            99998                           6778999999999876543322  334568999999999999999999


Q ss_pred             cchhhHHHHHHHHHhCC-CCCCCCCCCCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhc-
Q psy3151         223 CDIWSLGVIMYILLCGF-PPFFSNHGQAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVME-  300 (372)
Q Consensus       223 ~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~-  300 (372)
                      +|||||||++|||+||. +||.+.+.    ......+..+.....   ...+++++.+||.+||+.||++|||++++++ 
T Consensus       216 ~Dv~S~G~il~El~t~~~~p~~~~~~----~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         216 SDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             HHHHHHHHHHHHHHHTSCCTTTTSCH----HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccccHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999984 67754332    233444444433211   2468999999999999999999999999998 


Q ss_pred             -----CCcccc
Q psy3151         301 -----NKWISQ  306 (372)
Q Consensus       301 -----hp~~~~  306 (372)
                           +|+|++
T Consensus       289 L~~~~~~~~~~  299 (308)
T d1p4oa_         289 IKEEMEPGFRE  299 (308)
T ss_dssp             HGGGSCTTHHH
T ss_pred             HHHhcCCCCcC
Confidence                 566554

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-49  Score=360.15  Aligned_cols=254  Identities=20%  Similarity=0.252  Sum_probs=193.2

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecchh--hhHHHHHHH-HHhcCCCCEeEEeEeeeeecCCceEEEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDTV--KARREVELQ-LAVGSHKHIVNIKDVYENIYNGSRCLLV   90 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~e~~~~-~~~~~h~ni~~~~~~~~~~~~~~~~~~l   90 (372)
                      ..+|.+ ++.||+|+||+||+|++  +|+.||||++....  ...+|.+++ +..++||||+++++++.........+|+
T Consensus         2 ~~~~~l-~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVL-QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEE-EEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEE-EEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            457877 68899999999999986  58999999996433  233455543 2346899999999998765444568999


Q ss_pred             EEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCceeeecCCCCCceeeecc
Q psy3151          91 IMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD--------QNIAHRDVKPENLLYTKPGDGGILKLTDF  162 (372)
Q Consensus        91 v~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~--------~~ivHrDlkp~NIli~~~~~~~~~~~~d~  162 (372)
                      |||||++|+|.+++.+.   .+++..+..++.|++.||+|||+        +||+||||||+||||+             
T Consensus        79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-------------  142 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------------  142 (303)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-------------
T ss_pred             EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-------------
Confidence            99999999999999864   49999999999999999999996        5999999999999998             


Q ss_pred             CCCCccccccCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCCCC------CCCccchhhHHHHH
Q psy3151         163 GDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGPDK------YDKSCDIWSLGVIM  232 (372)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il  232 (372)
                                    .++.+||+|||++........    .....+||+.|+|||++.+..      ++.++|||||||++
T Consensus       143 --------------~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl  208 (303)
T d1vjya_         143 --------------KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF  208 (303)
T ss_dssp             --------------TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred             --------------CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHH
Confidence                          677899999999987644322    234568999999999986543      56789999999999


Q ss_pred             HHHHhCCCCCCCCCCCCC----------C-HhHHHHHhhCCccCCCCc-c--cccCHHHHHHHHHhccCCCCCCCChhHH
Q psy3151         233 YILLCGFPPFFSNHGQAI----------S-PGMKNRIRLGQFDFPNPE-W--EHVSQEAKTLIKNMLCVDPSERLTIDQV  298 (372)
Q Consensus       233 ~~ll~g~~pf~~~~~~~~----------~-~~~~~~~~~~~~~~~~~~-~--~~~s~~~~~li~~ll~~dP~~R~s~~ei  298 (372)
                      |||+||..||........          . ..+...........+.+. +  .....++.+|+.+||+.||++|||+.|+
T Consensus       209 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei  288 (303)
T d1vjya_         209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  288 (303)
T ss_dssp             HHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred             HHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence            999999988754332211          1 122223322232211111 1  1233568899999999999999999999


Q ss_pred             hc
Q psy3151         299 ME  300 (372)
Q Consensus       299 l~  300 (372)
                      ++
T Consensus       289 ~~  290 (303)
T d1vjya_         289 KK  290 (303)
T ss_dssp             HH
T ss_pred             HH
Confidence            77

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-49  Score=361.69  Aligned_cols=243  Identities=18%  Similarity=0.261  Sum_probs=193.6

Q ss_pred             cccccccCCeEEEEEEEcCCC---cEEEEEEecch------hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEEEEE
Q psy3151          21 TEILGLGINGKVLQIVEKKTS---EVYALKVLHDT------VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCLLVI   91 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~------~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~~lv   91 (372)
                      .++||+|+||+||+|.+..++   ..||||++...      ....+|+++ ++.++||||+++++++..   .+..+++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~~~g~~~~---~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-MKDFSHPNVLSLLGICLR---SEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHH-HHTCCCTTBCCCCEEEEE---TTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHH-HHhCCCCCEeEEeEEEEe---cCCceEEE
Confidence            467999999999999986654   36899998631      345678877 677799999999998753   24578999


Q ss_pred             EeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCceeeeccCCCCccccc
Q psy3151          92 MECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGILKLTDFGDVKPENLL  171 (372)
Q Consensus        92 ~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~~~~d~~~~~~~~~~  171 (372)
                      ||||++|+|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||++                      
T Consensus       108 ~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~----------------------  164 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----------------------  164 (311)
T ss_dssp             EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----------------------
T ss_pred             EEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC----------------------
Confidence            99999999999887643 4688999999999999999999999999999999999998                      


Q ss_pred             cCCCCCCCCeeeeccccccccccCCC----cccccccCCCcCCCcccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q psy3151         172 YTKPGDGGILKLTDFGFAKKIVSNKA----SLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVIMYILLCGFPPFFSNHG  247 (372)
Q Consensus       172 ~~~~~~~~~~ki~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  247 (372)
                           .++.+||+|||+++.......    ......||+.|+|||.+....++.++|||||||++|||++|..||.....
T Consensus       165 -----~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~  239 (311)
T d1r0pa_         165 -----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  239 (311)
T ss_dssp             -----TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred             -----CCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC
Confidence                 567899999999987644322    12235678999999999888999999999999999999998777754332


Q ss_pred             CCCCHhHHHHHhhCCccCCCCcccccCHHHHHHHHHhccCCCCCCCChhHHhcC
Q psy3151         248 QAISPGMKNRIRLGQFDFPNPEWEHVSQEAKTLIKNMLCVDPSERLTIDQVMEN  301 (372)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ll~~dP~~R~s~~eil~h  301 (372)
                      ..   .+...+..+.....   ...+++++.+||.+||+.||++|||+.|+++|
T Consensus       240 ~~---~~~~~i~~g~~~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         240 TF---DITVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ------CHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH---HHHHHHHcCCCCCC---cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            21   22333443332211   14689999999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-48  Score=364.70  Aligned_cols=273  Identities=22%  Similarity=0.314  Sum_probs=196.7

Q ss_pred             ccCCcc-cceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHh----------cCCCCEeE
Q psy3151           9 KTTPIQ-DDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAV----------GSHKHIVN   73 (372)
Q Consensus         9 ~~~~~~-~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~----------~~h~ni~~   73 (372)
                      ...+|. +||+++ +.||+|+||+||+|++..+|+.||||+++..    ....+|+.++..+          ..|+||++
T Consensus         6 ~g~~~~~~rY~i~-~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~   84 (362)
T d1q8ya_           6 KGEPYKDARYILV-RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   84 (362)
T ss_dssp             TTCEETTTTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CCCCccCCcEEEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence            344565 579995 7799999999999999999999999999753    3445677664333          24789999


Q ss_pred             EeEeeeeecCCceEEEEEEeccCCC-chhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceeeecC
Q psy3151          74 IKDVYENIYNGSRCLLVIMECMHGG-ELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHD-QNIAHRDVKPENLLYTKP  151 (372)
Q Consensus        74 ~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~-~~ivHrDlkp~NIli~~~  151 (372)
                      +++++....  ....+++++++..+ +............+++..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus        85 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          85 LLDHFNHKG--PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCEEEEEEE--TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEeeecc--ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            999886532  33455555555443 33344444445679999999999999999999998 899999999999999854


Q ss_pred             CCCCceeeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCCcccCCCCCCCccchhhHHHH
Q psy3151         152 GDGGILKLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAPEVLGPDKYDKSCDIWSLGVI  231 (372)
Q Consensus       152 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  231 (372)
                      +...                     ....++++|||.|.....   .....+||+.|+|||++....|+.++||||+||+
T Consensus       163 ~~~~---------------------~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  218 (362)
T d1q8ya_         163 DSPE---------------------NLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACL  218 (362)
T ss_dssp             ETTT---------------------TEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHH
T ss_pred             Cccc---------------------ccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHH
Confidence            3210                     123489999999876533   3355678999999999988999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCHh---HHHHH-hhCCc----------------------cC--------------CCCccc
Q psy3151         232 MYILLCGFPPFFSNHGQAISPG---MKNRI-RLGQF----------------------DF--------------PNPEWE  271 (372)
Q Consensus       232 l~~ll~g~~pf~~~~~~~~~~~---~~~~~-~~~~~----------------------~~--------------~~~~~~  271 (372)
                      +++|++|+.||...........   +...+ ..+..                      ..              ......
T Consensus       219 l~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
T d1q8ya_         219 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK  298 (362)
T ss_dssp             HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH
T ss_pred             HHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCc
Confidence            9999999999975543221110   00000 00000                      00              001113


Q ss_pred             ccCHHHHHHHHHhccCCCCCCCChhHHhcCCccccCC
Q psy3151         272 HVSQEAKTLIKNMLCVDPSERLTIDQVMENKWISQFN  308 (372)
Q Consensus       272 ~~s~~~~~li~~ll~~dP~~R~s~~eil~hp~~~~~~  308 (372)
                      ..++++.|||.+||++||.+||||+|+|+||||++..
T Consensus       299 ~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         299 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             ccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence            4568899999999999999999999999999999654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.2e-25  Score=190.57  Aligned_cols=155  Identities=16%  Similarity=0.159  Sum_probs=111.5

Q ss_pred             cccccccCCeEEEEEEEcCCCcEEEEEEecch-----------------------hhhHHHHHHHHHhcCCCCEeEEeEe
Q psy3151          21 TEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----------------------VKARREVELQLAVGSHKHIVNIKDV   77 (372)
Q Consensus        21 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------------~~~~~e~~~~~~~~~h~ni~~~~~~   77 (372)
                      ++.||+|+||+||+|.+. +|+.||||+++..                       ....+|... +..+.|.+++..+++
T Consensus         5 g~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~v~~~~~~   82 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA-LQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH-HHHTTTSSSCCEEEE
T ss_pred             CCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHH-HHHccCCCcceEEEe
Confidence            788999999999999985 7999999987421                       112234444 455678898887764


Q ss_pred             eeeecCCceEEEEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceeeecCCCCCce
Q psy3151          78 YENIYNGSRCLLVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLHDQNIAHRDVKPENLLYTKPGDGGIL  157 (372)
Q Consensus        78 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH~~~ivHrDlkp~NIli~~~~~~~~~  157 (372)
                      ..        .+++|||+.+..+.+         +++..+..++.|++.+|.|||++||+||||||+|||++        
T Consensus        83 ~~--------~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~--------  137 (191)
T d1zara2          83 EG--------NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--------  137 (191)
T ss_dssp             ET--------TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE--------
T ss_pred             cC--------CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee--------
Confidence            32        268999998765432         56667788999999999999999999999999999997        


Q ss_pred             eeeccCCCCccccccCCCCCCCCeeeeccccccccccCCCcccccccCCCcCCC------cccCCCCCCCccchhhHHHH
Q psy3151         158 KLTDFGDVKPENLLYTKPGDGGILKLTDFGFAKKIVSNKASLQTPCYTPYYVAP------EVLGPDKYDKSCDIWSLGVI  231 (372)
Q Consensus       158 ~~~d~~~~~~~~~~~~~~~~~~~~ki~Dfg~a~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwslG~i  231 (372)
                                         + ..++++|||+|.....+...  .      |...      +.+ ...|+.++|+||+.--
T Consensus       138 -------------------~-~~~~liDFG~a~~~~~~~~~--~------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         138 -------------------E-EGIWIIDFPQSVEVGEEGWR--E------ILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             -------------------T-TEEEECCCTTCEETTSTTHH--H------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             -------------------C-CCEEEEECCCcccCCCCCcH--H------HHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence                               2 23788999998765322110  0      1110      111 2568899999996543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.41  E-value=1.1e-06  Score=75.70  Aligned_cols=105  Identities=15%  Similarity=0.160  Sum_probs=63.9

Q ss_pred             ccceeeccccccccCCeEEEEEEEcCCCcEEEEEEecch-----hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCceEE
Q psy3151          14 QDDYDISTEILGLGINGKVLQIVEKKTSEVYALKVLHDT-----VKARREVELQLAVGSHKHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        14 ~~~Y~i~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~~~~   88 (372)
                      ...|+++ +..+.|+.+.||+..  .+++.+++|+....     ....+|...+..+..+--+.+++.+.+.    ++..
T Consensus        13 ~~~~~~~-~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~----~~~~   85 (263)
T d1j7la_          13 IEKYRCV-KDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH----DGWS   85 (263)
T ss_dssp             HTTSEEE-ECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE----TTEE
T ss_pred             hhceEEE-EcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec----CCce
Confidence            3566664 434455567899875  45777889988533     2345677765445444345666666554    5678


Q ss_pred             EEEEeccCCCchhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy3151          89 LVIMECMHGGELFQRIQQKEDGAFTEREAAIIMNEICSAIKFLH  132 (372)
Q Consensus        89 ~lv~e~~~~g~L~~~i~~~~~~~l~~~~~~~i~~qil~~l~~LH  132 (372)
                      |+||++++|.++.+...       +......++.++...+..||
T Consensus        86 ~lv~~~l~G~~~~~~~~-------~~~~~~~~~~~l~~~l~~lH  122 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFH  122 (263)
T ss_dssp             EEEEECCSSEEHHHHTT-------TCSCHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeccccccccccc-------ccccHHHHHHHHHHHHHHHh
Confidence            99999999887755432       11122334555555666666

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.90  E-value=1.9e-05  Score=72.13  Aligned_cols=72  Identities=17%  Similarity=0.179  Sum_probs=44.6

Q ss_pred             cccccCCeEEEEEEEcCCCcEEEEEEecc------------hhhhHHHHHHHHHhcCC--CCEeEEeEeeeeecCCceEE
Q psy3151          23 ILGLGINGKVLQIVEKKTSEVYALKVLHD------------TVKARREVELQLAVGSH--KHIVNIKDVYENIYNGSRCL   88 (372)
Q Consensus        23 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------------~~~~~~e~~~~~~~~~h--~ni~~~~~~~~~~~~~~~~~   88 (372)
                      -||.|....||++.+..+++.++||.-..            ..+...|.+.+.....+  ..+++++.+-      ....
T Consensus        33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d------~~~~  106 (392)
T d2pula1          33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD------TEMA  106 (392)
T ss_dssp             ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE------TTTT
T ss_pred             EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc------CCCC
Confidence            48999999999999888889999997531            12345677775444443  2345554432      2234


Q ss_pred             EEEEeccCCCch
Q psy3151          89 LVIMECMHGGEL  100 (372)
Q Consensus        89 ~lv~e~~~~g~L  100 (372)
                      ++|||++.+..+
T Consensus       107 ~lvmE~L~~~~~  118 (392)
T d2pula1         107 VTVMEDLSHLKI  118 (392)
T ss_dssp             EEEECCCTTSEE
T ss_pred             EEEEeccCCccc
Confidence            689999976543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.66  E-value=0.00012  Score=62.01  Aligned_cols=72  Identities=13%  Similarity=0.137  Sum_probs=45.2

Q ss_pred             ccccC-CeEEEEEEEcCCCcEEEEEEecchh--hhHHHHHHHHHhcCC-CCEeEEeEeeeeecCCceEEEEEEeccCCCc
Q psy3151          24 LGLGI-NGKVLQIVEKKTSEVYALKVLHDTV--KARREVELQLAVGSH-KHIVNIKDVYENIYNGSRCLLVIMECMHGGE   99 (372)
Q Consensus        24 lG~G~-~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~e~~~~~~~~~h-~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~   99 (372)
                      +..|. -+.||++.. .++..+++|......  ...+|.+.+..+..+ -.+.+++.+..+    ++..++||++++|.+
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~----~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE----AGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC----SSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc----ccceEEEEEeeeccc
Confidence            44444 467898875 457778899875332  345677664333332 224556665443    456789999998866


Q ss_pred             h
Q psy3151         100 L  100 (372)
Q Consensus       100 L  100 (372)
                      +
T Consensus        93 ~   93 (255)
T d1nd4a_          93 L   93 (255)
T ss_dssp             T
T ss_pred             c
Confidence            5

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.34  E-value=0.0096  Score=53.51  Aligned_cols=75  Identities=9%  Similarity=0.078  Sum_probs=47.9

Q ss_pred             ceeeccccccccCCeEEEEEEEcC-------CCcEEEEEEecch---hhhHHHHHHHHHhcCCCCEeEEeEeeeeecCCc
Q psy3151          16 DYDISTEILGLGINGKVLQIVEKK-------TSEVYALKVLHDT---VKARREVELQLAVGSHKHIVNIKDVYENIYNGS   85 (372)
Q Consensus        16 ~Y~i~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~ni~~~~~~~~~~~~~~   85 (372)
                      ..+|  +.|+.|..-.+|++....       ..+.|.+++.-..   ....+|..++..+..+.=.++++.++.+     
T Consensus        44 ~l~v--~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-----  116 (395)
T d1nw1a_          44 HLRI--SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG-----  116 (395)
T ss_dssp             GEEE--EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred             ceEE--EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----
Confidence            3444  458899999999998753       3467888876422   2344677765444444333567776642     


Q ss_pred             eEEEEEEeccCCCch
Q psy3151          86 RCLLVIMECMHGGEL  100 (372)
Q Consensus        86 ~~~~lv~e~~~~g~L  100 (372)
                         .+|+||++|..|
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               478999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.99  E-value=0.0088  Score=52.22  Aligned_cols=71  Identities=10%  Similarity=0.188  Sum_probs=38.3

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEecch----hhhHHHHHHHHHhcCC-CCEeEEeEee-eeecCCceEEEEEEeccCCCc
Q psy3151          28 INGKVLQIVEKKTSEVYALKVLHDT----VKARREVELQLAVGSH-KHIVNIKDVY-ENIYNGSRCLLVIMECMHGGE   99 (372)
Q Consensus        28 ~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h-~ni~~~~~~~-~~~~~~~~~~~lv~e~~~~g~   99 (372)
                      .--.||++.. .+|..|++|+.+..    .....|...+..+..+ --++..+..- ......+...+.+++++.|..
T Consensus        34 ~EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          34 YENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ccceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            3468999877 47888999998632    2344566554444322 1111111110 011112456788899987643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=92.67  E-value=0.015  Score=50.23  Aligned_cols=26  Identities=8%  Similarity=0.199  Sum_probs=16.8

Q ss_pred             ccccCCeEEEEEEEcCCCcEEEEEEecc
Q psy3151          24 LGLGINGKVLQIVEKKTSEVYALKVLHD   51 (372)
Q Consensus        24 lG~G~~g~V~~~~~~~~~~~vaiK~~~~   51 (372)
                      |..|.--+.|++... +| .+++|+++.
T Consensus        26 i~~G~~N~ny~v~t~-~g-~yVLri~~~   51 (316)
T d2ppqa1          26 IAEGVENSNFLLHTT-KD-PLILTLYEK   51 (316)
T ss_dssp             ECC---EEEEEEEES-SC-CEEEEEECC
T ss_pred             CCCCcccCeEEEEEC-CC-cEEEEEcCC
Confidence            456777888998764 34 489999864